Citrus Sinensis ID: 023568

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280
Protein Sequence
MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDPTC
Secondary Structure (PSIPRED)
cccccccccccccccccccccccEEEEcccHHcHHHHHHHccccccHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccHHHHHccccccccHHHHHHHHHHHHHHHccccccccccHHHHHHHHHcccccccHHHHcccccHHHHHHHHHcccccccccccccccccHHHHHHHHHHHcccccccccHHHHHcccccccccccccccccccccccccccccccHHHHHHHHHHHHHHccccccc
Secondary Structure Prediction (SSPRO)
cccccEccEEEEEccccccccccEEEEEEcccEEHHHHHccccccHHHHHHHHHHHHHHHHHHHHHcccccccccHHHEEEcccccEEEccccccccccHccccccccccHHHccHHHcccEcccccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHccccHHHHcccccHHHHHHHHcccccccccHHHHcccccHHHHHHHHHHccccccccccHHHHHccHHHcccccHHHccccccccccccccccccHHHHHHHHHHHHccccccccc
Coil and Loop (DISEMBL)
MEHENVIAIkdiirppkkdtfndVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYvhsasvlhrdlkpsnlllnascdlkigdfglarttsetdfMTEYVVTrwyrapelllncteyTAAIDIWSVGCIlgeimtreplfpgkdyvHQLRLITELigspddaslgflrsdnARRYVRqlprcrkqqfatrfpnkssgAVDLLEKMlvfdpnkritveealrhpylqslhdlndepvcprpfhfdfehsscteDHIRELIWResvkfnpdptc
Flexible Loop (DISEMBL)
mehenviaikdiirppkkdtfNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFglarttsetdfMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELigspddaslgflRSDNARRYVRQLprcrkqqfatrfpnkssgavDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIwresvkfnpdptc
Low Complexity Region (SEG)
MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDPTC
Disordered region (IsUnstruct)
*****VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESV********
Disordered Region (DISOPRED)
MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP******FATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP****
Disordered Region (DISEMBL)
MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDPTC
Disordered Region (DISPRO)
*EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP****
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDPTC
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	280	2.2.26 [Sep-21-2011]
Q39024	376	Mitogen-activated protein	yes	no	0.985	0.734	0.836	1e-139
Q5J4W4	394	Mitogen-activated protein	yes	no	0.992	0.705	0.820	1e-137
Q40353	371	Mitogen-activated protein	N/A	no	0.992	0.749	0.816	1e-137
Q336X9	376	Mitogen-activated protein	no	no	0.992	0.739	0.809	1e-136
Q9LMM5	369	Mitogen-activated protein	no	no	0.985	0.747	0.833	1e-135
Q8GYQ5	372	Mitogen-activated protein	no	no	0.989	0.744	0.779	1e-131
Q39025	376	Mitogen-activated protein	no	no	0.996	0.742	0.774	1e-129
Q40531	371	Mitogen-activated protein	N/A	no	0.989	0.746	0.754	1e-126
Q9LQQ9	363	Mitogen-activated protein	no	no	0.978	0.754	0.737	1e-121
Q06060	394	Mitogen-activated protein	N/A	no	0.985	0.700	0.707	1e-120

>sp|Q39024|MPK4_ARATH Mitogen-activated protein kinase 4 OS=Arabidopsis thaliana GN=MPK4 PE=1 SV=2

 Score =  495 bits (1275), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 231/276 (83%), Positives = 260/276 (94%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           M+HENVIA+KDII+PP+++ FNDVYIVYELMDTDLHQIIRS+Q LTDDHC++FLYQLLRG
Sbjct: 97  MDHENVIAVKDIIKPPQRENFNDVYIVYELMDTDLHQIIRSNQPLTDDHCRFFLYQLLRG 156

Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 120
           LKYVHSA+VLHRDLKPSNLLLNA+CDLK+GDFGLART SETDFMTEYVVTRWYRAPELLL
Sbjct: 157 LKYVHSANVLHRDLKPSNLLLNANCDLKLGDFGLARTKSETDFMTEYVVTRWYRAPELLL 216

Query: 121 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 180
           NC+EYTAAIDIWSVGCILGE MTREPLFPGKDYVHQLRLITELIGSPDD+SLGFLRSDNA
Sbjct: 217 NCSEYTAAIDIWSVGCILGETMTREPLFPGKDYVHQLRLITELIGSPDDSSLGFLRSDNA 276

Query: 181 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 240
           RRYVRQLP+  +Q FA RFPN S+GAVDLLEKMLVFDP++RITV+EAL HPYL  LHD+N
Sbjct: 277 RRYVRQLPQYPRQNFAARFPNMSAGAVDLLEKMLVFDPSRRITVDEALCHPYLAPLHDIN 336

Query: 241 DEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 276
           +EPVC RPF+FDFE  + TE++I+ELI+RE+VKFNP
Sbjct: 337 EEPVCVRPFNFDFEQPTLTEENIKELIYRETVKFNP 372

Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1. Involved in root hair development process. Negative regulator of systemic acquired resistance (SAR) and salicylic acid- (SA) mediated defense response. Required for jasmonic acid- (JA) mediated defense gene expression. May regulate activity of transcription factor controlling pathogenesis-related (PR) gene expression. Seems to act independently of the SAR regulatory protein NPR1 (Nonexpresser of PR1). Phosphorylates MKS1 and transcription factors WRKY25 and WRKY33. May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6). May act as negative regulator of salt tolerance.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 4

>sp|Q5J4W4|MPK2_ORYSJ Mitogen-activated protein kinase 2 OS=Oryza sativa subsp. japonica GN=MPK2 PE=2 SV=1

 Score =  488 bits (1257), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 228/278 (82%), Positives = 257/278 (92%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           M+H+NVI+IKDIIRPP+++ FNDVYIVYELMDTDLH ++RS+Q LTDDHCQYFLYQ+LRG
Sbjct: 115 MDHDNVISIKDIIRPPRRENFNDVYIVYELMDTDLHHLLRSNQPLTDDHCQYFLYQVLRG 174

Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 120
           LKYVHSA+VLHRDL+PSNLLLNA CDLKIGDFGLARTT+ETDFM EYVVTRWYRAPELLL
Sbjct: 175 LKYVHSANVLHRDLRPSNLLLNAKCDLKIGDFGLARTTNETDFMMEYVVTRWYRAPELLL 234

Query: 121 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 180
           NC+EYTAAIDIWSVGCILGEI+TREPLFPGKDYVHQLRLITELIGSPDD+SLGFLRSDNA
Sbjct: 235 NCSEYTAAIDIWSVGCILGEIVTREPLFPGKDYVHQLRLITELIGSPDDSSLGFLRSDNA 294

Query: 181 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 240
           RRYVR LP+  KQQF  RFP  SSGA+DLLE+MLVFDP+KRITV+EAL HPYL SLH++ 
Sbjct: 295 RRYVRSLPQYPKQQFRARFPTMSSGAMDLLERMLVFDPSKRITVDEALCHPYLASLHEIY 354

Query: 241 DEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           DEPVCP PF FDFE  S TE+ I+E+IWRE++KFNP+P
Sbjct: 355 DEPVCPAPFSFDFEQPSLTEEDIKEIIWREALKFNPEP 392

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q40353|MMK2_MEDSA Mitogen-activated protein kinase homolog MMK2 OS=Medicago sativa GN=MMK2 PE=2 SV=1

 Score =  487 bits (1254), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 227/278 (81%), Positives = 257/278 (92%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           M+HENV++IKDIIRPP+K+ FN VYIV ELMDTDLHQIIRS+Q +TDDHC+YF+YQLLRG
Sbjct: 91  MDHENVMSIKDIIRPPQKENFNHVYIVSELMDTDLHQIIRSNQPMTDDHCRYFVYQLLRG 150

Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 120
           LKYVHSA+VLHRDLKPSNLLLNA+CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL
Sbjct: 151 LKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 210

Query: 121 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 180
           NC++YTAAIDIWSVGCILGEI+TR+PLFPG+DYVHQLRL+TELIGSPDDASLGFLRS+NA
Sbjct: 211 NCSDYTAAIDIWSVGCILGEIVTRQPLFPGRDYVHQLRLVTELIGSPDDASLGFLRSENA 270

Query: 181 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 240
           RRYVRQLP+  KQ F+ RFPN S GAVDLLEKML+FDP+KRI V+EAL HPY+  LHD+N
Sbjct: 271 RRYVRQLPQYPKQNFSARFPNMSPGAVDLLEKMLIFDPSKRIKVDEALCHPYMAPLHDIN 330

Query: 241 DEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +EPVC RPF FDFE    TE+ I+ELIW+ESV+FNPDP
Sbjct: 331 EEPVCARPFSFDFEEPMFTEEDIKELIWKESVRFNPDP 368

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q336X9|MPK6_ORYSJ Mitogen-activated protein kinase 6 OS=Oryza sativa subsp. japonica GN=MPK6 PE=2 SV=1

 Score =  486 bits (1250), Expect = e-136,   Method: Compositional matrix adjust.
 Identities = 225/278 (80%), Positives = 255/278 (91%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           M+HEN+IAIKDIIRPP++D FNDVYIV ELMDTDLHQIIRS+Q LTDDHCQYFLYQLLRG
Sbjct: 97  MDHENIIAIKDIIRPPRRDNFNDVYIVSELMDTDLHQIIRSNQPLTDDHCQYFLYQLLRG 156

Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 120
           LKYVHSA+VLHRDLKPSNL LNA+CDLKI DFGLARTT+ETD MTEYVVTRWYRAPELLL
Sbjct: 157 LKYVHSANVLHRDLKPSNLFLNANCDLKIADFGLARTTTETDLMTEYVVTRWYRAPELLL 216

Query: 121 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 180
           NC++YTAAID+WSVGCILGEI+TR+PLFPG+DY+ QL+LITELIGSPDD+SLGFLRSDNA
Sbjct: 217 NCSQYTAAIDVWSVGCILGEIVTRQPLFPGRDYIQQLKLITELIGSPDDSSLGFLRSDNA 276

Query: 181 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 240
           RRY++QLP+  +Q F  RF N S+GAVDLLEKMLVFDP++RITV+EAL HPYL SLHD+N
Sbjct: 277 RRYMKQLPQYPRQDFRLRFRNMSAGAVDLLEKMLVFDPSRRITVDEALHHPYLASLHDIN 336

Query: 241 DEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +EP CP PF FDFE  S TE+HI+ELIWRES+ FNPDP
Sbjct: 337 EEPTCPAPFSFDFEQPSFTEEHIKELIWRESLAFNPDP 374

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q9LMM5|MPK11_ARATH Mitogen-activated protein kinase 11 OS=Arabidopsis thaliana GN=MPK11 PE=1 SV=1

 Score =  481 bits (1239), Expect = e-135,   Method: Compositional matrix adjust.
 Identities = 230/276 (83%), Positives = 253/276 (91%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           M+H+NVIAI DIIRPP+ D FNDV+IVYELMDTDLH IIRS+Q LTDDH ++FLYQLLRG
Sbjct: 94  MDHDNVIAIIDIIRPPQPDNFNDVHIVYELMDTDLHHIIRSNQPLTDDHSRFFLYQLLRG 153

Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 120
           LKYVHSA+VLHRDLKPSNLLLNA+CDLKIGDFGLART SETDFMTEYVVTRWYRAPELLL
Sbjct: 154 LKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTKSETDFMTEYVVTRWYRAPELLL 213

Query: 121 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 180
           NC+EYTAAIDIWSVGCILGEIMTREPLFPG+DYV QLRLITELIGSPDD+SLGFLRSDNA
Sbjct: 214 NCSEYTAAIDIWSVGCILGEIMTREPLFPGRDYVQQLRLITELIGSPDDSSLGFLRSDNA 273

Query: 181 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 240
           RRYVRQLP+  +Q FA RFPN S  AVDLL+KMLVFDPN+RITV+EAL HPYL  LH+ N
Sbjct: 274 RRYVRQLPQYPRQNFAARFPNMSVNAVDLLQKMLVFDPNRRITVDEALCHPYLAPLHEYN 333

Query: 241 DEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 276
           +EPVC RPFHFDFE  S TE++I+ELI+RESVKFNP
Sbjct: 334 EEPVCVRPFHFDFEQPSLTEENIKELIYRESVKFNP 369

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q8GYQ5|MPK12_ARATH Mitogen-activated protein kinase 12 OS=Arabidopsis thaliana GN=MPK12 PE=1 SV=1

 Score =  466 bits (1199), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 216/277 (77%), Positives = 249/277 (89%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           M+HENVI IKDI+RPP++D FNDVYIVYELMDTDL +I+RS+Q LT D C++ +YQLLRG
Sbjct: 95  MDHENVITIKDIVRPPQRDIFNDVYIVYELMDTDLQRILRSNQTLTSDQCRFLVYQLLRG 154

Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 120
           LKYVHSA++LHRDL+PSN+LLN+  +LKIGDFGLARTTS+TDFMTEYVVTRWYRAPELLL
Sbjct: 155 LKYVHSANILHRDLRPSNVLLNSKNELKIGDFGLARTTSDTDFMTEYVVTRWYRAPELLL 214

Query: 121 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 180
           NC+EYTAAIDIWSVGCILGEIMT +PLFPGKDYVHQLRLITEL+GSPD++SLGFLRSDNA
Sbjct: 215 NCSEYTAAIDIWSVGCILGEIMTGQPLFPGKDYVHQLRLITELVGSPDNSSLGFLRSDNA 274

Query: 181 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 240
           RRYVRQLPR  KQQFA RFP   + A+DLLE+MLVFDPN+RI+V+EAL H YL   HD+ 
Sbjct: 275 RRYVRQLPRYPKQQFAARFPKMPTTAIDLLERMLVFDPNRRISVDEALGHAYLSPHHDVA 334

Query: 241 DEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPD 277
            EPVC  PF FDFEH SCTE+HI+ELI++ESVKFNPD
Sbjct: 335 KEPVCSTPFSFDFEHPSCTEEHIKELIYKESVKFNPD 371

Negative regulator of the auxin transduction signaling pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q39025|MPK5_ARATH Mitogen-activated protein kinase 5 OS=Arabidopsis thaliana GN=MPK5 PE=2 SV=2

 Score =  461 bits (1185), Expect = e-129,   Method: Compositional matrix adjust.
 Identities = 216/279 (77%), Positives = 247/279 (88%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           +EHENV+ IKDIIRPPKK+ F DVYIV+ELMDTDLHQIIRS+Q L DDHCQYFLYQ+LRG
Sbjct: 97  LEHENVVVIKDIIRPPKKEDFVDVYIVFELMDTDLHQIIRSNQSLNDDHCQYFLYQILRG 156

Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 120
           LKY+HSA+VLHRDLKPSNLLLN++CDLKI DFGLARTTSET++MTEYVVTRWYRAPELLL
Sbjct: 157 LKYIHSANVLHRDLKPSNLLLNSNCDLKITDFGLARTTSETEYMTEYVVTRWYRAPELLL 216

Query: 121 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 180
           N +EYT+AID+WSVGCI  EIMTREPLFPGKDYVHQL+LITELIGSPD ASL FLRS NA
Sbjct: 217 NSSEYTSAIDVWSVGCIFAEIMTREPLFPGKDYVHQLKLITELIGSPDGASLEFLRSANA 276

Query: 181 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 240
           R+YV++LP+  +Q F+ RFP+ +S A+DLLEKMLVFDP KRITVEEAL +PYL +LHDLN
Sbjct: 277 RKYVKELPKFPRQNFSARFPSMNSTAIDLLEKMLVFDPVKRITVEEALCYPYLSALHDLN 336

Query: 241 DEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDPT 279
           DEPVC   F F FE  S TE+ I+EL+W ESVKFNP P+
Sbjct: 337 DEPVCSNHFSFHFEDPSSTEEEIKELVWLESVKFNPLPS 375

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q40531|NTF6_TOBAC Mitogen-activated protein kinase homolog NTF6 OS=Nicotiana tabacum GN=NTF6 PE=2 SV=1

 Score =  449 bits (1156), Expect = e-126,   Method: Compositional matrix adjust.
 Identities = 209/277 (75%), Positives = 243/277 (87%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           M+HEN+I IKDI+RPP ++ FNDVYIVYELMDTDLHQIIRS Q LTDDHCQYFLYQLLRG
Sbjct: 92  MDHENIIKIKDIVRPPDREEFNDVYIVYELMDTDLHQIIRSSQALTDDHCQYFLYQLLRG 151

Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 120
           LKYVHSA+VLHRDLKPSNLLLNA+CDLKI DFGLARTTSE DFMTEYVVTRWYRAPELLL
Sbjct: 152 LKYVHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEADFMTEYVVTRWYRAPELLL 211

Query: 121 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 180
           NCTEYTAAIDIWSVGCIL E++ REPLFPG+DY  QL LI  L+GSP+D+ LGFLRSDNA
Sbjct: 212 NCTEYTAAIDIWSVGCILMELIKREPLFPGRDYAQQLGLIIALLGSPEDSDLGFLRSDNA 271

Query: 181 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 240
           R+YV+ LPR  +  F+ +FP+ S  A+DL E+MLVFDP KRITVE+AL HP+L SLH++N
Sbjct: 272 RKYVKHLPRVPRHPFSQKFPDVSPLALDLAERMLVFDPAKRITVEDALNHPFLISLHEIN 331

Query: 241 DEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPD 277
           +EPVC  PF+FDFE +S +ED I+ELIW E++KF+P+
Sbjct: 332 EEPVCDSPFNFDFEQASLSEDDIKELIWNEALKFDPN 368

Nicotiana tabacum (taxid: 4097)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q9LQQ9|MPK13_ARATH Mitogen-activated protein kinase 13 OS=Arabidopsis thaliana GN=MPK13 PE=1 SV=1

 Score =  433 bits (1113), Expect = e-121,   Method: Compositional matrix adjust.
 Identities = 202/274 (73%), Positives = 235/274 (85%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           M+H+NVI IKDII  P+K+ F DVYIVYELMDTDLHQIIRS Q LTDDHCQYFLYQ+LRG
Sbjct: 87  MDHDNVIKIKDIIELPEKERFEDVYIVYELMDTDLHQIIRSTQTLTDDHCQYFLYQILRG 146

Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 120
           LKY+HSA+VLHRDLKPSNL+LN +CDLKI DFGLART++ET+ MTEYVVTRWYRAPELLL
Sbjct: 147 LKYIHSANVLHRDLKPSNLVLNTNCDLKICDFGLARTSNETEIMTEYVVTRWYRAPELLL 206

Query: 121 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 180
           N +EYT AIDIWSVGCI  EI+ RE LFPGKDYV QL+LITEL+GSPDD+ L FLRSDNA
Sbjct: 207 NSSEYTGAIDIWSVGCIFMEILRRETLFPGKDYVQQLKLITELLGSPDDSDLDFLRSDNA 266

Query: 181 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 240
           R+YV+QLP  +KQ F  +FPN S  A+DL EKMLVFDP+KRITV+EAL+ PYL SLH++N
Sbjct: 267 RKYVKQLPHVQKQSFREKFPNISPMALDLAEKMLVFDPSKRITVDEALKQPYLASLHEIN 326

Query: 241 DEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKF 274
           +EP CP PF FDFE ++  E  I+EL+WRES+ F
Sbjct: 327 EEPTCPTPFSFDFEETALDEQDIKELVWRESLHF 360

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q06060|MAPK_PEA Mitogen-activated protein kinase homolog D5 OS=Pisum sativum PE=2 SV=1

 Score =  430 bits (1106), Expect = e-120,   Method: Compositional matrix adjust.
 Identities = 196/277 (70%), Positives = 241/277 (87%), Gaps = 1/277 (0%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           M+HENV+AI+DI+ PP+++ FNDVYI YELMDTDLHQIIRS+Q L+++HCQYFLYQ+LRG
Sbjct: 116 MDHENVVAIRDIVPPPQREVFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 175

Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 120
           LKY+HSA+VLHRDLKPSNLLLNA+CDLKI DFGLAR TSETDFMTEYVVTRWYRAPELLL
Sbjct: 176 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 235

Query: 121 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 180
           N ++YTAAID+WSVGCI  E+M R+PLFPG+D+VHQLRL+ ELIG+P +A LGFL ++NA
Sbjct: 236 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLMELIGTPSEADLGFL-NENA 294

Query: 181 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 240
           +RY+RQLP  R+Q F  +FP+    A+DL+EKML FDP +RITVE AL HPYL SLHD++
Sbjct: 295 KRYIRQLPLYRRQSFQEKFPHVHPEAIDLVEKMLTFDPRQRITVENALAHPYLTSLHDIS 354

Query: 241 DEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPD 277
           DEPVC  PF FDFE  + TE+ ++ELI+RE++ FNP+
Sbjct: 355 DEPVCTTPFSFDFEQHALTEEQMKELIYREALAFNPE 391

Pisum sativum (taxid: 3888)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	280
255537569	387	big map kinase/bmk, putative [Ricinus co	0.992	0.718	0.902	1e-148
297748121	377	mitogen-activated protein kinase 4 [Goss	0.992	0.737	0.903	1e-148
449452284	383	PREDICTED: mitogen-activated protein kin	1.0	0.731	0.882	1e-147
224075008	362	predicted protein [Populus trichocarpa]	0.989	0.765	0.895	1e-147
225426166	375	PREDICTED: mitogen-activated protein kin	0.996	0.744	0.888	1e-145
25052804	374	mitogen-activated protein kinase 4 [Petr	0.992	0.743	0.870	1e-144
224053859	377	predicted protein [Populus trichocarpa]	1.0	0.742	0.857	1e-144
315258227	373	mitogen-activated protein kinase 4 [Nico	0.996	0.747	0.849	1e-143
356528691	380	PREDICTED: mitogen-activated protein kin	1.0	0.736	0.842	1e-142
357507521	372	Mitogen-activated protein kinase [Medica	0.992	0.747	0.859	1e-141

>gi|255537569|ref|XP_002509851.1| big map kinase/bmk, putative [Ricinus communis] gi|223549750|gb|EEF51238.1| big map kinase/bmk, putative [Ricinus communis]

 Score =  531 bits (1368), Expect = e-148,   Method: Compositional matrix adjust.
 Identities = 251/278 (90%), Positives = 265/278 (95%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           M+HEN+IAI+DIIRPPKK+ FNDVYIVYELMDTDLH IIRSDQ LTDDHCQYFLYQLLRG
Sbjct: 107 MDHENIIAIRDIIRPPKKEAFNDVYIVYELMDTDLHHIIRSDQPLTDDHCQYFLYQLLRG 166

Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 120
           LKYVHSA VLHRDLKPSNLLLNA+CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL
Sbjct: 167 LKYVHSAHVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 226

Query: 121 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 180
           NC+EYTAAIDIWSVGCILGEI+TREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA
Sbjct: 227 NCSEYTAAIDIWSVGCILGEIVTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 286

Query: 181 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 240
           RRYVRQLP+ RKQ F  RFPN S+GA DLLEKMLVFDPNKRITVEEAL HPYL SLHD+N
Sbjct: 287 RRYVRQLPQYRKQNFTLRFPNVSAGAADLLEKMLVFDPNKRITVEEALCHPYLSSLHDIN 346

Query: 241 DEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           DEPVCPRPFHFDFEH SCTE+HI++LIWRES+KFNPDP
Sbjct: 347 DEPVCPRPFHFDFEHPSCTEEHIKDLIWRESMKFNPDP 384

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297748121|gb|ADI52627.1| mitogen-activated protein kinase 4 [Gossypium hirsutum]

 Score =  530 bits (1366), Expect = e-148,   Method: Compositional matrix adjust.
 Identities = 252/279 (90%), Positives = 265/279 (94%), Gaps = 1/279 (0%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           M+HENVIAIKDIIRPPKK+TFNDVYIVYELMDTDLH IIRSDQ LTDDHCQYFLYQLLRG
Sbjct: 99  MDHENVIAIKDIIRPPKKETFNDVYIVYELMDTDLHHIIRSDQPLTDDHCQYFLYQLLRG 158

Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 120
           LKYVHSA+VLHRDLKPS+LLLNA CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL
Sbjct: 159 LKYVHSANVLHRDLKPSSLLLNAKCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 218

Query: 121 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 180
           NC+EYTAAID+WSVGCI GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS+NA
Sbjct: 219 NCSEYTAAIDMWSVGCIFGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSNNA 278

Query: 181 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 240
           RRY RQLP+CRKQQF+ RFPN S GAVDLLEKMLVFDPNKRIT EEAL HPYL SLHD+N
Sbjct: 279 RRYFRQLPQCRKQQFSARFPNMSPGAVDLLEKMLVFDPNKRIT-EEALCHPYLASLHDIN 337

Query: 241 DEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDPT 279
           DEPVCPRPF FDFE SSCTEDHI+ELIWRES++FNPDP 
Sbjct: 338 DEPVCPRPFSFDFEQSSCTEDHIKELIWRESLQFNPDPV 376

Source: Gossypium hirsutum

Species: Gossypium hirsutum

Genus: Gossypium

Family: Malvaceae

Order: Malvales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449452284|ref|XP_004143889.1| PREDICTED: mitogen-activated protein kinase 4-like [Cucumis sativus] gi|449518403|ref|XP_004166231.1| PREDICTED: mitogen-activated protein kinase 4-like [Cucumis sativus]

 Score =  528 bits (1360), Expect = e-147,   Method: Compositional matrix adjust.
 Identities = 247/280 (88%), Positives = 266/280 (95%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           MEHEN+IAI+DIIRPPK++ FNDVYIVYELMDTDLHQIIRSDQ LTDDHCQYFLYQLLRG
Sbjct: 97  MEHENIIAIRDIIRPPKREVFNDVYIVYELMDTDLHQIIRSDQPLTDDHCQYFLYQLLRG 156

Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 120
           LKYVHSA VLHRDLKPSNLLLNA+CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL
Sbjct: 157 LKYVHSAKVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 216

Query: 121 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 180
           NC+EYTAAID+WSVGCILGEIMTREPLFPGKDYVHQLRLITEL+GSPDDASLGFLRSDNA
Sbjct: 217 NCSEYTAAIDVWSVGCILGEIMTREPLFPGKDYVHQLRLITELLGSPDDASLGFLRSDNA 276

Query: 181 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 240
           RRYV+QLP+ RKQQF+ RFPN S  A+DLLEKMLVFDPNKRITVEEAL HPYLQSLHD+N
Sbjct: 277 RRYVKQLPQYRKQQFSARFPNMSPSALDLLEKMLVFDPNKRITVEEALCHPYLQSLHDIN 336

Query: 241 DEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDPTC 280
           DEPVC RPF+FDFE  SCTE+HI+ELIW+ESV+FNPD + 
Sbjct: 337 DEPVCARPFNFDFEQPSCTEEHIKELIWKESVRFNPDESA 376

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224075008|ref|XP_002304516.1| predicted protein [Populus trichocarpa] gi|222841948|gb|EEE79495.1| predicted protein [Populus trichocarpa]

 Score =  526 bits (1354), Expect = e-147,   Method: Compositional matrix adjust.
 Identities = 248/277 (89%), Positives = 263/277 (94%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           M+HENVIAI+DI RPPKK+ FNDVYIVYELMDTDLHQIIRSDQ L DDHCQYFLYQLLRG
Sbjct: 84  MDHENVIAIRDITRPPKKEAFNDVYIVYELMDTDLHQIIRSDQALNDDHCQYFLYQLLRG 143

Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 120
           LKYVHSA+VLHRDLKPSNLLLN++CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL
Sbjct: 144 LKYVHSANVLHRDLKPSNLLLNSNCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 203

Query: 121 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 180
           NC+EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS+NA
Sbjct: 204 NCSEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSNNA 263

Query: 181 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 240
           RRYVRQLP+ +KQ F+ RFPN S GAVDLLEKMLVFDPN RITV+EAL H YL SLHD+N
Sbjct: 264 RRYVRQLPQYKKQNFSARFPNMSPGAVDLLEKMLVFDPNNRITVDEALCHSYLSSLHDIN 323

Query: 241 DEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPD 277
           DEPVCPRPFHFDFEH SCTE+HI+ELIWRESVKFNPD
Sbjct: 324 DEPVCPRPFHFDFEHPSCTEEHIKELIWRESVKFNPD 360

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225426166|ref|XP_002278860.1| PREDICTED: mitogen-activated protein kinase homolog MMK2 [Vitis vinifera] gi|297742231|emb|CBI34380.3| unnamed protein product [Vitis vinifera]

 Score =  519 bits (1337), Expect = e-145,   Method: Compositional matrix adjust.
 Identities = 248/279 (88%), Positives = 263/279 (94%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           M+HENVIAIKDIIRPPKK+TFNDVYIVYELMDTDLHQII S+Q LTDDHCQYFLYQLLRG
Sbjct: 96  MDHENVIAIKDIIRPPKKETFNDVYIVYELMDTDLHQIICSNQSLTDDHCQYFLYQLLRG 155

Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 120
           LKYVHSA+VLHRDLKPSNLLLNA+CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL
Sbjct: 156 LKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 215

Query: 121 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 180
           NC+EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEL+GSPDDASLGFLRS+NA
Sbjct: 216 NCSEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELLGSPDDASLGFLRSNNA 275

Query: 181 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 240
           RRYVRQLP+  KQQ + RFPN S  AVDLLEKMLVFDP KRITV+EAL HPYL SLHD+N
Sbjct: 276 RRYVRQLPQYPKQQISARFPNMSPSAVDLLEKMLVFDPTKRITVDEALCHPYLSSLHDIN 335

Query: 241 DEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDPT 279
           DEPVCP PF FDFE SS TE++I+ELIWRESVKFNPDPT
Sbjct: 336 DEPVCPSPFSFDFEQSSITEENIKELIWRESVKFNPDPT 374

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|25052804|gb|AAN65180.1| mitogen-activated protein kinase 4 [Petroselinum crispum]

 Score =  517 bits (1332), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 242/278 (87%), Positives = 266/278 (95%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           M HENVIAIKDIIRPP+ ++FNDVYIVYELMDTDLHQIIRS+QQLTDDHC+YFLYQLLRG
Sbjct: 95  MNHENVIAIKDIIRPPQIESFNDVYIVYELMDTDLHQIIRSNQQLTDDHCRYFLYQLLRG 154

Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 120
           LKYVHSA+VLHRDLKPSNLLLNA+CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL
Sbjct: 155 LKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 214

Query: 121 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 180
           NC+EYTAAIDIWSVGCILGE+MTR+PLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA
Sbjct: 215 NCSEYTAAIDIWSVGCILGEVMTRQPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 274

Query: 181 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 240
           RRYVRQLP+  KQQF+ RF NKS GA+DLLEKML+FDPN+RITV+EAL HPYL +LHD+N
Sbjct: 275 RRYVRQLPQYPKQQFSARFLNKSPGALDLLEKMLIFDPNRRITVDEALCHPYLAALHDIN 334

Query: 241 DEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +EPVCPRPF FDFE  +CTE++I+ELIW+ESVKFNPDP
Sbjct: 335 EEPVCPRPFSFDFEQPTCTEENIKELIWKESVKFNPDP 372

Source: Petroselinum crispum

Species: Petroselinum crispum

Genus: Petroselinum

Family: Apiaceae

Order: Apiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224053859|ref|XP_002298015.1| predicted protein [Populus trichocarpa] gi|222845273|gb|EEE82820.1| predicted protein [Populus trichocarpa]

 Score =  515 bits (1326), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 240/280 (85%), Positives = 263/280 (93%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           M+HENVIA++DIIRPPK + FNDVYIVYELMDTDLHQIIRS+Q L DDHCQYFLYQLLRG
Sbjct: 98  MDHENVIAMRDIIRPPKMEAFNDVYIVYELMDTDLHQIIRSEQSLNDDHCQYFLYQLLRG 157

Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 120
           LKYVHSA+VLHRDLKPSNLLLN++CDLKIGDFGLARTT+ETDFMTEYVVTRWYRAPELLL
Sbjct: 158 LKYVHSANVLHRDLKPSNLLLNSNCDLKIGDFGLARTTAETDFMTEYVVTRWYRAPELLL 217

Query: 121 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 180
           NC+EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS+NA
Sbjct: 218 NCSEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSNNA 277

Query: 181 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 240
           RRYVRQLP+ +K+ F+  FPN S GA+DLLEKMLVFDP+ RITV+EAL H YL SLH +N
Sbjct: 278 RRYVRQLPQYKKKIFSATFPNMSPGAIDLLEKMLVFDPSNRITVDEALCHQYLSSLHAIN 337

Query: 241 DEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDPTC 280
           DEPVCPRPFHFDFE  SCTE+HI+ELIWRES+KFNPDP+C
Sbjct: 338 DEPVCPRPFHFDFEQPSCTEEHIKELIWRESMKFNPDPSC 377

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|315258227|gb|ADT91692.1| mitogen-activated protein kinase 4 [Nicotiana attenuata]

 Score =  512 bits (1318), Expect = e-143,   Method: Compositional matrix adjust.
 Identities = 237/279 (84%), Positives = 265/279 (94%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           M+H+NVIAIKDIIRPP+ + FNDVYIVYELMDTDLHQIIRS+QQLTDDHC+YFLYQ+LRG
Sbjct: 94  MDHDNVIAIKDIIRPPQTENFNDVYIVYELMDTDLHQIIRSNQQLTDDHCRYFLYQILRG 153

Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 120
           LKY+HSA+VLHRDLKPSNLLLNA+CDLK+GDFGLARTTSETDFMTEYVVTRWYRAPELLL
Sbjct: 154 LKYIHSANVLHRDLKPSNLLLNANCDLKVGDFGLARTTSETDFMTEYVVTRWYRAPELLL 213

Query: 121 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 180
           NC+EYTAAIDIWSVGCILGE+MTR+PLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA
Sbjct: 214 NCSEYTAAIDIWSVGCILGEMMTRQPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 273

Query: 181 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 240
           RRYVRQLP+  +QQFA RFPN S GAVDLLEKMLVFDP++R+TV++AL HPYL  LHD+N
Sbjct: 274 RRYVRQLPQYPRQQFAARFPNSSPGAVDLLEKMLVFDPSRRVTVDQALCHPYLAPLHDIN 333

Query: 241 DEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDPT 279
           +EP+CP+PF FDFE  S TE++I+ELIWRESVKFNPDPT
Sbjct: 334 EEPICPKPFSFDFEQPSFTEENIKELIWRESVKFNPDPT 372

Source: Nicotiana attenuata

Species: Nicotiana attenuata

Genus: Nicotiana

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356528691|ref|XP_003532933.1| PREDICTED: mitogen-activated protein kinase 2-like [Glycine max]

 Score =  511 bits (1315), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 236/280 (84%), Positives = 265/280 (94%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           M+H+N+IAIKDIIRPPKK+TFNDVYIVYELMDTDLH II SDQ L+++HCQYFLYQLLRG
Sbjct: 101 MDHDNIIAIKDIIRPPKKETFNDVYIVYELMDTDLHHIIHSDQPLSEEHCQYFLYQLLRG 160

Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 120
           LKYVHSA+VLHRDLKPSNLL+NA+CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL
Sbjct: 161 LKYVHSANVLHRDLKPSNLLMNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 220

Query: 121 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 180
           NC+EYT+AID+WSVGCILGEIMTREPLFPGKDYVHQLRLITEL+GSPDDASL FLRSDNA
Sbjct: 221 NCSEYTSAIDVWSVGCILGEIMTREPLFPGKDYVHQLRLITELLGSPDDASLEFLRSDNA 280

Query: 181 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 240
           RRY+RQLP+ RKQ+F+TRFPN    A+DLLEKML+FDPNKRITV+EAL HPYL SLH++N
Sbjct: 281 RRYIRQLPQYRKQKFSTRFPNMLPKALDLLEKMLIFDPNKRITVDEALCHPYLSSLHNIN 340

Query: 241 DEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDPTC 280
           DEPVCPRPF FDF+  +CTE+H++ELIW+ESVKFNPDP C
Sbjct: 341 DEPVCPRPFSFDFDQPTCTEEHMKELIWKESVKFNPDPPC 380

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357507521|ref|XP_003624049.1| Mitogen-activated protein kinase [Medicago truncatula] gi|355499064|gb|AES80267.1| Mitogen-activated protein kinase [Medicago truncatula]

 Score =  508 bits (1308), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 239/278 (85%), Positives = 262/278 (94%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           M+HENVIA+KDIIRPP+K+ FNDVYIVYELMDTDLHQIIRS+Q LTDDHC+YFLYQLLRG
Sbjct: 92  MDHENVIALKDIIRPPQKENFNDVYIVYELMDTDLHQIIRSNQTLTDDHCRYFLYQLLRG 151

Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 120
           LKYVHSA+VLHRDLKPSNLLLN++CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL
Sbjct: 152 LKYVHSANVLHRDLKPSNLLLNSNCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 211

Query: 121 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 180
           NC+EYTAAIDIWSVGCILGEIMTR+PLFPGKDYVHQL+LITELIGSPDDASLGF+RSDNA
Sbjct: 212 NCSEYTAAIDIWSVGCILGEIMTRKPLFPGKDYVHQLKLITELIGSPDDASLGFIRSDNA 271

Query: 181 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 240
           RRYV+QLP+  +QQFA RFPN S GAVDLLE+MLVFDPN+RITV+EALRH YL  LHD+N
Sbjct: 272 RRYVKQLPQYPRQQFAARFPNMSPGAVDLLERMLVFDPNRRITVDEALRHQYLAPLHDIN 331

Query: 241 DEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +EPVC RPF+FDFE  S TE  I+ELIWRESVKFNPDP
Sbjct: 332 EEPVCSRPFNFDFEKPSFTEADIKELIWRESVKFNPDP 369

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	280
TAIR|locus:2124943	376	MPK4 "MAP kinase 4" [Arabidops	0.985	0.734	0.836	4.6e-128
TAIR|locus:2025341	369	MPK11 "MAP kinase 11" [Arabido	0.985	0.747	0.833	8.9e-125
TAIR|locus:2062897	372	MPK12 "mitogen-activated prote	0.989	0.744	0.779	5.2e-120
TAIR|locus:2128263	376	MPK5 "MAP kinase 5" [Arabidops	0.996	0.742	0.774	2.6e-118
TAIR|locus:2026484	363	ATMPK13 [Arabidopsis thaliana	0.978	0.754	0.737	3.3e-111
TAIR|locus:2043904	395	MPK6 "MAP kinase 6" [Arabidops	0.985	0.698	0.678	1.4e-105
TAIR|locus:2085632	370	MPK3 "mitogen-activated protei	0.985	0.745	0.644	1.6e-102
TAIR|locus:2080457	393	MPK10 "MAP kinase 10" [Arabido	0.982	0.699	0.630	2.9e-96
DICTYBASE|DDB_G0286353	529	erkA "mitogen-activated protei	0.989	0.523	0.585	5.3e-88
TAIR|locus:2053119	368	MPK7 "MAP kinase 7" [Arabidops	0.985	0.75	0.543	3.9e-83

TAIR|locus:2124943 MPK4 "MAP kinase 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 1257 (447.5 bits), Expect = 4.6e-128, P = 4.6e-128
 Identities = 231/276 (83%), Positives = 260/276 (94%)

Query:     1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
             M+HENVIA+KDII+PP+++ FNDVYIVYELMDTDLHQIIRS+Q LTDDHC++FLYQLLRG
Sbjct:    97 MDHENVIAVKDIIKPPQRENFNDVYIVYELMDTDLHQIIRSNQPLTDDHCRFFLYQLLRG 156

Query:    61 LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 120
             LKYVHSA+VLHRDLKPSNLLLNA+CDLK+GDFGLART SETDFMTEYVVTRWYRAPELLL
Sbjct:   157 LKYVHSANVLHRDLKPSNLLLNANCDLKLGDFGLARTKSETDFMTEYVVTRWYRAPELLL 216

Query:   121 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 180
             NC+EYTAAIDIWSVGCILGE MTREPLFPGKDYVHQLRLITELIGSPDD+SLGFLRSDNA
Sbjct:   217 NCSEYTAAIDIWSVGCILGETMTREPLFPGKDYVHQLRLITELIGSPDDSSLGFLRSDNA 276

Query:   181 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 240
             RRYVRQLP+  +Q FA RFPN S+GAVDLLEKMLVFDP++RITV+EAL HPYL  LHD+N
Sbjct:   277 RRYVRQLPQYPRQNFAARFPNMSAGAVDLLEKMLVFDPSRRITVDEALCHPYLAPLHDIN 336

Query:   241 DEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 276
             +EPVC RPF+FDFE  + TE++I+ELI+RE+VKFNP
Sbjct:   337 EEPVCVRPFNFDFEQPTLTEENIKELIYRETVKFNP 372

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0009868 "jasmonic acid and ethylene-dependent systemic resistance, jasmonic acid mediated signaling pathway" evidence=TAS

GO:0004707 "MAP kinase activity" evidence=ISS;IDA

GO:0007165 "signal transduction" evidence=IC;RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA;IMP;TAS

GO:0005515 "protein binding" evidence=IPI

GO:0009409 "response to cold" evidence=RCA;IDA

GO:0009651 "response to salt stress" evidence=RCA;IDA

GO:0006972 "hyperosmotic response" evidence=RCA;IMP

GO:0042539 "hypotonic salinity response" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0016310 "phosphorylation" evidence=IDA

GO:0009620 "response to fungus" evidence=IMP

GO:0009861 "jasmonic acid and ethylene-dependent systemic resistance" evidence=IMP

GO:0009737 "response to abscisic acid stimulus" evidence=IEP

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0043622 "cortical microtubule organization" evidence=IMP

GO:0005829 "cytosol" evidence=IDA

GO:0007112 "male meiosis cytokinesis" evidence=IMP

GO:0009555 "pollen development" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006096 "glycolysis" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006833 "water transport" evidence=RCA

GO:0006970 "response to osmotic stress" evidence=RCA

GO:0007030 "Golgi organization" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009266 "response to temperature stimulus" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0010374 "stomatal complex development" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0045088 "regulation of innate immune response" evidence=RCA

GO:0046686 "response to cadmium ion" evidence=RCA

GO:0048481 "ovule development" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0051707 "response to other organism" evidence=RCA

GO:0004672 "protein kinase activity" evidence=IDA

TAIR|locus:2025341 MPK11 "MAP kinase 11" [Arabidopsis thaliana (taxid:3702)]

 Score = 1226 (436.6 bits), Expect = 8.9e-125, P = 8.9e-125
 Identities = 230/276 (83%), Positives = 253/276 (91%)

Query:     1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
             M+H+NVIAI DIIRPP+ D FNDV+IVYELMDTDLH IIRS+Q LTDDH ++FLYQLLRG
Sbjct:    94 MDHDNVIAIIDIIRPPQPDNFNDVHIVYELMDTDLHHIIRSNQPLTDDHSRFFLYQLLRG 153

Query:    61 LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 120
             LKYVHSA+VLHRDLKPSNLLLNA+CDLKIGDFGLART SETDFMTEYVVTRWYRAPELLL
Sbjct:   154 LKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTKSETDFMTEYVVTRWYRAPELLL 213

Query:   121 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 180
             NC+EYTAAIDIWSVGCILGEIMTREPLFPG+DYV QLRLITELIGSPDD+SLGFLRSDNA
Sbjct:   214 NCSEYTAAIDIWSVGCILGEIMTREPLFPGRDYVQQLRLITELIGSPDDSSLGFLRSDNA 273

Query:   181 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 240
             RRYVRQLP+  +Q FA RFPN S  AVDLL+KMLVFDPN+RITV+EAL HPYL  LH+ N
Sbjct:   274 RRYVRQLPQYPRQNFAARFPNMSVNAVDLLQKMLVFDPNRRITVDEALCHPYLAPLHEYN 333

Query:   241 DEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 276
             +EPVC RPFHFDFE  S TE++I+ELI+RESVKFNP
Sbjct:   334 EEPVCVRPFHFDFEQPSLTEENIKELIYRESVKFNP 369

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC;RCA

GO:0009737 "response to abscisic acid stimulus" evidence=IEP

GO:0005515 "protein binding" evidence=IPI

GO:0005829 "cytosol" evidence=IDA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2062897 MPK12 "mitogen-activated protein kinase 12" [Arabidopsis thaliana (taxid:3702)]

 Score = 1181 (420.8 bits), Expect = 5.2e-120, P = 5.2e-120
 Identities = 216/277 (77%), Positives = 249/277 (89%)

Query:     1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
             M+HENVI IKDI+RPP++D FNDVYIVYELMDTDL +I+RS+Q LT D C++ +YQLLRG
Sbjct:    95 MDHENVITIKDIVRPPQRDIFNDVYIVYELMDTDLQRILRSNQTLTSDQCRFLVYQLLRG 154

Query:    61 LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 120
             LKYVHSA++LHRDL+PSN+LLN+  +LKIGDFGLARTTS+TDFMTEYVVTRWYRAPELLL
Sbjct:   155 LKYVHSANILHRDLRPSNVLLNSKNELKIGDFGLARTTSDTDFMTEYVVTRWYRAPELLL 214

Query:   121 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 180
             NC+EYTAAIDIWSVGCILGEIMT +PLFPGKDYVHQLRLITEL+GSPD++SLGFLRSDNA
Sbjct:   215 NCSEYTAAIDIWSVGCILGEIMTGQPLFPGKDYVHQLRLITELVGSPDNSSLGFLRSDNA 274

Query:   181 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 240
             RRYVRQLPR  KQQFA RFP   + A+DLLE+MLVFDPN+RI+V+EAL H YL   HD+ 
Sbjct:   275 RRYVRQLPRYPKQQFAARFPKMPTTAIDLLERMLVFDPNRRISVDEALGHAYLSPHHDVA 334

Query:   241 DEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPD 277
              EPVC  PF FDFEH SCTE+HI+ELI++ESVKFNPD
Sbjct:   335 KEPVCSTPFSFDFEHPSCTEEHIKELIYKESVKFNPD 371

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0005515 "protein binding" evidence=IPI

GO:0007243 "intracellular protein kinase cascade" evidence=IC

GO:0009733 "response to auxin stimulus" evidence=IMP

GO:0080026 "response to indolebutyric acid stimulus" evidence=IMP

TAIR|locus:2128263 MPK5 "MAP kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 1165 (415.2 bits), Expect = 2.6e-118, P = 2.6e-118
 Identities = 216/279 (77%), Positives = 247/279 (88%)

Query:     1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
             +EHENV+ IKDIIRPPKK+ F DVYIV+ELMDTDLHQIIRS+Q L DDHCQYFLYQ+LRG
Sbjct:    97 LEHENVVVIKDIIRPPKKEDFVDVYIVFELMDTDLHQIIRSNQSLNDDHCQYFLYQILRG 156

Query:    61 LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 120
             LKY+HSA+VLHRDLKPSNLLLN++CDLKI DFGLARTTSET++MTEYVVTRWYRAPELLL
Sbjct:   157 LKYIHSANVLHRDLKPSNLLLNSNCDLKITDFGLARTTSETEYMTEYVVTRWYRAPELLL 216

Query:   121 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 180
             N +EYT+AID+WSVGCI  EIMTREPLFPGKDYVHQL+LITELIGSPD ASL FLRS NA
Sbjct:   217 NSSEYTSAIDVWSVGCIFAEIMTREPLFPGKDYVHQLKLITELIGSPDGASLEFLRSANA 276

Query:   181 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 240
             R+YV++LP+  +Q F+ RFP+ +S A+DLLEKMLVFDP KRITVEEAL +PYL +LHDLN
Sbjct:   277 RKYVKELPKFPRQNFSARFPSMNSTAIDLLEKMLVFDPVKRITVEEALCYPYLSALHDLN 336

Query:   241 DEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDPT 279
             DEPVC   F F FE  S TE+ I+EL+W ESVKFNP P+
Sbjct:   337 DEPVCSNHFSFHFEDPSSTEEEIKELVWLESVKFNPLPS 375

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

TAIR|locus:2026484 ATMPK13 [Arabidopsis thaliana (taxid:3702)]

 Score = 1098 (391.6 bits), Expect = 3.3e-111, P = 3.3e-111
 Identities = 202/274 (73%), Positives = 235/274 (85%)

Query:     1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
             M+H+NVI IKDII  P+K+ F DVYIVYELMDTDLHQIIRS Q LTDDHCQYFLYQ+LRG
Sbjct:    87 MDHDNVIKIKDIIELPEKERFEDVYIVYELMDTDLHQIIRSTQTLTDDHCQYFLYQILRG 146

Query:    61 LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 120
             LKY+HSA+VLHRDLKPSNL+LN +CDLKI DFGLART++ET+ MTEYVVTRWYRAPELLL
Sbjct:   147 LKYIHSANVLHRDLKPSNLVLNTNCDLKICDFGLARTSNETEIMTEYVVTRWYRAPELLL 206

Query:   121 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 180
             N +EYT AIDIWSVGCI  EI+ RE LFPGKDYV QL+LITEL+GSPDD+ L FLRSDNA
Sbjct:   207 NSSEYTGAIDIWSVGCIFMEILRRETLFPGKDYVQQLKLITELLGSPDDSDLDFLRSDNA 266

Query:   181 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 240
             R+YV+QLP  +KQ F  +FPN S  A+DL EKMLVFDP+KRITV+EAL+ PYL SLH++N
Sbjct:   267 RKYVKQLPHVQKQSFREKFPNISPMALDLAEKMLVFDPSKRITVDEALKQPYLASLHEIN 326

Query:   241 DEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKF 274
             +EP CP PF FDFE ++  E  I+EL+WRES+ F
Sbjct:   327 EEPTCPTPFSFDFEETALDEQDIKELVWRESLHF 360

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2043904 MPK6 "MAP kinase 6" [Arabidopsis thaliana (taxid:3702)]

 Score = 1045 (372.9 bits), Expect = 1.4e-105, P = 1.4e-105
 Identities = 188/277 (67%), Positives = 236/277 (85%)

Query:     1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
             M+HEN++AI+DII PP ++ FNDVYI YELMDTDLHQIIRS+Q L+++HCQYFLYQ+LRG
Sbjct:   117 MDHENIVAIRDIIPPPLRNAFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 176

Query:    61 LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 120
             LKY+HSA+VLHRDLKPSNLLLNA+CDLKI DFGLAR TSE+DFMTEYVVTRWYRAPELLL
Sbjct:   177 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSESDFMTEYVVTRWYRAPELLL 236

Query:   121 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 180
             N ++YTAAID+WSVGCI  E+M R+PLFPG+D+VHQLRL+ ELIG+P +  L FL ++NA
Sbjct:   237 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLMELIGTPSEEELEFL-NENA 295

Query:   181 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 240
             +RY+RQLP   +Q    +FP     A+DL+EKML FDP +RITV +AL HPYL SLHD++
Sbjct:   296 KRYIRQLPPYPRQSITDKFPTVHPLAIDLIEKMLTFDPRRRITVLDALAHPYLNSLHDIS 355

Query:   241 DEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPD 277
             DEP C  PF+FDFE+ + +E+ ++ELI+RE++ FNP+
Sbjct:   356 DEPECTIPFNFDFENHALSEEQMKELIYREALAFNPE 392

GO:0005634 "nucleus" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0004707 "MAP kinase activity" evidence=ISS;IDA

GO:0006979 "response to oxidative stress" evidence=IEP

GO:0000302 "response to reactive oxygen species" evidence=IEP

GO:0042742 "defense response to bacterium" evidence=IEP

GO:0007165 "signal transduction" evidence=IC

GO:0006970 "response to osmotic stress" evidence=RCA;IDA

GO:0009723 "response to ethylene stimulus" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0009409 "response to cold" evidence=RCA;IDA

GO:0009651 "response to salt stress" evidence=IGI;RCA

GO:2000037 "regulation of stomatal complex patterning" evidence=IGI

GO:2000038 "regulation of stomatal complex development" evidence=IGI

GO:0009864 "induced systemic resistance, jasmonic acid mediated signaling pathway" evidence=IMP

GO:0042542 "response to hydrogen peroxide" evidence=IDA

GO:0009737 "response to abscisic acid stimulus" evidence=IEP;RCA

GO:0048481 "ovule development" evidence=IGI;RCA

GO:0010120 "camalexin biosynthetic process" evidence=IMP

GO:0080136 "priming of cellular response to stress" evidence=IMP

GO:0005802 "trans-Golgi network" evidence=IDA

GO:0009524 "phragmoplast" evidence=IDA

GO:0009574 "preprophase band" evidence=IDA

GO:0048364 "root development" evidence=IMP

GO:0051301 "cell division" evidence=IMP

GO:0010224 "response to UV-B" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0000303 "response to superoxide" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009743 "response to carbohydrate stimulus" evidence=RCA

GO:0009751 "response to salicylic acid stimulus" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0009873 "ethylene mediated signaling pathway" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0010374 "stomatal complex development" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0004672 "protein kinase activity" evidence=IDA

GO:0010229 "inflorescence development" evidence=IMP

TAIR|locus:2085632 MPK3 "mitogen-activated protein kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1016 (362.7 bits), Expect = 1.6e-102, P = 1.6e-102
 Identities = 178/276 (64%), Positives = 231/276 (83%)

Query:     1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
             ++HEN+IAI+D++ PP +  F+DVYI  ELMDTDLHQIIRS+Q L+++HCQYFLYQLLRG
Sbjct:    92 LDHENIIAIRDVVPPPLRRQFSDVYISTELMDTDLHQIIRSNQSLSEEHCQYFLYQLLRG 151

Query:    61 LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 120
             LKY+HSA+++HRDLKPSNLLLNA+CDLKI DFGLAR TSE DFMTEYVVTRWYRAPELLL
Sbjct:   152 LKYIHSANIIHRDLKPSNLLLNANCDLKICDFGLARPTSENDFMTEYVVTRWYRAPELLL 211

Query:   121 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 180
             N ++YTAAID+WSVGCI  E+M R+PLFPGKD+VHQ+RL+TEL+G+P ++ LGF  +++A
Sbjct:   212 NSSDYTAAIDVWSVGCIFMELMNRKPLFPGKDHVHQMRLLTELLGTPTESDLGFTHNEDA 271

Query:   181 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 240
             +RY+RQLP   +Q  A  F + +  A+DL+++ML FDPN+RITVE+AL H YL  LHD N
Sbjct:   272 KRYIRQLPNFPRQPLAKLFSHVNPMAIDLVDRMLTFDPNRRITVEQALNHQYLAKLHDPN 331

Query:   241 DEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 276
             DEP+C +PF F+FE     E+ I+E+I++E++  NP
Sbjct:   332 DEPICQKPFSFEFEQQPLDEEQIKEMIYQEAIALNP 367

GO:0005634 "nucleus" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0006979 "response to oxidative stress" evidence=IEP;TAS

GO:0004707 "MAP kinase activity" evidence=ISS

GO:0007165 "signal transduction" evidence=IC

GO:0000169 "activation of MAPK activity involved in osmosensory signaling pathway" evidence=IDA

GO:0006970 "response to osmotic stress" evidence=RCA;IDA

GO:0004672 "protein kinase activity" evidence=IDA;TAS

GO:0009738 "abscisic acid mediated signaling pathway" evidence=TAS

GO:0005515 "protein binding" evidence=IPI

GO:0010200 "response to chitin" evidence=IEP;RCA

GO:2000037 "regulation of stomatal complex patterning" evidence=IGI

GO:2000038 "regulation of stomatal complex development" evidence=IGI

GO:0009611 "response to wounding" evidence=IEP

GO:0048481 "ovule development" evidence=IGI;RCA

GO:0010120 "camalexin biosynthetic process" evidence=IMP

GO:0009617 "response to bacterium" evidence=IEP;RCA

GO:0080136 "priming of cellular response to stress" evidence=IMP

GO:0010224 "response to UV-B" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0001666 "response to hypoxia" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009409 "response to cold" evidence=IEP;RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0010374 "stomatal complex development" evidence=RCA

GO:0019684 "photosynthesis, light reaction" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0051707 "response to other organism" evidence=RCA

GO:0010229 "inflorescence development" evidence=IGI

TAIR|locus:2080457 MPK10 "MAP kinase 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 957 (341.9 bits), Expect = 2.9e-96, P = 2.9e-96
 Identities = 174/276 (63%), Positives = 221/276 (80%)

Query:     2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGL 61
             +HEN++AI+D+I PP++D+F DVYIV ELM+ DL++ ++SDQ+LT DH  YF+YQ+LRGL
Sbjct:   115 DHENIVAIRDVILPPQRDSFEDVYIVNELMEFDLYRTLKSDQELTKDHGMYFMYQILRGL 174

Query:    62 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 121
             KY+HSA+VLHRDLKPSNLLL+  CDLKI DFGLAR T E++ MTEYVVTRWYRAPELLL 
Sbjct:   175 KYIHSANVLHRDLKPSNLLLSTQCDLKICDFGLARATPESNLMTEYVVTRWYRAPELLLG 234

Query:   122 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR 181
              ++YTAAID+WSVGCI  EIM REPLFPGKD V+QLRL+ ELIG+P +  LG L S+ A+
Sbjct:   235 SSDYTAAIDVWSVGCIFMEIMNREPLFPGKDQVNQLRLLLELIGTPSEEELGSL-SEYAK 293

Query:   182 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLND 241
             RY+RQLP   +Q F  +FPN    A+DL+EKML FDP +RI+V+EAL HPYL S HD+ D
Sbjct:   294 RYIRQLPTLPRQSFTEKFPNVPPLAIDLVEKMLTFDPKQRISVKEALAHPYLSSFHDITD 353

Query:   242 EPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPD 277
             EP C  PF+FD +    +E+  RELI+ E++ FNP+
Sbjct:   354 EPECSEPFNFDLDEHPFSEEQFRELIYCEALAFNPE 389

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0005515 "protein binding" evidence=IPI

DICTYBASE|DDB_G0286353 erkA "mitogen-activated protein kinase" [Dictyostelium discoideum (taxid:44689)]

 Score = 879 (314.5 bits), Expect = 5.3e-88, P = 5.3e-88
 Identities = 164/280 (58%), Positives = 209/280 (74%)

Query:     2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGL 61
             +HEN+I+IKDI++P  K+ F DVYIV ELMDTDLHQII S Q L+DDHCQYF+YQ+LRGL
Sbjct:   204 KHENLISIKDILKPNSKEQFEDVYIVSELMDTDLHQIITSPQPLSDDHCQYFVYQMLRGL 263

Query:    62 KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPELL 119
             K++HSA+VLHRDLKPSNLL+N  C LKI D GLAR    T   FMTEYV TRWYRAPE++
Sbjct:   264 KHIHSANVLHRDLKPSNLLINEDCLLKICDLGLARVEDATHQGFMTEYVATRWYRAPEVI 323

Query:   120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
             L+  +YT AIDIWSVGCI  E++ R+PLF GKDY+HQ+ LI E IGSP +  +  + ++ 
Sbjct:   324 LSWNKYTKAIDIWSVGCIFAELLGRKPLFQGKDYIHQITLIIETIGSPSEEDICNIANEQ 383

Query:   180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
             AR+++R +    K  FA  FP  +  A+DLLE+ML FDP+KR+TVEEAL HPY QSLHD 
Sbjct:   384 ARQFIRNMGNQPKVNFANMFPKANPDAIDLLERMLYFDPSKRLTVEEALAHPYFQSLHDP 443

Query:   240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP-DP 278
             +DEP+C   F  +FE      D ++ELI+ E + ++P DP
Sbjct:   444 SDEPICLHKFSLNFEAWDLNRDLLKELIYNEMLAYHPEDP 483

GO:0030587 "sorocarp development" evidence=IMP

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0000165 "MAPK cascade" evidence=IEA

GO:0051301 "cell division" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0007067 "mitosis" evidence=IEA

GO:0007049 "cell cycle" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

TAIR|locus:2053119 MPK7 "MAP kinase 7" [Arabidopsis thaliana (taxid:3702)]

 Score = 833 (298.3 bits), Expect = 3.9e-83, P = 3.9e-83
 Identities = 151/278 (54%), Positives = 205/278 (73%)

Query:     1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
             + HENVIA+KD++ P  + +F DVY+VYELMDTDLHQII+S Q L+DDHC+YFL+QLLRG
Sbjct:    86 VRHENVIALKDVMLPANRSSFKDVYLVYELMDTDLHQIIKSSQSLSDDHCKYFLFQLLRG 145

Query:    61 LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELL 119
             LKY+HSA++LHRDLKP NLL+NA+CDLKI DFGLART+   + FMTEYVVTRWYRAPELL
Sbjct:   146 LKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSQGNEQFMTEYVVTRWYRAPELL 205

Query:   120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
             L C  Y  +ID+WSVGCI  EI+ R+P+FPG + ++QL+LI  ++GS  ++ + F+ +  
Sbjct:   206 LCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIINVVGSQQESDIRFIDNPK 265

Query:   180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
             ARR+++ LP  R    +  +P  +  A+DLL++MLVFDP KRI+V +AL HPY+  L D 
Sbjct:   266 ARRFIKSLPYSRGTHLSNLYPQANPLAIDLLQRMLVFDPTKRISVTDALLHPYMAGLFDP 325

Query:   240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPD 277
                P    P   D + +   E  IRE++W E + ++P+
Sbjct:   326 GSNPPAHVPISLDIDENM-EEPVIREMMWNEMLYYHPE 362

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0007623 "circadian rhythm" evidence=TAS

GO:0042542 "response to hydrogen peroxide" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q06060	MAPK_PEA	2, ., 7, ., 1, 1, ., 2, 4	0.7075	0.9857	0.7005	N/A	no
Q40353	MMK2_MEDSA	2, ., 7, ., 1, 1, ., 2, 4	0.8165	0.9928	0.7493	N/A	no
P40417	ERKA_DROME	2, ., 7, ., 1, 1, ., 2, 4	0.5323	0.975	0.6408	yes	no
Q5J4W4	MPK2_ORYSJ	2, ., 7, ., 1, 1, ., 2, 4	0.8201	0.9928	0.7055	yes	no
P21708	MK03_RAT	2, ., 7, ., 1, 1, ., 2, 4	0.5539	0.975	0.7184	yes	no
P27361	MK03_HUMAN	2, ., 7, ., 1, 1, ., 2, 4	0.5467	0.975	0.7203	yes	no
Q40531	NTF6_TOBAC	2, ., 7, ., 1, 1, ., 2, 4	0.7545	0.9892	0.7466	N/A	no
Q63844	MK03_MOUSE	2, ., 7, ., 1, 1, ., 2, 4	0.5539	0.975	0.7184	yes	no
Q40532	NTF4_TOBAC	2, ., 7, ., 1, 1, ., 2, 4	0.7003	0.9857	0.7022	N/A	no
P0CP66	CPK1_CRYNJ	2, ., 7, ., 1, 1, ., 2, 4	0.5275	0.9785	0.7486	yes	no
P16892	FUS3_YEAST	2, ., 7, ., 1, 1, ., 2, 4	0.5034	0.9607	0.7620	yes	no
Q39024	MPK4_ARATH	2, ., 7, ., 1, 1, ., 2, 4	0.8369	0.9857	0.7340	yes	no
P27638	SPK1_SCHPO	2, ., 7, ., 1, 1, ., 2, 4	0.5737	0.875	0.6586	yes	no
Q07176	MMK1_MEDSA	2, ., 7, ., 1, 1, ., 2, 4	0.7075	0.9857	0.7131	N/A	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.24	0.991
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.976

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	280
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	0.0
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-166
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-148
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-133
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-125
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-124
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-112
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-107
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-100
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-97
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	6e-96
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-93
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	5e-93
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-92
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-92
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-90
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	8e-86
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	4e-84
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-77
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-75
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-74
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-73
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	7e-73
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-71
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-68
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	6e-68
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	5e-67
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-66
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	9e-66
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-65
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-64
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	3e-64
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	9e-64
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	5e-63
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-61
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-60
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-60
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-60
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-60
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-58
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	3e-57
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	4e-57
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-56
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-55
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-55
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	4e-55
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	7e-54
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	8e-54
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-50
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	6e-49
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	4e-48
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	5e-45
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	5e-42
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-41
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-41
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	5e-39
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	8e-38
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-37
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-35
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-34
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-32
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-32
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-30
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-30
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	6e-30
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	7e-29
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-27
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	4e-27
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	6e-26
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	9e-26
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	9e-25
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-24
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-23
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-23
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-22
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-22
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-21
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	4e-21
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-21
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-20
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	4e-20
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	4e-20
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	7e-20
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	7e-20
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-19
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-19
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-19
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-19
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	4e-19
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	9e-19
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	6e-18
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	6e-18
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	8e-18
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-17
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	6e-17
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-16
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-16
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-16
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-16
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-16
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-16
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	5e-16
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	6e-16
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	7e-16
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	8e-16
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	9e-16
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	9e-16
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-15
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-15
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-15
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-15
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-15
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-15
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-15
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-15
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-15
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	4e-15
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	4e-15
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	5e-15
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	8e-15
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	9e-15
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-14
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-14
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-14
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-14
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-14
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-14
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-14
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-14
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-14
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-14
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-14
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-14
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-14
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	5e-14
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	5e-14
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	8e-14
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	9e-14
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-13
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-13
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-13
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-13
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-13
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-13
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-13
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	3e-13
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-13
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	5e-13
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	5e-13
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	6e-13
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	7e-13
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	8e-13
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-12
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-12
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-12
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-12
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-12
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-12
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-12
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-12
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-12
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-12
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-12
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-12
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-12
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-12
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-12
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	4e-12
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	4e-12
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	4e-12
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	4e-12
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	5e-12
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	5e-12
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	5e-12
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	5e-12
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	5e-12
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	6e-12
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	7e-12
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	8e-12
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	9e-12
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	9e-12
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	9e-12
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-11
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-11
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-11
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-11
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-11
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-11
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-11
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-11
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-11
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-11
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-11
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-11
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-11
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-11
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-11
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-11
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	3e-11
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-11
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-11
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	4e-11
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	4e-11
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	4e-11
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	5e-11
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	6e-11
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	7e-11
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	7e-11
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	8e-11
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	8e-11
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-10
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-10
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-10
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-10
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-10
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-10
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-10
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-10
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-10
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-10
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-10
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-10
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	4e-10
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	4e-10
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	4e-10
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	6e-10
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	6e-10
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	7e-10
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	9e-10
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	9e-10
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	9e-10
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-09
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-09
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-09
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-09
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-09
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-09
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-09
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-09
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-09
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-09
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-09
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	3e-09
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	4e-09
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-09
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	4e-09
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	5e-09
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	6e-09
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	6e-09
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	7e-09
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	8e-09
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	8e-09
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-08
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-08
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-08
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-08
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-08
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-08
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-08
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	3e-08
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	3e-08
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-08
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	5e-08
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	5e-08
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	5e-08
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	6e-08
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	6e-08
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	7e-08
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	7e-08
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	9e-08
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-07
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-07
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-07
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-07
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-07
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	3e-07
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-07
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	4e-07
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	4e-07
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	5e-07
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	6e-07
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	6e-07
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	7e-07
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	8e-07
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	8e-07
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	9e-07
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	9e-07
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-06
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-06
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	1e-06
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-06
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-06
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	4e-06
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	4e-06
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	9e-06
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	1e-05
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-05
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-05
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	8e-05
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	8e-05
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	0.001

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  546 bits (1409), Expect = 0.0
 Identities = 204/277 (73%), Positives = 238/277 (85%), Gaps = 1/277 (0%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           ++HENVIAIKDI+ PP ++ FNDVYIVYELMDTDLHQIIRS Q L+DDHCQYFLYQLLRG
Sbjct: 61  LDHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRG 120

Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELL 119
           LKY+HSA+VLHRDLKPSNLLLNA+CDLKI DFGLARTTSE  DFMTEYVVTRWYRAPELL
Sbjct: 121 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELL 180

Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LNC+EYT AID+WSVGCI  E++ R+PLFPGKDYVHQL+LITEL+GSP +  LGF+R++ 
Sbjct: 181 LNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK 240

Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           ARRY+R LP   +Q FA  FP+ +  A+DLLEKMLVFDP+KRITVEEAL HPYL SLHD 
Sbjct: 241 ARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP 300

Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 276
           +DEPVC  PF FDFE  + TE+ I+ELI+ E + ++P
Sbjct: 301 SDEPVCQTPFSFDFEEDALTEEDIKELIYNEMLAYHP 337

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  462 bits (1192), Expect = e-166
 Identities = 167/275 (60%), Positives = 210/275 (76%), Gaps = 5/275 (1%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           + HEN+I + DI+RPP  + FNDVYIV ELM+TDLH++I+S Q LTDDH QYFLYQ+LRG
Sbjct: 56  LRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRG 115

Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT----SETDFMTEYVVTRWYRAP 116
           LKY+HSA+V+HRDLKPSN+L+N++CDLKI DFGLAR       E  F+TEYVVTRWYRAP
Sbjct: 116 LKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAP 175

Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 176
           ELLL+ + YT AIDIWSVGCI  E++TR+PLFPG+DY+ QL LI E++G+P +  L F+ 
Sbjct: 176 ELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFIT 235

Query: 177 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 236
           S+ AR Y++ LP+  K+  +  FP  S  A+DLLEKMLVFDP KRIT +EAL HPYL  L
Sbjct: 236 SEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295

Query: 237 HDLNDEPVCPRPFHF-DFEHSSCTEDHIRELIWRE 270
           HD  DEPV   PF F  F+    TE+ ++ELI+ E
Sbjct: 296 HDPEDEPVAKPPFDFDFFDDDELTEEELKELIYEE 330

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  417 bits (1075), Expect = e-148
 Identities = 163/278 (58%), Positives = 206/278 (74%), Gaps = 6/278 (2%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
            +HEN+I I DIIRPP  ++FNDVYIV ELM+TDL+++I++ Q L++DH QYFLYQ+LRG
Sbjct: 60  FKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKT-QHLSNDHIQYFLYQILRG 118

Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE----TDFMTEYVVTRWYRAP 116
           LKY+HSA+VLHRDLKPSNLLLN +CDLKI DFGLAR        T F+TEYV TRWYRAP
Sbjct: 119 LKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAP 178

Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 176
           E++LN   YT AIDIWSVGCIL E+++  PLFPGKDY+HQL LI  ++G+P    L  + 
Sbjct: 179 EIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCII 238

Query: 177 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 236
           S  AR Y++ LP   K  +   FPN    A+DLL+KML F+P+KRITVEEAL HPYL+  
Sbjct: 239 SLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298

Query: 237 HDLNDEPVCPRPFHFDFE-HSSCTEDHIRELIWRESVK 273
           HD +DEPV   PF FDFE      ++ ++ELI+ E ++
Sbjct: 299 HDPSDEPVAEEPFPFDFELFDDLPKEKLKELIFEEIMR 336

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  380 bits (978), Expect = e-133
 Identities = 158/270 (58%), Positives = 206/270 (76%), Gaps = 6/270 (2%)

Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 62
           H+N+IAI+DI+RPP  D F DVY+V +LM++DLH II SDQ LT++H +YFLYQLLRGLK
Sbjct: 63  HDNIIAIRDILRPPGAD-FKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLK 121

Query: 63  YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSETD---FMTEYVVTRWYRAPE 117
           Y+HSA+V+HRDLKPSNLL+N  C+L+IGDFG+AR  ++S T+   FMTEYV TRWYRAPE
Sbjct: 122 YIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPE 181

Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 177
           LLL+  EYT AID+WSVGCI  E++ R  LFPGK+YVHQL+LI  ++GSP +  L  + S
Sbjct: 182 LLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS 241

Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH 237
           D  R+Y++ LPR +   ++  FP  S  A+DLL +ML FDP +RITVE+AL+HP+L   H
Sbjct: 242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH 301

Query: 238 DLNDEPVCPRPFHFDFEHSSCTEDHIRELI 267
           D +DEP CP PF FDFE    + + ++E I
Sbjct: 302 DPDDEPTCPPPFDFDFEAIELSREQLKEAI 331

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  361 bits (928), Expect = e-125
 Identities = 141/277 (50%), Positives = 190/277 (68%), Gaps = 5/277 (1%)

Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P    + F DVY+V  LM  DL+ I++  Q+L+DDH Q+ +YQ+LR
Sbjct: 71  MDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKC-QKLSDDHIQFLVYQILR 129

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSN+ +N  C+LKI DFGLAR T +   MT YV TRWYRAPE++
Sbjct: 130 GLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIM 187

Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T + LFPG D++ QL+ I  L+G+PD+  L  + S++
Sbjct: 188 LNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSES 247

Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ LP+  K+ F   F   +  A+DLLEKMLV DP+KRIT  EAL HPYL   HD 
Sbjct: 248 ARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP 307

Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 276
            DEPV P P+   FE    T D  +EL+++E + F P
Sbjct: 308 EDEPVAP-PYDQSFESRDLTVDEWKELVYKEIMNFKP 343

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  357 bits (917), Expect = e-124
 Identities = 153/276 (55%), Positives = 196/276 (71%), Gaps = 11/276 (3%)

Query: 2   EHENVIAI--KDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
            H+N+  +   DI+ P     FN++Y+  ELM+ DLHQIIRS Q LTD H Q F+YQ+L 
Sbjct: 60  GHKNITCLYDMDIVFP---GNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILC 116

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-----TDFMTEYVVTRWYR 114
           GLKY+HSA+VLHRDLKP NLL+NA C+LKI DFGLAR  SE       FMTEYV TRWYR
Sbjct: 117 GLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYR 176

Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF 174
           APE++L+   YT AID+WSVGCIL E++ R+P+F GKDYV QL  I +++G+PD+ +L  
Sbjct: 177 APEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR 236

Query: 175 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
           + S  A+ Y+R LP   K+ F + FPN +  A+DLLEK+L FDP KRI+VEEAL HPYL 
Sbjct: 237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLA 296

Query: 235 SLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRE 270
             HD +DEPVC +PF F FE     E+ +R++I  E
Sbjct: 297 IWHDPDDEPVCQKPFDFSFESEDSMEE-LRDMIIEE 331

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  327 bits (841), Expect = e-112
 Identities = 139/286 (48%), Positives = 196/286 (68%), Gaps = 13/286 (4%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           + H +++ IK I+ PP +  F D+Y+V+ELM++DLHQ+I+++  LT +H Q+FLYQLLR 
Sbjct: 56  LRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRA 115

Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART----TSETDFMTEYVVTRWYRAP 116
           LKY+H+A+V HRDLKP N+L NA C LKI DFGLAR     T    F T+YV TRWYRAP
Sbjct: 116 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 175

Query: 117 ELLLNC----TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL 172
           EL   C    ++YT AIDIWS+GCI  E++T +PLFPGK+ VHQL LIT+L+G+P   ++
Sbjct: 176 EL---CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232

Query: 173 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 232
             +R++ ARRY+  + + +   F+ +FPN    A+ LLE++L FDP  R T EEAL  PY
Sbjct: 233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPY 292

Query: 233 LQSLHDLNDEPVC-PRP-FHFDFEHSSCTEDHIRELIWRESVKFNP 276
            + L  +  EP   P     F+FE    T++ +RELI+RE ++++P
Sbjct: 293 FKGLAKVEREPSAQPITKLEFEFERRRLTKEDVRELIYREILEYHP 338

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  314 bits (808), Expect = e-107
 Identities = 120/253 (47%), Positives = 172/253 (67%), Gaps = 10/253 (3%)

Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGL 61
           +H N++ + ++I+    +   D+Y+V+E M+TDLH +IR++  L D H +Y +YQLL+ L
Sbjct: 65  DHPNIVKLLNVIK---AENDKDIYLVFEYMETDLHAVIRANI-LEDVHKRYIMYQLLKAL 120

Query: 62  KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD------FMTEYVVTRWYRA 115
           KY+HS +V+HRDLKPSN+LLN+ C +K+ DFGLAR+ SE +       +T+YV TRWYRA
Sbjct: 121 KYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRA 180

Query: 116 PELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL 175
           PE+LL  T YT  +D+WSVGCILGE++  +PLFPG   ++QL  I E+IG P    +  +
Sbjct: 181 PEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240

Query: 176 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
           +S  A   +  LP   ++      P  S  A+DLL+K+LVF+PNKR+T EEAL HPY+  
Sbjct: 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQ 300

Query: 236 LHDLNDEPVCPRP 248
            H+ +DEPV P P
Sbjct: 301 FHNPSDEPVLPYP 313

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  295 bits (756), Expect = e-100
 Identities = 133/270 (49%), Positives = 178/270 (65%), Gaps = 7/270 (2%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           + HEN+I++ DI   P      D+Y V EL+ TDLH+++ S + L     QYFLYQ+LRG
Sbjct: 66  LRHENIISLSDIFISP----LEDIYFVTELLGTDLHRLLTS-RPLEKQFIQYFLYQILRG 120

Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 120
           LKYVHSA V+HRDLKPSN+L+N +CDLKI DFGLAR       MT YV TR+YRAPE++L
Sbjct: 121 LKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ--MTGYVSTRYYRAPEIML 178

Query: 121 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 180
              +Y   +DIWS GCI  E++  +PLFPGKD+V+Q  +IT+L+G+P D  +  + S+N 
Sbjct: 179 TWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENT 238

Query: 181 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 240
            R+V+ LP+     F+ +F N    A+DLLEKMLVFDP KRI+  EAL HPYL   HD  
Sbjct: 239 LRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPT 298

Query: 241 DEPVCPRPFHFDFEHSSCTEDHIRELIWRE 270
           DEPV    F + F  +    D  + +++ E
Sbjct: 299 DEPVAEEKFDWSFNDADLPVDTWKVMMYSE 328

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  287 bits (736), Expect = 2e-97
 Identities = 111/235 (47%), Positives = 146/235 (62%), Gaps = 8/235 (3%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQ-LTDDHCQYFLYQLLR 59
           + H N+I + D+ R        D+Y+V+E MDTDL+++I+  Q+ L +   + +LYQLL+
Sbjct: 55  LNHPNIIKLLDVFRHK-----GDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQ 109

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPEL 118
           GL + HS  +LHRDLKP NLL+N    LK+ DFGLAR+  S     T YVVTRWYRAPEL
Sbjct: 110 GLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPEL 169

Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 178
           LL    Y+  +DIWSVGCI  E+++R PLFPGK  + QL  I   +G+PD        S 
Sbjct: 170 LLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTS- 228

Query: 179 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
            AR Y    P+         FPN S  A+DLL +ML +DP+KRIT E+AL HPY 
Sbjct: 229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  285 bits (731), Expect = 6e-96
 Identities = 138/277 (49%), Positives = 182/277 (65%), Gaps = 5/277 (1%)

Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 73  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 131

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T +   MT YV TRWYRAPE++
Sbjct: 132 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIM 189

Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 190 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 249

Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 250 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 309

Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 276
           +DEPV   P+   FE      D  + L + E + F P
Sbjct: 310 DDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 345

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  278 bits (713), Expect = 3e-93
 Identities = 131/277 (47%), Positives = 180/277 (64%), Gaps = 5/277 (1%)

Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P    + FN+VY+V  LM  DL+ I++  Q+L+D+H Q+ +YQLLR
Sbjct: 71  MKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKC-QKLSDEHVQFLIYQLLR 129

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSN+ +N  C+L+I DFGLAR     D MT YV TRWYRAPE++
Sbjct: 130 GLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD--DEMTGYVATRWYRAPEIM 187

Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++  + LFPG DY+ QL+ I E++G+P    L  + S++
Sbjct: 188 LNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEH 247

Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR+Y++ LP   +Q     F   +  A+DLLEKMLV D +KRI+  EAL HPY    HD 
Sbjct: 248 ARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDP 307

Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 276
            DEP    P+    E+   T +  +EL + E   F P
Sbjct: 308 EDEPEAE-PYDESPENKERTIEEWKELTYEEVSSFKP 343

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  279 bits (715), Expect = 5e-93
 Identities = 123/293 (41%), Positives = 177/293 (60%), Gaps = 29/293 (9%)

Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 62
           H+NV++  DI++PP  D F ++Y+V ELM +DLH+II S Q L+ DH + FLYQ+LRGLK
Sbjct: 58  HDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLK 117

Query: 63  YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS--ETDFMTEYVVTRWYRAPELLL 120
           Y+HSA +LHRD+KP NLL+N++C LKI DFGLAR     E+  MT+ VVT++YRAPE+L+
Sbjct: 118 YLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILM 177

Query: 121 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 180
               YT+A+DIWSVGCI  E++ R  LF  +  + QL LIT+L+G+P   ++       A
Sbjct: 178 GSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE-GA 236

Query: 181 RRYVRQLPRCRKQQFATRFPNKSSG----AVDLLEKMLVFDPNKRITVEEALRHPYLQS- 235
           R ++ + P   K          SS     AV LL +MLVFDP+KRI+  +AL HPYL   
Sbjct: 237 RAHILRGP--HKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294

Query: 236 -------------------LHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWR 269
                              ++  + EP    PF  ++E +  +   ++E + +
Sbjct: 295 RLRYHTCMCKCCYTTSGGRVYTSDFEPSANPPFDDEYEKNLTSVRQVKEELHQ 347

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  276 bits (708), Expect = 2e-92
 Identities = 128/277 (46%), Positives = 183/277 (66%), Gaps = 5/277 (1%)

Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P    D F+D Y+V   M TDL ++++  ++L++D  Q+ +YQ+L+
Sbjct: 71  MKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH-EKLSEDRIQFLVYQMLK 129

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+H+A ++HRDLKP NL +N  C+LKI DFGLAR T     MT YVVTRWYRAPE++
Sbjct: 130 GLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE--MTGYVVTRWYRAPEVI 187

Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   YT  +DIWSVGCI+ E++T +PLF G D++ QL  I ++ G+P    +  L+S++
Sbjct: 188 LNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSED 247

Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           A+ YV++LPR RK+ F +  PN +  AV++LEKMLV D   RIT  EAL HPY +  HD 
Sbjct: 248 AKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP 307

Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 276
            DE   P P+   F+    + +  + L + E + F P
Sbjct: 308 EDETEAP-PYDDSFDEVDQSLEEWKRLTFTEILSFQP 343

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  276 bits (707), Expect = 3e-92
 Identities = 126/277 (45%), Positives = 172/277 (62%), Gaps = 6/277 (2%)

Query: 1   MEHENVIAIKDIIRP-PKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+       D F D Y+V   M TDL +I+     L++D  QY +YQ+L 
Sbjct: 71  MQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIM--GHPLSEDKVQYLVYQMLC 128

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKP NL +N  C+LKI DFGLAR       MT YVVTRWYRAPE++
Sbjct: 129 GLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVI 186

Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T + LF GKDY+ QL  I ++ G P    +  L    
Sbjct: 187 LNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKA 246

Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           A+ Y++ LP+  ++ F+T FP  S  AVDLLEKML  D +KR+T  EAL HPY  S  D 
Sbjct: 247 AKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306

Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 276
           ++E    +P+    E+   + D  ++ I++E   F+P
Sbjct: 307 DEETE-QQPYDDSLENEKLSVDEWKKHIYKEVKSFSP 342

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  269 bits (691), Expect = 1e-90
 Identities = 95/236 (40%), Positives = 137/236 (58%), Gaps = 11/236 (4%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLR 59
           ++H N++ + D+I   +K     +Y+V+E  D DL + +      L+ +  +  +YQLLR
Sbjct: 55  LKHPNIVKLLDVIHTERK-----LYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLR 109

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPEL 118
           GL Y HS  +LHRDLKP N+L+N    LK+ DFGLAR         T  VVT WYRAPE+
Sbjct: 110 GLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEI 169

Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDAS-LGFLRS 177
           LL    Y+ A+DIWSVGCI  E++T +PLFPG   + QL  I +++G+P + S  G  + 
Sbjct: 170 LLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKL 229

Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
            +   Y    P+   +      P      +DLL KML ++P KRI+ +EAL+HPY 
Sbjct: 230 PD---YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score =  260 bits (665), Expect = 8e-86
 Identities = 124/288 (43%), Positives = 173/288 (60%), Gaps = 25/288 (8%)

Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H+N+I + ++  P K  + F DVY+V ELMD +L Q+I+ D  L  +   Y LYQ+L 
Sbjct: 72  VNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMD--LDHERMSYLLYQMLC 129

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ + C LKI DFGLART   +  MT YVVTR+YRAPE++
Sbjct: 130 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 189

Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           L    Y   +DIWSVGCI+GE++    LFPG D++ Q   I E +G+P D  +  L+   
Sbjct: 190 LG-MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQP-T 247

Query: 180 ARRYVRQLPRCRKQQFATRFP-------------NKSSGAVDLLEKMLVFDPNKRITVEE 226
            R YV   P+     F   FP              K+S A DLL KMLV DP KRI+V++
Sbjct: 248 VRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDD 307

Query: 227 ALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHI----RELIWRE 270
           AL+HPY+   +D   E   P P  +D  HS    +H     +ELI++E
Sbjct: 308 ALQHPYINVWYD-PSEVEAPPPAPYD--HSIDEREHTVEEWKELIYKE 352

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  253 bits (648), Expect = 4e-84
 Identities = 91/237 (38%), Positives = 138/237 (58%), Gaps = 10/237 (4%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLR 59
           + H N++ +K+I+    K     +Y+V+E MD DL  ++ S + + T+   + ++ QLL 
Sbjct: 55  LRHPNIVRLKEIVTSKGK---GSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLE 111

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS--ETDFMTEYVVTRWYRAPE 117
           GL+Y+HS  +LHRD+K SN+L+N    LK+ DFGLAR  +   +   T  V+T WYR PE
Sbjct: 112 GLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPE 171

Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL-GFLR 176
           LLL  T Y   +D+WSVGCIL E+   +P+F G   + QL  I EL GSP D +  G  +
Sbjct: 172 LLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSK 231

Query: 177 SDNARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPY 232
                    +  +  K++    F +     A+DLL+K+L  DP KRI+ ++AL+H Y
Sbjct: 232 LPWFENL--KPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  238 bits (608), Expect = 2e-77
 Identities = 113/295 (38%), Positives = 165/295 (55%), Gaps = 37/295 (12%)

Query: 1   MEHENVIAIKDIIRPPKKD---------TFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQ 51
           ++H+N++ + +++ P   D           N VYIV E M+TDL  ++     L+++H +
Sbjct: 59  LDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVL-EQGPLSEEHAR 117

Query: 52  YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTT----SETDFMTE 106
            F+YQLLRGLKY+HSA+VLHRDLKP+N+ +N     LKIGDFGLAR      S   +++E
Sbjct: 118 LFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSE 177

Query: 107 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGS 166
            +VT+WYR+P LLL+   YT AID+W+ GCI  E++T +PLF G   + Q++LI E +  
Sbjct: 178 GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237

Query: 167 PDDASLG--------FLRSDNA--RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVF 216
             +            F+R+D    RR +R L            P  +  A+D LE++L F
Sbjct: 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDL-----------LPGVNPEALDFLEQILTF 286

Query: 217 DPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTE-DHIRELIWRE 270
           +P  R+T EEAL HPY+       DEPV   PFH + E         I  +I+  
Sbjct: 287 NPMDRLTAEEALMHPYMSCYSCPFDEPVSLHPFHIEDELDDILLMTEIHSIIYNW 341

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  231 bits (592), Expect = 2e-75
 Identities = 97/234 (41%), Positives = 135/234 (57%), Gaps = 10/234 (4%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLR 59
           ++H N+I + D+     K   N   +V+E M+TDL ++I+     LT    + ++   LR
Sbjct: 59  LKHPNIIGLLDVF--GHKSNIN---LVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLR 113

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDFMTEYVVTRWYRAPEL 118
           GL+Y+HS  +LHRDLKP+NLL+ +   LK+ DFGLAR+  S    MT  VVTRWYRAPEL
Sbjct: 114 GLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPEL 173

Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 178
           L     Y   +D+WSVGCI  E++ R P  PG   + QL  I E +G+P + +   + S 
Sbjct: 174 LFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSL 233

Query: 179 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 232
               YV   P          FP  S  A+DLL+++L  +PNKRIT  +AL HPY
Sbjct: 234 P--DYVEFKPF-PPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPY 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  227 bits (582), Expect = 2e-74
 Identities = 83/232 (35%), Positives = 127/232 (54%), Gaps = 34/232 (14%)

Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 61
           H N++ + D+      +  + +Y+V E  +  DL  +++   +L++D  +++L Q+L  L
Sbjct: 56  HPNIVRLYDVF-----EDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSAL 110

Query: 62  KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 121
           +Y+HS  ++HRDLKP N+LL+    +K+ DFGLAR     + +T +V T  Y APE+LL 
Sbjct: 111 EYLHSKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLL- 169

Query: 122 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR 181
              Y  A+DIWS+G IL E++T +P FPG D   QL  + + IG P              
Sbjct: 170 GKGYGKAVDIWSLGVILYELLTGKPPFPGDD---QLLELFKKIGKP-------------- 212

Query: 182 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
                     K  F     + S  A DL+ K+LV DP KR+T EEAL+HP+ 
Sbjct: 213 ----------KPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  226 bits (578), Expect = 2e-73
 Identities = 96/236 (40%), Positives = 136/236 (57%), Gaps = 12/236 (5%)

Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQII-RSDQQLTDDHCQYFLYQLLRGL 61
           H N++ +K+++        + +Y+V E ++ DL  ++    Q       +  + QLL G+
Sbjct: 63  HPNIVTVKEVV---VGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGV 119

Query: 62  KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-TDFMTEYVVTRWYRAPELLL 120
            ++H   +LHRDLK SNLLLN    LKI DFGLAR         T+ VVT WYRAPELLL
Sbjct: 120 AHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLL 179

Query: 121 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL-GFLRSDN 179
              EY+ AID+WSVGCI  E++T++PLFPGK  + QL  I +L+G+P +    GF     
Sbjct: 180 GAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG 239

Query: 180 ARRYVRQ-LPRCRKQQFATRFPNK--SSGAVDLLEKMLVFDPNKRITVEEALRHPY 232
           A++      P     Q   +FP    S    DLL ++L +DP KRI+ E+AL+HPY
Sbjct: 240 AKKKTFTKYPYN---QLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  224 bits (574), Expect = 7e-73
 Identities = 89/244 (36%), Positives = 138/244 (56%), Gaps = 28/244 (11%)

Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQ--LTDDHCQYFLYQLLR 59
           EH N++ +K++ R       +++Y V+E M+ +L+Q+++  +    ++   +  +YQ+L+
Sbjct: 56  EHPNIVKLKEVFR-----ENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQ 110

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GL ++H     HRDLKP NLL++    +KI DFGLAR        T+YV TRWYRAPE+L
Sbjct: 111 GLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEIL 170

Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDD---------- 169
           L  T Y++ +DIW++GCI+ E+ T  PLFPG   + QL  I  ++G+P            
Sbjct: 171 LRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLA 230

Query: 170 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 229
           + LGF           + P+          PN S  A+DL++ ML +DP KR T  +AL+
Sbjct: 231 SKLGF-----------RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279

Query: 230 HPYL 233
           HPY 
Sbjct: 280 HPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  220 bits (563), Expect = 3e-71
 Identities = 87/238 (36%), Positives = 142/238 (59%), Gaps = 13/238 (5%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIR-SDQQLTDDHCQYFLYQLLR 59
            +H  V+ + D+         +   +V E M +DL +++R  ++ L +   + ++  LL+
Sbjct: 56  CQHPYVVKLLDVFPHG-----SGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLK 110

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPE 117
           G+ Y+H+  ++HRDLKP+NLL++A   LKI DFGLAR  SE +    +  V TRWYRAPE
Sbjct: 111 GVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPE 170

Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 177
           LL    +Y   +D+W+VGCI  E++   PLFPG++ + QL ++   +G+P++ +   L S
Sbjct: 171 LLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTS 230

Query: 178 --DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
             D  +    +      ++    FP+ S  A+DLL+ +LV+DP+KR++  EALRHPY 
Sbjct: 231 LPDYNKITFPESKPIPLEEI---FPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score =  216 bits (550), Expect = 2e-68
 Identities = 120/287 (41%), Positives = 170/287 (59%), Gaps = 24/287 (8%)

Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H+N+I++ ++  P K  + F DVY+V ELMD +L Q+I  +  L  +   Y LYQ+L 
Sbjct: 77  VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHME--LDHERMSYLLYQMLC 134

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ + C LKI DFGLART      MT YVVTR+YRAPE++
Sbjct: 135 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVI 194

Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS-- 177
           L    Y   +DIWSVGCI+GE++    +F G D++ Q   + E +G+P   S  F+    
Sbjct: 195 LG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTP---SAEFMNRLQ 250

Query: 178 DNARRYVRQLPRCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVE 225
              R YV   P+     F   FP+            K+S A DLL KMLV DP+KRI+V+
Sbjct: 251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVD 310

Query: 226 EALRHPYLQSLHDLNDEPVCPRPFHFD--FEHSSCTEDHIRELIWRE 270
           EALRHPY+   +D   E   P P  +D   E      +  +ELI++E
Sbjct: 311 EALRHPYITVWYD-PAEAEAPPPQIYDAQLEEREHAIEEWKELIYKE 356

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score =  214 bits (546), Expect = 6e-68
 Identities = 119/284 (41%), Positives = 175/284 (61%), Gaps = 18/284 (6%)

Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H+N+I++ ++  P K  + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L 
Sbjct: 73  VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLC 130

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ + C LKI DFGLART   +  MT YVVTR+YRAPE++
Sbjct: 131 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190

Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           L    Y   +DIWSVGCI+GE++  + LFPG+DY+ Q   + E +G+P    +  L+   
Sbjct: 191 LG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-T 248

Query: 180 ARRYVRQLPRCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEA 227
            R YV   P+     F   FP+            K+S A DLL KMLV DP KRI+V+EA
Sbjct: 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEA 308

Query: 228 LRHPYLQSLHDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRE 270
           L+HPY+   +D  + E   P+ +    +    T +  +ELI++E
Sbjct: 309 LQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKE 352

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score =  212 bits (540), Expect = 5e-67
 Identities = 118/284 (41%), Positives = 170/284 (59%), Gaps = 18/284 (6%)

Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H+N+I + ++  P K  + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L 
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLC 137

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ + C LKI DFGLART   +  MT YVVTR+YRAPE++
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197

Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           L    Y   +DIWSVGCI+GE++    LFPG D++ Q   + E +G+P    +  L+   
Sbjct: 198 LG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP-T 255

Query: 180 ARRYVRQLPRCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEA 227
            R YV   P+     F   FP+            K+S A DLL KMLV D +KRI+V+EA
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315

Query: 228 LRHPYLQSLHD-LNDEPVCPRPFHFDFEHSSCTEDHIRELIWRE 270
           L+HPY+   +D    E   P+      +    T +  +ELI++E
Sbjct: 316 LQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKE 359

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  208 bits (532), Expect = 1e-66
 Identities = 98/243 (40%), Positives = 137/243 (56%), Gaps = 24/243 (9%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS--DQQLTDDHCQYFLYQLL 58
           + H N++ + D++    K     +Y+V+E +D DL + + S     L     + +LYQLL
Sbjct: 55  LNHPNIVRLLDVVHSENK-----LYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLL 109

Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF------MTEYVVTRW 112
           +G+ Y HS  VLHRDLKP NLL++    LK+ DFGLAR      F       T  VVT W
Sbjct: 110 QGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARA-----FGVPVRTYTHEVVTLW 164

Query: 113 YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL 172
           YRAPE+LL   +Y+  +DIWS+GCI  E++ R PLFPG   + QL  I   +G+PD+   
Sbjct: 165 YRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVW 224

Query: 173 GFLRS--DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 230
             + S  D    Y    P+  +Q  +   PN     +DLL KMLV+DP KRI+ + AL+H
Sbjct: 225 PGVTSLPD----YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280

Query: 231 PYL 233
           PY 
Sbjct: 281 PYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  205 bits (524), Expect = 9e-66
 Identities = 79/235 (33%), Positives = 124/235 (52%), Gaps = 31/235 (13%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H N++ + D          + +Y+V E  +  DL   +     L++D  +    Q+LR
Sbjct: 55  LSHPNIVRLIDAFE-----DKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILR 109

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPEL 118
           GL+Y+HS  ++HRDLKP N+LL+ +  +KI DFGLA+   ++   +T +V T WY APE+
Sbjct: 110 GLEYLHSNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEV 169

Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 178
           LL    Y   +D+WS+G IL E++T +P F G++ + QL+LI  ++G P +       S 
Sbjct: 170 LLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSS- 228

Query: 179 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
                                   S  A DL++K L  DP+KR T EE L+HP+ 
Sbjct: 229 -----------------------GSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  205 bits (523), Expect = 2e-65
 Identities = 85/233 (36%), Positives = 135/233 (57%), Gaps = 11/233 (4%)

Query: 3   HENVIAIKDII--RPPKKDTFNDVYIVYELMDTDLHQIIRSDQQ-LTDDHCQYFLYQLLR 59
           H N++ + +++  R   +        V+ELMD +L+++I+  ++ L +   + ++YQLL+
Sbjct: 57  HPNILRLIEVLFDRKTGRLAL-----VFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLK 111

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
            L ++H   + HRD+KP N+L+     LK+ DFG  R        TEY+ TRWYRAPE L
Sbjct: 112 SLDHMHRNGIFHRDIKPENILIKDDI-LKLADFGSCRGIYSKPPYTEYISTRWYRAPECL 170

Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           L    Y   +DIW+VGC+  EI++  PLFPG + + Q+  I +++G+PD   L   R   
Sbjct: 171 LTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR 230

Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 232
              Y    P  +        PN S+  +DLL+K+L +DP++RIT ++ALRHPY
Sbjct: 231 HMNY--NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  203 bits (519), Expect = 1e-64
 Identities = 92/240 (38%), Positives = 131/240 (54%), Gaps = 19/240 (7%)

Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIR--SDQQLTDDHCQYFLYQLLR 59
           EH N++ + D+   P+ D    + +V+E +D DL   +       L  +  +  + QLLR
Sbjct: 59  EHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLR 118

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           G+ ++HS  ++HRDLKP N+L+ +   +KI DFGLAR  S    +T  VVT WYRAPE+L
Sbjct: 119 GVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVL 178

Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGS------PDDASLG 173
           L  + Y   +D+WSVGCI  E+  R PLF G     QL  I ++IG       P + SL 
Sbjct: 179 LQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSL- 236

Query: 174 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
             RS          P    + F +  P      +DLL+KML F+P+KRI+  EAL+HPY 
Sbjct: 237 -PRS--------SFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  203 bits (518), Expect = 3e-64
 Identities = 95/235 (40%), Positives = 138/235 (58%), Gaps = 8/235 (3%)

Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQ-LTDDHCQYFLYQLLRGL 61
           H N++ +K+++        + +++V E  + DL  ++ +     ++   +  + QLLRGL
Sbjct: 65  HPNIVELKEVV---VGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGL 121

Query: 62  KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF-MTEYVVTRWYRAPELLL 120
           +Y+H   ++HRDLK SNLLL     LKI DFGLART       MT  VVT WYRAPELLL
Sbjct: 122 QYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLL 181

Query: 121 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL-GFLRSDN 179
            CT YT AID+W+VGCIL E++  +PL PGK  + QL LI +L+G+P+++   GF     
Sbjct: 182 GCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL 241

Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
             ++   LP+        +FP  S   + LL  +L++DP KR T EEAL   Y +
Sbjct: 242 VGKFT--LPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK 294

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  202 bits (515), Expect = 9e-64
 Identities = 95/255 (37%), Positives = 131/255 (51%), Gaps = 35/255 (13%)

Query: 3   HENVIAIKDII--RPPK-KDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLL 58
           H NV+ + D+   RP K K     VY+V   MD DL  ++ +   +LT+   + ++ QLL
Sbjct: 66  HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLL 125

Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR-------------TTSETDFMT 105
            G+ Y+H   +LHRD+K +N+L++    LKI DFGLAR                   + T
Sbjct: 126 EGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKY-T 184

Query: 106 EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG 165
             VVTRWYR PELLL    YT A+DIW +GC+  E+ TR P+  GK  + QL LI +L G
Sbjct: 185 NLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCG 244

Query: 166 SPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK--------SSGAVDLLEKMLVFD 217
           +P + +    RS         LP C      T +P              +DLL K+L  D
Sbjct: 245 TPTEETWPGWRS---------LPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLD 295

Query: 218 PNKRITVEEALRHPY 232
           P KR+T  +AL HPY
Sbjct: 296 PYKRLTASDALEHPY 310

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  199 bits (508), Expect = 5e-63
 Identities = 92/237 (38%), Positives = 135/237 (56%), Gaps = 13/237 (5%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQ---LTDDHCQYFLYQL 57
           ++HEN++ + D+I      T N + +V+E MD DL + + +      L  +  + F YQL
Sbjct: 55  LKHENIVRLHDVIH-----TENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQL 109

Query: 58  LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART--TSETDFMTEYVVTRWYRA 115
           L+G+ + H   VLHRDLKP NLL+N   +LK+ DFGLAR        F  E VVT WYRA
Sbjct: 110 LKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNE-VVTLWYRA 168

Query: 116 PELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL 175
           P++LL    Y+ +IDIWSVGCI+ E++T  PLFPG +   QL  I  ++G+P +++    
Sbjct: 169 PDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWP-- 226

Query: 176 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 232
                  Y    PR   Q     FP+     +DLL ++L  +P  RI+  +AL+HP+
Sbjct: 227 GISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  197 bits (502), Expect = 1e-61
 Identities = 96/274 (35%), Positives = 151/274 (55%), Gaps = 41/274 (14%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           ++HEN++ + D+    + D  N   +V ++M +DL +++    +LT+   +  L Q+L G
Sbjct: 77  IKHENIMGLVDVY--VEGDFIN---LVMDIMASDLKKVVDRKIRLTESQVKCILLQILNG 131

Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR---------------TTSETDFMT 105
           L  +H    +HRDL P+N+ +N+    KI DFGLAR               T    + MT
Sbjct: 132 LNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMT 191

Query: 106 EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG 165
             VVT WYRAPELL+   +Y  A+D+WSVGCI  E++T +PLFPG++ + QL  I EL+G
Sbjct: 192 SKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLG 251

Query: 166 SPDDASLGFLRSDNARRYVRQLP------RCRKQQFATRFPNKSSGAVDLLEKMLVFDPN 219
           +P         +++     ++LP        + +   T FPN S  A+DLL+ +L  +P 
Sbjct: 252 TP---------NEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPL 302

Query: 220 KRITVEEALRHPYLQSLHDLNDEPVCPR--PFHF 251
           +RI+ +EAL+H Y +S    +  P  P   PF+F
Sbjct: 303 ERISAKEALKHEYFKS----DPLPCDPSQLPFNF 332

Length = 335

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  193 bits (493), Expect = 1e-60
 Identities = 84/237 (35%), Positives = 136/237 (57%), Gaps = 9/237 (3%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQII-RSDQQLTDDHCQYFLYQLLR 59
           + HEN++ +K+  R   +     +Y+V+E ++  L +++  S   L  D  + +++QLL+
Sbjct: 57  LRHENIVNLKEAFRRKGR-----LYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQ 111

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE--TDFMTEYVVTRWYRAPE 117
            + Y HS +++HRD+KP N+L++ S  LK+ DFG AR         +T+YV TRWYRAPE
Sbjct: 112 AIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPE 171

Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 177
           LL+  T Y   +D+W++GCI+ E++  EPLFPG   + QL LI + +G    +      S
Sbjct: 172 LLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSS 231

Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSG-AVDLLEKMLVFDPNKRITVEEALRHPYL 233
           +     V      + +    R+P K S  A+D L+  L  DP +R+T +E L+HPY 
Sbjct: 232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  193 bits (493), Expect = 1e-60
 Identities = 92/239 (38%), Positives = 131/239 (54%), Gaps = 13/239 (5%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDH-CQYFLYQLLR 59
           ++H N++ + DII   K  T      V+E +DTDL Q +         H  + FL+QLLR
Sbjct: 60  LKHANIVTLHDIIHTKKTLTL-----VFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLR 114

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPEL 118
           GL Y H   VLHRDLKP NLL++   +LK+ DFGLAR  S  +   +  VVT WYR P++
Sbjct: 115 GLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDV 174

Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPG-KDYVHQLRLITELIGSP-DDASLGFLR 176
           LL  TEY+ ++D+W VGCI  E+ T  PLFPG  D   QL  I  ++G+P ++   G   
Sbjct: 175 LLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSS 234

Query: 177 SDNARRYVRQLPRCRKQQFATRFP--NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
           +   + Y    P    +      P  ++     +L  K L ++P KRI+  EA++HPY 
Sbjct: 235 NPEFKPY--SFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  193 bits (491), Expect = 2e-60
 Identities = 93/235 (39%), Positives = 133/235 (56%), Gaps = 10/235 (4%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLL 58
           + H N++ + D+I    K     +Y+V+E +  DL + + +     +     + +L+QLL
Sbjct: 56  LNHPNIVKLLDVIHTENK-----LYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLL 110

Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE
Sbjct: 111 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 170

Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 177
           +LL C  Y+ A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S
Sbjct: 171 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 230

Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 232
                Y    P+  +Q F+   P       DLL +ML +DPNKRI+ + AL HP+
Sbjct: 231 --LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  193 bits (491), Expect = 2e-60
 Identities = 96/242 (39%), Positives = 139/242 (57%), Gaps = 11/242 (4%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDH--CQYFLYQLL 58
           M+H N++ ++D++   K+     +Y+V+E +D DL + + S      +    + +LYQ+L
Sbjct: 58  MQHGNIVRLQDVVHSEKR-----LYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQIL 112

Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCD-LKIGDFGLARTTS-ETDFMTEYVVTRWYRAP 116
           RG+ Y HS  VLHRDLKP NLL++   + LK+ DFGLAR         T  VVT WYRAP
Sbjct: 113 RGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAP 172

Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 176
           E+LL    Y+  +DIWSVGCI  E++ ++PLFPG   + +L  I  ++G+P++ +   + 
Sbjct: 173 EILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVT 232

Query: 177 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 236
           S     Y    P+   +  AT  P      VDLL KML  DP+KRIT   AL H Y + L
Sbjct: 233 S--LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290

Query: 237 HD 238
            D
Sbjct: 291 GD 292

Length = 294

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  188 bits (479), Expect = 1e-58
 Identities = 85/237 (35%), Positives = 135/237 (56%), Gaps = 11/237 (4%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQI---IRSDQQLTDDHCQYFLYQL 57
           ++H N++ ++D++    +     +Y+++E +  DL +    +   Q +  +  + +LYQ+
Sbjct: 56  LQHPNIVCLQDVLMQESR-----LYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQI 110

Query: 58  LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAP 116
           L+G+ + HS  VLHRDLKP NLL++    +K+ DFGLAR         T  VVT WYRAP
Sbjct: 111 LQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAP 170

Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 176
           E+LL    Y+  +DIWS+G I  E+ T++PLF G   + QL  I  ++G+P +     + 
Sbjct: 171 EVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVT 230

Query: 177 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
           S     Y    P+ +K    +   N     +DLLEKML++DP KRI+ ++AL HPY 
Sbjct: 231 S--LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  185 bits (470), Expect = 3e-57
 Identities = 98/239 (41%), Positives = 135/239 (56%), Gaps = 10/239 (4%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDH-CQYFLYQLLR 59
           ++H N++ + DII   K  T     +V+E +D DL Q +       + H  + FL+QLLR
Sbjct: 61  LKHANIVTLHDIIHTEKSLT-----LVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLR 115

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPEL 118
           GL Y H   VLHRDLKP NLL+N   +LK+ DFGLAR  S  T   +  VVT WYR P++
Sbjct: 116 GLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDI 175

Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL-GFLRS 177
           LL  T+Y+  ID+W VGCI  E+ T  PLFPG     QL  I  ++G+P + +  G L +
Sbjct: 176 LLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 235

Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 236
           +  + Y    P+ R        P   S   +LL K+L F+  KRI+ EEA++HPY   L
Sbjct: 236 EEFKSY--NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  184 bits (470), Expect = 4e-57
 Identities = 101/245 (41%), Positives = 142/245 (57%), Gaps = 17/245 (6%)

Query: 1   MEHENVIAIKDIIRPP------KKDTFNDVYIVYELMDTDLHQIIRSDQ-QLTDDHCQYF 53
           + H N++ +K+I+         KKD     Y+V+E MD DL  ++ S     ++DH + F
Sbjct: 63  LNHRNIVNLKEIVTDKQDALDFKKDKGA-FYLVFEYMDHDLMGLLESGLVHFSEDHIKSF 121

Query: 54  LYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSETDFMTEYVVTR 111
           + QLL GL Y H  + LHRD+K SN+LLN    +K+ DFGLAR   + E+   T  V+T 
Sbjct: 122 MKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITL 181

Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA- 170
           WYR PELLL    Y  AID+WS GCILGE+ T++P+F     + QL LI+ L GSP  A 
Sbjct: 182 WYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAV 241

Query: 171 --SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL 228
              +  L   N  +  +Q  R  +++F+   P   + A+DLL+ ML  DP+KR T EEAL
Sbjct: 242 WPDVIKLPYFNTMKPKKQYRRRLREEFSF-IP---TPALDLLDHMLTLDPSKRCTAEEAL 297

Query: 229 RHPYL 233
             P+L
Sbjct: 298 NSPWL 302

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  182 bits (464), Expect = 3e-56
 Identities = 86/217 (39%), Positives = 128/217 (58%), Gaps = 12/217 (5%)

Query: 24  VYIVYELMDTDLHQIIRSDQQ-----LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 78
           +Y+V+E +D+DL + + S+ +     L     + F+YQLL+G+ + H   V+HRDLKP N
Sbjct: 81  LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQN 140

Query: 79  LLLNASCD-LKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 136
           LL++     LKI D GL R  +      T  +VT WYRAPE+LL  T Y+  +DIWSVGC
Sbjct: 141 LLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGC 200

Query: 137 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL-GFLRSDNARRYVRQLPRCRKQQF 195
           I  E+  ++PLFPG   + QL  I +L+G+P +    G  +  +   +    P+ + Q  
Sbjct: 201 IFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEF----PQWKPQDL 256

Query: 196 ATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 232
           +   P+ S   +DLL+KML +DP KRI+ + AL HPY
Sbjct: 257 SRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  180 bits (459), Expect = 1e-55
 Identities = 91/237 (38%), Positives = 133/237 (56%), Gaps = 14/237 (5%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDH-CQYFLYQLLR 59
           ++H+N++ + D++   KK T     +V+E  D DL +   S     D    + F++QLL+
Sbjct: 56  LKHKNIVRLYDVLHSDKKLT-----LVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLK 110

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART--TSETDFMTEYVVTRWYRAPE 117
           GL + HS +VLHRDLKP NLL+N + +LK+ DFGLAR        +  E VVT WYR P+
Sbjct: 111 GLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAE-VVTLWYRPPD 169

Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPDDASL-GFL 175
           +L     Y+ +ID+WS GCI  E+     PLFPG D   QL+ I  L+G+P + S  G  
Sbjct: 170 VLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVS 229

Query: 176 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 232
           +  + + Y                P  +S   DLL+ +LV +P +RI+ EEAL+HPY
Sbjct: 230 KLPDYKPYPMYPATTSLVNVV---PKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  180 bits (457), Expect = 2e-55
 Identities = 95/236 (40%), Positives = 137/236 (58%), Gaps = 10/236 (4%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDH-CQYFLYQLLR 59
           ++H N++ + DII   +  T     +V+E +D+DL Q + +   L   H  + F++QLLR
Sbjct: 60  LKHANIVTLHDIIHTERCLT-----LVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLR 114

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPEL 118
           GL Y H   +LHRDLKP NLL+N   +LK+ DFGLAR  S  T   +  VVT WYR P++
Sbjct: 115 GLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDV 174

Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP-DDASLGFLRS 177
           LL  TEY+  ID+W VGCIL E+ T  P+FPG     +L LI  L+G+P ++   G   +
Sbjct: 175 LLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSN 234

Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
           +  R Y+   P+ R Q      P   +  +DLL  +L+++   RI+ E ALRH Y 
Sbjct: 235 EEFRSYL--FPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  180 bits (458), Expect = 4e-55
 Identities = 92/263 (34%), Positives = 138/263 (52%), Gaps = 37/263 (14%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIR-----SDQQLTDDHCQYFLY 55
           ++HENV+++ ++     +     VY++++  + DL QII+         +     +  L+
Sbjct: 59  LKHENVVSLVEVFL---EHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLW 115

Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCD----LKIGDFGLAR-------TTSETDFM 104
           Q+L G+ Y+HS  VLHRDLKP+N+L+         +KIGD GLAR         ++ D  
Sbjct: 116 QILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD-- 173

Query: 105 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD---------YVH 155
              VVT WYRAPELLL    YT AIDIW++GCI  E++T EP+F G++            
Sbjct: 174 -PVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRD 232

Query: 156 QLRLITELIGSPDDASLGFLRS----DNARRYVRQL--PRCRKQQFATRFPNKSSGAVDL 209
           QL  I E++G+P +     ++     D   +  +    P     ++  +     S   DL
Sbjct: 233 QLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDL 292

Query: 210 LEKMLVFDPNKRITVEEALRHPY 232
           L K+L +DP KRIT EEAL HPY
Sbjct: 293 LRKLLEYDPTKRITAEEALEHPY 315

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  176 bits (448), Expect = 7e-54
 Identities = 95/239 (39%), Positives = 137/239 (57%), Gaps = 10/239 (4%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDH-CQYFLYQLLR 59
           ++H N++ + DI+   K  T     +V+E +D DL Q +     +   H  + FLYQ+LR
Sbjct: 61  LKHANIVTLHDIVHTDKSLT-----LVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILR 115

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPEL 118
           GL Y H   VLHRDLKP NLL+N   +LK+ DFGLAR  S  T   +  VVT WYR P++
Sbjct: 116 GLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDV 175

Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP-DDASLGFLRS 177
           LL  +EY+  ID+W VGCI  E+ +  PLFPG     +L LI  L+G+P ++   G   +
Sbjct: 176 LLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSN 235

Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 236
           D  + Y    P+ + Q      P   +  ++LL K L ++  KRI+ EEA++H Y +SL
Sbjct: 236 DEFKNY--NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  176 bits (449), Expect = 8e-54
 Identities = 87/249 (34%), Positives = 129/249 (51%), Gaps = 24/249 (9%)

Query: 1   MEHENVIAIKDIIRPPKKDTFN---DVYIVYELMDTDLHQIIRSDQ-QLTDDHCQYFLYQ 56
           ++HENV+ + +I R             Y+V+E  + DL  ++ +   + T    +  +  
Sbjct: 68  LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKM 127

Query: 57  LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-----DFMTEYVVTR 111
           LL GL Y+H   +LHRD+K +N+L+     LK+ DFGLAR  S +     +  T  VVT 
Sbjct: 128 LLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTL 187

Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGS----- 166
           WYR PELLL   +Y   ID+W  GCI+ E+ TR P+  G    HQL LI++L GS     
Sbjct: 188 WYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEV 247

Query: 167 -PDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP--NKSSGAVDLLEKMLVFDPNKRIT 223
            P    L   +         +LP+ +K++   R     K   A+DL++K+LV DP KRI 
Sbjct: 248 WPGVDKLELFK-------KMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRID 300

Query: 224 VEEALRHPY 232
            + AL H +
Sbjct: 301 ADTALNHDF 309

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  167 bits (425), Expect = 1e-50
 Identities = 78/236 (33%), Positives = 137/236 (58%), Gaps = 11/236 (4%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++H N++ + ++ R  +K     +++V+E  D T L+++ ++ + + +   +  ++Q L+
Sbjct: 57  LKHPNLVNLIEVFRRKRK-----LHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQ 111

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM-TEYVVTRWYRAPEL 118
            + + H  + +HRD+KP N+L+     +K+ DFG AR  +      T+YV TRWYRAPEL
Sbjct: 112 AVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPEL 171

Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGS--PDDASLGFLR 176
           L+  T+Y   +D+W++GC+  E++T +PL+PGK  V QL LI + +G   P    + F  
Sbjct: 172 LVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQI-FST 230

Query: 177 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 232
           +   +      P  R+    ++FPN SS A+  L+  L  DP +R++ EE L HPY
Sbjct: 231 NQFFKGLSIPEPETRE-PLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  163 bits (414), Expect = 6e-49
 Identities = 89/237 (37%), Positives = 136/237 (57%), Gaps = 9/237 (3%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQ-IIRSDQQLTDDHCQYFLYQLLR 59
           ++H N++ + DII   +  TF     V+E M TDL Q +I+    L   + + F++QLLR
Sbjct: 60  LKHANIVLLHDIIHTKETLTF-----VFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLR 114

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPEL 118
           GL Y+H   +LHRDLKP NLL++   +LK+ DFGLAR  S  +   +  VVT WYR P++
Sbjct: 115 GLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDV 174

Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPG-KDYVHQLRLITELIGSP-DDASLGFLR 176
           LL  T+Y++A+DIW  GCI  E++  +P FPG  D   QL  I  ++G P +D   G  +
Sbjct: 175 LLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK 234

Query: 177 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
             N +       + ++ +   +  ++   A DL  +ML+  P  RI+ ++AL HPY 
Sbjct: 235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  161 bits (408), Expect = 4e-48
 Identities = 85/237 (35%), Positives = 142/237 (59%), Gaps = 13/237 (5%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + HEN++ + ++ R  K+     +Y+V+E +D T L  + +    L +   + +L+Q+LR
Sbjct: 57  LRHENLVNLIEVFRRKKR-----LYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILR 111

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPEL 118
           G+++ HS +++HRD+KP N+L++ S  +K+ DFG ART  +  +  T+YV TRWYRAPEL
Sbjct: 112 GIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPEL 171

Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG--SPDDASLGFLR 176
           L+  T+Y  A+DIW+VGC++ E++T EPLFPG   + QL  I + +G   P    + F +
Sbjct: 172 LVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEI-FQK 230

Query: 177 SDNARRYVRQLPRCRK-QQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 232
             N      +LP  ++ +    RFP  S   +DL ++ L  DP+ R +  + L H +
Sbjct: 231 --NPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  153 bits (387), Expect = 5e-45
 Identities = 88/239 (36%), Positives = 127/239 (53%), Gaps = 17/239 (7%)

Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS--DQQLTDDHCQYFLYQLLR 59
           +H N++ + D+    + D    V +V+E +D DL   +       L  +  +  + Q LR
Sbjct: 60  DHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLR 119

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GL ++H+  ++HRDLKP N+L+ +   +K+ DFGLAR  S    +T  VVT WYRAPE+L
Sbjct: 120 GLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVL 179

Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           L  T Y   +D+WSVGCI  E+  R+PLF G     QL  I +LIG P +        D+
Sbjct: 180 LQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE--------DD 230

Query: 180 ARRYVRQLPRC----RKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
             R V  LPR     R  +      P        LL +ML F+P+KRI+   AL+HP+ 
Sbjct: 231 WPRDV-TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  145 bits (367), Expect = 5e-42
 Identities = 87/237 (36%), Positives = 125/237 (52%), Gaps = 15/237 (6%)

Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS--DQQLTDDHCQYFLYQLLR 59
           EH NV+ + D+    + D    + +V+E +D DL   +    +  +  +  +  ++QLLR
Sbjct: 62  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 121

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GL ++HS  V+HRDLKP N+L+ +S  +K+ DFGLAR  S    +T  VVT WYRAPE+L
Sbjct: 122 GLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVL 181

Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA----SLGFL 175
           L  + Y   +D+WSVGCI  E+  R+PLF G   V QL  I ++IG P +      +   
Sbjct: 182 LQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 240

Query: 176 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 232
           R     +          Q       +      DLL K L F+P KRI+   AL HPY
Sbjct: 241 RQAFHSK--------SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  144 bits (364), Expect = 2e-41
 Identities = 90/250 (36%), Positives = 138/250 (55%), Gaps = 29/250 (11%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQII-RSDQQLTDDHCQYFLYQLLR 59
           ++H N++ + DII    K+T     +V+E + TDL Q + +    L  ++ + FL+QLLR
Sbjct: 60  LKHANIVLLHDIIH--TKETLT---LVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLR 114

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPEL 118
           GL Y+H   +LHRDLKP NLL++ + +LK+ DFGLAR  S  +   +  VVT WYR P++
Sbjct: 115 GLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDV 174

Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPG-KDYVHQLRLITELIGSPDDASLGFLRS 177
           LL  TEY+  +D+W VGCI  E++     FPG KD   QL  I  ++G+P++ +   + S
Sbjct: 175 LLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHS 234

Query: 178 DNARRYVRQLPRCRKQQFATRFPNKS-----------SGAVDLLEKMLVFDPNKRITVEE 226
                    LP  + ++F T +  K+           + A DL  K+L   P  R++ + 
Sbjct: 235 ---------LPHFKPERF-TLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQA 284

Query: 227 ALRHPYLQSL 236
           AL H Y   L
Sbjct: 285 ALSHEYFSDL 294

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  143 bits (361), Expect = 3e-41
 Identities = 83/236 (35%), Positives = 134/236 (56%), Gaps = 12/236 (5%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLR 59
           ++ EN++ +K+  R   K     +Y+V+E ++ ++ +++      +  +  + ++YQL++
Sbjct: 57  LKQENIVELKEAFRRRGK-----LYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIK 111

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPE 117
            + + H   ++HRD+KP NLL++ +  LK+ DFG AR  SE      TEYV TRWYR+PE
Sbjct: 112 AIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPE 171

Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 177
           LLL    Y  A+D+WSVGCILGE+   +PLFPG+  + QL  I +++G P  A    L  
Sbjct: 172 LLLG-APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLG-PLPAEQMKLFY 229

Query: 178 DNARRYVRQLPRC-RKQQFATRFPNKSSGA-VDLLEKMLVFDPNKRITVEEALRHP 231
            N R +  + P     Q    R+    SG  +DL++ +L  +P  R   E+ L HP
Sbjct: 230 SNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  135 bits (342), Expect = 5e-39
 Identities = 50/145 (34%), Positives = 84/145 (57%), Gaps = 9/145 (6%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQ-LTDDHCQYFLYQLL 58
           + H N++ +  +      +  N +Y+V E  +   L  +++ ++  L++D     L Q+L
Sbjct: 48  LNHPNIVKLYGVF-----EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQIL 102

Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCD-LKIGDFGLART-TSETDFMTEYVVTRWYRAP 116
            GL+Y+HS  ++HRDLKP N+LL++    +K+ DFGL++  TS+   +   V T  Y AP
Sbjct: 103 EGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAP 162

Query: 117 ELLLNCTEYTAAIDIWSVGCILGEI 141
           E+LL    Y+   DIWS+G IL E+
Sbjct: 163 EVLLGKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  133 bits (337), Expect = 8e-38
 Identities = 68/235 (28%), Positives = 109/235 (46%), Gaps = 36/235 (15%)

Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 61
           H N++      R  +K+T N   I  E +    L  +++   +L +   + +  Q+L GL
Sbjct: 58  HPNIVRYYGSERDEEKNTLN---IFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGL 114

Query: 62  KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART--TSETDFMTEYVV-TRWYRAPEL 118
            Y+HS  ++HRD+K +N+L+++   +K+ DFG A+     ET   T  V  T ++ APE 
Sbjct: 115 AYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE- 173

Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 178
           ++   EY  A DIWS+GC + E+ T +P +               IGS  +         
Sbjct: 174 VIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALY---KIGSSGE--------- 221

Query: 179 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
                  ++P            + S  A D L K L  DP KR T +E L+HP+L
Sbjct: 222 -----PPEIP-----------EHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  137 bits (346), Expect = 1e-37
 Identities = 81/249 (32%), Positives = 133/249 (53%), Gaps = 16/249 (6%)

Query: 1   MEHENVIAIKDI-----IRPPKKDTFNDVYIVYELMDTDLHQII----RSDQQLTDDHCQ 51
           + H N+I +KD       +  +K+ F +V  V E +   +H+ +    R++  L     +
Sbjct: 116 LNHINIIFLKDYYYTECFKKNEKNIFLNV--VMEFIPQTVHKYMKHYARNNHALPLFLVK 173

Query: 52  YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVT 110
            + YQL R L Y+HS  + HRDLKP NLL++ +   LK+ DFG A+          Y+ +
Sbjct: 174 LYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICS 233

Query: 111 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA 170
           R+YRAPEL+L  T YT  ID+WS+GCI+ E++   P+F G+  V QL  I +++G+P + 
Sbjct: 234 RFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293

Query: 171 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKS-SGAVDLLEKMLVFDPNKRITVEEALR 229
            L  +  + A     + P  + +     FP  +   A++ + + L ++P KR+   EAL 
Sbjct: 294 QLKEMNPNYAD---IKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350

Query: 230 HPYLQSLHD 238
            P+   L D
Sbjct: 351 DPFFDDLRD 359

Length = 440

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  131 bits (328), Expect = 1e-35
 Identities = 64/269 (23%), Positives = 108/269 (40%), Gaps = 37/269 (13%)

Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQ---LTDDHCQYFLYQLL 58
             N++ + D  +         +Y+V E +D   L  +++   +   L++    + L Q+L
Sbjct: 57  PPNIVKLYDFFQDE-----GSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQIL 111

Query: 59  RGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETD-------FMTEYVVT 110
             L+Y+HS  ++HRD+KP N+LL+     +K+ DFGLA+   +           +  V T
Sbjct: 112 SALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGT 171

Query: 111 RWYRAPELLL--NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD 168
             Y APE+LL  +    +++ DIWS+G  L E++T  P F G+          ++I    
Sbjct: 172 PGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKII---- 227

Query: 169 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL 228
                              P        +     S  A DLL+K+L  DP  R++    L
Sbjct: 228 --------------LELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273

Query: 229 RHPYLQSLHDLNDEPVCPRPFHFDFEHSS 257
            H  L  L     +               
Sbjct: 274 SHDLLAHLKLKESDLSDLLKPDDSAPLRL 302

Length = 384

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score =  125 bits (316), Expect = 3e-34
 Identities = 90/272 (33%), Positives = 132/272 (48%), Gaps = 48/272 (17%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIR---------SDQQLTDDHCQ 51
           ++H NVIA++ +       +   V+++++  + DL  II+            QL     +
Sbjct: 55  LKHPNVIALQKVFL---SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVK 111

Query: 52  YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD----LKIGDFGLARTTSET----DF 103
             LYQ+L G+ Y+H+  VLHRDLKP+N+L+         +KI D G AR  +        
Sbjct: 112 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 171

Query: 104 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD---------YV 154
           +   VVT WYRAPELLL    YT AIDIW++GCI  E++T EP+F  +          + 
Sbjct: 172 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHH 231

Query: 155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKS----------- 203
            QL  I  ++G P D     +R       + + P  +K    T + N S           
Sbjct: 232 DQLDRIFSVMGFPADKDWEDIRK------MPEYPTLQKDFRRTTYANSSLIKYMEKHKVK 285

Query: 204 --SGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
             S    LL+K+L  DP KRIT E+AL+ PY 
Sbjct: 286 PDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score =  121 bits (305), Expect = 1e-32
 Identities = 89/266 (33%), Positives = 134/266 (50%), Gaps = 36/266 (13%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ---------QLTDDHCQ 51
           ++H NVI+++ +           V+++++  + DL  II+  +         QL     +
Sbjct: 55  LKHPNVISLQKVFLSHAD---RKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVK 111

Query: 52  YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD----LKIGDFGLARTTSET----DF 103
             LYQ+L G+ Y+H+  VLHRDLKP+N+L+         +KI D G AR  +        
Sbjct: 112 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 171

Query: 104 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD--------YVH 155
           +   VVT WYRAPELLL    YT AIDIW++GCI  E++T EP+F  +         Y H
Sbjct: 172 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 231

Query: 156 -QLRLITELIGSPDDASLGFLR-----SDNARRYVRQ-LPRCRKQQFATRFPNK-SSGAV 207
            QL  I  ++G P D     ++     S   + + R     C   ++  +   K  S A 
Sbjct: 232 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAF 291

Query: 208 DLLEKMLVFDPNKRITVEEALRHPYL 233
            LL+K+L  DP KRIT E+A++ PY 
Sbjct: 292 HLLQKLLTMDPIKRITSEQAMQDPYF 317

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  119 bits (300), Expect = 3e-32
 Identities = 65/242 (26%), Positives = 116/242 (47%), Gaps = 48/242 (19%)

Query: 1   MEHENVIAIKDIIRPPKKDTFND---VYIVYELMD-TDLHQIIRSDQQ----LTDDHCQY 52
           + H N+I   +        +F +   + IV E  D  DL Q I+  ++      ++    
Sbjct: 56  LNHPNIIKYYE--------SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILD 107

Query: 53  FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV-TR 111
           +  QL   LKY+HS  +LHRD+KP N+ L ++  +K+GDFG+++  S T  + + VV T 
Sbjct: 108 WFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTP 167

Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDAS 171
           +Y +PEL  N   Y    DIWS+GC+L E+ T +  F G+   + L L  +++       
Sbjct: 168 YYLSPELCQN-KPYNYKSDIWSLGCVLYELCTLKHPFEGE---NLLELALKIL------- 216

Query: 172 LGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHP 231
                            + +     +++   SS   +L+  +L  DP +R ++ + L+ P
Sbjct: 217 -----------------KGQYPPIPSQY---SSELRNLVSSLLQKDPEERPSIAQILQSP 256

Query: 232 YL 233
           ++
Sbjct: 257 FI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  115 bits (289), Expect = 2e-30
 Identities = 66/218 (30%), Positives = 108/218 (49%), Gaps = 36/218 (16%)

Query: 22  NDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 77
           +++++V E MD    TD+  I ++  ++ +    Y   ++L+GL+Y+HS +V+HRD+K  
Sbjct: 88  DELWVVMEYMDGGSLTDI--ITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSD 145

Query: 78  NLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 136
           N+LL+    +K+ DFG  A+ T E       V T ++ APE++    +Y   +DIWS+G 
Sbjct: 146 NILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKR-KDYGPKVDIWSLGI 204

Query: 137 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 196
           +  E+   EP +  +  +  L LIT   G P           N  ++             
Sbjct: 205 MCIEMAEGEPPYLREPPLRALFLITTK-GIP--------PLKNPEKW------------- 242

Query: 197 TRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
                 S    D L K LV DP KR + EE L+HP+L+
Sbjct: 243 ------SPEFKDFLNKCLVKDPEKRPSAEELLQHPFLK 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  113 bits (286), Expect = 3e-30
 Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 37/216 (17%)

Query: 22  NDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 79
           ++++IV E      L  +++S +Q LT+    Y   +LL+GL+Y+HS  ++HRD+K +N+
Sbjct: 70  DELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANI 129

Query: 80  LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 139
           LL +  ++K+ DFGL+   S+T      V T ++ APE ++N   Y    DIWS+G    
Sbjct: 130 LLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPE-VINGKPYDYKADIWSLGITAI 188

Query: 140 EIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF 199
           E+   +P  P  +                      L    A   +               
Sbjct: 189 ELAEGKP--PYSE----------------------LPPMKALFKIATNG-------PPGL 217

Query: 200 PNK---SSGAVDLLEKMLVFDPNKRITVEEALRHPY 232
            N    S    D L+K L  +P KR T E+ L+HP+
Sbjct: 218 RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  112 bits (284), Expect = 6e-30
 Identities = 65/219 (29%), Positives = 105/219 (47%), Gaps = 39/219 (17%)

Query: 20  TFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 78
           T   +Y+V E     +L   +  + + +++  +++  +++  L+Y+HS  +++RDLKP N
Sbjct: 64  TEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPEN 123

Query: 79  LLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 137
           +LL+A   +K+ DFGLA+  +SE      +  T  Y APE+LL    Y  A+D WS+G +
Sbjct: 124 ILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLG-KGYGKAVDWWSLGVL 182

Query: 138 LGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFAT 197
           L E++T +P F  +D       I E I          L+                     
Sbjct: 183 LYEMLTGKPPFYAEDRK----EIYEKI----------LKDP------------------L 210

Query: 198 RFP-NKSSGAVDLLEKMLVFDPNKRIT---VEEALRHPY 232
           RFP   S  A DL+  +L  DP KR+     EE   HP+
Sbjct: 211 RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPF 249

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  110 bits (277), Expect = 7e-29
 Identities = 72/243 (29%), Positives = 117/243 (48%), Gaps = 47/243 (19%)

Query: 3   HENVIAIKD-IIRPPKKDTFNDVYIVYELMDT-DLHQII----RSDQQLTDDHCQYFLYQ 56
           H N++   D II    +     +YIV E  +  DL Q+I    +  + + ++     L Q
Sbjct: 58  HPNIVRYYDRIIDRSNQT----LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQ 113

Query: 57  LLRGLKYVH-----SASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVT 110
           LL  L   H       +VLHRDLKP+N+ L+A+ ++K+GDFGLA+    ++ F   YV T
Sbjct: 114 LLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGT 173

Query: 111 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA 170
            +Y +PE L +   Y    DIWS+GC++ E+    P F  ++   QL+L +++       
Sbjct: 174 PYYMSPEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFTARN---QLQLASKIKEGK--- 226

Query: 171 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 230
                         R++P              SS   ++++ ML  DP+KR + EE L+ 
Sbjct: 227 -------------FRRIP-----------YRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262

Query: 231 PYL 233
           P +
Sbjct: 263 PLI 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  106 bits (268), Expect = 1e-27
 Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 40/220 (18%)

Query: 23  DVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS-VLHRDLKPSNLL 80
           ++ IV E MD   L  +++   ++ +    Y   Q+L+GL Y+H+   ++HRD+KPSNLL
Sbjct: 73  EISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLL 132

Query: 81  LNASCDLKIGDFGLARTTSETDFMT-EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 139
           +N+  ++KI DFG+++    T      +V T  Y +PE  +    Y+ A DIWS+G  L 
Sbjct: 133 INSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPE-RIQGESYSYAADIWSLGLTLL 191

Query: 140 E-IMTREPLFPGK--DYVHQLRLI--TELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQ 194
           E  + + P  P     +   ++ I        P +       S   R ++     C    
Sbjct: 192 ECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEF-----SPEFRDFIS---AC---- 239

Query: 195 FATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
                          L+K    DP KR +  E L+HP+++
Sbjct: 240 ---------------LQK----DPKKRPSAAELLQHPFIK 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  105 bits (264), Expect = 4e-27
 Identities = 65/227 (28%), Positives = 101/227 (44%), Gaps = 49/227 (21%)

Query: 22  NDVYIVYELMD-TDLHQIIRSDQQLTDDHC-QYFLYQLLRGLKYVHSASVLHRDLKPSNL 79
             VYI  E      L +++   + L D+H  + +  QLL GL Y+HS  ++HRD+KP+N+
Sbjct: 72  EKVYIFMEYCSGGTLEELLEHGRIL-DEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANI 130

Query: 80  LLNASCDLKIGDFGLA-----RTTSETDFMTEYVVTRWYRAPELLLN--CTEYTAAIDIW 132
            L+ +  +K+GDFG A      TT+  + +     T  Y APE++       +  A DIW
Sbjct: 131 FLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIW 190

Query: 133 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGS------PDDASLGFLRSDNARRYVRQ 186
           S+GC++ E+ T +  +   D   Q   I   +G+      PD   L              
Sbjct: 191 SLGCVVLEMATGKRPWSELDNEFQ---IMFHVGAGHKPPIPDSLQL-------------- 233

Query: 187 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
                           S    D L++ L  DP KR T  E L+HP++
Sbjct: 234 ----------------SPEGKDFLDRCLESDPKKRPTASELLQHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  103 bits (258), Expect = 6e-26
 Identities = 65/242 (26%), Positives = 102/242 (42%), Gaps = 61/242 (25%)

Query: 20  TFND---VYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 75
           TF D   +Y V E   + +L Q IR    L +   +++  ++L  L+Y+HS  ++HRDLK
Sbjct: 70  TFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLK 129

Query: 76  PSNLLLNASCDLKIGDFGLARTTSETDFMTE---------------------YVVTRWYR 114
           P N+LL+    +KI DFG A+                               +V T  Y 
Sbjct: 130 PENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYV 189

Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF 174
           +PELL        + D+W++GCI+ +++T +P F G +     + I +            
Sbjct: 190 SPELLNEK-PAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILK------------ 236

Query: 175 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV----EEALRH 230
                            +  F   FP     A DL+EK+LV DP  R+ V    +E   H
Sbjct: 237 ----------------LEYSFPPNFPPD---AKDLIEKLLVLDPQDRLGVNEGYDELKAH 277

Query: 231 PY 232
           P+
Sbjct: 278 PF 279

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  102 bits (255), Expect = 9e-26
 Identities = 56/220 (25%), Positives = 100/220 (45%), Gaps = 48/220 (21%)

Query: 24  VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 82
           +YI  EL+    L ++++      +   + +  Q+L GL+Y+H  + +HRD+K +N+L++
Sbjct: 77  LYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVD 136

Query: 83  ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM 142
            +  +K+ DFG+A+   E  F   +  + ++ APE++     Y  A DIWS+GC + E+ 
Sbjct: 137 TNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMA 196

Query: 143 TREPLFPGKDYVHQLRLITEL--IGS-------PDDASLGFLRSDNARRYVRQLPRCRKQ 193
           T +P +       QL  +  +  IG        PD        SD A+ ++ +       
Sbjct: 197 TGKPPW------SQLEGVAAVFKIGRSKELPPIPDHL------SDEAKDFILKC------ 238

Query: 194 QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
                               L  DP+ R T  E L HP++
Sbjct: 239 --------------------LQRDPSLRPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 99.2 bits (248), Expect = 9e-25
 Identities = 61/229 (26%), Positives = 107/229 (46%), Gaps = 43/229 (18%)

Query: 22  NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
            ++Y+V E +   DL  ++ +   L +D  + ++ +++  L+Y+HS  ++HRDLKP N+L
Sbjct: 66  KNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNIL 125

Query: 81  LNASCDLKIGDFGLART--TSETDFM-------TEYVVTRWYRAPELLLNCTEYTAAIDI 131
           ++++  LK+ DFGL++         +          V T  Y APE++L    ++  +D 
Sbjct: 126 IDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG-QGHSKTVDW 184

Query: 132 WSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCR 191
           WS+GCIL E +   P F G+          E+               N      + P   
Sbjct: 185 WSLGCILYEFLVGIPPFHGET-------PEEIF-------------QNILNGKIEWPED- 223

Query: 192 KQQFATRFPNKSSGAVDLLEKMLVFDPNKRI---TVEEALRHPYLQSLH 237
                      S  A+DL+ K+LV DP KR+   ++EE   HP+ + + 
Sbjct: 224 --------VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGID 264

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 97.7 bits (244), Expect = 3e-24
 Identities = 62/235 (26%), Positives = 106/235 (45%), Gaps = 38/235 (16%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++H N++     I      T + +YI+ E  +   L QII+      +     ++YQ+L+
Sbjct: 56  LKHPNIVKYIGSIE-----TSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQ 110

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV-TRWYRAPEL 118
           GL Y+H   V+HRD+K +N+L      +K+ DFG+A   ++       VV T ++ APE+
Sbjct: 111 GLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEV 170

Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 178
           +   +  + A DIWS+GC + E++T  P +   + +  L  I +    P           
Sbjct: 171 IEM-SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPP----------- 218

Query: 179 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
                   LP              S    D L +    DPN R T ++ L+HP++
Sbjct: 219 --------LP-----------EGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 96.1 bits (240), Expect = 1e-23
 Identities = 51/161 (31%), Positives = 80/161 (49%), Gaps = 19/161 (11%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR-SDQQLTDDHCQYFLYQLL 58
           ++H NV+ +  +    +      +YIV E M+  DL   +R +  +L+      F  Q+ 
Sbjct: 58  LDHPNVVKLLGVCTEEEP-----LYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIA 112

Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RW 112
           RG++Y+ S + +HRDL   N L+  +  +KI DFGL+R   + D    Y         RW
Sbjct: 113 RGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD---YYRKRGGKLPIRW 169

Query: 113 YRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKD 152
             APE L    ++T+  D+WS G +L EI T  E  +PG  
Sbjct: 170 M-APESLKEG-KFTSKSDVWSFGVLLWEIFTLGEQPYPGMS 208

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 96.1 bits (240), Expect = 1e-23
 Identities = 50/162 (30%), Positives = 79/162 (48%), Gaps = 20/162 (12%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS--DQQLTDDHCQYFLYQL 57
           ++H N++ +  +    +      + IV E M   DL   +R    ++L+      F  Q+
Sbjct: 58  LDHPNIVKLLGVCTEEEP-----LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQI 112

Query: 58  LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------R 111
            RG++Y+ S + +HRDL   N L+  +  +KI DFGL+R   + D    Y V       R
Sbjct: 113 ARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD---YYKVKGGKLPIR 169

Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKD 152
           W  APE L    ++T+  D+WS G +L EI T  E  +PG  
Sbjct: 170 WM-APESLKEG-KFTSKSDVWSFGVLLWEIFTLGEEPYPGMS 209

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 92.9 bits (231), Expect = 2e-22
 Identities = 58/219 (26%), Positives = 105/219 (47%), Gaps = 39/219 (17%)

Query: 24  VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 82
           +Y+V E ++  D   +I++   L +D  + ++ +++ G++ +H   ++HRD+KP NLL++
Sbjct: 72  LYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLID 131

Query: 83  ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM 142
            +  LK+ DFGL+R   E     ++V T  Y APE +L   +     D WS+GC++ E +
Sbjct: 132 QTGHLKLTDFGLSRNGLEN---KKFVGTPDYLAPETILGVGD-DKMSDWWSLGCVIFEFL 187

Query: 143 TREPLFPGK--DYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 200
              P F  +  D V    +++  I  P++                               
Sbjct: 188 FGYPPFHAETPDAVFD-NILSRRINWPEEV----------------------------KE 218

Query: 201 NKSSGAVDLLEKMLVFDPNKRI---TVEEALRHPYLQSL 236
             S  AVDL+ ++L  DP KR+     +E   HP+ +S+
Sbjct: 219 FCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSI 257

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 92.1 bits (229), Expect = 3e-22
 Identities = 66/244 (27%), Positives = 110/244 (45%), Gaps = 54/244 (22%)

Query: 1   MEHENVIA-----IKDIIRPPKKDTFNDVYIVYELMDT-DLHQII-RSDQQLTDDH-CQY 52
           ++H N+IA     + D          N + I  E  +   L+  I R   QL ++    +
Sbjct: 56  LQHPNIIAYYNHFMDD----------NTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLW 105

Query: 53  FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV-TR 111
           +L+Q++  + Y+H A +LHRD+K  N+ L  +  +K+GDFG+++       M E VV T 
Sbjct: 106 YLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTP 165

Query: 112 WYRAPELLLNCT--EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDD 169
           +Y +PEL   C   +Y    DIW++GC+L E++T +  F   +    L L+ +++     
Sbjct: 166 YYMSPEL---CQGVKYNFKSDIWALGCVLYELLTLKRTFDATN---PLNLVVKIVQGN-- 217

Query: 170 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 229
                  +     Y                   SS  + L+  +L  DP KR T +E L 
Sbjct: 218 ------YTPVVSVY-------------------SSELISLVHSLLQQDPEKRPTADEVLD 252

Query: 230 HPYL 233
            P L
Sbjct: 253 QPLL 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 90.6 bits (225), Expect = 1e-21
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 37/217 (17%)

Query: 22  NDVYIVYELMD-TDLHQIIRSDQQ----LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP 76
           N + IV E     DL + I   ++    + +        QLLRGL+ +H   +LHRDLK 
Sbjct: 72  NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKS 131

Query: 77  SNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 136
           +N+LL A+  +KIGD G+++   +    T+ + T  Y APE+      Y+   DIWS+GC
Sbjct: 132 ANILLVANDLVKIGDLGISKVLKKNMAKTQ-IGTPHYMAPEVWKG-RPYSYKSDIWSLGC 189

Query: 137 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 196
           +L E+ T  P F  +  +  LR                              + ++ ++ 
Sbjct: 190 LLYEMATFAPPFEARS-MQDLRY-----------------------------KVQRGKYP 219

Query: 197 TRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
              P  S    + +  ML   P  R   ++ L  P +
Sbjct: 220 PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 89.5 bits (222), Expect = 4e-21
 Identities = 59/189 (31%), Positives = 92/189 (48%), Gaps = 40/189 (21%)

Query: 53  FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR- 111
           F+ Q+L+GL Y+H+  ++HRD+K +N+L++    +KI DFG+++        T+    R 
Sbjct: 111 FVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARP 170

Query: 112 ------WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG 165
                 ++ APE++   T YT   DIWS+GC++ E++T +  FP    +  +  I E   
Sbjct: 171 SLQGSVFWMAPEVVKQ-TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA- 228

Query: 166 SPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP-NKSSGAVDLLEKMLVFDPNKRITV 224
           SP+                               P N SS A+D LEK    D NKR T 
Sbjct: 229 SPE------------------------------IPSNISSEAIDFLEKTFEIDHNKRPTA 258

Query: 225 EEALRHPYL 233
            E L+HP+L
Sbjct: 259 AELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 89.3 bits (222), Expect = 4e-21
 Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 33/218 (15%)

Query: 22  NDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFL-YQLLRGLKYVHSA-SVLHRDLKPSN 78
            D+ I  E MD   L +I++  Q    +     +   +L+GL Y+H    ++HRD+KPSN
Sbjct: 72  GDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSN 131

Query: 79  LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 138
           +L+N+   +K+ DFG++     +   T +V T  Y APE  +   +Y+   DIWS+G  L
Sbjct: 132 ILVNSRGQIKLCDFGVSGQLVNSLAKT-FVGTSSYMAPE-RIQGNDYSVKSDIWSLGLSL 189

Query: 139 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 198
            E+ T    FP                  +D   G            +L +    +   R
Sbjct: 190 IELATGR--FP--------------YPPENDPPDGIF----------ELLQYIVNEPPPR 223

Query: 199 FPNK--SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
            P+   S    D +   L+ DP +R + +E L HP+++
Sbjct: 224 LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIK 261

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 88.1 bits (219), Expect = 1e-20
 Identities = 43/137 (31%), Positives = 75/137 (54%), Gaps = 5/137 (3%)

Query: 20  TFNDVYIVYELMDT----DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 75
           TF D   +Y LM+     +L  I+R      +   ++++  ++   +Y+H+  +++RDLK
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120

Query: 76  PSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVG 135
           P NLLL+++  +K+ DFG A+          +  T  Y APE++LN   Y  ++D WS+G
Sbjct: 121 PENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILN-KGYDFSVDYWSLG 179

Query: 136 CILGEIMTREPLFPGKD 152
            +L E++T  P F   D
Sbjct: 180 ILLYELLTGRPPFGEDD 196

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 86.6 bits (214), Expect = 4e-20
 Identities = 55/160 (34%), Positives = 83/160 (51%), Gaps = 12/160 (7%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQ---LTDDHCQYFLYQ 56
           M+H N++A K+       +    +YIV E  D  DL Q I+  Q+     +D    +  Q
Sbjct: 55  MKHPNIVAFKESF-----EADGHLYIVMEYCDGGDLMQKIK-LQRGKLFPEDTILQWFVQ 108

Query: 57  LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRA 115
           +  G++++H   VLHRD+K  N+ L  +  +K+GDFG AR  TS   +   YV T +Y  
Sbjct: 109 MCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVP 168

Query: 116 PELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH 155
           PE+  N   Y    DIWS+GCIL E+ T +  F    + +
Sbjct: 169 PEIWEN-MPYNNKSDIWSLGCILYELCTLKHPFQANSWKN 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 86.6 bits (215), Expect = 4e-20
 Identities = 62/218 (28%), Positives = 100/218 (45%), Gaps = 38/218 (17%)

Query: 22  NDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 77
            D++IV E       +D+ +I      LT++     LYQ L+GL+Y+HS   +HRD+K  
Sbjct: 71  TDLWIVMEYCGAGSVSDIMKITNK--TLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAG 128

Query: 78  NLLLNASCDLKIGDFGLARTTSETDFMTEYVV-TRWYRAPELLLNCTEYTAAIDIWSVGC 136
           N+LLN     K+ DFG++   ++T      V+ T ++ APE++     Y    DIWS+G 
Sbjct: 129 NILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYNNKADIWSLGI 187

Query: 137 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 196
              E+   +P  P  D +H +R I  +   P                            +
Sbjct: 188 TAIEMAEGKP--PYSD-IHPMRAIFMIPNKP------------------------PPTLS 220

Query: 197 TRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
              P K S    D ++K LV DP +R +  + L+HP++
Sbjct: 221 D--PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 86.2 bits (214), Expect = 7e-20
 Identities = 55/216 (25%), Positives = 100/216 (46%), Gaps = 36/216 (16%)

Query: 23  DVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 81
           ++Y+V +L+   DL   +    + +++  ++++ +++  L+Y+HS  ++HRD+KP N+LL
Sbjct: 74  NMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILL 133

Query: 82  NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 141
           +    + I DF +A   +     T    T  Y APE +L    Y+ A+D WS+G    E 
Sbjct: 134 DEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPE-VLCRQGYSVAVDWWSLGVTAYEC 192

Query: 142 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR-FP 200
           +  +  + G       R I + I                           KQ+ A   +P
Sbjct: 193 LRGKRPYRGHS-----RTIRDQI-------------------------RAKQETADVLYP 222

Query: 201 NK-SSGAVDLLEKMLVFDPNKRI--TVEEALRHPYL 233
              S+ A+D + K+L  DP KR+   +++   HPY 
Sbjct: 223 ATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 86.3 bits (214), Expect = 7e-20
 Identities = 59/200 (29%), Positives = 94/200 (47%), Gaps = 35/200 (17%)

Query: 45  LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDF 103
           LT+   +Y   Q+L  L ++HS  V+HRDLK  N+LL    D+K+ DFG+ A+  S    
Sbjct: 100 LTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK 159

Query: 104 MTEYVVTRWYRAPELLLNC-----TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR 158
              ++ T ++ APE ++ C       Y    DIWS+G  L E+   EP  P  + ++ +R
Sbjct: 160 RDTFIGTPYWMAPE-VVACETFKDNPYDYKADIWSLGITLIELAQMEP--PHHE-LNPMR 215

Query: 159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDP 218
           ++ + I   +  +L     D   ++                   SS   D L+  LV DP
Sbjct: 216 VLLK-ILKSEPPTL-----DQPSKW-------------------SSSFNDFLKSCLVKDP 250

Query: 219 NKRITVEEALRHPYLQSLHD 238
           + R T  E L+HP++    D
Sbjct: 251 DDRPTAAELLKHPFVSDQSD 270

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 85.9 bits (213), Expect = 1e-19
 Identities = 51/151 (33%), Positives = 83/151 (54%), Gaps = 20/151 (13%)

Query: 1   MEHENVIAIKDIIRPPKKDTF---NDVYIVYELMDT-DLHQII---RSDQQLTDDHC--Q 51
           ++H NVI            +F   N++ IV EL D  DL ++I   +  ++L  +    +
Sbjct: 59  LDHPNVIKYLA--------SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWK 110

Query: 52  YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVT 110
           YF  QL   L+++HS  ++HRD+KP+N+ + A+  +K+GD GL R  +S+T      V T
Sbjct: 111 YF-VQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGT 169

Query: 111 RWYRAPELLLNCTEYTAAIDIWSVGCILGEI 141
            +Y +PE +     Y    DIWS+GC+L E+
Sbjct: 170 PYYMSPERIHE-NGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 85.3 bits (211), Expect = 1e-19
 Identities = 63/224 (28%), Positives = 104/224 (46%), Gaps = 42/224 (18%)

Query: 19  DTFND---VYIVYELMDT-DLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHR 72
           ++F D   + IV E  +  DLH++++    + L +D    F  Q+L GL ++HS  +LHR
Sbjct: 66  ESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHR 125

Query: 73  DLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTE--YTAAI 129
           D+K  NL L+A  ++KIGD G+A+  S  T+F    V T +Y +PEL   C +  Y    
Sbjct: 126 DIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPEL---CEDKPYNEKS 182

Query: 130 DIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPR 189
           D+W++G +L E  T +                     P DA       +N    + ++ R
Sbjct: 183 DVWALGVVLYECCTGK--------------------HPFDA-------NNQGALILKIIR 215

Query: 190 CRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
                 +  +   S     L+++ L  D  +R    + LR+P L
Sbjct: 216 GVFPPVSQMY---SQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 85.4 bits (212), Expect = 1e-19
 Identities = 54/214 (25%), Positives = 97/214 (45%), Gaps = 39/214 (18%)

Query: 25  YIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
           +I+ E        DL +  +    L + +  + L ++L GL+Y+H    +HRD+K +N+L
Sbjct: 75  WIIMEYCGGGSCLDLLKPGK----LDETYIAFILREVLLGLEYLHEEGKIHRDIKAANIL 130

Query: 81  LNASCDLKIGDFGLA-RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 139
           L+   D+K+ DFG++ + TS       +V T ++ APE++   + Y    DIWS+G    
Sbjct: 131 LSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQ-SGYDEKADIWSLGITAI 189

Query: 140 EIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF 199
           E+   EP  P  D  H +R++  +  +   +  G   S   + +V     C         
Sbjct: 190 ELAKGEP--PLSDL-HPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSL---C--------- 234

Query: 200 PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
                         L  DP +R + +E L+H ++
Sbjct: 235 --------------LNKDPKERPSAKELLKHKFI 254

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 84.6 bits (209), Expect = 3e-19
 Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 33/204 (16%)

Query: 31  MDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIG 90
           +D  L ++  + + L+++    +  QLL G+ Y+H   +LHRDLK  N+ L  +  LKIG
Sbjct: 89  LDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIG 147

Query: 91  DFGLAR-TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFP 149
           DFG++R      D  T +  T +Y +PE L +   Y +  DIWS+GCIL E+      F 
Sbjct: 148 DFGVSRLLMGSCDLATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFE 206

Query: 150 GKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDL 209
           G+++   L ++  ++  P  +                LP    +Q  +           +
Sbjct: 207 GQNF---LSVVLRIVEGPTPS----------------LPETYSRQLNS-----------I 236

Query: 210 LEKMLVFDPNKRITVEEALRHPYL 233
           ++ ML  DP+ R +  E LR+P++
Sbjct: 237 MQSMLNKDPSLRPSAAEILRNPFI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 84.1 bits (209), Expect = 4e-19
 Identities = 49/161 (30%), Positives = 78/161 (48%), Gaps = 22/161 (13%)

Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRG 60
           H N++ +  +    +      +YIV E M   DL   +R   ++LT         Q+ +G
Sbjct: 60  HPNIVRLLGVCTQGEP-----LYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKG 114

Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-------RWY 113
           ++Y+ S + +HRDL   N L+  +  +KI DFGL+R   E D    Y          +W 
Sbjct: 115 MEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDD---YYRKRGGGKLPIKWM 171

Query: 114 RAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPGKD 152
            APE L +  ++T+  D+WS G +L EI T   +P +PG  
Sbjct: 172 -APESLKDG-KFTSKSDVWSFGVLLWEIFTLGEQP-YPGMS 209

Length = 258

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 82.9 bits (205), Expect = 9e-19
 Identities = 58/237 (24%), Positives = 109/237 (45%), Gaps = 40/237 (16%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++HE ++     +R  +      + I  E M    +   +++   LT+   + +  Q+L 
Sbjct: 61  LQHERIVQYYGCLRDDET-----LSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILE 115

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG----LARTTSETDFMTEYVVTRWYRA 115
           G++Y+HS  ++HRD+K +N+L +++ ++K+GDFG    L    S    M     T ++ +
Sbjct: 116 GVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMS 175

Query: 116 PELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL 175
           PE++     Y    D+WSVGC + E++T +P  P  ++   +  I ++   P +      
Sbjct: 176 PEVISGEG-YGRKADVWSVGCTVVEMLTEKP--PWAEF-EAMAAIFKIATQPTNP----- 226

Query: 176 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 232
                     QLP            + S  A + L +  V +  KR + EE LRH +
Sbjct: 227 ----------QLP-----------SHVSPDARNFLRRTFVENAKKRPSAEELLRHFF 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 81.0 bits (200), Expect = 6e-18
 Identities = 57/199 (28%), Positives = 95/199 (47%), Gaps = 29/199 (14%)

Query: 38  IIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART 97
            +R+  +  +   ++F  Q+L GL Y+HS  +LHRDLK  NLL++A    KI DFG+++ 
Sbjct: 98  CLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKK 157

Query: 98  TSE---TDFMTEYVVTRWYRAPELLLNCTE-YTAAIDIWSVGCILGEIMTREPLFPGKDY 153
           + +    D       + ++ APE++ + ++ Y+A +DIWS+GC++ E      +F G+  
Sbjct: 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLE------MFAGRRP 211

Query: 154 VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKM 213
                 I  +        LG  RS         +P            N S  A+D L   
Sbjct: 212 WSDEEAIAAMF------KLGNKRS------APPIP-------PDVSMNLSPVALDFLNAC 252

Query: 214 LVFDPNKRITVEEALRHPY 232
              +P+ R T  E L+HP+
Sbjct: 253 FTINPDNRPTARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 80.8 bits (199), Expect = 6e-18
 Identities = 64/238 (26%), Positives = 108/238 (45%), Gaps = 41/238 (17%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQL--TDDHCQYFLYQL 57
           M+H N++      +   +     ++IV E  D  DL + I   + +  ++D    +  Q+
Sbjct: 56  MKHPNIVTFFASFQENGR-----LFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQI 110

Query: 58  LRGLKYVHSASVLHRDLKPSNLLLNASCDL-KIGDFGLARTTSET-DFMTEYVVTRWYRA 115
             GLK++H   +LHRD+K  N+ L+ +  + K+GDFG+AR  +++ +     V T +Y +
Sbjct: 111 SLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLS 170

Query: 116 PELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL 175
           PE+  N   Y    DIWS+GC+L E+ T +  F G +  HQL L                
Sbjct: 171 PEICQN-RPYNNKTDIWSLGCVLYELCTLKHPFEGNNL-HQLVLKI-------------- 214

Query: 176 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
                         C+   FA   PN S     L+ ++    P  R ++   L+ P+L
Sbjct: 215 --------------CQG-YFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 80.6 bits (199), Expect = 8e-18
 Identities = 47/145 (32%), Positives = 76/145 (52%), Gaps = 8/145 (5%)

Query: 11  DIIRPPKKDTFND-VYIVYELMD-TDLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYV 64
           +I+R  K    ND +YIV +L++   L +   S     Q+ T++       Q++  L+Y+
Sbjct: 70  NIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYL 129

Query: 65  HSAS-VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 123
           H    ++HRDL P+N++L     + I DFGLA+       +T  V T  Y  PE++ N  
Sbjct: 130 HKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKN-E 188

Query: 124 EYTAAIDIWSVGCILGEIMTREPLF 148
            Y    D+W+ GCIL ++ T +P F
Sbjct: 189 PYGEKADVWAFGCILYQMCTLQPPF 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 80.7 bits (200), Expect = 1e-17
 Identities = 55/215 (25%), Positives = 93/215 (43%), Gaps = 56/215 (26%)

Query: 20  TFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 75
           +F D   +Y +M+     +L   +R   +  +   +++  Q++  L+Y+HS  +++RDLK
Sbjct: 69  SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLK 128

Query: 76  PSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR-W-------YRAPELLLNCTEYTA 127
           P NLLL++   +KI DFG A+           V  R +       Y APE++L+   Y  
Sbjct: 129 PENLLLDSDGYIKITDFGFAK----------RVKGRTYTLCGTPEYLAPEIILS-KGYGK 177

Query: 128 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL 187
           A+D W++G ++ E++   P F    +      I E I        G +            
Sbjct: 178 AVDWWALGILIYEMLAGYPPF----FDDNPIQIYEKILE------GKV------------ 215

Query: 188 PRCRKQQFATRFPNKSSGAV-DLLEKMLVFDPNKR 221
                     RFP+  S    DL+  +L  D  KR
Sbjct: 216 ----------RFPSFFSPDAKDLIRNLLQVDLTKR 240

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 78.0 bits (193), Expect = 6e-17
 Identities = 50/181 (27%), Positives = 78/181 (43%), Gaps = 30/181 (16%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS---------DQQLTDDHC 50
           + H NV+ +  +           +Y+V E M+  DL   +R             L+    
Sbjct: 53  LGHPNVVRLLGVCT-----EEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDL 107

Query: 51  QYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT 110
             F  Q+ +G++Y+ S   +HRDL   N L+     +KI DFGL+R   + D+   Y   
Sbjct: 108 LSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY---YRKK 164

Query: 111 -------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR--EPLFPGKDYVHQLRLIT 161
                  RW  APE L +   +T+  D+WS G +L EI T    P +PG      L  + 
Sbjct: 165 TGGKLPIRWM-APESLKD-GIFTSKSDVWSFGVLLWEIFTLGATP-YPGLSNEEVLEYLR 221

Query: 162 E 162
           +
Sbjct: 222 K 222

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 77.4 bits (191), Expect = 1e-16
 Identities = 55/221 (24%), Positives = 94/221 (42%), Gaps = 36/221 (16%)

Query: 22  NDVYIVYELMDT-DLHQIIRS--DQQLTDDHC-QYFLYQLLRGLKYVHSASVLHRDLKPS 77
           +++++V   +    L  I++S   +   D+      L ++L+GL+Y+HS   +HRD+K  
Sbjct: 72  DELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAG 131

Query: 78  NLLLNASCDLKIGDFGLARTTSETDFMTE-----YVVTRWYRAPELLLNCTEYTAAIDIW 132
           N+LL     +KI DFG++ + ++    T      +V T  + APE++     Y    DIW
Sbjct: 132 NILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIW 191

Query: 133 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCR- 191
           S G    E+ T     P   Y     L+  L   P                   L     
Sbjct: 192 SFGITAIELATGAA--PYSKYPPMKVLMLTLQNDPP-----------------SLETGAD 232

Query: 192 KQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 232
            ++++  F         ++   L  DP+KR T EE L+H +
Sbjct: 233 YKKYSKSFR-------KMISLCLQKDPSKRPTAEELLKHKF 266

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 77.1 bits (190), Expect = 2e-16
 Identities = 50/214 (23%), Positives = 100/214 (46%), Gaps = 32/214 (14%)

Query: 22  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 81
           +++++V E ++      I +  ++ ++        +L+ L ++H+  V+HRD+K  ++LL
Sbjct: 89  DELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILL 148

Query: 82  NASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
            +   +K+ DFG  A+ + E       V T ++ APE++     Y   +DIWS+G ++ E
Sbjct: 149 TSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIE 207

Query: 141 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 200
           ++  EP +  +  +  ++ I               R +   +               +  
Sbjct: 208 MVDGEPPYFNEPPLQAMKRI---------------RDNLPPKL--------------KNL 238

Query: 201 NKSSGAV-DLLEKMLVFDPNKRITVEEALRHPYL 233
           +K S  +   L++MLV DP +R T  E L HP+L
Sbjct: 239 HKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 76.8 bits (189), Expect = 2e-16
 Identities = 42/125 (33%), Positives = 73/125 (58%), Gaps = 10/125 (8%)

Query: 53  FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC-DLKIGDFGLA-----RTTSETDFMTE 106
           +  QLLRGL Y+H   ++HRD+K +NLL++++   L+I DFG A     + T   +F  +
Sbjct: 108 YTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQ 167

Query: 107 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEL--- 163
            + T  + APE+L    +Y  + D+WSVGC++ E+ T +P +  + + + L LI ++   
Sbjct: 168 LLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASA 226

Query: 164 IGSPD 168
             +P 
Sbjct: 227 TTAPS 231

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 76.7 bits (189), Expect = 3e-16
 Identities = 34/119 (28%), Positives = 63/119 (52%), Gaps = 1/119 (0%)

Query: 43  QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSET 101
             + + +    + ++L  LKY+H   V+HRD+K +N+L+  + ++K+ DFG+ A     +
Sbjct: 96  GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155

Query: 102 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 160
              + +V T ++ APE++     Y    DIWS+G  + E+ T  P +   D    + LI
Sbjct: 156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI 214

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 76.2 bits (187), Expect = 3e-16
 Identities = 53/181 (29%), Positives = 81/181 (44%), Gaps = 36/181 (19%)

Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYR 114
           Q+   L+Y+H   +LHRDLK  N+ L  +  +K+GD G+AR   ++ D  +  + T +Y 
Sbjct: 110 QIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYM 169

Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE--LIGSPDDASL 172
           +PEL  N   Y    D+W++GC + E+ T +  F  KD    +  I E  L   P D   
Sbjct: 170 SPELFSN-KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKD--- 225

Query: 173 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 232
                     Y  +L                    +L+  ML   P KR +V+  LR PY
Sbjct: 226 ----------YSPEL-------------------GELIATMLSKRPEKRPSVKSILRQPY 256

Query: 233 L 233
           +
Sbjct: 257 I 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 76.0 bits (187), Expect = 3e-16
 Identities = 46/155 (29%), Positives = 81/155 (52%), Gaps = 16/155 (10%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQL--TDDHCQYFL 54
           M+H N++  ++        +F +   +Y +MD     DL++ I + + +   +D    + 
Sbjct: 56  MKHPNIVQYQE--------SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWF 107

Query: 55  YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWY 113
            Q+   LK+VH   +LHRD+K  N+ L     +K+GDFG+AR  + T +     + T +Y
Sbjct: 108 VQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYY 167

Query: 114 RAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF 148
            +PE+  N   Y    DIW++GC+L E+ T +  F
Sbjct: 168 LSPEICEN-RPYNNKSDIWALGCVLYEMCTLKHAF 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 75.9 bits (187), Expect = 5e-16
 Identities = 59/221 (26%), Positives = 99/221 (44%), Gaps = 38/221 (17%)

Query: 23  DVYIVYELMDTDLH----QIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPS 77
           DV+I  E+MDT L     ++      + +D        +++ L+Y+HS  SV+HRD+KPS
Sbjct: 74  DVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPS 133

Query: 78  NLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL---LNCTEYTAAIDIWSV 134
           N+L+N +  +K+ DFG++    ++   T     + Y APE +   LN   Y    D+WS+
Sbjct: 134 NVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSL 193

Query: 135 GCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ 193
           G  + E+ T R P    K    QL+ + E                         P+   +
Sbjct: 194 GITMIELATGRFPYDSWKTPFQQLKQVVE--EPS--------------------PQLPAE 231

Query: 194 QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
           +F+  F        D + K L  +  +R    E L+HP+ +
Sbjct: 232 KFSPEF-------QDFVNKCLKKNYKERPNYPELLQHPFFE 265

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 75.4 bits (185), Expect = 6e-16
 Identities = 56/182 (30%), Positives = 92/182 (50%), Gaps = 34/182 (18%)

Query: 19  DTF---NDVYIVYELMDT-DLHQII---RSDQQLTDDHC--QYFLYQLLRGLKYVHSASV 69
           D+F   N++ IV EL D  DL Q+I   +  ++L  +    +YF+ QL   ++++HS  V
Sbjct: 69  DSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFV-QLCSAVEHMHSRRV 127

Query: 70  LHRDLKPSNLLLNASCDLKIGDFGLAR-TTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 128
           +HRD+KP+N+ + A+  +K+GD GL R  +S+T      V T +Y +PE  ++   Y   
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE-RIHENGYNFK 186

Query: 129 IDIWSVGCILGEIMTRE----------------------PLFPGKDYVHQLRLITELIGS 166
            DIWS+GC+L E+   +                      P  P + Y  +LR +  +   
Sbjct: 187 SDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIY 246

Query: 167 PD 168
           PD
Sbjct: 247 PD 248

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 75.2 bits (185), Expect = 7e-16
 Identities = 43/145 (29%), Positives = 68/145 (46%), Gaps = 8/145 (5%)

Query: 24  VYIVYELMDT-DLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
           VYI+ ELM+   L   +RS   Q L          Q+  G+ Y+   + +HRDL   N+L
Sbjct: 77  VYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNIL 136

Query: 81  LNASCDLKIGDFGLARTTSETDFMTE--YVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 138
           +      K+ DFGLAR   E  +++    +  +W  APE   +   ++   D+WS G +L
Sbjct: 137 VGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKW-TAPE-AASHGTFSTKSDVWSFGILL 194

Query: 139 GEIMTREPL-FPGKDYVHQLRLITE 162
            E+ T   + +PG +       IT 
Sbjct: 195 YEMFTYGQVPYPGMNNHEVYDQITA 219

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 75.5 bits (185), Expect = 8e-16
 Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 30/212 (14%)

Query: 23  DVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 82
           +++++ E +       I S  +L ++        +L+ L Y+HS  V+HRD+K  ++LL 
Sbjct: 92  ELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLT 151

Query: 83  ASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 141
               +K+ DFG  A+ + +       V T ++ APE++   T Y   +DIWS+G ++ E+
Sbjct: 152 LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR-TPYGTEVDIWSLGIMVIEM 210

Query: 142 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 201
           +  EP +     V  ++    L  SP             +   +  P  R          
Sbjct: 211 VDGEPPYFSDSPVQAMK---RLRDSP---------PPKLKNAHKISPVLR---------- 248

Query: 202 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
                 D LE+ML  +P +R T +E L HP+L
Sbjct: 249 ------DFLERMLTREPQERATAQELLDHPFL 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 75.1 bits (184), Expect = 9e-16
 Identities = 50/190 (26%), Positives = 99/190 (52%), Gaps = 12/190 (6%)

Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGL 61
           HE ++     +R P + T +   I  E M    +   ++S   LT++  + +  Q+L G+
Sbjct: 63  HERIVQYYGCLRDPMERTLS---IFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGV 119

Query: 62  KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF----MTEYVVTRWYRAPE 117
            Y+HS  ++HRD+K +N+L ++  ++K+GDFG ++           M     T ++ +PE
Sbjct: 120 SYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPE 179

Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 177
            +++   Y    DIWSVGC + E++T +P  P  ++   +  I ++   P +  L    S
Sbjct: 180 -VISGEGYGRKADIWSVGCTVVEMLTEKP--PWAEF-EAMAAIFKIATQPTNPVLPPHVS 235

Query: 178 DNARRYVRQL 187
           D+ R +++++
Sbjct: 236 DHCRDFLKRI 245

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 75.1 bits (184), Expect = 9e-16
 Identities = 55/180 (30%), Positives = 93/180 (51%), Gaps = 17/180 (9%)

Query: 45  LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM 104
           L + +    L ++L+GL Y+HS   +HRD+K +N+LL+   D+K+ DFG+A   ++T   
Sbjct: 98  LEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157

Query: 105 -TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEL 163
              +V T ++ APE++   + Y    DIWS+G    E+   EP  P  D +H +R++  L
Sbjct: 158 RNTFVGTPFWMAPEVIKQ-SAYDFKADIWSLGITAIELAKGEP--PNSD-LHPMRVLF-L 212

Query: 164 IGSPDDASLGFLRSDNARRYVRQL----PRCR-------KQQFATRFPNKSSGAVDLLEK 212
           I      +L    S   + +V       PR R       K +F TR+  K+S   +L+++
Sbjct: 213 IPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYTKKTSFLTELIDR 272

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 74.5 bits (183), Expect = 1e-15
 Identities = 54/193 (27%), Positives = 84/193 (43%), Gaps = 32/193 (16%)

Query: 40  RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTT 98
           R +  L +D   +F  Q+L  L +VH+  +LHRDLK  N+LL+     +KIGDFG+++  
Sbjct: 93  RCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL 152

Query: 99  SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR 158
           S        V T  Y +PE L     Y    DIW++GC+L E+ + +  F   +    L 
Sbjct: 153 SSKSKAYTVVGTPCYISPE-LCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN----LP 207

Query: 159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDP 218
            +   I S   A +    S + R+                          L+  ML  DP
Sbjct: 208 ALVLKIMSGTFAPISDRYSPDLRQ--------------------------LILSMLNLDP 241

Query: 219 NKRITVEEALRHP 231
           +KR  + + +  P
Sbjct: 242 SKRPQLSQIMAQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 75.7 bits (186), Expect = 1e-15
 Identities = 68/254 (26%), Positives = 114/254 (44%), Gaps = 38/254 (14%)

Query: 1   MEHENVIAIKD-IIRPPKKDTFNDVYIVYELMDTDLHQII-RSDQQLTDDHCQYFLYQLL 58
           + H +VI +KD ++            +V     +DL+  + +  + L  D       Q+L
Sbjct: 114 VNHPSVIRMKDTLVSGAI------TCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQIL 167

Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR-TTSETDFMTEYVVTRWYRAPE 117
            GL+Y+H+  ++HRD+K  N+ +N    + IGD G A+       F+     T    APE
Sbjct: 168 EGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG-LAGTVETNAPE 226

Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMT------REPLFPGKDYV-----HQLRLITELIGS 166
           +L    +Y +  DIWS G +L E++        +P    ++YV     H L++I+ L   
Sbjct: 227 VLAR-DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVH 285

Query: 167 PDDASLGFLRSDNAR---RYVRQLPRCRKQQFATRFPNKS------SGAVDLLEKMLVFD 217
           P++    F R   +R    ++       +Q + TR+P          G   L+ KML FD
Sbjct: 286 PEE----FPRDPGSRLVRGFIE-YASLERQPY-TRYPCFQRVNLPIDGEF-LVHKMLTFD 338

Query: 218 PNKRITVEEALRHP 231
              R + EE L +P
Sbjct: 339 AAMRPSAEEILNYP 352

Length = 357

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 74.7 bits (183), Expect = 1e-15
 Identities = 58/229 (25%), Positives = 107/229 (46%), Gaps = 34/229 (14%)

Query: 22  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 81
           +++++V E ++      I +  ++ ++        +LR L Y+H+  V+HRD+K  ++LL
Sbjct: 92  DELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILL 151

Query: 82  NASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
            +   +K+ DFG  A+ + E       V T ++ APE +++   Y   +DIWS+G ++ E
Sbjct: 152 TSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPE-VISRLPYGTEVDIWSLGIMVIE 210

Query: 141 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 200
           ++  EP +  +  +  +R I                 DN    V+   +           
Sbjct: 211 MIDGEPPYFNEPPLQAMRRI----------------RDNLPPRVKDSHKV---------- 244

Query: 201 NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPF 249
             SS     L+ MLV +P++R T +E L+HP+L+    L   P C  P 
Sbjct: 245 --SSVLRGFLDLMLVREPSQRATAQELLQHPFLK----LAGPPSCIVPL 287

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 74.1 bits (182), Expect = 2e-15
 Identities = 39/100 (39%), Positives = 60/100 (60%), Gaps = 3/100 (3%)

Query: 52  YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTE-YVV 109
           ++  Q+L GLKY+H   ++HRD+K  N+L+N  S  +KI DFG ++  +  +  TE +  
Sbjct: 112 FYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTG 171

Query: 110 TRWYRAPELLLNCTE-YTAAIDIWSVGCILGEIMTREPLF 148
           T  Y APE++      Y A  DIWS+GC + E+ T +P F
Sbjct: 172 TLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF 211

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 73.9 bits (181), Expect = 2e-15
 Identities = 54/176 (30%), Positives = 89/176 (50%), Gaps = 31/176 (17%)

Query: 22  NDVYIVYELMDT-DLHQIIR---SDQQLTDDHC--QYFLYQLLRGLKYVHSASVLHRDLK 75
           N++ IV EL D  DL ++I+     ++L  +    +YF+ QL   L+++HS  V+HRD+K
Sbjct: 75  NELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFV-QLCSALEHMHSRRVMHRDIK 133

Query: 76  PSNLLLNASCDLKIGDFGLAR-TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSV 134
           P+N+ + A+  +K+GD GL R  +S+T      V T +Y +PE  ++   Y    DIWS+
Sbjct: 134 PANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE-RIHENGYNFKSDIWSL 192

Query: 135 GCILGEIMTRE----------------------PLFPGKDYVHQLRLITELIGSPD 168
           GC+L E+   +                      P  P   Y  +LR +  +  +PD
Sbjct: 193 GCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPD 248

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 74.6 bits (183), Expect = 2e-15
 Identities = 52/197 (26%), Positives = 98/197 (49%), Gaps = 26/197 (13%)

Query: 20  TFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 78
           T +D+Y+V + M   +L   ++ + + ++D  ++++ +L+  L+++H   +++RDLKP N
Sbjct: 67  TDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPEN 126

Query: 79  LLLNASCDLKIGDFGLARTT-SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 137
           +LL+A+  + + DFGL++   ++      +  T  Y APE+LL+   YT  +D WS+G +
Sbjct: 127 ILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVL 186

Query: 138 LGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR------SDNARRYVRQLPRCR 191
           + E+      F  +D     R I          + G +R      SD  R++V+ L    
Sbjct: 187 VFEMCCGWSPFYAEDTQQMYRNI----------AFGKVRFPKNVLSDEGRQFVKGL---- 232

Query: 192 KQQFATRFPNKSSGAVD 208
                 R P    GA  
Sbjct: 233 ----LNRNPQHRLGAHR 245

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 74.3 bits (182), Expect = 3e-15
 Identities = 58/217 (26%), Positives = 102/217 (47%), Gaps = 43/217 (19%)

Query: 42  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSE 100
           ++  ++D  +++  +++  L Y+HS  +++RDLK  NL+L+    +KI DFGL +   ++
Sbjct: 89  ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD 148

Query: 101 TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 160
              M  +  T  Y APE+L +  +Y  A+D W +G ++ E+M     F  +D+     LI
Sbjct: 149 AATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 207

Query: 161 TELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPN 219
                         L  D                   +FP   S+ A  LL  +L+ DPN
Sbjct: 208 --------------LMED------------------IKFPRTLSADAKSLLSGLLIKDPN 235

Query: 220 KRI-----TVEEALRHPYLQSLH--DLNDEPVCPRPF 249
           KR+       +E +RH +   ++  D+ D+ + P PF
Sbjct: 236 KRLGGGPDDAKEIMRHSFFTGVNWQDVYDKKLVP-PF 271

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 73.5 bits (181), Expect = 3e-15
 Identities = 56/208 (26%), Positives = 101/208 (48%), Gaps = 36/208 (17%)

Query: 33  TDLHQ-IIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGD 91
           TDL + + +  ++L ++   Y L + LRGL Y+H   V+HRD+K  N+LL  + ++K+ D
Sbjct: 97  TDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVD 156

Query: 92  FGLARTTSETDFMTE-YVVTRWYRAPELLLNCTE-----YTAAIDIWSVGCILGEIMTRE 145
           FG++     T      ++ T ++ APE++  C E     Y A  D+WS+G    E+   +
Sbjct: 157 FGVSAQLDSTLGRRNTFIGTPYWMAPEVIA-CDEQPDASYDARSDVWSLGITAIELADGK 215

Query: 146 PLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSG 205
           P  P  D +H +R + ++  +P       L+S          P    ++F          
Sbjct: 216 P--PLCD-MHPMRALFKIPRNPPPT----LKS----------PENWSKKF---------- 248

Query: 206 AVDLLEKMLVFDPNKRITVEEALRHPYL 233
             D + + L+ +  +R  +EE L HP++
Sbjct: 249 -NDFISECLIKNYEQRPFMEELLEHPFI 275

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 74.0 bits (182), Expect = 3e-15
 Identities = 49/193 (25%), Positives = 89/193 (46%), Gaps = 26/193 (13%)

Query: 45  LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM 104
           L++DH ++++ ++   +  +H    +HRDLKP N L++AS  +K+ DFGL++      + 
Sbjct: 98  LSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YA 155

Query: 105 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELI 164
              V +  Y APE +L    Y   +D WS+GC+L E +   P F G              
Sbjct: 156 NSVVGSPDYMAPE-VLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGS------------- 201

Query: 165 GSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 224
            +P++        +N + +   L R           N S  A DL+ K++     +  ++
Sbjct: 202 -TPNET------WENLKYWKETLQRPVYDD---PRFNLSDEAWDLITKLINDPSRRFGSL 251

Query: 225 EEALRHPYLQSLH 237
           E+   HP+ + + 
Sbjct: 252 EDIKNHPFFKEVD 264

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 73.3 bits (180), Expect = 4e-15
 Identities = 49/209 (23%), Positives = 93/209 (44%), Gaps = 39/209 (18%)

Query: 51  QYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT 110
            ++  ++  GL+ +H   +++RDLKP N+LL+    ++I D GLA    E + +   V T
Sbjct: 105 VFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGT 164

Query: 111 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA 170
             Y APE++ N   YT + D W +GC++ E++  +  F  +                   
Sbjct: 165 VGYMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFRQR------------------- 204

Query: 171 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVE 225
                +    R  V +  +  +++++ +F   S  A  +  ++L  DP  R+       E
Sbjct: 205 -----KEKVKREEVERRVKEDQEEYSEKF---SEAARSICRQLLTKDPGFRLGCRGEGAE 256

Query: 226 EALRHPYLQSLH------DLNDEPVCPRP 248
           E   HP+ ++ +       + + P CP P
Sbjct: 257 EVKAHPFFRTANFKRLEAGMLEPPFCPDP 285

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 73.6 bits (181), Expect = 4e-15
 Identities = 60/230 (26%), Positives = 105/230 (45%), Gaps = 27/230 (11%)

Query: 22  NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNL 79
            ++ I  E MD   L Q+++   ++ ++        +LRGL Y+     ++HRD+KPSN+
Sbjct: 72  GEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNI 131

Query: 80  LLNASCDLKIGDFGLARTTSETDFM-TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 138
           L+N+  ++K+ DFG++      D M   +V TR Y +PE L   T YT   DIWS+G  L
Sbjct: 132 LVNSRGEIKLCDFGVSGQL--IDSMANSFVGTRSYMSPERLQG-THYTVQSDIWSLGLSL 188

Query: 139 GEIMT-REPLFP--GKDYVHQLRLITELIGSPDDASLGFLRSDNARR---------YV-- 184
            E+   R P+ P   K+             + +          ++ R         Y+  
Sbjct: 189 VEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVN 248

Query: 185 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
              P+     F+  F        D ++K L  +P +R  ++E  +HP+++
Sbjct: 249 EPPPKLPSGAFSDEF-------QDFVDKCLKKNPKERADLKELTKHPFIK 291

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 72.9 bits (179), Expect = 5e-15
 Identities = 52/192 (27%), Positives = 87/192 (45%), Gaps = 37/192 (19%)

Query: 52  YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR 111
           ++  Q++ GL+++H   +++RDLKP N+LL+   +++I D GLA        +     T 
Sbjct: 99  FYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTP 158

Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGE-IMTREPLFPGKDYVHQLRLITELIGSPDDA 170
            Y APE+L     Y  ++D +++GC L E I  R P    K+ V                
Sbjct: 159 GYMAPEVLQG-EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV---------------- 201

Query: 171 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRI-----TV 224
                     +  +++    R  + A  +P+K S  A DL E +L  DP KR+     + 
Sbjct: 202 ---------EKEELKR----RTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSA 248

Query: 225 EEALRHPYLQSL 236
           +E   HP  + L
Sbjct: 249 DEVREHPLFKDL 260

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 72.9 bits (179), Expect = 8e-15
 Identities = 57/220 (25%), Positives = 99/220 (45%), Gaps = 43/220 (19%)

Query: 39  IRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART- 97
           +  ++  ++D  +++  +++  L Y+HS  V++RDLK  NL+L+    +KI DFGL +  
Sbjct: 86  LSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEG 145

Query: 98  TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL 157
            S+   M  +  T  Y APE+L +  +Y  A+D W +G ++ E+M     F  +D+    
Sbjct: 146 ISDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---- 200

Query: 158 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVF 216
             + ELI   +                             RFP   S  A  LL  +L  
Sbjct: 201 EKLFELILMEE----------------------------IRFPRTLSPEAKSLLAGLLKK 232

Query: 217 DPNKRI-----TVEEALRHPYLQSL--HDLNDEPVCPRPF 249
           DP +R+       +E + H +  S+   D+  + + P PF
Sbjct: 233 DPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKKLEP-PF 271

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 72.4 bits (177), Expect = 9e-15
 Identities = 50/181 (27%), Positives = 89/181 (49%), Gaps = 32/181 (17%)

Query: 54  LYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRW 112
           L ++L+GL Y+HS   +HRD+K +N+LL+   D+K+ DFG+A   ++T      +V T +
Sbjct: 107 LKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF 166

Query: 113 YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL 172
           + APE++   + Y +  DIWS+G    E+   EP  P  D +H +R++  +  +      
Sbjct: 167 WMAPEVIQQ-SAYDSKADIWSLGITAIELAKGEP--PNSD-MHPMRVLFLIPKNNPPTLT 222

Query: 173 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 232
           G                    +F+  F        + ++  L  DP+ R T +E L+H +
Sbjct: 223 G--------------------EFSKPFK-------EFIDACLNKDPSFRPTAKELLKHKF 255

Query: 233 L 233
           +
Sbjct: 256 I 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 72.0 bits (176), Expect = 1e-14
 Identities = 52/238 (21%), Positives = 111/238 (46%), Gaps = 37/238 (15%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           ++HE ++     +R   + T   +++ Y +    +   +++   LT+   + +  Q+L G
Sbjct: 61  LQHERIVQYYGCLRDRAEKTLT-IFMEY-MPGGSVKDQLKAYGALTESVTRKYTRQILEG 118

Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF----MTEYVVTRWYRAP 116
           + Y+HS  ++HRD+K +N+L +++ ++K+GDFG ++           +     T ++ +P
Sbjct: 119 MSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSP 178

Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 176
           E++ +   Y    D+WS+GC + E++T +P  P  +Y   +  I ++   P +  L    
Sbjct: 179 EVI-SGEGYGRKADVWSLGCTVVEMLTEKP--PWAEY-EAMAAIFKIATQPTNPQLPSHI 234

Query: 177 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
           S++AR ++  +                             +   R + EE LRHP+ Q
Sbjct: 235 SEHARDFLGCI---------------------------FVEARHRPSAEELLRHPFAQ 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 72.7 bits (178), Expect = 1e-14
 Identities = 55/191 (28%), Positives = 84/191 (43%), Gaps = 38/191 (19%)

Query: 51  QYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR-TTSETDFMTEYVV 109
           +++  +LL  L+ +H  +V++RDLKP N+LL+    + + DFGL +    + D    +  
Sbjct: 96  RFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCG 155

Query: 110 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDD 169
           T  Y APELLL    YT A+D W++G +L E++T  P F  ++     R I         
Sbjct: 156 TPEYLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKIL-------- 206

Query: 170 ASLGFLRSDNARRYVRQLPRCRKQQFATRFP-NKSSGAVDLLEKMLVFDPNKRITV---E 225
                                   Q   RFP      A DLL  +L  DP +R+     +
Sbjct: 207 ------------------------QEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQ 242

Query: 226 EALRHPYLQSL 236
           E   HP+   L
Sbjct: 243 EIKNHPFFSQL 253

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 72.5 bits (178), Expect = 1e-14
 Identities = 55/160 (34%), Positives = 82/160 (51%), Gaps = 22/160 (13%)

Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQL 57
            H NV+   D+      D   ++ ++ E MD       H  I  +Q L D        Q+
Sbjct: 130 NHPNVVKCHDMF-----DHNGEIQVLLEFMDGGSLEGTH--IADEQFLAD-----VARQI 177

Query: 58  LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAP 116
           L G+ Y+H   ++HRD+KPSNLL+N++ ++KI DFG++R  ++T D     V T  Y +P
Sbjct: 178 LSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSP 237

Query: 117 ELL---LNCTEYTA-AIDIWSVG-CILGEIMTREPLFPGK 151
           E +   LN   Y   A DIWS+G  IL   + R P   G+
Sbjct: 238 ERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR 277

Length = 353

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 71.6 bits (175), Expect = 1e-14
 Identities = 48/193 (24%), Positives = 103/193 (53%), Gaps = 14/193 (7%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H+ ++     +R P++   +   I  E M    +   +++   LT++  + +  Q+L+
Sbjct: 61  LRHDRIVQYYGCLRDPEEKKLS---IFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQ 117

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV-----TRWYR 114
           G+ Y+HS  ++HRD+K +N+L +++ ++K+GDFG ++   +T  M+   +     T ++ 
Sbjct: 118 GVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRI-QTICMSGTGIKSVTGTPYWM 176

Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF 174
           +PE +++   Y    D+WSV C + E++T +P  P  +Y   +  I ++   P    L  
Sbjct: 177 SPE-VISGEGYGRKADVWSVACTVVEMLTEKP--PWAEY-EAMAAIFKIATQPTKPMLPD 232

Query: 175 LRSDNARRYVRQL 187
             SD  R +++Q+
Sbjct: 233 GVSDACRDFLKQI 245

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 72.1 bits (177), Expect = 2e-14
 Identities = 69/243 (28%), Positives = 112/243 (46%), Gaps = 48/243 (19%)

Query: 34  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG 93
           DL   +  +   T++  +++L +L   L ++HS  +++RDLKP N+LL+    +K+ DFG
Sbjct: 84  DLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFG 143

Query: 94  LARTTSETDFMT-EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 152
           L++ + + +     +  T  Y APE ++N   +T + D WS G ++ E++T    F GKD
Sbjct: 144 LSKESIDHEKKAYSFCGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD 202

Query: 153 YVHQLRLITELIGSPDDASLG---FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDL 209
               + +I +       A LG   FL S  A+  +R L +        R P    GA   
Sbjct: 203 RKETMTMILK-------AKLGMPQFL-SPEAQSLLRALFK--------RNPANRLGAGPD 246

Query: 210 LEKMLVFDPNKRITVEEALRHPYLQSLHDLND----------EPVCPRP---FHFDFEHS 256
                         VEE  RHP+  ++ D N           +P   RP   F+FD E +
Sbjct: 247 -------------GVEEIKRHPFFSTI-DWNKLYRREIKPPFKPAVGRPDDTFYFDPEFT 292

Query: 257 SCT 259
           S T
Sbjct: 293 SRT 295

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 71.6 bits (175), Expect = 2e-14
 Identities = 55/233 (23%), Positives = 108/233 (46%), Gaps = 35/233 (15%)

Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGL 61
           +HENV+ + +          +++++V E ++      I +  ++ ++        +L+ L
Sbjct: 75  QHENVVEMYN-----SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKAL 129

Query: 62  KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLL 120
             +H+  V+HRD+K  ++LL     +K+ DFG  A+ + E       V T ++ APE L+
Sbjct: 130 SVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPE-LI 188

Query: 121 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 180
           +   Y   +DIWS+G ++ E++  EP +  +  +  +++I                 DN 
Sbjct: 189 SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI----------------RDNL 232

Query: 181 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
              ++ L +             S      L+++LV DP +R T  E L+HP+L
Sbjct: 233 PPKLKNLHKV------------SPSLKGFLDRLLVRDPAQRATAAELLKHPFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 71.2 bits (174), Expect = 2e-14
 Identities = 57/242 (23%), Positives = 104/242 (42%), Gaps = 39/242 (16%)

Query: 18  KDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 77
           KD    V  +    D   H     +    ++   ++  ++L GL+ +H  + ++RDLKP 
Sbjct: 72  KDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPE 131

Query: 78  NLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 137
           N+LL+    ++I D GLA    E + +   V T  Y APE+L N   YT + D W +GC+
Sbjct: 132 NILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNN-QRYTLSPDYWGLGCL 190

Query: 138 LGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFAT 197
           + E++  +  F G+                        +    R  V +     ++ ++ 
Sbjct: 191 IYEMIEGQSPFRGR------------------------KEKVKREEVDRRVLETEEVYSA 226

Query: 198 RFPNKSSGAVDLLEKMLVFDPNKRITVE-----EALRHPYLQSLH------DLNDEPVCP 246
           +F   S  A  + + +L  DP +R+  +     E  RHP+ ++++       + D P  P
Sbjct: 227 KF---SEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDPPFVP 283

Query: 247 RP 248
            P
Sbjct: 284 DP 285

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 71.1 bits (174), Expect = 2e-14
 Identities = 51/191 (26%), Positives = 89/191 (46%), Gaps = 37/191 (19%)

Query: 50  CQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR-------TTSETD 102
           C+Y   Q+L G+ Y+H+  V+HRD+K +N++L  +  +K+ DFG AR         + ++
Sbjct: 105 CKY-TKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSN 163

Query: 103 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE 162
            +     T ++ APE ++N + Y    DIWS+GC + E+ T +P     D +  +  I  
Sbjct: 164 MLKSMHGTPYWMAPE-VINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI-- 220

Query: 163 LIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI 222
                             R  + +LP          F   S+ A+D +   L  D ++R 
Sbjct: 221 ---------------GAHRGLMPRLPD--------SF---SAAAIDFVTSCLTRDQHERP 254

Query: 223 TVEEALRHPYL 233
           +  + LRH +L
Sbjct: 255 SALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 71.1 bits (174), Expect = 2e-14
 Identities = 52/180 (28%), Positives = 85/180 (47%), Gaps = 30/180 (16%)

Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYR 114
           + L+ L+++HS  V+HRD+K  N+LL     +K+ DFG  A+ T E    +  V T ++ 
Sbjct: 123 ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 182

Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF 174
           APE++     Y   +DIWS+G +  E++  EP +  ++ +  L LI    G+P+      
Sbjct: 183 APEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPE------ 234

Query: 175 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
                       L    K     R         D L + L  D  KR + +E L+HP+L+
Sbjct: 235 ------------LQNPEKLSAIFR---------DFLNRCLEMDVEKRGSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 70.9 bits (174), Expect = 3e-14
 Identities = 49/185 (26%), Positives = 86/185 (46%), Gaps = 35/185 (18%)

Query: 58  LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 117
           L+GL Y+HS  ++HRD+KPSN+LL     +K+ DFG++     +   T +  T +Y APE
Sbjct: 115 LKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGT-FTGTSFYMAPE 173

Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFP--GKDYVHQLRLITELIGSP-----DDA 170
            +     Y+   D+WS+G  L E+      FP  G+  +  + L++ ++  P     D+ 
Sbjct: 174 RIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEP 232

Query: 171 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 230
             G   S+  +                          D +++ L  DP +R T  + L H
Sbjct: 233 GNGIKWSEEFK--------------------------DFIKQCLEKDPTRRPTPWDMLEH 266

Query: 231 PYLQS 235
           P++++
Sbjct: 267 PWIKA 271

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 71.3 bits (175), Expect = 3e-14
 Identities = 50/214 (23%), Positives = 92/214 (42%), Gaps = 48/214 (22%)

Query: 34  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG 93
           DL   I+   +  +   +++  +++ GL+++H   +++RDLK  N+LL++   +KI DFG
Sbjct: 82  DLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFG 141

Query: 94  LARTTSETDFMTEYVVTRW------YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL 147
           + +     + +   V T        Y APE+L     Y  A+D W++G +L E++  +  
Sbjct: 142 MCK-----EGILGGVTTSTFCGTPDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSP 195

Query: 148 FPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAV 207
           F G D               +D     +  D   RY R L               S  A 
Sbjct: 196 FEGDD---------------EDELFQSILEDEV-RYPRWL---------------SKEAK 224

Query: 208 DLLEKMLVFDPNKRITV-----EEALRHPYLQSL 236
            +L+  L  +P KR+       ++   HP+ + +
Sbjct: 225 SILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI 258

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 70.9 bits (174), Expect = 3e-14
 Identities = 39/105 (37%), Positives = 54/105 (51%), Gaps = 6/105 (5%)

Query: 43  QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD 102
           + LT      F YQ+ RG++++ S   +HRDL   N+L+     +KI DFGLAR     D
Sbjct: 127 ETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHID 186

Query: 103 FMTEYVVTR----WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           +  +    R    W  APE L +   YT   D+WS G +L EI T
Sbjct: 187 YYRKTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 71.2 bits (174), Expect = 3e-14
 Identities = 63/220 (28%), Positives = 106/220 (48%), Gaps = 35/220 (15%)

Query: 20  TFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 78
           T  +++ V E ++  DL   I+S  +       ++  +++ GL+++HS  +++RDLK  N
Sbjct: 67  TKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDN 126

Query: 79  LLLNASCDLKIGDFGLARTTSETDFMT-EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 137
           +LL+    +KI DFG+ +     D  T  +  T  Y APE+LL   +Y  ++D WS G +
Sbjct: 127 ILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG-QKYNTSVDWWSFGVL 185

Query: 138 LGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFAT 197
           L E++  +  F G D         EL  S        +R DN   Y R L R        
Sbjct: 186 LYEMLIGQSPFHGHDE-------EELFQS--------IRMDNP-CYPRWLTR-------- 221

Query: 198 RFPNKSSGAVDLLEKMLVFDPNKRITVEEALR-HPYLQSL 236
                   A D+L K+ V +P +R+ V+  +R HP+ + +
Sbjct: 222 -------EAKDILVKLFVREPERRLGVKGDIRQHPFFREI 254

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 70.6 bits (173), Expect = 5e-14
 Identities = 61/247 (24%), Positives = 109/247 (44%), Gaps = 38/247 (15%)

Query: 34  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG 93
           DL   I+S  +  +   +++  +++ GL+++H   +++RDLK  N+LL+    +KI DFG
Sbjct: 82  DLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFG 141

Query: 94  LARTTSETDFMTE-YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 152
           + +     +     +  T  Y APE+L    +Y  ++D WS G +L E++  +  F G+D
Sbjct: 142 MCKENMNGEGKASTFCGTPDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSPFHGED 200

Query: 153 YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEK 212
                          +D     + +D    + R +               S  A D L K
Sbjct: 201 ---------------EDELFDSILNDRP-HFPRWI---------------SKEAKDCLSK 229

Query: 213 MLVFDPNKRITVEEALR-HPYLQSLH--DLNDEPVCPRPFHFDFEHSSCTEDHIRELIWR 269
           +   DP KR+ V+  +R HP+ + +    L    + P PF    +  S   +  RE    
Sbjct: 230 LFERDPTKRLGVDGDIRQHPFFRGIDWERLEKREIPP-PFKPKVKSPSDASNFDREFT-N 287

Query: 270 ESVKFNP 276
           E V+ +P
Sbjct: 288 EKVRLSP 294

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 70.5 bits (173), Expect = 5e-14
 Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 52/226 (23%)

Query: 20  TFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 78
           T + V  V E     DL   I +D   ++    ++   ++ GL+Y+H   +++RDLK  N
Sbjct: 73  TEDHVCFVMEYAAGGDLMMHIHTDV-FSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDN 131

Query: 79  LLLNASCDLKIGDFGLAR-------TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDI 131
           LLL+    +KI DFGL +        TS       +  T  + APE+L   T YT A+D 
Sbjct: 132 LLLDTEGFVKIADFGLCKEGMGFGDRTS------TFCGTPEFLAPEVLTE-TSYTRAVDW 184

Query: 132 WSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCR 191
           W +G ++ E++  E  FPG D               ++     + +D   RY R L R  
Sbjct: 185 WGLGVLIYEMLVGESPFPGDD---------------EEEVFDSIVNDEV-RYPRFLSR-- 226

Query: 192 KQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPY 232
                         A+ ++ ++L  +P +R+       E+  + P+
Sbjct: 227 -------------EAISIMRRLLRRNPERRLGSGEKDAEDVKKQPF 259

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 69.8 bits (170), Expect = 8e-14
 Identities = 51/181 (28%), Positives = 85/181 (46%), Gaps = 32/181 (17%)

Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYR 114
           + L+ L+++HS  V+HRD+K  N+LL     +K+ DFG  A+ T E    +  V T ++ 
Sbjct: 124 ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 183

Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF 174
           APE++     Y   +DIWS+G +  E++  EP +  ++ +  L LI    G+P+      
Sbjct: 184 APEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPE------ 235

Query: 175 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAV-DLLEKMLVFDPNKRITVEEALRHPYL 233
                                  + P K S    D L + L  D  KR + +E L+H +L
Sbjct: 236 ----------------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273

Query: 234 Q 234
           +
Sbjct: 274 K 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 69.7 bits (170), Expect = 9e-14
 Identities = 56/202 (27%), Positives = 90/202 (44%), Gaps = 37/202 (18%)

Query: 42  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSE 100
           D+ LT+   Q    Q+L  L+Y+HS  ++HRDLK  N+LL    D+K+ DFG+ A+    
Sbjct: 104 DRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT 163

Query: 101 TDFMTEYVVTRWYRAPELLLNC-----TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH 155
                 ++ T ++ APE+++ C     T Y    DIWS+G  L E+   EP        H
Sbjct: 164 LQRRDSFIGTPYWMAPEVVM-CETMKDTPYDYKADIWSLGITLIEMAQIEPPH------H 216

Query: 156 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAV-DLLEKML 214
           +L                     N  R + ++ +      +   P+K S    D L+  L
Sbjct: 217 EL---------------------NPMRVLLKIAKSEPPTLSQ--PSKWSMEFRDFLKTAL 253

Query: 215 VFDPNKRITVEEALRHPYLQSL 236
              P  R +  + L HP++ S+
Sbjct: 254 DKHPETRPSAAQLLEHPFVSSV 275

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 70.0 bits (171), Expect = 1e-13
 Identities = 59/212 (27%), Positives = 92/212 (43%), Gaps = 36/212 (16%)

Query: 57  LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWY--- 113
           +LR ++Y+H   ++HRD+K  N+ +N   D+ +GDFG A       F  +    ++Y   
Sbjct: 191 VLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAAC------FPVDINANKYYGWA 244

Query: 114 -----RAPELLLNCTEYTAAIDIWSVGCILGEIMT-------REPLFPGKDYVHQLRLIT 161
                 APELL     Y  A+DIWS G +L E+ T       ++ L    D   Q++LI 
Sbjct: 245 GTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLII 303

Query: 162 ELIGS-----PDDASLGFLRSDNARRYVRQLPR-CRKQQFATRFPNKSSGAVD---LLEK 212
              G+     P DA      ++    Y+    +  RK      + N     +D   L+ K
Sbjct: 304 RRSGTHPNEFPIDAQ-----ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICK 358

Query: 213 MLVFDPNKRITVEEALRHPYLQSLHDLNDEPV 244
           ML FD + R + E  L     Q + D    P+
Sbjct: 359 MLAFDAHHRPSAEALLDFAAFQDIPDPYPNPM 390

Length = 391

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 68.8 bits (168), Expect = 1e-13
 Identities = 47/154 (30%), Positives = 78/154 (50%), Gaps = 26/154 (16%)

Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQL---LR 59
           H N+I ++ ++       F    I+ E M+         D+ L D   ++  YQL   LR
Sbjct: 65  HHNIIRLEGVV-----TKFKPAMIITEYMENG-----ALDKYLRDHDGEFSSYQLVGMLR 114

Query: 60  G----LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT----- 110
           G    +KY+   + +HRDL   N+L+N++ + K+ DFGL+R   E D    Y  +     
Sbjct: 115 GIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVL-EDDPEGTYTTSGGKIP 173

Query: 111 -RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
            RW  APE  +   ++T+A D+WS G ++ E+M+
Sbjct: 174 IRW-TAPE-AIAYRKFTSASDVWSFGIVMWEVMS 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 69.4 bits (170), Expect = 1e-13
 Identities = 45/121 (37%), Positives = 64/121 (52%), Gaps = 18/121 (14%)

Query: 34  DLHQIIRSDQQ--LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGD 91
           DL   +R  ++  LT +    F YQ+ +G+ ++ S + +HRDL   N+LL     +KI D
Sbjct: 125 DLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICD 184

Query: 92  FGLARTTSETDFMTE--YVV-------TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM 142
           FGLAR     D M +  YVV        +W  APE + NC  YT   D+WS G +L EI 
Sbjct: 185 FGLAR-----DIMNDSNYVVKGNARLPVKWM-APESIFNCV-YTFESDVWSYGILLWEIF 237

Query: 143 T 143
           +
Sbjct: 238 S 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 69.0 bits (168), Expect = 1e-13
 Identities = 50/181 (27%), Positives = 86/181 (47%), Gaps = 32/181 (17%)

Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYR 114
           + L+ L ++HS  V+HRD+K  N+LL     +K+ DFG  A+ T E    +  V T ++ 
Sbjct: 123 ECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 182

Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF 174
           APE++     Y   +DIWS+G +  E++  EP +  ++ +  L LI    G+P+      
Sbjct: 183 APEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPE------ 234

Query: 175 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAV-DLLEKMLVFDPNKRITVEEALRHPYL 233
                                  + P + S    D L + L  D ++R + +E L+HP+L
Sbjct: 235 ----------------------LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFL 272

Query: 234 Q 234
           +
Sbjct: 273 K 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 68.7 bits (168), Expect = 2e-13
 Identities = 54/223 (24%), Positives = 101/223 (45%), Gaps = 38/223 (17%)

Query: 22  NDVYIVYELMDTD-LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNL 79
           N++ +  E MD   L +I +    +  +        ++ GL Y+++   ++HRD+KPSN+
Sbjct: 76  NNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNI 135

Query: 80  LLNASCDLKIGDFG----LARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVG 135
           L+N+   +K+ DFG    L  + ++T     +V T  Y +PE  +   +YT   D+WS+G
Sbjct: 136 LVNSRGQIKLCDFGVSGELINSIADT-----FVGTSTYMSPE-RIQGGKYTVKSDVWSLG 189

Query: 136 CILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ----LPRCR 191
             + E+   +  FP           + +     D  +G L  D  ++ V++    LP   
Sbjct: 190 ISIIELALGK--FPFAF--------SNIDDDGQDDPMGIL--DLLQQIVQEPPPRLP--- 234

Query: 192 KQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
               ++ FP       D ++  L+ DP +R T ++    P   
Sbjct: 235 ----SSDFPED---LRDFVDACLLKDPTERPTPQQLCAMPPFI 270

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 68.1 bits (167), Expect = 2e-13
 Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 33/204 (16%)

Query: 33  TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDF 92
            D++Q+ R    L++    Y   + L+GL Y+H    +HRD+K +N+LL    D+K+ DF
Sbjct: 88  QDIYQVTRG--PLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADF 145

Query: 93  GL-ARTTSETDFMTEYVVTRWYRAPELLLNCTE--YTAAIDIWSVGCILGEIMTREPLFP 149
           G+ A+ T+       ++ T ++ APE+     +  Y    DIW++G    E+   +P  P
Sbjct: 146 GVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQP--P 203

Query: 150 GKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCR-KQQFATRFPNKSSGAVD 208
             D +H +R +             FL S +        P+ + K++++  F        D
Sbjct: 204 MFD-LHPMRAL-------------FLISKSN----FPPPKLKDKEKWSPVF-------HD 238

Query: 209 LLEKMLVFDPNKRITVEEALRHPY 232
            ++K L  DP KR T  + L+HP+
Sbjct: 239 FIKKCLTKDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 68.6 bits (167), Expect = 2e-13
 Identities = 51/181 (28%), Positives = 86/181 (47%), Gaps = 32/181 (17%)

Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYR 114
           + L+ L+++H+  V+HRD+K  N+LL     +K+ DFG  A+ T E    +  V T ++ 
Sbjct: 123 ECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 182

Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF 174
           APE++     Y   +DIWS+G +  E++  EP +  ++ +  L LI    G+P+      
Sbjct: 183 APEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPE------ 234

Query: 175 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAV-DLLEKMLVFDPNKRITVEEALRHPYL 233
                                  + P K S    D L + L  D  KR + +E L+HP+L
Sbjct: 235 ----------------------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272

Query: 234 Q 234
           +
Sbjct: 273 K 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 68.3 bits (167), Expect = 3e-13
 Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 40/217 (18%)

Query: 22  NDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
           N VY + E ++  +L   +R   +  +D  +++  +L+   +Y+HS  +++RDLKP NLL
Sbjct: 91  NRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLL 150

Query: 81  LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           L+    +K+ DFG A+   +  F      T  Y APE ++    +  A+D W++G +L E
Sbjct: 151 LDNKGHVKVTDFGFAKKVPDRTFT--LCGTPEYLAPE-VIQSKGHGKAVDWWTMGVLLYE 207

Query: 141 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 200
            +   P F                   DD           R Y + L    + +F   F 
Sbjct: 208 FIAGYPPF------------------FDDTPF--------RIYEKILA--GRLKFPNWFD 239

Query: 201 NKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPY 232
            +   A DL++ +L  D  KR+      V +   HPY
Sbjct: 240 GR---ARDLVKGLLQTDHTKRLGTLKGGVADVKNHPY 273

Length = 329

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 68.9 bits (168), Expect = 3e-13
 Identities = 60/221 (27%), Positives = 95/221 (42%), Gaps = 43/221 (19%)

Query: 53  FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET---DFMTEYVV 109
             YQ++  L  VHS  ++HRDLK +N+ L  +  +K+GDFG ++  S++   D  + +  
Sbjct: 174 LFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCG 233

Query: 110 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDD 169
           T +Y APEL      Y+   D+WS+G IL E++T    F G      ++ +  L G  D 
Sbjct: 234 TPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQV--LYGKYDP 290

Query: 170 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 229
                                            SSG   LL+ +L  +P  R T ++ L 
Sbjct: 291 FPCPV----------------------------SSGMKALLDPLLSKNPALRPTTQQLLH 322

Query: 230 HPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRE 270
             +L+ + +L  + V          HS     H RE I R+
Sbjct: 323 TEFLKYVANLFQDIV---------RHSETISPHDREEILRQ 354

Length = 478

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 67.9 bits (166), Expect = 5e-13
 Identities = 33/107 (30%), Positives = 64/107 (59%), Gaps = 2/107 (1%)

Query: 47  DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE 106
           +D   ++L ++   L+++H   +++RDLKP N+LL+A   +K+ DFGL + +     +T 
Sbjct: 99  EDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH 158

Query: 107 -YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 152
            +  T  Y APE+L+    +  A+D WS+G ++ +++T  P F  ++
Sbjct: 159 TFCGTIEYMAPEILMRSG-HGKAVDWWSLGALMYDMLTGAPPFTAEN 204

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 67.4 bits (164), Expect = 5e-13
 Identities = 38/106 (35%), Positives = 57/106 (53%), Gaps = 4/106 (3%)

Query: 41  SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE 100
            D+Q+T        YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR  + 
Sbjct: 130 PDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNN 189

Query: 101 TDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
            D+  +    R    + APE L +   YT   D+WS G ++ EI T
Sbjct: 190 IDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 67.4 bits (164), Expect = 6e-13
 Identities = 43/130 (33%), Positives = 75/130 (57%), Gaps = 5/130 (3%)

Query: 23  DVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLL 80
           ++ I  E MD   L Q+++  +++ ++        +LRGL Y+     ++HRD+KPSN+L
Sbjct: 77  EISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNIL 136

Query: 81  LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           +N+  ++K+ DFG++    ++     +V TR Y +PE  L  T Y+   DIWS+G  L E
Sbjct: 137 VNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLVE 194

Query: 141 I-MTREPLFP 149
           + + R P+ P
Sbjct: 195 LAIGRYPIPP 204

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 66.8 bits (163), Expect = 7e-13
 Identities = 50/192 (26%), Positives = 87/192 (45%), Gaps = 32/192 (16%)

Query: 57  LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 116
           +++GL Y+ S  +LHRD+KPSN+L+N    +K+ DFG++     +     YV T  Y AP
Sbjct: 104 VVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-IAKTYVGTNAYMAP 162

Query: 117 ELLLNCTEYTAAIDIWSVGCILGEI-MTREP---LFPGKDYVHQLRLITELIGSPDDASL 172
           E +    +Y    D+WS+G    E+ + R P   +   +  +  L+L+  ++   D+   
Sbjct: 163 ERISG-EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIV---DEDP- 217

Query: 173 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 232
                          P     QF+ +F       V  + + +   P +R   E  + HP+
Sbjct: 218 ---------------PVLPVGQFSEKF-------VHFITQCMRKQPKERPAPENLMDHPF 255

Query: 233 LQSLHDLNDEPV 244
           +   +D N E V
Sbjct: 256 IVQYNDGNAEVV 267

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 67.1 bits (164), Expect = 8e-13
 Identities = 42/145 (28%), Positives = 76/145 (52%), Gaps = 3/145 (2%)

Query: 20  TFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 78
           T + +Y V E ++  DL   I+   +  + H  ++  ++  GL ++HS  +++RDLK  N
Sbjct: 72  TMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDN 131

Query: 79  LLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 137
           ++L+A   +KI DFG+ +        T  +  T  Y APE++     Y  ++D W+ G +
Sbjct: 132 VMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVL 190

Query: 138 LGEIMTREPLFPGKDYVHQLRLITE 162
           L E++  +P F G+D     + I E
Sbjct: 191 LYEMLAGQPPFDGEDEDELFQSIME 215

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 66.5 bits (162), Expect = 1e-12
 Identities = 64/231 (27%), Positives = 104/231 (45%), Gaps = 33/231 (14%)

Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQII-RSDQQLTDDHCQYFLYQLLRG 60
           HEN++  K I     +D  N + ++ E + +  L + + R+  ++       +  Q+ +G
Sbjct: 65  HENIVKYKGIC---TEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKG 121

Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR--------W 112
           + Y+ S   +HRDL   N+L+ +   +KIGDFGL +   ETD   EY   +        W
Sbjct: 122 MDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETD--KEYYTVKDDLDSPVFW 178

Query: 113 YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL 172
           Y APE L+    Y A+ D+WS G  L E++T    +   +    + L  ++IG P    +
Sbjct: 179 Y-APECLIQSKFYIAS-DVWSFGVTLYELLT----YCDSES-SPMTLFLKMIG-PTHGQM 230

Query: 173 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT 223
              R        ++LPR          PN       L+ K   F P+KR T
Sbjct: 231 TVTRLVRVLEEGKRLPRP---------PNCPEEVYQLMRKCWEFQPSKRTT 272

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 66.6 bits (162), Expect = 1e-12
 Identities = 34/91 (37%), Positives = 55/91 (60%), Gaps = 5/91 (5%)

Query: 58  LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 117
           L+GL Y+HS +++HRD+K  N+LL     +K+ DFG A  +S  +    +V T ++ APE
Sbjct: 131 LQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPAN---SFVGTPYWMAPE 187

Query: 118 LLLNCTE--YTAAIDIWSVGCILGEIMTREP 146
           ++L   E  Y   +D+WS+G    E+  R+P
Sbjct: 188 VILAMDEGQYDGKVDVWSLGITCIELAERKP 218

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 66.6 bits (162), Expect = 1e-12
 Identities = 47/147 (31%), Positives = 79/147 (53%), Gaps = 10/147 (6%)

Query: 45  LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDF 103
            T++  +++  +++  L+Y+HS  V++RD+K  NL+L+    +KI DFGL +   S+   
Sbjct: 92  FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 151

Query: 104 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI-TE 162
           M  +  T  Y APE+L +  +Y  A+D W +G ++ E+M     F  +D+     LI  E
Sbjct: 152 MKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME 210

Query: 163 LIG-----SPDDASL--GFLRSDNARR 182
            I      SP+  SL  G L+ D  +R
Sbjct: 211 EIRFPRTLSPEAKSLLAGLLKKDPKQR 237

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 66.2 bits (161), Expect = 1e-12
 Identities = 50/208 (24%), Positives = 93/208 (44%), Gaps = 39/208 (18%)

Query: 52  YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR 111
           ++  ++  GL+ +H   +++RDLKP N+LL+    ++I D GLA    E   +   V T 
Sbjct: 106 FYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTV 165

Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDAS 171
            Y APE++ N   YT + D W++GC+L E++  +                    SP    
Sbjct: 166 GYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQ--------------------SPFQQR 204

Query: 172 LGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEE 226
              ++ +   R V+++     ++++ +F   S  A  L + +L  DP +R+        E
Sbjct: 205 KKKIKREEVERLVKEVQ----EEYSEKF---SPDARSLCKMLLCKDPKERLGCQGGGARE 257

Query: 227 ALRHPYLQSLH------DLNDEPVCPRP 248
              HP  + ++       + + P  P P
Sbjct: 258 VKEHPLFKQINFKRLEAGMLEPPFKPDP 285

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 65.8 bits (160), Expect = 1e-12
 Identities = 48/163 (29%), Positives = 83/163 (50%), Gaps = 27/163 (16%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ-------QLTDDHCQY 52
           ++H+ ++ +  ++      T   +YI+ E M    L   ++SD+       +L D     
Sbjct: 58  LQHDKLVKLHAVV------TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLID----- 106

Query: 53  FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE---YVV 109
           F  Q+  G+ ++   + +HRDL+ +N+L++AS   KI DFGLAR   + ++         
Sbjct: 107 FSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP 166

Query: 110 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 150
            +W  APE  +N   +T   D+WS G +L EI+T  R P +PG
Sbjct: 167 IKW-TAPE-AINFGSFTIKSDVWSFGILLMEIVTYGRIP-YPG 206

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 67.0 bits (163), Expect = 2e-12
 Identities = 47/174 (27%), Positives = 83/174 (47%), Gaps = 17/174 (9%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQII-RSDQQLTDD----HCQYFLY 55
           + HEN++ I++I+R        + Y++ +  D DL+  +        D       +  + 
Sbjct: 220 LNHENILKIEEILRSE-----ANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMK 274

Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY--VVTRWY 113
           QLL  ++Y+H   ++HRD+K  N+ LN    + +GDFG A    +     +Y  V T   
Sbjct: 275 QLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVAT 334

Query: 114 RAPELLLNCTEYTAAIDIWSVGCILGEIMTRE--PLFPGKDYVHQ--LRLITEL 163
            +PE+L     Y    DIWS G IL ++++ +  P+  G     +  L++I  L
Sbjct: 335 NSPEILAG-DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSL 387

Length = 501

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 66.1 bits (161), Expect = 2e-12
 Identities = 57/229 (24%), Positives = 103/229 (44%), Gaps = 43/229 (18%)

Query: 31  MDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIG 90
           M T L+Q        ++D  +++  +++  L+++H   +++RD+K  N+LL++   + + 
Sbjct: 92  MFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLT 147

Query: 91  DFGLART--TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF 148
           DFGL++   + E +    +  T  Y APE++     +  A+D WS+G ++ E++T    F
Sbjct: 148 DFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPF 207

Query: 149 PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK-SSGAV 207
                         L G  +       +S+ +RR ++  P          FP+     A 
Sbjct: 208 -------------TLEGERNT------QSEVSRRILKCDP---------PFPSFIGPEAQ 239

Query: 208 DLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH--DLNDEPVCPRPF 249
           DLL K+L  DP KR+        E   HP+ + L    L    V   PF
Sbjct: 240 DLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKV-NPPF 287

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 66.3 bits (161), Expect = 2e-12
 Identities = 34/91 (37%), Positives = 54/91 (59%), Gaps = 5/91 (5%)

Query: 58  LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 117
           L+GL Y+HS +++HRD+K  N+LL     +K+ DFG A   S  +    +V T ++ APE
Sbjct: 135 LQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPAN---SFVGTPYWMAPE 191

Query: 118 LLLNCTE--YTAAIDIWSVGCILGEIMTREP 146
           ++L   E  Y   +D+WS+G    E+  R+P
Sbjct: 192 VILAMDEGQYDGKVDVWSLGITCIELAERKP 222

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 65.8 bits (160), Expect = 2e-12
 Identities = 34/91 (37%), Positives = 56/91 (61%), Gaps = 5/91 (5%)

Query: 58  LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 117
           L+GL Y+HS +++HRD+K  N+LL+    +K+GDFG A   +  +    +V T ++ APE
Sbjct: 125 LQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN---XFVGTPYWMAPE 181

Query: 118 LLLNCTE--YTAAIDIWSVGCILGEIMTREP 146
           ++L   E  Y   +D+WS+G    E+  R+P
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 65.4 bits (159), Expect = 2e-12
 Identities = 52/198 (26%), Positives = 88/198 (44%), Gaps = 35/198 (17%)

Query: 42  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSE 100
           ++ LT+   +    Q L  L Y+H   ++HRDLK  N+L     D+K+ DFG+ A+ T  
Sbjct: 97  ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 156

Query: 101 TDFMTEYVVTRWYRAPELLLNCTE----YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ 156
                 ++ T ++ APE+++  T     Y    D+WS+G  L E+   EP        H+
Sbjct: 157 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPH------HE 210

Query: 157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLV 215
           L                     N  R + ++ +      A   P++ SS   D L+K L 
Sbjct: 211 L---------------------NPMRVLLKIAKSEPPTLAQ--PSRWSSEFKDFLKKCLE 247

Query: 216 FDPNKRITVEEALRHPYL 233
            + + R T  + L+HP++
Sbjct: 248 KNVDARWTTTQLLQHPFV 265

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 65.6 bits (160), Expect = 2e-12
 Identities = 36/96 (37%), Positives = 54/96 (56%), Gaps = 6/96 (6%)

Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRA 115
             L+GL Y+HS   +HRD+K  N+LL     +K+ DFG A   S  +    +V T ++ A
Sbjct: 123 GALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN---SFVGTPYWMA 179

Query: 116 PELLLNCTE--YTAAIDIWSVGCILGEIMTRE-PLF 148
           PE++L   E  Y   +D+WS+G    E+  R+ PLF
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 65.5 bits (160), Expect = 2e-12
 Identities = 34/100 (34%), Positives = 50/100 (50%), Gaps = 13/100 (13%)

Query: 53  FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR- 111
           F  Q+ +G+ Y+ S   +HRDL   N+L+ +   +KI DFGLA+   E     +Y   + 
Sbjct: 114 FSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDK---DYYYVKE 170

Query: 112 -------WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR 144
                  WY APE L      +A+ D+WS G  L E+ T 
Sbjct: 171 PGESPIFWY-APECLRTSKFSSAS-DVWSFGVTLYELFTY 208

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 65.2 bits (159), Expect = 3e-12
 Identities = 46/201 (22%), Positives = 92/201 (45%), Gaps = 35/201 (17%)

Query: 43  QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSE 100
           +  T+   + ++ +++  L ++H   +++RD+K  N+LL++   + + DFGL++     E
Sbjct: 100 EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE 159

Query: 101 TDFMTEYVVTRWYRAPELLLNCTE-YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL 159
            +    +  T  Y APE++   +  +  A+D WS+G +  E++T    F      +    
Sbjct: 160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--- 216

Query: 160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDP 218
                           +S+ +RR ++  P          FP   S+ A D ++K+L  DP
Sbjct: 217 ----------------QSEISRRILKSKP---------PFPKTMSAEARDFIQKLLEKDP 251

Query: 219 NKRI---TVEEALRHPYLQSL 236
            KR+     +E   HP+ Q +
Sbjct: 252 KKRLGANGADEIKNHPFFQGI 272

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 65.1 bits (158), Expect = 3e-12
 Identities = 34/94 (36%), Positives = 58/94 (61%), Gaps = 2/94 (2%)

Query: 54  LYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM-TEYVVTRW 112
           L ++L+GL Y+HS   +HRD+K +N+LL+   ++K+ DFG+A   ++T      +V T +
Sbjct: 107 LREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPF 166

Query: 113 YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREP 146
           + APE++   + Y +  DIWS+G    E+   EP
Sbjct: 167 WMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 65.4 bits (159), Expect = 3e-12
 Identities = 45/136 (33%), Positives = 64/136 (47%), Gaps = 5/136 (3%)

Query: 31  MDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIG 90
           MD         ++QLT        YQ+ RG++Y+ S   +HRDL   N+L+     +KI 
Sbjct: 117 MDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIA 176

Query: 91  DFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL 147
           DFGLAR     D+  +    R    + APE L +   YT   D+WS G +L EI T    
Sbjct: 177 DFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGS 235

Query: 148 -FPGKDYVHQLRLITE 162
            +PG       +L+ E
Sbjct: 236 PYPGIPVEELFKLLKE 251

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 65.3 bits (159), Expect = 4e-12
 Identities = 45/140 (32%), Positives = 68/140 (48%), Gaps = 19/140 (13%)

Query: 11  DIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVL 70
           D  R  +  ++ D  +  E+++ D       +  L  +    F YQ+ +G+ ++ S + +
Sbjct: 184 DKRRSVRSGSYIDQDVTSEILEED-------ELALDTEDLLSFSYQVAKGMSFLASKNCI 236

Query: 71  HRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV-------TRWYRAPELLLNCT 123
           HRDL   N+LL      KI DFGLAR     D  + YVV        +W  APE + NC 
Sbjct: 237 HRDLAARNILLTHGRITKICDFGLARDIR-ND--SNYVVKGNARLPVKWM-APESIFNCV 292

Query: 124 EYTAAIDIWSVGCILGEIMT 143
            YT   D+WS G +L EI +
Sbjct: 293 -YTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 65.0 bits (158), Expect = 4e-12
 Identities = 50/188 (26%), Positives = 91/188 (48%), Gaps = 34/188 (18%)

Query: 52  YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF-MTEYVVT 110
           ++  +++ GL+++HS  +++RDLK  N++L+    +KI DFG+ +     D   + +  T
Sbjct: 100 FYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGT 159

Query: 111 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA 170
             Y APE+L    +YT ++D WS G +L E++  +  F G D               +D 
Sbjct: 160 PDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDD---------------EDE 203

Query: 171 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR- 229
               +R D    Y R + +  K               D+LEK+   DP +R+ V   +R 
Sbjct: 204 LFESIRVDTP-HYPRWITKESK---------------DILEKLFERDPTRRLGVVGNIRG 247

Query: 230 HPYLQSLH 237
           HP+ ++++
Sbjct: 248 HPFFKTIN 255

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 64.6 bits (157), Expect = 4e-12
 Identities = 50/169 (29%), Positives = 91/169 (53%), Gaps = 15/169 (8%)

Query: 27  VYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC 85
           + +LM+  DLH  +      ++   +++  +++ GL+++H+  V++RDLKP+N+LL+   
Sbjct: 75  ILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHG 134

Query: 86  DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTRE 145
            ++I D GLA   S+       V T  Y APE+L   T Y ++ D +S+GC+L +++   
Sbjct: 135 HVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGH 193

Query: 146 PLF---PGKDYVHQLRLITELIG-------SPDDASL--GFLRSDNARR 182
             F     KD  H++  +T  +        SP+  SL  G L+ D ++R
Sbjct: 194 SPFRQHKTKDK-HEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVSKR 241

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 64.8 bits (158), Expect = 4e-12
 Identities = 37/136 (27%), Positives = 72/136 (52%), Gaps = 7/136 (5%)

Query: 20  TFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 75
           T +D   +Y LM+     +L   +R+  + ++    ++  +++  L+Y+HS  +++RDLK
Sbjct: 69  TEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLK 128

Query: 76  PSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVG 135
           P N+LL+    +K+ DFG A+     D       T  Y APE++ +   +  A+D W++G
Sbjct: 129 PENILLDKEGHIKLTDFGFAKKLR--DRTWTLCGTPEYLAPEVIQS-KGHNKAVDWWALG 185

Query: 136 CILGEIMTREPLFPGK 151
            ++ E++   P F   
Sbjct: 186 ILIYEMLVGYPPFFDD 201

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 64.3 bits (157), Expect = 5e-12
 Identities = 44/152 (28%), Positives = 78/152 (51%), Gaps = 23/152 (15%)

Query: 3   HENVIAIKDII---RPPKKDTFNDVYIVYELMDT-DLHQIIR-SDQQLTDDHCQYFLYQL 57
           H N+I ++ ++   RP        V I+ E M+   L + +R +D + T       L  +
Sbjct: 64  HPNIIRLEGVVTKSRP--------VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGI 115

Query: 58  LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------R 111
             G+KY+   + +HRDL   N+L+N++   K+ DFGL+R   +++    Y         R
Sbjct: 116 ASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE--ATYTTKGGKIPIR 173

Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           W  APE  +   ++T+A D+WS G ++ E+M+
Sbjct: 174 W-TAPE-AIAYRKFTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 64.3 bits (156), Expect = 5e-12
 Identities = 57/229 (24%), Positives = 109/229 (47%), Gaps = 43/229 (18%)

Query: 15  PPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVL 70
           PP  D  + +++V E       TDL +  + +  L ++   Y   ++LRGL ++H   V+
Sbjct: 77  PPGMD--DQLWLVMEFCGAGSVTDLIKNTKGNT-LKEEWIAYICREILRGLSHLHQHKVI 133

Query: 71  HRDLKPSNLLLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTE----- 124
           HRD+K  N+LL  + ++K+ DFG++     T      ++ T ++ APE++  C E     
Sbjct: 134 HRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA-CDENPDAT 192

Query: 125 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV 184
           Y    D+WS+G    E+    P  P  D +H +R +  +  +P                 
Sbjct: 193 YDFKSDLWSLGITAIEMAEGAP--PLCD-MHPMRALFLIPRNP----------------- 232

Query: 185 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
              PR + ++++ +F +        +E  LV + ++R T E+ ++HP++
Sbjct: 233 --APRLKSKKWSKKFQS-------FIESCLVKNHSQRPTTEQLMKHPFI 272

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 64.5 bits (157), Expect = 5e-12
 Identities = 43/128 (33%), Positives = 59/128 (46%), Gaps = 25/128 (19%)

Query: 53  FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR- 111
           F  Q+  G+ Y+HS   +HRDL   N+LL+    +KIGDFGLA+   E     EY   R 
Sbjct: 112 FAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH---EYYRVRE 168

Query: 112 -------WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR------------EPLFPGKD 152
                  WY A E L       A+ D+WS G  L E++T             E + P + 
Sbjct: 169 DGDSPVFWY-AVECLKENKFSYAS-DVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQG 226

Query: 153 YVHQLRLI 160
            +  +RLI
Sbjct: 227 QMTVVRLI 234

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 64.6 bits (157), Expect = 5e-12
 Identities = 49/154 (31%), Positives = 71/154 (46%), Gaps = 20/154 (12%)

Query: 14  RPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRD 73
           RPP  D   D+  V E             +QL+        YQ+ RG++Y+ S   +HRD
Sbjct: 113 RPPGPDYTFDITKVPE-------------EQLSFKDLVSCAYQVARGMEYLESRRCIHRD 159

Query: 74  LKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTEYTAAID 130
           L   N+L+     +KI DFGLAR   + D+  +    R    + APE L +   YT   D
Sbjct: 160 LAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRV-YTHQSD 218

Query: 131 IWSVGCILGEIMTR--EPLFPGKDYVHQLRLITE 162
           +WS G ++ EI T    P +PG       +L+ E
Sbjct: 219 VWSFGILMWEIFTLGGSP-YPGIPVEELFKLLRE 251

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 65.5 bits (159), Expect = 5e-12
 Identities = 48/138 (34%), Positives = 65/138 (47%), Gaps = 27/138 (19%)

Query: 56  QLLRGLKYVHS-------ASVLHRDLKPSNLLL-----------------NASCDLKIGD 91
           QLL  L Y H+         VLHRDLKP N+ L                 N     KIGD
Sbjct: 126 QLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGD 185

Query: 92  FGLARTTSETDFMTEYVVTRWYRAPELLLNCTE-YTAAIDIWSVGCILGEIMTREPLFPG 150
           FGL++           V T +Y +PELLL+ T+ Y    D+W++GCI+ E+ + +  F  
Sbjct: 186 FGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245

Query: 151 KDYVHQLRLITELIGSPD 168
            +   Q  LI+EL   PD
Sbjct: 246 ANNFSQ--LISELKRGPD 261

Length = 1021

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 64.9 bits (158), Expect = 6e-12
 Identities = 40/109 (36%), Positives = 58/109 (53%), Gaps = 19/109 (17%)

Query: 53  FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE--YVV- 109
           F  Q+ +G+ ++ S + +HRD+   N+LL      KI DFGLAR     D M +  YVV 
Sbjct: 217 FSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLAR-----DIMNDSNYVVK 271

Query: 110 ------TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 150
                  +W  APE + +C  YT   D+WS G +L EI +  + P +PG
Sbjct: 272 GNARLPVKWM-APESIFDCV-YTVQSDVWSYGILLWEIFSLGKSP-YPG 317

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 63.9 bits (155), Expect = 7e-12
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 31/202 (15%)

Query: 35  LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL 94
           L  I      L++    Y   + L+GL Y+HS   +HRD+K +N+LL  + D+K+ DFG+
Sbjct: 93  LQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGV 152

Query: 95  -ARTTSETDFMTEYVVTRWYRAPEL--LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK 151
            A+ T+       ++ T ++ APE+  +     Y    DIW+VG    E+   +P  P  
Sbjct: 153 AAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQP--PMF 210

Query: 152 DYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCR-KQQFATRFPNKSSGAVDLL 210
           D +H +R +             FL S +      Q P+ + K ++++ F N        +
Sbjct: 211 D-LHPMRAL-------------FLMSKSN----FQPPKLKDKTKWSSTFHN-------FV 245

Query: 211 EKMLVFDPNKRITVEEALRHPY 232
           +  L  +P KR T E  L H +
Sbjct: 246 KISLTKNPKKRPTAERLLTHLF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 63.9 bits (155), Expect = 8e-12
 Identities = 49/220 (22%), Positives = 104/220 (47%), Gaps = 44/220 (20%)

Query: 43  QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART--TSE 100
           ++  +   Q +  +++  L+++H   +++RD+K  N+LL+++  + + DFGL++     E
Sbjct: 100 ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE 159

Query: 101 TDFMTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLFP--GKDYVHQL 157
            +    +  T  Y AP+++      +  A+D WS+G ++ E++T    F   G+      
Sbjct: 160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ-- 217

Query: 158 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSG-AVDLLEKMLVF 216
                              ++ +RR ++  P          +P + S  A D+++++L+ 
Sbjct: 218 -------------------AEISRRILKSEP---------PYPQEMSALAKDIIQRLLMK 249

Query: 217 DPNKRI-----TVEEALRHPYLQSLH--DLNDEPVCPRPF 249
           DP KR+       +E  +HP+ Q ++  DL  + V P PF
Sbjct: 250 DPKKRLGCGPSDADEIKKHPFFQKINWDDLAAKKV-PAPF 288

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 63.9 bits (155), Expect = 9e-12
 Identities = 38/105 (36%), Positives = 55/105 (52%), Gaps = 4/105 (3%)

Query: 42  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 101
           ++QL+        YQ+ RG++Y+ S   +HRDL   N+L+     +KI DFGLAR     
Sbjct: 134 EEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 193

Query: 102 DFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           D+  +    R    + APE L +   YT   D+WS G +L EI T
Sbjct: 194 DYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 63.4 bits (154), Expect = 9e-12
 Identities = 47/150 (31%), Positives = 74/150 (49%), Gaps = 16/150 (10%)

Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLR 59
           +H N+I ++ ++   K      V IV E M+   L   +R  D Q T       L  +  
Sbjct: 63  DHPNIIHLEGVVTKSKP-----VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIAS 117

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RWY 113
           G+KY+     +HRDL   N+L+N++   K+ DFGL+R   E D    Y         RW 
Sbjct: 118 GMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRW- 175

Query: 114 RAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
            APE  +   ++T+A D+WS G ++ E+M+
Sbjct: 176 TAPE-AIAYRKFTSASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 64.6 bits (157), Expect = 9e-12
 Identities = 57/217 (26%), Positives = 94/217 (43%), Gaps = 39/217 (17%)

Query: 49  HCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNAS----------------CDLKIGD 91
           H    ++Q    L Y H+   ++H DLKP N+L+  S                C ++I D
Sbjct: 232 HLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICD 291

Query: 92  FGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK 151
            G      E    T  V TR YR+PE++L    +  + D+WS+GCI+ E+ T + L+   
Sbjct: 292 LG--GCCDERHSRTAIVSTRHYRSPEVVLGLG-WMYSTDMWSMGCIIYELYTGKLLYDTH 348

Query: 152 DYVHQLRLITELIGS-PDD--------------ASLGFLRSDNARRYVRQLPRCRKQQFA 196
           D +  L L+ + +G  P +               S G LR     +++ ++ R R  +  
Sbjct: 349 DNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREV 408

Query: 197 TRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
            R         DL+  +L +D  KR+   +   HPY+
Sbjct: 409 IRDDL----LCDLIYGLLHYDRQKRLNARQMTTHPYV 441

Length = 467

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 63.9 bits (156), Expect = 1e-11
 Identities = 70/295 (23%), Positives = 113/295 (38%), Gaps = 85/295 (28%)

Query: 20  TFNDVYIVYELMD----TDL-HQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDL 74
           +F D   +Y +M+     DL + +IR D    ++  ++++ +L+  L  VH    +HRD+
Sbjct: 69  SFQDEEHLYLVMEYMPGGDLMNLLIRKDV-FPEETARFYIAELVLALDSVHKLGFIHRDI 127

Query: 75  KPSNLLLNASCDLKIGDFGLA------------RTTSETDFMTEYVVTRW---------- 112
           KP N+L++A   +K+ DFGL                S      + V+ R           
Sbjct: 128 KPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRA 187

Query: 113 --------YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELI 164
                   Y APE+L   T Y    D WS+G IL E++   P F                
Sbjct: 188 NSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPF---------------- 230

Query: 165 GSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK---SSGAVDLLEKMLVFDPNKR 221
              D     + +  N +  +             RFP     S  A+DL+ + L+ DP  R
Sbjct: 231 -YSDTLQETYNKIINWKESL-------------RFPPDPPVSPEAIDLICR-LLCDPEDR 275

Query: 222 IT-VEEALRHPYLQSLHDLNDEPVCPRPF-----------HFD-FEHSSCTEDHI 263
           +   EE   HP+ + + D  +      PF           +FD FE      D++
Sbjct: 276 LGSFEEIKSHPFFKGI-DWENLRETKPPFVPELSSPLDTSNFDDFEDDKDLSDYL 329

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 63.1 bits (154), Expect = 1e-11
 Identities = 42/139 (30%), Positives = 65/139 (46%), Gaps = 25/139 (17%)

Query: 24  VYIVYELMDT-DLHQIIRSDQQLTDDHC--------QYFLY---QLLRGLKYVHSASVLH 71
             +V ELM   DL   +RS ++   ++         Q F+    ++  G+ Y+ +   +H
Sbjct: 84  TLVVMELMAKGDLKSYLRS-RRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVH 142

Query: 72  RDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCTE 124
           RDL   N ++     +KIGDFG+ R   ETD+   Y          RW  APE L +   
Sbjct: 143 RDLAARNCMVAEDLTVKIGDFGMTRDIYETDY---YRKGGKGLLPVRWM-APESLKDGV- 197

Query: 125 YTAAIDIWSVGCILGEIMT 143
           +T   D+WS G +L E+ T
Sbjct: 198 FTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 63.3 bits (154), Expect = 1e-11
 Identities = 46/151 (30%), Positives = 71/151 (47%), Gaps = 16/151 (10%)

Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQ-LTDDHCQYFLYQLLRGL 61
           H NV+++  I  P +      V + Y +   DL   IRS+    T      F  Q+ +G+
Sbjct: 55  HPNVLSLLGICLPSEGSPL--VVLPY-MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGM 111

Query: 62  KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPEL--- 118
           +Y+ S   +HRDL   N +L+ S  +K+ DFGLAR   +     EY     +   +L   
Sbjct: 112 EYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYD----KEYYSVHNHTGAKLPVK 167

Query: 119 -----LLNCTEYTAAIDIWSVGCILGEIMTR 144
                 L   ++T   D+WS G +L E+MTR
Sbjct: 168 WMALESLQTQKFTTKSDVWSFGVLLWELMTR 198

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 63.5 bits (154), Expect = 1e-11
 Identities = 46/155 (29%), Positives = 80/155 (51%), Gaps = 12/155 (7%)

Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMD----TDLHQ-IIRSDQQLTDDHCQYFLYQL 57
           H NV+    +     K     +++V EL +    T+L + ++   Q+L +    Y LY  
Sbjct: 78  HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137

Query: 58  LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAP 116
           L GL+++H+  ++HRD+K +N+LL     +K+ DFG+ A+ TS        V T ++ AP
Sbjct: 138 LLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAP 197

Query: 117 ELLLNCTE-----YTAAIDIWSVGCILGEIMTREP 146
           E++  C +     Y A  D+WS+G    E+   +P
Sbjct: 198 EVIA-CEQQYDYSYDARCDVWSLGITAIELGDGDP 231

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 63.1 bits (153), Expect = 1e-11
 Identities = 49/209 (23%), Positives = 95/209 (45%), Gaps = 41/209 (19%)

Query: 52  YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR 111
           ++  +L  GL+ +    +++RDLKP N+LL+    ++I D GLA    E + +   V T 
Sbjct: 106 FYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTV 165

Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGE-IMTREPLFPGKDYVHQLRLITELIGSPDDA 170
            Y APE++ N  +YT + D W +GC++ E I  + P    K+ V                
Sbjct: 166 GYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV---------------- 208

Query: 171 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVE 225
                + +   R V++     +++++ +F   S  A  +   +L  +P +R+        
Sbjct: 209 -----KREEVDRRVKE----DQEEYSEKF---SEDAKSICRMLLTKNPKERLGCRGNGAA 256

Query: 226 EALRHPYLQSLH------DLNDEPVCPRP 248
              +HP  ++++      ++ + P CP P
Sbjct: 257 GVKQHPIFKNINFKRLEANMLEPPFCPDP 285

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 62.7 bits (152), Expect = 1e-11
 Identities = 45/151 (29%), Positives = 78/151 (51%), Gaps = 14/151 (9%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQL-- 57
           + H+N++ +  +I        N +YIV ELM   +L   +R+  +      Q   + L  
Sbjct: 56  LHHKNLVRLLGVI------LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDV 109

Query: 58  LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 117
             G++Y+ S  ++HRDL   N+L++     K+ DFGLAR  S     ++  V +W  APE
Sbjct: 110 AEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPV-KW-TAPE 167

Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMT--REP 146
            L +  ++++  D+WS G +L E+ +  R P
Sbjct: 168 ALKH-KKFSSKSDVWSYGVLLWEVFSYGRAP 197

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 63.0 bits (153), Expect = 1e-11
 Identities = 36/117 (30%), Positives = 69/117 (58%), Gaps = 2/117 (1%)

Query: 27  VYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC 85
           + +LM+  DLH  +      ++   +++  +++ GL+++H+  V++RDLKP+N+LL+   
Sbjct: 75  ILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG 134

Query: 86  DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM 142
            ++I D GLA   S+       V T  Y APE+L     Y ++ D +S+GC+L +++
Sbjct: 135 HVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 63.1 bits (153), Expect = 2e-11
 Identities = 60/243 (24%), Positives = 111/243 (45%), Gaps = 40/243 (16%)

Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMD----TDLHQ-IIRSDQQLTDDHCQYFLYQ 56
           +H NV+    +         + +++V EL +    TDL +  ++  +++ +    Y L++
Sbjct: 73  DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHE 132

Query: 57  LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRA 115
            L GL+++H    +HRD+K +N+LL     +K+ DFG+ A+ TS        V T ++ A
Sbjct: 133 ALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMA 192

Query: 116 PELLLNC-----TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA 170
           PE++  C     + Y A  D+WS+G    E+   +P  P  D +H +R + ++  +P   
Sbjct: 193 PEVIA-CEQQLDSTYDARCDVWSLGITAIELGDGDP--PLAD-LHPMRALFKIPRNPP-- 246

Query: 171 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 230
                            P   + +        S+   D + K L  D  KR TV + L+H
Sbjct: 247 -----------------PTLHQPELW------SNEFNDFIRKCLTKDYEKRPTVSDLLQH 283

Query: 231 PYL 233
            ++
Sbjct: 284 VFI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 63.7 bits (155), Expect = 2e-11
 Identities = 40/126 (31%), Positives = 72/126 (57%), Gaps = 8/126 (6%)

Query: 34  DLHQIIRSDQQLTD---DHCQYFLY-QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKI 89
           DL Q I+S  +      +H    L+ Q+L  + +VHS  ++HRD+K +N+LL ++  +K+
Sbjct: 125 DLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKL 184

Query: 90  GDFGLARTTSET---DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREP 146
           GDFG ++  + T   D    +  T +Y APE+      Y+   D++S+G +L E++T + 
Sbjct: 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKP-YSKKADMFSLGVLLYELLTLKR 243

Query: 147 LFPGKD 152
            F G++
Sbjct: 244 PFDGEN 249

Length = 496

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 62.7 bits (152), Expect = 2e-11
 Identities = 59/229 (25%), Positives = 109/229 (47%), Gaps = 43/229 (18%)

Query: 15  PPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVL 70
           PP  D  + +++V E       TDL +  + +  L +D   Y   ++LRGL ++H+  V+
Sbjct: 87  PPGHD--DQLWLVMEFCGAGSVTDLVKNTKGNA-LKEDWIAYICREILRGLAHLHAHKVI 143

Query: 71  HRDLKPSNLLLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTE----- 124
           HRD+K  N+LL  + ++K+ DFG++     T      ++ T ++ APE++  C E     
Sbjct: 144 HRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA-CDENPDAT 202

Query: 125 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV 184
           Y    DIWS+G    E+    P  P  D +H +R +  +  +P                 
Sbjct: 203 YDYRSDIWSLGITAIEMAEGAP--PLCD-MHPMRALFLIPRNPP---------------- 243

Query: 185 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
              P+ + ++++ +F       +D +E  LV +   R + E+ L+HP++
Sbjct: 244 ---PKLKSKKWSKKF-------IDFIEGCLVKNYLSRPSTEQLLKHPFI 282

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 62.6 bits (152), Expect = 2e-11
 Identities = 48/193 (24%), Positives = 88/193 (45%), Gaps = 36/193 (18%)

Query: 52  YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVT 110
           ++  Q++ GL+++H   +++RDLKP N+LL+   +++I D GLA    +    T+ Y  T
Sbjct: 101 FYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT 160

Query: 111 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA 170
             + APELL    EY  ++D +++G  L E++                           A
Sbjct: 161 PGFMAPELLQG-EEYDFSVDYFALGVTLYEMI---------------------------A 192

Query: 171 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRI-----TV 224
           + G  R+   +   ++L + R    +  +P+K S  +    E +L  DP KR+       
Sbjct: 193 ARGPFRARGEKVENKELKQ-RILNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNC 251

Query: 225 EEALRHPYLQSLH 237
           +    HP  + L+
Sbjct: 252 DGLRTHPLFRDLN 264

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 63.3 bits (154), Expect = 2e-11
 Identities = 52/187 (27%), Positives = 75/187 (40%), Gaps = 16/187 (8%)

Query: 57  LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE---YVVTRWY 113
           LL  L Y+H   ++HRD+K  N+ L+   +  +GDFG A          +   +  T   
Sbjct: 194 LLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLET 253

Query: 114 RAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLF--PGKDYVHQLRLITELIGSPDDA 170
            +PELL     Y A  DIWS G +L E+      LF    K    QLR I   I      
Sbjct: 254 NSPELLA-LDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSI---IRCMQVH 309

Query: 171 SLGFLRSDNAR---RYVRQLPRCRKQQFATRFPNKSSGAVD---LLEKMLVFDPNKRITV 224
            L F ++ +      + +     R          K    +D   L+ KML FD   R + 
Sbjct: 310 PLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSA 369

Query: 225 EEALRHP 231
           ++ L  P
Sbjct: 370 QDILSLP 376

Length = 392

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 62.9 bits (153), Expect = 2e-11
 Identities = 61/242 (25%), Positives = 102/242 (42%), Gaps = 48/242 (19%)

Query: 22  NDVYIVYELM-DTDLHQII-RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 79
           +++Y+V E     DL  ++ R + Q  +D  Q++L +L+  +  VH    +HRD+KP N+
Sbjct: 74  DNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENV 133

Query: 80  LLNASCDLKIGDFGLAR--TTSETDFMTEYVVTRWYRAPELLL------NCTEYTAAIDI 131
           L++ +  +K+ DFG A   T ++       V T  Y APE+L         T Y    D 
Sbjct: 134 LIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGT-YGVECDW 192

Query: 132 WSVGCILGE-IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRC 190
           WS+G I  E I  R P                       ++  +    N +R++      
Sbjct: 193 WSLGVIAYEMIYGRSPF------------------HEGTSAKTYNNIMNFQRFL------ 228

Query: 191 RKQQFATRFPNK---SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPR 247
                  +FP     SS  +DL++ +L     +R+  E    HP+   + D N+      
Sbjct: 229 -------KFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI-DWNNIRNSLP 279

Query: 248 PF 249
           PF
Sbjct: 280 PF 281

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 62.7 bits (152), Expect = 2e-11
 Identities = 38/135 (28%), Positives = 73/135 (54%), Gaps = 3/135 (2%)

Query: 20  TFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 78
           T + +Y V E ++  DL   I+   +  + H  ++  ++  GL ++HS  +++RDLK  N
Sbjct: 72  TMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDN 131

Query: 79  LLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 137
           ++L++   +KI DFG+ +        T+ +  T  Y APE ++    Y  ++D W+ G +
Sbjct: 132 VMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPE-IIAYQPYGKSVDWWAFGVL 190

Query: 138 LGEIMTREPLFPGKD 152
           L E++  +  F G+D
Sbjct: 191 LYEMLAGQAPFEGED 205

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 62.7 bits (152), Expect = 2e-11
 Identities = 37/140 (26%), Positives = 77/140 (55%), Gaps = 4/140 (2%)

Query: 20  TFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 78
           T   +Y V + ++  +L   ++ ++   +   +++  ++   L Y+HS ++++RDLKP N
Sbjct: 67  TTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPEN 126

Query: 79  LLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 137
           +LL++   + + DFGL +   +++D  T +  T  Y APE++     Y   +D W +G +
Sbjct: 127 ILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRK-QPYDNTVDWWCLGAV 185

Query: 138 LGEIMTREPLFPGKDYVHQL 157
           L E++   P F  +D V ++
Sbjct: 186 LYEMLYGLPPFYCRD-VAEM 204

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 62.0 bits (151), Expect = 3e-11
 Identities = 48/140 (34%), Positives = 67/140 (47%), Gaps = 21/140 (15%)

Query: 24  VYIVYELMDT-DLHQIIRSD-------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 75
           +YIV E M    L   ++S         QL D        Q+  G+ Y+ S + +HRDL 
Sbjct: 76  IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVD-----MAAQIAEGMAYLESRNYIHRDLA 130

Query: 76  PSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIW 132
             N+L+  +   KI DFGLAR   E D  T     ++   + APE   N   +T   D+W
Sbjct: 131 ARNILVGENLVCKIADFGLARLI-EDDEYTAREGAKFPIKWTAPE-AANYGRFTIKSDVW 188

Query: 133 SVGCILGEIMT--REPLFPG 150
           S G +L EI+T  R P +PG
Sbjct: 189 SFGILLTEIVTYGRVP-YPG 207

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 62.2 bits (151), Expect = 3e-11
 Identities = 61/231 (26%), Positives = 102/231 (44%), Gaps = 54/231 (23%)

Query: 24  VYIVYELMDT----DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSN 78
           VY+  E MD      L+    + + + +D  +   Y +++GLK++    +++HRD+KP+N
Sbjct: 74  VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTN 133

Query: 79  LLLNASCDLKIGDFG----LARTTSETDFMTEYVVTRWYRAPELLLNCT-----EYTAAI 129
           +L+N +  +K+ DFG    L  + ++T+     +  + Y APE + +        YT   
Sbjct: 134 VLVNGNGQVKLCDFGVSGNLVASLAKTN-----IGCQSYMAPERIKSGGPNQNPTYTVQS 188

Query: 130 DIWSVG-CILGEIMTREPLFPGKDYVH---QLRLITELIGSPDDASLGFLRSDNARRYVR 185
           D+WS+G  IL   + R P +P + Y +   QL  I +  G P                  
Sbjct: 189 DVWSLGLSILEMALGRYP-YPPETYANIFAQLSAIVD--GDPP----------------- 228

Query: 186 QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 236
            LP              S  A D + K L   PN+R T  + L HP+L   
Sbjct: 229 TLP-----------SGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 62.1 bits (151), Expect = 3e-11
 Identities = 54/159 (33%), Positives = 83/159 (52%), Gaps = 22/159 (13%)

Query: 52  YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR------TTS------ 99
           YF   +L  L+Y+H+  ++HRDLKP NLL+ +   +K+ DFGL++      TT+      
Sbjct: 106 YFAETVL-ALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHI 164

Query: 100 ETD---FMTEYVV-TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH 155
           E D   F+ + V  T  Y APE++L    Y   +D W++G IL E +     F G D   
Sbjct: 165 EKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFG-DTPE 222

Query: 156 QL--RLITELIGSPD-DASLGFLRSDNARRYVRQLPRCR 191
           +L  ++I++ I  P+ D +L     D   R +RQ P  R
Sbjct: 223 ELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLER 261

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 62.4 bits (151), Expect = 3e-11
 Identities = 41/130 (31%), Positives = 73/130 (56%), Gaps = 5/130 (3%)

Query: 23  DVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLL 80
           ++ I  E MD   L Q+++   ++ +         +++GL Y+     ++HRD+KPSN+L
Sbjct: 77  EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNIL 136

Query: 81  LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           +N+  ++K+ DFG++    ++     +V TR Y +PE  L  T Y+   DIWS+G  L E
Sbjct: 137 VNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLVE 194

Query: 141 I-MTREPLFP 149
           + + R P+ P
Sbjct: 195 MAIGRYPIPP 204

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 61.9 bits (150), Expect = 3e-11
 Identities = 34/95 (35%), Positives = 52/95 (54%), Gaps = 6/95 (6%)

Query: 53  FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE----YV 108
           F +Q+ RG++Y+    ++HRDL   N+L+     +KI DFGL+R   E D   +     +
Sbjct: 132 FAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRI 191

Query: 109 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
             +W  A E L +   YT   D+WS G +L EI+T
Sbjct: 192 PVKWM-AIESLFDHI-YTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 61.6 bits (149), Expect = 4e-11
 Identities = 44/139 (31%), Positives = 71/139 (51%), Gaps = 19/139 (13%)

Query: 24  VYIVYELM-DTDLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 75
           +YI+ E M    L   ++SD+       +L D     F  Q+  G+ Y+   + +HRDL+
Sbjct: 76  IYIITEYMAKGSLLDFLKSDEGGKVLLPKLID-----FSAQIAEGMAYIERKNYIHRDLR 130

Query: 76  PSNLLLNASCDLKIGDFGLARTTSETDFMTE---YVVTRWYRAPELLLNCTEYTAAIDIW 132
            +N+L++ S   KI DFGLAR   + ++          +W  APE  +N   +T   D+W
Sbjct: 131 AANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKW-TAPE-AINFGSFTIKSDVW 188

Query: 133 SVGCILGEIMTREPL-FPG 150
           S G +L EI+T   + +PG
Sbjct: 189 SFGILLYEIVTYGKIPYPG 207

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 61.7 bits (150), Expect = 4e-11
 Identities = 47/172 (27%), Positives = 76/172 (44%), Gaps = 34/172 (19%)

Query: 1   MEHENVIAIKDII---RPPKKDTFNDVYIVYELMDT-DLHQIIRSD-------------- 42
            +HEN++    +     PP         +V+E M+  DL++ +RS               
Sbjct: 65  FQHENIVKFYGVCTEGDPP--------IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPM 116

Query: 43  QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD 102
            +LT         Q+  G+ Y+ S   +HRDL   N L+     +KIGDFG++R    TD
Sbjct: 117 GELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTD 176

Query: 103 FM----TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLF 148
           +        +  RW   PE ++    +T   D+WS G +L EI T  ++P +
Sbjct: 177 YYRVGGHTMLPIRWM-PPESIMYRK-FTTESDVWSFGVVLWEIFTYGKQPWY 226

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 61.4 bits (149), Expect = 4e-11
 Identities = 45/154 (29%), Positives = 78/154 (50%), Gaps = 22/154 (14%)

Query: 2   EHENVIAIKDII---RPPKKDTFNDVYIVYELMDT-DLHQIIR-SDQQLTDDHCQYFLYQ 56
           +H N+I ++ ++   RP        V I+ E M+   L   +R +D Q T       L  
Sbjct: 63  DHPNIIHLEGVVTKSRP--------VMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRG 114

Query: 57  LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-------TDFMTEYVV 109
           +  G+KY+   + +HRDL   N+L+N++   K+ DFGL+R   +       T  +   + 
Sbjct: 115 IAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIP 174

Query: 110 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
            RW  APE  +   ++T+A D+WS G ++ E+M+
Sbjct: 175 IRW-TAPE-AIAYRKFTSASDVWSYGIVMWEVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 61.6 bits (149), Expect = 5e-11
 Identities = 46/151 (30%), Positives = 83/151 (54%), Gaps = 11/151 (7%)

Query: 42  DQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNASCDLKIGDFGLART-TS 99
           ++  ++D  +++  +++  L Y+HS  +V++RDLK  NL+L+    +KI DFGL +    
Sbjct: 89  ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 148

Query: 100 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY--VHQL 157
           +   M  +  T  Y APE+L +  +Y  A+D W +G ++ E+M     F  +D+  + +L
Sbjct: 149 DGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 207

Query: 158 RLITEL----IGSPDDASL--GFLRSDNARR 182
            L+ E+      SP+  SL  G L+ D  +R
Sbjct: 208 ILMEEIRFPRTLSPEAKSLLSGLLKKDPKQR 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 61.0 bits (149), Expect = 6e-11
 Identities = 49/207 (23%), Positives = 91/207 (43%), Gaps = 39/207 (18%)

Query: 32  DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD-LKIG 90
           D DL  +++ + +L++   +  + QL+  L  +H  +++H D+K  N+L + + D + + 
Sbjct: 93  DGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLC 152

Query: 91  DFGLAR---TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL 147
           D+GL +   T S  D   +Y       +PE  +    Y  + D W+VG +  E++T +  
Sbjct: 153 DYGLCKIIGTPSCYDGTLDYF------SPE-KIKGHNYDVSFDWWAVGVLTYELLTGK-- 203

Query: 148 FPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAV 207
            P K+                D  L        +R  ++LP            N S  A 
Sbjct: 204 HPFKEDE--------------DEELDL--ESLLKRQQKKLP---------FIKNVSKNAN 238

Query: 208 DLLEKMLVFDPNKR-ITVEEALRHPYL 233
           D ++ ML ++ N R     E ++HP+L
Sbjct: 239 DFVQSMLKYNINYRLTNYNEIIKHPFL 265

Length = 267

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 60.6 bits (147), Expect = 7e-11
 Identities = 41/135 (30%), Positives = 72/135 (53%), Gaps = 11/135 (8%)

Query: 24  VYIVYELMDT-DLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
           +YI+ E M+   L   +++ +  +LT +       Q+  G+ ++   + +HRDL+ +N+L
Sbjct: 75  IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANIL 134

Query: 81  LNASCDLKIGDFGLARTTSETDFMTE---YVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 137
           ++ +   KI DFGLAR   + ++          +W  APE  +N   +T   D+WS G +
Sbjct: 135 VSETLCCKIADFGLARLIEDNEYTAREGAKFPIKW-TAPE-AINYGTFTIKSDVWSFGIL 192

Query: 138 LGEIMT--REPLFPG 150
           L EI+T  R P +PG
Sbjct: 193 LTEIVTYGRIP-YPG 206

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 61.2 bits (148), Expect = 7e-11
 Identities = 45/166 (27%), Positives = 85/166 (51%), Gaps = 22/166 (13%)

Query: 1   MEHENVIAIKDIIRPPKK-------DTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQY 52
           M  + V+A++D  +PP          T + +Y V E ++  DL   I+   +  +    +
Sbjct: 48  MVEKRVLALQD--KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVF 105

Query: 53  FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW 112
           +  ++  GL ++H   +++RDLK  N++L++   +KI DFG+ +     + M + V TR 
Sbjct: 106 YAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCK-----EHMVDGVTTRT 160

Query: 113 ------YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 152
                 Y APE++     Y  ++D W+ G +L E++  +P F G+D
Sbjct: 161 FCGTPDYIAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFDGED 205

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 61.3 bits (149), Expect = 8e-11
 Identities = 40/131 (30%), Positives = 67/131 (51%), Gaps = 10/131 (7%)

Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-TDFMTEYVVTRWYRAPELL 119
           L Y+HS ++++RDLKP N+LL++   + + DFGL +   E +   + +  T  Y APE+L
Sbjct: 109 LGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVL 168

Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY-------VHQ-LRLITELIGSPDDAS 171
                Y   +D W +G +L E++   P F  +D        +++ LRL   +  S     
Sbjct: 169 RK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLL 227

Query: 172 LGFLRSDNARR 182
            G L+ D  +R
Sbjct: 228 EGLLQKDRTKR 238

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 61.1 bits (148), Expect = 8e-11
 Identities = 40/133 (30%), Positives = 73/133 (54%), Gaps = 6/133 (4%)

Query: 17  KKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 75
           K +++  +Y+V E ++  +    +R +++  +D   ++  Q++   +Y+ S ++++RDLK
Sbjct: 101 KDESY--LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLK 158

Query: 76  PSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVG 135
           P NLLL+    +K+ DFG A+      +      T  Y APE+LLN     AA D W++G
Sbjct: 159 PENLLLDKDGFIKMTDFGFAKVVDTRTYT--LCGTPEYIAPEILLNVGHGKAA-DWWTLG 215

Query: 136 CILGEIMTREPLF 148
             + EI+   P F
Sbjct: 216 IFIYEILVGCPPF 228

Length = 340

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 60.3 bits (146), Expect = 1e-10
 Identities = 31/103 (30%), Positives = 59/103 (57%), Gaps = 5/103 (4%)

Query: 52  YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR 111
           ++  Q+  G+ ++HS  +++RD+KP N+LL+   + ++ D GLA    +   +T+   T 
Sbjct: 99  HYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTN 158

Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDY 153
            Y APE+L     Y+  +D +++GC + E++  R P    KD+
Sbjct: 159 GYMAPEILKE-EPYSYPVDWFAMGCSIYEMVAGRTPF---KDH 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 61.1 bits (148), Expect = 1e-10
 Identities = 59/198 (29%), Positives = 88/198 (44%), Gaps = 23/198 (11%)

Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG---LARTTSETDFMTEYVVTRW 112
           QLL  + Y+H   ++HRD+K  N+L+N   D+ +GDFG    AR +  T F      T  
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVD 327

Query: 113 YRAPELLLNCTEYTAAIDIWSVGCILGEIMTRE-PLF--PGKDYVHQ-----LRLITELI 164
             APE+L     YT ++DIWS G ++ E       LF     D         LR+I +  
Sbjct: 328 TNAPEVLAG-DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQ 386

Query: 165 GSPDDASLGFLRSDNAR---RYVRQLPRCRKQQFA----TRFPNKSSGAVDLLEKMLVFD 217
              D+    F +   +R   +Y  +  R R+  +     TR+         L+ + L FD
Sbjct: 387 VHVDE----FPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFD 442

Query: 218 PNKRITVEEALRHPYLQS 235
             +R +  E LR P  QS
Sbjct: 443 GARRPSAAELLRLPLFQS 460

Length = 461

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 60.2 bits (146), Expect = 1e-10
 Identities = 35/133 (26%), Positives = 64/133 (48%), Gaps = 23/133 (17%)

Query: 24  VYIVYELMDTD-LHQIIRSDQ-----QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 77
           ++IV E M    L   +R  +     +   D C      +   ++Y+ S   +HRDL   
Sbjct: 74  IFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCS----DVCEAMEYLESNGFIHRDLAAR 129

Query: 78  NLLLNASCDLKIGDFGLAR-------TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAID 130
           N L+     +K+ DFGLAR       T+S+    T++ V +W  AP  + + + +++  D
Sbjct: 130 NCLVGEDNVVKVSDFGLARYVLDDQYTSSQG---TKFPV-KW--APPEVFDYSRFSSKSD 183

Query: 131 IWSVGCILGEIMT 143
           +WS G ++ E+ +
Sbjct: 184 VWSFGVLMWEVFS 196

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 60.1 bits (145), Expect = 2e-10
 Identities = 54/202 (26%), Positives = 95/202 (47%), Gaps = 31/202 (15%)

Query: 35  LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL 94
           L  I      L++    Y   + L+GL Y+HS   +HRD+K +N+LL  +  +K+ DFG+
Sbjct: 93  LQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGV 152

Query: 95  -ARTTSETDFMTEYVVTRWYRAPEL--LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK 151
            A+ T+       ++ T ++ APE+  +     Y    DIW+VG    E+   +P  P  
Sbjct: 153 SAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQP--PMF 210

Query: 152 DYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCR-KQQFATRFPNKSSGAVDLL 210
           D +H +R +             FL + +      Q P+ + K +++  F +        +
Sbjct: 211 D-LHPMRAL-------------FLMTKSN----FQPPKLKDKMKWSNSFHH-------FV 245

Query: 211 EKMLVFDPNKRITVEEALRHPY 232
           +  L  +P KR T E+ L+HP+
Sbjct: 246 KMALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 40/135 (29%), Positives = 68/135 (50%), Gaps = 6/135 (4%)

Query: 13  IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHR 72
           I     ++  D Y+      T    +I     L+      F YQ+  G++++ S + +HR
Sbjct: 204 IESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHR 263

Query: 73  DLKPSNLLLNASCDLKIGDFGLAR-TTSETDFMTE---YVVTRWYRAPELLLNCTEYTAA 128
           DL   N+L+     +KI DFGLAR    +++++++   ++  +W  APE + N   YT  
Sbjct: 264 DLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWM-APESIFN-NLYTTL 321

Query: 129 IDIWSVGCILGEIMT 143
            D+WS G +L EI T
Sbjct: 322 SDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 59.7 bits (144), Expect = 2e-10
 Identities = 39/121 (32%), Positives = 62/121 (51%), Gaps = 9/121 (7%)

Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE----YVVTR 111
           ++  G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD+  +     +  R
Sbjct: 127 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186

Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITE--LIGSPD 168
           W  +PE L +   +T   D+WS G +L EI T  E  + G      LR + E  L+  PD
Sbjct: 187 WM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKPD 244

Query: 169 D 169
           +
Sbjct: 245 N 245

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 59.7 bits (144), Expect = 2e-10
 Identities = 60/225 (26%), Positives = 108/225 (48%), Gaps = 34/225 (15%)

Query: 20  TFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 78
           T + +++V E ++  DL   ++  ++L ++H +++  ++   L ++H   +++RDLK  N
Sbjct: 67  TTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDN 126

Query: 79  LLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 137
           +LL+A   +K+ D+G+ +      D  + +  T  Y APE+L    EY  ++D W++G +
Sbjct: 127 VLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVL 185

Query: 138 LGEIM---------TREPLFPGKDYVHQLRLITELIGSPDDASL-------GFLRSDNAR 181
           + E+M         T  P    +DY+ Q+ ++ + I  P   S+       GFL  D   
Sbjct: 186 MFEMMAGRSPFDIITDNPDMNTEDYLFQV-ILEKPIRIPRFLSVKASHVLKGFLNKDPKE 244

Query: 182 RYVRQLPRCRKQQFATRFPNKSSGAV------DLLEKMLVFDPNK 220
           R       C+ Q   T F +  S         DLLEK  V  P K
Sbjct: 245 RL-----GCQPQ---TGFSDIKSHTFFRSIDWDLLEKKQVTPPFK 281

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 60.0 bits (145), Expect = 2e-10
 Identities = 38/118 (32%), Positives = 68/118 (57%), Gaps = 8/118 (6%)

Query: 32  DTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKI 89
           D+++  ++  D  + LT      F YQ+ RG++++ S + +HRDL   N+LL     +KI
Sbjct: 219 DSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKI 278

Query: 90  GDFGLAR-TTSETDFMTE---YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
            DFGLAR    +++++++   ++  +W  APE + +   YT   D+WS G +L EI +
Sbjct: 279 CDFGLARDIMHDSNYVSKGSTFLPVKWM-APESIFD-NLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 59.6 bits (144), Expect = 2e-10
 Identities = 42/141 (29%), Positives = 72/141 (51%), Gaps = 10/141 (7%)

Query: 51  QYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVV 109
           +++  ++   + Y+HS ++++RDLKP N+LL++   + + DFGL +   E +  T  +  
Sbjct: 99  RFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCG 158

Query: 110 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD----YVHQLRLITELIG 165
           T  Y APE+L     Y   +D W +G +L E++   P F  +D    Y + L    +L G
Sbjct: 159 TPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPG 217

Query: 166 SPDDAS----LGFLRSDNARR 182
               A+    +G L  D  RR
Sbjct: 218 GKTVAACDLLVGLLHKDQRRR 238

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 60.6 bits (147), Expect = 3e-10
 Identities = 57/227 (25%), Positives = 91/227 (40%), Gaps = 45/227 (19%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H N++A+ D    P       ++ V+E +    L +++ +D  L        + Q+L 
Sbjct: 35  LYHPNIVALLDSGEAP--PGL--LFAVFEYVPGRTLREVLAADGALPAGETGRLMLQVLD 90

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGL------------ARTTSETDFM 104
            L   H+  ++HRDLKP N++++ +      K+ DFG+            A  T      
Sbjct: 91  ALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRT---- 146

Query: 105 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD----YVHQLRLI 160
           TE + T  Y APE L      T   D+++ G I  E +T + +  G         QL   
Sbjct: 147 TEVLGTPTYCAPEQLRG-EPVTPNSDLYAWGLIFLECLTGQRVVQGASVAEILYQQL--- 202

Query: 161 TELIGSPDDASL-----GFLRSDNARRYVRQLPRCRK---QQFATRF 199
                SP D SL     G       R+ + + PR R       A RF
Sbjct: 203 -----SPVDVSLPPWIAGHPLGQVLRKALNKDPRQRAASAPALAERF 244

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 59.6 bits (145), Expect = 3e-10
 Identities = 52/239 (21%), Positives = 96/239 (40%), Gaps = 82/239 (34%)

Query: 40  RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS 99
           +  + L+++  +++  ++L  L+Y+H   +++RDLKP N+LL+ S  + + DF L++ + 
Sbjct: 95  QPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSD 154

Query: 100 -----------------------------ETDFMT-EYVVTRWYRAPELLLNCTEYTAAI 129
                                        E  F +  +V T  Y APE++     + +A+
Sbjct: 155 VEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAV 213

Query: 130 DIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPR 189
           D W++G +L E++     F G +                                     
Sbjct: 214 DWWTLGILLYEMLYGTTPFKGSN------------------------------------- 236

Query: 190 CRKQQFAT------RFPNK---SSGAVDLLEKMLVFDPNKRI----TVEEALRHPYLQS 235
            R + F+        FP     SS A DL+ K+LV DP+KR+       E  +HP+ + 
Sbjct: 237 -RDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG 294

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 59.3 bits (143), Expect = 3e-10
 Identities = 49/192 (25%), Positives = 93/192 (48%), Gaps = 28/192 (14%)

Query: 34  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG 93
           DL   ++  ++L ++H +++  ++   L Y+H   +++RDLK  N+LL++   +K+ D+G
Sbjct: 82  DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG 141

Query: 94  LART-TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGK 151
           + +      D  + +  T  Y APE+L    +Y  ++D W++G ++ E+M  R P     
Sbjct: 142 MCKEGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPF---- 196

Query: 152 DYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSS-GAVDLL 210
                     +++GS D+         N   Y+ Q+    KQ    R P   S  A  +L
Sbjct: 197 ----------DIVGSSDNP------DQNTEDYLFQVI-LEKQ---IRIPRSLSVKAASVL 236

Query: 211 EKMLVFDPNKRI 222
           +  L  DP +R+
Sbjct: 237 KSFLNKDPKERL 248

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 59.3 bits (143), Expect = 4e-10
 Identities = 53/207 (25%), Positives = 92/207 (44%), Gaps = 40/207 (19%)

Query: 51  QYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVV 109
           +++  ++   L Y+HS ++++RDLKP N+LL++   + + DFGL +   E +  T  +  
Sbjct: 99  RFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCG 158

Query: 110 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDD 169
           T  Y APE +L+   Y   +D W +G +L E++   P F  ++                 
Sbjct: 159 TPEYLAPE-VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY------------ 205

Query: 170 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVE---- 225
                   DN      QL            PN ++ A  LLE +L  D  KR+  +    
Sbjct: 206 --------DNILNKPLQLK-----------PNITNSARHLLEGLLQKDRTKRLGAKDDFM 246

Query: 226 EALRHPYLQSLH--DLNDEPVCPRPFH 250
           E   H +   ++  DL ++ + P PF+
Sbjct: 247 EIKNHIFFSPINWDDLINKKITP-PFN 272

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 59.3 bits (144), Expect = 4e-10
 Identities = 62/262 (23%), Positives = 104/262 (39%), Gaps = 81/262 (30%)

Query: 20  TFNDVYIVYELMD----TDLH-QIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDL 74
           +F D   +Y +M+     D+   +++ D   T++  ++++ + +  +  +H    +HRD+
Sbjct: 69  SFQDENYLYLIMEYLPGGDMMTLLMKKDT-FTEEETRFYIAETILAIDSIHKLGYIHRDI 127

Query: 75  KPSNLLLNASCDLKIGDFGLARTTSETDFMTEY--------------------------- 107
           KP NLLL+A   +K+ DFGL  T  +    TE+                           
Sbjct: 128 KPDNLLLDAKGHIKLSDFGLC-TGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAE 186

Query: 108 -------------VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV 154
                        V T  Y APE+ L  T Y    D WS+G I+ E+             
Sbjct: 187 TWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVIMYEM------------- 232

Query: 155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ-QFATRFPNKSSGAVDLLEKM 213
                   L+G P      F  SDN +   R++   ++  QF    P  S  A DL+++ 
Sbjct: 233 --------LVGYPP-----FC-SDNPQETYRKIINWKETLQFPDEVP-LSPEAKDLIKR- 276

Query: 214 LVFDPNKRI---TVEEALRHPY 232
           L  +  +R+    V E   HP+
Sbjct: 277 LCCEAERRLGNNGVNEIKSHPF 298

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 59.1 bits (143), Expect = 4e-10
 Identities = 34/116 (29%), Positives = 62/116 (53%), Gaps = 2/116 (1%)

Query: 34  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG 93
           DL   I+  ++  +   +++  ++   L ++H   V++RDLK  N+LL+A    K+ DFG
Sbjct: 82  DLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFG 141

Query: 94  LARTTSETDFMTE-YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF 148
           + +        T  +  T  Y APE+L    EY  ++D W++G ++ E+M  +P F
Sbjct: 142 MCKEGILNGVTTTTFCGTPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 58.2 bits (141), Expect = 6e-10
 Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 15/106 (14%)

Query: 48  DHCQYFLY--QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT 105
           DH +  LY  Q+ +G++Y+ S   +HRDL   N+L+ +   +KIGDFGL +   +     
Sbjct: 106 DHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD---K 162

Query: 106 EYVVTR--------WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           EY   R        WY APE  L  ++++ A D+WS G +L E+ T
Sbjct: 163 EYYKVREPGESPIFWY-APE-SLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 58.2 bits (141), Expect = 6e-10
 Identities = 42/140 (30%), Positives = 66/140 (47%), Gaps = 21/140 (15%)

Query: 24  VYIVYELMDT-DLHQIIRSD-------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 75
           +YIV ELM    L + ++          QL D        Q+  G+ Y+ + + +HRDL 
Sbjct: 76  IYIVTELMKYGSLLEYLQGGAGRALKLPQLID-----MAAQVASGMAYLEAQNYIHRDLA 130

Query: 76  PSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIW 132
             N+L+  +   K+ DFGLAR   E  +       ++   + APE       ++   D+W
Sbjct: 131 ARNVLVGENNICKVADFGLARVIKEDIY-EAREGAKFPIKWTAPE-AALYNRFSIKSDVW 188

Query: 133 SVGCILGEIMT--REPLFPG 150
           S G +L EI+T  R P +PG
Sbjct: 189 SFGILLTEIVTYGRMP-YPG 207

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 57.9 bits (140), Expect = 7e-10
 Identities = 33/125 (26%), Positives = 66/125 (52%), Gaps = 7/125 (5%)

Query: 24  VYIVYELMDTD--LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 81
           +YIV E M+    L+ + +   +L+ D        +  G++Y+   S +HRDL   N L+
Sbjct: 74  LYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLV 133

Query: 82  NASCDLKIGDFGLARTTSETDFMTEY---VVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 138
           +++  +K+ DFG+ R   + ++ +        +W   PE + N ++Y++  D+WS G ++
Sbjct: 134 SSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKW-SPPE-VFNFSKYSSKSDVWSFGVLM 191

Query: 139 GEIMT 143
            E+ T
Sbjct: 192 WEVFT 196

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 57.8 bits (139), Expect = 9e-10
 Identities = 41/139 (29%), Positives = 66/139 (47%), Gaps = 19/139 (13%)

Query: 24  VYIVYELMDT-DLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 75
           +YIV E M    L   ++ +        QL D        Q+  G+ YV   + +HRDL+
Sbjct: 75  IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD-----MAAQIASGMAYVERMNYVHRDLR 129

Query: 76  PSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTRWYRAPELLLNCTEYTAAIDIW 132
            +N+L+  +   K+ DFGLAR   + ++          +W  APE  L    +T   D+W
Sbjct: 130 AANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-TAPEAALY-GRFTIKSDVW 187

Query: 133 SVGCILGEIMTREPL-FPG 150
           S G +L E+ T+  + +PG
Sbjct: 188 SFGILLTELTTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 57.7 bits (139), Expect = 9e-10
 Identities = 30/111 (27%), Positives = 60/111 (54%), Gaps = 7/111 (6%)

Query: 35  LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL 94
           L++ ++ ++ +T+ +    ++Q+  G+KY+   + +HRDL   N+LL      KI DFGL
Sbjct: 82  LNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGL 141

Query: 95  ARTTSETDFMTEYVVT-----RWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           ++     +   +         +WY APE  +N  ++++  D+WS G ++ E
Sbjct: 142 SKALGADENYYKAKTHGKWPVKWY-APE-CMNYYKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 58.2 bits (141), Expect = 9e-10
 Identities = 40/137 (29%), Positives = 66/137 (48%), Gaps = 7/137 (5%)

Query: 24  VYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 82
           +Y+V E M   DL  ++ S+  + +   +++  +++  L  +HS   +HRD+KP N+LL+
Sbjct: 118 LYMVMEYMPGGDLVNLM-SNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD 176

Query: 83  ASCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAPELLLN---CTEYTAAIDIWSVGCI 137
            S  LK+ DFG          +     V T  Y +PE+L +      Y    D WSVG  
Sbjct: 177 KSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 236

Query: 138 LGEIMTREPLFPGKDYV 154
           L E++  +  F     V
Sbjct: 237 LYEMLVGDTPFYADSLV 253

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 57.7 bits (139), Expect = 1e-09
 Identities = 38/118 (32%), Positives = 60/118 (50%), Gaps = 8/118 (6%)

Query: 37  QIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR 96
           Q  ++  +L      +   Q+  G+ Y+ S   +HRDL   N L+ A+  +KIGDFG++R
Sbjct: 112 QPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 171

Query: 97  TTSETDFMT----EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLF 148
               TD+        +  RW   PE ++   ++T   D+WS G IL EI T  ++P F
Sbjct: 172 DVYSTDYYRVGGHTMLPIRWM-PPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWF 227

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 57.4 bits (138), Expect = 1e-09
 Identities = 35/111 (31%), Positives = 58/111 (52%), Gaps = 8/111 (7%)

Query: 44  QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF 103
           +LT     +   Q+  G+ Y+ S   +HRDL   N L+  +  +KIGDFG++R    TD+
Sbjct: 116 ELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDY 175

Query: 104 MT----EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLF 148
                   +  RW   PE ++   ++T   D+WS+G +L EI T  ++P +
Sbjct: 176 YRVGGHTMLPIRWM-PPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWY 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 57.0 bits (138), Expect = 1e-09
 Identities = 44/157 (28%), Positives = 73/157 (46%), Gaps = 18/157 (11%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS--DQQLTDDHCQYFLYQL 57
           + H N++ +  ++        N +YIV E M    L   +RS     +T      F   +
Sbjct: 57  LRHPNLVQLLGVVL-----QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDV 111

Query: 58  LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 117
             G++Y+   + +HRDL   N+L++     K+ DFGLA+  S+     +  V +W  APE
Sbjct: 112 CEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPV-KW-TAPE 169

Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMT-------REPL 147
            L    +++   D+WS G +L EI +       R PL
Sbjct: 170 ALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 205

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 57.2 bits (138), Expect = 2e-09
 Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 6/92 (6%)

Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM----TEYVVTR 111
           Q+  G+KY+ S + +HRDL   N L+  +  +KI DFG++R     D+        +  R
Sbjct: 138 QIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIR 197

Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           W     +LL   ++T A D+W+ G  L EI+T
Sbjct: 198 WMSWESILLG--KFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 56.6 bits (137), Expect = 2e-09
 Identities = 35/106 (33%), Positives = 53/106 (50%), Gaps = 14/106 (13%)

Query: 50  CQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV 109
           C Y + Q+  G++Y+ S   +HRDL   N+LL +   +KIGDFGL R   + +   ++ V
Sbjct: 100 CDYAV-QIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE---DHYV 155

Query: 110 TRWYR-------APELLLNCTEYTAAIDIWSVGCILGEIMT--REP 146
              +        APE  L    ++ A D+W  G  L E+ T   EP
Sbjct: 156 MEEHLKVPFAWCAPE-SLRTRTFSHASDVWMFGVTLWEMFTYGEEP 200

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 56.7 bits (137), Expect = 2e-09
 Identities = 41/148 (27%), Positives = 71/148 (47%), Gaps = 13/148 (8%)

Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQII-RSDQQLTDDHCQYFLYQLLR 59
           +H +++ +  +I      T N V+IV EL    +L   +  +   L       + YQL  
Sbjct: 65  DHPHIVKLIGVI------TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLST 118

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV---TRWYRAP 116
            L Y+ S   +HRD+   N+L+++   +K+GDFGL+R   +  +          +W  AP
Sbjct: 119 ALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWM-AP 177

Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTR 144
           E  +N   +T+A D+W  G  + EI+  
Sbjct: 178 E-SINFRRFTSASDVWMFGVCMWEILML 204

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 56.9 bits (137), Expect = 2e-09
 Identities = 37/104 (35%), Positives = 51/104 (49%), Gaps = 6/104 (5%)

Query: 44  QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF 103
           QLT         Q+  G+ Y+ S   +HRDL   N L+     +KIGDFG++R    TD+
Sbjct: 118 QLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY 177

Query: 104 M----TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
                   +  RW   PE +L   ++T   DIWS G +L EI T
Sbjct: 178 YRVGGRTMLPIRWM-PPESILY-RKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 56.3 bits (136), Expect = 2e-09
 Identities = 39/128 (30%), Positives = 61/128 (47%), Gaps = 12/128 (9%)

Query: 24  VYIVYELMDTD--LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 81
           +YIV EL+     L  + +   +LT             G++Y+ S + +HRDL   N L+
Sbjct: 67  IYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLV 126

Query: 82  NASCDLKIGDFGLARTTSETDFM------TEYVVTRWYRAPELLLNCTEYTAAIDIWSVG 135
             +  LKI DFG++R   E   +       + +  +W  APE  LN   YT+  D+WS G
Sbjct: 127 GENNVLKISDFGMSR--EEEGGIYTVSDGLKQIPIKW-TAPE-ALNYGRYTSESDVWSYG 182

Query: 136 CILGEIMT 143
            +L E  +
Sbjct: 183 ILLWETFS 190

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 56.9 bits (137), Expect = 2e-09
 Identities = 40/129 (31%), Positives = 74/129 (57%), Gaps = 14/129 (10%)

Query: 53  FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDFM---TEYV 108
           + +Q+ RG++++ S   +HRDL   N+LL+ +  +KI DFGLAR    + D++   +  +
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238

Query: 109 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG----KDYVHQLRLITE 162
             +W  APE + +   YT   D+WS G +L EI +    P +PG    +++  +L+  T 
Sbjct: 239 PLKWM-APESIFDKV-YTTQSDVWSFGVLLWEIFSLGASP-YPGVQINEEFCQRLKDGTR 295

Query: 163 LIGSPDDAS 171
           +  +P++A+
Sbjct: 296 M-RAPENAT 303

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 56.2 bits (136), Expect = 3e-09
 Identities = 32/117 (27%), Positives = 55/117 (47%), Gaps = 11/117 (9%)

Query: 35  LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL 94
           L + ++  +++     +   +Q+  G+ Y+ S   +HRDL   N+LL      KI DFG+
Sbjct: 82  LLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGM 141

Query: 95  ARTTSETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR 144
           +R          Y  T       +WY APE  +N  ++++  D+WS G  L E  + 
Sbjct: 142 SRALGAGS--DYYRATTAGRWPLKWY-APE-CINYGKFSSKSDVWSYGVTLWEAFSY 194

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 56.5 bits (136), Expect = 3e-09
 Identities = 29/96 (30%), Positives = 49/96 (51%), Gaps = 6/96 (6%)

Query: 53  FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-- 110
           F+  +  G++Y+ S + +HRDL   N +LN +  + + DFGL++     D+  +   +  
Sbjct: 118 FMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177

Query: 111 --RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR 144
             +W     L  N   YT   D+W+ G  + EIMTR
Sbjct: 178 PVKWLALESLADNV--YTTHSDVWAFGVTMWEIMTR 211

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 56.8 bits (137), Expect = 3e-09
 Identities = 43/144 (29%), Positives = 75/144 (52%), Gaps = 20/144 (13%)

Query: 41  SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE 100
             + LT +    + +Q+ RG++++ S   +HRDL   N+LL+ +  +KI DFGLAR   +
Sbjct: 166 YKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 225

Query: 101 TDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG- 150
                +YV         +W  APE + +   YT   D+WS G +L EI +    P +PG 
Sbjct: 226 D---PDYVRKGDARLPLKWM-APESIFDKV-YTTQSDVWSFGVLLWEIFSLGASP-YPGV 279

Query: 151 ---KDYVHQLRLITELIGSPDDAS 171
              +++  +L+  T +  +P+ A+
Sbjct: 280 QIDEEFCRRLKEGTRM-RAPEYAT 302

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 55.9 bits (135), Expect = 4e-09
 Identities = 35/160 (21%), Positives = 72/160 (45%), Gaps = 20/160 (12%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIR---------SDQQLTDDHC 50
           + H+NV+ +  + R  + +     Y++ E  D  DL Q +R             L+    
Sbjct: 65  LSHKNVVRLLGLCR--EAEPH---YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQK 119

Query: 51  QYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEY 107
                Q+  G+ ++ +A  +HRDL   N L+++  ++K+    L++    ++        
Sbjct: 120 VALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNAL 179

Query: 108 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL 147
           +  RW  APE +    +++   D+WS G ++ E+ T+  L
Sbjct: 180 IPLRWL-APEAVQE-DDFSTKSDVWSFGVLMWEVFTQGEL 217

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 55.8 bits (134), Expect = 4e-09
 Identities = 35/114 (30%), Positives = 59/114 (51%), Gaps = 11/114 (9%)

Query: 53  FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW 112
           F+  +  G++Y+ S S +HRDL   N +LN + ++ + DFGL++     D+  +  + + 
Sbjct: 117 FMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM 176

Query: 113 ---YRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPG------KDYVHQ 156
              + A E L +   YT   D+WS G  + EI TR +  +PG       DY+ Q
Sbjct: 177 PVKWIAIESLADRV-YTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQ 229

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 56.2 bits (135), Expect = 4e-09
 Identities = 34/103 (33%), Positives = 59/103 (57%), Gaps = 6/103 (5%)

Query: 45  LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDF 103
           LT +    + +Q+ +G++++ S   +HRDL   N+LL+ +  +KI DFGLAR    + D+
Sbjct: 176 LTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 235

Query: 104 MTE---YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           + +    +  +W  APE + +   YT   D+WS G +L EI +
Sbjct: 236 VRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 55.5 bits (134), Expect = 5e-09
 Identities = 34/112 (30%), Positives = 54/112 (48%), Gaps = 15/112 (13%)

Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT----- 110
           Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     +   EY        
Sbjct: 117 QIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE--KEYHAEGGKVP 174

Query: 111 -RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPL--FPGKDYVHQL 157
            +W  A E +L+   YT   D+WS G  + E+MT   +P    P  + +  L
Sbjct: 175 IKWM-ALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE-IPDL 223

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 55.6 bits (134), Expect = 6e-09
 Identities = 32/115 (27%), Positives = 66/115 (57%), Gaps = 3/115 (2%)

Query: 34  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG 93
           DL   ++  ++L ++H +++  ++   L ++H   +++RDLK  N+LL+A   +K+ D+G
Sbjct: 82  DLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYG 141

Query: 94  LART-TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REP 146
           + +      D  + +  T  Y APE+L    +Y  ++D W++G ++ E+M  R P
Sbjct: 142 MCKEGIRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 55.0 bits (132), Expect = 6e-09
 Identities = 34/100 (34%), Positives = 53/100 (53%), Gaps = 8/100 (8%)

Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTRW 112
           Q+  G+ Y+   + +HRDL+ +N+L+      KI DFGLAR   + ++          +W
Sbjct: 110 QVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKW 169

Query: 113 YRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 150
             APE  L    +T   D+WS G +L E++T  R P +PG
Sbjct: 170 -TAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVP-YPG 206

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 55.4 bits (133), Expect = 7e-09
 Identities = 31/96 (32%), Positives = 48/96 (50%), Gaps = 6/96 (6%)

Query: 52  YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM----TEY 107
           Y   Q+  G+KY+ S + +HRDL   N L+     +KI DFG++R     D+        
Sbjct: 133 YMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAV 192

Query: 108 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           +  RW     +LL   ++T A D+W+ G  L E+ T
Sbjct: 193 LPIRWMAWESILLG--KFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 55.1 bits (133), Expect = 8e-09
 Identities = 39/140 (27%), Positives = 66/140 (47%), Gaps = 12/140 (8%)

Query: 20  TFN--DVYIVYELMDTDLHQIIR-----SDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLH 71
            F   D +I  ELMD  L +  +         + ++         ++ L Y+     ++H
Sbjct: 72  LFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIH 131

Query: 72  RDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE--YTAAI 129
           RD+KPSN+LL+ + ++K+ DFG++    ++   T     R Y APE +       Y    
Sbjct: 132 RDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRS 191

Query: 130 DIWSVGCILGEIMTREPLFP 149
           D+WS+G  L E+ T +  FP
Sbjct: 192 DVWSLGITLYEVATGK--FP 209

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 55.0 bits (132), Expect = 8e-09
 Identities = 31/88 (35%), Positives = 49/88 (55%), Gaps = 6/88 (6%)

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE----YVVTRWYRA 115
           G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD+  +     +  RW  A
Sbjct: 131 GMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM-A 189

Query: 116 PELLLNCTEYTAAIDIWSVGCILGEIMT 143
           PE L +   +T + D+WS G +L EI +
Sbjct: 190 PESLKDGV-FTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 54.7 bits (132), Expect = 1e-08
 Identities = 42/135 (31%), Positives = 68/135 (50%), Gaps = 9/135 (6%)

Query: 23  DVYIVYELMDTDLHQIIRSDQQLTDD----HCQYFLYQLLRGLKYVHSASVLHRDLKPSN 78
           DV+I  ELM T L ++++  Q    +         + + L  LK  H   V+HRD+KPSN
Sbjct: 88  DVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSN 145

Query: 79  LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL---LNCTEYTAAIDIWSVG 135
           +LL+AS ++K+ DFG++    ++   T       Y APE +       +Y    D+WS+G
Sbjct: 146 ILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLG 205

Query: 136 CILGEIMTREPLFPG 150
             L E+ T +  +  
Sbjct: 206 ISLVELATGQFPYKN 220

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 54.3 bits (131), Expect = 1e-08
 Identities = 37/118 (31%), Positives = 59/118 (50%), Gaps = 12/118 (10%)

Query: 30  LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKI 89
           L + +  Q + S QQL          Q+  G+ Y+H   V+H+D+   N +++    +KI
Sbjct: 105 LGEANNPQAL-STQQLVH-----MAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKI 158

Query: 90  GDFGLARTTSETDFM----TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
            D  L+R     D+      E    +W  A E L+N  EY++A D+WS G +L E+MT
Sbjct: 159 TDNALSRDLFPMDYHCLGDNENRPVKWM-ALESLVN-KEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 54.1 bits (130), Expect = 1e-08
 Identities = 33/126 (26%), Positives = 62/126 (49%), Gaps = 9/126 (7%)

Query: 24  VYIVYELMDTD-LHQIIRSDQQ-LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 81
           +YIV E M    L   +R   +             +  G+ Y+ S   +HRDL   N L+
Sbjct: 74  IYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLV 133

Query: 82  NASCDLKIGDFGLARTTSETDFM----TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 137
           +    +K+ DFGL+R   + ++     +++ V RW   PE+LL   ++++  D+W+ G +
Sbjct: 134 DDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPV-RW-SPPEVLLYS-KFSSKSDVWAFGVL 190

Query: 138 LGEIMT 143
           + E+ +
Sbjct: 191 MWEVYS 196

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 53.9 bits (129), Expect = 2e-08
 Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 6/99 (6%)

Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTRW 112
           Q+  G+ Y+   + +HRDL+ +N+L+  +   KI DFGLAR   + ++          +W
Sbjct: 110 QIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKW 169

Query: 113 YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 150
             APE  L    +T   D+WS G +L E++T+  + +PG
Sbjct: 170 -TAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 53.7 bits (129), Expect = 2e-08
 Identities = 45/137 (32%), Positives = 68/137 (49%), Gaps = 19/137 (13%)

Query: 24  VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLL-------RGLKYVHSASVLHRDLK 75
            YI+ ELM+  DL   +R  +          L +LL       +G  Y+     +HRDL 
Sbjct: 74  QYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLA 133

Query: 76  PSNLLLNAS---CD--LKIGDFGLARTTSETDFMTE----YVVTRWYRAPELLLNCTEYT 126
             N L++      D  +KIGDFGLAR   ++D+  +     +  RW  APE LL+  ++T
Sbjct: 134 ARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWM-APESLLD-GKFT 191

Query: 127 AAIDIWSVGCILGEIMT 143
              D+WS G ++ EI+T
Sbjct: 192 TQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 53.5 bits (128), Expect = 2e-08
 Identities = 37/125 (29%), Positives = 61/125 (48%), Gaps = 7/125 (5%)

Query: 24  VYIVYELMDTD--LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 81
           +YIV EL+     L  + +   +L       F      G+ Y+ S + +HRDL   N L+
Sbjct: 67  IYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLV 126

Query: 82  NASCDLKIGDFGLARTTSETDFMT---EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 138
             +  LKI DFG++R   +  + +   + +  +W  APE  LN   Y++  D+WS G +L
Sbjct: 127 GENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKW-TAPE-ALNYGRYSSESDVWSYGILL 184

Query: 139 GEIMT 143
            E  +
Sbjct: 185 WETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 53.9 bits (129), Expect = 2e-08
 Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 10/158 (6%)

Query: 24  VYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 82
           +Y+V E M   DL  ++ S+  + +   +++  +++  L  +HS  ++HRD+KP N+LL+
Sbjct: 118 LYMVMEYMPGGDLVNLM-SNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLD 176

Query: 83  ASCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAPELLLNC---TEYTAAIDIWSVGCI 137
               LK+ DFG      ET  +     V T  Y +PE+L +      Y    D WSVG  
Sbjct: 177 KHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 236

Query: 138 LGEIMTREPLFPGKDYVHQLRLITELIGS---PDDASL 172
           L E++  +  F     V     I +   S   P+D  +
Sbjct: 237 LFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEI 274

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 53.9 bits (129), Expect = 3e-08
 Identities = 40/163 (24%), Positives = 74/163 (45%), Gaps = 38/163 (23%)

Query: 23  DVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 81
           ++Y++ E +   D+  ++     L+++  Q+++ + +  +  +H    +HRD+KP NLLL
Sbjct: 75  NLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLL 134

Query: 82  NASCDLKIGDFGLA-------RT--------TSETDFMTEYVVTR-----W--------- 112
           +A   +K+ DFGL        RT           +DF  + + ++     W         
Sbjct: 135 DAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAY 194

Query: 113 -------YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF 148
                  Y APE+ +  T Y    D WS+G I+ E++   P F
Sbjct: 195 STVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPF 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 53.9 bits (129), Expect = 3e-08
 Identities = 40/163 (24%), Positives = 75/163 (46%), Gaps = 38/163 (23%)

Query: 23  DVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 81
           ++Y++ E +   D+  ++     LT++  Q+++ + +  +  +H    +HRD+KP NLLL
Sbjct: 75  NLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLL 134

Query: 82  NASCDLKIGDFGLA-------RT--------TSETDFMTEYVVTR-----WYR------- 114
           ++   +K+ DFGL        RT        +  +DF  + + ++     W R       
Sbjct: 135 DSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAF 194

Query: 115 ---------APELLLNCTEYTAAIDIWSVGCILGEIMTREPLF 148
                    APE+ +  T Y    D WS+G I+ E++   P F
Sbjct: 195 STVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPF 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 53.1 bits (127), Expect = 3e-08
 Identities = 47/161 (29%), Positives = 75/161 (46%), Gaps = 14/161 (8%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQ--LTDDHCQYFLYQL 57
           + H N++ +  +I   K      +YIV E M    L   +RS  +  L  D    F   +
Sbjct: 56  LRHSNLVQLLGVIVEEK----GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 111

Query: 58  LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 117
              ++Y+ + + +HRDL   N+L++     K+ DFGL +  S T    +  V +W  APE
Sbjct: 112 CEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-KW-TAPE 169

Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMT----REPLFPGKDYV 154
            L    +++   D+WS G +L EI +      P  P KD V
Sbjct: 170 ALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 209

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 52.6 bits (126), Expect = 5e-08
 Identities = 31/126 (24%), Positives = 69/126 (54%), Gaps = 9/126 (7%)

Query: 24  VYIVYELMDTD-LHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 81
           + +V+E M+   L   +R+ + + + +        +  G+ Y+ S++V+HRDL   N L+
Sbjct: 74  ICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLV 133

Query: 82  NASCDLKIGDFGLARTTSETDFM----TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 137
             +  +K+ DFG+ R   +  +     T++ V +W  +PE + + ++Y++  D+WS G +
Sbjct: 134 GENQVVKVSDFGMTRFVLDDQYTSSTGTKFPV-KW-SSPE-VFSFSKYSSKSDVWSFGVL 190

Query: 138 LGEIMT 143
           + E+ +
Sbjct: 191 MWEVFS 196

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 52.5 bits (126), Expect = 5e-08
 Identities = 41/145 (28%), Positives = 64/145 (44%), Gaps = 23/145 (15%)

Query: 25  YIVYELMDT-DLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 81
           YI+ E M   +L   +R    Q++      Y   Q+   ++Y+   + +HRDL   N L+
Sbjct: 78  YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV 137

Query: 82  NASCDLKIGDFGLARTTSETDFMTEYVVT---------RWYRAPELLLNCTEYTAAIDIW 132
             +  +K+ DFGL+R       MT    T         +W  APE L     ++   D+W
Sbjct: 138 GENHLVKVADFGLSR------LMTGDTYTAHAGAKFPIKW-TAPESLAYNK-FSIKSDVW 189

Query: 133 SVGCILGEIMT--REPLFPGKDYVH 155
           + G +L EI T    P +PG D   
Sbjct: 190 AFGVLLWEIATYGMSP-YPGIDLSQ 213

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 52.6 bits (126), Expect = 5e-08
 Identities = 32/125 (25%), Positives = 65/125 (52%), Gaps = 3/125 (2%)

Query: 20  TFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 78
           T + ++ V E ++  DL   I+  ++  +   +++  ++   L ++H   +++RDLK  N
Sbjct: 67  TPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDN 126

Query: 79  LLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 137
           +LL+     K+ DFG+ +        T  +  T  Y APE+L     Y  ++D W++G +
Sbjct: 127 VLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQE-MLYGPSVDWWAMGVL 185

Query: 138 LGEIM 142
           L E++
Sbjct: 186 LYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 52.5 bits (126), Expect = 6e-08
 Identities = 28/92 (30%), Positives = 44/92 (47%), Gaps = 6/92 (6%)

Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM----TEYVVTR 111
           Q+  G+ Y+     +HRDL   N L+  +  +KI DFGL+R     D+      + +  R
Sbjct: 138 QVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIR 197

Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           W     +  N   YT   D+W+ G +L EI +
Sbjct: 198 WMPPESIFYN--RYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 52.5 bits (126), Expect = 6e-08
 Identities = 40/126 (31%), Positives = 62/126 (49%), Gaps = 17/126 (13%)

Query: 55  YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV----- 109
            Q+  G++Y+ S   +HRDL   N L+     +KI DFGL+R     D+   Y V     
Sbjct: 131 IQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADY---YRVQSKSL 187

Query: 110 --TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR--EPL--FPGKDYVHQLRLITEL 163
              RW   PE +L   ++T   DIWS G +L EI +   +P   F  ++ +  +R   +L
Sbjct: 188 LPVRWM-PPEAILY-GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR-SRQL 244

Query: 164 IGSPDD 169
           +  P+D
Sbjct: 245 LPCPED 250

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 52.3 bits (125), Expect = 7e-08
 Identities = 32/92 (34%), Positives = 50/92 (54%), Gaps = 6/92 (6%)

Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSETDFMTE--YVVTR 111
           Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E ++  E   V  +
Sbjct: 117 QIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIK 176

Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           W  A E +L+   YT   D+WS G  + E+MT
Sbjct: 177 WM-ALESILHRI-YTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 52.3 bits (125), Expect = 7e-08
 Identities = 48/181 (26%), Positives = 76/181 (41%), Gaps = 53/181 (29%)

Query: 20  TFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 75
           +F D   +Y +MD     D+  ++       +D  ++++ +L   ++ VH    +HRD+K
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIK 128

Query: 76  PSNLLLNASCDLKIGDFGLA---RTTSET--------------DFMTEY----------- 107
           P N+L++    +K+ DFGL    R T ++              DF  E+           
Sbjct: 129 PDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDR 188

Query: 108 --------------------VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL 147
                               V T  Y APE+LL  T YT   D WSVG IL E++  +P 
Sbjct: 189 LKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILYEMLVGQPP 247

Query: 148 F 148
           F
Sbjct: 248 F 248

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 51.9 bits (124), Expect = 9e-08
 Identities = 32/92 (34%), Positives = 52/92 (56%), Gaps = 6/92 (6%)

Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSETDFMTE--YVVTR 111
           Q+ +G+ Y+    ++HRDL   N+L+ +   +KI DFGLAR     ET++  +   V  +
Sbjct: 117 QIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK 176

Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           W  A E +L+   +T   D+WS G  + E+MT
Sbjct: 177 WM-ALESILH-RRFTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 52.0 bits (124), Expect = 1e-07
 Identities = 49/238 (20%), Positives = 105/238 (44%), Gaps = 37/238 (15%)

Query: 22  NDVYIVYEL-MDTDLHQII-RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 79
           N++Y+V +  +  DL  ++ + + +L +D  +++L +++  +  VH    +HRD+KP N+
Sbjct: 74  NNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNI 133

Query: 80  LLNASCDLKIGDFGLARTTSETDFMTEYVV--TRWYRAPELLLNCTE----YTAAIDIWS 133
           L++ +  +++ DFG      E   +   V   T  Y +PE+L    +    Y    D WS
Sbjct: 134 LMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWS 193

Query: 134 VGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ 193
           +G  + E++  E  F  +  V                            Y + +    + 
Sbjct: 194 LGVCMYEMLYGETPFYAESLVET--------------------------YGKIMNHKERF 227

Query: 194 QFATRFPNKSSGAVDLLEKMLVFDPNK--RITVEEALRHPYLQSLHDLNDEPVCPRPF 249
           QF  +  + S  A DL+ +++    ++  +  +E+  +HP+   + D ++   C  P+
Sbjct: 228 QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI-DWDNIRNCEAPY 284

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 51.6 bits (124), Expect = 1e-07
 Identities = 61/234 (26%), Positives = 99/234 (42%), Gaps = 57/234 (24%)

Query: 26  IVYELMDT-DLHQIIRSDQQLTDDHCQY--------FLY---QLLRGLKYVHSASVLHRD 73
           ++ E M+  DL+Q ++     T               LY   Q+  G++Y+ S + +HRD
Sbjct: 96  MIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRD 155

Query: 74  LKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV-------TRWYRAPELLLNCTEYT 126
           L   N L+  +  +KI DFG++R    +D+   Y V        RW     +LL   ++T
Sbjct: 156 LATRNCLVGKNYTIKIADFGMSRNLYSSDY---YRVQGRAPLPIRWMAWESVLL--GKFT 210

Query: 127 AAIDIWSVGCILGEIMT--REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV 184
              D+W+ G  L EI+T  RE  +   +++   ++I       ++A   F R D  + Y+
Sbjct: 211 TKSDVWAFGVTLWEILTLCREQPY---EHLTDQQVI-------ENAGHFF-RDDGRQIYL 259

Query: 185 RQLPRCRKQQFATRFPNKSSGAVDLLEKML---VFDPNKRITVEEALRHPYLQS 235
            + P C K               D+ E ML     D   R T  E   H +LQ 
Sbjct: 260 PRPPNCPK---------------DIYELMLECWRRDEEDRPTFREI--HLFLQR 296

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 51.2 bits (122), Expect = 1e-07
 Identities = 37/123 (30%), Positives = 61/123 (49%), Gaps = 8/123 (6%)

Query: 24  VYIVYELMDT-DLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 81
           +YIV EL+   D    +R++  +L        +     G++Y+ S   +HRDL   N L+
Sbjct: 68  IYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLV 127

Query: 82  NASCDLKIGDFGLARTTSETDFMT----EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 137
                LKI DFG++R   +  + +    + +  +W  APE  LN   Y++  D+WS G +
Sbjct: 128 TEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKW-TAPE-ALNYGRYSSESDVWSFGIL 185

Query: 138 LGE 140
           L E
Sbjct: 186 LWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 52.1 bits (125), Expect = 1e-07
 Identities = 34/103 (33%), Positives = 49/103 (47%), Gaps = 20/103 (19%)

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-------------------SE 100
            ++YVHS  VLHRDLKP N+LL    ++ I D+G A                      S 
Sbjct: 125 TIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184

Query: 101 TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
                + V T  Y APE LL     + + DI+++G IL +++T
Sbjct: 185 MTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 50.6 bits (121), Expect = 2e-07
 Identities = 33/158 (20%), Positives = 61/158 (38%), Gaps = 18/158 (11%)

Query: 1   MEHENVIAIKDI-IRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLL 58
            +H NV+ +  +              ++   M   DLH  +   +       +    Q L
Sbjct: 58  FDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSR--LGGLPEKLPLQTL 115

Query: 59  --------RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT 110
                    G++Y+ + + +HRDL   N +L     + + DFGL++     D+  +  + 
Sbjct: 116 LKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA 175

Query: 111 ----RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR 144
               +W     L      YT+  D+W+ G  + EI TR
Sbjct: 176 KMPVKWIAIESLADRV--YTSKSDVWAFGVTMWEIATR 211

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 50.8 bits (121), Expect = 3e-07
 Identities = 39/131 (29%), Positives = 67/131 (51%), Gaps = 7/131 (5%)

Query: 24  VYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 82
           +Y+V E M   DL  ++ S+  + +   +++  +++  L  +HS   +HRD+KP N+LL+
Sbjct: 118 LYMVMEYMPGGDLVNLM-SNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD 176

Query: 83  ASCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAPELLLNC---TEYTAAIDIWSVGCI 137
            S  LK+ DFG     ++   +     V T  Y +PE+L +      Y    D WSVG  
Sbjct: 177 KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 236

Query: 138 LGEIMTREPLF 148
           L E++  +  F
Sbjct: 237 LYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 50.6 bits (121), Expect = 3e-07
 Identities = 24/80 (30%), Positives = 47/80 (58%), Gaps = 1/80 (1%)

Query: 20  TFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 78
           + N+VY+V E L+  D+  ++       ++    ++ ++   L Y+H   ++HRDLKP N
Sbjct: 75  SANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDN 134

Query: 79  LLLNASCDLKIGDFGLARTT 98
           +L++    +K+ DFGL++ T
Sbjct: 135 MLISNEGHIKLTDFGLSKVT 154

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 50.0 bits (119), Expect = 4e-07
 Identities = 32/105 (30%), Positives = 49/105 (46%), Gaps = 3/105 (2%)

Query: 40  RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS 99
            +   L+     +F   + RG+ Y+     +HRDL   N+L+  +   KI DFGL+R   
Sbjct: 116 STASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE 175

Query: 100 ETDFMTE-YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
                T   +  RW       LN + YT   D+WS G +L EI++
Sbjct: 176 VYVKKTMGRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 49.7 bits (118), Expect = 4e-07
 Identities = 34/105 (32%), Positives = 53/105 (50%), Gaps = 16/105 (15%)

Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS--ETDFMTE--YVVTR 111
           Q+ +G+ Y+    ++HRDL   N+L+ +   +KI DFGLAR     E ++  +   +  +
Sbjct: 117 QIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK 176

Query: 112 WYRAPELLLNCTEY---TAAIDIWSVGCILGEIMTREPLFPGKDY 153
           W     + L C  Y   T   D+WS G  + E+MT    F GK Y
Sbjct: 177 W-----MALECIHYRKFTHQSDVWSYGVTIWELMT----FGGKPY 212

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 49.6 bits (118), Expect = 5e-07
 Identities = 34/119 (28%), Positives = 56/119 (47%), Gaps = 17/119 (14%)

Query: 43  QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD 102
            ++T  +    ++Q+  G+KY+   + +HRDL   N+LL      KI DFGL++     D
Sbjct: 90  DEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADD 149

Query: 103 FMTEYVVTR--------WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY 153
               Y   R        WY APE  +N  ++++  D+WS G  + E  +    +  K Y
Sbjct: 150 ---SYYKARSAGKWPLKWY-APE-CINFRKFSSRSDVWSYGITMWEAFS----YGQKPY 199

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 49.6 bits (118), Expect = 6e-07
 Identities = 38/145 (26%), Positives = 72/145 (49%), Gaps = 11/145 (7%)

Query: 21  FNDVYIVYELMD----TDLHQII-RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 75
           F D   +Y +MD     DL  ++ + + +L +D  ++++ +++  +  +H    +HRD+K
Sbjct: 70  FQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIK 129

Query: 76  PSNLLLNASCDLKIGDFG--LARTTSETDFMTEYVVTRWYRAPELLLNCTE----YTAAI 129
           P N+LL+ +  +++ DFG  L      T   +  V T  Y +PE+L    +    Y    
Sbjct: 130 PDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPEC 189

Query: 130 DIWSVGCILGEIMTREPLFPGKDYV 154
           D WS+G  + E++  E  F  +  V
Sbjct: 190 DWWSLGVCMYEMLYGETPFYAESLV 214

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 49.3 bits (117), Expect = 6e-07
 Identities = 31/98 (31%), Positives = 48/98 (48%), Gaps = 14/98 (14%)

Query: 56  QLLR-------GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY- 107
           QLL        G+ Y+     +HRDL   N+L+  +   KI DFGL+R   +  ++ +  
Sbjct: 113 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTM 170

Query: 108 --VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
             +  RW       LN + YT   D+WS G +L EI++
Sbjct: 171 GRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 49.2 bits (117), Expect = 7e-07
 Identities = 31/101 (30%), Positives = 50/101 (49%), Gaps = 11/101 (10%)

Query: 51  QYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE---- 106
           Q    ++  GL ++H  + +H DL   N LL A   +KIGD+GL+    + D+       
Sbjct: 103 QRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQL 162

Query: 107 YVVTRWYRAPELL------LNCTEYTAAIDIWSVGCILGEI 141
           +V  RW  APEL+      L   + T   ++WS+G  + E+
Sbjct: 163 WVPLRWI-APELVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 48.8 bits (116), Expect = 8e-07
 Identities = 39/147 (26%), Positives = 66/147 (44%), Gaps = 12/147 (8%)

Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTD-LHQIIRSDQ-QLTDDHCQYFLYQLLR 59
           +H N++ ++ +I        N + IV E M    L   +R  + QL        L  L  
Sbjct: 64  DHSNIVRLEGVI-----TRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLAS 118

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG-LARTTSETDF--MTEYVVTRWYRAP 116
           G+KY+     +H+ L    +L+N+    KI  F  L    SE  +  M+      W  AP
Sbjct: 119 GMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLW-AAP 177

Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMT 143
           E  +    +++A D+WS G ++ E+M+
Sbjct: 178 E-AIQYHHFSSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 48.7 bits (116), Expect = 8e-07
 Identities = 41/134 (30%), Positives = 60/134 (44%), Gaps = 17/134 (12%)

Query: 26  IVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQ-----LLRGLKYVHSASVLHRDLKPSNL 79
           +V E     DL   +RS++ +     Q  + Q     +  GL ++H A  +H DL   N 
Sbjct: 72  LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNC 131

Query: 80  LLNASCDLKIGDFGLARTTSETDFMT----EYVVTRWYRAPELL------LNCTEYTAAI 129
            L A   +KIGD+GLA      D+        V  RW  APEL+      L   + T   
Sbjct: 132 QLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWL-APELVEIRGQDLLPKDQTKKS 190

Query: 130 DIWSVGCILGEIMT 143
           +IWS+G  + E+ T
Sbjct: 191 NIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 49.2 bits (117), Expect = 9e-07
 Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 6/91 (6%)

Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM----TEYVVTR 111
           Q+  G+KY+ S + +HRDL   N L+  +  +KI DFG++R     D+        +  R
Sbjct: 146 QIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIR 205

Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIM 142
           W     +L+   ++T A D+W+ G  L EI+
Sbjct: 206 WMAWECILMG--KFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 49.0 bits (117), Expect = 9e-07
 Identities = 45/177 (25%), Positives = 74/177 (41%), Gaps = 49/177 (27%)

Query: 20  TFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 75
           +F D   +Y +MD     D+  ++       +D  ++++ +L   ++ VH    +HRD+K
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIK 128

Query: 76  PSNLLLNASCDLKIGDFGLA---RTTSETDFMTE-------------------------- 106
           P N+L++    +K+ DFGL    R T ++ +  +                          
Sbjct: 129 PDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPL 188

Query: 107 ---------------YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF 148
                           V T  Y APE+LL  T YT   D WSVG IL E++  +P F
Sbjct: 189 ERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILYEMLVGQPPF 244

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 48.8 bits (116), Expect = 1e-06
 Identities = 32/102 (31%), Positives = 50/102 (49%), Gaps = 7/102 (6%)

Query: 45  LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM 104
           LT      F   +  G++Y+     +HRDL   N+L+  +   KI DFGL+R   E  ++
Sbjct: 116 LTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR--GEEVYV 173

Query: 105 TEY---VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
            +    +  RW       LN + YT   D+WS G +L EI++
Sbjct: 174 KKTMGRLPVRWMAIES--LNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 48.6 bits (116), Expect = 1e-06
 Identities = 42/157 (26%), Positives = 68/157 (43%), Gaps = 24/157 (15%)

Query: 25  YIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR-------GLKYVHSASVLHRDLKP 76
           +I+ ELM   DL   +R ++   +      +  LL        G KY+     +HRD+  
Sbjct: 85  FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAA 144

Query: 77  SNLLLNASCD-----LKIGDFGLARTTSETDFMTE----YVVTRWYRAPELLLNCTEYTA 127
            N LL  +C       KI DFG+AR      +  +     +  +W   PE  L+   +T+
Sbjct: 145 RNCLL--TCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM-PPEAFLDGI-FTS 200

Query: 128 AIDIWSVGCILGEIMT--REPLFPGKDYVHQLRLITE 162
             D+WS G +L EI +    P +PG+     +  +T 
Sbjct: 201 KTDVWSFGVLLWEIFSLGYMP-YPGRTNQEVMEFVTG 236

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 47.9 bits (114), Expect = 1e-06
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 3/88 (3%)

Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRA 115
           +++  L  +H   ++ RDL P+N+LL+    +++  F   R +   D      V   Y A
Sbjct: 93  EMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFS--RWSEVEDSCDGEAVENMYCA 150

Query: 116 PELLLNCTEYTAAIDIWSVGCILGEIMT 143
           PE +   +E T A D WS+G IL E++T
Sbjct: 151 PE-VGGISEETEACDWWSLGAILFELLT 177

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 48.1 bits (114), Expect = 2e-06
 Identities = 28/92 (30%), Positives = 48/92 (52%), Gaps = 6/92 (6%)

Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM----TEYVVTR 111
           Q+  G++Y+ S   +H+DL   N+L+     +KI D GL+R     D+        +  R
Sbjct: 132 QIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIR 191

Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           W   PE ++   ++++  DIWS G +L EI +
Sbjct: 192 WM-PPEAIMY-GKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 47.9 bits (114), Expect = 2e-06
 Identities = 33/131 (25%), Positives = 61/131 (46%), Gaps = 16/131 (12%)

Query: 26  IVYELMDT-DLHQIIRSDQQLTDD----HCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
           +V+E  +  DL   +  +Q    +      Q    ++  G+ ++H  + LH DL   N  
Sbjct: 72  LVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCF 131

Query: 81  LNASCDLKIGDFGLARTTSETDFMT----EYVVTRWYRAPELL------LNCTEYTAAID 130
           L +   +K+GD+G+  +  + D++     + V  RW  APEL+      L   E T   +
Sbjct: 132 LTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWL-APELVGEFHGGLITAEQTKPSN 190

Query: 131 IWSVGCILGEI 141
           +W++G  L E+
Sbjct: 191 VWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 47.2 bits (112), Expect = 4e-06
 Identities = 50/218 (22%), Positives = 83/218 (38%), Gaps = 56/218 (25%)

Query: 20  TFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 75
           +F D   +Y +M+     DL  ++      ++D  ++++ + +  ++ VH    +HRD+K
Sbjct: 69  SFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIK 128

Query: 76  PSNLLLNASCDLKIGDFGLAR-------------------------------------TT 98
           P N+L++    +K+ DFGL+                                      T 
Sbjct: 129 PDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTM 188

Query: 99  SETDFMTEY-----------VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL 147
           S  D +  +           V T  Y APE+ L    Y    D WS+G I+ E +   P 
Sbjct: 189 SSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLGAIMFECLIGWPP 247

Query: 148 FPGKDYVHQLRLIT---ELIGSPDDASLGFLRSDNARR 182
           F  ++     R I    E +  PDD  L     D  RR
Sbjct: 248 FCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRR 285

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 47.0 bits (112), Expect = 4e-06
 Identities = 37/156 (23%), Positives = 62/156 (39%), Gaps = 35/156 (22%)

Query: 1   MEHENVIAIKDIIRPPKKDTF---NDVYIVYELMDTDLHQIIRSDQQLTDDHC------- 50
           ++H N++        P   +F   +++Y+V  LM         S + L   H        
Sbjct: 56  LQHPNIL--------PYVTSFIVDSELYVVSPLMAYG------SCEDLLKTHFPEGLPEL 101

Query: 51  --QYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA--------RTTSE 100
              + L  +L  L Y+HS   +HR +K S++LL+    + +     +        R    
Sbjct: 102 AIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161

Query: 101 TDFMTEYVVTRWYRAPELL-LNCTEYTAAIDIWSVG 135
            DF    V    + +PE+L  N   Y    DI+SVG
Sbjct: 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVG 197

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 45.8 bits (108), Expect = 9e-06
 Identities = 33/122 (27%), Positives = 63/122 (51%), Gaps = 11/122 (9%)

Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM----TEYVVTR 111
           Q+  G++++ S  V+H+DL   N+L+    ++KI D GL R     D+        +  R
Sbjct: 132 QIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIR 191

Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR--EPL--FPGKDYVHQLRLITELIGSP 167
           W  +PE ++   +++   DIWS G +L E+ +   +P   +  +D +  +R   +++  P
Sbjct: 192 WM-SPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR-NRQVLPCP 248

Query: 168 DD 169
           DD
Sbjct: 249 DD 250

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 19/42 (45%), Positives = 28/42 (66%)

Query: 54  LYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA 95
           + Q+L GL+ +H   ++HRD+KP NLL+     +KI DFG A
Sbjct: 315 MRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356

Length = 507

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 45.8 bits (108), Expect = 1e-05
 Identities = 42/181 (23%), Positives = 69/181 (38%), Gaps = 53/181 (29%)

Query: 20  TFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 75
           +F D   +Y +MD     D+  ++   +   +   ++++ +L   ++ VH    +HRD+K
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIK 128

Query: 76  PSNLLLNASCDLKIGDFGL----------------------------------------- 94
           P N+L++    +K+ DFGL                                         
Sbjct: 129 PDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDR 188

Query: 95  -------ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL 147
                  A    +       V T  Y APE+LL    YT   D WSVG IL E++  +P 
Sbjct: 189 LKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLCDWWSVGVILFEMLVGQPP 247

Query: 148 F 148
           F
Sbjct: 248 F 248

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 44.6 bits (105), Expect = 3e-05
 Identities = 27/92 (29%), Positives = 47/92 (51%), Gaps = 6/92 (6%)

Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVT-R 111
           Q+ +G+ Y+    ++HR+L   N+LL +   ++I DFG+A      D   F +E+    +
Sbjct: 117 QIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK 176

Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           W     +L     YT   D+WS G  + E+M+
Sbjct: 177 WMALESILFG--RYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 43.2 bits (102), Expect = 8e-05
 Identities = 39/139 (28%), Positives = 69/139 (49%), Gaps = 11/139 (7%)

Query: 21  FNDVYIVYELMD----TDLHQII-RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 75
           F D   +Y +MD     DL  ++ + + +L +D  +++L +++  +  VH    +HRD+K
Sbjct: 70  FQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIK 129

Query: 76  PSNLLLNASCDLKIGDFG--LARTTSETDFMTEYVVTRWYRAPELLLNCTE----YTAAI 129
           P N+LL+ +  +++ DFG  L      T      V T  Y +PE+L    +    Y    
Sbjct: 130 PDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPEC 189

Query: 130 DIWSVGCILGEIMTREPLF 148
           D WS+G  + E++  E  F
Sbjct: 190 DWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 43.2 bits (102), Expect = 8e-05
 Identities = 55/231 (23%), Positives = 85/231 (36%), Gaps = 81/231 (35%)

Query: 51  QYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN-ASCDLKIGDFGLARTTSETDFMT---- 105
           Q  + Q+L  L  +HS  ++HRD+KP N++ +  S   KI D G A      D       
Sbjct: 258 QTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA-----ADLRVGINY 312

Query: 106 ---EYVVTRWYRAPELLLNCTEYTAA---------------------IDIWSVGCILGEI 141
              E+++   Y APE  +  T+  +A                      DI+S G I  ++
Sbjct: 313 IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQM 372

Query: 142 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR-RYVRQLPRCRKQQFATR-- 198
                 FP                         LRSD+   ++ RQL R      A R  
Sbjct: 373 A-----FPN------------------------LRSDSNLIQFNRQLKRNDYDLVAWRKL 403

Query: 199 FPNKSSGAV---------------DLLEKMLVFDPNKRITVEEALRHPYLQ 234
              ++S  +               +LL+ M+ F   +RI+ + AL HPY  
Sbjct: 404 VEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFD 454

Length = 566

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score = 39.1 bits (92), Expect = 0.001
 Identities = 12/26 (46%), Positives = 15/26 (57%)

Query: 206 AVDLLEKMLVFDPNKRITVEEALRHP 231
             DL+ KML  DP KR + +E L H 
Sbjct: 190 LKDLIRKMLQKDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	280
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
PLN00181	793	protein SPA1-RELATED; Provisional	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.98
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.98
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.97
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.97
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.97
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.97
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.96
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.96
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.96
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.96
KOG3653	534	consensus Transforming growth factor beta/activin	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.95
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.94
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.94
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.94
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.94
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.93
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.91
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.9
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.89
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.88
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.87
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.87
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.85
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.85
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.85
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.84
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.83
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.83
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.74
PRK12274	218	serine/threonine protein kinase; Provisional	99.73
PRK09188	365	serine/threonine protein kinase; Provisional	99.72
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.71
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.71
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.68
PRK10345	210	hypothetical protein; Provisional	99.67
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.65
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.59
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.54
KOG1243	690	consensus Protein kinase [General function predict	99.53
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.49
PRK14879	211	serine/threonine protein kinase; Provisional	99.47
smart00090	237	RIO RIO-like kinase.	99.47
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.43
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.43
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.42
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.3
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.27
COG4248	637	Uncharacterized protein with protein kinase and he	99.25
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.18
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.17
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.15
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.11
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.1
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.08
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.05
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.05
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	98.91
KOG3087	229	consensus Serine/threonine protein kinase [General	98.88
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	98.86
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	98.8
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.76
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.76
PRK09902	216	hypothetical protein; Provisional	98.73
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.43
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.36
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.22
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.94
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.91
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.89
COG0661	517	AarF Predicted unusual protein kinase [General fun	97.7
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.61
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.27
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.21
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	97.17
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.12
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.85
PLN02876	822	acyl-CoA dehydrogenase	96.35
KOG2268	465	consensus Serine/threonine protein kinase [Signal	95.91
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	95.52
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	95.36
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	95.35
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	95.31
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	95.31
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	95.31
PRK05231	319	homoserine kinase; Provisional	95.08
PRK10271	188	thiK thiamine kinase; Provisional	94.87
PF01636	239	APH: Phosphotransferase enzyme family This family	94.84
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	94.79
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	94.36
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	94.28
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	94.05
PLN02236	344	choline kinase	93.83
smart00587	196	CHK ZnF_C4 abd HLH domain containing kinases domai	93.79
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	93.34
COG2334	331	Putative homoserine kinase type II (protein kinase	92.56
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	92.45
KOG2270	520	consensus Serine/threonine protein kinase involved	92.37
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	91.67
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	91.03
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	90.68
PRK11768	325	serine/threonine protein kinase; Provisional	90.42
PRK06148	1013	hypothetical protein; Provisional	90.01
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	89.76
PRK06149	972	hypothetical protein; Provisional	89.07
COG4499	434	Predicted membrane protein [Function unknown]	88.96
PHA03111	444	Ser/Thr kinase; Provisional	88.57
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	88.46
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	87.8
PRK14559	645	putative protein serine/threonine phosphatase; Pro	87.34

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-64  Score=406.46  Aligned_cols=275  Identities=67%  Similarity=1.149  Sum_probs=259.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      |+|+||+.+++++..+..+.++++|+|+|+|+.+|.++|++++.++++.++.+++|+++||+|+|++||+||||||.|++
T Consensus        78 ~~HeNIi~l~di~~p~~~~~f~DvYiV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll  157 (359)
T KOG0660|consen   78 LRHENIIGLLDIFRPPSRDKFNDVYLVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLL  157 (359)
T ss_pred             hcCCCcceEEeecccccccccceeEEehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhhee
Confidence            68999999999999977778899999999999999999999888999999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccccCC---CCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023568           81 LNASCDLKIGDFGLARTTSE---TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  157 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~  157 (280)
                      ++.+..+|++|||+|+....   ...++.+..|.+|.|||++.+...|+.+.||||+|||+.||++|++.|+|.+...++
T Consensus       158 ~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql  237 (359)
T KOG0660|consen  158 LNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQL  237 (359)
T ss_pred             eccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHH
Confidence            99999999999999998753   455678899999999999998899999999999999999999999999999999999


Q ss_pred             HHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCc
Q 023568          158 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  237 (280)
Q Consensus       158 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~  237 (280)
                      ..|...+|+|+++.........+..++++++...+.++...++..++.+.+|+++||..||.+|+|++|+|+|||+..++
T Consensus       238 ~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~h  317 (359)
T KOG0660|consen  238 QLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYH  317 (359)
T ss_pred             HHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCCCCCccCCCCCCHHHHHHHHHHHHHhhCCC
Q 023568          238 DLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPD  277 (280)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (280)
                      +++.||.+...+.. ++.. .+.+.||+++++|+.+|+|.
T Consensus       318 dp~dEP~~~~~~~~-~~~~-~~~~~~r~~i~~e~~~~~~~  355 (359)
T KOG0660|consen  318 DPEDEPVCQPIFDS-FEHE-LTEEELRELIYKEILDFHPD  355 (359)
T ss_pred             CCccCCCCCCCCcc-cccc-ccHHHHHHHHHHHHHhhCcc
Confidence            99999977766554 4444 89999999999999999986

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-53  Score=357.92  Aligned_cols=232  Identities=38%  Similarity=0.730  Sum_probs=209.6

Q ss_pred             CC-CcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 ME-HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~-Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      |+ |||||+|++++.+..    ..+|+|||||+.+|+++|+.+ +.|++.+++.|++||+.||+|+|++|+.|||+||+|
T Consensus        65 ln~hpniikL~Evi~d~~----~~L~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPEN  140 (538)
T KOG0661|consen   65 LNPHPNIIKLKEVIRDND----RILYFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPEN  140 (538)
T ss_pred             cCCCCcchhhHHHhhccC----ceEeeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhh
Confidence            45 999999999999882    289999999999999999765 569999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      ||+..+..+||+|||+|+...+....+.++.|.||.|||++...+.|+.+.|+|++|||++|+.+-++.|+|.+..+++.
T Consensus       141 iLi~~~~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~  220 (538)
T KOG0661|consen  141 ILISGNDVIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIY  220 (538)
T ss_pred             eEecccceeEecccccccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHH
Confidence            99998889999999999998888888999999999999999988999999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  237 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~  237 (280)
                      +|.+++|+|....+... ..-....--.++......+....+..+.++.++|.+||.+||.+||||+|+|+||||+.-.
T Consensus       221 KIc~VLGtP~~~~~~eg-~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~  298 (538)
T KOG0661|consen  221 KICEVLGTPDKDSWPEG-YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR  298 (538)
T ss_pred             HHHHHhCCCccccchhH-HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence            99999999998876542 1222333345677777778888888999999999999999999999999999999997643

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.1e-52  Score=342.41  Aligned_cols=273  Identities=32%  Similarity=0.600  Sum_probs=226.4

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP   76 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~   76 (280)
                      ++|||||++.-+|......+.-.+.+|||||+.+|.++++.    +.+++.-.++.+++||++||+|||+.|||||||||
T Consensus        74 l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKP  153 (364)
T KOG0658|consen   74 LDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKP  153 (364)
T ss_pred             cCCcCeeeEEEEEEecCCCchhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCCh
Confidence            58999999999999775432347789999999999999974    57899999999999999999999999999999999


Q ss_pred             CceEEcCC-CCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023568           77 SNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH  155 (280)
Q Consensus        77 ~Nili~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~  155 (280)
                      .|+|+|.+ |.+||||||.|+....++...++..|.+|.|||.+.|...|+.+.||||.||++.||+.|++.|+|.+..+
T Consensus       154 qNlLvD~~tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~d  233 (364)
T KOG0658|consen  154 QNLLVDPDTGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVD  233 (364)
T ss_pred             heEEEcCCCCeEEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHH
Confidence            99999985 99999999999998888777889999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccc-cCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 023568          156 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFAT-RFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ  234 (280)
Q Consensus       156 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~  234 (280)
                      ++..|.+++|.|..+.....+....+   ...+......+.. .....++++.+|+.++|+.+|.+|.++.|++.||||.
T Consensus       234 QL~eIik~lG~Pt~e~I~~mn~~y~~---~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFd  310 (364)
T KOG0658|consen  234 QLVEIIKVLGTPTREDIKSMNPNYTE---FKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFD  310 (364)
T ss_pred             HHHHHHHHhCCCCHHHHhhcCccccc---ccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhH
Confidence            99999999999999887766544321   1223333333333 4567899999999999999999999999999999999


Q ss_pred             cCcCCCCC----CCCCCCCCCccCCCCCCHHHHHHHHHHHHHhhCC
Q 023568          235 SLHDLNDE----PVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP  276 (280)
Q Consensus       235 ~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (280)
                      .+++++..    ...|..|++.......+.+-+...+..+...+..
T Consensus       311 elr~~~~~l~~g~~lp~lf~f~~~e~~~~~~~~~~l~p~~~~~~~~  356 (364)
T KOG0658|consen  311 ELRDPNTKLPNGRPLPPLFNFKRAELGISPELVNVLIPEHLREQEK  356 (364)
T ss_pred             HhhCcCccCcCCCcCCCccCchHHHhccchHHHHhhccHhhhhhcc
Confidence            99877432    1234444444445556666666666665555443

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.1e-52  Score=334.11  Aligned_cols=233  Identities=34%  Similarity=0.671  Sum_probs=204.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+|||+|.++++|...     ..++||+|||+.++.+.+... ..++.+.++.+++|++.|+.|+|+++++||||||+||
T Consensus        58 LkH~NLVnLiEVFrrk-----rklhLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENI  132 (396)
T KOG0593|consen   58 LKHENLVNLIEVFRRK-----RKLHLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENI  132 (396)
T ss_pred             cccchHHHHHHHHHhc-----ceeEEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhhe
Confidence            6899999999999987     569999999999888888654 5699999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccC-CCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      |++.+|.+||||||+|+... +++..+.+..|.||.|||.+.|...|+..+||||+||++.||++|.+.|++.++.+++.
T Consensus       133 Lit~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy  212 (396)
T KOG0593|consen  133 LITQNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLY  212 (396)
T ss_pred             EEecCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHH
Confidence            99999999999999999866 66778889999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCcC
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  238 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~~  238 (280)
                      .|.+.+|...+.....+.......-++-.......+.+..+|.++.-+.+|+++||+.||.+|++.+|+|.||||.++.+
T Consensus       213 ~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~e  292 (396)
T KOG0593|consen  213 LIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIE  292 (396)
T ss_pred             HHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHH
Confidence            99999998877755444433332222222333444566778899999999999999999999999999999999977653

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.8e-53  Score=349.80  Aligned_cols=205  Identities=35%  Similarity=0.600  Sum_probs=177.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+|||||+++++|+.+     ...|+||||++ |+|.+.+-.++.+.+...+.+++|++.||.|||++||+||||||+||
T Consensus       233 L~HP~IV~~~d~f~~~-----ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNI  307 (475)
T KOG0615|consen  233 LSHPNIVRIKDFFEVP-----DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENI  307 (475)
T ss_pred             cCCCCEEEEeeeeecC-----CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceE
Confidence            6899999999999998     66899999997 59999999889999999999999999999999999999999999999


Q ss_pred             EEcCC---CCeEEeecccccccCCCCccccceeccccccccccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023568           80 LLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC--TEYTAAIDIWSVGCILGEIMTREPLFPGKDYV  154 (280)
Q Consensus        80 li~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~  154 (280)
                      |++.+   ..+|++|||+|+..+....+.+.|||+.|.|||++.+.  ..+..++|+||+||++|-+|+|.+||......
T Consensus       308 Ll~~~~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~  387 (475)
T KOG0615|consen  308 LLSNDAEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD  387 (475)
T ss_pred             EeccCCcceEEEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC
Confidence            99776   67999999999999999999999999999999999763  23445899999999999999999999886533


Q ss_pred             H-HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          155 H-QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       155 ~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      . ..++|.+.                           +-.-.+..+..++..+++||.+||..||++|||++|+|+||||
T Consensus       388 ~sl~eQI~~G---------------------------~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~  440 (475)
T KOG0615|consen  388 PSLKEQILKG---------------------------RYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWF  440 (475)
T ss_pred             ccHHHHHhcC---------------------------cccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhh
Confidence            3 44444331                           1111233445789999999999999999999999999999999


Q ss_pred             ccCc
Q 023568          234 QSLH  237 (280)
Q Consensus       234 ~~~~  237 (280)
                      +...
T Consensus       441 ~~~~  444 (475)
T KOG0615|consen  441 KDAP  444 (475)
T ss_pred             hccc
Confidence            8653

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.4e-52  Score=355.88  Aligned_cols=200  Identities=34%  Similarity=0.578  Sum_probs=183.0

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+|||||+++++|++.     +++|||.|+|. ++|..+++.++.++|.+++++++||+.||.|||+.+|+|||||..|+
T Consensus        75 L~HpnIV~f~~~FEDs-----~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNl  149 (592)
T KOG0575|consen   75 LKHPNIVQFYHFFEDS-----NNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNL  149 (592)
T ss_pred             cCCCcEEeeeeEeecC-----CceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhhe
Confidence            7899999999999999     88999999998 79999999889999999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++++.++||+|||+|.....+ +...+.+||++|.|||++.. ...+..+||||+||++|.||.|++||..++-.+.+.
T Consensus       150 fL~~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~  228 (592)
T KOG0575|consen  150 FLNENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYN  228 (592)
T ss_pred             eecCcCcEEecccceeeeecCcccccceecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHH
Confidence            9999999999999999987644 67789999999999999986 899999999999999999999999999998888888


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  237 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~  237 (280)
                      +|...                               -...+..++..+++||.+||..||.+|||++++|.|+||++-.
T Consensus       229 ~Ik~~-------------------------------~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~  276 (592)
T KOG0575|consen  229 KIKLN-------------------------------EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGF  276 (592)
T ss_pred             HHHhc-------------------------------CcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCC
Confidence            77651                               1122336899999999999999999999999999999995543

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.7e-50  Score=316.14  Aligned_cols=232  Identities=40%  Similarity=0.721  Sum_probs=204.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+||||+.+.++|...     ..+.||+|||+.+|..+++.. ..++..+++.++.|+++||+|||+++|+||||||.|+
T Consensus        58 l~h~nIi~LiD~F~~~-----~~l~lVfEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNL  132 (318)
T KOG0659|consen   58 LKHPNIIELIDVFPHK-----SNLSLVFEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNL  132 (318)
T ss_pred             ccCcchhhhhhhccCC-----CceEEEEEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccce
Confidence            6899999999999988     669999999999999999864 5699999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCc-cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDF-MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      |++.+|.+|++|||+++..+.... ......|.+|.|||.+.|...|+..+|+||.||++.||+.|.+.|+|.++.+++.
T Consensus       133 Lis~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~  212 (318)
T KOG0659|consen  133 LISSDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLS  212 (318)
T ss_pred             EEcCCCcEEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHH
Confidence            999999999999999998776533 3445789999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCcccccccCC-hhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCc
Q 023568          159 LITELIGSPDDASLGFLRS-DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  237 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~  237 (280)
                      .|...+|+|.+..|+.+.. +...++.    ..........++..+.++.+|+.+||..||.+|+|+.|+|+|+||++.-
T Consensus       213 ~If~~LGTP~~~~WP~~~~lpdY~~~~----~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P  288 (318)
T KOG0659|consen  213 KIFRALGTPTPDQWPEMTSLPDYVKIQ----QFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLP  288 (318)
T ss_pred             HHHHHcCCCCcccCccccccccHHHHh----cCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCC
Confidence            9999999999999887754 3333222    2233334447888999999999999999999999999999999999854


Q ss_pred             CCCC
Q 023568          238 DLND  241 (280)
Q Consensus       238 ~~~~  241 (280)
                      .+..
T Consensus       289 ~pt~  292 (318)
T KOG0659|consen  289 LPTP  292 (318)
T ss_pred             CCCC
Confidence            4433

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-51  Score=334.46  Aligned_cols=204  Identities=26%  Similarity=0.472  Sum_probs=177.3

Q ss_pred             CCcccccccccccCCCCCCCC-cEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCc
Q 023568            2 EHENVIAIKDIIRPPKKDTFN-DVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSN   78 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~-~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~-~~i~H~dik~~N   78 (280)
                      +|||||++|++|..+     + .++|+||||+ |+|.++++..++++|.....++.+|++||.|||+ .+|+||||||+|
T Consensus       135 ~spyIV~~ygaF~~~-----~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsN  209 (364)
T KOG0581|consen  135 QSPYIVGFYGAFYSN-----GEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSN  209 (364)
T ss_pred             CCCCeeeEeEEEEeC-----CceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHH
Confidence            699999999999988     6 4999999998 5999999888999999999999999999999995 899999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC--ChHHH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK--DYVHQ  156 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~--~~~~~  156 (280)
                      ||++..|.+||||||.++...+. ...++.||..|||||.+.+ ..|+.++||||||+.++|+.+|+.||...  .....
T Consensus       210 lLvNskGeVKicDFGVS~~lvnS-~a~tfvGT~~YMsPERi~g-~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~  287 (364)
T KOG0581|consen  210 LLVNSKGEVKICDFGVSGILVNS-IANTFVGTSAYMSPERISG-ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDI  287 (364)
T ss_pred             eeeccCCCEEeccccccHHhhhh-hcccccccccccChhhhcC-CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCH
Confidence            99999999999999999887665 5788999999999999998 89999999999999999999999999885  22333


Q ss_pred             HHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCC-CCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 023568          157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP-NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  235 (280)
Q Consensus       157 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~  235 (280)
                      ...+..+...+++.                           .+. ..|+++++|+..||++||.+|||++|+++|||++.
T Consensus       288 ~~Ll~~Iv~~ppP~---------------------------lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~  340 (364)
T KOG0581|consen  288 FELLCAIVDEPPPR---------------------------LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKK  340 (364)
T ss_pred             HHHHHHHhcCCCCC---------------------------CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhh
Confidence            33333333333322                           222 37999999999999999999999999999999987


Q ss_pred             CcCC
Q 023568          236 LHDL  239 (280)
Q Consensus       236 ~~~~  239 (280)
                      ..+.
T Consensus       341 ~~~~  344 (364)
T KOG0581|consen  341 FEDP  344 (364)
T ss_pred             cccc
Confidence            6543

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.4e-50  Score=323.69  Aligned_cols=233  Identities=40%  Similarity=0.693  Sum_probs=203.4

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      .+|||||.+.++......   +.+|+|||||+.+|..+|..- .+|.+.+++.++.|++.|++|||.++|+|||||++|+
T Consensus       132 ~~H~NIV~vkEVVvG~~~---d~iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNL  208 (419)
T KOG0663|consen  132 ARHPNIVEVKEVVVGSNM---DKIYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNL  208 (419)
T ss_pred             cCCCCeeeeEEEEecccc---ceeeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhhe
Confidence            479999999999987754   679999999999999999764 4899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      |++..|.+|++|||+|+.+++. ..++....|.||.|||.+.+...|+.++|+||+|||+.||+++.+.|++....+++.
T Consensus       209 Lm~~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~  288 (419)
T KOG0663|consen  209 LLSHKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLD  288 (419)
T ss_pred             eeccCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHH
Confidence            9999999999999999988776 556778889999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCC--CCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN--KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  236 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~  236 (280)
                      +|...+|.|.+..|+.+......+... .+..........|+.  ++....+|+..+|..||.+|.||+|.|+|+||...
T Consensus       289 ~If~llGtPte~iwpg~~~lp~~k~~~-f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~  367 (419)
T KOG0663|consen  289 KIFKLLGTPSEAIWPGYSELPAVKKMT-FSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET  367 (419)
T ss_pred             HHHHHhCCCccccCCCccccchhhccc-cCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence            999999999999988876544333211 112222223333443  56999999999999999999999999999999874


Q ss_pred             c
Q 023568          237 H  237 (280)
Q Consensus       237 ~  237 (280)
                      -
T Consensus       368 P  368 (419)
T KOG0663|consen  368 P  368 (419)
T ss_pred             C
Confidence            3

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.3e-50  Score=339.07  Aligned_cols=230  Identities=40%  Similarity=0.691  Sum_probs=200.1

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+|||||+|.+...+...   ..+|||+|||+.+|.-++.. .-+|++.+++.+++||+.||.|+|++||+|||||.+||
T Consensus       173 l~HpNIikL~eivt~~~~---~siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNi  249 (560)
T KOG0600|consen  173 LDHPNIIKLEEIVTSKLS---GSIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNI  249 (560)
T ss_pred             cCCCcccceeeEEEecCC---ceEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccce
Confidence            689999999999987733   67999999999999999976 45899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC--CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSET--DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  157 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~  157 (280)
                      |||.+|.+||+|||+|+++...  ...+..+.|+||.|||.+.|...|+.++|+||.|||+.||++|++.|++....+++
T Consensus       250 Lidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl  329 (560)
T KOG0600|consen  250 LIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQL  329 (560)
T ss_pred             EEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHH
Confidence            9999999999999999976554  34677788999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 023568          158 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  235 (280)
Q Consensus       158 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~  235 (280)
                      ..|.+++|.|.+..|....-+....+.  ....-+..+.+.+...+..+.+|+..||..||.+|.||.++|.++||..
T Consensus       330 ~kIfklcGSP~e~~W~~~kLP~~~~~k--p~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t  405 (560)
T KOG0600|consen  330 HKIFKLCGSPTEDYWPVSKLPHATIFK--PQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT  405 (560)
T ss_pred             HHHHHHhCCCChhccccccCCcccccC--CCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence            999999999999998733333211111  1111123345557789999999999999999999999999999999943

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-50  Score=323.62  Aligned_cols=273  Identities=44%  Similarity=0.787  Sum_probs=231.9

Q ss_pred             CCCcccccccccccCCC-CCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPK-KDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~-~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++|+||++++.+|...+ ...+..+|+|||+|+.+|.+++.  -.++..++.++++|++.|++|||+.||+||||||+||
T Consensus        72 v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsni  149 (369)
T KOG0665|consen   72 VNHKNIISLLNVFTPQKTLEEFQEVYLVMELMDANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNI  149 (369)
T ss_pred             hcccceeeeeeccCccccHHHHHhHHHHHHhhhhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccc
Confidence            58999999999998764 35557899999999999999996  5789999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      ++..++.+|+.|||+++..+..-.++.+..+.+|.|||++.+ ..+...+||||+||++.||++|...|+|.+..+++.+
T Consensus       150 vv~~~~~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~-~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~k  228 (369)
T KOG0665|consen  150 VVNSDCTLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNK  228 (369)
T ss_pred             eecchhheeeccchhhcccCcccccCchhheeeccCchheec-cCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHH
Confidence            999999999999999988776645677889999999999999 4499999999999999999999999999999999999


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCC------------CCHHHHHHHHHhcccCCCCCCCHHHH
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEA  227 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~ll~~~L~~dp~~Rpt~~el  227 (280)
                      +.+.+|+|.+.+...+ .+.+..+++..+++....+.+.+|+            .+..+++++.+||..||++|.|++++
T Consensus       229 i~~~lgtpd~~F~~qL-~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~da  307 (369)
T KOG0665|consen  229 IIEQLGTPDPSFMKQL-QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDA  307 (369)
T ss_pred             HHHHhcCCCHHHHHHh-hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHH
Confidence            9999999999887655 3445666666666655555555443            35678999999999999999999999


Q ss_pred             hcCcccccCcCCCCCCCCCC-CCCCccCCCCCCHHHHHHHHHHHHHhhCCC
Q 023568          228 LRHPYLQSLHDLNDEPVCPR-PFHFDFEHSSCTEDHIRELIWRESVKFNPD  277 (280)
Q Consensus       228 l~hp~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (280)
                      |+|||++.|-+.......++ +.+-.++....+.++|+++|++|+++|.++
T Consensus       308 L~HPY~~vw~~~~ev~ap~pe~~d~~~d~~~~t~~e~ke~If~ev~~f~~~  358 (369)
T KOG0665|consen  308 LRHPYIKVWYDPDEVEAPPPEIYDKQLDEREHTIEEWKELIFKEVQRFEEF  358 (369)
T ss_pred             hcCCeeeeecccccccCCCCchhhhhcccccCCHHHHHHHHHHHHHhhccc
Confidence            99999997755443322222 233345566677999999999999999985

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.7e-48  Score=334.88  Aligned_cols=276  Identities=49%  Similarity=0.949  Sum_probs=226.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      |+||||+++++++.......+..+|+||||++++|.+++.....+++..+..++.|++.||.|||+.||+||||||+||+
T Consensus        56 l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl  135 (338)
T cd07859          56 LRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNIL  135 (338)
T ss_pred             CCCCCEeeecceEeccCCCCCceEEEEEecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeE
Confidence            58999999999987664444467999999999999999988888999999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccccCCC----CccccceeccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023568           81 LNASCDLKIGDFGLARTTSET----DFMTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH  155 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~  155 (280)
                      ++.++.++|+|||+++.....    .......+++.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+...
T Consensus       136 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~  215 (338)
T cd07859         136 ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH  215 (338)
T ss_pred             ECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH
Confidence            999999999999998754322    112345789999999987642 567889999999999999999999999998888


Q ss_pred             HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 023568          156 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  235 (280)
Q Consensus       156 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~  235 (280)
                      .+..+....+.++..............+...+...........++..++.+.+++.+||+.||++|||++|+++||||+.
T Consensus       216 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~  295 (338)
T cd07859         216 QLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKG  295 (338)
T ss_pred             HHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhh
Confidence            88888888888877765555444444555555444444455566778999999999999999999999999999999998


Q ss_pred             CcCCCCCCCCCC--CCCCccCCCCCCHHHHHHHHHHHHHhhCC
Q 023568          236 LHDLNDEPVCPR--PFHFDFEHSSCTEDHIRELIWRESVKFNP  276 (280)
Q Consensus       236 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (280)
                      +......+....  ...+.++....+.+.+++.+.++...++|
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (338)
T cd07859         296 LAKVEREPSAQPITKLEFEFERRRLTKEDVRELIYREILEYHP  338 (338)
T ss_pred             cCccccccccCccccccccHHHHhcCHHHHHHHHHHHHHhcCC
Confidence            876554333222  22345567789999999999999998886

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6e-49  Score=340.73  Aligned_cols=206  Identities=32%  Similarity=0.514  Sum_probs=189.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      +.||||++++++++..     .++|+|.||+. |.|++++..++++++.+++.+++||+.|+.|+|..+||||||||+|+
T Consensus        69 i~HpnVl~LydVwe~~-----~~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENl  143 (786)
T KOG0588|consen   69 IEHPNVLRLYDVWENK-----QHLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENL  143 (786)
T ss_pred             hcCCCeeeeeeeeccC-----ceEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhh
Confidence            5799999999999988     78999999997 69999999999999999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      |+|..+++||+|||+|....++....+.||++.|++||++.|..+.+.++||||+|||+|.||+|+.||++.+....+.+
T Consensus       144 LLd~~~nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlK  223 (786)
T KOG0588|consen  144 LLDVKNNIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLK  223 (786)
T ss_pred             hhhcccCEeeeccceeecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHH
Confidence            99999999999999999999999999999999999999999988999999999999999999999999998886666666


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCcCC
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL  239 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~~~  239 (280)
                      +..                               ...+.+..+++++++||++||..||++|+|.+|+++|||+......
T Consensus       224 V~~-------------------------------G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~  272 (786)
T KOG0588|consen  224 VQR-------------------------------GVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSL  272 (786)
T ss_pred             HHc-------------------------------CcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCC
Confidence            543                               2334455789999999999999999999999999999999988766


Q ss_pred             CCC
Q 023568          240 NDE  242 (280)
Q Consensus       240 ~~~  242 (280)
                      ...
T Consensus       273 ~~~  275 (786)
T KOG0588|consen  273 PSS  275 (786)
T ss_pred             Chh
Confidence            554

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.8e-47  Score=328.51  Aligned_cols=276  Identities=74%  Similarity=1.267  Sum_probs=241.4

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      ++||||+++++++.......+.++|+||||++++|.+++.+.+.+++..+..++.|++.||.|||+.|++||||+|+||+
T Consensus        61 l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil  140 (337)
T cd07858          61 LDHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLL  140 (337)
T ss_pred             cCCCCccchHHheecccccccCcEEEEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEE
Confidence            57999999999988764444467999999999999999988889999999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           81 LNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      ++.++.++|+|||++...... .......++..|+|||.+.+...++.++|+|||||++|+|++|++||.+.+.......
T Consensus       141 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~  220 (337)
T cd07858         141 LNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKL  220 (337)
T ss_pred             EcCCCCEEECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Confidence            999999999999998865443 3334556788999999887645688999999999999999999999999988888888


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCcCC
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL  239 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~~~  239 (280)
                      +....+.+.+.............+....+..........++..++.+.++|++||+.||++|||++++++||||+.+.+.
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~  300 (337)
T cd07858         221 ITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP  300 (337)
T ss_pred             HHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence            88888888777766666666666666666555555555667889999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCCCccCCCCCCHHHHHHHHHHHHHhhCC
Q 023568          240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP  276 (280)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (280)
                      ...+....++.++++....+.+.+++.+..|++.|+|
T Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (337)
T cd07858         301 SDEPVCQTPFSFDFEEDALTEEDIKELIYNEMLAYHP  337 (337)
T ss_pred             ccCccCCCccchhhhhhhcCHHHHHHHHHHHHhhcCC
Confidence            9999999999999999999999999999999999986

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-48  Score=317.56  Aligned_cols=200  Identities=30%  Similarity=0.573  Sum_probs=180.3

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||.||+++..|++.     .++|||+||+. |+|...|++.+.|+|+.++.++..|+.||.|||++||+||||||+||
T Consensus        82 v~hPFiv~l~ysFQt~-----~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENI  156 (357)
T KOG0598|consen   82 IKHPFIVKLIYSFQTE-----EKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENI  156 (357)
T ss_pred             CCCCcEeeeEEecccC-----CeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHe
Confidence            5899999999999999     77999999997 59999999999999999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeeccccccc-CCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTT-SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      |+|.+|.++|+|||+++.. .......+.+||+.|||||++.+ ..++.++|.||||+++|+|++|.+||.+.+.....+
T Consensus       157 LLd~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~-~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~  235 (357)
T KOG0598|consen  157 LLDEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLG-KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYD  235 (357)
T ss_pred             eecCCCcEEEeccccchhcccCCCccccccCCccccChHHHhc-CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHH
Confidence            9999999999999999854 44455667899999999999998 799999999999999999999999999999888877


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCC-CCCHHHHHHHHHhcccCCCCCC----CHHHHhcCccc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP-NKSSGAVDLLEKMLVFDPNKRI----TVEEALRHPYL  233 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ll~~~L~~dp~~Rp----t~~ell~hp~~  233 (280)
                      +|.+..                              . ..++ .++.+++++++++|..||.+|.    .++++-+||||
T Consensus       236 ~I~~~k------------------------------~-~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF  284 (357)
T KOG0598|consen  236 KILKGK------------------------------L-PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFF  284 (357)
T ss_pred             HHhcCc------------------------------C-CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCccc
Confidence            776521                              0 1122 3799999999999999999996    78999999999


Q ss_pred             ccCc
Q 023568          234 QSLH  237 (280)
Q Consensus       234 ~~~~  237 (280)
                      +.+.
T Consensus       285 ~~in  288 (357)
T KOG0598|consen  285 KGIN  288 (357)
T ss_pred             ccCC
Confidence            9875

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-48  Score=328.61  Aligned_cols=199  Identities=29%  Similarity=0.524  Sum_probs=179.8

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      .||.|++|+..|+++     ..+|+|+||+. |+|.++|++-+.|++..+++++.||+.||+|||+.|||||||||+|||
T Consensus       132 ~hPgivkLy~TFQD~-----~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENIL  206 (604)
T KOG0592|consen  132 GHPGIVKLYFTFQDE-----ESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENIL  206 (604)
T ss_pred             CCCCeEEEEEEeecc-----cceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhhee
Confidence            699999999999999     66999999997 799999999999999999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccccCCCC------------c--cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCC
Q 023568           81 LNASCDLKIGDFGLARTTSETD------------F--MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREP  146 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~~~~------------~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~  146 (280)
                      +|.+|+++|+|||.|+...+..            .  ..+++||..|.+||++.. ...+..+|+|+|||++|.|+.|.+
T Consensus       207 Ld~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~P  285 (604)
T KOG0592|consen  207 LDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQP  285 (604)
T ss_pred             EcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCC
Confidence            9999999999999998544321            1  145899999999999987 888999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHH
Q 023568          147 LFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEE  226 (280)
Q Consensus       147 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~e  226 (280)
                      ||.+.+..-..++|+++.-                               ...++.++.+++|++++|..||.+|+|++|
T Consensus       286 PFra~NeyliFqkI~~l~y-------------------------------~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~q  334 (604)
T KOG0592|consen  286 PFRAANEYLIFQKIQALDY-------------------------------EFPEGFPEDARDLIKKLLVRDPSDRLTSQQ  334 (604)
T ss_pred             CCccccHHHHHHHHHHhcc-------------------------------cCCCCCCHHHHHHHHHHHccCccccccHHH
Confidence            9999998888888877321                               223467899999999999999999999999


Q ss_pred             HhcCcccccCc
Q 023568          227 ALRHPYLQSLH  237 (280)
Q Consensus       227 ll~hp~~~~~~  237 (280)
                      +.+||||.++.
T Consensus       335 Ik~HpFF~~Vd  345 (604)
T KOG0592|consen  335 IKAHPFFEGVD  345 (604)
T ss_pred             HhhCcccccCC
Confidence            99999998764

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=7.7e-48  Score=314.05  Aligned_cols=237  Identities=40%  Similarity=0.736  Sum_probs=204.0

Q ss_pred             CCCcc-cccccccccCCCC-CCCCcEEEEEecCCccHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 023568            1 MEHEN-VIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQ----QLTDDHCQYFLYQLLRGLKYVHSASVLHRDL   74 (280)
Q Consensus         1 l~Hpn-iv~l~~~~~~~~~-~~~~~~~lv~e~~~g~L~~~l~~~~----~l~~~~~~~i~~qil~~l~~LH~~~i~H~di   74 (280)
                      |+|+| ||++++++...+. .+...+|+|+||++.+|.+++...+    .++...++.+++||+.||+|||++||+||||
T Consensus        67 L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDL  146 (323)
T KOG0594|consen   67 LSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDL  146 (323)
T ss_pred             hCCCcceEEEEeeeeecccccccceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccC
Confidence            68999 9999999998742 2224799999999999999997654    5888999999999999999999999999999


Q ss_pred             CCCceEEcCCCCeEEeecccccccC-CCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 023568           75 KPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY  153 (280)
Q Consensus        75 k~~Nili~~~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~  153 (280)
                      ||+||||+.+|.+||+|||+|+..+ +........+|.+|.|||++.+...|+...|+||+||+++||+++++.|++...
T Consensus       147 KPQNlLi~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se  226 (323)
T KOG0594|consen  147 KPQNLLISSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE  226 (323)
T ss_pred             CcceEEECCCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH
Confidence            9999999999999999999999766 445577889999999999999988999999999999999999999999999999


Q ss_pred             HHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccc-cccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 023568          154 VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCR-KQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY  232 (280)
Q Consensus       154 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~  232 (280)
                      .+++..|.+.+|+|++..|+....-.-.+.  ..+.+. ........+..++++.+++.+||+.+|.+|.|++.+|+|||
T Consensus       227 ~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~--~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~y  304 (323)
T KOG0594|consen  227 IDQLFRIFRLLGTPNEKDWPGVSSLPDYKA--PFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPY  304 (323)
T ss_pred             HHHHHHHHHHcCCCCccCCCCccccccccc--cCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChh
Confidence            999999999999999998876643211111  222222 44455556667789999999999999999999999999999


Q ss_pred             cccCcCC
Q 023568          233 LQSLHDL  239 (280)
Q Consensus       233 ~~~~~~~  239 (280)
                      |..+...
T Consensus       305 f~~~~~~  311 (323)
T KOG0594|consen  305 FSELPEK  311 (323)
T ss_pred             hcccccc
Confidence            9887543

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-47  Score=328.36  Aligned_cols=197  Identities=34%  Similarity=0.554  Sum_probs=177.4

Q ss_pred             CcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE
Q 023568            3 HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL   81 (280)
Q Consensus         3 Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nili   81 (280)
                      ||||+++++++...     .++|+||||+.| +|++++.+.+++.|.+++.+++|++.||+|+|+.||+||||||+|||+
T Consensus        79 HpnI~~l~ev~~t~-----~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENill  153 (370)
T KOG0583|consen   79 HPNIIRLLEVFATP-----TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILL  153 (370)
T ss_pred             CCCEeEEEEEEecC-----CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEe
Confidence            99999999999998     669999999985 999999988999999999999999999999999999999999999999


Q ss_pred             cCC-CCeEEeeccccccc-CCCCccccceeccccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           82 NAS-CDLKIGDFGLARTT-SETDFMTEYVVTRWYRAPELLLNCT-EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        82 ~~~-~~~kl~dfg~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +.+ +++||+|||++... .......+.+||+.|+|||++.+.. +.+.++||||+|+++|.|++|+.||...+......
T Consensus       154 d~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~  233 (370)
T KOG0583|consen  154 DGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYR  233 (370)
T ss_pred             cCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHH
Confidence            999 99999999999988 5667788999999999999999866 55789999999999999999999999987766666


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCC-CHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  235 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~  235 (280)
                      +|.+..                               ...+..+ |+++.+|+++||..||.+|+|+.+++.||||+.
T Consensus       234 ki~~~~-------------------------------~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  234 KIRKGE-------------------------------FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             HHhcCC-------------------------------ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            643310                               1112234 999999999999999999999999999999986

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.5e-48  Score=304.09  Aligned_cols=204  Identities=31%  Similarity=0.553  Sum_probs=181.7

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      -||||++++++|+++     ..+++|+|.|. |.|.|++.+.-.+++...+.|++|+++|+.|||..+|+||||||+|||
T Consensus        81 GHP~II~l~D~yes~-----sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENIL  155 (411)
T KOG0599|consen   81 GHPYIIDLQDVYESD-----AFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENIL  155 (411)
T ss_pred             CCCcEEEeeeeccCc-----chhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhhee
Confidence            499999999999998     77999999998 899999999889999999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccccCCCCccccceeccccccccccc-----cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023568           81 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL-----NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH  155 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~  155 (280)
                      ++++.+++|+|||+++...+++.....+||+.|+|||++.     +...|+..+|+|++|+++|.||.|.+||--....-
T Consensus       156 lddn~~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQml  235 (411)
T KOG0599|consen  156 LDDNMNIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQML  235 (411)
T ss_pred             eccccceEEeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHH
Confidence            9999999999999999999988889999999999999985     34678899999999999999999999997776666


Q ss_pred             HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 023568          156 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  235 (280)
Q Consensus       156 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~  235 (280)
                      .+..|++..-.-                           -.+.+.+++...++||.+||+.||.+|+|++|+|+||||..
T Consensus       236 MLR~ImeGkyqF---------------------------~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q  288 (411)
T KOG0599|consen  236 MLRMIMEGKYQF---------------------------RSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ  288 (411)
T ss_pred             HHHHHHhccccc---------------------------CCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence            666665521110                           11234577999999999999999999999999999999976


Q ss_pred             Cc
Q 023568          236 LH  237 (280)
Q Consensus       236 ~~  237 (280)
                      +-
T Consensus       289 ~~  290 (411)
T KOG0599|consen  289 IA  290 (411)
T ss_pred             HH
Confidence            64

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-46  Score=298.51  Aligned_cols=197  Identities=29%  Similarity=0.513  Sum_probs=179.4

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      +.||.++++.+.|.+.     ..+|+||||.+ |.|..++++.++|++..++.++.||+.||+|||+.+|++|||||+||
T Consensus       101 v~~PFlv~l~~t~~d~-----~~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENi  175 (355)
T KOG0616|consen  101 VSHPFLVKLYGTFKDN-----SNLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENL  175 (355)
T ss_pred             ccCceeEEEEEeeccC-----CeEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHe
Confidence            4699999999999998     78999999997 59999999999999999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      |+|.+|.+|++|||+|+.....  .-+.|||+.|+|||++.. ..++.++|.|||||++|||+.|.+||...+....+.+
T Consensus       176 LlD~~G~iKitDFGFAK~v~~r--T~TlCGTPeYLAPEii~s-k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~K  252 (355)
T KOG0616|consen  176 LLDQNGHIKITDFGFAKRVSGR--TWTLCGTPEYLAPEIIQS-KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEK  252 (355)
T ss_pred             eeccCCcEEEEeccceEEecCc--EEEecCCccccChHHhhc-CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHH
Confidence            9999999999999999987655  567899999999999988 8999999999999999999999999999999888888


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCcccc
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQ  234 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rp-----t~~ell~hp~~~  234 (280)
                      |.+..                               -..++..++++++||+++|+.|-.+|.     ...++..||||+
T Consensus       253 I~~~~-------------------------------v~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~  301 (355)
T KOG0616|consen  253 ILEGK-------------------------------VKFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFK  301 (355)
T ss_pred             HHhCc-------------------------------ccCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccc
Confidence            86621                               012235799999999999999999993     678999999998


Q ss_pred             cC
Q 023568          235 SL  236 (280)
Q Consensus       235 ~~  236 (280)
                      ++
T Consensus       302 ~v  303 (355)
T KOG0616|consen  302 GV  303 (355)
T ss_pred             cc
Confidence            75

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.1e-45  Score=316.49  Aligned_cols=272  Identities=48%  Similarity=0.904  Sum_probs=222.7

Q ss_pred             CCCcccccccccccCCCC-CCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~-~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||++++++|..... ......|++|++++++|.+++.. +.+++..+..++.|++.||.|||+.||+||||||+||
T Consensus        71 l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Ni  149 (343)
T cd07878          71 MKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNV  149 (343)
T ss_pred             cCCCchhhhhhhhcccccccccCcEEEEeecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhE
Confidence            589999999999975432 23356899999999999988754 6799999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.++.++|+|||+++.....  .....+++.|+|||.+.+...++.++|+|||||++|+|++|..||.+.+..+.+..
T Consensus       150 l~~~~~~~kl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  227 (343)
T cd07878         150 AVNEDCELRILDFGLARQADDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKR  227 (343)
T ss_pred             EECCCCCEEEcCCccceecCCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence            9999999999999999865443  34567899999999987766788999999999999999999999999988888888


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCcCC
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL  239 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~~~  239 (280)
                      +.+..+.+...............+...++..........+...++.+.+||.+||+.||.+|||++|+|+||||.....+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~  307 (343)
T cd07878         228 IMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDP  307 (343)
T ss_pred             HHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCC
Confidence            88888877766655554555555555555555545555566778899999999999999999999999999999998776


Q ss_pred             CCCCCCCCCCCCccCCCCCCHHHHHHHHHHHHHhhCC
Q 023568          240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP  276 (280)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (280)
                      ...+. ..+..........+.+++++..+.+...|.|
T Consensus       308 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (343)
T cd07878         308 EDEPE-AEPYDESPENKERTIEEWKELTYEEVSSFKP  343 (343)
T ss_pred             ccccc-cCccccchhhhhccHHHHHHHHHHHHHhcCC
Confidence            54432 2344444445667788999988888887765

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2e-46  Score=290.51  Aligned_cols=203  Identities=30%  Similarity=0.529  Sum_probs=178.1

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+|||||+|++.+.+.     +..|+|+|+|+| +|..-|-++--++|..+...++||++||+|+|.+||+|||+||+|+
T Consensus        67 LqHP~IvrL~~ti~~~-----~~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nl  141 (355)
T KOG0033|consen   67 LQHPNIVRLHDSIQEE-----SFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENL  141 (355)
T ss_pred             cCCCcEeehhhhhccc-----ceeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhhe
Confidence            6899999999999988     789999999986 8887666656789999999999999999999999999999999999


Q ss_pred             EEcC---CCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023568           80 LLNA---SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  156 (280)
Q Consensus        80 li~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~  156 (280)
                      ++-.   ..-+||+|||++...+.........||+.|+|||++.. ..++..+|||+.|+++|-||.|.+||.+.+....
T Consensus       142 lLASK~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrk-dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rl  220 (355)
T KOG0033|consen  142 LLASKAKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL  220 (355)
T ss_pred             eeeeccCCCceeecccceEEEeCCccccccccCCCcccCHHHhhc-CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHH
Confidence            9943   45599999999998776666677899999999999987 8999999999999999999999999999888888


Q ss_pred             HHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 023568          157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  236 (280)
Q Consensus       157 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~  236 (280)
                      +++|.+..-.-+                           ...++.+++.+++|+++||..||++|+|+.|+|+|||+++-
T Consensus       221 ye~I~~g~yd~~---------------------------~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r  273 (355)
T KOG0033|consen  221 YEQIKAGAYDYP---------------------------SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNR  273 (355)
T ss_pred             HHHHhccccCCC---------------------------CcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence            877765211111                           12456889999999999999999999999999999999764

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-46  Score=321.02  Aligned_cols=200  Identities=29%  Similarity=0.546  Sum_probs=175.9

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++|+|||++++.|...     +.+|+|||||+ |+|.|++.. ..++|.++..|++.++.||+|||.+||+|||||.+||
T Consensus       327 ~~H~NiVnfl~Sylv~-----deLWVVMEym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnI  400 (550)
T KOG0578|consen  327 LHHPNIVNFLDSYLVG-----DELWVVMEYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNI  400 (550)
T ss_pred             ccchHHHHHHHHhccc-----ceeEEEEeecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeecccccee
Confidence            4799999999999988     77999999998 498888865 5599999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCC-ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      |++.+|.+||+|||++....... ...+..||++|||||+... ..|+.++||||||++++||+-|++||-..+....+.
T Consensus       401 LL~~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtr-k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAly  479 (550)
T KOG0578|consen  401 LLTMDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTR-KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY  479 (550)
T ss_pred             EeccCCcEEEeeeeeeeccccccCccccccCCCCccchhhhhh-cccCccccchhhhhHHHHHhcCCCCccCCChHHHHH
Confidence            99999999999999998766553 5677899999999999977 899999999999999999999999999888777776


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  235 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~  235 (280)
                      .|..- |.|.-                           .....+|+.+++||.+||+.|+.+|++|.|||+||||+.
T Consensus       480 LIa~n-g~P~l---------------------------k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~  528 (550)
T KOG0578|consen  480 LIATN-GTPKL---------------------------KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM  528 (550)
T ss_pred             HHhhc-CCCCc---------------------------CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence            66541 11111                           122368999999999999999999999999999999943

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.1e-45  Score=309.07  Aligned_cols=227  Identities=40%  Similarity=0.759  Sum_probs=187.3

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+||||+++++++.+.     ...|+||||++|+|.+++... ..+++..++.++.|++.||+|||++||+||||||+||
T Consensus        60 l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Ni  134 (288)
T cd07871          60 LKHANIVTLHDIIHTE-----RCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNL  134 (288)
T ss_pred             CCCCCEeeEEEEEcCC-----CeEEEEEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHE
Confidence            5899999999999887     679999999999999988754 4589999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||+++..... .......+++.|+|||.+.+...++.++|+||+||++|+|++|++||.+.+..+.+.
T Consensus       135 l~~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~  214 (288)
T cd07871         135 LINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELH  214 (288)
T ss_pred             EECCCCCEEECcCcceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            9999999999999998764332 223445779999999998775678899999999999999999999999999888899


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      .+....+.++...++.......... ...+...........+..++++++||++||+.||.+|||++|+|+||||
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         215 LIFRLLGTPTEETWPGITSNEEFRS-YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             HHHHHhCCCChHHhhccccchhhhc-cccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence            9998888888776654432211100 0011122222233345678999999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=7.1e-45  Score=316.39  Aligned_cols=273  Identities=44%  Similarity=0.751  Sum_probs=213.6

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      ++||||+++++++.......+..+|+||||+.++|.+.+...+.+++..++.++.||+.||.|||+.|++||||||+||+
T Consensus        56 l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil  135 (372)
T cd07853          56 FKHDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLL  135 (372)
T ss_pred             CCCCCcCCHhheecCCCccccceEEEEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEE
Confidence            58999999999998874334457999999999999999988888999999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccccCCC--CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           81 LNASCDLKIGDFGLARTTSET--DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      ++.++.++|+|||+++.....  .......++..|+|||.+.+...++.++|+||+||++|+|++|+.||.+.+..+.+.
T Consensus       136 i~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~  215 (372)
T cd07853         136 VNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLD  215 (372)
T ss_pred             ECCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            999999999999998764332  223345678899999998875668899999999999999999999999999999999


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccc--cccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ--QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  236 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~  236 (280)
                      .+....+.+.......... .....+.........  .........++.+.+||.+||+.||.+|||++|+|+||||+..
T Consensus       216 ~i~~~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  294 (372)
T cd07853         216 LITDLLGTPSLEAMRSACE-GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG  294 (372)
T ss_pred             HHHHHcCCCCHHHHHHhhH-HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence            9999888877654332211 122222111111110  0112234568899999999999999999999999999999874


Q ss_pred             cC--------------------CCCCCCCCCCCCCccCCCCCCHHHHHHHHHHHHHhh
Q 023568          237 HD--------------------LNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKF  274 (280)
Q Consensus       237 ~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (280)
                      ..                    ...++....+++.+.+....+...+++.++.++..+
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (372)
T cd07853         295 RLRYHTCMCKCCYTTSGGRVYTSDFEPSANPPFDDEYEKNLTSVRQVKEELHQFILEQ  352 (372)
T ss_pred             cchhccccccccccccccccCCcccCCCCCCCCCcccccccCCHHHHHHHHHHHHHHh
Confidence            21                    112333344555555666678889999998887765

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-46  Score=307.56  Aligned_cols=202  Identities=31%  Similarity=0.524  Sum_probs=178.5

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+|||||.++++.+.+     +++|||||||+ |+|.++|+.++++++.+++.++.||+.||++||+++|+||||||+||
T Consensus        66 l~H~nIV~l~d~~~~~-----~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNi  140 (429)
T KOG0595|consen   66 LKHPNIVRLLDCIEDD-----DFIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNI  140 (429)
T ss_pred             cCCcceeeEEEEEecC-----CeEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceE
Confidence            6899999999999998     78999999998 69999999999999999999999999999999999999999999999


Q ss_pred             EEcCC------CCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 023568           80 LLNAS------CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY  153 (280)
Q Consensus        80 li~~~------~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~  153 (280)
                      |++.+      ..+||+|||+|+...+.....+.+|++.|||||++.. ..|+.++|+||+|+++|+|++|++||.....
T Consensus       141 LLs~~~~~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~  219 (429)
T KOG0595|consen  141 LLSTTARNDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPFDAETP  219 (429)
T ss_pred             EeccCCCCCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence            99765      4589999999999998888899999999999999976 8999999999999999999999999999887


Q ss_pred             HHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          154 VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       154 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      .+....+.+....                            .+......+....+++...|+.+|..|.+..+-+.|+++
T Consensus       220 ~eL~~~~~k~~~~----------------------------~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l  271 (429)
T KOG0595|consen  220 KELLLYIKKGNEI----------------------------VPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFL  271 (429)
T ss_pred             HHHHHHHhccccc----------------------------cCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhc
Confidence            7777655442111                            111222457778899999999999999999999999998


Q ss_pred             ccC
Q 023568          234 QSL  236 (280)
Q Consensus       234 ~~~  236 (280)
                      ..-
T Consensus       272 ~~~  274 (429)
T KOG0595|consen  272 AAN  274 (429)
T ss_pred             ccC
Confidence            653

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-46  Score=308.57  Aligned_cols=206  Identities=31%  Similarity=0.483  Sum_probs=169.0

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      |+|||||++++.......   ..+++.|||+. |+|.+++.+.+ ++++..++.+.+|+++||+|||++||+|+||||+|
T Consensus        71 l~~p~IV~~~G~~~~~~~---~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~N  147 (313)
T KOG0198|consen   71 LNHPNIVQYYGSSSSREN---DEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPAN  147 (313)
T ss_pred             CCCCCEEeeCCccccccC---eeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccce
Confidence            579999999998555421   36999999997 69999998766 79999999999999999999999999999999999


Q ss_pred             eEEcC-CCCeEEeecccccccCC----CCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC-C
Q 023568           79 LLLNA-SCDLKIGDFGLARTTSE----TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK-D  152 (280)
Q Consensus        79 ili~~-~~~~kl~dfg~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~-~  152 (280)
                      ||++. ++.+||+|||.++....    ........||+.|||||++.+......++||||+||++.||+||..||... .
T Consensus       148 iLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~  227 (313)
T KOG0198|consen  148 ILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFE  227 (313)
T ss_pred             EEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcc
Confidence            99999 79999999999886553    223456789999999999986233445999999999999999999999873 3


Q ss_pred             hHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 023568          153 YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY  232 (280)
Q Consensus       153 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~  232 (280)
                      ....+-.+..                             ....+..+..++.++++||.+||..||++||||+++|+|||
T Consensus       228 ~~~~~~~ig~-----------------------------~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf  278 (313)
T KOG0198|consen  228 EAEALLLIGR-----------------------------EDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF  278 (313)
T ss_pred             hHHHHHHHhc-----------------------------cCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence            2222222211                             11223445578999999999999999999999999999999


Q ss_pred             cccCcC
Q 023568          233 LQSLHD  238 (280)
Q Consensus       233 ~~~~~~  238 (280)
                      .+....
T Consensus       279 ~~~~~~  284 (313)
T KOG0198|consen  279 LKQNSI  284 (313)
T ss_pred             hhcccc
Confidence            977553

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.3e-45  Score=312.09  Aligned_cols=202  Identities=28%  Similarity=0.518  Sum_probs=173.7

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      ..|+||||+..|++.     .++||||||++ |++..+|...+.|+++.++.++.+++.|+.-||+.|++||||||+|+|
T Consensus       199 ds~~vVKLyYsFQD~-----~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlL  273 (550)
T KOG0605|consen  199 DSPWVVKLYYSFQDK-----EYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLL  273 (550)
T ss_pred             CCCcEEEEEEEecCC-----CeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhhee
Confidence            578999999999999     88999999997 599999999999999999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccccCC----------------------CCc--------------------------cccceeccc
Q 023568           81 LNASCDLKIGDFGLARTTSE----------------------TDF--------------------------MTEYVVTRW  112 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~~----------------------~~~--------------------------~~~~~~~~~  112 (280)
                      ||..|++||+|||++.....                      ...                          ..+.+|||.
T Consensus       274 iD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPD  353 (550)
T KOG0605|consen  274 IDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPD  353 (550)
T ss_pred             ecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCcc
Confidence            99999999999999852111                      000                          012478999


Q ss_pred             cccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCcccc
Q 023568          113 YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK  192 (280)
Q Consensus       113 y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (280)
                      |+|||++.+ ..|+..+|.||||||+||||.|.+||.+.+..+...+|..-..+..                        
T Consensus       354 YiAPEVll~-kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~------------------------  408 (550)
T KOG0605|consen  354 YIAPEVLLG-KGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLK------------------------  408 (550)
T ss_pred             ccchHHHhc-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc------------------------
Confidence            999999999 7799999999999999999999999999999999888865211100                        


Q ss_pred             ccccccCCCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCcccccCc
Q 023568          193 QQFATRFPNKSSGAVDLLEKMLVFDPNKRI---TVEEALRHPYLQSLH  237 (280)
Q Consensus       193 ~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rp---t~~ell~hp~~~~~~  237 (280)
                         .......+++++|||.+||. ||..|.   +++|+.+||||+++.
T Consensus       409 ---fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~  452 (550)
T KOG0605|consen  409 ---FPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVD  452 (550)
T ss_pred             ---CCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCC
Confidence               01112457999999999999 999998   699999999999874

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-44  Score=311.95  Aligned_cols=272  Identities=51%  Similarity=0.954  Sum_probs=234.3

Q ss_pred             CCCcccccccccccCCCC-CCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~-~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++..... ..+...|+|+||++++|.+++.. .++++..+..++.|++.||+|||+.|++||||+|+||
T Consensus        71 l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Ni  149 (343)
T cd07851          71 MDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNI  149 (343)
T ss_pred             ccCCCHHHHHHHhhccccccccccEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHe
Confidence            579999999999887632 33356999999999999999875 5799999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.++.++|+|||.+......  .....++..|+|||.+.+...++.++|+||+|+++|+|++|+.||.+.+....+..
T Consensus       150 ll~~~~~~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~  227 (343)
T cd07851         150 AVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKR  227 (343)
T ss_pred             EECCCCCEEEcccccccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence            9999999999999998765433  33456788899999987645778899999999999999999999999988888888


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCcCC
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL  239 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~~~  239 (280)
                      +....+.+++.............+....+......+...+...++.+.++|++||+.||.+|||+.++++||||..+...
T Consensus       228 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~  307 (343)
T cd07851         228 IMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP  307 (343)
T ss_pred             HHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence            88888887777666666666666666666666666666667789999999999999999999999999999999999887


Q ss_pred             CCCCCCCCCCCCccCCCCCCHHHHHHHHHHHHHhhCC
Q 023568          240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP  276 (280)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (280)
                      ..++. ...++.+++..+...+.|+++++.++.+|.|
T Consensus       308 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (343)
T cd07851         308 EDEPV-APPYDQSFESRDLTVDEWKELVYKEIMNFKP  343 (343)
T ss_pred             ccccc-ccccCcchhhhhcCHHHHHHHhHHHHHhccC
Confidence            76554 6777788999999999999999999999875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=4.6e-45  Score=313.21  Aligned_cols=268  Identities=58%  Similarity=1.081  Sum_probs=228.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      ++||||++++++|..... ....+|+||||++|+|.+++...+.+++..+..++.|++.||+|||+.|++||||||+||+
T Consensus        61 l~h~~iv~~~~~~~~~~~-~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil  139 (334)
T cd07855          61 FKHDNIIAIRDILRPPGA-DFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLL  139 (334)
T ss_pred             cCCCCccCHHHhccccCC-CCceEEEEEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEE
Confidence            579999999999886532 2257999999999999999987788999999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccccCCCC-----ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023568           81 LNASCDLKIGDFGLARTTSETD-----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH  155 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~  155 (280)
                      ++.++.++|+|||.+.......     ......++..|+|||.+.+...++.++|+||+||++|+|++|+.||.+.+...
T Consensus       140 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~  219 (334)
T cd07855         140 VNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH  219 (334)
T ss_pred             EcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH
Confidence            9999999999999987543321     12345678899999998665668899999999999999999999999999888


Q ss_pred             HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 023568          156 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  235 (280)
Q Consensus       156 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~  235 (280)
                      .+..+....+.++...................+...........+..+..+.++|++||+.||.+|||+++++.||||..
T Consensus       220 ~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~  299 (334)
T cd07855         220 QLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQ  299 (334)
T ss_pred             HHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhh
Confidence            88899999998888776655555555555544444444445556678999999999999999999999999999999999


Q ss_pred             CcCCCCCCCCCCCCCCccCCCCCCHHHHHHHHHH
Q 023568          236 LHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWR  269 (280)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (280)
                      +.+...++.+..+++.+++....+.|.+.+.|.+
T Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (334)
T cd07855         300 YHDPDDEPTCPPPFDFDFEAIELSREQLKEAIVK  333 (334)
T ss_pred             ccCCcccccCCCCCCCChhhhhcChhhHHHHhhc
Confidence            9999999999899999999998999999888754

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.2e-44  Score=312.47  Aligned_cols=269  Identities=43%  Similarity=0.757  Sum_probs=207.7

Q ss_pred             CCCcccccccccccCCCC-CCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~-~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++..... .....+|+||||++++|.+.+.  ..+++..+..++.|++.||+|||+.||+||||||+||
T Consensus        80 l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NI  157 (364)
T cd07875          80 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI  157 (364)
T ss_pred             cCCCCccccceeecccccccccCeEEEEEeCCCCCHHHHHH--hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHE
Confidence            579999999999876531 2235689999999999998884  4589999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.++.++|+|||+++............++..|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.+.......
T Consensus       158 ll~~~~~~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~  236 (364)
T cd07875         158 VVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK  236 (364)
T ss_pred             EECCCCcEEEEeCCCccccCCCCcccCCcccCCcCCHHHHhC-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            999999999999999987655544456678999999999987 7788999999999999999999999999998888888


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccc------------cccCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQF------------ATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA  227 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~el  227 (280)
                      +....+.+.+........ ....+....+.......            .......+..+++||.+||+.||.+|||++|+
T Consensus       237 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~  315 (364)
T cd07875         237 VIEQLGTPCPEFMKKLQP-TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA  315 (364)
T ss_pred             HHHhcCCCCHHHHHhhhH-HHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHH
Confidence            888888776654333221 11222222221111111            11112246789999999999999999999999


Q ss_pred             hcCcccccCcCCCCCCCCC-CCCCCccCCCCCCHHHHHHHHHHHHHh
Q 023568          228 LRHPYLQSLHDLNDEPVCP-RPFHFDFEHSSCTEDHIRELIWRESVK  273 (280)
Q Consensus       228 l~hp~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (280)
                      |+||||..+.++......+ .......+....+.+.|++.+++++..
T Consensus       316 L~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (364)
T cd07875         316 LQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMD  362 (364)
T ss_pred             hcCcccccccCcccCCCCCCCCCCccchhhhccHHHHHHHHHHHHHc
Confidence            9999999887665433222 222233445567888899988888753

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-44  Score=310.34  Aligned_cols=270  Identities=61%  Similarity=1.105  Sum_probs=234.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      ++||||+++++++.+....++..+|+||||++++|.+++.+...+++..+..++.|++.||++||+.|++||||||+||+
T Consensus        56 l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nil  135 (330)
T cd07834          56 LRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNIL  135 (330)
T ss_pred             cCCcchhhhhhhhcccCcccccceEEEecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence            57999999999998875444467999999999999999988789999999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccccCCCC----ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023568           81 LNASCDLKIGDFGLARTTSETD----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  156 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~  156 (280)
                      ++.++.++|+|||.+.......    ......++..|+|||.+.+....+.++|+||+|+++++|++|.+||.+.+....
T Consensus       136 i~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~  215 (330)
T cd07834         136 VNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ  215 (330)
T ss_pred             EcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH
Confidence            9999999999999998755442    234556788999999998744788999999999999999999999999999888


Q ss_pred             HHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 023568          157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  236 (280)
Q Consensus       157 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~  236 (280)
                      ...+....+.+....+..........++..............++..++.+.++|++||+.||.+|||+++++.||||+++
T Consensus       216 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  295 (330)
T cd07834         216 LNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL  295 (330)
T ss_pred             HHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence            88998888888877666555566666666666666666666677889999999999999999999999999999999999


Q ss_pred             cCCCCCCCCCCCCCC-ccCCCCCCHHHHHHHHHHH
Q 023568          237 HDLNDEPVCPRPFHF-DFEHSSCTEDHIRELIWRE  270 (280)
Q Consensus       237 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  270 (280)
                      .....++....+++. .++..+.++++.+++|..|
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (330)
T cd07834         296 HDPEDEPVAKPPFDFDFFDDDELTEEELKELIYEE  330 (330)
T ss_pred             cccccCCCCCCcccccccchhhcCHHHHhHHhhcC
Confidence            999888888788877 5788999999999998753

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-45  Score=303.89  Aligned_cols=213  Identities=24%  Similarity=0.405  Sum_probs=176.4

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      ++||||++++..|..+     ..+|+||+||. |++.++++..  ..++|..+..|+++++.||.|||.+|.+|||||+.
T Consensus        81 ~~HPNIv~~~~sFvv~-----~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAg  155 (516)
T KOG0582|consen   81 IDHPNIVTYHCSFVVD-----SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAG  155 (516)
T ss_pred             cCCCCcceEEEEEEec-----ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccc
Confidence            5899999999999998     77999999998 6999999753  46999999999999999999999999999999999


Q ss_pred             ceEEcCCCCeEEeecccccccCCC----Ccc-ccceeccccccccc-cccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 023568           78 NLLLNASCDLKIGDFGLARTTSET----DFM-TEYVVTRWYRAPEL-LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK  151 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~----~~~-~~~~~~~~y~aPE~-~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~  151 (280)
                      ||||+.+|.++|+|||.+......    ... ..+.|++.|||||+ ......|+.++||||||++..||.+|..||...
T Consensus       156 nILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~  235 (516)
T KOG0582|consen  156 NILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKY  235 (516)
T ss_pred             cEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccC
Confidence            999999999999999987643222    111 56789999999999 555678999999999999999999999999988


Q ss_pred             ChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 023568          152 DYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHP  231 (280)
Q Consensus       152 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp  231 (280)
                      ..+..+  ++++.+.|+..........                   .....+..++.++..||++||.+|||++++|+|+
T Consensus       236 pPmkvL--l~tLqn~pp~~~t~~~~~d-------------------~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~  294 (516)
T KOG0582|consen  236 PPMKVL--LLTLQNDPPTLLTSGLDKD-------------------EDKKFSKSFREMIALCLVKDPSKRPTASKLLKHA  294 (516)
T ss_pred             ChHHHH--HHHhcCCCCCcccccCChH-------------------HhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccH
Confidence            776654  3444454443222211111                   1124577999999999999999999999999999


Q ss_pred             ccccCcCC
Q 023568          232 YLQSLHDL  239 (280)
Q Consensus       232 ~~~~~~~~  239 (280)
                      ||+.....
T Consensus       295 FFk~~k~~  302 (516)
T KOG0582|consen  295 FFKKAKSK  302 (516)
T ss_pred             HHhhccch
Confidence            99886543

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=4.5e-44  Score=309.95  Aligned_cols=267  Identities=43%  Similarity=0.776  Sum_probs=200.2

Q ss_pred             CCCcccccccccccCCCC-CCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~-~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||++++++|..... ..+..+|+||||++++|.+.+.  ..+++..+..++.|++.||.|||+.||+||||||+||
T Consensus        77 l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NI  154 (359)
T cd07876          77 VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI  154 (359)
T ss_pred             CCCCCEeeeeeeeccCCCccccceeEEEEeCCCcCHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHE
Confidence            589999999999976532 2234689999999999988874  4689999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.++.++|+|||+++............+|..|+|||.+.+ ..++.++|+||+||++|+|++|+.||.+.+....+..
T Consensus       155 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~  233 (359)
T cd07876         155 VVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNK  233 (359)
T ss_pred             EECCCCCEEEecCCCccccccCccCCCCcccCCCCCchhccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            999999999999999976554444455678999999999987 7788899999999999999999999999988888888


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccc------------cCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFAT------------RFPNKSSGAVDLLEKMLVFDPNKRITVEEA  227 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~ll~~~L~~dp~~Rpt~~el  227 (280)
                      +.+..+.+.......... ....+....+......+..            .....++.+++||.+||+.||++|||+.|+
T Consensus       234 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~  312 (359)
T cd07876         234 VIEQLGTPSAEFMNRLQP-TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEA  312 (359)
T ss_pred             HHHhcCCCcHHHHHHHHH-HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHH
Confidence            888887776554332211 1122222222211111111            112346789999999999999999999999


Q ss_pred             hcCcccccCcCCCCCCCCC-CCCCCccCCCCCCHHHHHHHHHHHH
Q 023568          228 LRHPYLQSLHDLNDEPVCP-RPFHFDFEHSSCTEDHIRELIWRES  271 (280)
Q Consensus       228 l~hp~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  271 (280)
                      |+||||..+.++......+ ..............+++.+.+...+
T Consensus       313 l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  357 (359)
T cd07876         313 LRHPYITVWYDPAEAEAPPPQIYDAQLEEREHAIEEWKELIYKEV  357 (359)
T ss_pred             hcCchhhhhcCcccccCCCccccccccccccccHHHHHHHHHHHh
Confidence            9999998876655332211 1111222344455666666655443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-44  Score=307.08  Aligned_cols=271  Identities=60%  Similarity=1.051  Sum_probs=219.3

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      ++||||+++++++......+..++|+||||++++|.+++.. +.+++..++.++.|++.||+|||+.|++||||||+||+
T Consensus        60 l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nil  138 (336)
T cd07849          60 FKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLL  138 (336)
T ss_pred             CCCCCcCchhheeecccccccceEEEEehhcccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEE
Confidence            57999999999987664444467899999999999988854 67999999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccccCCCC----ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023568           81 LNASCDLKIGDFGLARTTSETD----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  156 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~  156 (280)
                      ++.++.++|+|||++.......    ......++..|+|||.+.+...++.++|+||+||++|+|++|++||.+.+....
T Consensus       139 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~  218 (336)
T cd07849         139 LNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ  218 (336)
T ss_pred             ECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            9999999999999987644322    123356788999999876656788999999999999999999999999888888


Q ss_pred             HHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 023568          157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  236 (280)
Q Consensus       157 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~  236 (280)
                      ...+...++.++.+............+....+...........+..++.+.+++++||+.||++|||+.|+++||||+.+
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~  298 (336)
T cd07849         219 LNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY  298 (336)
T ss_pred             HHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence            88888888877666544443433444444444333333344455678999999999999999999999999999999999


Q ss_pred             cCCCCCCCCCCCCCCccC-CCCCCHHHHHHHHHHHHH
Q 023568          237 HDLNDEPVCPRPFHFDFE-HSSCTEDHIRELIWRESV  272 (280)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  272 (280)
                      .+...++....++.++++ ......++.++.|+.+++
T Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (336)
T cd07849         299 HDPSDEPVAEEPFPFDFELFDDLPKEKLKELIFEEIM  335 (336)
T ss_pred             CCCCCcccCCCCCChhhccccccCHHHHHHHHHHHhc
Confidence            988778777666666665 344567788888888765

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=7.7e-44  Score=308.08  Aligned_cols=267  Identities=43%  Similarity=0.786  Sum_probs=202.9

Q ss_pred             CCCcccccccccccCCCC-CCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~-~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++..... ......|+||||++++|.+.+.  ..+++..+..++.|++.||.|||+.||+||||||+||
T Consensus        73 l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Ni  150 (355)
T cd07874          73 VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI  150 (355)
T ss_pred             hCCCchhceeeeeeccccccccceeEEEhhhhcccHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHE
Confidence            579999999999876532 2335689999999999988874  4689999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.++.++|+|||+++............++..|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.+.......
T Consensus       151 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  229 (355)
T cd07874         151 VVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK  229 (355)
T ss_pred             EECCCCCEEEeeCcccccCCCccccCCccccCCccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            999999999999999987655544556788999999999977 6788999999999999999999999999998888888


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCcccccccc------------ccCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA------------TRFPNKSSGAVDLLEKMLVFDPNKRITVEEA  227 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~el  227 (280)
                      +.+..+.+.++...... .....+....+.......+            ......+..+++||.+||+.||++|||++|+
T Consensus       230 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~el  308 (355)
T cd07874         230 VIEQLGTPCPEFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEA  308 (355)
T ss_pred             HHHHhCCCCHHHHHhhc-HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHH
Confidence            88877776655433321 2222222222221111111            1112346788999999999999999999999


Q ss_pred             hcCcccccCcCCCCCC-CCCCCCCCccCCCCCCHHHHHHHHHHHH
Q 023568          228 LRHPYLQSLHDLNDEP-VCPRPFHFDFEHSSCTEDHIRELIWRES  271 (280)
Q Consensus       228 l~hp~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (280)
                      |+||||..+.++.... ..+..+....++...+.+.+++.+..++
T Consensus       309 l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  353 (355)
T cd07874         309 LQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEV  353 (355)
T ss_pred             hcCcchhcccChhhccCCCccccccchhhhhccHHHHHHHHHHHh
Confidence            9999998876543322 2222233333444456677777776665

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3.1e-44  Score=302.12  Aligned_cols=228  Identities=38%  Similarity=0.636  Sum_probs=185.0

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||+++++++..........+++||||++++|.+++...  ..+++.++..++.|++.||.|||+.||+||||||+|
T Consensus        61 ~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~N  140 (290)
T cd07862          61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQN  140 (290)
T ss_pred             cCCCCcceEEEEEecccCCCCCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHH
Confidence            369999999999865433233679999999999999998653  458999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      |+++.++.++|+|||+++............+++.|+|||.+.+ ..++.++|+||+||++|+|++|.+||.+....+.+.
T Consensus       141 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~  219 (290)
T cd07862         141 ILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG  219 (290)
T ss_pred             EEEcCCCCEEEccccceEeccCCcccccccccccccChHHHhC-CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHH
Confidence            9999999999999999987655444456678999999999876 678889999999999999999999999999888888


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      .+....+.+.+..+.......    ................+.++..+.+++.+||+.||++|||+.|+|+||||
T Consensus       220 ~i~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         220 KILDVIGLPGEEDWPRDVALP----RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             HHHHHhCCCChhhchhhhccc----chhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence            888877766554432211000    00111112223334446788999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=6.1e-44  Score=316.10  Aligned_cols=236  Identities=32%  Similarity=0.609  Sum_probs=185.5

Q ss_pred             CCCcccccccccccCCCC---CCCCcEEEEEecCCccHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 023568            1 MEHENVIAIKDIIRPPKK---DTFNDVYIVYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRD   73 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~---~~~~~~~lv~e~~~g~L~~~l~----~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~d   73 (280)
                      |+|||||+++++|.....   .....+++||||++++|.+++.    ....+++..++.++.||+.||+|||+.||+|||
T Consensus       116 l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrD  195 (440)
T PTZ00036        116 LNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRD  195 (440)
T ss_pred             cCCCCCcceeeeEeecccccCCCceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCC
Confidence            589999999998765321   1113578999999999888774    346799999999999999999999999999999


Q ss_pred             CCCCceEEcCCC-CeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 023568           74 LKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD  152 (280)
Q Consensus        74 ik~~Nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~  152 (280)
                      |||+|||++.++ .+||+|||+++............+|+.|+|||++.+...++.++|+||+||++|+|++|.+||.+.+
T Consensus       196 LKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~  275 (440)
T PTZ00036        196 LKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQS  275 (440)
T ss_pred             cCHHHEEEcCCCCceeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999998664 6999999999876554444556789999999998775678999999999999999999999999999


Q ss_pred             hHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccC-CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 023568          153 YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHP  231 (280)
Q Consensus       153 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp  231 (280)
                      ..+.+..+.+.++.+............ ..  ...+..........+ ...++++++||++||+.||.+|||+.|+|+||
T Consensus       276 ~~~~~~~i~~~~~~p~~~~~~~~~~~~-~~--~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp  352 (440)
T PTZ00036        276 SVDQLVRIIQVLGTPTEDQLKEMNPNY-AD--IKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADP  352 (440)
T ss_pred             hHHHHHHHHHHhCCCCHHHHHHhchhh-hc--ccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCCh
Confidence            888999998888877655432211100 00  001111111111122 24688999999999999999999999999999


Q ss_pred             ccccCcCC
Q 023568          232 YLQSLHDL  239 (280)
Q Consensus       232 ~~~~~~~~  239 (280)
                      ||..+.+.
T Consensus       353 ~f~~~~~~  360 (440)
T PTZ00036        353 FFDDLRDP  360 (440)
T ss_pred             hHHhhhcc
Confidence            99987653

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.1e-43  Score=300.69  Aligned_cols=231  Identities=35%  Similarity=0.633  Sum_probs=178.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++.+.     ...|+||||++++|.+++.+. +.+++..++.++.|++.||+|||+.||+||||||+||
T Consensus        60 l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Ni  134 (303)
T cd07869          60 LKHANIVLLHDIIHTK-----ETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNL  134 (303)
T ss_pred             CCCCCcCeEEEEEecC-----CeEEEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence            5899999999999987     679999999999999988654 5799999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh-HHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY-VHQL  157 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~-~~~~  157 (280)
                      +++.++.++|+|||++...... .......+++.|+|||++.+...++.++|+||+||++|+|++|..||.+... ...+
T Consensus       135 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~  214 (303)
T cd07869         135 LISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQL  214 (303)
T ss_pred             EECCCCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHH
Confidence            9999999999999998754322 2234567789999999987756788899999999999999999999988644 4566


Q ss_pred             HHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccC--CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 023568          158 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF--PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  235 (280)
Q Consensus       158 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~  235 (280)
                      ..+....+.+....+......... ................+  ...++.+.+|+++||+.||.+|||++|+++||||++
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~  293 (303)
T cd07869         215 ERIFLVLGTPNEDTWPGVHSLPHF-KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSD  293 (303)
T ss_pred             HHHHHHhCCCChhhccchhhcccc-ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCccccc
Confidence            677776776655443321110000 00000000000111111  124678999999999999999999999999999987


Q ss_pred             Cc
Q 023568          236 LH  237 (280)
Q Consensus       236 ~~  237 (280)
                      +.
T Consensus       294 ~~  295 (303)
T cd07869         294 LP  295 (303)
T ss_pred             CC
Confidence            63

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1e-44  Score=309.60  Aligned_cols=202  Identities=32%  Similarity=0.566  Sum_probs=180.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      |+|||||+++++|++.     .++++|+|||.|+|..++...+.++|+.++.+++|++.||.|||+.+|.|||+||.|||
T Consensus        58 lkHpniv~m~esfEt~-----~~~~vVte~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniL  132 (808)
T KOG0597|consen   58 LKHPNIVEMLESFETS-----AHLWVVTEYAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNIL  132 (808)
T ss_pred             cCCcchhhHHHhhccc-----ceEEEEehhhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceee
Confidence            6899999999999998     78999999999999999999999999999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccccCCCC-ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           81 LNASCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      ++.+|.+|+||||+|+..+... ..++.-||+.|||||...+ ..|+..+|+||+||++|||..|++||......+....
T Consensus       133 l~~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~  211 (808)
T KOG0597|consen  133 LEKGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKS  211 (808)
T ss_pred             ecCCCceeechhhhhhhcccCceeeeeccCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHH
Confidence            9999999999999999866553 4566789999999999987 9999999999999999999999999988877666666


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCcCC
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL  239 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~~~  239 (280)
                      |.+---                               .-++..+..++.|++.+|.+||.+|+|-.+++.|||.++-...
T Consensus       212 I~~d~v-------------------------------~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~  260 (808)
T KOG0597|consen  212 ILKDPV-------------------------------KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINI  260 (808)
T ss_pred             HhcCCC-------------------------------CCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhh
Confidence            544111                               1112579999999999999999999999999999999875543

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.4e-45  Score=289.61  Aligned_cols=197  Identities=30%  Similarity=0.529  Sum_probs=167.4

Q ss_pred             CCCcccccccc-cccCCCCCCCCcEEEEEecCC-ccHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHh--CC--cc
Q 023568            1 MEHENVIAIKD-IIRPPKKDTFNDVYIVYELMD-TDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHS--AS--VL   70 (280)
Q Consensus         1 l~Hpniv~l~~-~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~----~~~~l~~~~~~~i~~qil~~l~~LH~--~~--i~   70 (280)
                      |+|||||++++ -|.++.    .-++||||||+ |+|.++++    +++.++|.+++.++.|++.||..+|+  ..  |+
T Consensus        75 L~HpNIVqYy~~~f~~~~----evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~Vm  150 (375)
T KOG0591|consen   75 LNHPNIVQYYAHSFIEDN----EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVM  150 (375)
T ss_pred             cCCchHHHHHHHhhhccc----hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcccccccee
Confidence            78999999999 555441    34999999998 79999985    35679999999999999999999999  44  99


Q ss_pred             ccCCCCCceEEcCCCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 023568           71 HRDLKPSNLLLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFP  149 (280)
Q Consensus        71 H~dik~~Nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~  149 (280)
                      ||||||.||+++.+|.+||+|||+++..... ....+..|||+||+||++.+ ..|+.++||||+||++|||..-++||.
T Consensus       151 HRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~-~~Y~~kSDiWslGCllyEMcaL~~PF~  229 (375)
T KOG0591|consen  151 HRDIKPANIFLTANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHE-SGYNFKSDIWSLGCLLYEMCALQSPFY  229 (375)
T ss_pred             eccCcchheEEcCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhc-CCCCcchhHHHHHHHHHHHHhcCCCcc
Confidence            9999999999999999999999999987665 44567899999999999988 899999999999999999999999999


Q ss_pred             CCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccC-CCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 023568          150 GKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEAL  228 (280)
Q Consensus       150 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ll~~~L~~dp~~Rpt~~ell  228 (280)
                      +++......+|.+.                              +++..+ ...|.++..+|.-|+..||..||+.    
T Consensus       230 g~n~~~L~~KI~qg------------------------------d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t----  275 (375)
T KOG0591|consen  230 GDNLLSLCKKIEQG------------------------------DYPPLPDEHYSTDLRELINMCIAVDPEQRPDT----  275 (375)
T ss_pred             cccHHHHHHHHHcC------------------------------CCCCCcHHHhhhHHHHHHHHHccCCcccCCCc----
Confidence            99877777776552                              112222 1468899999999999999999986    


Q ss_pred             cCcccccCc
Q 023568          229 RHPYLQSLH  237 (280)
Q Consensus       229 ~hp~~~~~~  237 (280)
                       +|++.++.
T Consensus       276 -~~~v~di~  283 (375)
T KOG0591|consen  276 -VPYVQDIQ  283 (375)
T ss_pred             -chHHHHHH
Confidence             55555544

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.6e-43  Score=300.80  Aligned_cols=272  Identities=47%  Similarity=0.874  Sum_probs=226.0

Q ss_pred             CCCcccccccccccCCCC-CCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~-~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++..... ......++||||++++|.+++.. ..+++..++.++.|++.||+|||+.||+||||+|+||
T Consensus        71 l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Ni  149 (343)
T cd07880          71 MKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNL  149 (343)
T ss_pred             cCCCCccceeeeecCCccccccceEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence            579999999999986632 22245799999998899988864 6799999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.++.++|+|||.+......  .....++..|+|||.+.+...++.++|+||+|+++++|++|..||.+.+.......
T Consensus       150 ll~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~  227 (343)
T cd07880         150 AVNEDCELKILDFGLARQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLME  227 (343)
T ss_pred             EEcCCCCEEEeecccccccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9999999999999998765433  23446688999999987645688899999999999999999999999888778888


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCcCC
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL  239 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~~~  239 (280)
                      +.+..+.++..............+...++...........+..++.+.++|.+||+.||.+|||+.+++.||||+.+...
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~  307 (343)
T cd07880         228 IMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP  307 (343)
T ss_pred             HHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCc
Confidence            87777776666555554444555555555555445555566789999999999999999999999999999999999876


Q ss_pred             CCCCCCCCCCCCccCCCCCCHHHHHHHHHHHHHhhCC
Q 023568          240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP  276 (280)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (280)
                      ..++. ..++..+++....+-++|+.+.+.|++.|+|
T Consensus       308 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (343)
T cd07880         308 EDETE-APPYDDSFDEVDQSLEEWKRLTFTEILSFQP  343 (343)
T ss_pred             ccccC-CCCccccHHhhccchHHHHHHHHHHHHhcCC
Confidence            65553 4457777888899999999999999999986

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=3.4e-44  Score=312.04  Aligned_cols=224  Identities=34%  Similarity=0.635  Sum_probs=186.4

Q ss_pred             ccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc
Q 023568            5 NVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN   82 (280)
Q Consensus         5 niv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nili~   82 (280)
                      |+|+++++|...     +|+|||+|.++-+|+++++++  ..++...++.++.||+.||.+||+.||||.||||+|||+.
T Consensus       249 n~Vrm~d~F~fr-----~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~  323 (586)
T KOG0667|consen  249 NIVRMLDYFYFR-----NHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLK  323 (586)
T ss_pred             eEEEeeeccccc-----cceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeec
Confidence            899999999998     999999999999999999875  4799999999999999999999999999999999999996


Q ss_pred             CC--CCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 023568           83 AS--CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  160 (280)
Q Consensus        83 ~~--~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~i  160 (280)
                      ..  ..+|++|||++...+....  +++.+++|.|||++.| ..|+.+.||||||||++||.+|.+.|+|.+..++++.|
T Consensus       324 ~~~r~~vKVIDFGSSc~~~q~vy--tYiQSRfYRAPEVILG-lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I  400 (586)
T KOG0667|consen  324 DPKRSRIKVIDFGSSCFESQRVY--TYIQSRFYRAPEVILG-LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARI  400 (586)
T ss_pred             cCCcCceeEEecccccccCCcce--eeeeccccccchhhcc-CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHH
Confidence            53  3699999999988776543  8889999999999999 99999999999999999999999999999999999999


Q ss_pred             HHHhCCCCcccccccCChhHHHHHHh-----------------------------CCccccc----cccccCC-CCCHHH
Q 023568          161 TELIGSPDDASLGFLRSDNARRYVRQ-----------------------------LPRCRKQ----QFATRFP-NKSSGA  206 (280)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~----~~~~~~~-~~~~~~  206 (280)
                      .+++|.|++..+......  ..+...                             ......+    ....... .....+
T Consensus       401 ~e~lG~Pp~~mL~~~~~~--~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F  478 (586)
T KOG0667|consen  401 IEVLGLPPPKMLDTAKKA--HKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLF  478 (586)
T ss_pred             HHHhCCCCHHHHHhcccc--ceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHH
Confidence            999999987754332211  111111                             0000011    1111122 345678


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCcccccCcC
Q 023568          207 VDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  238 (280)
Q Consensus       207 ~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~~  238 (280)
                      .+||++||.+||.+|+|+.|+|+||||+....
T Consensus       479 ~dflk~~L~~dP~~R~tp~qal~Hpfl~~~~~  510 (586)
T KOG0667|consen  479 IDFLKRCLEWDPAERITPAQALNHPFLTGTSL  510 (586)
T ss_pred             HHHHHHHhccCchhcCCHHHHhcCcccccccc
Confidence            99999999999999999999999999986543

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=4e-44  Score=284.87  Aligned_cols=212  Identities=29%  Similarity=0.498  Sum_probs=176.4

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCC--CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQ--LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~--l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      -|||||.++++|+.. -.+-..+.+|||.|+ |.|++.+++++.  |+|.++..|++||..|+.|||+.+|.||||||+|
T Consensus       113 ~h~~iV~IidVyeNs-~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpEN  191 (400)
T KOG0604|consen  113 GHPHIVSIIDVYENS-YQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPEN  191 (400)
T ss_pred             CCCceEEeehhhhhh-ccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhh
Confidence            399999999999865 223367999999998 599999987654  9999999999999999999999999999999999


Q ss_pred             eEEcC---CCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH-
Q 023568           79 LLLNA---SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV-  154 (280)
Q Consensus        79 ili~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~-  154 (280)
                      +|...   +..+||+|||+|+.........+.+.|++|.|||++.. .+|+.++|+||+||++|-||+|.+||...... 
T Consensus       192 LLyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~-eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a  270 (400)
T KOG0604|consen  192 LLYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA  270 (400)
T ss_pred             eeeecCCCCcceEecccccccccCCCccccCCcccccccCHHHhCc-hhcCCCCCccchhHHHHHhhcCCCcccccCCcc
Confidence            99965   45699999999998877766788899999999998865 88999999999999999999999999887532 


Q ss_pred             ---HHHHHHHHH-hCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 023568          155 ---HQLRLITEL-IGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  230 (280)
Q Consensus       155 ---~~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~h  230 (280)
                         ....+|... .+-|                            .+.+..+|.+++++|+++|..+|++|.|++++++|
T Consensus       271 ispgMk~rI~~gqy~FP----------------------------~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  271 ISPGMKRRIRTGQYEFP----------------------------EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             CChhHHhHhhccCccCC----------------------------ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence               222222211 1111                            12234679999999999999999999999999999


Q ss_pred             cccccCcCCCCCC
Q 023568          231 PYLQSLHDLNDEP  243 (280)
Q Consensus       231 p~~~~~~~~~~~~  243 (280)
                      ||+.+.....+-+
T Consensus       323 pwi~~~~~vp~tp  335 (400)
T KOG0604|consen  323 PWINQYEAVPQTP  335 (400)
T ss_pred             chhcccccCCCCC
Confidence            9998876554433

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=6.9e-43  Score=301.89  Aligned_cols=266  Identities=44%  Similarity=0.805  Sum_probs=206.8

Q ss_pred             CCCcccccccccccCCCC-CCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~-~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||++++++|..... .+..+.|+||||++++|.+.+...  +++..+..++.|++.||+|||+.|++||||||+||
T Consensus        72 l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Ni  149 (353)
T cd07850          72 VNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI  149 (353)
T ss_pred             cCCCCCcceeeeeccCCCccccCcEEEEEeccCCCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHE
Confidence            579999999999876532 233568999999999999988543  99999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.++.++|+|||.++............++..|+|||.+.+ ..++.++|+||+||++|+|++|..||...+.......
T Consensus       150 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~  228 (353)
T cd07850         150 VVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNK  228 (353)
T ss_pred             EECCCCCEEEccCccceeCCCCCCCCCCcccccccCHHHHhC-CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence            999999999999999987655444445567889999999877 7788999999999999999999999999998888888


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCcccccccccc-------------CCCCCHHHHHHHHHhcccCCCCCCCHHH
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR-------------FPNKSSGAVDLLEKMLVFDPNKRITVEE  226 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~ll~~~L~~dp~~Rpt~~e  226 (280)
                      +....+.+.+......... ...+....+......+...             ....+..++++|++||+.||.+|||+.|
T Consensus       229 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  307 (353)
T cd07850         229 IIEQLGTPSDEFMSRLQPT-VRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDD  307 (353)
T ss_pred             HHHhcCCCCHHHHHHhhhh-hhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHH
Confidence            8888888776554332211 1111211111111111111             1234667899999999999999999999


Q ss_pred             HhcCcccccCcCCCCCCC-CCCCCCCccCCCCCCHHHHHHHHHHH
Q 023568          227 ALRHPYLQSLHDLNDEPV-CPRPFHFDFEHSSCTEDHIRELIWRE  270 (280)
Q Consensus       227 ll~hp~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (280)
                      +|.||||+.|........ .+..++-..+.+..+.++|++.++.+
T Consensus       308 iL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (353)
T cd07850         308 ALQHPYINVWYDPSEVEAPPPAPYDHSIDEREHTVEEWKELIYKE  352 (353)
T ss_pred             HhcChhHhhccCCccCCCCCCCccccccccccccHHHHHHHHHhh
Confidence            999999998776544322 34444444566778888999887765

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=9.4e-43  Score=298.66  Aligned_cols=267  Identities=56%  Similarity=0.979  Sum_probs=219.2

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL   81 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nili   81 (280)
                      +||||+++++.+.... .+...+|++||+++++|.+++.....+++..++.++.|++.||+|||+.|++||||||+||++
T Consensus        60 ~h~~iv~~~~~~~~~~-~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili  138 (332)
T cd07857          60 GHKNITCLYDMDIVFP-GNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLV  138 (332)
T ss_pred             CCCChheeeeeeeecc-ccCCcEEEEEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEE
Confidence            5999999999754321 222568999999999999999888899999999999999999999999999999999999999


Q ss_pred             cCCCCeEEeecccccccCCCC-----ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023568           82 NASCDLKIGDFGLARTTSETD-----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  156 (280)
Q Consensus        82 ~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~  156 (280)
                      +.++.++|+|||.+.......     ......++..|+|||.+.+...++.++|+||+|+++|+|++|.+||.+.+....
T Consensus       139 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~  218 (332)
T cd07857         139 NADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQ  218 (332)
T ss_pred             cCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHH
Confidence            999999999999987544321     123356789999999887656788999999999999999999999999998889


Q ss_pred             HHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 023568          157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  236 (280)
Q Consensus       157 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~  236 (280)
                      ...+....+.++..............+...........+....+..+..+.+++.+||+.||.+|||+++++.||||+.+
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~  298 (332)
T cd07857         219 LNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW  298 (332)
T ss_pred             HHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence            99999988887776555444444444444444444445555566778999999999999999999999999999999999


Q ss_pred             cCCCCCCCCCCCCCCccCCCCCCHHHHHHHHHHH
Q 023568          237 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRE  270 (280)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (280)
                      +++...+.|..+++++|... -+-+.+|.+|-++
T Consensus       299 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  331 (332)
T cd07857         299 HDPDDEPVCQKPFDFSFESE-DSMEELRDMIIEE  331 (332)
T ss_pred             cCccccccccccccCCcccc-ccHHHHHHHHhhc
Confidence            99988888999999887643 3445666666544

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=4.1e-43  Score=298.03  Aligned_cols=231  Identities=39%  Similarity=0.753  Sum_probs=189.3

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++..+     ...|+||||++++|.+++... ..+++..++.++.|++.||+|||+.||+||||||+||
T Consensus        61 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Ni  135 (309)
T cd07872          61 LKHANIVTLHDIVHTD-----KSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNL  135 (309)
T ss_pred             CCCCCcceEEEEEeeC-----CeEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence            5799999999999887     679999999999999988654 4589999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||.+...... .......++..|+|||.+.+...++.++|+||+||++|+|++|+.||.+.+..+...
T Consensus       136 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~  215 (309)
T cd07872         136 LINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELH  215 (309)
T ss_pred             EECCCCCEEECccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence            9999999999999998764332 223345678999999998775678899999999999999999999999999888888


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  237 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~  237 (280)
                      .+....+.+....++.......... ...+...........+.++++++++|++||+.||.+|||++|+++||||+.+.
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  293 (309)
T cd07872         216 LIFRLLGTPTEETWPGISSNDEFKN-YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG  293 (309)
T ss_pred             HHHHHhCCCCHHHHhhhcchhhhhh-hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence            8988888877765544332211111 11122222222234456789999999999999999999999999999998875

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.3e-43  Score=289.83  Aligned_cols=202  Identities=27%  Similarity=0.481  Sum_probs=173.1

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      ++||.+++||..|+.+     ...|+|||||. |+|..+++++  +.|+++.++.++..++.||+|||-.||++|||||+
T Consensus       134 lDHPFlPTLYa~fet~-----~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPE  208 (459)
T KOG0610|consen  134 LDHPFLPTLYASFETD-----KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPE  208 (459)
T ss_pred             cCCCccchhhheeecc-----ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcc
Confidence            5899999999999998     78999999997 5999998754  67999999999999999999999999999999999


Q ss_pred             ceEEcCCCCeEEeecccccccCC-----------------------------------C---------------------
Q 023568           78 NLLLNASCDLKIGDFGLARTTSE-----------------------------------T---------------------  101 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~-----------------------------------~---------------------  101 (280)
                      ||||-++|.+.|+||.++....-                                   .                     
T Consensus       209 NILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~  288 (459)
T KOG0610|consen  209 NILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPT  288 (459)
T ss_pred             eeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCC
Confidence            99999999999999998742100                                   0                     


Q ss_pred             -CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhH
Q 023568          102 -DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA  180 (280)
Q Consensus       102 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  180 (280)
                       ....+++||-.|.|||++.| ...+.++|.|+|||++||||.|..||.+.+..+.+..|...                 
T Consensus       289 ~~RSnSFVGThEYlAPEvI~G-~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~-----------------  350 (459)
T KOG0610|consen  289 GARSNSFVGTHEYLAPEVIRG-EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQ-----------------  350 (459)
T ss_pred             Cccccccccccccccceeeec-CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcC-----------------
Confidence             01123578888999999998 88899999999999999999999999999988887776541                 


Q ss_pred             HHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCC----HHHHhcCcccccCc
Q 023568          181 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT----VEEALRHPYLQSLH  237 (280)
Q Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt----~~ell~hp~~~~~~  237 (280)
                                 ...+ ...+.++.+++|||+++|.+||.+|..    |.|+.+||||++++
T Consensus       351 -----------~l~F-p~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVn  399 (459)
T KOG0610|consen  351 -----------PLKF-PEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVN  399 (459)
T ss_pred             -----------CCcC-CCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCC
Confidence                       1111 112356799999999999999999997    99999999999875

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.4e-42  Score=298.69  Aligned_cols=271  Identities=46%  Similarity=0.856  Sum_probs=220.9

Q ss_pred             CCCcccccccccccCCCC-CCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~-~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++..... ......|+||||+..+|.+++  ...+++..+..++.|++.||+|||+.|++||||+|+||
T Consensus        71 l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NI  148 (342)
T cd07879          71 MQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNL  148 (342)
T ss_pred             cCCCCccchhheecccccCCCCceEEEEecccccCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence            579999999999986532 122457999999998888776  35799999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.++.++|+|||+++.....  .....++..|+|||.+.+...++.++|+|||||++|+|++|+.||.+.+....+..
T Consensus       149 ll~~~~~~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~  226 (342)
T cd07879         149 AVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQ  226 (342)
T ss_pred             EECCCCCEEEeeCCCCcCCCCC--CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9999999999999998764332  23456788999999987645688899999999999999999999999888888888


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCcCC
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL  239 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~~~  239 (280)
                      +....+.+.+.............+....+..........++..++.+.++|++||+.||.+||++++++.||||+...+.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~  306 (342)
T cd07879         227 ILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA  306 (342)
T ss_pred             HHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence            88888777766655555444455555555555555555566789999999999999999999999999999999999865


Q ss_pred             CCCCCCCCCCCCccCCCCCCHHHHHHHHHHHHHhhCC
Q 023568          240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP  276 (280)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (280)
                      +.++ .+.+++...+....+.+++..-++.|.+.|.|
T Consensus       307 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (342)
T cd07879         307 DEET-EQQPYDDSLENEKLSVDEWKKHIYKEVKSFSP  342 (342)
T ss_pred             cccC-CCCcccchhhhhhCCHHHHHHHhhhhhhccCC
Confidence            5443 35555555556677889999999999888865

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.7e-43  Score=295.90  Aligned_cols=226  Identities=33%  Similarity=0.674  Sum_probs=176.2

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIR-SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~-~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++...     ..+|+||||+++++.+.+. ....+++..++.++.|++.||.|||+.|++||||||+||
T Consensus        57 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Ni  131 (287)
T cd07848          57 LKQENIVELKEAFRRR-----GKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENL  131 (287)
T ss_pred             CCCccccchhhhEecC-----CEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence            5899999999999887     6799999999976655554 346799999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC--CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSET--DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  157 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~  157 (280)
                      +++.++.++|+|||++......  .......+++.|+|||++.+ ..++.++|+||+||++|+|++|++||.+.+..+..
T Consensus       132 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~  210 (287)
T cd07848         132 LISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLG-APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQL  210 (287)
T ss_pred             EEcCCCcEEEeeccCcccccccccccccccccccccCCcHHHcC-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            9999999999999999865432  22234578999999999977 66889999999999999999999999998887777


Q ss_pred             HHHHHHhCCCCcccccccCChhHHHHHHhCCcc--ccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          158 RLITELIGSPDDASLGFLRSDNARRYVRQLPRC--RKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       158 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      ..+.+..+..+................ ..+..  ............++.+.+||++||+.||++|||++|+|+||||
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         211 FTIQKVLGPLPAEQMKLFYSNPRFHGL-RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             HHHHHhhCCCCHHHHHhhhccchhccc-ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            777777665554433221110000000 00000  0000011123468899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.1e-43  Score=305.28  Aligned_cols=232  Identities=25%  Similarity=0.328  Sum_probs=178.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      |+||||++++++|...     ...++|||++.++|.+++...+.+++.+++.++.|++.||.|||+.||+||||||+||+
T Consensus       140 l~HpnIv~~~~~~~~~-----~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIl  214 (391)
T PHA03212        140 INHPSIIQLKGTFTYN-----KFTCLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIF  214 (391)
T ss_pred             CCCCCCCCEeEEEEEC-----CeeEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEE
Confidence            6899999999999877     67999999999999999988788999999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccccCCC--CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC------
Q 023568           81 LNASCDLKIGDFGLARTTSET--DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD------  152 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~------  152 (280)
                      ++.++.++|+|||++......  .......||+.|+|||++.+ ..++.++|+||+||++|+|++|..||....      
T Consensus       215 l~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~  293 (391)
T PHA03212        215 INHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDC  293 (391)
T ss_pred             EcCCCCEEEEeCCcccccccccccccccccCccCCCChhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccC
Confidence            999999999999998753322  22334678999999999877 678999999999999999999997765432      


Q ss_pred             -hHHHHHHHHHHhCCCCcccccccCChhHHHHH-HhCCcccccc----ccccCCCCCHHHHHHHHHhcccCCCCCCCHHH
Q 023568          153 -YVHQLRLITELIGSPDDASLGFLRSDNARRYV-RQLPRCRKQQ----FATRFPNKSSGAVDLLEKMLVFDPNKRITVEE  226 (280)
Q Consensus       153 -~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~e  226 (280)
                       ....+..+....+.++....... ........ ..........    ........+.++.+||.+||+.||.+|||++|
T Consensus       294 ~~~~~l~~i~~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~e  372 (391)
T PHA03212        294 DSDRQIKLIIRRSGTHPNEFPIDA-QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEA  372 (391)
T ss_pred             chhHHHHHHHHHhcCChhhcCcch-hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHH
Confidence             34566666666666554332111 11111111 1111100000    00111235778999999999999999999999


Q ss_pred             HhcCcccccCcCC
Q 023568          227 ALRHPYLQSLHDL  239 (280)
Q Consensus       227 ll~hp~~~~~~~~  239 (280)
                      +|+||||+.+..+
T Consensus       373 lL~hp~f~~~~~~  385 (391)
T PHA03212        373 LLDFAAFQDIPDP  385 (391)
T ss_pred             HhcChhhccCCCC
Confidence            9999999886543

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=5.6e-43  Score=294.11  Aligned_cols=228  Identities=35%  Similarity=0.636  Sum_probs=183.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||+++++++..........+++||||+.++|.+++...  ..+++..++.++.|++.||+|||+.|++||||||+|
T Consensus        59 ~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~N  138 (288)
T cd07863          59 FDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPEN  138 (288)
T ss_pred             cCCCCeeeeeeeeccccCCCCceEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence            369999999999886543334679999999999999988653  459999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      |+++.++.++|+|||++.............++..|+|||.+.+ ..++.++|+||+||++|+|++|.+||.+....+.+.
T Consensus       139 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~  217 (288)
T cd07863         139 ILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLG  217 (288)
T ss_pred             EEECCCCCEEECccCccccccCcccCCCccccccccCchHhhC-CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHH
Confidence            9999999999999999987655444455677899999999877 678999999999999999999999999988888888


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      ++....+.+....++......    ................+.++..+.+++.+||+.||.+|||++|++.||||
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         218 KIFDLIGLPPEDDWPRDVTLP----RGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             HHHHHhCCCChhhCccccccc----ccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            888777665544332110000    00011111222233445678899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.7e-43  Score=282.81  Aligned_cols=235  Identities=38%  Similarity=0.690  Sum_probs=193.6

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-----QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK   75 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~-----~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik   75 (280)
                      |+||||++|..+|-...    ..+++++||.+.+|..+|+-+     +.++...++.|+.||+.|+.|||++.|+|||||
T Consensus        84 l~h~nvi~Lv~Vfl~~d----~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLK  159 (438)
T KOG0666|consen   84 LKHPNVISLVKVFLSHD----KKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLK  159 (438)
T ss_pred             hcCCcchhHHHHHhccC----ceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCC
Confidence            68999999999998731    569999999999999999632     469999999999999999999999999999999


Q ss_pred             CCceEEcCC----CCeEEeecccccccCCC----CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 023568           76 PSNLLLNAS----CDLKIGDFGLARTTSET----DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL  147 (280)
Q Consensus        76 ~~Nili~~~----~~~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~p  147 (280)
                      |.|||+..+    |.+|++|+|+++...+.    ........|.+|.|||.+.|...|+.+.|+|++|||+.||++-++.
T Consensus       160 PaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~Pl  239 (438)
T KOG0666|consen  160 PANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPL  239 (438)
T ss_pred             cceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCcc
Confidence            999999877    89999999999976654    2234567799999999999999999999999999999999999999


Q ss_pred             CCCCC---------hHHHHHHHHHHhCCCCcccccccCC-hhHHHHHHhCC-----ccccccccccCCCCCHHHHHHHHH
Q 023568          148 FPGKD---------YVHQLRLITELIGSPDDASLGFLRS-DNARRYVRQLP-----RCRKQQFATRFPNKSSGAVDLLEK  212 (280)
Q Consensus       148 f~~~~---------~~~~~~~i~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ll~~  212 (280)
                      |.+..         ..+++.+|.+++|.|.+..|+.... +.....+...+     ......+......-++.+.+|+.+
T Consensus       240 F~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~k  319 (438)
T KOG0666|consen  240 FKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQK  319 (438)
T ss_pred             ccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHH
Confidence            98853         3578999999999999998877653 22211121111     111222333344557779999999


Q ss_pred             hcccCCCCCCCHHHHhcCcccccCcCC
Q 023568          213 MLVFDPNKRITVEEALRHPYLQSLHDL  239 (280)
Q Consensus       213 ~L~~dp~~Rpt~~ell~hp~~~~~~~~  239 (280)
                      ||..||.+|+|++++|+|+||+....+
T Consensus       320 lL~yDP~kRIta~qAleh~yF~~d~lp  346 (438)
T KOG0666|consen  320 LLTYDPIKRITAEQALEHPYFTEDPLP  346 (438)
T ss_pred             HhccCchhhccHHHHhcccccccCCCC
Confidence            999999999999999999999876433

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-44  Score=298.23  Aligned_cols=205  Identities=27%  Similarity=0.471  Sum_probs=172.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQ-LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~-l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      |+|||||+|+++..+...   ..+|||+|||+ |.+.. .-..+. +++.+++.+++.++.||.|||.+||+||||||+|
T Consensus       165 l~H~nVV~LiEvLDDP~s---~~~YlVley~s~G~v~w-~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsN  240 (576)
T KOG0585|consen  165 LHHPNVVKLIEVLDDPES---DKLYLVLEYCSKGEVKW-CPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSN  240 (576)
T ss_pred             cCCcCeeEEEEeecCccc---CceEEEEEeccCCcccc-CCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhh
Confidence            689999999999998855   78999999998 45543 333344 9999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeeccccccc------CCCCccccceecccccccccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 023568           79 LLLNASCDLKIGDFGLARTT------SETDFMTEYVVTRWYRAPELLLN---CTEYTAAIDIWSVGCILGEIMTREPLFP  149 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~------~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~DvwslG~~l~~ll~g~~pf~  149 (280)
                      +|++.+|.+||+|||.+...      +.........||+.|+|||...+   ....+.+.||||+||+||.|+.|+.||.
T Consensus       241 LLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~  320 (576)
T KOG0585|consen  241 LLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFF  320 (576)
T ss_pred             eEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcc
Confidence            99999999999999998754      22233455789999999999876   3455789999999999999999999999


Q ss_pred             CCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          150 GKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       150 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      +....+...+|...                             .......+.+..+++++|.+||++||.+|+++.++..
T Consensus       321 ~~~~~~l~~KIvn~-----------------------------pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~  371 (576)
T KOG0585|consen  321 DDFELELFDKIVND-----------------------------PLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKL  371 (576)
T ss_pred             cchHHHHHHHHhcC-----------------------------cccCCCcccccHHHHHHHHHHhhcChhheeehhhhee
Confidence            99888887777551                             1112233467899999999999999999999999999


Q ss_pred             CcccccCcC
Q 023568          230 HPYLQSLHD  238 (280)
Q Consensus       230 hp~~~~~~~  238 (280)
                      |||...-.+
T Consensus       372 Hpwvt~~g~  380 (576)
T KOG0585|consen  372 HPWVTRDGD  380 (576)
T ss_pred             cceeccCCC
Confidence            999977543

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-43  Score=292.36  Aligned_cols=198  Identities=27%  Similarity=0.501  Sum_probs=181.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+||||+.++++|+..     +.+.|||||.+ |.|+|++...+.+++.+++.+++||..|+.|+|+++++|||||.+||
T Consensus       110 LNHPhII~IyEVFENk-----dKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENI  184 (668)
T KOG0611|consen  110 LNHPHIIQIYEVFENK-----DKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENI  184 (668)
T ss_pred             cCCCceeehhhhhcCC-----ceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhhe
Confidence            7999999999999987     67999999997 69999999999999999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      |+|.++++|++|||++..+.......+++|++.|.+||+..|..+-+..+|.||||+++|.|+.|..||++.+....+.+
T Consensus       185 LLD~N~NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQ  264 (668)
T KOG0611|consen  185 LLDQNNNIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQ  264 (668)
T ss_pred             eecCCCCeeeeccchhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHH
Confidence            99999999999999999999999999999999999999999978888999999999999999999999999998888777


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  235 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~  235 (280)
                      |....-                                ..|..+.++.-||+.||..+|++|.|++++-+|=|+..
T Consensus       265 Is~GaY--------------------------------rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvNw  308 (668)
T KOG0611|consen  265 ISRGAY--------------------------------REPETPSDASGLIRWMLMVNPERRATIEDIASHWWVNW  308 (668)
T ss_pred             hhcccc--------------------------------cCCCCCchHHHHHHHHHhcCcccchhHHHHhhhheeec
Confidence            754110                                11345778999999999999999999999999988753

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.3e-43  Score=301.26  Aligned_cols=199  Identities=27%  Similarity=0.439  Sum_probs=170.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||++++++++..     ..+|+||||+. |+|.+++.+.+.+++..++.++.||+.||+|||+.||+||||||+||
T Consensus        52 l~hp~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NI  126 (323)
T cd05571          52 TRHPFLTALKYSFQTH-----DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENL  126 (323)
T ss_pred             CCCCCCCCEEEEEEcC-----CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHE
Confidence            5799999999999987     77999999997 59999998888999999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCC-CCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSE-TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||+++.... ........|++.|+|||++.+ ..++.++|+||+||++|+|++|..||.+.+......
T Consensus       127 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~  205 (323)
T cd05571         127 MLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE  205 (323)
T ss_pred             EECCCCCEEEeeCCCCcccccCCCcccceecCccccChhhhcC-CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHH
Confidence            999999999999999875322 223345678999999999877 778899999999999999999999998876554444


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYL  233 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rp-----t~~ell~hp~~  233 (280)
                      .+...                               .......+++.+.++|++||+.||++||     ++.++++||||
T Consensus       206 ~~~~~-------------------------------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f  254 (323)
T cd05571         206 LILME-------------------------------EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFF  254 (323)
T ss_pred             HHHcC-------------------------------CCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCc
Confidence            33210                               0011235789999999999999999999     89999999999


Q ss_pred             ccC
Q 023568          234 QSL  236 (280)
Q Consensus       234 ~~~  236 (280)
                      .++
T Consensus       255 ~~~  257 (323)
T cd05571         255 ASI  257 (323)
T ss_pred             CCC
Confidence            875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-43  Score=272.85  Aligned_cols=198  Identities=25%  Similarity=0.457  Sum_probs=179.0

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~--~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      |+||||++++++|.++     ..+||++||.+ |+++..|+  ...++++..+..+++|++.|+.|+|..+|+||||||+
T Consensus        79 L~hpnilrlY~~fhd~-----~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpe  153 (281)
T KOG0580|consen   79 LRHPNILRLYGYFHDS-----KRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPE  153 (281)
T ss_pred             cCCccHHhhhhheecc-----ceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHH
Confidence            7899999999999999     66999999997 79999998  5678999999999999999999999999999999999


Q ss_pred             ceEEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023568           78 NLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  157 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~  157 (280)
                      |+|++..+.+|++|||.+....++ ...+.+||..|.+||...+ ...+..+|+|++|++.||++.|.+||......+.+
T Consensus       154 nlLlg~~~~lkiAdfGwsV~~p~~-kR~tlcgt~dyl~pEmv~~-~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etY  231 (281)
T KOG0580|consen  154 NLLLGSAGELKIADFGWSVHAPSN-KRKTLCGTLDYLPPEMVEG-RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETY  231 (281)
T ss_pred             HhccCCCCCeeccCCCceeecCCC-CceeeecccccCCHhhcCC-CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHH
Confidence            999999999999999999877643 3568899999999999988 88889999999999999999999999999988888


Q ss_pred             HHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 023568          158 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  236 (280)
Q Consensus       158 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~  236 (280)
                      ++|.+.--.                               .+..++..+.|+|.+||.++|.+|.+..|++.|||+...
T Consensus       232 krI~k~~~~-------------------------------~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  232 KRIRKVDLK-------------------------------FPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             HHHHHcccc-------------------------------CCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence            888763211                               123689999999999999999999999999999998654

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.9e-42  Score=295.64  Aligned_cols=272  Identities=51%  Similarity=0.909  Sum_probs=224.1

Q ss_pred             CCCcccccccccccCCCC-CCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~-~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++..... ......|+++++++++|.+++.. ..+++..+..++.|++.||+|||+.|++||||||+||
T Consensus        73 l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NI  151 (345)
T cd07877          73 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL  151 (345)
T ss_pred             cCCCcccceeeeeeecccccccccEEEEehhcccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHE
Confidence            589999999999875432 22256899999999999988765 5799999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.++.++|+|||++......  .....++..|+|||.+.+...++.++|+||+||++|+|++|+.||.+.+.......
T Consensus       152 ll~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~  229 (345)
T cd07877         152 AVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL  229 (345)
T ss_pred             EEcCCCCEEEeccccccccccc--ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9999999999999998765432  23456788999999987656788899999999999999999999999888888888


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCcCC
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL  239 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~~~  239 (280)
                      +....+.+.+.............+...++......+.......++.+.++|.+||+.||.+|||+.++++||||.++..+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~  309 (345)
T cd07877         230 ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP  309 (345)
T ss_pred             HHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCC
Confidence            88888877777666655555555555555444444444444678999999999999999999999999999999999888


Q ss_pred             CCCCCCCCCCCCccCCCCCCHHHHHHHHHHHHHhhCC
Q 023568          240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP  276 (280)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (280)
                      ...+.. .++...+.......+++....+.++..|.|
T Consensus       310 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (345)
T cd07877         310 DDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP  345 (345)
T ss_pred             CccccC-CCccCcchhcccCHHHHHHHHHHHHHhcCC
Confidence            776644 356666666677779999999999998876

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-43  Score=294.19  Aligned_cols=198  Identities=23%  Similarity=0.398  Sum_probs=170.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++.+.     ..+|+||||+. |+|.+++.+.+.+++..+..++.|++.||+|||++|++||||||+||
T Consensus        58 l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NI  132 (291)
T cd05612          58 VSHPFIIRLFWTEHDQ-----RFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENI  132 (291)
T ss_pred             CCCCcHhhhHhhhccC-----CeEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHe
Confidence            5899999999999887     77999999997 59999998888999999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.++.++|+|||++......  .....|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......
T Consensus       133 li~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~  209 (291)
T cd05612         133 LLDKEGHIKLTDFGFAKKLRDR--TWTLCGTPEYLAPEVIQS-KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEK  209 (291)
T ss_pred             EECCCCCEEEEecCcchhccCC--cccccCChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9999999999999998765433  234578999999999877 6678999999999999999999999998776555544


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCcccc
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT-----VEEALRHPYLQ  234 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt-----~~ell~hp~~~  234 (280)
                      +....                               .......++.++++|++||+.||.+|++     ++++++||||+
T Consensus       210 i~~~~-------------------------------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~  258 (291)
T cd05612         210 ILAGK-------------------------------LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFK  258 (291)
T ss_pred             HHhCC-------------------------------cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCcccc
Confidence            43210                               0112246889999999999999999995     99999999998


Q ss_pred             cCc
Q 023568          235 SLH  237 (280)
Q Consensus       235 ~~~  237 (280)
                      .+.
T Consensus       259 ~~~  261 (291)
T cd05612         259 SVD  261 (291)
T ss_pred             CCC
Confidence            754

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-43  Score=308.12  Aligned_cols=198  Identities=26%  Similarity=0.491  Sum_probs=175.5

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      +||.++.+++.|++.     .++|+||||+.| + .-.+++.+.|++..++.++..|+.||.|||++||+|||||.+|||
T Consensus       427 ~HPFL~~L~~~fQT~-----~~l~fvmey~~Ggd-m~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiL  500 (694)
T KOG0694|consen  427 RHPFLVNLFSCFQTK-----EHLFFVMEYVAGGD-LMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLL  500 (694)
T ss_pred             cCCeEeecccccccC-----CeEEEEEEecCCCc-EEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheE
Confidence            599999999999998     899999999985 6 334445588999999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeeccccccc-CCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           81 LNASCDLKIGDFGLARTT-SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +|.+|.+||+|||+++.. .......+++||+.|+|||++.+ ..|+.++|.|||||++||||.|+.||++.+..+....
T Consensus       501 LD~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e-~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~Fds  579 (694)
T KOG0694|consen  501 LDTEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTE-QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDS  579 (694)
T ss_pred             EcccCcEEecccccccccCCCCCccccccCChhhcChhhhcc-CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence            999999999999999864 35556788999999999999998 9999999999999999999999999999998877777


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCcccc
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT-----VEEALRHPYLQ  234 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt-----~~ell~hp~~~  234 (280)
                      |..                               +-+..+..+|.++.++++++|.++|++|..     ++++..||||+
T Consensus       580 I~~-------------------------------d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr  628 (694)
T KOG0694|consen  580 IVN-------------------------------DEVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFR  628 (694)
T ss_pred             Hhc-------------------------------CCCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccc
Confidence            654                               111223358999999999999999999984     68999999999


Q ss_pred             cCc
Q 023568          235 SLH  237 (280)
Q Consensus       235 ~~~  237 (280)
                      .+.
T Consensus       629 ~i~  631 (694)
T KOG0694|consen  629 SID  631 (694)
T ss_pred             cCC
Confidence            874

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=5.4e-43  Score=300.66  Aligned_cols=198  Identities=25%  Similarity=0.413  Sum_probs=171.5

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++.+.     ..+|+||||+. |+|.+++...+.+++..+..++.|++.||.|||+.||+||||||+||
T Consensus        88 l~hp~Iv~~~~~~~~~-----~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NI  162 (340)
T PTZ00426         88 INHPFCVNLYGSFKDE-----SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENL  162 (340)
T ss_pred             CCCCCCcceEEEEEeC-----CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHE
Confidence            5799999999999987     77999999996 59999998888999999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      |++.++.++|+|||+++.....  .....||+.|+|||++.+ ..++.++|+||+||++|+|++|..||.+.+.......
T Consensus       163 Ll~~~~~ikL~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~  239 (340)
T PTZ00426        163 LLDKDGFIKMTDFGFAKVVDTR--TYTLCGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQK  239 (340)
T ss_pred             EECCCCCEEEecCCCCeecCCC--cceecCChhhcCHHHHhC-CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHH
Confidence            9999999999999998765432  235678999999999977 6788999999999999999999999998776555544


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCcccc
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQ  234 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rp-----t~~ell~hp~~~  234 (280)
                      +....                               ...++..++.+.++|++||+.||.+|+     |++++++||||.
T Consensus       240 i~~~~-------------------------------~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~  288 (340)
T PTZ00426        240 ILEGI-------------------------------IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFG  288 (340)
T ss_pred             HhcCC-------------------------------CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcC
Confidence            43210                               011234688999999999999999995     899999999998


Q ss_pred             cCc
Q 023568          235 SLH  237 (280)
Q Consensus       235 ~~~  237 (280)
                      ++.
T Consensus       289 ~~~  291 (340)
T PTZ00426        289 NID  291 (340)
T ss_pred             CCC
Confidence            753

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=2.2e-42  Score=292.48  Aligned_cols=231  Identities=40%  Similarity=0.751  Sum_probs=185.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+||||+++++++...     ...|+||||++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||||+||
T Consensus        61 l~h~nI~~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Ni  135 (301)
T cd07873          61 LKHANIVTLHDIIHTE-----KSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNL  135 (301)
T ss_pred             cCCCCcceEEEEEecC-----CeEEEEEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHE
Confidence            5899999999999887     67999999999999998865 35689999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||.+...... .......++..|+|||.+.+...++.++|+|||||++|+|++|++||.+.+......
T Consensus       136 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~  215 (301)
T cd07873         136 LINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLH  215 (301)
T ss_pred             EECCCCcEEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            9999999999999998764332 222345668899999998775678889999999999999999999999998888888


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  237 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~  237 (280)
                      .+....+.+....+......... .....+...........+.+++.+.+||.+||+.||.+|||++|+|+||||+.+.
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~  293 (301)
T cd07873         216 FIFRILGTPTEETWPGILSNEEF-KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG  293 (301)
T ss_pred             HHHHHcCCCChhhchhhhccccc-cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            88888777766554322111000 0001111111112223346789999999999999999999999999999998775

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.3e-42  Score=294.41  Aligned_cols=230  Identities=37%  Similarity=0.668  Sum_probs=173.6

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD---------QQLTDDHCQYFLYQLLRGLKYVHSASVLH   71 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~---------~~l~~~~~~~i~~qil~~l~~LH~~~i~H   71 (280)
                      ++||||++++++|.....   ..+|+||||++++|.+++...         ..+++..++.++.||+.||+|||++||+|
T Consensus        55 l~h~niv~~~~~~~~~~~---~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH  131 (317)
T cd07868          55 LKHPNVISLQKVFLSHAD---RKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLH  131 (317)
T ss_pred             cCCCCCcceeeeEecCCC---cEEEEEEeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEc
Confidence            589999999999976533   579999999999999887532         25899999999999999999999999999


Q ss_pred             cCCCCCceEE----cCCCCeEEeecccccccCCC----CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh
Q 023568           72 RDLKPSNLLL----NASCDLKIGDFGLARTTSET----DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT  143 (280)
Q Consensus        72 ~dik~~Nili----~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~  143 (280)
                      |||||+|||+    +.++.+||+|||+++.....    .......+|+.|+|||++.+...++.++|+||+||++|+|++
T Consensus       132 rDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~  211 (317)
T cd07868         132 RDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT  211 (317)
T ss_pred             CCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHh
Confidence            9999999999    45678999999999765432    122346779999999999875678899999999999999999


Q ss_pred             CCCCCCCCCh---------HHHHHHHHHHhCCCCcccccccCChh-HHHHHHhCCc-----cccc-cccccCCCCCHHHH
Q 023568          144 REPLFPGKDY---------VHQLRLITELIGSPDDASLGFLRSDN-ARRYVRQLPR-----CRKQ-QFATRFPNKSSGAV  207 (280)
Q Consensus       144 g~~pf~~~~~---------~~~~~~i~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~-~~~~~~~~~~~~~~  207 (280)
                      |.+||.+...         ...+..+....+.+....+....... ..........     .... ..+......+..+.
T Consensus       212 g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (317)
T cd07868         212 SEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAF  291 (317)
T ss_pred             CCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHH
Confidence            9999976432         35666777777766655443321100 0000000000     0000 01111123467799


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          208 DLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       208 ~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      +||++||+.||.+|||++|+|+||||
T Consensus       292 dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         292 HLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             HHHHHHhccCcccCCCHHHHhcCCCC
Confidence            99999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=9.2e-42  Score=291.94  Aligned_cols=262  Identities=50%  Similarity=0.927  Sum_probs=220.1

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      ++||||+++.++|....    ...|+||||++++|.+++.. .++++..+..++.|++.||+|||+.|++||||+|+||+
T Consensus        66 l~hpniv~~~~~~~~~~----~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nil  140 (328)
T cd07856          66 LRHENIISLSDIFISPL----EDIYFVTELLGTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNIL  140 (328)
T ss_pred             cCCCCeeeEeeeEecCC----CcEEEEeehhccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEe
Confidence            57999999999987542    46899999999999988864 56899999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 023568           81 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  160 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~i  160 (280)
                      ++.++.++|+|||.+......  .....++..|+|||.+.+...++.++|+||+|+++|+|++|.+||...........+
T Consensus       141 i~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~  218 (328)
T cd07856         141 INENCDLKICDFGLARIQDPQ--MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSII  218 (328)
T ss_pred             ECCCCCEEeCccccccccCCC--cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999999999999998754332  234566888999998766567889999999999999999999999999888888888


Q ss_pred             HHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCcCCC
Q 023568          161 TELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN  240 (280)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~  240 (280)
                      .+.++.++++............+..........+.....+..+..+.++|++||+.+|++|||+++++.||||..++.+.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~  298 (328)
T cd07856         219 TDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPT  298 (328)
T ss_pred             HHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCc
Confidence            88888888776655444444444444444344444455567889999999999999999999999999999999999998


Q ss_pred             CCCCCCCCCCCccCCCCCCHHHHHHHHHH
Q 023568          241 DEPVCPRPFHFDFEHSSCTEDHIRELIWR  269 (280)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (280)
                      .++.....|++.+++...-.|.|+-+.+.
T Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (328)
T cd07856         299 DEPVAEEKFDWSFNDADLPVDTWKVMMYS  327 (328)
T ss_pred             cccCchhhcCCchhcccCCHHHHHHHhcC
Confidence            88888889999999888899999877654

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.2e-42  Score=297.55  Aligned_cols=197  Identities=26%  Similarity=0.426  Sum_probs=169.9

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++.+.     +.+|+||||+. |+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+||
T Consensus        75 l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NI  149 (329)
T PTZ00263         75 LSHPFIVNMMCSFQDE-----NRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENL  149 (329)
T ss_pred             CCCCCCCcEEEEEEcC-----CEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHE
Confidence            5899999999999987     77999999997 59999998888999999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.++.++|+|||++......  .....|++.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+.......
T Consensus       150 ll~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~  226 (329)
T PTZ00263        150 LLDNKGHVKVTDFGFAKKVPDR--TFTLCGTPEYLAPEVIQS-KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEK  226 (329)
T ss_pred             EECCCCCEEEeeccCceEcCCC--cceecCChhhcCHHHHcC-CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence            9999999999999999866443  234578999999999987 6678999999999999999999999988775555444


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCcccc
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT-----VEEALRHPYLQ  234 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt-----~~ell~hp~~~  234 (280)
                      +....                               ......++..+.+||++||+.||.+|++     ++++++||||+
T Consensus       227 i~~~~-------------------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~  275 (329)
T PTZ00263        227 ILAGR-------------------------------LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFH  275 (329)
T ss_pred             HhcCC-------------------------------cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccC
Confidence            33200                               0111246888999999999999999996     79999999998


Q ss_pred             cC
Q 023568          235 SL  236 (280)
Q Consensus       235 ~~  236 (280)
                      +.
T Consensus       276 ~~  277 (329)
T PTZ00263        276 GA  277 (329)
T ss_pred             CC
Confidence            74

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=9.5e-42  Score=293.03  Aligned_cols=265  Identities=46%  Similarity=0.889  Sum_probs=211.4

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL   81 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nili   81 (280)
                      +||||+++++++.....   ...|+||||++++|.+++.+. .+++..+..++.|++.||.|||+.|++|+||+|+||++
T Consensus        65 ~h~ni~~~~~~~~~~~~---~~~~lv~e~~~~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill  140 (337)
T cd07852          65 DHPNIVKLLNVIKAEND---KDIYLVFEYMETDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILL  140 (337)
T ss_pred             CCCCccceeeeeccCCC---ceEEEEecccccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence            89999999999876522   468999999999999998765 88999999999999999999999999999999999999


Q ss_pred             cCCCCeEEeecccccccCCCC------ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023568           82 NASCDLKIGDFGLARTTSETD------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH  155 (280)
Q Consensus        82 ~~~~~~kl~dfg~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~  155 (280)
                      +.++.++|+|||.+.......      ......++..|+|||.+.+....+.++|+||+|+++|+|++|+.||.+.....
T Consensus       141 ~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~  220 (337)
T cd07852         141 NSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN  220 (337)
T ss_pred             cCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH
Confidence            999999999999987543321      22335678899999988765678889999999999999999999999988888


Q ss_pred             HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 023568          156 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  235 (280)
Q Consensus       156 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~  235 (280)
                      ....+....+.+....+...........+...............+..+..+.+++.+||+.||.+|||+.++++||||+.
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~  300 (337)
T cd07852         221 QLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQ  300 (337)
T ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhh
Confidence            88888887777666554444333333444444434444445555668999999999999999999999999999999999


Q ss_pred             CcCCCCCCCCCCCCCCcc-CCCCCCHHHHHHHHHHH
Q 023568          236 LHDLNDEPVCPRPFHFDF-EHSSCTEDHIRELIWRE  270 (280)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  270 (280)
                      +.....++..+.+....+ +.+..+..+-|..+++|
T Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (337)
T cd07852         301 FHNPSDEPVLPYPITIPLDDNVKLSVAEYRNKLYEE  336 (337)
T ss_pred             hccCCCCCCCCCCccCCccccceeeHHHHHhhhhhc
Confidence            977666655555544433 34456666677766665

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-42  Score=257.71  Aligned_cols=222  Identities=39%  Similarity=0.753  Sum_probs=195.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+|.|||+++++...+     ..+.+|+|||..+|..+..+ ++.++.+.++.++.|+++||.++|+.++.|||+||.|.
T Consensus        58 lkhknivrl~dvlhsd-----kkltlvfe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnl  132 (292)
T KOG0662|consen   58 LKHKNIVRLHDVLHSD-----KKLTLVFEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNL  132 (292)
T ss_pred             hhhcceeehhhhhccC-----ceeEEeHHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceE
Confidence            6899999999999888     66999999999999988865 57899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQL  157 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~~~~  157 (280)
                      +|+.+|.+||+|||+++..+-+ ........|.+|.+|.++.|..-|+.+.|+||.||++.|+.. |++.|++.+..+++
T Consensus       133 lin~ngelkladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddql  212 (292)
T KOG0662|consen  133 LINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL  212 (292)
T ss_pred             EeccCCcEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHH
Confidence            9999999999999999976655 345667889999999999999999999999999999999987 99999999999999


Q ss_pred             HHHHHHhCCCCcccccccCChhHHHHHHhCCcccccc-------ccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 023568          158 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQ-------FATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  230 (280)
Q Consensus       158 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~h  230 (280)
                      .+|.+.+|+|.+..|+....         ++++..-+       +..+.|..+...+++++++|.-+|.+|++++++++|
T Consensus       213 krif~~lg~p~ed~wps~t~---------lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  213 KRIFRLLGTPTEDQWPSMTK---------LPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             HHHHHHhCCCccccCCcccc---------CCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            99999999999998876532         22222221       233445667788999999999999999999999999


Q ss_pred             cccccC
Q 023568          231 PYLQSL  236 (280)
Q Consensus       231 p~~~~~  236 (280)
                      |||.+.
T Consensus       284 pyf~d~  289 (292)
T KOG0662|consen  284 PYFSDF  289 (292)
T ss_pred             cccccc
Confidence            999764

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=3.1e-42  Score=308.03  Aligned_cols=229  Identities=25%  Similarity=0.413  Sum_probs=181.0

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceE
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~-~~i~H~dik~~Nil   80 (280)
                      +|++|++++++|....    .++|+|||+++++|.+++.+.+.+++..++.++.||+.||.|||+ .||+||||||+|||
T Consensus       189 ~~~~i~~i~~~~~~~~----~~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NIL  264 (467)
T PTZ00284        189 DRFPLMKIQRYFQNET----GHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENIL  264 (467)
T ss_pred             cCcceeeeEEEEEcCC----ceEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEE
Confidence            4677999999998652    579999999999999999888899999999999999999999998 59999999999999


Q ss_pred             EcCCC----------------CeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhC
Q 023568           81 LNASC----------------DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR  144 (280)
Q Consensus        81 i~~~~----------------~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g  144 (280)
                      ++.++                .+||+|||.+......  .....||+.|+|||++.+ ..++.++|||||||++|||++|
T Consensus       265 l~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~--~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvil~elltG  341 (467)
T PTZ00284        265 METSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHS--RTAIVSTRHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTG  341 (467)
T ss_pred             EecCCcccccccccccCCCCceEEECCCCccccCccc--cccccCCccccCcHHhhc-CCCCcHHHHHHHHHHHHHHHhC
Confidence            98765                4999999987543322  345678999999999987 7789999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCcccccc----c-------cccCCCCCHHHHHHHHHh
Q 023568          145 EPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQ----F-------ATRFPNKSSGAVDLLEKM  213 (280)
Q Consensus       145 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~-------~~~~~~~~~~~~~ll~~~  213 (280)
                      +.||.+.+..+.+..+.+.++..+..+...........+...........    .       .......++.+.+||++|
T Consensus       342 ~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~m  421 (467)
T PTZ00284        342 KLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGL  421 (467)
T ss_pred             CCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHh
Confidence            99999999888999999988887766543322222222221111100000    0       000011256788999999


Q ss_pred             cccCCCCCCCHHHHhcCcccccCc
Q 023568          214 LVFDPNKRITVEEALRHPYLQSLH  237 (280)
Q Consensus       214 L~~dp~~Rpt~~ell~hp~~~~~~  237 (280)
                      |++||.+|||++|+|+||||....
T Consensus       422 L~~dP~~R~ta~e~L~Hp~~~~~~  445 (467)
T PTZ00284        422 LHYDRQKRLNARQMTTHPYVLKYY  445 (467)
T ss_pred             CCcChhhCCCHHHHhcCccccccC
Confidence            999999999999999999998754

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-42  Score=294.39  Aligned_cols=199  Identities=28%  Similarity=0.484  Sum_probs=170.2

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++...     ..+|+||||+. |+|.+++...+.+++..+..++.|++.||.|||+.||+||||||+||
T Consensus        50 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Ni  124 (312)
T cd05585          50 VNCPFIVPLKFSFQSP-----EKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENI  124 (312)
T ss_pred             CCCCcEeceeeEEecC-----CeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHe
Confidence            5799999999999887     77999999997 59999998888899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||+++..... .......||+.|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.+......
T Consensus       125 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~  203 (312)
T cd05585         125 LLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYR  203 (312)
T ss_pred             EECCCCcEEEEECcccccCccCCCccccccCCcccCCHHHHcC-CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHH
Confidence            9999999999999998754322 22345678999999999987 778899999999999999999999998876555444


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCccccc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI---TVEEALRHPYLQS  235 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rp---t~~ell~hp~~~~  235 (280)
                      .+...                               ........++.+.++|.+||+.||.+||   ++.+++.||||..
T Consensus       204 ~~~~~-------------------------------~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~  252 (312)
T cd05585         204 KILQE-------------------------------PLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQ  252 (312)
T ss_pred             HHHcC-------------------------------CCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCC
Confidence            33220                               0112235788999999999999999997   5899999999987


Q ss_pred             C
Q 023568          236 L  236 (280)
Q Consensus       236 ~  236 (280)
                      .
T Consensus       253 ~  253 (312)
T cd05585         253 L  253 (312)
T ss_pred             C
Confidence            5

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2e-42  Score=295.04  Aligned_cols=199  Identities=24%  Similarity=0.446  Sum_probs=171.1

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      +||||+++++++.+.     +.+|+||||++ |+|.+++.+.+.+++..+..++.|++.||+|||+.|++||||||+||+
T Consensus        54 ~h~~iv~~~~~~~~~-----~~~~iv~Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIl  128 (320)
T cd05590          54 NHPFLTQLYCCFQTP-----DRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVL  128 (320)
T ss_pred             CCCchhceeeEEEcC-----CEEEEEEcCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeE
Confidence            699999999999887     77999999997 599999988889999999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccccC-CCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           81 LNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      ++.++.++|+|||+++... .........|++.|+|||.+.+ ..++.++|+||+||++|+|++|+.||.+.+.......
T Consensus       129 i~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~  207 (320)
T cd05590         129 LDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQE-MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA  207 (320)
T ss_pred             ECCCCcEEEeeCCCCeecCcCCCcccccccCccccCHHHHcC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHH
Confidence            9999999999999987532 2233345678999999999876 6788899999999999999999999998876655554


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCH------HHHhcCccc
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV------EEALRHPYL  233 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~------~ell~hp~~  233 (280)
                      +....                               .......+.++.++|++||+.||.+||++      +++++||||
T Consensus       208 i~~~~-------------------------------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f  256 (320)
T cd05590         208 ILNDE-------------------------------VVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFF  256 (320)
T ss_pred             HhcCC-------------------------------CCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCc
Confidence            43200                               01122468899999999999999999998      999999999


Q ss_pred             ccCc
Q 023568          234 QSLH  237 (280)
Q Consensus       234 ~~~~  237 (280)
                      +.+.
T Consensus       257 ~~~~  260 (320)
T cd05590         257 KELD  260 (320)
T ss_pred             CCCC
Confidence            8753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-42  Score=292.77  Aligned_cols=203  Identities=30%  Similarity=0.494  Sum_probs=182.6

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++|||||+||++..+.     ..+|||+|+.+ |+|+|+|.++ ..++|+-++.++.||+.|+.|+|...++||||||+|
T Consensus        74 VQHpNiVRLYEViDTQ-----TKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPEN  148 (864)
T KOG4717|consen   74 VQHPNIVRLYEVIDTQ-----TKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPEN  148 (864)
T ss_pred             hcCcCeeeeeehhccc-----ceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcce
Confidence            4799999999999988     45999999998 5999999776 679999999999999999999999999999999999


Q ss_pred             eEE-cCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023568           79 LLL-NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  157 (280)
Q Consensus        79 ili-~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~  157 (280)
                      |++ ..-|-+||+|||++....++....+.+|++.|-|||++.|..+..+++||||||||+|.|++|++||...++.+.+
T Consensus       149 VVFFEKlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL  228 (864)
T KOG4717|consen  149 VVFFEKLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL  228 (864)
T ss_pred             eEEeeecCceEeeeccccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh
Confidence            976 5578899999999999998888899999999999999999778889999999999999999999999999888877


Q ss_pred             HHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCc
Q 023568          158 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  237 (280)
Q Consensus       158 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~  237 (280)
                      ..|+...                               ...+..++.++++||+.||+.||.+|.|++++..++|++..-
T Consensus       229 TmImDCK-------------------------------YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D  277 (864)
T KOG4717|consen  229 TMIMDCK-------------------------------YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGD  277 (864)
T ss_pred             hhhhccc-------------------------------ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCC
Confidence            7665421                               123346899999999999999999999999999999998875


Q ss_pred             CC
Q 023568          238 DL  239 (280)
Q Consensus       238 ~~  239 (280)
                      ..
T Consensus       278 ~~  279 (864)
T KOG4717|consen  278 RG  279 (864)
T ss_pred             CC
Confidence            43

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-42  Score=291.28  Aligned_cols=196  Identities=27%  Similarity=0.388  Sum_probs=167.9

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC-ccccCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSAS-VLHRDLKP   76 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~--~~~l~~~~~~~i~~qil~~l~~LH~~~-i~H~dik~   76 (280)
                      |+|||||+++|++..+.    ..+.|||||+. |+|.+++..  .+.++...+..++.||++|+.|||+++ |+|||||+
T Consensus        96 l~HpNIV~f~G~~~~~~----~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~  171 (362)
T KOG0192|consen   96 LRHPNIVQFYGACTSPP----GSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKS  171 (362)
T ss_pred             CCCCCeeeEEEEEcCCC----CceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccCh
Confidence            68999999999999872    15899999997 699999977  578999999999999999999999999 99999999


Q ss_pred             CceEEcCCC-CeEEeecccccccCCC-Cccccceecccccccccccc-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 023568           77 SNLLLNASC-DLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLN-CTEYTAAIDIWSVGCILGEIMTREPLFPGKDY  153 (280)
Q Consensus        77 ~Nili~~~~-~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~  153 (280)
                      +|||++.++ .+||+|||+++..... ...+...||+.|||||++.+ ...++.++||||||+++|||++|+.||.+...
T Consensus       172 ~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~  251 (362)
T KOG0192|consen  172 DNILVDLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP  251 (362)
T ss_pred             hhEEEcCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH
Confidence            999999997 9999999999876654 33445789999999999985 26899999999999999999999999999987


Q ss_pred             HHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          154 VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       154 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      .+....+......                             +..+...++.+..++.+|+..||.+||++.+++.
T Consensus       252 ~~~~~~v~~~~~R-----------------------------p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  252 VQVASAVVVGGLR-----------------------------PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             HHHHHHHHhcCCC-----------------------------CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence            5555444332111                             1222246889999999999999999999999875

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=3.9e-42  Score=294.25  Aligned_cols=199  Identities=27%  Similarity=0.467  Sum_probs=169.5

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++...     ..+|+||||++ |+|.+.+...+.+++.+++.++.||+.||+|||+.||+||||||+||
T Consensus        52 l~hp~iv~~~~~~~~~-----~~~~lv~Ey~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NI  126 (328)
T cd05593          52 TRHPFLTSLKYSFQTK-----DRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENL  126 (328)
T ss_pred             CCCCCCcceEEEEEcC-----CEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHe
Confidence            5799999999999987     77999999997 59999998878899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCC-CCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSE-TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      |++.++.++|+|||+++.... ........|++.|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.+......
T Consensus       127 ll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~  205 (328)
T cd05593         127 MLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE  205 (328)
T ss_pred             EECCCCcEEEecCcCCccCCCcccccccccCCcCccChhhhcC-CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHH
Confidence            999999999999999875332 222345678999999999876 678899999999999999999999998876544433


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYL  233 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rp-----t~~ell~hp~~  233 (280)
                      .+...                               ....+..+++++.++|++||+.||.+|+     ++.++++||||
T Consensus       206 ~~~~~-------------------------------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~  254 (328)
T cd05593         206 LILME-------------------------------DIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFF  254 (328)
T ss_pred             HhccC-------------------------------CccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCc
Confidence            32110                               0012235789999999999999999997     89999999999


Q ss_pred             ccC
Q 023568          234 QSL  236 (280)
Q Consensus       234 ~~~  236 (280)
                      ...
T Consensus       255 ~~~  257 (328)
T cd05593         255 TGV  257 (328)
T ss_pred             CCC
Confidence            764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-42  Score=293.75  Aligned_cols=203  Identities=34%  Similarity=0.563  Sum_probs=177.8

Q ss_pred             CcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE
Q 023568            3 HENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL   81 (280)
Q Consensus         3 Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nili   81 (280)
                      |||||+++++|++.     ..+|+|||+|. |.|.+.+.+. .+++..+..++.|++.|++|||+.||+||||||+|+|+
T Consensus        95 hpniv~l~~~~e~~-----~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~  168 (382)
T KOG0032|consen   95 HPNIVQLKDAFEDP-----DSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLL  168 (382)
T ss_pred             CCCEEEEEEEEEcC-----CeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeee
Confidence            99999999999998     67999999998 5999999765 49999999999999999999999999999999999999


Q ss_pred             cC----CCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023568           82 NA----SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  157 (280)
Q Consensus        82 ~~----~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~  157 (280)
                      ..    ++.++++|||++............+||+.|+|||++.. ..++..+|+||+|+++|.|++|.+||.+.......
T Consensus       169 ~~~~~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~  247 (382)
T KOG0032|consen  169 ASKDEGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIF  247 (382)
T ss_pred             ccccCCCCcEEEeeCCCceEccCCceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHH
Confidence            54    35799999999999887767788999999999999986 89999999999999999999999999998866655


Q ss_pred             HHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCc
Q 023568          158 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  237 (280)
Q Consensus       158 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~  237 (280)
                      ..+...--                           .-....|+.++..+++|+++||..||.+|+|+.++|+|||++...
T Consensus       248 ~~i~~~~~---------------------------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~  300 (382)
T KOG0032|consen  248 LAILRGDF---------------------------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIG  300 (382)
T ss_pred             HHHHcCCC---------------------------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCc
Confidence            54433111                           111244567899999999999999999999999999999998764


Q ss_pred             CC
Q 023568          238 DL  239 (280)
Q Consensus       238 ~~  239 (280)
                      ..
T Consensus       301 ~~  302 (382)
T KOG0032|consen  301 EA  302 (382)
T ss_pred             cc
Confidence            33

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=4.3e-42  Score=293.39  Aligned_cols=200  Identities=27%  Similarity=0.440  Sum_probs=170.5

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||++++++|...     ..+|+||||++ |+|.+++...+.+++..++.++.||+.||+|||+.||+||||||+||
T Consensus        52 l~hp~i~~~~~~~~~~-----~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NI  126 (323)
T cd05595          52 TRHPFLTALKYAFQTH-----DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENL  126 (323)
T ss_pred             CCCCCCcceeeEEecC-----CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHE
Confidence            5799999999999887     77999999997 59999998878899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCC-CCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSE-TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||++..... ........|++.|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+......
T Consensus       127 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~  205 (323)
T cd05595         127 MLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE  205 (323)
T ss_pred             EEcCCCCEEecccHHhccccCCCCccccccCCcCcCCcccccC-CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            999999999999999875322 222345678999999999877 678899999999999999999999998876555444


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYL  233 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rp-----t~~ell~hp~~  233 (280)
                      .+....                               ......+++.+.++|++||+.||.+|+     ++.++++||||
T Consensus       206 ~~~~~~-------------------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~  254 (323)
T cd05595         206 LILMEE-------------------------------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF  254 (323)
T ss_pred             HHhcCC-------------------------------CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCc
Confidence            332100                               011235689999999999999999998     99999999999


Q ss_pred             ccCc
Q 023568          234 QSLH  237 (280)
Q Consensus       234 ~~~~  237 (280)
                      .+..
T Consensus       255 ~~~~  258 (323)
T cd05595         255 LSIN  258 (323)
T ss_pred             CCCC
Confidence            8753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=5.6e-42  Score=287.81  Aligned_cols=204  Identities=22%  Similarity=0.393  Sum_probs=169.3

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~--~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      ++|+||+++++++.+.     +..++||||+. |+|.+.+..  ...+++..+..++.|++.||+|||+.||+||||||+
T Consensus        57 l~~~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~  131 (285)
T cd05631          57 VNSRFVVSLAYAYETK-----DALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPE  131 (285)
T ss_pred             cCCCcEEEEEEEEccC-----CeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHH
Confidence            5799999999999887     67999999997 589888754  346999999999999999999999999999999999


Q ss_pred             ceEEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023568           78 NLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  157 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~  157 (280)
                      ||+++.++.++|+|||++.............|+..|+|||.+.+ ..++.++||||+||++|+|++|+.||.+.+.....
T Consensus       132 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~  210 (285)
T cd05631         132 NILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR  210 (285)
T ss_pred             HEEECCCCCEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhcC-CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH
Confidence            99999999999999999987654443445678999999999987 77889999999999999999999999886543222


Q ss_pred             HHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCcc
Q 023568          158 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT-----VEEALRHPY  232 (280)
Q Consensus       158 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt-----~~ell~hp~  232 (280)
                      ..+.......                           ........+..+.+|+++||+.||.+||+     ++++++|||
T Consensus       211 ~~~~~~~~~~---------------------------~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~  263 (285)
T cd05631         211 EEVDRRVKED---------------------------QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPI  263 (285)
T ss_pred             HHHHHHhhcc---------------------------cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHh
Confidence            2222211100                           11122357899999999999999999997     899999999


Q ss_pred             cccCc
Q 023568          233 LQSLH  237 (280)
Q Consensus       233 ~~~~~  237 (280)
                      |.++.
T Consensus       264 ~~~~~  268 (285)
T cd05631         264 FKNIN  268 (285)
T ss_pred             hcCCC
Confidence            98864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.9e-41  Score=284.32  Aligned_cols=226  Identities=38%  Similarity=0.741  Sum_probs=182.4

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD---QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~---~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      ++||||+++++++.++     ..+|+||||++++|.+++...   ..+++..++.++.|++.||+|||+.|++|+||+|+
T Consensus        56 l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~  130 (285)
T cd07861          56 LQHPNIVCLQDVLMQE-----SRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQ  130 (285)
T ss_pred             cCCCCEeeeEEEEeeC-----CeEEEEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHH
Confidence            5799999999999987     679999999999999988642   56999999999999999999999999999999999


Q ss_pred             ceEEcCCCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023568           78 NLLLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  156 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~  156 (280)
                      ||+++.++.++|+|||++...... .......++..|+|||.+.+...++.++|+|||||++++|++|++||.+......
T Consensus       131 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~  210 (285)
T cd07861         131 NLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ  210 (285)
T ss_pred             HEEEcCCCcEEECcccceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence            999999999999999998754432 2223345688899999987656678899999999999999999999999887777


Q ss_pred             HHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       157 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      ...+.+..+.+....+.....  ...+....+.............+++++.++|++||+.||.+|||+.++++||||
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         211 LFRIFRILGTPTEDVWPGVTS--LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             HHHHHHHhCCCChhhhhcchh--hHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence            777777666655544432221  112222222333333333445689999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=5.8e-42  Score=292.64  Aligned_cols=199  Identities=25%  Similarity=0.479  Sum_probs=170.6

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||++++++|..+     +.+|+||||+.| +|.+++.+.+.+++..+..++.|++.||.|||+.||+||||||+||
T Consensus        57 l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Ni  131 (323)
T cd05584          57 VKHPFIVDLIYAFQTG-----GKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENI  131 (323)
T ss_pred             CCCCchhceeeEEecC-----CeEEEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHe
Confidence            5899999999999987     679999999985 9999998888899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCC-CCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSE-TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||+++.... ........|++.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+......
T Consensus       132 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~  210 (323)
T cd05584         132 LLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMR-SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTID  210 (323)
T ss_pred             EECCCCCEEEeeCcCCeecccCCCcccccCCCccccChhhccC-CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHH
Confidence            999999999999999875332 222344578999999999877 667889999999999999999999999877655544


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYL  233 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rp-----t~~ell~hp~~  233 (280)
                      .+...                               ....++..++.+.++|++||+.||++||     +++++++||||
T Consensus       211 ~~~~~-------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~  259 (323)
T cd05584         211 KILKG-------------------------------KLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFF  259 (323)
T ss_pred             HHHcC-------------------------------CCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCc
Confidence            44321                               0112235688999999999999999999     89999999999


Q ss_pred             ccC
Q 023568          234 QSL  236 (280)
Q Consensus       234 ~~~  236 (280)
                      +..
T Consensus       260 ~~~  262 (323)
T cd05584         260 RHV  262 (323)
T ss_pred             CCC
Confidence            764

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=7.1e-42  Score=291.19  Aligned_cols=200  Identities=25%  Similarity=0.434  Sum_probs=169.5

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++.+.     +++|+||||+. |+|.+++...+.+++.++..++.|++.||+|||++||+||||||+||
T Consensus        53 ~~~~~i~~~~~~~~~~-----~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Ni  127 (316)
T cd05620          53 WENPFLTHLYCTFQTK-----EHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNV  127 (316)
T ss_pred             cCCCCccCeeEEEEeC-----CEEEEEECCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHe
Confidence            3799999999999987     78999999997 59999998888899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCC-CCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSE-TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||+++.... ........|+..|+|||++.+ ..++.++|+||+||++|+|++|..||.+.+......
T Consensus       128 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~  206 (316)
T cd05620         128 MLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFE  206 (316)
T ss_pred             EECCCCCEEeCccCCCeecccCCCceeccCCCcCccCHHHHcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            999999999999999875322 222345678999999999987 778899999999999999999999998877554444


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCH-HHHhcCcccccCc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV-EEALRHPYLQSLH  237 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~-~ell~hp~~~~~~  237 (280)
                      .+...                               .+......+.++.++|++||+.||.+||++ +++++||||+.+.
T Consensus       207 ~~~~~-------------------------------~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~  255 (316)
T cd05620         207 SIRVD-------------------------------TPHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTIN  255 (316)
T ss_pred             HHHhC-------------------------------CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCC
Confidence            33210                               011122468899999999999999999998 5899999998763

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=6e-42  Score=292.59  Aligned_cols=200  Identities=26%  Similarity=0.463  Sum_probs=170.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++...     ...|+||||+. |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||
T Consensus        53 l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NI  127 (323)
T cd05575          53 VKHPFLVGLHYSFQTA-----DKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENI  127 (323)
T ss_pred             CCCCCCCCeeEEEEeC-----CEEEEEEcCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHe
Confidence            5799999999999887     77999999997 59999998888999999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCC-CCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSE-TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      |++.++.++|+|||++..... ........|++.|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+..+...
T Consensus       128 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~  206 (323)
T cd05575         128 LLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYD  206 (323)
T ss_pred             EECCCCcEEEeccCCCcccccCCCccccccCChhhcChhhhcC-CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHH
Confidence            999999999999999875322 223345678999999999877 678899999999999999999999998877555544


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCH----HHHhcCcccc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV----EEALRHPYLQ  234 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~----~ell~hp~~~  234 (280)
                      .+...                               .....+..++.+.++|++||+.||.+||++    .++++||||.
T Consensus       207 ~i~~~-------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~  255 (323)
T cd05575         207 NILNK-------------------------------PLRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFS  255 (323)
T ss_pred             HHHcC-------------------------------CCCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcC
Confidence            43320                               011234568999999999999999999987    6999999998


Q ss_pred             cCc
Q 023568          235 SLH  237 (280)
Q Consensus       235 ~~~  237 (280)
                      .+.
T Consensus       256 ~~~  258 (323)
T cd05575         256 SIN  258 (323)
T ss_pred             CCC
Confidence            753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=7.1e-42  Score=291.88  Aligned_cols=198  Identities=25%  Similarity=0.429  Sum_probs=170.9

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      +||||++++++|++.     ..+|+||||++ |+|.+.+.+.+.+++..+..++.|++.||.|||+.||+||||||+||+
T Consensus        54 ~hp~i~~~~~~~~~~-----~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nil  128 (321)
T cd05591          54 KHPFLTALHCCFQTK-----DRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNIL  128 (321)
T ss_pred             CCCCccceeeEEEcC-----CeEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeE
Confidence            699999999999987     67999999997 599999988889999999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccccCC-CCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           81 LNASCDLKIGDFGLARTTSE-TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      ++.++.++|+|||++..... ........|++.|+|||.+.+ ..++.++|+||+||++|+|++|+.||.+.+.......
T Consensus       129 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~  207 (321)
T cd05591         129 LDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFES  207 (321)
T ss_pred             ECCCCCEEEeecccceecccCCccccccccCccccCHHHHcC-CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHH
Confidence            99999999999999875332 223345678999999999876 6788999999999999999999999998876666555


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCC-------CHHHHhcCcc
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-------TVEEALRHPY  232 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rp-------t~~ell~hp~  232 (280)
                      +....                               ...+...+.++.++|++||+.||++|+       +++++++|||
T Consensus       208 i~~~~-------------------------------~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~  256 (321)
T cd05591         208 ILHDD-------------------------------VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPF  256 (321)
T ss_pred             HHcCC-------------------------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCc
Confidence            43210                               011124688999999999999999999       9999999999


Q ss_pred             cccC
Q 023568          233 LQSL  236 (280)
Q Consensus       233 ~~~~  236 (280)
                      |..+
T Consensus       257 ~~~~  260 (321)
T cd05591         257 FKEI  260 (321)
T ss_pred             cCCC
Confidence            9775

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.1e-41  Score=291.82  Aligned_cols=229  Identities=26%  Similarity=0.363  Sum_probs=171.2

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++...     ...++|||++.++|.+++.+ .+.+++..+..++.||+.||.|||+.||+||||||+||
T Consensus       114 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Ni  188 (357)
T PHA03209        114 VNHPSVIRMKDTLVSG-----AITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENI  188 (357)
T ss_pred             CCCCCCcChhheEEeC-----CeeEEEEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence            5899999999999987     67999999999999998865 46799999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCC-CCCCCCCh-----
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTRE-PLFPGKDY-----  153 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~-~pf~~~~~-----  153 (280)
                      +++.++.++|+|||.++............||..|+|||.+.+ ..++.++|+|||||++|+|+++. ++|.....     
T Consensus       189 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~  267 (357)
T PHA03209        189 FINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLAR-DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEY  267 (357)
T ss_pred             EECCCCCEEEecCccccccccCcccccccccccccCCeecCC-CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHH
Confidence            999999999999999876443333445678999999999877 67889999999999999999854 44444221     


Q ss_pred             ----HHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccc----cCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 023568          154 ----VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFAT----RFPNKSSGAVDLLEKMLVFDPNKRITVE  225 (280)
Q Consensus       154 ----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~ll~~~L~~dp~~Rpt~~  225 (280)
                          ...+..+....+..+..............++... ...+.+...    .....+.++.+||++||+.||.+|||++
T Consensus       268 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~  346 (357)
T PHA03209        268 VKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYA-SLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAE  346 (357)
T ss_pred             HHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhc-ccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHH
Confidence                1233333344443333322111111112222111 111111110    1124678889999999999999999999


Q ss_pred             HHhcCcccccC
Q 023568          226 EALRHPYLQSL  236 (280)
Q Consensus       226 ell~hp~~~~~  236 (280)
                      |+|+||||+++
T Consensus       347 e~l~hp~f~~~  357 (357)
T PHA03209        347 EILNYPMFAQL  357 (357)
T ss_pred             HHhcCchhccC
Confidence            99999999864

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.2e-41  Score=295.24  Aligned_cols=229  Identities=24%  Similarity=0.308  Sum_probs=178.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      |+||||++++++|...     ..+|+|||++.++|.+++...+.+++.++..++.||+.||.|||+.||+||||||+|||
T Consensus       143 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nil  217 (392)
T PHA03207        143 ISHRAIINLIHAYRWK-----STVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIF  217 (392)
T ss_pred             cCCCCccceeeeEeeC-----CEEEEEehhcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEE
Confidence            6899999999999877     77999999999999999977788999999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccccCCCC---ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC---hH
Q 023568           81 LNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD---YV  154 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~---~~  154 (280)
                      ++.++.++|+|||++.......   ......||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||.+..   ..
T Consensus       218 l~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~  296 (392)
T PHA03207        218 LDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLAL-DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSS  296 (392)
T ss_pred             EcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcH
Confidence            9999999999999987654332   1234578999999999876 678899999999999999999999998764   34


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccc--ccc--CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQF--ATR--FPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  230 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~--~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~h  230 (280)
                      ..+..+.+.++..+....... ..................+  +..  ....+.++.++|++||..||.+|||+.|+|.|
T Consensus       297 ~~l~~i~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        297 SQLRSIIRCMQVHPLEFPQNG-STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             HHHHHHHHHhccCccccCCcc-chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence            556666666554443322111 1111111222111111111  111  12457889999999999999999999999999


Q ss_pred             cccccC
Q 023568          231 PYLQSL  236 (280)
Q Consensus       231 p~~~~~  236 (280)
                      |||...
T Consensus       376 p~f~~~  381 (392)
T PHA03207        376 PLFTKE  381 (392)
T ss_pred             chhhcc
Confidence            999763

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-41  Score=291.55  Aligned_cols=205  Identities=24%  Similarity=0.447  Sum_probs=173.0

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++...     ...|+||||+. |+|.+++...+.+++..++.++.|++.||.|||+.||+||||||+||
T Consensus        58 ~~h~~iv~~~~~~~~~-----~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Ni  132 (333)
T cd05600          58 TKSEWLVKLLYAFQDD-----EYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENF  132 (333)
T ss_pred             CCCCCCccEEEEEEcC-----CEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHE
Confidence            4799999999999887     77999999997 59999998888899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.++.++|+|||++.....  ......|++.|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+..+....
T Consensus       133 l~~~~~~~kL~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~  209 (333)
T cd05600         133 LIDASGHIKLTDFGLSKGIVT--YANSVVGSPDYMAPEVLRG-KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWEN  209 (333)
T ss_pred             EECCCCCEEEEeCcCCccccc--ccCCcccCccccChhHhcC-CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHH
Confidence            999999999999999876544  2345678999999999987 6888999999999999999999999998876665554


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  236 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~  236 (280)
                      +.........                       .........++.++.++|++||..+|.+||+++++++||||...
T Consensus       210 i~~~~~~~~~-----------------------~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~  263 (333)
T cd05600         210 LKYWKETLQR-----------------------PVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV  263 (333)
T ss_pred             HHhccccccC-----------------------CCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence            4331110000                       00000112568999999999999999999999999999999875

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.3e-41  Score=283.79  Aligned_cols=225  Identities=37%  Similarity=0.700  Sum_probs=176.3

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++.+.     ...|+|+||++++|.+++.+ .+.+++..++.++.||+.||.|||+.|++||||+|+||
T Consensus        56 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~ni  130 (284)
T cd07839          56 LKHKNIVRLYDVLHSD-----KKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNL  130 (284)
T ss_pred             cCCCCeeeHHHHhccC-----CceEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHE
Confidence            5899999999999887     67999999999999998865 46799999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCC-CCCCChHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPGKDYVHQL  157 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~p-f~~~~~~~~~  157 (280)
                      +++.++.++|+|||.+...... .......++..|+|||.+.+...++.++|+||+||++|+|++|..| |.+.+....+
T Consensus       131 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~  210 (284)
T cd07839         131 LINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL  210 (284)
T ss_pred             EEcCCCcEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHH
Confidence            9999999999999998765432 2223456688999999987756678899999999999999998776 5556666777


Q ss_pred             HHHHHHhCCCCcccccccCChhHHHHHHhCCcc-ccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          158 RLITELIGSPDDASLGFLRSDNARRYVRQLPRC-RKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       158 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      ..+.+..+.+....+.........   ...... ....+....+..++.+.++|++||+.||.+|||++++++||||
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         211 KRIFRLLGTPTEESWPGVSKLPDY---KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             HHHHHHhCCCChHHhHHhhhcccc---cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            777776666554432211100000   000000 0111123345678999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.3e-41  Score=289.50  Aligned_cols=199  Identities=26%  Similarity=0.467  Sum_probs=169.6

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      +||||+++++++...     ..+|+||||++ |+|.+++...+.+++..+..++.|++.||+|||+.||+||||||+||+
T Consensus        54 ~hp~i~~~~~~~~~~-----~~~~lv~e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nil  128 (316)
T cd05592          54 EHPFLTHLFCTFQTK-----EHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVL  128 (316)
T ss_pred             CCCCccceeeEEEcC-----CEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeE
Confidence            799999999999887     77999999997 599999988889999999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccccCC-CCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           81 LNASCDLKIGDFGLARTTSE-TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      ++.++.++|+|||+++.... ........||+.|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.+.......
T Consensus       129 l~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~  207 (316)
T cd05592         129 LDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDS  207 (316)
T ss_pred             ECCCCCEEEccCcCCeECCCCCCccccccCCccccCHHHHcC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            99999999999999875432 223345678999999999887 6788999999999999999999999998876555444


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHH-HHhcCcccccCc
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVE-EALRHPYLQSLH  237 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~-ell~hp~~~~~~  237 (280)
                      +...                               .+......+..+.++|++||+.||.+||++. +++.||||+.+.
T Consensus       208 i~~~-------------------------------~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~  255 (316)
T cd05592         208 ILND-------------------------------RPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGID  255 (316)
T ss_pred             HHcC-------------------------------CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCC
Confidence            3220                               0111234688999999999999999999864 888999998753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.1e-41  Score=293.66  Aligned_cols=203  Identities=23%  Similarity=0.396  Sum_probs=166.4

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++.+++.     ..+|+||||+. |+|.+++.+.+.+++..++.++.|++.||+|||+.||+||||||+||
T Consensus        58 ~~~~~iv~~~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NI  132 (363)
T cd05628          58 ADSLWVVKMFYSFQDK-----LNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNL  132 (363)
T ss_pred             CCCCCcceEEEEEecC-----CeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHe
Confidence            5799999999999987     77999999997 59999998888999999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCC------------------------------------ccccceeccccccccccccCC
Q 023568           80 LLNASCDLKIGDFGLARTTSETD------------------------------------FMTEYVVTRWYRAPELLLNCT  123 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~------------------------------------~~~~~~~~~~y~aPE~~~~~~  123 (280)
                      |++.++.++|+|||+++......                                    .....+||+.|+|||++.+ .
T Consensus       133 Li~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~  211 (363)
T cd05628         133 LLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-T  211 (363)
T ss_pred             EECCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC-C
Confidence            99999999999999986432110                                    0123578999999999987 6


Q ss_pred             CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCC
Q 023568          124 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKS  203 (280)
Q Consensus       124 ~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  203 (280)
                      .++.++|+|||||++|+|++|..||.+.+......++.......                          .++. ...++
T Consensus       212 ~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~--------------------------~~p~-~~~~s  264 (363)
T cd05628         212 GYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETL--------------------------IFPP-EVPIS  264 (363)
T ss_pred             CCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcc--------------------------cCCC-cCCCC
Confidence            78899999999999999999999999887666555544311100                          0011 11368


Q ss_pred             HHHHHHHHHhccc--CCCCCCCHHHHhcCcccccC
Q 023568          204 SGAVDLLEKMLVF--DPNKRITVEEALRHPYLQSL  236 (280)
Q Consensus       204 ~~~~~ll~~~L~~--dp~~Rpt~~ell~hp~~~~~  236 (280)
                      ++++++|.+|+..  ++..||+++|+++||||+++
T Consensus       265 ~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~  299 (363)
T cd05628         265 EKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGV  299 (363)
T ss_pred             HHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCCC
Confidence            8999999998762  33356899999999999876

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.9e-41  Score=289.63  Aligned_cols=199  Identities=26%  Similarity=0.466  Sum_probs=169.0

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++.+.     ..+|+||||++| +|...+.. +.+++..+..++.|++.||+|||++|++||||||+||
T Consensus        59 l~hp~i~~~~~~~~~~-----~~~~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Ni  132 (324)
T cd05589          59 ERHPFLVNLFACFQTE-----DHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNL  132 (324)
T ss_pred             cCCCChhceeeEEEcC-----CEEEEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHe
Confidence            4699999999999887     779999999985 88887754 6799999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCC-CCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSE-TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||+++.... ........|++.|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+......
T Consensus       133 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~  211 (324)
T cd05589         133 LLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD  211 (324)
T ss_pred             EECCCCcEEeCcccCCccCCCCCCcccccccCccccCHhHhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            999999999999999875322 222345678999999999877 778899999999999999999999999887665554


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYL  233 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rp-----t~~ell~hp~~  233 (280)
                      .+....                               ...+...++.+.++|++||+.||.+||     ++.++++||||
T Consensus       212 ~i~~~~-------------------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f  260 (324)
T cd05589         212 SIVNDE-------------------------------VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFF  260 (324)
T ss_pred             HHHhCC-------------------------------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCc
Confidence            443210                               011235688999999999999999999     79999999999


Q ss_pred             ccCc
Q 023568          234 QSLH  237 (280)
Q Consensus       234 ~~~~  237 (280)
                      +++.
T Consensus       261 ~~~~  264 (324)
T cd05589         261 RDIN  264 (324)
T ss_pred             CCCC
Confidence            8764

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=5.1e-42  Score=293.26  Aligned_cols=199  Identities=27%  Similarity=0.443  Sum_probs=169.1

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~-~~i~H~dik~~N   78 (280)
                      ++||||+++++++...     ..+|+||||++ |+|.+++...+.+++..++.++.||+.||+|||+ .||+||||||+|
T Consensus        52 ~~hp~i~~~~~~~~~~-----~~~~lv~E~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~N  126 (325)
T cd05594          52 SRHPFLTALKYSFQTH-----DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLEN  126 (325)
T ss_pred             CCCCCCCceEEEEEcC-----CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCe
Confidence            5799999999999887     77999999997 5999999887889999999999999999999997 799999999999


Q ss_pred             eEEcCCCCeEEeecccccccCC-CCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023568           79 LLLNASCDLKIGDFGLARTTSE-TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  157 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~  157 (280)
                      |+++.++.++|+|||+++.... ........|++.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+.....
T Consensus       127 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~  205 (325)
T cd05594         127 LMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF  205 (325)
T ss_pred             EEECCCCCEEEecCCCCeecCCCCcccccccCCcccCCHHHHcc-CCCCCccccccccceeeeeccCCCCCCCCCHHHHH
Confidence            9999999999999999875332 222345678999999999877 67889999999999999999999999887654444


Q ss_pred             HHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCcc
Q 023568          158 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPY  232 (280)
Q Consensus       158 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rp-----t~~ell~hp~  232 (280)
                      ..+....                               .......++++.++|++||+.||.+|+     ++.++++|||
T Consensus       206 ~~i~~~~-------------------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~  254 (325)
T cd05594         206 ELILMEE-------------------------------IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKF  254 (325)
T ss_pred             HHHhcCC-------------------------------CCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCC
Confidence            3332100                               011235688999999999999999997     9999999999


Q ss_pred             cccC
Q 023568          233 LQSL  236 (280)
Q Consensus       233 ~~~~  236 (280)
                      |.+.
T Consensus       255 ~~~~  258 (325)
T cd05594         255 FAGI  258 (325)
T ss_pred             cCCC
Confidence            9875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.3e-41  Score=287.98  Aligned_cols=200  Identities=26%  Similarity=0.465  Sum_probs=169.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++.+.     ..+|+||||+. |+|.+++.+...+++.++..++.|++.||.|||+.|++||||||+||
T Consensus        53 ~~hp~iv~~~~~~~~~-----~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Ni  127 (316)
T cd05619          53 WEHPFLTHLYCTFQTK-----ENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNI  127 (316)
T ss_pred             cCCCcCcceEEEEEeC-----CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHE
Confidence            3799999999999987     67999999997 59999998878899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCC-CCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSE-TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||++..... ........||..|+|||++.+ ..++.++|+||+||++|+|++|..||.+.+......
T Consensus       128 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~  206 (316)
T cd05619         128 LLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQ  206 (316)
T ss_pred             EECCCCCEEEccCCcceECCCCCCceeeecCCccccCHHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            999999999999999875322 222345678999999999877 678899999999999999999999998877555444


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHH-HHhcCcccccCc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVE-EALRHPYLQSLH  237 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~-ell~hp~~~~~~  237 (280)
                      .+....                               +......+..+.+++.+||+.||.+||++. +++.||||+.+.
T Consensus       207 ~i~~~~-------------------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~  255 (316)
T cd05619         207 SIRMDN-------------------------------PCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREID  255 (316)
T ss_pred             HHHhCC-------------------------------CCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCC
Confidence            432100                               011124688899999999999999999996 999999998864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.7e-41  Score=287.88  Aligned_cols=199  Identities=24%  Similarity=0.449  Sum_probs=169.9

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      +||||+++++++++.     +.+|+||||+. |+|.+.+.+.+.+++..+..++.|++.||+|||+.|++||||||+||+
T Consensus        54 ~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil  128 (318)
T cd05570          54 KHPFLTQLHSCFQTK-----DRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVL  128 (318)
T ss_pred             CCCCccceeeEEEcC-----CEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeE
Confidence            699999999999887     77999999997 599999988789999999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccccCC-CCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           81 LNASCDLKIGDFGLARTTSE-TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      ++.++.++|+|||+++.... ........|+..|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.+.......
T Consensus       129 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~  207 (318)
T cd05570         129 LDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQS  207 (318)
T ss_pred             ECCCCcEEecccCCCeecCcCCCcccceecCccccCHHHhcC-CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHH
Confidence            99999999999999875322 222344578999999999987 7788999999999999999999999988775554443


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCH-----HHHhcCcccc
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV-----EEALRHPYLQ  234 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~-----~ell~hp~~~  234 (280)
                      +....                               .......+..+.++|++||+.||.+|||+     .++++||||+
T Consensus       208 i~~~~-------------------------------~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~  256 (318)
T cd05570         208 ILEDE-------------------------------VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFR  256 (318)
T ss_pred             HHcCC-------------------------------CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcC
Confidence            32200                               01123468899999999999999999999     9999999998


Q ss_pred             cCc
Q 023568          235 SLH  237 (280)
Q Consensus       235 ~~~  237 (280)
                      ...
T Consensus       257 ~~~  259 (318)
T cd05570         257 EID  259 (318)
T ss_pred             CCC
Confidence            753

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=7e-41  Score=285.16  Aligned_cols=230  Identities=37%  Similarity=0.640  Sum_probs=170.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD---------QQLTDDHCQYFLYQLLRGLKYVHSASVLH   71 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~---------~~l~~~~~~~i~~qil~~l~~LH~~~i~H   71 (280)
                      ++||||+++++++.....   ..+|+||||++++|.+++...         ..+++..++.++.|++.||.|||+.|++|
T Consensus        55 l~h~niv~~~~~~~~~~~---~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH  131 (317)
T cd07867          55 LKHPNVIALQKVFLSHSD---RKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLH  131 (317)
T ss_pred             CCCCCeeeEEEEEeccCC---CeEEEEEeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEc
Confidence            589999999999865432   678999999999999887521         24899999999999999999999999999


Q ss_pred             cCCCCCceEE----cCCCCeEEeecccccccCCCC----ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh
Q 023568           72 RDLKPSNLLL----NASCDLKIGDFGLARTTSETD----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT  143 (280)
Q Consensus        72 ~dik~~Nili----~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~  143 (280)
                      |||||+||++    +.++.++|+|||+++......    ......+|..|+|||.+.+...++.++|+||+||++|+|++
T Consensus       132 ~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~t  211 (317)
T cd07867         132 RDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT  211 (317)
T ss_pred             CCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHh
Confidence            9999999999    456789999999998654331    22345779999999998775668899999999999999999


Q ss_pred             CCCCCCCCCh---------HHHHHHHHHHhCCCCcccccccCChh-HHHHHHhCC--ccccc----cccccCCCCCHHHH
Q 023568          144 REPLFPGKDY---------VHQLRLITELIGSPDDASLGFLRSDN-ARRYVRQLP--RCRKQ----QFATRFPNKSSGAV  207 (280)
Q Consensus       144 g~~pf~~~~~---------~~~~~~i~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~----~~~~~~~~~~~~~~  207 (280)
                      |.+||.....         ......+....+.+....+....... .........  .....    .........+..+.
T Consensus       212 g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (317)
T cd07867         212 SEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVF  291 (317)
T ss_pred             CCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHH
Confidence            9999976432         34455666666655544432221100 000000000  00000    01111123567899


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          208 DLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       208 ~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      +++.+||+.||.+|||++|+|+||||
T Consensus       292 ~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         292 LLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             HHHHHHhccCcccccCHHHHhcCCCC
Confidence            99999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.6e-42  Score=289.60  Aligned_cols=200  Identities=33%  Similarity=0.520  Sum_probs=180.7

Q ss_pred             CCCcccccccccccCCCCCCCCc-EEEEEecCCc-cHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFND-VYIVYELMDT-DLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP   76 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~-~~lv~e~~~g-~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~   76 (280)
                      ++|||||.+++.|..+     +. ++|||+||+| ++.+.|.+.  ..|+++.+..|+.|++.||.|||+++|.|||||+
T Consensus        60 ~~hP~iv~y~ds~~~~-----~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~  134 (426)
T KOG0589|consen   60 LLHPNIVEYKDSFEED-----GQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKC  134 (426)
T ss_pred             ccCCCeeeeccchhcC-----CceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchh
Confidence            6899999999999988     55 9999999985 999998653  4699999999999999999999999999999999


Q ss_pred             CceEEcCCCCeEEeecccccccCCCC-ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023568           77 SNLLLNASCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH  155 (280)
Q Consensus        77 ~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~  155 (280)
                      .||+++.++.++|+|||+|+..+... ...+..||++|++||++.+ ..|+.++|+|||||++|||++-+++|.+.+...
T Consensus       135 ~Nifltk~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d-~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~  213 (426)
T KOG0589|consen  135 ANIFLTKDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSD-IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE  213 (426)
T ss_pred             hhhhccccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhCC-CCCCccCcchhhcchHHHHHhcccccCccchHH
Confidence            99999999999999999999988775 7788999999999999988 999999999999999999999999999999888


Q ss_pred             HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 023568          156 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  235 (280)
Q Consensus       156 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~  235 (280)
                      ...+|......|                              .....+.+++.+++.||..+|..||++.++|.+|.+..
T Consensus       214 Li~ki~~~~~~P------------------------------lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~  263 (426)
T KOG0589|consen  214 LILKINRGLYSP------------------------------LPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLR  263 (426)
T ss_pred             HHHHHhhccCCC------------------------------CCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence            888876644222                              23367999999999999999999999999999998864


Q ss_pred             C
Q 023568          236 L  236 (280)
Q Consensus       236 ~  236 (280)
                      .
T Consensus       264 ~  264 (426)
T KOG0589|consen  264 Y  264 (426)
T ss_pred             H
Confidence            3

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.6e-41  Score=291.06  Aligned_cols=203  Identities=20%  Similarity=0.348  Sum_probs=166.5

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      +||||+++++++...     +.+|+||||+. |+|.+++.+++.+++.+++.++.||+.||+|||+.||+||||||+|||
T Consensus        63 ~~~~i~~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil  137 (332)
T cd05614          63 QSPFLVTLHYAFQTE-----AKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENIL  137 (332)
T ss_pred             CCCCcccEEEEEecC-----CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeE
Confidence            599999999999887     67999999997 599999988888999999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccccCCC--CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           81 LNASCDLKIGDFGLARTTSET--DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      ++.++.++|+|||+++.....  .......||..|+|||.+.+...++.++|||||||++|+|++|..||..........
T Consensus       138 i~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~  217 (332)
T cd05614         138 LDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS  217 (332)
T ss_pred             ECCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH
Confidence            999999999999998764332  222345789999999999875567889999999999999999999997543211111


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYL  233 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rp-----t~~ell~hp~~  233 (280)
                      .+.....                           ...+...+.+++.+.+++++||+.||++||     +++++++||||
T Consensus       218 ~~~~~~~---------------------------~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~  270 (332)
T cd05614         218 EVSRRIL---------------------------KCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFF  270 (332)
T ss_pred             HHHHHHh---------------------------cCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCc
Confidence            1111000                           000112235789999999999999999999     88999999999


Q ss_pred             ccC
Q 023568          234 QSL  236 (280)
Q Consensus       234 ~~~  236 (280)
                      ++.
T Consensus       271 ~~~  273 (332)
T cd05614         271 KGL  273 (332)
T ss_pred             CCC
Confidence            875

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=9.5e-41  Score=283.47  Aligned_cols=234  Identities=40%  Similarity=0.711  Sum_probs=184.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++.....   +.+|+||||++++|.+++.. ...+++.++..++.|++.||+|||+.|++||||+|+||
T Consensus        63 l~h~~i~~~~~~~~~~~~---~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~ni  139 (309)
T cd07845          63 LRHPNIVELKEVVVGKHL---DSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNL  139 (309)
T ss_pred             CCCCCCcceEEEEecCCC---CeEEEEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence            589999999999976532   56899999999999998875 36799999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||.+...... .......++..|+|||.+.+...++.++|+||+||++|+|++|.+||.+.+..+.+.
T Consensus       140 l~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~  219 (309)
T cd07845         140 LLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLD  219 (309)
T ss_pred             EECCCCCEEECccceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            9999999999999998865543 222334457889999998775678899999999999999999999999999889999


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCcC
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  238 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~~  238 (280)
                      .+....+.+....+............ .............++..++.+.++|++||+.||++|||++++++||||+....
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~  298 (309)
T cd07845         220 LIIQLLGTPNESIWPGFSDLPLVGKF-TLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPL  298 (309)
T ss_pred             HHHHhcCCCChhhchhhhcccccccc-cccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCC
Confidence            88888877665544322111000000 00000011111223346889999999999999999999999999999987643

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-41  Score=292.94  Aligned_cols=203  Identities=28%  Similarity=0.478  Sum_probs=171.3

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++.+.     ..+|+||||+. ++|.+++.+.+.+++..++.++.|++.||+|||+.||+||||||+||
T Consensus        58 ~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NI  132 (350)
T cd05573          58 ADSPWIVKLYYSFQDE-----EHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNI  132 (350)
T ss_pred             cCCCCccchhhheecC-----CeEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHe
Confidence            4799999999999987     77999999997 59999998878999999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCC------------------------------ccccceeccccccccccccCCCCCcch
Q 023568           80 LLNASCDLKIGDFGLARTTSETD------------------------------FMTEYVVTRWYRAPELLLNCTEYTAAI  129 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~  129 (280)
                      +++.++.++|+|||++.......                              ......||+.|+|||++.+ ..++.++
T Consensus       133 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~  211 (350)
T cd05573         133 LIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLEC  211 (350)
T ss_pred             EECCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcC-CCCCCce
Confidence            99999999999999987654332                              2234578999999999987 6889999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHH
Q 023568          130 DIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDL  209 (280)
Q Consensus       130 DvwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  209 (280)
                      |||||||++|+|++|+.||...+.......+.......                           .......+++.+.++
T Consensus       212 DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~---------------------------~~p~~~~~~~~~~~l  264 (350)
T cd05573         212 DWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESL---------------------------RFPPDPPVSPEAIDL  264 (350)
T ss_pred             eeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcc---------------------------cCCCCCCCCHHHHHH
Confidence            99999999999999999999887655555443311100                           001112368999999


Q ss_pred             HHHhcccCCCCCCC-HHHHhcCcccccCc
Q 023568          210 LEKMLVFDPNKRIT-VEEALRHPYLQSLH  237 (280)
Q Consensus       210 l~~~L~~dp~~Rpt-~~ell~hp~~~~~~  237 (280)
                      |++||. ||.+|++ ++++++||||+.+.
T Consensus       265 i~~ll~-dp~~R~~s~~~ll~hp~~~~~~  292 (350)
T cd05573         265 ICRLLC-DPEDRLGSFEEIKSHPFFKGID  292 (350)
T ss_pred             HHHHcc-ChhhcCCCHHHHhcCCCcCCCC
Confidence            999997 9999999 99999999998753

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.5e-41  Score=290.81  Aligned_cols=207  Identities=22%  Similarity=0.453  Sum_probs=165.1

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      +||||++++++|.+.     ..+|+||||++ |+|.+++.+.+++++..++.++.|++.||.|||++|++||||||+||+
T Consensus        54 ~hp~Iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil  128 (329)
T cd05588          54 NHPFLVGLHSCFQTE-----SRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVL  128 (329)
T ss_pred             CCCCCCceEEEEEcC-----CEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeE
Confidence            699999999999987     77999999997 599999988889999999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeeccccccc-CCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           81 LNASCDLKIGDFGLARTT-SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      ++.++.++|+|||+++.. ..........||+.|+|||++.+ ..++.++|+||+||++|+|++|+.||........   
T Consensus       129 i~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~---  204 (329)
T cd05588         129 LDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDN---  204 (329)
T ss_pred             ECCCCCEEECcCccccccccCCCccccccCCccccCHHHHcC-CCCCCccceechHHHHHHHHHCCCCccccccccc---
Confidence            999999999999998753 22233445678999999999987 7788999999999999999999999964321000   


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCC------HHHHhcCccc
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT------VEEALRHPYL  233 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt------~~ell~hp~~  233 (280)
                             +....     .......+.       ......+..++..+.++|++||+.||.+|+|      ++++++||||
T Consensus       205 -------~~~~~-----~~~~~~~~~-------~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~  265 (329)
T cd05588         205 -------PDQNT-----EDYLFQVIL-------EKQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFF  265 (329)
T ss_pred             -------ccccc-----hHHHHHHHH-------cCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCC
Confidence                   00000     000000000       0001123357889999999999999999997      7899999999


Q ss_pred             ccC
Q 023568          234 QSL  236 (280)
Q Consensus       234 ~~~  236 (280)
                      ..+
T Consensus       266 ~~~  268 (329)
T cd05588         266 RNI  268 (329)
T ss_pred             CCC
Confidence            864

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-41  Score=294.02  Aligned_cols=203  Identities=26%  Similarity=0.478  Sum_probs=168.2

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||++++++|.+.     ..+|+||||+. |+|.+++...+.+++..++.++.|++.||+|||+.||+||||||+||
T Consensus        58 l~h~~iv~~~~~~~~~-----~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NI  132 (364)
T cd05599          58 ADNPWVVKLYYSFQDE-----NYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNL  132 (364)
T ss_pred             CCCCCCcceEEEEEcC-----CeEEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHe
Confidence            5799999999999988     78999999997 59999998888899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCC---------------------------------------ccccceeccccccccccc
Q 023568           80 LLNASCDLKIGDFGLARTTSETD---------------------------------------FMTEYVVTRWYRAPELLL  120 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~---------------------------------------~~~~~~~~~~y~aPE~~~  120 (280)
                      |++.++.++|+|||++.......                                       ......||+.|+|||++.
T Consensus       133 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  212 (364)
T cd05599         133 LLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL  212 (364)
T ss_pred             EECCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHc
Confidence            99999999999999986432110                                       011246899999999987


Q ss_pred             cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCC
Q 023568          121 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP  200 (280)
Q Consensus       121 ~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  200 (280)
                      + ..++.++|+|||||++|+|++|..||.+.+.......+.......                          ..+ ...
T Consensus       213 ~-~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~--------------------------~~~-~~~  264 (364)
T cd05599         213 Q-TGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETL--------------------------QFP-DEV  264 (364)
T ss_pred             C-CCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCcc--------------------------CCC-CCC
Confidence            6 778899999999999999999999999887655544443210000                          000 011


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCC---HHHHhcCcccccCc
Q 023568          201 NKSSGAVDLLEKMLVFDPNKRIT---VEEALRHPYLQSLH  237 (280)
Q Consensus       201 ~~~~~~~~ll~~~L~~dp~~Rpt---~~ell~hp~~~~~~  237 (280)
                      ..++.+.++|++||. +|.+|++   ++|+++||||+...
T Consensus       265 ~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~  303 (364)
T cd05599         265 PLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVD  303 (364)
T ss_pred             CCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCC
Confidence            468899999999997 9999998   99999999998753

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=6.7e-42  Score=291.69  Aligned_cols=199  Identities=26%  Similarity=0.475  Sum_probs=170.9

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++.++     ..+|+||||++ |+|.+++.+...+++..+..++.||+.||+|||+.||+||||||+||
T Consensus        55 l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni  129 (318)
T cd05582          55 VNHPFIVKLHYAFQTE-----GKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENI  129 (318)
T ss_pred             CCCCCcccEEEEEEcC-----CEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHe
Confidence            5799999999999987     77999999997 59999998878899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||++...... .......|+..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.+......
T Consensus       130 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~  208 (318)
T cd05582         130 LLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMT  208 (318)
T ss_pred             EECCCCcEEEeeccCCcccCCCCCceecccCChhhcCHHHHcC-CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHH
Confidence            9999999999999998765433 22345678999999999876 677889999999999999999999998877655554


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCccc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT-----VEEALRHPYL  233 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt-----~~ell~hp~~  233 (280)
                      .+....                               .......++.+.++|++||+.||.+|||     +++++.||||
T Consensus       209 ~i~~~~-------------------------------~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~  257 (318)
T cd05582         209 MILKAK-------------------------------LGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFF  257 (318)
T ss_pred             HHHcCC-------------------------------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCc
Confidence            443210                               0112356889999999999999999999     7889999999


Q ss_pred             ccC
Q 023568          234 QSL  236 (280)
Q Consensus       234 ~~~  236 (280)
                      ..+
T Consensus       258 ~~~  260 (318)
T cd05582         258 STI  260 (318)
T ss_pred             CCC
Confidence            875

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.5e-40  Score=278.80  Aligned_cols=226  Identities=41%  Similarity=0.769  Sum_probs=182.1

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~--~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||+++++++.+.     ...++||||+.++|.+++..  ...+++..+..++.|++.||+|||+.|++|+||+|+|
T Consensus        56 l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~n  130 (284)
T cd07860          56 LNHPNIVKLLDVIHTE-----NKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQN  130 (284)
T ss_pred             cCCCCCcchhhhcccC-----CcEEEEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHH
Confidence            5899999999999877     67999999999899998865  3568999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023568           79 LLLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  157 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~  157 (280)
                      |+++.++.++|+|||.+...... .......++..|+|||.+.+...++.++|+||||+++|+|++|+.||.+.+.....
T Consensus       131 ill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~  210 (284)
T cd07860         131 LLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL  210 (284)
T ss_pred             EEECCCCCEEEeeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence            99999999999999998755432 22233456788999998877555688999999999999999999999998877777


Q ss_pred             HHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          158 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       158 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      .++.+..+.+....++....  ........+...........+.+++.++++|.+||+.||++|||+++++.||||
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         211 FRIFRTLGTPDEVVWPGVTS--LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HHHHHHhCCCChhhhhhhhH--HHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence            77777777665543322111  111222223333333334455678999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.9e-41  Score=289.73  Aligned_cols=199  Identities=25%  Similarity=0.475  Sum_probs=169.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||++++++++..     +..|+||||+. |+|.+.+.+.+.+++..++.++.||+.||+|||+.||+||||||+||
T Consensus        53 ~~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NI  127 (325)
T cd05604          53 VKHPFLVGLHYSFQTT-----EKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENI  127 (325)
T ss_pred             CCCCCCccEEEEEecC-----CEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHe
Confidence            5799999999999887     77999999997 59999998888999999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCC-CCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSE-TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||+++.... ........|++.|+|||.+.+ ..++.++|+||+||++|+|++|..||...+......
T Consensus       128 ll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~  206 (325)
T cd05604         128 LLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYD  206 (325)
T ss_pred             EECCCCCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcC-CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHH
Confidence            999999999999999875322 223345678999999999877 678889999999999999999999998877555544


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCH----HHHhcCcccc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV----EEALRHPYLQ  234 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~----~ell~hp~~~  234 (280)
                      .+...                               .....+..+..+.++|++||+.||.+||++    .++++||||+
T Consensus       207 ~~~~~-------------------------------~~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~  255 (325)
T cd05604         207 NILHK-------------------------------PLVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFE  255 (325)
T ss_pred             HHHcC-------------------------------CccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcC
Confidence            43220                               011223568899999999999999999976    5999999998


Q ss_pred             cC
Q 023568          235 SL  236 (280)
Q Consensus       235 ~~  236 (280)
                      ..
T Consensus       256 ~~  257 (325)
T cd05604         256 SL  257 (325)
T ss_pred             CC
Confidence            75

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.4e-42  Score=292.24  Aligned_cols=200  Identities=25%  Similarity=0.452  Sum_probs=169.5

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      +||||++++++|.+.     ..+|+||||+. |+|.+++.+.+.+++..++.++.||+.||+|||+.||+||||||+|||
T Consensus        54 ~~p~i~~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nil  128 (330)
T cd05586          54 ESPFIVGLKFSFQTD-----SDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENIL  128 (330)
T ss_pred             CCCcCcceEEEEecC-----CeEEEEEcCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeE
Confidence            699999999999988     77999999997 599999988889999999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccccCC-CCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           81 LNASCDLKIGDFGLARTTSE-TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      ++.++.++|+|||++..... ........||..|+|||.+.+...++.++||||+||++|+|++|..||.+.+..+....
T Consensus       129 i~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~  208 (330)
T cd05586         129 LDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRN  208 (330)
T ss_pred             ECCCCCEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHH
Confidence            99999999999999875332 23334567899999999987655688999999999999999999999988775554444


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCC----CHHHHhcCccccc
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI----TVEEALRHPYLQS  235 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rp----t~~ell~hp~~~~  235 (280)
                      +.....                            .++  ...+++.+.++|++||+.||.+||    +++++++||||..
T Consensus       209 i~~~~~----------------------------~~~--~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~  258 (330)
T cd05586         209 IAFGKV----------------------------RFP--KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFAD  258 (330)
T ss_pred             HHcCCC----------------------------CCC--CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccC
Confidence            322100                            000  113688999999999999999998    7999999999986


Q ss_pred             C
Q 023568          236 L  236 (280)
Q Consensus       236 ~  236 (280)
                      .
T Consensus       259 ~  259 (330)
T cd05586         259 I  259 (330)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=3.3e-41  Score=294.37  Aligned_cols=203  Identities=27%  Similarity=0.448  Sum_probs=166.4

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++.|.+.     ..+|+||||++ |+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||
T Consensus        58 ~~h~~iv~~~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NI  132 (382)
T cd05625          58 ADNEWVVRLYYSFQDK-----DNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNI  132 (382)
T ss_pred             CCCCcCCeEEEEEEeC-----CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence            5799999999999987     77999999997 59999998878899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC------------------------------------------------Cccccceecc
Q 023568           80 LLNASCDLKIGDFGLARTTSET------------------------------------------------DFMTEYVVTR  111 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~------------------------------------------------~~~~~~~~~~  111 (280)
                      |++.++.++|+|||++......                                                .......||+
T Consensus       133 Ll~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  212 (382)
T cd05625         133 LIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTP  212 (382)
T ss_pred             EECCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCc
Confidence            9999999999999987422100                                                0012346899


Q ss_pred             ccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccc
Q 023568          112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCR  191 (280)
Q Consensus       112 ~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (280)
                      .|+|||++.+ ..++.++|+||+||++|+|++|++||.+.+.......+.......                        
T Consensus       213 ~Y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~------------------------  267 (382)
T cd05625         213 NYIAPEVLLR-TGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSL------------------------  267 (382)
T ss_pred             ccCCHHHhcC-CCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCc------------------------
Confidence            9999999877 678899999999999999999999999877655444433211000                        


Q ss_pred             cccccccCCCCCHHHHHHHHHhcccCCCCCCC---HHHHhcCcccccCc
Q 023568          192 KQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT---VEEALRHPYLQSLH  237 (280)
Q Consensus       192 ~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt---~~ell~hp~~~~~~  237 (280)
                         .......+++++.++|.+|+ .+|.+|++   ++++++||||+.+.
T Consensus       268 ---~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~  312 (382)
T cd05625         268 ---HIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTID  312 (382)
T ss_pred             ---CCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcC
Confidence               00112356899999999976 59999997   99999999998753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=6e-41  Score=292.57  Aligned_cols=204  Identities=25%  Similarity=0.399  Sum_probs=165.2

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++.+.     ..+|+||||+. |+|.+++.+.+.+++..++.++.||+.||.|||+.||+||||||+||
T Consensus        58 l~h~~iv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Ni  132 (381)
T cd05626          58 ADNEWVVKLYYSFQDK-----DNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNI  132 (381)
T ss_pred             cCCCCeeeeEEEEecC-----CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHE
Confidence            5799999999999987     77999999997 59999998888899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC------------------------------------------------Cccccceecc
Q 023568           80 LLNASCDLKIGDFGLARTTSET------------------------------------------------DFMTEYVVTR  111 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~------------------------------------------------~~~~~~~~~~  111 (280)
                      |++.++.++|+|||+++.....                                                .......||+
T Consensus       133 li~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  212 (381)
T cd05626         133 LIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTP  212 (381)
T ss_pred             EECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCc
Confidence            9999999999999987532100                                                0012356899


Q ss_pred             ccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccc
Q 023568          112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCR  191 (280)
Q Consensus       112 ~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (280)
                      .|+|||++.+ ..++.++|+|||||++|+|++|..||...+.......+.......                        
T Consensus       213 ~Y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~------------------------  267 (381)
T cd05626         213 NYIAPEVLLR-KGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTL------------------------  267 (381)
T ss_pred             cccCHHHHcC-CCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHcccccc------------------------
Confidence            9999999877 678899999999999999999999998877554443332210000                        


Q ss_pred             cccccccCCCCCHHHHHHHHHhcc--cCCCCCCCHHHHhcCcccccCc
Q 023568          192 KQQFATRFPNKSSGAVDLLEKMLV--FDPNKRITVEEALRHPYLQSLH  237 (280)
Q Consensus       192 ~~~~~~~~~~~~~~~~~ll~~~L~--~dp~~Rpt~~ell~hp~~~~~~  237 (280)
                         .......+++++.+||.+||.  .+|..|++++++++||||+.+.
T Consensus       268 ---~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~  312 (381)
T cd05626         268 ---HIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVD  312 (381)
T ss_pred             ---CCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCC
Confidence               001112468999999999665  4555699999999999998753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.6e-40  Score=284.63  Aligned_cols=226  Identities=21%  Similarity=0.358  Sum_probs=170.5

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~-~i~H~dik~~N   78 (280)
                      ++||||+++++++...     +.+++||||++| +|.+++...+.+++..+..++.|++.||.|||+. +|+||||||+|
T Consensus        60 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~N  134 (331)
T cd06649          60 CNSPYIVGFYGAFYSD-----GEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSN  134 (331)
T ss_pred             CCCCCCCeEEEEEEEC-----CEEEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhh
Confidence            5899999999999887     679999999985 9999998888899999999999999999999986 69999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      |+++.++.++|+|||++...... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+......
T Consensus       135 il~~~~~~~kl~Dfg~~~~~~~~-~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~  212 (331)
T cd06649         135 ILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEA  212 (331)
T ss_pred             EEEcCCCcEEEccCccccccccc-ccccCCCCcCcCCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            99999999999999998765432 2344578999999999987 678899999999999999999999998776544332


Q ss_pred             HHHHHhCCCCccccc-------------------ccCChhHHHHHHhCCcccccccccc-CCCCCHHHHHHHHHhcccCC
Q 023568          159 LITELIGSPDDASLG-------------------FLRSDNARRYVRQLPRCRKQQFATR-FPNKSSGAVDLLEKMLVFDP  218 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ll~~~L~~dp  218 (280)
                      .+.............                   .............+   .....+.. ....++++++||.+||+.||
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~~L~~~P  289 (331)
T cd06649         213 IFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYI---VNEPPPKLPNGVFTPDFQEFVNKCLIKNP  289 (331)
T ss_pred             HhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHH---HhCCCcCCCCccccHHHHHHHHHHccCCc
Confidence            221110000000000                   00000000111111   00011111 12468899999999999999


Q ss_pred             CCCCCHHHHhcCcccccC
Q 023568          219 NKRITVEEALRHPYLQSL  236 (280)
Q Consensus       219 ~~Rpt~~ell~hp~~~~~  236 (280)
                      ++|||++++++||||+..
T Consensus       290 ~~Rpt~~ell~h~~~~~~  307 (331)
T cd06649         290 AERADLKMLMNHTFIKRS  307 (331)
T ss_pred             ccCCCHHHHhcChHHhhc
Confidence            999999999999999764

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.1e-40  Score=279.22  Aligned_cols=204  Identities=24%  Similarity=0.412  Sum_probs=165.9

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK   75 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~----~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik   75 (280)
                      ++||||+++.+++...     ...|+||||++ |+|.+.+.    ....+++..+..++.|++.||+|||+.||+|||||
T Consensus        50 l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlk  124 (280)
T cd05608          50 VHSRFIVSLAYAFQTK-----TDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLK  124 (280)
T ss_pred             CCCCcEeeeeEEEcCC-----CeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence            5899999999999887     67999999997 58988774    23569999999999999999999999999999999


Q ss_pred             CCceEEcCCCCeEEeecccccccCCCC-ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023568           76 PSNLLLNASCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV  154 (280)
Q Consensus        76 ~~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~  154 (280)
                      |+||+++.++.++|+|||.+....... ......|++.|+|||.+.+ ..++.++|+||+||++|+|++|+.||......
T Consensus       125 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~  203 (280)
T cd05608         125 PENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEK  203 (280)
T ss_pred             HHHEEECCCCCEEEeeCccceecCCCCccccccCCCcCccCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCcc
Confidence            999999999999999999987654332 2234578899999999987 67888999999999999999999999876432


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALR  229 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rp-----t~~ell~  229 (280)
                      .....+.....                           ..........+..+.+++.+||+.||++||     |++++++
T Consensus       204 ~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         204 VENKELKQRIL---------------------------NDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             hhHHHHHHhhc---------------------------ccCCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            22111111000                           000112235789999999999999999999     8899999


Q ss_pred             CcccccCc
Q 023568          230 HPYLQSLH  237 (280)
Q Consensus       230 hp~~~~~~  237 (280)
                      ||||+++.
T Consensus       257 h~~~~~~~  264 (280)
T cd05608         257 HPLFRDLN  264 (280)
T ss_pred             ChhhhcCC
Confidence            99998864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.3e-40  Score=279.64  Aligned_cols=232  Identities=40%  Similarity=0.729  Sum_probs=184.2

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++.+.     ...|+||||++|+|.+++.... .+++..+..++.||+.||.|||++|++|+||+|+||
T Consensus        59 ~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~ni  133 (298)
T cd07841          59 LKHPNIIGLLDVFGHK-----SNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNL  133 (298)
T ss_pred             cCCCCChhhhheeecC-----CEEEEEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhE
Confidence            5799999999999986     7799999999889999997765 799999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||++...... .......++..|+|||.+.+...++.++|+||+||++++|++|.++|.+.+....+.
T Consensus       134 ll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~  213 (298)
T cd07841         134 LIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLG  213 (298)
T ss_pred             EEcCCCCEEEccceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHH
Confidence            9999999999999999765543 223334567889999998765677899999999999999999999999888777777


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCcC
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  238 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~~  238 (280)
                      ++....+.+....+.......  .+ ..............+...+..+.+++++||..||++|||+.|++.||||++...
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~--~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~  290 (298)
T cd07841         214 KIFEALGTPTEENWPGVTSLP--DY-VEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPA  290 (298)
T ss_pred             HHHHHcCCCchhhhhhccccc--cc-ccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCC
Confidence            776666555444332111100  00 000111111222334567889999999999999999999999999999988654


Q ss_pred             CC
Q 023568          239 LN  240 (280)
Q Consensus       239 ~~  240 (280)
                      +.
T Consensus       291 ~~  292 (298)
T cd07841         291 PT  292 (298)
T ss_pred             CC
Confidence            43

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=4.8e-41  Score=287.26  Aligned_cols=199  Identities=25%  Similarity=0.477  Sum_probs=170.3

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++...     +.+|+||||+.| +|.+++.+.+.+++..++.++.||+.||.|||+.||+||||||+||
T Consensus        53 ~~h~~Iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Ni  127 (325)
T cd05602          53 VKHPFLVGLHFSFQTA-----DKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENI  127 (325)
T ss_pred             CCCCCCCceeEEEEcC-----CeEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHe
Confidence            5799999999999887     679999999985 9999998888899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCC-CCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSE-TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||+++.... ........|++.|+|||++.+ ..++.++|+||+||++|+|++|..||.+.+......
T Consensus       128 li~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~  206 (325)
T cd05602         128 LLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD  206 (325)
T ss_pred             EECCCCCEEEccCCCCcccccCCCCcccccCCccccCHHHHcC-CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHH
Confidence            999999999999999875332 223345678999999999887 778899999999999999999999999877655554


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHH----HHhcCcccc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVE----EALRHPYLQ  234 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~----ell~hp~~~  234 (280)
                      .+...   +                            ....+.+++.+.++|++||+.||.+|+++.    ++++|+||.
T Consensus       207 ~i~~~---~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~  255 (325)
T cd05602         207 NILNK---P----------------------------LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFS  255 (325)
T ss_pred             HHHhC---C----------------------------cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccC
Confidence            44321   0                            012246789999999999999999999876    899999997


Q ss_pred             cC
Q 023568          235 SL  236 (280)
Q Consensus       235 ~~  236 (280)
                      ..
T Consensus       256 ~~  257 (325)
T cd05602         256 PI  257 (325)
T ss_pred             CC
Confidence            64

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.9e-40  Score=278.36  Aligned_cols=228  Identities=32%  Similarity=0.651  Sum_probs=174.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||++++++++..     ...++||||+++ .|..++.....+++..++.++.|++.||+|||+.|++|+||+|+||
T Consensus        57 ~~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~ni  131 (286)
T cd07847          57 LKHPNLVNLIEVFRRK-----RKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENI  131 (286)
T ss_pred             CCCCCEeeeeeEEeeC-----CEEEEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhE
Confidence            5799999999999887     679999999997 5555665666899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCC-ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||++....... ......++..|+|||.+.+...++.++|+||+|+++++|++|..||.+.+..+...
T Consensus       132 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~  211 (286)
T cd07847         132 LITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLY  211 (286)
T ss_pred             EEcCCCcEEECccccceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence            99999999999999998654432 23345678899999998765667889999999999999999999999988777766


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      .+....+...+........................+.....+.++..+.+|+.+||+.||++|||+.|++.||||
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         212 LIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             HHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            666554433222111110000000000000001111222345678999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=6.3e-41  Score=286.06  Aligned_cols=200  Identities=24%  Similarity=0.457  Sum_probs=168.9

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++.+.     +..|+||||++ |+|.+.+...+.+++..++.++.||+.||.|||+.||+||||||+||
T Consensus        53 ~~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NI  127 (321)
T cd05603          53 LKHPFLVGLHYSFQTA-----EKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENI  127 (321)
T ss_pred             CCCCCccceeeEEEcC-----CEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHe
Confidence            5799999999999887     77999999997 59999888878899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCC-CCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSE-TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||+++.... ........|++.|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+......
T Consensus       128 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~  206 (321)
T cd05603         128 LLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYD  206 (321)
T ss_pred             EECCCCCEEEccCCCCccCCCCCCccccccCCcccCCHHHhcC-CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHH
Confidence            999999999999999875322 222345678999999999876 678889999999999999999999998877554444


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCH----HHHhcCcccc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV----EEALRHPYLQ  234 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~----~ell~hp~~~  234 (280)
                      .+...   +                            ....+..+..+.+++.+||+.||.+|+++    .++++|+||.
T Consensus       207 ~i~~~---~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~  255 (321)
T cd05603         207 NILHK---P----------------------------LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFS  255 (321)
T ss_pred             HHhcC---C----------------------------CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcC
Confidence            33210   0                            11223568889999999999999999875    5999999998


Q ss_pred             cCc
Q 023568          235 SLH  237 (280)
Q Consensus       235 ~~~  237 (280)
                      .+.
T Consensus       256 ~~~  258 (321)
T cd05603         256 PIN  258 (321)
T ss_pred             CCC
Confidence            653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-41  Score=292.59  Aligned_cols=203  Identities=23%  Similarity=0.419  Sum_probs=165.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||++++++|.+.     .++|+||||+. |+|.+++.+.+.+++..++.++.|++.||+|||+.||+||||||+||
T Consensus        58 l~hp~iv~~~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NI  132 (377)
T cd05629          58 SDSPWVVSLYYSFQDA-----QYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNI  132 (377)
T ss_pred             CCCCCcceEEEEEEcC-----CeeEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHE
Confidence            5799999999999987     78999999996 59999998888999999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCC------------------------------------------------ccccceecc
Q 023568           80 LLNASCDLKIGDFGLARTTSETD------------------------------------------------FMTEYVVTR  111 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~------------------------------------------------~~~~~~~~~  111 (280)
                      |++.++.++|+|||+++......                                                ......||+
T Consensus       133 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  212 (377)
T cd05629         133 LIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTP  212 (377)
T ss_pred             EECCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCc
Confidence            99999999999999986321100                                                001246899


Q ss_pred             ccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccc
Q 023568          112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCR  191 (280)
Q Consensus       112 ~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (280)
                      .|+|||++.+ ..++.++|+||+||++|+|++|..||.+.+.......+.......                        
T Consensus       213 ~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~------------------------  267 (377)
T cd05629         213 DYIAPEIFLQ-QGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETL------------------------  267 (377)
T ss_pred             cccCHHHHcc-CCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCcc------------------------
Confidence            9999999876 678899999999999999999999998877655554443210000                        


Q ss_pred             cccccccCCCCCHHHHHHHHHhcccCCCCC---CCHHHHhcCcccccCc
Q 023568          192 KQQFATRFPNKSSGAVDLLEKMLVFDPNKR---ITVEEALRHPYLQSLH  237 (280)
Q Consensus       192 ~~~~~~~~~~~~~~~~~ll~~~L~~dp~~R---pt~~ell~hp~~~~~~  237 (280)
                        .+ .....++..+.+||.+||. +|.+|   +|+.|++.||||++..
T Consensus       268 --~~-p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~  312 (377)
T cd05629         268 --YF-PDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVD  312 (377)
T ss_pred             --CC-CCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCC
Confidence              00 0112468899999999998 67665   5999999999998653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2e-40  Score=277.63  Aligned_cols=226  Identities=37%  Similarity=0.723  Sum_probs=179.5

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      +||||+++++++.+...   +.+++||||++++|.+.+.+. ..+++.++..++.|++.||+|||+.|++||||+|+||+
T Consensus        56 ~h~~i~~~~~~~~~~~~---~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~  132 (282)
T cd07831          56 PHPNILRLIEVLFDRKT---GRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENIL  132 (282)
T ss_pred             CCCCccceEEEEecCCC---CcEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEE
Confidence            49999999999987632   568999999999999988753 57899999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 023568           81 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  160 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~i  160 (280)
                      ++. +.++|+|||.+.............++..|+|||.+.+....+.++|+||+||++|+|++|..||.+.+..+....+
T Consensus       133 l~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~  211 (282)
T cd07831         133 IKD-DILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKI  211 (282)
T ss_pred             EcC-CCeEEEecccccccccCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHH
Confidence            999 9999999999987654443445567889999998765466788999999999999999999999999888888888


Q ss_pred             HHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          161 TELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      ....+.+.+.............  ...+...........+..+..+.++|.+||+.||++|||++++++||||
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         212 HDVLGTPDAEVLKKFRKSRHMN--YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             HHHcCCCCHHHHHhhccccccc--ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            8877766654321111100000  0011111111122234568999999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2e-40  Score=279.37  Aligned_cols=229  Identities=40%  Similarity=0.746  Sum_probs=181.5

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++.....   ...|+||||++++|.+++... ..+++.+++.++.|++.||+|||+.|++|+||+|+||
T Consensus        61 l~h~ni~~~~~~~~~~~~---~~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~ni  137 (293)
T cd07843          61 LQHPNIVTVKEVVVGSNL---DKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNL  137 (293)
T ss_pred             cCCCCEEEEEEEEEecCC---CcEEEEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHE
Confidence            579999999999876533   679999999999999998764 4599999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||.+...... .......++..|+|||.+.+....+.++|+||+|+++++|++|.+||..........
T Consensus       138 li~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~  217 (293)
T cd07843         138 LLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLN  217 (293)
T ss_pred             EECCCCcEEEeecCceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence            9999999999999998865543 223445678889999998765567889999999999999999999999998888888


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCC--CCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN--KSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      ++....+.+....+.....-..... ..............++.  +++.+.++|++||+.||++|||++|+|.||||
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         218 KIFKLLGTPTEKIWPGFSELPGAKK-KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             HHHHHhCCCchHHHHHhhccchhcc-cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence            8888777666554432211000000 00001111111222333  48899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=8e-41  Score=286.23  Aligned_cols=202  Identities=21%  Similarity=0.441  Sum_probs=164.6

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      +||||+++++++.+.     ..+|+||||+. |+|.+++...+.+++..++.++.|++.||.|||+.||+||||||+||+
T Consensus        54 ~hp~iv~~~~~~~~~-----~~~~lv~E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nil  128 (329)
T cd05618          54 NHPFLVGLHSCFQTE-----SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVL  128 (329)
T ss_pred             CCCcCCceeeEEEeC-----CEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEE
Confidence            799999999999987     77999999998 599999888789999999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccccCC-CCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH-----
Q 023568           81 LNASCDLKIGDFGLARTTSE-TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV-----  154 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~-----  154 (280)
                      ++.++.++|+|||+++.... ........||..|+|||++.+ ..++.++|+|||||++|+|++|..||......     
T Consensus       129 i~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~  207 (329)
T cd05618         129 LDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ  207 (329)
T ss_pred             ECCCCCEEEeeCCccccccCCCCccccccCCccccCHHHHcC-CCCCCccceecccHHHHHHhhCCCCCccCCCcCCccc
Confidence            99999999999999875322 222345678999999999987 77888999999999999999999999632100     


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCC------HHHHh
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT------VEEAL  228 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt------~~ell  228 (280)
                      .....+.+.                    +       .......+...+..+.++|++||+.||.+|||      +++++
T Consensus       208 ~~~~~~~~~--------------------i-------~~~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~  260 (329)
T cd05618         208 NTEDYLFQV--------------------I-------LEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQ  260 (329)
T ss_pred             ccHHHHHHH--------------------H-------hcCCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHh
Confidence            000000000                    0       00001123457889999999999999999998      58999


Q ss_pred             cCcccccC
Q 023568          229 RHPYLQSL  236 (280)
Q Consensus       229 ~hp~~~~~  236 (280)
                      +||||+.+
T Consensus       261 ~hp~f~~~  268 (329)
T cd05618         261 GHPFFRNV  268 (329)
T ss_pred             cCCCCCCC
Confidence            99999875

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=3.1e-40  Score=277.04  Aligned_cols=228  Identities=38%  Similarity=0.756  Sum_probs=182.9

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++...     ...|+||||++++|.+++.. ...+++.+++.++.|++.||+|||+.|++|+||+|+||
T Consensus        56 ~~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni  130 (286)
T cd07832          56 CQHPYVVKLLDVFPHG-----SGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANL  130 (286)
T ss_pred             CCCCCCcceeeEEecC-----CeeEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHE
Confidence            5799999999999887     67999999997799999864 46799999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCC--ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  157 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~  157 (280)
                      +++.++.++|+|||.+.......  ......++..|+|||.+.+...++.++|+||+|+++++|++|.++|.+......+
T Consensus       131 ~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~  210 (286)
T cd07832         131 LISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQL  210 (286)
T ss_pred             EEcCCCcEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHH
Confidence            99999999999999987654432  2334567889999999876566789999999999999999999999998888888


Q ss_pred             HHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 023568          158 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ  234 (280)
Q Consensus       158 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~  234 (280)
                      ..+....+.+....+........... ..............++..+..+.++|++||..||.+|||++++++||||.
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         211 AIVFRTLGTPNEETWPGLTSLPDYNK-ITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             HHHHHHcCCCChHHHhhccCcchhhc-ccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence            88887777665543332211100000 00111111122344556789999999999999999999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.3e-40  Score=284.42  Aligned_cols=198  Identities=23%  Similarity=0.405  Sum_probs=170.2

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      +||+|+++++++++.     +.+|+||||++ |+|.+.+...+.+++.++..++.|++.||+|||+.||+||||||+|||
T Consensus        59 ~~~~i~~~~~~~~~~-----~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nil  133 (323)
T cd05616          59 KPPFLTQLHSCFQTM-----DRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVM  133 (323)
T ss_pred             CCCeEeeEEEEEecC-----CEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeE
Confidence            589999999999887     77999999997 599999988888999999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccccCC-CCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           81 LNASCDLKIGDFGLARTTSE-TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      ++.++.++|+|||+++.... ........|++.|+|||++.+ ..++.++|+||+||++|+|++|+.||.+.+.......
T Consensus       134 l~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~  212 (323)
T cd05616         134 LDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS  212 (323)
T ss_pred             ECCCCcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcC-CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            99999999999999875432 223345678999999999987 7788999999999999999999999998876665555


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCcccc
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT-----VEEALRHPYLQ  234 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt-----~~ell~hp~~~  234 (280)
                      +.....                               ..+...+..+.+++.+||+.||.+|++     .+++++||||+
T Consensus       213 i~~~~~-------------------------------~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~  261 (323)
T cd05616         213 IMEHNV-------------------------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR  261 (323)
T ss_pred             HHhCCC-------------------------------CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcC
Confidence            433110                               112256889999999999999999997     48999999998


Q ss_pred             cC
Q 023568          235 SL  236 (280)
Q Consensus       235 ~~  236 (280)
                      .+
T Consensus       262 ~~  263 (323)
T cd05616         262 YI  263 (323)
T ss_pred             CC
Confidence            65

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-41  Score=289.28  Aligned_cols=202  Identities=27%  Similarity=0.467  Sum_probs=173.3

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      +||+||+|++.|..+     +.++++.|||+| -+..++.. ++.+++.+++.+++|++.||.|||+++|+|||||+.||
T Consensus        87 dHP~ivkLl~ayy~e-----nkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNi  161 (1187)
T KOG0579|consen   87 DHPVIVKLLSAYYFE-----NKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNI  161 (1187)
T ss_pred             CChHHHHHHHHHhcc-----CceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccce
Confidence            699999999999998     779999999986 56666654 56899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC-Cccccceecccccccccccc----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023568           80 LLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV  154 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~  154 (280)
                      |+..+|.++|+|||.+...... ....+++||++|||||+...    ...|..++||||||+++.||..+.+|....+.+
T Consensus       162 L~TldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM  241 (1187)
T KOG0579|consen  162 LLTLDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM  241 (1187)
T ss_pred             EEEecCcEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH
Confidence            9999999999999987654332 44567999999999999754    367889999999999999999999999999988


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ  234 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~  234 (280)
                      ..+-+|.+.   .++.                         -..+..++..+.||+.+||.+||..||++.++|+||||.
T Consensus       242 RVllKiaKS---ePPT-------------------------LlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~  293 (1187)
T KOG0579|consen  242 RVLLKIAKS---EPPT-------------------------LLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQ  293 (1187)
T ss_pred             HHHHHHhhc---CCCc-------------------------ccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccc
Confidence            887776551   1111                         112235788999999999999999999999999999998


Q ss_pred             cC
Q 023568          235 SL  236 (280)
Q Consensus       235 ~~  236 (280)
                      +.
T Consensus       294 ~~  295 (1187)
T KOG0579|consen  294 NA  295 (1187)
T ss_pred             cC
Confidence            64

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.4e-40  Score=288.96  Aligned_cols=203  Identities=26%  Similarity=0.393  Sum_probs=168.5

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++.++     ..+|+||||++ |+|.+++.. ..+++..+..++.|++.||+|||+.||+||||||+||
T Consensus       100 ~~h~~iv~~~~~~~~~-----~~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NI  173 (370)
T cd05596         100 ANSEWIVQLHYAFQDD-----KYLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNM  173 (370)
T ss_pred             CCCCCcceEEEEEecC-----CEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence            5799999999999987     77999999997 599998865 5689999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCC--ccccceeccccccccccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023568           80 LLNASCDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPELLLNC---TEYTAAIDIWSVGCILGEIMTREPLFPGKDYV  154 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~---~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~  154 (280)
                      |++.++.++|+|||++.......  ......||+.|+|||++.+.   ..++.++|+|||||++|+|++|..||.+.+..
T Consensus       174 Ll~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~  253 (370)
T cd05596         174 LLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV  253 (370)
T ss_pred             EEcCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH
Confidence            99999999999999987654332  22346789999999998652   24788999999999999999999999988766


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCcc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNK--RITVEEALRHPY  232 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~--Rpt~~ell~hp~  232 (280)
                      .....+.......                          .+ .....++..+.+||++||+.+|.+  |+|++++++|||
T Consensus       254 ~~~~~i~~~~~~~--------------------------~~-~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~  306 (370)
T cd05596         254 GTYSKIMDHKNSL--------------------------TF-PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPF  306 (370)
T ss_pred             HHHHHHHcCCCcC--------------------------CC-CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcc
Confidence            5555543311000                          00 111246899999999999999988  999999999999


Q ss_pred             cccC
Q 023568          233 LQSL  236 (280)
Q Consensus       233 ~~~~  236 (280)
                      |+..
T Consensus       307 ~~~~  310 (370)
T cd05596         307 FKND  310 (370)
T ss_pred             cCCC
Confidence            9863

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.7e-40  Score=283.73  Aligned_cols=197  Identities=24%  Similarity=0.444  Sum_probs=167.6

Q ss_pred             CcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE
Q 023568            3 HENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL   81 (280)
Q Consensus         3 Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nili   81 (280)
                      |++|+++++++.+.     +.+|+||||++ |+|.+++...+.+++..+..++.|++.||.|||+.||+||||||+|||+
T Consensus        60 ~~~i~~~~~~~~~~-----~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill  134 (324)
T cd05587          60 PPFLTQLHSCFQTM-----DRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML  134 (324)
T ss_pred             CCceeeeEEEEEcC-----CEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE
Confidence            45689999999887     67999999997 5999999888889999999999999999999999999999999999999


Q ss_pred             cCCCCeEEeecccccccC-CCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 023568           82 NASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  160 (280)
Q Consensus        82 ~~~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~i  160 (280)
                      +.++.++|+|||++.... .........|++.|+|||++.+ ..++.++|+||+||++|+|++|+.||.+.+.......+
T Consensus       135 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i  213 (324)
T cd05587         135 DAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI  213 (324)
T ss_pred             cCCCCEEEeecCcceecCCCCCceeeecCCccccChhhhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999999999999987532 2222345678999999999987 67889999999999999999999999988766555544


Q ss_pred             HHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCH-----HHHhcCccccc
Q 023568          161 TELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV-----EEALRHPYLQS  235 (280)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~-----~ell~hp~~~~  235 (280)
                      ....                               ...+...++.+.+++++||..||.+|++.     +++++||||+.
T Consensus       214 ~~~~-------------------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~  262 (324)
T cd05587         214 MEHN-------------------------------VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRR  262 (324)
T ss_pred             HcCC-------------------------------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCC
Confidence            3210                               01123568899999999999999999976     89999999987


Q ss_pred             C
Q 023568          236 L  236 (280)
Q Consensus       236 ~  236 (280)
                      +
T Consensus       263 ~  263 (324)
T cd05587         263 I  263 (324)
T ss_pred             C
Confidence            5

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-42  Score=288.44  Aligned_cols=199  Identities=27%  Similarity=0.414  Sum_probs=173.3

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      +++|||.++|+.|-..     ..++++||||+ |++.++++..+.+.+.++..++++++.|+.|||+++.+|||||+.||
T Consensus        68 ~~~~~it~yygsyl~g-----~~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaani  142 (467)
T KOG0201|consen   68 CDSPNITEYYGSYLKG-----TKLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANI  142 (467)
T ss_pred             cCcchHHhhhhheeec-----ccHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccce
Confidence            4689999999999988     66999999998 59999999878889999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCC-ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      |+..+|.+||+|||.+....... ...++.||++|||||++.+ ..|+.++||||||++.+||++|.+|+.....+..+.
T Consensus       143 l~s~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf  221 (467)
T KOG0201|consen  143 LLSESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF  221 (467)
T ss_pred             eEeccCcEEEEecceeeeeechhhccccccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE
Confidence            99999999999999998766553 3478999999999999996 899999999999999999999999998876533322


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  235 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~  235 (280)
                      .|                              .+...+......++.+++|+..||.+||+.||+|.++|+|+|++.
T Consensus       222 lI------------------------------pk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~  268 (467)
T KOG0201|consen  222 LI------------------------------PKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR  268 (467)
T ss_pred             ec------------------------------cCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence            21                              111122222367999999999999999999999999999999976

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-40  Score=276.12  Aligned_cols=203  Identities=24%  Similarity=0.408  Sum_probs=168.5

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      |+||||+++++.+.+.     ..+++||||+. |+|.+++...  ..+++..+..++.|++.||.|||+.|++||||+|+
T Consensus        57 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~  131 (285)
T cd05605          57 VNSRFVVSLAYAYETK-----DALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPE  131 (285)
T ss_pred             cCCCCEeeeeeeecCC-----CeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHH
Confidence            5799999999999887     67999999997 5998887543  46999999999999999999999999999999999


Q ss_pred             ceEEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023568           78 NLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  157 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~  157 (280)
                      ||+++.++.++|+|||++.............|+..|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.+.....
T Consensus       132 Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~  210 (285)
T cd05605         132 NILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR  210 (285)
T ss_pred             HEEECCCCCEEEeeCCCceecCCCCccccccCCCCccCcHHhcC-CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH
Confidence            99999999999999999887554433345578999999999876 67888999999999999999999999887644333


Q ss_pred             HHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCcc
Q 023568          158 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPY  232 (280)
Q Consensus       158 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rp-----t~~ell~hp~  232 (280)
                      ..+.......                           .....+.++..+.+++.+||+.||.+||     +++++++|||
T Consensus       211 ~~~~~~~~~~---------------------------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~  263 (285)
T cd05605         211 EEVERRVKED---------------------------QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPF  263 (285)
T ss_pred             HHHHHHhhhc---------------------------ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcC
Confidence            3332211100                           0112235788999999999999999999     9999999999


Q ss_pred             cccC
Q 023568          233 LQSL  236 (280)
Q Consensus       233 ~~~~  236 (280)
                      |...
T Consensus       264 ~~~~  267 (285)
T cd05605         264 FRTA  267 (285)
T ss_pred             ccCC
Confidence            9864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=9.2e-40  Score=273.89  Aligned_cols=226  Identities=42%  Similarity=0.799  Sum_probs=182.3

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||+++++++.+.     ...|+||||++++|.+++...+  .+++..+..++.|++.||+|||+.+++||||+|+|
T Consensus        55 l~~~~iv~~~~~~~~~-----~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~n  129 (283)
T cd07835          55 LNHPNIVRLLDVVHSE-----NKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQN  129 (283)
T ss_pred             cCCCCccCHhheeccC-----CeEEEEEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHH
Confidence            5799999999999877     7799999999999999987655  79999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023568           79 LLLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  157 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~  157 (280)
                      |+++.++.++|+|||.+...... .......++..|+|||.+.+...++.++|+||+|+++|+|++|.+||.+.+.....
T Consensus       130 il~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~  209 (283)
T cd07835         130 LLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQL  209 (283)
T ss_pred             EEEcCCCcEEEeecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            99999999999999998754322 12233456888999998876456788999999999999999999999998887777


Q ss_pred             HHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          158 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       158 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      ..+.+..+.+....+.....  ...+....+...........+..+..+.+++.+||+.||.+|||++|++.||||
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         210 FRIFRTLGTPDEDVWPGVTS--LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             HHHHHHhCCCChHHhhhhhh--chhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence            77777666665544322111  111122222222333334455788999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=8.4e-41  Score=291.27  Aligned_cols=202  Identities=25%  Similarity=0.431  Sum_probs=165.9

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++.|++.     +.+|+||||+. |+|.+++.+.+.+++..++.++.||+.||+|||+.||+||||||+||
T Consensus        58 l~h~~iv~~~~~~~~~-----~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Ni  132 (376)
T cd05598          58 ADNEWVVKLYYSFQDK-----DNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNI  132 (376)
T ss_pred             CCCCCcceEEEEEEcC-----CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHE
Confidence            5799999999999987     78999999997 59999998888899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC--------------------------------------------Cccccceecccccc
Q 023568           80 LLNASCDLKIGDFGLARTTSET--------------------------------------------DFMTEYVVTRWYRA  115 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~--------------------------------------------~~~~~~~~~~~y~a  115 (280)
                      +++.++.++|+|||++......                                            .......||+.|+|
T Consensus       133 ll~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a  212 (376)
T cd05598         133 LIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIA  212 (376)
T ss_pred             EECCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccC
Confidence            9999999999999987422100                                            00113468999999


Q ss_pred             ccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccc
Q 023568          116 PELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQF  195 (280)
Q Consensus       116 PE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (280)
                      ||++.+ ..++.++|+|||||++|+|++|+.||.+.+.......+.......                           .
T Consensus       213 PE~~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~---------------------------~  264 (376)
T cd05598         213 PEVLLR-TGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTL---------------------------H  264 (376)
T ss_pred             HHHHcC-CCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccc---------------------------c
Confidence            999877 778899999999999999999999999877555444332110000                           0


Q ss_pred             cccCCCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCcccccC
Q 023568          196 ATRFPNKSSGAVDLLEKMLVFDPNKRI---TVEEALRHPYLQSL  236 (280)
Q Consensus       196 ~~~~~~~~~~~~~ll~~~L~~dp~~Rp---t~~ell~hp~~~~~  236 (280)
                      ......+++.+.++|.+|+ .+|.+|+   |+.++++||||+.+
T Consensus       265 ~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~  307 (376)
T cd05598         265 IPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI  307 (376)
T ss_pred             CCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence            0111256889999999976 5999999   99999999999875

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=7e-41  Score=286.86  Aligned_cols=204  Identities=25%  Similarity=0.417  Sum_probs=169.5

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||+++++++.+.     ..+|+||||++ |+|.+++.+. ..+++..++.++.|++.||.|||+.||+||||||+|
T Consensus        58 ~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~N  132 (330)
T cd05601          58 SNSPWIPQLQYAFQDK-----DNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPEN  132 (330)
T ss_pred             CCCCCCcceeeEEecC-----CeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHh
Confidence            4799999999999887     67999999996 5999999775 689999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCc--cccceecccccccccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDF--MTEYVVTRWYRAPELLLN-----CTEYTAAIDIWSVGCILGEIMTREPLFPGK  151 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-----~~~~~~~~DvwslG~~l~~ll~g~~pf~~~  151 (280)
                      |+++.++.++|+|||++........  .....||+.|+|||++..     ...++.++|+|||||++|+|++|..||...
T Consensus       133 Ill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~  212 (330)
T cd05601         133 VLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG  212 (330)
T ss_pred             eEECCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC
Confidence            9999999999999999976544322  233468999999999863     356778999999999999999999999887


Q ss_pred             ChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 023568          152 DYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHP  231 (280)
Q Consensus       152 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp  231 (280)
                      ........+......                          ..+ ...+.+++.+.+||++||+ +|.+|||++++++||
T Consensus       213 ~~~~~~~~i~~~~~~--------------------------~~~-~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~  264 (330)
T cd05601         213 TSAKTYNNIMNFQRF--------------------------LKF-PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHP  264 (330)
T ss_pred             CHHHHHHHHHcCCCc--------------------------cCC-CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCC
Confidence            766555544331100                          000 1123578999999999998 999999999999999


Q ss_pred             ccccCc
Q 023568          232 YLQSLH  237 (280)
Q Consensus       232 ~~~~~~  237 (280)
                      ||+.+.
T Consensus       265 ~~~~~~  270 (330)
T cd05601         265 FFSKID  270 (330)
T ss_pred             CcCCCC
Confidence            998753

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=4.1e-40  Score=275.39  Aligned_cols=205  Identities=20%  Similarity=0.353  Sum_probs=165.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      ++||||++++++++..     .+.|+||||+. ++|.+++...  ..+++..+..++.|++.||+|||+.|++||||||+
T Consensus        50 l~hp~i~~~~~~~~~~-----~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~  124 (277)
T cd05607          50 VNSPFIVNLAYAFESK-----THLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPE  124 (277)
T ss_pred             cCCCcEEEEEEEEecC-----CeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChH
Confidence            5899999999999877     77999999997 5998888543  35899999999999999999999999999999999


Q ss_pred             ceEEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023568           78 NLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  157 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~  157 (280)
                      ||+++.++.++|+|||++.............++..|+|||.+.+ ..++.++|+||+||++|+|++|..||.........
T Consensus       125 Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~  203 (277)
T cd05607         125 NVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKE-EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK  203 (277)
T ss_pred             hEEEcCCCCEEEeeceeeeecCCCceeeccCCCCCccCHHHHcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH
Confidence            99999999999999999877655433345578899999999877 56889999999999999999999999765322111


Q ss_pred             HHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCH----HHHhcCccc
Q 023568          158 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV----EEALRHPYL  233 (280)
Q Consensus       158 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~----~ell~hp~~  233 (280)
                      ..+.....                          ...........++++.+++++||+.||.+||++    ++++.||||
T Consensus       204 ~~~~~~~~--------------------------~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f  257 (277)
T cd05607         204 EELKRRTL--------------------------EDEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFF  257 (277)
T ss_pred             HHHHHHhh--------------------------ccccccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhh
Confidence            11111000                          000011123568899999999999999999999    778899999


Q ss_pred             ccCc
Q 023568          234 QSLH  237 (280)
Q Consensus       234 ~~~~  237 (280)
                      +.+.
T Consensus       258 ~~~~  261 (277)
T cd05607         258 KTIN  261 (277)
T ss_pred             cCCC
Confidence            8864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.9e-40  Score=295.67  Aligned_cols=200  Identities=27%  Similarity=0.443  Sum_probs=168.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK   75 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik   75 (280)
                      ++|||||++++++...     +.+||||||+. |+|.+++.+    ...+++.++..++.|++.||.|||+.||+|||||
T Consensus       122 l~Hpniv~~~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlk  196 (478)
T PTZ00267        122 CDHFGIVKHFDDFKSD-----DKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLK  196 (478)
T ss_pred             CCCCCEeEEEEEEEEC-----CEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcC
Confidence            5899999999999987     78999999997 599887753    3569999999999999999999999999999999


Q ss_pred             CCceEEcCCCCeEEeecccccccCCCC---ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 023568           76 PSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD  152 (280)
Q Consensus        76 ~~Nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~  152 (280)
                      |+|||++.++.++|+|||+++......   ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+
T Consensus       197 p~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~  275 (478)
T PTZ00267        197 SANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFKGPS  275 (478)
T ss_pred             HHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999998654331   2345678999999999877 778999999999999999999999998877


Q ss_pred             hHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 023568          153 YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY  232 (280)
Q Consensus       153 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~  232 (280)
                      .......+....                              .......+++.+.++|.+||..||++|||+++++.|+|
T Consensus       276 ~~~~~~~~~~~~------------------------------~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~  325 (478)
T PTZ00267        276 QREIMQQVLYGK------------------------------YDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEF  325 (478)
T ss_pred             HHHHHHHHHhCC------------------------------CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHH
Confidence            655444433210                              00112256889999999999999999999999999999


Q ss_pred             cccC
Q 023568          233 LQSL  236 (280)
Q Consensus       233 ~~~~  236 (280)
                      ++..
T Consensus       326 ~~~~  329 (478)
T PTZ00267        326 LKYV  329 (478)
T ss_pred             HHHH
Confidence            8654

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=3.6e-40  Score=276.41  Aligned_cols=226  Identities=39%  Similarity=0.779  Sum_probs=180.9

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD---QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~---~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      ++||||+++++++.+.     +..++||||++++|.+++...   ..+++..+..++.|++.||.|||+.|++||||+|+
T Consensus        55 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~  129 (284)
T cd07836          55 LKHENIVRLHDVIHTE-----NKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQ  129 (284)
T ss_pred             hcCCCEeeeeeeEeeC-----CcEEEEEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHH
Confidence            5799999999999987     679999999999999988653   36899999999999999999999999999999999


Q ss_pred             ceEEcCCCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023568           78 NLLLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  156 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~  156 (280)
                      ||+++.++.++|+|||.+...... .......++..|++||.+.+...++.++|+||+|+++|+|++|..||.+.+..+.
T Consensus       130 ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~  209 (284)
T cd07836         130 NLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ  209 (284)
T ss_pred             HEEECCCCcEEEeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence            999999999999999998754332 1223445688899999987656678899999999999999999999999988888


Q ss_pred             HHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       157 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      ...+....+.+....+.....  ...+....+...........+..++.+.+++.+||+.||.+||+++++++||||
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         210 LLKIFRIMGTPTESTWPGISQ--LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             HHHHHHHhCCCChhhHHHHhc--CchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            888877776665544332221  011111111111112223344668899999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2e-40  Score=287.85  Aligned_cols=203  Identities=27%  Similarity=0.389  Sum_probs=166.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++.++     ..+|+||||++ |+|.+++.. ..+++..++.++.||+.||+|||+.||+||||||+||
T Consensus       100 ~~hp~iv~~~~~~~~~-----~~~~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NI  173 (370)
T cd05621         100 ANSPWVVQLFCAFQDD-----KYLYMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNM  173 (370)
T ss_pred             CCCCCEeeEEEEEEcC-----CEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHE
Confidence            5799999999999987     77999999997 599999865 4689999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCC--ccccceeccccccccccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023568           80 LLNASCDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPELLLNC---TEYTAAIDIWSVGCILGEIMTREPLFPGKDYV  154 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~---~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~  154 (280)
                      |++.++.+||+|||++.......  ......||+.|+|||++.+.   ..++.++|+||+||++|+|++|..||.+.+..
T Consensus       174 Ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~  253 (370)
T cd05621         174 LLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV  253 (370)
T ss_pred             EECCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH
Confidence            99999999999999998654332  22456789999999998653   23778999999999999999999999988766


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCcc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNK--RITVEEALRHPY  232 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~--Rpt~~ell~hp~  232 (280)
                      .....+........                          + .....++..+++++.+||..++.+  |+|++|+++|||
T Consensus       254 ~~~~~i~~~~~~~~--------------------------~-p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~  306 (370)
T cd05621         254 GTYSKIMDHKNSLN--------------------------F-PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPF  306 (370)
T ss_pred             HHHHHHHhCCcccC--------------------------C-CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcc
Confidence            65555443111000                          0 001246889999999999865543  899999999999


Q ss_pred             cccC
Q 023568          233 LQSL  236 (280)
Q Consensus       233 ~~~~  236 (280)
                      |+..
T Consensus       307 ~~~~  310 (370)
T cd05621         307 FKND  310 (370)
T ss_pred             cCCC
Confidence            9863

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-40  Score=283.34  Aligned_cols=193  Identities=26%  Similarity=0.430  Sum_probs=168.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~--~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      |+|+|||++++++..+     .-+|||||||. |+|.++|+.  ++.++..+...++.||++|++||.++++|||||-+.
T Consensus       258 L~H~~lV~l~gV~~~~-----~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAAR  332 (468)
T KOG0197|consen  258 LRHEKLVKLYGVCTKQ-----EPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAAR  332 (468)
T ss_pred             CcccCeEEEEEEEecC-----CceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhh
Confidence            6899999999999987     45999999997 899999986  567999999999999999999999999999999999


Q ss_pred             ceEEcCCCCeEEeecccccccCCCCcccc--ceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023568           78 NLLLNASCDLKIGDFGLARTTSETDFMTE--YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYV  154 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~~~~~~--~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~  154 (280)
                      ||||+.+..+||+|||+|+...++.....  .--...|.|||.+.. ..++.+||||||||+||||+| |+.||++....
T Consensus       333 NiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~-~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~  411 (468)
T KOG0197|consen  333 NILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNY-GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE  411 (468)
T ss_pred             heeeccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhh-CCcccccceeehhhhHHHHhccCCCCCCCCCHH
Confidence            99999999999999999996555433222  122456999999987 889999999999999999998 99999999999


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      +.+..+.+....|.+                              +..|+.+.++++.|++.+|++|||++.+..
T Consensus       412 ev~~~le~GyRlp~P------------------------------~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~  456 (468)
T KOG0197|consen  412 EVLELLERGYRLPRP------------------------------EGCPDEVYELMKSCWHEDPEDRPTFETLRE  456 (468)
T ss_pred             HHHHHHhccCcCCCC------------------------------CCCCHHHHHHHHHHhhCCcccCCCHHHHHH
Confidence            999888775444433                              357899999999999999999999997654

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-40  Score=276.10  Aligned_cols=227  Identities=39%  Similarity=0.722  Sum_probs=175.1

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++.+.     ...|+||||++++|.+++... ..+++..++.++.|++.||.|||+.|++||||+|+||
T Consensus        60 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~ni  134 (291)
T cd07844          60 LKHANIVTLHDIIHTK-----KTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNL  134 (291)
T ss_pred             CCCcceeeEEEEEecC-----CeEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHE
Confidence            5899999999999877     779999999999999988653 4689999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-hHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD-YVHQL  157 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~-~~~~~  157 (280)
                      +++.++.++|+|||.++..... .......++..|+|||.+.+...++.++|+||+|+++|+|++|..||.+.. ..+..
T Consensus       135 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~  214 (291)
T cd07844         135 LISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQL  214 (291)
T ss_pred             EEcCCCCEEECccccccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHH
Confidence            9999999999999998754322 112233467889999998765667889999999999999999999998765 45666


Q ss_pred             HHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCC--HHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          158 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKS--SGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       158 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      ..+.+..+.+.+..+.......... ................+.++  ..+.+++.+||+.||.+|||+++++.||||
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         215 HKIFRVLGTPTEETWPGVSSNPEFK-PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             HHHHHhcCCCChhhhhhhhhccccc-cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            6666666665554432221100000 00001111111222223444  889999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=3.2e-40  Score=282.35  Aligned_cols=200  Identities=22%  Similarity=0.404  Sum_probs=165.3

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      +||||+++++++++.     ..+|+||||+. |+|.+++...+.+++..++.++.||+.||+|||+.|++||||||+||+
T Consensus        54 ~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nil  128 (327)
T cd05617          54 SNPFLVGLHSCFQTT-----SRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVL  128 (327)
T ss_pred             CCCCEeeEEEEEEeC-----CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence            699999999999887     77999999997 599999988788999999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccccC-CCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh------
Q 023568           81 LNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY------  153 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~------  153 (280)
                      ++.++.++|+|||+++... .........|++.|+|||.+.+ ..++.++|+|||||++|+|++|..||.....      
T Consensus       129 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~  207 (327)
T cd05617         129 LDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNT  207 (327)
T ss_pred             EeCCCCEEEeccccceeccCCCCceecccCCcccCCHHHHCC-CCCCchheeehhHHHHHHHHhCCCCCCccCCCccccc
Confidence            9999999999999987532 2233345678999999999977 7788999999999999999999999964321      


Q ss_pred             HHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCC------HHHH
Q 023568          154 VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT------VEEA  227 (280)
Q Consensus       154 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt------~~el  227 (280)
                      .........  .                            .....+...+..+.+++++||+.||.+|++      ++++
T Consensus       208 ~~~~~~~~~--~----------------------------~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i  257 (327)
T cd05617         208 EDYLFQVIL--E----------------------------KPIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDI  257 (327)
T ss_pred             HHHHHHHHH--h----------------------------CCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHH
Confidence            111111100  0                            001122357889999999999999999997      5799


Q ss_pred             hcCcccccCc
Q 023568          228 LRHPYLQSLH  237 (280)
Q Consensus       228 l~hp~~~~~~  237 (280)
                      ++||||+.+.
T Consensus       258 ~~h~~f~~~~  267 (327)
T cd05617         258 KSHTFFRSID  267 (327)
T ss_pred             HcCCCCCCCC
Confidence            9999998764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.1e-40  Score=289.85  Aligned_cols=228  Identities=26%  Similarity=0.360  Sum_probs=167.3

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+|||||++++++...     ...++|||++.++|.+++... +.+++.++..++.|++.||.|||++||+||||||+||
T Consensus       217 L~HpnIv~l~~~~~~~-----~~~~lv~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NI  291 (461)
T PHA03211        217 LSHPAVLALLDVRVVG-----GLTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENV  291 (461)
T ss_pred             CCCCCCCcEEEEEEEC-----CEEEEEEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHE
Confidence            6899999999998877     679999999999999988654 5699999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCC---ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCC-CCCC---
Q 023568           80 LLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF-PGKD---  152 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf-~~~~---  152 (280)
                      |++.++.++|+|||+++......   ......||..|+|||.+.+ ..++.++|||||||++|||++|..++ ....   
T Consensus       292 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~  370 (461)
T PHA03211        292 LVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDE  370 (461)
T ss_pred             EECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcC-CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccc
Confidence            99999999999999987643321   1223568999999999987 67889999999999999999977543 3221   


Q ss_pred             ---hHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCc-----cccccccccCCCCCHHHHHHHHHhcccCCCCCCCH
Q 023568          153 ---YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPR-----CRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV  224 (280)
Q Consensus       153 ---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~  224 (280)
                         ....+.++....+.................+......     .....+ ..+...+.++.+||++||+.||.+|||+
T Consensus       371 ~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~dli~~mL~~DP~~RPsa  449 (461)
T PHA03211        371 RRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAW-TRYYKLDLDVEYLVCRALTFDGARRPSA  449 (461)
T ss_pred             cCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcch-hhhccccchHHHHHHHHcccChhhCcCH
Confidence               1233344433333222111111111111111111000     001111 1122457789999999999999999999


Q ss_pred             HHHhcCccccc
Q 023568          225 EEALRHPYLQS  235 (280)
Q Consensus       225 ~ell~hp~~~~  235 (280)
                      .|+|+||||++
T Consensus       450 ~elL~hp~f~~  460 (461)
T PHA03211        450 AELLRLPLFQS  460 (461)
T ss_pred             HHHhhCcccCC
Confidence            99999999964

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.7e-40  Score=287.68  Aligned_cols=203  Identities=26%  Similarity=0.454  Sum_probs=167.1

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++.|++.     ..+|+||||+. |+|.+++.+.+.+++..++.++.|++.||+|||+.||+||||||+||
T Consensus        58 l~~~~iv~~~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NI  132 (360)
T cd05627          58 ADGAWVVKMFYSFQDK-----RNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNL  132 (360)
T ss_pred             CCCCCEeeEEEEEEcC-----CEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHE
Confidence            5799999999999987     77999999997 59999998888999999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCC------------------------------------ccccceeccccccccccccCC
Q 023568           80 LLNASCDLKIGDFGLARTTSETD------------------------------------FMTEYVVTRWYRAPELLLNCT  123 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~------------------------------------~~~~~~~~~~y~aPE~~~~~~  123 (280)
                      +++.++.++|+|||++.......                                    ......||+.|+|||++.+ .
T Consensus       133 li~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~  211 (360)
T cd05627         133 LLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-T  211 (360)
T ss_pred             EECCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC-C
Confidence            99999999999999986432110                                    0123468999999999987 7


Q ss_pred             CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCC
Q 023568          124 EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKS  203 (280)
Q Consensus       124 ~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  203 (280)
                      .++.++|+|||||++|+|++|..||.+.+.......+.....                          ...++. ....+
T Consensus       212 ~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~--------------------------~~~~p~-~~~~s  264 (360)
T cd05627         212 GYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKE--------------------------TLVFPP-EVPIS  264 (360)
T ss_pred             CCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCC--------------------------ceecCC-CCCCC
Confidence            788999999999999999999999988876555544432100                          000010 11368


Q ss_pred             HHHHHHHHHhcccCCCCCC---CHHHHhcCcccccCc
Q 023568          204 SGAVDLLEKMLVFDPNKRI---TVEEALRHPYLQSLH  237 (280)
Q Consensus       204 ~~~~~ll~~~L~~dp~~Rp---t~~ell~hp~~~~~~  237 (280)
                      ..++++|.+|+ .||.+|+   +++++++||||+++.
T Consensus       265 ~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~  300 (360)
T cd05627         265 EKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGVD  300 (360)
T ss_pred             HHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCCC
Confidence            89999999987 4999998   589999999998763

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-39  Score=270.56  Aligned_cols=198  Identities=26%  Similarity=0.470  Sum_probs=166.3

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++++.     ..+|+||||+. ++|.+++.+.+.+++..+..++.|++.||.|||+.|++|+||+|+||
T Consensus        61 l~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~ni  135 (263)
T cd06625          61 LQHERIVQYYGCLRDD-----ETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANI  135 (263)
T ss_pred             CCCCCeeeeEEEEccC-----CeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence            5799999999999987     67999999997 49999998878899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCc----cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDF----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH  155 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~  155 (280)
                      +++.++.++|+|||.++.......    .....++..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||...+...
T Consensus       136 lv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~  214 (263)
T cd06625         136 LRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISG-EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA  214 (263)
T ss_pred             EEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceecc-CCCCchhhhHHHHHHHHHHHhCCCCccccchHH
Confidence            999999999999999875433211    123457789999999987 668899999999999999999999998765444


Q ss_pred             HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          156 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       156 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      ....+...                             ..........+..+.+++++||..+|.+|||+.++++||||
T Consensus       215 ~~~~~~~~-----------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         215 AIFKIATQ-----------------------------PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             HHHHHhcc-----------------------------CCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence            33322210                             00112233578899999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.4e-39  Score=274.43  Aligned_cols=231  Identities=41%  Similarity=0.767  Sum_probs=183.0

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||+++++++.+.     ...|+||||++++|.+.+....  .+++..+..++.||+.||+|||++|++|+||+|+|
T Consensus        58 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~n  132 (294)
T PLN00009         58 MQHGNIVRLQDVVHSE-----KRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQN  132 (294)
T ss_pred             ccCCCEeeEEEEEecC-----CeEEEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcce
Confidence            5799999999999887     7799999999999998886543  36889999999999999999999999999999999


Q ss_pred             eEEcC-CCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023568           79 LLLNA-SCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  156 (280)
Q Consensus        79 ili~~-~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~  156 (280)
                      |+++. ++.++|+|||.+...... .......++..|+|||.+.+...++.++|+||+|+++|+|++|.+||......+.
T Consensus       133 ill~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~  212 (294)
T PLN00009        133 LLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE  212 (294)
T ss_pred             EEEECCCCEEEEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            99985 567999999998765432 2223446688999999987655678899999999999999999999999888888


Q ss_pred             HHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 023568          157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  236 (280)
Q Consensus       157 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~  236 (280)
                      ..++....+.+....+.....  ...+....+...........+..++.+.+++.+||..||++||+++++++||||+++
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~  290 (294)
T PLN00009        213 LFKIFRILGTPNEETWPGVTS--LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL  290 (294)
T ss_pred             HHHHHHHhCCCChhhcccccc--chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence            887777777766555432211  111111122222222222345678999999999999999999999999999999886


Q ss_pred             cC
Q 023568          237 HD  238 (280)
Q Consensus       237 ~~  238 (280)
                      ..
T Consensus       291 ~~  292 (294)
T PLN00009        291 GD  292 (294)
T ss_pred             hc
Confidence            53

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.1e-40  Score=257.26  Aligned_cols=235  Identities=36%  Similarity=0.632  Sum_probs=193.9

Q ss_pred             CCCcccccccccccCCCC---CCCCcEEEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 023568            1 MEHENVIAIKDIIRPPKK---DTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP   76 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~---~~~~~~~lv~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~   76 (280)
                      |+|+|++.+.+++.....   .....+|+||.+|+.+|..++.+. .+++..++..++.++..||.|+|+..|+|||+|+
T Consensus        73 lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKa  152 (376)
T KOG0669|consen   73 LKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKA  152 (376)
T ss_pred             hcchhHHHHHHHHhhccCCcccccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccH
Confidence            689999999999876432   122459999999999999999765 6899999999999999999999999999999999


Q ss_pred             CceEEcCCCCeEEeecccccccCCC-----CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 023568           77 SNLLLNASCDLKIGDFGLARTTSET-----DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK  151 (280)
Q Consensus        77 ~Nili~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~  151 (280)
                      .|+||+.+|.++|+|||+++..+-.     ...+....|.+|.+||.+.|...++.+.|+|..||++.+|.+|.+.+++.
T Consensus       153 aNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgn  232 (376)
T KOG0669|consen  153 ANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGN  232 (376)
T ss_pred             hhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCC
Confidence            9999999999999999999643322     12344566999999999999999999999999999999999999999999


Q ss_pred             ChHHHHHHHHHHhCCCCcccccccCChhHHHHHH--hCCccccccccccCC--CCCHHHHHHHHHhcccCCCCCCCHHHH
Q 023568          152 DYVHQLRLITELIGSPDDASLGFLRSDNARRYVR--QLPRCRKQQFATRFP--NKSSGAVDLLEKMLVFDPNKRITVEEA  227 (280)
Q Consensus       152 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~--~~~~~~~~ll~~~L~~dp~~Rpt~~el  227 (280)
                      ..-+++..|..++|....+-|+....-..-..+.  -++.......+....  ...+++.+|+.++|..||.+|+.++++
T Consensus       233 teqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~a  312 (376)
T KOG0669|consen  233 TEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQA  312 (376)
T ss_pred             hHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhh
Confidence            9999999999999999988887765443333331  122222222222222  246789999999999999999999999


Q ss_pred             hcCccccc
Q 023568          228 LRHPYLQS  235 (280)
Q Consensus       228 l~hp~~~~  235 (280)
                      |+|.||..
T Consensus       313 lnh~~F~k  320 (376)
T KOG0669|consen  313 LNHDFFWK  320 (376)
T ss_pred             hchhhhhc
Confidence            99999954

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2e-39  Score=279.14  Aligned_cols=249  Identities=42%  Similarity=0.780  Sum_probs=185.1

Q ss_pred             CCCcccccccccccCCCCCC---------CCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 023568            1 MEHENVIAIKDIIRPPKKDT---------FNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH   71 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~---------~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H   71 (280)
                      ++||||+++++++.......         ....|+||||++++|.+++.. ..+++..++.++.|++.||.|||+.|++|
T Consensus        59 l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH  137 (342)
T cd07854          59 LDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLH  137 (342)
T ss_pred             cCCCcchhhHhhhcccccccccccccccccceEEEEeecccccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            57999999999887653211         135899999999999988864 57999999999999999999999999999


Q ss_pred             cCCCCCceEEcC-CCCeEEeecccccccCCCC----ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCC
Q 023568           72 RDLKPSNLLLNA-SCDLKIGDFGLARTTSETD----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREP  146 (280)
Q Consensus        72 ~dik~~Nili~~-~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~  146 (280)
                      |||||+||+++. ++.++|+|||.+.......    ......++..|+|||.+.+...++.++|+|||||++|+|++|+.
T Consensus       138 ~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~  217 (342)
T cd07854         138 RDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKP  217 (342)
T ss_pred             CCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCC
Confidence            999999999975 5678999999987543221    11234568889999987664668889999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHH
Q 023568          147 LFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEE  226 (280)
Q Consensus       147 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~e  226 (280)
                      ||.+.+.......+.................... ..................+..+.++.+|+++||+.||.+|||+++
T Consensus       218 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  296 (342)
T cd07854         218 LFAGAHELEQMQLILESVPVVREEDRNELLNVIP-SFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEE  296 (342)
T ss_pred             CCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhh-hhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHH
Confidence            9998887766666655443333221111101000 111101111122223334568899999999999999999999999


Q ss_pred             HhcCcccccCcCCCCCCCCCCCCCC
Q 023568          227 ALRHPYLQSLHDLNDEPVCPRPFHF  251 (280)
Q Consensus       227 ll~hp~~~~~~~~~~~~~~~~~~~~  251 (280)
                      ++.||||+.+..+...+....++..
T Consensus       297 ll~h~~~~~~~~~~~~~~~~~~~~~  321 (342)
T cd07854         297 ALMHPYMSCYSCPFDEPVSLHPFHI  321 (342)
T ss_pred             HhCCCccccccCCccccCCCCCccc
Confidence            9999999988777666666555543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.5e-39  Score=273.01  Aligned_cols=228  Identities=35%  Similarity=0.676  Sum_probs=175.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++...     ...|+||||+++ .|.++......+++.++..++.|++.||+|||+.|++|+||+|+||
T Consensus        57 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni  131 (286)
T cd07846          57 LRHENLVNLIEVFRRK-----KRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENI  131 (286)
T ss_pred             cCCcchhhHHHhcccC-----CeEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHE
Confidence            5799999999999877     779999999986 6666666656799999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||++...... .......++..|+|||.+.+...++.++|+||+|+++++|++|.+||..........
T Consensus       132 ~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~  211 (286)
T cd07846         132 LVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLY  211 (286)
T ss_pred             EECCCCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHH
Confidence            9999999999999998764332 223345678899999998765667889999999999999999999999887777777


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      .+....+..................................+.++..+.+++++||+.+|++||++.++++||||
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         212 HIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             HHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence            776655543322111111000000000000001111222345778999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=9.4e-40  Score=278.98  Aligned_cols=199  Identities=22%  Similarity=0.416  Sum_probs=169.0

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      +|++|+++++++++.     +.+|+||||++ |+|.+++.+.+.+++.++..++.|++.||+|||+.|++||||||+||+
T Consensus        59 ~~~~i~~~~~~~~~~-----~~~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nil  133 (323)
T cd05615          59 KPPFLTQLHSCFQTV-----DRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVM  133 (323)
T ss_pred             CCCchhheeeEEecC-----CEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeE
Confidence            478899999999887     67999999997 599999988888999999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           81 LNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      ++.++.++|+|||+++..... .......||+.|+|||++.+ ..++.++|+||+||++|+|++|..||.+.+.......
T Consensus       134 l~~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~  212 (323)
T cd05615         134 LDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQS  212 (323)
T ss_pred             ECCCCCEEEeccccccccCCCCccccCccCCccccCHHHHcC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            999999999999998754322 22344568999999999876 6788999999999999999999999998876555554


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCcccc
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT-----VEEALRHPYLQ  234 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt-----~~ell~hp~~~  234 (280)
                      +....                               ...+...+..+.+++.+||+.||.+|++     .+++++||||+
T Consensus       213 i~~~~-------------------------------~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~  261 (323)
T cd05615         213 IMEHN-------------------------------VSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFR  261 (323)
T ss_pred             HHhCC-------------------------------CCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccC
Confidence            43310                               0112356889999999999999999997     57999999998


Q ss_pred             cCc
Q 023568          235 SLH  237 (280)
Q Consensus       235 ~~~  237 (280)
                      .+.
T Consensus       262 ~~~  264 (323)
T cd05615         262 RID  264 (323)
T ss_pred             CCC
Confidence            763

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=9.9e-40  Score=279.94  Aligned_cols=226  Identities=21%  Similarity=0.361  Sum_probs=168.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~-~i~H~dik~~N   78 (280)
                      ++||||++++++|.+.     +.+|+||||+. |+|.+++...+.+++..+..++.|++.||.|||+. +++|+||||+|
T Consensus        60 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~N  134 (333)
T cd06650          60 CNSPYIVGFYGAFYSD-----GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSN  134 (333)
T ss_pred             CCCCcccceeEEEEEC-----CEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhh
Confidence            5799999999999987     78999999997 59999998888899999999999999999999975 79999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      |+++.++.++|+|||++...... ......++..|+|||.+.+ ..++.++|+||+||++|+|++|+.||..........
T Consensus       135 ili~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~  212 (333)
T cd06650         135 ILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELEL  212 (333)
T ss_pred             EEEcCCCCEEEeeCCcchhhhhh-ccccCCCCccccCHHHhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHH
Confidence            99999999999999998754332 2234568899999999877 678899999999999999999999998766433322


Q ss_pred             HHHHH-hCCCCcccccccCC----------------hhHHHHHHhCCcccccccccc-CCCCCHHHHHHHHHhcccCCCC
Q 023568          159 LITEL-IGSPDDASLGFLRS----------------DNARRYVRQLPRCRKQQFATR-FPNKSSGAVDLLEKMLVFDPNK  220 (280)
Q Consensus       159 ~i~~~-~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ll~~~L~~dp~~  220 (280)
                      .+... .+.+..........                ...........   ....+.. ....+.++++|+.+||+.||++
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~~P~~  289 (333)
T cd06650         213 MFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIV---NEPPPKLPSGVFGAEFQDFVNKCLIKNPAE  289 (333)
T ss_pred             HhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHh---cCCCccCCCCCcCHHHHHHHHHhccCCccc
Confidence            22111 01111000000000                00000000000   0000111 1236788999999999999999


Q ss_pred             CCCHHHHhcCcccccC
Q 023568          221 RITVEEALRHPYLQSL  236 (280)
Q Consensus       221 Rpt~~ell~hp~~~~~  236 (280)
                      |||++|++.||||+..
T Consensus       290 Rpt~~ell~h~~~~~~  305 (333)
T cd06650         290 RADLKQLMVHAFIKRS  305 (333)
T ss_pred             CcCHHHHhhCHHHhcC
Confidence            9999999999999764

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-39  Score=271.86  Aligned_cols=226  Identities=41%  Similarity=0.764  Sum_probs=185.2

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++.+.     ...++||||++++|.+++.+. ..+++..+..++.|++.||++||+.|++||||+|+||
T Consensus        55 ~~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni  129 (282)
T cd07829          55 LKHPNIVKLLDVIHTE-----RKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNI  129 (282)
T ss_pred             cCCCCHHHHHhhhhcC-----CceEEEecCcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheE
Confidence            4799999999999987     679999999999999999876 5899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCC-ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||.+....... ......++..|+|||.+.+...++.++|+||+||++++|++|..||.+......+.
T Consensus       130 ~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~  209 (282)
T cd07829         130 LINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLF  209 (282)
T ss_pred             EEcCCCCEEEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHH
Confidence            99999999999999987654432 23344567789999998775588899999999999999999999999999888888


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      ++....+.+.+..+.......  .+....+..........++..+..+.++|++||..||++||++++++.||||
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         210 KIFQILGTPTEESWPGVTKLP--DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             HHHHHhCCCcHHHHHhhcccc--cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            888887776665443222111  0111122222222233445668899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-40  Score=285.37  Aligned_cols=191  Identities=32%  Similarity=0.539  Sum_probs=164.3

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      +||||+++++++.+.     .++|+|||.+.| .+.+.+...+.+. ..+..|+.||+.|+.|||++|++||||||+|||
T Consensus       374 ~h~niv~~~~v~~~~-----~~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL  447 (612)
T KOG0603|consen  374 DHPNIVKSHDVYEDG-----KEIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNIL  447 (612)
T ss_pred             CCCcceeecceecCC-----ceeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhhee
Confidence            699999999999998     789999999985 7777777756666 888899999999999999999999999999999


Q ss_pred             E-cCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           81 L-NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        81 i-~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      + +..++++|+|||.++.....  ..+.+-|..|.|||++.. ..++.++|+||||+++|+||+|+.||......   ..
T Consensus       448 ~~~~~g~lrltyFG~a~~~~~~--~~tp~~t~~y~APEvl~~-~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~e  521 (612)
T KOG0603|consen  448 LDGSAGHLRLTYFGFWSELERS--CDTPALTLQYVAPEVLAI-QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IE  521 (612)
T ss_pred             ecCCCCcEEEEEechhhhCchh--hcccchhhcccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCccccCCch---HH
Confidence            9 68999999999998876655  455677999999999985 99999999999999999999999999886544   22


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      +...++.+...                             ..+|..+++||++||+.||.+|+++++++.||||
T Consensus       522 i~~~i~~~~~s-----------------------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  522 IHTRIQMPKFS-----------------------------ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             HHHhhcCCccc-----------------------------cccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence            22222222111                             2679999999999999999999999999999999

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=3e-39  Score=277.28  Aligned_cols=229  Identities=38%  Similarity=0.690  Sum_probs=185.1

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      ++||||+++++++...     ...|+||||++|+|.+++.....+++..+..++.|++.||+|||+.|++|+||+|+||+
T Consensus        77 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nil  151 (335)
T PTZ00024         77 IKHENIMGLVDVYVEG-----DFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIF  151 (335)
T ss_pred             CCCcceeeeeEEEecC-----CcEEEEEeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeE
Confidence            5799999999999877     77999999999999999988788999999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccccCCC---------------CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCC
Q 023568           81 LNASCDLKIGDFGLARTTSET---------------DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTRE  145 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~  145 (280)
                      ++.++.++|+|||.+......               .......++..|+|||.+.+...++.++|+||+||++|+|++|.
T Consensus       152 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~  231 (335)
T PTZ00024        152 INSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK  231 (335)
T ss_pred             ECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCC
Confidence            999999999999998765411               11123345778999999877556789999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 023568          146 PLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVE  225 (280)
Q Consensus       146 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~  225 (280)
                      +||.+.+....+..+.+..+.+....+.......  . ................+..+..+.++|.+||+.||++|||++
T Consensus       232 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~--~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~  308 (335)
T PTZ00024        232 PLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLP--L-YTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAK  308 (335)
T ss_pred             CCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcc--c-ccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHH
Confidence            9999999888888888888777665432211000  0 000011111222233456788999999999999999999999


Q ss_pred             HHhcCcccccCc
Q 023568          226 EALRHPYLQSLH  237 (280)
Q Consensus       226 ell~hp~~~~~~  237 (280)
                      |+|.||||+...
T Consensus       309 ~~l~~~~~~~~~  320 (335)
T PTZ00024        309 EALKHEYFKSDP  320 (335)
T ss_pred             HHhcCcccCCCC
Confidence            999999998764

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-39  Score=278.62  Aligned_cols=205  Identities=22%  Similarity=0.412  Sum_probs=166.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||++++++|.++     +++|+||||+. |+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|
T Consensus        58 ~~~~~i~~~~~~~~~~-----~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~N  132 (331)
T cd05597          58 GDRRWITNLHYAFQDE-----NNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDN  132 (331)
T ss_pred             CCCCCCCceEEEEecC-----CeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHH
Confidence            4799999999999987     78999999996 599999976 4679999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCc--cccceecccccccccccc----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDF--MTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTREPLFPGKD  152 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~  152 (280)
                      ||++.++.++|+|||++........  .....||+.|+|||++.+    ...++.++|+||+||++|+|++|+.||.+.+
T Consensus       133 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~  212 (331)
T cd05597         133 VLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES  212 (331)
T ss_pred             EEECCCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC
Confidence            9999999999999999876543321  223468999999999863    2456789999999999999999999998877


Q ss_pred             hHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCC--CCCHHHHhcC
Q 023568          153 YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNK--RITVEEALRH  230 (280)
Q Consensus       153 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~--Rpt~~ell~h  230 (280)
                      ..+....+.....                          ....+...+.++..+++++++||..++.+  |++++++++|
T Consensus       213 ~~~~~~~i~~~~~--------------------------~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         213 LVETYGKIMNHKE--------------------------HFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             HHHHHHHHHcCCC--------------------------cccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            6555544432110                          01112222357899999999999764444  7899999999


Q ss_pred             cccccC
Q 023568          231 PYLQSL  236 (280)
Q Consensus       231 p~~~~~  236 (280)
                      |||+..
T Consensus       267 p~~~~~  272 (331)
T cd05597         267 PFFEGI  272 (331)
T ss_pred             CCCCCC
Confidence            999875

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=4.1e-39  Score=271.55  Aligned_cols=230  Identities=39%  Similarity=0.708  Sum_probs=179.0

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP   76 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~-----~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~   76 (280)
                      +||||+++++++......+....|+||||++++|.+++..     ...+++..++.++.||+.||.|||+.|++||||+|
T Consensus        59 ~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~  138 (295)
T cd07837          59 ESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKP  138 (295)
T ss_pred             CCCCccceeeeEeecCCCCCceEEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCh
Confidence            4799999999998763322245899999999999998854     23589999999999999999999999999999999


Q ss_pred             CceEEcC-CCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023568           77 SNLLLNA-SCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV  154 (280)
Q Consensus        77 ~Nili~~-~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~  154 (280)
                      +||+++. ++.++|+|||.+...... .......+++.|+|||.+.+...++.++|+||+|+++|+|++|..||.+.+..
T Consensus       139 ~nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~  218 (295)
T cd07837         139 QNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL  218 (295)
T ss_pred             HHEEEecCCCeEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH
Confidence            9999998 889999999998754332 22233456888999999876566789999999999999999999999998888


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ  234 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~  234 (280)
                      ..+..+....+.+....+........   ....+...........+..+..+.+||.+||..||.+|||++|++.||||+
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         219 QQLLHIFKLLGTPTEQVWPGVSKLRD---WHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             HHHHHHHHHhCCCChhhCcchhhccc---hhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence            88877777766655443321111000   001111122222233456789999999999999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-39  Score=270.64  Aligned_cols=227  Identities=48%  Similarity=0.842  Sum_probs=185.3

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++.+.     ...|+||||++++|.+.+.. ...+++.++..++.|++.||.|||+.|++|+||+|+||
T Consensus        55 l~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~ni  129 (283)
T cd05118          55 LNHPNIIKLLDVFRHK-----GDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENL  129 (283)
T ss_pred             hcCCCcchHHHhhccC-----CCEEEEEeccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHE
Confidence            5799999999999887     67999999999999998876 36899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCC-ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||.+....... ......++..|+|||.+.+....+.++|+||+|+++|+|++|+.||.+.+..+...
T Consensus       130 li~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~  209 (283)
T cd05118         130 LINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLF  209 (283)
T ss_pred             EECCCCcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            99999999999999987665442 23345678889999998775578899999999999999999999999999888888


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      .+...++.+.+..+....... .......+...........+..+..+.++|++||..||.+||++++++.||||
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         210 KIFRTLGTPDPEVWPKFTSLA-RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             HHHHHcCCCchHhcccchhhh-hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence            888777776655544332211 11111122222222233445678999999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.2e-39  Score=283.09  Aligned_cols=203  Identities=26%  Similarity=0.371  Sum_probs=166.3

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++.+.     ..+|+||||++ |+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus       100 ~~hp~iv~~~~~~~~~-----~~~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NI  173 (371)
T cd05622         100 ANSPWVVQLFYAFQDD-----RYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNM  173 (371)
T ss_pred             CCCCCCCeEEEEEEcC-----CEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHE
Confidence            4799999999999887     77999999997 599998865 5689999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCC--ccccceeccccccccccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023568           80 LLNASCDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPELLLNC---TEYTAAIDIWSVGCILGEIMTREPLFPGKDYV  154 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~---~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~  154 (280)
                      +++.++.++|+|||++.......  ......||+.|+|||++.+.   ..++.++|+|||||++|+|++|..||.+.+..
T Consensus       174 ll~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~  253 (371)
T cd05622         174 LLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV  253 (371)
T ss_pred             EECCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH
Confidence            99999999999999998654332  22356789999999998653   23788999999999999999999999988766


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCcc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNK--RITVEEALRHPY  232 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~--Rpt~~ell~hp~  232 (280)
                      .....+.......                          .+ ...+.++..++++|.+||..++.+  |++++++++|||
T Consensus       254 ~~~~~i~~~~~~~--------------------------~~-~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~  306 (371)
T cd05622         254 GTYSKIMNHKNSL--------------------------TF-PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF  306 (371)
T ss_pred             HHHHHHHcCCCcc--------------------------cC-CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence            5555544311100                          00 112357899999999999844433  789999999999


Q ss_pred             cccC
Q 023568          233 LQSL  236 (280)
Q Consensus       233 ~~~~  236 (280)
                      |++.
T Consensus       307 ~~~~  310 (371)
T cd05622         307 FKND  310 (371)
T ss_pred             cCCC
Confidence            9774

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=3.8e-39  Score=273.41  Aligned_cols=232  Identities=36%  Similarity=0.620  Sum_probs=177.6

Q ss_pred             CCCcccccccccccCCCC---CCCCcEEEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 023568            1 MEHENVIAIKDIIRPPKK---DTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP   76 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~---~~~~~~~lv~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~   76 (280)
                      ++||||+++++++.....   ......|+||||++++|.+.+... ..+++.++..++.|++.||+|||+.|++|+||+|
T Consensus        68 l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p  147 (310)
T cd07865          68 LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKA  147 (310)
T ss_pred             CCCCCccceEEEEecccccccCCCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCH
Confidence            579999999999876521   112467999999999999888654 3799999999999999999999999999999999


Q ss_pred             CceEEcCCCCeEEeecccccccCCCC-----ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 023568           77 SNLLLNASCDLKIGDFGLARTTSETD-----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK  151 (280)
Q Consensus        77 ~Nili~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~  151 (280)
                      +||+++.++.++|+|||.+.......     ......++..|+|||.+.+...++.++|+||+|+++|+|++|.+||.+.
T Consensus       148 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~  227 (310)
T cd07865         148 ANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGN  227 (310)
T ss_pred             HHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence            99999999999999999987543321     1123456788999998876555788999999999999999999999998


Q ss_pred             ChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccc-c-CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          152 DYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFAT-R-FPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       152 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      +.......+.+..+..++...+............ .+......... . ....+..+.++|.+||..||.+|||++++|+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         228 TEQHQLTLISQLCGSITPEVWPGVDKLELFKKME-LPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             CHHHHHHHHHHHhCCCChhhcccccchhhhhhcc-CCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            8888888888877766655443332211111000 01100000000 0 1124678899999999999999999999999


Q ss_pred             Cccc
Q 023568          230 HPYL  233 (280)
Q Consensus       230 hp~~  233 (280)
                      ||||
T Consensus       307 h~~f  310 (310)
T cd07865         307 HDFF  310 (310)
T ss_pred             CCCC
Confidence            9998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-40  Score=284.46  Aligned_cols=198  Identities=24%  Similarity=0.378  Sum_probs=170.9

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+|||||++++++...     ..++||||||. |.|+.+|+.+..++..-...|..+|+.|+.|||.++|+|||||.-||
T Consensus       169 LkH~NII~FkGVCtqs-----PcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNi  243 (904)
T KOG4721|consen  169 LKHPNIITFKGVCTQS-----PCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNI  243 (904)
T ss_pred             ccCcceeeEeeeecCC-----ceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCce
Confidence            7899999999999987     67999999998 89999999999999999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      ||..+..+||+|||-++-......+..++||..|||||++.+ ..++.++|||||||+|||||||..||.+-+....+  
T Consensus       244 LIs~~d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrn-ePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII--  320 (904)
T KOG4721|consen  244 LISYDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRN-EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII--  320 (904)
T ss_pred             EeeccceEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhc-CCcccccceehhHHHHHHHHhcCCCccccchheeE--
Confidence            999999999999999988777777788999999999999998 99999999999999999999999999775422111  


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                          .|-...                       ...-..+...+..++-||++||+-.|.-||++.++|.|-=+
T Consensus       321 ----wGVGsN-----------------------sL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI  367 (904)
T KOG4721|consen  321 ----WGVGSN-----------------------SLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI  367 (904)
T ss_pred             ----EeccCC-----------------------cccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence                110000                       00011223567889999999999999999999999998543

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=3.7e-39  Score=278.63  Aligned_cols=203  Identities=27%  Similarity=0.369  Sum_probs=160.0

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++...     +.+|+||||+.+ +|.+.    ...++..+..++.||+.||+|||++||+||||||+||
T Consensus       129 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI  199 (353)
T PLN00034        129 VNHPNVVKCHDMFDHN-----GEIQVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNL  199 (353)
T ss_pred             CCCCCcceeeeEeccC-----CeEEEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHE
Confidence            5799999999999887     679999999985 76542    4567888999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC-CccccceeccccccccccccC----CCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023568           80 LLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNC----TEYTAAIDIWSVGCILGEIMTREPLFPGKDYV  154 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~----~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~  154 (280)
                      |++.++.++|+|||++...... .......|+..|+|||.+...    ...+.++|||||||++|+|++|+.||......
T Consensus       200 ll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~  279 (353)
T PLN00034        200 LINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG  279 (353)
T ss_pred             EEcCCCCEEEcccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc
Confidence            9999999999999998765433 223456789999999987431    33456899999999999999999999744322


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ  234 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~  234 (280)
                      +....+....                           ...........+..+.+||++||+.||++|||++|+++||||.
T Consensus       280 ~~~~~~~~~~---------------------------~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~  332 (353)
T PLN00034        280 DWASLMCAIC---------------------------MSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFIL  332 (353)
T ss_pred             cHHHHHHHHh---------------------------ccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccc
Confidence            2111111110                           0011122335788999999999999999999999999999998


Q ss_pred             cCcCC
Q 023568          235 SLHDL  239 (280)
Q Consensus       235 ~~~~~  239 (280)
                      .-...
T Consensus       333 ~~~~~  337 (353)
T PLN00034        333 RAQPG  337 (353)
T ss_pred             cCCcc
Confidence            86543

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.8e-39  Score=278.37  Aligned_cols=206  Identities=22%  Similarity=0.433  Sum_probs=168.4

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||+++++++.+.     ..+|+||||+. |+|.+++.+ ...+++..++.++.|++.||.|||+.||+||||||+|
T Consensus        58 ~~~~~i~~~~~~~~~~-----~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~N  132 (332)
T cd05623          58 GDNQWITTLHYAFQDE-----NNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDN  132 (332)
T ss_pred             CCCCCEeeEEEEEecC-----CEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHH
Confidence            4799999999999987     77999999997 699999976 4679999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCC--ccccceecccccccccccc----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 023568           79 LLLNASCDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTREPLFPGKD  152 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~  152 (280)
                      |+++.++.++|+|||++.......  ......||+.|+|||++.+    ...++.++|+|||||++|+|++|+.||.+.+
T Consensus       133 ili~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~  212 (332)
T cd05623         133 ILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES  212 (332)
T ss_pred             EEECCCCCEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC
Confidence            999999999999999987543322  1223578999999999863    3567889999999999999999999999887


Q ss_pred             hHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCC--CCCHHHHhcC
Q 023568          153 YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNK--RITVEEALRH  230 (280)
Q Consensus       153 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~--Rpt~~ell~h  230 (280)
                      .......+.....                          ...++.....+++++.+++++||+.++.+  |++++++++|
T Consensus       213 ~~~~~~~i~~~~~--------------------------~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         213 LVETYGKIMNHKE--------------------------RFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             HHHHHHHHhCCCc--------------------------cccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            6666555432110                          01122223457899999999999765544  6899999999


Q ss_pred             cccccCc
Q 023568          231 PYLQSLH  237 (280)
Q Consensus       231 p~~~~~~  237 (280)
                      |||.++.
T Consensus       267 ~~f~~~~  273 (332)
T cd05623         267 PFFTGID  273 (332)
T ss_pred             CCcCCCC
Confidence            9998753

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.3e-39  Score=271.94  Aligned_cols=203  Identities=25%  Similarity=0.417  Sum_probs=165.6

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      ++|+||+++++.+.+.     ..+|+||||+. ++|.+++...  ..+++..+..++.|++.||.|||+.|++||||||+
T Consensus        57 l~~~~i~~~~~~~~~~-----~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~  131 (285)
T cd05630          57 VNSRFVVSLAYAYETK-----DALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPE  131 (285)
T ss_pred             CCCCCeeeeeEEEecC-----CEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHH
Confidence            5799999999999887     67999999997 5999888543  36999999999999999999999999999999999


Q ss_pred             ceEEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023568           78 NLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  157 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~  157 (280)
                      ||+++.++.++|+|||++.............|+..|+|||.+.+ ..++.++|+||+|+++|+|++|..||.........
T Consensus       132 Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~  210 (285)
T cd05630         132 NILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR  210 (285)
T ss_pred             HEEECCCCCEEEeeccceeecCCCccccCCCCCccccChHHHcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH
Confidence            99999999999999999876544433344578999999999877 67889999999999999999999999875422111


Q ss_pred             HHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCcc
Q 023568          158 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT-----VEEALRHPY  232 (280)
Q Consensus       158 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt-----~~ell~hp~  232 (280)
                      ..........                           ........++.+.+|+++||+.||++|||     ++|+++|||
T Consensus       211 ~~~~~~~~~~---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~  263 (285)
T cd05630         211 EEVERLVKEV---------------------------QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPL  263 (285)
T ss_pred             HHHHhhhhhh---------------------------hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChh
Confidence            1111110000                           00112356888999999999999999999     999999999


Q ss_pred             cccC
Q 023568          233 LQSL  236 (280)
Q Consensus       233 ~~~~  236 (280)
                      |+.+
T Consensus       264 ~~~~  267 (285)
T cd05630         264 FKQI  267 (285)
T ss_pred             hhcc
Confidence            9875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-39  Score=269.50  Aligned_cols=228  Identities=37%  Similarity=0.716  Sum_probs=176.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHH-HHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQ-IIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~-~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++...     +..|+||||+++++.+ +..+...+++.++..++.|++.||.|||+.|++|+||+|+||
T Consensus        57 l~~~~i~~~~~~~~~~-----~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni  131 (288)
T cd07833          57 LRHENIVNLKEAFRRK-----GRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENI  131 (288)
T ss_pred             cCCCCeeehhheEEEC-----CEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHe
Confidence            5799999999999886     6799999999975554 455556799999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCC--ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  157 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~  157 (280)
                      +++.++.++|+|||.+.......  ......++..|+|||.+.+...++.++|+||+|+++|+|++|.+||.+....+.+
T Consensus       132 ~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~  211 (288)
T cd07833         132 LVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQL  211 (288)
T ss_pred             EECCCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            99999999999999987654432  3345667889999999987448889999999999999999999999988877777


Q ss_pred             HHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCC-CCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          158 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       158 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      ..+....+..++.............-...............++. ++..+.+|+++||..+|++|||++++++||||
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         212 YLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             HHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence            77777666555433222111000000000000001111122233 48999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=4.6e-39  Score=275.27  Aligned_cols=230  Identities=19%  Similarity=0.278  Sum_probs=164.1

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      ++||||+++++++..+     +..|+||||++ |+|.+++..+  +.+++..++.++.|++.||+|||++||+||||||+
T Consensus        56 l~hpniv~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~  130 (327)
T cd08227          56 FNHPNIVPYRATFIAD-----NELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKAS  130 (327)
T ss_pred             cCCCCeeeEEEEEEEC-----CEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChh
Confidence            5899999999999987     67999999998 5999998653  46999999999999999999999999999999999


Q ss_pred             ceEEcCCCCeEEeecccccccCCC--------CccccceeccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCC
Q 023568           78 NLLLNASCDLKIGDFGLARTTSET--------DFMTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLF  148 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~~l~~ll~g~~pf  148 (280)
                      ||+++.++.++++||+........        .......++..|+|||.+.+. ..++.++|+||+||++|+|++|..||
T Consensus       131 Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf  210 (327)
T cd08227         131 HILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF  210 (327)
T ss_pred             hEEEecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence            999999999999999865432211        011223457789999998653 45788999999999999999999999


Q ss_pred             CCCChHHHHHHHHHHhCCCCccc---------ccccC-Ch-----hHHH-HH-HhCCccccccccccCCCCCHHHHHHHH
Q 023568          149 PGKDYVHQLRLITELIGSPDDAS---------LGFLR-SD-----NARR-YV-RQLPRCRKQQFATRFPNKSSGAVDLLE  211 (280)
Q Consensus       149 ~~~~~~~~~~~i~~~~~~~~~~~---------~~~~~-~~-----~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~ll~  211 (280)
                      .............  .+..+...         ..... ..     .... .. ..................++.+.+|++
T Consensus       211 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  288 (327)
T cd08227         211 KDMPATQMLLEKL--NGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVE  288 (327)
T ss_pred             CCcchhHHHHHHh--cCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHH
Confidence            8765433322221  11111000         00000 00     0000 00 000000000001112245789999999


Q ss_pred             HhcccCCCCCCCHHHHhcCcccccCc
Q 023568          212 KMLVFDPNKRITVEEALRHPYLQSLH  237 (280)
Q Consensus       212 ~~L~~dp~~Rpt~~ell~hp~~~~~~  237 (280)
                      +||+.||++|||++|+++||||+.+.
T Consensus       289 ~~l~~dP~~Rpt~~ell~~p~f~~~~  314 (327)
T cd08227         289 QCLQRNPDARPSASTLLNHSFFKQIK  314 (327)
T ss_pred             HHHhhCchhcCCHHHHhcChhhhhcc
Confidence            99999999999999999999998764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=7.3e-39  Score=265.51  Aligned_cols=201  Identities=24%  Similarity=0.441  Sum_probs=168.6

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++.+.     ...|+||||++ ++|.+++.+...+++..+..++.|++.||+|||++|++|+||+|+||
T Consensus        50 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~ni  124 (262)
T cd05572          50 CNHPFIVKLYRTFKDK-----KYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENL  124 (262)
T ss_pred             CCCCCEeeeeeeEEcC-----CccEEEEecCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHE
Confidence            5799999999999877     67999999997 59999998878899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--hHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD--YVHQL  157 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~--~~~~~  157 (280)
                      +++.++.++|+|||.+.............++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||....  .....
T Consensus       125 lv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~  203 (262)
T cd05572         125 LLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIY  203 (262)
T ss_pred             EEcCCCCEEEeeCCcccccCcccccccccCCcCccChhHhcC-CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHH
Confidence            999999999999999987655433344567889999999876 667889999999999999999999998765  33333


Q ss_pred             HHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCcc
Q 023568          158 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT-----VEEALRHPY  232 (280)
Q Consensus       158 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt-----~~ell~hp~  232 (280)
                      ..+...                             ..........++.+.++|++||+.||.+||+     ++|+++|||
T Consensus       204 ~~~~~~-----------------------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~  254 (262)
T cd05572         204 NDILKG-----------------------------NGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKW  254 (262)
T ss_pred             HHHhcc-----------------------------CCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChh
Confidence            222210                             0011112234789999999999999999999     999999999


Q ss_pred             cccC
Q 023568          233 LQSL  236 (280)
Q Consensus       233 ~~~~  236 (280)
                      |+++
T Consensus       255 ~~~~  258 (262)
T cd05572         255 FNGF  258 (262)
T ss_pred             hhCC
Confidence            9875

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4e-40  Score=284.38  Aligned_cols=203  Identities=24%  Similarity=0.418  Sum_probs=180.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+||||||++.+.+.+     ..+|+||||+. |.+++++.+++++.+..++.++.|++.|++|||+++|+|||||++|+
T Consensus       112 l~HPnIvkl~~v~~t~-----~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNi  186 (596)
T KOG0586|consen  112 LNHPNIVKLFSVIETE-----ATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENI  186 (596)
T ss_pred             cCCcceeeeeeeeeec-----ceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhc
Confidence            6899999999999988     66999999997 69999999999999999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      |++.+..+||+|||++..........+.+|++.|+|||++.+..+.+..+|+||+|+++|.|+.|..||.+........+
T Consensus       187 lL~~~mnikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~r  266 (596)
T KOG0586|consen  187 LLDENMNIKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPR  266 (596)
T ss_pred             ccccccceeeeccccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccch
Confidence            99999999999999999988888889999999999999999988889999999999999999999999998763322211


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCcCC
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL  239 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~~~  239 (280)
                      .                               ......++--++.++.++|+++|..+|.+|++.+++..|.|....+..
T Consensus       267 v-------------------------------l~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  267 V-------------------------------LRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             h-------------------------------eeeeecccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence            1                               111112223578999999999999999999999999999999887765

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=9e-39  Score=267.82  Aligned_cols=225  Identities=38%  Similarity=0.733  Sum_probs=180.4

Q ss_pred             CcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            3 HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         3 Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      ||||+++++++.+.     ...|+||||++|+|.+.+....  .+++..+..++.|++.||.|||++|++|+||+|+||+
T Consensus        57 h~~i~~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~  131 (283)
T cd07830          57 HPNIVKLKEVFREN-----DELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLL  131 (283)
T ss_pred             CCCchhHHHHhhcC-----CcEEEEEecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEE
Confidence            99999999999986     7799999999889999987654  7899999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 023568           81 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  160 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~i  160 (280)
                      ++.++.++|+|||.+.............++..|+|||.+.+...++.++|+||||+++++|++|.+||+.....+....+
T Consensus       132 i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~  211 (283)
T cd07830         132 VSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKI  211 (283)
T ss_pred             EcCCCCEEEeecccceeccCCCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHH
Confidence            99999999999999987655444445667889999998866566789999999999999999999999999888888888


Q ss_pred             HHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          161 TELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      ...++.+....+....... ...-...+...........+..+..+.+++++||+.||.+|||++|++.||||
T Consensus       212 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         212 CSVLGTPTKQDWPEGYKLA-SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             HHhcCCCChhhhhhHhhhh-ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            8877766544321100000 00000011111111122233457899999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=7e-39  Score=268.22  Aligned_cols=202  Identities=25%  Similarity=0.410  Sum_probs=165.6

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      +||||+++++++..+     +..|+||||+. |+|.+++..++.+++..+..++.|++.||.|||+.|++|+||||+||+
T Consensus        55 ~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil  129 (279)
T cd05633          55 DCPFIVCMTYAFHTP-----DKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANIL  129 (279)
T ss_pred             CCCcEeEEEEEEecC-----CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEE
Confidence            699999999999887     67999999998 599999988888999999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 023568           81 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  160 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~i  160 (280)
                      ++.++.++|+|||++....... .....++..|+|||.+.+...++.++|+||+||++|+|++|..||......... .+
T Consensus       130 ~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~  207 (279)
T cd05633         130 LDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EI  207 (279)
T ss_pred             ECCCCCEEEccCCcceeccccC-ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HH
Confidence            9999999999999987544322 233568899999999865466788999999999999999999999765321111 11


Q ss_pred             HHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccccc
Q 023568          161 TELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQS  235 (280)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rp-----t~~ell~hp~~~~  235 (280)
                      .....                           ......++..++.+.++|++||..||++|+     |++++++||||+.
T Consensus       208 ~~~~~---------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~  260 (279)
T cd05633         208 DRMTL---------------------------TVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKG  260 (279)
T ss_pred             HHHhh---------------------------cCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccC
Confidence            11000                           000112335788999999999999999999     6999999999988


Q ss_pred             Cc
Q 023568          236 LH  237 (280)
Q Consensus       236 ~~  237 (280)
                      +.
T Consensus       261 ~~  262 (279)
T cd05633         261 ID  262 (279)
T ss_pred             CC
Confidence            64

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.1e-38  Score=270.84  Aligned_cols=227  Identities=23%  Similarity=0.376  Sum_probs=169.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~-~~i~H~dik~~N   78 (280)
                      ++||||+++++++.+.     +.+|+||||++ ++|.+++.+.+.+++..+..++.|++.||.|||+ .+++|+||+|+|
T Consensus        56 l~h~~iv~~~~~~~~~-----~~~~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~n  130 (308)
T cd06615          56 CNSPYIVGFYGAFYSD-----GEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSN  130 (308)
T ss_pred             CCCCCCCeEEEEEeeC-----CEEEEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHH
Confidence            5799999999999887     78999999997 5999999888889999999999999999999997 599999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      |+++.++.++|+|||++...... ......++..|+|||.+.+ ..++.++|+||+|+++++|++|..||...+......
T Consensus       131 il~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~  208 (308)
T cd06615         131 ILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEA  208 (308)
T ss_pred             EEEecCCcEEEccCCCccccccc-ccccCCCCcCccChhHhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHH
Confidence            99999999999999998754332 2244577889999999876 668889999999999999999999998766433322


Q ss_pred             HHHHHhCCCCcccc------cccCC---hhHHHHHHhCCccccccccccC-CCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 023568          159 LITELIGSPDDASL------GFLRS---DNARRYVRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEAL  228 (280)
Q Consensus       159 ~i~~~~~~~~~~~~------~~~~~---~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ll~~~L~~dp~~Rpt~~ell  228 (280)
                      .+............      .....   ...........   ....+... ...+.++.+++.+||..||++|||+++++
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll  285 (308)
T cd06615         209 MFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIV---NEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELT  285 (308)
T ss_pred             hhcCccccccccCCcccccCCCCCccchhhHHHHHHHHh---cCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence            22111111100000      00000   00011111111   01111111 13688899999999999999999999999


Q ss_pred             cCcccccCc
Q 023568          229 RHPYLQSLH  237 (280)
Q Consensus       229 ~hp~~~~~~  237 (280)
                      +||||....
T Consensus       286 ~~~~~~~~~  294 (308)
T cd06615         286 KHPFIKRAE  294 (308)
T ss_pred             cChhhhhcc
Confidence            999997753

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.7e-39  Score=268.73  Aligned_cols=204  Identities=34%  Similarity=0.581  Sum_probs=169.3

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++.+.     ...++|||++.+ +|.+++.+.+.+++.++..++.|++.||.+||+.|++|+||||+||
T Consensus        55 l~~~~i~~~~~~~~~~-----~~~~~v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NI  129 (260)
T PF00069_consen   55 LRHPNIVQILDVFQDD-----NYLYIVMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENI  129 (260)
T ss_dssp             HTBTTBCHEEEEEEES-----SEEEEEEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGE
T ss_pred             cccccccccccccccc-----ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            4799999999999987     779999999997 9999998778999999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeeccccccc-CCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTT-SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||.+... ..........++..|+|||.+......+.++|+||+|+++++|++|..||..........
T Consensus       130 l~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~  209 (260)
T PF00069_consen  130 LLDENGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLE  209 (260)
T ss_dssp             EESTTSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhh
Confidence            9999999999999998763 333344567789999999998734788999999999999999999999999885444444


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      .+.+...........                        .....+..+.++|++||+.||++|||++++++||||
T Consensus       210 ~~~~~~~~~~~~~~~------------------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  210 IIEKILKRPLPSSSQ------------------------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHHHHHTHHHHHTT------------------------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             hhhhccccccccccc------------------------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence            443322211111000                        000123789999999999999999999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.1e-38  Score=267.42  Aligned_cols=197  Identities=21%  Similarity=0.217  Sum_probs=162.0

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~-~~i~H~dik~~N   78 (280)
                      ++||||+++++++.+.. .+...+++||||+. |+|.+++.+.+.+++..+..++.|++.||.|||+ .+++||||||+|
T Consensus        75 l~h~nIv~~~g~~~~~~-~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~n  153 (283)
T PHA02988         75 IDSNNILKIYGFIIDIV-DDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVS  153 (283)
T ss_pred             cCCCCEEEEeeeEEecc-cCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhh
Confidence            58999999999997611 11156899999998 5999999888889999999999999999999998 599999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCccccceeccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  157 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~  157 (280)
                      |+++.++.+||+|||+++......  ....++..|+|||.+.+. ..++.++|||||||++|+|++|..||.+.+..+..
T Consensus       154 ill~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~  231 (283)
T PHA02988        154 FLVTENYKLKIICHGLEKILSSPP--FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIY  231 (283)
T ss_pred             EEECCCCcEEEcccchHhhhcccc--ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence            999999999999999987654332  245678899999998652 57889999999999999999999999987755554


Q ss_pred             HHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          158 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       158 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      ..+......                             .......++.+.+++.+||+.||.+|||++++++
T Consensus       232 ~~i~~~~~~-----------------------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        232 DLIINKNNS-----------------------------LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             HHHHhcCCC-----------------------------CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            443321110                             0111246889999999999999999999999986

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.2e-38  Score=264.87  Aligned_cols=197  Identities=30%  Similarity=0.532  Sum_probs=165.0

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++...     ...++||||+++ +|.+++...+.+++..+..++.|++.||+|||+.|++||||+|+||
T Consensus        63 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~ni  137 (267)
T cd06628          63 LQHENIVQYLGSSLDA-----DHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANI  137 (267)
T ss_pred             cCCCCeeeEEEEEEeC-----CccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHE
Confidence            5799999999999887     779999999975 9999998888899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCC-------ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 023568           80 LLNASCDLKIGDFGLARTTSETD-------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD  152 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~  152 (280)
                      +++.++.++|+|||.++......       ......++..|+|||.+.+ ..++.++|+||+||++|+|++|..||...+
T Consensus       138 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~  216 (267)
T cd06628         138 LVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQ-TSYTRKADIWSLGCLVVEMLTGKHPFPDCT  216 (267)
T ss_pred             EEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhcc-CCCCchhhhHHHHHHHHHHhhCCCCCCCcc
Confidence            99999999999999987654211       1123457888999999876 677889999999999999999999998765


Q ss_pred             hHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 023568          153 YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY  232 (280)
Q Consensus       153 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~  232 (280)
                      .......+...                              ..+......+..+.++|++||+.||.+||++.++++|||
T Consensus       217 ~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  266 (267)
T cd06628         217 QLQAIFKIGEN------------------------------ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPF  266 (267)
T ss_pred             HHHHHHHHhcc------------------------------CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCC
Confidence            44333222110                              011122356889999999999999999999999999999


Q ss_pred             c
Q 023568          233 L  233 (280)
Q Consensus       233 ~  233 (280)
                      |
T Consensus       267 ~  267 (267)
T cd06628         267 L  267 (267)
T ss_pred             C
Confidence            7

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-38  Score=263.94  Aligned_cols=200  Identities=29%  Similarity=0.465  Sum_probs=167.2

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      +||||++++++++..     +..|+||||++ ++|.+++...+.+++..+..++.|++.||.|||+.|++|+||+|+||+
T Consensus        55 ~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil  129 (260)
T cd05611          55 ESPYVAKLYYSFQSK-----DYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLL  129 (260)
T ss_pred             CCCCeeeeeeeEEcC-----CeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeE
Confidence            699999999999877     77999999997 599999988788999999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 023568           81 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  160 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~i  160 (280)
                      ++.++.++|+|||.+.....   .....++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||...+.......+
T Consensus       130 ~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~  205 (260)
T cd05611         130 IDQTGHLKLTDFGLSRNGLE---NKKFVGTPDYLAPETILG-VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNI  205 (260)
T ss_pred             ECCCCcEEEeecccceeccc---cccCCCCcCccChhhhcC-CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            99999999999998876443   234457788999999877 55889999999999999999999999887765544433


Q ss_pred             HHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCcccccCc
Q 023568          161 TELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI---TVEEALRHPYLQSLH  237 (280)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rp---t~~ell~hp~~~~~~  237 (280)
                      ......                           .........++.+.+++++||+.||++||   +++|+++||||++++
T Consensus       206 ~~~~~~---------------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~  258 (260)
T cd05611         206 LSRRIN---------------------------WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSIN  258 (260)
T ss_pred             HhcccC---------------------------CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCC
Confidence            221000                           00111225688999999999999999999   558999999997753

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-38  Score=265.98  Aligned_cols=228  Identities=39%  Similarity=0.692  Sum_probs=178.4

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||+++++++.+....+...++++|||++++|.+++...  ..+++..+..++.|++.||+|||+.|++|+||+|+|
T Consensus        58 ~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~n  137 (287)
T cd07838          58 FEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQN  137 (287)
T ss_pred             cCCCCcceEEEEEeeccCCCCceeEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhh
Confidence            369999999999987632222359999999999999988654  359999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      |+++.++.++|+|||.+.............++..|+|||.+.+ ..++.++|+||+||++|+|++|.+||.+....+...
T Consensus       138 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~  216 (287)
T cd07838         138 ILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQ-SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLD  216 (287)
T ss_pred             EEEccCCCEEEeccCcceeccCCcccccccccccccChHHhcc-CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHH
Confidence            9999999999999999887655444445567889999999877 678889999999999999999999999988888777


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      ++....+.+....+........    ...+...........+.+++.+.+++++||+.||.+||++++++.||||
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         217 KIFDVIGLPSEEEWPRNVSLPR----SSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             HHHHHcCCCChHhcCCCcccch----hhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence            7776555433222111100000    0001111111222234567889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.4e-38  Score=264.75  Aligned_cols=197  Identities=23%  Similarity=0.417  Sum_probs=163.5

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      +||||+++++.|...     +..|+||||+. ++|.+++.+.+.+++.++..++.|++.||.|||+.|++||||+|+||+
T Consensus        67 ~h~~iv~~~~~~~~~-----~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil  141 (267)
T PHA03390         67 DNPNFIKLYYSVTTL-----KGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVL  141 (267)
T ss_pred             cCCCEEEEEEEEecC-----CeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEE
Confidence            599999999999987     67999999997 599999988779999999999999999999999999999999999999


Q ss_pred             EcCCC-CeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH-HH
Q 023568           81 LNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ-LR  158 (280)
Q Consensus        81 i~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~-~~  158 (280)
                      ++.++ .++|+|||.+......   ....++..|+|||.+.+ ..++.++|+||+|+++++|++|..||........ ..
T Consensus       142 ~~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~  217 (267)
T PHA03390        142 YDRAKDRIYLCDYGLCKIIGTP---SCYDGTLDYFSPEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLE  217 (267)
T ss_pred             EeCCCCeEEEecCccceecCCC---ccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHH
Confidence            99988 9999999998765433   23457889999999876 6678899999999999999999999986542211 11


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCC-HHHHhcCccccc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT-VEEALRHPYLQS  235 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt-~~ell~hp~~~~  235 (280)
                      .+....                            .......+..++.+.+||.+||+.||.+||+ ++++|+||||++
T Consensus       218 ~~~~~~----------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        218 SLLKRQ----------------------------QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             HHHHhh----------------------------cccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence            111100                            0011122357999999999999999999996 699999999964

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-38  Score=266.52  Aligned_cols=229  Identities=39%  Similarity=0.716  Sum_probs=180.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++.....   ...++||||++++|.+++.+. ..+++..+..++.|++.||+|||+.|++|+||+|+||
T Consensus        55 l~~~~i~~~~~~~~~~~~---~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~ni  131 (287)
T cd07840          55 LRHPNIVRLKEIVTSKGK---GSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNI  131 (287)
T ss_pred             ccCCCeeeheeeEecCCC---CcEEEEeccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHe
Confidence            579999999999986621   569999999999999998765 5799999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCC--ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  157 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~  157 (280)
                      +++.++.++|+|||.+.......  ......++..|+|||.+.+...++.++|+||||+++++|++|..||...+.....
T Consensus       132 l~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~  211 (287)
T cd07840         132 LINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQL  211 (287)
T ss_pred             EEcCCCCEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence            99999999999999988655432  1233456788999998876566789999999999999999999999999888888


Q ss_pred             HHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCC-CCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          158 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       158 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      ..+....+.+....+.............. ...........+.. .++.+.+++++||+.+|.+||++++++.||||
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         212 EKIFELCGSPTDENWPGVSKLPWFENLKP-KKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             HHHHHHhCCCchhhccccccchhhhhccc-cccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence            88887777666554433222100000000 00001111122333 38999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.5e-38  Score=267.55  Aligned_cols=198  Identities=27%  Similarity=0.495  Sum_probs=169.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++...     ...|+||||++ ++|.+++.+.+.+++..+..++.|++.||.|||+.|++|+||+|.||
T Consensus        58 l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~ni  132 (290)
T cd05580          58 IRHPFLVNLYGSFQDD-----SNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENL  132 (290)
T ss_pred             CCCCCccceeeEEEcC-----CeEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHE
Confidence            5799999999999887     77999999995 69999998888999999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.++.++|+|||++......  .....+++.|+|||.+.+ ...+.++|+||||+++|+|++|..||...+.......
T Consensus       133 li~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~  209 (290)
T cd05580         133 LLDSDGYIKITDFGFAKRVKGR--TYTLCGTPEYLAPEIILS-KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEK  209 (290)
T ss_pred             EECCCCCEEEeeCCCccccCCC--CCCCCCCccccChhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9999999999999998876544  334567889999999876 5678899999999999999999999988774444433


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCcccc
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQ  234 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rp-----t~~ell~hp~~~  234 (280)
                      +..  +.                             .......+..+.++|++||..||.+|+     +++|+++||||+
T Consensus       210 ~~~--~~-----------------------------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~  258 (290)
T cd05580         210 ILE--GK-----------------------------VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFA  258 (290)
T ss_pred             Hhc--CC-----------------------------ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccc
Confidence            321  00                             011224588999999999999999999     999999999998


Q ss_pred             cCc
Q 023568          235 SLH  237 (280)
Q Consensus       235 ~~~  237 (280)
                      .+.
T Consensus       259 ~~~  261 (290)
T cd05580         259 GID  261 (290)
T ss_pred             cCC
Confidence            764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.8e-38  Score=263.53  Aligned_cols=199  Identities=26%  Similarity=0.426  Sum_probs=165.6

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++.+.     ...|+||||+.| +|.+++.+...+++..+..++.|++.||+|||+.|++|+||+|+||
T Consensus        59 l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~ni  133 (265)
T cd06631          59 LKHVNIVQYLGTCLDD-----NTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNV  133 (265)
T ss_pred             cCCCCEeeEeeEeecC-----CeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhE
Confidence            5799999999999887     779999999975 9999998878899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC-------CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 023568           80 LLNASCDLKIGDFGLARTTSET-------DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD  152 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~  152 (280)
                      +++.++.++|+|||.+......       .......++..|+|||.+.+ ..++.++|+||+|+++++|++|..||...+
T Consensus       134 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~  212 (265)
T cd06631         134 MLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE-SGYGRKSDIWSIGCTVFEMATGKPPLASMD  212 (265)
T ss_pred             EECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcC-CCCcchhhHHHHHHHHHHHHhCCCccccCC
Confidence            9999999999999988754211       11234567889999999876 677899999999999999999999998765


Q ss_pred             hHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 023568          153 YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY  232 (280)
Q Consensus       153 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~  232 (280)
                      .......+....+                            ..+......+..+.+++++||+.+|.+||++.++++|||
T Consensus       213 ~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~  264 (265)
T cd06631         213 RLAAMFYIGAHRG----------------------------LMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDF  264 (265)
T ss_pred             hHHHHHHhhhccC----------------------------CCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCC
Confidence            4433322221100                            111223357889999999999999999999999999999


Q ss_pred             c
Q 023568          233 L  233 (280)
Q Consensus       233 ~  233 (280)
                      |
T Consensus       265 ~  265 (265)
T cd06631         265 L  265 (265)
T ss_pred             C
Confidence            7

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.3e-38  Score=270.22  Aligned_cols=232  Identities=38%  Similarity=0.682  Sum_probs=179.4

Q ss_pred             CCCcccccccccccCCCC---CCCCcEEEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 023568            1 MEHENVIAIKDIIRPPKK---DTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP   76 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~---~~~~~~~lv~e~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~   76 (280)
                      ++||||+++++++.....   .....+|+||||++++|.+.+.. ...+++..+..++.|++.||+|||+.|++|+||+|
T Consensus        64 l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p  143 (311)
T cd07866          64 LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKA  143 (311)
T ss_pred             cCCCCccchhhheecccccccccCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence            589999999999876532   11246899999999999888764 45799999999999999999999999999999999


Q ss_pred             CceEEcCCCCeEEeecccccccCCCCc------------cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhC
Q 023568           77 SNLLLNASCDLKIGDFGLARTTSETDF------------MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR  144 (280)
Q Consensus        77 ~Nili~~~~~~kl~dfg~~~~~~~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g  144 (280)
                      +||+++.++.++|+|||++........            .....++..|+|||.+.+...++.++|+||+||++|+|++|
T Consensus       144 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g  223 (311)
T cd07866         144 ANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR  223 (311)
T ss_pred             HHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhC
Confidence            999999999999999999875432211            12235678899999987655688899999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCH
Q 023568          145 EPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV  224 (280)
Q Consensus       145 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~  224 (280)
                      .+||.+.+.......+....+.+.+..+............ .............+...++.+.++|++||+.||.+|||+
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~  302 (311)
T cd07866         224 RPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGV-HSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTA  302 (311)
T ss_pred             CCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhccccccc-ccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCH
Confidence            9999999888888888887776655543322110000000 000111112222345567889999999999999999999


Q ss_pred             HHHhcCccc
Q 023568          225 EEALRHPYL  233 (280)
Q Consensus       225 ~ell~hp~~  233 (280)
                      .+++.||||
T Consensus       303 ~ell~~~~f  311 (311)
T cd07866         303 SDALEHPYF  311 (311)
T ss_pred             HHHhcCCCC
Confidence            999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-38  Score=286.46  Aligned_cols=228  Identities=25%  Similarity=0.347  Sum_probs=168.3

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-----QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK   75 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~-----~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik   75 (280)
                      |+|||||++++++...     ...|+||+++.++|.+++...     ......+++.++.||+.||.|||++||+|||||
T Consensus       220 l~HpnIv~l~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLK  294 (501)
T PHA03210        220 LNHENILKIEEILRSE-----ANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIK  294 (501)
T ss_pred             CCCCCcCcEeEEEEEC-----CeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence            5899999999999987     679999999999999887532     234567788999999999999999999999999


Q ss_pred             CCceEEcCCCCeEEeecccccccCCCC--ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCC-CCCCC-
Q 023568           76 PSNLLLNASCDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREP-LFPGK-  151 (280)
Q Consensus        76 ~~Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~-pf~~~-  151 (280)
                      |+|||++.++.++|+|||+++......  ......|+..|+|||.+.+ ..++.++|||||||++|+|++|.. |+... 
T Consensus       295 P~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~~~~~p~~~~~  373 (501)
T PHA03210        295 LENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG-DGYCEITDIWSCGLILLDMLSHDFCPIGDGG  373 (501)
T ss_pred             HHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCccCCC
Confidence            999999999999999999998654432  2234678999999999987 778899999999999999999875 44332 


Q ss_pred             -ChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCcc-cccccccc--CCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 023568          152 -DYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRC-RKQQFATR--FPNKSSGAVDLLEKMLVFDPNKRITVEEA  227 (280)
Q Consensus       152 -~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~--~~~~~~~~~~ll~~~L~~dp~~Rpt~~el  227 (280)
                       .....+.++...++.........  ......++...... .....+..  ....+.++.++|.+||+.||.+|||+.|+
T Consensus       374 ~~~~~~~~~~~~~~~~~~~~~p~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~el  451 (501)
T PHA03210        374 GKPGKQLLKIIDSLSVCDEEFPDP--PCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAEL  451 (501)
T ss_pred             CCHHHHHHHHHHhcccChhhcCCc--HHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHH
Confidence             23344445444444333222110  00111121111100 00011111  11367889999999999999999999999


Q ss_pred             hcCcccccC
Q 023568          228 LRHPYLQSL  236 (280)
Q Consensus       228 l~hp~~~~~  236 (280)
                      |+||||...
T Consensus       452 L~hp~f~~~  460 (501)
T PHA03210        452 LALPLFSAE  460 (501)
T ss_pred             hhChhhhcC
Confidence            999999764

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-38  Score=271.28  Aligned_cols=230  Identities=39%  Similarity=0.716  Sum_probs=170.4

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-----QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK   75 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~-----~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik   75 (280)
                      ++||||+++++++.+...   ..+|+||||++++|.+++...     ..+++..+..++.|++.||+|||+.|++|||||
T Consensus        59 l~h~~i~~~~~~~~~~~~---~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlk  135 (316)
T cd07842          59 LKHENVVSLVEVFLEHAD---KSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLK  135 (316)
T ss_pred             cCCCCccceEEEEeCCCC---ceEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCC
Confidence            589999999999987633   569999999999888877532     368999999999999999999999999999999


Q ss_pred             CCceEEcC----CCCeEEeecccccccCCCCc----cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 023568           76 PSNLLLNA----SCDLKIGDFGLARTTSETDF----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL  147 (280)
Q Consensus        76 ~~Nili~~----~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~p  147 (280)
                      |+||+++.    ++.++|+|||++........    .....++..|+|||.+.+...++.++|+|||||++++|++|++|
T Consensus       136 p~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~  215 (316)
T cd07842         136 PANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPI  215 (316)
T ss_pred             HHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCC
Confidence            99999999    89999999999876543311    23346788899999987756678899999999999999999999


Q ss_pred             CCCCChH---------HHHHHHHHHhCCCCcccccccCC-hhHHHHHHhCC--cccccc---ccccCCCCCHHHHHHHHH
Q 023568          148 FPGKDYV---------HQLRLITELIGSPDDASLGFLRS-DNARRYVRQLP--RCRKQQ---FATRFPNKSSGAVDLLEK  212 (280)
Q Consensus       148 f~~~~~~---------~~~~~i~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~---~~~~~~~~~~~~~~ll~~  212 (280)
                      |.+....         ..+..+...++.+.+..+..... ...........  ......   ........+..+.+++++
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  295 (316)
T cd07842         216 FKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRK  295 (316)
T ss_pred             CcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHH
Confidence            9876432         24445555555444332211110 00000000000  000000   001112567889999999


Q ss_pred             hcccCCCCCCCHHHHhcCccc
Q 023568          213 MLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       213 ~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      ||+.||++|||+.|++.||||
T Consensus       296 ~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         296 LLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HhcCCcccCcCHHHHhcCCCC
Confidence            999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-39  Score=267.37  Aligned_cols=221  Identities=32%  Similarity=0.561  Sum_probs=175.7

Q ss_pred             cccccccccCCCCCCCCcEEEEEecCCccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc-
Q 023568            6 VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN-   82 (280)
Q Consensus         6 iv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nili~-   82 (280)
                      +|.+.++|...     ++++||+|.++.+++|+|.++  .+++...++.+++|++.++++||+.+++|.||||+|||+- 
T Consensus       153 cv~m~~wFdyr-----ghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvs  227 (415)
T KOG0671|consen  153 CVQMRDWFDYR-----GHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVS  227 (415)
T ss_pred             EEeeehhhhcc-----CceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEec
Confidence            57788889888     899999999999999999865  4799999999999999999999999999999999999983 


Q ss_pred             -------------------CCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh
Q 023568           83 -------------------ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT  143 (280)
Q Consensus        83 -------------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~  143 (280)
                                         .+..++++|||.|+......  .....|..|.|||++.+ -.++..+||||+||||+|+.+
T Consensus       228 s~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLg-LGwS~pCDvWSiGCIL~Elyt  304 (415)
T KOG0671|consen  228 SEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILG-LGWSQPCDVWSIGCILVELYT  304 (415)
T ss_pred             cceEEEeccCCccceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheec-cCcCCccCceeeeeEEEEeec
Confidence                               12348999999998876553  56788999999999999 899999999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhC----------------Ccccccc--ccccCCCCCHH
Q 023568          144 REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL----------------PRCRKQQ--FATRFPNKSSG  205 (280)
Q Consensus       144 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~--~~~~~~~~~~~  205 (280)
                      |...|++-++.+.++-|+.++|..+........   ..++...-                .+..++.  +.......-..
T Consensus       305 G~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~---~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~  381 (415)
T KOG0671|consen  305 GETLFQTHENLEHLAMMERILGPIPSRMIKKTR---KEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQ  381 (415)
T ss_pred             cceecccCCcHHHHHHHHHhhCCCcHHHhhhhh---hHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhH
Confidence            999999999999999999999965544322110   11111100                0000000  00001112356


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCcccccCc
Q 023568          206 AVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  237 (280)
Q Consensus       206 ~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~  237 (280)
                      +.|||++||..||.+|+|+.|+|.||||+...
T Consensus       382 LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  382 LFDLLRRMLEFDPARRITLREALSHPFFARLT  413 (415)
T ss_pred             HHHHHHHHHccCccccccHHHHhcCHHhhcCC
Confidence            88999999999999999999999999998753

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=3.5e-38  Score=265.43  Aligned_cols=226  Identities=38%  Similarity=0.699  Sum_probs=170.1

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++|+||+++++++.+.     ...|+||||+.++|.+.+.. ...+++..++.++.|++.||.|||+.|++|+||||+||
T Consensus        60 l~h~ni~~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Ni  134 (291)
T cd07870          60 LKHANIVLLHDIIHTK-----ETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNL  134 (291)
T ss_pred             cCCCCEeEEEEEEecC-----CeEEEEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHE
Confidence            5799999999999877     67999999999998887754 35689999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh-HHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY-VHQL  157 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~-~~~~  157 (280)
                      +++.++.++|+|||+++..... .......++..|+|||.+.+...++.++|+||+|+++|+|++|..||.+.+. .+.+
T Consensus       135 l~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~  214 (291)
T cd07870         135 LISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQL  214 (291)
T ss_pred             EEcCCCcEEEeccccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHH
Confidence            9999999999999998754332 1223445688999999987656678899999999999999999999987653 3455


Q ss_pred             HHHHHHhCCCCcccccccCC-hhHHHHHHhCCccccccccccCC--CCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          158 RLITELIGSPDDASLGFLRS-DNARRYVRQLPRCRKQQFATRFP--NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       158 ~~i~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      ..+....+.+.+........ .......  ..............  ..++.+.+++++||..||++|||++|++.||||
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         215 EKIWTVLGVPTEDTWPGVSKLPNYKPEW--FLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             HHHHHHcCCCChhhhhhhhhcccccchh--ccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence            55555555444433211110 0000000  00000111111111  236789999999999999999999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-40  Score=262.04  Aligned_cols=235  Identities=47%  Similarity=0.831  Sum_probs=202.9

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      ++|.|++..+++.+....+-|..+|+|+|+|..+|..+|-+-..++.+.++-+++||++||+|||+.||.||||||.|.|
T Consensus       109 FkHdNVLSaLDILQPph~dfFqEiYV~TELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLL  188 (449)
T KOG0664|consen  109 FRHDNVLSLLDILQPANPSFFQELYVLTELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLL  188 (449)
T ss_pred             hccccHHHHHHhcCCCCchHHHHHHHHHHHHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEE
Confidence            48999999999999887777788999999999999999988889999999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccccCCC--CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           81 LNASCDLKIGDFGLARTTSET--DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      ++.+..+|+||||+++.....  ..++....|-+|.|||++.|...|+.+.||||.||++.|++..+..|...+..++++
T Consensus       189 VNSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~  268 (449)
T KOG0664|consen  189 VNSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQ  268 (449)
T ss_pred             eccCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHH
Confidence            999999999999999976544  445667789999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCC-----CCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP-----NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      .|..++|+|..+.+..-+...-...++.-.+.  +..+..+.     .-.....+++.++|..||.+|++.++++.|++.
T Consensus       269 lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~--Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~  346 (449)
T KOG0664|consen  269 MIIDLLGTPSQEAMKYACEGAKNHVLRAGLRA--PDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL  346 (449)
T ss_pred             HHHHHhCCCcHHHHHHHhhhhHHHhhccCCCC--CCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence            99999999998877665554444444433322  22222221     334677899999999999999999999999998


Q ss_pred             ccCc
Q 023568          234 QSLH  237 (280)
Q Consensus       234 ~~~~  237 (280)
                      ...+
T Consensus       347 ~e~R  350 (449)
T KOG0664|consen  347 EEGR  350 (449)
T ss_pred             cccc
Confidence            7654

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.9e-38  Score=266.38  Aligned_cols=204  Identities=25%  Similarity=0.445  Sum_probs=169.6

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      ++|+||+++.+++.+.     +..++||||+.+ +|.+++...  ..+++..+..++.|++.||.|||+.||+||||||+
T Consensus        57 l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~  131 (285)
T cd05632          57 VNSQFVVNLAYAYETK-----DALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPE  131 (285)
T ss_pred             cCCcCceeEEEEEecC-----CEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHH
Confidence            5899999999999887     679999999984 898887543  46999999999999999999999999999999999


Q ss_pred             ceEEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023568           78 NLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  157 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~  157 (280)
                      ||+++.++.++|+|||++.............|+..|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.......
T Consensus       132 Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~  210 (285)
T cd05632         132 NILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNN-QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR  210 (285)
T ss_pred             HEEECCCCCEEEecCCcceecCCCCcccCCCCCcCccChHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            99999999999999999876544333345678999999999877 67889999999999999999999999887654444


Q ss_pred             HHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCcc
Q 023568          158 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT-----VEEALRHPY  232 (280)
Q Consensus       158 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt-----~~ell~hp~  232 (280)
                      ..+........                           ....+..+..+.+|+.+||+.||++|||     ++++++|+|
T Consensus       211 ~~~~~~~~~~~---------------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~  263 (285)
T cd05632         211 EEVDRRVLETE---------------------------EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPF  263 (285)
T ss_pred             HHHHHhhhccc---------------------------cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChh
Confidence            33332211111                           0112356888999999999999999999     899999999


Q ss_pred             cccCc
Q 023568          233 LQSLH  237 (280)
Q Consensus       233 ~~~~~  237 (280)
                      |+...
T Consensus       264 ~~~~~  268 (285)
T cd05632         264 FRNMN  268 (285)
T ss_pred             hhcCC
Confidence            98863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.8e-38  Score=263.83  Aligned_cols=201  Identities=26%  Similarity=0.404  Sum_probs=162.4

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++...     ...|+||||++ ++|.+++...+.+++.++..++.|++.||.|||+.|++|+||||+||
T Consensus        63 l~h~~ii~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~ni  137 (267)
T cd06645          63 CKHSNIVAYFGSYLRR-----DKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANI  137 (267)
T ss_pred             CCCCCeeeEEEEEEeC-----CEEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence            5799999999999877     77999999998 59999998888999999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC-Cccccceecccccccccccc--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  156 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~  156 (280)
                      +++.++.++|+|||.+...... .......|+..|+|||.+..  ...++.++|+||+||++|+|++|..||........
T Consensus       138 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~  217 (267)
T cd06645         138 LLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA  217 (267)
T ss_pred             EECCCCCEEECcceeeeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh
Confidence            9999999999999998754432 22234578899999998742  24578899999999999999999999876553332


Q ss_pred             HHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 023568          157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY  232 (280)
Q Consensus       157 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~  232 (280)
                      ...+......+                          ........++..+.+++++||+.||.+|||++++++|||
T Consensus       218 ~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         218 LFLMTKSNFQP--------------------------PKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             HHhhhccCCCC--------------------------CcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence            22211100000                          000001135778999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=3.1e-38  Score=266.99  Aligned_cols=232  Identities=40%  Similarity=0.688  Sum_probs=179.4

Q ss_pred             CCCcccccccccccCCCC-----CCCCcEEEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 023568            1 MEHENVIAIKDIIRPPKK-----DTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDL   74 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~-----~~~~~~~lv~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~di   74 (280)
                      ++||||+++++++.+...     .....+|+||||+++++.+.+... ..+++..+..++.|++.||+|||+.||+|+||
T Consensus        63 l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl  142 (302)
T cd07864          63 LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDI  142 (302)
T ss_pred             CCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence            579999999999987530     112479999999999988888654 47999999999999999999999999999999


Q ss_pred             CCCceEEcCCCCeEEeecccccccCCCC--ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 023568           75 KPSNLLLNASCDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD  152 (280)
Q Consensus        75 k~~Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~  152 (280)
                      +|+||+++.++.++|+|||.+.......  ......++..|+|||.+.+....+.++|+||+||++++|++|++||...+
T Consensus       143 ~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~  222 (302)
T cd07864         143 KCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ  222 (302)
T ss_pred             CHHHEEECCCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999987654332  12233557789999988764567889999999999999999999999988


Q ss_pred             hHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 023568          153 YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY  232 (280)
Q Consensus       153 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~  232 (280)
                      ....+..+.+..+.+.+..++............... .........+..++..+.+++.+||+.||.+|||+++++.|||
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~  301 (302)
T cd07864         223 ELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKK-QYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPW  301 (302)
T ss_pred             hHHHHHHHHHHhCCCChhhccccccccccccccccc-ccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence            888888888877766655433221110000000000 0001111233456899999999999999999999999999999


Q ss_pred             c
Q 023568          233 L  233 (280)
Q Consensus       233 ~  233 (280)
                      |
T Consensus       302 ~  302 (302)
T cd07864         302 L  302 (302)
T ss_pred             C
Confidence            7

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=3.7e-38  Score=260.14  Aligned_cols=197  Identities=29%  Similarity=0.441  Sum_probs=165.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      ++||||+++++++...     ...|+||||+. ++|.+++.+.  ..+++..+..++.|++.||.|||+.|++|+||+|+
T Consensus        56 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~  130 (256)
T cd08529          56 LDSSYIIRYYESFLDK-----GKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSL  130 (256)
T ss_pred             cCCCCeehheeeeccC-----CEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcc
Confidence            5899999999999887     67999999997 5999999764  57999999999999999999999999999999999


Q ss_pred             ceEEcCCCCeEEeecccccccCCCCc-cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023568           78 NLLLNASCDLKIGDFGLARTTSETDF-MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  156 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~  156 (280)
                      ||+++.++.++|+|||++........ .....++..|+|||.+.+ ..++.++|+||||+++++|++|..||...+....
T Consensus       131 nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~  209 (256)
T cd08529         131 NLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCED-KPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL  209 (256)
T ss_pred             eEEEeCCCCEEEcccccceeccCccchhhccccCccccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            99999999999999999876544322 234567889999999877 6678899999999999999999999988775444


Q ss_pred             HHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       157 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      ...+...                              ..+......+..+.+++++||+.+|++||++.++++|||+
T Consensus       210 ~~~~~~~------------------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         210 ILKIIRG------------------------------VFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             HHHHHcC------------------------------CCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence            4333220                              0111112468899999999999999999999999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-38  Score=264.52  Aligned_cols=203  Identities=30%  Similarity=0.466  Sum_probs=165.9

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      |+||||+++++++...     ...|+||||+++ +|.+++.+. +.+++..++.++.|++.||.|||+.|++|+||+|+|
T Consensus        59 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~n  133 (280)
T cd06611          59 CKHPNIVGLYEAYFYE-----NKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGN  133 (280)
T ss_pred             CCCCceeEEEEEEecC-----CeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhh
Confidence            5899999999999877     679999999985 999988763 579999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCC-Cccccceecccccccccccc----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 023568           79 LLLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDY  153 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~  153 (280)
                      |+++.++.++|+|||.+...... .......++..|+|||.+..    ...++.++|+||+|+++|+|++|..||...+.
T Consensus       134 ili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~  213 (280)
T cd06611         134 ILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP  213 (280)
T ss_pred             EEECCCCCEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH
Confidence            99999999999999988754332 22334567889999998752    24467789999999999999999999988765


Q ss_pred             HHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          154 VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       154 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      ......+...   ..+                         ........+..+.+++++||+.||.+|||++++++||||
T Consensus       214 ~~~~~~~~~~---~~~-------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  265 (280)
T cd06611         214 MRVLLKILKS---EPP-------------------------TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFV  265 (280)
T ss_pred             HHHHHHHhcC---CCC-------------------------CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhh
Confidence            4443333210   000                         001122467889999999999999999999999999999


Q ss_pred             ccC
Q 023568          234 QSL  236 (280)
Q Consensus       234 ~~~  236 (280)
                      .+.
T Consensus       266 ~~~  268 (280)
T cd06611         266 SDQ  268 (280)
T ss_pred             ccc
Confidence            765

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-39  Score=282.77  Aligned_cols=203  Identities=27%  Similarity=0.426  Sum_probs=171.1

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCC--CHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS-DQQL--TDDHCQYFLYQLLRGLKYVHSASVLHRDLKP   76 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~-~~~l--~~~~~~~i~~qil~~l~~LH~~~i~H~dik~   76 (280)
                      |+|.|||+++|.+..+     +++-|.||-++ |+|.++++. .+++  +|+++.++.+||++||.|||++.|+|||||.
T Consensus       629 LrHkNIVrYLGs~sen-----Gf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKG  703 (1226)
T KOG4279|consen  629 LRHKNIVRYLGSVSEN-----GFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKG  703 (1226)
T ss_pred             HhhHhHHHHhhccCCC-----CeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccC
Confidence            6899999999998777     78999999997 599999975 4777  8999999999999999999999999999999


Q ss_pred             CceEEcC-CCCeEEeecccccccC-CCCccccceeccccccccccc-cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 023568           77 SNLLLNA-SCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLL-NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY  153 (280)
Q Consensus        77 ~Nili~~-~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~  153 (280)
                      +||||+. .|.+|++|||-++... -.....++.||..|||||++. |...|+.++|||||||++.||.||++||-....
T Consensus       704 DNVLvNTySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgs  783 (1226)
T KOG4279|consen  704 DNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGS  783 (1226)
T ss_pred             CcEEEeeccceEEecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCC
Confidence            9999976 7899999999988644 345567899999999999985 446799999999999999999999999977654


Q ss_pred             HHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          154 VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       154 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      .+...-...+                            -+..++++..++..++.||.+|+..||.+||+|.++|.+||+
T Consensus       784 pqAAMFkVGm----------------------------yKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFl  835 (1226)
T KOG4279|consen  784 PQAAMFKVGM----------------------------YKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFL  835 (1226)
T ss_pred             hhHhhhhhcc----------------------------eecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCccc
Confidence            3322111110                            112234445679999999999999999999999999999999


Q ss_pred             ccC
Q 023568          234 QSL  236 (280)
Q Consensus       234 ~~~  236 (280)
                      +.-
T Consensus       836 q~~  838 (1226)
T KOG4279|consen  836 QHN  838 (1226)
T ss_pred             ccC
Confidence            765

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2e-38  Score=265.19  Aligned_cols=204  Identities=25%  Similarity=0.397  Sum_probs=167.4

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      ++||||++++++++..     +..|+||||++ ++|.+++.+.+  .+++..+..++.|++.||.|||+.|++||||+|+
T Consensus        50 l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~  124 (277)
T cd05577          50 VSSRFIVSLAYAFETK-----DDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPE  124 (277)
T ss_pred             CCCCCEeeeeeEEecC-----CeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHH
Confidence            5799999999999877     67999999998 59999987654  7999999999999999999999999999999999


Q ss_pred             ceEEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023568           78 NLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  157 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~  157 (280)
                      ||+++.++.++|+|||.+.............++..|+|||.+.+ ..++.++|+||+|+++++|++|+.||.........
T Consensus       125 Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~  203 (277)
T cd05577         125 NVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQG-EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK  203 (277)
T ss_pred             HEEECCCCCEEEccCcchhhhccCCccccccCCCCcCCHHHhcC-CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH
Confidence            99999999999999999876544333344567888999999877 55888999999999999999999999876542222


Q ss_pred             HHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCcc
Q 023568          158 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPY  232 (280)
Q Consensus       158 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rp-----t~~ell~hp~  232 (280)
                      ..+.....                           .......+..++.+.++|++||+.||.+||     ++.++++|||
T Consensus       204 ~~~~~~~~---------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~  256 (277)
T cd05577         204 EELKRRTL---------------------------EMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPL  256 (277)
T ss_pred             HHHHhccc---------------------------cccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChh
Confidence            22211100                           001112235689999999999999999999     8999999999


Q ss_pred             cccCc
Q 023568          233 LQSLH  237 (280)
Q Consensus       233 ~~~~~  237 (280)
                      |+.+.
T Consensus       257 ~~~~~  261 (277)
T cd05577         257 FKDLN  261 (277)
T ss_pred             hhcCC
Confidence            97654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=4.3e-38  Score=263.73  Aligned_cols=203  Identities=26%  Similarity=0.423  Sum_probs=165.0

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||+++++++...     ...|+||||+++ +|..++.+ ...+++..+..++.|++.||.|||+.|++||||+|+|
T Consensus        59 l~h~~ii~~~~~~~~~-----~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~n  133 (282)
T cd06643          59 CDHPNIVKLLDAFYYE-----NNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGN  133 (282)
T ss_pred             CCCCCeeeEEEEEeeC-----CEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCccc
Confidence            5799999999999887     679999999985 88777754 4679999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCC-Cccccceecccccccccccc----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 023568           79 LLLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDY  153 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~  153 (280)
                      |+++.++.++|+|||++...... .......++..|+|||.+..    ...++.++|+||+||++|+|++|.+||...+.
T Consensus       134 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~  213 (282)
T cd06643         134 ILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP  213 (282)
T ss_pred             EEEccCCCEEEccccccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH
Confidence            99999999999999998764332 22334567889999998742    24567799999999999999999999987765


Q ss_pred             HHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          154 VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       154 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      ......+.....  +                          .......++..+.++|++||+.||.+|||++++++||||
T Consensus       214 ~~~~~~~~~~~~--~--------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  265 (282)
T cd06643         214 MRVLLKIAKSEP--P--------------------------TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFV  265 (282)
T ss_pred             HHHHHHHhhcCC--C--------------------------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCE
Confidence            444433322100  0                          001122467889999999999999999999999999999


Q ss_pred             ccC
Q 023568          234 QSL  236 (280)
Q Consensus       234 ~~~  236 (280)
                      +..
T Consensus       266 ~~~  268 (282)
T cd06643         266 TVN  268 (282)
T ss_pred             ecc
Confidence            763

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2.4e-38  Score=266.66  Aligned_cols=205  Identities=27%  Similarity=0.499  Sum_probs=168.0

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++.+...     +..|+||||+++ +|.+++.. +.+++.++..++.|++.||+|||+.|++||||+|+||
T Consensus        76 l~h~~ii~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Ni  149 (292)
T cd06658          76 YHHENVVDMYNSYLVG-----DELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSI  149 (292)
T ss_pred             CCCCcHHHHHHheecC-----CeEEEEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHE
Confidence            5799999999999887     779999999975 88888754 5799999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||++...... .......++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||...+......
T Consensus       150 ll~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~  228 (292)
T cd06658         150 LLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMR  228 (292)
T ss_pred             EEcCCCCEEEccCcchhhcccccccCceeecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            9999999999999998754322 22234567889999999876 678889999999999999999999998776554443


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCcC
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  238 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~~  238 (280)
                      .+.......                            .......+..+.+++.+||..||.+|||++++++||||.....
T Consensus       229 ~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~  280 (292)
T cd06658         229 RIRDNLPPR----------------------------VKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGP  280 (292)
T ss_pred             HHHhcCCCc----------------------------cccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCC
Confidence            332211100                            0011245788999999999999999999999999999987764


Q ss_pred             CC
Q 023568          239 LN  240 (280)
Q Consensus       239 ~~  240 (280)
                      +.
T Consensus       281 ~~  282 (292)
T cd06658         281 PS  282 (292)
T ss_pred             cc
Confidence            43

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-38  Score=263.38  Aligned_cols=200  Identities=25%  Similarity=0.408  Sum_probs=167.3

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++.++     ...|+|+||+.+ +|.+++... .+++..+..++.|++.|+.|||+.+++|+||+|+||
T Consensus        56 l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni  129 (274)
T cd06609          56 CRSPYITKYYGSFLKG-----SKLWIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANI  129 (274)
T ss_pred             cCCCCeeeeeEEEEEC-----CeEEEEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHE
Confidence            5799999999999877     679999999975 999998764 899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||.++..... .......++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||...+......
T Consensus       130 ~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~  208 (274)
T cd06609         130 LLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQ-SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLF  208 (274)
T ss_pred             EECCCCCEEEcccccceeecccccccccccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHH
Confidence            9999999999999998776543 22344567888999999887 568899999999999999999999998766443333


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCC-CCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  237 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~  237 (280)
                      .+....                              .+..... .+.++.+++.+||..||++|||++++++||||+...
T Consensus       209 ~~~~~~------------------------------~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~  258 (274)
T cd06609         209 LIPKNN------------------------------PPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAK  258 (274)
T ss_pred             HhhhcC------------------------------CCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCC
Confidence            222110                              0011112 678899999999999999999999999999997754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=5.9e-38  Score=264.26  Aligned_cols=204  Identities=27%  Similarity=0.433  Sum_probs=164.4

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||+++++.+..+     ...|+||||++| +|..++.+ ...+++..+..++.|++.||.|||+.|++||||+|+|
T Consensus        66 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~N  140 (292)
T cd06644          66 CNHPYIVKLLGAFYWD-----GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGN  140 (292)
T ss_pred             CCCCcEeeeEEEEEeC-----CeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcce
Confidence            5899999999999877     679999999985 77777754 4679999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCC-Cccccceecccccccccccc----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 023568           79 LLLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDY  153 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~  153 (280)
                      |+++.++.++|+|||.+...... .......++..|+|||.+.+    ...++.++|+|||||++|+|++|..||...+.
T Consensus       141 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~  220 (292)
T cd06644         141 VLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP  220 (292)
T ss_pred             EEEcCCCCEEEccCccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH
Confidence            99999999999999988654332 22234567889999998853    24467789999999999999999999987664


Q ss_pred             HHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          154 VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       154 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      .....++..   ...+                         .......++.++.+++++||+.||++||+++++++||||
T Consensus       221 ~~~~~~~~~---~~~~-------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  272 (292)
T cd06644         221 MRVLLKIAK---SEPP-------------------------TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFV  272 (292)
T ss_pred             HHHHHHHhc---CCCc-------------------------cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence            433322211   1000                         001123567889999999999999999999999999999


Q ss_pred             ccCc
Q 023568          234 QSLH  237 (280)
Q Consensus       234 ~~~~  237 (280)
                      ..+.
T Consensus       273 ~~~~  276 (292)
T cd06644         273 SSVT  276 (292)
T ss_pred             cccc
Confidence            8764

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=6.9e-38  Score=258.79  Aligned_cols=198  Identities=29%  Similarity=0.523  Sum_probs=163.3

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~--~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      ++||||+++++.+....    ..+|+||||++ ++|.+++..  ...+++.++..++.|++.||++||+.|++||||+|+
T Consensus        56 l~~~~i~~~~~~~~~~~----~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~  131 (257)
T cd08223          56 LKHPNIVAYRESWEGED----GLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQ  131 (257)
T ss_pred             CCCCCeeeeeeeecCCC----CEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCch
Confidence            57999999999886431    46899999997 599999875  346899999999999999999999999999999999


Q ss_pred             ceEEcCCCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023568           78 NLLLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  156 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~  156 (280)
                      ||+++.++.++|+|||++...... .......+++.|+|||.+.+ ..++.++|+||+|+++++|++|+.||...+....
T Consensus       132 nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~  210 (257)
T cd08223         132 NVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSN-KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL  210 (257)
T ss_pred             hEEEecCCcEEEecccceEEecccCCccccccCCcCccChhHhcC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH
Confidence            999999999999999998765432 22334567889999999877 6788899999999999999999999987764443


Q ss_pred             HHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       157 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      ...+...  .                            .+......++.+.+++.+||+.||.+|||+.++++||||
T Consensus       211 ~~~~~~~--~----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         211 VYRIIEG--K----------------------------LPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             HHHHHhc--C----------------------------CCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            3332210  0                            011123568899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.1e-38  Score=273.19  Aligned_cols=205  Identities=21%  Similarity=0.419  Sum_probs=167.2

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||+++++++++.     +..|+||||+. |+|.+++.+ ...+++..++.++.|++.||.|||+.||+||||||+|
T Consensus        58 ~~~~~i~~l~~~~~~~-----~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~N  132 (331)
T cd05624          58 GDCQWITTLHYAFQDE-----NYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDN  132 (331)
T ss_pred             CCCCCEeeEEEEEEcC-----CEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHH
Confidence            4799999999999987     78999999997 599999976 4689999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCc--cccceeccccccccccccC----CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDF--MTEYVVTRWYRAPELLLNC----TEYTAAIDIWSVGCILGEIMTREPLFPGKD  152 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~----~~~~~~~DvwslG~~l~~ll~g~~pf~~~~  152 (280)
                      |+++.++.++|+|||++........  .....|++.|+|||.+.+.    ..++.++|+||+||++|+|++|+.||.+.+
T Consensus       133 ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~  212 (331)
T cd05624         133 VLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES  212 (331)
T ss_pred             EEEcCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC
Confidence            9999999999999999876544322  1235689999999988642    356789999999999999999999998877


Q ss_pred             hHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCC--CCCHHHHhcC
Q 023568          153 YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNK--RITVEEALRH  230 (280)
Q Consensus       153 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~--Rpt~~ell~h  230 (280)
                      .......+.....                          ...++.....++..+++++++||+.++.+  |++++++++|
T Consensus       213 ~~~~~~~i~~~~~--------------------------~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         213 LVETYGKIMNHEE--------------------------RFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             HHHHHHHHHcCCC--------------------------cccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            6555544432110                          01112223357899999999999976654  5699999999


Q ss_pred             cccccC
Q 023568          231 PYLQSL  236 (280)
Q Consensus       231 p~~~~~  236 (280)
                      |||+.+
T Consensus       267 ~~f~~~  272 (331)
T cd05624         267 AFFEGI  272 (331)
T ss_pred             CCcCCC
Confidence            999875

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=3.5e-38  Score=263.86  Aligned_cols=202  Identities=25%  Similarity=0.424  Sum_probs=166.0

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      .||||+++++++...     ...|+||||+. |+|.+++.+.+.+++..++.++.|++.||.|||+.+++||||+|+||+
T Consensus        55 ~~~~i~~~~~~~~~~-----~~~~~v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nil  129 (278)
T cd05606          55 DCPFIVCMSYAFHTP-----DKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANIL  129 (278)
T ss_pred             CCCcEeeeeeeeecC-----CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEE
Confidence            699999999999987     67999999997 599999887788999999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 023568           81 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  160 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~i  160 (280)
                      ++.++.++|+|||++....... .....|+..|+|||.+.+...++.++|+||+|+++|+|++|..||............
T Consensus       130 i~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~  208 (278)
T cd05606         130 LDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID  208 (278)
T ss_pred             ECCCCCEEEccCcCccccCccC-CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH
Confidence            9999999999999987543322 234578999999999876456888999999999999999999999876322111100


Q ss_pred             HHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccccc
Q 023568          161 TELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQS  235 (280)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rp-----t~~ell~hp~~~~  235 (280)
                      .....                            .........++.+.+++.+||..+|.+||     ++.++++||||+.
T Consensus       209 ~~~~~----------------------------~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~  260 (278)
T cd05606         209 RMTLT----------------------------MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRS  260 (278)
T ss_pred             HHhhc----------------------------cCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccC
Confidence            00000                            00112234689999999999999999999     9999999999987


Q ss_pred             Cc
Q 023568          236 LH  237 (280)
Q Consensus       236 ~~  237 (280)
                      ..
T Consensus       261 ~~  262 (278)
T cd05606         261 LD  262 (278)
T ss_pred             CC
Confidence            64

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=4.1e-38  Score=259.94  Aligned_cols=199  Identities=27%  Similarity=0.478  Sum_probs=163.9

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||+++++++.+.     ...|++|||+++ +|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+|
T Consensus        55 l~~~~i~~~~~~~~~~-----~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~n  129 (256)
T cd06612          55 CDSPYIVKYYGSYFKN-----TDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGN  129 (256)
T ss_pred             CCCCcEeeeeeeeecC-----CcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcce
Confidence            5799999999999987     679999999985 99999875 4678999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCC-ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  157 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~  157 (280)
                      |+++.++.++|+|||++....... ......++..|+|||.+.+ ..++.++|+||+|+++++|++|+.||.........
T Consensus       130 i~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~  208 (256)
T cd06612         130 ILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI  208 (256)
T ss_pred             EEECCCCcEEEcccccchhcccCccccccccCCccccCHHHHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh
Confidence            999999999999999988655432 2334557889999999877 67888999999999999999999999876543322


Q ss_pred             HHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          158 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       158 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      ..+..   ...                         .........+..+.+++.+||+.||.+|||++|+|.||||
T Consensus       209 ~~~~~---~~~-------------------------~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         209 FMIPN---KPP-------------------------PTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             hhhcc---CCC-------------------------CCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence            11110   000                         0001112457889999999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=6.8e-38  Score=264.43  Aligned_cols=203  Identities=25%  Similarity=0.462  Sum_probs=167.6

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++...     ..+|+||||+.| +|.+++.+ ..+++.++..++.|++.||+|||+.|++|+||+|+||
T Consensus        73 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Ni  146 (296)
T cd06655          73 LKNPNIVNFLDSFLVG-----DELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNV  146 (296)
T ss_pred             cCCCceeeeeeeEecC-----ceEEEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence            5799999999999877     679999999975 88888765 5699999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCC-ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||++....... ......++..|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.+......
T Consensus       147 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~  225 (296)
T cd06655         147 LLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY  225 (296)
T ss_pred             EECCCCCEEEccCccchhcccccccCCCcCCCccccCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            99999999999999987654332 2234567889999999876 667889999999999999999999998876544433


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCcC
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  238 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~~  238 (280)
                      .+... +.+                           .......+++.+.++|++||..||.+|||+.+++.||||+....
T Consensus       226 ~~~~~-~~~---------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~  277 (296)
T cd06655         226 LIATN-GTP---------------------------ELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKP  277 (296)
T ss_pred             HHHhc-CCc---------------------------ccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence            32210 000                           00112356889999999999999999999999999999987653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=4.2e-38  Score=261.66  Aligned_cols=200  Identities=26%  Similarity=0.490  Sum_probs=161.6

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++.+...   ..++++|||+. ++|.+++.+.+.+++..+..++.|++.||+|||+.|++||||+|+||
T Consensus        61 l~h~~i~~~~~~~~~~~~---~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~ni  137 (266)
T cd06651          61 LQHERIVQYYGCLRDRAE---KTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANI  137 (266)
T ss_pred             cCCCCeeeEEEEEEcCCC---CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHE
Confidence            589999999999876422   56899999997 49999998878899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC----CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023568           80 LLNASCDLKIGDFGLARTTSET----DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH  155 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~  155 (280)
                      +++.++.++|+|||++......    .......++..|+|||.+.+ ..++.++|+||+||++|+|++|+.||.......
T Consensus       138 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~  216 (266)
T cd06651         138 LRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA  216 (266)
T ss_pred             EECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCC-CCCCchhhhHHHHHHHHHHHHCCCCccccchHH
Confidence            9999999999999998754321    11123457888999999877 678899999999999999999999998765433


Q ss_pred             HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 023568          156 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ  234 (280)
Q Consensus       156 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~  234 (280)
                      ....+..   .+.                          .+......++.+.+++ +||..+|++|||++|+++||||+
T Consensus       217 ~~~~~~~---~~~--------------------------~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         217 AIFKIAT---QPT--------------------------NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             HHHHHhc---CCC--------------------------CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence            3322211   000                          0111224678888999 57778999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=7.2e-38  Score=262.87  Aligned_cols=204  Identities=25%  Similarity=0.479  Sum_probs=168.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++...     +..++|+||+.| +|.+++.. +++++..+..++.|++.||+|||++|++||||+|+||
T Consensus        73 ~~h~~vv~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Ni  146 (285)
T cd06648          73 YQHPNIVEMYSSYLVG-----DELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSI  146 (285)
T ss_pred             cCCCChheEEEEEEcC-----CeEEEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhE
Confidence            4799999999999877     779999999974 99999877 6799999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||.+...... .......++..|+|||.+.+ ..++.++|+||+|+++++|++|..||.+.+......
T Consensus       147 l~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~  225 (285)
T cd06648         147 LLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMK  225 (285)
T ss_pred             EEcCCCcEEEcccccchhhccCCcccccccCCccccCHHHhcC-CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHH
Confidence            9999999999999987654332 12233567889999999876 668889999999999999999999998776544444


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCcC
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  238 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~~  238 (280)
                      .+...   ...                         ........+..+.+++++||..+|.+|||+.++++||||+...+
T Consensus       226 ~~~~~---~~~-------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  277 (285)
T cd06648         226 RIRDN---LPP-------------------------KLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGP  277 (285)
T ss_pred             HHHhc---CCC-------------------------CCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCC
Confidence            33221   000                         00111236789999999999999999999999999999988764


Q ss_pred             C
Q 023568          239 L  239 (280)
Q Consensus       239 ~  239 (280)
                      +
T Consensus       278 ~  278 (285)
T cd06648         278 P  278 (285)
T ss_pred             c
Confidence            3

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-38  Score=271.14  Aligned_cols=199  Identities=29%  Similarity=0.498  Sum_probs=158.6

Q ss_pred             CcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE
Q 023568            3 HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQ-LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL   81 (280)
Q Consensus         3 Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~-l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nili   81 (280)
                      |.+||+|++|=..+     +.+|+|||+.+.+|..+|++... ++.-.++.++.|++.|+.++|..||||.||||.|+|+
T Consensus       419 ~~~IIqL~DYEv~d-----~~lYmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl  493 (677)
T KOG0596|consen  419 HDKIIQLYDYEVTD-----GYLYMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL  493 (677)
T ss_pred             CceEEEEeeeeccC-----ceEEEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE
Confidence            78999999997776     78999999999999999987654 4445899999999999999999999999999999987


Q ss_pred             cCCCCeEEeecccccccCCCC---ccccceeccccccccccccC----------CCCCcchhHHHHHHHHHHHHhCCCCC
Q 023568           82 NASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNC----------TEYTAAIDIWSVGCILGEIMTREPLF  148 (280)
Q Consensus        82 ~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~----------~~~~~~~DvwslG~~l~~ll~g~~pf  148 (280)
                      = .|.+||+|||.|.....+.   ...+.+||..|||||.+...          -+.+.++||||||||+|+|+.|++||
T Consensus       494 V-kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf  572 (677)
T KOG0596|consen  494 V-KGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPF  572 (677)
T ss_pred             E-eeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCch
Confidence            4 5789999999998776653   34568999999999998431          22577899999999999999999999


Q ss_pred             CCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCC--CHHHHHHHHHhcccCCCCCCCHHH
Q 023568          149 PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK--SSGAVDLLEKMLVFDPNKRITVEE  226 (280)
Q Consensus       149 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ll~~~L~~dp~~Rpt~~e  226 (280)
                      ..-.  ..++++..+.                           .+..+..||..  ..+++++++.||.+||.+|||+.+
T Consensus       573 ~~~~--n~~aKl~aI~---------------------------~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~e  623 (677)
T KOG0596|consen  573 GQII--NQIAKLHAIT---------------------------DPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPE  623 (677)
T ss_pred             HHHH--HHHHHHHhhc---------------------------CCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHH
Confidence            5421  2222322211                           11112223332  233899999999999999999999


Q ss_pred             HhcCcccccC
Q 023568          227 ALRHPYLQSL  236 (280)
Q Consensus       227 ll~hp~~~~~  236 (280)
                      +|+|||+...
T Consensus       624 LLqhpFl~~~  633 (677)
T KOG0596|consen  624 LLQHPFLQIQ  633 (677)
T ss_pred             HhcCcccccc
Confidence            9999999763

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=5.8e-38  Score=260.82  Aligned_cols=202  Identities=27%  Similarity=0.478  Sum_probs=164.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+||||+++++++.+.     ++.++||||+.| +|.+++.+.+.+++..+..++.|++.||+|||++|++|+||+|+||
T Consensus        60 l~h~~iv~~~~~~~~~-----~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~ni  134 (268)
T cd06630          60 LNHPHIIRMLGATCED-----SHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANL  134 (268)
T ss_pred             cCCCceehhhceeccC-----CeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence            5899999999999887     779999999985 9999998878899999999999999999999999999999999999


Q ss_pred             EEcCCC-CeEEeecccccccCCCC-----ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 023568           80 LLNASC-DLKIGDFGLARTTSETD-----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY  153 (280)
Q Consensus        80 li~~~~-~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~  153 (280)
                      +++.++ .++|+|||.+.......     ......++..|+|||.+.+ ..++.++|+||+|+++++|++|..||.....
T Consensus       135 l~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~  213 (268)
T cd06630         135 LIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKH  213 (268)
T ss_pred             EEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence            998776 59999999987654331     1123467889999999876 6778999999999999999999999976543


Q ss_pred             HHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          154 VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       154 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      ......+.+...                          ....+...+..++.+.+++.+||..+|++|||+.++++||||
T Consensus       214 ~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~  267 (268)
T cd06630         214 SNHLALIFKIAS--------------------------ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVF  267 (268)
T ss_pred             cchHHHHHHHhc--------------------------cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCccc
Confidence            322222221110                          000112223568899999999999999999999999999998


Q ss_pred             c
Q 023568          234 Q  234 (280)
Q Consensus       234 ~  234 (280)
                      +
T Consensus       268 ~  268 (268)
T cd06630         268 R  268 (268)
T ss_pred             C
Confidence            5

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=8.9e-38  Score=260.32  Aligned_cols=203  Identities=24%  Similarity=0.429  Sum_probs=161.8

Q ss_pred             CCcccccccccccCCCCCC-CCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            2 EHENVIAIKDIIRPPKKDT-FNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~-~~~~~lv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      +||||+++++++......+ ...+|+||||++ ++|.+++...  ..+++..+..++.|++.||+|||+.|++|+||+|+
T Consensus        61 ~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~  140 (272)
T cd06637          61 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQ  140 (272)
T ss_pred             CCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHH
Confidence            6999999999997653222 246899999998 5999998753  46899999999999999999999999999999999


Q ss_pred             ceEEcCCCCeEEeecccccccCCC-Cccccceecccccccccccc----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 023568           78 NLLLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTREPLFPGKD  152 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~  152 (280)
                      ||+++.++.++|+|||++...... .......|+..|+|||.+.+    ...++.++|+||+||++|+|++|..||....
T Consensus       141 nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~  220 (272)
T cd06637         141 NVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH  220 (272)
T ss_pred             HEEECCCCCEEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccC
Confidence            999999999999999998764332 22344678889999999853    2457789999999999999999999997655


Q ss_pred             hHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 023568          153 YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY  232 (280)
Q Consensus       153 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~  232 (280)
                      .......+..   .+                          .........+..+.+|+.+||+.||.+|||+++++.|||
T Consensus       221 ~~~~~~~~~~---~~--------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  271 (272)
T cd06637         221 PMRALFLIPR---NP--------------------------APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPF  271 (272)
T ss_pred             HHHHHHHHhc---CC--------------------------CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCC
Confidence            3332222111   00                          000111246789999999999999999999999999999


Q ss_pred             c
Q 023568          233 L  233 (280)
Q Consensus       233 ~  233 (280)
                      |
T Consensus       272 ~  272 (272)
T cd06637         272 I  272 (272)
T ss_pred             C
Confidence            7

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-38  Score=289.67  Aligned_cols=201  Identities=26%  Similarity=0.445  Sum_probs=173.0

Q ss_pred             cccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc
Q 023568            4 ENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN   82 (280)
Q Consensus         4 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nili~   82 (280)
                      +=|+.++-.|+++     .++|+|||||. |+|..+|.+..++++..+++++..|+.||.-||+.|+|||||||+|||+|
T Consensus       135 ~Wiv~LhyAFQD~-----~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld  209 (1317)
T KOG0612|consen  135 EWIVQLHYAFQDE-----RYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLD  209 (1317)
T ss_pred             HHHHHHHHHhcCc-----cceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEec
Confidence            3478899999999     88999999996 59999999888999999999999999999999999999999999999999


Q ss_pred             CCCCeEEeecccccccCCC-C-ccccceecccccccccccc----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023568           83 ASCDLKIGDFGLARTTSET-D-FMTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  156 (280)
Q Consensus        83 ~~~~~kl~dfg~~~~~~~~-~-~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~  156 (280)
                      ..|++||+|||.+-....+ . .....+|||.|.|||++..    .+.|+..+|.||+||++|||+.|..||...+-...
T Consensus       210 ~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveT  289 (1317)
T KOG0612|consen  210 KSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVET  289 (1317)
T ss_pred             ccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHH
Confidence            9999999999998766533 2 2456789999999999853    26789999999999999999999999999998888


Q ss_pred             HHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCC---HHHHhcCccc
Q 023568          157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT---VEEALRHPYL  233 (280)
Q Consensus       157 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt---~~ell~hp~~  233 (280)
                      +.+|+.-..                          .-.+| ....+|..+++||++++. +|+.|..   ++++.+||||
T Consensus       290 Y~KIm~hk~--------------------------~l~FP-~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF  341 (1317)
T KOG0612|consen  290 YGKIMNHKE--------------------------SLSFP-DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFF  341 (1317)
T ss_pred             HHHHhchhh--------------------------hcCCC-cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccc
Confidence            888876311                          01111 112589999999999876 7889987   9999999999


Q ss_pred             ccCc
Q 023568          234 QSLH  237 (280)
Q Consensus       234 ~~~~  237 (280)
                      .++.
T Consensus       342 ~g~~  345 (1317)
T KOG0612|consen  342 EGID  345 (1317)
T ss_pred             cCCC
Confidence            8764

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-38  Score=254.45  Aligned_cols=221  Identities=24%  Similarity=0.380  Sum_probs=167.4

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      -|+||+.|+++|+++     ..+|||||-|. |.|.+.|++++.|+|.++.++++.|+.||.|||.+||.|||+||+|||
T Consensus       134 gh~nilqLiefFEdd-----~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiL  208 (463)
T KOG0607|consen  134 GHKNILQLIEFFEDD-----TRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENIL  208 (463)
T ss_pred             CCccHHHHHHHhccc-----ceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCcccee
Confidence            399999999999999     66999999996 599999999999999999999999999999999999999999999999


Q ss_pred             EcCCC---CeEEeecccccccCCC--------Cccccceeccccccccccc----cCCCCCcchhHHHHHHHHHHHHhCC
Q 023568           81 LNASC---DLKIGDFGLARTTSET--------DFMTEYVVTRWYRAPELLL----NCTEYTAAIDIWSVGCILGEIMTRE  145 (280)
Q Consensus        81 i~~~~---~~kl~dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~----~~~~~~~~~DvwslG~~l~~ll~g~  145 (280)
                      -....   -+|||||.+.......        ....+.+|+..|||||+..    ....|..++|+||||+|+|-||.|.
T Consensus       209 C~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGY  288 (463)
T KOG0607|consen  209 CESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGY  288 (463)
T ss_pred             ecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCC
Confidence            86543   3899999887532111        1124567888999999863    2467889999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 023568          146 PLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVE  225 (280)
Q Consensus       146 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~  225 (280)
                      +||.+.-..+-          .  +..+..+..=-......++.-.-.-....+..+|..++++++.+|..|+..|.++.
T Consensus       289 pPFvG~Cg~dC----------G--WdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~  356 (463)
T KOG0607|consen  289 PPFVGHCGADC----------G--WDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAA  356 (463)
T ss_pred             CCccCccCCcC----------C--ccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhh
Confidence            99988642100          0  00000000001111111111111111223456899999999999999999999999


Q ss_pred             HHhcCcccccCcCC
Q 023568          226 EALRHPYLQSLHDL  239 (280)
Q Consensus       226 ell~hp~~~~~~~~  239 (280)
                      ++++|||+......
T Consensus       357 ~vlnhPw~~~~~~e  370 (463)
T KOG0607|consen  357 QVLNHPWVQRCAPE  370 (463)
T ss_pred             hccCCccccccchh
Confidence            99999999877543

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.1e-37  Score=264.17  Aligned_cols=203  Identities=24%  Similarity=0.376  Sum_probs=165.9

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++.+..+     ..+|+||||++| +|.+++...+.+++..+..++.|++.||+|||+.|++||||+|+||
T Consensus        58 ~~~~~i~~~~~~~~~~-----~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NI  132 (305)
T cd05609          58 AENPFVVSMFCSFETK-----RHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNL  132 (305)
T ss_pred             CCCCCeeeeEEEEecC-----CEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHE
Confidence            5799999999999877     779999999985 9999998888899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC----------------CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh
Q 023568           80 LLNASCDLKIGDFGLARTTSET----------------DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT  143 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~  143 (280)
                      +++.++.++|+|||.++.....                .......++..|+|||.+.+ ..++.++|+|||||++|+|++
T Consensus       133 ll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~vl~el~~  211 (305)
T cd05609         133 LITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLV  211 (305)
T ss_pred             EECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccC-CCCCchhhHHHHHHHHHHHHh
Confidence            9999999999999988632110                00112356778999999876 678899999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCC
Q 023568          144 REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT  223 (280)
Q Consensus       144 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt  223 (280)
                      |..||.+....+....+.....                            ..+......+..+.++|++||+.||++||+
T Consensus       212 g~~pf~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~li~~~l~~~P~~R~~  263 (305)
T cd05609         212 GCVPFFGDTPEELFGQVISDDI----------------------------EWPEGDEALPADAQDLISRLLRQNPLERLG  263 (305)
T ss_pred             CCCCCCCCCHHHHHHHHHhccc----------------------------CCCCccccCCHHHHHHHHHHhccChhhccC
Confidence            9999987765544443322100                            001111246888999999999999999997


Q ss_pred             ---HHHHhcCcccccCc
Q 023568          224 ---VEEALRHPYLQSLH  237 (280)
Q Consensus       224 ---~~ell~hp~~~~~~  237 (280)
                         +.++|+||||....
T Consensus       264 ~~~~~~ll~~~~~~~~~  280 (305)
T cd05609         264 TGGAFEVKQHRFFLGLD  280 (305)
T ss_pred             ccCHHHHHhCccccCCC
Confidence               79999999996643

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-38  Score=266.73  Aligned_cols=202  Identities=26%  Similarity=0.476  Sum_probs=166.2

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      ++||||+++++.+.+.     ...|+||||+.| +|.+++...  ..+++..+..++.|++.||+|||+.|++|+||||+
T Consensus        58 l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~  132 (316)
T cd05574          58 LDHPFLPTLYASFQTE-----TYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPE  132 (316)
T ss_pred             CCCCCchhheeeeecC-----CEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChH
Confidence            5799999999999887     779999999975 999998753  57999999999999999999999999999999999


Q ss_pred             ceEEcCCCCeEEeecccccccCCCC------------------------------ccccceeccccccccccccCCCCCc
Q 023568           78 NLLLNASCDLKIGDFGLARTTSETD------------------------------FMTEYVVTRWYRAPELLLNCTEYTA  127 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~~------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~  127 (280)
                      ||+++.++.++|+|||++.......                              ......|+..|+|||.+.+ ..++.
T Consensus       133 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~  211 (316)
T cd05574         133 NILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG-DGHGS  211 (316)
T ss_pred             HeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC-CCCCc
Confidence            9999999999999999886543211                              0112457888999999877 66788


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHH
Q 023568          128 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAV  207 (280)
Q Consensus       128 ~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  207 (280)
                      ++|+||||+++|+|++|..||.+.+.......+...   ..                         .. ......+..+.
T Consensus       212 ~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~---~~-------------------------~~-~~~~~~~~~~~  262 (316)
T cd05574         212 AVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKK---EV-------------------------TF-PGSPPVSSSAR  262 (316)
T ss_pred             hHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcC---Cc-------------------------cC-CCccccCHHHH
Confidence            999999999999999999999887755444333210   00                         00 01112688999


Q ss_pred             HHHHHhcccCCCCCCC----HHHHhcCcccccCc
Q 023568          208 DLLEKMLVFDPNKRIT----VEEALRHPYLQSLH  237 (280)
Q Consensus       208 ~ll~~~L~~dp~~Rpt----~~ell~hp~~~~~~  237 (280)
                      +++++||+.||++|||    ++++|+||||++..
T Consensus       263 ~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~  296 (316)
T cd05574         263 DLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVN  296 (316)
T ss_pred             HHHHHHccCCHhHCCCchhhHHHHHcCchhhcCC
Confidence            9999999999999999    99999999998754

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.1e-37  Score=257.63  Aligned_cols=199  Identities=28%  Similarity=0.509  Sum_probs=166.5

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++...     ...|+||||+++ +|.+++.+.+.+++..+..++.|++.||+|||+.|++|+||+|+||
T Consensus        59 ~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni  133 (258)
T cd06632          59 LQHPNIVQYLGTEREE-----DNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANI  133 (258)
T ss_pred             cCCCCchheeeeEecC-----CeEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence            5799999999999877     679999999975 9999998877899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.++.++|+|||.+.............++..|+|||.+.....++.++|+||+|+++|+|++|..||...........
T Consensus       134 ~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~  213 (258)
T cd06632         134 LVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFK  213 (258)
T ss_pred             EECCCCCEEEccCccceeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHH
Confidence            99999999999999987655443344566788999999987633488999999999999999999999977653333322


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      +...                             ...+...+.+++.+.+++++||+.+|.+|||+++++.|||+
T Consensus       214 ~~~~-----------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         214 IGRS-----------------------------KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             HHhc-----------------------------ccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence            2110                             01112233568899999999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=7.1e-38  Score=264.30  Aligned_cols=202  Identities=25%  Similarity=0.443  Sum_probs=165.3

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++.+...     ...|+||||+. ++|.+++.+ ..+++.++..++.|++.||+|||+.|++||||+|+||
T Consensus        74 ~~h~~v~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Ni  147 (296)
T cd06654          74 NKNPNIVNYLDSYLVG-----DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNI  147 (296)
T ss_pred             CCCCCEeeEEEEEEeC-----CEEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence            4799999999999877     67999999997 599998865 5689999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCC-ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||.+....... ......+++.|+|||.+.+ ..++.++|+||+||++|+|++|+.||..........
T Consensus       148 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~  226 (296)
T cd06654         148 LLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY  226 (296)
T ss_pred             EEcCCCCEEECccccchhccccccccCcccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHH
Confidence            99999999999999987644332 2234567889999999876 667899999999999999999999998766433322


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  237 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~  237 (280)
                      .+.. .+.+                           .......++..+.+++.+||..||.+|||+++++.||||....
T Consensus       227 ~~~~-~~~~---------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~  277 (296)
T cd06654         227 LIAT-NGTP---------------------------ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK  277 (296)
T ss_pred             HHhc-CCCC---------------------------CCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccC
Confidence            2111 0000                           0011235678899999999999999999999999999997643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-38  Score=259.19  Aligned_cols=201  Identities=27%  Similarity=0.410  Sum_probs=163.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||+++++++...     ..+|++|||+++ +|.+++... ..+++.++..++.|++.||+|||+.|++|+||+|+|
T Consensus        57 ~~h~~i~~~~~~~~~~-----~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~n  131 (262)
T cd06613          57 CRHPNIVAYFGSYLRR-----DKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGAN  131 (262)
T ss_pred             CCCCChhceEEEEEeC-----CEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhh
Confidence            5899999999999877     679999999985 999988775 789999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCC-ccccceeccccccccccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNC--TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH  155 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~  155 (280)
                      |+++.++.++|+|||.+....... ......++..|+|||.+.+.  ..++.++|+||+|+++|+|++|..||...+...
T Consensus       132 i~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~  211 (262)
T cd06613         132 ILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR  211 (262)
T ss_pred             EEECCCCCEEECccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            999999999999999987654332 23345678889999998662  267789999999999999999999998876544


Q ss_pred             HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 023568          156 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY  232 (280)
Q Consensus       156 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~  232 (280)
                      ....+....- .+.                         ........+.++.+++++||..||..|||+++++.|+|
T Consensus       212 ~~~~~~~~~~-~~~-------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         212 ALFLISKSNF-PPP-------------------------KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             HHHHHHhccC-CCc-------------------------cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence            4333222100 000                         00011234678999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.1e-37  Score=261.67  Aligned_cols=205  Identities=24%  Similarity=0.445  Sum_probs=166.6

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSD---QQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLK   75 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~---~~l~~~~~~~i~~qil~~l~~LH~-~~i~H~dik   75 (280)
                      ++||||+++++++...     +..|+||||+.| +|.+++...   ..+++..+..++.|++.||.|||+ .|++|+||+
T Consensus        56 ~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~  130 (286)
T cd06622          56 AVSPYIVDFYGAFFIE-----GAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVK  130 (286)
T ss_pred             cCCCcHHhhhhheecC-----CeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCC
Confidence            5799999999999987     779999999985 888888653   379999999999999999999997 599999999


Q ss_pred             CCceEEcCCCCeEEeecccccccCCCCccccceeccccccccccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 023568           76 PSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC-----TEYTAAIDIWSVGCILGEIMTREPLFPG  150 (280)
Q Consensus        76 ~~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~DvwslG~~l~~ll~g~~pf~~  150 (280)
                      |+||+++.++.++|+|||.+...... ......++..|+|||.+.+.     ..++.++|+||+||++|+|++|..||..
T Consensus       131 p~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  209 (286)
T cd06622         131 PTNVLVNGNGQVKLCDFGVSGNLVAS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPP  209 (286)
T ss_pred             HHHEEECCCCCEEEeecCCcccccCC-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCC
Confidence            99999999999999999998765332 22345678889999988542     2357899999999999999999999977


Q ss_pred             CChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 023568          151 KDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  230 (280)
Q Consensus       151 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~h  230 (280)
                      .........+.......                           .+..++..+.++.++|.+||+.+|.+||+++++++|
T Consensus       210 ~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         210 ETYANIFAQLSAIVDGD---------------------------PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             cchhhHHHHHHHHhhcC---------------------------CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence            65444333333222111                           112233578999999999999999999999999999


Q ss_pred             cccccCcC
Q 023568          231 PYLQSLHD  238 (280)
Q Consensus       231 p~~~~~~~  238 (280)
                      |||.....
T Consensus       263 ~~~~~~~~  270 (286)
T cd06622         263 PWLVKYKN  270 (286)
T ss_pred             hhhhhccC
Confidence            99987653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-39  Score=272.13  Aligned_cols=200  Identities=27%  Similarity=0.479  Sum_probs=183.3

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecC-CccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~-~g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      +.|.||++|..|.++     ..+|++||.| +|.|+..+++++.|++.++++++..+++|+.|||++||++|||||+|.+
T Consensus       478 ~s~fIvrLYrTfrd~-----kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENll  552 (732)
T KOG0614|consen  478 RSDFIVRLYRTFRDS-----KYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLL  552 (732)
T ss_pred             CchHHHHHHHHhccc-----hhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhhee
Confidence            468999999999998     7799999999 5799999999999999999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 023568           81 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  160 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~i  160 (280)
                      ++.+|-+||.|||+|+..+.+...-+++||+.|.|||++.+ .....++|.||||+++||||+|.+||.+.+.+..++.|
T Consensus       553 Ld~~Gy~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILn-KGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~I  631 (732)
T KOG0614|consen  553 LDNRGYLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILN-KGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLI  631 (732)
T ss_pred             eccCCceEEeehhhHHHhccCCceeeecCCcccccchhhhc-cCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH
Confidence            99999999999999999999888889999999999999998 78889999999999999999999999999999999988


Q ss_pred             HHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccccc
Q 023568          161 TELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQS  235 (280)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rp-----t~~ell~hp~~~~  235 (280)
                      .+.+...                             ..+..++..+.++++++...+|.+|.     .+.++-+|.||.+
T Consensus       632 LkGid~i-----------------------------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g  682 (732)
T KOG0614|consen  632 LKGIDKI-----------------------------EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEG  682 (732)
T ss_pred             Hhhhhhh-----------------------------hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence            7743311                             11235788999999999999999998     4899999999986


Q ss_pred             C
Q 023568          236 L  236 (280)
Q Consensus       236 ~  236 (280)
                      .
T Consensus       683 f  683 (732)
T KOG0614|consen  683 F  683 (732)
T ss_pred             C
Confidence            5

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1e-37  Score=268.19  Aligned_cols=194  Identities=25%  Similarity=0.399  Sum_probs=153.9

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC--------------------------------------
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD--------------------------------------   42 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~--------------------------------------   42 (280)
                      +||||+++++++....    ..+|+||||++ |+|.+++...                                      
T Consensus        69 ~h~niv~~~~~~~~~~----~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (338)
T cd05102          69 NHLNVVNLLGACTKPN----GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASV  144 (338)
T ss_pred             cCcceeeEEeEecCCC----CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCc
Confidence            7999999999887542    45899999997 5999998642                                      


Q ss_pred             ------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEeeccccccc
Q 023568           43 ------------------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT   98 (280)
Q Consensus        43 ------------------------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~   98 (280)
                                              ..+++.++..++.|++.||.|||+.||+||||||+||+++.++.++|+|||+++..
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~  224 (338)
T cd05102         145 LFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDI  224 (338)
T ss_pred             cccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeeccccccc
Confidence                                    24788899999999999999999999999999999999999999999999999764


Q ss_pred             CCCCc---cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccc
Q 023568           99 SETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGF  174 (280)
Q Consensus        99 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  174 (280)
                      .....   .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+............. +         
T Consensus       225 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~---------  293 (338)
T cd05102         225 YKDPDYVRKGSARLPLKWMAPESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD-G---------  293 (338)
T ss_pred             ccCcchhcccCCCCCccccCcHHhhc-CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhc-C---------
Confidence            33211   122344678999999876 678899999999999999997 99999876533222111110 0         


Q ss_pred             cCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          175 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                                         .........++.+.+++.+||+.||.+|||+.|+++
T Consensus       294 -------------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~  329 (338)
T cd05102         294 -------------------TRMRAPENATPEIYRIMLACWQGDPKERPTFSALVE  329 (338)
T ss_pred             -------------------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                               001112356889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=5.2e-38  Score=261.12  Aligned_cols=201  Identities=26%  Similarity=0.369  Sum_probs=161.3

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++...     ...|+||||++ ++|.+++.+.+.+++..+..++.|++.||.|||+.||+||||+|+||
T Consensus        63 ~~h~~ii~~~~~~~~~-----~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~ni  137 (267)
T cd06646          63 CKHCNIVAYFGSYLSR-----EKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANI  137 (267)
T ss_pred             cCCCCeeeeeEEEEeC-----CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHE
Confidence            5799999999999877     67999999998 59999998778899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCC-ccccceecccccccccccc--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  156 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~  156 (280)
                      +++.++.++|+|||++....... ......++..|+|||.+.+  ...++.++|+||+||++|+|++|..||........
T Consensus       138 ll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~  217 (267)
T cd06646         138 LLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA  217 (267)
T ss_pred             EECCCCCEEECcCccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh
Confidence            99999999999999987654321 2234567889999998753  24567899999999999999999999865543222


Q ss_pred             HHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 023568          157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY  232 (280)
Q Consensus       157 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~  232 (280)
                      ...+.....                          ..........++..+.+++++||..||++|||++++++|+|
T Consensus       218 ~~~~~~~~~--------------------------~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         218 LFLMSKSNF--------------------------QPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             heeeecCCC--------------------------CCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            111111000                          00000111246789999999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=5.9e-38  Score=266.84  Aligned_cols=229  Identities=19%  Similarity=0.277  Sum_probs=166.1

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      ++||||++++++|...     ...|++|||++ |+|.+++...  ..+++..++.++.|++.||+|||+.||+||||+|+
T Consensus        56 l~h~~i~~~~~~~~~~-----~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~  130 (314)
T cd08216          56 LQHPNILPYVTSFIVD-----SELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKAS  130 (314)
T ss_pred             cCCcchhhhhheeecC-----CeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcc
Confidence            5899999999999887     67999999998 5899998753  46899999999999999999999999999999999


Q ss_pred             ceEEcCCCCeEEeecccccccCCCC--------ccccceeccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCC
Q 023568           78 NLLLNASCDLKIGDFGLARTTSETD--------FMTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLF  148 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~~l~~ll~g~~pf  148 (280)
                      ||+++.++.++++|||.+.......        ......++..|+|||.+.+. ..++.++|+||+||++++|++|..||
T Consensus       131 Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf  210 (314)
T cd08216         131 HILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPF  210 (314)
T ss_pred             eEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCC
Confidence            9999999999999999886432211        12234567789999998653 35788999999999999999999999


Q ss_pred             CCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHH------hCCccccccccccCCCCCHHHHHHHHHhcccCCCCCC
Q 023568          149 PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVR------QLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI  222 (280)
Q Consensus       149 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rp  222 (280)
                      ..........  ....+..+...... ..........      ................++.++.+|+++||+.||++||
T Consensus       211 ~~~~~~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp  287 (314)
T cd08216         211 KDMPATQMLL--EKVRGTVPCLLDKS-TYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRP  287 (314)
T ss_pred             CCCCHHHHHH--HHHhccCccccccC-chhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCc
Confidence            8865443321  12222211110000 0000000000      0000000001111223567899999999999999999


Q ss_pred             CHHHHhcCcccccCc
Q 023568          223 TVEEALRHPYLQSLH  237 (280)
Q Consensus       223 t~~ell~hp~~~~~~  237 (280)
                      |++++|+||||+.+.
T Consensus       288 t~~~ll~~p~~~~~~  302 (314)
T cd08216         288 SASQLLNHSFFKQCK  302 (314)
T ss_pred             CHHHHhcCchHhhhc
Confidence            999999999998776

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=7.8e-38  Score=280.47  Aligned_cols=206  Identities=23%  Similarity=0.407  Sum_probs=168.3

Q ss_pred             CCCcccccccccccCCCC---CCCCcEEEEEecCC-ccHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 023568            1 MEHENVIAIKDIIRPPKK---DTFNDVYIVYELMD-TDLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHR   72 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~---~~~~~~~lv~e~~~-g~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~   72 (280)
                      ++|+||+++++.+.....   .....+++||||+. |+|.+++..    ...+++..+..++.|++.||.|||+.||+||
T Consensus        88 ~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHr  167 (496)
T PTZ00283         88 CDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHR  167 (496)
T ss_pred             CCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecC
Confidence            479999999988765421   11124789999997 599998864    2469999999999999999999999999999


Q ss_pred             CCCCCceEEcCCCCeEEeecccccccCCC---CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 023568           73 DLKPSNLLLNASCDLKIGDFGLARTTSET---DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFP  149 (280)
Q Consensus        73 dik~~Nili~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~  149 (280)
                      ||||+||+++.++.++|+|||+++.....   .......||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.
T Consensus       168 DLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~k~DVwSlGvilyeLltG~~Pf~  246 (496)
T PTZ00283        168 DIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRR-KPYSKKADMFSLGVLLYELLTLKRPFD  246 (496)
T ss_pred             CCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence            99999999999999999999998764432   22345678999999999987 678899999999999999999999998


Q ss_pred             CCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          150 GKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       150 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      +.+.......+...                              ......+..++.+.+++.+||+.||.+||++.++++
T Consensus       247 ~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~  296 (496)
T PTZ00283        247 GENMEEVMHKTLAG------------------------------RYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN  296 (496)
T ss_pred             CCCHHHHHHHHhcC------------------------------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence            87655444333210                              011223467899999999999999999999999999


Q ss_pred             CcccccCc
Q 023568          230 HPYLQSLH  237 (280)
Q Consensus       230 hp~~~~~~  237 (280)
                      |||++.+.
T Consensus       297 ~p~~~~~~  304 (496)
T PTZ00283        297 MPICKLFI  304 (496)
T ss_pred             CHHHHHhh
Confidence            99987654

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.4e-38  Score=273.83  Aligned_cols=200  Identities=25%  Similarity=0.424  Sum_probs=171.6

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS--VLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~--i~H~dik~~   77 (280)
                      |+|||||++++++.+...   ..+.+|+|.|. |+|..+++++++++...++.|++||+.||.|||++.  |+|||||.+
T Consensus        98 L~H~NIirfy~SW~d~~n---~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCD  174 (632)
T KOG0584|consen   98 LKHPNIIRFYDSWVDTDN---KTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCD  174 (632)
T ss_pred             CCCCceeeeeeheecCCC---ceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccc
Confidence            789999999999998854   66999999997 799999999999999999999999999999999987  999999999


Q ss_pred             ceEEcC-CCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC-ChHH
Q 023568           78 NLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK-DYVH  155 (280)
Q Consensus        78 Nili~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~-~~~~  155 (280)
                      ||+|+. .|.+||+|+|+|+...... ....+|||.|||||.+.  ..|...+||||||+.++||+|+.-||..= +..+
T Consensus       175 NIFinG~~G~VKIGDLGLAtl~r~s~-aksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQ  251 (632)
T KOG0584|consen  175 NIFVNGNLGEVKIGDLGLATLLRKSH-AKSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQ  251 (632)
T ss_pred             eEEEcCCcCceeecchhHHHHhhccc-cceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHH
Confidence            999976 6899999999998765543 34589999999999986  58999999999999999999999999764 4445


Q ss_pred             HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 023568          156 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  235 (280)
Q Consensus       156 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~  235 (280)
                      .++++..  |.++..+                           .....+.+++||.+||.. .+.|+|+.|+|.||||..
T Consensus       252 IYKKV~S--GiKP~sl---------------------------~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~  301 (632)
T KOG0584|consen  252 IYKKVTS--GIKPAAL---------------------------SKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDE  301 (632)
T ss_pred             HHHHHHc--CCCHHHh---------------------------hccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence            5555443  2222211                           113478999999999999 999999999999999987


Q ss_pred             C
Q 023568          236 L  236 (280)
Q Consensus       236 ~  236 (280)
                      -
T Consensus       302 d  302 (632)
T KOG0584|consen  302 D  302 (632)
T ss_pred             c
Confidence            4

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=7.1e-38  Score=291.25  Aligned_cols=205  Identities=28%  Similarity=0.461  Sum_probs=165.2

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhC-------C
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSA-------S   68 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH~~-------~   68 (280)
                      |+|||||+++++|.....   ..+||||||++ |+|.++|..    .+.+++..++.|+.||+.||.|||+.       +
T Consensus        69 L~HPNIVrl~d~f~de~~---~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~  145 (1021)
T PTZ00266         69 LKHKNIVRYIDRFLNKAN---QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGER  145 (1021)
T ss_pred             cCCCCcCeEEEEEEecCC---CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCC
Confidence            689999999999875532   56999999998 599999864    35799999999999999999999985       4


Q ss_pred             ccccCCCCCceEEcC-----------------CCCeEEeecccccccCCCCccccceeccccccccccccC-CCCCcchh
Q 023568           69 VLHRDLKPSNLLLNA-----------------SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC-TEYTAAID  130 (280)
Q Consensus        69 i~H~dik~~Nili~~-----------------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~D  130 (280)
                      |+||||||+|||++.                 .+.++|+|||++.............||+.|+|||++.+. ..++.++|
T Consensus       146 IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSD  225 (1021)
T PTZ00266        146 VLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSD  225 (1021)
T ss_pred             ceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhH
Confidence            999999999999964                 234899999999876555444566789999999998642 45788999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHH
Q 023568          131 IWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLL  210 (280)
Q Consensus       131 vwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll  210 (280)
                      ||||||++|+|++|..||...+....+.....  ..+                            ....+..+.++.+||
T Consensus       226 VWSLG~ILYELLTGk~PF~~~~~~~qli~~lk--~~p----------------------------~lpi~~~S~eL~dLI  275 (1021)
T PTZ00266        226 MWALGCIIYELCSGKTPFHKANNFSQLISELK--RGP----------------------------DLPIKGKSKELNILI  275 (1021)
T ss_pred             HHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHh--cCC----------------------------CCCcCCCCHHHHHHH
Confidence            99999999999999999987654433222211  000                            001124688999999


Q ss_pred             HHhcccCCCCCCCHHHHhcCcccccCcC
Q 023568          211 EKMLVFDPNKRITVEEALRHPYLQSLHD  238 (280)
Q Consensus       211 ~~~L~~dp~~Rpt~~ell~hp~~~~~~~  238 (280)
                      ..||+.+|.+||++.|+|.|||+..+..
T Consensus       276 ~~~L~~dPeeRPSa~QlL~h~~ik~i~~  303 (1021)
T PTZ00266        276 KNLLNLSAKERPSALQCLGYQIIKNVGP  303 (1021)
T ss_pred             HHHhcCChhHCcCHHHHhccHHHhhcCC
Confidence            9999999999999999999999987653

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-38  Score=264.65  Aligned_cols=203  Identities=26%  Similarity=0.408  Sum_probs=172.6

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      +-+.||.+--.|++.     +.+++||..|+ |+|.-.|-+.+  .|+++.++.++.+|+.||.+||+.+|++||+||+|
T Consensus       243 ~s~FiVslaYAfeTk-----d~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeN  317 (591)
T KOG0986|consen  243 SSPFIVSLAYAFETK-----DALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPEN  317 (591)
T ss_pred             ccCcEEEEeeeecCC-----CceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhh
Confidence            467889998899887     77999999997 59988776654  89999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      ||+|..|+++|+|.|+|.............||..|||||++.+ ..|+.+.|.|||||++|+|+.|+.||..........
T Consensus       318 ILLDd~GhvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~n-e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~e  396 (591)
T KOG0986|consen  318 ILLDDHGHVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQN-EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKRE  396 (591)
T ss_pred             eeeccCCCeEeeccceEEecCCCCccccccCcccccCHHHHcC-CcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHH
Confidence            9999999999999999998887776667799999999999998 669999999999999999999999998765433322


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYL  233 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rp-----t~~ell~hp~~  233 (280)
                      .+....-                           ....+.....|++++++.+.+|++||++|.     ++.++.+||||
T Consensus       397 Evdrr~~---------------------------~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfF  449 (591)
T KOG0986|consen  397 EVDRRTL---------------------------EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFF  449 (591)
T ss_pred             HHHHHHh---------------------------cchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCccc
Confidence            2222111                           111122236799999999999999999997     78899999999


Q ss_pred             ccCc
Q 023568          234 QSLH  237 (280)
Q Consensus       234 ~~~~  237 (280)
                      ++++
T Consensus       450 k~ln  453 (591)
T KOG0986|consen  450 KDLN  453 (591)
T ss_pred             ccCC
Confidence            9875

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.1e-37  Score=258.20  Aligned_cols=201  Identities=30%  Similarity=0.546  Sum_probs=167.0

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++.+...     ...|+||||+. ++|.+++.+.+.+++..+..++.|++.||+|||+.|++|+||+|+||
T Consensus        50 ~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~ni  124 (265)
T cd05579          50 AQSPYVVKLYYSFQGK-----KNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNI  124 (265)
T ss_pred             CCCcchhHHHHheecC-----cEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHe
Confidence            5799999999999877     67999999997 59999998877899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCC---------ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 023568           80 LLNASCDLKIGDFGLARTTSETD---------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG  150 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~  150 (280)
                      +++.++.++|+|||++.......         ......++..|+|||...+ ...+.++|+||||++++++++|..||..
T Consensus       125 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~  203 (265)
T cd05579         125 LIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG-QGHSKTVDWWSLGCILYEFLVGIPPFHG  203 (265)
T ss_pred             EEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence            99999999999999987543321         1233456788999999876 5588899999999999999999999988


Q ss_pred             CChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCH---HHH
Q 023568          151 KDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV---EEA  227 (280)
Q Consensus       151 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~---~el  227 (280)
                      .........+..  +..                          ..+. ....+..+.+++++||+.+|.+|||+   .++
T Consensus       204 ~~~~~~~~~~~~--~~~--------------------------~~~~-~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~  254 (265)
T cd05579         204 ETPEEIFQNILN--GKI--------------------------EWPE-DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEI  254 (265)
T ss_pred             CCHHHHHHHHhc--CCc--------------------------CCCc-cccCCHHHHHHHHHHhcCCHhhcCCCccHHHH
Confidence            775544444322  000                          0000 01248899999999999999999999   999


Q ss_pred             hcCcccccC
Q 023568          228 LRHPYLQSL  236 (280)
Q Consensus       228 l~hp~~~~~  236 (280)
                      |+||||+++
T Consensus       255 l~~~~~~~~  263 (265)
T cd05579         255 KNHPFFKGI  263 (265)
T ss_pred             hcCccccCC
Confidence            999999865

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=8.3e-38  Score=259.47  Aligned_cols=203  Identities=26%  Similarity=0.458  Sum_probs=165.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~-~~i~H~dik~~   77 (280)
                      ++||||+++++++...     ...|+||||++ ++|.+++... ..+++..+..++.|++.||+|||+ .|++|+||+|+
T Consensus        56 ~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~  130 (265)
T cd06605          56 CNSPYIVGFYGAFYNN-----GDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPS  130 (265)
T ss_pred             CCCCchhhhheeeecC-----CEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHH
Confidence            5799999999999887     77999999998 5999999765 789999999999999999999999 99999999999


Q ss_pred             ceEEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh--HH
Q 023568           78 NLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY--VH  155 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~--~~  155 (280)
                      ||+++.++.++|+|||.+........ ....++..|+|||.+.+ ..++.++|+||+|+++++|++|..||...+.  ..
T Consensus       131 ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~  208 (265)
T cd06605         131 NILVNSRGQIKLCDFGVSGQLVNSLA-KTFVGTSSYMAPERIQG-NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG  208 (265)
T ss_pred             HEEECCCCCEEEeecccchhhHHHHh-hcccCChhccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc
Confidence            99999999999999999876543321 12667888999999877 6788999999999999999999999976531  11


Q ss_pred             HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCC-CCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 023568          156 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ  234 (280)
Q Consensus       156 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~  234 (280)
                      ....+........                           +..... .+..+.++|.+||..||.+|||+.+++.||||+
T Consensus       209 ~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~  261 (265)
T cd06605         209 IFELLQYIVNEPP---------------------------PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIK  261 (265)
T ss_pred             HHHHHHHHhcCCC---------------------------CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhh
Confidence            1111211111111                           111112 688899999999999999999999999999998


Q ss_pred             cCc
Q 023568          235 SLH  237 (280)
Q Consensus       235 ~~~  237 (280)
                      .+.
T Consensus       262 ~~~  264 (265)
T cd06605         262 KYE  264 (265)
T ss_pred             ccc
Confidence            764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2.2e-37  Score=260.59  Aligned_cols=205  Identities=25%  Similarity=0.419  Sum_probs=162.7

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP   76 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~----~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~   76 (280)
                      +||||+++++++...........|+||||++ ++|.++++    ....+++..++.++.|++.||+|||+.|++|+||+|
T Consensus        77 ~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp  156 (291)
T cd06639          77 NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKG  156 (291)
T ss_pred             CCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCH
Confidence            6999999999998653322357999999997 49998875    246799999999999999999999999999999999


Q ss_pred             CceEEcCCCCeEEeecccccccCCCC-ccccceeccccccccccccCC----CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 023568           77 SNLLLNASCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCT----EYTAAIDIWSVGCILGEIMTREPLFPGK  151 (280)
Q Consensus        77 ~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~----~~~~~~DvwslG~~l~~ll~g~~pf~~~  151 (280)
                      +||+++.++.++|+|||++....... ......++..|+|||.+....    .++.++|+||+||++|+|++|+.||...
T Consensus       157 ~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~  236 (291)
T cd06639         157 NNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM  236 (291)
T ss_pred             HHEEEcCCCCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCC
Confidence            99999999999999999987654332 123456788899999875422    3578999999999999999999999877


Q ss_pred             ChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 023568          152 DYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHP  231 (280)
Q Consensus       152 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp  231 (280)
                      +....+..+.+   .+...                         .......+..+.+++.+||+.||++||++.++++||
T Consensus       237 ~~~~~~~~~~~---~~~~~-------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~  288 (291)
T cd06639         237 HPVKTLFKIPR---NPPPT-------------------------LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHP  288 (291)
T ss_pred             cHHHHHHHHhc---CCCCC-------------------------CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCc
Confidence            65444333221   10000                         001123567899999999999999999999999999


Q ss_pred             ccc
Q 023568          232 YLQ  234 (280)
Q Consensus       232 ~~~  234 (280)
                      ||+
T Consensus       289 ~~~  291 (291)
T cd06639         289 FIK  291 (291)
T ss_pred             ccC
Confidence            984

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=9.7e-38  Score=263.61  Aligned_cols=203  Identities=25%  Similarity=0.454  Sum_probs=165.6

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++...     ...|+||||++ ++|.+++.+ ..+++.++..++.|++.||.|||+.|++||||+|+||
T Consensus        73 ~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Ni  146 (297)
T cd06656          73 NKNPNIVNYLDSYLVG-----DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNI  146 (297)
T ss_pred             CCCCCEeeEEEEEecC-----CEEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence            5799999999999887     77999999997 599998865 5689999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCC-ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||.+....... ......+++.|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.+......
T Consensus       147 li~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~  225 (297)
T cd06656         147 LLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY  225 (297)
T ss_pred             EECCCCCEEECcCccceEccCCccCcCcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee
Confidence            99999999999999987654332 2234567889999999877 777899999999999999999999997765322211


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCcC
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  238 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~~  238 (280)
                      .+.. .+.+                           ........+..+.+++.+||..||.+|||+++++.||||+....
T Consensus       226 ~~~~-~~~~---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  277 (297)
T cd06656         226 LIAT-NGTP---------------------------ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP  277 (297)
T ss_pred             eecc-CCCC---------------------------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccc
Confidence            1100 0000                           00112346788999999999999999999999999999987653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-40  Score=260.99  Aligned_cols=201  Identities=24%  Similarity=0.404  Sum_probs=170.0

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      +.|+|||+++.|-..     .++++|||||+ |++.|.++. +++++++++..+++..+.||.|||...-+|||||+.||
T Consensus        86 ~S~yVVKYYGSYFK~-----sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNI  160 (502)
T KOG0574|consen   86 KSKYVVKYYGSYFKH-----SDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNI  160 (502)
T ss_pred             CCchhhhhhhhhccC-----CceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccE
Confidence            468999999998876     56999999998 899999975 57899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      |++.+|..||+|||.+....+. ....+..||+.|||||++.. -.|...+|+||||++..||..|++||..-..+..+-
T Consensus       161 LLNT~G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~E-IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF  239 (502)
T KOG0574|consen  161 LLNTDGIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEE-IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF  239 (502)
T ss_pred             EEcccchhhhhhccccchhhhhHHhhCccccCcccccHHHHHH-hccchhhhHhhhcchhhhhhcCCCCcccccccceeE
Confidence            9999999999999999876554 44567899999999999987 788899999999999999999999997755433221


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  236 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~  236 (280)
                         -+-..|++.+                         ..+..+|.++-+|+++||.+.|++|-|+-++++|||+++-
T Consensus       240 ---MIPT~PPPTF-------------------------~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA  289 (502)
T KOG0574|consen  240 ---MIPTKPPPTF-------------------------KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNA  289 (502)
T ss_pred             ---eccCCCCCCC-------------------------CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCC
Confidence               1111222221                         1122468899999999999999999999999999999764

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=8.1e-38  Score=258.66  Aligned_cols=199  Identities=25%  Similarity=0.461  Sum_probs=166.5

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++...     ...|+||||+.| +|.+.+.+...+++..+..++.|++.||.|||++|++|+||+|+||
T Consensus        57 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni  131 (258)
T cd05578          57 LNHPFLVNLWYSFQDE-----ENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNI  131 (258)
T ss_pred             CCCCChHHHHHhhcCC-----CeEEEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHe
Confidence            5899999999999877     779999999975 9999998777899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.++.++|+|||.+.............++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||...+... ...
T Consensus       132 l~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~  209 (258)
T cd05578         132 LLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCR-QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI-RDQ  209 (258)
T ss_pred             EEcCCCCEEEeecccccccCCCccccccCCChhhcCHHHHcc-cCCCCcccchhhHHHHHHHHhCCCCCCCCCccH-HHH
Confidence            999999999999999887655433445667889999999877 668899999999999999999999998876421 111


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCH--HHHhcCccc
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV--EEALRHPYL  233 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~--~ell~hp~~  233 (280)
                      +......                           ......+..+.++.++|++||..||.+||++  +|+++||||
T Consensus       210 ~~~~~~~---------------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         210 IRAKQET---------------------------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             HHHHhcc---------------------------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence            1111000                           1112223567899999999999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.6e-37  Score=262.29  Aligned_cols=203  Identities=28%  Similarity=0.491  Sum_probs=167.5

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++.+..+     +..|+||||+++ +|.+++.. ..+++..+..++.|++.||+|||++|++||||+|+||
T Consensus        75 l~hp~i~~~~~~~~~~-----~~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Ni  148 (297)
T cd06659          75 YQHQNVVEMYKSYLVG-----EELWVLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSI  148 (297)
T ss_pred             CCCCchhhhhhheeeC-----CeEEEEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHe
Confidence            5799999999999887     679999999985 88887654 6799999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||++...... .......++..|+|||.+.+ ..++.++|+||+||++++|++|..||...+......
T Consensus       149 ll~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~  227 (297)
T cd06659         149 LLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR-TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK  227 (297)
T ss_pred             EEccCCcEEEeechhHhhcccccccccceecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            9999999999999998754332 12234567899999999876 678899999999999999999999998776554444


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCcC
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  238 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~~  238 (280)
                      .+..   .+..                         ........+..+.++|++||+.+|.+||+++++++||||.....
T Consensus       228 ~~~~---~~~~-------------------------~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~  279 (297)
T cd06659         228 RLRD---SPPP-------------------------KLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGL  279 (297)
T ss_pred             HHhc---cCCC-------------------------CccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCC
Confidence            3321   0000                         01112346788999999999999999999999999999976543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=9.9e-38  Score=261.51  Aligned_cols=203  Identities=26%  Similarity=0.394  Sum_probs=162.6

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLK   75 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH~~-~i~H~dik   75 (280)
                      ++||||+++++++...     ..+|+||||++|+|.+++..    ...+++..+..++.|++.||+|||++ +++|||||
T Consensus        57 ~~~~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlk  131 (283)
T cd06617          57 VDCPYTVTFYGALFRE-----GDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVK  131 (283)
T ss_pred             cCCCCeeeeeEEEecC-----CcEEEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCC
Confidence            4799999999999877     67999999999999888753    34689999999999999999999997 99999999


Q ss_pred             CCceEEcCCCCeEEeecccccccCCCCccccceeccccccccccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 023568           76 PSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC---TEYTAAIDIWSVGCILGEIMTREPLFPGKD  152 (280)
Q Consensus        76 ~~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~DvwslG~~l~~ll~g~~pf~~~~  152 (280)
                      |+||+++.++.++|+|||.+.............++..|+|||.+.+.   ..++.++|+||+||++|+|++|+.||....
T Consensus       132 p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~  211 (283)
T cd06617         132 PSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWK  211 (283)
T ss_pred             HHHEEECCCCCEEEeecccccccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccc
Confidence            99999999999999999998765443333345678889999988642   346789999999999999999999996532


Q ss_pred             -hHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 023568          153 -YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHP  231 (280)
Q Consensus       153 -~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp  231 (280)
                       ....+..+..   .....                          .....++.++.+++++||..+|.+|||++++++||
T Consensus       212 ~~~~~~~~~~~---~~~~~--------------------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~  262 (283)
T cd06617         212 TPFQQLKQVVE---EPSPQ--------------------------LPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHP  262 (283)
T ss_pred             cCHHHHHHHHh---cCCCC--------------------------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence             2222222111   00000                          00113688999999999999999999999999999


Q ss_pred             ccccCc
Q 023568          232 YLQSLH  237 (280)
Q Consensus       232 ~~~~~~  237 (280)
                      ||....
T Consensus       263 ~~~~~~  268 (283)
T cd06617         263 FFELHL  268 (283)
T ss_pred             hhhhcc
Confidence            998753

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.3e-37  Score=256.96  Aligned_cols=200  Identities=27%  Similarity=0.509  Sum_probs=162.9

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++.+...   ..+|+||||++ ++|.+++.+.+.+++..+..++.|++.||+|||+.|++|+||+|+||
T Consensus        61 l~h~~i~~~~~~~~~~~~---~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~ni  137 (265)
T cd06652          61 LLHERIVQYYGCLRDPME---RTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANI  137 (265)
T ss_pred             cCCCCeeeEEeEeccCCC---ceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHE
Confidence            579999999999876522   46899999997 59999998878899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC----CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023568           80 LLNASCDLKIGDFGLARTTSET----DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH  155 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~  155 (280)
                      +++.++.++|+|||.+......    .......++..|+|||.+.+ ...+.++|+|||||++|+|++|+.||.......
T Consensus       138 l~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~  216 (265)
T cd06652         138 LRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA  216 (265)
T ss_pred             EecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcC-CCCCcchhHHHHHHHHHHHhhCCCCCCccchHH
Confidence            9999999999999998754321    11233467889999999877 678899999999999999999999998765443


Q ss_pred             HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 023568          156 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ  234 (280)
Q Consensus       156 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~  234 (280)
                      ....+.   ..+.                          .+..++..+..+.++|++|+. +|++||++++++.|||+.
T Consensus       217 ~~~~~~---~~~~--------------------------~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         217 AIFKIA---TQPT--------------------------NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             HHHHHh---cCCC--------------------------CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence            332221   1110                          111223567889999999995 999999999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=256.42  Aligned_cols=199  Identities=29%  Similarity=0.459  Sum_probs=177.3

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      +||.+..|.-.|+..     +.+++||||.. |.|.-.+...+.|++..++.+...|+.||.|||+++|++||||.+|.|
T Consensus       226 ~HPFLt~LKYsFQt~-----drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLl  300 (516)
T KOG0690|consen  226 RHPFLTSLKYSFQTQ-----DRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLL  300 (516)
T ss_pred             cCcHHHHhhhhhccC-----ceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhhe
Confidence            699999999999988     78999999997 599988887889999999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccc-cCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           81 LNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~-~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +|.+|.+|++|||+++. +.......+++||+.|+|||++.. ..|+.++|.|.+|+++|||++|+.||.+.+.......
T Consensus       301 LDkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeL  379 (516)
T KOG0690|consen  301 LDKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFEL  379 (516)
T ss_pred             eccCCceEeeecccchhcccccceeccccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCcccccchhHHHHH
Confidence            99999999999999985 455566789999999999999977 8999999999999999999999999999987776665


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCcccc
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQ  234 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rp-----t~~ell~hp~~~  234 (280)
                      |...                            .   -..+..++++++.|+..+|.+||.+|.     .+.|+.+|+||.
T Consensus       380 Il~e----------------------------d---~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~  428 (516)
T KOG0690|consen  380 ILME----------------------------D---LKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFA  428 (516)
T ss_pred             HHhh----------------------------h---ccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhc
Confidence            5431                            0   011235899999999999999999997     789999999998


Q ss_pred             cCc
Q 023568          235 SLH  237 (280)
Q Consensus       235 ~~~  237 (280)
                      ++.
T Consensus       429 ~v~  431 (516)
T KOG0690|consen  429 SVD  431 (516)
T ss_pred             cCC
Confidence            764

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.5e-37  Score=258.01  Aligned_cols=203  Identities=26%  Similarity=0.423  Sum_probs=165.6

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSD---QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP   76 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~---~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~   76 (280)
                      ++||||+++++.+...     ...|+|||++.| +|.+++...   ..+++..+..++.|++.||++||+.|++|+||+|
T Consensus        56 l~~~~i~~~~~~~~~~-----~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p  130 (267)
T cd06610          56 CNHPNVVKYYTSFVVG-----DELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKA  130 (267)
T ss_pred             cCCCCEEEEEEEEeeC-----CEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence            5799999999999887     779999999974 999998753   4699999999999999999999999999999999


Q ss_pred             CceEEcCCCCeEEeecccccccCCCC-----ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 023568           77 SNLLLNASCDLKIGDFGLARTTSETD-----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK  151 (280)
Q Consensus        77 ~Nili~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~  151 (280)
                      +||+++.++.++|+|||.+.......     ......++..|+|||.+......+.++|+||+|+++++|++|+.||...
T Consensus       131 ~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~  210 (267)
T cd06610         131 GNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKY  210 (267)
T ss_pred             HhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCcccc
Confidence            99999999999999999987644332     1233467889999999877447889999999999999999999999877


Q ss_pred             ChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 023568          152 DYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHP  231 (280)
Q Consensus       152 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp  231 (280)
                      +...........   .+...                      .....+...++.+.+++++||+.||.+|||+++++.||
T Consensus       211 ~~~~~~~~~~~~---~~~~~----------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p  265 (267)
T cd06610         211 PPMKVLMLTLQN---DPPSL----------------------ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHK  265 (267)
T ss_pred             ChhhhHHHHhcC---CCCCc----------------------CCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCC
Confidence            654433332221   10000                      00011235688999999999999999999999999999


Q ss_pred             cc
Q 023568          232 YL  233 (280)
Q Consensus       232 ~~  233 (280)
                      ||
T Consensus       266 ~~  267 (267)
T cd06610         266 FF  267 (267)
T ss_pred             CC
Confidence            97

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=4.3e-37  Score=254.00  Aligned_cols=197  Identities=29%  Similarity=0.541  Sum_probs=166.2

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      ++|+||+++++++.+.     ..+++||||+. ++|.+++.+.  ..+++.++..++.|++.||.|||+.|++|+||+|+
T Consensus        56 ~~h~~i~~~~~~~~~~-----~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~  130 (256)
T cd08221          56 LQHPNIIAYYNHFMDD-----NTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTL  130 (256)
T ss_pred             CCCCCeeEEEeEEecC-----CeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChH
Confidence            5799999999999987     67999999997 5999999764  46899999999999999999999999999999999


Q ss_pred             ceEEcCCCCeEEeecccccccCCCC-ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023568           78 NLLLNASCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  156 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~  156 (280)
                      ||+++.++.++|+|||.+....... ......++..|+|||.+.+ ...+.++|+||+|+++++|++|..||........
T Consensus       131 ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~  209 (256)
T cd08221         131 NIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQG-VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL  209 (256)
T ss_pred             hEEEeCCCCEEECcCcceEEcccccccccccCCCccccCHhhcCC-CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence            9999999999999999987654432 2344567899999999877 5578899999999999999999999988765554


Q ss_pred             HHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       157 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      ...+..  +.                            .....+..+..+.+++.+||+.+|.+|||++++++|||+
T Consensus       210 ~~~~~~--~~----------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         210 VVKIVQ--GN----------------------------YTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             HHHHHc--CC----------------------------CCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence            444322  10                            011113568899999999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-39  Score=299.40  Aligned_cols=203  Identities=28%  Similarity=0.410  Sum_probs=172.5

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+|||+|+++++=.+.     +.+||.||||+ |+|.+++..++..++...+.+..|++.|++|||+.||+||||||.||
T Consensus      1291 lnHpNlV~YyGVEvHR-----ekv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI 1365 (1509)
T KOG4645|consen 1291 LNHPNLVRYYGVEVHR-----EKVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANI 1365 (1509)
T ss_pred             ccCccccccCceeecH-----HHHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccce
Confidence            6899999999998877     66999999997 69999998878889999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCC-----ccccceeccccccccccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 023568           80 LLNASCDLKIGDFGLARTTSETD-----FMTEYVVTRWYRAPELLLNC--TEYTAAIDIWSVGCILGEIMTREPLFPGKD  152 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwslG~~l~~ll~g~~pf~~~~  152 (280)
                      +++.+|.+|++|||.|....+..     ......||+.|||||++.+.  .+...++|||||||++.||+||+.||...+
T Consensus      1366 ~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d 1445 (1509)
T KOG4645|consen 1366 LLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD 1445 (1509)
T ss_pred             eeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc
Confidence            99999999999999998765542     23457899999999999774  345679999999999999999999999887


Q ss_pred             hHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 023568          153 YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY  232 (280)
Q Consensus       153 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~  232 (280)
                      ...++.-.....-.                             +..+..++++.++||..||+.||++|.++.|+|+|-|
T Consensus      1446 ne~aIMy~V~~gh~-----------------------------Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f 1496 (1509)
T KOG4645|consen 1446 NEWAIMYHVAAGHK-----------------------------PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAF 1496 (1509)
T ss_pred             chhHHHhHHhccCC-----------------------------CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhc
Confidence            66554433332222                             2223358999999999999999999999999999998


Q ss_pred             cccCc
Q 023568          233 LQSLH  237 (280)
Q Consensus       233 ~~~~~  237 (280)
                      -+.-.
T Consensus      1497 ~~~~~ 1501 (1509)
T KOG4645|consen 1497 GKSCT 1501 (1509)
T ss_pred             ccccc
Confidence            65543

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2.4e-37  Score=259.97  Aligned_cols=206  Identities=23%  Similarity=0.391  Sum_probs=162.4

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHH-----cCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCC
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIR-----SDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLK   75 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~-----~~~~l~~~~~~~i~~qil~~l~~LH~~-~i~H~dik   75 (280)
                      +||||+++++++..+     ...+++|||+++++.++..     ....+++..+..++.|++.||+|||+. |++|||||
T Consensus        61 ~~~~iv~~~~~~~~~-----~~~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlk  135 (288)
T cd06616          61 DCPYIVKFYGALFRE-----GDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVK  135 (288)
T ss_pred             CCCCEeeeeeEEecC-----CcEEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCC
Confidence            499999999999876     6799999999877665432     236799999999999999999999975 99999999


Q ss_pred             CCceEEcCCCCeEEeecccccccCCCCccccceeccccccccccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 023568           76 PSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC--TEYTAAIDIWSVGCILGEIMTREPLFPGKDY  153 (280)
Q Consensus        76 ~~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~  153 (280)
                      |+||+++.++.++|+|||+++............++..|+|||.+.+.  ..++.++|+||+||++|+|++|..||.....
T Consensus       136 p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~  215 (288)
T cd06616         136 PSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS  215 (288)
T ss_pred             HHHEEEccCCcEEEeecchhHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch
Confidence            99999999999999999998765444333445678899999998764  3688899999999999999999999976541


Q ss_pred             HHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          154 VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       154 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                        ....+.+......+..                       .......++..+.+|+++||+.||++|||++++++||||
T Consensus       216 --~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~  270 (288)
T cd06616         216 --VFDQLTQVVKGDPPIL-----------------------SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFI  270 (288)
T ss_pred             --HHHHHhhhcCCCCCcC-----------------------CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence              2222222111110000                       001112468899999999999999999999999999999


Q ss_pred             ccCc
Q 023568          234 QSLH  237 (280)
Q Consensus       234 ~~~~  237 (280)
                      +...
T Consensus       271 ~~~~  274 (288)
T cd06616         271 KDYE  274 (288)
T ss_pred             hchh
Confidence            7753

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.5e-37  Score=255.33  Aligned_cols=197  Identities=27%  Similarity=0.504  Sum_probs=164.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      ++||||+++++++...     ++.|+||||+. ++|.+.+...  ..+++.++..++.|++.||.|||++|++|+||+|+
T Consensus        56 l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~  130 (256)
T cd08218          56 MKHPNIVQYQESFEEN-----GNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQ  130 (256)
T ss_pred             CCCCCeeeeEeeecCC-----CeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHH
Confidence            5799999999999877     78999999997 5999988653  35899999999999999999999999999999999


Q ss_pred             ceEEcCCCCeEEeecccccccCCCC-ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023568           78 NLLLNASCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  156 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~  156 (280)
                      ||+++.++.++|+|||.+....... ......++..|+|||.+.+ ...+.++|+||+||++++|++|..||...+....
T Consensus       131 nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~  209 (256)
T cd08218         131 NIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICEN-RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL  209 (256)
T ss_pred             HEEEcCCCCEEEeeccceeecCcchhhhhhccCCccccCHHHhCC-CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH
Confidence            9999999999999999987654432 1233457888999999876 6678899999999999999999999987765544


Q ss_pred             HHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       157 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      ...+..  +                            ..+......+.++.+++.+||+.+|.+||++.++++||||
T Consensus       210 ~~~~~~--~----------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         210 VLKIIR--G----------------------------SYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             HHHHhc--C----------------------------CCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence            433321  1                            0111223568899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=3.6e-37  Score=254.28  Aligned_cols=197  Identities=30%  Similarity=0.445  Sum_probs=164.1

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      ++||||+++++.+...     ...++||||++| +|.+++.+.  ..+++..+..++.|++.||+|||++|++|+||+|+
T Consensus        56 ~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~  130 (256)
T cd08220          56 LSHPNIIEYYENFLED-----KALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQ  130 (256)
T ss_pred             CCCCchhheeeeEecC-----CEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence            5799999999999876     679999999975 999999763  35899999999999999999999999999999999


Q ss_pred             ceEEcCC-CCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023568           78 NLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  156 (280)
Q Consensus        78 Nili~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~  156 (280)
                      ||+++.+ +.++|+|||.+.............++..|+|||.+.+ ...+.++|+||+|+++++|++|..||.+.+....
T Consensus       131 nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~  209 (256)
T cd08220         131 NILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFEAANLPAL  209 (256)
T ss_pred             HEEEcCCCCEEEEccCCCceecCCCccccccccCCcccCchhccC-CCCCcccchHHHHHHHHHHHhCCCCcccCchHHH
Confidence            9999865 4589999999987665443444567889999999876 6678899999999999999999999988765444


Q ss_pred             HHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       157 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      ...+....                              ........+..+.+++.+||+.||.+|||++|+++||||
T Consensus       210 ~~~~~~~~------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         210 VLKIMSGT------------------------------FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             HHHHHhcC------------------------------CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence            33332210                              011122468899999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3.2e-37  Score=255.65  Aligned_cols=204  Identities=29%  Similarity=0.465  Sum_probs=168.5

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~-~~i~H~dik~~N   78 (280)
                      ++||||+++++++...     ...|+||||++ ++|.+++.....+++..+..++.|++.|++|||+ .|++|+||+|+|
T Consensus        56 l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~n  130 (264)
T cd06623          56 CESPYVVKCYGAFYKE-----GEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSN  130 (264)
T ss_pred             cCCCCeeeEEEEEccC-----CeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHH
Confidence            5799999999999887     77999999998 5999999887889999999999999999999999 999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCcc-ccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDFM-TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  157 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~  157 (280)
                      |+++.++.++|+|||.+......... ....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.........
T Consensus       131 i~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~  209 (264)
T cd06623         131 LLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQG-ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFF  209 (264)
T ss_pred             EEECCCCCEEEccCccceecccCCCcccceeecccccCHhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHH
Confidence            99999999999999998865543322 24567889999999877 67888999999999999999999999877421111


Q ss_pred             HHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCC-CCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 023568          158 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  236 (280)
Q Consensus       158 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~  236 (280)
                      +.+........                           +..... .+..+.++|++||..+|++|||+.++++||||+..
T Consensus       210 ~~~~~~~~~~~---------------------------~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~  262 (264)
T cd06623         210 ELMQAICDGPP---------------------------PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA  262 (264)
T ss_pred             HHHHHHhcCCC---------------------------CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence            11111111110                           111123 68899999999999999999999999999999765


Q ss_pred             c
Q 023568          237 H  237 (280)
Q Consensus       237 ~  237 (280)
                      .
T Consensus       263 ~  263 (264)
T cd06623         263 D  263 (264)
T ss_pred             c
Confidence            3

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=4.4e-37  Score=254.70  Aligned_cols=199  Identities=34%  Similarity=0.561  Sum_probs=165.3

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHH-----hCCcc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVH-----SASVL   70 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH-----~~~i~   70 (280)
                      ++||||+++++++.....   ...|++|||++ ++|.+++..    ...+++..+..++.|++.||+|||     +.+++
T Consensus        56 l~~~~i~~~~~~~~~~~~---~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~  132 (265)
T cd08217          56 LKHPNIVRYYDRIIDRSN---QTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVL  132 (265)
T ss_pred             cCCCccceeeeeeecCCC---CEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcce
Confidence            579999999998865432   56899999997 599999865    367999999999999999999999     89999


Q ss_pred             ccCCCCCceEEcCCCCeEEeecccccccCCCCc-cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 023568           71 HRDLKPSNLLLNASCDLKIGDFGLARTTSETDF-MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFP  149 (280)
Q Consensus        71 H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~  149 (280)
                      |+||+|+||+++.++.++|+|||++........ .....++..|+|||.+.+ ..++.++|+||||+++++|++|..||.
T Consensus       133 h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~  211 (265)
T cd08217         133 HRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFT  211 (265)
T ss_pred             ecCCCHHHEEEecCCCEEEecccccccccCCcccccccccCCCccChhhhcC-CCCCchhHHHHHHHHHHHHHHCCCccc
Confidence            999999999999999999999999887655432 344578899999999877 668889999999999999999999998


Q ss_pred             CCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          150 GKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       150 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      ..+.......+...                              ..+......+..+.+++++||+.+|.+|||++++++
T Consensus       212 ~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         212 ARNQLQLASKIKEG------------------------------KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             CcCHHHHHHHHhcC------------------------------CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence            87644333332210                              111222356889999999999999999999999999


Q ss_pred             Cccc
Q 023568          230 HPYL  233 (280)
Q Consensus       230 hp~~  233 (280)
                      |||+
T Consensus       262 ~~~~  265 (265)
T cd08217         262 LPLI  265 (265)
T ss_pred             CCCC
Confidence            9995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.1e-37  Score=255.82  Aligned_cols=202  Identities=26%  Similarity=0.498  Sum_probs=164.1

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++...     ..+++||||+. ++|.+++.+.+.+++..++.++.|++.||.|||++|++||||+|+||
T Consensus        65 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~ni  139 (272)
T cd06629          65 LDHLNIVQYLGFETTE-----EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNL  139 (272)
T ss_pred             cCCCCcceEEEEeccC-----CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhE
Confidence            5799999999999877     67999999997 59999998878899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC---CccccceeccccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023568           80 LLNASCDLKIGDFGLARTTSET---DFMTEYVVTRWYRAPELLLNCT-EYTAAIDIWSVGCILGEIMTREPLFPGKDYVH  155 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~  155 (280)
                      +++.++.++|+|||.+......   .......++..|+|||.+.+.. .++.++|+||+|++++++++|..||...+...
T Consensus       140 l~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~  219 (272)
T cd06629         140 LVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA  219 (272)
T ss_pred             EEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH
Confidence            9999999999999998754332   1123345788999999987633 47889999999999999999999997655433


Q ss_pred             HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccc-cccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          156 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQF-ATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       156 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      ....+...   .                       ..... ....+.++..+.+++.+||..||.+|||++++|+||||
T Consensus       220 ~~~~~~~~---~-----------------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         220 AMFKLGNK---R-----------------------SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             HHHHhhcc---c-----------------------cCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            22221110   0                       00000 11223568899999999999999999999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=3.3e-37  Score=258.35  Aligned_cols=203  Identities=25%  Similarity=0.437  Sum_probs=160.9

Q ss_pred             CCcccccccccccCCCC-CCCCcEEEEEecCCc-cHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            2 EHENVIAIKDIIRPPKK-DTFNDVYIVYELMDT-DLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~-~~~~~~~lv~e~~~g-~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      +||||+++++++..... ......|+||||+++ +|.+++...  ..+++..+..++.|++.||+|||+.|++|+||+|+
T Consensus        71 ~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~  150 (282)
T cd06636          71 HHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQ  150 (282)
T ss_pred             CCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHH
Confidence            69999999999865321 122679999999985 999988653  45899999999999999999999999999999999


Q ss_pred             ceEEcCCCCeEEeecccccccCCC-Cccccceecccccccccccc----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 023568           78 NLLLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTREPLFPGKD  152 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~  152 (280)
                      ||+++.++.++|+|||.+...... .......++..|+|||.+..    ...++.++|+|||||++|+|++|..||....
T Consensus       151 nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~  230 (282)
T cd06636         151 NVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMH  230 (282)
T ss_pred             HEEECCCCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccC
Confidence            999999999999999998754322 22334568889999998753    2457788999999999999999999997655


Q ss_pred             hHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 023568          153 YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY  232 (280)
Q Consensus       153 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~  232 (280)
                      .......+..   ...                          ........+..+.++|++||+.||.+|||+.|+++|||
T Consensus       231 ~~~~~~~~~~---~~~--------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~  281 (282)
T cd06636         231 PMRALFLIPR---NPP--------------------------PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPF  281 (282)
T ss_pred             HHhhhhhHhh---CCC--------------------------CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCC
Confidence            3332221111   000                          00111246889999999999999999999999999999


Q ss_pred             c
Q 023568          233 L  233 (280)
Q Consensus       233 ~  233 (280)
                      |
T Consensus       282 ~  282 (282)
T cd06636         282 I  282 (282)
T ss_pred             C
Confidence            7

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-37  Score=256.84  Aligned_cols=204  Identities=25%  Similarity=0.456  Sum_probs=162.2

Q ss_pred             CCcccccccccccCCCC-CCCCcEEEEEecCCc-cHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 023568            2 EHENVIAIKDIIRPPKK-DTFNDVYIVYELMDT-DLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK   75 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~-~~~~~~~lv~e~~~g-~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik   75 (280)
                      +||||+++++++..... .....+|+||||+++ +|.+++..    ...+++..+..++.|++.||.|||+.|++|+||+
T Consensus        61 ~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~  140 (275)
T cd06608          61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIK  140 (275)
T ss_pred             CCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCC
Confidence            69999999999987532 222568999999985 89888864    3579999999999999999999999999999999


Q ss_pred             CCceEEcCCCCeEEeecccccccCCC-Cccccceecccccccccccc----CCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 023568           76 PSNLLLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTREPLFPG  150 (280)
Q Consensus        76 ~~Nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslG~~l~~ll~g~~pf~~  150 (280)
                      |+||+++.++.++|+|||.+...... .......++..|+|||.+..    ...++.++|+||+|+++++|++|..||..
T Consensus       141 p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~  220 (275)
T cd06608         141 GQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD  220 (275)
T ss_pred             HHHEEEccCCeEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccc
Confidence            99999999999999999998764432 22334567889999998753    23467789999999999999999999987


Q ss_pred             CChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 023568          151 KDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  230 (280)
Q Consensus       151 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~h  230 (280)
                      .........+..   .+.+..                         ......+..+.+++++||..||.+|||++++++|
T Consensus       221 ~~~~~~~~~~~~---~~~~~~-------------------------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         221 MHPMRALFKIPR---NPPPTL-------------------------KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             cchHHHHHHhhc---cCCCCC-------------------------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            654443333221   111000                         0011357889999999999999999999999999


Q ss_pred             ccc
Q 023568          231 PYL  233 (280)
Q Consensus       231 p~~  233 (280)
                      ||+
T Consensus       273 ~~~  275 (275)
T cd06608         273 PFI  275 (275)
T ss_pred             CCC
Confidence            996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2e-37  Score=259.09  Aligned_cols=200  Identities=26%  Similarity=0.416  Sum_probs=164.1

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++...     ...|+||||+++ +|.+++.. +.+++..+..++.|++.|+.|||+.|++|+||+|+||
T Consensus        59 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni  132 (277)
T cd06642          59 CDSPYITRYYGSYLKG-----TKLWIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANV  132 (277)
T ss_pred             CCCCccHhhhcccccC-----CceEEEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheE
Confidence            5799999999999877     679999999985 89888864 6799999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCc-cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDF-MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||++........ .....++..|+|||.+.+ ..++.++|+||+||++++|++|..||..........
T Consensus       133 ~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~  211 (277)
T cd06642         133 LLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ-SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF  211 (277)
T ss_pred             EEeCCCCEEEccccccccccCcchhhhcccCcccccCHHHhCc-CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh
Confidence            999999999999999876543321 223457888999999876 678889999999999999999999987654332221


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  237 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~  237 (280)
                      .+..                              ...+......+..+.+++.+||+.+|.+|||+.++++||||..+.
T Consensus       212 ~~~~------------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06642         212 LIPK------------------------------NSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYT  260 (277)
T ss_pred             hhhc------------------------------CCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHh
Confidence            1100                              000111224678899999999999999999999999999997654

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.9e-37  Score=259.53  Aligned_cols=201  Identities=23%  Similarity=0.367  Sum_probs=159.6

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++.+...     +..++||||+++ +|..+    ..+++..+..++.|++.||.|||+.|++|+||||+||
T Consensus        56 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni  126 (279)
T cd06619          56 CDSPYIIGFYGAFFVE-----NRISICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNM  126 (279)
T ss_pred             CCCCCeeeEEEEEEEC-----CEEEEEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHE
Confidence            5799999999999987     679999999986 66433    4588999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH--
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL--  157 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~--  157 (280)
                      +++.++.++|+|||++....... .....++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||.........  
T Consensus       127 ll~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~  204 (279)
T cd06619         127 LVNTRGQVKLCDFGVSTQLVNSI-AKTYVGTNAYMAPERISG-EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLM  204 (279)
T ss_pred             EECCCCCEEEeeCCcceeccccc-ccCCCCChhhcCceeecC-CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccc
Confidence            99999999999999987654332 334578899999999877 67889999999999999999999999763311100  


Q ss_pred             -HHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 023568          158 -RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  236 (280)
Q Consensus       158 -~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~  236 (280)
                       ..........                       .  .........++++.+++.+||+.||.+||++++++.||||...
T Consensus       205 ~~~~~~~~~~~-----------------------~--~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~  259 (279)
T cd06619         205 PLQLLQCIVDE-----------------------D--PPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY  259 (279)
T ss_pred             hHHHHHHHhcc-----------------------C--CCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence             0000000000                       0  0001112467899999999999999999999999999999776


Q ss_pred             c
Q 023568          237 H  237 (280)
Q Consensus       237 ~  237 (280)
                      .
T Consensus       260 ~  260 (279)
T cd06619         260 N  260 (279)
T ss_pred             c
Confidence            3

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=2.3e-37  Score=253.06  Aligned_cols=189  Identities=23%  Similarity=0.363  Sum_probs=156.8

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      .||||+++++++...     ...|+||||++ |+|.+++.+...+++..+..++.|++.||.|||+.|++||||||+||+
T Consensus        43 ~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil  117 (237)
T cd05576          43 CVPNMVCLHKYIVSE-----DSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNIL  117 (237)
T ss_pred             CCCceeehhhheecC-----CeEEEEEecCCCCCHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEE
Confidence            589999999999887     77999999998 599999987778999999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 023568           81 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  160 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~i  160 (280)
                      ++.++.++++|||.+......  .....++..|+|||.+.+ ..++.++|+||+|+++|+|++|..|+........    
T Consensus       118 ~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~----  190 (237)
T cd05576         118 LDDRGHIQLTYFSRWSEVEDS--CDGEAVENMYCAPEVGGI-SEETEACDWWSLGAILFELLTGKTLVECHPSGIN----  190 (237)
T ss_pred             EcCCCCEEEecccchhccccc--cccCCcCccccCCcccCC-CCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc----
Confidence            999999999999987654432  223445677999998865 6678899999999999999999987753211000    


Q ss_pred             HHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCH-----HHHhcCccc
Q 023568          161 TELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV-----EEALRHPYL  233 (280)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~-----~ell~hp~~  233 (280)
                                                     ........+..++.+.++|.+||+.||++||++     +++++||||
T Consensus       191 -------------------------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         191 -------------------------------THTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             -------------------------------cccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence                                           000001223468899999999999999999985     999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=6.2e-37  Score=254.81  Aligned_cols=200  Identities=27%  Similarity=0.441  Sum_probs=159.3

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCC--CHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-QQL--TDDHCQYFLYQLLRGLKYVHSASVLHRDLKP   76 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~l--~~~~~~~i~~qil~~l~~LH~~~i~H~dik~   76 (280)
                      ++||||+++++++...     +..++||||+. ++|.+++... ..+  ++..+..++.|++.||+|||+.||+||||+|
T Consensus        62 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p  136 (268)
T cd06624          62 LKHRNIVQYLGSDSEN-----GFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKG  136 (268)
T ss_pred             cCCCCeeeeeeeeccC-----CEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCH
Confidence            5899999999999887     77999999997 5999999764 455  8899999999999999999999999999999


Q ss_pred             CceEEcC-CCCeEEeecccccccCCC-CccccceeccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 023568           77 SNLLLNA-SCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLFPGKDY  153 (280)
Q Consensus        77 ~Nili~~-~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~  153 (280)
                      +||+++. ++.++|+|||.+...... .......++..|+|||.+.+. ..++.++|+||+|+++|+|++|..||.....
T Consensus       137 ~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~  216 (268)
T cd06624         137 DNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE  216 (268)
T ss_pred             HHEEEcCCCCeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccC
Confidence            9999976 678999999998764332 222334578899999998552 3478899999999999999999999976432


Q ss_pred             HHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          154 VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       154 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      ..........                            ....+......++.+.+++++||+.+|.+|||+.|++.||||
T Consensus       217 ~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         217 PQAAMFKVGM----------------------------FKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             hhhhHhhhhh----------------------------hccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence            2111100000                            001112233568899999999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=5.8e-37  Score=260.05  Aligned_cols=199  Identities=26%  Similarity=0.393  Sum_probs=164.3

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++.+.     ...|+||||+.|++.+++.. .+.+++..+..++.|++.||.|||+.|++|+||+|+||
T Consensus        72 l~h~niv~~~~~~~~~-----~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nI  146 (307)
T cd06607          72 LRHPNTIEYKGCYLRE-----HTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNI  146 (307)
T ss_pred             CCCCCEEEEEEEEEeC-----CeEEEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccE
Confidence            5799999999999887     67999999999999888754 45799999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceecccccccccccc--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  157 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~  157 (280)
                      +++.++.++|+|||++......   ....++..|+|||.+.+  ...++.++|+||+|+++|+|++|..||.+.+.....
T Consensus       147 l~~~~~~~kL~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~  223 (307)
T cd06607         147 LLTEPGTVKLADFGSASLVSPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL  223 (307)
T ss_pred             EECCCCCEEEeecCcceecCCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHH
Confidence            9999999999999998765433   24567888999998742  356788999999999999999999999887655443


Q ss_pred             HHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 023568          158 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  236 (280)
Q Consensus       158 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~  236 (280)
                      ..+...   ....                          ......+..+.+++++||+.||.+||++.+++.||||..-
T Consensus       224 ~~~~~~---~~~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  273 (307)
T cd06607         224 YHIAQN---DSPT--------------------------LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE  273 (307)
T ss_pred             HHHhcC---CCCC--------------------------CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence            332210   0000                          0011357789999999999999999999999999999763

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-38  Score=272.86  Aligned_cols=197  Identities=26%  Similarity=0.387  Sum_probs=172.4

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+|||+|.|.++|--+     ...|||||||-|+-.|++.- .+++.+-++..|..+.+.||+|||+.+.+|||||+.||
T Consensus        83 l~HPntieYkgCyLre-----~TaWLVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNI  157 (948)
T KOG0577|consen   83 LRHPNTIEYKGCYLRE-----HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNI  157 (948)
T ss_pred             ccCCCcccccceeecc-----chHHHHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccce
Confidence            6899999999999987     66899999998877777753 36899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceecccccccccccc--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  157 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~  157 (280)
                      |++..|.|||+|||.+....+   ..+++|||+|||||++.-  .+.|+-++||||||++..||.-.++|+.+.+.+..+
T Consensus       158 LLse~g~VKLaDFGSAsi~~P---AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSAL  234 (948)
T KOG0577|consen  158 LLSEPGLVKLADFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL  234 (948)
T ss_pred             EecCCCeeeeccccchhhcCc---hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHH
Confidence            999999999999999876554   468999999999999853  367888999999999999999999999999988888


Q ss_pred             HHHHHHhCCCCcccccccCChhHHHHHHhCCcccccccccc-CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 023568          158 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR-FPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  235 (280)
Q Consensus       158 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~  235 (280)
                      ..|..--                              .+.. -+.+|..++.|+..||++-|.+|||.+++|.|+|+..
T Consensus       235 YHIAQNe------------------------------sPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R  283 (948)
T KOG0577|consen  235 YHIAQNE------------------------------SPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLR  283 (948)
T ss_pred             HHHHhcC------------------------------CCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence            8775410                              0111 1357899999999999999999999999999999854

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=5.6e-37  Score=256.38  Aligned_cols=199  Identities=26%  Similarity=0.417  Sum_probs=165.0

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++.+.     ...|+||||++| +|.+++.. +++++.++..++.|++.||+|||+.+++|+||+|+||
T Consensus        59 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Ni  132 (277)
T cd06640          59 CDSPYVTKYYGSYLKG-----TKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANV  132 (277)
T ss_pred             CCCCCEeeEEEEEEEC-----CEEEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhE
Confidence            5799999999999987     779999999975 99998875 5799999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCC-ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++++|||++....... ......++..|+|||.+.+ ...+.++|+|||||++|+|++|..||..........
T Consensus       133 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~  211 (277)
T cd06640         133 LLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQ-SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF  211 (277)
T ss_pred             EEcCCCCEEEcccccceeccCCccccccccCcccccCHhHhcc-CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh
Confidence            99999999999999987654432 2233467888999999876 678899999999999999999999998765443332


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  236 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~  236 (280)
                      .+..                              ...+......+..+.+++++||+.+|.+||++++++.||||...
T Consensus       212 ~~~~------------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  259 (277)
T cd06640         212 LIPK------------------------------NNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKN  259 (277)
T ss_pred             hhhc------------------------------CCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhc
Confidence            2110                              00111222457889999999999999999999999999999654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-38  Score=248.05  Aligned_cols=202  Identities=23%  Similarity=0.361  Sum_probs=168.0

Q ss_pred             CcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceE
Q 023568            3 HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLL   80 (280)
Q Consensus         3 Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~-~~i~H~dik~~Nil   80 (280)
                      -|.||+.+|+|..+     ..+++.||.|+.=+..+++. .++++|..+-.+...++.||.||-+ .||+|||+||+|||
T Consensus       150 cpyIV~c~GyFi~n-----~dV~IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNIL  224 (391)
T KOG0983|consen  150 CPYIVQCFGYFITN-----TDVFICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNIL  224 (391)
T ss_pred             CCeeeeeeeEEeeC-----chHHHHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceE
Confidence            48999999999988     56999999998544444432 4679999999999999999999996 58999999999999


Q ss_pred             EcCCCCeEEeecccccccCCCCccccceecccccccccccc--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh-HHHH
Q 023568           81 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILGEIMTREPLFPGKDY-VHQL  157 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~-~~~~  157 (280)
                      +|..|.+||||||.+....+....+...|.+.|||||.+..  ...|..++||||||+.++||.||+.||.+-+. .+.+
T Consensus       225 lDe~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~l  304 (391)
T KOG0983|consen  225 LDERGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVL  304 (391)
T ss_pred             EccCCCEEeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHH
Confidence            99999999999999998887777788899999999999854  36788899999999999999999999998543 3444


Q ss_pred             HHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCc
Q 023568          158 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  237 (280)
Q Consensus       158 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~  237 (280)
                      .++..   ..++..                         ..-.+.|+++++|+..||.+|+.+||...++|+|||+....
T Consensus       305 tkvln---~ePP~L-------------------------~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye  356 (391)
T KOG0983|consen  305 TKVLN---EEPPLL-------------------------PGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE  356 (391)
T ss_pred             HHHHh---cCCCCC-------------------------CcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence            44433   111111                         00114799999999999999999999999999999997653

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-37  Score=256.74  Aligned_cols=198  Identities=24%  Similarity=0.435  Sum_probs=176.3

Q ss_pred             CcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE
Q 023568            3 HENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL   81 (280)
Q Consensus         3 Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nili   81 (280)
                      -|.+++++..|++.     +.+|+||||+. |+|.-.|++-+++-|..+..++..|+.||-+||++||++||||.+||++
T Consensus       409 ppFL~qlHScFQTm-----DRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmL  483 (683)
T KOG0696|consen  409 PPFLVQLHSCFQTM-----DRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML  483 (683)
T ss_pred             CchHHHHHHHhhhh-----hheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEe
Confidence            47889999999988     77999999997 5999999999999999999999999999999999999999999999999


Q ss_pred             cCCCCeEEeecccccc-cCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 023568           82 NASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  160 (280)
Q Consensus        82 ~~~~~~kl~dfg~~~~-~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~i  160 (280)
                      +.+|.+||+|||+++. .-......+++||+.|+|||++.- ..|+.++|.||+|+++|||+.|++||.+.+..+..+.|
T Consensus       484 d~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~Y-qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI  562 (683)
T KOG0696|consen  484 DSEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAI  562 (683)
T ss_pred             ccCCceEeeecccccccccCCcceeeecCCCcccccceEEe-cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence            9999999999999985 334455678999999999999876 89999999999999999999999999999988888888


Q ss_pred             HHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccccc
Q 023568          161 TELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQS  235 (280)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rp-----t~~ell~hp~~~~  235 (280)
                      ++-.-                               ..+..+|.++.++.+..|.+.|.+|.     .-.++-.||||+.
T Consensus       563 ~ehnv-------------------------------syPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~  611 (683)
T KOG0696|consen  563 MEHNV-------------------------------SYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRR  611 (683)
T ss_pred             HHccC-------------------------------cCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhh
Confidence            66211                               12336799999999999999999997     3458889999987


Q ss_pred             Cc
Q 023568          236 LH  237 (280)
Q Consensus       236 ~~  237 (280)
                      +-
T Consensus       612 iD  613 (683)
T KOG0696|consen  612 ID  613 (683)
T ss_pred             cc
Confidence            63

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1e-36  Score=256.73  Aligned_cols=204  Identities=25%  Similarity=0.493  Sum_probs=167.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++...     +..|+||||+++ +|.+++.. +.+++..+..++.|++.||+|||+.|++||||+|+||
T Consensus        74 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Ni  147 (292)
T cd06657          74 YQHENVVEMYNSYLVG-----DELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSI  147 (292)
T ss_pred             cCCcchhheeeEEEeC-----CEEEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence            5799999999999987     779999999985 88887654 5789999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCC-ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||.+....... ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+........
T Consensus       148 lv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~  226 (292)
T cd06657         148 LLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK  226 (292)
T ss_pred             EECCCCCEEEcccccceecccccccccccccCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            99999999999999887554321 1233567889999998865 677889999999999999999999998876554443


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCcC
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  238 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~~  238 (280)
                      .+.....                            .........++.+.+++.+||..||.+||++.+++.||||.....
T Consensus       227 ~~~~~~~----------------------------~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~  278 (292)
T cd06657         227 MIRDNLP----------------------------PKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP  278 (292)
T ss_pred             HHHhhCC----------------------------cccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence            3322110                            000112346888999999999999999999999999999988764


Q ss_pred             C
Q 023568          239 L  239 (280)
Q Consensus       239 ~  239 (280)
                      +
T Consensus       279 ~  279 (292)
T cd06657         279 P  279 (292)
T ss_pred             C
Confidence            3

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-37  Score=255.55  Aligned_cols=200  Identities=23%  Similarity=0.419  Sum_probs=163.9

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      .||||+++++++...     ...|+||||+.| +|.+++.. +.+++..+..++.|++.||.|||+.|++|+||+|+||+
T Consensus        60 ~~~~vi~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~  133 (277)
T cd06917          60 QPPNITKYYGSYLKG-----PRLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANIL  133 (277)
T ss_pred             CCCCeeeEeeeeeeC-----CEEEEEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEE
Confidence            499999999999876     679999999975 99998865 57999999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccccCCCC-ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           81 LNASCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      ++.++.++|+|||.+....... ......++..|+|||.+.+...++.++|+||+|+++|+|++|..||.+.........
T Consensus       134 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~  213 (277)
T cd06917         134 VTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML  213 (277)
T ss_pred             EcCCCCEEEccCCceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhc
Confidence            9999999999999987654432 223456788999999987645678899999999999999999999987653322211


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCC-CCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCc
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP-NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  237 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~  237 (280)
                      +..   .                           ..+.... ..+.++.+++++||..||++||++.+++.||||+...
T Consensus       214 ~~~---~---------------------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         214 IPK---S---------------------------KPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             ccc---C---------------------------CCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence            110   0                           0001111 2678899999999999999999999999999997643

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=2e-36  Score=257.45  Aligned_cols=199  Identities=26%  Similarity=0.417  Sum_probs=165.4

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++|||++++++++.+.     ...|+||||+.|++.+++.. ...+++.++..++.|++.||.|||+.|++|+||+|+||
T Consensus        78 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~ni  152 (313)
T cd06633          78 LKHPNTIEYKGCYLKE-----HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNI  152 (313)
T ss_pred             CCCCCCccEEEEEEeC-----CEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhE
Confidence            5799999999999987     67999999999999888864 45799999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceecccccccccccc--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  157 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~  157 (280)
                      +++.++.++|+|||++.....   .....++..|+|||.+.+  ...++.++|+||+||++|+|++|..||...+.....
T Consensus       153 li~~~~~~kL~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~  229 (313)
T cd06633         153 LLTEPGQVKLADFGSASKSSP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL  229 (313)
T ss_pred             EECCCCCEEEeecCCCcccCC---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence            999999999999998865432   234567889999999742  255778999999999999999999999887655554


Q ss_pred             HHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 023568          158 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  236 (280)
Q Consensus       158 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~  236 (280)
                      ..+.... .+                            ....+..+..+.+|+.+||+.+|.+||++++++.||||+..
T Consensus       230 ~~~~~~~-~~----------------------------~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~  279 (313)
T cd06633         230 YHIAQND-SP----------------------------TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRD  279 (313)
T ss_pred             HHHHhcC-CC----------------------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence            4432210 00                            00112457789999999999999999999999999999763

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=4.7e-37  Score=262.96  Aligned_cols=232  Identities=19%  Similarity=0.264  Sum_probs=164.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      ++||||++++++|...     ...++||||+. ++|.+++.+.  ..+++..+..++.|++.||+|||+.|++||||||+
T Consensus        56 l~h~niv~~~~~~~~~-----~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~  130 (328)
T cd08226          56 FRHPNIMTSWTVFTTG-----SWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKAS  130 (328)
T ss_pred             CCCCCcceEeeeEecC-----CceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence            5799999999999987     67999999998 5999998764  45899999999999999999999999999999999


Q ss_pred             ceEEcCCCCeEEeecccccccCCCC----c----cccceeccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCC
Q 023568           78 NLLLNASCDLKIGDFGLARTTSETD----F----MTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLF  148 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~~----~----~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~~l~~ll~g~~pf  148 (280)
                      ||+++.++.++++||+.+.......    .    .....++..|+|||.+.+. ..++.++|+||+||++|+|++|..||
T Consensus       131 Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~  210 (328)
T cd08226         131 HILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPF  210 (328)
T ss_pred             HEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            9999999999999998653221110    0    0112335679999998753 34688999999999999999999999


Q ss_pred             CCCChHHHHHHHHHHhCCCCcccccccCChhHHHH---------------HH-hCC-cccccc-ccccCCCCCHHHHHHH
Q 023568          149 PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRY---------------VR-QLP-RCRKQQ-FATRFPNKSSGAVDLL  210 (280)
Q Consensus       149 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~---------------~~-~~~-~~~~~~-~~~~~~~~~~~~~~ll  210 (280)
                      ..............  +.+................               .. ... ...... ........++.+.+|+
T Consensus       211 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  288 (328)
T cd08226         211 QDMLRTQMLLQKLK--GPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLV  288 (328)
T ss_pred             CCcChHHHHHHHhc--CCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHH
Confidence            88765443332222  1111110000000000000               00 000 000000 0111224678899999


Q ss_pred             HHhcccCCCCCCCHHHHhcCcccccCcCC
Q 023568          211 EKMLVFDPNKRITVEEALRHPYLQSLHDL  239 (280)
Q Consensus       211 ~~~L~~dp~~Rpt~~ell~hp~~~~~~~~  239 (280)
                      ++||+.||++|||++|+|+||||+.+...
T Consensus       289 ~~~l~~dP~~Rpta~e~l~~~~~~~~~~~  317 (328)
T cd08226         289 ELCLQQDPEKRPSASSLLSHAFFKQVKEQ  317 (328)
T ss_pred             HHHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence            99999999999999999999999887654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=9.4e-37  Score=253.60  Aligned_cols=193  Identities=20%  Similarity=0.293  Sum_probs=158.5

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||+++++++...     ...|+||||+++ +|.+++... ..+++..+..++.|++.||+|||+.|++||||||+|
T Consensus        63 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~n  137 (266)
T cd05064          63 FDHSNIVRLEGVITRG-----NTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHK  137 (266)
T ss_pred             CCCCCcCeEEEEEecC-----CCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhh
Confidence            5799999999999876     679999999985 899988763 579999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCcc--ccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVH  155 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~~  155 (280)
                      |+++.++.++++|||.+.........  ....++..|+|||.+.+ ..++.++|+||+||++|++++ |..||.+.+..+
T Consensus       138 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~  216 (266)
T cd05064         138 VLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD  216 (266)
T ss_pred             EEEcCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH
Confidence            99999999999999987654322211  12334578999999876 788899999999999999775 999998877655


Q ss_pred             HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          156 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       156 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      ....+.....                              .......+..+.+++.+||+.+|.+|||++++++
T Consensus       217 ~~~~~~~~~~------------------------------~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         217 VIKAVEDGFR------------------------------LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             HHHHHHCCCC------------------------------CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence            5544432110                              1112356888999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1e-36  Score=255.36  Aligned_cols=194  Identities=22%  Similarity=0.385  Sum_probs=160.6

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHH
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD----------------QQLTDDHCQYFLYQLLRGLKY   63 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~----------------~~l~~~~~~~i~~qil~~l~~   63 (280)
                      ++||||+++++++...     ...|++|||++ ++|.+++...                ..+++.++..++.|++.||+|
T Consensus        65 l~h~~i~~~~~~~~~~-----~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~  139 (283)
T cd05048          65 LQHPNIVCLLGVCTKE-----QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEY  139 (283)
T ss_pred             cCCcccceEEEEEcCC-----CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHH
Confidence            5799999999999877     66999999997 5999998754                458899999999999999999


Q ss_pred             HHhCCccccCCCCCceEEcCCCCeEEeecccccccCCCC---ccccceeccccccccccccCCCCCcchhHHHHHHHHHH
Q 023568           64 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE  140 (280)
Q Consensus        64 LH~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~  140 (280)
                      ||+.|++|+||||+||+++.++.++|+|||++.......   ......+++.|+|||.+.+ ..++.++|+|||||++|+
T Consensus       140 lH~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~slG~il~e  218 (283)
T cd05048         140 LSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY-GKFTTESDIWSFGVVLWE  218 (283)
T ss_pred             HHhCCeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhcc-CcCchhhhHHHHHHHHHH
Confidence            999999999999999999999999999999987543321   1233456788999999876 678899999999999999


Q ss_pred             HHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCC
Q 023568          141 IMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPN  219 (280)
Q Consensus       141 ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~  219 (280)
                      |++ |..||.+....+....+.+.                              .........++.+.+++.+||+.||.
T Consensus       219 l~~~g~~p~~~~~~~~~~~~i~~~------------------------------~~~~~~~~~~~~~~~l~~~c~~~~p~  268 (283)
T cd05048         219 IFSYGLQPYYGFSNQEVIEMIRSR------------------------------QLLPCPEDCPARVYALMIECWNEIPA  268 (283)
T ss_pred             HHcCCCCCCCCCCHHHHHHHHHcC------------------------------CcCCCcccCCHHHHHHHHHHccCChh
Confidence            998 99999887655544433221                              01112235789999999999999999


Q ss_pred             CCCCHHHHhcC
Q 023568          220 KRITVEEALRH  230 (280)
Q Consensus       220 ~Rpt~~ell~h  230 (280)
                      +||++.+++++
T Consensus       269 ~Rp~~~~i~~~  279 (283)
T cd05048         269 RRPRFKDIHTR  279 (283)
T ss_pred             hCcCHHHHHHH
Confidence            99999999873

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2.5e-36  Score=250.39  Aligned_cols=201  Identities=29%  Similarity=0.491  Sum_probs=162.3

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++.+...     +..++|+||+. ++|.+++.+.+.+++..+..++.|++.||.|||+.|++|+||+|+||
T Consensus        56 l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~ni  130 (264)
T cd06626          56 LKHPNLVKYYGVEVHR-----EKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANI  130 (264)
T ss_pred             CCCCChhheeeeEecC-----CEEEEEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence            5899999999998876     67999999998 59999998877899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCcc-----ccceeccccccccccccCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFM-----TEYVVTRWYRAPELLLNCT--EYTAAIDIWSVGCILGEIMTREPLFPGKD  152 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~--~~~~~~DvwslG~~l~~ll~g~~pf~~~~  152 (280)
                      +++.++.++|+|||.+.........     ....++..|+|||.+.+..  ..+.++|+||+|++++++++|..||...+
T Consensus       131 l~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~  210 (264)
T cd06626         131 FLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD  210 (264)
T ss_pred             EECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc
Confidence            9999999999999998765443221     1345678899999987632  37889999999999999999999997764


Q ss_pred             hHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 023568          153 YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY  232 (280)
Q Consensus       153 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~  232 (280)
                      ........... +..+                         .. ......++.+.+++++||+.||.+|||+++++.|||
T Consensus       211 ~~~~~~~~~~~-~~~~-------------------------~~-~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~  263 (264)
T cd06626         211 NEFQIMFHVGA-GHKP-------------------------PI-PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPF  263 (264)
T ss_pred             chHHHHHHHhc-CCCC-------------------------CC-CcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCC
Confidence            32222111110 0000                         00 011235888999999999999999999999999999


Q ss_pred             c
Q 023568          233 L  233 (280)
Q Consensus       233 ~  233 (280)
                      +
T Consensus       264 ~  264 (264)
T cd06626         264 V  264 (264)
T ss_pred             C
Confidence            6

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.6e-36  Score=254.61  Aligned_cols=204  Identities=25%  Similarity=0.397  Sum_probs=159.4

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP   76 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~----~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~   76 (280)
                      +||||+++++++...........|+||||++ ++|.+++.    ....+++..+..++.|++.||.|||+.+++||||+|
T Consensus        73 ~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp  152 (286)
T cd06638          73 DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKG  152 (286)
T ss_pred             cCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCH
Confidence            6999999999885432222267999999997 59988874    235689999999999999999999999999999999


Q ss_pred             CceEEcCCCCeEEeecccccccCCCC-ccccceecccccccccccc----CCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 023568           77 SNLLLNASCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTREPLFPGK  151 (280)
Q Consensus        77 ~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslG~~l~~ll~g~~pf~~~  151 (280)
                      +||+++.++.++|+|||++....... ......++..|+|||.+.+    ...++.++|+||+||++|+|++|+.||...
T Consensus       153 ~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~  232 (286)
T cd06638         153 NNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL  232 (286)
T ss_pred             HhEEECCCCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCC
Confidence            99999999999999999987654332 2234568889999998753    144678999999999999999999999876


Q ss_pred             ChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 023568          152 DYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHP  231 (280)
Q Consensus       152 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp  231 (280)
                      +.......+..   ....                         ........+..+.+++.+||+.||++|||+.|+++|+
T Consensus       233 ~~~~~~~~~~~---~~~~-------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         233 HPMRALFKIPR---NPPP-------------------------TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             chhHHHhhccc---cCCC-------------------------cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence            54333222111   0000                         0001123577899999999999999999999999999


Q ss_pred             cc
Q 023568          232 YL  233 (280)
Q Consensus       232 ~~  233 (280)
                      ||
T Consensus       285 ~~  286 (286)
T cd06638         285 FI  286 (286)
T ss_pred             cC
Confidence            97

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.9e-36  Score=254.53  Aligned_cols=193  Identities=25%  Similarity=0.409  Sum_probs=158.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCC-------------CCCHHHHHHHHHHHHHHHHHHHh
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ-------------QLTDDHCQYFLYQLLRGLKYVHS   66 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~-------------~l~~~~~~~i~~qil~~l~~LH~   66 (280)
                      ++||||+++++++...     ...++||||+. ++|.+++...+             .+++.++..++.|++.||+|||+
T Consensus        64 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~  138 (288)
T cd05093          64 LQHEHIVKFYGVCVEG-----DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS  138 (288)
T ss_pred             CCCCCcceEEEEEecC-----CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            5799999999999877     67999999997 59999987543             48999999999999999999999


Q ss_pred             CCccccCCCCCceEEcCCCCeEEeecccccccCCCC---ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh
Q 023568           67 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT  143 (280)
Q Consensus        67 ~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~  143 (280)
                      .|++||||||+||+++.++.++|+|||.++......   ......++..|+|||.+.+ ..++.++|+|||||++++|++
T Consensus       139 ~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t  217 (288)
T cd05093         139 QHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFT  217 (288)
T ss_pred             CCeeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHh
Confidence            999999999999999999999999999987643321   1223345678999999876 778889999999999999998


Q ss_pred             -CCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCC
Q 023568          144 -REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI  222 (280)
Q Consensus       144 -g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rp  222 (280)
                       |..||...........+....                              ........+..+.+++.+||+.||.+||
T Consensus       218 ~g~~p~~~~~~~~~~~~i~~~~------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rp  267 (288)
T cd05093         218 YGKQPWYQLSNNEVIECITQGR------------------------------VLQRPRTCPKEVYDLMLGCWQREPHMRL  267 (288)
T ss_pred             CCCCCCCCCCHHHHHHHHHcCC------------------------------cCCCCCCCCHHHHHHHHHHccCChhhCC
Confidence             999998876555444432210                              0011124678899999999999999999


Q ss_pred             CHHHHhc
Q 023568          223 TVEEALR  229 (280)
Q Consensus       223 t~~ell~  229 (280)
                      |+.++++
T Consensus       268 t~~~v~~  274 (288)
T cd05093         268 NIKEIHS  274 (288)
T ss_pred             CHHHHHH
Confidence            9999965

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.3e-36  Score=254.50  Aligned_cols=193  Identities=25%  Similarity=0.414  Sum_probs=158.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHH
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD----------------QQLTDDHCQYFLYQLLRGLKY   63 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~----------------~~l~~~~~~~i~~qil~~l~~   63 (280)
                      ++||||+++++++...     ...++||||++ ++|.+++..+                +.+++..+..++.|++.||+|
T Consensus        64 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~  138 (291)
T cd05094          64 LQHEHIVKFYGVCGDG-----DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVY  138 (291)
T ss_pred             CCCCCcceEEEEEccC-----CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            5799999999999877     67999999997 5999999653                238999999999999999999


Q ss_pred             HHhCCccccCCCCCceEEcCCCCeEEeecccccccCCCC---ccccceeccccccccccccCCCCCcchhHHHHHHHHHH
Q 023568           64 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE  140 (280)
Q Consensus        64 LH~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~  140 (280)
                      ||++|++||||||+||+++.++.++|+|||++.......   ......++..|+|||.+.+ ..++.++|+|||||++|+
T Consensus       139 lH~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~e  217 (291)
T cd05094         139 LASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVILWE  217 (291)
T ss_pred             HHhCCeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc-CCCCchhhHHHHHHHHHH
Confidence            999999999999999999999999999999987654321   1233455788999999877 678889999999999999


Q ss_pred             HHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCC
Q 023568          141 IMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPN  219 (280)
Q Consensus       141 ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~  219 (280)
                      |++ |..||...+.......+...                              .........+..+.+++.+||+.||.
T Consensus       218 l~t~g~~p~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~~li~~~l~~~P~  267 (291)
T cd05094         218 IFTYGKQPWFQLSNTEVIECITQG------------------------------RVLERPRVCPKEVYDIMLGCWQREPQ  267 (291)
T ss_pred             HHhCCCCCCCCCCHHHHHHHHhCC------------------------------CCCCCCccCCHHHHHHHHHHcccChh
Confidence            998 99999877655444332210                              01111224578899999999999999


Q ss_pred             CCCCHHHHhc
Q 023568          220 KRITVEEALR  229 (280)
Q Consensus       220 ~Rpt~~ell~  229 (280)
                      +|||++++++
T Consensus       268 ~Rpt~~~v~~  277 (291)
T cd05094         268 QRLNIKEIYK  277 (291)
T ss_pred             hCcCHHHHHH
Confidence            9999999976

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-36  Score=249.73  Aligned_cols=194  Identities=27%  Similarity=0.420  Sum_probs=163.6

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD---------QQLTDDHCQYFLYQLLRGLKYVHSASVL   70 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~---------~~l~~~~~~~i~~qil~~l~~LH~~~i~   70 (280)
                      ++||||+++++++.+.     ..+++||||+. ++|.+++...         ..+++..+..++.|++.||+|||++|++
T Consensus        53 ~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~  127 (262)
T cd00192          53 LGHPNVVRLLGVCTEE-----EPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFV  127 (262)
T ss_pred             cCCCChheeeeeecCC-----CceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcc
Confidence            5799999999999986     67999999995 6999999875         7799999999999999999999999999


Q ss_pred             ccCCCCCceEEcCCCCeEEeecccccccCCCC---ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCC
Q 023568           71 HRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REP  146 (280)
Q Consensus        71 H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~  146 (280)
                      |+||+|+||+++.++.++|+|||.+.......   ......++..|+|||.+.+ ..++.++|+||+|+++|+|++ |..
T Consensus       128 H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~  206 (262)
T cd00192         128 HRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKD-GIFTSKSDVWSFGVLLWEIFTLGAT  206 (262)
T ss_pred             cCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhcc-CCcchhhccHHHHHHHHHHHhcCCC
Confidence            99999999999999999999999998755432   2234556788999999877 578899999999999999998 699


Q ss_pred             CCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHH
Q 023568          147 LFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEE  226 (280)
Q Consensus       147 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~e  226 (280)
                      ||......+....+...                              .........+.++.+++.+||..||.+|||+.+
T Consensus       207 p~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  256 (262)
T cd00192         207 PYPGLSNEEVLEYLRKG------------------------------YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSE  256 (262)
T ss_pred             CCCCCCHHHHHHHHHcC------------------------------CCCCCCccCChHHHHHHHHHccCCcccCcCHHH
Confidence            99888665555444320                              001122356889999999999999999999999


Q ss_pred             HhcC
Q 023568          227 ALRH  230 (280)
Q Consensus       227 ll~h  230 (280)
                      ++++
T Consensus       257 l~~~  260 (262)
T cd00192         257 LVER  260 (262)
T ss_pred             HHHh
Confidence            9874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.4e-36  Score=255.07  Aligned_cols=202  Identities=33%  Similarity=0.553  Sum_probs=167.2

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||+++++++...     ...|+|+||++ ++|.+++...+ .+++..+..++.|++.||+|||+.|++|+||+|+|
T Consensus        72 l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~n  146 (286)
T cd06614          72 CKHPNIVDYYDSYLVG-----DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDN  146 (286)
T ss_pred             CCCCCeeEEEEEEEEC-----CEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhh
Confidence            5799999999999987     67999999998 59999998766 89999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023568           79 LLLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  157 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~  157 (280)
                      |+++.++.++|+|||.+...... .......++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||...+.....
T Consensus       147 i~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~  225 (286)
T cd06614         147 ILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKR-KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL  225 (286)
T ss_pred             EEEcCCCCEEECccchhhhhccchhhhccccCCcccCCHhHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            99999999999999987654432 12233456788999999876 66789999999999999999999999877654443


Q ss_pred             HHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 023568          158 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  236 (280)
Q Consensus       158 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~  236 (280)
                      ..+... +.+.                           ......++..+.++|++||+.+|.+|||+.++++||||...
T Consensus       226 ~~~~~~-~~~~---------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~  276 (286)
T cd06614         226 FLITTK-GIPP---------------------------LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA  276 (286)
T ss_pred             HHHHhc-CCCC---------------------------CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence            332210 0000                           00112367889999999999999999999999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.2e-36  Score=253.11  Aligned_cols=211  Identities=23%  Similarity=0.403  Sum_probs=161.3

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK   75 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik   75 (280)
                      ++||||++++++|.+...   ..+|+||||++| +|.+++..    ...+++..+..++.|++.||+|||+.|++|+||+
T Consensus        56 l~h~~iv~~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~  132 (287)
T cd06621          56 CKSPYIVKYYGAFLDESS---SSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIK  132 (287)
T ss_pred             CCCCCeeeeeeEEEccCC---CeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence            589999999999876532   569999999974 99887642    3568999999999999999999999999999999


Q ss_pred             CCceEEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh--
Q 023568           76 PSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY--  153 (280)
Q Consensus        76 ~~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~--  153 (280)
                      |+||+++.++.++|+|||++....... .....++..|+|||.+.+ ..++.++|+||+||++|+|++|..||.....  
T Consensus       133 ~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~  210 (287)
T cd06621         133 PSNILLTRKGQVKLCDFGVSGELVNSL-AGTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP  210 (287)
T ss_pred             HHHEEEecCCeEEEeeccccccccccc-cccccCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC
Confidence            999999999999999999986544322 224456888999999876 6788899999999999999999999987632  


Q ss_pred             HHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          154 VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       154 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      ..................                     ..........++.+.+++.+||..+|++|||+.|++.||||
T Consensus       211 ~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~  269 (287)
T cd06621         211 LGPIELLSYIVNMPNPEL---------------------KDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWI  269 (287)
T ss_pred             CChHHHHHHHhcCCchhh---------------------ccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccc
Confidence            111111111111000000                     00000001346789999999999999999999999999999


Q ss_pred             ccCc
Q 023568          234 QSLH  237 (280)
Q Consensus       234 ~~~~  237 (280)
                      +...
T Consensus       270 ~~~~  273 (287)
T cd06621         270 KAQM  273 (287)
T ss_pred             cccc
Confidence            6653

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-36  Score=248.25  Aligned_cols=196  Identities=30%  Similarity=0.518  Sum_probs=166.3

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++.++.+     ...|+||||+. ++|.+++...+.+++..+..++.|++.||.|||+.+++|+||+|+||
T Consensus        50 l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni  124 (250)
T cd05123          50 INHPFIVKLHYAFQTE-----EKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENI  124 (250)
T ss_pred             cCCCcHHHHHHHeecC-----CeeEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceE
Confidence            5799999999999887     77999999995 69999998877899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||.+...... .......++..|+|||...+ ...+.++|+||||+++|++++|..||...+......
T Consensus       125 ~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~  203 (250)
T cd05123         125 LLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLG-KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYE  203 (250)
T ss_pred             EEcCCCcEEEeecCcceecccCCCcccCCcCCccccChHHhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence            9999999999999998765443 22345567889999999876 567889999999999999999999998776543333


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCH---HHHhcCccc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV---EEALRHPYL  233 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~---~ell~hp~~  233 (280)
                      .+..  .                             ........+..+.+++++||..||.+|||+   +++++||||
T Consensus       204 ~~~~--~-----------------------------~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         204 KILK--D-----------------------------PLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             HHhc--C-----------------------------CCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence            3322  0                             011222458899999999999999999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=3.2e-36  Score=255.13  Aligned_cols=200  Identities=24%  Similarity=0.373  Sum_probs=156.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC-------------------CCCCHHHHHHHHHHHHHH
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-------------------QQLTDDHCQYFLYQLLRG   60 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-------------------~~l~~~~~~~i~~qil~~   60 (280)
                      ++||||+++++++.+.     +..++||||+. |+|.+++...                   ..+++..+..++.|++.|
T Consensus        76 l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~a  150 (304)
T cd05096          76 LKDPNIIRLLGVCVDE-----DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASG  150 (304)
T ss_pred             cCCCCeeEEEEEEecC-----CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            5799999999999887     66999999997 5999988542                   236788999999999999


Q ss_pred             HHHHHhCCccccCCCCCceEEcCCCCeEEeecccccccCCCCc---cccceeccccccccccccCCCCCcchhHHHHHHH
Q 023568           61 LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCI  137 (280)
Q Consensus        61 l~~LH~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~  137 (280)
                      |+|||+.||+||||||+||+++.++.++|+|||+++.......   .....++..|+|||.+.+ ..++.++|+|||||+
T Consensus       151 l~~lH~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~  229 (304)
T cd05096         151 MKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM-GKFTTASDVWAFGVT  229 (304)
T ss_pred             HHHHHHCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc-CCCCchhhhHHHHHH
Confidence            9999999999999999999999999999999999876533321   122344678999999876 678899999999999


Q ss_pred             HHHHHh--CCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcc
Q 023568          138 LGEIMT--REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLV  215 (280)
Q Consensus       138 l~~ll~--g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~  215 (280)
                      +|+|++  +..||...+..+....+........                       ........+..+..+.+++.+||+
T Consensus       230 l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~li~~cl~  286 (304)
T cd05096         230 LWEILMLCKEQPYGELTDEQVIENAGEFFRDQG-----------------------RQVYLFRPPPCPQGLYELMLQCWS  286 (304)
T ss_pred             HHHHHHccCCCCCCcCCHHHHHHHHHHHhhhcc-----------------------ccccccCCCCCCHHHHHHHHHHcc
Confidence            999987  5678877665544443322111000                       000111234568899999999999


Q ss_pred             cCCCCCCCHHHHhc
Q 023568          216 FDPNKRITVEEALR  229 (280)
Q Consensus       216 ~dp~~Rpt~~ell~  229 (280)
                      .||++|||++++.+
T Consensus       287 ~~p~~RPs~~~i~~  300 (304)
T cd05096         287 RDCRERPSFSDIHA  300 (304)
T ss_pred             CCchhCcCHHHHHH
Confidence            99999999999953

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=3.1e-36  Score=248.84  Aligned_cols=197  Identities=30%  Similarity=0.547  Sum_probs=162.3

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      ++||||+++++.+.+.     ...|+|+||+. ++|.+++....  .+++..+..++.|++.||.|||+.+++|+||+|+
T Consensus        56 ~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~  130 (257)
T cd08225          56 MKHPNIVTFFASFQEN-----GRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQ  130 (257)
T ss_pred             CCCCChhhhhheeccC-----CeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHH
Confidence            5799999999999887     67999999997 49999986543  5899999999999999999999999999999999


Q ss_pred             ceEEcCCCC-eEEeecccccccCCCC-ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023568           78 NLLLNASCD-LKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH  155 (280)
Q Consensus        78 Nili~~~~~-~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~  155 (280)
                      ||+++.++. ++|+|||.+....... ......++..|+|||.+.+ ..++.++|+||+|+++++|++|..||...+...
T Consensus       131 nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~  209 (257)
T cd08225         131 NIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQN-RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ  209 (257)
T ss_pred             HEEEcCCCCeEEecccccchhccCCcccccccCCCccccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence            999988764 6999999987654432 2233457889999998876 668889999999999999999999998765444


Q ss_pred             HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          156 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       156 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      ....+..                              .......+..+.++.+++.+||..+|++|||+.++++||||
T Consensus       210 ~~~~~~~------------------------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         210 LVLKICQ------------------------------GYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             HHHHHhc------------------------------ccCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence            3322211                              00112234568899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.4e-36  Score=256.05  Aligned_cols=204  Identities=26%  Similarity=0.474  Sum_probs=165.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++...     +..|+|+||+. ++|.+++.+ ..+++.++..++.|++.||+|||+.|++|+||+|+||
T Consensus        73 l~hp~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Ni  146 (293)
T cd06647          73 NKHPNIVNYLDSYLVG-----DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNI  146 (293)
T ss_pred             cCCCCeeehhheeeeC-----CcEEEEEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHE
Confidence            5799999999999887     67999999997 599999865 4689999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCC-ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||.+....... ......+++.|+|||.+.+ ..++.++|+||+|+++|++++|..||...+......
T Consensus       147 li~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~  225 (293)
T cd06647         147 LLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY  225 (293)
T ss_pred             EEcCCCCEEEccCcceecccccccccccccCChhhcCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee
Confidence            99999999999999876544332 2234467888999999876 677889999999999999999999998765432221


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCcC
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  238 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~~  238 (280)
                      .+.. .+.+                          . ......++..+.+++++||..+|.+||++++++.||||+..+.
T Consensus       226 ~~~~-~~~~--------------------------~-~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~  277 (293)
T cd06647         226 LIAT-NGTP--------------------------E-LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKP  277 (293)
T ss_pred             ehhc-CCCC--------------------------C-CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCcc
Confidence            1110 0000                          0 0112245788999999999999999999999999999987764


Q ss_pred             C
Q 023568          239 L  239 (280)
Q Consensus       239 ~  239 (280)
                      .
T Consensus       278 ~  278 (293)
T cd06647         278 L  278 (293)
T ss_pred             c
Confidence            4

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2e-36  Score=252.96  Aligned_cols=194  Identities=33%  Similarity=0.593  Sum_probs=164.4

Q ss_pred             CcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE
Q 023568            3 HENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL   81 (280)
Q Consensus         3 Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nili   81 (280)
                      ||||+++++++...     ...++|||++. ++|.+++.+.+.+++..+..++.|++.||.+||+.|++|+||+|+||++
T Consensus        61 ~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i  135 (280)
T cd05581          61 HPGIIKLYYTFQDE-----ENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILL  135 (280)
T ss_pred             CCCchhHHHHhcCC-----ceEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE
Confidence            99999999999887     67999999995 6999999888899999999999999999999999999999999999999


Q ss_pred             cCCCCeEEeecccccccCCCC---------------------ccccceeccccccccccccCCCCCcchhHHHHHHHHHH
Q 023568           82 NASCDLKIGDFGLARTTSETD---------------------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE  140 (280)
Q Consensus        82 ~~~~~~kl~dfg~~~~~~~~~---------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~  140 (280)
                      +.++.++|+|||++.......                     ......++..|+|||...+ ...+.++|+||||+++++
T Consensus       136 ~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~~  214 (280)
T cd05581         136 DKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQ  214 (280)
T ss_pred             CCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCC-CCCChhhhHHHHHHHHHH
Confidence            999999999999987644322                     1123356788999998876 668889999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCC
Q 023568          141 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNK  220 (280)
Q Consensus       141 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~  220 (280)
                      +++|..||...........+....                               ......+++.+.+++++||+.||.+
T Consensus       215 l~~g~~p~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~~li~~~l~~~p~~  263 (280)
T cd05581         215 MLTGKPPFRGSNEYLTFQKILKLE-------------------------------YSFPPNFPPDAKDLIEKLLVLDPQD  263 (280)
T ss_pred             HHhCCCCCCCccHHHHHHHHHhcC-------------------------------CCCCCccCHHHHHHHHHHhcCCHhh
Confidence            999999999876444433332100                               0112345889999999999999999


Q ss_pred             CCCH----HHHhcCccc
Q 023568          221 RITV----EEALRHPYL  233 (280)
Q Consensus       221 Rpt~----~ell~hp~~  233 (280)
                      |||+    +++++||||
T Consensus       264 R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         264 RLGVNEGYDELKAHPFF  280 (280)
T ss_pred             CCCcccCHHHHhcCCCC
Confidence            9999    999999997

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=3.6e-36  Score=249.59  Aligned_cols=193  Identities=23%  Similarity=0.403  Sum_probs=158.5

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      ++||||+++++++...     ..+++||||++ ++|.+++...  ..+++..+..++.|++.||+|||+.|++||||||+
T Consensus        59 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~  133 (263)
T cd05052          59 IKHPNLVQLLGVCTRE-----PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR  133 (263)
T ss_pred             CCCCChhheEEEEcCC-----CCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcc
Confidence            5799999999999877     66999999997 5999998653  46899999999999999999999999999999999


Q ss_pred             ceEEcCCCCeEEeecccccccCCCCcc--ccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023568           78 NLLLNASCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYV  154 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~  154 (280)
                      ||+++.++.++|+|||.+.........  ....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||++.+..
T Consensus       134 nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~  212 (263)
T cd05052         134 NCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS  212 (263)
T ss_pred             eEEEcCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            999999999999999998765443211  12233567999998876 678889999999999999998 99999887655


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      +....+.....                              .......+..+.+++.+||..||++|||+.++++
T Consensus       213 ~~~~~~~~~~~------------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         213 QVYELLEKGYR------------------------------MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             HHHHHHHCCCC------------------------------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            44443322100                              1122356889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.3e-36  Score=264.38  Aligned_cols=193  Identities=23%  Similarity=0.336  Sum_probs=154.3

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC--------------------------------------
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD--------------------------------------   42 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~--------------------------------------   42 (280)
                      +|||||++++++...     ..+|+||||+. |+|.+++.+.                                      
T Consensus       100 ~h~nIv~~~~~~~~~-----~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (374)
T cd05106         100 QHKNIVNLLGACTHG-----GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFS  174 (374)
T ss_pred             cCCceeeEeeEecCC-----CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccccccc
Confidence            799999999999887     67999999997 5999988532                                      


Q ss_pred             --------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEe
Q 023568           43 --------------------------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIG   90 (280)
Q Consensus        43 --------------------------------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nili~~~~~~kl~   90 (280)
                                                      ..+++.++..++.|++.||.|||++|++||||||+||+++.++.++|+
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~  254 (374)
T cd05106         175 SQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKIC  254 (374)
T ss_pred             ccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEe
Confidence                                            247889999999999999999999999999999999999999999999


Q ss_pred             ecccccccCCCCc---cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Q 023568           91 DFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGS  166 (280)
Q Consensus        91 dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~  166 (280)
                      |||+++.......   .....++..|+|||++.+ ..++.++|+||+||++|+|++ |..||...........+..... 
T Consensus       255 DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~-  332 (374)
T cd05106         255 DFGLARDIMNDSNYVVKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGY-  332 (374)
T ss_pred             eceeeeeccCCcceeeccCCCCccceeCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHccc-
Confidence            9999876433221   112234567999999876 778999999999999999997 9999987654332222221000 


Q ss_pred             CCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          167 PDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                                                  ........++++.+++.+||+.||.+|||+.++++
T Consensus       333 ----------------------------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         333 ----------------------------QMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             ----------------------------CccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                        00111235889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=3.1e-36  Score=254.45  Aligned_cols=193  Identities=23%  Similarity=0.310  Sum_probs=156.0

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHH
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ----------------QLTDDHCQYFLYQLLRGLKYV   64 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~----------------~l~~~~~~~i~~qil~~l~~L   64 (280)
                      +||||+++++++...     +..|+||||+. ++|.+++.+.+                .+++..++.++.|++.||+||
T Consensus        61 ~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~l  135 (297)
T cd05089          61 HHPNIINLLGACENR-----GYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYL  135 (297)
T ss_pred             CCCchhheEEEEccC-----CcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHH
Confidence            699999999999877     66999999997 69999996532                488999999999999999999


Q ss_pred             HhCCccccCCCCCceEEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-
Q 023568           65 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-  143 (280)
Q Consensus        65 H~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-  143 (280)
                      |+.|++||||||+||+++.++.++|+|||++..............+..|+|||.+.+ ..++.++|+|||||++|+|++ 
T Consensus       136 H~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~t~  214 (297)
T cd05089         136 SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNY-SVYTTKSDVWSFGVLLWEIVSL  214 (297)
T ss_pred             HHCCcccCcCCcceEEECCCCeEEECCcCCCccccceeccCCCCcCccccCchhhcc-CCCCchhhHHHHHHHHHHHHcC
Confidence            999999999999999999999999999999864322211112223457999998876 668899999999999999997 


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCC
Q 023568          144 REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT  223 (280)
Q Consensus       144 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt  223 (280)
                      |..||...........+....                              .......++..+.+++.+||+.||.+|||
T Consensus       215 g~~pf~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~  264 (297)
T cd05089         215 GGTPYCGMTCAELYEKLPQGY------------------------------RMEKPRNCDDEVYELMRQCWRDRPYERPP  264 (297)
T ss_pred             CCCCCCCCCHHHHHHHHhcCC------------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcC
Confidence            999998876554443322110                              01112356889999999999999999999


Q ss_pred             HHHHhcC
Q 023568          224 VEEALRH  230 (280)
Q Consensus       224 ~~ell~h  230 (280)
                      ++++++.
T Consensus       265 ~~~i~~~  271 (297)
T cd05089         265 FAQISVQ  271 (297)
T ss_pred             HHHHHHH
Confidence            9999764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=3e-36  Score=248.60  Aligned_cols=197  Identities=32%  Similarity=0.546  Sum_probs=166.3

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSD----QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK   75 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~----~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik   75 (280)
                      ++|||++++.+.+...     ...++|||++++ +|.+.+.+.    ..+++..+..++.|++.||.+||+.|++|+||+
T Consensus        56 l~~~~~~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~  130 (258)
T cd08215          56 LNHPNIIKYYESFEEK-----GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIK  130 (258)
T ss_pred             cCCCChhheEEEEecC-----CEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCC
Confidence            5799999999999887     779999999985 999998763    679999999999999999999999999999999


Q ss_pred             CCceEEcCCCCeEEeecccccccCCCC-ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023568           76 PSNLLLNASCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV  154 (280)
Q Consensus        76 ~~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~  154 (280)
                      |+||+++.++.++|+|||.+....... ......+++.|+|||...+ ..++.++|+||+|+++++|++|..||...+..
T Consensus       131 ~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~  209 (258)
T cd08215         131 PQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQN-KPYNYKSDIWSLGCVLYELCTLKHPFEGENLL  209 (258)
T ss_pred             hHHeEEcCCCcEEECCccceeecccCcceecceeeeecccChhHhcc-CCCCccccHHHHHHHHHHHHcCCCCCCCCcHH
Confidence            999999999999999999987655442 3344578889999998876 66888999999999999999999999877644


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      .....+...                              .........+..+.+++++||..+|++|||++++|+||||
T Consensus       210 ~~~~~~~~~------------------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         210 ELALKILKG------------------------------QYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             HHHHHHhcC------------------------------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence            433332210                              0111222568899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=4.1e-36  Score=248.37  Aligned_cols=194  Identities=19%  Similarity=0.355  Sum_probs=158.4

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||+++++++...     ...|+||||+. |+|.+++... ..+++.++..++.|++.||+|||+.|++|+||+|+|
T Consensus        56 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~n  130 (256)
T cd05113          56 LSHEKLVQLYGVCTKQ-----RPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARN  130 (256)
T ss_pred             CCCCCeeeEEEEEccC-----CCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcce
Confidence            5799999999999876     56899999997 5999998764 478999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCcc--ccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVH  155 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~~  155 (280)
                      |+++.++.++|+|||.++........  ....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||.......
T Consensus       131 ili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~  209 (256)
T cd05113         131 CLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLY-SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE  209 (256)
T ss_pred             EEEcCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhc-CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH
Confidence            99999999999999998765433211  12334567999999876 668889999999999999998 999998776554


Q ss_pred             HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 023568          156 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  230 (280)
Q Consensus       156 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~h  230 (280)
                      ....+.....                              .......+..+.+++.+||+.||.+|||+.+++++
T Consensus       210 ~~~~~~~~~~------------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         210 TVEKVSQGLR------------------------------LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             HHHHHhcCCC------------------------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence            4444322110                              00112357889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.3e-36  Score=252.65  Aligned_cols=211  Identities=20%  Similarity=0.322  Sum_probs=163.6

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~-~~i~H~dik~~N   78 (280)
                      ++||||+++++++...     ...|+||||++ ++|.+++.+.+.+++..+..++.|++.||.|||+ .|++|+||+|+|
T Consensus        60 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~n  134 (284)
T cd06620          60 CRSPYIVSFYGAFLNE-----NNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSN  134 (284)
T ss_pred             cCCCCcceEeeeEecC-----CEEEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHH
Confidence            5799999999999987     77999999998 4999998887889999999999999999999997 689999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      |+++.++.++|+|||++....... .....++..|+|||.+.+ ...+.++|+||+||++|+|++|..||..........
T Consensus       135 il~~~~~~~~l~d~gl~~~~~~~~-~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~  212 (284)
T cd06620         135 ILVNSRGQIKLCDFGVSGELINSI-ADTFVGTSTYMSPERIQG-GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQ  212 (284)
T ss_pred             EEECCCCcEEEccCCcccchhhhc-cCccccCcccCCHHHHcc-CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhh
Confidence            999999999999999886543221 234568899999999876 678889999999999999999999998754321100


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  236 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~  236 (280)
                      ..                ...................+  ....+..+.+|+.+||+.||.+|||++|+++|+||..-
T Consensus       213 ~~----------------~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~  272 (284)
T cd06620         213 DD----------------PMGILDLLQQIVQEPPPRLP--SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA  272 (284)
T ss_pred             hh----------------hhHHHHHHHHHhhccCCCCC--chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence            00                00000000000000000000  01257789999999999999999999999999998553

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.5e-36  Score=262.73  Aligned_cols=194  Identities=25%  Similarity=0.352  Sum_probs=154.4

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCC-------------------------------------
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ-------------------------------------   43 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~-------------------------------------   43 (280)
                      +||||+++++++.+.     ...|+||||++ |+|.++++...                                     
T Consensus        97 ~HpnIv~l~~~~~~~-----~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  171 (375)
T cd05104          97 NHINIVNLLGACTVG-----GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDM  171 (375)
T ss_pred             CCcceeeeeeeeccC-----CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhc
Confidence            699999999999887     67999999997 59999886421                                     


Q ss_pred             --------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC
Q 023568           44 --------------------------------------QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC   85 (280)
Q Consensus        44 --------------------------------------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nili~~~~   85 (280)
                                                            .+++..+..++.||+.||+|||+.|++||||||+||+++.++
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~  251 (375)
T cd05104         172 KPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGR  251 (375)
T ss_pred             CCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCC
Confidence                                                  478889999999999999999999999999999999999999


Q ss_pred             CeEEeecccccccCCCCc---cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 023568           86 DLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLIT  161 (280)
Q Consensus        86 ~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~  161 (280)
                      .++|+|||+++.......   .....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||..........+..
T Consensus       252 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~  330 (375)
T cd05104         252 ITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMI  330 (375)
T ss_pred             cEEEecCccceeccCcccccccCCCCCCcceeChhHhcC-CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHH
Confidence            999999999876543321   112234567999999877 778899999999999999998 899998765333222221


Q ss_pred             HHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 023568          162 ELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  230 (280)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~h  230 (280)
                      ....                             ........+.++.+++.+||+.||++|||+.|+++.
T Consensus       331 ~~~~-----------------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         331 KEGY-----------------------------RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             HhCc-----------------------------cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            1000                             001112357889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=4.4e-36  Score=251.13  Aligned_cols=193  Identities=27%  Similarity=0.435  Sum_probs=159.4

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC--------------CCCCHHHHHHHHHHHHHHHHHHH
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD--------------QQLTDDHCQYFLYQLLRGLKYVH   65 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~--------------~~l~~~~~~~i~~qil~~l~~LH   65 (280)
                      ++||||+++++++...     ...|+||||+. ++|.+++...              ..+++.++..++.|++.||++||
T Consensus        65 l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH  139 (280)
T cd05049          65 FQHENIVKFYGVCTEG-----DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA  139 (280)
T ss_pred             cCCCCchheeeEEecC-----CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh
Confidence            5799999999999987     67999999997 5999999653              34889999999999999999999


Q ss_pred             hCCccccCCCCCceEEcCCCCeEEeecccccccCCCC---ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHH
Q 023568           66 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM  142 (280)
Q Consensus        66 ~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll  142 (280)
                      ++|++||||||+||+++.++.++|+|||++.......   ......++..|+|||.+.+ ..++.++|+|||||++|+|+
T Consensus       140 ~~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~e~~  218 (280)
T cd05049         140 SQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVVLWEIF  218 (280)
T ss_pred             hCCeeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhcc-CCcchhhhHHHHHHHHHHHH
Confidence            9999999999999999999999999999987543221   1223345678999999877 77888999999999999999


Q ss_pred             h-CCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCC
Q 023568          143 T-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKR  221 (280)
Q Consensus       143 ~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~R  221 (280)
                      + |..||...+.......+...                              .........+..+.+++++||+.||.+|
T Consensus       219 ~~g~~p~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R  268 (280)
T cd05049         219 TYGKQPWYGLSNEEVIECITQG------------------------------RLLQRPRTCPSEVYDIMLGCWKRDPQQR  268 (280)
T ss_pred             hcCCCCCCCCCHHHHHHHHHcC------------------------------CcCCCCCCCCHHHHHHHHHHcCCCcccC
Confidence            8 99999877655544443210                              0111123568899999999999999999


Q ss_pred             CCHHHHhc
Q 023568          222 ITVEEALR  229 (280)
Q Consensus       222 pt~~ell~  229 (280)
                      ||+.|+++
T Consensus       269 p~~~eil~  276 (280)
T cd05049         269 INIKDIHE  276 (280)
T ss_pred             CCHHHHHH
Confidence            99999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=3.6e-36  Score=253.90  Aligned_cols=204  Identities=25%  Similarity=0.391  Sum_probs=163.1

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCce
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNL   79 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~-~~i~H~dik~~Ni   79 (280)
                      .||||+++++++.+.     ...|+||||+++++.+++.. ...+++..+..++.|++.||+|||+ .|++||||+|+||
T Consensus        72 ~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~ni  146 (296)
T cd06618          72 DCPYIVKCYGYFITD-----SDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNI  146 (296)
T ss_pred             CCCchHhhheeeecC-----CeEEEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHE
Confidence            499999999999887     67999999999888887765 4579999999999999999999997 5999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceeccccccccccccC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCCh-HH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC---TEYTAAIDIWSVGCILGEIMTREPLFPGKDY-VH  155 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~-~~  155 (280)
                      +++.++.++|+|||.+.............++..|+|||.+.+.   ..++.++|+||||+++|+|++|+.||..... .+
T Consensus       147 ll~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~  226 (296)
T cd06618         147 LLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE  226 (296)
T ss_pred             EEcCCCCEEECccccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHH
Confidence            9999999999999998765443333344577889999998652   2467899999999999999999999976432 12


Q ss_pred             HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 023568          156 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  235 (280)
Q Consensus       156 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~  235 (280)
                      .+..+.   ......                        . ......+..+.+|+.+||..||.+|||+++++.||||..
T Consensus       227 ~~~~~~---~~~~~~------------------------~-~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~  278 (296)
T cd06618         227 VLTKIL---QEEPPS------------------------L-PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR  278 (296)
T ss_pred             HHHHHh---cCCCCC------------------------C-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhc
Confidence            222211   110000                        0 001135788999999999999999999999999999987


Q ss_pred             CcC
Q 023568          236 LHD  238 (280)
Q Consensus       236 ~~~  238 (280)
                      +..
T Consensus       279 ~~~  281 (296)
T cd06618         279 YET  281 (296)
T ss_pred             cch
Confidence            653

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=5.8e-36  Score=247.35  Aligned_cols=193  Identities=23%  Similarity=0.391  Sum_probs=159.0

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||+++++++...     ...++||||++ |+|.+++... +.+++..+..++.|++.||+|||+.|++|+||+|+|
T Consensus        56 l~h~~i~~~~~~~~~~-----~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~n  130 (256)
T cd05114          56 LSHPKLVQLYGVCTQQ-----KPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARN  130 (256)
T ss_pred             CCCCCceeEEEEEccC-----CCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcce
Confidence            5899999999999877     67999999997 6999998753 568999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCcc--ccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVH  155 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~~  155 (280)
                      |+++.++.++|+|||.++........  ....++..|+|||.+.+ ..++.++|+||+|+++|+|++ |+.||...+..+
T Consensus       131 i~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~  209 (256)
T cd05114         131 CLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNF-SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE  209 (256)
T ss_pred             EEEcCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhccc-CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            99999999999999998765433221  12234567999999876 678889999999999999999 999998877655


Q ss_pred             HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          156 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       156 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      ....+.....                              .......+..+.+++.+||+.||.+|||++++++
T Consensus       210 ~~~~i~~~~~------------------------------~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         210 VVEMISRGFR------------------------------LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             HHHHHHCCCC------------------------------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            5554433110                              0011235778999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.6e-36  Score=256.83  Aligned_cols=193  Identities=23%  Similarity=0.321  Sum_probs=155.3

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHH
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD----------------QQLTDDHCQYFLYQLLRGLKYV   64 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~----------------~~l~~~~~~~i~~qil~~l~~L   64 (280)
                      +||||+++++++.+.     ...|+||||+. ++|.+++.+.                ..+++.++..++.|++.||+||
T Consensus        66 ~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L  140 (303)
T cd05088          66 HHPNIINLLGACEHR-----GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL  140 (303)
T ss_pred             CCCCcceEEEEECCC-----CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHH
Confidence            799999999999887     67999999997 5999999643                2578999999999999999999


Q ss_pred             HhCCccccCCCCCceEEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-
Q 023568           65 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-  143 (280)
Q Consensus        65 H~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-  143 (280)
                      |+.|++||||||+||+++.++.++|+|||++.............++..|+|||.+.+ ..++.++|+|||||++|+|++ 
T Consensus       141 H~~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~  219 (303)
T cd05088         141 SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSL  219 (303)
T ss_pred             HhCCccccccchheEEecCCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhc-cCCcccccchhhhhHHHHHHhc
Confidence            999999999999999999999999999999864322111112233567999998866 667889999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCC
Q 023568          144 REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT  223 (280)
Q Consensus       144 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt  223 (280)
                      |..||.+.+..+....+....                              ........++++.+++.+||+.+|.+||+
T Consensus       220 g~~p~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~  269 (303)
T cd05088         220 GGTPYCGMTCAELYEKLPQGY------------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPS  269 (303)
T ss_pred             CCCCcccCChHHHHHHHhcCC------------------------------cCCCCCCCCHHHHHHHHHHcCCChhhCcC
Confidence            999998766544333221100                              00111245788999999999999999999


Q ss_pred             HHHHhcC
Q 023568          224 VEEALRH  230 (280)
Q Consensus       224 ~~ell~h  230 (280)
                      +++++.+
T Consensus       270 ~~~il~~  276 (303)
T cd05088         270 FAQILVS  276 (303)
T ss_pred             HHHHHHH
Confidence            9999985

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.2e-36  Score=249.62  Aligned_cols=194  Identities=30%  Similarity=0.515  Sum_probs=161.4

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~--~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      ++||||+++++.+++.     ..+|+||||++ ++|.+++..  ...++++.+..++.|++.||.+||++|++|+||+|+
T Consensus        55 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~  129 (255)
T cd08219          55 MKHPNIVAFKESFEAD-----GHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSK  129 (255)
T ss_pred             CCCCCcceEEEEEEEC-----CEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcc
Confidence            5799999999999887     78999999997 599998864  346899999999999999999999999999999999


Q ss_pred             ceEEcCCCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023568           78 NLLLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  156 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~  156 (280)
                      ||+++.++.++++|||.+...... .......++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||...+....
T Consensus       130 nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~  208 (255)
T cd08219         130 NIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWEN-MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL  208 (255)
T ss_pred             eEEECCCCcEEEcccCcceeecccccccccccCCccccCHHHHcc-CCcCchhhhhhhchhheehhhccCCCCCCCHHHH
Confidence            999999999999999998765433 22334567889999999876 6688899999999999999999999988765444


Q ss_pred             HHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 023568          157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  230 (280)
Q Consensus       157 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~h  230 (280)
                      ...+...                              .........+..+.+++++||+.||.+|||++++++-
T Consensus       209 ~~~~~~~------------------------------~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         209 ILKVCQG------------------------------SYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHHHhcC------------------------------CCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            4333210                              0111223467889999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=4.8e-36  Score=250.71  Aligned_cols=194  Identities=24%  Similarity=0.400  Sum_probs=156.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCC----------CCCHHHHHHHHHHHHHHHHHHHhCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ----------QLTDDHCQYFLYQLLRGLKYVHSASV   69 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~----------~l~~~~~~~i~~qil~~l~~LH~~~i   69 (280)
                      ++||||+++++++...     ...++||||++ |+|.+++.+.+          .+++..+..++.|++.||.|||+.|+
T Consensus        66 l~~~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~  140 (277)
T cd05062          66 FNCHHVVRLLGVVSQG-----QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKF  140 (277)
T ss_pred             CCCCCeeeEEEEEcCC-----CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            5799999999999877     67999999997 59999986522          35788899999999999999999999


Q ss_pred             cccCCCCCceEEcCCCCeEEeecccccccCCCCc---cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CC
Q 023568           70 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-RE  145 (280)
Q Consensus        70 ~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~  145 (280)
                      +|+||||+||+++.++.++|+|||+++.......   .....++..|+|||.+.+ ..++.++|+|||||++|+|++ |.
T Consensus       141 vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~  219 (277)
T cd05062         141 VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAE  219 (277)
T ss_pred             ccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhc-CCcCchhHHHHHHHHHHHHHcCCC
Confidence            9999999999999999999999999875433221   112344678999999876 678899999999999999998 78


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 023568          146 PLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVE  225 (280)
Q Consensus       146 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~  225 (280)
                      .||.+.........+....                              ........+..+.+++.+||+.||++|||+.
T Consensus       220 ~p~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  269 (277)
T cd05062         220 QPYQGMSNEQVLRFVMEGG------------------------------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFL  269 (277)
T ss_pred             CCCCCCCHHHHHHHHHcCC------------------------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHH
Confidence            9998876554443332210                              0111224678899999999999999999999


Q ss_pred             HHhcC
Q 023568          226 EALRH  230 (280)
Q Consensus       226 ell~h  230 (280)
                      |++++
T Consensus       270 e~l~~  274 (277)
T cd05062         270 EIISS  274 (277)
T ss_pred             HHHHH
Confidence            99864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=5.4e-36  Score=247.74  Aligned_cols=192  Identities=19%  Similarity=0.308  Sum_probs=157.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||++++++++.      ...++||||++ |+|.+++...+.+++..+..++.|++.||+|||++|++||||||.||
T Consensus        53 l~h~~i~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~ni  126 (257)
T cd05116          53 LDNPYIVRMIGICEA------ESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNV  126 (257)
T ss_pred             CCCCCcceEEEEEcC------CCcEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhE
Confidence            579999999998754      34789999998 58999998878899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCc----cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDF----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYV  154 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~  154 (280)
                      +++.++.++|+|||.+........    .....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||...+..
T Consensus       127 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~  205 (257)
T cd05116         127 LLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN  205 (257)
T ss_pred             EEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            999999999999999876543321    112233578999998865 678889999999999999998 99999887655


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      .....+.+..                              ....+...++.+.++|++||+.||.+||+++++..
T Consensus       206 ~~~~~i~~~~------------------------------~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         206 EVTQMIESGE------------------------------RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             HHHHHHHCCC------------------------------CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence            4444433210                              01122357899999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=6.7e-36  Score=251.26  Aligned_cols=200  Identities=26%  Similarity=0.434  Sum_probs=160.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD----------QQLTDDHCQYFLYQLLRGLKYVHSASV   69 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~----------~~l~~~~~~~i~~qil~~l~~LH~~~i   69 (280)
                      ++||||+++++++.+.     ...|+||||+. |+|.+++.+.          ..++...+..++.|++.||.|||+.|+
T Consensus        66 l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i  140 (288)
T cd05061          66 FTCHHVVRLLGVVSKG-----QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKF  140 (288)
T ss_pred             CCCCCeeeEEEEEcCC-----CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Confidence            5799999999999877     66999999997 6999999642          235678899999999999999999999


Q ss_pred             cccCCCCCceEEcCCCCeEEeecccccccCCCCc---cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CC
Q 023568           70 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-RE  145 (280)
Q Consensus        70 ~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~  145 (280)
                      +||||||+||+++.++.++|+|||+++.......   .....++..|+|||.+.+ ..++.++|+||+||++|+|++ |.
T Consensus       141 ~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~DvwslG~~l~el~~~~~  219 (288)
T cd05061         141 VHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAE  219 (288)
T ss_pred             cCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhcc-CCCChHhHHHHHHHHHHHHHhCCC
Confidence            9999999999999999999999999875433211   122344677999999876 678889999999999999998 78


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 023568          146 PLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVE  225 (280)
Q Consensus       146 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~  225 (280)
                      .||.+....+....+...                              .........++.+.+++++||+.||.+|||+.
T Consensus       220 ~p~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  269 (288)
T cd05061         220 QPYQGLSNEQVLKFVMDG------------------------------GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFL  269 (288)
T ss_pred             CCCCCCCHHHHHHHHHcC------------------------------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHH
Confidence            899887655444332210                              00011124578899999999999999999999


Q ss_pred             HHhc------CcccccC
Q 023568          226 EALR------HPYLQSL  236 (280)
Q Consensus       226 ell~------hp~~~~~  236 (280)
                      ++++      ||||+++
T Consensus       270 ~ll~~l~~~~~~~~~~~  286 (288)
T cd05061         270 EIVNLLKDDLHPSFPEV  286 (288)
T ss_pred             HHHHHHHhhcCCCCCCC
Confidence            9987      8888764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=5.8e-36  Score=246.71  Aligned_cols=193  Identities=22%  Similarity=0.377  Sum_probs=154.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||+++++++...     ...|+||||+. ++|.+++... ..+++.++..++.|++.||.|||+.|++||||+|+|
T Consensus        50 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~n  124 (252)
T cd05084          50 YSHPNIVRLIGVCTQK-----QPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARN  124 (252)
T ss_pred             CCCCCcceEEEEEcCC-----CCeEEEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchhe
Confidence            5799999999999887     67999999997 5999998654 468999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCcc---ccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDFM---TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYV  154 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~  154 (280)
                      |+++.++.++|+|||.+.........   .....+..|+|||.+.+ ..++.++|+||||+++|+|++ |..||......
T Consensus       125 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~  203 (252)
T cd05084         125 CLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNY-GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ  203 (252)
T ss_pred             EEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccCHH
Confidence            99999999999999998754332111   11122456999999876 678889999999999999997 88898766543


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      .....+.....                              .......+..+.+++++||+.||++|||+.++++
T Consensus       204 ~~~~~~~~~~~------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         204 QTREAIEQGVR------------------------------LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             HHHHHHHcCCC------------------------------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            33322221000                              0111245788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=6e-36  Score=245.85  Aligned_cols=198  Identities=30%  Similarity=0.500  Sum_probs=164.4

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||+++++.+...     ...++++||++ ++|.+++... +.+++..+..++.|++.||++||+.|++||||+|+|
T Consensus        54 l~~~~i~~~~~~~~~~-----~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~n  128 (253)
T cd05122          54 CKHPNIVKYYGSYLKK-----DELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAAN  128 (253)
T ss_pred             CCCCCEeEEEEEEecC-----CeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHH
Confidence            5799999999999887     67999999998 5999998775 689999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      |+++.++.++|+|||.+.............++..|+|||.+.+ ...+.++|+||+|+++++|++|..||...+......
T Consensus       129 i~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~  207 (253)
T cd05122         129 ILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVING-KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF  207 (253)
T ss_pred             EEEccCCeEEEeeccccccccccccccceecCCcccCHHHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHH
Confidence            9999999999999999887655432345677889999999876 568889999999999999999999998775443333


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY  232 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~  232 (280)
                      .+..  . .....                         .....++..+.+++++||+.||++|||+.+++.|||
T Consensus       208 ~~~~--~-~~~~~-------------------------~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         208 KIAT--N-GPPGL-------------------------RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             HHHh--c-CCCCc-------------------------CcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence            2221  0 00000                         000123788999999999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=8.3e-36  Score=254.06  Aligned_cols=198  Identities=26%  Similarity=0.407  Sum_probs=163.9

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++|||++++++++.+.     ...|+||||+.|+|.+.+.. ..++++.++..++.|++.||.|||+.|++||||+|+||
T Consensus        82 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Ni  156 (317)
T cd06635          82 IKHPNSIEYKGCYLRE-----HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNI  156 (317)
T ss_pred             CCCCCEEEEEEEEeeC-----CeEEEEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccE
Confidence            5799999999999887     67999999999999888754 46799999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceecccccccccccc--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  157 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~  157 (280)
                      +++.++.++|+|||++......   ....++..|+|||.+.+  ...++.++|+||+||++|+|++|..||...+.....
T Consensus       157 l~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~  233 (317)
T cd06635         157 LLTEPGQVKLADFGSASIASPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL  233 (317)
T ss_pred             EECCCCCEEEecCCCccccCCc---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHH
Confidence            9999999999999988654432   34567889999998742  256788999999999999999999999876655444


Q ss_pred             HHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 023568          158 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  235 (280)
Q Consensus       158 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~  235 (280)
                      ..+......                             .......++.+.+++.+||+.+|.+||++.++++|+|+..
T Consensus       234 ~~~~~~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  282 (317)
T cd06635         234 YHIAQNESP-----------------------------TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR  282 (317)
T ss_pred             HHHHhccCC-----------------------------CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence            443321100                             0011245778999999999999999999999999999854

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=4.3e-36  Score=251.04  Aligned_cols=199  Identities=26%  Similarity=0.428  Sum_probs=164.9

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++...     ...|+||||+++ +|.+++.+ ..+++..+..++.|++.|+.+||+.|++|+||+|+||
T Consensus        59 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni  132 (277)
T cd06641          59 CDSPYVTKYYGSYLKD-----TKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANV  132 (277)
T ss_pred             cCCCCEeEEEEEEEeC-----CeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhE
Confidence            5799999999999887     679999999985 89888865 5789999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCC-ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||++....... ......++..|+|||.+.+ ...+.++|+||+||++++|++|..||..........
T Consensus       133 ~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~  211 (277)
T cd06641         133 LLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLF  211 (277)
T ss_pred             EECCCCCEEEeecccceecccchhhhccccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHH
Confidence            99999999999999987654332 1233467888999999876 677889999999999999999999998765433333


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  236 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~  236 (280)
                      .+..   .                           ..+......+..+.+++.+||+.+|.+||++.++++||||...
T Consensus       212 ~~~~---~---------------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~  259 (277)
T cd06641         212 LIPK---N---------------------------NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF  259 (277)
T ss_pred             HHhc---C---------------------------CCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence            2211   0                           0011123568889999999999999999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.1e-36  Score=247.62  Aligned_cols=199  Identities=25%  Similarity=0.505  Sum_probs=162.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++.+...   ..+++||||+. ++|.+++.+.+.+++..+..++.|++.||.|||+.|++|+||+|+||
T Consensus        61 l~h~~i~~~~~~~~~~~~---~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni  137 (264)
T cd06653          61 LRHDRIVQYYGCLRDPEE---KKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANI  137 (264)
T ss_pred             cCCCCcceEEEEEEcCCC---CEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHE
Confidence            589999999999876532   56899999997 59999998777899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC----CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023568           80 LLNASCDLKIGDFGLARTTSET----DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH  155 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~  155 (280)
                      +++.++.++|+|||.++.....    .......++..|+|||.+.+ ...+.++|+|||||++++|++|+.||.......
T Consensus       138 ~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~  216 (264)
T cd06653         138 LRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG-EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA  216 (264)
T ss_pred             EEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccCHHH
Confidence            9999999999999998764321    11233567889999999877 667889999999999999999999998765443


Q ss_pred             HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          156 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       156 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      ...++   ...+.                          .+...+.+++.+.+++++||+ +|.+|||+.++++|||.
T Consensus       217 ~~~~~---~~~~~--------------------------~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         217 AIFKI---ATQPT--------------------------KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             HHHHH---HcCCC--------------------------CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence            33222   11111                          112234578999999999999 57999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=6e-36  Score=247.33  Aligned_cols=194  Identities=18%  Similarity=0.317  Sum_probs=158.6

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||+++++++...     ...|+||||++ ++|.+++... ..+++..+..++.|++.||+|||+.|++||||||+|
T Consensus        56 l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~n  130 (256)
T cd05059          56 LSHPNLVQLYGVCTKQ-----RPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARN  130 (256)
T ss_pred             CCCCCEEEEEEEEcCC-----CceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhh
Confidence            5799999999999877     67999999997 5999998753 578999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCccc--cceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDFMT--EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVH  155 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~~  155 (280)
                      |+++.++.++|+|||.++...+.....  ...++..|+|||.+.+ ..++.++|+||+|+++|+|++ |..||...+...
T Consensus       131 i~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~  209 (256)
T cd05059         131 CLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDY-SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE  209 (256)
T ss_pred             EEECCCCcEEECCcccceecccccccccCCCCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH
Confidence            999999999999999987654332211  1223457999999877 678889999999999999998 899998776554


Q ss_pred             HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 023568          156 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  230 (280)
Q Consensus       156 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~h  230 (280)
                      ....+.....                              .......+..+.+++.+||..+|++|||+.++++.
T Consensus       210 ~~~~~~~~~~------------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         210 VVESVSAGYR------------------------------LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             HHHHHHcCCc------------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            4443322100                              01123468899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=8.3e-36  Score=246.04  Aligned_cols=196  Identities=30%  Similarity=0.484  Sum_probs=164.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK   75 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik   75 (280)
                      ++||||+++++++.+.     ...|+||||+++ +|.+++.+    ...++++.+..++.|++.||+|||+.|++|+||+
T Consensus        56 l~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~  130 (256)
T cd08530          56 VNHPNIISYKEAFLDG-----NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLK  130 (256)
T ss_pred             CCCCCchhhhhhhccC-----CEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCC
Confidence            5799999999999887     779999999975 99998865    3579999999999999999999999999999999


Q ss_pred             CCceEEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023568           76 PSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH  155 (280)
Q Consensus        76 ~~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~  155 (280)
                      |+||+++.++.++|+|||++...... ......++..|+|||.+.+ ..++.++|+||+|+++++|++|+.||...+...
T Consensus       131 ~~ni~~~~~~~~kl~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~  208 (256)
T cd08530         131 SANILLVANDLVKIGDLGISKVLKKN-MAKTQIGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD  208 (256)
T ss_pred             cceEEEecCCcEEEeeccchhhhccC-CcccccCCccccCHHHHCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            99999999999999999998776544 2334567889999999876 677889999999999999999999998876543


Q ss_pred             HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          156 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       156 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      ....+..                              ...+......+.++.+++.+||+.+|.+|||+.++++||++
T Consensus       209 ~~~~~~~------------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         209 LRYKVQR------------------------------GKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             HHHHHhc------------------------------CCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence            3322211                              11111222568889999999999999999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=7.4e-36  Score=246.27  Aligned_cols=201  Identities=29%  Similarity=0.482  Sum_probs=166.2

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++.+.....   ...++||||++ ++|.+++.+...+++..+..++.|++.||+|||+.|++|+||+|+||
T Consensus        56 l~~~~i~~~~~~~~~~~~---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni  132 (260)
T cd06606          56 LQHPNIVRYYGSERDEEK---NTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANI  132 (260)
T ss_pred             cCCCCEeeEEEEEecCCC---CeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHE
Confidence            579999999999987632   46999999995 69999998877999999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCc---cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  156 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~  156 (280)
                      +++.++.++|+|||.+........   .....++..|+|||.+.+ ...+.++|+||||+++++|++|..||...+... 
T Consensus       133 ~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-  210 (260)
T cd06606         133 LVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG-EEYGRAADIWSLGCTVIEMATGKPPWSELGNPM-  210 (260)
T ss_pred             EEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-
Confidence            999999999999999887655432   345667889999999876 568899999999999999999999998876211 


Q ss_pred             HHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       157 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                       ..+.....                          ...........+..+.+++.+||+.||.+||++.+++.||||
T Consensus       211 -~~~~~~~~--------------------------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         211 -AALYKIGS--------------------------SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             -HHHHhccc--------------------------cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence             11111000                          011122233568899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=7.3e-36  Score=253.41  Aligned_cols=200  Identities=25%  Similarity=0.383  Sum_probs=163.5

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++|||++++.+++...     ...|+||||+.|++.+.+.. ...+++.++..++.|++.||.|||+.|++||||+|+||
T Consensus        72 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~ni  146 (308)
T cd06634          72 LRHPNTIQYRGCYLRE-----HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNI  146 (308)
T ss_pred             CCCCCcccEEEEEEcC-----CeeEEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhE
Confidence            5799999999999877     67999999999999887754 45689999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceecccccccccccc--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  157 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~  157 (280)
                      +++.++.++|+|||++......   ....++..|+|||.+.+  ....+.++|+|||||++|+|++|..||...+.....
T Consensus       147 l~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~  223 (308)
T cd06634         147 LLSEPGLVKLGDFGSASIMAPA---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL  223 (308)
T ss_pred             EECCCCcEEECCcccceeecCc---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHH
Confidence            9999999999999998765432   34467889999999752  245678999999999999999999998776544333


Q ss_pred             HHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCc
Q 023568          158 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  237 (280)
Q Consensus       158 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~  237 (280)
                      ..+.....                             ........+..+.++|++||..+|.+||+++++++|||+....
T Consensus       224 ~~~~~~~~-----------------------------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~  274 (308)
T cd06634         224 YHIAQNES-----------------------------PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  274 (308)
T ss_pred             HHHhhcCC-----------------------------CCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccC
Confidence            32221000                             0001124678899999999999999999999999999997743

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=5.7e-36  Score=248.38  Aligned_cols=190  Identities=22%  Similarity=0.305  Sum_probs=151.2

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||+++++++...     ...++||||+++ +|..++.. ...+++..+..++.|++.||+|||+.|++||||||+|
T Consensus        61 l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N  135 (262)
T cd05077          61 VSHKHIVLLYGVCVRD-----VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKN  135 (262)
T ss_pred             CCCCCEeeEEEEEecC-----CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCccc
Confidence            5899999999999877     668999999984 78777764 4579999999999999999999999999999999999


Q ss_pred             eEEcCCCC-------eEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHH-hCCCCCCC
Q 023568           79 LLLNASCD-------LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM-TREPLFPG  150 (280)
Q Consensus        79 ili~~~~~-------~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll-~g~~pf~~  150 (280)
                      |+++.++.       ++++|||.+......   ....++..|+|||.+.+...++.++|||||||++|+|+ .|..||..
T Consensus       136 ill~~~~~~~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~  212 (262)
T cd05077         136 ILLAREGIDGECGPFIKLSDPGIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKD  212 (262)
T ss_pred             EEEecCCccCCCCceeEeCCCCCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence            99987664       899999988654322   23456788999998875577889999999999999998 58888876


Q ss_pred             CChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 023568          151 KDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  230 (280)
Q Consensus       151 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~h  230 (280)
                      ........ ...   ..                            .......+.++.+++.+||+.||.+||++.+++++
T Consensus       213 ~~~~~~~~-~~~---~~----------------------------~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         213 KTLAEKER-FYE---GQ----------------------------CMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             cchhHHHH-HHh---cC----------------------------ccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            54322211 100   00                            00111235778999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=6.5e-36  Score=251.54  Aligned_cols=204  Identities=20%  Similarity=0.382  Sum_probs=165.3

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      +||||+++++.|+.+     ...|+||||+. ++|.+++.....+++..+..++.|++.||.|||+.|++||||+|+||+
T Consensus        63 ~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil  137 (290)
T cd05613          63 QSPFLVTLHYAFQTD-----TKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENIL  137 (290)
T ss_pred             cCCChhceeeEeecC-----CeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeE
Confidence            589999999999887     67999999998 499999988888999999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccccCCCC--ccccceeccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023568           81 LNASCDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  157 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~  157 (280)
                      ++.++.++|+|||++.......  ......++..|+|||.+.+. ..++.++|+||+|+++|+|++|..||.........
T Consensus       138 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~  217 (290)
T cd05613         138 LDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ  217 (290)
T ss_pred             ECCCCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccH
Confidence            9999999999999987654322  12345678899999998652 34678899999999999999999999754332222


Q ss_pred             HHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCcc
Q 023568          158 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPY  232 (280)
Q Consensus       158 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rp-----t~~ell~hp~  232 (280)
                      ..+.+....                           ..+......++.+.+++++||+.||++||     +++++++|||
T Consensus       218 ~~~~~~~~~---------------------------~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~  270 (290)
T cd05613         218 AEISRRILK---------------------------SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPF  270 (290)
T ss_pred             HHHHHHhhc---------------------------cCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcc
Confidence            222211100                           00111234688899999999999999997     8999999999


Q ss_pred             cccCc
Q 023568          233 LQSLH  237 (280)
Q Consensus       233 ~~~~~  237 (280)
                      |..+.
T Consensus       271 ~~~~~  275 (290)
T cd05613         271 FQKIN  275 (290)
T ss_pred             cccCC
Confidence            98875

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=6.4e-36  Score=250.00  Aligned_cols=194  Identities=23%  Similarity=0.381  Sum_probs=156.2

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCC-------CCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKYVHSASVLHR   72 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~-------~l~~~~~~~i~~qil~~l~~LH~~~i~H~   72 (280)
                      ++||||+++++++.+.     ...++||||+. ++|.+++...+       .+++..+..++.||+.||+|||+.|++|+
T Consensus        66 l~~~~i~~~~~~~~~~-----~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~  140 (277)
T cd05036          66 FNHQNIVRLIGVSFER-----LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHR  140 (277)
T ss_pred             CCCCCEeeEEEEEccC-----CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeec
Confidence            5799999999998876     56899999996 59999996543       48999999999999999999999999999


Q ss_pred             CCCCCceEEcCCC---CeEEeecccccccCCCCc---cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CC
Q 023568           73 DLKPSNLLLNASC---DLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-RE  145 (280)
Q Consensus        73 dik~~Nili~~~~---~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~  145 (280)
                      ||+|+||+++.++   .++|+|||+++.......   ......+..|+|||.+.+ ..++.++|+|||||++|+|++ |.
T Consensus       141 dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~~g~  219 (277)
T cd05036         141 DIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD-GIFTSKTDVWSFGVLLWEIFSLGY  219 (277)
T ss_pred             ccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhc-CCcCchhHHHHHHHHHHHHHcCCC
Confidence            9999999998754   599999999886533211   112233567999999876 678999999999999999997 99


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 023568          146 PLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVE  225 (280)
Q Consensus       146 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~  225 (280)
                      .||.+.........+....                              ........+..+.+++++||+.+|++|||+.
T Consensus       220 ~pf~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~  269 (277)
T cd05036         220 MPYPGRTNQEVMEFVTGGG------------------------------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFA  269 (277)
T ss_pred             CCCCCCCHHHHHHHHHcCC------------------------------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHH
Confidence            9998876554433322100                              0011235688999999999999999999999


Q ss_pred             HHhcC
Q 023568          226 EALRH  230 (280)
Q Consensus       226 ell~h  230 (280)
                      ++++|
T Consensus       270 ~vl~~  274 (277)
T cd05036         270 TILER  274 (277)
T ss_pred             HHHHH
Confidence            99985

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-35  Score=246.36  Aligned_cols=193  Identities=25%  Similarity=0.379  Sum_probs=158.6

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      ++||||+++++++...     +..|+||||+. ++|.+++....  .+++..+..++.|++.||.+||+.|++|+||||+
T Consensus        58 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~  132 (261)
T cd05068          58 LRHPKLIQLYAVCTLE-----EPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAAR  132 (261)
T ss_pred             CCCCCccceeEEEecC-----CCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcc
Confidence            5799999999999877     67999999995 69999997643  7999999999999999999999999999999999


Q ss_pred             ceEEcCCCCeEEeecccccccCCCCcc--ccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023568           78 NLLLNASCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYV  154 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~  154 (280)
                      ||+++.++.++|+|||+++........  .....+..|+|||.+.+ ..++.++|+||||+++++|++ |+.||.+....
T Consensus       133 Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~  211 (261)
T cd05068         133 NVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALY-NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA  211 (261)
T ss_pred             eEEEcCCCCEEECCcceEEEccCCcccccCCCcCceeccCcccccc-CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence            999999999999999998876533211  11122457999998876 678889999999999999999 99999887755


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      .....+......                              ......+..+.+++.+||+.||.+||+++++++
T Consensus       212 ~~~~~~~~~~~~------------------------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         212 EVLQQVDQGYRM------------------------------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             HHHHHHHcCCCC------------------------------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            555444321100                              111246788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-35  Score=244.26  Aligned_cols=197  Identities=29%  Similarity=0.515  Sum_probs=165.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++|||++++++++.+.     ...|+||||+++ +|.+++.....+++..+..++.|++.||.+||+.|++||||+|+||
T Consensus        56 l~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni  130 (254)
T cd06627          56 LKHPNIVKYIGSIETS-----DSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANI  130 (254)
T ss_pred             CCCCCccEEEEEEEeC-----CEEEEEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHE
Confidence            5799999999999877     679999999985 9999998878899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCc-cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDF-MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||.+........ .....++..|+|||...+ ...+.++|+||+|+++++|++|..||...+......
T Consensus       131 ~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~  209 (254)
T cd06627         131 LTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM-SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALF  209 (254)
T ss_pred             EECCCCCEEEeccccceecCCCcccccccccchhhcCHhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHH
Confidence            999999999999999886554322 234567888999999876 558889999999999999999999998765333322


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      .+..                              .......+..+..+.+++.+||..+|++|||+.+++.||||
T Consensus       210 ~~~~------------------------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         210 RIVQ------------------------------DDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             HHhc------------------------------cCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence            2211                              01112233568899999999999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.3e-35  Score=247.88  Aligned_cols=190  Identities=20%  Similarity=0.256  Sum_probs=151.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||+++++++...     ...++||||++ |+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|
T Consensus        73 l~h~niv~~~~~~~~~-----~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~N  147 (274)
T cd05076          73 VSHIHLAFVHGVCVRG-----SENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKN  147 (274)
T ss_pred             CCCCCeeeEEEEEEeC-----CceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCccc
Confidence            5799999999999877     67899999998 488888865 4679999999999999999999999999999999999


Q ss_pred             eEEcCCC-------CeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHH-hCCCCCCC
Q 023568           79 LLLNASC-------DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM-TREPLFPG  150 (280)
Q Consensus        79 ili~~~~-------~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll-~g~~pf~~  150 (280)
                      |+++..+       .++++|||.+......   ....++..|+|||.+.+...++.++|+|||||++|+|+ +|..||..
T Consensus       148 ill~~~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~  224 (274)
T cd05076         148 ILLARLGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKE  224 (274)
T ss_pred             EEEeccCcccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccc
Confidence            9997643       3899999987654322   22356778999998876567889999999999999995 69999977


Q ss_pred             CChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 023568          151 KDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  230 (280)
Q Consensus       151 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~h  230 (280)
                      ..............                                ......++.+.+++++||+.+|++|||+.+++++
T Consensus       225 ~~~~~~~~~~~~~~--------------------------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         225 RTPSEKERFYEKKH--------------------------------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             cChHHHHHHHHhcc--------------------------------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            65433222111100                                0111245679999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1e-35  Score=246.36  Aligned_cols=196  Identities=30%  Similarity=0.539  Sum_probs=160.5

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK   75 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik   75 (280)
                      ++||||+++++++.+.     ...++||||+.+ +|.+++.+    ...+++.++..++.|++.||.|||+.|++|+||+
T Consensus        59 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~  133 (260)
T cd08222          59 LDHPAIVKFHASFLER-----DAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLK  133 (260)
T ss_pred             CCCCcHHHHHHHHhcC-----CceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCC
Confidence            5799999999999877     569999999985 99888753    4579999999999999999999999999999999


Q ss_pred             CCceEEcCCCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023568           76 PSNLLLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV  154 (280)
Q Consensus        76 ~~Nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~  154 (280)
                      |+||+++. +.++|+|||.+...... .......++..|+|||.+.+ ..++.++|+||+|+++++|++|..||.+....
T Consensus       134 ~~nili~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~  211 (260)
T cd08222         134 AKNIFLKN-NLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL  211 (260)
T ss_pred             hhheEeec-CCEeecccCceeecCCCcccccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHH
Confidence            99999975 56999999998765332 22334567888999998866 66778999999999999999999999776544


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      .....+..   .                           ..+......+.++.++|.+||..||++||++.++++||||
T Consensus       212 ~~~~~~~~---~---------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         212 SVVLRIVE---G---------------------------PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HHHHHHHc---C---------------------------CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence            33332211   0                           0111123567899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=7.5e-36  Score=248.66  Aligned_cols=192  Identities=23%  Similarity=0.325  Sum_probs=154.3

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHH
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ----------------QLTDDHCQYFLYQLLRGLKYV   64 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~----------------~l~~~~~~~i~~qil~~l~~L   64 (280)
                      +||||+++++++...     +..|+||||+. |+|.+++.+.+                .+++.++..++.|++.||+||
T Consensus        54 ~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~l  128 (270)
T cd05047          54 HHPNIINLLGACEHR-----GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL  128 (270)
T ss_pred             cCCCeeeEEEEEecC-----CCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            699999999999877     66999999997 69999997532                478999999999999999999


Q ss_pred             HhCCccccCCCCCceEEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-
Q 023568           65 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-  143 (280)
Q Consensus        65 H~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-  143 (280)
                      |+.|++||||||+||+++.++.++|+|||++..............+..|+|||.+.+ ..++.++|+|||||++++|++ 
T Consensus       129 H~~~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~  207 (270)
T cd05047         129 SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSL  207 (270)
T ss_pred             HHCCEeecccccceEEEcCCCeEEECCCCCccccchhhhccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcC
Confidence            999999999999999999999999999999864322111112233567999998866 678889999999999999997 


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCC
Q 023568          144 REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT  223 (280)
Q Consensus       144 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt  223 (280)
                      |..||.+.+.......+....                              ........+.++.+++.+||+.||.+|||
T Consensus       208 g~~pf~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps  257 (270)
T cd05047         208 GGTPYCGMTCAELYEKLPQGY------------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPS  257 (270)
T ss_pred             CCCCccccCHHHHHHHHhCCC------------------------------CCCCCCcCCHHHHHHHHHHcccChhhCCC
Confidence            999998766544433321100                              00111245788999999999999999999


Q ss_pred             HHHHhc
Q 023568          224 VEEALR  229 (280)
Q Consensus       224 ~~ell~  229 (280)
                      +.+++.
T Consensus       258 ~~~il~  263 (270)
T cd05047         258 FAQILV  263 (270)
T ss_pred             HHHHHH
Confidence            999986

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.4e-35  Score=245.78  Aligned_cols=193  Identities=23%  Similarity=0.397  Sum_probs=158.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~--~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      ++||||+++++++.+.     +..|+||||+. ++|.+++.+  ...+++..+..++.|++.||+|||+.|++|+||+|+
T Consensus        58 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~  132 (261)
T cd05072          58 LQHDKLVRLYAVVTKE-----EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAA  132 (261)
T ss_pred             CCCCCeeeEEEEEcCC-----CCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchh
Confidence            5799999999999877     66999999997 599999865  356899999999999999999999999999999999


Q ss_pred             ceEEcCCCCeEEeecccccccCCCCc--cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023568           78 NLLLNASCDLKIGDFGLARTTSETDF--MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYV  154 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~  154 (280)
                      ||+++.++.++|+|||.+........  .....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||......
T Consensus       133 nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~  211 (261)
T cd05072         133 NVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS  211 (261)
T ss_pred             hEEecCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhcc-CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH
Confidence            99999999999999999976543321  122334667999999876 678889999999999999998 99999887655


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      .....+.....                              .......+.++.+++.+||..+|++|||++++++
T Consensus       212 ~~~~~~~~~~~------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         212 DVMSALQRGYR------------------------------MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             HHHHHHHcCCC------------------------------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            54444322110                              0112346788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.6e-35  Score=248.06  Aligned_cols=193  Identities=25%  Similarity=0.410  Sum_probs=157.3

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCC---------------CCCHHHHHHHHHHHHHHHHHH
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ---------------QLTDDHCQYFLYQLLRGLKYV   64 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~---------------~l~~~~~~~i~~qil~~l~~L   64 (280)
                      ++||||+++++++.+.     ...++||||+. ++|.+++...+               .+++..+..++.|++.||+||
T Consensus        64 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L  138 (280)
T cd05092          64 LQHQHIVRFYGVCTEG-----RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYL  138 (280)
T ss_pred             CCCCCCceEEEEEecC-----CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHH
Confidence            5799999999999877     66999999997 59999987542               489999999999999999999


Q ss_pred             HhCCccccCCCCCceEEcCCCCeEEeecccccccCCCCc---cccceeccccccccccccCCCCCcchhHHHHHHHHHHH
Q 023568           65 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI  141 (280)
Q Consensus        65 H~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l  141 (280)
                      |+.|++||||||+||+++.++.++|+|||++........   .....+++.|+|||.+.+ ..++.++|+|||||++|+|
T Consensus       139 H~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el  217 (280)
T cd05092         139 ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDIWSFGVVLWEI  217 (280)
T ss_pred             HHCCeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhcc-CCcCchhhHHHHHHHHHHH
Confidence            999999999999999999999999999999875432211   122334678999999877 6788999999999999999


Q ss_pred             Hh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCC
Q 023568          142 MT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNK  220 (280)
Q Consensus       142 l~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~  220 (280)
                      ++ |.+||...........+.....                              .......++.+.+++.+||+.||.+
T Consensus       218 ~~~g~~p~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~li~~cl~~~P~~  267 (280)
T cd05092         218 FTYGKQPWYQLSNTEAIECITQGRE------------------------------LERPRTCPPEVYAIMQGCWQREPQQ  267 (280)
T ss_pred             HcCCCCCCccCCHHHHHHHHHcCcc------------------------------CCCCCCCCHHHHHHHHHHccCChhh
Confidence            98 9999987665544433322100                              0112256888999999999999999


Q ss_pred             CCCHHHHhc
Q 023568          221 RITVEEALR  229 (280)
Q Consensus       221 Rpt~~ell~  229 (280)
                      ||+++++++
T Consensus       268 Rp~~~~l~~  276 (280)
T cd05092         268 RMVIKDIHS  276 (280)
T ss_pred             CCCHHHHHH
Confidence            999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2.9e-36  Score=249.77  Aligned_cols=193  Identities=27%  Similarity=0.431  Sum_probs=154.2

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      ++||||+++++++...     ...++||||+. |+|.+++...  ..+++.++..|+.|++.||.|||+.+++|++|+++
T Consensus        58 l~h~ni~~~~g~~~~~-----~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~  132 (259)
T PF07714_consen   58 LRHPNIVKLYGFCIEN-----EPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPS  132 (259)
T ss_dssp             HSBTTBE-EEEEEESS-----SSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGG
T ss_pred             cccccccccccccccc-----ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            4799999999999966     55999999997 6999999876  68999999999999999999999999999999999


Q ss_pred             ceEEcCCCCeEEeecccccccCCC---CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 023568           78 NLLLNASCDLKIGDFGLARTTSET---DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDY  153 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~  153 (280)
                      ||+++.++.+||+|||++......   ...........|+|||.+.+ ..++.++||||||+++||+++ |+.||...+.
T Consensus       133 nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~  211 (259)
T PF07714_consen  133 NILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKD-GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN  211 (259)
T ss_dssp             GEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHH-SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccc
Confidence            999999999999999999876322   11233456778999999877 668999999999999999999 7899988866


Q ss_pred             HHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          154 VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       154 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      ......+.+..                              ........+..+.+++.+||..||.+|||+.++++
T Consensus       212 ~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  212 EEIIEKLKQGQ------------------------------RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             HHHHHHHHTTE------------------------------ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             ccccccccccc------------------------------cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            55555442211                              11122356889999999999999999999999975

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-35  Score=244.66  Aligned_cols=192  Identities=19%  Similarity=0.290  Sum_probs=157.5

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++..      ...++||||+. |+|.+++.+.+.+++..+..++.|++.||+|||+.|++|+||||+||
T Consensus        53 l~h~~iv~~~~~~~~------~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~ni  126 (257)
T cd05060          53 LDHPCIVRLIGVCKG------EPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNV  126 (257)
T ss_pred             cCCCCeeeEEEEEcC------CceEEEEEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceE
Confidence            579999999998763      35899999997 59999998878899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCcc----ccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFM----TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYV  154 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~  154 (280)
                      +++.++.++|+|||.++........    ....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...+..
T Consensus       127 li~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~  205 (257)
T cd05060         127 LLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY-GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA  205 (257)
T ss_pred             EEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcC-CCCCccchHHHHHHHHHHHHcCCCCCcccCCHH
Confidence            9999999999999998765433211    11122457999998876 678899999999999999997 99999887655


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      +....+....                              ........+..+.+++.+||..+|.+|||+.++++
T Consensus       206 ~~~~~~~~~~------------------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         206 EVIAMLESGE------------------------------RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             HHHHHHHcCC------------------------------cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            4444332210                              01122356789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.4e-35  Score=245.39  Aligned_cols=190  Identities=18%  Similarity=0.264  Sum_probs=152.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||+++++++...     ...++||||++ |+|.+++... ..+++..+..++.|++.||+|||+.||+||||||+|
T Consensus        56 ~~h~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~n  130 (258)
T cd05078          56 LSHKHLVLNYGVCVCG-----DESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKN  130 (258)
T ss_pred             CCCCChhheeeEEEeC-----CCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccce
Confidence            5799999999999887     66899999997 5999999764 468999999999999999999999999999999999


Q ss_pred             eEEcCCCC--------eEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhC-CCCCC
Q 023568           79 LLLNASCD--------LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFP  149 (280)
Q Consensus        79 ili~~~~~--------~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g-~~pf~  149 (280)
                      |+++.++.        ++++|||.+......   ....++..|+|||.+.+...++.++|+||+|+++|+|++| ..||.
T Consensus       131 ili~~~~~~~~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~  207 (258)
T cd05078         131 VLLIREEDRKTGNPPFIKLSDPGISITVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLS  207 (258)
T ss_pred             EEEecccccccCCCceEEecccccccccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChh
Confidence            99987664        699999988654432   2345678899999987656678899999999999999998 46666


Q ss_pred             CCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          150 GKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       150 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      ..+..........                                ........+..+.+++.+||+.||.+|||++++++
T Consensus       208 ~~~~~~~~~~~~~--------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  255 (258)
T cd05078         208 ALDSQKKLQFYED--------------------------------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIR  255 (258)
T ss_pred             hccHHHHHHHHHc--------------------------------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            5543322211110                                00112235678999999999999999999999987


Q ss_pred             C
Q 023568          230 H  230 (280)
Q Consensus       230 h  230 (280)
                      .
T Consensus       256 ~  256 (258)
T cd05078         256 D  256 (258)
T ss_pred             h
Confidence            3

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2e-35  Score=244.73  Aligned_cols=193  Identities=24%  Similarity=0.379  Sum_probs=159.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      ++||||+++++++.+.     ...++||||++ ++|.+++.+.  ..+++..+..++.|++.||.|||+.|++|+||+|+
T Consensus        59 l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~  133 (261)
T cd05148          59 LRHKHLISLFAVCSVG-----EPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAAR  133 (261)
T ss_pred             CCCcchhheeeeEecC-----CCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcc
Confidence            5899999999999887     66999999997 5999999753  46899999999999999999999999999999999


Q ss_pred             ceEEcCCCCeEEeecccccccCCCCc-cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 023568           78 NLLLNASCDLKIGDFGLARTTSETDF-MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVH  155 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~~  155 (280)
                      ||+++.++.++|+|||.+........ .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |+.||.+.+...
T Consensus       134 nilv~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~  212 (261)
T cd05148         134 NILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE  212 (261)
T ss_pred             eEEEcCCceEEEccccchhhcCCccccccCCCCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence            99999999999999999876543321 123344667999999876 678889999999999999998 899998877555


Q ss_pred             HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          156 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       156 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      ....+.....                              .......++.+.+++.+||+.||.+|||+.++++
T Consensus       213 ~~~~~~~~~~------------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         213 VYDQITAGYR------------------------------MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             HHHHHHhCCc------------------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            5444432110                              0112356889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.8e-35  Score=247.96  Aligned_cols=193  Identities=19%  Similarity=0.365  Sum_probs=157.5

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHH
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD----------------QQLTDDHCQYFLYQLLRGLKY   63 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~----------------~~l~~~~~~~i~~qil~~l~~   63 (280)
                      ++||||+++++++.+.     ...++++||+. ++|.+++...                ..+++..+..++.|++.||.|
T Consensus        65 l~h~~iv~~~~~~~~~-----~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~  139 (283)
T cd05091          65 LQHPNIVCLLGVVTKE-----QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEF  139 (283)
T ss_pred             CCCCCcCeEEEEEcCC-----CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHH
Confidence            5799999999999887     66999999997 5999988531                348899999999999999999


Q ss_pred             HHhCCccccCCCCCceEEcCCCCeEEeecccccccCCCCc---cccceeccccccccccccCCCCCcchhHHHHHHHHHH
Q 023568           64 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE  140 (280)
Q Consensus        64 LH~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~  140 (280)
                      ||+.|++||||||+||+++.++.++|+|||+++.......   .....+++.|+|||.+.+ ..++.++|+|||||++|+
T Consensus       140 lH~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~e  218 (283)
T cd05091         140 LSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY-GKFSIDSDIWSYGVVLWE  218 (283)
T ss_pred             HHHcCccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhc-CCCCcchhHHHHHHHHHH
Confidence            9999999999999999999999999999999876433221   223345678999999876 678899999999999999


Q ss_pred             HHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCC
Q 023568          141 IMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPN  219 (280)
Q Consensus       141 ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~  219 (280)
                      |++ |..||.+....+....+....                              ........+..+.+++.+||+.+|.
T Consensus       219 l~~~g~~p~~~~~~~~~~~~i~~~~------------------------------~~~~~~~~~~~~~~li~~cl~~~p~  268 (283)
T cd05091         219 VFSYGLQPYCGYSNQDVIEMIRNRQ------------------------------VLPCPDDCPAWVYTLMLECWNEFPS  268 (283)
T ss_pred             HHcCCCCCCCCCCHHHHHHHHHcCC------------------------------cCCCCCCCCHHHHHHHHHHhCCCcc
Confidence            998 888998876554444433211                              0111235688899999999999999


Q ss_pred             CCCCHHHHhc
Q 023568          220 KRITVEEALR  229 (280)
Q Consensus       220 ~Rpt~~ell~  229 (280)
                      +||++.++++
T Consensus       269 ~RP~~~~i~~  278 (283)
T cd05091         269 RRPRFKDIHS  278 (283)
T ss_pred             cCCCHHHHHH
Confidence            9999999986

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-35  Score=245.33  Aligned_cols=194  Identities=23%  Similarity=0.385  Sum_probs=158.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||+++++++...     ...++||||+. ++|.+++... +.+++..+..++.|++.||+|||+.|++|+||+|+|
T Consensus        62 l~h~~i~~~~~~~~~~-----~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~n  136 (266)
T cd05033          62 FDHPNIIRLEGVVTKS-----RPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARN  136 (266)
T ss_pred             CCCCCcceEeEEEecC-----CceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcce
Confidence            5799999999999877     66999999997 5999998653 579999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCC-Ccc--ccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023568           79 LLLNASCDLKIGDFGLARTTSET-DFM--TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYV  154 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~-~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~  154 (280)
                      |+++.++.++|+|||++...... ...  ....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||......
T Consensus       137 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~  215 (266)
T cd05033         137 ILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ  215 (266)
T ss_pred             EEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhcc-CCCccccchHHHHHHHHHHHccCCCCCCCCCHH
Confidence            99999999999999999876421 111  12234567999999876 678899999999999999998 99999776655


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  230 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~h  230 (280)
                      .....+......                              ......+..+.+++.+||+.+|++||++++++++
T Consensus       216 ~~~~~~~~~~~~------------------------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         216 DVIKAVEDGYRL------------------------------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             HHHHHHHcCCCC------------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            444443321110                              0112468889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.9e-35  Score=247.88  Aligned_cols=194  Identities=20%  Similarity=0.400  Sum_probs=157.1

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC-----------------CCCCHHHHHHHHHHHHHHHH
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-----------------QQLTDDHCQYFLYQLLRGLK   62 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-----------------~~l~~~~~~~i~~qil~~l~   62 (280)
                      ++||||+++++++...     ...|+||||+. ++|.+++...                 ..+++.++..++.|++.||+
T Consensus        64 l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~  138 (283)
T cd05090          64 LHHPNIVCLLGVVTQE-----QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGME  138 (283)
T ss_pred             CCCCCeeeEEEEEecC-----CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHH
Confidence            5799999999999887     66999999997 5999998532                 24789999999999999999


Q ss_pred             HHHhCCccccCCCCCceEEcCCCCeEEeecccccccCCCC---ccccceeccccccccccccCCCCCcchhHHHHHHHHH
Q 023568           63 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG  139 (280)
Q Consensus        63 ~LH~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~  139 (280)
                      |||++|++||||||+||+++.++.++|+|||+++......   ......++..|+|||.+.+ ..++.++|+||||+++|
T Consensus       139 ~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~  217 (283)
T cd05090         139 YLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY-GKFSSDSDIWSFGVVLW  217 (283)
T ss_pred             HHHhcCeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhcc-CCCCchhhhHHHHHHHH
Confidence            9999999999999999999999999999999997653321   1223345667999999876 67889999999999999


Q ss_pred             HHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCC
Q 023568          140 EIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDP  218 (280)
Q Consensus       140 ~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp  218 (280)
                      +|++ |..||.+.........+...                              .........++.+.+++.+||+.||
T Consensus       218 el~~~g~~p~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~~li~~cl~~~p  267 (283)
T cd05090         218 EIFSFGLQPYYGFSNQEVIEMVRKR------------------------------QLLPCSEDCPPRMYSLMTECWQEGP  267 (283)
T ss_pred             HHHcCCCCCCCCCCHHHHHHHHHcC------------------------------CcCCCCCCCCHHHHHHHHHHcccCc
Confidence            9998 99999876644333332210                              0011223568899999999999999


Q ss_pred             CCCCCHHHHhcC
Q 023568          219 NKRITVEEALRH  230 (280)
Q Consensus       219 ~~Rpt~~ell~h  230 (280)
                      .+||++.+++++
T Consensus       268 ~~Rp~~~~i~~~  279 (283)
T cd05090         268 SRRPRFKDIHTR  279 (283)
T ss_pred             ccCcCHHHHHHH
Confidence            999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=2.6e-35  Score=245.47  Aligned_cols=199  Identities=23%  Similarity=0.397  Sum_probs=156.9

Q ss_pred             CCCcccccccccccCC-CCCCCCcEEEEEecCC-ccHHHHHHc------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 023568            1 MEHENVIAIKDIIRPP-KKDTFNDVYIVYELMD-TDLHQIIRS------DQQLTDDHCQYFLYQLLRGLKYVHSASVLHR   72 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~-~~~~~~~~~lv~e~~~-g~L~~~l~~------~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~   72 (280)
                      ++||||+++++++... ...+....++||||+. |+|.+++..      ...+++..+..++.|++.||+|||+.||+||
T Consensus        57 l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~  136 (272)
T cd05075          57 FDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHR  136 (272)
T ss_pred             CCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence            5899999999976433 2223356899999997 699888742      2358999999999999999999999999999


Q ss_pred             CCCCCceEEcCCCCeEEeecccccccCCCCc---cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCC
Q 023568           73 DLKPSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLF  148 (280)
Q Consensus        73 dik~~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf  148 (280)
                      ||||+||+++.++.++|+|||.++.......   .....++..|+|||...+ ..++.++|+|||||++|+|++ |+.||
T Consensus       137 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~el~~~g~~p~  215 (272)
T cd05075         137 DLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPY  215 (272)
T ss_pred             ccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccC-CCcChHHHHHHHHHHHHHHHcCCCCCC
Confidence            9999999999999999999999886543321   122345667999999876 678899999999999999999 89999


Q ss_pred             CCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 023568          149 PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL  228 (280)
Q Consensus       149 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell  228 (280)
                      .+.........+...                              ......+..+..+.+++.+||+.||.+|||+++++
T Consensus       216 ~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~  265 (272)
T cd05075         216 PGVENSEIYDYLRQG------------------------------NRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLR  265 (272)
T ss_pred             CCCCHHHHHHHHHcC------------------------------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHH
Confidence            886654443333210                              00111235678899999999999999999999998


Q ss_pred             cC
Q 023568          229 RH  230 (280)
Q Consensus       229 ~h  230 (280)
                      ++
T Consensus       266 ~~  267 (272)
T cd05075         266 CE  267 (272)
T ss_pred             HH
Confidence            63

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2.7e-35  Score=243.33  Aligned_cols=192  Identities=23%  Similarity=0.356  Sum_probs=156.1

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      ++||||+++++++....    +..|+||||++ ++|.+++++.+  .+++..+..++.|++.||+|||++|++||||||+
T Consensus        56 l~~~~i~~~~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~  131 (256)
T cd05082          56 LRHSNLVQLLGVIVEEK----GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAAR  131 (256)
T ss_pred             CCCCCeeeEEEEEEcCC----CceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchh
Confidence            57999999999764331    56899999997 59999997643  4899999999999999999999999999999999


Q ss_pred             ceEEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 023568           78 NLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQ  156 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~~~  156 (280)
                      ||+++.++.++|+|||++.......  ....++..|+|||.+.+ ..++.++|+||+||++|+|++ |..||......+.
T Consensus       132 nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~  208 (256)
T cd05082         132 NVLVSEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV  208 (256)
T ss_pred             eEEEcCCCcEEecCCccceeccccC--CCCccceeecCHHHHcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            9999999999999999987543322  23344567999998876 678889999999999999997 9999987665444


Q ss_pred             HHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       157 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      ...+.+..                              .....+..++.+.+++.+||+.||++|||+.++++
T Consensus       209 ~~~~~~~~------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         209 VPRVEKGY------------------------------KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             HHHHhcCC------------------------------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            43332210                              01122356889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.8e-35  Score=248.64  Aligned_cols=204  Identities=21%  Similarity=0.364  Sum_probs=162.8

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      +||||+++.+.+...     ...|+||||+. |+|.+.+.....+++..++.++.|++.||.|||+.|++||||+|+||+
T Consensus        63 ~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil  137 (288)
T cd05583          63 RCPFLVTLHYAFQTD-----TKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENIL  137 (288)
T ss_pred             CCcchhhhheeeecC-----CEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeE
Confidence            599999999999877     67999999997 599999987788999999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccccCCCCc--cccceeccccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023568           81 LNASCDLKIGDFGLARTTSETDF--MTEYVVTRWYRAPELLLNCT-EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  157 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~-~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~  157 (280)
                      ++.++.++|+|||++........  .....++..|+|||.+.+.. ..+.++|+||+|+++++|++|..||.........
T Consensus       138 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~  217 (288)
T cd05583         138 LDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ  217 (288)
T ss_pred             ECCCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchH
Confidence            99999999999999876433321  22345788999999986522 3678999999999999999999999754322111


Q ss_pred             HHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCC---HHHHhcCcccc
Q 023568          158 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT---VEEALRHPYLQ  234 (280)
Q Consensus       158 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt---~~ell~hp~~~  234 (280)
                      ..+.+...                           ..........++.+.+++++||+.||++|||   +.++|+||||+
T Consensus       218 ~~~~~~~~---------------------------~~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~  270 (288)
T cd05583         218 SEISRRIL---------------------------KSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQ  270 (288)
T ss_pred             HHHHHHHH---------------------------ccCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccc
Confidence            11111000                           0011122346888999999999999999998   56789999998


Q ss_pred             cCc
Q 023568          235 SLH  237 (280)
Q Consensus       235 ~~~  237 (280)
                      .+.
T Consensus       271 ~~~  273 (288)
T cd05583         271 GID  273 (288)
T ss_pred             cCC
Confidence            874

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=3.2e-35  Score=248.82  Aligned_cols=193  Identities=26%  Similarity=0.372  Sum_probs=156.1

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      +||||+++++++...     +..|+||||+. |+|.++++...  .+++.++..++.|++.||+|||+.|++|+||||+|
T Consensus        97 ~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~N  171 (302)
T cd05055          97 NHENIVNLLGACTIG-----GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN  171 (302)
T ss_pred             CCCCcceEEEEEecC-----CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccce
Confidence            699999999999877     66999999997 69999997533  38999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCc---cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYV  154 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~  154 (280)
                      |+++.++.++|+|||.++.......   .....++..|+|||.+.+ ..++.++|+||+||++|+|++ |..||......
T Consensus       172 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~  250 (302)
T cd05055         172 VLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD  250 (302)
T ss_pred             EEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhcc-CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch
Confidence            9999999999999999876543211   122344678999999877 678889999999999999998 99999876544


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      ...........                             ........++.+.+++++||..+|++|||+.|++.
T Consensus       251 ~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         251 SKFYKLIKEGY-----------------------------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             HHHHHHHHcCC-----------------------------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            33322211000                             00112245789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.3e-35  Score=250.08  Aligned_cols=193  Identities=28%  Similarity=0.481  Sum_probs=157.5

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHc----------------CCCCCHHHHHHHHHHHHHHHHHH
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS----------------DQQLTDDHCQYFLYQLLRGLKYV   64 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~----------------~~~l~~~~~~~i~~qil~~l~~L   64 (280)
                      +||||+++++++...     ..+++||||+. |+|.+++..                .+.+++..+..++.|++.||+||
T Consensus        74 ~h~~i~~~~~~~~~~-----~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L  148 (293)
T cd05053          74 KHKNIINLLGVCTQE-----GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFL  148 (293)
T ss_pred             CCCCeeeEEEEEcCC-----CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH
Confidence            699999999999877     66999999997 599999853                24689999999999999999999


Q ss_pred             HhCCccccCCCCCceEEcCCCCeEEeecccccccCCCCc---cccceeccccccccccccCCCCCcchhHHHHHHHHHHH
Q 023568           65 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI  141 (280)
Q Consensus        65 H~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l  141 (280)
                      |+.|++||||||+||+++.++.++|+|||.++.......   .....++..|+|||.+.+ ..++.++|+|||||++|+|
T Consensus       149 H~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el  227 (293)
T cd05053         149 ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEI  227 (293)
T ss_pred             HHCCccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhcc-CCcCcccceeehhhHHHHH
Confidence            999999999999999999999999999999876543321   112234567999998876 6788999999999999999


Q ss_pred             Hh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCC
Q 023568          142 MT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNK  220 (280)
Q Consensus       142 l~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~  220 (280)
                      ++ |..||.+....+....+....                              ........+..+.+++.+||..||.+
T Consensus       228 ~~~g~~p~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~  277 (293)
T cd05053         228 FTLGGSPYPGIPVEELFKLLKEGY------------------------------RMEKPQNCTQELYHLMRDCWHEVPSQ  277 (293)
T ss_pred             hcCCCCCCCCCCHHHHHHHHHcCC------------------------------cCCCCCCCCHHHHHHHHHHcccCccc
Confidence            97 999998876555444332210                              00112245788999999999999999


Q ss_pred             CCCHHHHhcC
Q 023568          221 RITVEEALRH  230 (280)
Q Consensus       221 Rpt~~ell~h  230 (280)
                      |||+.+++++
T Consensus       278 Rps~~eil~~  287 (293)
T cd05053         278 RPTFKQLVED  287 (293)
T ss_pred             CcCHHHHHHH
Confidence            9999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.3e-35  Score=253.20  Aligned_cols=195  Identities=24%  Similarity=0.366  Sum_probs=154.1

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC--------------------------------------
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD--------------------------------------   42 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~--------------------------------------   42 (280)
                      +||||+++++++....    ..++++|||+. ++|.+++...                                      
T Consensus        69 ~h~niv~~~~~~~~~~----~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (337)
T cd05054          69 HHLNVVNLLGACTKPG----GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSAS  144 (337)
T ss_pred             cCcchhheeeeEecCC----CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccc
Confidence            6999999999886542    56899999998 5999988532                                      


Q ss_pred             -----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEeecccccccC
Q 023568           43 -----------------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS   99 (280)
Q Consensus        43 -----------------------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~   99 (280)
                                             ..+++..+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||++....
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~  224 (337)
T cd05054         145 SGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIY  224 (337)
T ss_pred             cccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcc
Confidence                                   268999999999999999999999999999999999999999999999999998653


Q ss_pred             CCCc---cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCccccccc
Q 023568          100 ETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFL  175 (280)
Q Consensus       100 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  175 (280)
                      ....   .....++..|+|||.+.+ ..++.++|+||+||++|+|++ |..||.+....+.........           
T Consensus       225 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~-----------  292 (337)
T cd05054         225 KDPDYVRKGDARLPLKWMAPESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEG-----------  292 (337)
T ss_pred             cCcchhhccCCCCCccccCcHHhcC-CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhcc-----------
Confidence            3211   122344678999999877 778899999999999999997 999997754322221111100           


Q ss_pred             CChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 023568          176 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  230 (280)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~h  230 (280)
                                        .........++.+.+++.+||+.+|++||+++|+++|
T Consensus       293 ------------------~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~  329 (337)
T cd05054         293 ------------------TRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI  329 (337)
T ss_pred             ------------------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                              0001122457889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-35  Score=246.02  Aligned_cols=193  Identities=25%  Similarity=0.422  Sum_probs=157.9

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD----------QQLTDDHCQYFLYQLLRGLKYVHSASV   69 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~----------~~l~~~~~~~i~~qil~~l~~LH~~~i   69 (280)
                      ++||||+++++++...     ...|+||||++ |+|.+++...          ..+++..+..++.|++.||.|||+.|+
T Consensus        66 ~~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i  140 (277)
T cd05032          66 FNCHHVVRLLGVVSTG-----QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKF  140 (277)
T ss_pred             CCCCceeEEEEEEcCC-----CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            5799999999999887     67999999997 6999998642          247888999999999999999999999


Q ss_pred             cccCCCCCceEEcCCCCeEEeecccccccCCCCc---cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CC
Q 023568           70 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-RE  145 (280)
Q Consensus        70 ~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~  145 (280)
                      +|+||+|+||+++.++.++|+|||+++.......   .....++..|+|||.+.+ ...+.++|+|||||++|++++ |.
T Consensus       141 ~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~  219 (277)
T cd05032         141 VHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTKSDVWSFGVVLWEMATLAE  219 (277)
T ss_pred             cccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhc-CCCCcccchHHHHHHHHHhhccCC
Confidence            9999999999999999999999999876543321   223445778999999876 668889999999999999998 99


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 023568          146 PLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVE  225 (280)
Q Consensus       146 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~  225 (280)
                      .||.+.+.......+..  +                            .....+...+..+.+++++||+.+|++|||+.
T Consensus       220 ~p~~~~~~~~~~~~~~~--~----------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~  269 (277)
T cd05032         220 QPYQGLSNEEVLKFVID--G----------------------------GHLDLPENCPDKLLELMRMCWQYNPKMRPTFL  269 (277)
T ss_pred             CCCccCCHHHHHHHHhc--C----------------------------CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHH
Confidence            99987765444433321  0                            01112224588999999999999999999999


Q ss_pred             HHhc
Q 023568          226 EALR  229 (280)
Q Consensus       226 ell~  229 (280)
                      ++++
T Consensus       270 ~l~~  273 (277)
T cd05032         270 EIVS  273 (277)
T ss_pred             HHHH
Confidence            9986

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.7e-35  Score=241.84  Aligned_cols=191  Identities=24%  Similarity=0.367  Sum_probs=158.0

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      ++||||+++++++.+.     ...|+||||++ ++|.+++....  .+++..+..++.|++.||.|||+.|++|+||+|+
T Consensus        57 l~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~  131 (256)
T cd05039          57 LRHPNLVQLLGVVLQG-----NPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAAR  131 (256)
T ss_pred             cCCcceeeeEEEEcCC-----CCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccc
Confidence            5799999999999876     67999999998 59999997654  7999999999999999999999999999999999


Q ss_pred             ceEEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 023568           78 NLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQ  156 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~~~  156 (280)
                      ||+++.++.++|+|||.++.......  ....+..|+|||.+.+ ..++.++|+||+|+++++|++ |..||......+.
T Consensus       132 Nili~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~ape~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~  208 (256)
T cd05039         132 NVLVSEDLVAKVSDFGLAKEASQGQD--SGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV  208 (256)
T ss_pred             eEEEeCCCCEEEcccccccccccccc--cCCCcccccCchhhcC-CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence            99999999999999999887643321  2334567999998876 678889999999999999997 9999987764443


Q ss_pred             HHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       157 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      ...+....                              ........++.+.+++.+||..+|++|||++++++
T Consensus       209 ~~~~~~~~------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         209 VPHVEKGY------------------------------RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             HHHHhcCC------------------------------CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            33322100                              01112346889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=3.2e-35  Score=247.31  Aligned_cols=193  Identities=27%  Similarity=0.411  Sum_probs=156.2

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC------------------------CCCCHHHHHHHHH
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD------------------------QQLTDDHCQYFLY   55 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~------------------------~~l~~~~~~~i~~   55 (280)
                      ++||||+++++.+...     +..|+||||+. ++|.+++.+.                        ..+++..+..++.
T Consensus        60 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~  134 (290)
T cd05045          60 VNHPHVIKLYGACSQD-----GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAW  134 (290)
T ss_pred             CCCCCEeeEEEEEecC-----CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHH
Confidence            5799999999999877     66899999998 5999988642                        2478999999999


Q ss_pred             HHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEeecccccccCCCCc---cccceeccccccccccccCCCCCcchhHH
Q 023568           56 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIW  132 (280)
Q Consensus        56 qil~~l~~LH~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dvw  132 (280)
                      |++.||.|||+.|++||||||+||+++.++.++|+|||+++.......   .....++..|+|||.+.+ ..++.++|+|
T Consensus       135 ~i~~~l~~LH~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~  213 (290)
T cd05045         135 QISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-HIYTTQSDVW  213 (290)
T ss_pred             HHHHHHHHHHHCCeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc-CCcchHhHHH
Confidence            999999999999999999999999999999999999999875432211   122344668999998876 6788999999


Q ss_pred             HHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHH
Q 023568          133 SVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLE  211 (280)
Q Consensus       133 slG~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~  211 (280)
                      |||+++++|++ |..||.+.........+.....                              .......+.++.+++.
T Consensus       214 slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~i~  263 (290)
T cd05045         214 SFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYR------------------------------MERPENCSEEMYNLML  263 (290)
T ss_pred             HHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC------------------------------CCCCCCCCHHHHHHHH
Confidence            99999999998 9999987765444333221100                              0112246789999999


Q ss_pred             HhcccCCCCCCCHHHHhc
Q 023568          212 KMLVFDPNKRITVEEALR  229 (280)
Q Consensus       212 ~~L~~dp~~Rpt~~ell~  229 (280)
                      +||+.||.+||+++++++
T Consensus       264 ~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         264 TCWKQEPDKRPTFADISK  281 (290)
T ss_pred             HHccCCcccCCCHHHHHH
Confidence            999999999999999976

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=4.9e-35  Score=242.06  Aligned_cols=192  Identities=17%  Similarity=0.282  Sum_probs=155.6

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      |+||||++++++++.      ...++||||++ ++|.+++.. ...+++..+..++.|++.||+|||+.|++||||||+|
T Consensus        52 l~h~~ii~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~n  125 (257)
T cd05115          52 LDNPYIVRMIGVCEA------EALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARN  125 (257)
T ss_pred             cCCCCeEEEEEEEcC------CCeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchhe
Confidence            589999999998853      35899999997 599999874 4579999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCc----cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDF----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDY  153 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~  153 (280)
                      |+++.++.++|+|||.+........    .....++..|+|||.+.+ ..++.++|+|||||++|++++ |..||.....
T Consensus       126 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~  204 (257)
T cd05115         126 VLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG  204 (257)
T ss_pred             EEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHcc-CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH
Confidence            9999999999999999875443321    111223567999998876 668889999999999999996 9999988765


Q ss_pred             HHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          154 VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       154 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      .+....+.+..                              .....+..++++.+++.+||+.||++||++.++.+
T Consensus       205 ~~~~~~~~~~~------------------------------~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         205 PEVMSFIEQGK------------------------------RLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             HHHHHHHHCCC------------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            55443332210                              01112356889999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=4.5e-35  Score=243.74  Aligned_cols=198  Identities=25%  Similarity=0.328  Sum_probs=153.4

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ-----QLTDDHCQYFLYQLLRGLKYVHSASVLHRDL   74 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~-----~l~~~~~~~i~~qil~~l~~LH~~~i~H~di   74 (280)
                      ++||||+++++.+...     ...|+||||++ |+|.+++.+.+     ..++..+..++.|++.||+|||+.||+||||
T Consensus        52 l~h~nii~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dl  126 (269)
T cd05042          52 LNHPNVLQCLGQCIES-----IPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDL  126 (269)
T ss_pred             CCCCCcceEEEEECCC-----CceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccc
Confidence            5799999999999877     66999999997 59999997532     3568889999999999999999999999999


Q ss_pred             CCCceEEcCCCCeEEeecccccccCCCCc---cccceecccccccccccc------CCCCCcchhHHHHHHHHHHHHh-C
Q 023568           75 KPSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLN------CTEYTAAIDIWSVGCILGEIMT-R  144 (280)
Q Consensus        75 k~~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~------~~~~~~~~DvwslG~~l~~ll~-g  144 (280)
                      ||+||+++.++.++|+|||++........   .....++..|+|||.+..      ...++.++|+||+||++|+|++ |
T Consensus       127 kp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~  206 (269)
T cd05042         127 ALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAA  206 (269)
T ss_pred             cHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCC
Confidence            99999999999999999999865332211   122344667999998743      2356789999999999999998 7


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCH
Q 023568          145 EPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV  224 (280)
Q Consensus       145 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~  224 (280)
                      ..||......+.+..+.......                         ...+......+..+.+++..|+ .||++|||+
T Consensus       207 ~~p~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~  260 (269)
T cd05042         207 DQPYPDLSDEQVLKQVVREQDIK-------------------------LPKPQLDLKYSDRWYEVMQFCW-LDPETRPTA  260 (269)
T ss_pred             CCCCCcCCHHHHHHHHhhccCcc-------------------------CCCCcccccCCHHHHHHHHHHh-cCcccccCH
Confidence            88998776555444332211100                         0011122356788899999998 599999999


Q ss_pred             HHHhc
Q 023568          225 EEALR  229 (280)
Q Consensus       225 ~ell~  229 (280)
                      +++++
T Consensus       261 ~~v~~  265 (269)
T cd05042         261 EEVHE  265 (269)
T ss_pred             HHHHH
Confidence            99986

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=5.6e-35  Score=244.59  Aligned_cols=192  Identities=22%  Similarity=0.321  Sum_probs=154.5

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||+++++++..      ...++|+||+. |+|.+++.. .+.+++..+..++.|++.||+|||+.|++||||||+|
T Consensus        66 l~h~~iv~~~~~~~~------~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~n  139 (279)
T cd05111          66 LDHAYIVRLLGICPG------ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARN  139 (279)
T ss_pred             CCCCCcceEEEEECC------CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcce
Confidence            479999999998753      34789999997 699999975 4579999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCC---ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYV  154 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~  154 (280)
                      |+++.++.++|+|||.++......   ......++..|+|||.+.+ ..++.++|+|||||++|||++ |..||.+....
T Consensus       140 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~  218 (279)
T cd05111         140 ILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILF-GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH  218 (279)
T ss_pred             EEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            999999999999999997643321   1223445678999999876 678899999999999999998 99999887643


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      .....+.+ ...+                             ......+.++.+++.+|+..||++|||+.|+++
T Consensus       219 ~~~~~~~~-~~~~-----------------------------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         219 EVPDLLEK-GERL-----------------------------AQPQICTIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             HHHHHHHC-CCcC-----------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            33222211 0000                             011134678899999999999999999999976

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=7.2e-36  Score=229.84  Aligned_cols=231  Identities=29%  Similarity=0.593  Sum_probs=181.8

Q ss_pred             CcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE
Q 023568            3 HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL   81 (280)
Q Consensus         3 Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nili   81 (280)
                      ||||++++++..++.+   ...-||+||.+. +...+.   ++++.-.++.+++|++.||.|+|++||+|||+||.|++|
T Consensus        92 g~NIi~L~DiV~Dp~S---ktpaLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmI  165 (338)
T KOG0668|consen   92 GPNIIKLLDIVKDPES---KTPSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMI  165 (338)
T ss_pred             CCCeeehhhhhcCccc---cCchhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeee
Confidence            8999999999998855   567899999986 666664   679999999999999999999999999999999999999


Q ss_pred             cC-CCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCC-CCCCCChHHHHHH
Q 023568           82 NA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREP-LFPGKDYVHQLRL  159 (280)
Q Consensus        82 ~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~-pf~~~~~~~~~~~  159 (280)
                      |. ...++|+|+|+|.+..+.....-...+.+|.-||.+.....+..+-|+|||||++..|+..+. .|.|.++.+++-+
T Consensus       166 dh~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVk  245 (338)
T KOG0668|consen  166 DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVK  245 (338)
T ss_pred             chhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHH
Confidence            87 456999999999998887666666778899999999888889999999999999999998665 4677889999999


Q ss_pred             HHHHhCCCCcccc-c---ccCChhHHHHHHhCCcccccccc-ccCC-CCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          160 ITELIGSPDDASL-G---FLRSDNARRYVRQLPRCRKQQFA-TRFP-NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       160 i~~~~~~~~~~~~-~---~~~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      |.+++|+..-... .   ..-.+.....+.+-.+..-..+- .... -.++++.||+.++|..|-.+|+||.|++.||||
T Consensus       246 IakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF  325 (338)
T KOG0668|consen  246 IAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYF  325 (338)
T ss_pred             HHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchH
Confidence            9999985432210 0   00011122222222111111111 1111 257999999999999999999999999999999


Q ss_pred             ccCcCC
Q 023568          234 QSLHDL  239 (280)
Q Consensus       234 ~~~~~~  239 (280)
                      ..+.+.
T Consensus       326 ~~~~~~  331 (338)
T KOG0668|consen  326 APVREA  331 (338)
T ss_pred             HHHHHH
Confidence            877543

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2.9e-35  Score=250.59  Aligned_cols=193  Identities=22%  Similarity=0.313  Sum_probs=156.1

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||+++++++...      ..++|+||+. |+|.+++.+. ..+++..+..++.|++.||+|||+.||+||||||+|
T Consensus        66 l~h~niv~~~g~~~~~------~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~N  139 (316)
T cd05108          66 VDNPHVCRLLGICLTS------TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARN  139 (316)
T ss_pred             CCCCCCCeEEEEEcCC------CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhh
Confidence            5799999999998754      3679999997 6999999764 468999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCcc---ccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDFM---TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYV  154 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~  154 (280)
                      |+++.++.++|+|||+++........   ....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+....
T Consensus       140 ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~  218 (316)
T cd05108         140 VLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS  218 (316)
T ss_pred             eEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            99999999999999999875543221   12234567999999876 778899999999999999997 99999876544


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  230 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~h  230 (280)
                      +....+.. ..                             .....+..+.++.+++.+||..||.+|||+.+++.+
T Consensus       219 ~~~~~~~~-~~-----------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         219 EISSILEK-GE-----------------------------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             HHHHHHhC-CC-----------------------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            33222111 00                             001123457789999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=4.9e-35  Score=246.77  Aligned_cols=200  Identities=24%  Similarity=0.363  Sum_probs=159.9

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCC-----------CCCHHHHHHHHHHHHHHHHHHHhCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ-----------QLTDDHCQYFLYQLLRGLKYVHSAS   68 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~-----------~l~~~~~~~i~~qil~~l~~LH~~~   68 (280)
                      ++||||+++++++...     ...++|||++. ++|.+++.+..           .+++..+..++.|++.||+|||+.|
T Consensus        76 l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~  150 (296)
T cd05051          76 LSDPNIARLLGVCTVD-----PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN  150 (296)
T ss_pred             cCCCCEeEEEEEEecC-----CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC
Confidence            5899999999999887     67999999997 59999987655           6899999999999999999999999


Q ss_pred             ccccCCCCCceEEcCCCCeEEeecccccccCCCC---ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh--
Q 023568           69 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--  143 (280)
Q Consensus        69 i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~--  143 (280)
                      ++|+||||+||+++.++.++|+|||.++......   ......++..|+|||.+.+ ..++.++|||||||++|+|++  
T Consensus       151 i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~  229 (296)
T cd05051         151 FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL-GKFTTKSDVWAFGVTLWEILTLC  229 (296)
T ss_pred             ccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc-CCCCccchhhhhHHHHHHHHhcC
Confidence            9999999999999999999999999987643322   1223345678999999876 678899999999999999998  


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCC
Q 023568          144 REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT  223 (280)
Q Consensus       144 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt  223 (280)
                      |..||......+.+...........                       ........+..+.++.+++.+||+.||.+|||
T Consensus       230 ~~~p~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt  286 (296)
T cd05051         230 REQPYEHLTDQQVIENAGHFFRDDG-----------------------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPT  286 (296)
T ss_pred             CCCCCCCcChHHHHHHHHhcccccc-----------------------ccccCCCccCCCHHHHHHHHHHhccChhcCCC
Confidence            6788877665555444432211000                       00111122346789999999999999999999


Q ss_pred             HHHHhc
Q 023568          224 VEEALR  229 (280)
Q Consensus       224 ~~ell~  229 (280)
                      +.++++
T Consensus       287 ~~el~~  292 (296)
T cd05051         287 FREIHL  292 (296)
T ss_pred             HHHHHH
Confidence            999965

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=5e-35  Score=248.97  Aligned_cols=192  Identities=27%  Similarity=0.456  Sum_probs=156.7

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHH
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD----------------QQLTDDHCQYFLYQLLRGLKYV   64 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~----------------~~l~~~~~~~i~~qil~~l~~L   64 (280)
                      +||||+++++++.+.     ...|+||||+. |+|.+++...                ..+++.++..++.|++.||.||
T Consensus        76 ~h~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~l  150 (314)
T cd05099          76 KHKNIINLLGVCTQE-----GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYL  150 (314)
T ss_pred             CCCCeeeEEEEEccC-----CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHH
Confidence            599999999999877     66999999997 5999999653                3488999999999999999999


Q ss_pred             HhCCccccCCCCCceEEcCCCCeEEeecccccccCCCCc---cccceeccccccccccccCCCCCcchhHHHHHHHHHHH
Q 023568           65 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI  141 (280)
Q Consensus        65 H~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l  141 (280)
                      |+.|++||||||+||+++.++.++|+|||.++.......   .....++..|+|||.+.+ ..++.++|+||||+++|+|
T Consensus       151 H~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el  229 (314)
T cd05099         151 ESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEI  229 (314)
T ss_pred             HHCCeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHcc-CCcCccchhhHHHHHHHHH
Confidence            999999999999999999999999999999976543211   112233467999999877 7788999999999999999


Q ss_pred             Hh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCC
Q 023568          142 MT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNK  220 (280)
Q Consensus       142 l~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~  220 (280)
                      ++ |..||.+....+....+....                              ........+.++.+++.+||..||++
T Consensus       230 ~~~g~~p~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~l~~li~~cl~~~p~~  279 (314)
T cd05099         230 FTLGGSPYPGIPVEELFKLLREGH------------------------------RMDKPSNCTHELYMLMRECWHAVPTQ  279 (314)
T ss_pred             HhCCCCCCCCCCHHHHHHHHHcCC------------------------------CCCCCCCCCHHHHHHHHHHcCCCccc
Confidence            98 899998776555444332200                              00112356788999999999999999


Q ss_pred             CCCHHHHhc
Q 023568          221 RITVEEALR  229 (280)
Q Consensus       221 Rpt~~ell~  229 (280)
                      |||+.++++
T Consensus       280 Rps~~~ll~  288 (314)
T cd05099         280 RPTFKQLVE  288 (314)
T ss_pred             CcCHHHHHH
Confidence            999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.3e-35  Score=242.16  Aligned_cols=193  Identities=27%  Similarity=0.407  Sum_probs=159.0

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      ++||||+++++++...     ...++||||++ ++|.+++.+.  ..+++.++..++.|++.||.|||++|++|+||+|+
T Consensus        58 l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~  132 (261)
T cd05034          58 LRHDKLVQLYAVCSEE-----EPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAAR  132 (261)
T ss_pred             CCCCCEeeeeeeeecC-----CceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchh
Confidence            5799999999999876     56999999997 5999999764  46999999999999999999999999999999999


Q ss_pred             ceEEcCCCCeEEeecccccccCCCCc--cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023568           78 NLLLNASCDLKIGDFGLARTTSETDF--MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYV  154 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~  154 (280)
                      ||+++.++.++|+|||.+........  ......+..|+|||.+.+ ...+.++|+||+|+++++|++ |+.||.+....
T Consensus       133 nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~  211 (261)
T cd05034         133 NILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR  211 (261)
T ss_pred             eEEEcCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999876543211  112233567999999876 678899999999999999998 99999887765


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      .....+......                              ......+..+.+++.+||..+|.+||+++++++
T Consensus       212 ~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         212 EVLEQVERGYRM------------------------------PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             HHHHHHHcCCCC------------------------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            555544321110                              111245788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=3.9e-35  Score=248.80  Aligned_cols=193  Identities=27%  Similarity=0.447  Sum_probs=156.3

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHH
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD----------------QQLTDDHCQYFLYQLLRGLKYV   64 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~----------------~~l~~~~~~~i~~qil~~l~~L   64 (280)
                      +||||+++++++...     +..|+||||++ |+|.+++...                ..+++.++..++.|++.||+||
T Consensus        82 ~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~l  156 (307)
T cd05098          82 KHKNIINLLGACTQD-----GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL  156 (307)
T ss_pred             CCCCEeeEEEEEecC-----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHH
Confidence            699999999999887     67999999997 5999999753                2488999999999999999999


Q ss_pred             HhCCccccCCCCCceEEcCCCCeEEeecccccccCCCCcc---ccceeccccccccccccCCCCCcchhHHHHHHHHHHH
Q 023568           65 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM---TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI  141 (280)
Q Consensus        65 H~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l  141 (280)
                      |+.|++||||||+||+++.++.++|+|||.+.........   ....++..|+|||.+.+ ..++.++|+||+||++|+|
T Consensus       157 H~~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el  235 (307)
T cd05098         157 ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEI  235 (307)
T ss_pred             HHCCcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhcc-CCCCcHHHHHHHHHHHHHH
Confidence            9999999999999999999999999999998765432111   12233567999999877 6788999999999999999


Q ss_pred             Hh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCC
Q 023568          142 MT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNK  220 (280)
Q Consensus       142 l~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~  220 (280)
                      ++ |..||.+....+....+....                              ........+.++.+++++||..+|.+
T Consensus       236 ~~~g~~p~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~  285 (307)
T cd05098         236 FTLGGSPYPGVPVEELFKLLKEGH------------------------------RMDKPSNCTNELYMMMRDCWHAVPSQ  285 (307)
T ss_pred             HcCCCCCCCcCCHHHHHHHHHcCC------------------------------CCCCCCcCCHHHHHHHHHHcccChhh
Confidence            98 889997766444333322100                              01112346889999999999999999


Q ss_pred             CCCHHHHhcC
Q 023568          221 RITVEEALRH  230 (280)
Q Consensus       221 Rpt~~ell~h  230 (280)
                      |||+.+++++
T Consensus       286 Rps~~evl~~  295 (307)
T cd05098         286 RPTFKQLVED  295 (307)
T ss_pred             CcCHHHHHHH
Confidence            9999999873

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=8.7e-35  Score=240.33  Aligned_cols=193  Identities=25%  Similarity=0.387  Sum_probs=158.4

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      ++||||+++++++..      ...++||||+. ++|.+++.+..  .+++..+..++.|++.||.|||+.|++|+||+|+
T Consensus        53 l~h~~iv~~~~~~~~------~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~  126 (257)
T cd05040          53 LDHENLIRLYGVVLT------HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAAR  126 (257)
T ss_pred             cCCCCccceeEEEcC------CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcc
Confidence            579999999999876      34899999997 69999997653  6899999999999999999999999999999999


Q ss_pred             ceEEcCCCCeEEeecccccccCCCC----ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 023568           78 NLLLNASCDLKIGDFGLARTTSETD----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKD  152 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~  152 (280)
                      ||+++.++.++|+|||.+.......    ......++..|+|||.+.+ ..++.++|+||+||++++|++ |..||...+
T Consensus       127 nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~  205 (257)
T cd05040         127 NILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT-RTFSHASDVWMFGVTLWEMFTYGEEPWAGLS  205 (257)
T ss_pred             cEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcc-cCcCchhhhHHHHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999988654321    1122345678999998876 678889999999999999998 999998776


Q ss_pred             hHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          153 YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       153 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      ..+....+.....                             ........+..+.+++.+||+.+|++|||+.++++
T Consensus       206 ~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         206 GSQILKKIDKEGE-----------------------------RLERPEACPQDIYNVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             HHHHHHHHHhcCC-----------------------------cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence            6655544432100                             00111245788999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=6.1e-35  Score=247.31  Aligned_cols=193  Identities=27%  Similarity=0.446  Sum_probs=157.3

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHH
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD----------------QQLTDDHCQYFLYQLLRGLKYV   64 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~----------------~~l~~~~~~~i~~qil~~l~~L   64 (280)
                      +||||+++++++...     ...|+||||+. |+|.+++.+.                ..++..++..++.|++.||.||
T Consensus        79 ~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~L  153 (304)
T cd05101          79 KHKNIINLLGACTQD-----GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL  153 (304)
T ss_pred             cCCCchheeEEEecC-----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHH
Confidence            699999999999887     67999999997 5999998653                2478889999999999999999


Q ss_pred             HhCCccccCCCCCceEEcCCCCeEEeecccccccCCCCc---cccceeccccccccccccCCCCCcchhHHHHHHHHHHH
Q 023568           65 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI  141 (280)
Q Consensus        65 H~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l  141 (280)
                      |+.|++||||||+||+++.++.++|+|||.++.......   .....++..|+|||.+.+ ..++.++|+||||+++|+|
T Consensus       154 H~~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el  232 (304)
T cd05101         154 ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEI  232 (304)
T ss_pred             HHCCeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhcc-CCCCchhhHHHHHHHHHHH
Confidence            999999999999999999999999999999876543321   122334677999999877 6788899999999999999


Q ss_pred             Hh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCC
Q 023568          142 MT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNK  220 (280)
Q Consensus       142 l~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~  220 (280)
                      ++ |..||.+....+....+....                              ........+..+.+++.+||+.+|.+
T Consensus       233 ~~~g~~p~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~li~~cl~~~p~~  282 (304)
T cd05101         233 FTLGGSPYPGIPVEELFKLLKEGH------------------------------RMDKPANCTNELYMMMRDCWHAIPSH  282 (304)
T ss_pred             HcCCCCCcccCCHHHHHHHHHcCC------------------------------cCCCCCCCCHHHHHHHHHHcccChhh
Confidence            98 888998776555444332110                              00112246789999999999999999


Q ss_pred             CCCHHHHhcC
Q 023568          221 RITVEEALRH  230 (280)
Q Consensus       221 Rpt~~ell~h  230 (280)
                      |||+.++++.
T Consensus       283 Rps~~e~l~~  292 (304)
T cd05101         283 RPTFKQLVED  292 (304)
T ss_pred             CCCHHHHHHH
Confidence            9999999873

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=7.2e-35  Score=241.34  Aligned_cols=192  Identities=24%  Similarity=0.396  Sum_probs=155.9

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      ++||||+++++++..      ...|+||||++ ++|.+++.+.  ..+++.++..++.|++.||+|||+.|++|+||+|+
T Consensus        58 l~~~~i~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~  131 (260)
T cd05070          58 LRHDKLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSA  131 (260)
T ss_pred             cCCCceEEEEeEECC------CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccc
Confidence            589999999998753      34799999997 5999998753  46899999999999999999999999999999999


Q ss_pred             ceEEcCCCCeEEeecccccccCCCCc--cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023568           78 NLLLNASCDLKIGDFGLARTTSETDF--MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYV  154 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~  154 (280)
                      ||+++.++.++|+|||.+........  .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||.+.+..
T Consensus       132 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~  210 (260)
T cd05070         132 NILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR  210 (260)
T ss_pred             eEEEeCCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhc-CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence            99999999999999999876543321  112334567999998866 678889999999999999999 89999887655


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      +....+.....                              .......+..+.+++++||..||.+|||++++++
T Consensus       211 ~~~~~~~~~~~------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         211 EVLEQVERGYR------------------------------MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             HHHHHHHcCCC------------------------------CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence            55444322100                              0112356788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.1e-35  Score=243.20  Aligned_cols=199  Identities=21%  Similarity=0.330  Sum_probs=158.0

Q ss_pred             CCCcccccccccccCCCC-CCCCcEEEEEecCC-ccHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 023568            1 MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMD-TDLHQIIRSD------QQLTDDHCQYFLYQLLRGLKYVHSASVLHR   72 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~-~~~~~~~lv~e~~~-g~L~~~l~~~------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~   72 (280)
                      ++||||+++++++..... .+....++||||+. |+|.+++...      ..+++..+..++.|++.||.|||+.|++||
T Consensus        58 l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~  137 (273)
T cd05035          58 FDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHR  137 (273)
T ss_pred             CCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence            579999999998876532 22345899999997 5999888432      368999999999999999999999999999


Q ss_pred             CCCCCceEEcCCCCeEEeecccccccCCCCc---cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCC
Q 023568           73 DLKPSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLF  148 (280)
Q Consensus        73 dik~~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf  148 (280)
                      ||||+||+++.++.++|+|||.++.......   .....++..|+|||.+.+ ..++.++|+||+||++|+|++ |..||
T Consensus       138 dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~  216 (273)
T cd05035         138 DLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPY  216 (273)
T ss_pred             ccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCC
Confidence            9999999999999999999999876543321   112234567999998866 778899999999999999999 89999


Q ss_pred             CCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 023568          149 PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL  228 (280)
Q Consensus       149 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell  228 (280)
                      .+....+....+...                              .....+...+..+.+++++||+.||.+|||+.+++
T Consensus       217 ~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~  266 (273)
T cd05035         217 PGVENHEIYDYLRHG------------------------------NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLR  266 (273)
T ss_pred             CCCCHHHHHHHHHcC------------------------------CCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence            877654443333210                              01112235688999999999999999999999998


Q ss_pred             cC
Q 023568          229 RH  230 (280)
Q Consensus       229 ~h  230 (280)
                      ++
T Consensus       267 ~~  268 (273)
T cd05035         267 EV  268 (273)
T ss_pred             HH
Confidence            63

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=7.4e-35  Score=242.39  Aligned_cols=195  Identities=26%  Similarity=0.461  Sum_probs=161.2

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDL   74 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~----~~~~l~~~~~~~i~~qil~~l~~LH~-~~i~H~di   74 (280)
                      ++||||+++++++...     +..++||||++| +|.+++.    ....+++..+..++.|++.||.|||+ .|++|+||
T Consensus        66 ~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl  140 (269)
T cd08528          66 LRHPNIVRYYKTFLEN-----DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDL  140 (269)
T ss_pred             CCCCCeeeEEeeEccC-----CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCC
Confidence            4799999999999887     779999999975 8988874    23569999999999999999999996 68999999


Q ss_pred             CCCceEEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023568           75 KPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV  154 (280)
Q Consensus        75 k~~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~  154 (280)
                      +|.||+++.++.++|+|||.+.............++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+..
T Consensus       141 ~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~  219 (269)
T cd08528         141 TPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNML  219 (269)
T ss_pred             CHHHEEECCCCcEEEecccceeecccccccccccCcccCcChhhhcC-CCCchHHHHHHHHHHHHHHHhCCCcccccCHH
Confidence            99999999999999999999987655544455678889999999977 66889999999999999999999999877655


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  230 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~h  230 (280)
                      .....+......+                             ......++.+.+++++||+.||++||++.|+.++
T Consensus       220 ~~~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         220 SLATKIVEAVYEP-----------------------------LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             HHHHHHhhccCCc-----------------------------CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            4444332211100                             0011457889999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=6.6e-35  Score=244.55  Aligned_cols=209  Identities=23%  Similarity=0.317  Sum_probs=155.6

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++.....   ..+|+||||+. ++|.+++.. ..+++.++..++.|++.||.|||+.|++||||||+||
T Consensus        63 l~h~~i~~~~~~~~~~~~---~~~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Ni  138 (283)
T cd05080          63 LYHENIVKYKGCCSEQGG---KGLQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNV  138 (283)
T ss_pred             CCCCCEeeEEEEEecCCC---ceEEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheE
Confidence            589999999998876432   56899999998 599999875 4699999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCc----cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDF----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH  155 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~  155 (280)
                      +++.++.++|+|||++........    .....++..|+|||.+.+ ..++.++|+||||+++++|++|..||...... 
T Consensus       139 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-  216 (283)
T cd05080         139 LLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKE-NKFSYASDVWSFGVTLYELLTHCDSKQSPPKK-  216 (283)
T ss_pred             EEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcc-cCCCcccccHHHHHHHHHHHhCCCCCCCCcch-
Confidence            999999999999999876543211    122345667999998876 67889999999999999999999998654321 


Q ss_pred             HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          156 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       156 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                       ...+   .......       ............   ..........+..+.+++.+||+.||++|||++++++
T Consensus       217 -~~~~---~~~~~~~-------~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         217 -FEEM---IGPKQGQ-------MTVVRLIELLER---GMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             -hhhh---hcccccc-------cchhhhhhhhhc---CCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence             0000   0000000       000000000000   0011123356889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=9.1e-35  Score=241.79  Aligned_cols=193  Identities=27%  Similarity=0.433  Sum_probs=156.3

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC-------CCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-------QQLTDDHCQYFLYQLLRGLKYVHSASVLHR   72 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~   72 (280)
                      ++||||+++++++...     ...|+||||+. ++|.+++...       ..+++.++..++.|++.||+|||+.+++|+
T Consensus        56 l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~  130 (269)
T cd05044          56 FNHPNIVKLLGVCLLN-----EPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHR  130 (269)
T ss_pred             cCCCCeeeEeeeecCC-----CCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence            5799999999999877     66999999997 5999998642       348899999999999999999999999999


Q ss_pred             CCCCCceEEcCCC-----CeEEeecccccccCCCCc---cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-
Q 023568           73 DLKPSNLLLNASC-----DLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-  143 (280)
Q Consensus        73 dik~~Nili~~~~-----~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-  143 (280)
                      ||+|+||+++.++     .++|+|||++........   .....++..|+|||.+.+ ..++.++|+|||||++|+|++ 
T Consensus       131 dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~ellt~  209 (269)
T cd05044         131 DLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLD-GKFTTQSDVWSFGVLMWEILTL  209 (269)
T ss_pred             CCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHcc-CCcccchhHHHHHHHHHHHHHc
Confidence            9999999999877     899999999875433211   122344678999999876 678899999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCC
Q 023568          144 REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT  223 (280)
Q Consensus       144 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt  223 (280)
                      |..||...+.......+...                              .........+..+.+++.+||+.+|.+||+
T Consensus       210 g~~p~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~  259 (269)
T cd05044         210 GQQPYPALNNQEVLQHVTAG------------------------------GRLQKPENCPDKIYQLMTNCWAQDPSERPT  259 (269)
T ss_pred             CCCCCcccCHHHHHHHHhcC------------------------------CccCCcccchHHHHHHHHHHcCCCcccCCC
Confidence            99999877655444333210                              001112346788999999999999999999


Q ss_pred             HHHHhc
Q 023568          224 VEEALR  229 (280)
Q Consensus       224 ~~ell~  229 (280)
                      ++++++
T Consensus       260 ~~~i~~  265 (269)
T cd05044         260 FDRIQE  265 (269)
T ss_pred             HHHHHH
Confidence            999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=4.9e-35  Score=243.17  Aligned_cols=194  Identities=29%  Similarity=0.466  Sum_probs=155.9

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK   75 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik   75 (280)
                      ++||||+++++++.+.     +..++||||++ |+|.+++..    ...+++..+..++.|++.||+|||++|++|+||+
T Consensus        59 l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~  133 (267)
T cd08228          59 LNHPNVIKYLDSFIED-----NELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIK  133 (267)
T ss_pred             CCCcceeeeeeeEEEC-----CeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCC
Confidence            5799999999999877     67999999998 499888752    3458999999999999999999999999999999


Q ss_pred             CCceEEcCCCCeEEeecccccccCCCCc-cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh-
Q 023568           76 PSNLLLNASCDLKIGDFGLARTTSETDF-MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY-  153 (280)
Q Consensus        76 ~~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~-  153 (280)
                      |+||+++.++.++|+|||.+........ .....++..|+|||.+.+ ...+.++|+||+|+++|+|++|..||..... 
T Consensus       134 ~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~  212 (267)
T cd08228         134 PANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN  212 (267)
T ss_pred             HHHEEEcCCCCEEECccccceeccchhHHHhcCCCCccccChhhhcc-CCCCchhhHHHHHHHHHHHhcCCCCCcccccc
Confidence            9999999999999999999876544321 233567889999999876 6678899999999999999999999866532 


Q ss_pred             -HHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          154 -VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       154 -~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                       ......+.. .+.++                            ......+..+.+++.+||..+|++|||+.++++
T Consensus       213 ~~~~~~~~~~-~~~~~----------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~  260 (267)
T cd08228         213 LFSLCQKIEQ-CDYPP----------------------------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ  260 (267)
T ss_pred             HHHHHHHHhc-CCCCC----------------------------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence             111111111 01000                            001245788999999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.2e-36  Score=257.82  Aligned_cols=201  Identities=26%  Similarity=0.451  Sum_probs=163.1

Q ss_pred             CcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE
Q 023568            3 HENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL   81 (280)
Q Consensus         3 Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nili   81 (280)
                      ++=||+|+-.|++.     +.+|+||+|.. |++..+|-+.+.|.|+-+++++..+.+|+++.|+.|++||||||+||||
T Consensus       688 n~WVVrLyySFQDk-----dnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILI  762 (1034)
T KOG0608|consen  688 NEWVVRLYYSFQDK-----DNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI  762 (1034)
T ss_pred             CcceEEEEEEeccC-----CceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEE
Confidence            56799999999998     77999999997 5999999888999999999999999999999999999999999999999


Q ss_pred             cCCCCeEEeecccccccCC---------C-----C-----------------------------ccccceeccccccccc
Q 023568           82 NASCDLKIGDFGLARTTSE---------T-----D-----------------------------FMTEYVVTRWYRAPEL  118 (280)
Q Consensus        82 ~~~~~~kl~dfg~~~~~~~---------~-----~-----------------------------~~~~~~~~~~y~aPE~  118 (280)
                      |.+|.+||+|||+++....         +     +                             ..-...||+.|+|||+
T Consensus       763 DrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapev  842 (1034)
T KOG0608|consen  763 DRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEV  842 (1034)
T ss_pred             ccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHH
Confidence            9999999999999863210         0     0                             0023478999999999


Q ss_pred             cccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCcccccccccc
Q 023568          119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR  198 (280)
Q Consensus       119 ~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (280)
                      +.. ..+...+|.||.|||||||+.|++||-.....+...++..                           +..-..-..
T Consensus       843 l~r-~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~n---------------------------w~~~l~~~~  894 (1034)
T KOG0608|consen  843 LAR-TGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVIN---------------------------WRNFLHIPY  894 (1034)
T ss_pred             hcc-cCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeee---------------------------hhhcccccc
Confidence            987 8899999999999999999999999988765443333211                           000000111


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCcccccCc
Q 023568          199 FPNKSSGAVDLLEKMLVFDPNKRI---TVEEALRHPYLQSLH  237 (280)
Q Consensus       199 ~~~~~~~~~~ll~~~L~~dp~~Rp---t~~ell~hp~~~~~~  237 (280)
                      ...+++++.++|+++ +-+++.|.   .++|+.+||||+.+-
T Consensus       895 ~~~ls~e~~~li~kL-c~sad~RLGkng~d~vKaHpfFkgID  935 (1034)
T KOG0608|consen  895 QGNLSKEALDLIQKL-CCSADSRLGKNGADQVKAHPFFKGID  935 (1034)
T ss_pred             ccccCHHHHHHHHHH-hcChhhhhcccchhhhhcCccccccc
Confidence            235799999999986 44788887   677899999999874

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=6.9e-35  Score=242.42  Aligned_cols=193  Identities=25%  Similarity=0.370  Sum_probs=158.0

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||+++++++...     +..|+||||++ ++|.+++.+. +.+++.++..++.|++.||++||+.|++||||||+|
T Consensus        62 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~n  136 (267)
T cd05066          62 FDHPNIIHLEGVVTKS-----KPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARN  136 (267)
T ss_pred             CCCCCcceEEEEEecC-----CccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhc
Confidence            5799999999999877     67999999997 5999999754 568999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCc----cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDF----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDY  153 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~  153 (280)
                      |+++.++.++|+|||.+........    .....++..|+|||.+.+ ..++.++|+||+|+++|++++ |..||...+.
T Consensus       137 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~  215 (267)
T cd05066         137 ILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWEMSN  215 (267)
T ss_pred             EEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhcc-CccCchhhhHHHHHHHHHHhcCCCCCcccCCH
Confidence            9999999999999999876543321    111223467999999876 678899999999999999886 9999988765


Q ss_pred             HHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          154 VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       154 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      .+....+.+...                              .......++.+.+++.+||+.+|.+|||+.++++
T Consensus       216 ~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         216 QDVIKAIEEGYR------------------------------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             HHHHHHHhCCCc------------------------------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence            554444432111                              0112246888999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=8e-35  Score=240.32  Aligned_cols=193  Identities=28%  Similarity=0.458  Sum_probs=160.3

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCC--CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQ--LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~--l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      ++||||+++++++.+.     ...|+||||+. ++|.+++.....  +++.++..++.|++.||++||+.|++|+||+|+
T Consensus        58 l~~~~i~~~~~~~~~~-----~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~  132 (258)
T smart00219       58 LDHPNIVKLLGVCTEE-----EPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAAR  132 (258)
T ss_pred             cCCCchheEEEEEcCC-----CeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccc
Confidence            4799999999999987     67999999997 599999976544  999999999999999999999999999999999


Q ss_pred             ceEEcCCCCeEEeecccccccCCCCccc--cceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023568           78 NLLLNASCDLKIGDFGLARTTSETDFMT--EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYV  154 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~  154 (280)
                      ||+++.++.++|+|||.+..........  ...++..|+|||.+.+ ..++.++|+||+|+++++|++ |.+||...+..
T Consensus       133 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~  211 (258)
T smart00219      133 NCLVGENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE  211 (258)
T ss_pred             eEEEccCCeEEEcccCCceecccccccccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999998665442221  1235678999999865 778899999999999999998 88999887655


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      .....+....                              ........+.++.+++.+||..||++|||+.|+++
T Consensus       212 ~~~~~~~~~~------------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      212 EVLEYLKKGY------------------------------RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             HHHHHHhcCC------------------------------CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence            5554443211                              01112246889999999999999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=8.7e-35  Score=243.33  Aligned_cols=192  Identities=23%  Similarity=0.310  Sum_probs=155.3

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||+++++++...      ..+++|||+. |+|.+++++. +.+++.++..++.|++.||+|||+.|++||||||+|
T Consensus        66 ~~~~~i~~~~~~~~~~------~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~N  139 (279)
T cd05109          66 VGSPYVCRLLGICLTS------TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARN  139 (279)
T ss_pred             cCCCCCceEEEEEcCC------CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccce
Confidence            4799999999998753      3789999997 6999999764 569999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCc---cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYV  154 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~  154 (280)
                      |+++.++.++|+|||+++.......   .....++..|+|||...+ ..++.++|+|||||++|||++ |..||......
T Consensus       140 il~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~  218 (279)
T cd05109         140 VLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILH-RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR  218 (279)
T ss_pred             EEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            9999999999999999876543321   122334678999999876 678899999999999999998 99999876544


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      .....+... .                             .....+..+.++.+++.+||..||++||++.+++.
T Consensus       219 ~~~~~~~~~-~-----------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         219 EIPDLLEKG-E-----------------------------RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             HHHHHHHCC-C-----------------------------cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            333322210 0                             01112346888999999999999999999999985

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.2e-34  Score=238.64  Aligned_cols=193  Identities=22%  Similarity=0.388  Sum_probs=157.0

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||+++++++...     ...++||||++ ++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+|
T Consensus        49 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~n  123 (250)
T cd05085          49 YDHPNIVKLIGVCTQR-----QPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARN  123 (250)
T ss_pred             CCCCCcCeEEEEEecC-----CccEEEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChhe
Confidence            5799999999999877     66999999997 599998865 3568999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCcc--ccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVH  155 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~~  155 (280)
                      |+++.++.++|+|||++.........  ....++..|+|||.+.+ ..++.++|+||+|+++|++++ |..||.+.....
T Consensus       124 ili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~  202 (250)
T cd05085         124 CLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ  202 (250)
T ss_pred             EEEcCCCeEEECCCccceeccccccccCCCCCCcccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH
Confidence            99999999999999998754332211  12233567999999876 678889999999999999998 999998876544


Q ss_pred             HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          156 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       156 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      ....+....                              ........+..+.+++.+||..+|.+|||+.++++
T Consensus       203 ~~~~~~~~~------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  246 (250)
T cd05085         203 AREQVEKGY------------------------------RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK  246 (250)
T ss_pred             HHHHHHcCC------------------------------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            433332210                              00112346889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.2e-34  Score=241.89  Aligned_cols=195  Identities=21%  Similarity=0.354  Sum_probs=158.4

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCC---------CCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ---------QLTDDHCQYFLYQLLRGLKYVHSASVL   70 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~---------~l~~~~~~~i~~qil~~l~~LH~~~i~   70 (280)
                      ++||||+++++++.+.     ...|+||||+. |+|.+++....         .+++..+..++.|++.||+|||+.|++
T Consensus        65 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~  139 (275)
T cd05046          65 LSHKNVVRLLGLCREA-----EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFV  139 (275)
T ss_pred             cCCcceeeeEEEECCC-----CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcc
Confidence            5799999999999877     66899999998 69999997655         699999999999999999999999999


Q ss_pred             ccCCCCCceEEcCCCCeEEeecccccccCCCC--ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCC
Q 023568           71 HRDLKPSNLLLNASCDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPL  147 (280)
Q Consensus        71 H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p  147 (280)
                      ||||||+||+++.++.++++|||.+.......  ......++..|+|||.+.+ ...+.++|+||||+++|+|++ |..|
T Consensus       140 H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~~~~~p  218 (275)
T cd05046         140 HRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQE-DDFSTKSDVWSFGVLMWEVFTQGELP  218 (275)
T ss_pred             cCcCccceEEEeCCCcEEEcccccccccCcccccccCCceeEEeecChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            99999999999999999999999986543221  2234456778999998876 567889999999999999998 8889


Q ss_pred             CCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 023568          148 FPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA  227 (280)
Q Consensus       148 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~el  227 (280)
                      |...........+....  .                           ........+..+.+++.+||+.||.+|||+.|+
T Consensus       219 ~~~~~~~~~~~~~~~~~--~---------------------------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~  269 (275)
T cd05046         219 FYGLSDEEVLNRLQAGK--L---------------------------ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSEL  269 (275)
T ss_pred             ccccchHHHHHHHHcCC--c---------------------------CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHH
Confidence            97765444433322100  0                           001122467899999999999999999999999


Q ss_pred             hcC
Q 023568          228 LRH  230 (280)
Q Consensus       228 l~h  230 (280)
                      ++.
T Consensus       270 l~~  272 (275)
T cd05046         270 VSA  272 (275)
T ss_pred             HHH
Confidence            874

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-34  Score=239.09  Aligned_cols=193  Identities=24%  Similarity=0.382  Sum_probs=156.5

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||+++++++.+.     ...|+||||+. ++|.+++.+ ...+++..+..++.|++.||.|||++|++||||+|+|
T Consensus        49 l~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~n  123 (251)
T cd05041          49 YDHPNIVKLIGVCVQK-----QPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARN  123 (251)
T ss_pred             CCCCCeEEEEEEEecC-----CCeEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcce
Confidence            5799999999999887     67999999997 599999865 3568999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCcc---ccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDFM---TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYV  154 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~  154 (280)
                      |+++.++.++|+|||.+.........   .....+..|+|||.+.+ ..++.++|+||||+++|+|++ |..||......
T Consensus       124 ili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~  202 (251)
T cd05041         124 CLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNY-GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ  202 (251)
T ss_pred             EEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhcc-CCCCcchhHHHHHHHHHHHHhccCCCCccCCHH
Confidence            99999999999999998765422111   11223556999999876 678899999999999999998 88999877644


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      .....+....+                              .......+..+.+++.+||+.+|.+|||++|+++
T Consensus       203 ~~~~~~~~~~~------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         203 QTRERIESGYR------------------------------MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             HHHHHHhcCCC------------------------------CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            43333221100                              0111246789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=7.1e-35  Score=242.19  Aligned_cols=193  Identities=29%  Similarity=0.466  Sum_probs=155.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK   75 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik   75 (280)
                      ++||||+++++++...     +..++||||+.| +|.+++..    ...+++..+..++.|++.||+|||+.|++|+||+
T Consensus        59 ~~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~  133 (267)
T cd08229          59 LNHPNVIKYYASFIED-----NELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIK  133 (267)
T ss_pred             ccCCchhhhhheeEeC-----CeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence            5799999999999887     679999999985 99998863    3568999999999999999999999999999999


Q ss_pred             CCceEEcCCCCeEEeecccccccCCCC-ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023568           76 PSNLLLNASCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV  154 (280)
Q Consensus        76 ~~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~  154 (280)
                      |+||+++.++.++|+|||.+....... ......++..|+|||.+.+ ...+.++|+||+|+++|+|++|..||.+....
T Consensus       134 p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~  212 (267)
T cd08229         134 PANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN  212 (267)
T ss_pred             HHHEEEcCCCCEEECcchhhhccccCCcccccccCCcCccCHHHhcC-CCccchhhHHHHHHHHHHHHhCCCCcccccch
Confidence            999999999999999999987654332 1234567889999999876 66788999999999999999999999765321


Q ss_pred             --HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccc-cCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          155 --HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFAT-RFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       155 --~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                        .....+..                              ...+. .....+..+.+++.+||..||.+|||+.++++
T Consensus       213 ~~~~~~~~~~------------------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         213 LYSLCKKIEQ------------------------------CDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             HHHHhhhhhc------------------------------CCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence              11111110                              00011 11246789999999999999999999997764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.3e-34  Score=240.21  Aligned_cols=192  Identities=25%  Similarity=0.401  Sum_probs=155.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      ++||||+++++.+..      ...|+||||++ |+|.+++.+.  ..+++..+..++.|++.||+|||+.|++|+||+|+
T Consensus        58 l~~~~i~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~  131 (262)
T cd05071          58 LRHEKLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAA  131 (262)
T ss_pred             CCCCCcceEEEEECC------CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcc
Confidence            579999999998754      34799999998 5999999753  45899999999999999999999999999999999


Q ss_pred             ceEEcCCCCeEEeecccccccCCCCcc--ccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023568           78 NLLLNASCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYV  154 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~  154 (280)
                      ||+++.++.++|+|||.++........  ....++..|+|||...+ ..++.++|+||||+++|+|++ |..||.+....
T Consensus       132 Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~  210 (262)
T cd05071         132 NILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR  210 (262)
T ss_pred             cEEEcCCCcEEeccCCceeeccccccccccCCcccceecCHhHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH
Confidence            999999999999999998765433221  22345678999998866 678899999999999999999 88899877655


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      .....+.....                              .......+..+.+++.+||+.||.+|||+.++++
T Consensus       211 ~~~~~~~~~~~------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         211 EVLDQVERGYR------------------------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             HHHHHHhcCCC------------------------------CCCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            44443322100                              0111246788999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-37  Score=259.30  Aligned_cols=202  Identities=30%  Similarity=0.525  Sum_probs=175.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~--~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||.||.+...|++.     +.+++|||-+.|+..++|.+  .+++++...++++.||+.||+|||-+||+|.||||+|
T Consensus       620 l~HPGiV~le~M~ET~-----ervFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPEN  694 (888)
T KOG4236|consen  620 LHHPGIVNLECMFETP-----ERVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPEN  694 (888)
T ss_pred             cCCCCeeEEEEeecCC-----ceEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchh
Confidence            5899999999999998     77999999999999998864  4789999999999999999999999999999999999


Q ss_pred             eEEcCC---CCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023568           79 LLLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH  155 (280)
Q Consensus        79 ili~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~  155 (280)
                      ||+...   .++||||||+|+.++......+..||+.|+|||++.+ +.|..+-|+||.|+|+|--|.|..||+...+. 
T Consensus       695 VLLas~~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLrn-kGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI-  772 (888)
T KOG4236|consen  695 VLLASASPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRN-KGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI-  772 (888)
T ss_pred             eeeccCCCCCceeeccccceeecchhhhhhhhcCCccccCHHHHhh-ccccccccceeeeEEEEEEecccccCCCccch-
Confidence            999653   4699999999999999988899999999999999998 88999999999999999999999999876432 


Q ss_pred             HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 023568          156 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  235 (280)
Q Consensus       156 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~  235 (280)
                       -.+|+.....-++.                           -+..+++.+.+||..+|+..-.+|.|++..|.|||+++
T Consensus       773 -ndQIQNAaFMyPp~---------------------------PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~  824 (888)
T KOG4236|consen  773 -NDQIQNAAFMYPPN---------------------------PWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQD  824 (888)
T ss_pred             -hHHhhccccccCCC---------------------------chhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhc
Confidence             22333222221111                           12367999999999999999999999999999999987


Q ss_pred             Cc
Q 023568          236 LH  237 (280)
Q Consensus       236 ~~  237 (280)
                      .+
T Consensus       825 yq  826 (888)
T KOG4236|consen  825 YQ  826 (888)
T ss_pred             ch
Confidence            65

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.3e-34  Score=239.80  Aligned_cols=192  Identities=24%  Similarity=0.394  Sum_probs=155.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      ++||||+++++++..      ...|+||||+. ++|.+++.+.  ..+++..+..++.|++.||.|||+.|++|+||+|+
T Consensus        58 l~h~~i~~~~~~~~~------~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~  131 (260)
T cd05069          58 LRHDKLVPLYAVVSE------EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAA  131 (260)
T ss_pred             CCCCCeeeEEEEEcC------CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcc
Confidence            579999999998753      34799999998 4999999753  35899999999999999999999999999999999


Q ss_pred             ceEEcCCCCeEEeecccccccCCCCc--cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023568           78 NLLLNASCDLKIGDFGLARTTSETDF--MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYV  154 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~  154 (280)
                      ||+++.++.++|+|||.+........  .....++..|+|||...+ ...+.++|+||||+++|+|++ |..||.+....
T Consensus       132 Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~  210 (260)
T cd05069         132 NILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR  210 (260)
T ss_pred             eEEEcCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhcc-CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999876543321  122345678999998876 678899999999999999999 99999887655


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      .....+.....                              .......+..+.+++++||..||.+||+++++++
T Consensus       211 ~~~~~~~~~~~------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         211 EVLEQVERGYR------------------------------MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             HHHHHHHcCCC------------------------------CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            54443322100                              0112246788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.3e-34  Score=240.86  Aligned_cols=193  Identities=23%  Similarity=0.378  Sum_probs=157.1

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||+++.+++...     ...|+||||+++ +|.+++.. .+.+++.++..++.|++.||+|||+.|++|+||||+|
T Consensus        63 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~N  137 (268)
T cd05063          63 FSHHNIIRLEGVVTKF-----KPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARN  137 (268)
T ss_pred             CCCCCeeEEEEEEccC-----CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhh
Confidence            5799999999999877     679999999984 99999865 3679999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCcc--c--cceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDFM--T--EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDY  153 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~~--~--~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~  153 (280)
                      |+++.++.++|+|||++.........  .  ....+..|+|||.+.+ ..++.++|+||+||++|+|++ |..||...+.
T Consensus       138 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~  216 (268)
T cd05063         138 ILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSFGERPYWDMSN  216 (268)
T ss_pred             EEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhc-CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH
Confidence            99999999999999998755432111  1  1122456999999876 677899999999999999997 9999987765


Q ss_pred             HHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          154 VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       154 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      ......+......                              ......+..+.+++.+||+.||.+||++.++++
T Consensus       217 ~~~~~~i~~~~~~------------------------------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         217 HEVMKAINDGFRL------------------------------PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             HHHHHHHhcCCCC------------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            5544444321110                              011145788999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.1e-34  Score=241.51  Aligned_cols=193  Identities=24%  Similarity=0.370  Sum_probs=156.2

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||+++++++..+     ...++||||+++ +|.+++.. .+.+++.++..++.|++.||+|||+.|++|+||+|+|
T Consensus        62 l~h~ni~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~n  136 (269)
T cd05065          62 FDHPNIIHLEGVVTKS-----RPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARN  136 (269)
T ss_pred             CCCcCcceEEEEECCC-----CceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChhe
Confidence            5799999999999877     669999999975 89998875 4568999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCcc---ccc---eeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDFM---TEY---VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGK  151 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~~---~~~---~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~  151 (280)
                      |+++.++.++|+|||.+.........   ...   ..+..|+|||.+.+ ..++.++|+||+||++|||++ |..||...
T Consensus       137 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~g~~p~~~~  215 (269)
T cd05065         137 ILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDM  215 (269)
T ss_pred             EEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcCCCCCCCCC
Confidence            99999999999999998754332111   111   12457999999876 677889999999999999886 99999877


Q ss_pred             ChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          152 DYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       152 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      +.......+......                              ......+..+.+++.+||+.+|.+||++++++.
T Consensus       216 ~~~~~~~~i~~~~~~------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         216 SNQDVINAIEQDYRL------------------------------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             CHHHHHHHHHcCCcC------------------------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            655444443221100                              111346788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=7.9e-35  Score=254.55  Aligned_cols=193  Identities=25%  Similarity=0.351  Sum_probs=153.3

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC--------------------------------------
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD--------------------------------------   42 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~--------------------------------------   42 (280)
                      .||||+++++++.+.     ..+|||||||. |+|.+++.+.                                      
T Consensus        99 ~HpnIv~l~~~~~~~-----~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (400)
T cd05105          99 PHLNIVNLLGACTKS-----GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFEN  173 (400)
T ss_pred             CCCCeeeEEEEEccC-----CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcc
Confidence            399999999999877     67999999997 5999887542                                      


Q ss_pred             ----------------------------------------------------------CCCCHHHHHHHHHHHHHHHHHH
Q 023568           43 ----------------------------------------------------------QQLTDDHCQYFLYQLLRGLKYV   64 (280)
Q Consensus        43 ----------------------------------------------------------~~l~~~~~~~i~~qil~~l~~L   64 (280)
                                                                                +.+++..+..++.|++.||+||
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L  253 (400)
T cd05105         174 KGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL  253 (400)
T ss_pred             cccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHH
Confidence                                                                      2478888999999999999999


Q ss_pred             HhCCccccCCCCCceEEcCCCCeEEeecccccccCCCCc---cccceeccccccccccccCCCCCcchhHHHHHHHHHHH
Q 023568           65 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI  141 (280)
Q Consensus        65 H~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l  141 (280)
                      |+.|++||||||+||+++.++.++|+|||+++.......   .....++..|+|||.+.+ ..++.++|||||||++|+|
T Consensus       254 H~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlGvil~el  332 (400)
T cd05105         254 ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD-NLYTTLSDVWSYGILLWEI  332 (400)
T ss_pred             HhCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC-CCCCchhhHHHHHHHHHHH
Confidence            999999999999999999999999999999876433211   123345678999999876 6788999999999999999


Q ss_pred             Hh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCC
Q 023568          142 MT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNK  220 (280)
Q Consensus       142 l~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~  220 (280)
                      ++ |..||................                             .........+..+.+++.+||+.||++
T Consensus       333 lt~g~~P~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l~~li~~cl~~dP~~  383 (400)
T cd05105         333 FSLGGTPYPGMIVDSTFYNKIKSG-----------------------------YRMAKPDHATQEVYDIMVKCWNSEPEK  383 (400)
T ss_pred             HHCCCCCCcccchhHHHHHHHhcC-----------------------------CCCCCCccCCHHHHHHHHHHCccCHhH
Confidence            97 999998754322221111100                             000112356889999999999999999


Q ss_pred             CCCHHHHhc
Q 023568          221 RITVEEALR  229 (280)
Q Consensus       221 Rpt~~ell~  229 (280)
                      |||+.++.+
T Consensus       384 RPt~~~l~~  392 (400)
T cd05105         384 RPSFLHLSD  392 (400)
T ss_pred             CcCHHHHHH
Confidence            999998875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-35  Score=239.51  Aligned_cols=206  Identities=22%  Similarity=0.430  Sum_probs=171.9

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      +||.+|-++.+|+++     ..+++|.||+. |+|.=.+++.++++++.++.+-..|+.||.|||+.||++||||.+|+|
T Consensus       309 n~pflvglhscfqte-----srlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvl  383 (593)
T KOG0695|consen  309 NNPFLVGLHSCFQTE-----SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVL  383 (593)
T ss_pred             CCCeEEehhhhhccc-----ceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceE
Confidence            699999999999999     67999999997 599888888899999999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccc-cCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           81 LNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~-~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +|..|.+||+|+|+++. ..+.....+++||++|.|||++.+ ..|+.++|.|+||++++||+.|+.||.--.       
T Consensus       384 ldaeghikltdygmcke~l~~gd~tstfcgtpnyiapeilrg-eeygfsvdwwalgvlmfemmagrspfdivg-------  455 (593)
T KOG0695|consen  384 LDAEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIVG-------  455 (593)
T ss_pred             EccCCceeecccchhhcCCCCCcccccccCCCcccchhhhcc-cccCceehHHHHHHHHHHHHcCCCCcceec-------
Confidence            99999999999999985 555677788999999999999998 999999999999999999999999995321       


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCC------CHHHHhcCccc
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI------TVEEALRHPYL  233 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rp------t~~ell~hp~~  233 (280)
                            ..+       ...+.+.++-++.-..+..   ++..+|-.+..+++..|.+||.+|.      .+.++..|+||
T Consensus       456 ------m~n-------~d~ntedylfqvilekqir---iprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ff  519 (593)
T KOG0695|consen  456 ------MDN-------PDMNTEDYLFQVILEKQIR---IPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFF  519 (593)
T ss_pred             ------CCC-------cccchhHHHHHHHhhhccc---ccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhh
Confidence                  000       0111222222222222222   2335677888999999999999996      67899999999


Q ss_pred             ccC
Q 023568          234 QSL  236 (280)
Q Consensus       234 ~~~  236 (280)
                      +.+
T Consensus       520 r~i  522 (593)
T KOG0695|consen  520 RSI  522 (593)
T ss_pred             hhC
Confidence            865

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.6e-34  Score=239.43  Aligned_cols=194  Identities=27%  Similarity=0.377  Sum_probs=152.5

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||+++++++....    ...++||||+. |+|.+++.+. ..+++..+..++.|++.||+|||+.|++||||||+|
T Consensus        53 l~h~~iv~~~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~n  128 (262)
T cd05058          53 FSHPNVLSLLGICLPSE----GSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARN  128 (262)
T ss_pred             CCCCCcceEEEEeecCC----CCcEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcce
Confidence            58999999999765431    45889999997 6999999753 457888899999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCC-----ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 023568           79 LLLNASCDLKIGDFGLARTTSETD-----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKD  152 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~  152 (280)
                      |+++.++.++|+|||+++......     ......++..|+|||.+.+ ..++.++|+|||||++|+|++ |.+||...+
T Consensus       129 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~  207 (262)
T cd05058         129 CMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVD  207 (262)
T ss_pred             EEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhcc-CccchHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence            999999999999999987543221     1122344668999999876 678899999999999999999 567777665


Q ss_pred             hHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          153 YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       153 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      .......+....                              ........++.+.+++.+||..+|++||++.+++.
T Consensus       208 ~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~  254 (262)
T cd05058         208 SFDITVYLLQGR------------------------------RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVS  254 (262)
T ss_pred             HHHHHHHHhcCC------------------------------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            444333221100                              00111235788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-35  Score=252.53  Aligned_cols=205  Identities=24%  Similarity=0.380  Sum_probs=154.4

Q ss_pred             CCCcccccccccccCCCCCCCC-cEEEEEecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccccC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFN-DVYIVYELMD-TDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSAS---VLHRD   73 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~-~~~lv~e~~~-g~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~---i~H~d   73 (280)
                      ++|||||+|+||+.+.     + ..+||+|||. |+|.+.+....  .++|..+..|+.+++.||+|||...   |+|||
T Consensus       128 l~H~Nlv~LlGyC~e~-----~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrD  202 (361)
T KOG1187|consen  128 LRHPNLVKLLGYCLEG-----GEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRD  202 (361)
T ss_pred             CCCcCcccEEEEEecC-----CceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCC
Confidence            6899999999999987     5 5999999997 79999997654  8999999999999999999999865   99999


Q ss_pred             CCCCceEEcCCCCeEEeecccccccCC-CCccccc-eeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 023568           74 LKPSNLLLNASCDLKIGDFGLARTTSE-TDFMTEY-VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK  151 (280)
Q Consensus        74 ik~~Nili~~~~~~kl~dfg~~~~~~~-~~~~~~~-~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~  151 (280)
                      ||++|||+|.+...||+|||+++.... ....... .||..|+|||.+.. +..+.++||||||+++.|+++|+.+....
T Consensus       203 iKssNILLD~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~  281 (361)
T KOG1187|consen  203 IKSSNILLDEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQS  281 (361)
T ss_pred             CCHHHeeECCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCC
Confidence            999999999999999999999976554 3322233 78999999999877 78999999999999999999999877654


Q ss_pred             ChHH---HHHHHHHHhCCCCcccccccCChhHHHHHHhCCcccccccc-ccCC--CCCHHHHHHHHHhcccCCCCCCCHH
Q 023568          152 DYVH---QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA-TRFP--NKSSGAVDLLEKMLVFDPNKRITVE  225 (280)
Q Consensus       152 ~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~ll~~~L~~dp~~Rpt~~  225 (280)
                      ....   ........+...               .+..+   ...... ..++  ..-..+..+..+|++.+|.+||++.
T Consensus       282 ~~~~~~~l~~w~~~~~~~~---------------~~~ei---iD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~  343 (361)
T KOG1187|consen  282 RPRGELSLVEWAKPLLEEG---------------KLREI---VDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMS  343 (361)
T ss_pred             CCcccccHHHHHHHHHHCc---------------chhhe---eCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHH
Confidence            3111   111111111110               00001   011110 1111  1122356778899999999999999


Q ss_pred             HHhc
Q 023568          226 EALR  229 (280)
Q Consensus       226 ell~  229 (280)
                      |+++
T Consensus       344 ~Vv~  347 (361)
T KOG1187|consen  344 QVVK  347 (361)
T ss_pred             HHHH
Confidence            9855

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-34  Score=243.35  Aligned_cols=200  Identities=24%  Similarity=0.382  Sum_probs=157.4

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCC------------CCCHHHHHHHHHHHHHHHHHHHhC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ------------QLTDDHCQYFLYQLLRGLKYVHSA   67 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~------------~l~~~~~~~i~~qil~~l~~LH~~   67 (280)
                      ++||||+++++++...     ...++||||+. ++|.+++....            .+++..+..++.|++.||+|||+.
T Consensus        74 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~  148 (295)
T cd05097          74 LKNPNIIRLLGVCVSD-----DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL  148 (295)
T ss_pred             CCCCCcCeEEEEEcCC-----CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc
Confidence            5899999999999877     67999999997 59999885431            378899999999999999999999


Q ss_pred             CccccCCCCCceEEcCCCCeEEeecccccccCCCCc---cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-
Q 023568           68 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-  143 (280)
Q Consensus        68 ~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-  143 (280)
                      |++|+||||+||+++.++.++|+|||++........   .....++..|+|||.+.+ ..++.++|+|||||++++|++ 
T Consensus       149 ~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~~l~el~~~  227 (295)
T cd05097         149 NFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEMFTL  227 (295)
T ss_pred             CeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhcc-CCcCchhhHHHHHHHHHHHHHc
Confidence            999999999999999999999999999875433211   122334678999999876 678999999999999999988 


Q ss_pred             -CCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCC
Q 023568          144 -REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI  222 (280)
Q Consensus       144 -g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rp  222 (280)
                       |..||...+..+....+.+......                       ........+..++.+.+++.+||+.||.+||
T Consensus       228 ~~~~p~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~RP  284 (295)
T cd05097         228 CKEQPYSLLSDEQVIENTGEFFRNQG-----------------------RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRP  284 (295)
T ss_pred             CCCCCCcccChHHHHHHHHHhhhhcc-----------------------ccccCCCCCCCCHHHHHHHHHHcCCCchhCc
Confidence             6678887765554444333111000                       0011112334688999999999999999999


Q ss_pred             CHHHHhc
Q 023568          223 TVEEALR  229 (280)
Q Consensus       223 t~~ell~  229 (280)
                      |++++++
T Consensus       285 s~~~i~~  291 (295)
T cd05097         285 TFNKIHH  291 (295)
T ss_pred             CHHHHHH
Confidence            9999965

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.3e-34  Score=248.38  Aligned_cols=194  Identities=28%  Similarity=0.441  Sum_probs=157.7

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHH
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD----------------QQLTDDHCQYFLYQLLRGLKYV   64 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~----------------~~l~~~~~~~i~~qil~~l~~L   64 (280)
                      +||||+++++++...     ..+|+||||++ |+|.+++.+.                ..++..++..++.|++.||+||
T Consensus        76 ~h~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L  150 (334)
T cd05100          76 KHKNIINLLGACTQD-----GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL  150 (334)
T ss_pred             CCCCeeeeeEEEccC-----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHH
Confidence            699999999999877     66999999997 5999998643                2478899999999999999999


Q ss_pred             HhCCccccCCCCCceEEcCCCCeEEeecccccccCCCCc---cccceeccccccccccccCCCCCcchhHHHHHHHHHHH
Q 023568           65 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI  141 (280)
Q Consensus        65 H~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l  141 (280)
                      |++|++||||||+||+++.++.++|+|||+++.......   .....++..|+|||.+.+ ..++.++|+||||+++|+|
T Consensus       151 H~~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el  229 (334)
T cd05100         151 ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEI  229 (334)
T ss_pred             HHCCeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhcc-CCcCchhhhHHHHHHHHHH
Confidence            999999999999999999999999999999876543321   122233567999999877 7788899999999999999


Q ss_pred             Hh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCC
Q 023568          142 MT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNK  220 (280)
Q Consensus       142 l~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~  220 (280)
                      ++ |..||.+.+..+....+....                              ........+..+.+++.+||+.+|.+
T Consensus       230 ~~~g~~p~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~l~~li~~cl~~~p~~  279 (334)
T cd05100         230 FTLGGSPYPGIPVEELFKLLKEGH------------------------------RMDKPANCTHELYMIMRECWHAVPSQ  279 (334)
T ss_pred             HhcCCCCCCCCCHHHHHHHHHcCC------------------------------CCCCCCCCCHHHHHHHHHHcccChhh
Confidence            98 889998876555444332100                              01112346788999999999999999


Q ss_pred             CCCHHHHhcCc
Q 023568          221 RITVEEALRHP  231 (280)
Q Consensus       221 Rpt~~ell~hp  231 (280)
                      |||+.+++++-
T Consensus       280 Rps~~ell~~l  290 (334)
T cd05100         280 RPTFKQLVEDL  290 (334)
T ss_pred             CcCHHHHHHHH
Confidence            99999999853

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.4e-34  Score=237.45  Aligned_cols=190  Identities=23%  Similarity=0.389  Sum_probs=155.1

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      ++||||+++++++...      ..|+||||+. ++|.+++...  ..+++..+..++.|++.||.|||+.|++||||+|+
T Consensus        56 ~~~~~i~~~~~~~~~~------~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~  129 (254)
T cd05083          56 LHHKNLVRLLGVILHN------GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAAR  129 (254)
T ss_pred             CCCCCcCeEEEEEcCC------CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcc
Confidence            5799999999998654      3799999997 5999999754  35899999999999999999999999999999999


Q ss_pred             ceEEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 023568           78 NLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQ  156 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~~~  156 (280)
                      ||+++.++.++|+|||.+......  ......+..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...+....
T Consensus       130 nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~  206 (254)
T cd05083         130 NILVSEDGVAKVSDFGLARVGSMG--VDNSKLPVKWTAPEALKH-KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV  206 (254)
T ss_pred             eEEEcCCCcEEECCCccceecccc--CCCCCCCceecCHHHhcc-CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH
Confidence            999999999999999998764332  122334567999998876 678889999999999999997 9999988765544


Q ss_pred             HHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       157 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      ...+.+...                              .......+..+.+++++||+.+|.+||++++++.
T Consensus       207 ~~~~~~~~~------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         207 KECVEKGYR------------------------------MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             HHHHhCCCC------------------------------CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            333322100                              0112356889999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=5.4e-35  Score=261.27  Aligned_cols=192  Identities=25%  Similarity=0.443  Sum_probs=165.4

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCC----------C----CCHHHHHHHHHHHHHHHHHHH
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ----------Q----LTDDHCQYFLYQLLRGLKYVH   65 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~----------~----l~~~~~~~i~~qil~~l~~LH   65 (280)
                      |+|||||+|+|++...     +-+|+|+|||. |||.++|+.+.          .    ++..+...|+.||+.|+.||-
T Consensus       546 l~H~nIVrLlGVC~~~-----~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs  620 (774)
T KOG1026|consen  546 LQHPNIVRLLGVCREG-----DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS  620 (774)
T ss_pred             ccCCCeEEEEEEEccC-----CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            6899999999999998     44999999998 89999997421          2    889999999999999999999


Q ss_pred             hCCccccCCCCCceEEcCCCCeEEeecccccccCCCCcc---ccceeccccccccccccCCCCCcchhHHHHHHHHHHHH
Q 023568           66 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM---TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM  142 (280)
Q Consensus        66 ~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll  142 (280)
                      ++.++||||-..|+||+++..|||+|||+++..-..+..   ....-..+|||||.+.- ++++.++||||+||++||++
T Consensus       621 ~~~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly-~kFTteSDVWs~GVvLWEIF  699 (774)
T KOG1026|consen  621 SHHFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY-GKFTTESDVWSFGVVLWEIF  699 (774)
T ss_pred             hCcccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhc-Ccccchhhhhhhhhhhhhhh
Confidence            999999999999999999999999999999975444322   23445678999999987 89999999999999999999


Q ss_pred             h-CCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCC
Q 023568          143 T-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKR  221 (280)
Q Consensus       143 ~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~R  221 (280)
                      + |.-||.+..+.+.++.+.+..                              .-+-+...+..+.+|+..|++..|.+|
T Consensus       700 syG~QPy~glSn~EVIe~i~~g~------------------------------lL~~Pe~CP~~vY~LM~~CW~~~P~~R  749 (774)
T KOG1026|consen  700 SYGKQPYYGLSNQEVIECIRAGQ------------------------------LLSCPENCPTEVYSLMLECWNENPKRR  749 (774)
T ss_pred             ccccCcccccchHHHHHHHHcCC------------------------------cccCCCCCCHHHHHHHHHHhhcCcccC
Confidence            8 999999999888887775521                              112223679999999999999999999


Q ss_pred             CCHHHHh
Q 023568          222 ITVEEAL  228 (280)
Q Consensus       222 pt~~ell  228 (280)
                      |+++|+=
T Consensus       750 PsF~eI~  756 (774)
T KOG1026|consen  750 PSFKEIH  756 (774)
T ss_pred             CCHHHHH
Confidence            9999983

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=2.7e-34  Score=239.09  Aligned_cols=198  Identities=22%  Similarity=0.281  Sum_probs=151.9

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-----QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDL   74 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-----~~l~~~~~~~i~~qil~~l~~LH~~~i~H~di   74 (280)
                      ++||||+++++++.+.     ...++||||++ |+|.+++.+.     ...++..++.++.|++.||+|||+.|++|+||
T Consensus        52 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl  126 (269)
T cd05087          52 LQHSNLLQCLGQCTEV-----TPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDL  126 (269)
T ss_pred             CCCCCEeeEEEEEcCC-----CCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEecccc
Confidence            5799999999999877     56899999998 6999998643     24677888999999999999999999999999


Q ss_pred             CCCceEEcCCCCeEEeecccccccCCCCc---cccceeccccccccccccC------CCCCcchhHHHHHHHHHHHHh-C
Q 023568           75 KPSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNC------TEYTAAIDIWSVGCILGEIMT-R  144 (280)
Q Consensus        75 k~~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~------~~~~~~~DvwslG~~l~~ll~-g  144 (280)
                      ||+||+++.++.++|+|||.++.......   .....++..|+|||++.+.      ..++.++|+||+|+++|+|++ |
T Consensus       127 kp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g  206 (269)
T cd05087         127 ALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELG  206 (269)
T ss_pred             CcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCC
Confidence            99999999999999999999875433221   1224457789999988542      135779999999999999996 9


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCH
Q 023568          145 EPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV  224 (280)
Q Consensus       145 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~  224 (280)
                      ..||......+..........                         .....+......+..+.+++++|+ .+|++|||+
T Consensus       207 ~~p~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~  260 (269)
T cd05087         207 SQPYRHLSDEQVLTYTVREQQ-------------------------LKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSA  260 (269)
T ss_pred             CCCCCCCChHHHHHHHhhccc-------------------------CCCCCCccCCCCChHHHHHHHHHh-cCcccCCCH
Confidence            999987654443322111000                         000011112245778899999998 689999999


Q ss_pred             HHHhc
Q 023568          225 EEALR  229 (280)
Q Consensus       225 ~ell~  229 (280)
                      ++++.
T Consensus       261 ~~l~~  265 (269)
T cd05087         261 EEVHL  265 (269)
T ss_pred             HHHHH
Confidence            99975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.3e-34  Score=239.67  Aligned_cols=192  Identities=26%  Similarity=0.400  Sum_probs=156.9

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||+++++++.+.      ..|+||||+. |+|.+++.+. ..+++..+..++.|++.||+|||+.|++|+||+|+|
T Consensus        64 ~~h~~i~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~n  137 (270)
T cd05056          64 FDHPHIVKLIGVITEN------PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARN  137 (270)
T ss_pred             CCCCchhceeEEEcCC------CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChhe
Confidence            5799999999998754      3789999997 5999999764 468999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCcc--ccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVH  155 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~~  155 (280)
                      |+++.++.++|+|||++.........  ....++..|+|||.+.+ ..++.++|+||||+++++|++ |..||.+....+
T Consensus       138 ili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~  216 (270)
T cd05056         138 VLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND  216 (270)
T ss_pred             EEEecCCCeEEccCceeeecccccceecCCCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH
Confidence            99999999999999998765433221  12233567999998866 678899999999999999986 999998877655


Q ss_pred             HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          156 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       156 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      ....+....                              ....++..+..+.+++.+|+..+|.+|||+.+++.
T Consensus       217 ~~~~~~~~~------------------------------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~  260 (270)
T cd05056         217 VIGRIENGE------------------------------RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA  260 (270)
T ss_pred             HHHHHHcCC------------------------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            544432210                              01122356889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=3.8e-34  Score=238.15  Aligned_cols=198  Identities=21%  Similarity=0.281  Sum_probs=152.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD----QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK   75 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~----~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik   75 (280)
                      ++||||+++++.+...     ...|+||||+. |+|.+++.+.    ..+++..+..++.|++.||+|||+.+++|||||
T Consensus        52 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dik  126 (268)
T cd05086          52 LQHPNILQCLGQCVEA-----IPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLA  126 (268)
T ss_pred             cCCcchhheEEEecCC-----CccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCc
Confidence            5899999999999877     67999999998 5999999753    346778889999999999999999999999999


Q ss_pred             CCceEEcCCCCeEEeecccccccCCC---CccccceeccccccccccccC------CCCCcchhHHHHHHHHHHHHh-CC
Q 023568           76 PSNLLLNASCDLKIGDFGLARTTSET---DFMTEYVVTRWYRAPELLLNC------TEYTAAIDIWSVGCILGEIMT-RE  145 (280)
Q Consensus        76 ~~Nili~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~------~~~~~~~DvwslG~~l~~ll~-g~  145 (280)
                      |+||+++.++.++|+|||++......   .......++..|+|||.+.+.      ..++.++|+||||+++|+|++ |.
T Consensus       127 p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~  206 (268)
T cd05086         127 LRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAA  206 (268)
T ss_pred             cceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCC
Confidence            99999999999999999987643221   112345678889999987431      234678999999999999997 57


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 023568          146 PLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVE  225 (280)
Q Consensus       146 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~  225 (280)
                      .||...+.......+......                         ....+......++.+.++++.|+ .+|.+|||++
T Consensus       207 ~p~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~  260 (268)
T cd05086         207 QPYSHLSDREVLNHVIKDQQV-------------------------KLFKPQLELPYSERWYEVLQFCW-LSPEKRATAE  260 (268)
T ss_pred             CCCCCCCHHHHHHHHHhhccc-------------------------ccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHH
Confidence            788776655444443221000                         00001122346788999999999 6899999999


Q ss_pred             HHhc
Q 023568          226 EALR  229 (280)
Q Consensus       226 ell~  229 (280)
                      ++++
T Consensus       261 ~i~~  264 (268)
T cd05086         261 EVHR  264 (268)
T ss_pred             HHHH
Confidence            9975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2.5e-34  Score=237.44  Aligned_cols=194  Identities=19%  Similarity=0.380  Sum_probs=158.0

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||+++++++...     ...++||||+. ++|.+++... ..++++.+..++.|++.||++||+.|++|+||+|+|
T Consensus        56 l~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~n  130 (256)
T cd05112          56 LSHPKLVQLYGVCTER-----SPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARN  130 (256)
T ss_pred             CCCCCeeeEEEEEccC-----CceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccce
Confidence            5799999999999887     66999999997 5999998754 568999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCc--cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDF--MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVH  155 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~~  155 (280)
                      |+++.++.++|+|||.+........  .....++..|+|||.+.+ ..++.++|+||+|+++|+|++ |..||.......
T Consensus       131 i~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~  209 (256)
T cd05112         131 CLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSF-SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE  209 (256)
T ss_pred             EEEcCCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhcc-CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence            9999999999999999876543321  112234568999999876 678889999999999999998 999998776555


Q ss_pred             HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 023568          156 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  230 (280)
Q Consensus       156 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~h  230 (280)
                      ....+.+...                              .......+..+.+++.+||+.+|++|||+.+++++
T Consensus       210 ~~~~~~~~~~------------------------------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         210 VVETINAGFR------------------------------LYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             HHHHHhCCCC------------------------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence            4444322100                              00112357889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2.1e-34  Score=242.06  Aligned_cols=193  Identities=21%  Similarity=0.352  Sum_probs=155.4

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC----------------------CCCCHHHHHHHHHHH
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD----------------------QQLTDDHCQYFLYQL   57 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~----------------------~~l~~~~~~~i~~qi   57 (280)
                      ++||||+++++++.+.     ...++||||++ |+|.+++...                      ..+++.++..++.|+
T Consensus        65 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i  139 (288)
T cd05050          65 FDHPNIVKLLGVCAVG-----KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQV  139 (288)
T ss_pred             cCCCchheEEEEEcCC-----CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHH
Confidence            5799999999999877     66999999998 5999998642                      247888999999999


Q ss_pred             HHHHHHHHhCCccccCCCCCceEEcCCCCeEEeecccccccCCCCc---cccceeccccccccccccCCCCCcchhHHHH
Q 023568           58 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSV  134 (280)
Q Consensus        58 l~~l~~LH~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dvwsl  134 (280)
                      +.||.|||+.|++||||+|+||+++.++.++|+|||.+........   ......+..|+|||.+.+ ..++.++|+|||
T Consensus       140 ~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~sl  218 (288)
T cd05050         140 AAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY-NRYTTESDVWAY  218 (288)
T ss_pred             HHHHHHHHhCCeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhc-CCCCchhHHHHH
Confidence            9999999999999999999999999999999999999875433211   122334567999998876 678899999999


Q ss_pred             HHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHh
Q 023568          135 GCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKM  213 (280)
Q Consensus       135 G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~  213 (280)
                      ||++|+|++ |..||.+....+....+....                              ........+..+.+++.+|
T Consensus       219 G~il~el~~~~~~p~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~l~~li~~~  268 (288)
T cd05050         219 GVVLWEIFSYGMQPYYGMAHEEVIYYVRDGN------------------------------VLSCPDNCPLELYNLMRLC  268 (288)
T ss_pred             HHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC------------------------------CCCCCCCCCHHHHHHHHHH
Confidence            999999997 888987766554443332100                              0011224678899999999


Q ss_pred             cccCCCCCCCHHHHhc
Q 023568          214 LVFDPNKRITVEEALR  229 (280)
Q Consensus       214 L~~dp~~Rpt~~ell~  229 (280)
                      |+.||.+|||++|+++
T Consensus       269 l~~~p~~Rpt~~el~~  284 (288)
T cd05050         269 WSKLPSDRPSFASINR  284 (288)
T ss_pred             cccCcccCCCHHHHHH
Confidence            9999999999999875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=2.4e-34  Score=266.18  Aligned_cols=91  Identities=24%  Similarity=0.534  Sum_probs=85.5

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++...     .++|+||||+. ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+||
T Consensus        61 l~hp~Iv~~~~~~~~~-----~~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NI  135 (669)
T cd05610          61 SKSPFIVHLYYSLQSA-----NNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNM  135 (669)
T ss_pred             cCCCCcCeEEEEEEEC-----CEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHE
Confidence            5899999999999877     77999999996 59999998778899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeeccccc
Q 023568           80 LLNASCDLKIGDFGLAR   96 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~   96 (280)
                      |++.++.++|+|||+++
T Consensus       136 Ll~~~g~vkL~DFGls~  152 (669)
T cd05610         136 LISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EEcCCCCEEEEeCCCCc
Confidence            99999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=4e-35  Score=262.91  Aligned_cols=194  Identities=26%  Similarity=0.412  Sum_probs=153.0

Q ss_pred             CcccccccccccCC-CCCC-CCcEEEEEecCC-ccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCC
Q 023568            3 HENVIAIKDIIRPP-KKDT-FNDVYIVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSAS--VLHRDLK   75 (280)
Q Consensus         3 Hpniv~l~~~~~~~-~~~~-~~~~~lv~e~~~-g~L~~~l~~--~~~l~~~~~~~i~~qil~~l~~LH~~~--i~H~dik   75 (280)
                      |||||.|++..... ...+ -..++|.||||. |+|.|+|.+  ..+|++.++..|++|+++||++||..+  |+|||||
T Consensus        94 h~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLK  173 (738)
T KOG1989|consen   94 HKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLK  173 (738)
T ss_pred             CCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhh
Confidence            99999999943332 2222 256899999998 699999974  356999999999999999999999998  9999999


Q ss_pred             CCceEEcCCCCeEEeecccccccCCCC-cc---------ccceeccccccccccc--cCCCCCcchhHHHHHHHHHHHHh
Q 023568           76 PSNLLLNASCDLKIGDFGLARTTSETD-FM---------TEYVVTRWYRAPELLL--NCTEYTAAIDIWSVGCILGEIMT  143 (280)
Q Consensus        76 ~~Nili~~~~~~kl~dfg~~~~~~~~~-~~---------~~~~~~~~y~aPE~~~--~~~~~~~~~DvwslG~~l~~ll~  143 (280)
                      -+|||++.++..||||||.+....... ..         .....|+-|+|||.+.  .....+.++|||+|||+||.|+.
T Consensus       174 iENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy  253 (738)
T KOG1989|consen  174 IENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCY  253 (738)
T ss_pred             hhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHH
Confidence            999999999999999999987432221 11         1235688999999973  22667889999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCC
Q 023568          144 REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT  223 (280)
Q Consensus       144 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt  223 (280)
                      ...||........+.                             .   .-. ...++..+..+.+||+.||+.||.+||+
T Consensus       254 ~t~PFe~sg~laIln-----------------------------g---~Y~-~P~~p~ys~~l~~LI~~mL~~nP~~RPn  300 (738)
T KOG1989|consen  254 FTTPFEESGKLAILN-----------------------------G---NYS-FPPFPNYSDRLKDLIRTMLQPNPDERPN  300 (738)
T ss_pred             hCCCcCcCcceeEEe-----------------------------c---ccc-CCCCccHHHHHHHHHHHHhccCcccCCC
Confidence            999997753111110                             0   000 1123567999999999999999999999


Q ss_pred             HHHHhc
Q 023568          224 VEEALR  229 (280)
Q Consensus       224 ~~ell~  229 (280)
                      +-|++.
T Consensus       301 I~Qv~~  306 (738)
T KOG1989|consen  301 IYQVLE  306 (738)
T ss_pred             HHHHHH
Confidence            999985

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=3.7e-34  Score=241.61  Aligned_cols=200  Identities=22%  Similarity=0.362  Sum_probs=155.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCC-----------CCCHHHHHHHHHHHHHHHHHHHhCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ-----------QLTDDHCQYFLYQLLRGLKYVHSAS   68 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~-----------~l~~~~~~~i~~qil~~l~~LH~~~   68 (280)
                      ++||||+++++++...     ...++||||+. |+|.+++.+..           .+++.++..++.|++.||+|||+.|
T Consensus        76 l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~  150 (296)
T cd05095          76 LKDPNIIRLLAVCITS-----DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN  150 (296)
T ss_pred             CCCCCcceEEEEEecC-----CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC
Confidence            5899999999999887     66999999997 59999986532           3778899999999999999999999


Q ss_pred             ccccCCCCCceEEcCCCCeEEeecccccccCCCCc---cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh--
Q 023568           69 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--  143 (280)
Q Consensus        69 i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~--  143 (280)
                      ++|+||||+||+++.++.++|+|||+++.......   .....++..|++||...+ ..++.++|+|||||++|+|++  
T Consensus       151 i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~DiwSlG~~l~el~~~~  229 (296)
T cd05095         151 FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL-GKFTTASDVWAFGVTLWEILTLC  229 (296)
T ss_pred             eecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc-CCccchhhhhHHHHHHHHHHHhC
Confidence            99999999999999999999999999876433221   122334567999998766 678899999999999999998  


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCC
Q 023568          144 REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT  223 (280)
Q Consensus       144 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt  223 (280)
                      |..||......+......+...                    ..   .........+..++.+.+++.+||+.||.+|||
T Consensus       230 ~~~p~~~~~~~~~~~~~~~~~~--------------------~~---~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~  286 (296)
T cd05095         230 KEQPYSQLSDEQVIENTGEFFR--------------------DQ---GRQVYLPKPALCPDSLYKLMLSCWRRNAKERPS  286 (296)
T ss_pred             CCCCccccChHHHHHHHHHHHh--------------------hc---cccccCCCCCCCCHHHHHHHHHHcCCCcccCCC
Confidence            7788877665444332211100                    00   000011122346789999999999999999999


Q ss_pred             HHHHhc
Q 023568          224 VEEALR  229 (280)
Q Consensus       224 ~~ell~  229 (280)
                      +.++++
T Consensus       287 ~~~i~~  292 (296)
T cd05095         287 FQEIHA  292 (296)
T ss_pred             HHHHHH
Confidence            999875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=3.6e-34  Score=237.18  Aligned_cols=192  Identities=23%  Similarity=0.395  Sum_probs=156.6

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      ++||||+++++++..      ...|+||||+. ++|.+++.+.  ..+++.++..++.|++.||+|||+.|++|+||+|+
T Consensus        58 l~h~~i~~~~~~~~~------~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~  131 (260)
T cd05067          58 LQHPRLVRLYAVVTQ------EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAA  131 (260)
T ss_pred             cCCcCeeeEEEEEcc------CCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHH
Confidence            579999999998743      35899999997 5999998653  46899999999999999999999999999999999


Q ss_pred             ceEEcCCCCeEEeecccccccCCCCc--cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023568           78 NLLLNASCDLKIGDFGLARTTSETDF--MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYV  154 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~  154 (280)
                      ||+++.++.++|+|||.+........  .....++..|+|||.+.+ ..++.++|+||+|+++|+|++ |..||.+.+..
T Consensus       132 ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~  210 (260)
T cd05067         132 NILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP  210 (260)
T ss_pred             hEEEcCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhcc-CCcCcccchHHHHHHHHHHHhCCCCCCCCCChH
Confidence            99999999999999999876543221  122334668999998876 678889999999999999998 99999887765


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      +....+......                              ......+..+.+++++||..+|++|||++++++
T Consensus       211 ~~~~~~~~~~~~------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         211 EVIQNLERGYRM------------------------------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             HHHHHHHcCCCC------------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            555444221110                              112245788999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-34  Score=225.16  Aligned_cols=203  Identities=28%  Similarity=0.348  Sum_probs=156.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSAS--VLHRD   73 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH~~~--i~H~d   73 (280)
                      ++||||++++++...+..++....||+++|.. |+|.+.+..    +..+++.++..|+.++.+||.+||+..  ++|||
T Consensus        75 f~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~D  154 (302)
T KOG2345|consen   75 FNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRD  154 (302)
T ss_pred             hCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccC
Confidence            57999999999988776667788999999997 899998853    336999999999999999999999999  99999


Q ss_pred             CCCCceEEcCCCCeEEeecccccccCCCCcc----------ccceeccccccccccccC--CCCCcchhHHHHHHHHHHH
Q 023568           74 LKPSNLLLNASCDLKIGDFGLARTTSETDFM----------TEYVVTRWYRAPELLLNC--TEYTAAIDIWSVGCILGEI  141 (280)
Q Consensus        74 ik~~Nili~~~~~~kl~dfg~~~~~~~~~~~----------~~~~~~~~y~aPE~~~~~--~~~~~~~DvwslG~~l~~l  141 (280)
                      |||.|||++..+.+++.|||.++...-....          ....-|..|.|||.+.-.  ...+.++|||||||++|+|
T Consensus       155 iKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~  234 (302)
T KOG2345|consen  155 IKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAM  234 (302)
T ss_pred             CCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHH
Confidence            9999999999999999999998753321100          112347889999998542  3457899999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCC
Q 023568          142 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKR  221 (280)
Q Consensus       142 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~R  221 (280)
                      +.|..||..-         .+..++..-.   ..              ..+-.++... ..|..+.++|+.||+.||.+|
T Consensus       235 mf~~sPfe~~---------~~~GgSlaLA---v~--------------n~q~s~P~~~-~yse~l~~lik~mlqvdP~qR  287 (302)
T KOG2345|consen  235 MFGESPFERI---------YQQGGSLALA---VQ--------------NAQISIPNSS-RYSEALHQLIKSMLQVDPNQR  287 (302)
T ss_pred             HHcCCcchHH---------hhcCCeEEEe---ee--------------ccccccCCCC-CccHHHHHHHHHHhcCCcccC
Confidence            9999999542         1111100000   00              0011112221 378999999999999999999


Q ss_pred             CCHHHHhcC
Q 023568          222 ITVEEALRH  230 (280)
Q Consensus       222 pt~~ell~h  230 (280)
                      |++.+++.+
T Consensus       288 P~i~~ll~~  296 (302)
T KOG2345|consen  288 PTIPELLSK  296 (302)
T ss_pred             CCHHHHHHH
Confidence            999999874

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-35  Score=253.74  Aligned_cols=193  Identities=25%  Similarity=0.384  Sum_probs=163.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      |+|||||+++|+.....+     +|||||+|. |+|.++|++.+ .++..+...++.+.+.||+|||+++++||||-++|
T Consensus       218 l~H~NVVr~yGVa~~~~P-----l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARN  292 (474)
T KOG0194|consen  218 LNHPNVVRFYGVAVLEEP-----LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARN  292 (474)
T ss_pred             CCCCCEEEEEEEEcCCCc-----cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHH
Confidence            689999999999998844     999999997 59999999876 59999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCccc-cceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDFMT-EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQ  156 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~~~  156 (280)
                      +|++.++.+|++|||+++......... ..--...|+|||++.. +.++.++||||+||++||+.+ |..||.+....+.
T Consensus       293 cL~~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~-~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v  371 (474)
T KOG0194|consen  293 CLYSKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNT-GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEV  371 (474)
T ss_pred             heecCCCeEEeCccccccCCcceeeccccccCcceecChhhhcc-CccccccchhheeeeEEeeeccCCCCCCCCCHHHH
Confidence            999999999999999987765322222 1123567999999987 699999999999999999998 8899999998887


Q ss_pred             HHHHHH-HhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          157 LRLITE-LIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       157 ~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      .+++.. ....+                              .++..+..+..++.+|+..||+.|||+.++.+
T Consensus       372 ~~kI~~~~~r~~------------------------------~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  372 KAKIVKNGYRMP------------------------------IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             HHHHHhcCccCC------------------------------CCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence            777733 11111                              11245778889999999999999999999875

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=5.3e-34  Score=236.80  Aligned_cols=193  Identities=30%  Similarity=0.483  Sum_probs=155.9

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK   75 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik   75 (280)
                      ++|+||+++++++...     +..++||||++ |+|.+++..    ...+++.++..++.|++.||+|||+.|++||||+
T Consensus        59 ~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~  133 (267)
T cd08224          59 LDHPNVIKYLASFIEN-----NELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIK  133 (267)
T ss_pred             CCCCCeeeeeeeeecC-----CeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcC
Confidence            5799999999999887     67999999998 599998853    3458999999999999999999999999999999


Q ss_pred             CCceEEcCCCCeEEeecccccccCCCC-ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh-
Q 023568           76 PSNLLLNASCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY-  153 (280)
Q Consensus        76 ~~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~-  153 (280)
                      |+||+++.++.++|+|||.+....... ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||..... 
T Consensus       134 p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~  212 (267)
T cd08224         134 PANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN  212 (267)
T ss_pred             hhhEEECCCCcEEEeccceeeeccCCCcccceecCCccccCHHHhcc-CCCCchhcHHHHHHHHHHHHHCCCCcccCCcc
Confidence            999999999999999999987644332 2234567888999999876 6788899999999999999999999966531 


Q ss_pred             -HHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccC-CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          154 -VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       154 -~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                       ......+..                              ...+..+ ...+..+.++|.+||..+|++|||+.++++
T Consensus       213 ~~~~~~~~~~------------------------------~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         213 LYSLCKKIEK------------------------------CDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             HHHHHhhhhc------------------------------CCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence             111111110                              0011111 146778999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.9e-34  Score=236.56  Aligned_cols=188  Identities=21%  Similarity=0.282  Sum_probs=150.1

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||+++++++...      ..++||||+. |+|.+++...+ .+++..+..++.|++.||+|||+.|++||||||+|
T Consensus        58 l~h~~i~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~N  131 (259)
T cd05037          58 LSHKHLVKLYGVCVRD------ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKN  131 (259)
T ss_pred             CCCcchhheeeEEecC------CcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccce
Confidence            5799999999988762      2689999998 59999997655 79999999999999999999999999999999999


Q ss_pred             eEEcCCC-------CeEEeecccccccCCCCccccceeccccccccccccC-CCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 023568           79 LLLNASC-------DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMT-REPLFP  149 (280)
Q Consensus        79 ili~~~~-------~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~~l~~ll~-g~~pf~  149 (280)
                      |+++.++       .++|+|||.+......   ....++..|+|||.+.+. ..++.++|+||+|+++++|++ |..||.
T Consensus       132 ill~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~  208 (259)
T cd05037         132 ILVARYGLNEGYVPFIKLSDPGIPITVLSR---EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLS  208 (259)
T ss_pred             EEEecCccccCCceeEEeCCCCcccccccc---cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcc
Confidence            9999887       7999999998765432   233456779999998763 378889999999999999999 577786


Q ss_pred             CCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          150 GKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       150 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      ..+..........    ..                            .........+.+++.+||..+|.+|||+.++++
T Consensus       209 ~~~~~~~~~~~~~----~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         209 TLSSSEKERFYQD----QH----------------------------RLPMPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             cCCchhHHHHHhc----CC----------------------------CCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence            6542222111110    00                            000112378899999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=6.1e-34  Score=238.87  Aligned_cols=211  Identities=26%  Similarity=0.434  Sum_probs=155.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||+++++++.+...   ...++||||+. ++|.+++.+. ..+++.++..++.|++.||+|||+.|++||||||+|
T Consensus        63 l~h~~i~~~~~~~~~~~~---~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~N  139 (284)
T cd05079          63 LYHENIVKYKGICTEDGG---NGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARN  139 (284)
T ss_pred             CCCCCeeeeeeEEecCCC---CceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchhe
Confidence            579999999999877532   56899999997 5999998654 468999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCc----cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDF----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV  154 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~  154 (280)
                      |+++.++.++|+|||+++.......    .....++..|+|||.+.+ ..++.++|+||||+++|+|+++..|...... 
T Consensus       140 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~ellt~~~~~~~~~~-  217 (284)
T cd05079         140 VLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ-SKFYIASDVWSFGVTLYELLTYCDSESSPMT-  217 (284)
T ss_pred             EEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhcc-CCCCccccchhhhhhhhhhhcCCCCCccccc-
Confidence            9999999999999999886543321    123445677999999876 6788899999999999999998765433210 


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  230 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~h  230 (280)
                          ...+..+......       ..........   ...........+..+.+|+.+||+.||.+|||++++++.
T Consensus       218 ----~~~~~~~~~~~~~-------~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         218 ----LFLKMIGPTHGQM-------TVTRLVRVLE---EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             ----hhhhhcccccccc-------cHHHHHHHHH---cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence                1111111111000       0000011000   001112234578999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=4.1e-34  Score=265.07  Aligned_cols=196  Identities=25%  Similarity=0.337  Sum_probs=152.9

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcC-----------CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSD-----------QQLTDDHCQYFLYQLLRGLKYVHSAS   68 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~-----------~~l~~~~~~~i~~qil~~l~~LH~~~   68 (280)
                      ++||||+++++++.+.     +..|+||||++| +|.+++...           ..++...+..++.||+.||+|||+.|
T Consensus        59 L~HPNIVkl~~v~~d~-----~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G  133 (932)
T PRK13184         59 LIHPGIVPVYSICSDG-----DPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG  133 (932)
T ss_pred             CCCcCcCeEEEEEeeC-----CEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC
Confidence            5799999999999877     679999999975 999988531           23567788999999999999999999


Q ss_pred             ccccCCCCCceEEcCCCCeEEeecccccccCCC-------------------CccccceeccccccccccccCCCCCcch
Q 023568           69 VLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-------------------DFMTEYVVTRWYRAPELLLNCTEYTAAI  129 (280)
Q Consensus        69 i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~-------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~  129 (280)
                      |+||||||+||+++.++.++|+|||+++.....                   .......||+.|+|||.+.+ ..++.++
T Consensus       134 IIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g-~~~S~kS  212 (932)
T PRK13184        134 VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG-VPASEST  212 (932)
T ss_pred             ccccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC-CCCCcHh
Confidence            999999999999999999999999999754110                   01122468999999999877 6788999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHH
Q 023568          130 DIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDL  209 (280)
Q Consensus       130 DvwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  209 (280)
                      |+||+||++|+|++|..||...+.......  .....+.                          .......+++.+.++
T Consensus       213 DIWSLGVILyELLTG~~PF~~~~~~ki~~~--~~i~~P~--------------------------~~~p~~~iP~~L~~L  264 (932)
T PRK13184        213 DIYALGVILYQMLTLSFPYRRKKGRKISYR--DVILSPI--------------------------EVAPYREIPPFLSQI  264 (932)
T ss_pred             HHHHHHHHHHHHHHCCCCCCCcchhhhhhh--hhccChh--------------------------hccccccCCHHHHHH
Confidence            999999999999999999987543222111  0000000                          001123568899999


Q ss_pred             HHHhcccCCCCCCCHHHHhcC
Q 023568          210 LEKMLVFDPNKRITVEEALRH  230 (280)
Q Consensus       210 l~~~L~~dp~~Rpt~~ell~h  230 (280)
                      +.+||..||++|++..+.+.+
T Consensus       265 I~rcL~~DP~kR~ss~eeLl~  285 (932)
T PRK13184        265 AMKALAVDPAERYSSVQELKQ  285 (932)
T ss_pred             HHHHccCChhhCcCHHHHHHH
Confidence            999999999999876655543

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=6.9e-34  Score=237.97  Aligned_cols=194  Identities=22%  Similarity=0.366  Sum_probs=155.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC--------CCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD--------QQLTDDHCQYFLYQLLRGLKYVHSASVLH   71 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~--------~~l~~~~~~~i~~qil~~l~~LH~~~i~H   71 (280)
                      |+||||+++++++....    ...++++||+. ++|.+++...        ..+++.++..++.|++.||+|||+.|++|
T Consensus        65 l~h~ni~~~~~~~~~~~----~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H  140 (280)
T cd05043          65 LSHQNILPILHVCIEDG----EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIH  140 (280)
T ss_pred             CCCCCCCeEEEEEecCC----CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEee
Confidence            58999999999876542    56899999997 6999998653        45899999999999999999999999999


Q ss_pred             cCCCCCceEEcCCCCeEEeecccccccCCCCc---cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCC
Q 023568           72 RDLKPSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPL  147 (280)
Q Consensus        72 ~dik~~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p  147 (280)
                      +||+|+||+++.++.++|+|||+++.......   .....++..|+|||.+.+ ..++.++|+|||||++|++++ |+.|
T Consensus       141 ~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p  219 (280)
T cd05043         141 KDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQTP  219 (280)
T ss_pred             cccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhc-CCCCchhhHHHhHHHHHHHhcCCCCC
Confidence            99999999999999999999999975433211   122345677999999876 678899999999999999998 9999


Q ss_pred             CCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 023568          148 FPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA  227 (280)
Q Consensus       148 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~el  227 (280)
                      |...+..+....+.....                              .......++.+.+++.+||+.||++|||+.++
T Consensus       220 ~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~  269 (280)
T cd05043         220 YVEIDPFEMAAYLKDGYR------------------------------LAQPINCPDELFAVMACCWALDPEERPSFSQL  269 (280)
T ss_pred             cCcCCHHHHHHHHHcCCC------------------------------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence            987765443332221000                              00112457889999999999999999999999


Q ss_pred             hc
Q 023568          228 LR  229 (280)
Q Consensus       228 l~  229 (280)
                      ++
T Consensus       270 ~~  271 (280)
T cd05043         270 VQ  271 (280)
T ss_pred             HH
Confidence            85

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=9.9e-34  Score=238.80  Aligned_cols=204  Identities=14%  Similarity=0.167  Sum_probs=155.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      +.|+||+++++....... .....+++|+++..++.+.+......++..+..++.|++.||+|||+.+++||||||+|||
T Consensus        80 ~~h~~i~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nil  158 (294)
T PHA02882         80 IDHLGIPKYYGCGSFKRC-RMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIM  158 (294)
T ss_pred             CCCCCCCcEEEeeeEecC-CceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence            469999999987665421 1134688999988888888776566789999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccccCCC--------CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 023568           81 LNASCDLKIGDFGLARTTSET--------DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD  152 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~  152 (280)
                      ++.++.++|+|||+++.....        .......||+.|+|||++.+ ..++.++||||+||++++|++|..||.+..
T Consensus       159 l~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-~~~~~~~DiwSlG~~l~el~~g~~P~~~~~  237 (294)
T PHA02882        159 VDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-ACVTRRGDLESLGYCMLKWAGIKLPWKGFG  237 (294)
T ss_pred             EcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence            999999999999998754321        11123468999999999877 778999999999999999999999998874


Q ss_pred             hHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          153 YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       153 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      .........+.                  .++..+...     ....+..++.+.++++.|+..+|++||++.++++
T Consensus       238 ~~~~~~~~~~~------------------~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        238 HNGNLIHAAKC------------------DFIKRLHEG-----KIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             cchHHHHHhHH------------------HHHHHhhhh-----hhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            32222111110                  001111000     0112345788999999999999999999999875

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=9.9e-34  Score=237.50  Aligned_cols=211  Identities=20%  Similarity=0.363  Sum_probs=153.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||+++++++.....   ..+++||||+. ++|.+++.+. ..+++..+..++.|++.||+|||+.|++||||||+|
T Consensus        62 l~h~~iv~~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~n  138 (284)
T cd05081          62 LQHDNIVKYKGVCYSAGR---RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRN  138 (284)
T ss_pred             CCCCCeeEEEEEEccCCC---CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhh
Confidence            589999999998765422   56899999997 6999999754 568999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCc----cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDF----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV  154 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~  154 (280)
                      |+++.++.++|+|||++........    .....++..|+|||.+.+ ..++.++|+||||+++++|++|..++......
T Consensus       139 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~  217 (284)
T cd05081         139 ILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYSDKSCSPPAE  217 (284)
T ss_pred             EEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhcc-CCcChHHHHHHHHHHHHHHhhcCCcCCCcchh
Confidence            9999999999999999886543211    111223456999999876 67888999999999999999988766443211


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                       .    ....+......   ............      ..........+..+.+++.+||..+|++|||+.++++
T Consensus       218 -~----~~~~~~~~~~~---~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         218 -F----MRMMGNDKQGQ---MIVYHLIELLKN------NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             -h----hhhcccccccc---cchHHHHHHHhc------CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence             0    01011000000   000000011100      0111123457889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.5e-33  Score=246.47  Aligned_cols=193  Identities=24%  Similarity=0.340  Sum_probs=154.4

Q ss_pred             CcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC---------------------------------------
Q 023568            3 HENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD---------------------------------------   42 (280)
Q Consensus         3 Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~---------------------------------------   42 (280)
                      ||||+++++++...     ..+++||||+. |+|.+++...                                       
T Consensus       100 H~niv~~~~~~~~~-----~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (401)
T cd05107         100 HLNIVNLLGACTKG-----GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSES  174 (401)
T ss_pred             CCCeEEEEEEEccC-----CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhcc
Confidence            99999999999887     67999999998 5999998642                                       


Q ss_pred             -----------------------------------------------------------CCCCHHHHHHHHHHHHHHHHH
Q 023568           43 -----------------------------------------------------------QQLTDDHCQYFLYQLLRGLKY   63 (280)
Q Consensus        43 -----------------------------------------------------------~~l~~~~~~~i~~qil~~l~~   63 (280)
                                                                                 ..+++..+..++.|++.||+|
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~  254 (401)
T cd05107         175 DGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEF  254 (401)
T ss_pred             CccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHH
Confidence                                                                       136777889999999999999


Q ss_pred             HHhCCccccCCCCCceEEcCCCCeEEeecccccccCCCC---ccccceeccccccccccccCCCCCcchhHHHHHHHHHH
Q 023568           64 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE  140 (280)
Q Consensus        64 LH~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~  140 (280)
                      ||+.|++||||||+||+++.++.++|+|||+++......   ......++..|+|||.+.+ ..++.++|+||+|++++|
T Consensus       255 LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~e  333 (401)
T cd05107         255 LASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN-NLYTTLSDVWSFGILLWE  333 (401)
T ss_pred             HhcCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC-CCCCcHhHHHHHHHHHHH
Confidence            999999999999999999999999999999987643221   1223456778999999876 668889999999999999


Q ss_pred             HHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCC
Q 023568          141 IMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPN  219 (280)
Q Consensus       141 ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~  219 (280)
                      |++ |..||......+........ +                            .....+...+..+.+++.+||+.||.
T Consensus       334 ~l~~g~~P~~~~~~~~~~~~~~~~-~----------------------------~~~~~p~~~~~~l~~li~~cl~~~P~  384 (401)
T cd05107         334 IFTLGGTPYPELPMNEQFYNAIKR-G----------------------------YRMAKPAHASDEIYEIMQKCWEEKFE  384 (401)
T ss_pred             HHHcCCCCCCCCCchHHHHHHHHc-C----------------------------CCCCCCCCCCHHHHHHHHHHcCCChh
Confidence            998 88999776543332222110 0                            00011234688999999999999999


Q ss_pred             CCCCHHHHhcC
Q 023568          220 KRITVEEALRH  230 (280)
Q Consensus       220 ~Rpt~~ell~h  230 (280)
                      +||++++++..
T Consensus       385 ~RPs~~ell~~  395 (401)
T cd05107         385 IRPDFSQLVHL  395 (401)
T ss_pred             HCcCHHHHHHH
Confidence            99999999863

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.6e-33  Score=233.27  Aligned_cols=192  Identities=25%  Similarity=0.423  Sum_probs=156.0

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      ++|+||+++++.+..      ...|++|||++ ++|.+++.+.  ..+++..+..++.|++.||.|||+.|++|+||+|+
T Consensus        58 l~~~~i~~~~~~~~~------~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~  131 (260)
T cd05073          58 LQHDKLVKLHAVVTK------EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAA  131 (260)
T ss_pred             cCCCCcceEEEEEcC------CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcc
Confidence            579999999999876      24799999997 5999999753  46889999999999999999999999999999999


Q ss_pred             ceEEcCCCCeEEeecccccccCCCCc--cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023568           78 NLLLNASCDLKIGDFGLARTTSETDF--MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYV  154 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~  154 (280)
                      ||+++.++.++|+|||.+........  .....++..|+|||.+.+ ..++.++|+|||||++|++++ |..||.+.+..
T Consensus       132 ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~  210 (260)
T cd05073         132 NILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP  210 (260)
T ss_pred             eEEEcCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCCCCCCHH
Confidence            99999999999999999875443221  122334567999999876 678889999999999999998 99999887655


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      +....+.....                              .......+..+.+++.+||+.+|++||++.++++
T Consensus       211 ~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         211 EVIRALERGYR------------------------------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             HHHHHHhCCCC------------------------------CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence            55443322100                              0112356889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.6e-33  Score=229.90  Aligned_cols=200  Identities=39%  Similarity=0.694  Sum_probs=165.1

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++|+||+++++.+...     ...+++||++++ +|.+++.....+++..+..++.+++.++.+||+.|++|+||+|.||
T Consensus        44 l~~~~i~~~~~~~~~~-----~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni  118 (244)
T smart00220       44 LKHPNIVRLYDVFEDE-----DKLYLVMEYCDGGDLFDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENI  118 (244)
T ss_pred             CCCCcHHHHHhheeeC-----CEEEEEEeCCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHe
Confidence            4799999999999877     679999999986 9999997766699999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.++.++++|||.+.............++..|+|||.+.+ ...+.++|+||+|++++++++|..||...........
T Consensus       119 ~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~  197 (244)
T smart00220      119 LLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLLG-KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFK  197 (244)
T ss_pred             EECCCCcEEEccccceeeeccccccccccCCcCCCCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence            999999999999999987665544556677889999999875 6677899999999999999999999987433322222


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      .......                           .........+..+.+++++||..+|.+||++.++++||||
T Consensus       198 ~~~~~~~---------------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      198 KIGKPKP---------------------------PFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF  244 (244)
T ss_pred             HHhccCC---------------------------CCccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence            1110000                           0000011167889999999999999999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.6e-33  Score=242.53  Aligned_cols=195  Identities=24%  Similarity=0.371  Sum_probs=151.6

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC--------------------------------------
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD--------------------------------------   42 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~--------------------------------------   42 (280)
                      +||||+++++++....    ..+++||||++ |+|.+++...                                      
T Consensus        69 ~h~niv~~~~~~~~~~----~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (343)
T cd05103          69 HHLNVVNLLGACTKPG----GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSS  144 (343)
T ss_pred             CCccHhhhcceeecCC----CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccc
Confidence            5899999999886542    45899999998 5999998642                                      


Q ss_pred             -----------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEeecc
Q 023568           43 -----------------------------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG   93 (280)
Q Consensus        43 -----------------------------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nili~~~~~~kl~dfg   93 (280)
                                                   ..+++..+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg  224 (343)
T cd05103         145 QSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFG  224 (343)
T ss_pred             cccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecc
Confidence                                         236788889999999999999999999999999999999999999999999


Q ss_pred             cccccCCCCc---cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCc
Q 023568           94 LARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDD  169 (280)
Q Consensus        94 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~  169 (280)
                      ++........   .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||................     
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-----  298 (343)
T cd05103         225 LARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG-----  298 (343)
T ss_pred             cccccccCcchhhcCCCCCCcceECcHHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhcc-----
Confidence            9876432211   112334567999999876 678899999999999999997 999997754322221111100     


Q ss_pred             ccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 023568          170 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  230 (280)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~h  230 (280)
                                              .........++.+.+++.+||+.||.+|||+.++++|
T Consensus       299 ------------------------~~~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         299 ------------------------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             ------------------------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                    0001112357789999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-33  Score=235.01  Aligned_cols=192  Identities=24%  Similarity=0.343  Sum_probs=155.6

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||+++++++..      ...++||||+. |+|.+++.+. ..+++..+..++.|++.||+|||+.|++|+||+|+|
T Consensus        66 l~h~~i~~~~~~~~~------~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~n  139 (279)
T cd05057          66 VDHPHVVRLLGICLS------SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARN  139 (279)
T ss_pred             CCCCCcceEEEEEec------CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcce
Confidence            579999999999875      35899999997 6999998764 569999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCcc---ccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDFM---TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYV  154 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~  154 (280)
                      |+++.++.++|+|||.++........   ....++..|+|||.+.+ ..++.++|+||+|++++++++ |..||.+....
T Consensus       140 il~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~  218 (279)
T cd05057         140 VLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV  218 (279)
T ss_pred             EEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH
Confidence            99999999999999998765433211   11223567999998865 678889999999999999998 99999887654


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      +....+....                              ........+.++.+++.+||..||.+|||+.++++
T Consensus       219 ~~~~~~~~~~------------------------------~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         219 EIPDLLEKGE------------------------------RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             HHHHHHhCCC------------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            4443332210                              01112245788999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-34  Score=258.22  Aligned_cols=205  Identities=26%  Similarity=0.439  Sum_probs=173.5

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~--~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      +|||+++++++|.-..+.+.+.+|||||||+ |++-|++++  +.++.|..+.+|++.++.|+.+||.+.++|||||..|
T Consensus        74 ~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~N  153 (953)
T KOG0587|consen   74 HHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQN  153 (953)
T ss_pred             CCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCce
Confidence            5999999999998776655578999999998 599999864  5689999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCC-CccccceeccccccccccccC----CCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 023568           79 LLLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNC----TEYTAAIDIWSVGCILGEIMTREPLFPGKDY  153 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~----~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~  153 (280)
                      ||++.++.+||+|||.+...... ....+.+||+.|||||++...    ..|...+|+||||++..||.-|.+|+-....
T Consensus       154 iLLT~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP  233 (953)
T KOG0587|consen  154 VLLTENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP  233 (953)
T ss_pred             EEEeccCcEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch
Confidence            99999999999999998765544 345678999999999998642    4567899999999999999999999977765


Q ss_pred             HHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          154 VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       154 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      +..+-.|   ...|++...                         .+..++..+.+||..||.+|..+||+..++|.|||+
T Consensus       234 mraLF~I---pRNPPPkLk-------------------------rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi  285 (953)
T KOG0587|consen  234 MRALFLI---PRNPPPKLK-------------------------RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFI  285 (953)
T ss_pred             hhhhccC---CCCCCcccc-------------------------chhhHHHHHHHHHHHHHhhccccCcchhhhccCCcc
Confidence            5444322   233333321                         123578999999999999999999999999999999


Q ss_pred             c
Q 023568          234 Q  234 (280)
Q Consensus       234 ~  234 (280)
                      +
T Consensus       286 ~  286 (953)
T KOG0587|consen  286 T  286 (953)
T ss_pred             c
Confidence            7

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.7e-33  Score=238.33  Aligned_cols=193  Identities=21%  Similarity=0.320  Sum_probs=154.2

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||+++++++...      ..++++||+. |+|.+++..+. .+++..+..++.|++.||.|||+.|++|+||||+|
T Consensus        66 l~h~niv~~~~~~~~~------~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~N  139 (303)
T cd05110          66 MDHPHLVRLLGVCLSP------TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARN  139 (303)
T ss_pred             CCCCCcccEEEEEcCC------CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccce
Confidence            5799999999998654      3679999997 69999987643 68999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCc---cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYV  154 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~  154 (280)
                      |+++.++.++|+|||.++.......   .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||.+....
T Consensus       140 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~  218 (303)
T cd05110         140 VLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY-RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR  218 (303)
T ss_pred             eeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhcc-CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999976443211   122344678999999876 778899999999999999997 89999876533


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  230 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~h  230 (280)
                      .....+.. ..                             .....+..+.++.+++.+|+..||++||+++++++.
T Consensus       219 ~~~~~~~~-~~-----------------------------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         219 EIPDLLEK-GE-----------------------------RLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             HHHHHHHC-CC-----------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            32222211 00                             001123457789999999999999999999998873

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>PLN00181 protein SPA1-RELATED; Provisional

Probab=100.00  E-value=7.9e-35  Score=275.09  Aligned_cols=203  Identities=16%  Similarity=0.244  Sum_probs=149.9

Q ss_pred             CC-cccccccccccCCCCCCC--CcEEEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            2 EH-ENVIAIKDIIRPPKKDTF--NDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         2 ~H-pniv~l~~~~~~~~~~~~--~~~~lv~e~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      +| +||++++++|.....++.  ..++++||+++++|.++|.+ ...+++.+++.+++||+.||+|||++||+||||||+
T Consensus        30 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~  109 (793)
T PLN00181         30 SHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPS  109 (793)
T ss_pred             hHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCch
Confidence            56 799999999965543332  36889999999999999975 356999999999999999999999999999999999


Q ss_pred             ceEEcCCC-------------------CeEEeecccccccCCCC-----------------ccccceecccccccccccc
Q 023568           78 NLLLNASC-------------------DLKIGDFGLARTTSETD-----------------FMTEYVVTRWYRAPELLLN  121 (280)
Q Consensus        78 Nili~~~~-------------------~~kl~dfg~~~~~~~~~-----------------~~~~~~~~~~y~aPE~~~~  121 (280)
                      |||++..+                   .+|++|||+++......                 ......||++|+|||++.+
T Consensus       110 NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~  189 (793)
T PLN00181        110 CFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNG  189 (793)
T ss_pred             hEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhcc
Confidence            99996544                   45566666654321100                 0011357888999999887


Q ss_pred             CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCC
Q 023568          122 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN  201 (280)
Q Consensus       122 ~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  201 (280)
                       ..++.++|||||||++|||++|.+|+.....  ....+.... .+                             .....
T Consensus       190 -~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~-~~-----------------------------~~~~~  236 (793)
T PLN00181        190 -SSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRV-LP-----------------------------PQILL  236 (793)
T ss_pred             -CCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhh-cC-----------------------------hhhhh
Confidence             6789999999999999999999887654221  111111100 00                             00011


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCc
Q 023568          202 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  237 (280)
Q Consensus       202 ~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~  237 (280)
                      ..+...+++.+||+.||.+|||+.|+++||||....
T Consensus       237 ~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~~  272 (793)
T PLN00181        237 NWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEPR  272 (793)
T ss_pred             cCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhhh
Confidence            245567899999999999999999999999997653

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=6e-35  Score=247.68  Aligned_cols=224  Identities=35%  Similarity=0.584  Sum_probs=177.5

Q ss_pred             ccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE
Q 023568            5 NVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ---QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL   81 (280)
Q Consensus         5 niv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~---~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nili   81 (280)
                      |.++|+..|...     +|+|||+|-+.-+|.++|++-+   .|....++.++.|++.||..|-..||+|.||||+||||
T Consensus       495 Hclrl~r~F~hk-----nHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLV  569 (752)
T KOG0670|consen  495 HCLRLFRHFKHK-----NHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILV  569 (752)
T ss_pred             HHHHHHHHhhhc-----ceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEe
Confidence            577888888877     8999999999999999998744   58999999999999999999999999999999999999


Q ss_pred             cCCC-CeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 023568           82 NASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  160 (280)
Q Consensus        82 ~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~i  160 (280)
                      +... .+||||||.|...+.+.. +.+..+.+|.|||++.| ..|....|+||.||.||||.+|+..|+|..+.+.+...
T Consensus       570 NE~k~iLKLCDfGSA~~~~enei-tPYLVSRFYRaPEIiLG-~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~  647 (752)
T KOG0670|consen  570 NESKNILKLCDFGSASFASENEI-TPYLVSRFYRAPEIILG-LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLF  647 (752)
T ss_pred             ccCcceeeeccCccccccccccc-cHHHHHHhccCcceeec-CcccCCccceeeceeeEEeeccceecCCCCcHHHHHHH
Confidence            8854 589999999998887764 45667889999999999 88999999999999999999999999999999999999


Q ss_pred             HHHhCCCCccccccc--CChhHHH-----------HH-----HhCCcc-----------ccccccccCCCCCHHHHHHHH
Q 023568          161 TELIGSPDDASLGFL--RSDNARR-----------YV-----RQLPRC-----------RKQQFATRFPNKSSGAVDLLE  211 (280)
Q Consensus       161 ~~~~~~~~~~~~~~~--~~~~~~~-----------~~-----~~~~~~-----------~~~~~~~~~~~~~~~~~~ll~  211 (280)
                      +.+.|.-+...+.--  .......           .+     .-+...           ..+..+...+.+-.++.+||.
T Consensus       648 me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLd  727 (752)
T KOG0670|consen  648 MELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLD  727 (752)
T ss_pred             HHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHH
Confidence            998886664432100  0000000           00     000000           000011111223467899999


Q ss_pred             HhcccCCCCCCCHHHHhcCccccc
Q 023568          212 KMLVFDPNKRITVEEALRHPYLQS  235 (280)
Q Consensus       212 ~~L~~dp~~Rpt~~ell~hp~~~~  235 (280)
                      +||..||++|.|+.|+|.||||..
T Consensus       728 kml~LdP~KRit~nqAL~HpFi~~  751 (752)
T KOG0670|consen  728 KMLILDPEKRITVNQALKHPFITE  751 (752)
T ss_pred             HHhccChhhcCCHHHHhcCCcccC
Confidence            999999999999999999999964

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-33  Score=237.65  Aligned_cols=230  Identities=30%  Similarity=0.490  Sum_probs=173.7

Q ss_pred             cccccccccccCCCCCCCCcEEEEEecCCccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceE
Q 023568            4 ENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLL   80 (280)
Q Consensus         4 pniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~--~~~l~~~~~~~i~~qil~~l~~LH~-~~i~H~dik~~Nil   80 (280)
                      .+||+|++.|...++.| .|+++|+|+++.+|..+|..  .+.++...++.|++|||.||.|||+ .||+|.||||+|||
T Consensus       142 ~~VV~LlD~FkhsGpNG-~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvL  220 (590)
T KOG1290|consen  142 KCVVQLLDHFKHSGPNG-QHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVL  220 (590)
T ss_pred             ceeeeeeccceecCCCC-cEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceee
Confidence            57999999999987766 89999999999999999975  4789999999999999999999997 58999999999999


Q ss_pred             EcCC----------------------------------------------------------------------------
Q 023568           81 LNAS----------------------------------------------------------------------------   84 (280)
Q Consensus        81 i~~~----------------------------------------------------------------------------   84 (280)
                      +..+                                                                            
T Consensus       221 l~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~  300 (590)
T KOG1290|consen  221 LCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQ  300 (590)
T ss_pred             eeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccc
Confidence            8300                                                                            


Q ss_pred             --------------------------------------------------------------------------------
Q 023568           85 --------------------------------------------------------------------------------   84 (280)
Q Consensus        85 --------------------------------------------------------------------------------   84 (280)
                                                                                                      
T Consensus       301 ~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v  380 (590)
T KOG1290|consen  301 ESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLV  380 (590)
T ss_pred             cccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCcccccccccc
Confidence                                                                                            


Q ss_pred             ----------CCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC---
Q 023568           85 ----------CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK---  151 (280)
Q Consensus        85 ----------~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~---  151 (280)
                                .++||+|||-|......  ++.-+.|..|.|||++.| ..|+..+|+||++|+++||+||..+|...   
T Consensus       381 ~p~~~~~~~di~vKIaDlGNACW~~kh--FT~DIQTRQYRapEVllG-sgY~~~ADiWS~AC~~FELaTGDyLFePhsG~  457 (590)
T KOG1290|consen  381 NPDIPLPECDIRVKIADLGNACWVHKH--FTEDIQTRQYRAPEVLLG-SGYSTSADIWSTACMAFELATGDYLFEPHSGE  457 (590)
T ss_pred             CCCCCCCccceeEEEeeccchhhhhhh--hchhhhhhhccCcceeec-CCCCCchhHHHHHHHHHHhhcCceeecCCCCC
Confidence                      01233444433332211  233456778999999999 89999999999999999999999877664   


Q ss_pred             ---ChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCcccccccccc------------CC-CCCHHHHHHHHHhcc
Q 023568          152 ---DYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR------------FP-NKSSGAVDLLEKMLV  215 (280)
Q Consensus       152 ---~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~-~~~~~~~~ll~~~L~  215 (280)
                         .+.+.++.|++++|..+....-.  ....+.|+......+....-..            |+ ....++.+||.-||+
T Consensus       458 ~Y~rDEDHiA~i~ELLG~iPr~ia~~--Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLe  535 (590)
T KOG1290|consen  458 NYSRDEDHIALIMELLGKIPRKIALG--GKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLE  535 (590)
T ss_pred             CCCccHHHHHHHHHHHhhccHHHHhc--CcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHh
Confidence               35789999999999888765321  1222222222211111100000            11 246788999999999


Q ss_pred             cCCCCCCCHHHHhcCcccccCcCC
Q 023568          216 FDPNKRITVEEALRHPYLQSLHDL  239 (280)
Q Consensus       216 ~dp~~Rpt~~ell~hp~~~~~~~~  239 (280)
                      .+|++||||.++|+|||+..+-.+
T Consensus       536 f~PeKR~tA~~cl~hPwLn~~~~~  559 (590)
T KOG1290|consen  536 FDPEKRPTAAQCLKHPWLNPVAGP  559 (590)
T ss_pred             cCccccccHHHHhcCccccCCCCC
Confidence            999999999999999999887655

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-34  Score=261.87  Aligned_cols=193  Identities=24%  Similarity=0.397  Sum_probs=163.4

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC-------CCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-------QQLTDDHCQYFLYQLLRGLKYVHSASVLHR   72 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~   72 (280)
                      ++|||||+++|+.-+.     ...+|++|||. |+|..+|++.       ..++..+...++.||++|+.||++++++||
T Consensus       752 f~HpNiv~liGv~l~~-----~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHR  826 (1025)
T KOG1095|consen  752 FDHPNIVSLIGVCLDS-----GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHR  826 (1025)
T ss_pred             CCCcceeeEEEeecCC-----CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCc
Confidence            5899999999999987     66999999997 6999999865       358999999999999999999999999999


Q ss_pred             CCCCCceEEcCCCCeEEeecccccccCCCCcc-cc--ceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCC
Q 023568           73 DLKPSNLLLNASCDLKIGDFGLARTTSETDFM-TE--YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLF  148 (280)
Q Consensus        73 dik~~Nili~~~~~~kl~dfg~~~~~~~~~~~-~~--~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf  148 (280)
                      ||.+.|+|++....+|++|||+|+-....+.. ..  ..-...|||||.+.. +.++.++|||||||++||+++ |..||
T Consensus       827 DLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY  905 (1025)
T KOG1095|consen  827 DLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPY  905 (1025)
T ss_pred             chhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCC
Confidence            99999999999999999999999943332211 11  123457999999987 899999999999999999998 99999


Q ss_pred             CCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 023568          149 PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL  228 (280)
Q Consensus       149 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell  228 (280)
                      ++.+..+.+....+....+                              .++..+..+.+++.+|++.+|++||++..++
T Consensus       906 ~~~~n~~v~~~~~~ggRL~------------------------------~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~  955 (1025)
T KOG1095|consen  906 PSRSNFEVLLDVLEGGRLD------------------------------PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIV  955 (1025)
T ss_pred             CCcchHHHHHHHHhCCccC------------------------------CCCCCChHHHHHHHHHccCChhhCccHHHHH
Confidence            9998777766444422111                              1235688899999999999999999999999


Q ss_pred             c
Q 023568          229 R  229 (280)
Q Consensus       229 ~  229 (280)
                      +
T Consensus       956 ~  956 (1025)
T KOG1095|consen  956 E  956 (1025)
T ss_pred             h
Confidence            7

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-35  Score=228.42  Aligned_cols=207  Identities=22%  Similarity=0.336  Sum_probs=165.3

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHH-----cCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCC
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIR-----SDQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLK   75 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~-----~~~~l~~~~~~~i~~qil~~l~~LH~-~~i~H~dik   75 (280)
                      +-||||+++|+.-.+     +.-|+.||+|+-+|..+-+     +...++|+.+-.|....+.||.||-+ .+|+|||+|
T Consensus       121 ~cp~IVkfyGa~F~E-----GdcWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvK  195 (361)
T KOG1006|consen  121 NCPNIVKFYGALFSE-----GDCWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVK  195 (361)
T ss_pred             CCcHHHHHhhhhhcC-----CceeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCC
Confidence            358999999998888     6799999999976655442     35689999999999999999999996 589999999


Q ss_pred             CCceEEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023568           76 PSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE-YTAAIDIWSVGCILGEIMTREPLFPGKDYV  154 (280)
Q Consensus        76 ~~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~DvwslG~~l~~ll~g~~pf~~~~~~  154 (280)
                      |+|||++..|.+||||||.+....+.-..+.-.|...|+|||.+..... |..++|+||||++++|..||..|+.+-  .
T Consensus       196 PSNILldr~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w--~  273 (361)
T KOG1006|consen  196 PSNILLDRHGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKW--D  273 (361)
T ss_pred             hhheEEecCCCEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchH--H
Confidence            9999999999999999999887655544455678889999999976444 889999999999999999999887653  3


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ  234 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~  234 (280)
                      ....++..+....++.....                      ..--..+..+..||..||.+|-+.||+..+++++||++
T Consensus       274 svfeql~~Vv~gdpp~l~~~----------------------~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr  331 (361)
T KOG1006|consen  274 SVFEQLCQVVIGDPPILLFD----------------------KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYR  331 (361)
T ss_pred             HHHHHHHHHHcCCCCeecCc----------------------ccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhh
Confidence            34444444322222211110                      00114688999999999999999999999999999998


Q ss_pred             cCc
Q 023568          235 SLH  237 (280)
Q Consensus       235 ~~~  237 (280)
                      ...
T Consensus       332 ~y~  334 (361)
T KOG1006|consen  332 MYA  334 (361)
T ss_pred             hhh
Confidence            754

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-33  Score=235.70  Aligned_cols=206  Identities=25%  Similarity=0.457  Sum_probs=165.9

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS--VLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~--i~H~dik~~   77 (280)
                      |.||.|||++++|.-++    +.++.|+|||+| +|.=+|++++.+++.+++.|+.||+.||.||.+..  |+|-||||.
T Consensus       524 LDHpRIVKlYDyfslDt----dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPg  599 (775)
T KOG1151|consen  524 LDHPRIVKLYDYFSLDT----DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPG  599 (775)
T ss_pred             cCcceeeeeeeeeeecc----ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCc
Confidence            68999999999998764    568999999998 88888999999999999999999999999999875  999999999


Q ss_pred             ceEEc---CCCCeEEeecccccccCCC--------Cccccceecccccccccccc---CCCCCcchhHHHHHHHHHHHHh
Q 023568           78 NLLLN---ASCDLKIGDFGLARTTSET--------DFMTEYVVTRWYRAPELLLN---CTEYTAAIDIWSVGCILGEIMT  143 (280)
Q Consensus        78 Nili~---~~~~~kl~dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~---~~~~~~~~DvwslG~~l~~ll~  143 (280)
                      |||+-   .-|.+|++|||+++.....        +......||.||++||.+.-   ..+.+.++||||+|||+|..+.
T Consensus       600 NILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClY  679 (775)
T KOG1151|consen  600 NILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLY  679 (775)
T ss_pred             cEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhc
Confidence            99983   3578999999999865443        23356789999999999853   2567889999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCC
Q 023568          144 REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT  223 (280)
Q Consensus       144 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt  223 (280)
                      |+.||.....-   +.|.+......                     -....++ .-|.+++++++||++||+.--+.|..
T Consensus       680 GrKPFGhnqsQ---QdILqeNTIlk---------------------AtEVqFP-~KPvVsseAkaFIRRCLaYRKeDR~D  734 (775)
T KOG1151|consen  680 GRKPFGHNQSQ---QDILQENTILK---------------------ATEVQFP-PKPVVSSEAKAFIRRCLAYRKEDRID  734 (775)
T ss_pred             cCCCCCCchhH---HHHHhhhchhc---------------------ceeccCC-CCCccCHHHHHHHHHHHHhhhhhhhh
Confidence            99999775422   12221100000                     0111111 12468999999999999999999999


Q ss_pred             HHHHhcCccccc
Q 023568          224 VEEALRHPYLQS  235 (280)
Q Consensus       224 ~~ell~hp~~~~  235 (280)
                      +.++-.||||..
T Consensus       735 V~qLA~dpyllP  746 (775)
T KOG1151|consen  735 VQQLACDPYLLP  746 (775)
T ss_pred             HHHHccCccccc
Confidence            999999999965

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=7.5e-33  Score=250.71  Aligned_cols=203  Identities=22%  Similarity=0.302  Sum_probs=140.3

Q ss_pred             CcEEEEEecCC-ccHHHHHHcCCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568           22 NDVYIVYELMD-TDLHQIIRSDQQ--------------------LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus        22 ~~~~lv~e~~~-g~L~~~l~~~~~--------------------l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      ...++||||++ ++|.+++.....                    ..+..+..++.|++.||.|||+.||+||||||+|||
T Consensus       208 ~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NIL  287 (566)
T PLN03225        208 DEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNII  287 (566)
T ss_pred             CceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEE
Confidence            67999999998 589998864321                    124457789999999999999999999999999999


Q ss_pred             EcC-CCCeEEeecccccccCCC--CccccceeccccccccccccCC---------------------CCCcchhHHHHHH
Q 023568           81 LNA-SCDLKIGDFGLARTTSET--DFMTEYVVTRWYRAPELLLNCT---------------------EYTAAIDIWSVGC  136 (280)
Q Consensus        81 i~~-~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~---------------------~~~~~~DvwslG~  136 (280)
                      ++. ++.+||+|||+++.....  .......+++.|+|||.+....                     .+..++||||+||
T Consensus       288 l~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGv  367 (566)
T PLN03225        288 FSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL  367 (566)
T ss_pred             EeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHH
Confidence            986 688999999999754322  2334567899999999764211                     2334679999999


Q ss_pred             HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCcccccc---ccccCCCCCHHHHHHHHHh
Q 023568          137 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQ---FATRFPNKSSGAVDLLEKM  213 (280)
Q Consensus       137 ~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ll~~~  213 (280)
                      ++|||+++..++  .+.......+....+.....+            ...........   ........+....+||++|
T Consensus       368 iL~el~~~~~~~--~~~~~~~~~~l~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~m  433 (566)
T PLN03225        368 IFLQMAFPNLRS--DSNLIQFNRQLKRNDYDLVAW------------RKLVEPRASPDLRRGFEVLDLDGGAGWELLKSM  433 (566)
T ss_pred             HHHHHHhCcCCC--chHHHHHHHHHHhcCCcHHHH------------HHhhccccchhhhhhhhhccccchHHHHHHHHH
Confidence            999999866443  333333333332222111111            00000000000   0111223455677999999


Q ss_pred             cccCCCCCCCHHHHhcCcccccCcC
Q 023568          214 LVFDPNKRITVEEALRHPYLQSLHD  238 (280)
Q Consensus       214 L~~dp~~Rpt~~ell~hp~~~~~~~  238 (280)
                      |+.||.+|||++|+|+||||+....
T Consensus       434 L~~dP~kR~ta~e~L~Hpff~~~~~  458 (566)
T PLN03225        434 MRFKGRQRISAKAALAHPYFDREGL  458 (566)
T ss_pred             ccCCcccCCCHHHHhCCcCcCCCCc
Confidence            9999999999999999999987543

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.2e-32  Score=229.59  Aligned_cols=198  Identities=21%  Similarity=0.332  Sum_probs=154.6

Q ss_pred             CCCcccccccccccCCCCCCC-CcEEEEEecCC-ccHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 023568            1 MEHENVIAIKDIIRPPKKDTF-NDVYIVYELMD-TDLHQIIRSD------QQLTDDHCQYFLYQLLRGLKYVHSASVLHR   72 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~-~~~~lv~e~~~-g~L~~~l~~~------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~   72 (280)
                      ++||||+++++++......+. ...++++||+. |+|.+++...      ..++...+..++.|++.||+|||+.|++||
T Consensus        58 l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~  137 (273)
T cd05074          58 FDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHR  137 (273)
T ss_pred             CCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeec
Confidence            589999999999876532221 24588999997 6998877421      257999999999999999999999999999


Q ss_pred             CCCCCceEEcCCCCeEEeecccccccCCCCc---cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCC
Q 023568           73 DLKPSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLF  148 (280)
Q Consensus        73 dik~~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf  148 (280)
                      ||||+||+++.++.++|+|||.++.......   .....++..|++||.+.+ ..++.++|+|||||++|+|++ |.+||
T Consensus       138 dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~sDi~slG~il~el~~~g~~p~  216 (273)
T cd05074         138 DLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLAD-NVYTTHSDVWAFGVTMWEIMTRGQTPY  216 (273)
T ss_pred             ccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhc-CccchhhhhHHHHHHHHHHhhCCCCCC
Confidence            9999999999999999999999886543221   122344567999998876 677889999999999999998 89999


Q ss_pred             CCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 023568          149 PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL  228 (280)
Q Consensus       149 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell  228 (280)
                      .+.+.......+....                              .....+..+..+.+++.+||..+|++|||+.+++
T Consensus       217 ~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~  266 (273)
T cd05074         217 AGVENSEIYNYLIKGN------------------------------RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLR  266 (273)
T ss_pred             CCCCHHHHHHHHHcCC------------------------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence            8776544333322100                              0011134678999999999999999999999998


Q ss_pred             c
Q 023568          229 R  229 (280)
Q Consensus       229 ~  229 (280)
                      .
T Consensus       267 ~  267 (273)
T cd05074         267 D  267 (273)
T ss_pred             H
Confidence            6

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1e-33  Score=244.78  Aligned_cols=192  Identities=23%  Similarity=0.400  Sum_probs=164.6

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||||++|++.+.      -.+||||++. |.|..+++.+ ..++......+++||..||+|||+.+++||||-..|
T Consensus       448 fdHphIikLIGv~~e~------P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRN  521 (974)
T KOG4257|consen  448 FDHPHIIKLIGVCVEQ------PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARN  521 (974)
T ss_pred             CCCcchhheeeeeecc------ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhh
Confidence            5799999999999875      3899999998 8999999765 579999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCcccccee--ccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDFMTEYVV--TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVH  155 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~--~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~~  155 (280)
                      ||+.....+||+|||+++............|  ..-|||||.+.- ..++.++|||.||+.+||++. |..||.+-.+.+
T Consensus       522 iLVsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINf-RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD  600 (974)
T KOG4257|consen  522 ILVSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINF-RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD  600 (974)
T ss_pred             eeecCcceeeecccchhhhccccchhhccccccceeecCccccch-hcccchhhHHHHHHHHHHHHHhcCCccccccccc
Confidence            9999999999999999998887765555444  456999998865 889999999999999999986 999999977655


Q ss_pred             HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          156 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       156 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      .+..+++                              ......++..++.+..++.+|+..||.+||++.++..
T Consensus       601 VI~~iEn------------------------------GeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~  644 (974)
T KOG4257|consen  601 VIGHIEN------------------------------GERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKA  644 (974)
T ss_pred             eEEEecC------------------------------CCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence            5544432                              2223445678999999999999999999998877653

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1e-32  Score=231.04  Aligned_cols=210  Identities=23%  Similarity=0.375  Sum_probs=155.1

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||+++++++.....   ...++||||+. ++|.+++...+ .+++..+..++.|++.||+|||+.|++|+||+|+|
T Consensus        63 l~~~~i~~~~~~~~~~~~---~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~n  139 (284)
T cd05038          63 LDHENIVKYKGVCEKPGG---RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARN  139 (284)
T ss_pred             CCCCChheEEeeeecCCC---CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHh
Confidence            579999999999877422   57999999997 59999997644 69999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCc----cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDF----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV  154 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~  154 (280)
                      |+++.++.++|+|||.+........    .....++..|+|||.+.+ ..++.++|+||||+++++|++|..|+......
T Consensus       140 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~  218 (284)
T cd05038         140 ILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRT-SKFSSASDVWSFGVTLYELFTYGDPSQSPPAE  218 (284)
T ss_pred             EEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHcc-CCCCcccchHHHhhhhheeeccCCCcccccch
Confidence            9999999999999999987653211    112234556999998876 67888999999999999999999888654321


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      .     ....+.....       .........+...   .........+..+.+++.+||+.+|.+|||+.|+++
T Consensus       219 ~-----~~~~~~~~~~-------~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         219 F-----LRMIGIAQGQ-------MIVTRLLELLKEG---ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             h-----cccccccccc-------ccHHHHHHHHHcC---CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            1     0000000000       0000000000000   001112345788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-34  Score=252.29  Aligned_cols=196  Identities=31%  Similarity=0.422  Sum_probs=152.6

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcC-CCC---CHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQL---TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~-~~l---~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      .|||||++++.=++.     .++||..|.|..+|.|++... ...   ..-..+.++.|++.||++||+.+|+||||||.
T Consensus       561 ~H~NviRyyc~E~d~-----qF~YIalELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQ  635 (903)
T KOG1027|consen  561 EHPNVIRYYCSEQDR-----QFLYIALELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQ  635 (903)
T ss_pred             CCCceEEEEeeccCC-----ceEEEEehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCc
Confidence            599999999998777     889999999999999999764 111   11345788999999999999999999999999


Q ss_pred             ceEEcC---C--CCeEEeecccccccCCC----CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhC-CCC
Q 023568           78 NLLLNA---S--CDLKIGDFGLARTTSET----DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPL  147 (280)
Q Consensus        78 Nili~~---~--~~~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g-~~p  147 (280)
                      ||||+.   +  .+++|+|||+++....+    .......||..|+|||++.. ..-..++|+||+||++|+.++| .+|
T Consensus       636 NILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~-~~~~~avDiFslGCvfyYvltgG~Hp  714 (903)
T KOG1027|consen  636 NILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLRE-DRKTQAVDIFSLGCVFYYVLTGGSHP  714 (903)
T ss_pred             eEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhc-cccCcccchhhcCceEEEEecCCccC
Confidence            999976   3  46889999999976544    22456788999999999987 5556799999999999999985 899


Q ss_pred             CCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 023568          148 FPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA  227 (280)
Q Consensus       148 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~el  227 (280)
                      |...-..  ...|..  +..                          ......+.....+.+||.+||..||.+||+|.++
T Consensus       715 FGd~~~R--~~NIl~--~~~--------------------------~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~V  764 (903)
T KOG1027|consen  715 FGDSLER--QANILT--GNY--------------------------TLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDV  764 (903)
T ss_pred             CCchHHh--hhhhhc--Ccc--------------------------ceeeeccCchHHHHHHHHHhcCCCcccCCCHHHH
Confidence            9664311  111111  000                          0000111111278999999999999999999999


Q ss_pred             hcCccc
Q 023568          228 LRHPYL  233 (280)
Q Consensus       228 l~hp~~  233 (280)
                      |.||||
T Consensus       765 L~HPlF  770 (903)
T KOG1027|consen  765 LNHPLF  770 (903)
T ss_pred             hCCCcc
Confidence            999999

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-33  Score=242.82  Aligned_cols=196  Identities=20%  Similarity=0.326  Sum_probs=157.1

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      +|.||+=+.|++..+     . +.||+-+|+| +|+.+++. ..+|.+.+.+.|+.|+++|+.|||.++|+|||||..||
T Consensus       446 RH~NIlLFMG~~~~p-----~-~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNI  519 (678)
T KOG0193|consen  446 RHENILLFMGACMNP-----P-LAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNI  519 (678)
T ss_pred             chhhheeeehhhcCC-----c-eeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccce
Confidence            699999999999866     3 4999999998 99999964 46899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC---Cccccceecccccccccccc--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023568           80 LLNASCDLKIGDFGLARTTSET---DFMTEYVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV  154 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~  154 (280)
                      ++.++++|+|+|||++......   .......|...|||||+++.  ...|+..+|||||||++|||++|..||......
T Consensus       520 Fl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d  599 (678)
T KOG0193|consen  520 FLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD  599 (678)
T ss_pred             EEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh
Confidence            9999999999999998753322   22345667888999999864  246788999999999999999999999854432


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      +.+-.+-.....                          ++........++++++|+..|+..++++||.+.++|.
T Consensus       600 qIifmVGrG~l~--------------------------pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  600 QIIFMVGRGYLM--------------------------PDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             heEEEecccccC--------------------------ccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence            222111111111                          1111222345679999999999999999999999987

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.98  E-value=8.6e-33  Score=242.39  Aligned_cols=154  Identities=29%  Similarity=0.413  Sum_probs=134.3

Q ss_pred             CCCcccccccccccCCCC-CCCCcEEEEEecCC-ccHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 023568            1 MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMD-TDLHQIIRS---DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK   75 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~-~~~~~~~lv~e~~~-g~L~~~l~~---~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik   75 (280)
                      |+|||||+++++=++... .--....+|||||. |+|..++.+   ...+++.+...++..+..|+.|||++||+|||||
T Consensus        68 Lnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlK  147 (732)
T KOG4250|consen   68 LNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLK  147 (732)
T ss_pred             cCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCC
Confidence            689999999999776531 00145789999997 699999964   4679999999999999999999999999999999


Q ss_pred             CCceEE--cCCCC--eEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 023568           76 PSNLLL--NASCD--LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK  151 (280)
Q Consensus        76 ~~Nili--~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~  151 (280)
                      |.||++  +.+|+  .||+|||.|+...++....+..||+.|.+||.+...+.|+..+|.|||||++|+.+||..||-..
T Consensus       148 P~NIvl~~Gedgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~  227 (732)
T KOG4250|consen  148 PGNIVLQIGEDGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF  227 (732)
T ss_pred             CCcEEEeecCCCceEEeeecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence            999987  34444  69999999999999888999999999999999985589999999999999999999999998775


Q ss_pred             ChH
Q 023568          152 DYV  154 (280)
Q Consensus       152 ~~~  154 (280)
                      ...
T Consensus       228 ~~p  230 (732)
T KOG4250|consen  228 GGP  230 (732)
T ss_pred             CCc
Confidence            444

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.98  E-value=6.1e-32  Score=234.00  Aligned_cols=190  Identities=23%  Similarity=0.383  Sum_probs=162.5

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      ++|||+|+|++++..+     .-+|||+|||. |+|.++|+..  ..++.-...+++.||..|+.||..++++||||-..
T Consensus       320 ikHpNLVqLLGVCT~E-----pPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAAR  394 (1157)
T KOG4278|consen  320 IKHPNLVQLLGVCTHE-----PPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAAR  394 (1157)
T ss_pred             hcCccHHHHhhhhccC-----CCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhh
Confidence            5899999999999988     44999999997 8999999864  34777888899999999999999999999999999


Q ss_pred             ceEEcCCCCeEEeecccccccCCCCcccccee---ccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 023568           78 NLLLNASCDLKIGDFGLARTTSETDFMTEYVV---TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDY  153 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~---~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~  153 (280)
                      |+|++.+..+|++|||+++....+.. +...|   ...|.|||-+.- ..++.++|||+|||++||+.+ |-.||++-+.
T Consensus       395 NCLVgEnhiVKvADFGLsRlMtgDTY-TAHAGAKFPIKWTAPEsLAy-NtFSiKSDVWAFGVLLWEIATYGMsPYPGidl  472 (1157)
T KOG4278|consen  395 NCLVGENHIVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAY-NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL  472 (1157)
T ss_pred             hccccccceEEeeccchhhhhcCCce-ecccCccCcccccCcccccc-cccccchhhHHHHHHHHHHHhcCCCCCCCccH
Confidence            99999999999999999998665432 22223   445999998865 789999999999999999998 9999999988


Q ss_pred             HHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 023568          154 VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA  227 (280)
Q Consensus       154 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~el  227 (280)
                      .+.+..+++-..+..                              +.+.++.+.+|++.|+++.|+.||++.|+
T Consensus       473 SqVY~LLEkgyRM~~------------------------------PeGCPpkVYeLMraCW~WsPsDRPsFaei  516 (1157)
T KOG4278|consen  473 SQVYGLLEKGYRMDG------------------------------PEGCPPKVYELMRACWNWSPSDRPSFAEI  516 (1157)
T ss_pred             HHHHHHHhccccccC------------------------------CCCCCHHHHHHHHHHhcCCcccCccHHHH
Confidence            777776665333222                              23678999999999999999999999987

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.97  E-value=5.5e-32  Score=232.48  Aligned_cols=199  Identities=22%  Similarity=0.369  Sum_probs=166.3

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      |+|||||.|++++..+     +-+++|+|||+ |+|.+++.++  +.+.-....+|+.||+.|++||.+.+++||||.+.
T Consensus       592 LkhPNIveLvGVC~~D-----ePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~r  666 (807)
T KOG1094|consen  592 LKHPNIVELLGVCVQD-----DPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATR  666 (807)
T ss_pred             cCCCCeeEEEeeeecC-----CchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhcccccc
Confidence            6899999999999987     45999999998 8999999876  44455667779999999999999999999999999


Q ss_pred             ceEEcCCCCeEEeecccccccCCCCc---cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh--CCCCCCCCC
Q 023568           78 NLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPGKD  152 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~--g~~pf~~~~  152 (280)
                      |+|++.++++|++|||+++..-..+.   ........+|||+|.+.. ++++.++|+|++|+++||+++  .+.||....
T Consensus       667 NcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsill-gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt  745 (807)
T KOG1094|consen  667 NCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEVFMLCREQPYSQLT  745 (807)
T ss_pred             ceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHh-ccccchhhhhhhHHHHHHHHHHHhhCchhhhh
Confidence            99999999999999999997544432   233455788999999887 899999999999999999865  678998888


Q ss_pred             hHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 023568          153 YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL  228 (280)
Q Consensus       153 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell  228 (280)
                      +.+...........+...                       .....++..+..+.+++.+|+..|-++|||++++-
T Consensus       746 ~e~vven~~~~~~~~~~~-----------------------~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh  798 (807)
T KOG1094|consen  746 DEQVVENAGEFFRDQGRQ-----------------------VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLH  798 (807)
T ss_pred             HHHHHHhhhhhcCCCCcc-----------------------eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHH
Confidence            777776665554433322                       23344556788999999999999999999999983

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.97  E-value=1.4e-31  Score=246.23  Aligned_cols=183  Identities=34%  Similarity=0.545  Sum_probs=138.5

Q ss_pred             CcEEEEEecCCccH-HHHHHcCCCC-CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEeecccccccC
Q 023568           22 NDVYIVYELMDTDL-HQIIRSDQQL-TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS   99 (280)
Q Consensus        22 ~~~~lv~e~~~g~L-~~~l~~~~~l-~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~   99 (280)
                      ..+||-||||+.++ .+++..+... .-..++++++||++||+|+|++|++||||||.||+++.+..|||+|||+++...
T Consensus       669 ~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~  748 (1351)
T KOG1035|consen  669 LILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLK  748 (1351)
T ss_pred             eEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhh
Confidence            46899999999754 5555543333 477899999999999999999999999999999999999999999999997511


Q ss_pred             -------------------CCCccccceeccccccccccccCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568          100 -------------------ETDFMTEYVVTRWYRAPELLLNCT--EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus       100 -------------------~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                                         +....+...||.-|+|||++.+..  .|..++|+||||+|++||+.   ||...  ++...
T Consensus       749 ~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts--MERa~  823 (1351)
T KOG1035|consen  749 ENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTS--MERAS  823 (1351)
T ss_pred             hhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCch--HHHHH
Confidence                               111335678999999999998755  69999999999999999975   45443  22222


Q ss_pred             HHHHHh-CCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 023568          159 LITELI-GSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ  234 (280)
Q Consensus       159 ~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~  234 (280)
                      .+..+. +..+..                         +..+...-+....+|+.||+.||++||||.|+|++.||-
T Consensus       824 iL~~LR~g~iP~~-------------------------~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp  875 (1351)
T KOG1035|consen  824 ILTNLRKGSIPEP-------------------------ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLP  875 (1351)
T ss_pred             HHHhcccCCCCCC-------------------------cccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence            222211 111111                         011223345567999999999999999999999999986

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-32  Score=242.93  Aligned_cols=199  Identities=24%  Similarity=0.393  Sum_probs=171.6

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      +.||||++|.|+....+     -++||+|||+ |+|..+|+++ +.|+.-+...+++.|+.|++||-+.|++||||.+.|
T Consensus       687 FdHPNIIrLEGVVTks~-----PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARN  761 (996)
T KOG0196|consen  687 FDHPNIIRLEGVVTKSK-----PVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARN  761 (996)
T ss_pred             CCCCcEEEEEEEEecCc-----eeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhh
Confidence            47999999999998874     4999999998 7999999764 679999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCC-c-ccccee--ccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 023568           79 LLLNASCDLKIGDFGLARTTSETD-F-MTEYVV--TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDY  153 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~-~-~~~~~~--~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~  153 (280)
                      ||++.+-.+|++|||+++...++. . .++.-|  ..+|+|||.+.- .+++.++||||+|+++||-++ |..||=...+
T Consensus       762 ILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~-RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN  840 (996)
T KOG0196|consen  762 ILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSN  840 (996)
T ss_pred             eeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhh-cccCchhhccccceEEEEecccCCCcccccch
Confidence            999999999999999999765443 1 122222  467999999977 899999999999999999876 9999999988


Q ss_pred             HHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc--Cc
Q 023568          154 VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR--HP  231 (280)
Q Consensus       154 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~--hp  231 (280)
                      -+.++.|++-...|++-                              +.+..+..|+..|+++|-..||++.|+++  +.
T Consensus       841 QdVIkaIe~gyRLPpPm------------------------------DCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDk  890 (996)
T KOG0196|consen  841 QDVIKAIEQGYRLPPPM------------------------------DCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDK  890 (996)
T ss_pred             HHHHHHHHhccCCCCCC------------------------------CCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHH
Confidence            89999888866655543                              56888999999999999999999999987  44


Q ss_pred             cccc
Q 023568          232 YLQS  235 (280)
Q Consensus       232 ~~~~  235 (280)
                      .+++
T Consensus       891 lIrn  894 (996)
T KOG0196|consen  891 LIRN  894 (996)
T ss_pred             HhcC
Confidence            5443

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=2e-30  Score=229.97  Aligned_cols=213  Identities=21%  Similarity=0.295  Sum_probs=147.2

Q ss_pred             cccccccccccCCCCCC---CCcEEEEEecCC-ccHHHHHHcC------------------------CCCCHHHHHHHHH
Q 023568            4 ENVIAIKDIIRPPKKDT---FNDVYIVYELMD-TDLHQIIRSD------------------------QQLTDDHCQYFLY   55 (280)
Q Consensus         4 pniv~l~~~~~~~~~~~---~~~~~lv~e~~~-g~L~~~l~~~------------------------~~l~~~~~~~i~~   55 (280)
                      +++++++++|.....++   ....+|||||++ ++|.+++...                        ..+++..++.++.
T Consensus       237 ~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~  316 (507)
T PLN03224        237 ASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMR  316 (507)
T ss_pred             hhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHH
Confidence            34577778776532211   146899999998 5998888531                        1246778999999


Q ss_pred             HHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEeecccccccCCCCccc--cceeccccccccccccCCC---------
Q 023568           56 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT--EYVVTRWYRAPELLLNCTE---------  124 (280)
Q Consensus        56 qil~~l~~LH~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~---------  124 (280)
                      |++.||.|||+.+|+||||||+||+++.++.++|+|||++..........  ...+++.|+|||.+.....         
T Consensus       317 ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~  396 (507)
T PLN03224        317 QVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAM  396 (507)
T ss_pred             HHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchhhh
Confidence            99999999999999999999999999999999999999987543332222  2334789999998753111         


Q ss_pred             ------------CCcchhHHHHHHHHHHHHhCCC-CCCCCChHHH-HHHHHHHhCCCCcccccccCChhHHHHHHhCCcc
Q 023568          125 ------------YTAAIDIWSVGCILGEIMTREP-LFPGKDYVHQ-LRLITELIGSPDDASLGFLRSDNARRYVRQLPRC  190 (280)
Q Consensus       125 ------------~~~~~DvwslG~~l~~ll~g~~-pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (280)
                                  ...+.|+||+||++++|++|.. ||.+...... .....                 .....++.... 
T Consensus       397 ~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~-----------------~~~~~~r~~~~-  458 (507)
T PLN03224        397 AALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYD-----------------NDLNRWRMYKG-  458 (507)
T ss_pred             hhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhcc-----------------chHHHHHhhcc-
Confidence                        1234799999999999999874 6654321111 10000                 00000010000 


Q ss_pred             ccccccccCCCCCHHHHHHHHHhcccCC---CCCCCHHHHhcCccccc
Q 023568          191 RKQQFATRFPNKSSGAVDLLEKMLVFDP---NKRITVEEALRHPYLQS  235 (280)
Q Consensus       191 ~~~~~~~~~~~~~~~~~~ll~~~L~~dp---~~Rpt~~ell~hp~~~~  235 (280)
                      ....+ ..++..++.+++|+++||..+|   .+|+|++|+|+||||..
T Consensus       459 ~~~~~-~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        459 QKYDF-SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             cCCCc-ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            01111 2345678999999999999866   68999999999999954

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.97  E-value=1e-30  Score=204.04  Aligned_cols=165  Identities=22%  Similarity=0.285  Sum_probs=128.1

Q ss_pred             ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEeecccccccCCCCccccceecc
Q 023568           33 TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR  111 (280)
Q Consensus        33 g~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  111 (280)
                      |+|.+++.+ ++.+++.+++.++.|++.||+|||+.+      ||+||+++.++.+++  ||.+......    ...|++
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~----~~~g~~   68 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE----QSRVDP   68 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc----cCCCcc
Confidence            689999986 456999999999999999999999999      999999999999999  9998765443    236789


Q ss_pred             ccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCcc
Q 023568          112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV-HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRC  190 (280)
Q Consensus       112 ~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (280)
                      .|+|||++.+ ..++.++||||+||++|+|++|+.||...... ..+..+...........                   
T Consensus        69 ~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------------------  128 (176)
T smart00750       69 YFMAPEVIQG-QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRD-------------------  128 (176)
T ss_pred             cccChHHhcC-CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccc-------------------
Confidence            9999999987 77889999999999999999999999765432 22222222111000000                   


Q ss_pred             ccccccccCCCCC--HHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 023568          191 RKQQFATRFPNKS--SGAVDLLEKMLVFDPNKRITVEEALRHPYLQ  234 (280)
Q Consensus       191 ~~~~~~~~~~~~~--~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~  234 (280)
                           .......+  ..+.+++.+||..||.+|||+.|+++|+|+.
T Consensus       129 -----~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      129 -----RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             -----cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence                 00001122  2689999999999999999999999999975

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=3.5e-31  Score=231.69  Aligned_cols=198  Identities=25%  Similarity=0.354  Sum_probs=167.2

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~--~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      |+|||+|+|||+.-+.      -+.+|||++. |+|.+.|++  ...|-......++.||+.|+.||.++++|||||-..
T Consensus       168 L~H~hliRLyGvVl~q------p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAAR  241 (1039)
T KOG0199|consen  168 LQHPHLIRLYGVVLDQ------PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAAR  241 (1039)
T ss_pred             ccCcceeEEeeeeccc------hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhh
Confidence            6899999999999863      2889999998 799999987  346889999999999999999999999999999999


Q ss_pred             ceEEcCCCCeEEeecccccccCCCCccccc----eeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 023568           78 NLLLNASCDLKIGDFGLARTTSETDFMTEY----VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKD  152 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~~~~~~~----~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~  152 (280)
                      |+|+-....+||+|||+.+..+..+..-..    -....|+|||.+.. ..++.++|||++||++|||++ |+.||.+..
T Consensus       242 NlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh-~kFShaSDvWmyGVTiWEMFtyGEePW~G~~  320 (1039)
T KOG0199|consen  242 NLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRH-RKFSHASDVWMYGVTIWEMFTYGEEPWVGCR  320 (1039)
T ss_pred             hheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhcc-ccccccchhhhhhhhHHhhhccCCCCCCCCC
Confidence            999999999999999999987655332211    12456999999987 899999999999999999998 899999999


Q ss_pred             hHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 023568          153 YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY  232 (280)
Q Consensus       153 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~  232 (280)
                      ..+.+++|.+.-.                              -..++..+.++.+++..|+..+|..|||+..+.+.-+
T Consensus       321 g~qIL~~iD~~er------------------------------LpRPk~csedIY~imk~cWah~paDRptFsair~~~~  370 (1039)
T KOG0199|consen  321 GIQILKNIDAGER------------------------------LPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV  370 (1039)
T ss_pred             HHHHHHhcccccc------------------------------CCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence            8888887753111                              1223356889999999999999999999999976555


Q ss_pred             ccc
Q 023568          233 LQS  235 (280)
Q Consensus       233 ~~~  235 (280)
                      ...
T Consensus       371 l~e  373 (1039)
T KOG0199|consen  371 LAE  373 (1039)
T ss_pred             HHh
Confidence            543

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=2.4e-31  Score=231.52  Aligned_cols=203  Identities=27%  Similarity=0.399  Sum_probs=176.6

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      +|||||.|++.|--.     ..++++||||+ |+|.+.-+-.+.+++.++.++.+..+.|++|||++|-+|||||..||+
T Consensus        70 ~h~nivay~gsylr~-----dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanil  144 (829)
T KOG0576|consen   70 RHPNIVAYFGSYLRR-----DKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANIL  144 (829)
T ss_pred             CCcChHHHHhhhhhh-----cCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCccccccccccee
Confidence            799999999999877     66999999998 599988877789999999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccccCCC-Cccccceeccccccccccc--cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023568           81 LNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLL--NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  157 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~--~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~  157 (280)
                      ++..|.+|++|||.+..++-. ....++.||++|||||+..  .++.|...+|+|++|+...|+..-++|......++.+
T Consensus       145 ltd~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l  224 (829)
T KOG0576|consen  145 LTDEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRAL  224 (829)
T ss_pred             ecccCceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHH
Confidence            999999999999998765543 3456789999999999863  3478899999999999999999989998888888888


Q ss_pred             HHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 023568          158 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  235 (280)
Q Consensus       158 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~  235 (280)
                      ..+.+....|+....                          ....++.+-+|++.+|.++|++|||++.+|.|||...
T Consensus       225 ~LmTkS~~qpp~lkD--------------------------k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~  276 (829)
T KOG0576|consen  225 FLMTKSGFQPPTLKD--------------------------KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ  276 (829)
T ss_pred             HHhhccCCCCCcccC--------------------------CccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence            777765554443221                          1246888999999999999999999999999999965

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.97  E-value=2.2e-30  Score=250.53  Aligned_cols=202  Identities=18%  Similarity=0.314  Sum_probs=145.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH---SASVLHRDLKP   76 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH---~~~i~H~dik~   76 (280)
                      ++|||||++++++.+.     ...|+||||++ |+|.++++   .+++.++..++.|++.|++|||   +.+|+||||||
T Consensus       740 l~HpnIv~~~~~~~~~-----~~~~lv~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp  811 (968)
T PLN00113        740 LQHPNIVKLIGLCRSE-----KGAYLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSP  811 (968)
T ss_pred             CCCCCcceEEEEEEcC-----CCCEEEEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCH
Confidence            5899999999999887     66899999997 69999995   4899999999999999999999   67999999999


Q ss_pred             CceEEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH-H
Q 023568           77 SNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV-H  155 (280)
Q Consensus        77 ~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~-~  155 (280)
                      +||+++.++..++. ||........   ....++..|+|||.+.+ ..++.++||||+||++|||++|+.||...... .
T Consensus       812 ~Nil~~~~~~~~~~-~~~~~~~~~~---~~~~~t~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~  886 (968)
T PLN00113        812 EKIIIDGKDEPHLR-LSLPGLLCTD---TKCFISSAYVAPETRET-KDITEKSDIYGFGLILIELLTGKSPADAEFGVHG  886 (968)
T ss_pred             HhEEECCCCceEEE-eccccccccC---CCccccccccCcccccC-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCC
Confidence            99999998887775 5554432211   23367889999999876 77899999999999999999999998543210 0


Q ss_pred             HHHHHHH-HhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 023568          156 QLRLITE-LIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  230 (280)
Q Consensus       156 ~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~h  230 (280)
                      ....... ......           ......  +  ...............+.+++.+|++.||++|||++|+++.
T Consensus       887 ~~~~~~~~~~~~~~-----------~~~~~~--~--~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        887 SIVEWARYCYSDCH-----------LDMWID--P--SIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             cHHHHHHHhcCccc-----------hhheeC--c--cccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            1111110 000000           000000  0  0000000001123457789999999999999999999874

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=2.2e-29  Score=230.20  Aligned_cols=192  Identities=29%  Similarity=0.476  Sum_probs=157.7

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHH
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ----------------QLTDDHCQYFLYQLLRGLKYV   64 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~----------------~l~~~~~~~i~~qil~~l~~L   64 (280)
                      +||||+.+++++...     +.+++|+||+. |+|.++++..+                .++..+...++.||+.|++||
T Consensus       360 ~H~niv~llG~~t~~-----~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L  434 (609)
T KOG0200|consen  360 KHPNIVNLLGACTQD-----GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYL  434 (609)
T ss_pred             CCcchhhheeeeccC-----CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHH
Confidence            699999999999885     67999999998 79999998655                389999999999999999999


Q ss_pred             HhCCccccCCCCCceEEcCCCCeEEeecccccccCCCCcc--ccce--eccccccccccccCCCCCcchhHHHHHHHHHH
Q 023568           65 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM--TEYV--VTRWYRAPELLLNCTEYTAAIDIWSVGCILGE  140 (280)
Q Consensus        65 H~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~--~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~  140 (280)
                      ++.+++||||-+.|||+..+..+|++|||+++........  ....  -...|||||.+.. ..++.++||||+|+++||
T Consensus       435 ~~~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~E  513 (609)
T KOG0200|consen  435 ASVPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWE  513 (609)
T ss_pred             hhCCccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHH
Confidence            9999999999999999999999999999999865444322  2222  2345999999987 899999999999999999


Q ss_pred             HHh-CCCCCCCCC-hHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCC
Q 023568          141 IMT-REPLFPGKD-YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDP  218 (280)
Q Consensus       141 ll~-g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp  218 (280)
                      +.+ |..||++-. ..+....+....                              ....+...++++.++++.|++.+|
T Consensus       514 ifsLG~~PYp~~~~~~~l~~~l~~G~------------------------------r~~~P~~c~~eiY~iM~~CW~~~p  563 (609)
T KOG0200|consen  514 IFTLGGTPYPGIPPTEELLEFLKEGN------------------------------RMEQPEHCSDEIYDLMKSCWNADP  563 (609)
T ss_pred             HhhCCCCCCCCCCcHHHHHHHHhcCC------------------------------CCCCCCCCCHHHHHHHHHHhCCCc
Confidence            998 899998844 233333222211                              112223458899999999999999


Q ss_pred             CCCCCHHHHhc
Q 023568          219 NKRITVEEALR  229 (280)
Q Consensus       219 ~~Rpt~~ell~  229 (280)
                      ++||++.++..
T Consensus       564 ~~RP~F~~~~~  574 (609)
T KOG0200|consen  564 EDRPTFSECVE  574 (609)
T ss_pred             ccCCCHHHHHH
Confidence            99999999876

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.96  E-value=3.7e-30  Score=195.45  Aligned_cols=156  Identities=28%  Similarity=0.423  Sum_probs=131.8

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCCccHHHH----HHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCC
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQI----IRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKP   76 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~----l~~~~~l~~~~~~~i~~qil~~l~~LH~~-~i~H~dik~   76 (280)
                      ..|.+|.+++.+..+     .++++.||.|+-+|..+    +++++.++|..+-+|+..++.||.|||++ .++|||+||
T Consensus       103 ~CPf~V~FyGa~~re-----gdvwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKP  177 (282)
T KOG0984|consen  103 DCPFTVHFYGALFRE-----GDVWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKP  177 (282)
T ss_pred             CCCeEEEeehhhhcc-----ccEEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCc
Confidence            358899999998888     67999999999877655    45678899999999999999999999985 799999999


Q ss_pred             CceEEcCCCCeEEeecccccccCCCCccccceecccccccccccc---CCCCCcchhHHHHHHHHHHHHhCCCCCCCC-C
Q 023568           77 SNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN---CTEYTAAIDIWSVGCILGEIMTREPLFPGK-D  152 (280)
Q Consensus        77 ~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~DvwslG~~l~~ll~g~~pf~~~-~  152 (280)
                      +|||++.+|++|+||||.+....+.-..+...|...|+|||.+..   ...|+.++||||||+.+.||.+++.||..- .
T Consensus       178 sNiLIn~~GqVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t  257 (282)
T KOG0984|consen  178 SNILINYDGQVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT  257 (282)
T ss_pred             ceEEEccCCcEEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence            999999999999999999987665543444678889999999854   247889999999999999999999998764 4


Q ss_pred             hHHHHHHHHH
Q 023568          153 YVHQLRLITE  162 (280)
Q Consensus       153 ~~~~~~~i~~  162 (280)
                      ..+++.++.+
T Consensus       258 pF~qLkqvVe  267 (282)
T KOG0984|consen  258 PFQQLKQVVE  267 (282)
T ss_pred             HHHHHHHHhc
Confidence            4556555544

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.96  E-value=5e-30  Score=213.02  Aligned_cols=228  Identities=30%  Similarity=0.476  Sum_probs=167.8

Q ss_pred             CcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE
Q 023568            3 HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL   81 (280)
Q Consensus         3 Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nili   81 (280)
                      +.||+++.+++...     +.+.+||||++. +..++.   ..++..+++.+++.++.||+++|++||+||||||+|+|+
T Consensus        94 ~~ni~~~~~~~rnn-----d~v~ivlp~~~H~~f~~l~---~~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~  165 (418)
T KOG1167|consen   94 SDNIIKLNGCFRNN-----DQVAIVLPYFEHDRFRDLY---RSLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLY  165 (418)
T ss_pred             chhhhcchhhhccC-----CeeEEEecccCccCHHHHH---hcCCHHHHHHHHHHHHHHhhhhhccCccccCCCcccccc
Confidence            56999999999988     779999999995 778887   458899999999999999999999999999999999999


Q ss_pred             cC-CCCeEEeecccccccC-----------------C--C------Cc--------------------cccceecccccc
Q 023568           82 NA-SCDLKIGDFGLARTTS-----------------E--T------DF--------------------MTEYVVTRWYRA  115 (280)
Q Consensus        82 ~~-~~~~kl~dfg~~~~~~-----------------~--~------~~--------------------~~~~~~~~~y~a  115 (280)
                      +. .++-.|.|||++....                 .  .      ..                    .-...||++|.|
T Consensus       166 n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRa  245 (418)
T KOG1167|consen  166 NRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRA  245 (418)
T ss_pred             ccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCc
Confidence            86 5678999999996100                 0  0      00                    012368999999


Q ss_pred             ccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHHHhCCCCccc----cc---ccC---ChhHHHHH
Q 023568          116 PELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG-KDYVHQLRLITELIGSPDDAS----LG---FLR---SDNARRYV  184 (280)
Q Consensus       116 PE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~----~~---~~~---~~~~~~~~  184 (280)
                      ||++......+.++|+||.|+|+..+++++.||-. .++.+.+..|..+.|...-..    .+   .+.   ........
T Consensus       246 PEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~  325 (418)
T KOG1167|consen  246 PEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELR  325 (418)
T ss_pred             hHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHH
Confidence            99999888889999999999999999999987654 566677777766655221100    00   011   01111111


Q ss_pred             --------HhCCccccc-cccccC-CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCcC
Q 023568          185 --------RQLPRCRKQ-QFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  238 (280)
Q Consensus       185 --------~~~~~~~~~-~~~~~~-~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~~  238 (280)
                              ..+....+. ...... ...+..+.+|+.+||..||.+|+|++++|.||||...++
T Consensus       326 ~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~  389 (418)
T KOG1167|consen  326 VNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADR  389 (418)
T ss_pred             hchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhh
Confidence                    111111111 112222 235668999999999999999999999999999986553

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=3.6e-30  Score=232.88  Aligned_cols=210  Identities=29%  Similarity=0.357  Sum_probs=168.6

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      |+|||++.....+.+.     ...+-+||||.++|+.++...+.++..++..++.|++.||+|||+.|+.|||+|++|++
T Consensus       378 l~h~~~~e~l~~~~~~-----~~~~~~mE~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll  452 (601)
T KOG0590|consen  378 LSHPNIIETLDIVQEI-----DGILQSMEYCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLL  452 (601)
T ss_pred             ccCCchhhhHHHHhhc-----ccchhhhhcccHHHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEE
Confidence            6899999999888876     33445599999999999988789999999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccccCCC-----CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023568           81 LNASCDLKIGDFGLARTTSET-----DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH  155 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~  155 (280)
                      +..+|.+|++|||.+....-.     ......+|+..|+|||++.+........||||.|+++..|.+|+.||......+
T Consensus       453 ~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~  532 (601)
T KOG0590|consen  453 VTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSD  532 (601)
T ss_pred             EecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccc
Confidence            999999999999998753322     234567889999999999986777788999999999999999999998765332


Q ss_pred             HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 023568          156 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  235 (280)
Q Consensus       156 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~  235 (280)
                      ....-..                      .................++...+.+|.+||+.||.+|.|++++++.+||+.
T Consensus       533 ~~~~~~~----------------------~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~  590 (601)
T KOG0590|consen  533 NSFKTNN----------------------YSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRS  590 (601)
T ss_pred             cchhhhc----------------------cccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhh
Confidence            2210000                      000001111122233356888999999999999999999999999999998


Q ss_pred             Cc
Q 023568          236 LH  237 (280)
Q Consensus       236 ~~  237 (280)
                      +.
T Consensus       591 i~  592 (601)
T KOG0590|consen  591 IE  592 (601)
T ss_pred             cc
Confidence            75

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=4.5e-29  Score=209.95  Aligned_cols=215  Identities=22%  Similarity=0.287  Sum_probs=155.4

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---------Ccc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA---------SVL   70 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~---------~i~   70 (280)
                      |+|+||++++++-+..+.+ .-.++||++|.. |+|.++|+. ..+++....+++..+++||+|||+.         .|+
T Consensus       261 m~h~nIl~Fi~~ekr~t~~-~~eywLVt~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~Ia  338 (534)
T KOG3653|consen  261 MKHENILQFIGAEKRGTAD-RMEYWLVTEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIA  338 (534)
T ss_pred             ccchhHHHhhchhccCCcc-ccceeEEeeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccc
Confidence            6899999999997766433 257999999997 899999976 6799999999999999999999973         499


Q ss_pred             ccCCCCCceEEcCCCCeEEeecccccccCCCC---ccccceeccccccccccccCCCCC-----cchhHHHHHHHHHHHH
Q 023568           71 HRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYT-----AAIDIWSVGCILGEIM  142 (280)
Q Consensus        71 H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~-----~~~DvwslG~~l~~ll  142 (280)
                      |||||..||||..++++.|+|||+|.......   ..-...||.+|||||++.+...+.     .+.||||+|.++|||+
T Consensus       339 HRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~  418 (534)
T KOG3653|consen  339 HRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIA  418 (534)
T ss_pred             cccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHH
Confidence            99999999999999999999999998655432   123378999999999998866665     3699999999999999


Q ss_pred             hCCCCCCCCC-hHHHHHHHHHHhCCCCcccccccCChhHHHHHHhC-CccccccccccCCC--CCHHHHHHHHHhcccCC
Q 023568          143 TREPLFPGKD-YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL-PRCRKQQFATRFPN--KSSGAVDLLEKMLVFDP  218 (280)
Q Consensus       143 ~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~--~~~~~~~ll~~~L~~dp  218 (280)
                      +....+.... ..-++.--.++...|           ...+....+ .+...+.++..+..  --..+.+.+..|+..||
T Consensus       419 SRC~~~~~~~vp~Yqlpfe~evG~hP-----------t~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDa  487 (534)
T KOG3653|consen  419 SRCTDADPGPVPEYQLPFEAEVGNHP-----------TLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDA  487 (534)
T ss_pred             hhcccccCCCCCcccCchhHHhcCCC-----------CHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCch
Confidence            9775543211 111111111111111           111111111 11122223333222  24567899999999999


Q ss_pred             CCCCCHHHHh
Q 023568          219 NKRITVEEAL  228 (280)
Q Consensus       219 ~~Rpt~~ell  228 (280)
                      +.|.|+.-+-
T Consensus       488 eARLTA~Cv~  497 (534)
T KOG3653|consen  488 EARLTAGCVE  497 (534)
T ss_pred             hhhhhhHHHH
Confidence            9999987554

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=9.6e-30  Score=218.50  Aligned_cols=142  Identities=27%  Similarity=0.451  Sum_probs=131.6

Q ss_pred             CcccccccccccCCCCCCCCcEEEEEecCC-c-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            3 HENVIAIKDIIRPPKKDTFNDVYIVYELMD-T-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         3 Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      |+||+|++++|++.     +..||+||.-+ | +|+++|.-++.++|.+++.|++|+..|+++||++||+|||||-+||.
T Consensus       628 H~NIlKlLdfFEdd-----d~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvi  702 (772)
T KOG1152|consen  628 HENILKLLDFFEDD-----DYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVI  702 (772)
T ss_pred             ccchhhhhheeecC-----CeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEE
Confidence            99999999999998     88999999997 6 99999998899999999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 023568           81 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG  150 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~  150 (280)
                      ++.+|.+||+|||.+....++. ...+.||..|.|||++.|..+.+...|||+||+++|.++....||.+
T Consensus       703 vd~~g~~klidfgsaa~~ksgp-fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  703 VDSNGFVKLIDFGSAAYTKSGP-FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             EecCCeEEEeeccchhhhcCCC-cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            9999999999999987654443 56789999999999999977888999999999999999999988853

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.95  E-value=3.7e-28  Score=216.04  Aligned_cols=192  Identities=23%  Similarity=0.345  Sum_probs=160.3

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      |.||||+||+++...+      .+.||++||. |.|.|+++.+ .++-.+....|.+||++|+.|||+++++||||-+.|
T Consensus       755 ldHpnl~RLLgvc~~s------~~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRN  828 (1177)
T KOG1025|consen  755 LDHPNLLRLLGVCMLS------TLQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARN  828 (1177)
T ss_pred             CCCchHHHHhhhcccc------hHHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhh
Confidence            6899999999999876      2889999998 7999999865 579999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCcccc---ceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDFMTE---YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYV  154 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~~~~---~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~  154 (280)
                      |||..-..+|+.|||+++........-.   .-....|+|-|.+.. ..++.++||||+||++||++| |..|+.+....
T Consensus       829 VLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~  907 (1177)
T KOG1025|consen  829 VLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE  907 (1177)
T ss_pred             eeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH
Confidence            9999999999999999998665533211   222556899998877 899999999999999999998 99999988754


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      +.-+.+.+..                              .-..+|..+.++.-++.+||..|+..||+++++.+
T Consensus       908 eI~dlle~ge------------------------------RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  908 EIPDLLEKGE------------------------------RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             HhhHHHhccc------------------------------cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence            4433332211                              12234567889999999999999999999999865

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.94  E-value=2.3e-26  Score=183.21  Aligned_cols=164  Identities=37%  Similarity=0.669  Sum_probs=143.4

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++|++|+++++++...     ...+++||+++ ++|.+++... ..++...+..++.+++.++++||+.|++|+||+|.|
T Consensus        48 l~~~~i~~~~~~~~~~-----~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~n  122 (215)
T cd00180          48 LNHPNIVKLYGVFEDE-----NHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPEN  122 (215)
T ss_pred             cCCCCeeeEeeeeecC-----CeEEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhh
Confidence            5789999999999987     67999999999 5999999765 579999999999999999999999999999999999


Q ss_pred             eEEcC-CCCeEEeecccccccCCCC-ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023568           79 LLLNA-SCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  156 (280)
Q Consensus        79 ili~~-~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~  156 (280)
                      |+++. ++.++|+|||.+....... ......+...|++||........+.+.|+|++|++++++               
T Consensus       123 i~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------  187 (215)
T cd00180         123 ILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------  187 (215)
T ss_pred             EEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------
Confidence            99999 8999999999987654432 123455678899999987633788899999999999998               


Q ss_pred             HHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 023568          157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHP  231 (280)
Q Consensus       157 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp  231 (280)
                                                                     ..+.+++.+|++.||++||+++++++++
T Consensus       188 -----------------------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 -----------------------------------------------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             -----------------------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                                                           2367899999999999999999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=3.5e-26  Score=191.31  Aligned_cols=202  Identities=20%  Similarity=0.302  Sum_probs=147.6

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-----CC---ccc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS-----AS---VLH   71 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~-----~~---i~H   71 (280)
                      |+|+||+.+++.-..++ .....+|||++|.+ |+|+|+|.. ..++.+...+++..++.||++||.     +|   |.|
T Consensus       262 LRHENILgFIaaD~~~~-gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAH  339 (513)
T KOG2052|consen  262 LRHENILGFIAADNKDN-GSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAH  339 (513)
T ss_pred             hccchhhhhhhccccCC-CceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhc
Confidence            68999999999876553 34467999999998 899999976 789999999999999999999995     23   999


Q ss_pred             cCCCCCceEEcCCCCeEEeecccccccCCC-----CccccceeccccccccccccCCCC-----CcchhHHHHHHHHHHH
Q 023568           72 RDLKPSNLLLNASCDLKIGDFGLARTTSET-----DFMTEYVVTRWYRAPELLLNCTEY-----TAAIDIWSVGCILGEI  141 (280)
Q Consensus        72 ~dik~~Nili~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~-----~~~~DvwslG~~l~~l  141 (280)
                      ||||..||||..++.+.|+|+|+|......     ......+||.+|||||++...-..     -..+||||||.++||+
T Consensus       340 RDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEi  419 (513)
T KOG2052|consen  340 RDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEI  419 (513)
T ss_pred             cccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHH
Confidence            999999999999999999999999754433     223567899999999998652221     1369999999999999


Q ss_pred             HhC----------CCCCCCCCh----HHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCC--CHH
Q 023568          142 MTR----------EPLFPGKDY----VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK--SSG  205 (280)
Q Consensus       142 l~g----------~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  205 (280)
                      ...          ++||.+--+    .+...++..                         .+...+.++..+...  -..
T Consensus       420 arRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVC-------------------------v~~~RP~ipnrW~s~~~l~~  474 (513)
T KOG2052|consen  420 ARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVC-------------------------VQKLRPNIPNRWKSDPALRV  474 (513)
T ss_pred             HHHhhcCCEehhhcCCcccCCCCCCCHHHHhccee-------------------------ecccCCCCCcccccCHHHHH
Confidence            853          245544211    111111111                         001111122222221  124


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhc
Q 023568          206 AVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       206 ~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      +..+++.|+..+|..|.|+--+.+
T Consensus       475 m~klMkeCW~~Np~aRltALriKK  498 (513)
T KOG2052|consen  475 MAKLMKECWYANPAARLTALRIKK  498 (513)
T ss_pred             HHHHHHHhhcCCchhhhHHHHHHH
Confidence            567899999999999999876643

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.94  E-value=7.2e-26  Score=186.91  Aligned_cols=194  Identities=18%  Similarity=0.268  Sum_probs=156.2

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC--------CCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD--------QQLTDDHCQYFLYQLLRGLKYVHSASVLH   71 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~--------~~l~~~~~~~i~~qil~~l~~LH~~~i~H   71 (280)
                      +.|||+..+.++..++.    ...+.++.+++ |+|..+++..        +.++-.+...++.|++.|++|||+.|++|
T Consensus       344 ~sH~nll~V~~V~ie~~----~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViH  419 (563)
T KOG1024|consen  344 ASHPNLLSVLGVSIEDY----ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIH  419 (563)
T ss_pred             CcCCCccceeEEEeecc----CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCccc
Confidence            46999999999987653    45789999998 8999999721        34778888999999999999999999999


Q ss_pred             cCCCCCceEEcCCCCeEEeecccccccCCCCc---cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCC
Q 023568           72 RDLKPSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPL  147 (280)
Q Consensus        72 ~dik~~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~p  147 (280)
                      .||-..|.+|++.-++||+|=.+++-.-+.+.   .........||+||.+.+ ..|+.++|+||||+++|||++ |+.|
T Consensus       420 kDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n-~~yssasDvWsfGVllWELmtlg~~P  498 (563)
T KOG1024|consen  420 KDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQN-SHYSSASDVWSFGVLLWELMTLGKLP  498 (563)
T ss_pred             chhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhh-hhhcchhhhHHHHHHHHHHHhcCCCC
Confidence            99999999999999999999888875333221   112233567999999988 899999999999999999998 9999


Q ss_pred             CCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 023568          148 FPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA  227 (280)
Q Consensus       148 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~el  227 (280)
                      +-.-++.+...-+.....                              -..+-+.++++..++..|+..+|++||+.+|+
T Consensus       499 yaeIDPfEm~~ylkdGyR------------------------------laQP~NCPDeLf~vMacCWallpeeRPsf~Ql  548 (563)
T KOG1024|consen  499 YAEIDPFEMEHYLKDGYR------------------------------LAQPFNCPDELFTVMACCWALLPEERPSFSQL  548 (563)
T ss_pred             ccccCHHHHHHHHhccce------------------------------ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHH
Confidence            987776555443332111                              01122578899999999999999999999998


Q ss_pred             hc
Q 023568          228 LR  229 (280)
Q Consensus       228 l~  229 (280)
                      ..
T Consensus       549 v~  550 (563)
T KOG1024|consen  549 VI  550 (563)
T ss_pred             HH
Confidence            64

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=4.8e-27  Score=185.39  Aligned_cols=203  Identities=23%  Similarity=0.330  Sum_probs=150.2

Q ss_pred             CCccccccccc-ccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            2 EHENVIAIKDI-IRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         2 ~Hpniv~l~~~-~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      .|.||+.-+++ |++.     +..++++||++ |+|.+-+.. ..+.|...+.++.|++.|+.|||+++++|||||.+||
T Consensus        79 ~H~hIi~tY~vaFqt~-----d~YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNi  152 (378)
T KOG1345|consen   79 PHQHIIDTYEVAFQTS-----DAYVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENI  152 (378)
T ss_pred             cchhhhHHHHHHhhcC-----ceEEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceE
Confidence            48899886664 5555     67889999998 799988755 5689999999999999999999999999999999999


Q ss_pred             EEcC--CCCeEEeecccccccCCCCccccceecccccccccccc----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 023568           80 LLNA--SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDY  153 (280)
Q Consensus        80 li~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~  153 (280)
                      ||-.  ..++||||||.++..+..-.  ..-.+..|.+||....    .-.....+|+|.||++++..++|.+||+....
T Consensus       153 Lif~~df~rvKlcDFG~t~k~g~tV~--~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~  230 (378)
T KOG1345|consen  153 LIFDADFYRVKLCDFGLTRKVGTTVK--YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI  230 (378)
T ss_pred             EEecCCccEEEeeecccccccCceeh--hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc
Confidence            9933  34799999999877654321  1222456889988643    22346789999999999999999999985432


Q ss_pred             HH-HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCC---CCHHHHhc
Q 023568          154 VH-QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKR---ITVEEALR  229 (280)
Q Consensus       154 ~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~R---pt~~ell~  229 (280)
                      .+ .+...++                       .. .......+..|...++.+..+.++-|..+|+.|   -+++....
T Consensus       231 ~d~~Y~~~~~-----------------------w~-~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk  286 (378)
T KOG1345|consen  231 MDKPYWEWEQ-----------------------WL-KRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRK  286 (378)
T ss_pred             cCchHHHHHH-----------------------Hh-cccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence            11 1111111                       11 111223455667789999999999999999999   45555555


Q ss_pred             CcccccC
Q 023568          230 HPYLQSL  236 (280)
Q Consensus       230 hp~~~~~  236 (280)
                      ..|....
T Consensus       287 ~~w~E~~  293 (378)
T KOG1345|consen  287 CLWKEKL  293 (378)
T ss_pred             HHHHHhh
Confidence            6666543

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.93  E-value=5e-25  Score=177.91  Aligned_cols=145  Identities=36%  Similarity=0.680  Sum_probs=128.1

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQ-LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~-l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++|+|++++++++...     ...++++|++++ +|.+++..... +++..+..++.|++.++.+||+.+++|+||++.|
T Consensus        54 ~~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~n  128 (225)
T smart00221       54 LKHPNIVKLYGVFEDP-----EPLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPEN  128 (225)
T ss_pred             CCCCChhhheeeeecC-----CceEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence            4799999999999877     669999999986 99999987666 8999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCC--ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 023568           79 LLLNASCDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG  150 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~  150 (280)
                      |+++.++.++|+|||.+.......  ......++..|++||.+.+...++.++|+|++|+++++|++|+.||..
T Consensus       129 i~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      129 ILLGMDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             EEEcCCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            999999999999999988765442  334566788899999884336677799999999999999999999977

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=1.1e-23  Score=174.72  Aligned_cols=194  Identities=22%  Similarity=0.304  Sum_probs=146.5

Q ss_pred             CCcccccccccccCCCC----------------------CCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHH
Q 023568            2 EHENVIAIKDIIRPPKK----------------------DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR   59 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~----------------------~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qil~   59 (280)
                      +|||||+++.+|.++-+                      .....+|+||.....+|..++-. ...+....+-++.|+++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~-~~~s~r~~~~~laQlLE  352 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWT-RHRSYRTGRVILAQLLE  352 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhc-CCCchHHHHHHHHHHHH
Confidence            69999999999977311                      11145899999999999999865 56788888999999999


Q ss_pred             HHHHHHhCCccccCCCCCceEEc--CCC--CeEEeecccccccCCC-------CccccceeccccccccccccCCC----
Q 023568           60 GLKYVHSASVLHRDLKPSNLLLN--ASC--DLKIGDFGLARTTSET-------DFMTEYVVTRWYRAPELLLNCTE----  124 (280)
Q Consensus        60 ~l~~LH~~~i~H~dik~~Nili~--~~~--~~kl~dfg~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~----  124 (280)
                      |+.|||++||.|||+|.+|||+.  .++  .+.++|||.+-.-...       ......-|....||||+......    
T Consensus       353 av~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~av  432 (598)
T KOG4158|consen  353 AVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAV  432 (598)
T ss_pred             HHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCcee
Confidence            99999999999999999999983  333  4788999987422211       11233456667899999854322    


Q ss_pred             -CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCC
Q 023568          125 -YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKS  203 (280)
Q Consensus       125 -~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  203 (280)
                       .-.++|.|+.|.+.||+++...||.+...+..                             ....+++.+.+.....++
T Consensus       433 vny~kAD~WA~GalaYEIfg~~NPFY~rGem~L-----------------------------~~r~Yqe~qLPalp~~vp  483 (598)
T KOG4158|consen  433 VNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL-----------------------------DTRTYQESQLPALPSRVP  483 (598)
T ss_pred             eccchhhhhhhhhhHHHHhccCCcccccchhee-----------------------------chhhhhhhhCCCCcccCC
Confidence             23589999999999999999999987431111                             111133444556666789


Q ss_pred             HHHHHHHHHhcccCCCCCCCHH
Q 023568          204 SGAVDLLEKMLVFDPNKRITVE  225 (280)
Q Consensus       204 ~~~~~ll~~~L~~dp~~Rpt~~  225 (280)
                      +.+++++..+|+.||+||+++.
T Consensus       484 p~~rqlV~~lL~r~pskRvsp~  505 (598)
T KOG4158|consen  484 PVARQLVFDLLKRDPSKRVSPN  505 (598)
T ss_pred             hHHHHHHHHHhcCCccccCCcc
Confidence            9999999999999999999754

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.90  E-value=2.6e-24  Score=187.61  Aligned_cols=190  Identities=23%  Similarity=0.399  Sum_probs=163.9

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      +||.+|+++-.|+.+     ..+|+++++..| +|...+.+...+.+..++.+...++.|++++|+.|++|||+|++||+
T Consensus        55 ~~~f~v~lhyafqt~-----~kl~l~ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enil  129 (612)
T KOG0603|consen   55 NTPFLVKLHYAFQTD-----GKLYLILDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVL  129 (612)
T ss_pred             CCCceeeeeeeeccc-----cchhHhhhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhccccccee
Confidence            489999999999998     669999999975 99999888899999999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 023568           81 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  160 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~i  160 (280)
                      ++.+|.+++.|||+++.....+..   +||..|||||++.   ....++|.||+|+++++|++|..||.+    +....|
T Consensus       130 ld~~Ghi~~tdfglske~v~~~~~---cgt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~I  199 (612)
T KOG0603|consen  130 LLLEGHIKLTDFGLSKEAVKEKIA---CGTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRI  199 (612)
T ss_pred             ecccCccccCCchhhhHhHhhhhc---ccchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHH
Confidence            999999999999999876655432   8999999999986   567789999999999999999999988    344444


Q ss_pred             HHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccccc
Q 023568          161 TELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQS  235 (280)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rp-----t~~ell~hp~~~~  235 (280)
                      .+..                               ...+...+..+++++..++..+|..|.     -+.|+++|+||..
T Consensus       200 l~~~-------------------------------~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~  248 (612)
T KOG0603|consen  200 LKAE-------------------------------LEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQS  248 (612)
T ss_pred             hhhc-------------------------------cCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchhee
Confidence            3311                               112234688899999999999999997     4579999999988


Q ss_pred             Cc
Q 023568          236 LH  237 (280)
Q Consensus       236 ~~  237 (280)
                      +.
T Consensus       249 i~  250 (612)
T KOG0603|consen  249 ID  250 (612)
T ss_pred             ee
Confidence            75

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.89  E-value=6.7e-24  Score=194.38  Aligned_cols=195  Identities=24%  Similarity=0.414  Sum_probs=147.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      ++|||.+.+..+-+..     ...|||-+|...+|+|.+.-++-+..-+-+.|+.|++.||.-+|+.||+|||||.+|||
T Consensus        78 ~~~pn~lPfqk~~~t~-----kAAylvRqyvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENIL  152 (1431)
T KOG1240|consen   78 MKAPNCLPFQKVLVTD-----KAAYLVRQYVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENIL  152 (1431)
T ss_pred             hcCCcccchHHHHHhh-----HHHHHHHHHHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEE
Confidence            4799999999997776     56899999999999999987777899999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccccC----CCCccccce----eccccccccccccCC----------CCCcchhHHHHHHHHHHHH
Q 023568           81 LNASCDLKIGDFGLARTTS----ETDFMTEYV----VTRWYRAPELLLNCT----------EYTAAIDIWSVGCILGEIM  142 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~----~~~~~~~~~----~~~~y~aPE~~~~~~----------~~~~~~DvwslG~~l~~ll  142 (280)
                      |+.-..+.|+||..-+..-    ++....-+.    .-.=|.|||.+....          ....+.||||+||+++||+
T Consensus       153 iTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf  232 (1431)
T KOG1240|consen  153 ITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELF  232 (1431)
T ss_pred             EeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHH
Confidence            9988789999998776421    111111111    222399999985422          1567899999999999998


Q ss_pred             h-CCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCC
Q 023568          143 T-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKR  221 (280)
Q Consensus       143 ~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~R  221 (280)
                      + |++||.-.       ++.+....         .+...+..++.+              .+...+.+|..|++.||++|
T Consensus       233 ~Eg~PlF~LS-------QL~aYr~~---------~~~~~e~~Le~I--------------ed~~~Rnlil~Mi~rdPs~R  282 (1431)
T KOG1240|consen  233 LEGRPLFTLS-------QLLAYRSG---------NADDPEQLLEKI--------------EDVSLRNLILSMIQRDPSKR  282 (1431)
T ss_pred             hcCCCcccHH-------HHHhHhcc---------CccCHHHHHHhC--------------cCccHHHHHHHHHccCchhc
Confidence            8 89998432       11111000         011112222222              24578999999999999999


Q ss_pred             CCHHHHhcC
Q 023568          222 ITVEEALRH  230 (280)
Q Consensus       222 pt~~ell~h  230 (280)
                      .+|++.|+.
T Consensus       283 lSAedyL~~  291 (1431)
T KOG1240|consen  283 LSAEDYLQK  291 (1431)
T ss_pred             cCHHHHHHh
Confidence            999999975

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.88  E-value=3.9e-21  Score=163.12  Aligned_cols=212  Identities=32%  Similarity=0.509  Sum_probs=162.6

Q ss_pred             CCCc-ccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 023568            1 MEHE-NVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ---QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK   75 (280)
Q Consensus         1 l~Hp-niv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~---~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik   75 (280)
                      +.|+ ||+++.+.+...     ...+++++++.+ ++.+++....   .++...+..++.|++.++.++|+.|++|||+|
T Consensus        54 ~~~~~~i~~~~~~~~~~-----~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~k  128 (384)
T COG0515          54 LNHPPNIVKLYDFFQDE-----GSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIK  128 (384)
T ss_pred             ccCCcceeeEEEEEecC-----CEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCC
Confidence            3566 799999999655     458999999985 8887777654   79999999999999999999999999999999


Q ss_pred             CCceEEcCCC-CeEEeecccccccCCCC-------ccccceeccccccccccccC--CCCCcchhHHHHHHHHHHHHhCC
Q 023568           76 PSNLLLNASC-DLKIGDFGLARTTSETD-------FMTEYVVTRWYRAPELLLNC--TEYTAAIDIWSVGCILGEIMTRE  145 (280)
Q Consensus        76 ~~Nili~~~~-~~kl~dfg~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwslG~~l~~ll~g~  145 (280)
                      |+||+++..+ .++++|||.+.......       ......++..|++||.+.+.  .......|+||+|+++++++.|.
T Consensus       129 p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~  208 (384)
T COG0515         129 PENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGL  208 (384)
T ss_pred             HHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCC
Confidence            9999999988 69999999987544332       34677899999999998774  57888999999999999999999


Q ss_pred             CCCCCCCh---HHHHHHHHHHhCCC-CcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCC
Q 023568          146 PLFPGKDY---VHQLRLITELIGSP-DDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKR  221 (280)
Q Consensus       146 ~pf~~~~~---~~~~~~i~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~R  221 (280)
                      .||.....   .............+ .....                      ...........+.+++.+++..+|..|
T Consensus       209 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~r  266 (384)
T COG0515         209 PPFEGEKNSSATSQTLKIILELPTPSLASPL----------------------SPSNPELISKAASDLLKKLLAKDPKNR  266 (384)
T ss_pred             CCCCCCCccccHHHHHHHHHhcCCccccccc----------------------CccccchhhHHHHHHHHHHHhcCchhc
Confidence            99877763   22222222211111 00000                      000001223578899999999999999


Q ss_pred             CCHHHHhcCcccccCcCC
Q 023568          222 ITVEEALRHPYLQSLHDL  239 (280)
Q Consensus       222 pt~~ell~hp~~~~~~~~  239 (280)
                      .+..+...+++.......
T Consensus       267 ~~~~~~~~~~~~~~~~~~  284 (384)
T COG0515         267 LSSSSDLSHDLLAHLKLK  284 (384)
T ss_pred             CCHHHHhhchHhhCcccc
Confidence            999999998777655433

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.87  E-value=5e-22  Score=161.25  Aligned_cols=204  Identities=16%  Similarity=0.224  Sum_probs=157.8

Q ss_pred             cccccccccccCCCCCCCCcEEEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc
Q 023568            4 ENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN   82 (280)
Q Consensus         4 pniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nili~   82 (280)
                      +.|..++-+.+..     -+=.||||+++.+|.|++.= +++|+..++..++.|++.-++++|++.+|+|||||+|+||+
T Consensus        84 ~GIP~vYYFGqeG-----~~NiLVidLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIG  158 (449)
T KOG1165|consen   84 EGIPQVYYFGQEG-----KYNILVIDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIG  158 (449)
T ss_pred             CCCCceeeecccc-----chhhhhhhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeec
Confidence            4566666665555     45569999999888777753 57899999999999999999999999999999999999997


Q ss_pred             CCCC-----eEEeecccccccCCCCc--------cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 023568           83 ASCD-----LKIGDFGLARTTSETDF--------MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFP  149 (280)
Q Consensus        83 ~~~~-----~kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~  149 (280)
                      ..+.     +.++|||+|+.+.+.+.        ..+..||.+||+-.+..| .+-+.+.|+=|||-++.++|-|..||.
T Consensus       159 rp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlG-rEQSRRDDLEaLGHvFmYFLRGsLPWQ  237 (449)
T KOG1165|consen  159 RPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQ  237 (449)
T ss_pred             CCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeecccc-chhhhhhhHHHhhhhhhhhccCCCccc
Confidence            6543     88999999997765532        246789999999999998 888999999999999999999999999


Q ss_pred             CCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcc
Q 023568          150 GKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLV  215 (280)
Q Consensus       150 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~  215 (280)
                      +......-.+.+++..+.....+..++.....++...+...+...+.+.+.  -.-++.|+..+|.
T Consensus       238 GLKA~tnK~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PD--Ydylr~Lf~dvld  301 (449)
T KOG1165|consen  238 GLKADTNKEKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPD--YDYLRKLFDDVLD  301 (449)
T ss_pred             cccCcchHHHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCC--HHHHHHHHHHHHH
Confidence            998888888888877777766666666666666555444444444433321  2234444444443

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.87  E-value=7.8e-22  Score=156.33  Aligned_cols=188  Identities=19%  Similarity=0.277  Sum_probs=148.4

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCC--CCHHHHHHHHHHHHHHHHHHHhCC--ccccCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQ--LTDDHCQYFLYQLLRGLKYVHSAS--VLHRDLK   75 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~--l~~~~~~~i~~qil~~l~~LH~~~--i~H~dik   75 (280)
                      +.||||+.+++.+..+     .++.+|..||. |+|+++++....  .+..++.+++..+++|++|||+..  |.--.|+
T Consensus       244 fshpnilpvlgacnsp-----pnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~ln  318 (448)
T KOG0195|consen  244 FSHPNILPVLGACNSP-----PNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLN  318 (448)
T ss_pred             ecCCchhhhhhhccCC-----CCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcc
Confidence            4699999999999988     77999999998 799999986544  688899999999999999999976  4555688


Q ss_pred             CCceEEcCCCCeEEe--ecccccccCCCCccccceeccccccccccccCCCC--CcchhHHHHHHHHHHHHhCCCCCCCC
Q 023568           76 PSNLLLNASCDLKIG--DFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEY--TAAIDIWSVGCILGEIMTREPLFPGK  151 (280)
Q Consensus        76 ~~Nili~~~~~~kl~--dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~--~~~~DvwslG~~l~~ll~g~~pf~~~  151 (280)
                      ...++||++.+.+++  |--++-.      .......+.|++||.+......  -.++|+|||++++||+.|...||...
T Consensus       319 s~hvmidedltarismad~kfsfq------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadl  392 (448)
T KOG0195|consen  319 SKHVMIDEDLTARISMADTKFSFQ------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADL  392 (448)
T ss_pred             cceEEecchhhhheecccceeeee------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccC
Confidence            999999998776653  3222110      1122347789999999765443  45899999999999999999999988


Q ss_pred             ChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 023568          152 DYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL  228 (280)
Q Consensus       152 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell  228 (280)
                      ..++.-.+|.-                             ......++|+++.....|+.-|+..||.+||.++.++
T Consensus       393 spmecgmkial-----------------------------eglrv~ippgis~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  393 SPMECGMKIAL-----------------------------EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             Cchhhhhhhhh-----------------------------ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence            76655444321                             1122356778999999999999999999999988764

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.85  E-value=3.8e-22  Score=171.07  Aligned_cols=175  Identities=27%  Similarity=0.465  Sum_probs=139.1

Q ss_pred             CcEEEEEecCC-ccHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEeecccccc
Q 023568           22 NDVYIVYELMD-TDLHQIIRSD---QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART   97 (280)
Q Consensus        22 ~~~~lv~e~~~-g~L~~~l~~~---~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~   97 (280)
                      .++|+.|++|. ++|.+||...   ...+......++.|+..|+.|   +|.+|+|+||.||++..+..++|.|||+...
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts  405 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS  405 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence            46899999998 6999999643   357888999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCC-------ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCc
Q 023568           98 TSETD-------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDD  169 (280)
Q Consensus        98 ~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~  169 (280)
                      .....       ..+...||.+||+||.+.+ ..|+.++||||||++++|++. -...|..                   
T Consensus       406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g-~~y~~kvdIyaLGlil~EL~~~f~T~~er-------------------  465 (516)
T KOG1033|consen  406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRG-QQYSEKVDIYALGLILAELLIQFSTQFER-------------------  465 (516)
T ss_pred             cccCCcccchhhhhhhcccccccCCHHHHhh-hhhhhhcchhhHHHHHHHHHHHhccHHHH-------------------
Confidence            55443       4567789999999999998 899999999999999999987 2222211                   


Q ss_pred             ccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          170 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                                    +..+...+...+++.+....+.-..|+++||.+.|.+||++.+.--|+|.
T Consensus       466 --------------~~t~~d~r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  466 --------------IATLTDIRDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             --------------HHhhhhhhcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence                          11112222333343333445667899999999999999988877777764

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.85  E-value=3e-20  Score=158.41  Aligned_cols=195  Identities=19%  Similarity=0.175  Sum_probs=146.9

Q ss_pred             ccccccccccc-CCCCCCCCcEEEEEecCCccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            4 ENVIAIKDIIR-PPKKDTFNDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         4 pniv~l~~~~~-~~~~~~~~~~~lv~e~~~g~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      +++.++++.+. ..     ..-|+||+.++.+|.++....  +.++..++..++.|++.+|.+||+.|++||||||.|++
T Consensus        80 ~~~~~~~~~G~~~~-----~~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~  154 (322)
T KOG1164|consen   80 SHFPKLLDHGRSTE-----DFNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFV  154 (322)
T ss_pred             CCCCEEEEeccCCC-----ceeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHee
Confidence            47778888874 44     678999999999999988543  68999999999999999999999999999999999999


Q ss_pred             EcCC-----CCeEEeeccccc--ccCCCC--------c-cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhC
Q 023568           81 LNAS-----CDLKIGDFGLAR--TTSETD--------F-MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR  144 (280)
Q Consensus        81 i~~~-----~~~kl~dfg~~~--~~~~~~--------~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g  144 (280)
                      ++..     ..+.|.|||+++  ......        . .....||..|+++....+ ...+.+.|+||++-++.+++.|
T Consensus       155 ~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~-~e~~r~DDles~~Y~l~el~~g  233 (322)
T KOG1164|consen  155 VGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG-IEQGRRDDLESLFYMLLELLKG  233 (322)
T ss_pred             ecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCC-CccCCchhhhhHHHHHHHHhcC
Confidence            9865     358999999998  321111        1 123559999999999887 8899999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCH
Q 023568          145 EPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV  224 (280)
Q Consensus       145 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~  224 (280)
                      ..||.+........++.+........                          ......+..+.++...+-..+...+|..
T Consensus       234 ~LPW~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~~~~~~~~~~~~Pdy  287 (322)
T KOG1164|consen  234 SLPWEALEMTDLKSKFEKDPRKLLTD--------------------------RFGDLKPEEFAKILEYIDSLDYEDKPDY  287 (322)
T ss_pred             CCCCccccccchHHHHHHHhhhhccc--------------------------cccCCChHHHHHHHHHhhccCCcCCCCH
Confidence            99998766443333332211100000                          0112335566677776666888889987


Q ss_pred             HHHhcC
Q 023568          225 EEALRH  230 (280)
Q Consensus       225 ~ell~h  230 (280)
                      ..+...
T Consensus       288 ~~~~~~  293 (322)
T KOG1164|consen  288 EKLAEL  293 (322)
T ss_pred             HHHHHH
Confidence            776553

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.85  E-value=3.4e-21  Score=150.12  Aligned_cols=187  Identities=20%  Similarity=0.276  Sum_probs=147.2

Q ss_pred             cccccccccCCCCCCCCcEEEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCC
Q 023568            6 VIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS   84 (280)
Q Consensus         6 iv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nili~~~   84 (280)
                      |..+..++.+.     .+-.+||++.+.+|.+++.- .+.++..++.-++-|++.-++|+|..+++||||||+|+|++-+
T Consensus        73 iP~i~~y~~e~-----~ynvlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlg  147 (341)
T KOG1163|consen   73 IPHIRHYGTEK-----DYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLG  147 (341)
T ss_pred             Cchhhhhcccc-----ccceeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccc
Confidence            33445555544     56789999999999998864 4789999999999999999999999999999999999999654


Q ss_pred             ---CCeEEeecccccccCCCC--------ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 023568           85 ---CDLKIGDFGLARTTSETD--------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY  153 (280)
Q Consensus        85 ---~~~kl~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~  153 (280)
                         .++.|+|||+++...+..        ......||.+|++-....+ ...+.+.|+-|+|-++..+..|..||++...
T Consensus       148 rh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g-~eqSRRDDmeSvgYvLmYfnrG~LPWQglka  226 (341)
T KOG1163|consen  148 RHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLG-IEQSRRDDMESVGYVLMYFNRGSLPWQGLKA  226 (341)
T ss_pred             cccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhh-hhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence               358999999998755432        2245789999999988877 7788899999999999999999999999988


Q ss_pred             HHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCcccccccccc
Q 023568          154 VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR  198 (280)
Q Consensus       154 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (280)
                      ....++.+++....-......++.....++...+..++.-.+++.
T Consensus       227 ~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~  271 (341)
T KOG1163|consen  227 ATKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEK  271 (341)
T ss_pred             hhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCC
Confidence            777777777666555555555666666665555555555555443

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.84  E-value=4.1e-21  Score=157.64  Aligned_cols=162  Identities=21%  Similarity=0.280  Sum_probs=108.9

Q ss_pred             cEEEEEecCCccHHHHHH---cCC----CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEeecccc
Q 023568           23 DVYIVYELMDTDLHQIIR---SDQ----QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA   95 (280)
Q Consensus        23 ~~~lv~e~~~g~L~~~l~---~~~----~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nili~~~~~~kl~dfg~~   95 (280)
                      ..+++|+-+.++|.+++.   ...    .+.......+..|+++.+++||+.|++|+||+|+|++++.+|.++|+||+..
T Consensus       113 n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~  192 (288)
T PF14531_consen  113 NRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDGGVFLGDFSSL  192 (288)
T ss_dssp             SEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS-EEE--GGGE
T ss_pred             hhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEEcCCCCEEEcChHHH
Confidence            358899999999988864   211    1334444566689999999999999999999999999999999999999987


Q ss_pred             cccCCCCccccceeccccccccccccC-------CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 023568           96 RTTSETDFMTEYVVTRWYRAPELLLNC-------TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD  168 (280)
Q Consensus        96 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~  168 (280)
                      ...+.....  ...+..|.|||.....       ..++.+.|.|+||+++|.|++|..||.........           
T Consensus       193 ~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~-----------  259 (288)
T PF14531_consen  193 VRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADP-----------  259 (288)
T ss_dssp             EETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTS-----------
T ss_pred             eecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccc-----------
Confidence            766554222  3445779999976442       34678899999999999999999999765311000           


Q ss_pred             cccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCC
Q 023568          169 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKR  221 (280)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~R  221 (280)
                      +.                       .+..=. .++..+++||+.+|+.||.+|
T Consensus       260 ~~-----------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  260 EW-----------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             GG-----------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             cc-----------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            00                       111111 568899999999999999988

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.83  E-value=3.6e-20  Score=161.38  Aligned_cols=200  Identities=24%  Similarity=0.316  Sum_probs=152.0

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCc-cccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASV-LHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i-~H~dik~~   77 (280)
                      +.|.|+.++.+...++     ...+.|.+||+ |+|.|.+.. .-.+++-....+++.++.|++|||+.-| .|+.++..
T Consensus         4 l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~   78 (484)
T KOG1023|consen    4 LDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS   78 (484)
T ss_pred             cchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence            5799999999999988     67999999998 799999977 4578999999999999999999998765 99999999


Q ss_pred             ceEEcCCCCeEEeecccccccCCC---CccccceeccccccccccccCC--C----CCcchhHHHHHHHHHHHHhCCCCC
Q 023568           78 NLLLNASCDLKIGDFGLARTTSET---DFMTEYVVTRWYRAPELLLNCT--E----YTAAIDIWSVGCILGEIMTREPLF  148 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~--~----~~~~~DvwslG~~l~~ll~g~~pf  148 (280)
                      |.+++..+.+||+|||+.......   .......-..-|.|||.+.+..  .    .+.+.|+||+|++++|+++.+.||
T Consensus        79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~  158 (484)
T KOG1023|consen   79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF  158 (484)
T ss_pred             cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence            999999999999999998765321   1112223455699999987631  1    466799999999999999999999


Q ss_pred             CCCChH----HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCH
Q 023568          149 PGKDYV----HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV  224 (280)
Q Consensus       149 ~~~~~~----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~  224 (280)
                      ......    +....+.+ .  ......                    +..... ....++...+++.|+..+|..||++
T Consensus       159 ~~~~~~~~~~eii~~~~~-~--~~~~~r--------------------P~i~~~-~e~~~~l~~l~~~cw~e~P~~rPs~  214 (484)
T KOG1023|consen  159 DLRNLVEDPDEIILRVKK-G--GSNPFR--------------------PSIELL-NELPPELLLLVARCWEEIPEKRPSI  214 (484)
T ss_pred             ccccccCChHHHHHHHHh-c--CCCCcC--------------------cchhhh-hhcchHHHHHHHHhcccChhhCccH
Confidence            884321    12222221 0  110000                    000000 1345578999999999999999999


Q ss_pred             HHHhc
Q 023568          225 EEALR  229 (280)
Q Consensus       225 ~ell~  229 (280)
                      +++-.
T Consensus       215 ~~i~~  219 (484)
T KOG1023|consen  215 EQIRS  219 (484)
T ss_pred             HHHHh
Confidence            98754

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.83  E-value=1.4e-20  Score=172.56  Aligned_cols=151  Identities=28%  Similarity=0.428  Sum_probs=124.8

Q ss_pred             HHHHHHHHhCCccccCCCCCceEEcCCCCeEEeecccccccCCC---------------C-ccccceecccccccccccc
Q 023568           58 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET---------------D-FMTEYVVTRWYRAPELLLN  121 (280)
Q Consensus        58 l~~l~~LH~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~---------------~-~~~~~~~~~~y~aPE~~~~  121 (280)
                      +.+++|||+-||+|||+||+|.+|..-|.+|++|||+++.....               + .....+||+.|.|||++..
T Consensus       153 vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr  232 (1205)
T KOG0606|consen  153 VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR  232 (1205)
T ss_pred             hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhh
Confidence            77899999999999999999999999999999999998743211               0 1134589999999999987


Q ss_pred             CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCC
Q 023568          122 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN  201 (280)
Q Consensus       122 ~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  201 (280)
                       ..|+..+|.|++|+|+|+.+.|+.||.++...+.+.........                            +++.-..
T Consensus       233 -qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~----------------------------wpE~dea  283 (1205)
T KOG0606|consen  233 -QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE----------------------------WPEEDEA  283 (1205)
T ss_pred             -hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcc----------------------------ccccCcC
Confidence             88999999999999999999999999999877777665442221                            1122235


Q ss_pred             CCHHHHHHHHHhcccCCCCCC---CHHHHhcCcccccCc
Q 023568          202 KSSGAVDLLEKMLVFDPNKRI---TVEEALRHPYLQSLH  237 (280)
Q Consensus       202 ~~~~~~~ll~~~L~~dp~~Rp---t~~ell~hp~~~~~~  237 (280)
                      .++++++++.++|+.+|..|.   .+-++.+|+||+.+-
T Consensus       284 ~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LD  322 (1205)
T KOG0606|consen  284 LPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLD  322 (1205)
T ss_pred             CCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecc
Confidence            689999999999999999995   677888999998764

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.74  E-value=2.1e-19  Score=163.15  Aligned_cols=202  Identities=29%  Similarity=0.406  Sum_probs=165.5

Q ss_pred             CcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHH-HcCC-CCCHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCc
Q 023568            3 HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQII-RSDQ-QLTDDHCQYFLYQLLRGLKYVH-SASVLHRDLKPSN   78 (280)
Q Consensus         3 Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l-~~~~-~l~~~~~~~i~~qil~~l~~LH-~~~i~H~dik~~N   78 (280)
                      |+|++++++.....     ...+++++|..| ++.+-+ .... ..+...+..++.|+..++.|+| ..++.|+||+|+|
T Consensus        80 h~n~~~~~~~~~~~-----~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n  154 (601)
T KOG0590|consen   80 HSNTVHMIEPSSSP-----RSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSN  154 (601)
T ss_pred             cccccccCCccCCC-----cccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCcc
Confidence            99999999999888     779999999875 888888 5554 7888999999999999999999 9999999999999


Q ss_pred             eEEcCCC-CeEEeecccccccCC-C---Ccccccee-ccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 023568           79 LLLNASC-DLKIGDFGLARTTSE-T---DFMTEYVV-TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD  152 (280)
Q Consensus        79 ili~~~~-~~kl~dfg~~~~~~~-~---~~~~~~~~-~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~  152 (280)
                      .+++..+ .++++|||+|..... .   ......+| ++.|+|||...+........|+||+|+++..+++|..|+....
T Consensus       155 ~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~  234 (601)
T KOG0590|consen  155 SLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPS  234 (601)
T ss_pred             chhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccc
Confidence            9999999 999999999986555 2   22345677 9999999999886678889999999999999999999987754


Q ss_pred             hHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 023568          153 YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY  232 (280)
Q Consensus       153 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~  232 (280)
                      .....                          ...............+..++....+++.++|..+|..|.+.+++..+||
T Consensus       235 ~~~~~--------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~  288 (601)
T KOG0590|consen  235 RKDGR--------------------------YSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNW  288 (601)
T ss_pred             ccccc--------------------------ceeecccccccccCccccCChhhhhcccccccCCchhcccccccccccc
Confidence            22200                          0000000111123345578899999999999999999999999999999


Q ss_pred             ccc
Q 023568          233 LQS  235 (280)
Q Consensus       233 ~~~  235 (280)
                      +..
T Consensus       289 ~~~  291 (601)
T KOG0590|consen  289 LSS  291 (601)
T ss_pred             ccc
Confidence            988

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.73  E-value=2.1e-17  Score=129.38  Aligned_cols=133  Identities=15%  Similarity=0.050  Sum_probs=97.9

Q ss_pred             CcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC-CCCceE
Q 023568            3 HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDL-KPSNLL   80 (280)
Q Consensus         3 Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~di-k~~Nil   80 (280)
                      |++|++++++         +..|++|||+.| +|.+.+..      . ...++.|++.+|.++|++||+|||| ||+|||
T Consensus        61 ~~~vP~ll~~---------~~~~lvmeyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NIL  124 (218)
T PRK12274         61 LPRTPRLLHW---------DGRHLDRSYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWL  124 (218)
T ss_pred             CCCCCEEEEE---------cCEEEEEeeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEE
Confidence            5788888886         237999999987 67654321      1 2357889999999999999999999 799999


Q ss_pred             EcCCCCeEEeecccccccCCCCcc----c----------cceeccccccccccccCCCCC-cchhHHHHHHHHHHHHhCC
Q 023568           81 LNASCDLKIGDFGLARTTSETDFM----T----------EYVVTRWYRAPELLLNCTEYT-AAIDIWSVGCILGEIMTRE  145 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~~~~~~----~----------~~~~~~~y~aPE~~~~~~~~~-~~~DvwslG~~l~~ll~g~  145 (280)
                      ++.++.++|+|||++.........    .          -...++.|++|+...--...+ .+.+.++-|.-+|.++|+.
T Consensus       125 v~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~  204 (218)
T PRK12274        125 VQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRR  204 (218)
T ss_pred             EcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhcc
Confidence            999999999999999855433210    0          012366677776543323333 4567778899999999998


Q ss_pred             CCCCCC
Q 023568          146 PLFPGK  151 (280)
Q Consensus       146 ~pf~~~  151 (280)
                      .++-++
T Consensus       205 ~~~~~~  210 (218)
T PRK12274        205 VLHWED  210 (218)
T ss_pred             CCcccc
Confidence            776443

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.72  E-value=1e-17  Score=143.29  Aligned_cols=105  Identities=22%  Similarity=0.306  Sum_probs=80.1

Q ss_pred             CCCccccc-ccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC-CCC
Q 023568            1 MEHENVIA-IKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDL-KPS   77 (280)
Q Consensus         1 l~Hpniv~-l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~di-k~~   77 (280)
                      |+|+||+. +++.         +..|+||||++| +|. .+...+      ...++.|++.||.|||+.||+|||| ||+
T Consensus        78 L~h~~iv~~l~~~---------~~~~LVmE~~~G~~L~-~~~~~~------~~~~~~~i~~aL~~lH~~gIiHrDL~KP~  141 (365)
T PRK09188         78 VRGIGVVPQLLAT---------GKDGLVRGWTEGVPLH-LARPHG------DPAWFRSAHRALRDLHRAGITHNDLAKPQ  141 (365)
T ss_pred             ccCCCCCcEEEEc---------CCcEEEEEccCCCCHH-HhCccc------hHHHHHHHHHHHHHHHHCCCeeCCCCCcc
Confidence            57999985 5432         237999999986 675 322111      1467899999999999999999999 999


Q ss_pred             ceEEcCCCCeEEeecccccccCCCCc---------cccceecccccccccccc
Q 023568           78 NLLLNASCDLKIGDFGLARTTSETDF---------MTEYVVTRWYRAPELLLN  121 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~  121 (280)
                      |||++.++.++|+|||+++.......         .....+++.|.+||.+..
T Consensus       142 NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        142 NWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             eEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            99999999999999999986543311         123456778999998854

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.71  E-value=8.1e-18  Score=134.30  Aligned_cols=121  Identities=16%  Similarity=0.275  Sum_probs=90.0

Q ss_pred             CCCcccccccccccCCCCCC---CCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDT---FNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP   76 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~---~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~   76 (280)
                      |.||+|..+.+++.......   .+..+|||||++| +|.++.    .++++    .+.+++.+|..+|+.|++|||++|
T Consensus        92 L~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~~----~~~~i~~~l~~lH~~gi~H~Dikp  163 (232)
T PRK10359         92 VRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP----EISED----VKAKIKASIESLHQHGMVSGDPHK  163 (232)
T ss_pred             HHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhh----hccHH----HHHHHHHHHHHHHHcCCccCCCCh
Confidence            46999999999877542111   1458999999998 888773    23332    456999999999999999999999


Q ss_pred             CceEEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHH
Q 023568           77 SNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM  142 (280)
Q Consensus        77 ~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll  142 (280)
                      +||+++.+| ++|+|||.............           .... ..+..++|+|+||+++..+.
T Consensus       164 ~Nili~~~g-i~liDfg~~~~~~e~~a~d~-----------~vle-r~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        164 GNFIVSKNG-LRIIDLSGKRCTAQRKAKDR-----------IDLE-RHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             HHEEEeCCC-EEEEECCCcccccchhhHHH-----------HHHH-hHhcccccccceeEeehHHH
Confidence            999999988 99999998765533211110           2222 34557899999999987653

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.71  E-value=1.8e-17  Score=134.89  Aligned_cols=204  Identities=22%  Similarity=0.259  Sum_probs=146.5

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCC
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSAS--VLHRDL   74 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH~~~--i~H~di   74 (280)
                      -|.||||++.|+.+.+......+.+++|||+ |++.++|++    +..+.....++|+.||+.||.|||+..  |+|+++
T Consensus       125 vHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppiihgnl  204 (458)
T KOG1266|consen  125 VHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNL  204 (458)
T ss_pred             HHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCc
Confidence            5899999999998876544467899999997 799999864    356899999999999999999999976  999999


Q ss_pred             CCCceEEcCCCCeEEeecccccc-----cCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCC-C
Q 023568           75 KPSNLLLNASCDLKIGDFGLART-----TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-F  148 (280)
Q Consensus        75 k~~Nili~~~~~~kl~dfg~~~~-----~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~p-f  148 (280)
                      ..+.|++..+|-+|+..-.-...     ...........+-++|.+||.-.. .....++|||++|....+|..+..- -
T Consensus       205 Tc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~-tn~~~a~dIy~fgmcAlemailEiq~t  283 (458)
T KOG1266|consen  205 TCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTT-TNTTGASDIYKFGMCALEMAILEIQST  283 (458)
T ss_pred             chhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcc-cccccchhhhhhhHHHHHHHHheeccC
Confidence            99999999999888764222111     111111123345677889985433 5566789999999999999887743 2


Q ss_pred             CCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 023568          149 PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL  228 (280)
Q Consensus       149 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell  228 (280)
                      .+.+....-..+...                                  ++....+--++++++||+-.|..||++.+++
T Consensus       284 nseS~~~~ee~ia~~----------------------------------i~~len~lqr~~i~kcl~~eP~~rp~ar~ll  329 (458)
T KOG1266|consen  284 NSESKVEVEENIANV----------------------------------IIGLENGLQRGSITKCLEGEPNGRPDARLLL  329 (458)
T ss_pred             CCcceeehhhhhhhh----------------------------------eeeccCccccCcCcccccCCCCCCcchhhhh
Confidence            222211111111110                                  0111233345789999999999999999999


Q ss_pred             cCcccccCcCCC
Q 023568          229 RHPYLQSLHDLN  240 (280)
Q Consensus       229 ~hp~~~~~~~~~  240 (280)
                      .||.+..++...
T Consensus       330 fHpllfeVhslk  341 (458)
T KOG1266|consen  330 FHPLLFEVHSLK  341 (458)
T ss_pred             cCceeeecchHH
Confidence            999987776443

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.68  E-value=7.7e-17  Score=126.79  Aligned_cols=76  Identities=18%  Similarity=0.274  Sum_probs=65.5

Q ss_pred             EEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH-HhCCccccCCCCCceEEcCCCCeEEeecccccccCC
Q 023568           24 VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV-HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  100 (280)
Q Consensus        24 ~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~L-H~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~  100 (280)
                      .+|||||++| ++...+.+.+.+++..+..++.|++.+|.++ |+.||+||||||+||+++ ++.++|+|||++.....
T Consensus        92 ~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~LiDFG~a~~~~~  169 (190)
T cd05147          92 HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLYIIDVSQSVEHDH  169 (190)
T ss_pred             CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEEEEEccccccCCC
Confidence            3899999986 5555544457899999999999999999999 799999999999999998 57899999999875443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10345 hypothetical protein; Provisional

Probab=99.67  E-value=1.8e-16  Score=125.99  Aligned_cols=89  Identities=18%  Similarity=0.231  Sum_probs=71.3

Q ss_pred             CCcccccccccccCCCCCCCCcEE-EEEecCC---ccHHHHHHcCCCCCHHHHHHHHHHHHHHH-HHHHhCCccccCCCC
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVY-IVYELMD---TDLHQIIRSDQQLTDDHCQYFLYQLLRGL-KYVHSASVLHRDLKP   76 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~-lv~e~~~---g~L~~~l~~~~~l~~~~~~~i~~qil~~l-~~LH~~~i~H~dik~   76 (280)
                      +||||++++++++++.  +.+.++ +||||++   |+|.+++.+ +.+++.  ..++.|++.++ +|||+++|+||||||
T Consensus        59 ~h~nIvr~yg~~et~~--g~g~v~~~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp  133 (210)
T PRK10345         59 DWSGIPRYYGTVETDC--GTGYVYDVIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKP  133 (210)
T ss_pred             CCcccceeeEEEEeCC--CCeEEEEEEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCH
Confidence            6899999999999873  223434 7899965   599999976 457766  35688888888 999999999999999


Q ss_pred             CceEEcC----CCCeEEeecccc
Q 023568           77 SNLLLNA----SCDLKIGDFGLA   95 (280)
Q Consensus        77 ~Nili~~----~~~~kl~dfg~~   95 (280)
                      +|||++.    ++.++|+|++.+
T Consensus       134 ~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345        134 QNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             HHEEEeccCCCCCcEEEEECCCC
Confidence            9999974    347999995543

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.65  E-value=3.5e-16  Score=123.36  Aligned_cols=76  Identities=18%  Similarity=0.214  Sum_probs=65.3

Q ss_pred             EEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEcCCCCeEEeecccccccCC
Q 023568           24 VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  100 (280)
Q Consensus        24 ~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~-~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~  100 (280)
                      .||||||++| ++.........++..++..++.|++.++.++|+ .||+||||||+||+++ ++.++|+|||++.....
T Consensus        92 ~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~liDFG~a~~~~~  169 (190)
T cd05145          92 NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEEEEEcccceecCC
Confidence            4899999987 344333344678999999999999999999999 9999999999999999 88999999999876544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.59  E-value=4.3e-15  Score=138.62  Aligned_cols=135  Identities=21%  Similarity=0.311  Sum_probs=113.5

Q ss_pred             ccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC
Q 023568            5 NVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA   83 (280)
Q Consensus         5 niv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nili~~   83 (280)
                      -|+.+...+...     +.-+||+||.+ |+|.+++...+.+++.-+..+..|++.-|..||..+||||||||+|+++..
T Consensus       755 ~~~~~~~a~~~~-----~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~  829 (974)
T KOG1166|consen  755 SIMHISSAHVFQ-----NASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRR  829 (974)
T ss_pred             chHHHHHHHccC-----CcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeec
Confidence            344555555544     44789999998 899999998888999999999999999999999999999999999999842


Q ss_pred             -------CCCeEEeecccccc---cCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCC
Q 023568           84 -------SCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTRE  145 (280)
Q Consensus        84 -------~~~~kl~dfg~~~~---~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~  145 (280)
                             ..-++|+|||.+--   ..+........+|-.+-.+|...| ..++..+|.|.|+.+++-||.|+
T Consensus       830 ~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~g-rpWtYq~DyfGlAa~~h~mLFG~  900 (974)
T KOG1166|consen  830 EICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREG-RPWTYQIDYFGLAATVHVMLFGK  900 (974)
T ss_pred             ccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcC-CCCchhhhhHHHHHHHHHHHHHH
Confidence                   34599999998853   333334566677888999999888 88999999999999999999987

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.54  E-value=9.4e-15  Score=134.79  Aligned_cols=187  Identities=26%  Similarity=0.377  Sum_probs=150.4

Q ss_pred             CcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEeecccccccCC
Q 023568           22 NDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  100 (280)
Q Consensus        22 ~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~  100 (280)
                      .-.+|+|+|.+ ++|...+++.+..+++-++..+..+..++++||+..+.|+|++|.|.++..++..++++||.....+.
T Consensus       877 sP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~  956 (1205)
T KOG0606|consen  877 SPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL  956 (1205)
T ss_pred             CCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccccc
Confidence            45899999997 59999998888899999999999999999999999999999999999999999999999984321110


Q ss_pred             ---------------------C-----------CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 023568          101 ---------------------T-----------DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF  148 (280)
Q Consensus       101 ---------------------~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf  148 (280)
                                           .           .......+|+.|.+||...+ ......+|.|+.|+++++.++|.+||
T Consensus       957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg-~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen  957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG-RRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred             ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc-ccCCCcchhhhhhhhhhhhhcCCCCC
Confidence                                 0           00123467889999999988 77778899999999999999999999


Q ss_pred             CCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHH---
Q 023568          149 PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVE---  225 (280)
Q Consensus       149 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~---  225 (280)
                      +.....+....|..                            ....++.-....+..+++++..+|..+|.+|..+.   
T Consensus      1036 na~tpq~~f~ni~~----------------------------~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~ 1087 (1205)
T KOG0606|consen 1036 NAETPQQIFENILN----------------------------RDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAA 1087 (1205)
T ss_pred             CCcchhhhhhcccc----------------------------CCCCCCCCccccChhhhhhhhhhhccCchhccCccccc
Confidence            88775555433322                            11122222335688999999999999999999887   


Q ss_pred             HHhcCcccccCc
Q 023568          226 EALRHPYLQSLH  237 (280)
Q Consensus       226 ell~hp~~~~~~  237 (280)
                      ++-.|+||+...
T Consensus      1088 e~k~~~~~~~~~ 1099 (1205)
T KOG0606|consen 1088 EVKGHPFFQDVD 1099 (1205)
T ss_pred             ccccCCccCCCC
Confidence            888999998754

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.53  E-value=1.4e-13  Score=122.04  Aligned_cols=133  Identities=20%  Similarity=0.444  Sum_probs=101.3

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH-SASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH-~~~i~H~dik~~Ni   79 (280)
                      |+||||+++++.++.+     .++|||+|.+.. |..++.+   ++...+..-++||+.||.||| +.+++|++|..+.|
T Consensus        66 lRHP~Il~yL~t~e~~-----~~~ylvTErV~P-l~~~lk~---l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SV  136 (690)
T KOG1243|consen   66 LRHPNILSYLDTTEEE-----GTLYLVTERVRP-LETVLKE---LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSV  136 (690)
T ss_pred             ccCchhhhhhhhhccc-----CceEEEeecccc-HHHHHHH---hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeE
Confidence            6899999999999998     679999999853 3333322   337888999999999999998 67899999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCC-ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCC
Q 023568           80 LLNASCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTRE  145 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~  145 (280)
                      +|+..|..+|++|.++....... ........-.|..|+.+..   -.-..|.|.|||++++++.|.
T Consensus       137 fVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~---s~~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  137 FVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDP---SEWSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             EEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCc---cccchhhhhHHHHHHHHhCcc
Confidence            99999999999999875433221 1122222333566664422   114679999999999999993

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.49  E-value=8.6e-14  Score=121.99  Aligned_cols=195  Identities=27%  Similarity=0.272  Sum_probs=153.5

Q ss_pred             CcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcCCC-CCHHHHHHHHHHHHH----HHHHHHhCCccccCCCCC
Q 023568            3 HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQ-LTDDHCQYFLYQLLR----GLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         3 Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~-l~~~~~~~i~~qil~----~l~~LH~~~i~H~dik~~   77 (280)
                      |+|.++.+..++..     +.+|+-+|+|+.+|.++...... +++..++..+.+...    ||.++|+.+++|-|++|.
T Consensus       177 ~~~~v~~~~~~e~~-----~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~  251 (524)
T KOG0601|consen  177 HENPVRDSPAWEGS-----GILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPA  251 (524)
T ss_pred             cccccccCcccccC-----CcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchh
Confidence            88999988888777     78999999999999988865444 899999999999999    999999999999999999


Q ss_pred             ceEEcCC-CCeEEeecccccccCCCCcc------ccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 023568           78 NLLLNAS-CDLKIGDFGLARTTSETDFM------TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG  150 (280)
Q Consensus        78 Nili~~~-~~~kl~dfg~~~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~  150 (280)
                      ||+...+ ..++++|||+....+.....      ....+...|++||...+  .++..+|++++|.++.+-.+|..++..
T Consensus       252 ~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~  329 (524)
T KOG0601|consen  252 NIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSV  329 (524)
T ss_pred             heecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccC
Confidence            9999998 88999999999877665422      12256777999998764  778899999999999999888765544


Q ss_pred             C--ChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccc-cCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 023568          151 K--DYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFAT-RFPNKSSGAVDLLEKMLVFDPNKRITVEEA  227 (280)
Q Consensus       151 ~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ll~~~L~~dp~~Rpt~~el  227 (280)
                      .  +.-.++..                                 ..++. .....+......+..|+..+|..|+++..+
T Consensus       330 g~~~~W~~~r~---------------------------------~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~  376 (524)
T KOG0601|consen  330 GKNSSWSQLRQ---------------------------------GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQIL  376 (524)
T ss_pred             CCCCCcccccc---------------------------------ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHH
Confidence            3  11111100                                 00111 112446666678999999999999999999


Q ss_pred             hcCcccccCc
Q 023568          228 LRHPYLQSLH  237 (280)
Q Consensus       228 l~hp~~~~~~  237 (280)
                      ++|+++....
T Consensus       377 ~~l~~i~s~~  386 (524)
T KOG0601|consen  377 TALNVIHSKL  386 (524)
T ss_pred             hccccccchh
Confidence            9999987654

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.47  E-value=1.2e-13  Score=110.64  Aligned_cols=87  Identities=26%  Similarity=0.364  Sum_probs=73.0

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      +|++|.....++.+.     ...++||||++| +|.+++.....    .+..++.+++.+|.++|+.|++|+|++|.||+
T Consensus        57 ~~~~i~~p~~~~~~~-----~~~~lv~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil  127 (211)
T PRK14879         57 RKAGVNVPAVYFVDP-----ENFIIVMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMI  127 (211)
T ss_pred             HHCCCCCCeEEEEeC-----CCCEEEEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEE
Confidence            467777666666554     457899999986 99998865332    88899999999999999999999999999999


Q ss_pred             EcCCCCeEEeeccccccc
Q 023568           81 LNASCDLKIGDFGLARTT   98 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~   98 (280)
                      ++ ++.++|+|||.+...
T Consensus       128 ~~-~~~~~liDf~~a~~~  144 (211)
T PRK14879        128 LS-GGKIYLIDFGLAEFS  144 (211)
T ss_pred             EE-CCCEEEEECCcccCC
Confidence            99 788999999988653

>smart00090 RIO RIO-like kinase

Probab=99.47  E-value=7.9e-14  Score=113.41  Aligned_cols=76  Identities=16%  Similarity=0.199  Sum_probs=65.8

Q ss_pred             EEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC-ccccCCCCCceEEcCCCCeEEeecccccccCC
Q 023568           24 VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS-VLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  100 (280)
Q Consensus        24 ~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~-i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~  100 (280)
                      .++||||++| +|.........+...++..++.|++.+|.+||+.| ++|+||||+||+++ ++.++|+|||.+...+.
T Consensus       123 ~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~~~  200 (237)
T smart00090      123 NVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-DGKVVIIDVSQSVELDH  200 (237)
T ss_pred             ceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-CCCEEEEEChhhhccCC
Confidence            5899999997 66665544566777788999999999999999999 99999999999999 88999999998865544

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.43  E-value=3.5e-13  Score=122.61  Aligned_cols=85  Identities=22%  Similarity=0.305  Sum_probs=72.1

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++|++|+....+..+.     ...++||||++| +|.+++.        ....++.|++.+|.+||+.|++||||||+||
T Consensus       393 l~~~~i~~p~~~~~~~-----~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NI  459 (535)
T PRK09605        393 ARRAGVPTPVIYDVDP-----EEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNF  459 (535)
T ss_pred             hcccCCCeeEEEEEeC-----CCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHE
Confidence            4688888877666654     447899999985 9998875        4578899999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccC
Q 023568           80 LLNASCDLKIGDFGLARTTS   99 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~   99 (280)
                      ++ .++.++|+|||+++...
T Consensus       460 Ll-~~~~~~liDFGla~~~~  478 (535)
T PRK09605        460 IV-RDDRLYLIDFGLGKYSD  478 (535)
T ss_pred             EE-ECCcEEEEeCcccccCC
Confidence            99 67889999999987643

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.43  E-value=5.4e-13  Score=108.72  Aligned_cols=91  Identities=20%  Similarity=0.242  Sum_probs=69.2

Q ss_pred             CCcc--cccccccccCCCCCCCCcEEEEEecCCc--cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            2 EHEN--VIAIKDIIRPPKKDTFNDVYIVYELMDT--DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         2 ~Hpn--iv~l~~~~~~~~~~~~~~~~lv~e~~~g--~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      +|++  +++.+++...... .....++|||+++|  +|.+++.. ..+++..    +.|++.+|.+||++||+|+||||.
T Consensus        98 ~~~gi~vP~pl~~~~~~~~-~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~  171 (239)
T PRK01723         98 YEAGLPVPRPIAARVVRHG-LFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAH  171 (239)
T ss_pred             HhCCCCCceeEeeeeeecC-cceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCch
Confidence            3555  3666666443311 11234699999985  88888865 4566553    578999999999999999999999


Q ss_pred             ceEEcCCCCeEEeeccccccc
Q 023568           78 NLLLNASCDLKIGDFGLARTT   98 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~   98 (280)
                      |||++.++.++|+|||.+...
T Consensus       172 NILv~~~~~v~LIDfg~~~~~  192 (239)
T PRK01723        172 NILLDPDGKFWLIDFDRGELR  192 (239)
T ss_pred             hEEEcCCCCEEEEECCCcccC
Confidence            999999899999999987654

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.42  E-value=3.2e-13  Score=107.24  Aligned_cols=69  Identities=28%  Similarity=0.468  Sum_probs=59.9

Q ss_pred             CcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEeeccccccc
Q 023568           22 NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT   98 (280)
Q Consensus        22 ~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~   98 (280)
                      ...++||||++| +|.+++.....       .++.|++.+|.+||+.|++|+|++|.||+++ ++.++++|||.+...
T Consensus        70 ~~~~lv~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        70 DNKTIVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CCCEEEEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            347899999986 89888754321       7899999999999999999999999999999 889999999988664

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.30  E-value=6.1e-12  Score=99.86  Aligned_cols=73  Identities=21%  Similarity=0.271  Sum_probs=61.3

Q ss_pred             CcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEeecccccccCC
Q 023568           22 NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  100 (280)
Q Consensus        22 ~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~  100 (280)
                      ...++||||++| +|.++...      .....++.+++.++.++|+.|++||||+|.||+++.++.++|+|||.+.....
T Consensus       104 ~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         104 NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEEEECCccccCCC
Confidence            346899999987 77655321      34567889999999999999999999999999999999999999999865543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.27  E-value=1.4e-12  Score=116.16  Aligned_cols=156  Identities=23%  Similarity=0.314  Sum_probs=115.1

Q ss_pred             HHHHHHHHHHHHh-CCccccCCCCCceEEcCCCCeEEeecccccccCCCCc----------cccceeccccccccccccC
Q 023568           54 LYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF----------MTEYVVTRWYRAPELLLNC  122 (280)
Q Consensus        54 ~~qil~~l~~LH~-~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~  122 (280)
                      +.++..|+.|+|. .+++|++|.|++|.++.++..|++.|+++........          .........|.|||++.+ 
T Consensus       105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-  183 (700)
T KOG2137|consen  105 LGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-  183 (700)
T ss_pred             hhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-
Confidence            4566689999995 6899999999999999999999999998875444211          011233667999999988 


Q ss_pred             CCCCcchhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCC
Q 023568          123 TEYTAAIDIWSVGCILGEIM-TREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN  201 (280)
Q Consensus       123 ~~~~~~~DvwslG~~l~~ll-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  201 (280)
                      .....++|++|+|+++|.+. .|+..+...........-....+..                           ....-..
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~---------------------------~~~~s~~  236 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAG---------------------------AFGYSNN  236 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccc---------------------------ccccccc
Confidence            78889999999999999998 5666665543222211111100000                           0011136


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCc
Q 023568          202 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  237 (280)
Q Consensus       202 ~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~  237 (280)
                      +++++++=+.++|..++..||++.+++.-|||.+-.
T Consensus       237 ~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~  272 (700)
T KOG2137|consen  237 LPSELRESLKKLLNGDSAVRPTLDLLLSIPFFSDPG  272 (700)
T ss_pred             CcHHHHHHHHHHhcCCcccCcchhhhhcccccCCch
Confidence            789999999999999999999999999999998754

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.25  E-value=2.3e-10  Score=97.14  Aligned_cols=196  Identities=11%  Similarity=0.070  Sum_probs=132.9

Q ss_pred             cEEEEEecCCc--cHHHHHHc------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEeeccc
Q 023568           23 DVYIVYELMDT--DLHQIIRS------DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL   94 (280)
Q Consensus        23 ~~~lv~e~~~g--~L~~~l~~------~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nili~~~~~~kl~dfg~   94 (280)
                      .+-+.|+...|  .+.++...      .+...+....++++.++.+.+-||..|.+-+|++++|+|+++++.+.|.|=..
T Consensus        84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDs  163 (637)
T COG4248          84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDS  163 (637)
T ss_pred             eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccc
Confidence            37889999976  56665532      24588999999999999999999999999999999999999999999988655


Q ss_pred             ccccCCCCccccceecccccccccccc----CCCCCcchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCc
Q 023568           95 ARTTSETDFMTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPDD  169 (280)
Q Consensus        95 ~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslG~~l~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~  169 (280)
                      .....++.......|...|++||...-    ...-....|.|.||++++++|.| ++||.+-..         ....+++
T Consensus       164 fqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~---------~~~ap~p  234 (637)
T COG4248         164 FQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPL---------ISDAPNP  234 (637)
T ss_pred             eeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccc---------cCCCCCc
Confidence            554455555566788999999997541    13345679999999999999885 999987420         1111111


Q ss_pred             ccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhccc--CCCCCCCHHHHh
Q 023568          170 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVF--DPNKRITVEEAL  228 (280)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~--dp~~Rpt~~ell  228 (280)
                      . ............-.+-......+...-+..+++++..+..+|+..  .+.-|||++..+
T Consensus       235 ~-E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~  294 (637)
T COG4248         235 L-ETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWV  294 (637)
T ss_pred             c-hhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHH
Confidence            0 000000000000011111112222223345789999999999984  467899887543

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.18  E-value=5.8e-11  Score=93.28  Aligned_cols=75  Identities=19%  Similarity=0.248  Sum_probs=59.2

Q ss_pred             cEEEEEecCCc-cHH-HHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEcCCCCeEEeecccccccC
Q 023568           23 DVYIVYELMDT-DLH-QIIRSDQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS   99 (280)
Q Consensus        23 ~~~lv~e~~~g-~L~-~~l~~~~~l~~~~~~~i~~qil~~l~~LH~-~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~   99 (280)
                      ..++||||++| ++. ..+... ... .++..++.|++.++.++|+ .|++|+||+|+||+++ ++.++|+|||.+....
T Consensus        89 ~~~lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~liDfg~a~~~~  165 (187)
T cd05119          89 RHVLVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVYIIDVPQAVEID  165 (187)
T ss_pred             CCEEEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEEEEECccccccc
Confidence            46899999986 221 122111 111 7788999999999999999 9999999999999999 8999999999986544


Q ss_pred             C
Q 023568          100 E  100 (280)
Q Consensus       100 ~  100 (280)
                      .
T Consensus       166 ~  166 (187)
T cd05119         166 H  166 (187)
T ss_pred             C
Confidence            3

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.17  E-value=6.9e-10  Score=96.36  Aligned_cols=173  Identities=17%  Similarity=0.234  Sum_probs=124.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC--ccHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHH
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD--TDLHQIIRS---------------DQQLTDDHCQYFLYQLLRGLKY   63 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~--g~L~~~l~~---------------~~~l~~~~~~~i~~qil~~l~~   63 (280)
                      +.|+|||++.++|...+- +...+++|++|.+  ++|.++-..               +.+.+|+.++.++.|+..||.+
T Consensus       330 l~h~NvV~frevf~t~tF-~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~s  408 (655)
T KOG3741|consen  330 LCHTNVVPFREVFLTYTF-GDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYS  408 (655)
T ss_pred             hccCceeehhhhhhhhcc-CcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHH
Confidence            479999999999995432 2267999999997  488887532               2347899999999999999999


Q ss_pred             HHhCCccccCCCCCceEEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh
Q 023568           64 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT  143 (280)
Q Consensus        64 LH~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~  143 (280)
                      +|+.|+.-+-|.+.+|+++.+.+++++.-|.......+.           .  +.+    .-..+-|.-.||.+++.|.+
T Consensus       409 IHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~-----------~--~~l----e~~Qq~D~~~lG~ll~aLAt  471 (655)
T KOG3741|consen  409 IHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP-----------T--EPL----ESQQQNDLRDLGLLLLALAT  471 (655)
T ss_pred             HHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC-----------C--cch----hHHhhhhHHHHHHHHHHHhh
Confidence            999999999999999999999889988766554433322           1  111    22346799999999999999


Q ss_pred             CCCCCCCCChH-HH-HHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCC
Q 023568          144 REPLFPGKDYV-HQ-LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKR  221 (280)
Q Consensus       144 g~~pf~~~~~~-~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~R  221 (280)
                      |..--...+.. .. +..|                                      .+..+.++++++.-+....+.+ 
T Consensus       472 ~~~ns~~~d~~~~s~~~~I--------------------------------------~~~yS~D~rn~v~yl~s~~~~~-  512 (655)
T KOG3741|consen  472 GTENSNRTDSTQSSHLTRI--------------------------------------TTTYSTDLRNVVEYLESLNFRE-  512 (655)
T ss_pred             cccccccccchHHHHHHHh--------------------------------------hhhhhHHHHHHHHHHHhcCccc-
Confidence            96432122211 11 1111                                      2245778888888877777765 


Q ss_pred             CCHHHHhcC
Q 023568          222 ITVEEALRH  230 (280)
Q Consensus       222 pt~~ell~h  230 (280)
                      -++.+++.+
T Consensus       513 ksI~~llp~  521 (655)
T KOG3741|consen  513 KSIQDLLPM  521 (655)
T ss_pred             ccHHHHHHH
Confidence            677777764

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.15  E-value=1.1e-10  Score=91.44  Aligned_cols=76  Identities=18%  Similarity=0.279  Sum_probs=60.5

Q ss_pred             EEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH-HhCCccccCCCCCceEEcCCCCeEEeecccccccCC
Q 023568           24 VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV-HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  100 (280)
Q Consensus        24 ~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~L-H~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~  100 (280)
                      -+|||||+++ ++..-..+...+++++...++.|++.++..| |+.|++|+||++.||+++ ++.+.++|||.+.....
T Consensus        99 ~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~~-~~~v~iIDF~qav~~~h  176 (197)
T cd05146          99 HVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLWH-DGKVWFIDVSQSVEPTH  176 (197)
T ss_pred             CEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEE-CCcEEEEECCCceeCCC
Confidence            5799999986 3322222234567777888899999999998 899999999999999997 46799999998766543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.11  E-value=2e-10  Score=86.50  Aligned_cols=82  Identities=22%  Similarity=0.259  Sum_probs=68.9

Q ss_pred             cccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCCCce
Q 023568            4 ENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA---SVLHRDLKPSNL   79 (280)
Q Consensus         4 pniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~---~i~H~dik~~Ni   79 (280)
                      +++++++.++...     +..+++|||+.| .+..+       +......++.+++.+++.+|..   +++|+|++|.||
T Consensus        53 ~~~p~~~~~~~~~-----~~~~~v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Ni  120 (155)
T cd05120          53 LPVPKVLASGESD-----GWSYLLMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNI  120 (155)
T ss_pred             CCCCeEEEEcCCC-----CccEEEEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceE
Confidence            5778888877765     569999999986 44433       5667778899999999999985   699999999999


Q ss_pred             EEcCCCCeEEeecccccc
Q 023568           80 LLNASCDLKIGDFGLART   97 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~   97 (280)
                      +++..+.++++|||.+..
T Consensus       121 l~~~~~~~~l~Df~~~~~  138 (155)
T cd05120         121 LVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             EEECCcEEEEEecccccC
Confidence            999989999999998754

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.10  E-value=3.8e-10  Score=85.90  Aligned_cols=68  Identities=26%  Similarity=0.380  Sum_probs=56.6

Q ss_pred             EEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEeecccccccC
Q 023568           24 VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS   99 (280)
Q Consensus        24 ~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~   99 (280)
                      -.|+|||.+| .|.+.+...       ...++..+-.-+.-||.+||+|+||.++||+++.+. +.++|||++....
T Consensus        74 ~~I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s~  142 (204)
T COG3642          74 GLIVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFSD  142 (204)
T ss_pred             CEEEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccccc
Confidence            6799999998 666787553       255677777888899999999999999999998765 9999999987544

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.08  E-value=7.8e-10  Score=91.31  Aligned_cols=76  Identities=17%  Similarity=0.234  Sum_probs=65.4

Q ss_pred             CcEEEEEecCCc--cHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC-------CCCeEEe
Q 023568           22 NDVYIVYELMDT--DLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-------SCDLKIG   90 (280)
Q Consensus        22 ~~~~lv~e~~~g--~L~~~l~~--~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nili~~-------~~~~kl~   90 (280)
                      ..-+||||++++  +|.+++..  ....+......++.+++..+.-||.+||+|+|+++.|||++.       ++.+.|+
T Consensus       108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LI  187 (268)
T PRK15123        108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVI  187 (268)
T ss_pred             ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEE
Confidence            457899999987  79998864  345677888899999999999999999999999999999975       4679999


Q ss_pred             ecccccc
Q 023568           91 DFGLART   97 (280)
Q Consensus        91 dfg~~~~   97 (280)
                      ||+.+..
T Consensus       188 Dl~r~~~  194 (268)
T PRK15123        188 DLHRAQI  194 (268)
T ss_pred             ECCcccc
Confidence            9998753

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.05  E-value=9e-10  Score=87.87  Aligned_cols=91  Identities=23%  Similarity=0.276  Sum_probs=73.6

Q ss_pred             ccccccccCCCCCCCCcEEEEEecCCc--cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCC
Q 023568            7 IAIKDIIRPPKKDTFNDVYIVYELMDT--DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS   84 (280)
Q Consensus         7 v~l~~~~~~~~~~~~~~~~lv~e~~~g--~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nili~~~   84 (280)
                      .+.+++.+.... +...-+||||+++|  +|.+++......+......++.+++..++-||++||+|+|+++.|||++.+
T Consensus        76 P~pva~~~~r~~-~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~  154 (206)
T PF06293_consen   76 PEPVAYGERRKG-GGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPD  154 (206)
T ss_pred             CcEEEEEEEcCC-CceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCC
Confidence            344444444321 22456899999986  799999875568888899999999999999999999999999999999888


Q ss_pred             C---CeEEeeccccccc
Q 023568           85 C---DLKIGDFGLARTT   98 (280)
Q Consensus        85 ~---~~kl~dfg~~~~~   98 (280)
                      +   .+.++||+.++..
T Consensus       155 ~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  155 DGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             CCceeEEEEcchhceeC
Confidence            7   8999999977653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.05  E-value=1.5e-10  Score=101.78  Aligned_cols=193  Identities=23%  Similarity=0.233  Sum_probs=136.2

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      -|.+++.+...+..-     ...|+=-|||++ ++...+.-...+.+...+++..|++.++.++|+..++|+|++|+||+
T Consensus       324 ~~~~~~g~~~~W~~~-----r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~  398 (524)
T KOG0601|consen  324 SHLPSVGKNSSWSQL-----RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNIL  398 (524)
T ss_pred             cccccCCCCCCcccc-----ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhccccccccee
Confidence            367778777777665     457899999974 55444433357899999999999999999999999999999999999


Q ss_pred             EcCC-CCeEEeecccccccCCCCccccceeccccc-cccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           81 LNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYR-APELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        81 i~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~-aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +..+ +..+++|||..+...-.  .......-++. ..|++.....+..+.|++|||.-+.+.++|.+.-.......   
T Consensus       399 i~~~~~~~~~~~~~~~t~~~~~--~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~---  473 (524)
T KOG0601|consen  399 ISNDGFFSKLGDFGCWTRLAFS--SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSL---  473 (524)
T ss_pred             eccchhhhhcccccccccccee--cccccccccccccchhhccccccccccccccccccccccccCcccCcccccce---
Confidence            9886 77889999987642211  11112222333 35555555788889999999999999999885432221000   


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  235 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~  235 (280)
                                                    ....... ...+.....+..+.+.++..|+..|+.+-++..|+=|..
T Consensus       474 ------------------------------~i~~~~~-p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  474 ------------------------------TIRSGDT-PNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             ------------------------------eeecccc-cCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence                                          0001111 112233477888999999999999999999988875543

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=98.91  E-value=2.5e-09  Score=94.66  Aligned_cols=75  Identities=27%  Similarity=0.342  Sum_probs=58.0

Q ss_pred             cEEEEEecCCc-cHHHHHHcC-CCCCHHHHHHHHHHHHH-HHHHHHhCCccccCCCCCceEEcCCCCeEEeecccccccC
Q 023568           23 DVYIVYELMDT-DLHQIIRSD-QQLTDDHCQYFLYQLLR-GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS   99 (280)
Q Consensus        23 ~~~lv~e~~~g-~L~~~l~~~-~~l~~~~~~~i~~qil~-~l~~LH~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~   99 (280)
                      ..+|||||++| +|.++.... ...+   ...++.+++. .+..+|..|++|+|++|.||+++.+++++++|||++...+
T Consensus       232 ~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       232 ERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             CceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            36899999986 887776431 1222   3345555655 4678999999999999999999999999999999987665


Q ss_pred             C
Q 023568          100 E  100 (280)
Q Consensus       100 ~  100 (280)
                      +
T Consensus       309 ~  309 (437)
T TIGR01982       309 E  309 (437)
T ss_pred             H
Confidence            3

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.88  E-value=1.1e-08  Score=77.93  Aligned_cols=77  Identities=23%  Similarity=0.333  Sum_probs=61.4

Q ss_pred             CcEEEEEecCCc--cHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC---CeEEeeccc
Q 023568           22 NDVYIVYELMDT--DLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC---DLKIGDFGL   94 (280)
Q Consensus        22 ~~~~lv~e~~~g--~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nili~~~~---~~kl~dfg~   94 (280)
                      +.-.|+|||.+|  ++.+++.+.  ..........+++++-+.+.-||.++++|+||..+||++..++   .+.++|||+
T Consensus        83 ~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgl  162 (229)
T KOG3087|consen   83 YGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGL  162 (229)
T ss_pred             CCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecc
Confidence            345799999998  889988753  2233333378899999999999999999999999999996644   358999999


Q ss_pred             cccc
Q 023568           95 ARTT   98 (280)
Q Consensus        95 ~~~~   98 (280)
                      +...
T Consensus       163 s~~s  166 (229)
T KOG3087|consen  163 SSVS  166 (229)
T ss_pred             hhcc
Confidence            8654

>cd05151 ChoK Choline Kinase (ChoK)

Probab=98.86  E-value=4.3e-09  Score=81.20  Aligned_cols=65  Identities=28%  Similarity=0.330  Sum_probs=51.9

Q ss_pred             EEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCc-----cccCCCCCceEEcCCCCeEEeecccccc
Q 023568           24 VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASV-----LHRDLKPSNLLLNASCDLKIGDFGLART   97 (280)
Q Consensus        24 ~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i-----~H~dik~~Nili~~~~~~kl~dfg~~~~   97 (280)
                      -++|||+++| ++.+.        ......++.+++.+|+.||+.++     +|+|++|.||+++ ++.++++||+.+..
T Consensus        66 ~~lv~e~i~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          66 GVLITEFIEGSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             CeEEEEecCCCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            4799999997 55432        11123457899999999999885     9999999999999 67899999998653

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=98.80  E-value=4e-09  Score=94.81  Aligned_cols=71  Identities=20%  Similarity=0.397  Sum_probs=55.6

Q ss_pred             cEEEEEecCCc-cHHHH--HHcCC----CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC----CeEEee
Q 023568           23 DVYIVYELMDT-DLHQI--IRSDQ----QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC----DLKIGD   91 (280)
Q Consensus        23 ~~~lv~e~~~g-~L~~~--l~~~~----~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nili~~~~----~~kl~d   91 (280)
                      ..+|||||++| .+.++  +.+.+    .+.+..+..++.|++       ..|++|+|++|.||+++.++    +++++|
T Consensus       235 ~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-------~~GffHaDpHPGNIlv~~~g~~~~~i~llD  307 (537)
T PRK04750        235 ETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-------RDGFFHADMHPGNIFVSYDPPENPRYIALD  307 (537)
T ss_pred             CceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEe
Confidence            35799999987 88764  33333    356666667777766       48999999999999999888    999999


Q ss_pred             cccccccCC
Q 023568           92 FGLARTTSE  100 (280)
Q Consensus        92 fg~~~~~~~  100 (280)
                      ||++...+.
T Consensus       308 FGivg~l~~  316 (537)
T PRK04750        308 FGIVGSLNK  316 (537)
T ss_pred             cceEEECCH
Confidence            999976654

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.76  E-value=6.1e-09  Score=81.29  Aligned_cols=75  Identities=25%  Similarity=0.361  Sum_probs=51.6

Q ss_pred             EEEEEecCC--ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHH-HHhCCccccCCCCCceEEcCCCCeEEeecccccccCC
Q 023568           24 VYIVYELMD--TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY-VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  100 (280)
Q Consensus        24 ~~lv~e~~~--g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~-LH~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~  100 (280)
                      -+|||||++  |.....+.. ..++.+....++.+++..+.. +|+.|++|+||++.||+++.+ .+.++|||.+.....
T Consensus        81 ~~ivME~I~~~G~~~~~l~~-~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qav~~~~  158 (188)
T PF01163_consen   81 NVIVMEYIGEDGVPLPRLKD-VDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQAVDSSH  158 (188)
T ss_dssp             TEEEEE--EETTEEGGCHHH-CGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTEEETTS
T ss_pred             CEEEEEecCCCccchhhHHh-ccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCcceecCC
Confidence            469999998  733333332 222355667788888885555 689999999999999999888 899999998766543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.76  E-value=2.3e-08  Score=94.55  Aligned_cols=198  Identities=21%  Similarity=0.245  Sum_probs=139.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC--
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS--   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~--   77 (280)
                      ..|+|++.++.|--....++ --..+.-++|.+ ++.+.+..-..++.+.++.+..++++|++++|+....|.-+..+  
T Consensus       239 ~~~~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~  317 (1351)
T KOG1035|consen  239 IAHDNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSS  317 (1351)
T ss_pred             hccccccceeEEeehhhcch-HHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccceeEEecccc
Confidence            36999999999877664322 123455677775 88888888889999999999999999999999997666655555  


Q ss_pred             -ceEEcCCCCeEEe--ecccccccCCCCccccceeccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 023568           78 -NLLLNASCDLKIG--DFGLARTTSETDFMTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLFPGKDY  153 (280)
Q Consensus        78 -Nili~~~~~~kl~--dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~  153 (280)
                       +..++..+.+..+  ||+..+................+.++|..... ...+...|+|++|.....+..|..+-.....
T Consensus       318 ~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~  397 (1351)
T KOG1035|consen  318 KESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAV  397 (1351)
T ss_pred             cccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccccc
Confidence             3344555556655  88888877666554455556667888876541 2234457999999999999988754221110


Q ss_pred             HHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCC-HHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 023568          154 VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKS-SGAVDLLEKMLVFDPNKRITVEEALRHPY  232 (280)
Q Consensus       154 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ll~~~L~~dp~~Rpt~~ell~hp~  232 (280)
                      .      .                                   ...+..+ ....+.+.+|+..|+++|+++.+++.|+|
T Consensus       398 ~------~-----------------------------------~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f  436 (1351)
T KOG1035|consen  398 P------V-----------------------------------SLLDVLSTSELLDALPKCLDEDSEERLSALELLTHPF  436 (1351)
T ss_pred             h------h-----------------------------------hhhccccchhhhhhhhhhcchhhhhccchhhhhhchh
Confidence            0      0                                   0001111 15678889999999999999999999999


Q ss_pred             cccCcCCC
Q 023568          233 LQSLHDLN  240 (280)
Q Consensus       233 ~~~~~~~~  240 (280)
                      .+.-....
T Consensus       437 ~~~~~~~~  444 (1351)
T KOG1035|consen  437 LRFPTDNE  444 (1351)
T ss_pred             cccccccc
Confidence            87655443

>PRK09902 hypothetical protein; Provisional

Probab=98.73  E-value=8.4e-08  Score=75.53  Aligned_cols=77  Identities=16%  Similarity=0.104  Sum_probs=66.9

Q ss_pred             CCcEEEEEecCCc--cHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCC--eEEeeccc
Q 023568           21 FNDVYIVYELMDT--DLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD--LKIGDFGL   94 (280)
Q Consensus        21 ~~~~~lv~e~~~g--~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nili~~~~~--~kl~dfg~   94 (280)
                      ...-+||+|-++|  +|.+++.+.  .+.+......++.+++.+++-||+.|+.|+|+.+.||+++.++.  +.++||..
T Consensus        97 ~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk  176 (216)
T PRK09902         97 EWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEK  176 (216)
T ss_pred             ceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhc
Confidence            3567999998885  999998663  35688888999999999999999999999999999999987677  99999997


Q ss_pred             ccc
Q 023568           95 ART   97 (280)
Q Consensus        95 ~~~   97 (280)
                      ++.
T Consensus       177 ~r~  179 (216)
T PRK09902        177 SRR  179 (216)
T ss_pred             cch
Confidence            654

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.43  E-value=6.2e-07  Score=71.00  Aligned_cols=66  Identities=20%  Similarity=0.375  Sum_probs=51.3

Q ss_pred             cEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEeecccccc
Q 023568           23 DVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART   97 (280)
Q Consensus        23 ~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~   97 (280)
                      ..++||||++| .|.+..    .+++    .+...+..++.-||+.|+.|+|.+|.|++++.++ ++++||+..+.
T Consensus       117 ~~~ll~EYIeG~~l~d~~----~i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~~~k~~  183 (229)
T PF06176_consen  117 SYVLLMEYIEGVELNDIE----DIDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDTQGKRM  183 (229)
T ss_pred             EEEEEEEEecCeecccch----hcCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEECccccc
Confidence            35689999998 676653    2333    2445677889999999999999999999998655 99999986543

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.36  E-value=1e-06  Score=70.77  Aligned_cols=91  Identities=20%  Similarity=0.285  Sum_probs=65.8

Q ss_pred             ccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-----------------
Q 023568            5 NVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS-----------------   66 (280)
Q Consensus         5 niv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~-----------------   66 (280)
                      ++.+++.+.....  ..+..++||||++| ++.+.+.. ..+++++...++.+++.+|..||+                 
T Consensus        58 ~vp~~~~~~~~~~--~~~~~~~v~e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~  134 (223)
T cd05154          58 PVPKVLALCEDPS--VLGTPFYVMERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGY  134 (223)
T ss_pred             CCCCEEEECCCCC--ccCCceEEEEEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCch
Confidence            4566666655431  11356899999987 66654432 457777777888888888888874                 


Q ss_pred             ---------------------------------------CCccccCCCCCceEEcC--CCCeEEeeccccccc
Q 023568           67 ---------------------------------------ASVLHRDLKPSNLLLNA--SCDLKIGDFGLARTT   98 (280)
Q Consensus        67 ---------------------------------------~~i~H~dik~~Nili~~--~~~~kl~dfg~~~~~   98 (280)
                                                             ..++|+|+++.||+++.  ++.+.++||+.+...
T Consensus       135 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g  207 (223)
T cd05154         135 LERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG  207 (223)
T ss_pred             HHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence                                                   23689999999999988  566899999987543

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.22  E-value=2.7e-06  Score=69.03  Aligned_cols=81  Identities=22%  Similarity=0.344  Sum_probs=62.5

Q ss_pred             CCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEeeccc
Q 023568           16 PKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL   94 (280)
Q Consensus        16 ~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nili~~~~~~kl~dfg~   94 (280)
                      +.+-..+...+|||+.+| .|...     +++.+....++..|++-+..+-..|++|+|+++-||+++.+|.+.++||--
T Consensus       174 P~P~~~nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vIDwPQ  248 (304)
T COG0478         174 PKPIAWNRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVIDWPQ  248 (304)
T ss_pred             CCccccccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEEEeCcc
Confidence            344455678899999998 44433     224556667777788777777799999999999999999999999999987


Q ss_pred             ccccCCC
Q 023568           95 ARTTSET  101 (280)
Q Consensus        95 ~~~~~~~  101 (280)
                      +...+.+
T Consensus       249 ~v~~~hp  255 (304)
T COG0478         249 AVPISHP  255 (304)
T ss_pred             cccCCCC
Confidence            6554443

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.97  E-value=1.6e-05  Score=63.94  Aligned_cols=79  Identities=19%  Similarity=0.268  Sum_probs=59.9

Q ss_pred             CCcEEEEEecCCcc--HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEcCCCCeEEeecccccc
Q 023568           21 FNDVYIVYELMDTD--LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKIGDFGLART   97 (280)
Q Consensus        21 ~~~~~lv~e~~~g~--L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~-~~i~H~dik~~Nili~~~~~~kl~dfg~~~~   97 (280)
                      +..-.|||||++..  -.-.|+. -.+...++..+..++++.+.-|-. .|++|+||+.-|||+. ++.+.++|+|.+..
T Consensus       138 ~~~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~  215 (268)
T COG1718         138 FRNNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYIIDVSQAVT  215 (268)
T ss_pred             ecCCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEEEECccccc
Confidence            34557999999843  1112221 234444788889999999998877 9999999999999999 88899999998876


Q ss_pred             cCCC
Q 023568           98 TSET  101 (280)
Q Consensus        98 ~~~~  101 (280)
                      ...+
T Consensus       216 ~~hp  219 (268)
T COG1718         216 IDHP  219 (268)
T ss_pred             cCCC
Confidence            5543

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.94  E-value=2.4e-06  Score=76.63  Aligned_cols=195  Identities=19%  Similarity=0.127  Sum_probs=130.0

Q ss_pred             CCCcc-cccccccccCCCCCCCCcEEEEEecCCcc--HHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 023568            1 MEHEN-VIAIKDIIRPPKKDTFNDVYIVYELMDTD--LHQIIR-SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP   76 (280)
Q Consensus         1 l~Hpn-iv~l~~~~~~~~~~~~~~~~lv~e~~~g~--L~~~l~-~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~   76 (280)
                      ++||| .+..++-++.+     ...+++|+++++.  ....+. ..-.+.+-+...+.+.-+++++++|+.--+|+|   
T Consensus       290 ~n~P~~~v~~~~d~~~E-----~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d---  361 (829)
T KOG0576|consen  290 VNNPNPVVRYLEDYDGE-----DYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD---  361 (829)
T ss_pred             ccCCCCcccccccCCcc-----cccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc---
Confidence            47999 66666666665     7799999999843  332221 112345555667777888999999998778888   


Q ss_pred             CceEEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023568           77 SNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  156 (280)
Q Consensus        77 ~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~  156 (280)
                       ||+-.+ +..++++|+............+..+++.++|||+..+ ..+....|+|++|.-..+|.-|.+|-...-.  .
T Consensus       362 -~~l~s~-~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~-~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~--~  436 (829)
T KOG0576|consen  362 -NILGSE-EEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQE-NTIDGCPDSGSLAVSAIQMAPGLPPRSSPPA--V  436 (829)
T ss_pred             -cccccc-cccccccccCCcccCcccccccCCCCCCCCCchhhcc-cccccCCCccCCCcchhhcCCCCCCCCCCcc--c
Confidence             665544 6689999998877666545567788999999998776 7788899999999877778778777554210  0


Q ss_pred             HHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHH-HHHHHhcccCCCCCCCHHHHhcCccccc
Q 023568          157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAV-DLLEKMLVFDPNKRITVEEALRHPYLQS  235 (280)
Q Consensus       157 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ll~~~L~~dp~~Rpt~~ell~hp~~~~  235 (280)
                      .    ...+..+.  ...+...                     ...++... ++...|+..-|..|+..-.++.|++|..
T Consensus       437 ~----~~~g~~p~--s~~L~~~---------------------~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfng  489 (829)
T KOG0576|consen  437 L----PMIGNGPN--SPMLTDK---------------------SAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNG  489 (829)
T ss_pred             c----CCCCCCCC--ccccchh---------------------hhcCcccccCCcccccCCCCCCCcchhhHHHHHHhcc
Confidence            0    00010000  0000000                     01111122 4677899999999999999999999865

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.91  E-value=2.7e-05  Score=68.62  Aligned_cols=162  Identities=20%  Similarity=0.292  Sum_probs=103.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      +.|+|+..++++.+...    ....+|||+++-+|.|.++.+. +-.....              ..|+.|-.     + 
T Consensus        39 l~~~~l~~yl~~~r~~~----~r~IVV~e~~~~Sled~~~~~~-l~~~s~~--------------~~~~~~~~-----~-   93 (725)
T KOG1093|consen   39 LQHDNLCQYLDFSRGKH----ERVIVVMEHYTMSLEDILKTGN-LKDESLL--------------AHGVLHLN-----I-   93 (725)
T ss_pred             hcCccceeeEeeecCcc----ceEEEEehhhccchHHHHHhcc-cchhhhc--------------ccccceeh-----h-
Confidence            46888888888876542    3488999999999999986543 2222111              22222221     1 


Q ss_pred             EcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 023568           81 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  160 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~i  160 (280)
                            ++.+| -+...               |  |      ...+.++||||+|.++.++..|...+...........+
T Consensus        94 ------~~~td-~~~t~---------------~--~------~~~~pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i  143 (725)
T KOG1093|consen   94 ------IYITD-HFLTK---------------Y--P------SPIGPKSDVWSLGFIILELYLGISLEAELTESEYLEIL  143 (725)
T ss_pred             ------hhccc-ccccc---------------C--C------CCCCcchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHH
Confidence                  22222 00000               0  1      11114999999999999999999888888877777777


Q ss_pred             HHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 023568          161 TELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  236 (280)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~  236 (280)
                      .+....+.....-..     +. ..             .-..+.-...+..+|+-..|..||...++.+++-|...
T Consensus       144 ~k~~~~d~~~~~~a~-----e~-~~-------------~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev  200 (725)
T KOG1093|consen  144 LKYYTDDQELLSTAM-----EH-LI-------------QLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV  200 (725)
T ss_pred             HHhccCchhHHHHHH-----HH-HH-------------HHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence            775543333221110     00 00             01346667899999999999999999999999988754

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.89  E-value=1.4e-05  Score=78.30  Aligned_cols=143  Identities=16%  Similarity=0.133  Sum_probs=108.8

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCC-----ccc
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD----QQLTDDHCQYFLYQLLRGLKYVHSAS-----VLH   71 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~----~~l~~~~~~~i~~qil~~l~~LH~~~-----i~H   71 (280)
                      .|+++.....-..+.+.   ...|.+++|+. |.+.+.|.++    ..+...-+.....+.+.+..-+|+..     .+|
T Consensus      1287 ~h~~~~~~p~rI~ps~s---~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~ 1363 (2724)
T KOG1826|consen 1287 KHYLTEVDPLRIPPSES---TEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVS 1363 (2724)
T ss_pred             hceeeecccccCCCCCC---hHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchh
Confidence            57777776666665543   56899999997 7999988654    33555555555555577777777532     689


Q ss_pred             cCCCCCceEEcCCCCeEEeeccccccc-CCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 023568           72 RDLKPSNLLLNASCDLKIGDFGLARTT-SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF  148 (280)
Q Consensus        72 ~dik~~Nili~~~~~~kl~dfg~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf  148 (280)
                      +++++-|.+|..+..++++++|+.+.. ..........+++.|+.|++... -.++.++|+|+.|+.+|..-.|..+|
T Consensus      1364 ~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~-ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1364 KSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNE-IKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred             hhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHH-HhhhhHHHHHHHHHHHHHHhcccHHH
Confidence            999999999999999999999999833 33344556677889999997765 77777799999999999988777665

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=97.70  E-value=6.8e-05  Score=67.46  Aligned_cols=76  Identities=18%  Similarity=0.347  Sum_probs=54.0

Q ss_pred             cEEEEEecCCc-cHHHHH--HcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEeecccccccC
Q 023568           23 DVYIVYELMDT-DLHQII--RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS   99 (280)
Q Consensus        23 ~~~lv~e~~~g-~L~~~l--~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~   99 (280)
                      .-.|+|||++| .+.+..  ++ ..++.+.+...+.++.  +..+=..|++|.|.+|.||+++.+|++.+.|||......
T Consensus       240 ~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         240 RRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             CcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHhcCccccCCCccceEEecCCcEEEEcCcceecCC
Confidence            36899999998 777763  33 4455443333222222  222334899999999999999999999999999987665


Q ss_pred             CC
Q 023568          100 ET  101 (280)
Q Consensus       100 ~~  101 (280)
                      +.
T Consensus       317 ~~  318 (517)
T COG0661         317 PK  318 (517)
T ss_pred             HH
Confidence            43

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.61  E-value=0.00017  Score=56.48  Aligned_cols=85  Identities=20%  Similarity=0.132  Sum_probs=67.4

Q ss_pred             cccccccccccCCCCCCCCcEEEEEecCC-ccHHHH---HHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCC
Q 023568            4 ENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQI---IRSDQQLTDDHCQYFLYQLLRGLKYVHS---ASVLHRDLKP   76 (280)
Q Consensus         4 pniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~---l~~~~~l~~~~~~~i~~qil~~l~~LH~---~~i~H~dik~   76 (280)
                      +++.+++|++         .-++|.||.+ +++...   +.+-...++..+..|+.++++.+.+++.   ..+.-.|+++
T Consensus        20 ~~~pk~lG~C---------G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~   90 (188)
T PF12260_consen   20 EPFPKLLGSC---------GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSP   90 (188)
T ss_pred             CCCCCeeeEC---------CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecch
Confidence            4788888886         2467999998 455421   1222457899999999999999999997   3467799999


Q ss_pred             CceEEcCCCCeEEeecccccc
Q 023568           77 SNLLLNASCDLKIGDFGLART   97 (280)
Q Consensus        77 ~Nili~~~~~~kl~dfg~~~~   97 (280)
                      +|+-++.++++|++|...+..
T Consensus        91 ~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   91 DNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             HHeEEeCCCcEEEEechhcch
Confidence            999999999999999987654

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.27  E-value=0.00091  Score=60.30  Aligned_cols=75  Identities=17%  Similarity=0.289  Sum_probs=51.5

Q ss_pred             EEEEEecCCc-cHH--HHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC----CCCeEEeeccccc
Q 023568           24 VYIVYELMDT-DLH--QIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA----SCDLKIGDFGLAR   96 (280)
Q Consensus        24 ~~lv~e~~~g-~L~--~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nili~~----~~~~kl~dfg~~~   96 (280)
                      -.|+||||+| .+.  +.|.+ ..++...+..-+.+...  .-|=..|++|.|-+|.||++..    ++.+.+.|||+..
T Consensus       277 RVLtME~~~G~~i~Dl~~i~~-~gi~~~~i~~~l~~~~~--~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~  353 (538)
T KOG1235|consen  277 RVLTMEYVDGIKINDLDAIDK-RGISPHDILNKLVEAYL--EQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYA  353 (538)
T ss_pred             eEEEEEecCCccCCCHHHHHH-cCCCHHHHHHHHHHHHH--HHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccc
Confidence            7899999987 443  34444 44555544433333222  2234578999999999999983    6789999999987


Q ss_pred             ccCCC
Q 023568           97 TTSET  101 (280)
Q Consensus        97 ~~~~~  101 (280)
                      .....
T Consensus       354 ~is~~  358 (538)
T KOG1235|consen  354 VISHK  358 (538)
T ss_pred             cccHH
Confidence            76543

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.21  E-value=0.0012  Score=54.07  Aligned_cols=30  Identities=20%  Similarity=0.156  Sum_probs=26.0

Q ss_pred             CccccCCCCCceEEcCCCCeEEeecccccc
Q 023568           68 SVLHRDLKPSNLLLNASCDLKIGDFGLART   97 (280)
Q Consensus        68 ~i~H~dik~~Nili~~~~~~kl~dfg~~~~   97 (280)
                      .++|+|+.|.||+++.++...|+||+.+..
T Consensus       164 ~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         164 VVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             EEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            489999999999999977778999997643

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=97.17  E-value=0.0017  Score=52.47  Aligned_cols=29  Identities=24%  Similarity=0.228  Sum_probs=25.6

Q ss_pred             CccccCCCCCceEEcCCCCeEEeecccccc
Q 023568           68 SVLHRDLKPSNLLLNASCDLKIGDFGLART   97 (280)
Q Consensus        68 ~i~H~dik~~Nili~~~~~~kl~dfg~~~~   97 (280)
                      .++|+|+.|.||+++.++ +.++||+.+..
T Consensus       154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       154 TCLHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             ceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            478999999999999888 99999997653

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.12  E-value=0.0035  Score=49.51  Aligned_cols=80  Identities=20%  Similarity=0.318  Sum_probs=59.8

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecC---Cc----cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELM---DT----DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDL   74 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~---~g----~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~di   74 (280)
                      .+.+|.+++|+.+++     ..+-+|+|..   +|    +|.+++.+ +.++. ....   .+-+-..+|-+.+|+.+|+
T Consensus        75 ~~~~i~r~~G~veT~-----~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~~~---~L~~f~~~l~~~~Iv~~dl  144 (199)
T PF10707_consen   75 DWSHIPRFYGFVETN-----LGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-ELRQ---ALDEFKRYLLDHHIVIRDL  144 (199)
T ss_pred             cccccccEeEEEecC-----CceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HHHH---HHHHHHHHHHHcCCeecCC
Confidence            367899999999988     5688999987   22    78888855 55666 3333   3445566889999999999


Q ss_pred             CCCceEEcCC--C--CeEEee
Q 023568           75 KPSNLLLNAS--C--DLKIGD   91 (280)
Q Consensus        75 k~~Nili~~~--~--~~kl~d   91 (280)
                      +|.||++...  +  .+.|+|
T Consensus       145 ~~~NIv~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  145 NPHNIVVQRRDSGEFRLVLID  165 (199)
T ss_pred             CcccEEEEecCCCceEEEEEe
Confidence            9999999543  2  477777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.85  E-value=0.0036  Score=53.48  Aligned_cols=75  Identities=19%  Similarity=0.313  Sum_probs=60.4

Q ss_pred             CcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEEcCCCCeEEeecccccccCC
Q 023568           22 NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE  100 (280)
Q Consensus        22 ~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~-~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~  100 (280)
                      ...|++|++.++++.-.    +.-..+++..++.+.+..+.-+.++ ..-||++...||+|+ +|++-|+||.+++....
T Consensus       299 ~y~yl~~kdhgt~is~i----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~~~  373 (488)
T COG5072         299 LYLYLHFKDHGTPISII----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLSYS  373 (488)
T ss_pred             eEEEEEEecCCceeeee----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecccC
Confidence            56888999988766432    3456788889999988877777764 589999999999999 99999999999985443


Q ss_pred             C
Q 023568          101 T  101 (280)
Q Consensus       101 ~  101 (280)
                      .
T Consensus       374 q  374 (488)
T COG5072         374 Q  374 (488)
T ss_pred             C
Confidence            3

>PLN02876 acyl-CoA dehydrogenase

Probab=96.35  E-value=0.013  Score=56.56  Aligned_cols=33  Identities=21%  Similarity=0.418  Sum_probs=26.1

Q ss_pred             CccccCCCCCceEEcC-CCC-eEEeecccccccCC
Q 023568           68 SVLHRDLKPSNLLLNA-SCD-LKIGDFGLARTTSE  100 (280)
Q Consensus        68 ~i~H~dik~~Nili~~-~~~-~kl~dfg~~~~~~~  100 (280)
                      .++|+|+++.||+++. ++. .-+.||+++....+
T Consensus       226 ~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~GdP  260 (822)
T PLN02876        226 GIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGNQ  260 (822)
T ss_pred             ceEecCcccccEEEcCCCCeEEEEEeeeccccCCh
Confidence            4999999999999985 334 56899998875443

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=95.91  E-value=0.0088  Score=50.47  Aligned_cols=74  Identities=20%  Similarity=0.253  Sum_probs=54.3

Q ss_pred             CCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEeeccccccc
Q 023568           20 TFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT   98 (280)
Q Consensus        20 ~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~   98 (280)
                      ..+..++|||+..| .|.++-+   --+   +..+...+..-+.-|-..|++|+|.+-=||+++.++.+.++||--....
T Consensus       179 D~~RH~Vvmelv~g~Pl~~v~~---v~d---~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~vIDFPQmvS~  252 (465)
T KOG2268|consen  179 DHNRHCVVMELVDGYPLRQVRH---VED---PPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIVVIDFPQMVST  252 (465)
T ss_pred             cccceeeHHHhhcccceeeeee---cCC---hHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEEEeechHhhcc
Confidence            33567899999987 6665531   122   2334445555566788999999999999999999999999999865443


Q ss_pred             C
Q 023568           99 S   99 (280)
Q Consensus        99 ~   99 (280)
                      +
T Consensus       253 s  253 (465)
T KOG2268|consen  253 S  253 (465)
T ss_pred             C
Confidence            3

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=95.52  E-value=0.022  Score=46.20  Aligned_cols=30  Identities=27%  Similarity=0.371  Sum_probs=26.4

Q ss_pred             CccccCCCCCceEEcC-CCCeEEeecccccc
Q 023568           68 SVLHRDLKPSNLLLNA-SCDLKIGDFGLART   97 (280)
Q Consensus        68 ~i~H~dik~~Nili~~-~~~~kl~dfg~~~~   97 (280)
                      +++|+|+.+.||+++. ++.+.++||..+..
T Consensus       171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~  201 (235)
T cd05157         171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY  201 (235)
T ss_pred             EEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence            5899999999999998 57899999987653

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=95.36  E-value=0.041  Score=46.68  Aligned_cols=29  Identities=24%  Similarity=0.384  Sum_probs=25.2

Q ss_pred             CCccccCCCCCceEEcCCCCeEEeeccccc
Q 023568           67 ASVLHRDLKPSNLLLNASCDLKIGDFGLAR   96 (280)
Q Consensus        67 ~~i~H~dik~~Nili~~~~~~kl~dfg~~~   96 (280)
                      .+++|+|+.+.||+++. +.+.++||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            47899999999999987 678999998653

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=95.35  E-value=0.036  Score=46.85  Aligned_cols=30  Identities=33%  Similarity=0.392  Sum_probs=26.2

Q ss_pred             CccccCCCCCceEEcCC----CCeEEeecccccc
Q 023568           68 SVLHRDLKPSNLLLNAS----CDLKIGDFGLART   97 (280)
Q Consensus        68 ~i~H~dik~~Nili~~~----~~~kl~dfg~~~~   97 (280)
                      ++||+|+.+.||+++.+    +.+.++||+.+..
T Consensus       180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            58999999999999874    8899999997643

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=95.31  E-value=0.034  Score=46.21  Aligned_cols=53  Identities=30%  Similarity=0.327  Sum_probs=40.3

Q ss_pred             HHHHHHHHHHHHHHHHHHHhC--CccccCCCCCceEEcCCCCeEEeecccccccC
Q 023568           47 DDHCQYFLYQLLRGLKYVHSA--SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS   99 (280)
Q Consensus        47 ~~~~~~i~~qil~~l~~LH~~--~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~   99 (280)
                      -...+..+..+-.++.-++..  -+||+|+.++|++.+..+.++|+||..|....
T Consensus       131 ~~~~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~~D  185 (269)
T COG0510         131 NHLLRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGLND  185 (269)
T ss_pred             hHHHHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCCcc
Confidence            334444555666666666655  58999999999999999999999999886543

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=95.31  E-value=0.035  Score=47.10  Aligned_cols=30  Identities=33%  Similarity=0.470  Sum_probs=26.6

Q ss_pred             CCccccCCCCCceEEcCCCCeEEeeccccc
Q 023568           67 ASVLHRDLKPSNLLLNASCDLKIGDFGLAR   96 (280)
Q Consensus        67 ~~i~H~dik~~Nili~~~~~~kl~dfg~~~   96 (280)
                      .+++|+|+++.||+++.++...++||+.+.
T Consensus       187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            579999999999999988767899999764

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=95.31  E-value=0.02  Score=46.58  Aligned_cols=31  Identities=32%  Similarity=0.419  Sum_probs=25.5

Q ss_pred             CCccccCCCCCceEEcCCCCeEEeecccccc
Q 023568           67 ASVLHRDLKPSNLLLNASCDLKIGDFGLART   97 (280)
Q Consensus        67 ~~i~H~dik~~Nili~~~~~~kl~dfg~~~~   97 (280)
                      .+++|+|+.+.||+++.++..-++||+.+..
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            3589999999999998765557999997644

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK05231 homoserine kinase; Provisional

Probab=95.08  E-value=0.053  Score=46.22  Aligned_cols=31  Identities=29%  Similarity=0.296  Sum_probs=26.0

Q ss_pred             CCccccCCCCCceEEcCCCCeEEeecccccc
Q 023568           67 ASVLHRDLKPSNLLLNASCDLKIGDFGLART   97 (280)
Q Consensus        67 ~~i~H~dik~~Nili~~~~~~kl~dfg~~~~   97 (280)
                      .++||+|+.+.||+++.+...-++||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            4799999999999998665568999997643

>PRK10271 thiK thiamine kinase; Provisional

Probab=94.87  E-value=0.025  Score=44.12  Aligned_cols=30  Identities=33%  Similarity=0.432  Sum_probs=26.2

Q ss_pred             ccccCCCCCceEEcCCCCeEEeecccccccC
Q 023568           69 VLHRDLKPSNLLLNASCDLKIGDFGLARTTS   99 (280)
Q Consensus        69 i~H~dik~~Nili~~~~~~kl~dfg~~~~~~   99 (280)
                      .+|+|+.|.|++++.++ ++++||+.+....
T Consensus        79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~~gD  108 (188)
T PRK10271         79 PLHMDVHAGNLVHSASG-LRLIDWEYAGDGD  108 (188)
T ss_pred             eecCCCCCccEEEECCC-EEEEeCCcccCCC
Confidence            69999999999998777 9999999886544

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=94.84  E-value=0.019  Score=46.16  Aligned_cols=30  Identities=33%  Similarity=0.552  Sum_probs=20.9

Q ss_pred             CCccccCCCCCceEEc-CCCCeEEeeccccc
Q 023568           67 ASVLHRDLKPSNLLLN-ASCDLKIGDFGLAR   96 (280)
Q Consensus        67 ~~i~H~dik~~Nili~-~~~~~kl~dfg~~~   96 (280)
                      ..++|+|+.+.||+++ .++.+.++||+.+.
T Consensus       166 ~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  166 PVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             EEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             cEEEEeccccccceeeeccceeEEEecccce
Confidence            4599999999999999 66777899998653

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=94.79  E-value=0.053  Score=45.63  Aligned_cols=30  Identities=30%  Similarity=0.329  Sum_probs=26.3

Q ss_pred             CCccccCCCCCceEEcCCCCeEEeeccccc
Q 023568           67 ASVLHRDLKPSNLLLNASCDLKIGDFGLAR   96 (280)
Q Consensus        67 ~~i~H~dik~~Nili~~~~~~kl~dfg~~~   96 (280)
                      .+++|+|+.|.||+++.++.+.|+||+.+.
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            469999999999999987777899998764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=94.36  E-value=0.025  Score=45.10  Aligned_cols=30  Identities=37%  Similarity=0.591  Sum_probs=21.3

Q ss_pred             CccccCCCCCceEE-cCCCCeEEeecccccc
Q 023568           68 SVLHRDLKPSNLLL-NASCDLKIGDFGLART   97 (280)
Q Consensus        68 ~i~H~dik~~Nili-~~~~~~kl~dfg~~~~   97 (280)
                      .++|+|+.+.||++ +.++.++|+||..+..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            48999999999999 8889999999998753

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>TIGR02721 ycfN_thiK thiamine kinase

Probab=94.28  E-value=0.034  Score=45.77  Aligned_cols=31  Identities=29%  Similarity=0.411  Sum_probs=26.7

Q ss_pred             CccccCCCCCceEEcCCCCeEEeecccccccC
Q 023568           68 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS   99 (280)
Q Consensus        68 ~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~   99 (280)
                      .++|+|+.+.||+++.++ +.++||+.+....
T Consensus       147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~gd  177 (256)
T TIGR02721       147 APLHMDVHAYNLVVTPQG-LKLIDWEYASDGD  177 (256)
T ss_pred             eeecCCCCcCcEEEeCCC-CEEEeccccCcCC
Confidence            589999999999999877 7899999876543

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=94.05  E-value=0.085  Score=44.82  Aligned_cols=30  Identities=20%  Similarity=0.193  Sum_probs=27.2

Q ss_pred             CccccCCCCCceEEcCCCCeEEeecccccc
Q 023568           68 SVLHRDLKPSNLLLNASCDLKIGDFGLART   97 (280)
Q Consensus        68 ~i~H~dik~~Nili~~~~~~kl~dfg~~~~   97 (280)
                      ++||+|+.+.|++++.++.+.++||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            699999999999999999999999987644

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PLN02236 choline kinase

Probab=93.83  E-value=0.089  Score=45.47  Aligned_cols=30  Identities=23%  Similarity=0.422  Sum_probs=26.0

Q ss_pred             CccccCCCCCceEEcC-CCCeEEeecccccc
Q 023568           68 SVLHRDLKPSNLLLNA-SCDLKIGDFGLART   97 (280)
Q Consensus        68 ~i~H~dik~~Nili~~-~~~~kl~dfg~~~~   97 (280)
                      .++|+|+++.||+++. ++.+.++||..+..
T Consensus       201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        201 GFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             eEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            5899999999999986 47899999997753

>smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain

Probab=93.79  E-value=0.16  Score=40.04  Aligned_cols=31  Identities=26%  Similarity=0.379  Sum_probs=25.3

Q ss_pred             CCccccCCCCCceEEcCCC-----CeEEeecccccc
Q 023568           67 ASVLHRDLKPSNLLLNASC-----DLKIGDFGLART   97 (280)
Q Consensus        67 ~~i~H~dik~~Nili~~~~-----~~kl~dfg~~~~   97 (280)
                      ..++|||+.+.|+++..++     .+.++||..++.
T Consensus       120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~  155 (196)
T smart00587      120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHY  155 (196)
T ss_pred             eEEeeCCCCccceeeccCCCCCccceEEEecccCCc
Confidence            4589999999999997543     589999987643

subfamily of choline kinases

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=93.34  E-value=0.07  Score=45.45  Aligned_cols=58  Identities=19%  Similarity=0.319  Sum_probs=36.4

Q ss_pred             EEEEEecCCccHHHH-----HHcCCCCCHHHHHHHHHHHHHHHHHHH----hCCccccCCCCCceEE
Q 023568           24 VYIVYELMDTDLHQI-----IRSDQQLTDDHCQYFLYQLLRGLKYVH----SASVLHRDLKPSNLLL   81 (280)
Q Consensus        24 ~~lv~e~~~g~L~~~-----l~~~~~l~~~~~~~i~~qil~~l~~LH----~~~i~H~dik~~Nili   81 (280)
                      -.+|++++-++-..+     ..-+=.--.+-++.++.|++.-.-.+-    ..+.+|.||||+|||+
T Consensus       246 nIIIfPLA~~Sadkv~~~~~~e~GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILi  312 (434)
T PF05445_consen  246 NIIIFPLARCSADKVTESNAAELGFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILI  312 (434)
T ss_pred             cEEEEehhhcchhhcCHHHHHhcCchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEE
Confidence            358999875432222     111112234557788888876553332    3569999999999998

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=92.56  E-value=0.21  Score=42.82  Aligned_cols=28  Identities=36%  Similarity=0.584  Sum_probs=25.0

Q ss_pred             ccccCCCCCceEEcCCCC-eEEeeccccc
Q 023568           69 VLHRDLKPSNLLLNASCD-LKIGDFGLAR   96 (280)
Q Consensus        69 i~H~dik~~Nili~~~~~-~kl~dfg~~~   96 (280)
                      +||+|+.+.||+++.+.. ..++||+-+.
T Consensus       199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             eeecCCCccceeEcCCCCeeeEEEccccc
Confidence            999999999999999885 8899999653

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=92.45  E-value=0.093  Score=43.84  Aligned_cols=31  Identities=23%  Similarity=0.462  Sum_probs=25.6

Q ss_pred             CccccCCCCCceEEcCCCC-eEEeeccccccc
Q 023568           68 SVLHRDLKPSNLLLNASCD-LKIGDFGLARTT   98 (280)
Q Consensus        68 ~i~H~dik~~Nili~~~~~-~kl~dfg~~~~~   98 (280)
                      .++|+|+++.||+++.++. .-|+||+.+...
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            4899999999999997565 469999987554

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=92.37  E-value=0.28  Score=42.51  Aligned_cols=75  Identities=20%  Similarity=0.271  Sum_probs=56.1

Q ss_pred             cEEEEEecCCc-c-HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCceEEcCCCCeEEeecccccccC
Q 023568           23 DVYIVYELMDT-D-LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH-SASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS   99 (280)
Q Consensus        23 ~~~lv~e~~~g-~-L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH-~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~   99 (280)
                      .-.|||+++++ + ..-.| +.-.++...+..+-.|++.-+.-|- ..+++|.||+--|+|+- +|.+.++|.+-+.-..
T Consensus       238 ~hVLVM~FlGrdgw~aPkL-Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-dG~lyiIDVSQSVE~D  315 (520)
T KOG2270|consen  238 NHVLVMEFLGRDGWAAPKL-KDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-DGKLYIIDVSQSVEHD  315 (520)
T ss_pred             cceEeeeeccCCCCcCccc-ccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-CCEEEEEEccccccCC
Confidence            35799999984 2 22222 2356788888888888888888775 56899999999999874 5679999998765433

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=91.67  E-value=0.33  Score=41.71  Aligned_cols=29  Identities=34%  Similarity=0.431  Sum_probs=25.5

Q ss_pred             ccccCCCCCceEEcC-CCCeEEeecccccc
Q 023568           69 VLHRDLKPSNLLLNA-SCDLKIGDFGLART   97 (280)
Q Consensus        69 i~H~dik~~Nili~~-~~~~kl~dfg~~~~   97 (280)
                      ++|+|+.+.||+++. ++.++++||+.|..
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            799999999999975 57899999998754

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=91.03  E-value=0.37  Score=37.27  Aligned_cols=67  Identities=24%  Similarity=0.277  Sum_probs=46.9

Q ss_pred             EEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC-C-ceEEcCCCCeEEeeccccccc
Q 023568           24 VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP-S-NLLLNASCDLKIGDFGLARTT   98 (280)
Q Consensus        24 ~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~-~-Nili~~~~~~kl~dfg~~~~~   98 (280)
                      .++.|||..| .|.++-...   +    +.-+..++++---|-..||-|+.|+- . ||+++. +.+.|+||..|+..
T Consensus        87 ~~i~me~i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~-~~~~iIDFd~At~k  156 (201)
T COG2112          87 DFIRMEYIDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVND-RDVYIIDFDSATFK  156 (201)
T ss_pred             hhhhhhhhcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecC-CcEEEEEccchhhc
Confidence            4566999988 887765321   2    23344566666668889999999984 4 555554 48999999988743

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=90.68  E-value=0.22  Score=42.30  Aligned_cols=34  Identities=24%  Similarity=0.420  Sum_probs=30.0

Q ss_pred             CccccCCCCCceEEcCCCCeEEeecccccccCCC
Q 023568           68 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  101 (280)
Q Consensus        68 ~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~  101 (280)
                      .++|+|+.+.|++++.++.+-+.||+++....+.
T Consensus       199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP~  232 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLGDPL  232 (321)
T ss_pred             eeeeCCcccCCEEEeCCCeeEEEeccccccCCcH
Confidence            4899999999999999888999999998766554

>PRK11768 serine/threonine protein kinase; Provisional

Probab=90.42  E-value=0.45  Score=40.76  Aligned_cols=28  Identities=32%  Similarity=0.385  Sum_probs=23.5

Q ss_pred             CCccccCCCCCceEEcCCCCeEEeeccccc
Q 023568           67 ASVLHRDLKPSNLLLNASCDLKIGDFGLAR   96 (280)
Q Consensus        67 ~~i~H~dik~~Nili~~~~~~kl~dfg~~~   96 (280)
                      .+++|+|+.+.||+++ + .+.++||+.+.
T Consensus       196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~  223 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR  223 (325)
T ss_pred             ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence            4689999999999995 4 57899999653

>PRK06148 hypothetical protein; Provisional

Probab=90.01  E-value=0.51  Score=46.90  Aligned_cols=31  Identities=35%  Similarity=0.500  Sum_probs=26.2

Q ss_pred             CCccccCCCCCceEEcCCC--CeE-Eeecccccc
Q 023568           67 ASVLHRDLKPSNLLLNASC--DLK-IGDFGLART   97 (280)
Q Consensus        67 ~~i~H~dik~~Nili~~~~--~~k-l~dfg~~~~   97 (280)
                      .+++|+|+++.||+++.++  ++. |+|||-+..
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            5799999999999998875  555 999998754

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=89.76  E-value=0.33  Score=39.01  Aligned_cols=58  Identities=22%  Similarity=0.234  Sum_probs=43.0

Q ss_pred             CcEEEEEecCCc---cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh--CCccccCCCCCceEEcCCCCeEEeeccc
Q 023568           22 NDVYIVYELMDT---DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS--ASVLHRDLKPSNLLLNASCDLKIGDFGL   94 (280)
Q Consensus        22 ~~~~lv~e~~~g---~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~--~~i~H~dik~~Nili~~~~~~kl~dfg~   94 (280)
                      ...-+|.|+|-.   .....+               ..-+.+|.-.|+  .+..|||-.|+||+-|..|.+||.|-+.
T Consensus       127 ~~yGvIlE~Cy~~~i~~~N~i---------------~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  127 YKYGVILERCYKIKINFSNFI---------------TAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             ceeEEEEeeccCcccchhHHH---------------HHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence            567788888852   112221               223567888895  4699999999999999999999998763

The function of this family is unknown.

>PRK06149 hypothetical protein; Provisional

Probab=89.07  E-value=0.58  Score=46.33  Aligned_cols=31  Identities=19%  Similarity=0.202  Sum_probs=25.1

Q ss_pred             hCCccccCCCCCceEEcCC--CC---eEEeeccccc
Q 023568           66 SASVLHRDLKPSNLLLNAS--CD---LKIGDFGLAR   96 (280)
Q Consensus        66 ~~~i~H~dik~~Nili~~~--~~---~kl~dfg~~~   96 (280)
                      ..+++|+|+++.||+++.+  +.   .-|+|||-+.
T Consensus       207 ~~g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~  242 (972)
T PRK06149        207 PLQAVHLDITDDNVVGSRDADGRWQPDGVIDFGDLV  242 (972)
T ss_pred             cccccCCCCCcccEEEcCCCCCCcceeEEEEcccch
Confidence            3679999999999999865  33   3689999765

>COG4499 Predicted membrane protein [Function unknown]

Probab=88.96  E-value=3.1  Score=35.85  Aligned_cols=100  Identities=13%  Similarity=0.129  Sum_probs=63.6

Q ss_pred             EEEEEecCCc--cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEeecccccccCCC
Q 023568           24 VYIVYELMDT--DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET  101 (280)
Q Consensus        24 ~~lv~e~~~g--~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~  101 (280)
                      ..|-++-...  ++..+    +.+....-.+++.|.+..|.-+-... .|-=+.|+||+++.++.+.+.-+|+-....+ 
T Consensus        63 ~vIsy~i~~~~~~F~~~----k~~~k~~Klr~a~~~I~~l~e~~~tr-~~~~laPeNilf~~~l~p~~vH~Glk~~lpP-  136 (434)
T COG4499          63 FVISYPIPEAAKSFASA----KRKEKTRKLRLALQNIATLSELNNTR-YTFFLAPENILFDGGLTPFFVHRGLKNSLPP-  136 (434)
T ss_pred             eEEEecCccccchHHHH----HHHHHHHHHHHHHHHHHHHHHhhccc-eeEEecchheEEcCCCceEEEecchhccCCC-
Confidence            4555555442  33333    34566666777888888777654443 4556889999999999999999997544432 


Q ss_pred             CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 023568          102 DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG  150 (280)
Q Consensus       102 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~  150 (280)
                                +=+.||.+..           ++-+++..++.|..+|..
T Consensus       137 ----------ye~tee~f~~-----------~ykA~~~~~fn~k~~Fe~  164 (434)
T COG4499         137 ----------YEMTEERFLK-----------EYKALAIYAFNGKFSFES  164 (434)
T ss_pred             ----------CCCCHHHHHH-----------HHHHHHHHHHcCCccHHH
Confidence                      2245555433           455666667777766643

>PHA03111 Ser/Thr kinase; Provisional

Probab=88.57  E-value=1  Score=38.47  Aligned_cols=59  Identities=19%  Similarity=0.239  Sum_probs=38.2

Q ss_pred             EEEEEecCCcc-----HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH----hCCccccCCCCCceEEc
Q 023568           24 VYIVYELMDTD-----LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH----SASVLHRDLKPSNLLLN   82 (280)
Q Consensus        24 ~~lv~e~~~g~-----L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH----~~~i~H~dik~~Nili~   82 (280)
                      -.+|++++-++     +.....-+=.--.+-++.++.||+.-.-.+-    ..+.+|.||||+|||+-
T Consensus       250 nIIIfPLArcSadkv~~~~~~e~GF~s~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiF  317 (444)
T PHA03111        250 NIIIFPLARCSADKVTEENAAELGFKSLVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIF  317 (444)
T ss_pred             cEEEEehhhcccccCCHHHHHHcCCccHHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEe
Confidence            46888887543     2222222112234557888999987664553    34699999999999983

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=88.46  E-value=0.82  Score=38.38  Aligned_cols=29  Identities=34%  Similarity=0.486  Sum_probs=24.1

Q ss_pred             ccccCCCCCceEEcCC--C---CeEEeecccccc
Q 023568           69 VLHRDLKPSNLLLNAS--C---DLKIGDFGLART   97 (280)
Q Consensus        69 i~H~dik~~Nili~~~--~---~~kl~dfg~~~~   97 (280)
                      ++|||+...||++..+  |   .+.+.||..++.
T Consensus       217 l~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~~  250 (294)
T PF02958_consen  217 LCHGDFWTNNILFKYDDDGKPIDVVLIDFQLARY  250 (294)
T ss_pred             EEcCccCHHhEeEccccccccccceeeccccccC
Confidence            8999999999999654  3   589999987644

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=87.80  E-value=0.77  Score=36.33  Aligned_cols=38  Identities=37%  Similarity=0.525  Sum_probs=31.4

Q ss_pred             HHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEeecccc
Q 023568           53 FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA   95 (280)
Q Consensus        53 i~~qil~~l~~LH~~~i~H~dik~~Nili~~~~~~kl~dfg~~   95 (280)
                      -+.+|++-+..+|+.||+-+|+++.|..     .=+|+|||.+
T Consensus       169 ~~~~~~~dl~~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  169 DIPQMLRDLKILHKLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHHHHHHHHHHHCCeeeccCcccccc-----CCEEEecccC
Confidence            3557788888999999999999999975     3488999864

>PRK14559 putative protein serine/threonine phosphatase; Provisional

Probab=87.34  E-value=1.8  Score=40.62  Aligned_cols=84  Identities=18%  Similarity=0.152  Sum_probs=67.0

Q ss_pred             cccccccccccCCCCCCCCcEEEEEecCCc--cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE
Q 023568            4 ENVIAIKDIIRPPKKDTFNDVYIVYELMDT--DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL   81 (280)
Q Consensus         4 pniv~l~~~~~~~~~~~~~~~~lv~e~~~g--~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nili   81 (280)
                      .||.++|+++...     +.-.+++|+.+.  .|.+.... ...+.-+...|+.||+.-=.-|...|++-.=|.++|+-|
T Consensus       180 ~~iP~v~~~~~~~-----~~~i~Lle~~~~~~~l~~~w~~-~~~~~l~~l~Wl~q~~~LW~~l~~~~~~~sll~~~nlrv  253 (645)
T PRK14559        180 TEIPKIHDAWQDG-----DLQVILLEDRSHWQPLLDLWQD-QTLPTLQILYWLNQMTQLWKALEPWGCCQSLLELENLRV  253 (645)
T ss_pred             ccCcchheeecCC-----CCcEEEeCCCCCCchHHHHhhh-cCCcHHHHHHHHHHHHHHHHHHHhcCeehhccchhheee
Confidence            4599999999986     445788898863  67666643 346778889999999999999999999999999999999


Q ss_pred             cCCCCeEEeecc
Q 023568           82 NASCDLKIGDFG   93 (280)
Q Consensus        82 ~~~~~~kl~dfg   93 (280)
                      +.+..+.|..+-
T Consensus       254 ~~~~~~~l~~l~  265 (645)
T PRK14559        254 DEDQTLGLQQLY  265 (645)
T ss_pred             CCCceehHhhhh
Confidence            877666655443

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	280
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-85
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		6e-85
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		9e-85
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		9e-85
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		9e-85
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		9e-85
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		9e-85
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-84
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-84
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-84
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-84
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-84
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-84
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-84
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-84
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		3e-84
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		9e-84
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-83
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-83
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-83
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		4e-83
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		4e-83
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		4e-83
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-83
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		6e-83
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		3e-82
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-78
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		8e-78
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		9e-78
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-75
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-75
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-75
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-75
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-75
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-75
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-75
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-75
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-75
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-75
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-75
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-75
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-75
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		3e-75
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-75
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-75
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-75
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-75
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-75
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		3e-75
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-75
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-75
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-75
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-75
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-75
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-75
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-75
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		3e-75
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-75
3hec_A	348	P38 In Complex With Imatinib Length = 348		3e-75
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		4e-75
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		4e-75
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		4e-75
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		5e-75
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-75
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-74
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-74
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-74
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-74
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-74
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-74
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-74
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-74
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-74
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-74
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-74
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-74
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-74
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-74
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-74
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		3e-74
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-74
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		4e-74
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		4e-74
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-74
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		4e-74
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		9e-74
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-73
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-73
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-68
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-67
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		5e-67
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-66
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-66
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		4e-66
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-56
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-56
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-56
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-56
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-56
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-56
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-56
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		3e-56
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		3e-56
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		3e-56
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-56
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		5e-56
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		5e-56
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		6e-56
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		7e-56
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		8e-56
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		8e-56
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-55
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-55
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-55
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-55
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-55
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		4e-55
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		4e-55
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		4e-55
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		5e-55
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-54
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-54
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-54
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-54
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-54
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		4e-54
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		8e-54
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-53
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-50
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		3e-50
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-48
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		5e-47
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		4e-46
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-45
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		6e-44
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		6e-44
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-44
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		7e-44
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		7e-44
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		7e-44
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		7e-44
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		7e-44
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		7e-44
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		7e-44
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-43
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-43
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-43
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-43
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-43
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-43
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-43
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-43
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-43
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-43
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-43
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-43
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-43
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-43
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-43
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-43
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-43
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-43
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-43
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-43
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		5e-43
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-43
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		5e-43
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		5e-43
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-43
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		8e-43
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-42
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-40
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		4e-39
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		5e-39
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		7e-39
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-37
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-37
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		5e-37
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		6e-37
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-36
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		5e-36
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		8e-36
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-35
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-35
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-35
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-35
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-35
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-34
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-34
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-33
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-33
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-33
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-33
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-33
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-33
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-33
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-33
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-33
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-33
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		5e-33
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		5e-33
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		5e-33
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		8e-33
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-32
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-32
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-32
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-32
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-32
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-32
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-32
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-32
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-32
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-32
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-32
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-32
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		7e-31
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		7e-29
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		1e-27
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		1e-27
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		1e-27
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		2e-27
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		2e-27
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		2e-27
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		2e-27
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		2e-27
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		2e-27
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		2e-27
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		2e-27
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		2e-27
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		2e-27
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		2e-27
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		3e-27
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		3e-27
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		3e-27
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		4e-26
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		4e-26
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		4e-26
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		5e-26
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		5e-26
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		5e-26
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		5e-26
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		5e-26
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		6e-26
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		6e-26
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		9e-26
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		9e-26
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-25
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-25
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-25
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-25
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-25
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		3e-23
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		3e-23
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		5e-23
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-21
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-21
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-21
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		2e-20
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		4e-20
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-20
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		7e-20
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-19
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		1e-18
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		1e-18
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		2e-18
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-18
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-18
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-18
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-18
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-18
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-18
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-18
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-18
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-18
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		6e-18
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		8e-18
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		8e-18
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		1e-17
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		3e-17
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		4e-17
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-17
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		5e-17
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		5e-17
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		5e-17
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		6e-17
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-17
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		6e-17
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		6e-17
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		6e-17
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		7e-17
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		7e-17
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		7e-17
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		7e-17
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		8e-17
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		9e-17
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-16
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-16
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-16
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-16
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-16
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-16
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-16
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-16
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-16
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-16
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-16
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-16
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-16
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-16
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-16
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-16
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		4e-16
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-16
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		4e-16
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		4e-16
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		4e-16
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		4e-16
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		4e-16
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		4e-16
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		4e-16
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		5e-16
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		5e-16
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		5e-16
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		5e-16
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		5e-16
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		5e-16
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		6e-16
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-15
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-15
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-15
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-15
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-15
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-15
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-15
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-15
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-15
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-15
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-15
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-15
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-15
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-15
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-15
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-15
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-15
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-15
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-15
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-15
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-15
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-15
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-15
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-15
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-15
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-15
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-15
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		3e-15
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-15
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		3e-15
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		3e-15
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		4e-15
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		4e-15
3soa_A	444	Full-Length Human Camkii Length = 444		4e-15
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		5e-15
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		5e-15
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		5e-15
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		6e-15
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		6e-15
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		6e-15
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		7e-15
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		7e-15
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		7e-15
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		8e-15
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		9e-15
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-14
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-14
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-14
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-14
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-14
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-14
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-14
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-14
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-14
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-14
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-14
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-14
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-14
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-14
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-14
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-14
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-14
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-14
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-14
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-14
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-14
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-14
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-14
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-14
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-14
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-14
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-14
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-14
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-14
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		2e-14
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-14
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-14
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		2e-14
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		2e-14
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-14
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-14
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-14
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-14
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		2e-14
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		2e-14
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		2e-14
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		2e-14
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-14
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-14
2oza_A	356	Structure Of P38alpha Complex Length = 356		3e-14
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-14
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		3e-14
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-14
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		3e-14
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-14
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-14
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-14
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		3e-14
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-14
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-14
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		4e-14
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-14
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		4e-14
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		4e-14
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		5e-14
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		5e-14
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		5e-14
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		5e-14
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		5e-14
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		5e-14
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		5e-14
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		6e-14
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		6e-14
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		6e-14
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		6e-14
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		6e-14
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		6e-14
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		6e-14
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		7e-14
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		8e-14
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		8e-14
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		8e-14
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		8e-14
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		8e-14
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		8e-14
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		9e-14
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		9e-14
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-13
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-13
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-13
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-13
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-13
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-13
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-13
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-13
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-13
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-13
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-13
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-13
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-13
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-13
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-13
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-13
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-13
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-13
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-13
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-13
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-13
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-13
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-13
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-13
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-13
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-13
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-13
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		3e-13
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-13
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-13
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		4e-13
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-13
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-13
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-13
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		5e-13
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		5e-13
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		5e-13
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		6e-13
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		6e-13
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		7e-13
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		7e-13
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		7e-13
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		9e-13
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-12
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-12
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-12
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		1e-12
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-12
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-12
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		1e-12
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-12
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-12
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-12
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-12
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-12
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		3e-12
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-12
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-12
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-12
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-12
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-12
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		3e-12
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		4e-12
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		4e-12
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-12
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		4e-12
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		4e-12
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		4e-12
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-12
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		4e-12
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		5e-12
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		5e-12
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		5e-12
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		5e-12
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		5e-12
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		5e-12
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		5e-12
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-12
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		6e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-12
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		8e-12
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		9e-12
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		9e-12
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		9e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		9e-12
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-11
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-11
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-11
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-11
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-11
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-11
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-11
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-11
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-11
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-11
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-11
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-11
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-11
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-11
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-11
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-11
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-11
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-11
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-11
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-11
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-11
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-11
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-11
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-11
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-11
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-11
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-11
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-11
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-11
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-11
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-11
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-11
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-11
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-11
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-11
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-11
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-11
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-11
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-11
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-11
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-11
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-11
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-11
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-11
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-11
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-11
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-11
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-11
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-11
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-11
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-11
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-11
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-11
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-11
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-11
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-11
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-11
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-11
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-11
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-11
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-11
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-11
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-11
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-11
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		3e-11
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		3e-11
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-11
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		3e-11
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-11
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		3e-11
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-11
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-11
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-11
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-11
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-11
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		3e-11
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-11
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		4e-11
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		4e-11
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		4e-11
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-11
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		4e-11
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		4e-11
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		4e-11
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		4e-11
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		5e-11
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-11
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		5e-11
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		5e-11
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		5e-11
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		5e-11
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		5e-11
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		5e-11
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		5e-11
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		5e-11
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		5e-11
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		5e-11
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		5e-11
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-11
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		5e-11
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		5e-11
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		5e-11
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		5e-11
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		6e-11
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		6e-11
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		6e-11
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		6e-11
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-11
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		7e-11
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		8e-11
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		8e-11
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		8e-11
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		8e-11
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		8e-11
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		8e-11
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		9e-11
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-10
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-10
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-10
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-10
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-10
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-10
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-10
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-10
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-10
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-10
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-10
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-10
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-10
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-10
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-10
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-10
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-10
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-10
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-10
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-10
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-10
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-10
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-10
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-10
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		3e-10
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-10
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-10
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-10
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		3e-10
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-10
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		3e-10
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		4e-10
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		4e-10
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		4e-10
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-10
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		4e-10
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		4e-10
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-10
2pl0_A	289	Lck Bound To Imatinib Length = 289		5e-10
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		5e-10
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		5e-10
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		5e-10
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		5e-10
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		5e-10
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		6e-10
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		7e-10
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		8e-10
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		9e-10
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		9e-10
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		9e-10
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		9e-10
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		9e-10
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-09
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-09
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-09
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-09
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-09
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-09
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-09
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-09
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-09
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-09
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-09
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-09
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-09
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-09
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-09
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-09
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-09
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-09
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-09
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-09
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-09
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-09
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-09
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-09
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-09
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-09
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-09
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-09
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-09
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-09
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-09
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-09
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-09
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-09
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-09
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-09
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-09
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-09
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-09
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-09
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-09
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-09
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-09
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-09
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-09
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-09
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		3e-09
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		3e-09
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-09
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-09
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		3e-09
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-09
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		3e-09
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-09
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		3e-09
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-09
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		3e-09
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-09
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-09
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-09
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-09
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		4e-09
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		4e-09
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		4e-09
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		4e-09
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		4e-09
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		4e-09
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		4e-09
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		4e-09
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-09
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		5e-09
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		5e-09
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		6e-09
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		6e-09
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-09
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		6e-09
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		6e-09
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-09
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		7e-09
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		8e-09
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		8e-09
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		8e-09
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		9e-09
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-08
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-08
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-08
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-08
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-08
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-08
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-08
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-08
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-08
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-08
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-08
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-08
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		1e-08
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-08
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-08
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-08
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-08
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-08
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-08
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-08
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-08
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-08
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-08
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		2e-08
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-08
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-08
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-08
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		2e-08
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		2e-08
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-08
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-08
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-08
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-08
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-08
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-08
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-08
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-08
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-08
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-08
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-08
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-08
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-08
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-08
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		2e-08
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-08
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-08
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-08
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-08
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-08
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-08
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-08
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-08
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-08
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-08
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-08
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-08
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-08
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-08
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-08
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-08
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-08
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-08
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-08
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-08
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-08
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-08
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-08
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-08
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-08
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-08
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-08
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-08
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-08
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-08
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-08
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-08
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-08
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		3e-08
4fl2_A	636	Structural And Biophysical Characterization Of The		3e-08
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-08
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-08
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-08
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-08
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		3e-08
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-08
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-08
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-08
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-08
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		3e-08
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-08
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		3e-08
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-08
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		3e-08
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		4e-08
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		4e-08
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		4e-08
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		4e-08
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		5e-08
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		5e-08
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		5e-08
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		5e-08
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		6e-08
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		7e-08
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		7e-08
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		8e-08
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		8e-08
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		9e-08
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		9e-08
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-07
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-07
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-07
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-07
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-07
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-07
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-07
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-07
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-07
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-07
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-07
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-07
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-07
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-07
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-07
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-07
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-07
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		3e-07
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		3e-07
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-07
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		3e-07
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		4e-07
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		4e-07
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		4e-07
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		4e-07
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-07
1fvr_A	327	Tie2 Kinase Domain Length = 327		4e-07
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		4e-07
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		4e-07
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		4e-07
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		5e-07
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		5e-07
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		5e-07
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		5e-07
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		6e-07
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		6e-07
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-07
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		6e-07
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-07
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		6e-07
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		7e-07
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		7e-07
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		7e-07
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		7e-07
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		7e-07
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		7e-07
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		7e-07
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		7e-07
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		7e-07
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		7e-07
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		7e-07
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		7e-07
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		7e-07
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-07
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-07
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		8e-07
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		8e-07
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		8e-07
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		8e-07
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		8e-07
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		8e-07
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		8e-07
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		8e-07
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		9e-07
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		9e-07
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		9e-07
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		9e-07
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-06
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-06
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-06
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-06
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-06
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-06
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-06
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-06
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-06
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-06
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-06
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-06
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-06

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  311 bits (796), Expect = 3e-85,   Method: Compositional matrix adjust.
 Identities = 151/278 (54%), Positives = 198/278 (71%), Gaps = 5/278 (1%)
Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 62
           HENVI I+DI+R    +   DVYIV +LM+TDL+++++S QQL++DH  YFLYQ+LRGLK
Sbjct: 100 HENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKS-QQLSNDHICYFLYQILRGLK 158
Query: 63  YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVTRWYRAPEL 118
           Y+HSA+VLHRDLKPSNLL+N +CDLKI DFGLAR        T F+TE V TRWYRAPE+
Sbjct: 159 YIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEI 218
Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 178
           +LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I  ++GSP    L  + + 
Sbjct: 219 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINM 278
Query: 179 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 238
            AR Y++ LP   K  +A  FP   S A+DLL++ML F+PNKRITVEEAL HPYL+  +D
Sbjct: 279 KARNYLQSLPSKTKVAWAKLFPKSDSKALDLLDRMLTFNPNKRITVEEALAHPYLEQYYD 338
Query: 239 LNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 276
             DEPV   PF F  E     ++ ++ELI++E+ +F P
Sbjct: 339 PTDEPVAEEPFTFAMELDDLPKERLKELIFQETARFQP 376

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score =  310 bits (794), Expect = 6e-85,   Method: Compositional matrix adjust.
 Identities = 150/278 (53%), Positives = 198/278 (71%), Gaps = 5/278 (1%)
Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 62
           HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFLYQ+LRGLK
Sbjct: 78  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLK 136
Query: 63  YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVTRWYRAPEL 118
           Y+HSA+VLHRDLKPSNLLLN +CDLKI DFGLAR        T F+TEYV TRWYRAPE+
Sbjct: 137 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 196
Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 178
           +LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I  ++GSP+   L  + + 
Sbjct: 197 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQEDLNCIINL 256
Query: 179 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 238
            AR Y+  LP   K  +   FPN  S A+DLL+KML F+P+KRI VE+AL HPYL+  +D
Sbjct: 257 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 316
Query: 239 LNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 276
            +DEP+   PF FD E     ++ ++ELI+ E+ +F P
Sbjct: 317 PSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 354

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  309 bits (792), Expect = 9e-85,   Method: Compositional matrix adjust.
 Identities = 150/278 (53%), Positives = 197/278 (70%), Gaps = 5/278 (1%)
Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 62
           HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFLYQ+LRGLK
Sbjct: 82  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLK 140
Query: 63  YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVTRWYRAPEL 118
           Y+HSA+VLHRDLKPSNLLLN +CDLKI DFGLAR        T F+TEYV TRWYRAPE+
Sbjct: 141 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 200
Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 178
           +LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I  ++GSP    L  + + 
Sbjct: 201 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 260
Query: 179 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 238
            AR Y+  LP   K  +   FPN  S A+DLL+KML F+P+KRI VE+AL HPYL+  +D
Sbjct: 261 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 320
Query: 239 LNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 276
            +DEP+   PF FD E     ++ ++ELI+ E+ +F P
Sbjct: 321 PSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 358

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score =  309 bits (792), Expect = 9e-85,   Method: Compositional matrix adjust.
 Identities = 150/278 (53%), Positives = 197/278 (70%), Gaps = 5/278 (1%)
Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 62
           HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFLYQ+LRGLK
Sbjct: 88  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLK 146
Query: 63  YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVTRWYRAPEL 118
           Y+HSA+VLHRDLKPSNLLLN +CDLKI DFGLAR        T F+TEYV TRWYRAPE+
Sbjct: 147 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 206
Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 178
           +LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I  ++GSP    L  + + 
Sbjct: 207 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 266
Query: 179 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 238
            AR Y+  LP   K  +   FPN  S A+DLL+KML F+P+KRI VE+AL HPYL+  +D
Sbjct: 267 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 326
Query: 239 LNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 276
            +DEP+   PF FD E     ++ ++ELI+ E+ +F P
Sbjct: 327 PSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 364

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score =  309 bits (792), Expect = 9e-85,   Method: Compositional matrix adjust.
 Identities = 150/278 (53%), Positives = 197/278 (70%), Gaps = 5/278 (1%)
Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 62
           HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFLYQ+LRGLK
Sbjct: 80  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLK 138
Query: 63  YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVTRWYRAPEL 118
           Y+HSA+VLHRDLKPSNLLLN +CDLKI DFGLAR        T F+TEYV TRWYRAPE+
Sbjct: 139 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 178
           +LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I  ++GSP    L  + + 
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 258
Query: 179 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 238
            AR Y+  LP   K  +   FPN  S A+DLL+KML F+P+KRI VE+AL HPYL+  +D
Sbjct: 259 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 318
Query: 239 LNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 276
            +DEP+   PF FD E     ++ ++ELI+ E+ +F P
Sbjct: 319 PSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 356

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score =  309 bits (792), Expect = 9e-85,   Method: Compositional matrix adjust.
 Identities = 150/278 (53%), Positives = 197/278 (70%), Gaps = 5/278 (1%)
Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 62
           HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFLYQ+LRGLK
Sbjct: 78  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLK 136
Query: 63  YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVTRWYRAPEL 118
           Y+HSA+VLHRDLKPSNLLLN +CDLKI DFGLAR        T F+TEYV TRWYRAPE+
Sbjct: 137 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 196
Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 178
           +LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I  ++GSP    L  + + 
Sbjct: 197 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 256
Query: 179 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 238
            AR Y+  LP   K  +   FPN  S A+DLL+KML F+P+KRI VE+AL HPYL+  +D
Sbjct: 257 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 316
Query: 239 LNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 276
            +DEP+   PF FD E     ++ ++ELI+ E+ +F P
Sbjct: 317 PSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 354

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  309 bits (792), Expect = 9e-85,   Method: Compositional matrix adjust.
 Identities = 150/278 (53%), Positives = 197/278 (70%), Gaps = 5/278 (1%)
Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 62
           HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFLYQ+LRGLK
Sbjct: 80  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLK 138
Query: 63  YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVTRWYRAPEL 118
           Y+HSA+VLHRDLKPSNLLLN +CDLKI DFGLAR        T F+TEYV TRWYRAPE+
Sbjct: 139 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 178
           +LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I  ++GSP    L  + + 
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 258
Query: 179 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 238
            AR Y+  LP   K  +   FPN  S A+DLL+KML F+P+KRI VE+AL HPYL+  +D
Sbjct: 259 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 318
Query: 239 LNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 276
            +DEP+   PF FD E     ++ ++ELI+ E+ +F P
Sbjct: 319 PSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 356

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  309 bits (792), Expect = 1e-84,   Method: Compositional matrix adjust.
 Identities = 150/278 (53%), Positives = 197/278 (70%), Gaps = 5/278 (1%)
Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 62
           HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFLYQ+LRGLK
Sbjct: 85  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLK 143
Query: 63  YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVTRWYRAPEL 118
           Y+HSA+VLHRDLKPSNLLLN +CDLKI DFGLAR        T F+TEYV TRWYRAPE+
Sbjct: 144 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 203
Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 178
           +LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I  ++GSP    L  + + 
Sbjct: 204 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 263
Query: 179 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 238
            AR Y+  LP   K  +   FPN  S A+DLL+KML F+P+KRI VE+AL HPYL+  +D
Sbjct: 264 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 323
Query: 239 LNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 276
            +DEP+   PF FD E     ++ ++ELI+ E+ +F P
Sbjct: 324 PSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 361

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score =  309 bits (792), Expect = 1e-84,   Method: Compositional matrix adjust.
 Identities = 150/278 (53%), Positives = 197/278 (70%), Gaps = 5/278 (1%)
Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 62
           HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFLYQ+LRGLK
Sbjct: 86  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLK 144
Query: 63  YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVTRWYRAPEL 118
           Y+HSA+VLHRDLKPSNLLLN +CDLKI DFGLAR        T F+TEYV TRWYRAPE+
Sbjct: 145 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 204
Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 178
           +LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I  ++GSP    L  + + 
Sbjct: 205 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 264
Query: 179 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 238
            AR Y+  LP   K  +   FPN  S A+DLL+KML F+P+KRI VE+AL HPYL+  +D
Sbjct: 265 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 324
Query: 239 LNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 276
            +DEP+   PF FD E     ++ ++ELI+ E+ +F P
Sbjct: 325 PSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 362

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score =  309 bits (792), Expect = 1e-84,   Method: Compositional matrix adjust.
 Identities = 150/278 (53%), Positives = 197/278 (70%), Gaps = 5/278 (1%)
Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 62
           HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFLYQ+LRGLK
Sbjct: 77  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLK 135
Query: 63  YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVTRWYRAPEL 118
           Y+HSA+VLHRDLKPSNLLLN +CDLKI DFGLAR        T F+TEYV TRWYRAPE+
Sbjct: 136 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 195
Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 178
           +LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I  ++GSP    L  + + 
Sbjct: 196 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 255
Query: 179 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 238
            AR Y+  LP   K  +   FPN  S A+DLL+KML F+P+KRI VE+AL HPYL+  +D
Sbjct: 256 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 315
Query: 239 LNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 276
            +DEP+   PF FD E     ++ ++ELI+ E+ +F P
Sbjct: 316 PSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 353

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score =  309 bits (792), Expect = 1e-84,   Method: Compositional matrix adjust.
 Identities = 150/278 (53%), Positives = 197/278 (70%), Gaps = 5/278 (1%)
Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 62
           HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFLYQ+LRGLK
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLK 142
Query: 63  YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVTRWYRAPEL 118
           Y+HSA+VLHRDLKPSNLLLN +CDLKI DFGLAR        T F+TEYV TRWYRAPE+
Sbjct: 143 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 178
           +LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I  ++GSP    L  + + 
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 262
Query: 179 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 238
            AR Y+  LP   K  +   FPN  S A+DLL+KML F+P+KRI VE+AL HPYL+  +D
Sbjct: 263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322
Query: 239 LNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 276
            +DEP+   PF FD E     ++ ++ELI+ E+ +F P
Sbjct: 323 PSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 360

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score =  309 bits (792), Expect = 1e-84,   Method: Compositional matrix adjust.
 Identities = 150/278 (53%), Positives = 197/278 (70%), Gaps = 5/278 (1%)
Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 62
           HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFLYQ+LRGLK
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLK 142
Query: 63  YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVTRWYRAPEL 118
           Y+HSA+VLHRDLKPSNLLLN +CDLKI DFGLAR        T F+TEYV TRWYRAPE+
Sbjct: 143 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 178
           +LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I  ++GSP    L  + + 
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 262
Query: 179 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 238
            AR Y+  LP   K  +   FPN  S A+DLL+KML F+P+KRI VE+AL HPYL+  +D
Sbjct: 263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322
Query: 239 LNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 276
            +DEP+   PF FD E     ++ ++ELI+ E+ +F P
Sbjct: 323 PSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 360

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score =  309 bits (791), Expect = 1e-84,   Method: Compositional matrix adjust.
 Identities = 150/278 (53%), Positives = 197/278 (70%), Gaps = 5/278 (1%)
Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 62
           HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFLYQ+LRGLK
Sbjct: 100 HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLK 158
Query: 63  YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVTRWYRAPEL 118
           Y+HSA+VLHRDLKPSNLLLN +CDLKI DFGLAR        T F+TEYV TRWYRAPE+
Sbjct: 159 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 218
Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 178
           +LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I  ++GSP    L  + + 
Sbjct: 219 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 278
Query: 179 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 238
            AR Y+  LP   K  +   FPN  S A+DLL+KML F+P+KRI VE+AL HPYL+  +D
Sbjct: 279 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 338
Query: 239 LNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 276
            +DEP+   PF FD E     ++ ++ELI+ E+ +F P
Sbjct: 339 PSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 376

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  309 bits (791), Expect = 1e-84,   Method: Compositional matrix adjust.
 Identities = 150/278 (53%), Positives = 196/278 (70%), Gaps = 5/278 (1%)
Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 62
           HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFLYQ+LRGLK
Sbjct: 82  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLK 140
Query: 63  YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVTRWYRAPEL 118
           Y+HSA+VLHRDLKPSNLLLN +CDLKI DFGLAR        T F+TEYV TRWYRAPE+
Sbjct: 141 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 200
Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 178
           +LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I  ++GSP    L  + + 
Sbjct: 201 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 260
Query: 179 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 238
            AR Y+  LP   K  +   FPN  S A+DLL+KML F+P+KRI VE+AL HPYL   +D
Sbjct: 261 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQYYD 320
Query: 239 LNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 276
            +DEP+   PF FD E     ++ ++ELI+ E+ +F P
Sbjct: 321 PSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 358

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  308 bits (788), Expect = 3e-84,   Method: Compositional matrix adjust.
 Identities = 150/278 (53%), Positives = 196/278 (70%), Gaps = 5/278 (1%)
Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 62
           HEN+I I DIIR P  +   DVYIV +LM+TDL+++++  Q L++DH  YFLYQ+LRGLK
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKC-QHLSNDHICYFLYQILRGLK 142
Query: 63  YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVTRWYRAPEL 118
           Y+HSA+VLHRDLKPSNLLLN +CDLKI DFGLAR        T F+TEYV TRWYRAPE+
Sbjct: 143 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 178
           +LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I  ++GSP    L  + + 
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 262
Query: 179 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 238
            AR Y+  LP   K  +   FPN  S A+DLL+KML F+P+KRI VE+AL HPYL+  +D
Sbjct: 263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322
Query: 239 LNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 276
            +DEP+   PF FD E     ++ ++ELI+ E+ +F P
Sbjct: 323 PSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 360

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  308 bits (788), Expect = 3e-84,   Method: Compositional matrix adjust.
 Identities = 149/278 (53%), Positives = 196/278 (70%), Gaps = 5/278 (1%)
Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 62
           HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFLYQ+LRGLK
Sbjct: 80  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLK 138
Query: 63  YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVTRWYRAPEL 118
           Y+HSA+VLHRDLKPSNLLLN + DLKI DFGLAR        T F+TEYV TRWYRAPE+
Sbjct: 139 YIHSANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 178
           +LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I  ++GSP    L  + + 
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINL 258
Query: 179 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 238
            AR Y+  LP   K  +   FPN  S A+DLL+KML F+P+KRI VE+AL HPYL+  +D
Sbjct: 259 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 318
Query: 239 LNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 276
            +DEP+   PF FD E     ++ ++ELI+ E+ +F P
Sbjct: 319 PSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 356

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  306 bits (784), Expect = 9e-84,   Method: Compositional matrix adjust.
 Identities = 149/278 (53%), Positives = 196/278 (70%), Gaps = 5/278 (1%)
Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 62
           HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFLYQ+LRGLK
Sbjct: 80  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLK 138
Query: 63  YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVTRWYRAPEL 118
           Y+HSA+VLHRDLKPSNLLLN + DLKI DFGLAR        T F+TEYV TRWYRAPE+
Sbjct: 139 YIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 178
           +LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I  ++GSP    L  + + 
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINL 258
Query: 179 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 238
            AR Y+  LP   K  +   FPN  S A+DLL+KML F+P+KRI VE+AL HPYL+  +D
Sbjct: 259 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 318
Query: 239 LNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 276
            +DEP+   PF FD E     ++ ++ELI+ E+ +F P
Sbjct: 319 PSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 356

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score =  305 bits (782), Expect = 1e-83,   Method: Compositional matrix adjust.
 Identities = 149/278 (53%), Positives = 196/278 (70%), Gaps = 5/278 (1%)
Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 62
           HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFLYQ+LRGLK
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLK 142
Query: 63  YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVTRWYRAPEL 118
           Y+HSA+VLHRDLKPSNLLLN + DLKI DFGLAR        T F+TEYV TRWYRAPE+
Sbjct: 143 YIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 178
           +LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I  ++GSP    L  + + 
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 262
Query: 179 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 238
            AR Y+  LP   K  +   FPN  S A+DLL+KML F+P+KRI VE+AL HPYL+  +D
Sbjct: 263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322
Query: 239 LNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 276
            +DEP+   PF FD E     ++ ++ELI+ E+ +F P
Sbjct: 323 PSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 360

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score =  305 bits (782), Expect = 1e-83,   Method: Compositional matrix adjust.
 Identities = 149/278 (53%), Positives = 196/278 (70%), Gaps = 5/278 (1%)
Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 62
           HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFLYQ+LRGLK
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLK 142
Query: 63  YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVTRWYRAPEL 118
           Y+HSA+VLHRDLKPSNLLLN + DLKI DFGLAR        T F+TEYV TRWYRAPE+
Sbjct: 143 YIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 178
           +LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I  ++GSP    L  + + 
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 262
Query: 179 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 238
            AR Y+  LP   K  +   FPN  S A+DLL+KML F+P+KRI VE+AL HPYL+  +D
Sbjct: 263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322
Query: 239 LNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 276
            +DEP+   PF FD E     ++ ++ELI+ E+ +F P
Sbjct: 323 PSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 360

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  305 bits (782), Expect = 1e-83,   Method: Compositional matrix adjust.
 Identities = 149/278 (53%), Positives = 196/278 (70%), Gaps = 5/278 (1%)
Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 62
           HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFLYQ+LRGLK
Sbjct: 80  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLK 138
Query: 63  YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVTRWYRAPEL 118
           Y+HSA+VLHRDLKPSNLLLN + DLKI DFGLAR        T F+TEYV TRWYRAPE+
Sbjct: 139 YIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 178
           +LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I  ++GSP    L  + + 
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 258
Query: 179 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 238
            AR Y+  LP   K  +   FPN  S A+DLL+KML F+P+KRI VE+AL HPYL+  +D
Sbjct: 259 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 318
Query: 239 LNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 276
            +DEP+   PF FD E     ++ ++ELI+ E+ +F P
Sbjct: 319 PSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 356

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  304 bits (778), Expect = 4e-83,   Method: Compositional matrix adjust.
 Identities = 148/278 (53%), Positives = 195/278 (70%), Gaps = 5/278 (1%)
Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 62
           HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFLYQ+LRGLK
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLK 142
Query: 63  YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVTRWYRAPEL 118
           Y+HSA+VLHRDLKPSNLLLN +CDLKI DFGLAR        T F+ E V TRWYRAPE+
Sbjct: 143 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEI 202
Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 178
           +LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I  ++GSP    L  + + 
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 262
Query: 179 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 238
            AR Y+  LP   K  +   FPN  S A+DLL+KML F+P+KRI VE+AL HPYL+  +D
Sbjct: 263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322
Query: 239 LNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 276
            +DEP+   PF FD E     ++ ++ELI+ E+ +F P
Sbjct: 323 PSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 360

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  304 bits (778), Expect = 4e-83,   Method: Compositional matrix adjust.
 Identities = 148/278 (53%), Positives = 195/278 (70%), Gaps = 5/278 (1%)
Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 62
           HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFLYQ+LRGLK
Sbjct: 85  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLK 143
Query: 63  YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVTRWYRAPEL 118
           Y+HSA+VLHRDLKPSNLLLN +CDLKI DFGLAR        T F+ E V TRWYRAPE+
Sbjct: 144 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEI 203
Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 178
           +LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I  ++GSP    L  + + 
Sbjct: 204 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 263
Query: 179 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 238
            AR Y+  LP   K  +   FPN  S A+DLL+KML F+P+KRI VE+AL HPYL+  +D
Sbjct: 264 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 323
Query: 239 LNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 276
            +DEP+   PF FD E     ++ ++ELI+ E+ +F P
Sbjct: 324 PSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 361

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score =  304 bits (778), Expect = 4e-83,   Method: Compositional matrix adjust.
 Identities = 149/280 (53%), Positives = 197/280 (70%), Gaps = 6/280 (2%)
Query: 2   EHENVIAIKDIIRPP-KKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           +H+N+IAIKDI+RP      F  VY+V +LM++DLHQII S Q LT +H +YFLYQLLRG
Sbjct: 111 KHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRG 170
Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART--TSETD---FMTEYVVTRWYRA 115
           LKY+HSA V+HRDLKPSNLL+N +C+LKIGDFG+AR   TS  +   FMTEYV TRWYRA
Sbjct: 171 LKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRA 230
Query: 116 PELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL 175
           PEL+L+  EYT AID+WSVGCI GE++ R  LFPGK+YVHQL+LI  ++G+P  A +  +
Sbjct: 231 PELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAV 290
Query: 176 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
            ++  R Y++ LP  +   + T +P     A+ LL +ML F+P+ RI+   ALRHP+L  
Sbjct: 291 GAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAK 350
Query: 236 LHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFN 275
            HD +DEP C  PF F F+  + T + I+E I  E   F+
Sbjct: 351 YHDPDDEPDCAPPFDFAFDREALTRERIKEAIVAEIEDFH 390

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  303 bits (777), Expect = 5e-83,   Method: Compositional matrix adjust.
 Identities = 149/278 (53%), Positives = 194/278 (69%), Gaps = 5/278 (1%)
Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 62
           HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFLYQ+LRGLK
Sbjct: 82  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLK 140
Query: 63  YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVTRWYRAPEL 118
           Y+HSA+VLHRDLKPSNLLLN + DLKI DFGLAR        T F+TEYV TRWYRAPE+
Sbjct: 141 YIHSANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 200
Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 178
           +LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I  ++GSP    L    + 
Sbjct: 201 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCGINL 260
Query: 179 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 238
            AR Y+  LP   K  +   FPN  S A+DLL+KML F+P+KRI VE+AL HPYL   +D
Sbjct: 261 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQYYD 320
Query: 239 LNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 276
            +DEP+   PF FD E     ++ ++ELI+ E+ +F P
Sbjct: 321 PSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 358

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score =  303 bits (776), Expect = 6e-83,   Method: Compositional matrix adjust.
 Identities = 149/280 (53%), Positives = 197/280 (70%), Gaps = 6/280 (2%)
Query: 2   EHENVIAIKDIIRPP-KKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           +H+N+IAIKDI+RP      F  VY+V +LM++DLHQII S Q LT +H +YFLYQLLRG
Sbjct: 112 KHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRG 171
Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART--TSETD---FMTEYVVTRWYRA 115
           LKY+HSA V+HRDLKPSNLL+N +C+LKIGDFG+AR   TS  +   FMTEYV TRWYRA
Sbjct: 172 LKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRA 231
Query: 116 PELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL 175
           PEL+L+  EYT AID+WSVGCI GE++ R  LFPGK+YVHQL+LI  ++G+P  A +  +
Sbjct: 232 PELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAV 291
Query: 176 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
            ++  R Y++ LP  +   + T +P     A+ LL +ML F+P+ RI+   ALRHP+L  
Sbjct: 292 GAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAK 351
Query: 236 LHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFN 275
            HD +DEP C  PF F F+  + T + I+E I  E   F+
Sbjct: 352 YHDPDDEPDCAPPFDFAFDREALTRERIKEAIVAEIEDFH 391

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  301 bits (771), Expect = 3e-82,   Method: Compositional matrix adjust.
 Identities = 147/278 (52%), Positives = 193/278 (69%), Gaps = 5/278 (1%)
Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 62
           HEN+I I DIIR P  +   DVY+V  LM  DL++++++ Q L++DH  YFLYQ+LRGLK
Sbjct: 100 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLK 158
Query: 63  YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVTRWYRAPEL 118
           Y+HSA+VLHRDLKPSNLLLN + DLKI DFGLAR        T F+TEYV TRWYRAPE+
Sbjct: 159 YIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 218
Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 178
           +LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I  ++GSP    L  + + 
Sbjct: 219 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 278
Query: 179 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 238
            AR Y+  LP   K  +   FPN  S A+DLL+KML F+P+KRI VE+AL HPYL+  +D
Sbjct: 279 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 338
Query: 239 LNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 276
            +DEP+   PF FD E     ++ ++ELI+ E+ +F P
Sbjct: 339 PSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 376

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  289 bits (740), Expect = 1e-78,   Method: Compositional matrix adjust.
 Identities = 144/286 (50%), Positives = 189/286 (66%), Gaps = 17/286 (5%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
            +HEN+I I +I RP   + FN+VYI+ ELM TDLH++I S Q L+DDH QYF+YQ LR 
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI-STQMLSDDHIQYFIYQTLRA 124
Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-----------TSETDFMTEYVV 109
           +K +H ++V+HRDLKPSNLL+N++CDLK+ DFGLAR            T +   MTEYV 
Sbjct: 125 VKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVA 184
Query: 110 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP-D 168
           TRWYRAPE++L   +Y+ A+D+WS GCIL E+  R P+FPG+DY HQL LI  +IG+P  
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244
Query: 169 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL 228
           D  L  + S  AR Y++ LP          FP  +   +DLL++MLVFDP KRIT +EAL
Sbjct: 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEAL 304
Query: 229 RHPYLQSLHDLND----EPVCPRPFHFDFEHSSCTEDHIRELIWRE 270
            HPYLQ+ HD ND    EP+ P  F FD    + T   +++LIW E
Sbjct: 305 EHPYLQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLKKLIWNE 350

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  286 bits (732), Expect = 8e-78,   Method: Compositional matrix adjust.
 Identities = 143/286 (50%), Positives = 188/286 (65%), Gaps = 17/286 (5%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
            +HEN+I I +I RP   + FN+VYI+ ELM TDLH++I S Q L+DDH QYF+YQ LR 
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI-STQMLSDDHIQYFIYQTLRA 124
Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-----------TSETDFMTEYVV 109
           +K +H ++V+HRDLKPSNLL+N++CDLK+ DFGLAR            T +   MTE V 
Sbjct: 125 VKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVA 184
Query: 110 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP-D 168
           TRWYRAPE++L   +Y+ A+D+WS GCIL E+  R P+FPG+DY HQL LI  +IG+P  
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244
Query: 169 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL 228
           D  L  + S  AR Y++ LP          FP  +   +DLL++MLVFDP KRIT +EAL
Sbjct: 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEAL 304
Query: 229 RHPYLQSLHDLND----EPVCPRPFHFDFEHSSCTEDHIRELIWRE 270
            HPYLQ+ HD ND    EP+ P  F FD    + T   +++LIW E
Sbjct: 305 EHPYLQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLKKLIWNE 350

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  286 bits (732), Expect = 9e-78,   Method: Compositional matrix adjust.
 Identities = 142/286 (49%), Positives = 188/286 (65%), Gaps = 17/286 (5%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
            +HEN+I I +I RP   + FN+VYI+ ELM TDLH++I S Q L+DDH QYF+YQ LR 
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI-STQMLSDDHIQYFIYQTLRA 124
Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-----------TSETDFMTEYVV 109
           +K +H ++V+HRDLKPSNLL+N++CDLK+ DFGLAR            T +   M E+V 
Sbjct: 125 VKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA 184
Query: 110 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP-D 168
           TRWYRAPE++L   +Y+ A+D+WS GCIL E+  R P+FPG+DY HQL LI  +IG+P  
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244
Query: 169 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL 228
           D  L  + S  AR Y++ LP          FP  +   +DLL++MLVFDP KRIT +EAL
Sbjct: 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEAL 304
Query: 229 RHPYLQSLHDLND----EPVCPRPFHFDFEHSSCTEDHIRELIWRE 270
            HPYLQ+ HD ND    EP+ P  F FD    + T   +++LIW E
Sbjct: 305 EHPYLQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLKKLIWNE 350

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  279 bits (714), Expect = 1e-75,   Method: Compositional matrix adjust.
 Identities = 141/279 (50%), Positives = 183/279 (65%), Gaps = 5/279 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 136
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 194
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 255 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 314
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   PF   FE      D  + L + E + F P P
Sbjct: 315 DDEPVAD-PFDQSFESRDLLIDEWKSLTYDEVISFVPPP 352

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  279 bits (713), Expect = 1e-75,   Method: Compositional matrix adjust.
 Identities = 140/279 (50%), Positives = 184/279 (65%), Gaps = 5/279 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 85  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 143
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T+  D MT YV TRWYRAPE++
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA--DEMTGYVATRWYRAPEIM 201
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 261
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 262 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 321
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 322 DDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVPPP 359

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  279 bits (713), Expect = 1e-75,   Method: Compositional matrix adjust.
 Identities = 140/279 (50%), Positives = 183/279 (65%), Gaps = 5/279 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 136
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 194
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 195 LNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 255 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 314
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 315 DDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVPPP 352

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  278 bits (712), Expect = 2e-75,   Method: Compositional matrix adjust.
 Identities = 140/279 (50%), Positives = 183/279 (65%), Gaps = 5/279 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKX-QKLTDDHVQFLIYQILR 136
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 194
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 255 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 314
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 315 DDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVPPP 352

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score =  278 bits (711), Expect = 2e-75,   Method: Compositional matrix adjust.
 Identities = 140/279 (50%), Positives = 183/279 (65%), Gaps = 5/279 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 136
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 194
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 255 ARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 314
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 315 DDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVPPP 352

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  278 bits (711), Expect = 3e-75,   Method: Compositional matrix adjust.
 Identities = 140/279 (50%), Positives = 183/279 (65%), Gaps = 5/279 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 84  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 142
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 143 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 200
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 260
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 261 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 320
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 321 DDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVPPP 358

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  278 bits (711), Expect = 3e-75,   Method: Compositional matrix adjust.
 Identities = 140/279 (50%), Positives = 183/279 (65%), Gaps = 5/279 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 136
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 194
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 255 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 314
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 315 DDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVPPP 352

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  278 bits (711), Expect = 3e-75,   Method: Compositional matrix adjust.
 Identities = 140/279 (50%), Positives = 183/279 (65%), Gaps = 5/279 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 136
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 194
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 255 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 314
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 315 DDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVPPP 352

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score =  278 bits (711), Expect = 3e-75,   Method: Compositional matrix adjust.
 Identities = 140/279 (50%), Positives = 183/279 (65%), Gaps = 5/279 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 88  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 146
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 147 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 204
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 205 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 264
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 265 ARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 324
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 325 DDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVPPP 362

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  278 bits (711), Expect = 3e-75,   Method: Compositional matrix adjust.
 Identities = 140/279 (50%), Positives = 183/279 (65%), Gaps = 5/279 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 83  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 141
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 142 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 199
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 200 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 259
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 260 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 319
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 320 DDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVPPP 357

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  278 bits (711), Expect = 3e-75,   Method: Compositional matrix adjust.
 Identities = 140/279 (50%), Positives = 183/279 (65%), Gaps = 5/279 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 98  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 156
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 157 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 214
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 215 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 274
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 275 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 334
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 335 DDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVPPP 372

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  278 bits (711), Expect = 3e-75,   Method: Compositional matrix adjust.
 Identities = 140/279 (50%), Positives = 183/279 (65%), Gaps = 5/279 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 77  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 135
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 136 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 193
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 194 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 253
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 254 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 313
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 314 DDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVPPP 351

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  278 bits (711), Expect = 3e-75,   Method: Compositional matrix adjust.
 Identities = 140/279 (50%), Positives = 183/279 (65%), Gaps = 5/279 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 80  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 138
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 139 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 196
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 256
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 257 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 316
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 317 DDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVPPP 354

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  278 bits (711), Expect = 3e-75,   Method: Compositional matrix adjust.
 Identities = 140/279 (50%), Positives = 183/279 (65%), Gaps = 5/279 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 89  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 147
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 148 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 205
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 206 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 265
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 266 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 325
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 326 DDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVPPP 363

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  278 bits (711), Expect = 3e-75,   Method: Compositional matrix adjust.
 Identities = 140/279 (50%), Positives = 183/279 (65%), Gaps = 5/279 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 98  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 156
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 157 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 214
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 215 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 274
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 275 ARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 334
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 335 DDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVPPP 372

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  278 bits (710), Expect = 3e-75,   Method: Compositional matrix adjust.
 Identities = 140/279 (50%), Positives = 183/279 (65%), Gaps = 5/279 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 85  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 143
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 201
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 261
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 262 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 321
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 322 DDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVPPP 359

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  278 bits (710), Expect = 3e-75,   Method: Compositional matrix adjust.
 Identities = 140/279 (50%), Positives = 183/279 (65%), Gaps = 5/279 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 90  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 148
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 149 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 206
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 207 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 266
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 267 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 326
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 327 DDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVPPP 364

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score =  278 bits (710), Expect = 3e-75,   Method: Compositional matrix adjust.
 Identities = 140/279 (50%), Positives = 183/279 (65%), Gaps = 5/279 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 74  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 132
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 190
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 251 ARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 310
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 311 DDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVPPP 348

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  278 bits (710), Expect = 3e-75,   Method: Compositional matrix adjust.
 Identities = 140/279 (50%), Positives = 183/279 (65%), Gaps = 5/279 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 90  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 148
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 149 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 206
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 207 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 266
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 267 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 326
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 327 DDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVPPP 364

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  278 bits (710), Expect = 3e-75,   Method: Compositional matrix adjust.
 Identities = 140/279 (50%), Positives = 183/279 (65%), Gaps = 5/279 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 80  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 138
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 139 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 196
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 256
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 257 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 316
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 317 DDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVPPP 354

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  278 bits (710), Expect = 3e-75,   Method: Compositional matrix adjust.
 Identities = 140/279 (50%), Positives = 183/279 (65%), Gaps = 5/279 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 90  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 148
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 149 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 206
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 207 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 266
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 267 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 326
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 327 DDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVPPP 364

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  278 bits (710), Expect = 3e-75,   Method: Compositional matrix adjust.
 Identities = 140/279 (50%), Positives = 183/279 (65%), Gaps = 5/279 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 97  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 155
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 156 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 213
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 214 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 273
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 274 ARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 333
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 334 DDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVPPP 371

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  278 bits (710), Expect = 3e-75,   Method: Compositional matrix adjust.
 Identities = 140/279 (50%), Positives = 183/279 (65%), Gaps = 5/279 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 97  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 155
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 156 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 213
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 214 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 273
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 274 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 333
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 334 DDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVPPP 371

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score =  278 bits (710), Expect = 3e-75,   Method: Compositional matrix adjust.
 Identities = 140/279 (50%), Positives = 183/279 (65%), Gaps = 5/279 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 83  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 141
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 142 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 199
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 200 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 259
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 260 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 319
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 320 DDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVPPP 357

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score =  278 bits (710), Expect = 3e-75,   Method: Compositional matrix adjust.
 Identities = 140/279 (50%), Positives = 183/279 (65%), Gaps = 5/279 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 75  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 133
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 134 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 191
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 192 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 251
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 252 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 311
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 312 DDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVPPP 349

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score =  278 bits (710), Expect = 3e-75,   Method: Compositional matrix adjust.
 Identities = 140/279 (50%), Positives = 183/279 (65%), Gaps = 5/279 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 84  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 142
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 143 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 200
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 260
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 261 ARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 320
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 321 DDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVPPP 358

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  278 bits (710), Expect = 3e-75,   Method: Compositional matrix adjust.
 Identities = 140/279 (50%), Positives = 183/279 (65%), Gaps = 5/279 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 80  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 138
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 139 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 196
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 256
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 257 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 316
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 317 DDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVPPP 354

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score =  278 bits (710), Expect = 3e-75,   Method: Compositional matrix adjust.
 Identities = 140/279 (50%), Positives = 183/279 (65%), Gaps = 5/279 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 76  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 134
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 135 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 192
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 193 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 252
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 253 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 312
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 313 DDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVPPP 350

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score =  278 bits (710), Expect = 3e-75,   Method: Compositional matrix adjust.
 Identities = 140/279 (50%), Positives = 183/279 (65%), Gaps = 5/279 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 101 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 159
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 160 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 217
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 218 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 277
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 278 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 337
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 338 DDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVPPP 375

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score =  278 bits (710), Expect = 3e-75,   Method: Compositional matrix adjust.
 Identities = 140/279 (50%), Positives = 183/279 (65%), Gaps = 5/279 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 74  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 132
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 190
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 310
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 311 DDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVPPP 348

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score =  278 bits (710), Expect = 4e-75,   Method: Compositional matrix adjust.
 Identities = 140/279 (50%), Positives = 183/279 (65%), Gaps = 5/279 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 84  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 142
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 143 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 200
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 260
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 261 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 320
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 321 DDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVPPP 358

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score =  277 bits (709), Expect = 4e-75,   Method: Compositional matrix adjust.
 Identities = 140/279 (50%), Positives = 183/279 (65%), Gaps = 5/279 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 75  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 133
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 134 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 191
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 192 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 251
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 252 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 311
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 312 DDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVPPP 349

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score =  277 bits (709), Expect = 4e-75,   Method: Compositional matrix adjust.
 Identities = 140/279 (50%), Positives = 183/279 (65%), Gaps = 5/279 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 136
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 194
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 255 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 314
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 315 DDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVPPP 352

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  277 bits (708), Expect = 5e-75,   Method: Compositional matrix adjust.
 Identities = 139/279 (49%), Positives = 183/279 (65%), Gaps = 5/279 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 85  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 143
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T+  D MT YV TRWYRAPE++
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA--DEMTGYVATRWYRAPEIM 201
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 261
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 262 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 321
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   P+    E      D  + L + E + F P P
Sbjct: 322 DDEPVAD-PYDQSLESRDLLIDEWKSLTYDEVISFVPPP 359

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  276 bits (707), Expect = 7e-75,   Method: Compositional matrix adjust.
 Identities = 139/279 (49%), Positives = 183/279 (65%), Gaps = 5/279 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 136
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N  C+LKI D+GLAR T   D MT YV TRWYRAPE++
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDYGLARHTD--DEMTGYVATRWYRAPEIM 194
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 255 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 314
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 315 DDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVPPP 352

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score =  276 bits (706), Expect = 1e-74,   Method: Compositional matrix adjust.
 Identities = 139/279 (49%), Positives = 182/279 (65%), Gaps = 5/279 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 101 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 159
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D M  YV TRWYRAPE++
Sbjct: 160 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMXGYVATRWYRAPEIM 217
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 218 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 277
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 278 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 337
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 338 DDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVPPP 375

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  276 bits (706), Expect = 1e-74,   Method: Compositional matrix adjust.
 Identities = 140/279 (50%), Positives = 182/279 (65%), Gaps = 5/279 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 136
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 194
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 255 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 314
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   P    FE      D  + L + E + F P P
Sbjct: 315 DDEPVAD-PTDQSFESRDLLIDEWKSLTYDEVISFVPPP 352

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score =  276 bits (705), Expect = 1e-74,   Method: Compositional matrix adjust.
 Identities = 139/279 (49%), Positives = 182/279 (65%), Gaps = 5/279 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 136
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N  C+LKI  FGLAR T   D MT YV TRWYRAPE++
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILGFGLARHTD--DEMTGYVATRWYRAPEIM 194
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 255 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 314
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 315 DDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVPPP 352

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  276 bits (705), Expect = 1e-74,   Method: Compositional matrix adjust.
 Identities = 140/279 (50%), Positives = 182/279 (65%), Gaps = 5/279 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 136
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 194
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 255 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 314
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   P    FE      D  + L + E + F P P
Sbjct: 315 DDEPVAD-PRDQSFESRDLLIDEWKSLTYDEVISFVPPP 352

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  276 bits (705), Expect = 1e-74,   Method: Compositional matrix adjust.
 Identities = 140/279 (50%), Positives = 182/279 (65%), Gaps = 5/279 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 136
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 194
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 255 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 314
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   P    FE      D  + L + E + F P P
Sbjct: 315 DDEPVAD-PQDQSFESRDLLIDEWKSLTYDEVISFVPPP 352

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  275 bits (704), Expect = 1e-74,   Method: Compositional matrix adjust.
 Identities = 139/279 (49%), Positives = 183/279 (65%), Gaps = 5/279 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 85  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 143
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T+  D MT YV TRWYRAPE++
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA--DEMTGYVATRWYRAPEIM 201
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 261
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 262 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 321
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   P+    E      D  + L + E + F P P
Sbjct: 322 DDEPVAD-PYDQSSESRDLLIDEWKSLTYDEVISFVPPP 359

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score =  275 bits (704), Expect = 1e-74,   Method: Compositional matrix adjust.
 Identities = 139/279 (49%), Positives = 182/279 (65%), Gaps = 5/279 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++   +LTDDH Q+ +YQ+LR
Sbjct: 74  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-AKLTDDHVQFLIYQILR 132
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 190
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 251 ARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 310
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 311 DDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVPPP 348

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  275 bits (703), Expect = 2e-74,   Method: Compositional matrix adjust.
 Identities = 139/279 (49%), Positives = 182/279 (65%), Gaps = 5/279 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKX-QKLTDDHVQFLIYQILR 136
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N   +LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 194
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 255 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 314
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 315 DDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVPPP 352

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  275 bits (703), Expect = 2e-74,   Method: Compositional matrix adjust.
 Identities = 139/279 (49%), Positives = 182/279 (65%), Gaps = 5/279 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 136
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N  C+LKI D GLAR T   D MT YV TRWYRAPE++
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDAGLARHTD--DEMTGYVATRWYRAPEIM 194
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 255 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 314
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 315 DDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVPPP 352

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score =  275 bits (702), Expect = 2e-74,   Method: Compositional matrix adjust.
 Identities = 138/279 (49%), Positives = 182/279 (65%), Gaps = 5/279 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 136
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D M  +V TRWYRAPE++
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMAGFVATRWYRAPEIM 194
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 255 ARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 314
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 315 DDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVPPP 352

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  275 bits (702), Expect = 3e-74,   Method: Compositional matrix adjust.
 Identities = 139/279 (49%), Positives = 182/279 (65%), Gaps = 5/279 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 136
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N  C+LKI D GLAR T   D MT YV TRWYRAPE++
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDGGLARHTD--DEMTGYVATRWYRAPEIM 194
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 255 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 314
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 315 DDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVPPP 352

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score =  275 bits (702), Expect = 3e-74,   Method: Compositional matrix adjust.
 Identities = 138/279 (49%), Positives = 182/279 (65%), Gaps = 5/279 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 74  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 132
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D M  +V TRWYRAPE++
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMAGFVATRWYRAPEIM 190
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 251 ARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 310
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 311 DDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVPPP 348

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  275 bits (702), Expect = 3e-74,   Method: Compositional matrix adjust.
 Identities = 139/279 (49%), Positives = 182/279 (65%), Gaps = 5/279 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 84  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 142
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N   +LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 143 GLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 200
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 260
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 261 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 320
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 321 DDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVPPP 358

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  275 bits (702), Expect = 3e-74,   Method: Compositional matrix adjust.
 Identities = 139/279 (49%), Positives = 182/279 (65%), Gaps = 5/279 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 80  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 138
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N   +LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 139 GLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 196
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 256
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 257 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 316
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 317 DDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVPPP 354

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score =  275 bits (702), Expect = 3e-74,   Method: Compositional matrix adjust.
 Identities = 139/279 (49%), Positives = 182/279 (65%), Gaps = 5/279 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 136
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT  V TRWYRAPE++
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGXVATRWYRAPEIM 194
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 255 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 314
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 315 DDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVPPP 352

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score =  275 bits (702), Expect = 3e-74,   Method: Compositional matrix adjust.
 Identities = 138/279 (49%), Positives = 182/279 (65%), Gaps = 5/279 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 136
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D M  +V TRWYRAPE++
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMAGFVATRWYRAPEIM 194
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 255 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 314
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 315 DDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVPPP 352

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  274 bits (701), Expect = 3e-74,   Method: Compositional matrix adjust.
 Identities = 139/279 (49%), Positives = 182/279 (65%), Gaps = 5/279 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 136
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N  C+LKI D GLAR T   D MT YV TRWYRAPE++
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDRGLARHTD--DEMTGYVATRWYRAPEIM 194
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 255 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 314
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 315 DDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVPPP 352

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  274 bits (701), Expect = 4e-74,   Method: Compositional matrix adjust.
 Identities = 139/279 (49%), Positives = 182/279 (65%), Gaps = 5/279 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 89  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 147
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N   +LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 148 GLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 205
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 206 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 265
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 266 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 325
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 326 DDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVPPP 363

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  274 bits (700), Expect = 4e-74,   Method: Compositional matrix adjust.
 Identities = 139/279 (49%), Positives = 182/279 (65%), Gaps = 5/279 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 83  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 141
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N   +LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 142 GLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 199
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 200 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 259
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 260 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 319
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 320 DDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVPPP 357

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  274 bits (700), Expect = 4e-74,   Method: Compositional matrix adjust.
 Identities = 139/279 (49%), Positives = 182/279 (65%), Gaps = 5/279 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 83  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 141
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N   +LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 142 GLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 199
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 200 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 259
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 260 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 319
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 320 DDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVPPP 357

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score =  274 bits (700), Expect = 4e-74,   Method: Compositional matrix adjust.
 Identities = 139/279 (49%), Positives = 182/279 (65%), Gaps = 5/279 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 136
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N  C+LKI DF LAR T   D MT YV TRWYRAPE++
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFYLARHTD--DEMTGYVATRWYRAPEIM 194
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 255 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 314
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 315 DDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVPPP 352

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score =  273 bits (697), Expect = 9e-74,   Method: Compositional matrix adjust.
 Identities = 138/279 (49%), Positives = 181/279 (64%), Gaps = 5/279 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 98  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 156
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D M   V TRWYRAPE++
Sbjct: 157 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMXGXVATRWYRAPEIM 214
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 215 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 274
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 275 ARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 334
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 335 DDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVPPP 372

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  272 bits (696), Expect = 1e-73,   Method: Compositional matrix adjust.
 Identities = 138/279 (49%), Positives = 181/279 (64%), Gaps = 5/279 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++S Q+LTDDH Q+ +YQ+LR
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKS-QKLTDDHVQFLIYQILR 136
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N   +LKI DFGL R T   D MT YV TRWYRAPE++
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLCRHTD--DEMTGYVATRWYRAPEIM 194
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 255 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 314
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   P+    E      D  + L + E + F P P
Sbjct: 315 DDEPVAD-PYDQSLESRDLLIDEWKSLTYDEVISFVPPP 352

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  271 bits (693), Expect = 3e-73,   Method: Compositional matrix adjust.
 Identities = 138/279 (49%), Positives = 179/279 (64%), Gaps = 5/279 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P    + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 107 MKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 165
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 166 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 223
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D+++QL+ I  L G+P  + +  + S  
Sbjct: 224 LNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRMPSHE 283
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y+  LP+  K+ FA  F   +  AVDLLEKMLV D +KRIT  EAL HPY    HD 
Sbjct: 284 ARNYINSLPQMPKRNFADVFIGANPLAVDLLEKMLVLDTDKRITASEALAHPYFSQYHDP 343
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEP    P+   FE      +  + L + E   F   P
Sbjct: 344 DDEPES-EPYDQSFESRQLEIEEWKRLTYEEVCSFETPP 381

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score =  255 bits (652), Expect = 2e-68,   Method: Compositional matrix adjust.
 Identities = 123/277 (44%), Positives = 179/277 (64%), Gaps = 5/277 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++HENVI + D+  P    + F++VY+V  LM  DL+ I++  Q L+D+H Q+ +YQLLR
Sbjct: 76  LKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKC-QALSDEHVQFLVYQLLR 134
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSN+ +N  C+L+I DFGLAR   E   MT YV TRWYRAPE++
Sbjct: 135 GLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADEE--MTGYVATRWYRAPEIM 192
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++  + LFPG DY+ QL+ I E++G+P    L  + S++
Sbjct: 193 LNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEH 252
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ LP   ++  ++ F   +  A+DLL +MLV D ++R++  EAL H Y    HD 
Sbjct: 253 ARTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDP 312
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 276
            DEP    P+    E    T +  +EL ++E + F P
Sbjct: 313 EDEPEA-EPYDESVEAKERTLEEWKELTYQEVLSFKP 348

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score =  252 bits (643), Expect = 2e-67,   Method: Compositional matrix adjust.
 Identities = 122/275 (44%), Positives = 178/275 (64%), Gaps = 5/275 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++HENVI + D+  P    + F++VY+V  LM  DL+ I++S Q L+D+H Q+ +YQLLR
Sbjct: 84  LKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKS-QALSDEHVQFLVYQLLR 142
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSN+ +N   +L+I DFGLAR   E   MT YV TRWYRAPE++
Sbjct: 143 GLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEE--MTGYVATRWYRAPEIM 200
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++  + LFPG DY+ QL+ I E++G+P    L  + S++
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEH 260
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ LP   ++  ++ F   +  A+DLL +MLV D ++R++  EAL H Y    HD 
Sbjct: 261 ARTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDP 320
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKF 274
            DEP    P+    E    T +  +EL ++E + F
Sbjct: 321 EDEPEA-EPYDESVEAKERTLEEWKELTYQEVLSF 354

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  250 bits (639), Expect = 5e-67,   Method: Compositional matrix adjust.
 Identities = 124/277 (44%), Positives = 178/277 (64%), Gaps = 5/277 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M HENVI + D+  P +  D F D Y+V   M TDL ++++  ++L +D  Q+ +YQ+L+
Sbjct: 81  MRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLK 139
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GL+Y+H+A ++HRDLKP NL +N  C+LKI DFGLAR       M   VVTRWYRAPE++
Sbjct: 140 GLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE--MXGXVVTRWYRAPEVI 197
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   YT  +DIWSVGCI+ E++T + LF G D++ QL+ I ++ G+P    +  L+SD 
Sbjct: 198 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 257
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           A+ Y++ LP   K+ FA+   N S  AV+LLEKMLV D  +R+T  EAL HPY +SLHD 
Sbjct: 258 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 317
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 276
            DEP   + +   F+    T D  + + ++E + F P
Sbjct: 318 EDEPQVQK-YDDSFDDVDRTLDEWKRVTYKEVLSFKP 353

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score =  249 bits (636), Expect = 1e-66,   Method: Compositional matrix adjust.
 Identities = 121/275 (44%), Positives = 177/275 (64%), Gaps = 5/275 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++HENVI + D+  P    + F++VY+V  LM  DL+ I++  Q L+D+H Q+ +YQLLR
Sbjct: 84  LKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKC-QALSDEHVQFLVYQLLR 142
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSN+ +N   +L+I DFGLAR   E   MT YV TRWYRAPE++
Sbjct: 143 GLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEE--MTGYVATRWYRAPEIM 200
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++  + LFPG DY+ QL+ I E++G+P    L  + S++
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEH 260
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ LP   ++  ++ F   +  A+DLL +MLV D ++R++  EAL H Y    HD 
Sbjct: 261 ARTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDP 320
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKF 274
            DEP    P+    E    T +  +EL ++E + F
Sbjct: 321 EDEPEA-EPYDESVEAKERTLEEWKELTYQEVLSF 354

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score =  248 bits (633), Expect = 3e-66,   Method: Compositional matrix adjust.
 Identities = 123/277 (44%), Positives = 170/277 (61%), Gaps = 5/277 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P      F D Y+V   M TDL +I+    + +++  QY +YQ+L+
Sbjct: 98  MQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIM--GMEFSEEKIQYLVYQMLK 155
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA V+HRDLKP NL +N  C+LKI DFGLAR       MT YVVTRWYRAPE++
Sbjct: 156 GLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVI 213
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           L+   Y   +DIWSVGCI+ E++T + LF GKDY+ QL  I ++ G P    +  L    
Sbjct: 214 LSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 273
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           A+ Y++ LP+  ++ F   FP  S  A DLLEKML  D +KR+T  +AL HP+ +   D 
Sbjct: 274 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDP 333
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 276
            +E    +PF    EH   T D  ++ I++E V F+P
Sbjct: 334 EEETEAQQPFDDSLEHEKLTVDEWKQHIYKEIVNFSP 370

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  247 bits (631), Expect = 4e-66,   Method: Compositional matrix adjust.
 Identities = 123/277 (44%), Positives = 170/277 (61%), Gaps = 5/277 (1%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P      F D Y+V   M TDL +I+    + +++  QY +YQ+L+
Sbjct: 80  MQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIM--GLKFSEEKIQYLVYQMLK 137
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA V+HRDLKP NL +N  C+LKI DFGLAR       MT YVVTRWYRAPE++
Sbjct: 138 GLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVI 195
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           L+   Y   +DIWSVGCI+ E++T + LF GKDY+ QL  I ++ G P    +  L    
Sbjct: 196 LSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 255
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           A+ Y++ LP+  ++ F   FP  S  A DLLEKML  D +KR+T  +AL HP+ +   D 
Sbjct: 256 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDP 315
Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 276
            +E    +PF    EH   T D  ++ I++E V F+P
Sbjct: 316 EEETEAQQPFDDSLEHEKLTVDEWKQHIYKEIVNFSP 352

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score =  215 bits (548), Expect = 2e-56,   Method: Compositional matrix adjust.
 Identities = 118/284 (41%), Positives = 175/284 (61%), Gaps = 18/284 (6%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H+N+I++ ++  P K  + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L 
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLC 175
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ + C LKI DFGLART   +  MT YVVTR+YRAPE++
Sbjct: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 235
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           L    Y   +DIWSVGCI+GE++  + LFPG+DY+ Q   + E +G+P    +  L+   
Sbjct: 236 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-T 293
Query: 180 ARRYVRQLPRCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEA 227
            R YV   P+     F   FP+            K+S A DLL KMLV DP KRI+V++A
Sbjct: 294 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 353
Query: 228 LRHPYLQSLHDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRE 270
           L+HPY+   +D  + E   P+ +    +    T +  +ELI++E
Sbjct: 354 LQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKE 397

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score =  215 bits (548), Expect = 2e-56,   Method: Compositional matrix adjust.
 Identities = 118/284 (41%), Positives = 175/284 (61%), Gaps = 18/284 (6%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H+N+I++ ++  P K  + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L 
Sbjct: 81  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLC 138
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ + C LKI DFGLART   +  MT YVVTR+YRAPE++
Sbjct: 139 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 198
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           L    Y   +DIWSVGCI+GE++  + LFPG+DY+ Q   + E +G+P    +  L+   
Sbjct: 199 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-T 256
Query: 180 ARRYVRQLPRCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEA 227
            R YV   P+     F   FP+            K+S A DLL KMLV DP KRI+V++A
Sbjct: 257 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 316
Query: 228 LRHPYLQSLHDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRE 270
           L+HPY+   +D  + E   P+ +    +    T +  +ELI++E
Sbjct: 317 LQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKE 360

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score =  215 bits (548), Expect = 2e-56,   Method: Compositional matrix adjust.
 Identities = 118/284 (41%), Positives = 175/284 (61%), Gaps = 18/284 (6%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H+N+I++ ++  P K  + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L 
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLC 137
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ + C LKI DFGLART   +  MT YVVTR+YRAPE++
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           L    Y   +DIWSVGCI+GE++  + LFPG+DY+ Q   + E +G+P    +  L+   
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-T 255
Query: 180 ARRYVRQLPRCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEA 227
            R YV   P+     F   FP+            K+S A DLL KMLV DP KRI+V++A
Sbjct: 256 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 315
Query: 228 LRHPYLQSLHDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRE 270
           L+HPY+   +D  + E   P+ +    +    T +  +ELI++E
Sbjct: 316 LQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKE 359

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score =  215 bits (548), Expect = 2e-56,   Method: Compositional matrix adjust.
 Identities = 118/284 (41%), Positives = 175/284 (61%), Gaps = 18/284 (6%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H+N+I++ ++  P K  + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L 
Sbjct: 81  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLC 138
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ + C LKI DFGLART   +  MT YVVTR+YRAPE++
Sbjct: 139 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 198
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           L    Y   +DIWSVGCI+GE++  + LFPG+DY+ Q   + E +G+P    +  L+   
Sbjct: 199 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-T 256
Query: 180 ARRYVRQLPRCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEA 227
            R YV   P+     F   FP+            K+S A DLL KMLV DP KRI+V++A
Sbjct: 257 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 316
Query: 228 LRHPYLQSLHDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRE 270
           L+HPY+   +D  + E   P+ +    +    T +  +ELI++E
Sbjct: 317 LQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKE 360

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score =  215 bits (547), Expect = 2e-56,   Method: Compositional matrix adjust.
 Identities = 118/284 (41%), Positives = 175/284 (61%), Gaps = 18/284 (6%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H+N+I++ ++  P K  + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L 
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLC 175
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ + C LKI DFGLART   +  MT YVVTR+YRAPE++
Sbjct: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 235
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           L    Y   +DIWSVGCI+GE++  + LFPG+DY+ Q   + E +G+P    +  L+   
Sbjct: 236 LG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-T 293
Query: 180 ARRYVRQLPRCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEA 227
            R YV   P+     F   FP+            K+S A DLL KMLV DP KRI+V++A
Sbjct: 294 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 353
Query: 228 LRHPYLQSLHDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRE 270
           L+HPY+   +D  + E   P+ +    +    T +  +ELI++E
Sbjct: 354 LQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKE 397

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score =  215 bits (547), Expect = 2e-56,   Method: Compositional matrix adjust.
 Identities = 118/284 (41%), Positives = 175/284 (61%), Gaps = 18/284 (6%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H+N+I++ ++  P K  + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L 
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLC 137
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ + C LKI DFGLART   +  MT YVVTR+YRAPE++
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           L    Y   +DIWSVGCI+GE++  + LFPG+DY+ Q   + E +G+P    +  L+   
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-T 255
Query: 180 ARRYVRQLPRCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEA 227
            R YV   P+     F   FP+            K+S A DLL KMLV DP KRI+V++A
Sbjct: 256 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 315
Query: 228 LRHPYLQSLHDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRE 270
           L+HPY+   +D  + E   P+ +    +    T +  +ELI++E
Sbjct: 316 LQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKE 359

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score =  215 bits (547), Expect = 2e-56,   Method: Compositional matrix adjust.
 Identities = 118/284 (41%), Positives = 175/284 (61%), Gaps = 18/284 (6%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H+N+I++ ++  P K  + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L 
Sbjct: 79  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLC 136
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ + C LKI DFGLART   +  MT YVVTR+YRAPE++
Sbjct: 137 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 196
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           L    Y   +DIWSVGCI+GE++  + LFPG+DY+ Q   + E +G+P    +  L+   
Sbjct: 197 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-T 254
Query: 180 ARRYVRQLPRCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEA 227
            R YV   P+     F   FP+            K+S A DLL KMLV DP KRI+V++A
Sbjct: 255 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 314
Query: 228 LRHPYLQSLHDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRE 270
           L+HPY+   +D  + E   P+ +    +    T +  +ELI++E
Sbjct: 315 LQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKE 358

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score =  215 bits (547), Expect = 3e-56,   Method: Compositional matrix adjust.
 Identities = 118/284 (41%), Positives = 175/284 (61%), Gaps = 18/284 (6%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H+N+I++ ++  P K  + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L 
Sbjct: 74  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLC 131
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ + C LKI DFGLART   +  MT YVVTR+YRAPE++
Sbjct: 132 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 191
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           L    Y   +DIWSVGCI+GE++  + LFPG+DY+ Q   + E +G+P    +  L+   
Sbjct: 192 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-T 249
Query: 180 ARRYVRQLPRCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEA 227
            R YV   P+     F   FP+            K+S A DLL KMLV DP KRI+V++A
Sbjct: 250 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 309
Query: 228 LRHPYLQSLHDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRE 270
           L+HPY+   +D  + E   P+ +    +    T +  +ELI++E
Sbjct: 310 LQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKE 353

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score =  215 bits (547), Expect = 3e-56,   Method: Compositional matrix adjust.
 Identities = 118/284 (41%), Positives = 175/284 (61%), Gaps = 18/284 (6%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H+N+I++ ++  P K  + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L 
Sbjct: 74  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLC 131
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ + C LKI DFGLART   +  MT YVVTR+YRAPE++
Sbjct: 132 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 191
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           L    Y   +DIWSVGCI+GE++  + LFPG+DY+ Q   + E +G+P    +  L+   
Sbjct: 192 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-T 249
Query: 180 ARRYVRQLPRCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEA 227
            R YV   P+     F   FP+            K+S A DLL KMLV DP KRI+V++A
Sbjct: 250 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 309
Query: 228 LRHPYLQSLHDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRE 270
           L+HPY+   +D  + E   P+ +    +    T +  +ELI++E
Sbjct: 310 LQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKE 353

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score =  215 bits (547), Expect = 3e-56,   Method: Compositional matrix adjust.
 Identities = 118/284 (41%), Positives = 175/284 (61%), Gaps = 18/284 (6%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H+N+I++ ++  P K  + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L 
Sbjct: 73  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLC 130
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ + C LKI DFGLART   +  MT YVVTR+YRAPE++
Sbjct: 131 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           L    Y   +DIWSVGCI+GE++  + LFPG+DY+ Q   + E +G+P    +  L+   
Sbjct: 191 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-T 248
Query: 180 ARRYVRQLPRCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEA 227
            R YV   P+     F   FP+            K+S A DLL KMLV DP KRI+V++A
Sbjct: 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
Query: 228 LRHPYLQSLHDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRE 270
           L+HPY+   +D  + E   P+ +    +    T +  +ELI++E
Sbjct: 309 LQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKE 352

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  214 bits (544), Expect = 5e-56,   Method: Compositional matrix adjust.
 Identities = 118/284 (41%), Positives = 172/284 (60%), Gaps = 18/284 (6%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H+N+I + ++  P K  + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L 
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ--MELDHERMSYLLYQMLC 137
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ + C LKI DFGLART   +  MT YVVTR+YRAPE++
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           L    Y   +DIWSVGCI+GE++    LFPG D++ Q   + E +G+P    +  L+   
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQP-T 255
Query: 180 ARRYVRQLPRCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEA 227
            R YV   P+     F   FP+            K+S A DLL KMLV D +KRI+V+EA
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 228 LRHPYLQSLHDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRE 270
           L+HPY+   +D ++ E   P+      +    T +  +ELI++E
Sbjct: 316 LQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKE 359

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score =  214 bits (544), Expect = 5e-56,   Method: Compositional matrix adjust.
 Identities = 117/284 (41%), Positives = 174/284 (61%), Gaps = 18/284 (6%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H+N+I++ ++  P K  + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L 
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ--MELDHERMSYLLYQMLX 137
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ +   LKI DFGLART   +  MT YVVTR+YRAPE++
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           L    Y   +DIWSVGCI+GE++  + LFPG+DY+ Q   + E +G+P    +  L+   
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-T 255
Query: 180 ARRYVRQLPRCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEA 227
            R YV   P+     F   FP+            K+S A DLL KMLV DP KRI+V++A
Sbjct: 256 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 315
Query: 228 LRHPYLQSLHDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRE 270
           L+HPY+   +D  + E   P+ +    +    T +  +ELI++E
Sbjct: 316 LQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKE 359

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score =  214 bits (544), Expect = 5e-56,   Method: Compositional matrix adjust.
 Identities = 117/284 (41%), Positives = 174/284 (61%), Gaps = 18/284 (6%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H+N+I++ ++  P K  + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L 
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ--MELDHERMSYLLYQMLX 137
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ +   LKI DFGLART   +  MT YVVTR+YRAPE++
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           L    Y   +DIWSVGCI+GE++  + LFPG+DY+ Q   + E +G+P    +  L+   
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-T 255
Query: 180 ARRYVRQLPRCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEA 227
            R YV   P+     F   FP+            K+S A DLL KMLV DP KRI+V++A
Sbjct: 256 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 315
Query: 228 LRHPYLQSLHDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRE 270
           L+HPY+   +D  + E   P+ +    +    T +  +ELI++E
Sbjct: 316 LQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKE 359

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score =  213 bits (543), Expect = 6e-56,   Method: Compositional matrix adjust.
 Identities = 118/284 (41%), Positives = 171/284 (60%), Gaps = 18/284 (6%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H+N+I++ ++  P K  + F DVY+V ELMD +L Q+I    +L  +   Y LYQ+L 
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIH--MELDHERMSYLLYQMLC 137
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ + C LKI DFGLART      MT YVVTR+YRAPE++
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVI 197
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           L    Y A +DIWSVGCI+GE++    +F G D++ Q   + E +G+P    +  L+   
Sbjct: 198 LGMG-YAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQP-T 255
Query: 180 ARRYVRQLPRCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEA 227
            R YV   P+    +F   FP+            K+S A DLL KMLV DP+KRI+V+EA
Sbjct: 256 VRNYVENRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEA 315
Query: 228 LRHPYLQSLHD-LNDEPVCPRPFHFDFEHSSCTEDHIRELIWRE 270
           LRHPY+   +D    E   P+ +    E      +  +ELI++E
Sbjct: 316 LRHPYITVWYDPAEAEAPPPQIYDAQLEEREHAIEEWKELIYKE 359

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score =  213 bits (543), Expect = 7e-56,   Method: Compositional matrix adjust.
 Identities = 117/284 (41%), Positives = 174/284 (61%), Gaps = 18/284 (6%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H+N+I++ ++  P K  + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L 
Sbjct: 73  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ--MELDHERMSYLLYQMLX 130
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ +   LKI DFGLART   +  MT YVVTR+YRAPE++
Sbjct: 131 GIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           L    Y   +DIWSVGCI+GE++  + LFPG+DY+ Q   + E +G+P    +  L+   
Sbjct: 191 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-T 248
Query: 180 ARRYVRQLPRCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEA 227
            R YV   P+     F   FP+            K+S A DLL KMLV DP KRI+V++A
Sbjct: 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
Query: 228 LRHPYLQSLHDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRE 270
           L+HPY+   +D  + E   P+ +    +    T +  +ELI++E
Sbjct: 309 LQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKE 352

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score =  213 bits (543), Expect = 8e-56,   Method: Compositional matrix adjust.
 Identities = 118/284 (41%), Positives = 174/284 (61%), Gaps = 18/284 (6%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H+N+I + ++  P K  + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L 
Sbjct: 74  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLC 131
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ + C LKI DFGLART   +  MT YVVTR+YRAPE++
Sbjct: 132 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 191
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           L    Y   +D+WSVGCI+GE++  + LFPG+DY+ Q   + E +G+P    +  L+   
Sbjct: 192 LGMG-YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-T 249
Query: 180 ARRYVRQLPRCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEA 227
            R YV   P+     F   FP+            K+S A DLL KMLV D +KRI+V+EA
Sbjct: 250 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 309
Query: 228 LRHPYLQSLHDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRE 270
           L+HPY+   +D ++ E   P+      +    T +  +ELI++E
Sbjct: 310 LQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKE 353

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score =  213 bits (543), Expect = 8e-56,   Method: Compositional matrix adjust.
 Identities = 118/284 (41%), Positives = 174/284 (61%), Gaps = 18/284 (6%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H+N+I + ++  P K  + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L 
Sbjct: 85  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLC 142
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ + C LKI DFGLART   +  MT YVVTR+YRAPE++
Sbjct: 143 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 202
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           L    Y   +D+WSVGCI+GE++  + LFPG+DY+ Q   + E +G+P    +  L+   
Sbjct: 203 LGMG-YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-T 260
Query: 180 ARRYVRQLPRCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEA 227
            R YV   P+     F   FP+            K+S A DLL KMLV D +KRI+V+EA
Sbjct: 261 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 320
Query: 228 LRHPYLQSLHDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRE 270
           L+HPY+   +D ++ E   P+      +    T +  +ELI++E
Sbjct: 321 LQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKE 364

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score =  213 bits (542), Expect = 1e-55,   Method: Compositional matrix adjust.
 Identities = 118/284 (41%), Positives = 169/284 (59%), Gaps = 18/284 (6%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H+N+I++ ++  P K  + F DVY+V ELMD +L Q+I    +L  +   Y LYQ+L 
Sbjct: 78  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIH--MELDHERMSYLLYQMLC 135
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ + C LKI DFGLART S    MT YVVTR+YRAPE++
Sbjct: 136 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVVTRYYRAPEVI 195
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           L    Y   +DIWSVGCI+GE++    +F G D++ Q   + E +G+P    +  L+   
Sbjct: 196 LGMG-YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQP-T 253
Query: 180 ARRYVRQLPRCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEA 227
            R YV   P      F   FP+            K+S A DLL KMLV DP+KRI+V+EA
Sbjct: 254 VRNYVENRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEA 313
Query: 228 LRHPYLQSLHD-LNDEPVCPRPFHFDFEHSSCTEDHIRELIWRE 270
           LRHPY+   +D    E   P+ +    E      +  +ELI++E
Sbjct: 314 LRHPYITVWYDPAEAEAPPPQIYDAQLEEREHAIEEWKELIYKE 357

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  213 bits (541), Expect = 1e-55,   Method: Compositional matrix adjust.
 Identities = 118/310 (38%), Positives = 182/310 (58%), Gaps = 49/310 (15%)
Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 62
           HEN++ + +++R    D   DVY+V++ M+TDLH +IR++  L   H QY +YQL++ +K
Sbjct: 68  HENIVNLLNVLRA---DNDRDVYLVFDYMETDLHAVIRANI-LEPVHKQYVVYQLIKVIK 123
Query: 63  YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART------------------TSETD-- 102
           Y+HS  +LHRD+KPSN+LLNA C +K+ DFGL+R+                  T   D  
Sbjct: 124 YLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183
Query: 103 --FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 160
              +T+YV TRWYRAPE+LL  T+YT  ID+WS+GCILGEI+  +P+FPG   ++QL  I
Sbjct: 184 QPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243
Query: 161 TELIGSPDDASLGFLRSDNARRYVRQLP------RCRKQQFATRFPNK----------SS 204
             +I  P +  +  ++S  A+  +  L       +  K+   T++ N           + 
Sbjct: 244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNE 303
Query: 205 GAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPR----PFHFDFEHSSCTE 260
            A+DLL+K+L F+PNKRI+  +AL+HP++   H+ N+EP C      P + + +HS    
Sbjct: 304 EALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKHSI--- 360
Query: 261 DHIRELIWRE 270
           D  R L++ E
Sbjct: 361 DDYRNLVYSE 370

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  213 bits (541), Expect = 1e-55,   Method: Compositional matrix adjust.
 Identities = 118/284 (41%), Positives = 172/284 (60%), Gaps = 18/284 (6%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H+N+I + ++  P K  + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L 
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLC 137
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ + C LKI DFGLART   +  MT YVVTR+YRAPE++
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           L    Y   +DIWSVGCI+GE++    LFPG D++ Q   + E +G+P    +  L+   
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQP-T 255
Query: 180 ARRYVRQLPRCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEA 227
            R YV   P+     F   FP+            K+S A DLL KMLV D +KRI+V+EA
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 228 LRHPYLQSLHDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRE 270
           L+HPY+   +D ++ E   P+      +    T +  +ELI++E
Sbjct: 316 LQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKE 359

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  212 bits (540), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 117/284 (41%), Positives = 171/284 (60%), Gaps = 18/284 (6%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H+N+I + ++  P K  + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L 
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ--MELDHERMSYLLYQMLV 137
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ +   LKI DFGLART   +  MT YVVTR+YRAPE++
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           L    Y   +DIWSVGCI+GE++    LFPG D++ Q   + E +G+P    +  L+   
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQP-T 255
Query: 180 ARRYVRQLPRCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEA 227
            R YV   P+     F   FP+            K+S A DLL KMLV D +KRI+V+EA
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 228 LRHPYLQSLHDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRE 270
           L+HPY+   +D ++ E   P+      +    T +  +ELI++E
Sbjct: 316 LQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKE 359

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  211 bits (537), Expect = 3e-55,   Method: Compositional matrix adjust.
 Identities = 117/284 (41%), Positives = 171/284 (60%), Gaps = 18/284 (6%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H+N+I + ++  P K  + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L 
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ--MELDHERMSYLLYQMLC 137
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ +   LKI DFGLART   +  MT YVVTR+YRAPE++
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           L    Y   +DIWSVGCI+GE++    LFPG D++ Q   + E +G+P    +  L+   
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQP-T 255
Query: 180 ARRYVRQLPRCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEA 227
            R YV   P+     F   FP+            K+S A DLL KMLV D +KRI+V+EA
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 228 LRHPYLQSLHDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRE 270
           L+HPY+   +D ++ E   P+      +    T +  +ELI++E
Sbjct: 316 LQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKE 359

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score =  211 bits (537), Expect = 4e-55,   Method: Compositional matrix adjust.
 Identities = 118/284 (41%), Positives = 173/284 (60%), Gaps = 18/284 (6%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H+N+I + ++  P K  + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L 
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLC 137
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ + C LKI DFGLART   +  M   VVTR+YRAPE++
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVI 197
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           L    Y   +DIWSVGCI+GE++  + LFPG+DY+ Q   + E +G+P  A +  L+   
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPAFMKKLQP-T 255
Query: 180 ARRYVRQLPRCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEA 227
            R YV   P+     F   FP+            K+S A DLL KMLV D +KRI+V+EA
Sbjct: 256 VRNYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 228 LRHPYLQSLHDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRE 270
           L+HPY+   +D ++ E   P+      +    T +  +ELI++E
Sbjct: 316 LQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKE 359

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score =  211 bits (536), Expect = 4e-55,   Method: Compositional matrix adjust.
 Identities = 118/284 (41%), Positives = 172/284 (60%), Gaps = 18/284 (6%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H+N+I + ++  P K  + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L 
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLC 137
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ + C LKI DFGLART   +  MT YVVTR+YRAPE++
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           L    Y   +DIWSVGCI+GE++    LFPG D++ Q   + E +G+P    +  L+   
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP-T 255
Query: 180 ARRYVRQLPRCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEA 227
            R YV   P+     F   FP+            K+S A DLL KMLV D +KRI+V+EA
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 228 LRHPYLQSLHDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRE 270
           L+HPY+   +D ++ E   P+      +    T +  +ELI++E
Sbjct: 316 LQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKE 359

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score =  211 bits (536), Expect = 4e-55,   Method: Compositional matrix adjust.
 Identities = 118/284 (41%), Positives = 172/284 (60%), Gaps = 18/284 (6%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H+N+I + ++  P K  + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L 
Sbjct: 81  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLC 138
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ + C LKI DFGLART   +  MT YVVTR+YRAPE++
Sbjct: 139 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 198
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           L    Y   +DIWSVGCI+GE++    LFPG D++ Q   + E +G+P    +  L+   
Sbjct: 199 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP-T 256
Query: 180 ARRYVRQLPRCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEA 227
            R YV   P+     F   FP+            K+S A DLL KMLV D +KRI+V+EA
Sbjct: 257 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 316
Query: 228 LRHPYLQSLHDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRE 270
           L+HPY+   +D ++ E   P+      +    T +  +ELI++E
Sbjct: 317 LQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKE 360

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  211 bits (536), Expect = 5e-55,   Method: Compositional matrix adjust.
 Identities = 117/284 (41%), Positives = 171/284 (60%), Gaps = 18/284 (6%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H+N+I + ++  P K  + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L 
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ--MELDHERMSYLLYQMLC 137
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ +   LKI DFGLART   +  MT YVVTR+YRAPE++
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           L    Y   +DIWSVGCI+GE++    LFPG D++ Q   + E +G+P    +  L+   
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQP-T 255
Query: 180 ARRYVRQLPRCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEA 227
            R YV   P+     F   FP+            K+S A DLL KMLV D +KRI+V+EA
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 228 LRHPYLQSLHDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRE 270
           L+HPY+   +D ++ E   P+      +    T +  +ELI++E
Sbjct: 316 LQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKE 359

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  209 bits (533), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 116/284 (40%), Positives = 170/284 (59%), Gaps = 18/284 (6%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H+N+I + ++  P K  + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L 
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ--MELDHERMSYLLYQMLV 137
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ +   LKI DFGLART   +  MT YVVTR+YRAPE++
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           L    Y   +DIWSVG I+GE++    LFPG D++ Q   + E +G+P    +  L+   
Sbjct: 198 LGMG-YKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQP-T 255
Query: 180 ARRYVRQLPRCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEA 227
            R YV   P+     F   FP+            K+S A DLL KMLV D +KRI+V+EA
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 228 LRHPYLQSLHDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRE 270
           L+HPY+   +D ++ E   P+      +    T +  +ELI++E
Sbjct: 316 LQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKE 359

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score =  209 bits (533), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 119/293 (40%), Positives = 174/293 (59%), Gaps = 18/293 (6%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H+N+I + ++  P K  + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L 
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLC 137
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ + C LKI DFGLART   +  MT  VVTR+YRAPE++
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVVTRYYRAPEVI 197
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           L    Y   +DIWSVGCI+GE++    LFPG D++ Q   + E +G+P    +  L+   
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP-T 255
Query: 180 ARRYVRQLPRCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEA 227
            R YV   P+     F   FP+            K+S A DLL KMLV D +KRI+V+EA
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNALKASQARDLLSKMLVIDASKRISVDEA 315
Query: 228 LRHPYLQSLHDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDPT 279
           L+HPY+   +D ++ E   P+      +    T +  +ELI++E +     PT
Sbjct: 316 LQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDLPKRPT 368

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  209 bits (532), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 116/284 (40%), Positives = 170/284 (59%), Gaps = 18/284 (6%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H+N+I + ++  P K  + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L 
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ--MELDHERMSYLLYQMLV 137
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ +   LKI DFGLART   +  MT YVVTR+YRAPE++
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           L    Y   +DIWSVG I+GE++    LFPG D++ Q   + E +G+P    +  L+   
Sbjct: 198 LGMG-YKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQP-T 255
Query: 180 ARRYVRQLPRCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEA 227
            R YV   P+     F   FP+            K+S A DLL KMLV D +KRI+V+EA
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 228 LRHPYLQSLHDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRE 270
           L+HPY+   +D ++ E   P+      +    T +  +ELI++E
Sbjct: 316 LQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKE 359

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score =  208 bits (530), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 110/251 (43%), Positives = 159/251 (63%), Gaps = 17/251 (6%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H+N+I++ ++  P K  + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L 
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ--MELDHERMSYLLYQMLC 137
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ +   LKI DFGLART   +  MT YVVTR+YRAPE++
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           L    Y   +DIWSVGCI+GE++  + LFPG+DY+ Q   + E +G+P    +  L+   
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-T 255
Query: 180 ARRYVRQLPRCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEA 227
            R YV   P+     F   FP+            K+S A DLL KMLV DP KRI+V++A
Sbjct: 256 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 315
Query: 228 LRHPYLQSLHD 238
           L+HPY+   +D
Sbjct: 316 LQHPYINVWYD 326

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score =  208 bits (529), Expect = 3e-54,   Method: Compositional matrix adjust.
 Identities = 116/284 (40%), Positives = 171/284 (60%), Gaps = 18/284 (6%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H+N+I + ++  P K  + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L 
Sbjct: 82  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLC 139
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ + C LKI DFGLART   +  M  +VVTR+YRAPE++
Sbjct: 140 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVVTRYYRAPEVI 199
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           L    Y   +DIWSVGCI+GE++    LFPG D++ Q   + E +G+P    +  L+   
Sbjct: 200 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP-T 257
Query: 180 ARRYVRQLPRCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEA 227
            R YV   P+     F   FP+            K+S A DLL KMLV D +KRI+V+EA
Sbjct: 258 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 317
Query: 228 LRHPYLQSLHDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRE 270
           L+HPY+   +D ++ E   P+      +    T +  +ELI++E
Sbjct: 318 LQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKE 361

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score =  207 bits (528), Expect = 4e-54,   Method: Compositional matrix adjust.
 Identities = 116/284 (40%), Positives = 172/284 (60%), Gaps = 18/284 (6%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H+N+I + ++  P K  + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L 
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLC 137
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ + C LKI DFGLART   +  M   VVTR+YRAPE++
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVI 197
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           L    Y   +D+WSVGCI+GE++  + LFPG+DY+ Q   + E +G+P    +  L+   
Sbjct: 198 LGMG-YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-T 255
Query: 180 ARRYVRQLPRCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEA 227
            R YV   P+     F   FP+            K+S A DLL KMLV D +KRI+V+EA
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 228 LRHPYLQSLHDLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRE 270
           L+HPY+   +D ++ E   P+      +    T +  +ELI++E
Sbjct: 316 LQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKE 359

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score =  206 bits (525), Expect = 8e-54,   Method: Compositional matrix adjust.
 Identities = 110/295 (37%), Positives = 162/295 (54%), Gaps = 59/295 (20%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           + H++V+ + DI+ P   + F+++Y+V E+ D+D  ++ R+   LT+ H +  LY LL G
Sbjct: 109 LNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVG 168
Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS--------------ETDF--- 103
           +KYVHSA +LHRDLKP+N L+N  C +K+ DFGLART                E D    
Sbjct: 169 VKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228
Query: 104 -----------MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--------- 143
                      +T +VVTRWYRAPEL+L    YT AID+WS+GCI  E++          
Sbjct: 229 TFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288
Query: 144 --REPLFPG--------------------KDYVHQLRLITELIGSPDDASLGFLRSDNAR 181
             R PLFPG                    +    QL +I  ++G+P +  +  L  ++A+
Sbjct: 289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAK 348
Query: 182 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 236
           RY+R  P+      A RFP  S+ A+ LL++MLVF+PNKRIT+ E L HP+ + +
Sbjct: 349 RYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score =  206 bits (523), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 109/246 (44%), Positives = 157/246 (63%), Gaps = 17/246 (6%)
Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H+N+I++ ++  P K  + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L 
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLC 137
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ +   LKI DFGLART   +  MT YVVTR+YRAPE++
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           L    Y   +DIWSVGCI+GE++  + LFPG+DY+ Q   + E +G+P    +  L+   
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP-T 255
Query: 180 ARRYVRQLPRCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEA 227
            R YV   P+     F   FP+            K+S A DLL KMLV DP KRI+V++A
Sbjct: 256 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 315
Query: 228 LRHPYL 233
           L+HPY+
Sbjct: 316 LQHPYI 321

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score =  195 bits (495), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 104/255 (40%), Positives = 152/255 (59%), Gaps = 7/255 (2%)
Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQL--TDDHCQYFLYQLLRG 60
           H N++ ++DI    ++   + +Y+V ELM TDL Q+I  DQ++  +  H QYF+Y +L G
Sbjct: 88  HPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIH-DQRIVISPQHIQYFMYHILLG 146
Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 120
           L  +H A V+HRDL P N+LL  + D+ I DF LAR  +     T YV  RWYRAPEL++
Sbjct: 147 LHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVM 206
Query: 121 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 180
               +T  +D+WS GC++ E+  R+ LF G  + +QL  I E++G+P    +    S +A
Sbjct: 207 QFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSA 266
Query: 181 RRYVRQ-LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           R Y+R  L     + +    P     A+DL+ KML F+P +RI+ E+ALRHPY +SL D 
Sbjct: 267 RDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDP 326
Query: 240 ND--EPVCPRPFHFD 252
            D  E +  R FHFD
Sbjct: 327 LDLTEGLSER-FHFD 340

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score =  195 bits (495), Expect = 3e-50,   Method: Compositional matrix adjust.
 Identities = 104/255 (40%), Positives = 152/255 (59%), Gaps = 7/255 (2%)
Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQL--TDDHCQYFLYQLLRG 60
           H N++ ++DI    ++   + +Y+V ELM TDL Q+I  DQ++  +  H QYF+Y +L G
Sbjct: 88  HPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIH-DQRIVISPQHIQYFMYHILLG 146
Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 120
           L  +H A V+HRDL P N+LL  + D+ I DF LAR  +     T YV  RWYRAPEL++
Sbjct: 147 LHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVM 206
Query: 121 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 180
               +T  +D+WS GC++ E+  R+ LF G  + +QL  I E++G+P    +    S +A
Sbjct: 207 QFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSA 266
Query: 181 RRYVRQ-LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           R Y+R  L     + +    P     A+DL+ KML F+P +RI+ E+ALRHPY +SL D 
Sbjct: 267 RDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDP 326
Query: 240 ND--EPVCPRPFHFD 252
            D  E +  R FHFD
Sbjct: 327 LDLTEGLSER-FHFD 340

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score =  188 bits (478), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 111/329 (33%), Positives = 171/329 (51%), Gaps = 52/329 (15%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           ++ + +I + D+I P     F+++YIV E+ D+DL ++ ++   LT++H +  LY LL G
Sbjct: 82  LKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLG 141
Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDF---------------- 103
             ++H + ++HRDLKP+N LLN  C +K+ DFGLART  SE D                 
Sbjct: 142 ENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHN 201
Query: 104 ------MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM-----------TREP 146
                 +T +VVTRWYRAPEL+L    YT +IDIWS GCI  E++            R P
Sbjct: 202 KNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFP 261
Query: 147 LFPGKD-----------YVH------QLRLITELIGSPDDASLGFLRSDNARRYVRQLPR 189
           LFPG              VH      QL +I  +IG+P +  L  +      +Y++  P 
Sbjct: 262 LFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPH 321
Query: 190 CRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPF 249
            +      ++P+ S   ++LLE ML F+PNKRIT+++AL HPYL+ +     E    +  
Sbjct: 322 RKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKI 381
Query: 250 HFDFEH-SSCTEDHIRELIWRESVKFNPD 277
              F+     +E  +R +  +E   F+P+
Sbjct: 382 ILPFDDWMVLSETQLRYIFLKEVQSFHPE 410

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score =  184 bits (467), Expect = 5e-47,   Method: Compositional matrix adjust.
 Identities = 106/258 (41%), Positives = 147/258 (56%), Gaps = 16/258 (6%)
Query: 1   MEHENVIAIKDIIRPPKKD---------TFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQ 51
           ++H+N++ + +I+ P               N VYIV E M+TDL  ++     L ++H +
Sbjct: 65  LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGP-LLEEHAR 123
Query: 52  YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTT----SETDFMTE 106
            F+YQLLRGLKY+HSA+VLHRDLKP+NL +N     LKIGDFGLAR      S    ++E
Sbjct: 124 LFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSE 183
Query: 107 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGS 166
            +VT+WYR+P LLL+   YT AID+W+ GCI  E++T + LF G   + Q++LI E I  
Sbjct: 184 GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPV 243
Query: 167 PDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEE 226
             +     L S     Y+R       +      P  S  AVD LE++L F P  R+T EE
Sbjct: 244 VHEEDRQELLS-VIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEE 302
Query: 227 ALRHPYLQSLHDLNDEPV 244
           AL HPY+       DEP+
Sbjct: 303 ALSHPYMSIYSFPMDEPI 320

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score =  181 bits (459), Expect = 4e-46,   Method: Compositional matrix adjust.
 Identities = 111/332 (33%), Positives = 167/332 (50%), Gaps = 55/332 (16%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           ++ + +I + D+I P     F+++YIV E+ D+DL ++ ++   LT+ H +  LY LL G
Sbjct: 84  LKSDYIIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTILYNLLLG 143
Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDF---------------- 103
            K++H + ++HRDLKP+N LLN  C +KI DFGLART  S+ D                 
Sbjct: 144 EKFIHESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPG 203
Query: 104 ---------MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM-----------T 143
                    +T +VVTRWYRAPEL+L    YT +IDIWS GCI  E++            
Sbjct: 204 PHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKSHINNPTN 263
Query: 144 REPLFPGKD-----------YVH------QLRLITELIGSPDDASLGFLRSDNARRYVRQ 186
           R PLFPG              VH      QL +I  +IG+P +  L  +      +Y++ 
Sbjct: 264 RFPLFPGSSCFPLSPDHNSKKVHEKSNRDQLNIIFNVIGTPPEEDLKCITKQEVIKYIKL 323
Query: 187 LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCP 246
            P       + ++ + S   +DLLE ML F+  KRIT+++AL HPYL+ +   N E    
Sbjct: 324 FPTRDGIDLSKKYSSISKEGIDLLESMLRFNAQKRITIDKALSHPYLKDVRKENLENFST 383
Query: 247 RPFHFDFEH-SSCTEDHIRELIWRESVKFNPD 277
                 F+     +E  +R +  +E   F+ D
Sbjct: 384 EKIILPFDDWMVLSETQLRYIFLKEIQSFHAD 415

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  179 bits (453), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 97/241 (40%), Positives = 138/241 (57%), Gaps = 10/241 (4%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDH-CQYFLYQLLR 59
           ++H N++ + DII   K  T     +V+E +D DL Q +     + + H  + FL+QLLR
Sbjct: 57  LKHANIVTLHDIIHTEKSLT-----LVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLR 111
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPEL 118
           GL Y H   VLHRDLKP NLL+N   +LK+ DFGLAR  S  T      VVT WYR P++
Sbjct: 112 GLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDI 171
Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL-GFLRS 177
           LL  T+Y+  ID+W VGCI  E+ T  PLFPG     QL  I  ++G+P + +  G L +
Sbjct: 172 LLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 231
Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH 237
           +  + Y    P+ R +   +  P   S   DLL K+L F+   RI+ E+A++HP+  SL 
Sbjct: 232 EEFKTY--NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289
Query: 238 D 238
           +
Sbjct: 290 E 290

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  174 bits (440), Expect = 6e-44,   Method: Compositional matrix adjust.
 Identities = 94/237 (39%), Positives = 134/237 (56%), Gaps = 10/237 (4%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLL 58
           + H N++ + D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL
Sbjct: 66  LNHPNIVKLLDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 120
Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE
Sbjct: 121 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 180
Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 177
           +LL C  Y+ A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S
Sbjct: 181 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 240
Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
                Y    P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q
Sbjct: 241 --MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 295

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  174 bits (440), Expect = 6e-44,   Method: Compositional matrix adjust.
 Identities = 94/239 (39%), Positives = 135/239 (56%), Gaps = 10/239 (4%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLL 58
           + H N++ + D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL
Sbjct: 63  LNHPNIVKLLDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 117
Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE
Sbjct: 118 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 177
Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 177
           +LL C  Y+ A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S
Sbjct: 178 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 237
Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 236
                Y    P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q +
Sbjct: 238 --MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 294

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  174 bits (440), Expect = 6e-44,   Method: Compositional matrix adjust.
 Identities = 94/237 (39%), Positives = 134/237 (56%), Gaps = 10/237 (4%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLL 58
           + H N++ + D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL
Sbjct: 59  LNHPNIVKLLDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE
Sbjct: 114 QGLSFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 173
Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 177
           +LL C  Y+ A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 233
Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
                Y    P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q
Sbjct: 234 --MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  174 bits (440), Expect = 7e-44,   Method: Compositional matrix adjust.
 Identities = 94/239 (39%), Positives = 135/239 (56%), Gaps = 10/239 (4%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLL 58
           + H N++ + D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL
Sbjct: 58  LNHPNIVKLLDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE
Sbjct: 113 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 172
Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 177
           +LL C  Y+ A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232
Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 236
                Y    P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q +
Sbjct: 233 --MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  174 bits (440), Expect = 7e-44,   Method: Compositional matrix adjust.
 Identities = 94/239 (39%), Positives = 135/239 (56%), Gaps = 10/239 (4%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLL 58
           + H N++ + D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL
Sbjct: 59  LNHPNIVKLLDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE
Sbjct: 114 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 173
Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 177
           +LL C  Y+ A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 233
Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 236
                Y    P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q +
Sbjct: 234 --MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 290

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  174 bits (440), Expect = 7e-44,   Method: Compositional matrix adjust.
 Identities = 94/239 (39%), Positives = 135/239 (56%), Gaps = 10/239 (4%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLL 58
           + H N++ + D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL
Sbjct: 58  LNHPNIVKLLDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE
Sbjct: 113 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 172
Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 177
           +LL C  Y+ A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232
Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 236
                Y    P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q +
Sbjct: 233 --MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  174 bits (440), Expect = 7e-44,   Method: Compositional matrix adjust.
 Identities = 94/239 (39%), Positives = 135/239 (56%), Gaps = 10/239 (4%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLL 58
           + H N++ + D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL
Sbjct: 59  LNHPNIVKLLDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE
Sbjct: 114 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 173
Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 177
           +LL C  Y+ A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 233
Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 236
                Y    P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q +
Sbjct: 234 --MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 290

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  174 bits (440), Expect = 7e-44,   Method: Compositional matrix adjust.
 Identities = 94/239 (39%), Positives = 135/239 (56%), Gaps = 10/239 (4%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLL 58
           + H N++ + D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL
Sbjct: 58  LNHPNIVKLLDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE
Sbjct: 113 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 172
Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 177
           +LL C  Y+ A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232
Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 236
                Y    P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q +
Sbjct: 233 --MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  174 bits (440), Expect = 7e-44,   Method: Compositional matrix adjust.
 Identities = 94/239 (39%), Positives = 135/239 (56%), Gaps = 10/239 (4%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLL 58
           + H N++ + D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL
Sbjct: 59  LNHPNIVKLLDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE
Sbjct: 114 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 173
Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 177
           +LL C  Y+ A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 233
Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 236
                Y    P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q +
Sbjct: 234 --MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 290

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  173 bits (439), Expect = 7e-44,   Method: Compositional matrix adjust.
 Identities = 94/237 (39%), Positives = 134/237 (56%), Gaps = 10/237 (4%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLL 58
           + H N++ + D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL
Sbjct: 60  LNHPNIVKLLDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 114
Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE
Sbjct: 115 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 174
Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 177
           +LL C  Y+ A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 234
Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
                Y    P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q
Sbjct: 235 --MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 289

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  172 bits (437), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 94/239 (39%), Positives = 135/239 (56%), Gaps = 10/239 (4%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLL 58
           + H N++ + D+I      T N +Y+V+E +D DL + + +     +     + +L+QLL
Sbjct: 62  LNHPNIVKLLDVIH-----TENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLL 116
Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE
Sbjct: 117 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 176
Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 177
           +LL C  Y+ A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 236
Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 236
                Y    P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q +
Sbjct: 237 --MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 293

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  172 bits (437), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 93/237 (39%), Positives = 133/237 (56%), Gaps = 10/237 (4%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLL 58
           + H N++ + D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL
Sbjct: 62  LNHPNIVKLLDVIH-----TENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLL 116
Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE
Sbjct: 117 QGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 176
Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 177
           +LL C  Y+ A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 236
Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
                Y    P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q
Sbjct: 237 --MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  172 bits (436), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 93/237 (39%), Positives = 133/237 (56%), Gaps = 10/237 (4%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLL 58
           + H N++ + D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL
Sbjct: 60  LNHPNIVKLLDVIH-----TENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLL 114
Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE
Sbjct: 115 QGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 174
Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 177
           +LL C  Y+ A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 234
Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
                Y    P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q
Sbjct: 235 --MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 289

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  172 bits (435), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 93/237 (39%), Positives = 133/237 (56%), Gaps = 10/237 (4%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLL 58
           + H N++ + D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL
Sbjct: 62  LNHPNIVKLLDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 116
Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE
Sbjct: 117 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 176
Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 177
           +LL C  Y+ A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 236
Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
                Y    P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q
Sbjct: 237 --MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  172 bits (435), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 93/237 (39%), Positives = 133/237 (56%), Gaps = 10/237 (4%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLL 58
           + H N++ + D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL
Sbjct: 61  LNHPNIVKLLDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 115
Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE
Sbjct: 116 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 175
Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 177
           +LL C  Y+ A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 235
Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
                Y    P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q
Sbjct: 236 --MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 290

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  172 bits (435), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 93/239 (38%), Positives = 134/239 (56%), Gaps = 10/239 (4%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLL 58
           + H N++ + D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL
Sbjct: 59  LNHPNIVKLLDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE
Sbjct: 114 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 173
Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 177
           +LL C  Y+ A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 233
Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 236
                Y    P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q +
Sbjct: 234 --MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 290

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  172 bits (435), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 93/239 (38%), Positives = 134/239 (56%), Gaps = 10/239 (4%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLL 58
           + H N++ + D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL
Sbjct: 58  LNHPNIVKLLDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE
Sbjct: 113 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 172
Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 177
           +LL C  Y+ A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232
Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 236
                Y    P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q +
Sbjct: 233 --MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  172 bits (435), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 93/237 (39%), Positives = 133/237 (56%), Gaps = 10/237 (4%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLL 58
           + H N++ + D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL
Sbjct: 63  LNHPNIVKLLDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 117
Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE
Sbjct: 118 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 177
Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 177
           +LL C  Y+ A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S
Sbjct: 178 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 237
Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
                Y    P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q
Sbjct: 238 --MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 292

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  172 bits (435), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 93/239 (38%), Positives = 134/239 (56%), Gaps = 10/239 (4%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLL 58
           + H N++ + D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL
Sbjct: 62  LNHPNIVKLLDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 116
Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE
Sbjct: 117 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 176
Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 177
           +LL C  Y+ A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 236
Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 236
                Y    P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q +
Sbjct: 237 --MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 293

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  172 bits (435), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 93/239 (38%), Positives = 134/239 (56%), Gaps = 10/239 (4%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLL 58
           + H N++ + D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL
Sbjct: 61  LNHPNIVKLLDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 115
Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE
Sbjct: 116 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 175
Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 177
           +LL C  Y+ A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 235
Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 236
                Y    P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q +
Sbjct: 236 --MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 292

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  172 bits (435), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 93/239 (38%), Positives = 134/239 (56%), Gaps = 10/239 (4%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLL 58
           + H N++ + D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL
Sbjct: 58  LNHPNIVKLLDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE
Sbjct: 113 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 172
Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 177
           +LL C  Y+ A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232
Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 236
                Y    P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q +
Sbjct: 233 --MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  172 bits (435), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 93/239 (38%), Positives = 134/239 (56%), Gaps = 10/239 (4%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLL 58
           + H N++ + D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL
Sbjct: 61  LNHPNIVKLLDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 115
Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE
Sbjct: 116 QGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 175
Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 177
           +LL C  Y+ A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 235
Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 236
                Y    P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q +
Sbjct: 236 --MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 292

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  172 bits (435), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 93/239 (38%), Positives = 134/239 (56%), Gaps = 10/239 (4%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLL 58
           + H N++ + D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL
Sbjct: 59  LNHPNIVKLLDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE
Sbjct: 114 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 173
Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 177
           +LL C  Y+ A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 233
Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 236
                Y    P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q +
Sbjct: 234 --MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 290

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  172 bits (435), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 93/239 (38%), Positives = 134/239 (56%), Gaps = 10/239 (4%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLL 58
           + H N++ + D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL
Sbjct: 60  LNHPNIVKLLDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 114
Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE
Sbjct: 115 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 174
Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 177
           +LL C  Y+ A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 234
Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 236
                Y    P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q +
Sbjct: 235 --MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 291

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  171 bits (434), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 93/237 (39%), Positives = 133/237 (56%), Gaps = 10/237 (4%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLL 58
           + H N++ + D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL
Sbjct: 60  LNHPNIVKLLDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 114
Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE
Sbjct: 115 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 174
Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 177
           +LL C  Y+ A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 234
Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
                Y    P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q
Sbjct: 235 --MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 289

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  171 bits (434), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 93/237 (39%), Positives = 133/237 (56%), Gaps = 10/237 (4%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLL 58
           + H N++ + D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL
Sbjct: 59  LNHPNIVKLLDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE
Sbjct: 114 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 173
Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 177
           +LL C  Y+ A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 233
Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
                Y    P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q
Sbjct: 234 --MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  171 bits (434), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 93/239 (38%), Positives = 134/239 (56%), Gaps = 10/239 (4%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLL 58
           + H N++ + D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL
Sbjct: 60  LNHPNIVKLLDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 114
Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE
Sbjct: 115 QGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 174
Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 177
           +LL C  Y+ A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 234
Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 236
                Y    P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q +
Sbjct: 235 --MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 291

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  171 bits (434), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 93/237 (39%), Positives = 132/237 (55%), Gaps = 10/237 (4%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLL 58
           + H N++ + D+I      T N +Y+V+E +  DL   + +     +     + +L+QLL
Sbjct: 61  LNHPNIVKLLDVIH-----TENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLL 115
Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE
Sbjct: 116 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 175
Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 177
           +LL C  Y+ A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 235
Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
                Y    P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q
Sbjct: 236 --MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 290

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  171 bits (434), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 93/237 (39%), Positives = 133/237 (56%), Gaps = 10/237 (4%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLL 58
           + H N++ + D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL
Sbjct: 59  LNHPNIVKLLDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE
Sbjct: 114 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 173
Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 177
           +LL C  Y+ A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 233
Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
                Y    P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q
Sbjct: 234 --MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  171 bits (434), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 93/237 (39%), Positives = 132/237 (55%), Gaps = 10/237 (4%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLL 58
           + H N++ + D+I      T N +Y+V+E +  DL   + +     +     + +L+QLL
Sbjct: 62  LNHPNIVKLLDVIH-----TENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLL 116
Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE
Sbjct: 117 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 176
Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 177
           +LL C  Y+ A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 236
Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
                Y    P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q
Sbjct: 237 --MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  171 bits (432), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 93/239 (38%), Positives = 133/239 (55%), Gaps = 10/239 (4%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLL 58
           + H N++ + D+I      T N +Y+V+E +  DL   + +     +     + +L+QLL
Sbjct: 62  LNHPNIVKLLDVIH-----TENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLL 116
Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE
Sbjct: 117 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 176
Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 177
           +LL C  Y+ A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 236
Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 236
                Y    P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q +
Sbjct: 237 --MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 293

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  171 bits (432), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 93/248 (37%), Positives = 143/248 (57%), Gaps = 28/248 (11%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQ-LTDDHCQYFLYQLLR 59
           + H N++++ D+I   +  T     +V+E M+ DL +++  ++  L D   + +LYQLLR
Sbjct: 76  LHHPNIVSLIDVIHSERCLT-----LVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLR 130
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPEL 118
           G+ + H   +LHRDLKP NLL+N+   LK+ DFGLAR         T  VVT WYRAP++
Sbjct: 131 GVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDV 190
Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 178
           L+   +Y+ ++DIWS+GCI  E++T +PLFPG     QL  I  ++G+P           
Sbjct: 191 LMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTP----------- 239
Query: 179 NARRY--VRQLPRCRKQQF--------ATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL 228
           N R +  V++LP  +++ F        ++  P      +DLL  ML FDPNKRI+  +A+
Sbjct: 240 NPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAM 299
Query: 229 RHPYLQSL 236
            HPY + L
Sbjct: 300 NHPYFKDL 307

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  171 bits (432), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 94/239 (39%), Positives = 134/239 (56%), Gaps = 10/239 (4%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLL 58
           + H N++ + D+I      T N +Y+V+E +  DL   + +     +     + +L+QLL
Sbjct: 58  LNHPNIVKLLDVIH-----TENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLL 112
Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE
Sbjct: 113 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 172
Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 177
           +LL C  Y+ A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232
Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 236
                Y    P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q +
Sbjct: 233 --MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  171 bits (432), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 93/239 (38%), Positives = 133/239 (55%), Gaps = 10/239 (4%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLL 58
           + H N++ + D+I      T N +Y+V+E +  DL   + +     +     + +L+QLL
Sbjct: 59  LNHPNIVKLLDVIH-----TENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLL 113
Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE
Sbjct: 114 QGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 173
Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 177
           +LL C  Y+ A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 233
Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 236
                Y    P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q +
Sbjct: 234 --MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 290

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  171 bits (432), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 93/248 (37%), Positives = 143/248 (57%), Gaps = 28/248 (11%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQ-LTDDHCQYFLYQLLR 59
           + H N++++ D+I   +  T     +V+E M+ DL +++  ++  L D   + +LYQLLR
Sbjct: 76  LHHPNIVSLIDVIHSERCLT-----LVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLR 130
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPEL 118
           G+ + H   +LHRDLKP NLL+N+   LK+ DFGLAR         T  VVT WYRAP++
Sbjct: 131 GVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDV 190
Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 178
           L+   +Y+ ++DIWS+GCI  E++T +PLFPG     QL  I  ++G+P           
Sbjct: 191 LMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTP----------- 239
Query: 179 NARRY--VRQLPRCRKQQF--------ATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL 228
           N R +  V++LP  +++ F        ++  P      +DLL  ML FDPNKRI+  +A+
Sbjct: 240 NPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAM 299
Query: 229 RHPYLQSL 236
            HPY + L
Sbjct: 300 NHPYFKDL 307

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  170 bits (430), Expect = 8e-43,   Method: Compositional matrix adjust.
 Identities = 93/237 (39%), Positives = 133/237 (56%), Gaps = 10/237 (4%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLL 58
           + H N++ + D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL
Sbjct: 66  LNHPNIVKLLDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 120
Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE
Sbjct: 121 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 180
Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 177
           +LL    Y+ A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S
Sbjct: 181 ILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 240
Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
                Y    P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q
Sbjct: 241 --MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 295

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  170 bits (430), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 93/237 (39%), Positives = 133/237 (56%), Gaps = 10/237 (4%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLL 58
           + H N++ + D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL
Sbjct: 59  LNHPNIVKLLDVIH-----TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE
Sbjct: 114 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 173
Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 177
           +LL    Y+ A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+     + S
Sbjct: 174 ILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 233
Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
                Y    P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q
Sbjct: 234 --MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  162 bits (410), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 94/245 (38%), Positives = 145/245 (59%), Gaps = 19/245 (7%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS------DQQLTDDHCQYFL 54
           ++HEN++ + D+I      T N + +V+E MD DL + + S       + L  +  +YF 
Sbjct: 60  LKHENIVRLYDVIH-----TENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQ 114
Query: 55  YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWY 113
           +QLL+GL + H   +LHRDLKP NLL+N    LK+GDFGLAR      +  +  VVT WY
Sbjct: 115 WQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWY 174
Query: 114 RAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA--- 170
           RAP++L+    Y+ +IDIWS GCIL E++T +PLFPG +   QL+LI +++G+P+++   
Sbjct: 175 RAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWP 234
Query: 171 SLGFLRSDNARRYVRQLPRCRKQ--QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL 228
           S+  L   N     R  PR  +Q  Q  T+ P      +D L  +L  +P+ R++ ++AL
Sbjct: 235 SVTKLPKYNPNIQQRP-PRDLRQVLQPHTKEP-LDGNLMDFLHGLLQLNPDMRLSAKQAL 292
Query: 229 RHPYL 233
            HP+ 
Sbjct: 293 HHPWF 297

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  157 bits (398), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 89/236 (37%), Positives = 128/236 (54%), Gaps = 9/236 (3%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLR 59
           ++H N++ + D+I   K+     + +V+E +D DL +++   +  L     + FL QLL 
Sbjct: 57  LKHSNIVKLYDVIHTKKR-----LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLN 111
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPEL 118
           G+ Y H   VLHRDLKP NLL+N   +LKI DFGLAR         T  VVT WYRAP++
Sbjct: 112 GIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDV 171
Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 178
           L+   +Y+  IDIWSVGCI  E++   PLFPG     QL  I  ++G+P+  S  +    
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPN--SKNWPNVT 229
Query: 179 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
              +Y           + +         +DLL KML  DPN+RIT ++AL H Y +
Sbjct: 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  157 bits (398), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 89/236 (37%), Positives = 128/236 (54%), Gaps = 9/236 (3%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLR 59
           ++H N++ + D+I   K+     + +V+E +D DL +++   +  L     + FL QLL 
Sbjct: 57  LKHSNIVKLYDVIHTKKR-----LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLN 111
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPEL 118
           G+ Y H   VLHRDLKP NLL+N   +LKI DFGLAR         T  VVT WYRAP++
Sbjct: 112 GIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDV 171
Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 178
           L+   +Y+  IDIWSVGCI  E++   PLFPG     QL  I  ++G+P+  S  +    
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPN--SKNWPNVT 229
Query: 179 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
              +Y           + +         +DLL KML  DPN+RIT ++AL H Y +
Sbjct: 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  157 bits (397), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 88/236 (37%), Positives = 128/236 (54%), Gaps = 9/236 (3%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLR 59
           ++H N++ + D+I   K+     + +V+E +D DL +++   +  L     + FL QLL 
Sbjct: 57  LKHSNIVKLYDVIHTKKR-----LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLN 111
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPEL 118
           G+ Y H   VLHRDLKP NLL+N   +LKI DFGLAR         T  +VT WYRAP++
Sbjct: 112 GIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDV 171
Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 178
           L+   +Y+  IDIWSVGCI  E++   PLFPG     QL  I  ++G+P+  S  +    
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPN--SKNWPNVT 229
Query: 179 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
              +Y           + +         +DLL KML  DPN+RIT ++AL H Y +
Sbjct: 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  152 bits (384), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 93/241 (38%), Positives = 131/241 (54%), Gaps = 13/241 (5%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS--DQQLTDDHCQYFLYQLL 58
            EH NV+ + D+    + D    + +V+E +D DL   +    +  +  +  +  ++QLL
Sbjct: 71  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 130
Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPEL 118
           RGL ++HS  V+HRDLKP N+L+ +S  +K+ DFGLAR  S    +T  VVT WYRAPE+
Sbjct: 131 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV 190
Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 178
           LL  + Y   +D+WSVGCI  E+  R+PLF G   V QL  I ++IG P +        D
Sbjct: 191 LLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE-------ED 242
Query: 179 NARRYV--RQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
             R     RQ    +  Q   +F  +      DLL K L F+P KRI+   AL HPY Q 
Sbjct: 243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 302
Query: 236 L 236
           L
Sbjct: 303 L 303

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  152 bits (383), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 93/241 (38%), Positives = 131/241 (54%), Gaps = 13/241 (5%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS--DQQLTDDHCQYFLYQLL 58
            EH NV+ + D+    + D    + +V+E +D DL   +    +  +  +  +  ++QLL
Sbjct: 71  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 130
Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPEL 118
           RGL ++HS  V+HRDLKP N+L+ +S  +K+ DFGLAR  S    +T  VVT WYRAPE+
Sbjct: 131 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV 190
Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 178
           LL  + Y   +D+WSVGCI  E+  R+PLF G   V QL  I ++IG P +        D
Sbjct: 191 LLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE-------ED 242
Query: 179 NARRYV--RQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
             R     RQ    +  Q   +F  +      DLL K L F+P KRI+   AL HPY Q 
Sbjct: 243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 302
Query: 236 L 236
           L
Sbjct: 303 L 303

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  150 bits (380), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 92/239 (38%), Positives = 130/239 (54%), Gaps = 13/239 (5%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS--DQQLTDDHCQYFLYQLL 58
            EH NV+ + D+    + D    + +V+E +D DL   +    +  +  +  +  ++QLL
Sbjct: 71  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 130
Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPEL 118
           RGL ++HS  V+HRDLKP N+L+ +S  +K+ DFGLAR  S    +T  VVT WYRAPE+
Sbjct: 131 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV 190
Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 178
           LL  + Y   +D+WSVGCI  E+  R+PLF G   V QL  I ++IG P +        D
Sbjct: 191 LLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE-------ED 242
Query: 179 NARRYV--RQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
             R     RQ    +  Q   +F  +      DLL K L F+P KRI+   AL HPY Q
Sbjct: 243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  150 bits (380), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 87/236 (36%), Positives = 130/236 (55%), Gaps = 10/236 (4%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLR 59
           ++H+N++ + D++   KK T     +V+E  D DL +   S +  L  +  + FL+QLL+
Sbjct: 58  LKHKNIVRLHDVLHSDKKLT-----LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLK 112
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPEL 118
           GL + HS +VLHRDLKP NLL+N + +LK+ DFGLAR         +  VVT WYR P++
Sbjct: 113 GLGFCHSRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDV 172
Query: 119 LLNCTEYTAAIDIWSVGCILGEIM-TREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 177
           L     Y+ +ID+WS GCI  E+     PLFPG D   QL+ I  L+G+P +     +  
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232
Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
               +     P           P  ++   DLL+ +L  +P +RI+ EEAL+HPY 
Sbjct: 233 LPDYKPYPMYPAT--TSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  149 bits (375), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 86/236 (36%), Positives = 130/236 (55%), Gaps = 10/236 (4%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLR 59
           ++H+N++ + D++   KK T     +V+E  D DL +   S +  L  +  + FL+QLL+
Sbjct: 58  LKHKNIVRLHDVLHSDKKLT-----LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLK 112
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPEL 118
           GL + HS +VLHRDLKP NLL+N + +LK+ +FGLAR         +  VVT WYR P++
Sbjct: 113 GLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDV 172
Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 177
           L     Y+ +ID+WS GCI  E+     PLFPG D   QL+ I  L+G+P +     +  
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232
Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
               +     P           P  ++   DLL+ +L  +P +RI+ EEAL+HPY 
Sbjct: 233 LPDYKPYPMYPAT--TSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score =  147 bits (372), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 79/233 (33%), Positives = 137/233 (58%), Gaps = 7/233 (3%)
Query: 10  KDIIRPPKKDTFNDVYIVY--ELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA 67
           K +I  P ++ + +V + Y  + +   L   IRS + +  +    ++YQL R + ++HS 
Sbjct: 101 KSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL 160
Query: 68  SVLHRDLKPSNLLLNASCD-LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYT 126
            + HRD+KP NLL+N+  + LK+ DFG A+    ++     + +R+YRAPEL+L  TEYT
Sbjct: 161 GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAXICSRFYRAPELMLGATEYT 220
Query: 127 AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ 186
            +ID+WS+GC+ GE++  +PLF G+  + QL  I +++G+P    +  +R +     VR 
Sbjct: 221 PSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQM--IRMNPHYTEVR- 277
Query: 187 LPRCRKQQFATRFPNKS-SGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 238
            P  + + +    P  + S A+DLLE++L ++P+ RI   EA+ HP+   L +
Sbjct: 278 FPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRN 330

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score =  147 bits (370), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 91/240 (37%), Positives = 126/240 (52%), Gaps = 17/240 (7%)
Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQII--RSDQQLTDDHCQYFLYQLLR 59
           EH NV+ + D+    + D    V +V+E +D DL   +       L  +  +  + Q LR
Sbjct: 72  EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLR 131
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GL ++H+  ++HRDLKP N+L+ +   +K+ DFGLAR  S    +T  VVT WYRAPE+L
Sbjct: 132 GLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVL 191
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           L  T Y   +D+WSVGCI  E+  R+PLF G     QL  I +LIG P +        D+
Sbjct: 192 LQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE--------DD 242
Query: 180 ARRYVRQLPRCRKQQFATR-----FPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
             R V  LPR        R      P        LL +ML F+P+KRI+   AL+H YL 
Sbjct: 243 WPRDV-SLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH 301

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  146 bits (368), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 85/250 (34%), Positives = 130/250 (52%), Gaps = 10/250 (4%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ-QLTDDHCQYFLYQLLR 59
           + H N+I + D          +++ +V++ M+TDL  II+ +   LT  H + ++   L+
Sbjct: 69  LSHPNIIGLLDAF-----GHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQ 123
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPEL 118
           GL+Y+H   +LHRDLKP+NLLL+ +  LK+ DFGLA++  S        VVTRWYRAPEL
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPEL 183
Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 178
           L     Y   +D+W+VGCIL E++ R P  PG   + QL  I E +G+P +     + S 
Sbjct: 184 LFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 243
Query: 179 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 238
                 +  P          F       +DL++ + +F+P  RIT  +AL+  Y  +   
Sbjct: 244 PDYVTFKSFPGIPLHHI---FSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 300
Query: 239 LNDEPVCPRP 248
                  PRP
Sbjct: 301 PTPGCQLPRP 310

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  145 bits (367), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 73/188 (38%), Positives = 111/188 (59%), Gaps = 5/188 (2%)
Query: 51  QYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVV 109
           + ++YQLLR L Y+HS  + HRD+KP NLLL+  S  LK+ DFG A+     +     + 
Sbjct: 144 KLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXIC 203
Query: 110 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDD 169
           +R+YRAPEL+   T YT  IDIWS GC++ E+M  +PLFPG+  + QL  I +++G+P  
Sbjct: 204 SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSR 263
Query: 170 ASLGFLRSDNARRYVRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEAL 228
                +++ N      + P+ R   F+  F P     A+DL+ ++L + P+ R+T  EAL
Sbjct: 264 EQ---IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEAL 320
Query: 229 RHPYLQSL 236
            HP+   L
Sbjct: 321 CHPFFDEL 328

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  145 bits (366), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 90/240 (37%), Positives = 125/240 (52%), Gaps = 17/240 (7%)
Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQII--RSDQQLTDDHCQYFLYQLLR 59
           EH NV+ + D+    + D    V +V+E +D DL   +       L  +  +  + Q LR
Sbjct: 64  EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLR 123
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GL ++H+  ++HRDLKP N+L+ +   +K+ DFGLAR  S    +   VVT WYRAPE+L
Sbjct: 124 GLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVVTLWYRAPEVL 183
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           L  T Y   +D+WSVGCI  E+  R+PLF G     QL  I +LIG P +        D+
Sbjct: 184 LQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE--------DD 234
Query: 180 ARRYVRQLPRCRKQQFATR-----FPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
             R V  LPR        R      P        LL +ML F+P+KRI+   AL+H YL 
Sbjct: 235 WPRDV-SLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH 293

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  144 bits (364), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 90/240 (37%), Positives = 125/240 (52%), Gaps = 17/240 (7%)
Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQII--RSDQQLTDDHCQYFLYQLLR 59
           EH NV+ + D+    + D    V +V+E +D DL   +       L  +  +  + Q LR
Sbjct: 64  EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLR 123
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GL ++H+  ++HRDLKP N+L+ +   +K+ DFGLAR  S    +   VVT WYRAPE+L
Sbjct: 124 GLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTLWYRAPEVL 183
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           L  T Y   +D+WSVGCI  E+  R+PLF G     QL  I +LIG P +        D+
Sbjct: 184 LQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE--------DD 234
Query: 180 ARRYVRQLPRCRKQQFATR-----FPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
             R V  LPR        R      P        LL +ML F+P+KRI+   AL+H YL 
Sbjct: 235 WPRDV-SLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH 293

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  144 bits (363), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 90/240 (37%), Positives = 125/240 (52%), Gaps = 17/240 (7%)
Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQII--RSDQQLTDDHCQYFLYQLLR 59
           EH NV+ + D+    + D    V +V+E +D DL   +       L  +  +  + Q LR
Sbjct: 64  EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLR 123
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GL ++H+  ++HRDLKP N+L+ +   +K+ DFGLAR  S    +   VVT WYRAPE+L
Sbjct: 124 GLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVTLWYRAPEVL 183
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           L  T Y   +D+WSVGCI  E+  R+PLF G     QL  I +LIG P +        D+
Sbjct: 184 LQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE--------DD 234
Query: 180 ARRYVRQLPRCRKQQFATR-----FPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
             R V  LPR        R      P        LL +ML F+P+KRI+   AL+H YL 
Sbjct: 235 WPRDV-SLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH 293

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  143 bits (360), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 85/241 (35%), Positives = 130/241 (53%), Gaps = 14/241 (5%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           ++H N+I +K +I    +     +++++E  + DL + +  +  ++    + FLYQL+ G
Sbjct: 90  LQHRNIIELKSVIHHNHR-----LHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLING 144
Query: 61  LKYVHSASVLHRDLKPSNLLLNASCD-----LKIGDFGLARTTS-ETDFMTEYVVTRWYR 114
           + + HS   LHRDLKP NLLL+ S       LKIGDFGLAR         T  ++T WYR
Sbjct: 145 VNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYR 204
Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF 174
            PE+LL    Y+ ++DIWS+ CI  E++ + PLFPG   + QL  I E++G PDD +   
Sbjct: 205 PPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPG 264
Query: 175 LRSDNARRYVRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
           + +     + +  P+ R +              +DLL  ML  DP KRI+ + AL HPY 
Sbjct: 265 VTA--LPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYF 322
Query: 234 Q 234
Sbjct: 323 S 323

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 75/243 (30%), Positives = 137/243 (56%), Gaps = 7/243 (2%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++H N++ + ++ R  ++     +++V+E  D T LH++ R  + + +   +   +Q L+
Sbjct: 59  LKHPNLVNLLEVFRRKRR-----LHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQ 113
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPEL 118
            + + H  + +HRD+KP N+L+     +K+ DFG AR  T  +D+  + V TRWYR+PEL
Sbjct: 114 AVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPEL 173
Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 178
           L+  T+Y   +D+W++GC+  E+++  PL+PGK  V QL LI + +G           ++
Sbjct: 174 LVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN 233
Query: 179 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 238
                V+       +    +FPN S  A+ LL+  L  DP +R+T E+ L HPY +++ +
Sbjct: 234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293
Query: 239 LND 241
           + D
Sbjct: 294 IED 296

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 72/203 (35%), Positives = 113/203 (55%), Gaps = 5/203 (2%)
Query: 40  RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTT 98
           R+ Q L   + + ++YQL R L Y+HS  + HRD+KP NLLL+  +  LK+ DFG A+  
Sbjct: 114 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173
Query: 99  SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR 158
              +    Y+ +R+YRAPEL+   T+YT++ID+WS GC+L E++  +P+FPG   V QL 
Sbjct: 174 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233
Query: 159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFD 217
            I +++G+P       +R  N      + P+ +   +   F P     A+ L  ++L + 
Sbjct: 234 EIIKVLGTPTREQ---IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYT 290
Query: 218 PNKRITVEEALRHPYLQSLHDLN 240
           P  R+T  EA  H +   L D N
Sbjct: 291 PTARLTPLEACAHSFFDELRDPN 313

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  139 bits (350), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 72/203 (35%), Positives = 113/203 (55%), Gaps = 5/203 (2%)
Query: 40  RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTT 98
           R+ Q L   + + ++YQL R L Y+HS  + HRD+KP NLLL+  +  LK+ DFG A+  
Sbjct: 114 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173
Query: 99  SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR 158
              +    Y+ +R+YRAPEL+   T+YT++ID+WS GC+L E++  +P+FPG   V QL 
Sbjct: 174 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233
Query: 159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFD 217
            I +++G+P       +R  N      + P+ +   +   F P     A+ L  ++L + 
Sbjct: 234 EIIKVLGTPTREQ---IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYT 290
Query: 218 PNKRITVEEALRHPYLQSLHDLN 240
           P  R+T  EA  H +   L D N
Sbjct: 291 PTARLTPLEACAHSFFDELRDPN 313

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  139 bits (350), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 72/203 (35%), Positives = 113/203 (55%), Gaps = 5/203 (2%)
Query: 40  RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTT 98
           R+ Q L   + + ++YQL R L Y+HS  + HRD+KP NLLL+  +  LK+ DFG A+  
Sbjct: 150 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 209
Query: 99  SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR 158
              +    Y+ +R+YRAPEL+   T+YT++ID+WS GC+L E++  +P+FPG   V QL 
Sbjct: 210 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 269
Query: 159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFD 217
            I +++G+P       +R  N      + P+ +   +   F P     A+ L  ++L + 
Sbjct: 270 EIIKVLGTPTREQ---IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYT 326
Query: 218 PNKRITVEEALRHPYLQSLHDLN 240
           P  R+T  EA  H +   L D N
Sbjct: 327 PTARLTPLEACAHSFFDELRDPN 349

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  139 bits (350), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 72/203 (35%), Positives = 113/203 (55%), Gaps = 5/203 (2%)
Query: 40  RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTT 98
           R+ Q L   + + ++YQL R L Y+HS  + HRD+KP NLLL+  +  LK+ DFG A+  
Sbjct: 127 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 186
Query: 99  SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR 158
              +    Y+ +R+YRAPEL+   T+YT++ID+WS GC+L E++  +P+FPG   V QL 
Sbjct: 187 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 246
Query: 159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFD 217
            I +++G+P       +R  N      + P+ +   +   F P     A+ L  ++L + 
Sbjct: 247 EIIKVLGTPTREQ---IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYT 303
Query: 218 PNKRITVEEALRHPYLQSLHDLN 240
           P  R+T  EA  H +   L D N
Sbjct: 304 PTARLTPLEACAHSFFDELRDPN 326

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  139 bits (349), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 72/203 (35%), Positives = 113/203 (55%), Gaps = 5/203 (2%)
Query: 40  RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTT 98
           R+ Q L   + + ++YQL R L Y+HS  + HRD+KP NLLL+  +  LK+ DFG A+  
Sbjct: 148 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207
Query: 99  SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR 158
              +    Y+ +R+YRAPEL+   T+YT++ID+WS GC+L E++  +P+FPG   V QL 
Sbjct: 208 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 267
Query: 159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFD 217
            I +++G+P       +R  N      + P+ +   +   F P     A+ L  ++L + 
Sbjct: 268 EIIKVLGTPTREQ---IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYT 324
Query: 218 PNKRITVEEALRHPYLQSLHDLN 240
           P  R+T  EA  H +   L D N
Sbjct: 325 PTARLTPLEACAHSFFDELRDPN 347

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  139 bits (349), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 72/203 (35%), Positives = 113/203 (55%), Gaps = 5/203 (2%)
Query: 40  RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTT 98
           R+ Q L   + + ++YQL R L Y+HS  + HRD+KP NLLL+  +  LK+ DFG A+  
Sbjct: 142 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 201
Query: 99  SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR 158
              +    Y+ +R+YRAPEL+   T+YT++ID+WS GC+L E++  +P+FPG   V QL 
Sbjct: 202 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 261
Query: 159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFD 217
            I +++G+P       +R  N      + P+ +   +   F P     A+ L  ++L + 
Sbjct: 262 EIIKVLGTPTREQ---IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYT 318
Query: 218 PNKRITVEEALRHPYLQSLHDLN 240
           P  R+T  EA  H +   L D N
Sbjct: 319 PTARLTPLEACAHSFFDELRDPN 341

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  139 bits (349), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 72/203 (35%), Positives = 113/203 (55%), Gaps = 5/203 (2%)
Query: 40  RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTT 98
           R+ Q L   + + ++YQL R L Y+HS  + HRD+KP NLLL+  +  LK+ DFG A+  
Sbjct: 119 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 178
Query: 99  SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR 158
              +    Y+ +R+YRAPEL+   T+YT++ID+WS GC+L E++  +P+FPG   V QL 
Sbjct: 179 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 238
Query: 159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFD 217
            I +++G+P       +R  N      + P+ +   +   F P     A+ L  ++L + 
Sbjct: 239 EIIKVLGTPTREQ---IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYT 295
Query: 218 PNKRITVEEALRHPYLQSLHDLN 240
           P  R+T  EA  H +   L D N
Sbjct: 296 PTARLTPLEACAHSFFDELRDPN 318

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  139 bits (349), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 72/203 (35%), Positives = 113/203 (55%), Gaps = 5/203 (2%)
Query: 40  RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTT 98
           R+ Q L   + + ++YQL R L Y+HS  + HRD+KP NLLL+  +  LK+ DFG A+  
Sbjct: 152 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 211
Query: 99  SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR 158
              +    Y+ +R+YRAPEL+   T+YT++ID+WS GC+L E++  +P+FPG   V QL 
Sbjct: 212 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 271
Query: 159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFD 217
            I +++G+P       +R  N      + P+ +   +   F P     A+ L  ++L + 
Sbjct: 272 EIIKVLGTPTREQ---IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYT 328
Query: 218 PNKRITVEEALRHPYLQSLHDLN 240
           P  R+T  EA  H +   L D N
Sbjct: 329 PTARLTPLEACAHSFFDELRDPN 351

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  138 bits (348), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 72/203 (35%), Positives = 113/203 (55%), Gaps = 5/203 (2%)
Query: 40  RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTT 98
           R+ Q L   + + ++YQL R L Y+HS  + HRD+KP NLLL+  +  LK+ DFG A+  
Sbjct: 193 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 252
Query: 99  SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR 158
              +    Y+ +R+YRAPEL+   T+YT++ID+WS GC+L E++  +P+FPG   V QL 
Sbjct: 253 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 312
Query: 159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFD 217
            I +++G+P       +R  N      + P+ +   +   F P     A+ L  ++L + 
Sbjct: 313 EIIKVLGTPTREQ---IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYT 369
Query: 218 PNKRITVEEALRHPYLQSLHDLN 240
           P  R+T  EA  H +   L D N
Sbjct: 370 PTARLTPLEACAHSFFDELRDPN 392

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  138 bits (348), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 72/203 (35%), Positives = 112/203 (55%), Gaps = 5/203 (2%)
Query: 40  RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTT 98
           R+ Q L   + + ++YQL R L Y+HS  + HRD+KP NLLL+  +  LK+ DFG A+  
Sbjct: 114 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173
Query: 99  SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR 158
              +    Y+ +R+YRAPEL+   T+YT++ID+WS GC+L E++  +P+FPG   V QL 
Sbjct: 174 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233
Query: 159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFD 217
            I +++G+P       +R  N        P+ +   +   F P     A+ L  ++L + 
Sbjct: 234 EIIKVLGTPTREQ---IREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYT 290
Query: 218 PNKRITVEEALRHPYLQSLHDLN 240
           P  R+T  EA  H +   L D N
Sbjct: 291 PTARLTPLEACAHSFFDELRDPN 313

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score =  137 bits (346), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 85/247 (34%), Positives = 133/247 (53%), Gaps = 14/247 (5%)
Query: 1   MEHENVIAIKDIIR---PPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQ 56
           ++HENV+ + +I R    P       +Y+V++  + DL  ++ +   + T    +  +  
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 133
Query: 57  LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-----TSETDFMTEYVVTR 111
           LL GL Y+H   +LHRD+K +N+L+     LK+ DFGLAR       S+ +     VVT 
Sbjct: 134 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTL 193
Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDAS 171
           WYR PELLL   +Y   ID+W  GCI+ E+ TR P+  G    HQL LI++L GS     
Sbjct: 194 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 253
Query: 172 LGFLRSDNARRYVR-QLPRCRKQQFATRFPN--KSSGAVDLLEKMLVFDPNKRITVEEAL 228
             +   DN   Y + +L + +K++   R     +   A+DL++K+LV DP +RI  ++AL
Sbjct: 254 --WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 311
Query: 229 RHPYLQS 235
            H +  S
Sbjct: 312 NHDFFWS 318

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score =  137 bits (346), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 85/247 (34%), Positives = 133/247 (53%), Gaps = 14/247 (5%)
Query: 1   MEHENVIAIKDIIR---PPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQ 56
           ++HENV+ + +I R    P       +Y+V++  + DL  ++ +   + T    +  +  
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 133
Query: 57  LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-----TSETDFMTEYVVTR 111
           LL GL Y+H   +LHRD+K +N+L+     LK+ DFGLAR       S+ +     VVT 
Sbjct: 134 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTL 193
Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDAS 171
           WYR PELLL   +Y   ID+W  GCI+ E+ TR P+  G    HQL LI++L GS     
Sbjct: 194 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 253
Query: 172 LGFLRSDNARRYVR-QLPRCRKQQFATRFPN--KSSGAVDLLEKMLVFDPNKRITVEEAL 228
             +   DN   Y + +L + +K++   R     +   A+DL++K+LV DP +RI  ++AL
Sbjct: 254 --WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 311
Query: 229 RHPYLQS 235
            H +  S
Sbjct: 312 NHDFFWS 318

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score =  137 bits (346), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 85/247 (34%), Positives = 133/247 (53%), Gaps = 14/247 (5%)
Query: 1   MEHENVIAIKDIIR---PPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQ 56
           ++HENV+ + +I R    P       +Y+V++  + DL  ++ +   + T    +  +  
Sbjct: 73  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 132
Query: 57  LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-----TSETDFMTEYVVTR 111
           LL GL Y+H   +LHRD+K +N+L+     LK+ DFGLAR       S+ +     VVT 
Sbjct: 133 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTL 192
Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDAS 171
           WYR PELLL   +Y   ID+W  GCI+ E+ TR P+  G    HQL LI++L GS     
Sbjct: 193 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 252
Query: 172 LGFLRSDNARRYVR-QLPRCRKQQFATRFPN--KSSGAVDLLEKMLVFDPNKRITVEEAL 228
             +   DN   Y + +L + +K++   R     +   A+DL++K+LV DP +RI  ++AL
Sbjct: 253 --WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 310
Query: 229 RHPYLQS 235
            H +  S
Sbjct: 311 NHDFFWS 317

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score =  137 bits (344), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 86/248 (34%), Positives = 135/248 (54%), Gaps = 16/248 (6%)
Query: 1   MEHENVIAIKDIIRPPKKDTFN----DVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLY 55
           ++HENV+ + +I R  K   +N     +Y+V++  + DL  ++ +   + T    +  + 
Sbjct: 74  LKHENVVNLIEICRT-KASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQ 132
Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-----TSETDFMTEYVVT 110
            LL GL Y+H   +LHRD+K +N+L+     LK+ DFGLAR       S+ +     VVT
Sbjct: 133 MLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVT 192
Query: 111 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA 170
            WYR PELLL   +Y   ID+W  GCI+ E+ TR P+  G    HQL LI++L GS    
Sbjct: 193 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 252
Query: 171 SLGFLRSDNARRYVR-QLPRCRKQQFATRFPN--KSSGAVDLLEKMLVFDPNKRITVEEA 227
              +   DN   Y + +L + +K++   R     +   A+DL++K+LV DP +RI  ++A
Sbjct: 253 V--WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 310
Query: 228 LRHPYLQS 235
           L H +  S
Sbjct: 311 LNHDFFWS 318

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  136 bits (343), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 79/237 (33%), Positives = 131/237 (55%), Gaps = 9/237 (3%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + HEN++ + ++ +  K+      Y+V+E +D T L  +      L     Q +L+Q++ 
Sbjct: 81  LRHENLVNLLEVCKKKKR-----WYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIIN 135
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPEL 118
           G+ + HS +++HRD+KP N+L++ S  +K+ DFG ART  +  +   + V TRWYRAPEL
Sbjct: 136 GIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPEL 195
Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 178
           L+   +Y  A+D+W++GC++ E+   EPLFPG   + QL  I   +G+           +
Sbjct: 196 LVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255
Query: 179 NARRYVRQLPRCRKQQ-FATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
                VR LP  ++++    R+P  S   +DL +K L  DP+KR    E L H + Q
Sbjct: 256 PVFAGVR-LPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ 311

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  136 bits (342), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 71/203 (34%), Positives = 112/203 (55%), Gaps = 5/203 (2%)
Query: 40  RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTT 98
           R+ Q L   + + ++YQL R L Y+HS  + HRD+KP NLLL+  +  LK+ DFG A+  
Sbjct: 114 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173
Query: 99  SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR 158
              +     + +R+YRAPEL+   T+YT++ID+WS GC+L E++  +P+FPG   V QL 
Sbjct: 174 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233
Query: 159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFD 217
            I +++G+P       +R  N      + P+ +   +   F P     A+ L  ++L + 
Sbjct: 234 EIIKVLGTPTREQ---IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYT 290
Query: 218 PNKRITVEEALRHPYLQSLHDLN 240
           P  R+T  EA  H +   L D N
Sbjct: 291 PTARLTPLEACAHSFFDELRDPN 313

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  136 bits (342), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 71/203 (34%), Positives = 112/203 (55%), Gaps = 5/203 (2%)
Query: 40  RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTT 98
           R+ Q L   + + ++YQL R L Y+HS  + HRD+KP NLLL+  +  LK+ DFG A+  
Sbjct: 114 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173
Query: 99  SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR 158
              +     + +R+YRAPEL+   T+YT++ID+WS GC+L E++  +P+FPG   V QL 
Sbjct: 174 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233
Query: 159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFD 217
            I +++G+P       +R  N      + P+ +   +   F P     A+ L  ++L + 
Sbjct: 234 EIIKVLGTPTREQ---IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYT 290
Query: 218 PNKRITVEEALRHPYLQSLHDLN 240
           P  R+T  EA  H +   L D N
Sbjct: 291 PTARLTPLEACAHSFFDELRDPN 313

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  136 bits (342), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 71/203 (34%), Positives = 112/203 (55%), Gaps = 5/203 (2%)
Query: 40  RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTT 98
           R+ Q L   + + ++YQL R L Y+HS  + HRD+KP NLLL+  +  LK+ DFG A+  
Sbjct: 115 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 174
Query: 99  SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR 158
              +     + +R+YRAPEL+   T+YT++ID+WS GC+L E++  +P+FPG   V QL 
Sbjct: 175 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 234
Query: 159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFD 217
            I +++G+P       +R  N      + P+ +   +   F P     A+ L  ++L + 
Sbjct: 235 EIIKVLGTPTREQ---IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYT 291
Query: 218 PNKRITVEEALRHPYLQSLHDLN 240
           P  R+T  EA  H +   L D N
Sbjct: 292 PTARLTPLEACAHSFFDELRDPN 314

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  136 bits (342), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 71/203 (34%), Positives = 112/203 (55%), Gaps = 5/203 (2%)
Query: 40  RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTT 98
           R+ Q L   + + ++YQL R L Y+HS  + HRD+KP NLLL+  +  LK+ DFG A+  
Sbjct: 114 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173
Query: 99  SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR 158
              +     + +R+YRAPEL+   T+YT++ID+WS GC+L E++  +P+FPG   V QL 
Sbjct: 174 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233
Query: 159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFD 217
            I +++G+P       +R  N      + P+ +   +   F P     A+ L  ++L + 
Sbjct: 234 EIIKVLGTPTREQ---IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYT 290
Query: 218 PNKRITVEEALRHPYLQSLHDLN 240
           P  R+T  EA  H +   L D N
Sbjct: 291 PTARLTPLEACAHSFFDELRDPN 313

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  136 bits (342), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 71/203 (34%), Positives = 112/203 (55%), Gaps = 5/203 (2%)
Query: 40  RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTT 98
           R+ Q L   + + ++YQL R L Y+HS  + HRD+KP NLLL+  +  LK+ DFG A+  
Sbjct: 126 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 185
Query: 99  SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR 158
              +     + +R+YRAPEL+   T+YT++ID+WS GC+L E++  +P+FPG   V QL 
Sbjct: 186 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 245
Query: 159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFD 217
            I +++G+P       +R  N      + P+ +   +   F P     A+ L  ++L + 
Sbjct: 246 EIIKVLGTPTREQ---IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYT 302
Query: 218 PNKRITVEEALRHPYLQSLHDLN 240
           P  R+T  EA  H +   L D N
Sbjct: 303 PTARLTPLEACAHSFFDELRDPN 325

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 71/203 (34%), Positives = 112/203 (55%), Gaps = 5/203 (2%)
Query: 40  RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTT 98
           R+ Q L   + + ++YQL R L Y+HS  + HRD+KP NLLL+  +  LK+ DFG A+  
Sbjct: 122 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 181
Query: 99  SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR 158
              +     + +R+YRAPEL+   T+YT++ID+WS GC+L E++  +P+FPG   V QL 
Sbjct: 182 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 241
Query: 159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFD 217
            I +++G+P       +R  N      + P+ +   +   F P     A+ L  ++L + 
Sbjct: 242 EIIKVLGTPTREQ---IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYT 298
Query: 218 PNKRITVEEALRHPYLQSLHDLN 240
           P  R+T  EA  H +   L D N
Sbjct: 299 PTARLTPLEACAHSFFDELRDPN 321

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 71/203 (34%), Positives = 112/203 (55%), Gaps = 5/203 (2%)
Query: 40  RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTT 98
           R+ Q L   + + ++YQL R L Y+HS  + HRD+KP NLLL+  +  LK+ DFG A+  
Sbjct: 133 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 192
Query: 99  SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR 158
              +     + +R+YRAPEL+   T+YT++ID+WS GC+L E++  +P+FPG   V QL 
Sbjct: 193 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 252
Query: 159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFD 217
            I +++G+P       +R  N      + P+ +   +   F P     A+ L  ++L + 
Sbjct: 253 EIIKVLGTPTREQ---IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYT 309
Query: 218 PNKRITVEEALRHPYLQSLHDLN 240
           P  R+T  EA  H +   L D N
Sbjct: 310 PTARLTPLEACAHSFFDELRDPN 332

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 71/203 (34%), Positives = 112/203 (55%), Gaps = 5/203 (2%)
Query: 40  RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTT 98
           R+ Q L   + + ++YQL R L Y+HS  + HRD+KP NLLL+  +  LK+ DFG A+  
Sbjct: 118 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 177
Query: 99  SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR 158
              +     + +R+YRAPEL+   T+YT++ID+WS GC+L E++  +P+FPG   V QL 
Sbjct: 178 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 237
Query: 159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFD 217
            I +++G+P       +R  N      + P+ +   +   F P     A+ L  ++L + 
Sbjct: 238 EIIKVLGTPTREQ---IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYT 294
Query: 218 PNKRITVEEALRHPYLQSLHDLN 240
           P  R+T  EA  H +   L D N
Sbjct: 295 PTARLTPLEACAHSFFDELRDPN 317

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 71/203 (34%), Positives = 112/203 (55%), Gaps = 5/203 (2%)
Query: 40  RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTT 98
           R+ Q L   + + ++YQL R L Y+HS  + HRD+KP NLLL+  +  LK+ DFG A+  
Sbjct: 126 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 185
Query: 99  SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR 158
              +     + +R+YRAPEL+   T+YT++ID+WS GC+L E++  +P+FPG   V QL 
Sbjct: 186 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 245
Query: 159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFD 217
            I +++G+P       +R  N      + P+ +   +   F P     A+ L  ++L + 
Sbjct: 246 EIIKVLGTPTREQ---IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYT 302
Query: 218 PNKRITVEEALRHPYLQSLHDLN 240
           P  R+T  EA  H +   L D N
Sbjct: 303 PTARLTPLEACAHSFFDELRDPN 325

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  135 bits (341), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 71/203 (34%), Positives = 112/203 (55%), Gaps = 5/203 (2%)
Query: 40  RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTT 98
           R+ Q L   + + ++YQL R L Y+HS  + HRD+KP NLLL+  +  LK+ DFG A+  
Sbjct: 148 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207
Query: 99  SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR 158
              +     + +R+YRAPEL+   T+YT++ID+WS GC+L E++  +P+FPG   V QL 
Sbjct: 208 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 267
Query: 159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFD 217
            I +++G+P       +R  N      + P+ +   +   F P     A+ L  ++L + 
Sbjct: 268 EIIKVLGTPTREQ---IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYT 324
Query: 218 PNKRITVEEALRHPYLQSLHDLN 240
           P  R+T  EA  H +   L D N
Sbjct: 325 PTARLTPLEACAHSFFDELRDPN 347

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  135 bits (341), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 71/203 (34%), Positives = 111/203 (54%), Gaps = 5/203 (2%)
Query: 40  RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTT 98
           R+ Q L   + + ++YQL R L Y+HS  + HRD+KP NLLL+  +  LK+ DFG A+  
Sbjct: 114 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173
Query: 99  SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR 158
              +     + +R+YRAPEL+   T+YT++ID+WS GC+L E++  +P+FPG   V QL 
Sbjct: 174 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233
Query: 159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFD 217
            I +++G+P       +R  N        P+ +   +   F P     A+ L  ++L + 
Sbjct: 234 EIIKVLGTPTREQ---IREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYT 290
Query: 218 PNKRITVEEALRHPYLQSLHDLN 240
           P  R+T  EA  H +   L D N
Sbjct: 291 PTARLTPLEACAHSFFDELRDPN 313

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score =  130 bits (328), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 87/251 (34%), Positives = 131/251 (52%), Gaps = 16/251 (6%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVY--IVYELMDTDLHQIIRS--DQQLTDDHC--QYFL 54
           + H N++ ++       +    D+Y  +V E +   LH+  R+   +Q+       + FL
Sbjct: 76  LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFL 135
Query: 55  YQLLRGLKYVH--SASVLHRDLKPSNLLLN-ASCDLKIGDFGLARTTSETDFMTEYVVTR 111
           +QL+R +  +H  S +V HRD+KP N+L+N A   LK+ DFG A+  S ++    Y+ +R
Sbjct: 136 FQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSR 195
Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDAS 171
           +YRAPEL+     YT A+DIWSVGCI  E+M  EP+F G +   QL  I  ++G P   S
Sbjct: 196 YYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCP---S 252
Query: 172 LGFLRSDNARRYVRQLPRCRKQQFATRFPNKS----SGAVDLLEKMLVFDPNKRITVEEA 227
              LR  N       L   +   ++  F + S      A DLL  +L + P +R+   EA
Sbjct: 253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEA 312
Query: 228 LRHPYLQSLHD 238
           L HPY   LHD
Sbjct: 313 LCHPYFDELHD 323

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score =  124 bits (310), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 89/266 (33%), Positives = 133/266 (50%), Gaps = 36/266 (13%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ---------QLTDDHCQ 51
           ++H NVI+++ +           V+++++  + DL  II+  +         QL     +
Sbjct: 75  LKHPNVISLQKVFL---SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVK 131
Query: 52  YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD----LKIGDFGLARTTSET----DF 103
             LYQ+L G+ Y+H+  VLHRDLKP+N+L+         +KI D G AR  +        
Sbjct: 132 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 191
Query: 104 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF--------PGKDYVH 155
           +   VVT WYRAPELLL    YT AIDIW++GCI  E++T EP+F            Y H
Sbjct: 192 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 251
Query: 156 -QLRLITELIGSPDDASLGFLR-----SDNARRYVRQ-LPRCRKQQFATRFPNK-SSGAV 207
            QL  I  ++G P D     ++     S   + + R     C   ++  +   K  S A 
Sbjct: 252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAF 311
Query: 208 DLLEKMLVFDPNKRITVEEALRHPYL 233
            LL+K+L  DP KRIT E+A++ PY 
Sbjct: 312 HLLQKLLTMDPIKRITSEQAMQDPYF 337

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score =  120 bits (300), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 78/241 (32%), Positives = 134/241 (55%), Gaps = 21/241 (8%)
Query: 5   NVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 63
           N+I + D ++ P   T     +V+E ++ TD  Q+    Q LTD   ++++Y+LL+ L Y
Sbjct: 94  NIIKLIDTVKDPVSKT---PALVFEYINNTDFKQLY---QILTDFDIRFYMYELLKALDY 147
Query: 64  VHSASVLHRDLKPSNLLLN-ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 122
            HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++ 
Sbjct: 148 CHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDY 207
Query: 123 TEYTAAIDIWSVGCILGE-IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS---- 177
             Y  ++D+WS+GC+L   I  REP F G+D   QL  I +++G+  +   G+L+     
Sbjct: 208 QMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGT--EELYGYLKKYHID 265
Query: 178 --DNARRYVRQLPRCRKQQFATRFPNK---SSGAVDLLEKMLVFDPNKRITVEEALRHPY 232
              +    + Q  R R + F     N+   S  A+DLL+K+L +D  +R+T +EA+ HPY
Sbjct: 266 LDPHFNDILGQHSRKRWENF-IHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPY 324
Query: 233 L 233
Sbjct: 325 F 325

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score =  119 bits (299), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 78/241 (32%), Positives = 134/241 (55%), Gaps = 21/241 (8%)
Query: 5   NVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 63
           N+I + D ++ P   T     +V+E ++ TD  Q+    Q LTD   ++++Y+LL+ L Y
Sbjct: 99  NIIKLIDTVKDPVSKT---PALVFEYINNTDFKQLY---QILTDFDIRFYMYELLKALDY 152
Query: 64  VHSASVLHRDLKPSNLLLN-ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 122
            HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++ 
Sbjct: 153 CHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDY 212
Query: 123 TEYTAAIDIWSVGCILGE-IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS---- 177
             Y  ++D+WS+GC+L   I  REP F G+D   QL  I +++G+  +   G+L+     
Sbjct: 213 QMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGT--EELYGYLKKYHID 270
Query: 178 --DNARRYVRQLPRCRKQQFATRFPNK---SSGAVDLLEKMLVFDPNKRITVEEALRHPY 232
              +    + Q  R R + F     N+   S  A+DLL+K+L +D  +R+T +EA+ HPY
Sbjct: 271 LDPHFNDILGQHSRKRWENF-IHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPY 329
Query: 233 L 233
Sbjct: 330 F 330

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score =  119 bits (299), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 74/247 (29%), Positives = 129/247 (52%), Gaps = 27/247 (10%)
Query: 5   NVIAIKDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 63
           N+I + DI++ P   T     +V+E + +TD  Q+    Q LTD   ++++Y++L+ L Y
Sbjct: 93  NIITLADIVKDPVSRT---PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDY 146
Query: 64  VHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 122
            HS  ++HRD+KP N+L++     L++ D+GLA            V +R+++ PELL++ 
Sbjct: 147 CHSMGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 123 TEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPD------------D 169
             Y  ++D+WS+GC+L  ++ R EP F G D   QL  I +++G+ D            D
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 266
Query: 170 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 229
                +   ++R+   +      Q         S  A+D L+K+L +D   R+T  EA+ 
Sbjct: 267 PRFNDILGRHSRKRWERFVHSENQHLV------SPEALDFLDKLLRYDHQSRLTAREAME 320
Query: 230 HPYLQSL 236
           HPY  ++
Sbjct: 321 HPYFYTV 327

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score =  119 bits (298), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 129/247 (52%), Gaps = 27/247 (10%)
Query: 5   NVIAIKDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 63
           N+I + DI++ P   T     +V+E + +TD  Q+    Q LTD   ++++Y++L+ L Y
Sbjct: 92  NIITLADIVKDPVSRT---PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDY 145
Query: 64  VHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 122
            HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++ 
Sbjct: 146 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 205
Query: 123 TEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPD------------D 169
             Y  ++D+WS+GC+L  ++ R EP F G D   QL  I +++G+ D            D
Sbjct: 206 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 265
Query: 170 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 229
                +   ++R+   +      Q         S  A+D L+K+L +D   R+T  EA+ 
Sbjct: 266 PRFNDILGRHSRKRWERFVHSENQHLV------SPEALDFLDKLLRYDHQSRLTAREAME 319
Query: 230 HPYLQSL 236
           HPY  ++
Sbjct: 320 HPYFYTV 326

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score =  119 bits (298), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 129/247 (52%), Gaps = 27/247 (10%)
Query: 5   NVIAIKDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 63
           N+I + DI++ P   T     +V+E + +TD  Q+    Q LTD   ++++Y++L+ L Y
Sbjct: 93  NIITLADIVKDPVSRT---PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDY 146
Query: 64  VHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 122
            HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++ 
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 123 TEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPD------------D 169
             Y  ++D+WS+GC+L  ++ R EP F G D   QL  I +++G+ D            D
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 266
Query: 170 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 229
                +   ++R+   +      Q         S  A+D L+K+L +D   R+T  EA+ 
Sbjct: 267 PRFNDILGRHSRKRWERFVHSENQHLV------SPEALDFLDKLLRYDHQSRLTAREAME 320
Query: 230 HPYLQSL 236
           HPY  ++
Sbjct: 321 HPYFYTV 327

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score =  119 bits (298), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 129/247 (52%), Gaps = 27/247 (10%)
Query: 5   NVIAIKDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 63
           N+I + DI++ P   T     +V+E + +TD  Q+    Q LTD   ++++Y++L+ L Y
Sbjct: 93  NIITLADIVKDPVSRT---PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDY 146
Query: 64  VHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 122
            HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++ 
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 123 TEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPD------------D 169
             Y  ++D+WS+GC+L  ++ R EP F G D   QL  I +++G+ D            D
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 266
Query: 170 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 229
                +   ++R+   +      Q         S  A+D L+K+L +D   R+T  EA+ 
Sbjct: 267 PRFNDILGRHSRKRWERFVHSENQHLV------SPEALDFLDKLLRYDHQSRLTAREAME 320
Query: 230 HPYLQSL 236
           HPY  ++
Sbjct: 321 HPYFYTV 327

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score =  119 bits (298), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 129/247 (52%), Gaps = 27/247 (10%)
Query: 5   NVIAIKDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 63
           N+I + DI++ P   T     +V+E + +TD  Q+    Q LTD   ++++Y++L+ L Y
Sbjct: 93  NIITLADIVKDPVSRT---PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDY 146
Query: 64  VHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 122
            HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++ 
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 123 TEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPD------------D 169
             Y  ++D+WS+GC+L  ++ R EP F G D   QL  I +++G+ D            D
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 266
Query: 170 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 229
                +   ++R+   +      Q         S  A+D L+K+L +D   R+T  EA+ 
Sbjct: 267 PRFNDILGRHSRKRWERFVHSENQHLV------SPEALDFLDKLLRYDHQSRLTAREAME 320
Query: 230 HPYLQSL 236
           HPY  ++
Sbjct: 321 HPYFYTV 327

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score =  119 bits (298), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 129/247 (52%), Gaps = 27/247 (10%)
Query: 5   NVIAIKDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 63
           N+I + DI++ P   T     +V+E + +TD  Q+    Q LTD   ++++Y++L+ L Y
Sbjct: 93  NIITLADIVKDPVSRT---PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDY 146
Query: 64  VHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 122
            HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++ 
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 123 TEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPD------------D 169
             Y  ++D+WS+GC+L  ++ R EP F G D   QL  I +++G+ D            D
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 266
Query: 170 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 229
                +   ++R+   +      Q         S  A+D L+K+L +D   R+T  EA+ 
Sbjct: 267 PRFNDILGRHSRKRWERFVHSENQHLV------SPEALDFLDKLLRYDHQSRLTAREAME 320
Query: 230 HPYLQSL 236
           HPY  ++
Sbjct: 321 HPYFYTV 327

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  119 bits (298), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 129/247 (52%), Gaps = 27/247 (10%)
Query: 5   NVIAIKDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 63
           N+I + DI++ P   T     +V+E + +TD  Q+    Q LTD   ++++Y++L+ L Y
Sbjct: 93  NIITLADIVKDPVSRT---PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDY 146
Query: 64  VHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 122
            HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++ 
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 123 TEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPD------------D 169
             Y  ++D+WS+GC+L  ++ R EP F G D   QL  I +++G+ D            D
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 266
Query: 170 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 229
                +   ++R+   +      Q         S  A+D L+K+L +D   R+T  EA+ 
Sbjct: 267 PRFNDILGRHSRKRWERFVHSENQHLV------SPEALDFLDKLLRYDHQSRLTAREAME 320
Query: 230 HPYLQSL 236
           HPY  ++
Sbjct: 321 HPYFYTV 327

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score =  119 bits (297), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 129/247 (52%), Gaps = 27/247 (10%)
Query: 5   NVIAIKDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 63
           N+I + DI++ P   T     +V+E + +TD  Q+    Q LTD   ++++Y++L+ L Y
Sbjct: 93  NIITLADIVKDPVSRT---PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDY 146
Query: 64  VHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 122
            HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++ 
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 123 TEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPD------------D 169
             Y  ++D+WS+GC+L  ++ R EP F G D   QL  I +++G+ D            D
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 266
Query: 170 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 229
                +   ++R+   +      Q         S  A+D L+K+L +D   R+T  EA+ 
Sbjct: 267 PRFNDILGRHSRKRWERFVHSENQHLV------SPEALDFLDKLLRYDHQSRLTAREAME 320
Query: 230 HPYLQSL 236
           HPY  ++
Sbjct: 321 HPYFYTV 327

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  119 bits (297), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 129/247 (52%), Gaps = 27/247 (10%)
Query: 5   NVIAIKDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 63
           N+I + DI++ P   T     +V+E + +TD  Q+    Q LTD   ++++Y++L+ L Y
Sbjct: 93  NIITLADIVKDPVSRT---PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDY 146
Query: 64  VHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 122
            HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++ 
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 123 TEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPD------------D 169
             Y  ++D+WS+GC+L  ++ R EP F G D   QL  I +++G+ D            D
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 266
Query: 170 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 229
                +   ++R+   +      Q         S  A+D L+K+L +D   R+T  EA+ 
Sbjct: 267 PRFNDILGRHSRKRWERFVHSENQHLV------SPEALDFLDKLLRYDHQSRLTAREAME 320
Query: 230 HPYLQSL 236
           HPY  ++
Sbjct: 321 HPYFYTV 327

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score =  119 bits (297), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 129/247 (52%), Gaps = 27/247 (10%)
Query: 5   NVIAIKDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 63
           N+I + DI++ P   T     +V+E + +TD  Q+    Q LTD   ++++Y++L+ L Y
Sbjct: 91  NIITLADIVKDPVSRT---PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDY 144
Query: 64  VHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 122
            HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++ 
Sbjct: 145 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 204
Query: 123 TEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPD------------D 169
             Y  ++D+WS+GC+L  ++ R EP F G D   QL  I +++G+ D            D
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264
Query: 170 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 229
                +   ++R+   +      Q         S  A+D L+K+L +D   R+T  EA+ 
Sbjct: 265 PRFNDILGRHSRKRWERFVHSENQHLV------SPEALDFLDKLLRYDHQSRLTAREAME 318
Query: 230 HPYLQSL 236
           HPY  ++
Sbjct: 319 HPYFYTV 325

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score =  119 bits (297), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 129/247 (52%), Gaps = 27/247 (10%)
Query: 5   NVIAIKDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 63
           N+I + DI++ P   T     +V+E + +TD  Q+    Q LTD   ++++Y++L+ L Y
Sbjct: 92  NIITLADIVKDPVSRT---PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDY 145
Query: 64  VHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 122
            HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++ 
Sbjct: 146 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 205
Query: 123 TEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPD------------D 169
             Y  ++D+WS+GC+L  ++ R EP F G D   QL  I +++G+ D            D
Sbjct: 206 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 265
Query: 170 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 229
                +   ++R+   +      Q         S  A+D L+K+L +D   R+T  EA+ 
Sbjct: 266 PRFNDILGRHSRKRWERFVHSENQHLV------SPEALDFLDKLLRYDHQSRLTAREAME 319
Query: 230 HPYLQSL 236
           HPY  ++
Sbjct: 320 HPYFYTV 326

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score =  119 bits (297), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 129/247 (52%), Gaps = 27/247 (10%)
Query: 5   NVIAIKDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 63
           N+I + DI++ P   T     +V+E + +TD  Q+    Q LTD   ++++Y++L+ L Y
Sbjct: 93  NIITLADIVKDPVSRT---PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDY 146
Query: 64  VHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 122
            HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++ 
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 123 TEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPD------------D 169
             Y  ++D+WS+GC+L  ++ R EP F G D   QL  I +++G+ D            D
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 266
Query: 170 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 229
                +   ++R+   +      Q         S  A+D L+K+L +D   R+T  EA+ 
Sbjct: 267 PRFNDILGRHSRKRWERFVHSENQHLV------SPEALDFLDKLLRYDHQSRLTAREAME 320
Query: 230 HPYLQSL 236
           HPY  ++
Sbjct: 321 HPYFYTV 327

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 129/247 (52%), Gaps = 27/247 (10%)
Query: 5   NVIAIKDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 63
           N+I + DI++ P   T     +V+E + +TD  Q+    Q LTD   ++++Y++L+ L Y
Sbjct: 98  NIITLADIVKDPVSRT---PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDY 151
Query: 64  VHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 122
            HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++ 
Sbjct: 152 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 211
Query: 123 TEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPD------------D 169
             Y  ++D+WS+GC+L  ++ R EP F G D   QL  I +++G+ D            D
Sbjct: 212 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 271
Query: 170 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 229
                +   ++R+   +      Q         S  A+D L+K+L +D   R+T  EA+ 
Sbjct: 272 PRFNDILGRHSRKRWERFVHSENQHLV------SPEALDFLDKLLRYDHQSRLTAREAME 325
Query: 230 HPYLQSL 236
           HPY  ++
Sbjct: 326 HPYFYTV 332

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score =  118 bits (296), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 129/247 (52%), Gaps = 27/247 (10%)
Query: 5   NVIAIKDIIRPPKKDTFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKY 63
           N+I + DI++ P   T     +V+E + +TD  Q+    Q LTD   ++++Y++L+ L Y
Sbjct: 93  NIITLADIVKDPVSRT---PALVFEHVNNTDFKQL---RQTLTDYDIRFYMYEILKALDY 146
Query: 64  VHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 122
            HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++ 
Sbjct: 147 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 123 TEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPD------------D 169
             Y  ++D+WS+GC+L  ++ R EP F G D   QL  I +++G+ D            D
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 266
Query: 170 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 229
                +   ++R+   +      Q         S  A+D L+K+L +D   R+T  EA+ 
Sbjct: 267 PRFNDILGRHSRKRWERFVHSENQHLV------SPEALDFLDKLLRYDHQSRLTAREAME 320
Query: 230 HPYLQSL 236
           HPY  ++
Sbjct: 321 HPYFYTV 327

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score =  118 bits (296), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 124/243 (51%), Gaps = 25/243 (10%)
Query: 5   NVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 64
           N+I + DI++ P   T     +   + +TD  Q+    Q LTD   ++++Y++L+ L Y 
Sbjct: 93  NIITLADIVKDPVSRT--PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 147
Query: 65  HSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 123
           HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++  
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 124 EYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPD------------DA 170
            Y  ++D+WS+GC+L  ++ R EP F G D   QL  I +++G+ D            D 
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 267
Query: 171 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 230
               +   ++R+   +      Q         S  A+D L+K+L +D   R+T  EA+ H
Sbjct: 268 RFNDILGRHSRKRWERFVHSENQHLV------SPEALDFLDKLLRYDHQSRLTAREAMEH 321
Query: 231 PYL 233
           PY 
Sbjct: 322 PYF 324

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score =  114 bits (286), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 72/250 (28%), Positives = 129/250 (51%), Gaps = 25/250 (10%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           M   N++ + DI+R     T +   +++E ++    +++     LTD   +Y++Y+LL+ 
Sbjct: 83  MGGPNIVKLLDIVRDQHSKTPS---LIFEYVNNTDFKVLYP--TLTDYDIRYYIYELLKA 137
Query: 61  LKYVHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           L Y HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL
Sbjct: 138 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 197
Query: 120 LNCTEYTAAIDIWSVGCIL-GEIMTREPLFPGKDYVHQLRLITELIGSPD---------- 168
           ++  +Y  ++D+WS+GC+  G I  +EP F G D   QL  I +++G+            
Sbjct: 198 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRI 257
Query: 169 --DASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEE 226
             D  L  L   ++R+   +      Q         S  A+D L+K+L +D  +R+T  E
Sbjct: 258 ELDPQLEALVGRHSRKPWLKFMNADNQHLV------SPEAIDFLDKLLRYDHQERLTALE 311
Query: 227 ALRHPYLQSL 236
           A+ HPY Q +
Sbjct: 312 AMTHPYFQQV 321

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score =  114 bits (286), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 71/246 (28%), Positives = 128/246 (52%), Gaps = 25/246 (10%)
Query: 5   NVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 64
           N++ + DI+R     T +   +++E ++    +++     LTD   +Y++Y+LL+ L Y 
Sbjct: 87  NIVKLLDIVRDQHSKTPS---LIFEYVNNTDFKVLYP--TLTDYDIRYYIYELLKALDYC 141
Query: 65  HSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 123
           HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++  
Sbjct: 142 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 124 EYTAAIDIWSVGCIL-GEIMTREPLFPGKDYVHQLRLITELIGSPD------------DA 170
           +Y  ++D+WS+GC+  G I  +EP F G D   QL  I +++G+              D 
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDP 261
Query: 171 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 230
            L  L   ++R+   +      Q         S  A+D L+K+L +D  +R+T  EA+ H
Sbjct: 262 QLEALVGRHSRKPWLKFMNADNQHLV------SPEAIDFLDKLLRYDHQERLTALEAMTH 315
Query: 231 PYLQSL 236
           PY Q +
Sbjct: 316 PYFQQV 321

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score =  114 bits (286), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 71/246 (28%), Positives = 128/246 (52%), Gaps = 25/246 (10%)
Query: 5   NVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 64
           N++ + DI+R     T +   +++E ++    +++     LTD   +Y++Y+LL+ L Y 
Sbjct: 87  NIVKLLDIVRDQHSKTPS---LIFEYVNNTDFKVLYP--TLTDYDIRYYIYELLKALDYC 141
Query: 65  HSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 123
           HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++  
Sbjct: 142 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 124 EYTAAIDIWSVGCIL-GEIMTREPLFPGKDYVHQLRLITELIGSPD------------DA 170
           +Y  ++D+WS+GC+  G I  +EP F G D   QL  I +++G+              D 
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDP 261
Query: 171 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 230
            L  L   ++R+   +      Q         S  A+D L+K+L +D  +R+T  EA+ H
Sbjct: 262 QLEALVGRHSRKPWLKFMNADNQHLV------SPEAIDFLDKLLRYDHQERLTALEAMTH 315
Query: 231 PYLQSL 236
           PY Q +
Sbjct: 316 PYFQQV 321

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score =  114 bits (286), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 71/246 (28%), Positives = 128/246 (52%), Gaps = 25/246 (10%)
Query: 5   NVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 64
           N++ + DI+R     T +   +++E ++    +++     LTD   +Y++Y+LL+ L Y 
Sbjct: 87  NIVKLLDIVRDQHSKTPS---LIFEYVNNTDFKVLYP--TLTDYDIRYYIYELLKALDYC 141
Query: 65  HSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 123
           HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++  
Sbjct: 142 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 124 EYTAAIDIWSVGCIL-GEIMTREPLFPGKDYVHQLRLITELIGSPD------------DA 170
           +Y  ++D+WS+GC+  G I  +EP F G D   QL  I +++G+              D 
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDP 261
Query: 171 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 230
            L  L   ++R+   +      Q         S  A+D L+K+L +D  +R+T  EA+ H
Sbjct: 262 QLEALVGRHSRKPWLKFMNADNQHLV------SPEAIDFLDKLLRYDHQERLTALEAMTH 315
Query: 231 PYLQSL 236
           PY Q +
Sbjct: 316 PYFQQV 321

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score =  114 bits (286), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 71/246 (28%), Positives = 128/246 (52%), Gaps = 25/246 (10%)
Query: 5   NVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 64
           N++ + DI+R     T +   +++E ++    +++     LTD   +Y++Y+LL+ L Y 
Sbjct: 87  NIVKLLDIVRDQHSKTPS---LIFEYVNNTDFKVLYP--TLTDYDIRYYIYELLKALDYC 141
Query: 65  HSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 123
           HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++  
Sbjct: 142 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 124 EYTAAIDIWSVGCIL-GEIMTREPLFPGKDYVHQLRLITELIGSPD------------DA 170
           +Y  ++D+WS+GC+  G I  +EP F G D   QL  I +++G+              D 
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDP 261
Query: 171 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 230
            L  L   ++R+   +      Q         S  A+D L+K+L +D  +R+T  EA+ H
Sbjct: 262 QLEALVGRHSRKPWLKFMNADNQHLV------SPEAIDFLDKLLRYDHQERLTALEAMTH 315
Query: 231 PYLQSL 236
           PY Q +
Sbjct: 316 PYFQQV 321

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score =  114 bits (285), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 71/246 (28%), Positives = 128/246 (52%), Gaps = 25/246 (10%)
Query: 5   NVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 64
           N++ + DI+R     T +   +++E ++    +++     LTD   +Y++Y+LL+ L Y 
Sbjct: 87  NIVKLLDIVRDQHSKTPS---LIFEYVNNTDFKVLYP--TLTDYDIRYYIYELLKALDYC 141
Query: 65  HSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 123
           HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++  
Sbjct: 142 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 124 EYTAAIDIWSVGCIL-GEIMTREPLFPGKDYVHQLRLITELIGSPD------------DA 170
           +Y  ++D+WS+GC+  G I  +EP F G D   QL  I +++G+              D 
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDP 261
Query: 171 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 230
            L  L   ++R+   +      Q         S  A+D L+K+L +D  +R+T  EA+ H
Sbjct: 262 QLEALVGRHSRKPWLKFMNADNQHLV------SPEAIDFLDKLLRYDHQERLTALEAMTH 315
Query: 231 PYLQSL 236
           PY Q +
Sbjct: 316 PYFQQV 321

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score =  114 bits (285), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 71/246 (28%), Positives = 128/246 (52%), Gaps = 25/246 (10%)
Query: 5   NVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 64
           N++ + DI+R     T +   +++E ++    +++     LTD   +Y++Y+LL+ L Y 
Sbjct: 89  NIVKLLDIVRDQHSKTPS---LIFEYVNNTDFKVLYP--TLTDYDIRYYIYELLKALDYC 143
Query: 65  HSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 123
           HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++  
Sbjct: 144 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 203
Query: 124 EYTAAIDIWSVGCIL-GEIMTREPLFPGKDYVHQLRLITELIGSPD------------DA 170
           +Y  ++D+WS+GC+  G I  +EP F G D   QL  I +++G+              D 
Sbjct: 204 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDP 263
Query: 171 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 230
            L  L   ++R+   +      Q         S  A+D L+K+L +D  +R+T  EA+ H
Sbjct: 264 QLEALVGRHSRKPWLKFMNADNQHLV------SPEAIDFLDKLLRYDHQERLTALEAMTH 317
Query: 231 PYLQSL 236
           PY Q +
Sbjct: 318 PYFQQV 323

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score =  114 bits (285), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 71/246 (28%), Positives = 128/246 (52%), Gaps = 25/246 (10%)
Query: 5   NVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 64
           N++ + DI+R     T +   +++E ++    +++     LTD   +Y++Y+LL+ L Y 
Sbjct: 88  NIVKLLDIVRDQHSKTPS---LIFEYVNNTDFKVLYP--TLTDYDIRYYIYELLKALDYC 142
Query: 65  HSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 123
           HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++  
Sbjct: 143 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 202
Query: 124 EYTAAIDIWSVGCIL-GEIMTREPLFPGKDYVHQLRLITELIGSPD------------DA 170
           +Y  ++D+WS+GC+  G I  +EP F G D   QL  I +++G+              D 
Sbjct: 203 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDP 262
Query: 171 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 230
            L  L   ++R+   +      Q         S  A+D L+K+L +D  +R+T  EA+ H
Sbjct: 263 QLEALVGRHSRKPWLKFMNADNQHLV------SPEAIDFLDKLLRYDHQERLTALEAMTH 316
Query: 231 PYLQSL 236
           PY Q +
Sbjct: 317 PYFQQV 322

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score =  114 bits (285), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 71/246 (28%), Positives = 128/246 (52%), Gaps = 25/246 (10%)
Query: 5   NVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 64
           N++ + DI+R     T +   +++E ++    +++     LTD   +Y++Y+LL+ L Y 
Sbjct: 108 NIVKLLDIVRDQHSKTPS---LIFEYVNNTDFKVLYP--TLTDYDIRYYIYELLKALDYC 162
Query: 65  HSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 123
           HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++  
Sbjct: 163 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 222
Query: 124 EYTAAIDIWSVGCIL-GEIMTREPLFPGKDYVHQLRLITELIGSPD------------DA 170
           +Y  ++D+WS+GC+  G I  +EP F G D   QL  I +++G+              D 
Sbjct: 223 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNAYLNKYRIELDP 282
Query: 171 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 230
            L  L   ++R+   +      Q         S  A+D L+K+L +D  +R+T  EA+ H
Sbjct: 283 QLEALVGRHSRKPWLKFMNADNQHLV------SPEAIDFLDKLLRYDHQERLTALEAMTH 336
Query: 231 PYLQSL 236
           PY Q +
Sbjct: 337 PYFQQV 342

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score =  114 bits (285), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 71/246 (28%), Positives = 128/246 (52%), Gaps = 25/246 (10%)
Query: 5   NVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYV 64
           N++ + DI+R     T +   +++E ++    +++     LTD   +Y++Y+LL+ L Y 
Sbjct: 88  NIVKLLDIVRDQHSKTPS---LIFEYVNNTDFKVLYP--TLTDYDIRYYIYELLKALDYC 142
Query: 65  HSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT 123
           HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++  
Sbjct: 143 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 202
Query: 124 EYTAAIDIWSVGCIL-GEIMTREPLFPGKDYVHQLRLITELIGSPD------------DA 170
           +Y  ++D+WS+GC+  G I  +EP F G D   QL  I +++G+              D 
Sbjct: 203 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDP 262
Query: 171 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 230
            L  L   ++R+   +      Q         S  A+D L+K+L +D  +R+T  EA+ H
Sbjct: 263 QLEALVGRHSRKPWLKFMNADNQHLV------SPEAIDFLDKLLRYDHQERLTALEAMTH 316
Query: 231 PYLQSL 236
           PY Q +
Sbjct: 317 PYFQQV 322

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  113 bits (283), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 75/240 (31%), Positives = 122/240 (50%), Gaps = 38/240 (15%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H  +I IK+           D YIV ELM+  +L   +  +++L +  C+ + YQ+L 
Sbjct: 72  LNHPCIIKIKNFFDA------EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 125
Query: 60  GLKYVHSASVLHRDLKPSNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 116
            ++Y+H   ++HRDLKP N+LL++    C +KI DFG ++   ET  M     T  Y AP
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 185
Query: 117 ELLLNC--TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF 174
           E+L++     Y  A+D WS+G IL   ++  P  P  ++  Q+ L  ++           
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYP--PFSEHRTQVSLKDQI----------- 232
Query: 175 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
             +     ++ ++           +   S  A+DL++K+LV DP  R T EEALRHP+LQ
Sbjct: 233 --TSGKYNFIPEV-----------WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 279

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  113 bits (283), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 75/240 (31%), Positives = 122/240 (50%), Gaps = 38/240 (15%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H  +I IK+           D YIV ELM+  +L   +  +++L +  C+ + YQ+L 
Sbjct: 71  LNHPCIIKIKNFFDA------EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 124
Query: 60  GLKYVHSASVLHRDLKPSNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 116
            ++Y+H   ++HRDLKP N+LL++    C +KI DFG ++   ET  M     T  Y AP
Sbjct: 125 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 184
Query: 117 ELLLNC--TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF 174
           E+L++     Y  A+D WS+G IL   ++  P  P  ++  Q+ L  ++           
Sbjct: 185 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYP--PFSEHRTQVSLKDQI----------- 231
Query: 175 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
             +     ++ ++           +   S  A+DL++K+LV DP  R T EEALRHP+LQ
Sbjct: 232 --TSGKYNFIPEV-----------WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 278

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 75/240 (31%), Positives = 122/240 (50%), Gaps = 38/240 (15%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H  +I IK+           D YIV ELM+  +L   +  +++L +  C+ + YQ+L 
Sbjct: 211 LNHPCIIKIKNFFDA------EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 264
Query: 60  GLKYVHSASVLHRDLKPSNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 116
            ++Y+H   ++HRDLKP N+LL++    C +KI DFG ++   ET  M     T  Y AP
Sbjct: 265 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 324
Query: 117 ELLLNC--TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF 174
           E+L++     Y  A+D WS+G IL   ++  P  P  ++  Q+ L  ++           
Sbjct: 325 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYP--PFSEHRTQVSLKDQI----------- 371
Query: 175 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
             +     ++ ++           +   S  A+DL++K+LV DP  R T EEALRHP+LQ
Sbjct: 372 --TSGKYNFIPEV-----------WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 418

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 75/240 (31%), Positives = 122/240 (50%), Gaps = 38/240 (15%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H  +I IK+           D YIV ELM+  +L   +  +++L +  C+ + YQ+L 
Sbjct: 197 LNHPCIIKIKNFFDA------EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 250
Query: 60  GLKYVHSASVLHRDLKPSNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 116
            ++Y+H   ++HRDLKP N+LL++    C +KI DFG ++   ET  M     T  Y AP
Sbjct: 251 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 310
Query: 117 ELLLNC--TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF 174
           E+L++     Y  A+D WS+G IL   ++  P  P  ++  Q+ L  ++           
Sbjct: 311 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYP--PFSEHRTQVSLKDQI----------- 357
Query: 175 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
             +     ++ ++           +   S  A+DL++K+LV DP  R T EEALRHP+LQ
Sbjct: 358 --TSGKYNFIPEV-----------WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 404

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 75/240 (31%), Positives = 122/240 (50%), Gaps = 38/240 (15%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H  +I IK+           D YIV ELM+  +L   +  +++L +  C+ + YQ+L 
Sbjct: 78  LNHPCIIKIKNFFDA------EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 131
Query: 60  GLKYVHSASVLHRDLKPSNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 116
            ++Y+H   ++HRDLKP N+LL++    C +KI DFG ++   ET  M     T  Y AP
Sbjct: 132 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 191
Query: 117 ELLLNC--TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF 174
           E+L++     Y  A+D WS+G IL   ++  P  P  ++  Q+ L  ++           
Sbjct: 192 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYP--PFSEHRTQVSLKDQI----------- 238
Query: 175 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
             +     ++ ++           +   S  A+DL++K+LV DP  R T EEALRHP+LQ
Sbjct: 239 --TSGKYNFIPEV-----------WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 285

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 75/240 (31%), Positives = 122/240 (50%), Gaps = 38/240 (15%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H  +I IK+           D YIV ELM+  +L   +  +++L +  C+ + YQ+L 
Sbjct: 72  LNHPCIIKIKNFFDA------EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 125
Query: 60  GLKYVHSASVLHRDLKPSNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 116
            ++Y+H   ++HRDLKP N+LL++    C +KI DFG ++   ET  M     T  Y AP
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 185
Query: 117 ELLLNC--TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF 174
           E+L++     Y  A+D WS+G IL   ++  P  P  ++  Q+ L  ++           
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYP--PFSEHRTQVSLKDQI----------- 232
Query: 175 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
             +     ++ ++           +   S  A+DL++K+LV DP  R T EEALRHP+LQ
Sbjct: 233 --TSGKYNFIPEV-----------WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 279

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 75/240 (31%), Positives = 122/240 (50%), Gaps = 38/240 (15%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H  +I IK+           D YIV ELM+  +L   +  +++L +  C+ + YQ+L 
Sbjct: 72  LNHPCIIKIKNFFDA------EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 125
Query: 60  GLKYVHSASVLHRDLKPSNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 116
            ++Y+H   ++HRDLKP N+LL++    C +KI DFG ++   ET  M     T  Y AP
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 185
Query: 117 ELLLNC--TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF 174
           E+L++     Y  A+D WS+G IL   ++  P  P  ++  Q+ L  ++           
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYP--PFSEHRTQVSLKDQI----------- 232
Query: 175 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
             +     ++ ++           +   S  A+DL++K+LV DP  R T EEALRHP+LQ
Sbjct: 233 --TSGKYNFIPEV-----------WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 279

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score =  105 bits (262), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 76/245 (31%), Positives = 124/245 (50%), Gaps = 35/245 (14%)
Query: 22  NDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 79
           N + + +EL+  +L+++I+ +  Q  +    + F + +L+ L  +H   ++H DLKP N+
Sbjct: 172 NHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENI 231
Query: 80  LL--NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 137
           LL       +K+ DFG   +  E   +   + +R+YRAPE++L    Y   ID+WS+GCI
Sbjct: 232 LLKQQGRSGIKVIDFG--SSCYEHQRVYTXIQSRFYRAPEVILG-ARYGMPIDMWSLGCI 288
Query: 138 LGEIMTREPLFPGKDYVHQLRLITELIGSPD----DAS---LGFLRSDNARRY------- 183
           L E++T  PL PG+D   QL  + EL+G P     DAS     F+      RY       
Sbjct: 289 LAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSXKGYPRYCTVTTLS 348
Query: 184 ----VRQLPRCRKQQF-----ATRFPNKSSGA-----VDLLEKMLVFDPNKRITVEEALR 229
               V    R R+ +      +  + N   G      +D L++ L +DP  R+T  +ALR
Sbjct: 349 DGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALR 408
Query: 230 HPYLQ 234
           HP+L+
Sbjct: 409 HPWLR 413

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score =  105 bits (261), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 76/245 (31%), Positives = 124/245 (50%), Gaps = 35/245 (14%)
Query: 22  NDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 79
           N + + +EL+  +L+++I+ +  Q  +    + F + +L+ L  +H   ++H DLKP N+
Sbjct: 172 NHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENI 231
Query: 80  LL--NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 137
           LL       +K+ DFG   +  E   +   + +R+YRAPE++L    Y   ID+WS+GCI
Sbjct: 232 LLKQQGRSGIKVIDFG--SSCYEHQRVYTXIQSRFYRAPEVILG-ARYGMPIDMWSLGCI 288
Query: 138 LGEIMTREPLFPGKDYVHQLRLITELIGSPD----DAS---LGFLRSDNARRY------- 183
           L E++T  PL PG+D   QL  + EL+G P     DAS     F+      RY       
Sbjct: 289 LAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSXKGYPRYCTVTTLS 348
Query: 184 ----VRQLPRCRKQQF-----ATRFPNKSSGA-----VDLLEKMLVFDPNKRITVEEALR 229
               V    R R+ +      +  + N   G      +D L++ L +DP  R+T  +ALR
Sbjct: 349 DGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALR 408
Query: 230 HPYLQ 234
           HP+L+
Sbjct: 409 HPWLR 413

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score =  104 bits (260), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 76/245 (31%), Positives = 124/245 (50%), Gaps = 35/245 (14%)
Query: 22  NDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 79
           N + + +EL+  +L+++I+ +  Q  +    + F + +L+ L  +H   ++H DLKP N+
Sbjct: 172 NHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENI 231
Query: 80  LL--NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 137
           LL       +K+ DFG   +  E   +   + +R+YRAPE++L    Y   ID+WS+GCI
Sbjct: 232 LLKQQGRSGIKVIDFG--SSCYEHQRVYXXIQSRFYRAPEVILG-ARYGMPIDMWSLGCI 288
Query: 138 LGEIMTREPLFPGKDYVHQLRLITELIGSPD----DAS---LGFLRSDNARRY------- 183
           L E++T  PL PG+D   QL  + EL+G P     DAS     F+      RY       
Sbjct: 289 LAELLTGYPLLPGEDEGDQLACMIELLGMPXQKLLDASKRAKNFVSXKGYPRYCTVTTLS 348
Query: 184 ----VRQLPRCRKQQF-----ATRFPNKSSGA-----VDLLEKMLVFDPNKRITVEEALR 229
               V    R R+ +      +  + N   G      +D L++ L +DP  R+T  +ALR
Sbjct: 349 DGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALR 408
Query: 230 HPYLQ 234
           HP+L+
Sbjct: 409 HPWLR 413

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 70/238 (29%), Positives = 113/238 (47%), Gaps = 38/238 (15%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYEL-MDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++H N++ + +I+        +  YIV EL    +L   I   ++ ++      + Q+  
Sbjct: 78  LDHPNIMKLFEILEDS-----SSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFS 132
Query: 60  GLKYVHSASVLHRDLKPSNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 116
           G+ Y+H  +++HRDLKP N+LL +    CD+KI DFGL+    +   M + + T +Y AP
Sbjct: 133 GITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAP 192
Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 176
           E+L     Y    D+WS G IL  +++  P F GK+    L+ +                
Sbjct: 193 EVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV---------------- 234
Query: 177 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
                +Y   LP+ R           S  A DL+ KML F P+ RIT  + L HP++Q
Sbjct: 235 --ETGKYAFDLPQWR---------TISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQ 281

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 70/238 (29%), Positives = 112/238 (47%), Gaps = 38/238 (15%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYEL-MDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++H N++ + +I+        +  YIV EL    +L   I   ++ ++      + Q+  
Sbjct: 78  LDHPNIMKLFEILEDS-----SSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFS 132
Query: 60  GLKYVHSASVLHRDLKPSNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 116
           G+ Y+H  +++HRDLKP N+LL +    CD+KI DFGL+    +   M + + T +Y AP
Sbjct: 133 GITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAP 192
Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 176
           E+L     Y    D+WS G IL  +++  P F GK+                      L+
Sbjct: 193 EVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKN------------------EYDILK 232
Query: 177 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
                +Y   LP+ R           S  A DL+ KML F P+ RIT  + L HP++Q
Sbjct: 233 RVETGKYAFDLPQWR---------TISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQ 281

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 70/238 (29%), Positives = 112/238 (47%), Gaps = 38/238 (15%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYEL-MDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++H N++ + +I+        +  YIV EL    +L   I   ++ ++      + Q+  
Sbjct: 78  LDHPNIMKLFEILEDS-----SSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFS 132
Query: 60  GLKYVHSASVLHRDLKPSNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 116
           G+ Y+H  +++HRDLKP N+LL +    CD+KI DFGL+    +   M + + T +Y AP
Sbjct: 133 GITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAP 192
Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 176
           E+L     Y    D+WS G IL  +++  P F GK+                      L+
Sbjct: 193 EVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKN------------------EYDILK 232
Query: 177 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
                +Y   LP+ R           S  A DL+ KML F P+ RIT  + L HP++Q
Sbjct: 233 RVETGKYAFDLPQWR---------TISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQ 281

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 115/248 (46%), Gaps = 39/248 (15%)
Query: 24  VYIVYELMDTDLHQIIRSDQQL--TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 81
           + IV+EL+    +  I+ +  L    DH +   YQ+ + + ++HS  + H DLKP N+L 
Sbjct: 92  ICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILF 151
Query: 82  NAS-------------------CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 122
             S                    D+K+ DFG A  T + +  +  V TR YRAPE++L  
Sbjct: 152 VQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA--TYDDEHHSTLVSTRHYRAPEVIL-A 208
Query: 123 TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS----- 177
             ++   D+WS+GCIL E      +FP  D    L ++  ++G      +   R      
Sbjct: 209 LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFH 268
Query: 178 ---------DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL 228
                     +A RYV +  +  K+ F      +     DL++KML +DP KRIT+ EAL
Sbjct: 269 HDRLDWDEHSSAGRYVSRACKPLKE-FMLSQDVEHERLFDLIQKMLEYDPAKRITLREAL 327
Query: 229 RHPYLQSL 236
           +HP+   L
Sbjct: 328 KHPFFDLL 335

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 94.7 bits (234), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 113/240 (47%), Gaps = 38/240 (15%)
Query: 1   MEHENVIAIKDIIRPPKKDTF-NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++H N++ + D     +      + Y   EL D  +H++     +  +      + Q+L 
Sbjct: 93  LDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRM-----KFNEVDAAVIIKQVLS 147
Query: 60  GLKYVHSASVLHRDLKPSNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 116
           G+ Y+H  +++HRDLKP NLLL +      +KI DFGL+        M E + T +Y AP
Sbjct: 148 GVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAP 207
Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 176
           E+L    +Y    D+WS+G IL  ++   P F G+     LR + +              
Sbjct: 208 EVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEK-------------- 251
Query: 177 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 236
                +Y    P          + N S GA DL+++ML FD  +RI+ ++AL HP+++ +
Sbjct: 252 ----GKYTFDSPE---------WKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 94.7 bits (234), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 111/244 (45%), Gaps = 37/244 (15%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++HEN++A++DI   P     N +Y+V +L+   +L   I      T+      + Q+L 
Sbjct: 77  IKHENIVALEDIYESP-----NHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLD 131
Query: 60  GLKYVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 116
            + Y+H   ++HRDLKP NLL    +    + I DFGL++   + D M+    T  Y AP
Sbjct: 132 AVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAP 191
Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 176
           E+L     Y+ A+D WS+G I   ++   P F                            
Sbjct: 192 EVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPF---------------------------Y 223
Query: 177 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 236
            +N  +   Q+ +   +  +  + + S  A D +  ++  DPNKR T E+A RHP++   
Sbjct: 224 DENDSKLFEQILKAEYEFDSPYWDDISDSAKDFIRNLMEKDPNKRYTCEQAARHPWIAGD 283
Query: 237 HDLN 240
             LN
Sbjct: 284 TALN 287

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 94.4 bits (233), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 72/248 (29%), Positives = 114/248 (45%), Gaps = 39/248 (15%)
Query: 24  VYIVYELMDTDLHQIIRSDQQL--TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 81
           + IV+EL+    +  I+ +  L    DH +   YQ+ + + ++HS  + H DLKP N+L 
Sbjct: 92  ICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILF 151
Query: 82  NAS-------------------CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 122
             S                    D+K+ DFG A  T + +  +  V  R YRAPE++L  
Sbjct: 152 VQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA--TYDDEHHSTLVXXRHYRAPEVIL-A 208
Query: 123 TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS----- 177
             ++   D+WS+GCIL E      +FP  D    L ++  ++G      +   R      
Sbjct: 209 LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFH 268
Query: 178 ---------DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL 228
                     +A RYV +  +  K+ F      +     DL++KML +DP KRIT+ EAL
Sbjct: 269 HDRLDWDEHSSAGRYVSRACKPLKE-FMLSQDVEHERLFDLIQKMLEYDPAKRITLREAL 327
Query: 229 RHPYLQSL 236
           +HP+   L
Sbjct: 328 KHPFFDLL 335

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 112/235 (47%), Gaps = 38/235 (16%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           + H ++I + D+I  P      D+ +V E    +L   I   +++T+D  + F  Q++  
Sbjct: 66  LRHPHIIKLYDVITTP-----TDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICA 120
Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 120
           ++Y H   ++HRDLKP NLLL+ + ++KI DFGL+   ++ +F+     +  Y APE++ 
Sbjct: 121 IEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVIN 180
Query: 121 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 180
                   +D+WS G +L  ++           V +L    E I +         +  N+
Sbjct: 181 GKLYAGPEVDVWSCGIVLYVML-----------VGRLPFDDEFIPN-------LFKKVNS 222
Query: 181 RRYVRQLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
             YV               P+  S GA  L+ +M+V DP +RIT++E  R P+  
Sbjct: 223 CVYV--------------MPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFN 263

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 89.7 bits (221), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/258 (28%), Positives = 128/258 (49%), Gaps = 46/258 (17%)
Query: 22  NDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSA--SVLHRDLKPS 77
           N + +V+E++  +L+ ++R+   + ++ +  + F  Q+   L ++ +   S++H DLKP 
Sbjct: 129 NHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPE 188
Query: 78  NLLL--NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVG 135
           N+LL       +KI DFG +    +  +  + + +R+YR+PE+LL    Y  AID+WS+G
Sbjct: 189 NILLCNPKRSAIKIVDFGSSCQLGQRIY--QXIQSRFYRSPEVLLGMP-YDLAIDMWSLG 245
Query: 136 CILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP------- 188
           CIL E+ T EPLF G + V Q+  I E++G P    L   ++  AR++  +LP       
Sbjct: 246 CILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILD--QAPKARKFFEKLPDGTWNLK 303
Query: 189 --RCRKQQF-------------------ATRFPNKSSGAV-------DLLEKMLVFDPNK 220
             +  K+++                     R   +S   V       DL+ +ML +DP  
Sbjct: 304 KTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKT 363
Query: 221 RITVEEALRHPYLQSLHD 238
           RI    AL+H + +   D
Sbjct: 364 RIQPYYALQHSFFKKTAD 381

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 89.7 bits (221), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/258 (28%), Positives = 128/258 (49%), Gaps = 46/258 (17%)
Query: 22  NDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSA--SVLHRDLKPS 77
           N + +V+E++  +L+ ++R+   + ++ +  + F  Q+   L ++ +   S++H DLKP 
Sbjct: 110 NHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPE 169
Query: 78  NLLL--NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVG 135
           N+LL       +KI DFG +    +  +  + + +R+YR+PE+LL    Y  AID+WS+G
Sbjct: 170 NILLCNPKRSAIKIVDFGSSCQLGQRIY--QXIQSRFYRSPEVLLGMP-YDLAIDMWSLG 226
Query: 136 CILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP------- 188
           CIL E+ T EPLF G + V Q+  I E++G P    L   ++  AR++  +LP       
Sbjct: 227 CILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILD--QAPKARKFFEKLPDGTWNLK 284
Query: 189 --RCRKQQF-------------------ATRFPNKSSGAV-------DLLEKMLVFDPNK 220
             +  K+++                     R   +S   V       DL+ +ML +DP  
Sbjct: 285 KTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKT 344
Query: 221 RITVEEALRHPYLQSLHD 238
           RI    AL+H + +   D
Sbjct: 345 RIQPYYALQHSFFKKTAD 362

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/261 (28%), Positives = 130/261 (49%), Gaps = 52/261 (19%)
Query: 22  NDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSA--SVLHRDLKPS 77
           N + +V+E++  +L+ ++R+   + ++ +  + F  Q+   L ++ +   S++H DLKP 
Sbjct: 129 NHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPE 188
Query: 78  NLLLNASCD-----LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIW 132
           N+LL   C+     +KI DFG +    +  +  + + +R+YR+PE+LL    Y  AID+W
Sbjct: 189 NILL---CNPKRXAIKIVDFGSSCQLGQRIY--QXIQSRFYRSPEVLLGMP-YDLAIDMW 242
Query: 133 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP---- 188
           S+GCIL E+ T EPLF G + V Q+  I E++G P    L   ++  AR++  +LP    
Sbjct: 243 SLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILD--QAPKARKFFEKLPDGTW 300
Query: 189 -----RCRKQQF-------------------ATRFPNKSSGAV-------DLLEKMLVFD 217
                +  K+++                     R   +S   V       DL+ +ML +D
Sbjct: 301 NLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYD 360
Query: 218 PNKRITVEEALRHPYLQSLHD 238
           P  RI    AL+H + +   D
Sbjct: 361 PKTRIQPYYALQHSFFKKTAD 381

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 110/234 (47%), Gaps = 36/234 (15%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           + H ++I + D+I+     + +++ +V E    +L   I    ++++   + F  Q++  
Sbjct: 61  LRHPHIIKLYDVIK-----SKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISA 115
Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 120
           ++Y H   ++HRDLKP NLLL+   ++KI DFGL+   ++ +F+     +  Y APE++ 
Sbjct: 116 VEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVIS 175
Query: 121 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 180
                   +D+WS G IL  ++ R   F                   DD S+  L   N 
Sbjct: 176 GKLYAGPEVDVWSCGVILYVMLCRRLPF-------------------DDESIPVLFK-NI 215
Query: 181 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
              V  LP+             S GA  L+++ML+ +P  RI++ E ++  + +
Sbjct: 216 SNGVYTLPKFL-----------SPGAAGLIKRMLIVNPLNRISIHEIMQDDWFK 258

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 110/234 (47%), Gaps = 36/234 (15%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           + H ++I + D+I+     + +++ +V E    +L   I    ++++   + F  Q++  
Sbjct: 65  LRHPHIIKLYDVIK-----SKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISA 119
Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 120
           ++Y H   ++HRDLKP NLLL+   ++KI DFGL+   ++ +F+     +  Y APE++ 
Sbjct: 120 VEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVIS 179
Query: 121 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 180
                   +D+WS G IL  ++ R   F                   DD S+  L   N 
Sbjct: 180 GKLYAGPEVDVWSCGVILYVMLCRRLPF-------------------DDESIPVLFK-NI 219
Query: 181 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
              V  LP+             S GA  L+++ML+ +P  RI++ E ++  + +
Sbjct: 220 SNGVYTLPKFL-----------SPGAAGLIKRMLIVNPLNRISIHEIMQDDWFK 262

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 89.0 bits (219), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 110/234 (47%), Gaps = 36/234 (15%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           + H ++I + D+I+     + +++ +V E    +L   I    ++++   + F  Q++  
Sbjct: 70  LRHPHIIKLYDVIK-----SKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISA 124
Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 120
           ++Y H   ++HRDLKP NLLL+   ++KI DFGL+   ++ +F+     +  Y APE++ 
Sbjct: 125 VEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVIS 184
Query: 121 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 180
                   +D+WS G IL  ++ R   F                   DD S+  L   N 
Sbjct: 185 GKLYAGPEVDVWSCGVILYVMLCRRLPF-------------------DDESIPVLFK-NI 224
Query: 181 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
              V  LP+             S GA  L+++ML+ +P  RI++ E ++  + +
Sbjct: 225 SNGVYTLPKFL-----------SPGAAGLIKRMLIVNPLNRISIHEIMQDDWFK 267

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 110/234 (47%), Gaps = 36/234 (15%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           + H ++I + D+I+     + +++ +V E    +L   I    ++++   + F  Q++  
Sbjct: 71  LRHPHIIKLYDVIK-----SKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISA 125
Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 120
           ++Y H   ++HRDLKP NLLL+   ++KI DFGL+   ++ +F+     +  Y APE++ 
Sbjct: 126 VEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVIS 185
Query: 121 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 180
                   +D+WS G IL  ++ R   F                   DD S+  L   N 
Sbjct: 186 GKLYAGPEVDVWSCGVILYVMLCRRLPF-------------------DDESIPVLFK-NI 225
Query: 181 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
              V  LP+             S GA  L+++ML+ +P  RI++ E ++  + +
Sbjct: 226 SNGVYTLPKFL-----------SPGAAGLIKRMLIVNPLNRISIHEIMQDDWFK 268

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 37/217 (17%)
Query: 22  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 81
            +VY   EL D      I S ++ ++      + Q+L G+ Y+H   ++HRDLKP NLLL
Sbjct: 128 GEVYTGGELFDE-----IISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLL 182
Query: 82  NAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 138
            +     +++I DFGL+     +  M + + T +Y APE+L     Y    D+WS G IL
Sbjct: 183 ESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVIL 240
Query: 139 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 198
             +++  P F G +    L+ + +                   +Y  +LP+ +K      
Sbjct: 241 YILLSGCPPFNGANEYDILKKVEK------------------GKYTFELPQWKKV----- 277
Query: 199 FPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
               S  A DL+ KML + P+ RI+  +AL H ++Q+
Sbjct: 278 ----SESAKDLIRKMLTYVPSMRISARDALDHEWIQT 310

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 37/217 (17%)
Query: 22  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 81
            +VY   EL D      I S ++ ++      + Q+L G+ Y+H   ++HRDLKP NLLL
Sbjct: 129 GEVYTGGELFDE-----IISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLL 183
Query: 82  NAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 138
            +     +++I DFGL+     +  M + + T +Y APE+L     Y    D+WS G IL
Sbjct: 184 ESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVIL 241
Query: 139 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 198
             +++  P F G +    L+ + +                   +Y  +LP+ +K      
Sbjct: 242 YILLSGCPPFNGANEYDILKKVEK------------------GKYTFELPQWKKV----- 278
Query: 199 FPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
               S  A DL+ KML + P+ RI+  +AL H ++Q+
Sbjct: 279 ----SESAKDLIRKMLTYVPSMRISARDALDHEWIQT 311

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 37/217 (17%)
Query: 22  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 81
            +VY   EL D      I S ++ ++      + Q+L G+ Y+H   ++HRDLKP NLLL
Sbjct: 105 GEVYTGGELFDE-----IISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLL 159
Query: 82  NAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 138
            +     +++I DFGL+     +  M + + T +Y APE+L     Y    D+WS G IL
Sbjct: 160 ESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVIL 217
Query: 139 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 198
             +++  P F G +    L+ + +                   +Y  +LP+ +K      
Sbjct: 218 YILLSGCPPFNGANEYDILKKVEK------------------GKYTFELPQWKKV----- 254
Query: 199 FPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
               S  A DL+ KML + P+ RI+  +AL H ++Q+
Sbjct: 255 ----SESAKDLIRKMLTYVPSMRISARDALDHEWIQT 287

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 107/219 (48%), Gaps = 37/219 (16%)
Query: 24  VYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 82
           +++V++LM   +L   +     L++   +  +  LL  + ++H+ +++HRDLKP N+LL+
Sbjct: 175 MFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLD 234
Query: 83  ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT------EYTAAIDIWSVGC 136
            +  +++ DFG +      + + E   T  Y APE+L  C+       Y   +D+W+ G 
Sbjct: 235 DNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEIL-KCSMDETHPGYGKEVDLWACGV 293
Query: 137 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 196
           IL  ++   P F  +  +  LR+I E                             + QF+
Sbjct: 294 ILFTLLAGSPPFWHRRQILMLRMIME----------------------------GQYQFS 325
Query: 197 T-RFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
           +  + ++SS   DL+ ++L  DP  R+T E+AL+HP+ +
Sbjct: 326 SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 102/217 (47%), Gaps = 37/217 (17%)
Query: 22  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 81
            +VY   EL D      I S ++ ++      + Q+L G+ Y+H   ++HRDLKP NLLL
Sbjct: 111 GEVYTGGELFDE-----IISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLL 165
Query: 82  NAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 138
            +     +++I DFGL+     +  M + + T +Y APE+L     Y    D+WS G IL
Sbjct: 166 ESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVIL 223
Query: 139 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 198
             +++  P F G +                      L+     +Y  +LP+ +K      
Sbjct: 224 YILLSGCPPFNGAN------------------EYDILKKVEKGKYTFELPQWKKV----- 260
Query: 199 FPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
               S  A DL+ KML + P+ RI+  +AL H ++Q+
Sbjct: 261 ----SESAKDLIRKMLTYVPSMRISARDALDHEWIQT 293

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 87.8 bits (216), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 67/247 (27%), Positives = 115/247 (46%), Gaps = 41/247 (16%)
Query: 26  IVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL-- 81
           I +EL+  +  + ++ +  Q     H ++  YQL   L+++H   + H DLKP N+L   
Sbjct: 99  IAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVN 158
Query: 82  ---------NASCD--------LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE 124
                    + SC+        +++ DFG A  T + +  T  V TR YR PE++L    
Sbjct: 159 SEFETLYNEHKSCEEKSVKNTSIRVADFGSA--TFDHEHHTTIVATRHYRPPEVILELG- 215
Query: 125 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL------------ 172
           +    D+WS+GCIL E      LF   +    L ++ +++G      +            
Sbjct: 216 WAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKG 275
Query: 173 GFLRSDNAR--RYVRQLPRCRK-QQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 229
           G +  +N+   RYV++   C+  + +  +   +     DL+ +ML FDP +RIT+ EAL 
Sbjct: 276 GLVWDENSSDGRYVKE--NCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL 333
Query: 230 HPYLQSL 236
           HP+   L
Sbjct: 334 HPFFAGL 340

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 87.4 bits (215), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 67/247 (27%), Positives = 115/247 (46%), Gaps = 41/247 (16%)
Query: 26  IVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL-- 81
           I +EL+  +  + ++ +  Q     H ++  YQL   L+++H   + H DLKP N+L   
Sbjct: 108 IAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVN 167
Query: 82  ---------NASCD--------LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE 124
                    + SC+        +++ DFG A  T + +  T  V TR YR PE++L    
Sbjct: 168 SEFETLYNEHKSCEEKSVKNTSIRVADFGSA--TFDHEHHTTIVATRHYRPPEVILELG- 224
Query: 125 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL------------ 172
           +    D+WS+GCIL E      LF   +    L ++ +++G      +            
Sbjct: 225 WAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKG 284
Query: 173 GFLRSDNAR--RYVRQLPRCRK-QQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 229
           G +  +N+   RYV++   C+  + +  +   +     DL+ +ML FDP +RIT+ EAL 
Sbjct: 285 GLVWDENSSDGRYVKE--NCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL 342
Query: 230 HPYLQSL 236
           HP+   L
Sbjct: 343 HPFFAGL 349

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 87.4 bits (215), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 106/238 (44%), Gaps = 38/238 (15%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H N+I +K+I   P      ++ +V EL+   +L   I      ++      + Q+L 
Sbjct: 105 LSHPNIIKLKEIFETP-----TEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILE 159
Query: 60  GLKYVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 116
            + Y+H   ++HRDLKP NLL         LKI DFGL++       M     T  Y AP
Sbjct: 160 AVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAP 219
Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPDDASLGFL 175
           E+L  C  Y   +D+WSVG I   ++   EP +                   D+    F+
Sbjct: 220 EILRGCA-YGPEVDMWSVGIITYILLCGFEPFY-------------------DERGDQFM 259
Query: 176 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
                    R++  C     +  +   S  A DL+ K++V DP KR+T  +AL+HP++
Sbjct: 260 --------FRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWV 309

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/247 (27%), Positives = 115/247 (46%), Gaps = 41/247 (16%)
Query: 26  IVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL-- 81
           I +EL+  +  + ++ +  Q     H ++  YQL   L+++H   + H DLKP N+L   
Sbjct: 131 IAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVN 190
Query: 82  ---------NASCD--------LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE 124
                    + SC+        +++ DFG A  T + +  T  V TR YR PE++L    
Sbjct: 191 SEFETLYNEHKSCEEKSVKNTSIRVADFGSA--TFDHEHHTTIVATRHYRPPEVILELG- 247
Query: 125 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL------------ 172
           +    D+WS+GCIL E      LF   +    L ++ +++G      +            
Sbjct: 248 WAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKG 307
Query: 173 GFLRSDNAR--RYVRQLPRCRK-QQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 229
           G +  +N+   RYV++   C+  + +  +   +     DL+ +ML FDP +RIT+ EAL 
Sbjct: 308 GLVWDENSSDGRYVKE--NCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL 365
Query: 230 HPYLQSL 236
           HP+   L
Sbjct: 366 HPFFAGL 372

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 85.1 bits (209), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/239 (29%), Positives = 114/239 (47%), Gaps = 38/239 (15%)
Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTD--LHQIIRSDQQLTDDHCQYFLYQLLR 59
           +H N+I +KD+      D    VY+V ELM     L +I+R  +  ++      L+ + +
Sbjct: 74  QHPNIITLKDVY-----DDGKYVYVVTELMKGGELLDKILR-QKFFSEREASAVLFTITK 127
Query: 60  GLKYVHSASVLHRDLKPSNLL-LNASCD---LKIGDFGLARTT-SETDFMTEYVVTRWYR 114
            ++Y+H+  V+HRDLKPSN+L ++ S +   ++I DFG A+   +E   +     T  + 
Sbjct: 128 TVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFV 187
Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF 174
           APE +L    Y AA DIWS+G +L  ++T                 T     PDD     
Sbjct: 188 APE-VLERQGYDAACDIWSLGVLLYTMLTG---------------YTPFANGPDDTPEEI 231
Query: 175 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
           L    + ++               + + S  A DL+ KML  DP++R+T    LRHP++
Sbjct: 232 LARIGSGKFSLS---------GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 84.7 bits (208), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 116/253 (45%), Gaps = 43/253 (16%)
Query: 3   HENVIAIKDIIRPPKKDTFND---VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLL 58
           H N++ + ++        F+D    ++V EL++  +L + I+  +  ++    Y + +L+
Sbjct: 65  HPNIVKLHEV--------FHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLV 116
Query: 59  RGLKYVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLARTT-SETDFMTEYVVTRWYR 114
             + ++H   V+HRDLKP NLL    N + ++KI DFG AR    +   +     T  Y 
Sbjct: 117 SAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYA 176
Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF 174
           APE LLN   Y  + D+WS+G IL  +++ +  F   D                      
Sbjct: 177 APE-LLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHD---------------------- 213
Query: 175 LRSDNARRYVRQLPRCRKQQFA---TRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHP 231
            RS      V  + + +K  F+     + N S  A DL++ +L  DPNKR+ +     + 
Sbjct: 214 -RSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNE 272
Query: 232 YLQSLHDLNDEPV 244
           +LQ    L+  P+
Sbjct: 273 WLQDGSQLSSNPL 285

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 84.7 bits (208), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 47/127 (37%), Positives = 77/127 (60%), Gaps = 3/127 (2%)
Query: 24  VYIVYEL-MDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 82
           VY+V E+     L ++ +  + +T+   +YF+ Q ++G++Y+H+  V+HRDLK  NL LN
Sbjct: 117 VYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLN 176
Query: 83  ASCDLKIGDFGLA-RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 141
              D+KIGDFGLA +   + +   +   T  Y APE+L     ++  +DIWS+GCIL  +
Sbjct: 177 DDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCK-KGHSFEVDIWSLGCILYTL 235
Query: 142 MTREPLF 148
           +  +P F
Sbjct: 236 LVGKPPF 242

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 84.7 bits (208), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 108/239 (45%), Gaps = 37/239 (15%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++H N++A+ DI      ++   +Y++ +L+   +L   I      T+      ++Q+L 
Sbjct: 73  IKHPNIVALDDIY-----ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD 127
Query: 60  GLKYVHSASVLHRDLKPSNLL---LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 116
            +KY+H   ++HRDLKP NLL   L+    + I DFGL++       ++    T  Y AP
Sbjct: 128 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAP 187
Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 176
           E+L     Y+ A+D WS+G I   ++   P F                            
Sbjct: 188 EVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPF---------------------------Y 219
Query: 177 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
            +N  +   Q+ +   +  +  + + S  A D +  ++  DP KR T E+AL+HP++  
Sbjct: 220 DENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 278

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 84.7 bits (208), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 50/128 (39%), Positives = 78/128 (60%), Gaps = 5/128 (3%)
Query: 24  VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 82
           VY+V E+     L ++ +  + +T+   +YF+ Q ++G++Y+H+  V+HRDLK  NL LN
Sbjct: 117 VYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLN 176
Query: 83  ASCDLKIGDFGLARTTSETDFMTEYVV--TRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
              D+KIGDFGLA T  E D   +  +  T  Y APE+L     ++  +DIWS+GCIL  
Sbjct: 177 DDMDVKIGDFGLA-TKIEFDGERKKTLCGTPNYIAPEVLCK-KGHSFEVDIWSLGCILYT 234
Query: 141 IMTREPLF 148
           ++  +P F
Sbjct: 235 LLVGKPPF 242

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 84.7 bits (208), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 111/221 (50%), Gaps = 40/221 (18%)
Query: 24  VYIVYELMD-TDL--HQIIRSDQQL--TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 78
           +Y+V+E MD  DL    + R+D     ++    +++ Q+L  L+Y H  +++HRD+KP N
Sbjct: 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPEN 160
Query: 79  LLLNA---SCDLKIGDFGLARTTSETDFMT-EYVVTRWYRAPELLLNCTEYTAAIDIWSV 134
           +LL +   S  +K+GDFG+A    E+  +    V T  + APE++     Y   +D+W  
Sbjct: 161 VLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPEVVKR-EPYGKPVDVWGC 219
Query: 135 GCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ 193
           G IL  +++   P +  K+     RL   +I                +   +  PR    
Sbjct: 220 GVILFILLSGCLPFYGTKE-----RLFEGII----------------KGKYKMNPR---- 254
Query: 194 QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
               ++ + S  A DL+ +ML+ DP +RITV EAL HP+L+
Sbjct: 255 ----QWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLK 291

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 108/241 (44%), Gaps = 44/241 (18%)
Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 61
           H N+I +KD     + +TF   ++V++LM   +L   +     L++   +  +  LL  +
Sbjct: 83  HPNIIQLKDTY---ETNTF--FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 137
Query: 62  KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL- 120
             +H  +++HRDLKP N+LL+   ++K+ DFG +      + + E   T  Y APE++  
Sbjct: 138 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIEC 197
Query: 121 ----NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE---LIGSPDDASLG 173
               N   Y   +D+WS G I+  ++   P F  +  +  LR+I       GSP+     
Sbjct: 198 SMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE----- 252
Query: 174 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
                                    + + S    DL+ + LV  P KR T EEAL HP+ 
Sbjct: 253 -------------------------WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 287
Query: 234 Q 234
           Q
Sbjct: 288 Q 288

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 47/127 (37%), Positives = 77/127 (60%), Gaps = 3/127 (2%)
Query: 24  VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 82
           VY+V E+     L ++ +  + +T+   +YF+ Q ++G++Y+H+  V+HRDLK  NL LN
Sbjct: 101 VYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLN 160
Query: 83  ASCDLKIGDFGLA-RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 141
              D+KIGDFGLA +   + +   +   T  Y APE+L     ++  +DIWS+GCIL  +
Sbjct: 161 DDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCK-KGHSFEVDIWSLGCILYTL 219
Query: 142 MTREPLF 148
           +  +P F
Sbjct: 220 LVGKPPF 226

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 108/239 (45%), Gaps = 37/239 (15%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++H N++A+ DI      ++   +Y++ +L+   +L   I      T+      ++Q+L 
Sbjct: 73  IKHPNIVALDDIY-----ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD 127
Query: 60  GLKYVHSASVLHRDLKPSNLL---LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 116
            +KY+H   ++HRDLKP NLL   L+    + I DFGL++       ++    T  Y AP
Sbjct: 128 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAP 187
Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 176
           E+L     Y+ A+D WS+G I   ++   P F                            
Sbjct: 188 EVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPF---------------------------Y 219
Query: 177 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
            +N  +   Q+ +   +  +  + + S  A D +  ++  DP KR T E+AL+HP++  
Sbjct: 220 DENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 278

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 84.3 bits (207), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 108/239 (45%), Gaps = 37/239 (15%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++H N++A+ DI      ++   +Y++ +L+   +L   I      T+      ++Q+L 
Sbjct: 73  IKHPNIVALDDIY-----ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD 127
Query: 60  GLKYVHSASVLHRDLKPSNLL---LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 116
            +KY+H   ++HRDLKP NLL   L+    + I DFGL++       ++    T  Y AP
Sbjct: 128 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAP 187
Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 176
           E+L     Y+ A+D WS+G I   ++   P F                            
Sbjct: 188 EVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPF---------------------------Y 219
Query: 177 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
            +N  +   Q+ +   +  +  + + S  A D +  ++  DP KR T E+AL+HP++  
Sbjct: 220 DENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 278

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 84.3 bits (207), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 110/240 (45%), Gaps = 40/240 (16%)
Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTD--LHQIIRSDQQLTDDHCQYFLYQLLR 59
           +H N+I +KD+      D    VY+V ELM     L +I+R  +  ++    + L+ + +
Sbjct: 79  QHPNIITLKDVY-----DDGKHVYLVTELMRGGELLDKILR-QKFFSEREASFVLHTIGK 132
Query: 60  GLKYVHSASVLHRDLKPSNLLL-----NASCDLKIGDFGLARTT-SETDFMTEYVVTRWY 113
            ++Y+HS  V+HRDLKPSN+L      N  C L+I DFG A+   +E   +     T  +
Sbjct: 133 TVEYLHSQGVVHRDLKPSNILYVDESGNPEC-LRICDFGFAKQLRAENGLLMTPCYTANF 191
Query: 114 RAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLG 173
            APE+L     Y    DIWS+G +L  ++                  T     P D    
Sbjct: 192 VAPEVLKR-QGYDEGCDIWSLGILLYTMLAG---------------YTPFANGPSDTPEE 235
Query: 174 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
            L    + ++               +   S  A DL+ KML  DP++R+T ++ L+HP++
Sbjct: 236 ILTRIGSGKFTLS---------GGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPWV 286

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 50/128 (39%), Positives = 78/128 (60%), Gaps = 5/128 (3%)
Query: 24  VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 82
           VY+V E+     L ++ +  + +T+   +YF+ Q ++G++Y+H+  V+HRDLK  NL LN
Sbjct: 117 VYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLN 176
Query: 83  ASCDLKIGDFGLARTTSETDFMTEYVV--TRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
              D+KIGDFGLA T  E D   +  +  T  Y APE+L     ++  +DIWS+GCIL  
Sbjct: 177 DDMDVKIGDFGLA-TKIEFDGERKKXLCGTPNYIAPEVLCK-KGHSFEVDIWSLGCILYT 234
Query: 141 IMTREPLF 148
           ++  +P F
Sbjct: 235 LLVGKPPF 242

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 108/241 (44%), Gaps = 44/241 (18%)
Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 61
           H N+I +KD     + +TF   ++V++LM   +L   +     L++   +  +  LL  +
Sbjct: 70  HPNIIQLKDTY---ETNTF--FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 124
Query: 62  KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL- 120
             +H  +++HRDLKP N+LL+   ++K+ DFG +      + + E   T  Y APE++  
Sbjct: 125 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIEC 184
Query: 121 ----NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE---LIGSPDDASLG 173
               N   Y   +D+WS G I+  ++   P F  +  +  LR+I       GSP+     
Sbjct: 185 SMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE----- 239
Query: 174 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
                                    + + S    DL+ + LV  P KR T EEAL HP+ 
Sbjct: 240 -------------------------WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 274
Query: 234 Q 234
           Q
Sbjct: 275 Q 275

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 110/240 (45%), Gaps = 40/240 (16%)
Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTD--LHQIIRSDQQLTDDHCQYFLYQLLR 59
           +H N+I +KD+      D    VY+V ELM     L +I+R  +  ++    + L+ + +
Sbjct: 79  QHPNIITLKDVY-----DDGKHVYLVTELMRGGELLDKILR-QKFFSEREASFVLHTIGK 132
Query: 60  GLKYVHSASVLHRDLKPSNLLL-----NASCDLKIGDFGLARTT-SETDFMTEYVVTRWY 113
            ++Y+HS  V+HRDLKPSN+L      N  C L+I DFG A+   +E   +     T  +
Sbjct: 133 TVEYLHSQGVVHRDLKPSNILYVDESGNPEC-LRICDFGFAKQLRAENGLLMTPCYTANF 191
Query: 114 RAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLG 173
            APE+L     Y    DIWS+G +L  ++                  T     P D    
Sbjct: 192 VAPEVLKR-QGYDEGCDIWSLGILLYTMLAG---------------YTPFANGPSDTPEE 235
Query: 174 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
            L    + ++               +   S  A DL+ KML  DP++R+T ++ L+HP++
Sbjct: 236 ILTRIGSGKFTLS---------GGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHPWV 286

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 108/239 (45%), Gaps = 37/239 (15%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++H N++A+ DI      ++   +Y++ +L+   +L   I      T+      ++Q+L 
Sbjct: 73  IKHPNIVALDDIY-----ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD 127
Query: 60  GLKYVHSASVLHRDLKPSNLL---LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 116
            +KY+H   ++HRDLKP NLL   L+    + I DFGL++       ++    T  Y AP
Sbjct: 128 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAP 187
Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 176
           E+L     Y+ A+D WS+G I   ++   P F                            
Sbjct: 188 EVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPF---------------------------Y 219
Query: 177 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
            +N  +   Q+ +   +  +  + + S  A D +  ++  DP KR T E+AL+HP++  
Sbjct: 220 DENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 278

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 106/220 (48%), Gaps = 39/220 (17%)
Query: 51  QYFLYQLLRGLKYVHSASVLHRDLKPSNLL-LNA------------------SCDLKIGD 91
           ++  +QL + +K++H   + H DLKP N+L +N+                  S  +++ D
Sbjct: 140 RHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVD 199
Query: 92  FGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK 151
           FG A  T + +  +  V TR YRAPE++L    ++   D+WS+GCI+ E      LF   
Sbjct: 200 FGSA--TFDHEHHSTIVSTRHYRAPEVILELG-WSQPCDVWSIGCIIFEYYVGFTLFQTH 256
Query: 152 DYVHQLRLITELIGSPDD--------------ASLGFLRSDNARRYVRQLPRCRK-QQFA 196
           D    L ++  ++G                    L +  + +A RYVR+   C+  +++ 
Sbjct: 257 DNREHLAMMERILGPIPSRMIRKTRKQKYFYRGRLDWDENTSAGRYVRE--NCKPLRRYL 314
Query: 197 TRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 236
           T    +     DL+E ML ++P KR+T+ EAL+HP+   L
Sbjct: 315 TSEAEEHHQLFDLIESMLEYEPAKRLTLGEALQHPFFARL 354

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 84.0 bits (206), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 111/240 (46%), Gaps = 44/240 (18%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++H N++ + +     +     + Y+V E+    +L   I   Q+ ++      + Q+L 
Sbjct: 78  LDHPNIMKLYEFFEDKR-----NYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLS 132
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGLARTTSETDFMTEYVVTRWYRAP 116
           G  Y+H  +++HRDLKP NLLL +      +KI DFGL+        M E + T +Y AP
Sbjct: 133 GTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAP 192
Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 176
           E+L    +Y    D+WS G IL  ++   P F G+                 D  +    
Sbjct: 193 EVLRK--KYDEKCDVWSCGVILYILLCGYPPFGGQ----------------TDQEI---- 230
Query: 177 SDNARRYVRQLPRCRKQQFATRFPN---KSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
                     L R  K +F+   P+    S  A  L++ ML ++P+KRI+ EEAL HP++
Sbjct: 231 ----------LKRVEKGKFSFDPPDWTQVSDEAKQLVKLMLTYEPSKRISAEEALNHPWI 280

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 120/237 (50%), Gaps = 37/237 (15%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++H N++ + D I   ++++F+  Y+V++L+   +L + I + +  ++    + + Q+L 
Sbjct: 61  LQHPNIVRLHDSI---QEESFH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE 115
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGLARTTSETDFMTEYVVTRWYRAP 116
            + Y HS  ++HR+LKP NLLL +      +K+ DFGLA   ++++    +  T  Y +P
Sbjct: 116 SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSP 175
Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 176
           E+L     Y+  +DIW+ G IL  ++   P F  +D   Q RL  ++             
Sbjct: 176 EVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLYAQI------------- 218
Query: 177 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
              A  Y    P     ++ T  P   S    L++ ML  +P KRIT ++AL+ P++
Sbjct: 219 --KAGAYDYPSP-----EWDTVTPEAKS----LIDSMLTVNPKKRITADQALKVPWI 264

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 101/217 (46%), Gaps = 37/217 (17%)
Query: 22  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 81
            +VY   EL D      I S ++ ++      + Q+L G+ Y H   ++HRDLKP NLLL
Sbjct: 105 GEVYTGGELFDE-----IISRKRFSEVDAARIIRQVLSGITYXHKNKIVHRDLKPENLLL 159
Query: 82  NAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 138
            +     +++I DFGL+     +    + + T +Y APE+L     Y    D+WS G IL
Sbjct: 160 ESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVIL 217
Query: 139 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 198
             +++  P F G +    L+ + +                   +Y  +LP+ +K      
Sbjct: 218 YILLSGCPPFNGANEYDILKKVEK------------------GKYTFELPQWKKV----- 254
Query: 199 FPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
               S  A DL+ K L + P+ RI+  +AL H ++Q+
Sbjct: 255 ----SESAKDLIRKXLTYVPSXRISARDALDHEWIQT 287

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 106/215 (49%), Gaps = 36/215 (16%)
Query: 24  VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 82
           V++V EL     L ++ +  + LT+   +Y+L Q++ G +Y+H   V+HRDLK  NL LN
Sbjct: 114 VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN 173
Query: 83  ASCDLKIGDFGLARTTSETDFMTEYVV--TRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
              ++KIGDFGLA T  E D   + V+  T  Y APE +L+   ++  +D+WS+GCI   
Sbjct: 174 EDLEVKIGDFGLA-TKVEYDGERKKVLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCI--- 228
Query: 141 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 200
                             + T L+G P      F  S     Y+    R +K +++    
Sbjct: 229 ------------------MYTLLVGKPP-----FETSCLKETYL----RIKKNEYSIP-K 260
Query: 201 NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
           + +  A  L++KML  DP  R T+ E L   +  S
Sbjct: 261 HINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 295

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 106/215 (49%), Gaps = 36/215 (16%)
Query: 24  VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 82
           V++V EL     L ++ +  + LT+   +Y+L Q++ G +Y+H   V+HRDLK  NL LN
Sbjct: 116 VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN 175
Query: 83  ASCDLKIGDFGLARTTSETDFMTEYVV--TRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
              ++KIGDFGLA T  E D   + V+  T  Y APE +L+   ++  +D+WS+GCI   
Sbjct: 176 EDLEVKIGDFGLA-TKVEYDGERKKVLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCI--- 230
Query: 141 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 200
                             + T L+G P      F  S     Y+    R +K +++    
Sbjct: 231 ------------------MYTLLVGKPP-----FETSCLKETYL----RIKKNEYSIP-K 262
Query: 201 NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
           + +  A  L++KML  DP  R T+ E L   +  S
Sbjct: 263 HINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 297

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 111/240 (46%), Gaps = 44/240 (18%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++H N++ + +     +     + Y+V E+    +L   I   Q+ ++      + Q+L 
Sbjct: 61  LDHPNIMKLYEFFEDKR-----NYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLS 115
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGLARTTSETDFMTEYVVTRWYRAP 116
           G  Y+H  +++HRDLKP NLLL +      +KI DFGL+        M E + T +Y AP
Sbjct: 116 GTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAP 175
Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 176
           E+L    +Y    D+WS G IL  ++   P F G+                 D  +    
Sbjct: 176 EVLRK--KYDEKCDVWSCGVILYILLCGYPPFGGQ----------------TDQEI---- 213
Query: 177 SDNARRYVRQLPRCRKQQFATRFPN---KSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
                     L R  K +F+   P+    S  A  L++ ML ++P+KRI+ EEAL HP++
Sbjct: 214 ----------LKRVEKGKFSFDPPDWTQVSDEAKQLVKLMLTYEPSKRISAEEALNHPWI 263

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 120/237 (50%), Gaps = 37/237 (15%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++H N++ + D I+   +++F+  Y+V++L+   +L + I + +  ++    + + Q+L 
Sbjct: 62  LQHPNIVRLHDSIQ---EESFH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE 116
Query: 60  GLKYVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 116
            + Y HS  ++HR+LKP NLLL +      +K+ DFGLA   ++++    +  T  Y +P
Sbjct: 117 SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSP 176
Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 176
           E+L     Y+  +DIW+ G IL  ++   P F  +D   Q RL  ++             
Sbjct: 177 EVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLYAQI------------- 219
Query: 177 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
              A  Y    P     ++ T  P   S    L++ ML  +P KRIT ++AL+ P++
Sbjct: 220 --KAGAYDYPSP-----EWDTVTPEAKS----LIDSMLTVNPKKRITADQALKVPWI 265

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 106/215 (49%), Gaps = 36/215 (16%)
Query: 24  VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 82
           V++V EL     L ++ +  + LT+   +Y+L Q++ G +Y+H   V+HRDLK  NL LN
Sbjct: 90  VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN 149
Query: 83  ASCDLKIGDFGLARTTSETDFMTEYVV--TRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
              ++KIGDFGLA T  E D   + V+  T  Y APE +L+   ++  +D+WS+GCI   
Sbjct: 150 EDLEVKIGDFGLA-TKVEYDGERKKVLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCI--- 204
Query: 141 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 200
                             + T L+G P      F  S     Y+    R +K +++    
Sbjct: 205 ------------------MYTLLVGKPP-----FETSCLKETYL----RIKKNEYSIP-K 236
Query: 201 NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
           + +  A  L++KML  DP  R T+ E L   +  S
Sbjct: 237 HINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 271

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 120/237 (50%), Gaps = 37/237 (15%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++H N++ + D I   ++++F+  Y+V++L+   +L + I + +  ++    + + Q+L 
Sbjct: 62  LQHPNIVRLHDSI---QEESFH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE 116
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGLARTTSETDFMTEYVVTRWYRAP 116
            + Y HS  ++HR+LKP NLLL +      +K+ DFGLA   ++++    +  T  Y +P
Sbjct: 117 SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSP 176
Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 176
           E+L     Y+  +DIW+ G IL  ++   P F  +D   Q RL  ++             
Sbjct: 177 EVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLYAQI------------- 219
Query: 177 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
              A  Y    P     ++ T  P   S    L++ ML  +P KRIT ++AL+ P++
Sbjct: 220 --KAGAYDYPSP-----EWDTVTPEAKS----LIDSMLTVNPKKRITADQALKVPWI 265

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 120/237 (50%), Gaps = 37/237 (15%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++H N++ + D I   ++++F+  Y+V++L+   +L + I + +  ++    + + Q+L 
Sbjct: 85  LQHPNIVRLHDSI---QEESFH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE 139
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGLARTTSETDFMTEYVVTRWYRAP 116
            + Y HS  ++HR+LKP NLLL +      +K+ DFGLA   ++++    +  T  Y +P
Sbjct: 140 SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSP 199
Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 176
           E+L     Y+  +DIW+ G IL  ++   P F  +D   Q RL  ++             
Sbjct: 200 EVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLYAQI------------- 242
Query: 177 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
              A  Y    P     ++ T  P   S    L++ ML  +P KRIT ++AL+ P++
Sbjct: 243 --KAGAYDYPSP-----EWDTVTPEAKS----LIDSMLTVNPKKRITADQALKVPWI 288

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 107/241 (44%), Gaps = 44/241 (18%)
Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 61
           H N+I +KD     + +TF   ++V++LM   +L   +     L++   +  +  LL  +
Sbjct: 83  HPNIIQLKDTY---ETNTF--FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 137
Query: 62  KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL- 120
             +H  +++HRDLKP N+LL+   ++K+ DFG +      + +     T  Y APE++  
Sbjct: 138 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEIIEC 197
Query: 121 ----NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITE---LIGSPDDASLG 173
               N   Y   +D+WS G I+  ++   P F  +  +  LR+I       GSP+     
Sbjct: 198 SMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE----- 252
Query: 174 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
                                    + + S    DL+ + LV  P KR T EEAL HP+ 
Sbjct: 253 -------------------------WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 287
Query: 234 Q 234
           Q
Sbjct: 288 Q 288

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 73/278 (26%), Positives = 128/278 (46%), Gaps = 49/278 (17%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++H N++ + D I    ++ F+  Y+V++L+   +L + I + +  ++    + ++Q+L 
Sbjct: 87  LKHPNIVRLHDSI---SEEGFH--YLVFDLVTGGELFEDIVAREYYSEADASHCIHQILE 141
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGLA-RTTSETDFMTEYVVTRWYRA 115
            + ++H   ++HRDLKP NLLL + C    +K+ DFGLA     E      +  T  Y +
Sbjct: 142 SVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLS 201
Query: 116 PELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL 175
           PE+L     Y   +DIW+ G IL  ++   P F  +D   Q +L  ++     D      
Sbjct: 202 PEVLRK-DPYGKPVDIWACGVILYILLVGYPPFWDED---QHKLYQQIKAGAYD------ 251
Query: 176 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
                       P     ++ T  P     A +L+ +ML  +P KRIT ++AL+HP+   
Sbjct: 252 -----------FP---SPEWDTVTPE----AKNLINQMLTINPAKRITADQALKHPW--- 290
Query: 236 LHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVK 273
                   VC R       H   T + +R+   R  +K
Sbjct: 291 --------VCQRSTVASMMHRQETVECLRKFNARRKLK 320

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 84/141 (59%), Gaps = 6/141 (4%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           ++H NV+ + +++  P +D    +Y+V+EL++      + + + L++D  +++   L++G
Sbjct: 93  LDHPNVVKLVEVLDDPNED---HLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKG 149
Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELL 119
           ++Y+H   ++HRD+KPSNLL+     +KI DFG++     +D  ++  V T  + APE L
Sbjct: 150 IEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESL 209
Query: 120 LNCTEYTA--AIDIWSVGCIL 138
               +  +  A+D+W++G  L
Sbjct: 210 SETRKIFSGKALDVWAMGVTL 230

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 105/215 (48%), Gaps = 36/215 (16%)
Query: 24  VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 82
           V++V EL     L ++ +  + LT+   +Y+L Q++ G +Y+H   V+HRDLK  NL LN
Sbjct: 96  VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN 155
Query: 83  ASCDLKIGDFGLARTTSETDFMTEYVV--TRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
              ++KIGDFGLA T  E D   +  +  T  Y APE +L+   ++  +D+WS+GCI   
Sbjct: 156 EDLEVKIGDFGLA-TKVEYDGERKKTLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCI--- 210
Query: 141 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 200
                             + T L+G P      F  S     Y+    R +K +++    
Sbjct: 211 ------------------MYTLLVGKPP-----FETSCLKETYL----RIKKNEYSIP-K 242
Query: 201 NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
           + +  A  L++KML  DP  R T+ E L   +  S
Sbjct: 243 HINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 277

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 105/215 (48%), Gaps = 36/215 (16%)
Query: 24  VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 82
           V++V EL     L ++ +  + LT+   +Y+L Q++ G +Y+H   V+HRDLK  NL LN
Sbjct: 92  VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN 151
Query: 83  ASCDLKIGDFGLARTTSETDFMTEYVV--TRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
              ++KIGDFGLA T  E D   +  +  T  Y APE +L+   ++  +D+WS+GCI   
Sbjct: 152 EDLEVKIGDFGLA-TKVEYDGERKKTLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCI--- 206
Query: 141 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 200
                             + T L+G P      F  S     Y+    R +K +++    
Sbjct: 207 ------------------MYTLLVGKPP-----FETSCLKETYL----RIKKNEYSIP-K 238
Query: 201 NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
           + +  A  L++KML  DP  R T+ E L   +  S
Sbjct: 239 HINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 273

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 112/242 (46%), Gaps = 44/242 (18%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++H NVI + ++      +   DV ++ EL+   +L   +   + LT++    FL Q+L 
Sbjct: 71  IQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 125
Query: 60  GLKYVHSASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEY---VVTRW 112
           G+ Y+HS  + H DLKP N++L         +KI DFGLA    + DF  E+     T  
Sbjct: 126 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPE 182
Query: 113 YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL 172
           + APE++ N        D+WS+G I   +++    F G                      
Sbjct: 183 FVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLG---------------------- 219
Query: 173 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 232
                D  +  +  +     +     F N S+ A D + ++LV DP KR+T++++L+HP+
Sbjct: 220 -----DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274
Query: 233 LQ 234
           ++
Sbjct: 275 IK 276

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 105/215 (48%), Gaps = 36/215 (16%)
Query: 24  VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 82
           V++V EL     L ++ +  + LT+   +Y+L Q++ G +Y+H   V+HRDLK  NL LN
Sbjct: 92  VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN 151
Query: 83  ASCDLKIGDFGLARTTSETDFMTEYVV--TRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
              ++KIGDFGLA T  E D   +  +  T  Y APE +L+   ++  +D+WS+GCI   
Sbjct: 152 EDLEVKIGDFGLA-TKVEYDGERKKTLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCI--- 206
Query: 141 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 200
                             + T L+G P      F  S     Y+    R +K +++    
Sbjct: 207 ------------------MYTLLVGKPP-----FETSCLKETYL----RIKKNEYSIP-K 238
Query: 201 NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
           + +  A  L++KML  DP  R T+ E L   +  S
Sbjct: 239 HINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 273

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 112/242 (46%), Gaps = 44/242 (18%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++H NVI + ++      +   DV ++ EL+   +L   +   + LT++    FL Q+L 
Sbjct: 70  IQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 124
Query: 60  GLKYVHSASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEY---VVTRW 112
           G+ Y+HS  + H DLKP N++L         +KI DFGLA    + DF  E+     T  
Sbjct: 125 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPE 181
Query: 113 YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL 172
           + APE++ N        D+WS+G I   +++    F G                      
Sbjct: 182 FVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLG---------------------- 218
Query: 173 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 232
                D  +  +  +     +     F N S+ A D + ++LV DP KR+T++++L+HP+
Sbjct: 219 -----DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 273
Query: 233 LQ 234
           ++
Sbjct: 274 IK 275

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 112/242 (46%), Gaps = 44/242 (18%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++H NVI + ++      +   DV ++ EL+   +L   +   + LT++    FL Q+L 
Sbjct: 70  IQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 124
Query: 60  GLKYVHSASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEY---VVTRW 112
           G+ Y+HS  + H DLKP N++L         +KI DFGLA    + DF  E+     T  
Sbjct: 125 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPE 181
Query: 113 YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL 172
           + APE++ N        D+WS+G I   +++    F G                      
Sbjct: 182 FVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLG---------------------- 218
Query: 173 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 232
                D  +  +  +     +     F N S+ A D + ++LV DP KR+T++++L+HP+
Sbjct: 219 -----DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 273
Query: 233 LQ 234
           ++
Sbjct: 274 IK 275

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 112/242 (46%), Gaps = 44/242 (18%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++H NVI + ++      +   DV ++ EL+   +L   +   + LT++    FL Q+L 
Sbjct: 71  IQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 125
Query: 60  GLKYVHSASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEY---VVTRW 112
           G+ Y+HS  + H DLKP N++L         +KI DFGLA    + DF  E+     T  
Sbjct: 126 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPE 182
Query: 113 YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL 172
           + APE++ N        D+WS+G I   +++    F G                      
Sbjct: 183 FVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLG---------------------- 219
Query: 173 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 232
                D  +  +  +     +     F N S+ A D + ++LV DP KR+T++++L+HP+
Sbjct: 220 -----DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274
Query: 233 LQ 234
           ++
Sbjct: 275 IK 276

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 112/242 (46%), Gaps = 44/242 (18%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++H NVI + ++      +   DV ++ EL+   +L   +   + LT++    FL Q+L 
Sbjct: 71  IQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 125
Query: 60  GLKYVHSASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEY---VVTRW 112
           G+ Y+HS  + H DLKP N++L         +KI DFGLA    + DF  E+     T  
Sbjct: 126 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPE 182
Query: 113 YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL 172
           + APE++ N        D+WS+G I   +++    F G                      
Sbjct: 183 FVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLG---------------------- 219
Query: 173 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 232
                D  +  +  +     +     F N S+ A D + ++LV DP KR+T++++L+HP+
Sbjct: 220 -----DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274
Query: 233 LQ 234
           ++
Sbjct: 275 IK 276

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 114/238 (47%), Gaps = 38/238 (15%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++H N+I + D+    K       Y+V E  +  +L + I +  +  +      + Q+L 
Sbjct: 103 LDHPNIIKLFDVFEDKKY-----FYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILS 157
Query: 60  GLKYVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 116
           G+ Y+H  +++HRD+KP N+LL   N+  ++KI DFGL+   S+   + + + T +Y AP
Sbjct: 158 GICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAP 217
Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 176
           E+L    +Y    D+WS G I+  ++   P F G+                         
Sbjct: 218 EVLK--KKYNEKCDVWSCGVIMYILLCGYPPFGGQ------------------------- 250
Query: 177 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
             N +  ++++ + +       + N S  A +L++ ML +D NKR T EEAL   +++
Sbjct: 251 --NDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIK 306

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 112/242 (46%), Gaps = 44/242 (18%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++H NVI + ++      +   DV ++ EL+   +L   +   + LT++    FL Q+L 
Sbjct: 71  IQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 125
Query: 60  GLKYVHSASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEY---VVTRW 112
           G+ Y+HS  + H DLKP N++L         +KI DFGLA    + DF  E+     T  
Sbjct: 126 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPE 182
Query: 113 YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL 172
           + APE++ N        D+WS+G I   +++    F G                      
Sbjct: 183 FVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLG---------------------- 219
Query: 173 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 232
                D  +  +  +     +     F N S+ A D + ++LV DP KR+T++++L+HP+
Sbjct: 220 -----DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274
Query: 233 LQ 234
           ++
Sbjct: 275 IK 276

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 113/242 (46%), Gaps = 44/242 (18%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++H NVI + ++      +   DV ++ EL+   +L   +   + LT++    FL Q+L 
Sbjct: 71  IQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 125
Query: 60  GLKYVHSASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEY---VVTRW 112
           G+ Y+HS  + H DLKP N++L         +KI DFGLA    + DF  E+     T  
Sbjct: 126 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPA 182
Query: 113 YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL 172
           + APE ++N        D+WS+G I   +++    F G      L  ++ +    +D   
Sbjct: 183 FVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED--- 238
Query: 173 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 232
                                     F N S+ A D + ++LV DP KR+T++++L+HP+
Sbjct: 239 ------------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274
Query: 233 LQ 234
           ++
Sbjct: 275 IK 276

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 112/242 (46%), Gaps = 44/242 (18%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++H NVI + ++      +   DV ++ EL+   +L   +   + LT++    FL Q+L 
Sbjct: 71  IQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 125
Query: 60  GLKYVHSASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEY---VVTRW 112
           G+ Y+HS  + H DLKP N++L         +KI DFGLA    + DF  E+     T  
Sbjct: 126 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPE 182
Query: 113 YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL 172
           + APE++ N        D+WS+G I   +++    F G                      
Sbjct: 183 FVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLG---------------------- 219
Query: 173 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 232
                D  +  +  +     +     F N S+ A D + ++LV DP KR+T++++L+HP+
Sbjct: 220 -----DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274
Query: 233 LQ 234
           ++
Sbjct: 275 IK 276

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 112/242 (46%), Gaps = 44/242 (18%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++H NVI + ++      +   DV ++ EL+   +L   +   + LT++    FL Q+L 
Sbjct: 71  IQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 125
Query: 60  GLKYVHSASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEY---VVTRW 112
           G+ Y+HS  + H DLKP N++L         +KI DFGLA    + DF  E+     T  
Sbjct: 126 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPE 182
Query: 113 YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL 172
           + APE++ N        D+WS+G I   +++    F G                      
Sbjct: 183 FVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLG---------------------- 219
Query: 173 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 232
                D  +  +  +     +     F N S+ A D + ++LV DP KR+T++++L+HP+
Sbjct: 220 -----DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274
Query: 233 LQ 234
           ++
Sbjct: 275 IK 276

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 113/242 (46%), Gaps = 44/242 (18%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++H NVI + ++      +   DV ++ EL+   +L   +   + LT++    FL Q+L 
Sbjct: 71  IQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 125
Query: 60  GLKYVHSASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEY---VVTRW 112
           G+ Y+HS  + H DLKP N++L         +KI DFGLA    + DF  E+     T  
Sbjct: 126 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPE 182
Query: 113 YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL 172
           + APE++ N        D+WS+G I   +++    F G      L  ++ +    +D   
Sbjct: 183 FVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY- 240
Query: 173 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 232
                                     F N S+ A D + ++LV DP KR+T++++L+HP+
Sbjct: 241 --------------------------FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274
Query: 233 LQ 234
           ++
Sbjct: 275 IK 276

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 112/242 (46%), Gaps = 44/242 (18%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++H NVI + ++      +   DV ++ EL+   +L   +   + LT++    FL Q+L 
Sbjct: 71  IQHPNVITLHEVY-----ENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILN 125
Query: 60  GLKYVHSASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEY---VVTRW 112
           G+ Y+HS  + H DLKP N++L         +KI DFGLA    + DF  E+     T  
Sbjct: 126 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPE 182
Query: 113 YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL 172
           + APE++ N        D+WS+G I   +++    F G                      
Sbjct: 183 FVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLG---------------------- 219
Query: 173 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 232
                D  +  +  +     +     F N S+ A D + ++LV DP KR+T++++L+HP+
Sbjct: 220 -----DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274
Query: 233 LQ 234
           ++
Sbjct: 275 IK 276

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 58/159 (36%), Positives = 84/159 (52%), Gaps = 15/159 (9%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQII----RSDQQLTDDHCQYFLY 55
           ++H N++   D I      T   +YIV E  +  DL  +I    +  Q L ++     + 
Sbjct: 62  LKHPNIVRYYDRIIDRTNTT---LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 56  QLLRGLKYVHSAS-----VLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVV 109
           QL   LK  H  S     VLHRDLKP+N+ L+   ++K+GDFGLAR  + + DF  E+V 
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVG 178
Query: 110 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF 148
           T +Y +PE  +N   Y    DIWS+GC+L E+    P F
Sbjct: 179 TPYYMSPE-QMNRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 112/242 (46%), Gaps = 44/242 (18%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++H NVI + ++      +   DV ++ EL+   +L   +   + LT++    FL Q+L 
Sbjct: 71  IQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 125
Query: 60  GLKYVHSASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEY---VVTRW 112
           G+ Y+HS  + H DLKP N++L         +KI DFGLA    + DF  E+     T  
Sbjct: 126 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPE 182
Query: 113 YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL 172
           + APE++ N        D+WS+G I   +++    F G                      
Sbjct: 183 FVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLG---------------------- 219
Query: 173 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 232
                D  +  +  +     +     F N S+ A D + ++LV DP KR+T++++L+HP+
Sbjct: 220 -----DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274
Query: 233 LQ 234
           ++
Sbjct: 275 IK 276

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 113/242 (46%), Gaps = 44/242 (18%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++H NVI + ++      +   DV ++ EL+   +L   +   + LT++    FL Q+L 
Sbjct: 71  IQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 125
Query: 60  GLKYVHSASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEY---VVTRW 112
           G+ Y+HS  + H DLKP N++L         +KI DFGLA    + DF  E+     T  
Sbjct: 126 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPE 182
Query: 113 YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL 172
           + APE++ N        D+WS+G I   +++    F G      L  ++ +    +D   
Sbjct: 183 FVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY- 240
Query: 173 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 232
                                     F N S+ A D + ++LV DP KR+T++++L+HP+
Sbjct: 241 --------------------------FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274
Query: 233 LQ 234
           ++
Sbjct: 275 IK 276

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 112/242 (46%), Gaps = 44/242 (18%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++H NVI + ++      +   DV ++ EL+   +L   +   + LT++    FL Q+L 
Sbjct: 71  IQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 125
Query: 60  GLKYVHSASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEY---VVTRW 112
           G+ Y+HS  + H DLKP N++L         +KI DFGLA    + DF  E+     T  
Sbjct: 126 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPE 182
Query: 113 YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL 172
           + APE++ N        D+WS+G I   +++    F G                      
Sbjct: 183 FVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLG---------------------- 219
Query: 173 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 232
                D  +  +  +     +     F N S+ A D + ++LV DP KR+T++++L+HP+
Sbjct: 220 -----DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274
Query: 233 LQ 234
           ++
Sbjct: 275 IK 276

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 114/238 (47%), Gaps = 38/238 (15%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++H N++ + D I    ++ F+  Y+V++L+   +L + I + +  ++    + + Q+L 
Sbjct: 60  LKHSNIVRLHDSI---SEEGFH--YLVFDLVTGGELFEDIVAREYYSEADASHCIQQILE 114
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGLA-RTTSETDFMTEYVVTRWYRA 115
            + + H   V+HRDLKP NLLL + C    +K+ DFGLA     +      +  T  Y +
Sbjct: 115 AVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLS 174
Query: 116 PELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL 175
           PE+L     Y   +DIW+ G IL  ++   P F  +D   Q +L  ++     D      
Sbjct: 175 PEVLRK-EAYGKPVDIWACGVILYILLVGYPPFWDED---QHKLYQQIKAGAYD------ 224
Query: 176 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
                       P     ++ T  P     A +L+ +ML  +P KRIT  EAL+HP++
Sbjct: 225 -----------FP---SPEWDTVTPE----AKNLINQMLTINPAKRITAHEALKHPWV 264

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 22  NDVYIVYELMDTDL----HQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKP 76
            DV+I  ELMDT L     Q+I   Q + +D        +++ L+++HS  SV+HRD+KP
Sbjct: 123 GDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKP 182
Query: 77  SNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL---LNCTEYTAAIDIWS 133
           SN+L+NA   +K+ DFG++    ++   T     + Y APE +   LN   Y+   DIWS
Sbjct: 183 SNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYSVKSDIWS 242
Query: 134 VGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ 193
           +G  + E+      FP   +    + + +++  P                    P+    
Sbjct: 243 LGITMIELAILR--FPYDSWGTPFQQLKQVVEEPS-------------------PQLPAD 281
Query: 194 QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 238
           +F+  F       VD   + L  +  +R T  E ++HP+  +LH+
Sbjct: 282 KFSAEF-------VDFTSQCLKKNSKERPTYPELMQHPFF-TLHE 318

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/245 (25%), Positives = 109/245 (44%), Gaps = 38/245 (15%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H N+I + DI      +   DV ++ EL+   +L   +   + LT+D    FL Q+L 
Sbjct: 65  IRHPNIITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD 119
Query: 60  GLKYVHSASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRA 115
           G+ Y+HS  + H DLKP N++L      +  +K+ DFG+A      +       T  + A
Sbjct: 120 GVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVA 179
Query: 116 PELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL 175
           PE ++N        D+WS+G I   +++    F G+     L  I+ +    D+      
Sbjct: 180 PE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEY---- 234
Query: 176 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
                                  F N S  A D + ++LV DP +R+T+ ++L H ++++
Sbjct: 235 -----------------------FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271
Query: 236 LHDLN 240
           +   N
Sbjct: 272 IRRRN 276

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 106/233 (45%), Gaps = 37/233 (15%)
Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 61
           H ++I +  +I  P     +D+++V E +   +L   I  + +L +   +    Q+L G+
Sbjct: 75  HPHIIKLYQVISTP-----SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGV 129
Query: 62  KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 121
            Y H   V+HRDLKP N+LL+A  + KI DFGL+   S+ +F+     +  Y APE++  
Sbjct: 130 DYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISG 189
Query: 122 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR 181
                  +DIWS G IL  ++     F                   DD        D+  
Sbjct: 190 RLYAGPEVDIWSSGVILYALLCGTLPF-------------------DD--------DHVP 222
Query: 182 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
              +++  C    +  ++ N S   + LL+ ML  DP KR T+++   H + +
Sbjct: 223 TLFKKI--CDGIFYTPQYLNPS--VISLLKHMLQVDPMKRATIKDIREHEWFK 271

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 47/217 (21%)
Query: 32  DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGD 91
           + +L + IR      +   +++  +++  L+Y+H   ++HRDLKP N+LLN    ++I D
Sbjct: 117 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 176
Query: 92  FGLART---TSETDFMTEYVVTRWYRAPELLLNCTEYTA--AIDIWSVGCILGEIMTREP 146
           FG A+     S+      +V T  Y +PELL   TE +A  + D+W++GCI+ +++   P
Sbjct: 177 FGTAKVLSPESKQARANSFVGTAQYVSPELL---TEKSACKSSDLWALGCIIYQLVAGLP 233
Query: 147 LF-PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSG 205
            F  G +Y+   ++I              L  D   ++    P+ R              
Sbjct: 234 PFRAGNEYLIFQKIIK-------------LEYDFPEKF---FPKAR-------------- 263
Query: 206 AVDLLEKMLVFDPNKRITVEEA------LRHPYLQSL 236
             DL+EK+LV D  KR+  EE         HP+ +S+
Sbjct: 264 --DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 298

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 47/217 (21%)
Query: 32  DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGD 91
           + +L + IR      +   +++  +++  L+Y+H   ++HRDLKP N+LLN    ++I D
Sbjct: 114 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 173
Query: 92  FGLART---TSETDFMTEYVVTRWYRAPELLLNCTEYTA--AIDIWSVGCILGEIMTREP 146
           FG A+     S+      +V T  Y +PELL   TE +A  + D+W++GCI+ +++   P
Sbjct: 174 FGTAKVLSPESKQARANAFVGTAQYVSPELL---TEKSACKSSDLWALGCIIYQLVAGLP 230
Query: 147 LF-PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSG 205
            F  G +Y+   ++I              L  D   ++    P+ R              
Sbjct: 231 PFRAGNEYLIFQKIIK-------------LEYDFPEKF---FPKAR-------------- 260
Query: 206 AVDLLEKMLVFDPNKRITVEEA------LRHPYLQSL 236
             DL+EK+LV D  KR+  EE         HP+ +S+
Sbjct: 261 --DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 295

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 110/238 (46%), Gaps = 38/238 (15%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++H N++ + D I           Y++++L+   +L + I + +  ++    + + Q+L 
Sbjct: 78  LKHPNIVRLHDSISEEGHH-----YLIFDLVTGGELFEDIVAREYYSEADASHCIQQILE 132
Query: 60  GLKYVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLA-RTTSETDFMTEYVVTRWYRA 115
            + + H   V+HRDLKP NLLL +      +K+ DFGLA     E      +  T  Y +
Sbjct: 133 AVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLS 192
Query: 116 PELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL 175
           PE+L     Y   +D+W+ G IL  ++   P F  +D   Q RL  ++     D      
Sbjct: 193 PEVLRK-DPYGKPVDLWACGVILYILLVGYPPFWDED---QHRLYQQIKAGAYD------ 242
Query: 176 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
                       P     ++ T  P     A DL+ KML  +P+KRIT  EAL+HP++
Sbjct: 243 -----------FP---SPEWDTVTPE----AKDLINKMLTINPSKRITAAEALKHPWI 282

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/162 (33%), Positives = 90/162 (55%), Gaps = 19/162 (11%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H+N++++ D+    + D +   Y+V E ++   L + I S   L+ D    F  Q+L 
Sbjct: 68  LSHQNIVSMIDV--DEEDDCY---YLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILD 122
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF-MTEYVV-TRWYRAPE 117
           G+K+ H   ++HRD+KP N+L++++  LKI DFG+A+  SET    T +V+ T  Y +PE
Sbjct: 123 GIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE 182
Query: 118 LLLN-----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV 154
                    CT      DI+S+G +L E++  EP F G+  V
Sbjct: 183 QAKGEATDECT------DIYSIGIVLYEMLVGEPPFNGETAV 218

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 47/217 (21%)
Query: 32  DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGD 91
           + +L + IR      +   +++  +++  L+Y+H   ++HRDLKP N+LLN    ++I D
Sbjct: 117 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 176
Query: 92  FGLART---TSETDFMTEYVVTRWYRAPELLLNCTEYTA--AIDIWSVGCILGEIMTREP 146
           FG A+     S+      +V T  Y +PELL   TE +A  + D+W++GCI+ +++   P
Sbjct: 177 FGTAKVLSPESKQARANXFVGTAQYVSPELL---TEKSACKSSDLWALGCIIYQLVAGLP 233
Query: 147 LF-PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSG 205
            F  G +Y+   ++I              L  D   ++    P+ R              
Sbjct: 234 PFRAGNEYLIFQKIIK-------------LEYDFPEKF---FPKAR-------------- 263
Query: 206 AVDLLEKMLVFDPNKRITVEEA------LRHPYLQSL 236
             DL+EK+LV D  KR+  EE         HP+ +S+
Sbjct: 264 --DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 298

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/235 (24%), Positives = 108/235 (45%), Gaps = 34/235 (14%)
Query: 22  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 81
           +++++V E ++      I +  ++ ++        +LR L Y+H+  V+HRD+K  ++LL
Sbjct: 115 DELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILL 174
Query: 82  NASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
            +   +K+ DFG  A+ + E       V T ++ APE +++   Y   +DIWS+G ++ E
Sbjct: 175 TSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPE-VISRLPYGTEVDIWSLGIMVIE 233
Query: 141 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 200
           ++  EP +  +  +  +R I + +                       PR +         
Sbjct: 234 MIDGEPPYFNEPPLQAMRRIRDSLP----------------------PRVKD------LH 265
Query: 201 NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEH 255
             SS     L+ MLV +P++R T +E L HP+L+    L   P C  P    + H
Sbjct: 266 KVSSVLRGFLDLMLVREPSQRATAQELLGHPFLK----LAGPPSCIVPLMRQYRH 316

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 47/217 (21%)
Query: 32  DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGD 91
           + +L + IR      +   +++  +++  L+Y+H   ++HRDLKP N+LLN    ++I D
Sbjct: 114 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 173
Query: 92  FGLART---TSETDFMTEYVVTRWYRAPELLLNCTEYTA--AIDIWSVGCILGEIMTREP 146
           FG A+     S+      +V T  Y +PELL   TE +A  + D+W++GCI+ +++   P
Sbjct: 174 FGTAKVLSPESKQARANXFVGTAQYVSPELL---TEKSACKSSDLWALGCIIYQLVAGLP 230
Query: 147 LF-PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSG 205
            F  G +Y+   ++I              L  D   ++    P+ R              
Sbjct: 231 PFRAGNEYLIFQKIIK-------------LEYDFPEKF---FPKAR-------------- 260
Query: 206 AVDLLEKMLVFDPNKRITVEEA------LRHPYLQSL 236
             DL+EK+LV D  KR+  EE         HP+ +S+
Sbjct: 261 --DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 295

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 47/217 (21%)
Query: 32  DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGD 91
           + +L + IR      +   +++  +++  L+Y+H   ++HRDLKP N+LLN    ++I D
Sbjct: 116 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 175
Query: 92  FGLART---TSETDFMTEYVVTRWYRAPELLLNCTEYTA--AIDIWSVGCILGEIMTREP 146
           FG A+     S+      +V T  Y +PELL   TE +A  + D+W++GCI+ +++   P
Sbjct: 176 FGTAKVLSPESKQARANXFVGTAQYVSPELL---TEKSACKSSDLWALGCIIYQLVAGLP 232
Query: 147 LF-PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSG 205
            F  G +Y+   ++I              L  D   ++    P+ R              
Sbjct: 233 PFRAGNEYLIFQKIIK-------------LEYDFPEKF---FPKAR-------------- 262
Query: 206 AVDLLEKMLVFDPNKRITVEEA------LRHPYLQSL 236
             DL+EK+LV D  KR+  EE         HP+ +S+
Sbjct: 263 --DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 47/217 (21%)
Query: 32  DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGD 91
           + +L + IR      +   +++  +++  L+Y+H   ++HRDLKP N+LLN    ++I D
Sbjct: 116 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 175
Query: 92  FGLART---TSETDFMTEYVVTRWYRAPELLLNCTEYTA--AIDIWSVGCILGEIMTREP 146
           FG A+     S+      +V T  Y +PELL   TE +A  + D+W++GCI+ +++   P
Sbjct: 176 FGTAKVLSPESKQARANXFVGTAQYVSPELL---TEKSACKSSDLWALGCIIYQLVAGLP 232
Query: 147 LF-PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSG 205
            F  G +Y+   ++I              L  D   ++    P+ R              
Sbjct: 233 PFRAGNEYLIFQKIIK-------------LEYDFPEKF---FPKAR-------------- 262
Query: 206 AVDLLEKMLVFDPNKRITVEEA------LRHPYLQSL 236
             DL+EK+LV D  KR+  EE         HP+ +S+
Sbjct: 263 --DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 47/217 (21%)
Query: 32  DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGD 91
           + +L + IR      +   +++  +++  L+Y+H   ++HRDLKP N+LLN    ++I D
Sbjct: 121 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 180
Query: 92  FGLART---TSETDFMTEYVVTRWYRAPELLLNCTEYTA--AIDIWSVGCILGEIMTREP 146
           FG A+     S+      +V T  Y +PELL   TE +A  + D+W++GCI+ +++   P
Sbjct: 181 FGTAKVLSPESKQARANXFVGTAQYVSPELL---TEKSACKSSDLWALGCIIYQLVAGLP 237
Query: 147 LF-PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSG 205
            F  G +Y+   ++I              L  D   ++    P+ R              
Sbjct: 238 PFRAGNEYLIFQKIIK-------------LEYDFPEKF---FPKAR-------------- 267
Query: 206 AVDLLEKMLVFDPNKRITVEEA------LRHPYLQSL 236
             DL+EK+LV D  KR+  EE         HP+ +S+
Sbjct: 268 --DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 302

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 47/217 (21%)
Query: 32  DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGD 91
           + +L + IR      +   +++  +++  L+Y+H   ++HRDLKP N+LLN    ++I D
Sbjct: 116 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 175
Query: 92  FGLART---TSETDFMTEYVVTRWYRAPELLLNCTEYTA--AIDIWSVGCILGEIMTREP 146
           FG A+     S+      +V T  Y +PELL   TE +A  + D+W++GCI+ +++   P
Sbjct: 176 FGTAKVLSPESKQARANXFVGTAQYVSPELL---TEKSACKSSDLWALGCIIYQLVAGLP 232
Query: 147 LF-PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSG 205
            F  G +Y+   ++I              L  D   ++    P+ R              
Sbjct: 233 PFRAGNEYLIFQKIIK-------------LEYDFPEKF---FPKAR-------------- 262
Query: 206 AVDLLEKMLVFDPNKRITVEEA------LRHPYLQSL 236
             DL+EK+LV D  KR+  EE         HP+ +S+
Sbjct: 263 --DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 47/217 (21%)
Query: 32  DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGD 91
           + +L + IR      +   +++  +++  L+Y+H   ++HRDLKP N+LLN    ++I D
Sbjct: 114 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 173
Query: 92  FGLART---TSETDFMTEYVVTRWYRAPELLLNCTEYTA--AIDIWSVGCILGEIMTREP 146
           FG A+     S+      +V T  Y +PELL   TE +A  + D+W++GCI+ +++   P
Sbjct: 174 FGTAKVLSPESKQARANXFVGTAQYVSPELL---TEKSACKSSDLWALGCIIYQLVAGLP 230
Query: 147 LF-PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSG 205
            F  G +Y+   ++I              L  D   ++    P+ R              
Sbjct: 231 PFRAGNEYLIFQKIIK-------------LEYDFPEKF---FPKAR-------------- 260
Query: 206 AVDLLEKMLVFDPNKRITVEEA------LRHPYLQSL 236
             DL+EK+LV D  KR+  EE         HP+ +S+
Sbjct: 261 --DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 295

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 47/217 (21%)
Query: 32  DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGD 91
           + +L + IR      +   +++  +++  L+Y+H   ++HRDLKP N+LLN    ++I D
Sbjct: 93  NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 152
Query: 92  FGLART---TSETDFMTEYVVTRWYRAPELLLNCTEYTA--AIDIWSVGCILGEIMTREP 146
           FG A+     S+      +V T  Y +PELL   TE +A  + D+W++GCI+ +++   P
Sbjct: 153 FGTAKVLSPESKQARANXFVGTAQYVSPELL---TEKSACKSSDLWALGCIIYQLVAGLP 209
Query: 147 LF-PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSG 205
            F  G +Y+   ++I              L  D   ++    P+ R              
Sbjct: 210 PFRAGNEYLIFQKIIK-------------LEYDFPEKF---FPKAR-------------- 239
Query: 206 AVDLLEKMLVFDPNKRITVEEA------LRHPYLQSL 236
             DL+EK+LV D  KR+  EE         HP+ +S+
Sbjct: 240 --DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 274

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 47/217 (21%)
Query: 32  DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGD 91
           + +L + IR      +   +++  +++  L+Y+H   ++HRDLKP N+LLN    ++I D
Sbjct: 114 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 173
Query: 92  FGLART---TSETDFMTEYVVTRWYRAPELLLNCTEYTA--AIDIWSVGCILGEIMTREP 146
           FG A+     S+      +V T  Y +PELL   TE +A  + D+W++GCI+ +++   P
Sbjct: 174 FGTAKVLSPESKQARANXFVGTAQYVSPELL---TEKSACKSSDLWALGCIIYQLVAGLP 230
Query: 147 LF-PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSG 205
            F  G +Y+   ++I              L  D   ++    P+ R              
Sbjct: 231 PFRAGNEYLIFQKIIK-------------LEYDFPEKF---FPKAR-------------- 260
Query: 206 AVDLLEKMLVFDPNKRITVEEA------LRHPYLQSL 236
             DL+EK+LV D  KR+  EE         HP+ +S+
Sbjct: 261 --DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 295

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 47/217 (21%)
Query: 32  DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGD 91
           + +L + IR      +   +++  +++  L+Y+H   ++HRDLKP N+LLN    ++I D
Sbjct: 92  NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 151
Query: 92  FGLART---TSETDFMTEYVVTRWYRAPELLLNCTEYTA--AIDIWSVGCILGEIMTREP 146
           FG A+     S+      +V T  Y +PELL   TE +A  + D+W++GCI+ +++   P
Sbjct: 152 FGTAKVLSPESKQARANXFVGTAQYVSPELL---TEKSACKSSDLWALGCIIYQLVAGLP 208
Query: 147 LF-PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSG 205
            F  G +Y+   ++I              L  D   ++    P+ R              
Sbjct: 209 PFRAGNEYLIFQKIIK-------------LEYDFPEKF---FPKAR-------------- 238
Query: 206 AVDLLEKMLVFDPNKRITVEEA------LRHPYLQSL 236
             DL+EK+LV D  KR+  EE         HP+ +S+
Sbjct: 239 --DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 273

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 47/217 (21%)
Query: 32  DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGD 91
           + +L + IR      +   +++  +++  L+Y+H   ++HRDLKP N+LLN    ++I D
Sbjct: 113 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 172
Query: 92  FGLART---TSETDFMTEYVVTRWYRAPELLLNCTEYTA--AIDIWSVGCILGEIMTREP 146
           FG A+     S+      +V T  Y +PELL   TE +A  + D+W++GCI+ +++   P
Sbjct: 173 FGTAKVLSPESKQARANSFVGTAQYVSPELL---TEKSACKSSDLWALGCIIYQLVAGLP 229
Query: 147 LF-PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSG 205
            F  G +Y+   ++I              L  D   ++    P+ R              
Sbjct: 230 PFRAGNEYLIFQKIIK-------------LEYDFPEKF---FPKAR-------------- 259
Query: 206 AVDLLEKMLVFDPNKRITVEEA------LRHPYLQSL 236
             DL+EK+LV D  KR+  EE         HP+ +S+
Sbjct: 260 --DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 294

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 47/217 (21%)
Query: 32  DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGD 91
           + +L + IR      +   +++  +++  L+Y+H   ++HRDLKP N+LLN    ++I D
Sbjct: 91  NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 150
Query: 92  FGLART---TSETDFMTEYVVTRWYRAPELLLNCTEYTA--AIDIWSVGCILGEIMTREP 146
           FG A+     S+      +V T  Y +PELL   TE +A  + D+W++GCI+ +++   P
Sbjct: 151 FGTAKVLSPESKQARANXFVGTAQYVSPELL---TEKSACKSSDLWALGCIIYQLVAGLP 207
Query: 147 LF-PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSG 205
            F  G +Y+   ++I              L  D   ++    P+ R              
Sbjct: 208 PFRAGNEYLIFQKIIK-------------LEYDFPEKF---FPKAR-------------- 237
Query: 206 AVDLLEKMLVFDPNKRITVEEA------LRHPYLQSL 236
             DL+EK+LV D  KR+  EE         HP+ +S+
Sbjct: 238 --DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 272

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 47/217 (21%)
Query: 32  DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGD 91
           + +L + IR      +   +++  +++  L+Y+H   ++HRDLKP N+LLN    ++I D
Sbjct: 94  NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 153
Query: 92  FGLART---TSETDFMTEYVVTRWYRAPELLLNCTEYTA--AIDIWSVGCILGEIMTREP 146
           FG A+     S+      +V T  Y +PELL   TE +A  + D+W++GCI+ +++   P
Sbjct: 154 FGTAKVLSPESKQARANXFVGTAQYVSPELL---TEKSACKSSDLWALGCIIYQLVAGLP 210
Query: 147 LF-PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSG 205
            F  G +Y+   ++I              L  D   ++    P+ R              
Sbjct: 211 PFRAGNEYLIFQKIIK-------------LEYDFPEKF---FPKAR-------------- 240
Query: 206 AVDLLEKMLVFDPNKRITVEEA------LRHPYLQSL 236
             DL+EK+LV D  KR+  EE         HP+ +S+
Sbjct: 241 --DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 275

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 100/216 (46%), Gaps = 45/216 (20%)
Query: 32  DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGD 91
           + +L + IR      +   +++  +++  L+Y+H   ++HRDLKP N+LLN    ++I D
Sbjct: 119 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 178
Query: 92  FGLART---TSETDFMTEYVVTRWYRAPELLLNCTEYTA--AIDIWSVGCILGEIMTREP 146
           FG A+     S+      +V T  Y +PELL   TE +A  + D+W++GCI+ +++   P
Sbjct: 179 FGTAKVLSPESKQARANXFVGTAQYVSPELL---TEKSACKSSDLWALGCIIYQLVAGLP 235
Query: 147 LFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGA 206
            F                           R+ N     +++ +      A  FP     A
Sbjct: 236 PF---------------------------RAGNEYLIFQKIIKLEYDFPAAFFPK----A 264
Query: 207 VDLLEKMLVFDPNKRITVEEA------LRHPYLQSL 236
            DL+EK+LV D  KR+  EE         HP+ +S+
Sbjct: 265 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 300

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 47/217 (21%)
Query: 32  DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGD 91
           + +L + IR      +   +++  +++  L+Y+H   ++HRDLKP N+LLN    ++I D
Sbjct: 98  NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 157
Query: 92  FGLART---TSETDFMTEYVVTRWYRAPELLLNCTEYTA--AIDIWSVGCILGEIMTREP 146
           FG A+     S+      +V T  Y +PELL   TE +A  + D+W++GCI+ +++   P
Sbjct: 158 FGTAKVLSPESKQARANXFVGTAQYVSPELL---TEKSACKSSDLWALGCIIYQLVAGLP 214
Query: 147 LF-PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSG 205
            F  G +Y+   ++I              L  D   ++    P+ R              
Sbjct: 215 PFRAGNEYLIFQKIIK-------------LEYDFPEKF---FPKAR-------------- 244
Query: 206 AVDLLEKMLVFDPNKRITVEEA------LRHPYLQSL 236
             DL+EK+LV D  KR+  EE         HP+ +S+
Sbjct: 245 --DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 279

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/239 (28%), Positives = 111/239 (46%), Gaps = 38/239 (15%)
Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTD--LHQIIRSDQQLTDDHCQYFLYQLLR 59
           +H N+I +KD+      D    VY+V EL      L +I+R  +  ++      L+ + +
Sbjct: 74  QHPNIITLKDVY-----DDGKYVYVVTELXKGGELLDKILRQ-KFFSEREASAVLFTITK 127
Query: 60  GLKYVHSASVLHRDLKPSNLL-LNASCD---LKIGDFGLARTT-SETDFMTEYVVTRWYR 114
            ++Y+H+  V+HRDLKPSN+L ++ S +   ++I DFG A+   +E   +     T  + 
Sbjct: 128 TVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFV 187
Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF 174
           APE +L    Y AA DIWS+G +L   +T                 T     PDD     
Sbjct: 188 APE-VLERQGYDAACDIWSLGVLLYTXLTG---------------YTPFANGPDDTPEEI 231
Query: 175 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
           L    + ++               + + S  A DL+ K L  DP++R+T    LRHP++
Sbjct: 232 LARIGSGKFSLS---------GGYWNSVSDTAKDLVSKXLHVDPHQRLTAALVLRHPWI 281

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 47/217 (21%)
Query: 32  DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGD 91
           + +L + IR      +   +++  +++  L+Y+H   ++HRDLKP N+LLN    ++I D
Sbjct: 113 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 172
Query: 92  FGLART---TSETDFMTEYVVTRWYRAPELLLNCTEYTA--AIDIWSVGCILGEIMTREP 146
           FG A+     S+      +V T  Y +PELL   TE +A  + D+W++GCI+ +++   P
Sbjct: 173 FGTAKVLSPESKQARANXFVGTAQYVSPELL---TEKSACKSSDLWALGCIIYQLVAGLP 229
Query: 147 LF-PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSG 205
            F  G +Y+   ++I              L  D   ++    P+ R              
Sbjct: 230 PFRAGNEYLIFQKIIK-------------LEYDFPEKF---FPKAR-------------- 259
Query: 206 AVDLLEKMLVFDPNKRITVEEA------LRHPYLQSL 236
             DL+EK+LV D  KR+  EE         HP+ +S+
Sbjct: 260 --DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 294

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/159 (35%), Positives = 83/159 (52%), Gaps = 15/159 (9%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQII----RSDQQLTDDHCQYFLY 55
           ++H N++   D I      T   +YIV E  +  DL  +I    +  Q L ++     + 
Sbjct: 62  LKHPNIVRYYDRIIDRTNTT---LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 56  QLLRGLKYVHSAS-----VLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVV 109
           QL   LK  H  S     VLHRDLKP+N+ L+   ++K+GDFGLAR  + +T F   +V 
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVG 178
Query: 110 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF 148
           T +Y +PE  +N   Y    DIWS+GC+L E+    P F
Sbjct: 179 TPYYMSPE-QMNRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 104/218 (47%), Gaps = 34/218 (15%)
Query: 22  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 81
           N  +++  L   DL   I+S  +       ++  +++ GL+++HS  +++RDLK  N+LL
Sbjct: 93  NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL 152
Query: 82  NASCDLKIGDFGLARTTSETDFMT-EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           +    +KI DFG+ +     D  T E+  T  Y APE+LL   +Y  ++D WS G +L E
Sbjct: 153 DKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYE 211
Query: 141 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 200
           ++  +  F G+D         EL  S        +R DN               F  R+ 
Sbjct: 212 MLIGQSPFHGQDE-------EELFHS--------IRMDNP--------------FYPRWL 242
Query: 201 NKSSGAVDLLEKMLVFDPNKRITVEEALR-HPYLQSLH 237
            K   A DLL K+ V +P KR+ V   +R HP  + ++
Sbjct: 243 EKE--AKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 278

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/159 (35%), Positives = 83/159 (52%), Gaps = 15/159 (9%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQII----RSDQQLTDDHCQYFLY 55
           ++H N++   D I      T   +YIV E  +  DL  +I    +  Q L ++     + 
Sbjct: 62  LKHPNIVRYYDRIIDRTNTT---LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 56  QLLRGLKYVHSAS-----VLHRDLKPSNLLLNASCDLKIGDFGLARTTS-ETDFMTEYVV 109
           QL   LK  H  S     VLHRDLKP+N+ L+   ++K+GDFGLAR  + +T F   +V 
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVG 178
Query: 110 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF 148
           T +Y +PE  +N   Y    DIWS+GC+L E+    P F
Sbjct: 179 TPYYMSPE-QMNRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 47/214 (21%)
Query: 35  LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL 94
           L + IR      +   +++  +++  L+Y+H   ++HRDLKP N+LLN    ++I DFG 
Sbjct: 119 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGT 178
Query: 95  ART---TSETDFMTEYVVTRWYRAPELLLNCTEYTA--AIDIWSVGCILGEIMTREPLF- 148
           A+     S+      +V T  Y +PELL   TE +A  + D+W++GCI+ +++   P F 
Sbjct: 179 AKVLSPESKQARANSFVGTAQYVSPELL---TEKSASKSSDLWALGCIIYQLVAGLPPFR 235
Query: 149 PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVD 208
            G +Y+   ++I              L  D   ++    P+ R                D
Sbjct: 236 AGNEYLIFQKIIK-------------LEYDFPEKF---FPKAR----------------D 263
Query: 209 LLEKMLVFDPNKRITVEEA------LRHPYLQSL 236
           L+EK+LV D  KR+  EE         HP+ +S+
Sbjct: 264 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 109/221 (49%), Gaps = 40/221 (18%)
Query: 24  VYIVYELMD-TDL--HQIIRSDQQL--TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 78
           +Y+V+E MD  DL    + R+D     ++    +++ Q+L  L+Y H  +++HRD+KP  
Sbjct: 103 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHC 162
Query: 79  LLLNA---SCDLKIGDFGLARTTSETDFMT-EYVVTRWYRAPELLLNCTEYTAAIDIWSV 134
           +LL +   S  +K+G FG+A    E+  +    V T  + APE++     Y   +D+W  
Sbjct: 163 VLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKR-EPYGKPVDVWGC 221
Query: 135 GCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ 193
           G IL  +++   P +  K+     RL   +I                +   +  PR    
Sbjct: 222 GVILFILLSGCLPFYGTKE-----RLFEGII----------------KGKYKMNPR---- 256
Query: 194 QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
               ++ + S  A DL+ +ML+ DP +RITV EAL HP+L+
Sbjct: 257 ----QWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLK 293

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 109/221 (49%), Gaps = 40/221 (18%)
Query: 24  VYIVYELMD-TDL--HQIIRSDQQL--TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 78
           +Y+V+E MD  DL    + R+D     ++    +++ Q+L  L+Y H  +++HRD+KP  
Sbjct: 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHC 160
Query: 79  LLLNA---SCDLKIGDFGLARTTSETDFMT-EYVVTRWYRAPELLLNCTEYTAAIDIWSV 134
           +LL +   S  +K+G FG+A    E+  +    V T  + APE++     Y   +D+W  
Sbjct: 161 VLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKR-EPYGKPVDVWGC 219
Query: 135 GCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ 193
           G IL  +++   P +  K+     RL   +I                +   +  PR    
Sbjct: 220 GVILFILLSGCLPFYGTKE-----RLFEGII----------------KGKYKMNPR---- 254
Query: 194 QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
               ++ + S  A DL+ +ML+ DP +RITV EAL HP+L+
Sbjct: 255 ----QWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLK 291

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 113/238 (47%), Gaps = 38/238 (15%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++H N++ + D I    ++ F+  Y+V++L+   +L + I + +  ++    + + Q+L 
Sbjct: 60  LKHPNIVRLHDSI---SEEGFH--YLVFDLVTGGELFEDIVAREYYSEADASHCIQQILE 114
Query: 60  GLKYVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLA-RTTSETDFMTEYVVTRWYRA 115
            + + H   ++HRDLKP NLLL   +    +K+ DFGLA     +      +  T  Y +
Sbjct: 115 SVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLS 174
Query: 116 PELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL 175
           PE+L     Y   +D+W+ G IL  ++   P F  +D   Q RL  ++     D      
Sbjct: 175 PEVLRK-DPYGKPVDMWACGVILYILLVGYPPFWDED---QHRLYQQIKAGAYD------ 224
Query: 176 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
                       P     ++ T  P     A DL+ KML  +P KRIT  EAL+HP++
Sbjct: 225 -----------FP---SPEWDTVTPE----AKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 113/238 (47%), Gaps = 38/238 (15%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++H N++ + D I    ++ F+  Y+V++L+   +L + I + +  ++    + + Q+L 
Sbjct: 60  LKHPNIVRLHDSI---SEEGFH--YLVFDLVTGGELFEDIVAREYYSEADASHCIQQILE 114
Query: 60  GLKYVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLA-RTTSETDFMTEYVVTRWYRA 115
            + + H   ++HRDLKP NLLL   +    +K+ DFGLA     +      +  T  Y +
Sbjct: 115 SVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLS 174
Query: 116 PELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL 175
           PE+L     Y   +D+W+ G IL  ++   P F  +D   Q RL  ++     D      
Sbjct: 175 PEVLRK-DPYGKPVDMWACGVILYILLVGYPPFWDED---QHRLYQQIKAGAYD------ 224
Query: 176 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
                       P     ++ T  P     A DL+ KML  +P KRIT  EAL+HP++
Sbjct: 225 -----------FP---SPEWDTVTPE----AKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 110/238 (46%), Gaps = 38/238 (15%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++H N++ + D I           Y++++L+   +L + I + +  ++    + + Q+L 
Sbjct: 67  LKHPNIVRLHDSISEEGHH-----YLIFDLVTGGELFEDIVAREYYSEADASHCIQQILE 121
Query: 60  GLKYVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLA-RTTSETDFMTEYVVTRWYRA 115
            + + H   V+HR+LKP NLLL +      +K+ DFGLA     E      +  T  Y +
Sbjct: 122 AVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLS 181
Query: 116 PELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL 175
           PE+L     Y   +D+W+ G IL  ++   P F  +D   Q RL  ++     D      
Sbjct: 182 PEVLRK-DPYGKPVDLWACGVILYILLVGYPPFWDED---QHRLYQQIKAGAYD------ 231
Query: 176 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
                       P     ++ T  P     A DL+ KML  +P+KRIT  EAL+HP++
Sbjct: 232 -----------FP---SPEWDTVTPE----AKDLINKMLTINPSKRITAAEALKHPWI 271

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 86/185 (46%), Gaps = 31/185 (16%)
Query: 53  FLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVV 109
            + Q+L G+ Y+H  +++H DLKP N+LL++     D+KI DFG++R       + E + 
Sbjct: 136 LIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMG 195
Query: 110 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDD 169
           T  Y APE+L N    T A D+W++G I   ++T    F G+D                 
Sbjct: 196 TPEYLAPEIL-NYDPITTATDMWNIGIIAYMLLTHTSPFVGED----------------- 237
Query: 170 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 229
                    N   Y+  + +         F + S  A D ++ +LV +P KR T E  L 
Sbjct: 238 ---------NQETYLN-ISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287
Query: 230 HPYLQ 234
           H +LQ
Sbjct: 288 HSWLQ 292

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 97/213 (45%), Gaps = 37/213 (17%)
Query: 40  RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLAR 96
           R DQ  T+      +  +   ++Y+HS ++ HRD+KP NLL  +   +  LK+ DFG A+
Sbjct: 107 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 166
Query: 97  TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ 156
            T+  + +TE   T +Y APE +L   +Y  + D+WS+G I+  ++   P F      H 
Sbjct: 167 ETTSHNSLTEPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN---HG 222
Query: 157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVD-----LLE 211
           L +      SP   +                 R R  Q+   FPN     V      L+ 
Sbjct: 223 LAI------SPGMKT-----------------RIRMGQY--EFPNPEWSEVSEEVKMLIR 257
Query: 212 KMLVFDPNKRITVEEALRHPYLQSLHDLNDEPV 244
            +L  +P +R+T+ E + HP++     +   P+
Sbjct: 258 NLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 290

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 108/236 (45%), Gaps = 38/236 (16%)
Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 61
           H NVI + D+      +   DV ++ EL+   +L   +   + L+++    F+ Q+L G+
Sbjct: 74  HHNVITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGV 128
Query: 62  KYVHSASVLHRDLKPSN-LLLNASC---DLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 117
            Y+H+  + H DLKP N +LL+ +     +K+ DFGLA    +         T  + APE
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 177
            ++N        D+WS+G I   +++    F G      L  IT +    D         
Sbjct: 189 -IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFD--------- 238
Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
                          ++F   F + S  A D + K+LV +  KR+T++EALRHP++
Sbjct: 239 ---------------EEF---FSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 106/236 (44%), Gaps = 38/236 (16%)
Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 61
           H NVI + D+      +   DV ++ EL+   +L   +   + L+++    F+ Q+L G+
Sbjct: 74  HHNVITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGV 128
Query: 62  KYVHSASVLHRDLKPSNLLLNASC----DLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 117
            Y+H+  + H DLKP N++L         +K+ DFGLA    +         T  + APE
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 177
            ++N        D+WS+G I   +++    F G      L  IT +    D         
Sbjct: 189 -IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFD--------- 238
Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
                          ++F   F + S  A D + K+LV +  KR+T++EALRHP++
Sbjct: 239 ---------------EEF---FSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/245 (24%), Positives = 108/245 (44%), Gaps = 38/245 (15%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H N+I + DI      +   DV ++ EL+   +L   +   + LT+D    FL Q+L 
Sbjct: 86  IRHPNIITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD 140
Query: 60  GLKYVHSASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRA 115
           G+ Y+HS  + H DLKP N++L      +  +K+ DFG+A      +       T  + A
Sbjct: 141 GVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVA 200
Query: 116 PELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL 175
           PE ++N        D+WS+G I   +++    F G+     L  I+ +    D+      
Sbjct: 201 PE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEY---- 255
Query: 176 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
                                  F N S  A D + ++LV DP +R+ + ++L H ++++
Sbjct: 256 -----------------------FSNTSELAKDFIRRLLVKDPKRRMXIAQSLEHSWIKA 292
Query: 236 LHDLN 240
           +   N
Sbjct: 293 IRRRN 297

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 107/236 (45%), Gaps = 38/236 (16%)
Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 61
           H NVI + D+      +   DV ++ EL+   +L   +   + L+++    F+ Q+L G+
Sbjct: 74  HHNVITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGV 128
Query: 62  KYVHSASVLHRDLKPSNLLL---NASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 117
            Y+H+  + H DLKP N++L   N     +K+ DFGLA    +         T  + APE
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 177
            ++N        D+WS+G I   +++    F G      L  IT +    D         
Sbjct: 189 -IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFD--------- 238
Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
                          ++F   F + S  A D + K+LV +  KR+T++EALRHP++
Sbjct: 239 ---------------EEF---FSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 107/236 (45%), Gaps = 38/236 (16%)
Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 61
           H NVI + D+      +   DV ++ EL+   +L   +   + L+++    F+ Q+L G+
Sbjct: 74  HHNVITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGV 128
Query: 62  KYVHSASVLHRDLKPSN-LLLNASC---DLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 117
            Y+H+  + H DLKP N +LL+ +     +K+ DFGLA    +         T  + APE
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 177
            ++N        D+WS+G I   +++    F G      L  IT +    D         
Sbjct: 189 -IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFD--------- 238
Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
                          ++F   F   S  A D + K+LV +  KR+T++EALRHP++
Sbjct: 239 ---------------EEF---FSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 77.4 bits (189), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 102/220 (46%), Gaps = 39/220 (17%)
Query: 21  FNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVHSASVLHRDLKP 76
           F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y HS  V+HRD+KP
Sbjct: 77  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 136
Query: 77  SNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 136
            NLLL ++ +LKI DFG +   + +   TE   T  Y  PE++     +   +D+WS+G 
Sbjct: 137 ENLLLGSAGELKIADFGWS-VHAPSSRRTELCGTLDYLPPEMI-EGRMHDEKVDLWSLGV 194
Query: 137 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 196
           +  E +  +P F    Y    + I+ +                              +F 
Sbjct: 195 LCYEFLVGKPPFEANTYQETYKRISRV------------------------------EFT 224
Query: 197 TRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
             FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 225 --FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 262

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 77.4 bits (189), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 105/236 (44%), Gaps = 38/236 (16%)
Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 61
           H NVI + D+      +   DV ++ EL+   +L   +   + L+++    F+ Q+L G+
Sbjct: 74  HHNVITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGV 128
Query: 62  KYVHSASVLHRDLKPSNLLLNASC----DLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 117
            Y+H+  + H DLKP N++L         +K+ DFGLA    +         T  + APE
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 177
            ++N        D+WS+G I   +++    F G      L  IT +    D         
Sbjct: 189 -IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFD--------- 238
Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
                          ++F   F   S  A D + K+LV +  KR+T++EALRHP++
Sbjct: 239 ---------------EEF---FSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 103/224 (45%), Gaps = 36/224 (16%)
Query: 22  NDVYIVYELMDT-DLHQIIR-SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 79
            D++IV E      +  IIR  ++ LT+D     L   L+GL+Y+H    +HRD+K  N+
Sbjct: 97  TDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNI 156
Query: 80  LLNASCDLKIGDFGLARTTSETDFMTE---YVVTRWYRAPELLLNCTEYTAAIDIWSVGC 136
           LLN     K+ DFG+A     TD M +    + T ++ APE++     Y    DIWS+G 
Sbjct: 157 LLNTEGHAKLADFGVAGQL--TDXMAKRNXVIGTPFWMAPEVIQEIG-YNCVADIWSLGI 213
Query: 137 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 196
              E+   +P  P  D +H +R I  +  +P                    P  RK +  
Sbjct: 214 TAIEMAEGKP--PYAD-IHPMRAIFMIPTNPP-------------------PTFRKPELW 251
Query: 197 TRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 240
                 S    D +++ LV  P +R T  + L+HP+++S   ++
Sbjct: 252 ------SDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVS 289

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 34/218 (15%)
Query: 22  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 81
           N  +++  L   DL   I+S  +       ++  +++ GL+++HS  +++RDLK  N+LL
Sbjct: 92  NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL 151
Query: 82  NASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           +    +KI DFG+ +     D  T  +  T  Y APE+LL   +Y  ++D WS G +L E
Sbjct: 152 DKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYE 210
Query: 141 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 200
           ++  +  F G+D         EL  S        +R DN               F  R+ 
Sbjct: 211 MLIGQSPFHGQDE-------EELFHS--------IRMDNP--------------FYPRWL 241
Query: 201 NKSSGAVDLLEKMLVFDPNKRITVEEALR-HPYLQSLH 237
            K   A DLL K+ V +P KR+ V   +R HP  + ++
Sbjct: 242 EKE--AKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 277

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 100/215 (46%), Gaps = 43/215 (20%)
Query: 32  DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGD 91
           + +L + IR      +   +++  +++  L+Y+H   ++HRDLKP N+LLN    ++I D
Sbjct: 116 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 175
Query: 92  FGLART---TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF 148
           FG A+     S+      +V T  Y +PELL   +   ++ D+W++GCI+ +++   P F
Sbjct: 176 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAXKSS-DLWALGCIIYQLVAGLPPF 234
Query: 149 -PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAV 207
             G + +   ++I              L  D   ++    P+ R                
Sbjct: 235 RAGNEGLIFAKIIK-------------LEYDFPEKF---FPKAR---------------- 262
Query: 208 DLLEKMLVFDPNKRITVEEA------LRHPYLQSL 236
           DL+EK+LV D  KR+  EE         HP+ +S+
Sbjct: 263 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/240 (25%), Positives = 106/240 (44%), Gaps = 38/240 (15%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H N+I + DI      +   DV ++ EL+   +L   +   + LT+D    FL Q+L 
Sbjct: 72  IRHPNIITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD 126
Query: 60  GLKYVHSASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRA 115
           G+ Y+HS  + H DLKP N++L      +  +K+ DFG+A      +       T  + A
Sbjct: 127 GVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVA 186
Query: 116 PELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL 175
           PE ++N        D+WS+G I   +++    F G+     L  I+ +    D+      
Sbjct: 187 PE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEY---- 241
Query: 176 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
                                  F N S  A D + ++LV DP +R+ + ++L H ++++
Sbjct: 242 -----------------------FSNTSELAKDFIRRLLVKDPKRRMXIAQSLEHSWIKA 278

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 102/217 (47%), Gaps = 47/217 (21%)
Query: 32  DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGD 91
           + +L + IR      +   +++  +++  L+Y+H   ++HRDLKP N+LLN    ++I D
Sbjct: 116 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 175
Query: 92  FGLART---TSETDFMTEYVVTRWYRAPELLLNCTEYTA--AIDIWSVGCILGEIMTREP 146
           FG A+     S+      +V T  Y +PELL   TE +A  + D+W++GCI+ +++   P
Sbjct: 176 FGTAKVLSPESKQARANXFVGTAQYVSPELL---TEKSACKSSDLWALGCIIYQLVAGLP 232
Query: 147 LF-PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSG 205
            F  G + +   ++I              L  D   ++    P+ R              
Sbjct: 233 PFRAGNEGLIFAKIIK-------------LEYDFPEKF---FPKAR-------------- 262
Query: 206 AVDLLEKMLVFDPNKRITVEEA------LRHPYLQSL 236
             DL+EK+LV D  KR+  EE         HP+ +S+
Sbjct: 263 --DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 105/236 (44%), Gaps = 38/236 (16%)
Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 61
           H N+I + D+      +   DV ++ EL+   +L   +   + L+++    F+ Q+L G+
Sbjct: 74  HPNIITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGV 128
Query: 62  KYVHSASVLHRDLKPSNLLLNASC----DLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 117
            Y+H+  + H DLKP N++L         +K+ DFGLA    +         T  + APE
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 177
            ++N        D+WS+G I   +++    F G      L  IT +    D         
Sbjct: 189 -IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFD--------- 238
Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
                          ++F   F   S  A D + K+LV +  KR+T++EALRHP++
Sbjct: 239 ---------------EEF---FSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 87/194 (44%), Gaps = 31/194 (15%)
Query: 34  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG 93
           +L   I  D  + +   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 91  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 150
Query: 94  LA---RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG 150
           LA   R  +    + +   T  Y APELL     +   +D+WS G +L  ++  E     
Sbjct: 151 LATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE----- 205
Query: 151 KDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLL 210
                           P D       SD+ + Y        K+ +   +    S  + LL
Sbjct: 206 ---------------LPWDQP-----SDSCQEYSDW---KEKKTYLNPWKKIDSAPLALL 242
Query: 211 EKMLVFDPNKRITV 224
            K+LV +P+ RIT+
Sbjct: 243 HKILVENPSARITI 256

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 87/194 (44%), Gaps = 31/194 (15%)
Query: 34  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG 93
           +L   I  D  + +   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 91  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 150
Query: 94  LA---RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG 150
           LA   R  +    + +   T  Y APELL     +   +D+WS G +L  ++  E     
Sbjct: 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE----- 205
Query: 151 KDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLL 210
                           P D       SD+ + Y        K+ +   +    S  + LL
Sbjct: 206 ---------------LPWDQP-----SDSCQEYSDWK---EKKTYLNPWKKIDSAPLALL 242
Query: 211 EKMLVFDPNKRITV 224
            K+LV +P+ RIT+
Sbjct: 243 HKILVENPSARITI 256

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 87/194 (44%), Gaps = 31/194 (15%)
Query: 34  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG 93
           +L   I  D  + +   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 90  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 149
Query: 94  LA---RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG 150
           LA   R  +    + +   T  Y APELL     +   +D+WS G +L  ++  E     
Sbjct: 150 LATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE----- 204
Query: 151 KDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLL 210
                           P D       SD+ + Y        K+ +   +    S  + LL
Sbjct: 205 ---------------LPWDQP-----SDSXQEYSDW---KEKKTYLNPWKKIDSAPLALL 241
Query: 211 EKMLVFDPNKRITV 224
            K+LV +P+ RIT+
Sbjct: 242 HKILVENPSARITI 255

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 87/194 (44%), Gaps = 31/194 (15%)
Query: 34  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG 93
           +L   I  D  + +   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 90  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 149
Query: 94  LA---RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG 150
           LA   R  +    + +   T  Y APELL     +   +D+WS G +L  ++  E     
Sbjct: 150 LATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE----- 204
Query: 151 KDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLL 210
                           P D       SD+ + Y        K+ +   +    S  + LL
Sbjct: 205 ---------------LPWDQP-----SDSCQEYSDWK---EKKTYLNPWKKIDSAPLALL 241
Query: 211 EKMLVFDPNKRITV 224
            K+LV +P+ RIT+
Sbjct: 242 HKILVENPSARITI 255

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 87/194 (44%), Gaps = 31/194 (15%)
Query: 34  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG 93
           +L   I  D  + +   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 91  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 150
Query: 94  LA---RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG 150
           LA   R  +    + +   T  Y APELL     +   +D+WS G +L  ++  E     
Sbjct: 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE----- 205
Query: 151 KDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLL 210
                           P D       SD+ + Y        K+ +   +    S  + LL
Sbjct: 206 ---------------LPWDQP-----SDSCQEYSDWK---EKKTYLNPWKKIDSAPLALL 242
Query: 211 EKMLVFDPNKRITV 224
            K+LV +P+ RIT+
Sbjct: 243 HKILVENPSARITI 256

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 87/194 (44%), Gaps = 31/194 (15%)
Query: 34  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG 93
           +L   I  D  + +   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 90  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 149
Query: 94  LA---RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG 150
           LA   R  +    + +   T  Y APELL     +   +D+WS G +L  ++  E     
Sbjct: 150 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE----- 204
Query: 151 KDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLL 210
                           P D       SD+ + Y        K+ +   +    S  + LL
Sbjct: 205 ---------------LPWDQP-----SDSCQEYSDWK---EKKTYLNPWKKIDSAPLALL 241
Query: 211 EKMLVFDPNKRITV 224
            K+LV +P+ RIT+
Sbjct: 242 HKILVENPSARITI 255

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 87/194 (44%), Gaps = 31/194 (15%)
Query: 34  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG 93
           +L   I  D  + +   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 90  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 149
Query: 94  LA---RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG 150
           LA   R  +    + +   T  Y APELL     +   +D+WS G +L  ++  E     
Sbjct: 150 LATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE----- 204
Query: 151 KDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLL 210
                           P D       SD+ + Y        K+ +   +    S  + LL
Sbjct: 205 ---------------LPWDQP-----SDSCQEYSDW---KEKKTYLNPWKKIDSAPLALL 241
Query: 211 EKMLVFDPNKRITV 224
            K+LV +P+ RIT+
Sbjct: 242 HKILVENPSARITI 255

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 87/194 (44%), Gaps = 31/194 (15%)
Query: 34  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG 93
           +L   I  D  + +   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 90  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 149
Query: 94  LA---RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG 150
           LA   R  +    + +   T  Y APELL     +   +D+WS G +L  ++  E     
Sbjct: 150 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE----- 204
Query: 151 KDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLL 210
                           P D       SD+ + Y        K+ +   +    S  + LL
Sbjct: 205 ---------------LPWDQP-----SDSCQEYSDWK---EKKTYLNPWKKIDSAPLALL 241
Query: 211 EKMLVFDPNKRITV 224
            K+LV +P+ RIT+
Sbjct: 242 HKILVENPSARITI 255

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 87/194 (44%), Gaps = 31/194 (15%)
Query: 34  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG 93
           +L   I  D  + +   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 90  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 149
Query: 94  LA---RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG 150
           LA   R  +    + +   T  Y APELL     +   +D+WS G +L  ++  E     
Sbjct: 150 LATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE----- 204
Query: 151 KDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLL 210
                           P D       SD+ + Y        K+ +   +    S  + LL
Sbjct: 205 ---------------LPWDQP-----SDSCQEYSDWK---EKKTYLNPWKKIDSAPLALL 241
Query: 211 EKMLVFDPNKRITV 224
            K+LV +P+ RIT+
Sbjct: 242 HKILVENPSARITI 255

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 107/242 (44%), Gaps = 43/242 (17%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTD--LHQIIRSD---QQLTDDHCQYFLY 55
           ++H N+I I ++      + ++++YIV E  +    L +I+ +    + L++ +    + 
Sbjct: 77  LDHPNIIKIFEVF-----EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMK 131
Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRW 112
           Q++  L Y HS  V+H+DLKP N+L   +     +KI DFGLA      +  T    T  
Sbjct: 132 QMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTAL 191
Query: 113 YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL 172
           Y APE+     + T   DIWS G ++  ++T    F G                      
Sbjct: 192 YMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTG---------------------- 227
Query: 173 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 232
                  +   V+Q    ++  +A      +  AVDLL++ML  DP +R +  + L H +
Sbjct: 228 ------TSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEW 281
Query: 233 LQ 234
            +
Sbjct: 282 FK 283

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 87/194 (44%), Gaps = 31/194 (15%)
Query: 34  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG 93
           +L   I  D  + +   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 90  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 149
Query: 94  LA---RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG 150
           LA   R  +    + +   T  Y APELL     +   +D+WS G +L  ++  E     
Sbjct: 150 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE----- 204
Query: 151 KDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLL 210
                           P D       SD+ + Y        K+ +   +    S  + LL
Sbjct: 205 ---------------LPWDQP-----SDSCQEYSDWK---EKKTYLNPWKKIDSAPLALL 241
Query: 211 EKMLVFDPNKRITV 224
            K+LV +P+ RIT+
Sbjct: 242 HKILVENPSARITI 255

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 87/194 (44%), Gaps = 31/194 (15%)
Query: 34  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG 93
           +L   I  D  + +   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 90  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 149
Query: 94  LA---RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG 150
           LA   R  +    + +   T  Y APELL     +   +D+WS G +L  ++  E     
Sbjct: 150 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE----- 204
Query: 151 KDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLL 210
                           P D       SD+ + Y        K+ +   +    S  + LL
Sbjct: 205 ---------------LPWDQP-----SDSCQEYSDWK---EKKTYLNPWKKIDSAPLALL 241
Query: 211 EKMLVFDPNKRITV 224
            K+LV +P+ RIT+
Sbjct: 242 HKILVENPSARITI 255

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 87/194 (44%), Gaps = 31/194 (15%)
Query: 34  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG 93
           +L   I  D  + +   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 90  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 149
Query: 94  LA---RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG 150
           LA   R  +    + +   T  Y APELL     +   +D+WS G +L  ++  E     
Sbjct: 150 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE----- 204
Query: 151 KDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLL 210
                           P D       SD+ + Y        K+ +   +    S  + LL
Sbjct: 205 ---------------LPWDQP-----SDSCQEYSDWK---EKKTYLNPWKKIDSAPLALL 241
Query: 211 EKMLVFDPNKRITV 224
            K+LV +P+ RIT+
Sbjct: 242 HKILVENPSARITI 255

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 87/194 (44%), Gaps = 31/194 (15%)
Query: 34  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG 93
           +L   I  D  + +   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 89  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 148
Query: 94  LA---RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG 150
           LA   R  +    + +   T  Y APELL     +   +D+WS G +L  ++  E     
Sbjct: 149 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE----- 203
Query: 151 KDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLL 210
                           P D       SD+ + Y        K+ +   +    S  + LL
Sbjct: 204 ---------------LPWDQP-----SDSCQEYSDWK---EKKTYLNPWKKIDSAPLALL 240
Query: 211 EKMLVFDPNKRITV 224
            K+LV +P+ RIT+
Sbjct: 241 HKILVENPSARITI 254

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 87/194 (44%), Gaps = 31/194 (15%)
Query: 34  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG 93
           +L   I  D  + +   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 90  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 149
Query: 94  LA---RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG 150
           LA   R  +    + +   T  Y APELL     +   +D+WS G +L  ++  E     
Sbjct: 150 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE----- 204
Query: 151 KDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLL 210
                           P D       SD+ + Y        K+ +   +    S  + LL
Sbjct: 205 ---------------LPWDQP-----SDSCQEYSDWK---EKKTYLNPWKKIDSAPLALL 241
Query: 211 EKMLVFDPNKRITV 224
            K+LV +P+ RIT+
Sbjct: 242 HKILVENPSARITI 255

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 98/228 (42%), Gaps = 37/228 (16%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYEL-MDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + HENV+      R       N  Y+  E     +L   I  D  + +   Q F +QL+ 
Sbjct: 62  LNHENVVKFYGHRR-----EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA 116
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAP 116
           G+ Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y AP
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 176
           ELL     +   +D+WS G +L  ++  E                     P D       
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGE--------------------LPWDQP----- 211
Query: 177 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 224
           SD+ + Y        K+ +   +    S  + LL K+LV +P+ RIT+
Sbjct: 212 SDSCQEYSDWK---EKKTYLNPWKKIDSAPLALLHKILVENPSARITI 256

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 98/228 (42%), Gaps = 37/228 (16%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYEL-MDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + HENV+      R       N  Y+  E     +L   I  D  + +   Q F +QL+ 
Sbjct: 62  LNHENVVKFYGHRR-----EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA 116
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAP 116
           G+ Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y AP
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 176
           ELL     +   +D+WS G +L  ++  E                     P D       
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGE--------------------LPWDQP----- 211
Query: 177 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 224
           SD+ + Y        K+ +   +    S  + LL K+LV +P+ RIT+
Sbjct: 212 SDSCQEYSDWK---EKKTYLNPWKKIDSAPLALLHKILVENPSARITI 256

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 98/228 (42%), Gaps = 37/228 (16%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYEL-MDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + HENV+      R       N  Y+  E     +L   I  D  + +   Q F +QL+ 
Sbjct: 62  LNHENVVKFYGHRR-----EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA 116
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAP 116
           G+ Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y AP
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 176
           ELL     +   +D+WS G +L  ++  E                     P D       
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGE--------------------LPWDQP----- 211
Query: 177 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 224
           SD+ + Y        K+ +   +    S  + LL K+LV +P+ RIT+
Sbjct: 212 SDSCQEYSDWK---EKKTYLNPWKKIDSAPLALLHKILVENPSARITI 256

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 98/228 (42%), Gaps = 37/228 (16%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYEL-MDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + HENV+      R       N  Y+  E     +L   I  D  + +   Q F +QL+ 
Sbjct: 62  LNHENVVKFYGHRR-----EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA 116
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAP 116
           G+ Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y AP
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 176
           ELL     +   +D+WS G +L  ++  E                     P D       
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGE--------------------LPWDQP----- 211
Query: 177 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 224
           SD+ + Y        K+ +   +    S  + LL K+LV +P+ RIT+
Sbjct: 212 SDSCQEYSDWK---EKKTYLNPWKKIDSAPLALLHKILVENPSARITI 256

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 87/194 (44%), Gaps = 31/194 (15%)
Query: 34  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG 93
           +L   I  D  + +   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 90  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 149
Query: 94  LA---RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG 150
           LA   R  +    + +   T  Y APELL     +   +D+WS G +L  ++  E     
Sbjct: 150 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE----- 204
Query: 151 KDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLL 210
                           P D       SD+ + Y        K+ +   +    S  + LL
Sbjct: 205 ---------------LPWDQP-----SDSCQEYSDWK---EKKTYLNPWKKIDSAPLALL 241
Query: 211 EKMLVFDPNKRITV 224
            K+LV +P+ RIT+
Sbjct: 242 HKILVENPSARITI 255

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 98/228 (42%), Gaps = 37/228 (16%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYEL-MDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + HENV+      R       N  Y+  E     +L   I  D  + +   Q F +QL+ 
Sbjct: 61  LNHENVVKFYGHRR-----EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA 115
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAP 116
           G+ Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y AP
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 176
           ELL     +   +D+WS G +L  ++  E                     P D       
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGE--------------------LPWDQP----- 210
Query: 177 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 224
           SD+ + Y        K+ +   +    S  + LL K+LV +P+ RIT+
Sbjct: 211 SDSCQEYSDWK---EKKTYLNPWKKIDSAPLALLHKILVENPSARITI 255

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 87/194 (44%), Gaps = 31/194 (15%)
Query: 34  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG 93
           +L   I  D  + +   Q F +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFG
Sbjct: 91  ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFG 150
Query: 94  LA---RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG 150
           LA   R  +    + +   T  Y APELL     +   +D+WS G +L  ++  E     
Sbjct: 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE----- 205
Query: 151 KDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLL 210
                           P D       SD+ + Y        K+ +   +    S  + LL
Sbjct: 206 ---------------LPWDQP-----SDSCQEYSDWK---EKKTYLNPWKKIDSAPLALL 242
Query: 211 EKMLVFDPNKRITV 224
            K+LV +P+ RIT+
Sbjct: 243 HKILVENPSARITI 256

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 31/213 (14%)
Query: 35  LHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDF 92
           L+ +I S+   Q  D++ + F  Q+L  L Y+HS  ++HRDLKP N+ ++ S ++KIGDF
Sbjct: 102 LYDLIHSENLNQQRDEYWRLF-RQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDF 160
Query: 93  GLARTT---------------SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 137
           GLA+                   +D +T  + T  Y A E+L     Y   ID++S+G I
Sbjct: 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGII 220
Query: 138 LGEIMTREPLFPGKDYVHQLRLITEL-IGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 196
             E++   P   G + V+ L+ +  + I  P D        DN  +  +++ R       
Sbjct: 221 FFEMIY--PFSTGMERVNILKKLRSVSIEFPPDF------DDNKMKVEKKIIRL----LI 268
Query: 197 TRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 229
              PNK  GA  LL    +   ++   ++EAL+
Sbjct: 269 DHDPNKRPGARTLLNSGWLPVKHQDEVIKEALK 301

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 31/213 (14%)
Query: 35  LHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDF 92
           L+ +I S+   Q  D++ + F  Q+L  L Y+HS  ++HRDLKP N+ ++ S ++KIGDF
Sbjct: 102 LYDLIHSENLNQQRDEYWRLF-RQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDF 160
Query: 93  GLARTT---------------SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 137
           GLA+                   +D +T  + T  Y A E+L     Y   ID++S+G I
Sbjct: 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGII 220
Query: 138 LGEIMTREPLFPGKDYVHQLRLITEL-IGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 196
             E++   P   G + V+ L+ +  + I  P D        DN  +  +++ R       
Sbjct: 221 FFEMIY--PFSTGMERVNILKKLRSVSIEFPPDF------DDNKMKVEKKIIRL----LI 268
Query: 197 TRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 229
              PNK  GA  LL    +   ++   ++EAL+
Sbjct: 269 DHDPNKRPGARTLLNSGWLPVKHQDEVIKEALK 301

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 37/213 (17%)
Query: 40  RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLAR 96
           R DQ  T+      +  +   ++Y+HS ++ HRD+KP NLL  +   +  LK+ DFG A+
Sbjct: 113 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 172
Query: 97  TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ 156
            T+  + +T    T +Y APE +L   +Y  + D+WS+G I+  ++   P F      H 
Sbjct: 173 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN---HG 228
Query: 157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVD-----LLE 211
           L +      SP   +                 R R  Q+   FPN     V      L+ 
Sbjct: 229 LAI------SPGMKT-----------------RIRMGQY--EFPNPEWSEVSEEVKMLIR 263
Query: 212 KMLVFDPNKRITVEEALRHPYLQSLHDLNDEPV 244
            +L  +P +R+T+ E + HP++     +   P+
Sbjct: 264 NLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 296

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 102/220 (46%), Gaps = 39/220 (17%)
Query: 21  FNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVHSASVLHRDLKP 76
           F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y HS  V+HRD+KP
Sbjct: 78  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 137
Query: 77  SNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 136
            NLLL ++ +LKI DFG +   + +   T+   T  Y  PE++     +   +D+WS+G 
Sbjct: 138 ENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMI-EGRMHDEKVDLWSLGV 195
Query: 137 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 196
           +  E +  +P F    Y    + I+ +                              +F 
Sbjct: 196 LCYEFLVGKPPFEANTYQETYKRISRV------------------------------EFT 225
Query: 197 TRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
             FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 226 --FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 263

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 107/238 (44%), Gaps = 40/238 (16%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++HEN++ ++DI      ++    Y+V +L+   +L   I      T+      + Q+L 
Sbjct: 63  IKHENIVTLEDIY-----ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLS 117
Query: 60  GLKYVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 116
            +KY+H   ++HRDLKP NLL      +  + I DFGL++   +   M+    T  Y AP
Sbjct: 118 AVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK-MEQNGIMSTACGTPGYVAP 176
Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 176
           E+L     Y+ A+D WS+G I   ++   P F  +        I E          G+  
Sbjct: 177 EVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKE----------GYY- 224
Query: 177 SDNARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
                            +F + F +  S  A D +  +L  DPN+R T E+AL HP++
Sbjct: 225 -----------------EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWI 265

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 37/213 (17%)
Query: 40  RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLAR 96
           R DQ  T+      +  +   ++Y+HS ++ HRD+KP NLL  +   +  LK+ DFG A+
Sbjct: 108 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 167
Query: 97  TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ 156
            T+  + +T    T +Y APE +L   +Y  + D+WS+G I+  ++   P F      H 
Sbjct: 168 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN---HG 223
Query: 157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVD-----LLE 211
           L +      SP   +                 R R  Q+   FPN     V      L+ 
Sbjct: 224 LAI------SPGMKT-----------------RIRMGQY--EFPNPEWSEVSEEVKMLIR 258
Query: 212 KMLVFDPNKRITVEEALRHPYLQSLHDLNDEPV 244
            +L  +P +R+T+ E + HP++     +   P+
Sbjct: 259 NLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 291

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 37/213 (17%)
Query: 40  RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLAR 96
           R DQ  T+      +  +   ++Y+HS ++ HRD+KP NLL  +   +  LK+ DFG A+
Sbjct: 114 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 173
Query: 97  TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ 156
            T+  + +T    T +Y APE +L   +Y  + D+WS+G I+  ++   P F      H 
Sbjct: 174 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN---HG 229
Query: 157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVD-----LLE 211
           L +      SP   +                 R R  Q+   FPN     V      L+ 
Sbjct: 230 LAI------SPGMKT-----------------RIRMGQY--EFPNPEWSEVSEEVKMLIR 264
Query: 212 KMLVFDPNKRITVEEALRHPYLQSLHDLNDEPV 244
            +L  +P +R+T+ E + HP++     +   P+
Sbjct: 265 NLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 297

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 101/220 (45%), Gaps = 39/220 (17%)
Query: 21  FNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVHSASVLHRDLKP 76
           F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y HS  V+HRD+KP
Sbjct: 103 FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 162
Query: 77  SNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 136
            NLLL ++ +LKI DFG +   + +   T    T  Y  PE++     +   +D+WS+G 
Sbjct: 163 ENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMI-EGRMHDEKVDLWSLGV 220
Query: 137 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 196
           +  E +  +P F    Y    + I+ +                              +F 
Sbjct: 221 LCYEFLVGKPPFEANTYQETYKRISRV------------------------------EFT 250
Query: 197 TRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
             FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 251 --FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 288

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 102/220 (46%), Gaps = 39/220 (17%)
Query: 21  FNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVHSASVLHRDLKP 76
           F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y HS  V+HRD+KP
Sbjct: 82  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 141
Query: 77  SNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 136
            NLLL ++ +LKI DFG +   + +   T+   T  Y  PE++     +   +D+WS+G 
Sbjct: 142 ENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMI-EGRMHDEKVDLWSLGV 199
Query: 137 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 196
           +  E +  +P F    Y    + I+ +                              +F 
Sbjct: 200 LCYEFLVGKPPFEANTYQETYKRISRV------------------------------EFT 229
Query: 197 TRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
             FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 230 --FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 267

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 105/243 (43%), Gaps = 47/243 (19%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H N++  K++I  P       + IV E     +L + I +  + ++D  ++F  QL+ 
Sbjct: 72  LRHPNIVRFKEVILTP-----THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 126
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCD--LKIGDFGLARTTSETDFMTEYVVTRWYRAPE 117
           G+ Y H+  V HRDLK  N LL+ S    LKI DFG ++ +         V T  Y APE
Sbjct: 127 GVSYAHAMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPE 186
Query: 118 LLLNCTEYTAAI-DIWSVGCIL-----GEIMTREPLFPGKDYVHQL-RLITELIGSPDDA 170
           +LL   EY   + D+WS G  L     G     +P  P K++   + R++      PD  
Sbjct: 187 VLLK-KEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTIHRILNVQYAIPD-- 242
Query: 171 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 230
                       YV   P CR                 L+ ++ V DP KRI++ E   H
Sbjct: 243 ------------YVHISPECRH----------------LISRIFVADPAKRISIPEIRNH 274
Query: 231 PYL 233
            + 
Sbjct: 275 EWF 277

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 102/220 (46%), Gaps = 39/220 (17%)
Query: 21  FNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVHSASVLHRDLKP 76
           F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y HS  V+HRD+KP
Sbjct: 77  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 136
Query: 77  SNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 136
            NLLL ++ +LKI DFG +   + +   T+   T  Y  PE++     +   +D+WS+G 
Sbjct: 137 ENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMI-EGRMHDEKVDLWSLGV 194
Query: 137 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 196
           +  E +  +P F    Y    + I+ +                              +F 
Sbjct: 195 LCYEFLVGKPPFEANTYQETYKRISRV------------------------------EFT 224
Query: 197 TRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
             FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 225 --FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 262

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 37/213 (17%)
Query: 40  RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLAR 96
           R DQ  T+      +  +   ++Y+HS ++ HRD+KP NLL  +   +  LK+ DFG A+
Sbjct: 107 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 166
Query: 97  TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ 156
            T+  + +T    T +Y APE +L   +Y  + D+WS+G I+  ++   P F      H 
Sbjct: 167 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN---HG 222
Query: 157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVD-----LLE 211
           L +      SP   +                 R R  Q+   FPN     V      L+ 
Sbjct: 223 LAI------SPGMKT-----------------RIRMGQY--EFPNPEWSEVSEEVKMLIR 257
Query: 212 KMLVFDPNKRITVEEALRHPYLQSLHDLNDEPV 244
            +L  +P +R+T+ E + HP++     +   P+
Sbjct: 258 NLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 290

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 37/213 (17%)
Query: 40  RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLAR 96
           R DQ  T+      +  +   ++Y+HS ++ HRD+KP NLL  +   +  LK+ DFG A+
Sbjct: 123 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 182
Query: 97  TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ 156
            T+  + +T    T +Y APE +L   +Y  + D+WS+G I+  ++   P F      H 
Sbjct: 183 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN---HG 238
Query: 157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVD-----LLE 211
           L +      SP   +                 R R  Q+   FPN     V      L+ 
Sbjct: 239 LAI------SPGMKT-----------------RIRMGQY--EFPNPEWSEVSEEVKMLIR 273
Query: 212 KMLVFDPNKRITVEEALRHPYLQSLHDLNDEPV 244
            +L  +P +R+T+ E + HP++     +   P+
Sbjct: 274 NLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 306

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 37/213 (17%)
Query: 40  RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLAR 96
           R DQ  T+      +  +   ++Y+HS ++ HRD+KP NLL  +   +  LK+ DFG A+
Sbjct: 109 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
Query: 97  TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ 156
            T+  + +T    T +Y APE +L   +Y  + D+WS+G I+  ++   P F      H 
Sbjct: 169 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN---HG 224
Query: 157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVD-----LLE 211
           L +      SP   +                 R R  Q+   FPN     V      L+ 
Sbjct: 225 LAI------SPGMKT-----------------RIRMGQY--EFPNPEWSEVSEEVKMLIR 259
Query: 212 KMLVFDPNKRITVEEALRHPYLQSLHDLNDEPV 244
            +L  +P +R+T+ E + HP++     +   P+
Sbjct: 260 NLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 292

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 37/213 (17%)
Query: 40  RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLAR 96
           R DQ  T+      +  +   ++Y+HS ++ HRD+KP NLL  +   +  LK+ DFG A+
Sbjct: 115 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 174
Query: 97  TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ 156
            T+  + +T    T +Y APE +L   +Y  + D+WS+G I+  ++   P F      H 
Sbjct: 175 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN---HG 230
Query: 157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVD-----LLE 211
           L +      SP   +                 R R  Q+   FPN     V      L+ 
Sbjct: 231 LAI------SPGMKT-----------------RIRMGQY--EFPNPEWSEVSEEVKMLIR 265
Query: 212 KMLVFDPNKRITVEEALRHPYLQSLHDLNDEPV 244
            +L  +P +R+T+ E + HP++     +   P+
Sbjct: 266 NLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 298

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/233 (23%), Positives = 107/233 (45%), Gaps = 35/233 (15%)
Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGL 61
           +HENV+ + +          +++++V E ++      I +  ++ ++        +L+ L
Sbjct: 206 QHENVVEMYN-----SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQAL 260
Query: 62  KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLL 120
             +H+  V+HRD+K  ++LL     +K+ DFG  A+ + E       V T ++ APEL+ 
Sbjct: 261 SVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELIS 320
Query: 121 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 180
               Y   +DIWS+G ++ E++  EP +  +  +  +++I                 DN 
Sbjct: 321 RLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI----------------RDNL 363
Query: 181 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
              ++ L +             S      L+++LV DP +R T  E L+HP+L
Sbjct: 364 PPRLKNLHKV------------SPSLKGFLDRLLVRDPAQRATAAELLKHPFL 404

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 22  NDVYIVYELMDTDL----HQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKP 76
            DV+I  ELMDT L     Q+I   Q + +D        +++ L+++HS  SV+HRD+KP
Sbjct: 79  GDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKP 138
Query: 77  SNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL---LNCTEYTAAIDIWS 133
           SN+L+NA   +K+ DFG++    +          + Y APE +   LN   Y+   DIWS
Sbjct: 139 SNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWS 198
Query: 134 VGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ 193
           +G  + E+      FP   +    + + +++  P                    P+    
Sbjct: 199 LGITMIELAILR--FPYDSWGTPFQQLKQVVEEPS-------------------PQLPAD 237
Query: 194 QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 238
           +F+  F       VD   + L  +  +R T  E ++HP+  +LH+
Sbjct: 238 KFSAEF-------VDFTSQCLKKNSKERPTYPELMQHPFF-TLHE 274

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 37/213 (17%)
Query: 40  RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLAR 96
           R DQ  T+      +  +   ++Y+HS ++ HRD+KP NLL  +   +  LK+ DFG A+
Sbjct: 109 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
Query: 97  TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ 156
            T+  + +T    T +Y APE +L   +Y  + D+WS+G I+  ++   P F      H 
Sbjct: 169 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN---HG 224
Query: 157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVD-----LLE 211
           L +      SP   +                 R R  Q+   FPN     V      L+ 
Sbjct: 225 LAI------SPGMKT-----------------RIRMGQY--EFPNPEWSEVSEEVKMLIR 259
Query: 212 KMLVFDPNKRITVEEALRHPYLQSLHDLNDEPV 244
            +L  +P +R+T+ E + HP++     +   P+
Sbjct: 260 NLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 292

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 102/220 (46%), Gaps = 39/220 (17%)
Query: 21  FNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVHSASVLHRDLKP 76
           F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y HS  V+HRD+KP
Sbjct: 77  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 136
Query: 77  SNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 136
            NLLL ++ +LKI DFG +   + +   T+   T  Y  PE++     +   +D+WS+G 
Sbjct: 137 ENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMI-EGRMHDEKVDLWSLGV 194
Query: 137 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 196
           +  E +  +P F    Y    + I+ +                              +F 
Sbjct: 195 LCYEFLVGKPPFEANTYQETYKRISRV------------------------------EFT 224
Query: 197 TRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
             FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 225 --FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 262

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 37/213 (17%)
Query: 40  RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLAR 96
           R DQ  T+      +  +   ++Y+HS ++ HRD+KP NLL  +   +  LK+ DFG A+
Sbjct: 159 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 218
Query: 97  TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ 156
            T+  + +T    T +Y APE +L   +Y  + D+WS+G I+  ++   P F      H 
Sbjct: 219 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN---HG 274
Query: 157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVD-----LLE 211
           L +      SP   +                 R R  Q+   FPN     V      L+ 
Sbjct: 275 LAI------SPGMKT-----------------RIRMGQY--EFPNPEWSEVSEEVKMLIR 309
Query: 212 KMLVFDPNKRITVEEALRHPYLQSLHDLNDEPV 244
            +L  +P +R+T+ E + HP++     +   P+
Sbjct: 310 NLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 342

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 102/220 (46%), Gaps = 39/220 (17%)
Query: 21  FNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVHSASVLHRDLKP 76
           F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y HS  V+HRD+KP
Sbjct: 81  FHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRVIHRDIKP 140
Query: 77  SNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 136
            NLLL ++ +LKI DFG +   + +   T    T  Y  PE++     +   +D+WS+G 
Sbjct: 141 ENLLLGSNGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMI-EGRMHDEKVDLWSLGV 198
Query: 137 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 196
           +  E +   P F    Y    R I+ +                              +F 
Sbjct: 199 LCYEFLVGMPPFEAHTYQETYRRISRV------------------------------EFT 228
Query: 197 TRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
             FP+  + GA DL+ ++L  + ++R+T+ E L HP++++
Sbjct: 229 --FPDFVTEGARDLISRLLKHNASQRLTLAEVLEHPWIKA 266

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 37/213 (17%)
Query: 40  RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLAR 96
           R DQ  T+      +  +   ++Y+HS ++ HRD+KP NLL  +   +  LK+ DFG A+
Sbjct: 153 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212
Query: 97  TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ 156
            T+  + +T    T +Y APE +L   +Y  + D+WS+G I+  ++   P F      H 
Sbjct: 213 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN---HG 268
Query: 157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVD-----LLE 211
           L +      SP   +                 R R  Q+   FPN     V      L+ 
Sbjct: 269 LAI------SPGMKT-----------------RIRMGQY--EFPNPEWSEVSEEVKMLIR 303
Query: 212 KMLVFDPNKRITVEEALRHPYLQSLHDLNDEPV 244
            +L  +P +R+T+ E + HP++     +   P+
Sbjct: 304 NLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 336

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 107/237 (45%), Gaps = 37/237 (15%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTD--LHQIIRSDQQLTDDHCQYFLYQLL 58
           ++H N+I + D       ++ ND+ +V E +D      +II     LT+     F+ Q+ 
Sbjct: 143 LDHANLIQLYDAF-----ESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQIC 197
Query: 59  RGLKYVHSASVLHRDLKPSNLL-LNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAP 116
            G++++H   +LH DLKP N+L +N     +KI DFGLAR     + +     T  + AP
Sbjct: 198 EGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAP 257
Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 176
           E ++N    +   D+WSVG I   +++    F G                          
Sbjct: 258 E-VVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLG-------------------------- 290
Query: 177 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
            DN    +  +  CR       F + S  A + + K+L+ + + RI+  EAL+HP+L
Sbjct: 291 -DNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWL 346

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 101/220 (45%), Gaps = 39/220 (17%)
Query: 21  FNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVHSASVLHRDLKP 76
           F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y HS  V+HRD+KP
Sbjct: 94  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 153
Query: 77  SNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 136
            NLLL ++ +LKI DFG +   + +   T    T  Y  PE++     +   +D+WS+G 
Sbjct: 154 ENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMI-EGRMHDEKVDLWSLGV 211
Query: 137 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 196
           +  E +  +P F    Y    + I+ +                              +F 
Sbjct: 212 LCYEFLVGKPPFEANTYQETYKRISRV------------------------------EFT 241
Query: 197 TRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
             FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 242 --FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 279

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 93/180 (51%), Gaps = 17/180 (9%)
Query: 45  LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM 104
           L + +    L ++L+GL Y+HS   +HRD+K +N+LL+   D+K+ DFG+A   ++T   
Sbjct: 113 LEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 172
Query: 105 -TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEL 163
              +V T ++ APE ++  + Y    DIWS+G    E+   EP  P  D +H +R++  L
Sbjct: 173 RNXFVGTPFWMAPE-VIKQSAYDFKADIWSLGITAIELAKGEP--PNSD-LHPMRVLF-L 227
Query: 164 IGSPDDASLGFLRSDNARRYVRQL----PRCR-------KQQFATRFPNKSSGAVDLLEK 212
           I      +L    S   + +V       PR R       K +F TR+  K+S   +L+++
Sbjct: 228 IPKNSPPTLEGQHSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYTKKTSFLTELIDR 287

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/233 (23%), Positives = 108/233 (46%), Gaps = 35/233 (15%)
Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGL 61
           +HENV+ + +          +++++V E ++      I +  ++ ++        +L+ L
Sbjct: 129 QHENVVEMYN-----SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQAL 183
Query: 62  KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLL 120
             +H+  V+HRD+K  ++LL     +K+ DFG  A+ + E       V T ++ APE L+
Sbjct: 184 SVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LI 242
Query: 121 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 180
           +   Y   +DIWS+G ++ E++  EP +  +  +  +++I                 DN 
Sbjct: 243 SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI----------------RDNL 286
Query: 181 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
              ++ L +             S      L+++LV DP +R T  E L+HP+L
Sbjct: 287 PPRLKNLHKV------------SPSLKGFLDRLLVRDPAQRATAAELLKHPFL 327

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 101/220 (45%), Gaps = 39/220 (17%)
Query: 21  FNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVHSASVLHRDLKP 76
           F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y HS  V+HRD+KP
Sbjct: 80  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 139
Query: 77  SNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 136
            NLLL ++ +LKI DFG +   + +   T    T  Y  PE++     +   +D+WS+G 
Sbjct: 140 ENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMI-EGRMHDEKVDLWSLGV 197
Query: 137 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 196
           +  E +  +P F    Y    + I+ +                              +F 
Sbjct: 198 LCYEFLVGKPPFEANTYQETYKRISRV------------------------------EFT 227
Query: 197 TRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
             FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 228 --FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 265

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 101/220 (45%), Gaps = 39/220 (17%)
Query: 21  FNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVHSASVLHRDLKP 76
           F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y HS  V+HRD+KP
Sbjct: 77  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 136
Query: 77  SNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 136
            NLLL ++ +LKI DFG +   + +   T    T  Y  PE++     +   +D+WS+G 
Sbjct: 137 ENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMI-EGRMHDEKVDLWSLGV 194
Query: 137 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 196
           +  E +  +P F    Y    + I+ +                              +F 
Sbjct: 195 LCYEFLVGKPPFEANTYQETYKRISRV------------------------------EFT 224
Query: 197 TRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
             FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 225 --FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 262

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 49/136 (36%), Positives = 80/136 (58%), Gaps = 9/136 (6%)
Query: 22  NDVYIVYELMDT-DLHQIIR---SDQQLTDDHC--QYFLYQLLRGLKYVHSASVLHRDLK 75
           N++ IV EL D  DL ++I+     ++L  +    +YF+ QL   L+++HS  V+HRD+K
Sbjct: 105 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFV-QLCSALEHMHSRRVMHRDIK 163
Query: 76  PSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSV 134
           P+N+ + A+  +K+GD GL R  +S+T      V T +Y +PE + +   Y    DIWS+
Sbjct: 164 PANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI-HENGYNFKSDIWSL 222
Query: 135 GCILGEIMTREPLFPG 150
           GC+L E+   +  F G
Sbjct: 223 GCLLYEMAALQSPFYG 238

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 101/220 (45%), Gaps = 39/220 (17%)
Query: 21  FNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVHSASVLHRDLKP 76
           F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y HS  V+HRD+KP
Sbjct: 82  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 141
Query: 77  SNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 136
            NLLL ++ +LKI DFG +   + +   T    T  Y  PE++     +   +D+WS+G 
Sbjct: 142 ENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMI-EGRMHDEKVDLWSLGV 199
Query: 137 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 196
           +  E +  +P F    Y    + I+ +                              +F 
Sbjct: 200 LCYEFLVGKPPFEANTYQETYKRISRV------------------------------EFT 229
Query: 197 TRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
             FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 230 --FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 267

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 107/243 (44%), Gaps = 47/243 (19%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H N++  K++I  P       + I+ E     +L++ I +  + ++D  ++F  QLL 
Sbjct: 73  LRHPNIVRFKEVILTP-----THLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLS 127
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCD--LKIGDFGLARTTSETDFMTEYVVTRWYRAPE 117
           G+ Y HS  + HRDLK  N LL+ S    LKI DFG ++++         V T  Y APE
Sbjct: 128 GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 187
Query: 118 LLLNCTEYTAAI-DIWSVGCIL-----GEIMTREPLFPGKDYVHQL-RLITELIGSPDDA 170
           +LL   EY   I D+WS G  L     G     +P  P +DY   + R+++     PDD 
Sbjct: 188 VLLR-QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-RDYRKTIQRILSVKYSIPDD- 244
Query: 171 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 230
                        +R  P C                  L+ ++ V DP  RI++ E   H
Sbjct: 245 -------------IRISPEC----------------CHLISRIFVADPATRISIPEIKTH 275
Query: 231 PYL 233
            + 
Sbjct: 276 SWF 278

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/233 (23%), Positives = 108/233 (46%), Gaps = 35/233 (15%)
Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGL 61
           +HENV+ + +          +++++V E ++      I +  ++ ++        +L+ L
Sbjct: 86  QHENVVEMYN-----SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQAL 140
Query: 62  KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLL 120
             +H+  V+HRD+K  ++LL     +K+ DFG  A+ + E       V T ++ APE L+
Sbjct: 141 SVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LI 199
Query: 121 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 180
           +   Y   +DIWS+G ++ E++  EP +  +  +  +++I                 DN 
Sbjct: 200 SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI----------------RDNL 243
Query: 181 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
              ++ L +             S      L+++LV DP +R T  E L+HP+L
Sbjct: 244 PPRLKNLHKV------------SPSLKGFLDRLLVRDPAQRATAAELLKHPFL 284

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 100/220 (45%), Gaps = 39/220 (17%)
Query: 21  FNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVHSASVLHRDLKP 76
           F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y HS  V+HRD+KP
Sbjct: 77  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 136
Query: 77  SNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 136
            NLLL ++ +LKI DFG +   + +   T    T  Y  PE++     +   +D+WS+G 
Sbjct: 137 ENLLLGSAGELKIADFGWS-VHAPSSRRTXLCGTLDYLPPEMI-EGRMHDEKVDLWSLGV 194
Query: 137 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 196
           +  E +  +P F                               A  Y     R  + +F 
Sbjct: 195 LCYEFLVGKPPF------------------------------EANTYQETYKRISRVEFT 224
Query: 197 TRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
             FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 225 --FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 262

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 36/218 (16%)
Query: 22  NDVYIVYELMDTD--LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 79
           N++ ++YE M       ++     ++++D    ++ Q+ +GL ++H  + +H DLKP N+
Sbjct: 227 NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENI 286
Query: 80  LLNA--SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN--CTEYTAAIDIWSVG 135
           +     S +LK+ DFGL         +     T  + APE+        YT   D+WSVG
Sbjct: 287 MFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYT---DMWSVG 343
Query: 136 CILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQF 195
            +L  I+              L  ++   G  DD +L            R +  C     
Sbjct: 344 -VLSYIL--------------LSGLSPFGGENDDETL------------RNVKSCDWNMD 376
Query: 196 ATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
            + F   S    D + K+L+ DPN R+T+ +AL HP+L
Sbjct: 377 DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWL 414

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 100/220 (45%), Gaps = 39/220 (17%)
Query: 21  FNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVHSASVLHRDLKP 76
           F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y HS  V+HRD+KP
Sbjct: 81  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 140
Query: 77  SNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 136
            NLLL ++ +LKI DFG +   + +   T    T  Y  PE++     +   +D+WS+G 
Sbjct: 141 ENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMI-EGRMHDEKVDLWSLGV 198
Query: 137 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 196
           +  E +  +P F                               A  Y     R  + +F 
Sbjct: 199 LCYEFLVGKPPF------------------------------EANTYQETYKRISRVEFT 228
Query: 197 TRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
             FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 229 --FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 266

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 36/218 (16%)
Query: 22  NDVYIVYELMDTD--LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 79
           N++ ++YE M       ++     ++++D    ++ Q+ +GL ++H  + +H DLKP N+
Sbjct: 121 NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENI 180
Query: 80  LLNA--SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN--CTEYTAAIDIWSVG 135
           +     S +LK+ DFGL         +     T  + APE+        YT   D+WSVG
Sbjct: 181 MFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYT---DMWSVG 237
Query: 136 CILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQF 195
            +L  I+              L  ++   G  DD +L            R +  C     
Sbjct: 238 -VLSYIL--------------LSGLSPFGGENDDETL------------RNVKSCDWNMD 270
Query: 196 ATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
            + F   S    D + K+L+ DPN R+T+ +AL HP+L
Sbjct: 271 DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWL 308

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 100/220 (45%), Gaps = 39/220 (17%)
Query: 21  FNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVHSASVLHRDLKP 76
           F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y HS  V+HRD+KP
Sbjct: 76  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 135
Query: 77  SNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 136
            NLLL ++ +LKI DFG +   + +   T    T  Y  PE++     +   +D+WS+G 
Sbjct: 136 ENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMI-EGRMHDEKVDLWSLGV 193
Query: 137 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 196
           +  E +  +P F                               A  Y     R  + +F 
Sbjct: 194 LCYEFLVGKPPF------------------------------EANTYQETYKRISRVEFT 223
Query: 197 TRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
             FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 224 --FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 261

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 100/220 (45%), Gaps = 39/220 (17%)
Query: 21  FNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVHSASVLHRDLKP 76
           F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y HS  V+HRD+KP
Sbjct: 82  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 141
Query: 77  SNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 136
            NLLL ++ +LKI DFG +   + +   T    T  Y  PE +     +   +D+WS+G 
Sbjct: 142 ENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEXI-EGRXHDEKVDLWSLGV 199
Query: 137 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 196
           +  E +  +P F    Y    + I+ +                              +F 
Sbjct: 200 LCYEFLVGKPPFEANTYQETYKRISRV------------------------------EFT 229
Query: 197 TRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
             FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 230 --FPDFVTEGARDLISRLLKHNPSQRPXLREVLEHPWITA 267

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 55/233 (23%), Positives = 108/233 (46%), Gaps = 35/233 (15%)
Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGL 61
           +HENV+ + +          +++++V E ++      I +  ++ ++        +L+ L
Sbjct: 84  QHENVVEMYN-----SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQAL 138
Query: 62  KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLL 120
             +H+  V+HRD+K  ++LL     +K+ DFG  A+ + E       V T ++ APE L+
Sbjct: 139 SVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LI 197
Query: 121 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 180
           +   Y   +DIWS+G ++ E++  EP +  +  +  +++I                 DN 
Sbjct: 198 SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI----------------RDNL 241
Query: 181 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
              ++ L +             S      L+++LV DP +R T  E L+HP+L
Sbjct: 242 PPRLKNLHKV------------SPSLKGFLDRLLVRDPAQRATAAELLKHPFL 282

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/262 (23%), Positives = 110/262 (41%), Gaps = 57/262 (21%)
Query: 21  FNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 78
           ++ + +++E +   L++II  +       +  + +  ++L+ L Y+   S+ H DLKP N
Sbjct: 108 YDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPEN 167
Query: 79  LLLN-------------------------ASCDLKIGDFGLARTTSETDFMTEYVVTRWY 113
           +LL+                          S  +K+ DFG A  T ++D+    + TR Y
Sbjct: 168 ILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA--TFKSDYHGSIINTRQY 225
Query: 114 RAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLG 173
           RAPE++LN   +  + D+WS GC+L E+ T   LF   +++  L ++  +I       L 
Sbjct: 226 RAPEVILNLG-WDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLY 284
Query: 174 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGA---------------------VDLLEK 212
                N  +YV       K +    +P  +S                        D L  
Sbjct: 285 EATKTNGSKYV------NKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYS 338
Query: 213 MLVFDPNKRITVEEALRHPYLQ 234
           +L  DP  R +  E L+H +L+
Sbjct: 339 ILQIDPTLRPSPAELLKHKFLE 360

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 100/220 (45%), Gaps = 39/220 (17%)
Query: 21  FNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVHSASVLHRDLKP 76
           F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y HS  V+HRD+KP
Sbjct: 80  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 139
Query: 77  SNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 136
            NLLL ++ +LKI DFG +   + +   T    T  Y  PE++     +   +D+WS+G 
Sbjct: 140 ENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMI-EGRMHDEKVDLWSLGV 197
Query: 137 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 196
           +  E +  +P F                               A  Y     R  + +F 
Sbjct: 198 LCYEFLVGKPPF------------------------------EANTYQETYKRISRVEFT 227
Query: 197 TRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
             FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 228 --FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 265

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/233 (23%), Positives = 108/233 (46%), Gaps = 35/233 (15%)
Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGL 61
           +HENV+ + +          +++++V E ++      I +  ++ ++        +L+ L
Sbjct: 79  QHENVVEMYN-----SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQAL 133
Query: 62  KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLL 120
             +H+  V+HRD+K  ++LL     +K+ DFG  A+ + E       V T ++ APE L+
Sbjct: 134 SVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LI 192
Query: 121 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 180
           +   Y   +DIWS+G ++ E++  EP +  +  +  +++I                 DN 
Sbjct: 193 SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI----------------RDNL 236
Query: 181 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
              ++ L +             S      L+++LV DP +R T  E L+HP+L
Sbjct: 237 PPRLKNLHKV------------SPSLKGFLDRLLVRDPAQRATAAELLKHPFL 277

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 101/220 (45%), Gaps = 39/220 (17%)
Query: 21  FNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVHSASVLHRDLKP 76
           F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y HS  V+HRD+KP
Sbjct: 78  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 137
Query: 77  SNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 136
            NLLL ++ +LKI DFG +   + +   T    T  Y  PE++     +   +D+WS+G 
Sbjct: 138 ENLLLGSAGELKIADFGWS-CHAPSSRRTTLSGTLDYLPPEMI-EGRMHDEKVDLWSLGV 195
Query: 137 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 196
           +  E +  +P F    Y    + I+ +                              +F 
Sbjct: 196 LCYEFLVGKPPFEANTYQETYKRISRV------------------------------EFT 225
Query: 197 TRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
             FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 226 --FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 263

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 100/220 (45%), Gaps = 39/220 (17%)
Query: 21  FNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVHSASVLHRDLKP 76
           F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y HS  V+HRD+KP
Sbjct: 74  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 133
Query: 77  SNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 136
            NLLL ++ +LKI DFG +   + +   T    T  Y  PE++     +   +D+WS+G 
Sbjct: 134 ENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMI-EGRMHDEKVDLWSLGV 191
Query: 137 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 196
           +  E +  +P F                               A  Y     R  + +F 
Sbjct: 192 LCYEFLVGKPPF------------------------------EANTYQETYKRISRVEFT 221
Query: 197 TRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
             FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 222 --FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 259

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/233 (23%), Positives = 108/233 (46%), Gaps = 35/233 (15%)
Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGL 61
           +HENV+ + +          +++++V E ++      I +  ++ ++        +L+ L
Sbjct: 75  QHENVVEMYN-----SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQAL 129
Query: 62  KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLL 120
             +H+  V+HRD+K  ++LL     +K+ DFG  A+ + E       V T ++ APE L+
Sbjct: 130 SVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LI 188
Query: 121 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 180
           +   Y   +DIWS+G ++ E++  EP +  +  +  +++I                 DN 
Sbjct: 189 SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI----------------RDNL 232
Query: 181 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
              ++ L +             S      L+++LV DP +R T  E L+HP+L
Sbjct: 233 PPRLKNLHKV------------SPSLKGFLDRLLVRDPAQRATAAELLKHPFL 273

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 45/120 (37%), Positives = 68/120 (56%), Gaps = 6/120 (5%)
Query: 35  LHQIIRSDQQLTDDHCQ---YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIG 90
           L  ++RS      D+ Q   ++  Q+L GLKY+H   ++HRD+K  N+L+N  S  LKI 
Sbjct: 106 LSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKIS 165
Query: 91  DFGLARTTSETDFMTE-YVVTRWYRAPELL-LNCTEYTAAIDIWSVGCILGEIMTREPLF 148
           DFG ++  +  +  TE +  T  Y APE++      Y  A DIWS+GC + E+ T +P F
Sbjct: 166 DFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF 225

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 73/135 (54%), Gaps = 6/135 (4%)
Query: 25  YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 83
           YIV E +D   L  I+ ++  +T       +    + L + H   ++HRD+KP+N+L++A
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANILISA 151
Query: 84  SCDLKIGDFGLARTTSETD---FMTEYVV-TRWYRAPELLLNCTEYTAAIDIWSVGCILG 139
           +  +K+ DFG+AR  +++      T  V+ T  Y +PE         A  D++S+GC+L 
Sbjct: 152 TNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPE-QARGDSVDARSDVYSLGCVLY 210
Query: 140 EIMTREPLFPGKDYV 154
           E++T EP F G   V
Sbjct: 211 EVLTGEPPFTGDSPV 225

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 106/243 (43%), Gaps = 47/243 (19%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H N++  K++I  P       + IV E     +L + I +  + ++D  ++F  QL+ 
Sbjct: 72  LRHPNIVRFKEVILTP-----THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 126
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCD--LKIGDFGLARTTSETDFMTEYVVTRWYRAPE 117
           G+ Y H+  V HRDLK  N LL+ S    LKI DFG ++++         V T  Y APE
Sbjct: 127 GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 186
Query: 118 LLLNCTEYTAAI-DIWSVGCIL-----GEIMTREPLFPGKDYVHQL-RLITELIGSPDDA 170
           +LL   EY   + D+WS G  L     G     +P  P K++   + R++      PD  
Sbjct: 187 VLLK-KEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTIHRILNVQYAIPD-- 242
Query: 171 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 230
                       YV   P CR                 L+ ++ V DP KRI++ E   H
Sbjct: 243 ------------YVHISPECRH----------------LISRIFVADPAKRISIPEIRNH 274
Query: 231 PYL 233
            + 
Sbjct: 275 EWF 277

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 101/220 (45%), Gaps = 39/220 (17%)
Query: 21  FNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVHSASVLHRDLKP 76
           F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y HS  V+HRD+KP
Sbjct: 103 FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 162
Query: 77  SNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 136
            NLLL ++ +LKI DFG +   + +    +   T  Y  PE++     +   +D+WS+G 
Sbjct: 163 ENLLLGSAGELKIADFGWS-VHAPSSRRDDLCGTLDYLPPEMI-EGRMHDEKVDLWSLGV 220
Query: 137 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 196
           +  E +  +P F    Y    + I+ +                              +F 
Sbjct: 221 LCYEFLVGKPPFEANTYQETYKRISRV------------------------------EFT 250
Query: 197 TRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
             FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 251 --FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 288

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 73.9 bits (180), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 106/243 (43%), Gaps = 47/243 (19%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H N++  K++I  P       + IV E     +L + I +  + ++D  ++F  QL+ 
Sbjct: 71  LRHPNIVRFKEVILTP-----THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 125
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCD--LKIGDFGLARTTSETDFMTEYVVTRWYRAPE 117
           G+ Y H+  V HRDLK  N LL+ S    LKI DFG ++++         V T  Y APE
Sbjct: 126 GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 185
Query: 118 LLLNCTEYTAAI-DIWSVGCIL-----GEIMTREPLFPGKDYVHQL-RLITELIGSPDDA 170
           +LL   EY   + D+WS G  L     G     +P  P K++   + R++      PD  
Sbjct: 186 VLLK-KEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTIHRILNVQYAIPD-- 241
Query: 171 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 230
                       YV   P CR                 L+ ++ V DP KRI++ E   H
Sbjct: 242 ------------YVHISPECRH----------------LISRIFVADPAKRISIPEIRNH 273
Query: 231 PYL 233
            + 
Sbjct: 274 EWF 276

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 73.9 bits (180), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 102/224 (45%), Gaps = 47/224 (20%)
Query: 21  FNDVYIVYELMD--------TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHR 72
           F+D   VY +++         +L ++ + D+Q T      ++ +L   L Y HS  V+HR
Sbjct: 82  FHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTAT----YITELANALSYCHSKRVIHR 137
Query: 73  DLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIW 132
           D+KP NLLL ++ +LKI DFG +   + +   T    T  Y  PE++     +   +D+W
Sbjct: 138 DIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMI-EGRMHDEKVDLW 195
Query: 133 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 192
           S+G +  E +  +P F    Y    + I+ +                             
Sbjct: 196 SLGVLCYEFLVGKPPFEANTYQETYKRISRV----------------------------- 226
Query: 193 QQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
            +F   FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 227 -EFT--FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 267

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 73.9 bits (180), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 59/245 (24%), Positives = 110/245 (44%), Gaps = 39/245 (15%)
Query: 4   ENVIAIKDIIRPPK----KDTFNDVY---IVYELMDTD--LHQIIRSDQQLTDDHCQYFL 54
           +N I+I + +  PK     D F D Y   ++ E +       +I   D ++++     ++
Sbjct: 96  KNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYM 155
Query: 55  YQLLRGLKYVHSASVLHRDLKPSNLL--LNASCDLKIGDFGLARTTSETDFMTEYVVTRW 112
            Q   GLK++H  S++H D+KP N++     +  +KI DFGLA   +  + +     T  
Sbjct: 156 RQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAE 215
Query: 113 YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL 172
           + APE++ +        D+W++G +   +++    F G+D +  L+              
Sbjct: 216 FAAPEIV-DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQ-------------- 260
Query: 173 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 232
                         + RC  +     F + S  A D ++ +L  +P KR+TV +AL HP+
Sbjct: 261 -------------NVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPW 307
Query: 233 LQSLH 237
           L+  H
Sbjct: 308 LKGDH 312

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 54/239 (22%), Positives = 112/239 (46%), Gaps = 37/239 (15%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H N++ + ++I     +T   +Y+V E     ++   + +  ++ +   +    Q++ 
Sbjct: 70  LNHPNIVKLFEVI-----ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS 124
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
            ++Y H   ++HRDLK  NLLL+A  ++KI DFG +   +  + + E+  +  Y APEL 
Sbjct: 125 AVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELF 184
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
                    +D+WS+G IL  +++    F G++ + +LR                     
Sbjct: 185 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-LKELR--------------------- 222
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 238
                    R  + ++   F   S+   +LL+K L+ +P+KR T+E+ ++  ++   H+
Sbjct: 223 --------ERVLRGKYRIPF-YMSTDCENLLKKFLILNPSKRGTLEQIMKDRWMNVGHE 272

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 45/120 (37%), Positives = 68/120 (56%), Gaps = 6/120 (5%)
Query: 35  LHQIIRSDQQLTDDHCQ---YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIG 90
           L  ++RS      D+ Q   ++  Q+L GLKY+H   ++HRD+K  N+L+N  S  LKI 
Sbjct: 92  LSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKIS 151
Query: 91  DFGLARTTSETDFMTE-YVVTRWYRAPELL-LNCTEYTAAIDIWSVGCILGEIMTREPLF 148
           DFG ++  +  +  TE +  T  Y APE++      Y  A DIWS+GC + E+ T +P F
Sbjct: 152 DFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF 211

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 100/193 (51%), Gaps = 13/193 (6%)
Query: 20  TFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 78
           T   +Y++ + +   DL   +  +   T++  +++L +L  GL ++HS  +++RDLKP N
Sbjct: 101 TEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHLHSLGIIYRDLKPEN 160
Query: 79  LLLNASCDLKIGDFGLARTTSETDFMT-EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 137
           +LL+    +K+ DFGL++   + +     +  T  Y APE ++N   ++ + D WS G +
Sbjct: 161 ILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPE-VVNRQGHSHSADWWSYGVL 219
Query: 138 LGEIMTREPLFPGKDYVHQLRLITEL-IGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 196
           + E++T    F GKD    + LI +  +G P      FL S  A+  +R L    K+  A
Sbjct: 220 MFEMLTGSLPFQGKDRKETMTLILKAKLGMPQ-----FL-STEAQSLLRAL---FKRNPA 270
Query: 197 TRFPNKSSGAVDL 209
            R  +   GA ++
Sbjct: 271 NRLGSGPDGAEEI 283

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/256 (26%), Positives = 120/256 (46%), Gaps = 45/256 (17%)
Query: 20  TFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 78
           T   +Y++ + +   DL   +  +   T++  +++L +L   L ++HS  +++RDLKP N
Sbjct: 97  TEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPEN 156
Query: 79  LLLNASCDLKIGDFGLARTTSETDFMT-EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 137
           +LL+    +K+ DFGL++ + + +     +  T  Y APE ++N   +T + D WS G +
Sbjct: 157 ILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE-VVNRRGHTQSADWWSFGVL 215
Query: 138 LGEIMTREPLFPGKDYVHQLRLITEL-IGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 196
           + E++T    F GKD    + +I +  +G P      FL S  A+  +R L +       
Sbjct: 216 MFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ-----FL-SPEAQSLLRMLFK------- 262
Query: 197 TRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLND----------EPVCP 246
            R P    GA           P+    VEE  RH +  ++ D N           +P   
Sbjct: 263 -RNPANRLGA----------GPD---GVEEIKRHSFFSTI-DWNKLYRREIHPPFKPATG 307
Query: 247 RP---FHFDFEHSSCT 259
           RP   F+FD E ++ T
Sbjct: 308 RPEDTFYFDPEFTAKT 323

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 101/220 (45%), Gaps = 39/220 (17%)
Query: 21  FNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVHSASVLHRDLKP 76
           F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y HS  V+HRD+KP
Sbjct: 79  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 138
Query: 77  SNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 136
            NLLL ++ +LKI +FG +   + +   T    T  Y  PE++     +   +D+WS+G 
Sbjct: 139 ENLLLGSAGELKIANFGWS-VHAPSSRRTTLCGTLDYLPPEMI-EGRMHDEKVDLWSLGV 196
Query: 137 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 196
           +  E +  +P F    Y    + I+ +                              +F 
Sbjct: 197 LCYEFLVGKPPFEANTYQETYKRISRV------------------------------EFT 226
Query: 197 TRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
             FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 227 --FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 264

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 105/250 (42%), Gaps = 40/250 (16%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY--QLL 58
           + H+NVI + D++   +K     +Y+V E     + +++ S  +     CQ   Y  QL+
Sbjct: 63  LRHKNVIQLVDVLYNEEK---QKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLI 119
Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT---SETDFMTEYVVTRWYRA 115
            GL+Y+HS  ++H+D+KP NLLL     LKI   G+A      +  D       +  ++ 
Sbjct: 120 DGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179
Query: 116 PELLLNCTEYTA-AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF 174
           PE+      ++   +DIWS G  L  I T   L+P                         
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTG--LYP------------------------- 212
Query: 175 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
              DN  +    + +          P  S    DLL+ ML ++P KR ++ +  +H + +
Sbjct: 213 FEGDNIYKLFENIGKGSYAIPGDCGPPLS----DLLKGMLEYEPAKRFSIRQIRQHSWFR 268
Query: 235 SLHDLNDEPV 244
             H   + PV
Sbjct: 269 KKHPPAEAPV 278

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 73/135 (54%), Gaps = 6/135 (4%)
Query: 25  YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 83
           YIV E +D   L  I+ ++  +T       +    + L + H   ++HRD+KP+N++++A
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 151
Query: 84  SCDLKIGDFGLARTTSETD---FMTEYVV-TRWYRAPELLLNCTEYTAAIDIWSVGCILG 139
           +  +K+ DFG+AR  +++      T  V+ T  Y +PE         A  D++S+GC+L 
Sbjct: 152 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE-QARGDSVDARSDVYSLGCVLY 210
Query: 140 EIMTREPLFPGKDYV 154
           E++T EP F G   V
Sbjct: 211 EVLTGEPPFTGDSPV 225

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 100/220 (45%), Gaps = 39/220 (17%)
Query: 21  FNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVHSASVLHRDLKP 76
           F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y HS  V+HRD+KP
Sbjct: 80  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 139
Query: 77  SNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 136
            NLLL ++ +LKI DFG +   + +        T  Y  PE++     +   +D+WS+G 
Sbjct: 140 ENLLLGSAGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMI-EGRMHDEKVDLWSLGV 197
Query: 137 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 196
           +  E +  +P F    Y    + I+ +                              +F 
Sbjct: 198 LCYEFLVGKPPFEANTYQETYKRISRV------------------------------EFT 227
Query: 197 TRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
             FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 228 --FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 265

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 72/131 (54%), Gaps = 6/131 (4%)
Query: 25  YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 83
           YIV E +D   L  I+ ++  +T       +    + L + H   ++HRD+KP+N++++A
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 151
Query: 84  SCDLKIGDFGLARTTSETD---FMTEYVV-TRWYRAPELLLNCTEYTAAIDIWSVGCILG 139
           +  +K+ DFG+AR  +++      T  V+ T  Y +PE         A  D++S+GC+L 
Sbjct: 152 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE-QARGDSVDARSDVYSLGCVLY 210
Query: 140 EIMTREPLFPG 150
           E++T EP F G
Sbjct: 211 EVLTGEPPFTG 221

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 102/214 (47%), Gaps = 32/214 (14%)
Query: 22  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 81
            +++++ E +       I S  +L ++        +L+ L Y+H+  V+HRD+K  ++LL
Sbjct: 115 EELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILL 174
Query: 82  NASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
                +K+ DFG  A+ + +       V T ++ APE +++ + Y   +DIWS+G ++ E
Sbjct: 175 TLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPE-VISRSLYATEVDIWSLGIMVIE 233
Query: 141 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 200
           ++  EP +     V  ++ + +   SP                    P+ +         
Sbjct: 234 MVDGEPPYFSDSPVQAMKRLRD---SPP-------------------PKLKNS------- 264
Query: 201 NKSSGAV-DLLEKMLVFDPNKRITVEEALRHPYL 233
           +K S  + D LE+MLV DP +R T +E L HP+L
Sbjct: 265 HKVSPVLRDFLERMLVRDPQERATAQELLDHPFL 298

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 103/222 (46%), Gaps = 43/222 (19%)
Query: 21  FNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVHSASVLHRDLKP 76
           F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y HS  V+HRD+KP
Sbjct: 81  FHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRVIHRDIKP 140
Query: 77  SNLLLNASCDLKIGDFGLA--RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSV 134
            NLLL ++ +LKI DFG +    +S  D +     T  Y  PE++     +   +D+WS+
Sbjct: 141 ENLLLGSNGELKIADFGWSVHAPSSRRDTLCG---TLDYLPPEMI-EGRMHDEKVDLWSL 196
Query: 135 GCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQ 194
           G +  E +   P F    Y    R I+ +                              +
Sbjct: 197 GVLCYEFLVGMPPFEAHTYQETYRRISRV------------------------------E 226
Query: 195 FATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
           F   FP+  + GA DL+ ++L  + ++R+T+ E L HP++++
Sbjct: 227 FT--FPDFVTEGARDLISRLLKHNASQRLTLAEVLEHPWIKA 266

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 73/135 (54%), Gaps = 6/135 (4%)
Query: 25  YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 83
           YIV E +D   L  I+ ++  +T       +    + L + H   ++HRD+KP+N++++A
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 151
Query: 84  SCDLKIGDFGLARTTSETD---FMTEYVV-TRWYRAPELLLNCTEYTAAIDIWSVGCILG 139
           +  +K+ DFG+AR  +++      T  V+ T  Y +PE         A  D++S+GC+L 
Sbjct: 152 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE-QARGDSVDARSDVYSLGCVLY 210
Query: 140 EIMTREPLFPGKDYV 154
           E++T EP F G   V
Sbjct: 211 EVLTGEPPFTGDSPV 225

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 100/233 (42%), Gaps = 37/233 (15%)
Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 61
           H ++I +  +I  P      D ++V E +   +L   I    ++ +   +    Q+L  +
Sbjct: 70  HPHIIKLYQVISTP-----TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAV 124
Query: 62  KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 121
            Y H   V+HRDLKP N+LL+A  + KI DFGL+   S+ +F+ +   +  Y APE++  
Sbjct: 125 DYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISG 184
Query: 122 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR 181
                  +DIWS G IL  ++     F   D  H   L  ++ G                
Sbjct: 185 RLYAGPEVDIWSCGVILYALLCGTLPF---DDEHVPTLFKKIRGG--------------- 226
Query: 182 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
             V  +P    +  AT           LL  ML  DP KR T+++   H + +
Sbjct: 227 --VFYIPEYLNRSVAT-----------LLMHMLQVDPLKRATIKDIREHEWFK 266

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 100/220 (45%), Gaps = 39/220 (17%)
Query: 21  FNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVHSASVLHRDLKP 76
           F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y HS  V+HRD+KP
Sbjct: 79  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 138
Query: 77  SNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 136
            NLLL ++ +LKI DFG +   + +        T  Y  PE++     +   +D+WS+G 
Sbjct: 139 ENLLLGSAGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMI-EGRMHDEKVDLWSLGV 196
Query: 137 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 196
           +  E +  +P F    Y    + I+ +                              +F 
Sbjct: 197 LCYEFLVGKPPFEANTYQETYKRISRV------------------------------EFT 226
Query: 197 TRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
             FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 227 --FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 264

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 73/135 (54%), Gaps = 6/135 (4%)
Query: 25  YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 83
           YIV E +D   L  I+ ++  +T       +    + L + H   ++HRD+KP+N++++A
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 151
Query: 84  SCDLKIGDFGLARTTSETD---FMTEYVV-TRWYRAPELLLNCTEYTAAIDIWSVGCILG 139
           +  +K+ DFG+AR  +++      T  V+ T  Y +PE         A  D++S+GC+L 
Sbjct: 152 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE-QARGDSVDARSDVYSLGCVLY 210
Query: 140 EIMTREPLFPGKDYV 154
           E++T EP F G   V
Sbjct: 211 EVLTGEPPFTGDSPV 225

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 101/220 (45%), Gaps = 39/220 (17%)
Query: 21  FNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVHSASVLHRDLKP 76
           F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y HS  V+HRD+KP
Sbjct: 80  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 139
Query: 77  SNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 136
            NLLL ++ +LKI +FG +   + +   T    T  Y  PE++     +   +D+WS+G 
Sbjct: 140 ENLLLGSAGELKIANFGWS-VHAPSSRRTTLCGTLDYLPPEMI-EGRMHDEKVDLWSLGV 197
Query: 137 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 196
           +  E +  +P F    Y    + I+ +                              +F 
Sbjct: 198 LCYEFLVGKPPFEANTYQETYKRISRV------------------------------EFT 227
Query: 197 TRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
             FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 228 --FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 265

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 100/220 (45%), Gaps = 39/220 (17%)
Query: 21  FNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVHSASVLHRDLKP 76
           F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y HS  V+HRD+KP
Sbjct: 80  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 139
Query: 77  SNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 136
            NLLL ++ +LKI DFG +   + +    +   T  Y  PE++     +   +D+WS+G 
Sbjct: 140 ENLLLGSAGELKIADFGWS-VHAPSSRRDDLCGTLDYLPPEMI-EGRMHDEKVDLWSLGV 197
Query: 137 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 196
           +  E +  +P F                               A  Y     R  + +F 
Sbjct: 198 LCYEFLVGKPPF------------------------------EANTYQETYKRISRVEFT 227
Query: 197 TRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
             FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 228 --FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 265

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 99/220 (45%), Gaps = 39/220 (17%)
Query: 21  FNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVHSASVLHRDLKP 76
           F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y HS  V+HRD+KP
Sbjct: 77  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 136
Query: 77  SNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 136
            NLLL ++ +LKI DFG +   + +        T  Y  PE++     +   +D+WS+G 
Sbjct: 137 ENLLLGSAGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMI-EGRMHDEKVDLWSLGV 194
Query: 137 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 196
           +  E +  +P F                               A  Y     R  + +F 
Sbjct: 195 LCYEFLVGKPPF------------------------------EANTYQETYKRISRVEFT 224
Query: 197 TRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
             FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 225 --FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 262

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 31/213 (14%)
Query: 35  LHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDF 92
           L+ +I S+   Q  D++ + F  Q+L  L Y+HS  ++HR+LKP N+ ++ S ++KIGDF
Sbjct: 102 LYDLIHSENLNQQRDEYWRLF-RQILEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDF 160
Query: 93  GLARTT---------------SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 137
           GLA+                   +D +T  + T  Y A E+L     Y   ID +S+G I
Sbjct: 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGII 220
Query: 138 LGEIMTREPLFPGKDYVHQLRLITEL-IGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 196
             E +   P   G + V+ L+ +  + I  P D        DN  +  +++ R       
Sbjct: 221 FFEXIY--PFSTGXERVNILKKLRSVSIEFPPDF------DDNKXKVEKKIIRL----LI 268
Query: 197 TRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 229
              PNK  GA  LL    +   ++   ++EAL+
Sbjct: 269 DHDPNKRPGARTLLNSGWLPVKHQDEVIKEALK 301

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 102/222 (45%), Gaps = 43/222 (19%)
Query: 21  FNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVHSASVLHRDLKP 76
           F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y HS  V+HRD+KP
Sbjct: 78  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 137
Query: 77  SNLLLNASCDLKIGDFGLA--RTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSV 134
            NLLL ++ +LKI DFG +    +S  D +     T  Y  PE++     +   +D+WS+
Sbjct: 138 ENLLLGSAGELKIADFGWSVHAPSSRRDTLCG---TLDYLPPEMI-EGRMHDEKVDLWSL 193
Query: 135 GCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQ 194
           G +  E +  +P F    Y    + I+ +                              +
Sbjct: 194 GVLCYEFLVGKPPFEANTYQETYKRISRV------------------------------E 223
Query: 195 FATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
           F   FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 224 FT--FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 263

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 72/131 (54%), Gaps = 6/131 (4%)
Query: 25  YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 83
           YIV E +D   L  I+ ++  +T       +    + L + H   ++HRD+KP+N++++A
Sbjct: 109 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 168
Query: 84  SCDLKIGDFGLARTTSETD---FMTEYVV-TRWYRAPELLLNCTEYTAAIDIWSVGCILG 139
           +  +K+ DFG+AR  +++      T  V+ T  Y +PE         A  D++S+GC+L 
Sbjct: 169 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE-QARGDSVDARSDVYSLGCVLY 227
Query: 140 EIMTREPLFPG 150
           E++T EP F G
Sbjct: 228 EVLTGEPPFTG 238

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 99/220 (45%), Gaps = 39/220 (17%)
Query: 21  FNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVHSASVLHRDLKP 76
           F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y HS  V+HRD+KP
Sbjct: 77  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 136
Query: 77  SNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 136
            NLLL ++ +LKI DFG +   + +        T  Y  PE++     +   +D+WS+G 
Sbjct: 137 ENLLLGSAGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMI-EGRMHDEKVDLWSLGV 194
Query: 137 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 196
           +  E +  +P F                               A  Y     R  + +F 
Sbjct: 195 LCYEFLVGKPPF------------------------------EANTYQETYKRISRVEFT 224
Query: 197 TRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
             FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 225 --FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 262

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 99/220 (45%), Gaps = 39/220 (17%)
Query: 21  FNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVHSASVLHRDLKP 76
           F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y HS  V+HRD+KP
Sbjct: 80  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 139
Query: 77  SNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 136
            NLLL ++ +LKI DFG +   + +        T  Y  PE++     +   +D+WS+G 
Sbjct: 140 ENLLLGSAGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMI-EGRMHDEKVDLWSLGV 197
Query: 137 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 196
           +  E +  +P F                               A  Y     R  + +F 
Sbjct: 198 LCYEFLVGKPPF------------------------------EANTYQETYKRISRVEFT 227
Query: 197 TRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
             FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 228 --FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 265

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/131 (33%), Positives = 75/131 (57%), Gaps = 5/131 (3%)
Query: 22  NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNL 79
            ++ I  E MD   L Q+++  +++ ++        +LRGL Y+     ++HRD+KPSN+
Sbjct: 87  GEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNI 146
Query: 80  LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 139
           L+N+  ++K+ DFG++    ++     +V TR Y APE  L  T Y+   DIWS+G  L 
Sbjct: 147 LVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMAPE-RLQGTHYSVQSDIWSMGLSLV 204
Query: 140 EI-MTREPLFP 149
           E+ + R P+ P
Sbjct: 205 ELAVGRYPIPP 215

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 99/233 (42%), Gaps = 37/233 (15%)
Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 61
           H ++I +  +I  P      D ++V E +   +L   I    ++ +   +    Q+L  +
Sbjct: 70  HPHIIKLYQVISTP-----TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAV 124
Query: 62  KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 121
            Y H   V+HRDLKP N+LL+A  + KI DFGL+   S+ +F+     +  Y APE++  
Sbjct: 125 DYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISG 184
Query: 122 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR 181
                  +DIWS G IL  ++     F   D  H   L  ++ G                
Sbjct: 185 RLYAGPEVDIWSCGVILYALLCGTLPF---DDEHVPTLFKKIRGG--------------- 226
Query: 182 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
             V  +P    +  AT           LL  ML  DP KR T+++   H + +
Sbjct: 227 --VFYIPEYLNRSVAT-----------LLMHMLQVDPLKRATIKDIREHEWFK 266

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 38/128 (29%), Positives = 71/128 (55%), Gaps = 4/128 (3%)
Query: 22  NDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
           +++Y+V E M   D+   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 114 SNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 81  LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           ++    +K+ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 174 IDQQGYIKVADFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 230
Query: 141 IMTREPLF 148
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 38/128 (29%), Positives = 71/128 (55%), Gaps = 4/128 (3%)
Query: 22  NDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
           +++Y+V E M   D+   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 114 SNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 81  LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           ++    +K+ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 174 IDQQGYIKVADFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 230
Query: 141 IMTREPLF 148
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/277 (22%), Positives = 127/277 (45%), Gaps = 44/277 (15%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H N++ + ++I     +T   +Y+V E     ++   + +  ++ +   +    Q++ 
Sbjct: 70  LNHPNIVKLFEVI-----ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS 124
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
            ++Y H   ++HRDLK  NLLL+A  ++KI DFG +   +  + +  +  +  Y APEL 
Sbjct: 125 AVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELF 184
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
                    +D+WS+G IL  +++    F G++ + +LR                     
Sbjct: 185 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-LKELR--------------------- 222
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
                    R  + ++   F   S+   +LL+K L+ +P+KR T+E+ ++  ++   H+ 
Sbjct: 223 --------ERVLRGKYRIPF-YMSTDCENLLKKFLILNPSKRGTLEQIMKDRWMNVGHE- 272
Query: 240 NDEP---VCPRPFHFDFEHSSCTEDHIRELIWRESVK 273
           +DE    V P P   D++    TE  +     RE ++
Sbjct: 273 DDELKPYVAPLP---DYKDPRRTELMVSMGYTREEIQ 306

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 83/151 (54%), Gaps = 4/151 (2%)
Query: 20  TFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 78
           T   +Y++ + +   DL   +  +   T++  +++L +L   L ++HS  +++RDLKP N
Sbjct: 98  TEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPEN 157
Query: 79  LLLNASCDLKIGDFGLARTTSETDFMT-EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 137
           +LL+    +K+ DFGL++ + + +     +  T  Y APE ++N   +T + D WS G +
Sbjct: 158 ILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE-VVNRRGHTQSADWWSFGVL 216
Query: 138 LGEIMTREPLFPGKDYVHQLRLITEL-IGSP 167
           + E++T    F GKD    + +I +  +G P
Sbjct: 217 MFEMLTGTLPFQGKDRKETMTMILKAKLGMP 247

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 39/109 (35%), Positives = 66/109 (60%), Gaps = 5/109 (4%)
Query: 53  FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM-TEYVVTR 111
            L ++L+GL Y+HS   +HRD+K +N+LL+   D+K+ DFG+A   ++T      +V T 
Sbjct: 125 MLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTP 184
Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 160
           ++ APE ++  + Y +  DIWS+G    E+   EP  P  D +H +R++
Sbjct: 185 FWMAPE-VIQQSAYDSKADIWSLGITAIELAKGEP--PNSD-MHPMRVL 229

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 100/220 (45%), Gaps = 39/220 (17%)
Query: 21  FNDVYIVYELMD-TDLHQIIRSDQQLT---DDHCQYFLYQLLRGLKYVHSASVLHRDLKP 76
           F+D   VY +++   L  + R  Q+L+   +     ++ +L   L Y HS  V+HRD+KP
Sbjct: 77  FHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKKVIHRDIKP 136
Query: 77  SNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 136
            NLLL ++ +LKI DFG +   + +        T  Y  PE++     +   +D+WS+G 
Sbjct: 137 ENLLLGSAGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMI-EGRMHDEKVDLWSLGV 194
Query: 137 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 196
           +  E +  +P F    Y                        D  +R  R        +F 
Sbjct: 195 LCYEFLVGKPPFEANTY-----------------------QDTYKRISRV-------EFT 224
Query: 197 TRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
             FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 225 --FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 262

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 83/151 (54%), Gaps = 4/151 (2%)
Query: 20  TFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 78
           T   +Y++ + +   DL   +  +   T++  +++L +L   L ++HS  +++RDLKP N
Sbjct: 97  TEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPEN 156
Query: 79  LLLNASCDLKIGDFGLARTTSETDFMT-EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 137
           +LL+    +K+ DFGL++ + + +     +  T  Y APE ++N   +T + D WS G +
Sbjct: 157 ILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE-VVNRRGHTQSADWWSFGVL 215
Query: 138 LGEIMTREPLFPGKDYVHQLRLITEL-IGSP 167
           + E++T    F GKD    + +I +  +G P
Sbjct: 216 MFEMLTGTLPFQGKDRKETMTMILKAKLGMP 246

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 101/224 (45%), Gaps = 47/224 (20%)
Query: 21  FNDVYIVYELMD--------TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHR 72
           F+D   VY +++         +L ++ + D+Q T      ++ +L   L Y HS  V+HR
Sbjct: 82  FHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTAT----YITELANALSYCHSKRVIHR 137
Query: 73  DLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIW 132
           D+KP NLLL ++ +LKI DFG +   + +        T  Y  PE++     +   +D+W
Sbjct: 138 DIKPENLLLGSAGELKIADFGWS-VHAPSSRRXXLXGTLDYLPPEMI-EGRMHDEKVDLW 195
Query: 133 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 192
           S+G +  E +  +P F    Y    + I+ +                             
Sbjct: 196 SLGVLCYEFLVGKPPFEANTYQETYKRISRV----------------------------- 226
Query: 193 QQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
            +F   FP+  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 227 -EFT--FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 267

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/243 (27%), Positives = 106/243 (43%), Gaps = 47/243 (19%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H N++  K++I  P       + IV E     +L + I +  + ++D  ++F  QL+ 
Sbjct: 72  LRHPNIVRFKEVILTPTH-----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 126
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCD--LKIGDFGLARTTSETDFMTEYVVTRWYRAPE 117
           G+ Y H+  V HRDLK  N LL+ S    LKI  FG ++++       + V T  Y APE
Sbjct: 127 GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPE 186
Query: 118 LLLNCTEYTAAI-DIWSVGCIL-----GEIMTREPLFPGKDYVHQL-RLITELIGSPDDA 170
           +LL   EY   + D+WS G  L     G     +P  P K++   + R++      PD  
Sbjct: 187 VLLK-KEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTIHRILNVQYAIPD-- 242
Query: 171 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 230
                       YV   P CR                 L+ ++ V DP KRI++ E   H
Sbjct: 243 ------------YVHISPECRH----------------LISRIFVADPAKRISIPEIRNH 274
Query: 231 PYL 233
            + 
Sbjct: 275 EWF 277

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 111/239 (46%), Gaps = 37/239 (15%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H N++ + ++I     +T   +Y+V E     ++   + +  ++ +   +    Q++ 
Sbjct: 70  LNHPNIVKLFEVI-----ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS 124
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
            ++Y H   ++HRDLK  NLLL+A  ++KI DFG +   +  + +  +  +  Y APEL 
Sbjct: 125 AVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELF 184
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
                    +D+WS+G IL  +++    F G++ + +LR                     
Sbjct: 185 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-LKELR--------------------- 222
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 238
                    R  + ++   F   S+   +LL+K L+ +P+KR T+E+ ++  ++   H+
Sbjct: 223 --------ERVLRGKYRIPF-YMSTDCENLLKKFLILNPSKRGTLEQIMKDRWMNVGHE 272

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 111/239 (46%), Gaps = 37/239 (15%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H N++ + ++I     +T   +Y+V E     ++   + +  ++ +   +    Q++ 
Sbjct: 70  LNHPNIVKLFEVI-----ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS 124
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
            ++Y H   ++HRDLK  NLLL+A  ++KI DFG +   +  + +  +  +  Y APEL 
Sbjct: 125 AVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELF 184
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
                    +D+WS+G IL  +++    F G++ + +LR                     
Sbjct: 185 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-LKELR--------------------- 222
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 238
                    R  + ++   F   S+   +LL+K L+ +P+KR T+E+ ++  ++   H+
Sbjct: 223 --------ERVLRGKYRIPF-YMSTDCENLLKKFLILNPSKRGTLEQIMKDRWMNVGHE 272

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 110/239 (46%), Gaps = 37/239 (15%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H N++ + ++I     +T   +Y+V E     ++   + +  ++ +   +    Q++ 
Sbjct: 70  LNHPNIVKLFEVI-----ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS 124
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
            ++Y H   ++HRDLK  NLLL+A  ++KI DFG +   +  + +  +     Y APEL 
Sbjct: 125 AVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELF 184
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
                    +D+WS+G IL  +++    F G++ + +LR                     
Sbjct: 185 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-LKELR--------------------- 222
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 238
                    R  + ++   F   S+   +LL+K L+ +P+KR T+E+ ++  ++   H+
Sbjct: 223 --------ERVLRGKYRIPF-YMSTDCENLLKKFLILNPSKRGTLEQIMKDRWMNVGHE 272

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/243 (27%), Positives = 105/243 (43%), Gaps = 47/243 (19%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H N++  K++I  P       + IV E     +L + I +  + ++D  ++F  QL+ 
Sbjct: 72  LRHPNIVRFKEVILTP-----THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 126
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCD--LKIGDFGLARTTSETDFMTEYVVTRWYRAPE 117
           G+ Y H+  V HRDLK  N LL+ S    LKI  FG ++++         V T  Y APE
Sbjct: 127 GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPE 186
Query: 118 LLLNCTEYTAAI-DIWSVGCIL-----GEIMTREPLFPGKDYVHQL-RLITELIGSPDDA 170
           +LL   EY   + D+WS G  L     G     +P  P K++   + R++      PD  
Sbjct: 187 VLLK-KEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTIHRILNVQYAIPD-- 242
Query: 171 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 230
                       YV   P CR                 L+ ++ V DP KRI++ E   H
Sbjct: 243 ------------YVHISPECRH----------------LISRIFVADPAKRISIPEIRNH 274
Query: 231 PYL 233
            + 
Sbjct: 275 EWF 277

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 75/135 (55%), Gaps = 3/135 (2%)
Query: 20  TFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 78
           T   +Y++ E L   +L   +  +    +D   ++L ++   L ++H   +++RDLKP N
Sbjct: 92  TGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPEN 151
Query: 79  LLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 137
           ++LN    +K+ DFGL + +     +T  +  T  Y APE+L+  + +  A+D WS+G +
Sbjct: 152 IMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEILMR-SGHNRAVDWWSLGAL 210
Query: 138 LGEIMTREPLFPGKD 152
           + +++T  P F G++
Sbjct: 211 MYDMLTGAPPFTGEN 225

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 75/135 (55%), Gaps = 3/135 (2%)
Query: 20  TFNDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 78
           T   +Y++ E L   +L   +  +    +D   ++L ++   L ++H   +++RDLKP N
Sbjct: 92  TGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPEN 151
Query: 79  LLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 137
           ++LN    +K+ DFGL + +     +T  +  T  Y APE+L+  + +  A+D WS+G +
Sbjct: 152 IMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMR-SGHNRAVDWWSLGAL 210
Query: 138 LGEIMTREPLFPGKD 152
           + +++T  P F G++
Sbjct: 211 MYDMLTGAPPFTGEN 225

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 98/220 (44%), Gaps = 45/220 (20%)
Query: 40  RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS---CDLKIGDFGLAR 96
           R DQ  T+      +  +   ++++HS ++ HRD+KP NLL  +      LK+ DFG A+
Sbjct: 120 RGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179
Query: 97  TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ 156
            T++    T    T +Y APE +L   +Y  + D+WS+G I+  ++   P F        
Sbjct: 180 ETTQNALQTP-CYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGFPPF-------- 229
Query: 157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK-----SSGAVDLLE 211
                        ++ G   S   +R      R R  Q+   FPN      S  A  L+ 
Sbjct: 230 ------------YSNTGQAISPGMKR------RIRLGQYG--FPNPEWSEVSEDAKQLIR 269
Query: 212 KMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPR-PFH 250
            +L  DP +R+T+ + + HP+      +N   V P+ P H
Sbjct: 270 LLLKTDPTERLTITQFMNHPW------INQSMVVPQTPLH 303

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 98/220 (44%), Gaps = 45/220 (20%)
Query: 40  RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS---CDLKIGDFGLAR 96
           R DQ  T+      +  +   ++++HS ++ HRD+KP NLL  +      LK+ DFG A+
Sbjct: 101 RGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 160
Query: 97  TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ 156
            T++    T    T +Y APE +L   +Y  + D+WS+G I+  ++   P F        
Sbjct: 161 ETTQNALQTP-CYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGFPPF-------- 210
Query: 157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK-----SSGAVDLLE 211
                        ++ G   S   +R      R R  Q+   FPN      S  A  L+ 
Sbjct: 211 ------------YSNTGQAISPGMKR------RIRLGQYG--FPNPEWSEVSEDAKQLIR 250
Query: 212 KMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPR-PFH 250
            +L  DP +R+T+ + + HP+      +N   V P+ P H
Sbjct: 251 LLLKTDPTERLTITQFMNHPW------INQSMVVPQTPLH 284

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 101/216 (46%), Gaps = 31/216 (14%)
Query: 22  NDVYIVYELMDTD-LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNL 79
            ++ I  E MD   L Q+++   ++ +         +++GL Y+     ++HRD+KPSN+
Sbjct: 96  GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 155
Query: 80  LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 139
           L+N+  ++K+ DFG++    ++     +V TR Y +PE  L  T Y+   DIWS+G  L 
Sbjct: 156 LVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLV 213
Query: 140 EI-MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 198
           E+ + R P+  G   +    L+  ++  P                    P+     F+  
Sbjct: 214 EMAVGRYPIGSGSGSMAIFELLDYIVNEPP-------------------PKLPSGVFSLE 254
Query: 199 FPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
           F        D + K L+ +P +R  +++ + H +++
Sbjct: 255 FQ-------DFVNKCLIKNPAERADLKQLMVHAFIK 283

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 80/155 (51%), Gaps = 16/155 (10%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQL--TDDHCQYFL 54
           M+H N++  ++        +F +   +Y +MD     DL + I + + +   +D    + 
Sbjct: 80  MKHPNIVQYRE--------SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWF 131
Query: 55  YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWY 113
            Q+   LK+VH   +LHRD+K  N+ L     +++GDFG+AR  + T +     + T +Y
Sbjct: 132 VQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYY 191
Query: 114 RAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF 148
            +PE+  N   Y    DIW++GC+L E+ T +  F
Sbjct: 192 LSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAF 225

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 38/128 (29%), Positives = 71/128 (55%), Gaps = 7/128 (5%)
Query: 20  TFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 75
           TF D   ++ +MD     +L  ++R  Q+  +   +++  ++   L+Y+HS  +++RDLK
Sbjct: 74  TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLK 133
Query: 76  PSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVG 135
           P N+LL+ +  +KI DFG A+   +  +      T  Y APE +++   Y  +ID WS G
Sbjct: 134 PENILLDKNGHIKITDFGFAKYVPDVTYXL--CGTPDYIAPE-VVSTKPYNKSIDWWSFG 190
Query: 136 CILGEIMT 143
            ++ E++ 
Sbjct: 191 ILIYEMLA 198

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 91/213 (42%), Gaps = 37/213 (17%)
Query: 40  RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLAR 96
           R DQ  T+         +   ++Y+HS ++ HRD+KP NLL  +   +  LK+ DFG A+
Sbjct: 153 RGDQAFTEREASEIXKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212
Query: 97  TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ 156
            T+  + +T    T +Y APE +L   +Y  + D WS+G I   ++   P F      H 
Sbjct: 213 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDXWSLGVIXYILLCGYPPFYSN---HG 268
Query: 157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVD-----LLE 211
           L +      SP   +                 R R  Q+   FPN     V      L+ 
Sbjct: 269 LAI------SPGXKT-----------------RIRXGQY--EFPNPEWSEVSEEVKXLIR 303
Query: 212 KMLVFDPNKRITVEEALRHPYLQSLHDLNDEPV 244
            +L  +P +R T+ E   HP++     +   P+
Sbjct: 304 NLLKTEPTQRXTITEFXNHPWIXQSTKVPQTPL 336

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 110/239 (46%), Gaps = 37/239 (15%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H N++ + ++I     +T   +Y+V E     ++   + +   + +   +    Q++ 
Sbjct: 63  LNHPNIVKLFEVI-----ETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVS 117
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
            ++Y H   ++HRDLK  NLLL+A  ++KI DFG +   +  + +  +  +  Y APEL 
Sbjct: 118 AVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELF 177
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
                    +D+WS+G IL  +++    F G++ + +LR                     
Sbjct: 178 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-LKELR--------------------- 215
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 238
                    R  + ++   F   S+   +LL+K L+ +P+KR T+E+ ++  ++   H+
Sbjct: 216 --------ERVLRGKYRIPF-YMSTDCENLLKKFLILNPSKRGTLEQIMKDRWMNVGHE 265

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 107/236 (45%), Gaps = 54/236 (22%)
Query: 24  VYIVYELMDTDLHQIIRSDQQLTDDHCQY--------FLYQLLRGLKYVHSASVLHRDLK 75
           +YI  EL + +L  ++ S + ++D++ +          L Q+  G+ ++HS  ++HRDLK
Sbjct: 102 LYIALELCNLNLQDLVES-KNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLK 160
Query: 76  PSNLLLNASCDLK-------------IGDFGLART--TSETDF---MTEYVVTRWYRAPE 117
           P N+L++ S                 I DFGL +   + +  F   +     T  +RAPE
Sbjct: 161 PQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPE 220
Query: 118 LLLNCTE--YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL 175
           LL   T+   T +IDI+S+GC+   I+++     G  Y  +  +I  +       SL  +
Sbjct: 221 LLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIF------SLDEM 274
Query: 176 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHP 231
           +  + R  + +                   A DL+ +M+  DP KR T  + LRHP
Sbjct: 275 KCLHDRSLIAE-------------------ATDLISQMIDHDPLKRPTAMKVLRHP 311

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 97/225 (43%), Gaps = 33/225 (14%)
Query: 18  KDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 77
           KD    V  +    D   H          +    ++  ++  GL+ +H   +++RDLKP 
Sbjct: 256 KDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPE 315
Query: 78  NLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 137
           N+LL+    ++I D GLA    E   +   V T  Y APE++ N   YT + D W++GC+
Sbjct: 316 NILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCL 374
Query: 138 LGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFAT 197
           L E++  +                    SP       ++ +   R V+++P    ++++ 
Sbjct: 375 LYEMIAGQ--------------------SPFQQRKKKIKREEVERLVKEVP----EEYSE 410
Query: 198 RFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH 237
           RF   S  A  L  ++L  DP +R+     +  E   HP  + L+
Sbjct: 411 RF---SPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN 452

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 108/240 (45%), Gaps = 35/240 (14%)
Query: 24  VYIVYELMDTDLHQIIRSDQQ--LTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLL 80
           V +V+E++  +L  +I+  +   +   + +    QLL GL Y+H    ++H D+KP N+L
Sbjct: 105 VVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVL 164
Query: 81  LNAS------CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSV 134
           +           +KI D G A    E    T  + TR YR+PE+LL    +    DIWS 
Sbjct: 165 MEIVDSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAP-WGCGADIWST 221
Query: 135 GCILGEIMTREPLFP---GKDYVHQLRLITELIGSPDDASLGFLRSD-------NARRYV 184
            C++ E++T + LF    G  Y      I ++I    +     LR+        N+R  +
Sbjct: 222 ACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLL 281
Query: 185 RQLPRCR----------KQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
           R + + +          K +F+    +++    D L  ML  DP KR      + HP+L+
Sbjct: 282 RNISKLKFWPLEDVLTEKYKFSK---DEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLK 338

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 107/236 (45%), Gaps = 54/236 (22%)
Query: 24  VYIVYELMDTDLHQIIRSDQQLTDDHCQY--------FLYQLLRGLKYVHSASVLHRDLK 75
           +YI  EL + +L  ++ S + ++D++ +          L Q+  G+ ++HS  ++HRDLK
Sbjct: 102 LYIALELCNLNLQDLVES-KNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLK 160
Query: 76  PSNLLLNASCDLK-------------IGDFGLART--TSETDF---MTEYVVTRWYRAPE 117
           P N+L++ S                 I DFGL +   + +  F   +     T  +RAPE
Sbjct: 161 PQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPE 220
Query: 118 LLLNCTE--YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL 175
           LL   T+   T +IDI+S+GC+   I+++     G  Y  +  +I  +       SL  +
Sbjct: 221 LLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIF------SLDEM 274
Query: 176 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHP 231
           +  + R  + +                   A DL+ +M+  DP KR T  + LRHP
Sbjct: 275 KCLHDRSLIAE-------------------ATDLISQMIDHDPLKRPTAMKVLRHP 311

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 99/225 (44%), Gaps = 37/225 (16%)
Query: 22  NDVYIVYELMDTDL----HQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKP 76
            DV+I  EL DT L     Q+I   Q + +D        +++ L+++HS  SV+HRD+KP
Sbjct: 106 GDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKP 165
Query: 77  SNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL---LNCTEYTAAIDIWS 133
           SN+L+NA   +K  DFG++    +          + Y APE +   LN   Y+   DIWS
Sbjct: 166 SNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAPERINPELNQKGYSVKSDIWS 225
Query: 134 VGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ 193
           +G    E+      FP   +    + + +++  P                    P+    
Sbjct: 226 LGITXIELAILR--FPYDSWGTPFQQLKQVVEEPS-------------------PQLPAD 264
Query: 194 QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 238
           +F+  F       VD   + L  +  +R T  E  +HP+  +LH+
Sbjct: 265 KFSAEF-------VDFTSQCLKKNSKERPTYPELXQHPFF-TLHE 301

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 108/240 (45%), Gaps = 35/240 (14%)
Query: 24  VYIVYELMDTDLHQIIRSDQQ--LTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLL 80
           V +V+E++  +L  +I+  +   +   + +    QLL GL Y+H    ++H D+KP N+L
Sbjct: 105 VVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVL 164
Query: 81  LNAS------CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSV 134
           +           +KI D G A    E    T  + TR YR+PE+LL    +    DIWS 
Sbjct: 165 MEIVDSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAP-WGCGADIWST 221
Query: 135 GCILGEIMTREPLFP---GKDYVHQLRLITELIGSPDDASLGFLRSD-------NARRYV 184
            C++ E++T + LF    G  Y      I ++I    +     LR+        N+R  +
Sbjct: 222 ACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLL 281
Query: 185 RQLPRCR----------KQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
           R + + +          K +F+    +++    D L  ML  DP KR      + HP+L+
Sbjct: 282 RNISKLKFWPLEDVLTEKYKFSK---DEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLK 338

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 97/225 (43%), Gaps = 33/225 (14%)
Query: 18  KDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 77
           KD    V  +    D   H          +    ++  ++  GL+ +H   +++RDLKP 
Sbjct: 256 KDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPE 315
Query: 78  NLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 137
           N+LL+    ++I D GLA    E   +   V T  Y APE++ N   YT + D W++GC+
Sbjct: 316 NILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCL 374
Query: 138 LGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFAT 197
           L E++  +                    SP       ++ +   R V+++P    ++++ 
Sbjct: 375 LYEMIAGQ--------------------SPFQQRKKKIKREEVERLVKEVP----EEYSE 410
Query: 198 RFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSLH 237
           RF   S  A  L  ++L  DP +R+     +  E   HP  + L+
Sbjct: 411 RF---SPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN 452

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/239 (21%), Positives = 110/239 (46%), Gaps = 37/239 (15%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H N++ + ++I     +T   +Y++ E     ++   + +  ++ +   +    Q++ 
Sbjct: 68  LNHPNIVKLFEVI-----ETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS 122
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
            ++Y H   ++HRDLK  NLLL+A  ++KI DFG +   +    +  +  +  Y APEL 
Sbjct: 123 AVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELF 182
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
                    +D+WS+G IL  +++    F G++ + +LR                     
Sbjct: 183 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-LKELR--------------------- 220
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 238
                    R  + ++   F   S+   +LL++ LV +P KR T+E+ ++  ++ + H+
Sbjct: 221 --------ERVLRGKYRIPF-YMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHE 270

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/239 (21%), Positives = 109/239 (45%), Gaps = 37/239 (15%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H N++ + ++I     +T   +Y++ E     ++   + +  ++ +   +    Q++ 
Sbjct: 71  LNHPNIVKLFEVI-----ETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS 125
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
            ++Y H   ++HRDLK  NLLL+A  ++KI DFG +   +    +  +     Y APEL 
Sbjct: 126 AVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELF 185
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
                    +D+WS+G IL  +++    F G++ + +LR                     
Sbjct: 186 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-LKELR--------------------- 223
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 238
                    R  + ++   F   S+   +LL++ LV +P KR T+E+ ++  ++ + H+
Sbjct: 224 --------ERVLRGKYRIPF-YMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHE 273

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 78/131 (59%), Gaps = 6/131 (4%)
Query: 22  NDVYIVYELM-DTDLHQIIRSDQQ-LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 79
           N VY+V E+  + ++++ +++  +  +++  ++F++Q++ G+ Y+HS  +LHRDL  SNL
Sbjct: 84  NYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNL 143
Query: 80  LLNASCDLKIGDFGLARTTSETDFMTEYVV--TRWYRAPELLLNCTEYTAAIDIWSVGCI 137
           LL  + ++KI DFGLA T  +      Y +  T  Y +PE+    + +    D+WS+GC+
Sbjct: 144 LLTRNMNIKIADFGLA-TQLKMPHEKHYTLCGTPNYISPEIATR-SAHGLESDVWSLGCM 201
Query: 138 LGEIMTREPLF 148
              ++   P F
Sbjct: 202 FYTLLIGRPPF 212

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 70/130 (53%), Gaps = 4/130 (3%)
Query: 18  KDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 77
           KDT   ++I+ E +       +     L +      L ++L+GL Y+HS   +HRD+K +
Sbjct: 91  KDT--KLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAA 148
Query: 78  NLLLNASCDLKIGDFGLARTTSETDFM-TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 136
           N+LL+   ++K+ DFG+A   ++T      +V T ++ APE ++  + Y +  DIWS+G 
Sbjct: 149 NVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPE-VIKQSAYDSKADIWSLGI 207
Query: 137 ILGEIMTREP 146
              E+   EP
Sbjct: 208 TAIELARGEP 217

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 36/128 (28%), Positives = 71/128 (55%), Gaps = 4/128 (3%)
Query: 22  NDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
           +++Y+V E +   ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 114 SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 81  LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           ++    +K+ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 174 IDQQGYIKVADFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 230
Query: 141 IMTREPLF 148
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 82/147 (55%), Gaps = 10/147 (6%)
Query: 45  LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR-TTSETDF 103
            T++  +++  +++  L+Y+HS  V++RD+K  NL+L+    +KI DFGL +   S+   
Sbjct: 102 FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 161
Query: 104 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY--VHQLRLIT 161
           M  +  T  Y APE+L +  +Y  A+D W +G ++ E+M     F  +D+  + +L L+ 
Sbjct: 162 MKXFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME 220
Query: 162 EL----IGSPDDASL--GFLRSDNARR 182
           E+      SP+  SL  G L+ D  +R
Sbjct: 221 EIRFPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 82/147 (55%), Gaps = 10/147 (6%)
Query: 45  LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR-TTSETDF 103
            T++  +++  +++  L+Y+HS  V++RD+K  NL+L+    +KI DFGL +   S+   
Sbjct: 107 FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 166
Query: 104 MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY--VHQLRLIT 161
           M  +  T  Y APE+L +  +Y  A+D W +G ++ E+M     F  +D+  + +L L+ 
Sbjct: 167 MKXFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME 225
Query: 162 EL----IGSPDDASL--GFLRSDNARR 182
           E+      SP+  SL  G L+ D  +R
Sbjct: 226 EIRFPRTLSPEAKSLLAGLLKKDPKQR 252

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 84/150 (56%), Gaps = 10/150 (6%)
Query: 42  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR-TTSE 100
           ++  T++  +++  +++  L+Y+HS  V++RD+K  NL+L+    +KI DFGL +   S+
Sbjct: 99  ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158
Query: 101 TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY--VHQLR 158
              M  +  T  Y APE+L +  +Y  A+D W +G ++ E+M     F  +D+  + +L 
Sbjct: 159 GATMKXFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217
Query: 159 LITEL----IGSPDDASL--GFLRSDNARR 182
           L+ E+      SP+  SL  G L+ D  +R
Sbjct: 218 LMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 84/150 (56%), Gaps = 10/150 (6%)
Query: 42  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR-TTSE 100
           ++  T++  +++  +++  L+Y+HS  V++RD+K  NL+L+    +KI DFGL +   S+
Sbjct: 99  ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158
Query: 101 TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY--VHQLR 158
              M  +  T  Y APE+L +  +Y  A+D W +G ++ E+M     F  +D+  + +L 
Sbjct: 159 GATMKXFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217
Query: 159 LITEL----IGSPDDASL--GFLRSDNARR 182
           L+ E+      SP+  SL  G L+ D  +R
Sbjct: 218 LMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 70/130 (53%), Gaps = 4/130 (3%)
Query: 18  KDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 77
           KDT   ++I+ E +       +     L +      L ++L+GL Y+HS   +HRD+K +
Sbjct: 76  KDT--KLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAA 133
Query: 78  NLLLNASCDLKIGDFGLARTTSETDFM-TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 136
           N+LL+   ++K+ DFG+A   ++T      +V T ++ APE ++  + Y +  DIWS+G 
Sbjct: 134 NVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPE-VIKQSAYDSKADIWSLGI 192
Query: 137 ILGEIMTREP 146
              E+   EP
Sbjct: 193 TAIELARGEP 202

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 106/240 (44%), Gaps = 58/240 (24%)
Query: 24  VYIVYELMDTDLHQIIRSDQQLTDDHCQY--------FLYQLLRGLKYVHSASVLHRDLK 75
           +YI  EL + +L  ++ S + ++D++ +          L Q+  G+ ++HS  ++HRDLK
Sbjct: 84  LYIALELCNLNLQDLVES-KNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLK 142
Query: 76  PSNLLLNASCDLK-------------IGDFGLART--TSETDFMTEY---VVTRWYRAPE 117
           P N+L++ S                 I DFGL +   + ++ F T       T  +RAPE
Sbjct: 143 PQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPE 202
Query: 118 LLLNCTE------YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDAS 171
           LL            T +IDI+S+GC+   I+++     G  Y  +  +I  +       S
Sbjct: 203 LLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIF------S 256
Query: 172 LGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHP 231
           L  ++  + R  + +                   A DL+ +M+  DP KR T  + LRHP
Sbjct: 257 LDEMKCLHDRSLIAE-------------------ATDLISQMIDHDPLKRPTAMKVLRHP 297

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 99/215 (46%), Gaps = 32/215 (14%)
Query: 22  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 81
           +++++V E +       + ++  + +        + L+ L+++HS  V+HRD+K  N+LL
Sbjct: 90  DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL 149
Query: 82  NASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
                +K+ DFG  A+ T E    +E V T ++ APE++     Y   +DIWS+G +  E
Sbjct: 150 GMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIE 208
Query: 141 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 200
           ++  EP +  ++ +  L LI    G+P+                             + P
Sbjct: 209 MIEGEPPYLNENPLRALYLIA-TNGTPE----------------------------LQNP 239
Query: 201 NKSSGAV-DLLEKMLVFDPNKRITVEEALRHPYLQ 234
            K S    D L + L  D  KR + +E L+H +L+
Sbjct: 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 84/150 (56%), Gaps = 10/150 (6%)
Query: 42  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR-TTSE 100
           ++  T++  +++  +++  L+Y+HS  V++RD+K  NL+L+    +KI DFGL +   S+
Sbjct: 99  ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158
Query: 101 TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY--VHQLR 158
              M  +  T  Y APE+L +  +Y  A+D W +G ++ E+M     F  +D+  + +L 
Sbjct: 159 GATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217
Query: 159 LITEL----IGSPDDASL--GFLRSDNARR 182
           L+ E+      SP+  SL  G L+ D  +R
Sbjct: 218 LMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 70/130 (53%), Gaps = 4/130 (3%)
Query: 18  KDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 77
           KDT   ++I+ E +       +     L +      L ++L+GL Y+HS   +HRD+K +
Sbjct: 76  KDT--KLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAA 133
Query: 78  NLLLNASCDLKIGDFGLARTTSETDFM-TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 136
           N+LL+   ++K+ DFG+A   ++T      +V T ++ APE ++  + Y +  DIWS+G 
Sbjct: 134 NVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIKQSAYDSKADIWSLGI 192
Query: 137 ILGEIMTREP 146
              E+   EP
Sbjct: 193 TAIELARGEP 202

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 84/150 (56%), Gaps = 10/150 (6%)
Query: 42  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR-TTSE 100
           ++  T++  +++  +++  L+Y+HS  V++RD+K  NL+L+    +KI DFGL +   S+
Sbjct: 102 ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 161
Query: 101 TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY--VHQLR 158
              M  +  T  Y APE+L +  +Y  A+D W +G ++ E+M     F  +D+  + +L 
Sbjct: 162 GATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 220
Query: 159 LITEL----IGSPDDASL--GFLRSDNARR 182
           L+ E+      SP+  SL  G L+ D  +R
Sbjct: 221 LMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 250

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 84/150 (56%), Gaps = 10/150 (6%)
Query: 42  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR-TTSE 100
           ++  T++  +++  +++  L+Y+HS  V++RD+K  NL+L+    +KI DFGL +   S+
Sbjct: 99  ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158
Query: 101 TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY--VHQLR 158
              M  +  T  Y APE+L +  +Y  A+D W +G ++ E+M     F  +D+  + +L 
Sbjct: 159 GATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217
Query: 159 LITEL----IGSPDDASL--GFLRSDNARR 182
           L+ E+      SP+  SL  G L+ D  +R
Sbjct: 218 LMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/153 (32%), Positives = 76/153 (49%), Gaps = 16/153 (10%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQ-LTDDHCQYFLYQLLR 59
           + H NV+A+  I+ PP  +    V + Y +   DL Q IRS Q+  T      F  Q+ R
Sbjct: 79  LNHPNVLALIGIMLPP--EGLPHVLLPY-MCHGDLLQFIRSPQRNPTVKDLISFGLQVAR 135
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           G++Y+     +HRDL   N +L+ S  +K+ DFGLAR   +     EY   + +R   L 
Sbjct: 136 GMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILD----REYYSVQQHRHARLP 191
Query: 120 LNCT--------EYTAAIDIWSVGCILGEIMTR 144
           +  T         +T   D+WS G +L E++TR
Sbjct: 192 VKWTALESLQTYRFTTKSDVWSFGVLLWELLTR 224

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 70/130 (53%), Gaps = 4/130 (3%)
Query: 18  KDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 77
           KDT   ++I+ E +       +     L +      L ++L+GL Y+HS   +HRD+K +
Sbjct: 96  KDT--KLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAA 153
Query: 78  NLLLNASCDLKIGDFGLARTTSETDFM-TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 136
           N+LL+   ++K+ DFG+A   ++T      +V T ++ APE ++  + Y +  DIWS+G 
Sbjct: 154 NVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIKQSAYDSKADIWSLGI 212
Query: 137 ILGEIMTREP 146
              E+   EP
Sbjct: 213 TAIELARGEP 222

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 83/164 (50%), Gaps = 20/164 (12%)
Query: 1   MEHENVIAIKDI-IRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++H N+IA++ + ++ P      ++ +V E         + S +++  D    +  Q+ R
Sbjct: 63  LKHPNIIALRGVCLKEP------NLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIAR 116
Query: 60  GLKYVHSASV---LHRDLKPSNLLLNASCD--------LKIGDFGLARTTSETDFMTEYV 108
           G+ Y+H  ++   +HRDLK SN+L+    +        LKI DFGLAR    T  M+   
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAG 176
Query: 109 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 152
              W  APE ++  + ++   D+WS G +L E++T E  F G D
Sbjct: 177 AYAWM-APE-VIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID 218

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 36/128 (28%), Positives = 70/128 (54%), Gaps = 4/128 (3%)
Query: 22  NDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
           +++Y+V E     ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 115 SNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 174
Query: 81  LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           ++    +K+ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 175 IDQQGYIKVADFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 231
Query: 141 IMTREPLF 148
           +    P F
Sbjct: 232 MAAGYPPF 239

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 56/91 (61%), Gaps = 5/91 (5%)
Query: 58  LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 117
           L+GL Y+HS +++HRD+K  N+LL+    +K+GDFG A   +  +    +V T ++ APE
Sbjct: 164 LQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN---XFVGTPYWMAPE 220
Query: 118 LLLNCTE--YTAAIDIWSVGCILGEIMTREP 146
           ++L   E  Y   +D+WS+G    E+  R+P
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELAERKP 251

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 56/91 (61%), Gaps = 5/91 (5%)
Query: 58  LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 117
           L+GL Y+HS +++HRD+K  N+LL+    +K+GDFG A   +  +    +V T ++ APE
Sbjct: 125 LQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN---XFVGTPYWMAPE 181
Query: 118 LLLNCTE--YTAAIDIWSVGCILGEIMTREP 146
           ++L   E  Y   +D+WS+G    E+  R+P
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKP 212

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 61/114 (53%), Gaps = 5/114 (4%)
Query: 38  IIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL-AR 96
           ++  D+ LT+   Q    Q+L  L ++HS  ++HRDLK  N+L+    D+++ DFG+ A+
Sbjct: 107 MLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAK 166
Query: 97  TTSETDFMTEYVVTRWYRAPELL----LNCTEYTAAIDIWSVGCILGEIMTREP 146
                     ++ T ++ APE++    +  T Y    DIWS+G  L E+   EP
Sbjct: 167 NLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP 220

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 32/87 (36%), Positives = 53/87 (60%), Gaps = 1/87 (1%)
Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRA 115
           Q+ +G+ Y+HS  ++HRDLKPSN+ L  +  +KIGDFGL  +       T    T  Y +
Sbjct: 144 QITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMS 203
Query: 116 PELLLNCTEYTAAIDIWSVGCILGEIM 142
           PE  ++  +Y   +D++++G IL E++
Sbjct: 204 PE-QISSQDYGKEVDLYALGLILAELL 229

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 102/238 (42%), Gaps = 54/238 (22%)
Query: 53  FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDF-MTEYV-- 108
           ++  L + LK +H   ++HRD+KPSN L N       + DFGLA+ T +T   + ++V  
Sbjct: 122 YMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQS 181
Query: 109 --------------------------VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM 142
                                      T  +RAPE+L  C   T AID+WS G I   ++
Sbjct: 182 EAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLL 241
Query: 143 T-REPLFPGKDYVHQLRLITELIGSPD--DASLGFLRSDNARRYV-----RQL-PRCRKQ 193
           + R P +   D +  L  I  + GS +   A+  F +S    + V     R+L  R R  
Sbjct: 242 SGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGM 301
Query: 194 QFAT-RFPNKSSGAVDLLE--------------KMLVFDPNKRITVEEALRHPYLQSL 236
             +T +  +   G    LE              K+L  +P  RIT EEAL HP+ + +
Sbjct: 302 DSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 61/114 (53%), Gaps = 5/114 (4%)
Query: 38  IIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL-AR 96
           ++  D+ LT+   Q    Q+L  L ++HS  ++HRDLK  N+L+    D+++ DFG+ A+
Sbjct: 99  MLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAK 158
Query: 97  TTSETDFMTEYVVTRWYRAPELL----LNCTEYTAAIDIWSVGCILGEIMTREP 146
                     ++ T ++ APE++    +  T Y    DIWS+G  L E+   EP
Sbjct: 159 NLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP 212

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/255 (22%), Positives = 111/255 (43%), Gaps = 50/255 (19%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H N++ + ++I     +T   +Y+V E     ++   + +  +  +   +    Q++ 
Sbjct: 70  LNHPNIVKLFEVI-----ETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVS 124
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
            ++Y H   ++HRDLK  NLLL+A  ++KI DFG +   +  + +  +     Y APEL 
Sbjct: 125 AVQYCHQKFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELF 184
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
                    +D+WS+G IL  +++    F G++ + +LR                     
Sbjct: 185 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-LKELR--------------------- 222
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR---------- 229
                    R  + ++   F   S+   +LL+K L+ +P+KR T+E+  +          
Sbjct: 223 --------ERVLRGKYRIPF-YXSTDCENLLKKFLILNPSKRGTLEQIXKDRWXNVGHED 273
Query: 230 ---HPYLQSLHDLND 241
               PY++ L D  D
Sbjct: 274 DELKPYVEPLPDYKD 288

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 36/128 (28%), Positives = 71/128 (55%), Gaps = 4/128 (3%)
Query: 22  NDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
           +++Y+V E     ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NL+
Sbjct: 114 SNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLM 173
Query: 81  LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           ++    +K+ DFGLA+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 174 IDQQGYIKVTDFGLAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 230
Query: 141 IMTREPLF 148
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 73/131 (55%), Gaps = 5/131 (3%)
Query: 22  NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNL 79
            ++ I  E MD   L Q+++   ++ +         +++GL Y+     ++HRD+KPSN+
Sbjct: 139 GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 198
Query: 80  LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 139
           L+N+  ++K+ DFG++    ++     +V TR Y +PE  L  T Y+   DIWS+G  L 
Sbjct: 199 LVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLV 256
Query: 140 EI-MTREPLFP 149
           E+ + R P+ P
Sbjct: 257 EMAVGRYPIPP 267

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 73/131 (55%), Gaps = 5/131 (3%)
Query: 22  NDVYIVYELMDTD-LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNL 79
            ++ I  E MD   L Q+++   ++ +         +++GL Y+     ++HRD+KPSN+
Sbjct: 104 GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 163
Query: 80  LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 139
           L+N+  ++K+ DFG++    ++     +V TR Y +PE  L  T Y+   DIWS+G  L 
Sbjct: 164 LVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLV 221
Query: 140 EI-MTREPLFP 149
           E+ + R P+ P
Sbjct: 222 EMAVGRYPIPP 232

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 39/122 (31%), Positives = 69/122 (56%), Gaps = 4/122 (3%)
Query: 22  NDVYIVYELMDTD-LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNL 79
            ++ I  E MD   L Q+++   ++ +         +++GL Y+     ++HRD+KPSN+
Sbjct: 80  GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 139
Query: 80  LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 139
           L+N+  ++K+ DFG++    + +   E+V TR Y +PE  L  T Y+   DIWS+G  L 
Sbjct: 140 LVNSRGEIKLCDFGVSGQLID-EMANEFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLV 197
Query: 140 EI 141
           E+
Sbjct: 198 EM 199

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 73/131 (55%), Gaps = 5/131 (3%)
Query: 22  NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNL 79
            ++ I  E MD   L Q+++   ++ +         +++GL Y+     ++HRD+KPSN+
Sbjct: 77  GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 136
Query: 80  LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 139
           L+N+  ++K+ DFG++    ++     +V TR Y +PE  L  T Y+   DIWS+G  L 
Sbjct: 137 LVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLV 194
Query: 140 EI-MTREPLFP 149
           E+ + R P+ P
Sbjct: 195 EMAVGRYPIPP 205

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 82/156 (52%), Gaps = 17/156 (10%)
Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTRW 112
           Q  RG+ Y+H+ S++HRDLK +N+ L+    +KIGDFGLA   S      ++     +  
Sbjct: 116 QTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 175
Query: 113 YRAPEL--LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG----S 166
           + APE+  + +   Y+   D+++ G +L E+MT +  +   +   Q   I E++G    S
Sbjct: 176 WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEMVGRGSLS 232
Query: 167 PDDASLGFLRSDNARRYVRQLPRCRKQQFATR--FP 200
           PD   L  +RS+  +R  R +  C K++   R  FP
Sbjct: 233 PD---LSKVRSNCPKRMKRLMAECLKKKRDERPSFP 265

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 71/128 (55%), Gaps = 4/128 (3%)
Query: 22  NDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
           +++Y+V E +   ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 81  LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           ++    +++ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTWXL--AGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 230
Query: 141 IMTREPLF 148
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 90/202 (44%), Gaps = 35/202 (17%)
Query: 38  IIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL-AR 96
           ++  ++ LT+   Q    Q L  L Y+H   ++HRDLK  N+L     D+K+ DFG+ A+
Sbjct: 125 MLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAK 184
Query: 97  TTSETDFMTEYVVTRWYRAPELLLNCTE----YTAAIDIWSVGCILGEIMTREPLFPGKD 152
            T        ++ T ++ APE+++  T     Y    D+WS+G  L E+   EP      
Sbjct: 185 NTRXIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPH---- 240
Query: 153 YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLE 211
             H+L                     N  R + ++ +      A   P++ SS   D L+
Sbjct: 241 --HEL---------------------NPMRVLLKIAKSEPPTLAQ--PSRWSSNFKDFLK 275
Query: 212 KMLVFDPNKRITVEEALRHPYL 233
           K L  + + R T  + L+HP++
Sbjct: 276 KCLEKNVDARWTTSQLLQHPFV 297

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 71/128 (55%), Gaps = 4/128 (3%)
Query: 22  NDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
           +++Y+V E +   ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 135 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 194
Query: 81  LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           ++    +++ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 195 IDQQGYIQVTDFGFAKRVKGATWTL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 251
Query: 141 IMTREPLF 148
           +    P F
Sbjct: 252 MAAGYPPF 259

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/195 (30%), Positives = 89/195 (45%), Gaps = 38/195 (19%)
Query: 53  FLYQLLRGLKYVHSASVLHRDLKPSNLLL---NASCDLK--IGDFGLAR--TTSETDFMT 105
            L Q   GL ++HS +++HRDLKP N+L+   NA   +K  I DFGL +        F  
Sbjct: 123 LLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSR 182
Query: 106 EYVV--TRWYRAPELLL-NCTEY-TAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT 161
              V  T  + APE+L  +C E  T  +DI+S GC+   +++      GK    Q  +  
Sbjct: 183 RSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI-- 240
Query: 162 ELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKR 221
            L+G+    SL  L  +     +                     A +L+EKM+  DP KR
Sbjct: 241 -LLGA---CSLDCLHPEKHEDVI---------------------ARELIEKMIAMDPQKR 275
Query: 222 ITVEEALRHPYLQSL 236
            + +  L+HP+  SL
Sbjct: 276 PSAKHVLKHPFFWSL 290

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 90/202 (44%), Gaps = 35/202 (17%)
Query: 38  IIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL-AR 96
           ++  ++ LT+   Q    Q L  L Y+H   ++HRDLK  N+L     D+K+ DFG+ A+
Sbjct: 125 MLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAK 184
Query: 97  TTSETDFMTEYVVTRWYRAPELLLNCTE----YTAAIDIWSVGCILGEIMTREPLFPGKD 152
            T        ++ T ++ APE+++  T     Y    D+WS+G  L E+   EP      
Sbjct: 185 NTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPH---- 240
Query: 153 YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLE 211
             H+L                     N  R + ++ +      A   P++ SS   D L+
Sbjct: 241 --HEL---------------------NPMRVLLKIAKSEPPTLAQ--PSRWSSNFKDFLK 275
Query: 212 KMLVFDPNKRITVEEALRHPYL 233
           K L  + + R T  + L+HP++
Sbjct: 276 KCLEKNVDARWTTSQLLQHPFV 297

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 81/158 (51%), Gaps = 17/158 (10%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQLTDDHCQY--FLYQL 57
           ++H+ ++ +  ++      T   +YI+ E M    L   ++SD+       +   F  Q+
Sbjct: 67  LQHDKLVKLHAVV------TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI 120
Query: 58  LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYR 114
             G+ ++   + +HRDL+ +N+L++AS   KI DFGLAR   + ++          +W  
Sbjct: 121 AEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKW-T 179
Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 150
           APE  +N   +T   D+WS G +L EI+T  R P +PG
Sbjct: 180 APE-AINFGSFTIKSDVWSFGILLMEIVTYGRIP-YPG 215

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 81/157 (51%), Gaps = 19/157 (12%)
Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA----RTTSETDFMTEYVVTR 111
           Q  RG+ Y+H+ S++HRDLK +N+ L+    +KIGDFGLA    R +    F        
Sbjct: 128 QTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 187
Query: 112 WYRAPEL--LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG---- 165
           W  APE+  + +   Y+   D+++ G +L E+MT +  +   +   Q   I E++G    
Sbjct: 188 WM-APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEMVGRGSL 243
Query: 166 SPDDASLGFLRSDNARRYVRQLPRCRKQQFATR--FP 200
           SPD   L  +RS+  +R  R +  C K++   R  FP
Sbjct: 244 SPD---LSKVRSNCPKRMKRLMAECLKKKRDERPSFP 277

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 57/105 (54%), Gaps = 4/105 (3%)
Query: 42  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 101
           ++Q+T        YQL RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR  +  
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 102 DFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           D+  +    R    + APE L +   YT   D+WS G ++ EI T
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFT 254

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 81/157 (51%), Gaps = 19/157 (12%)
Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA----RTTSETDFMTEYVVTR 111
           Q  RG+ Y+H+ S++HRDLK +N+ L+    +KIGDFGLA    R +    F        
Sbjct: 128 QTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 187
Query: 112 WYRAPEL--LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG---- 165
           W  APE+  + +   Y+   D+++ G +L E+MT +  +   +   Q   I E++G    
Sbjct: 188 WM-APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEMVGRGSL 243
Query: 166 SPDDASLGFLRSDNARRYVRQLPRCRKQQFATR--FP 200
           SPD   L  +RS+  +R  R +  C K++   R  FP
Sbjct: 244 SPD---LSKVRSNCPKRMKRLMAECLKKKRDERPSFP 277

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 57/105 (54%), Gaps = 4/105 (3%)
Query: 42  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 101
           ++Q+T        YQL RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR  +  
Sbjct: 197 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 256
Query: 102 DFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           D+  +    R    + APE L +   YT   D+WS G ++ EI T
Sbjct: 257 DYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFT 300

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 90/202 (44%), Gaps = 35/202 (17%)
Query: 38  IIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL-AR 96
           ++  ++ LT+   Q    Q L  L Y+H   ++HRDLK  N+L     D+K+ DFG+ A+
Sbjct: 125 MLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAK 184
Query: 97  TTSETDFMTEYVVTRWYRAPELLLNCTE----YTAAIDIWSVGCILGEIMTREPLFPGKD 152
            T        ++ T ++ APE+++  T     Y    D+WS+G  L E+   EP      
Sbjct: 185 NTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPH---- 240
Query: 153 YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLE 211
             H+L                     N  R + ++ +      A   P++ SS   D L+
Sbjct: 241 --HEL---------------------NPMRVLLKIAKSEPPTLAQ--PSRWSSNFKDFLK 275
Query: 212 KMLVFDPNKRITVEEALRHPYL 233
           K L  + + R T  + L+HP++
Sbjct: 276 KCLEKNVDARWTTSQLLQHPFV 297

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 57/105 (54%), Gaps = 4/105 (3%)
Query: 42  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 101
           ++Q+T        YQL RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR  +  
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 102 DFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           D+  +    R    + APE L +   YT   D+WS G ++ EI T
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFT 254

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/125 (33%), Positives = 64/125 (51%), Gaps = 5/125 (4%)
Query: 42  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 101
           ++Q+T        YQL RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR  +  
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 102 DFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQL 157
           D+  +    R    + APE L +   YT   D+WS G ++ EI T     +PG       
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269
Query: 158 RLITE 162
           +L+ E
Sbjct: 270 KLLKE 274

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 73/131 (55%), Gaps = 5/131 (3%)
Query: 22  NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNL 79
            ++ I  E MD   L Q+++   ++ +         +++GL Y+     ++HRD+KPSN+
Sbjct: 77  GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 136
Query: 80  LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 139
           L+N+  ++K+ DFG++    ++     +V TR Y +PE  L  T Y+   DIWS+G  L 
Sbjct: 137 LVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLV 194
Query: 140 EI-MTREPLFP 149
           E+ + R P+ P
Sbjct: 195 EMAVGRYPIPP 205

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 57/105 (54%), Gaps = 4/105 (3%)
Query: 42  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 101
           ++Q+T        YQL RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR  +  
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 102 DFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           D+  +    R    + APE L +   YT   D+WS G ++ EI T
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFT 254

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 57/105 (54%), Gaps = 4/105 (3%)
Query: 42  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 101
           ++Q+T        YQL RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR  +  
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 102 DFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           D+  +    R    + APE L +   YT   D+WS G ++ EI T
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFT 254

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 73/131 (55%), Gaps = 5/131 (3%)
Query: 22  NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNL 79
            ++ I  E MD   L Q+++   ++ +         +++GL Y+     ++HRD+KPSN+
Sbjct: 77  GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 136
Query: 80  LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 139
           L+N+  ++K+ DFG++    ++     +V TR Y +PE  L  T Y+   DIWS+G  L 
Sbjct: 137 LVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLV 194
Query: 140 EI-MTREPLFP 149
           E+ + R P+ P
Sbjct: 195 EMAVGRYPIPP 205

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/125 (33%), Positives = 64/125 (51%), Gaps = 5/125 (4%)
Query: 42  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 101
           ++Q+T        YQL RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR  +  
Sbjct: 140 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 199
Query: 102 DFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQL 157
           D+  +    R    + APE L +   YT   D+WS G ++ EI T     +PG       
Sbjct: 200 DYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 258
Query: 158 RLITE 162
           +L+ E
Sbjct: 259 KLLKE 263

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 71/128 (55%), Gaps = 4/128 (3%)
Query: 22  NDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
           +++Y+V E +   ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 81  LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           ++    +++ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTWXL--XGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 230
Query: 141 IMTREPLF 148
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/125 (33%), Positives = 64/125 (51%), Gaps = 5/125 (4%)
Query: 42  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 101
           ++Q+T        YQL RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR  +  
Sbjct: 143 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 202
Query: 102 DFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQL 157
           D+  +    R    + APE L +   YT   D+WS G ++ EI T     +PG       
Sbjct: 203 DYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 261
Query: 158 RLITE 162
           +L+ E
Sbjct: 262 KLLKE 266

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/125 (33%), Positives = 64/125 (51%), Gaps = 5/125 (4%)
Query: 42  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 101
           ++Q+T        YQL RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR  +  
Sbjct: 138 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNI 197
Query: 102 DFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQL 157
           D+  +    R    + APE L +   YT   D+WS G ++ EI T     +PG       
Sbjct: 198 DYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 256
Query: 158 RLITE 162
           +L+ E
Sbjct: 257 KLLKE 261

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 73/131 (55%), Gaps = 5/131 (3%)
Query: 22  NDVYIVYELMDTD-LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNL 79
            ++ I  E MD   L Q+++   ++ +         +++GL Y+     ++HRD+KPSN+
Sbjct: 77  GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 136
Query: 80  LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 139
           L+N+  ++K+ DFG++    ++     +V TR Y +PE  L  T Y+   DIWS+G  L 
Sbjct: 137 LVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLV 194
Query: 140 EI-MTREPLFP 149
           E+ + R P+ P
Sbjct: 195 EMAVGRYPIPP 205

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 73/131 (55%), Gaps = 5/131 (3%)
Query: 22  NDVYIVYELMDTD-LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNL 79
            ++ I  E MD   L Q+++   ++ +         +++GL Y+     ++HRD+KPSN+
Sbjct: 77  GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 136
Query: 80  LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 139
           L+N+  ++K+ DFG++    ++     +V TR Y +PE  L  T Y+   DIWS+G  L 
Sbjct: 137 LVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLV 194
Query: 140 EI-MTREPLFP 149
           E+ + R P+ P
Sbjct: 195 EMAVGRYPIPP 205

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 83/163 (50%), Gaps = 27/163 (16%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQ-------QLTDDHCQY 52
           ++H+ ++ +  ++      T   +YI+ E M    L   ++SD+       +L D     
Sbjct: 240 LQHDKLVKLHAVV------TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLID----- 288
Query: 53  FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-- 110
           F  Q+  G+ ++   + +HRDL+ +N+L++AS   KI DFGLAR   + ++         
Sbjct: 289 FSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP 348
Query: 111 -RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 150
            +W  APE  +N   +T   D+WS G +L EI+T  R P +PG
Sbjct: 349 IKW-TAPE-AINFGSFTIKSDVWSFGILLMEIVTYGRIP-YPG 388

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 70/128 (54%), Gaps = 4/128 (3%)
Query: 22  NDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
           +++Y+V E     ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NL+
Sbjct: 114 SNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLM 173
Query: 81  LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           ++    +K+ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 174 IDQQGYIKVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 230
Query: 141 IMTREPLF 148
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 70/128 (54%), Gaps = 4/128 (3%)
Query: 22  NDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
           +++Y+V E     ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NL+
Sbjct: 115 SNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLM 174
Query: 81  LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           ++    +K+ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 175 IDQQGYIKVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 231
Query: 141 IMTREPLF 148
           +    P F
Sbjct: 232 MAAGYPPF 239

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 70/128 (54%), Gaps = 4/128 (3%)
Query: 22  NDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
           +++Y+V E     ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NL+
Sbjct: 115 SNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLM 174
Query: 81  LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           ++    +K+ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 175 IDQQGYIKVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 231
Query: 141 IMTREPLF 148
           +    P F
Sbjct: 232 MAAGYPPF 239

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 70/128 (54%), Gaps = 4/128 (3%)
Query: 22  NDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
           +++Y+V E     ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NL+
Sbjct: 115 SNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLM 174
Query: 81  LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           ++    +K+ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 175 IDQQGYIKVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 231
Query: 141 IMTREPLF 148
           +    P F
Sbjct: 232 MAAGYPPF 239

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 71/128 (55%), Gaps = 4/128 (3%)
Query: 22  NDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
           +++Y+V E +   ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 135 SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 194
Query: 81  LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           ++    +++ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 195 IDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 251
Query: 141 IMTREPLF 148
           +    P F
Sbjct: 252 MAAGYPPF 259

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 98/215 (45%), Gaps = 32/215 (14%)
Query: 22  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 81
           +++++V E +       + ++  + +        + L+ L+++HS  V+HRD+K  N+LL
Sbjct: 90  DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL 149
Query: 82  NASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
                +K+ DFG  A+ T E    +  V T ++ APE++     Y   +DIWS+G +  E
Sbjct: 150 GMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIE 208
Query: 141 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 200
           ++  EP +  ++ +  L LI    G+P+                             + P
Sbjct: 209 MIEGEPPYLNENPLRALYLIA-TNGTPE----------------------------LQNP 239
Query: 201 NKSSGAV-DLLEKMLVFDPNKRITVEEALRHPYLQ 234
            K S    D L + L  D  KR + +E L+H +L+
Sbjct: 240 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLK 274

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/125 (33%), Positives = 63/125 (50%), Gaps = 5/125 (4%)
Query: 42  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 101
           ++Q+T        YQL RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR  +  
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 102 DFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQL 157
           D+       R    + APE L +   YT   D+WS G ++ EI T     +PG       
Sbjct: 211 DYYKNTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269
Query: 158 RLITE 162
           +L+ E
Sbjct: 270 KLLKE 274

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 71/128 (55%), Gaps = 4/128 (3%)
Query: 22  NDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
           +++Y+V E +   ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 114 SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 81  LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           ++    +++ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 230
Query: 141 IMTREPLF 148
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 71/128 (55%), Gaps = 4/128 (3%)
Query: 22  NDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
           +++Y+V E +   ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 81  LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           ++    +++ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 230
Query: 141 IMTREPLF 148
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 71/128 (55%), Gaps = 4/128 (3%)
Query: 22  NDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
           +++Y+V E     ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NL+
Sbjct: 114 SNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLM 173
Query: 81  LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           ++    +++ DFGLA+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 174 IDQQGYIQVTDFGLAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 230
Query: 141 IMTREPLF 148
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 71/128 (55%), Gaps = 4/128 (3%)
Query: 22  NDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
           +++Y+V E +   ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 81  LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           ++    +++ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 230
Query: 141 IMTREPLF 148
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 71/128 (55%), Gaps = 4/128 (3%)
Query: 22  NDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
           +++Y+V E +   ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 114 SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 81  LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           ++    +++ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 230
Query: 141 IMTREPLF 148
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 71/128 (55%), Gaps = 4/128 (3%)
Query: 22  NDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
           +++Y+V E +   ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 114 SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 81  LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           ++    +++ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 230
Query: 141 IMTREPLF 148
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 71/128 (55%), Gaps = 4/128 (3%)
Query: 22  NDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
           +++Y+V E +   ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 115 SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 174
Query: 81  LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           ++    +++ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 175 IDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 231
Query: 141 IMTREPLF 148
           +    P F
Sbjct: 232 MAAGYPPF 239

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 71/128 (55%), Gaps = 4/128 (3%)
Query: 22  NDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
           +++Y+V E +   ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 81  LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           ++    +++ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 230
Query: 141 IMTREPLF 148
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 71/128 (55%), Gaps = 4/128 (3%)
Query: 22  NDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
           +++Y+V E +   ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 114 SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 81  LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           ++    +++ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 230
Query: 141 IMTREPLF 148
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 71/128 (55%), Gaps = 4/128 (3%)
Query: 22  NDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
           +++Y+V E +   ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 81  LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           ++    +++ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 230
Query: 141 IMTREPLF 148
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 71/128 (55%), Gaps = 4/128 (3%)
Query: 22  NDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
           +++Y+V E +   ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 115 SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 174
Query: 81  LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           ++    +++ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 175 IDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 231
Query: 141 IMTREPLF 148
           +    P F
Sbjct: 232 MAAGYPPF 239

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 71/128 (55%), Gaps = 4/128 (3%)
Query: 22  NDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
           +++Y+V E +   ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 81  LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           ++    +++ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 230
Query: 141 IMTREPLF 148
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 71/128 (55%), Gaps = 4/128 (3%)
Query: 22  NDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
           +++Y+V E +   ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 115 SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 174
Query: 81  LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           ++    +++ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 175 IDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 231
Query: 141 IMTREPLF 148
           +    P F
Sbjct: 232 MAAGYPPF 239

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 71/128 (55%), Gaps = 4/128 (3%)
Query: 22  NDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
           +++Y+V E +   ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 114 SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 81  LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           ++    +++ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 230
Query: 141 IMTREPLF 148
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 71/128 (55%), Gaps = 4/128 (3%)
Query: 22  NDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
           +++Y+V E +   ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 81  LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           ++    +++ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 230
Query: 141 IMTREPLF 148
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 77/153 (50%), Gaps = 6/153 (3%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H N++ + ++I     +T   +Y+V E     ++   + +  ++ +   +    Q++ 
Sbjct: 71  LNHPNIVKLFEVI-----ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS 125
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
            ++Y H   ++HRDLK  NLLL+   ++KI DFG +   +  + +  +  +  Y APEL 
Sbjct: 126 AVQYCHQKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELF 185
Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 152
                    +D+WS+G IL  +++    F G++
Sbjct: 186 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 71/128 (55%), Gaps = 4/128 (3%)
Query: 22  NDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
           +++Y+V E +   ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 115 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 174
Query: 81  LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           ++    +++ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 175 IDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 231
Query: 141 IMTREPLF 148
           +    P F
Sbjct: 232 MAAGYPPF 239

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 71/128 (55%), Gaps = 4/128 (3%)
Query: 22  NDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
           +++Y+V E +   ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 115 SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 174
Query: 81  LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           ++    +++ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 175 IDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 231
Query: 141 IMTREPLF 148
           +    P F
Sbjct: 232 MAAGYPPF 239

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 71/128 (55%), Gaps = 4/128 (3%)
Query: 22  NDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
           +++Y+V E +   ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 114 SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 81  LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           ++    +++ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 230
Query: 141 IMTREPLF 148
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 71/128 (55%), Gaps = 4/128 (3%)
Query: 22  NDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
           +++Y+V E +   ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 115 SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 174
Query: 81  LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           ++    +++ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 175 IDQQGYIQVTDFGFAKRVKGRTWTL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 231
Query: 141 IMTREPLF 148
           +    P F
Sbjct: 232 MAAGYPPF 239

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 72/128 (56%), Gaps = 4/128 (3%)
Query: 22  NDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
           +++Y+V E +   ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 100 SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 159
Query: 81  LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           ++    +++ DFG A+      +      T  Y APE++L+   Y  A+D W++G ++ E
Sbjct: 160 IDQQGYIQVTDFGFAKRVKGRTWTL--CGTPEYLAPEIILS-KGYNKAVDWWALGVLIYE 216
Query: 141 IMTREPLF 148
           +    P F
Sbjct: 217 MAAGYPPF 224

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 71/128 (55%), Gaps = 4/128 (3%)
Query: 22  NDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
           +++Y+V E +   ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 107 SNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 166
Query: 81  LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           ++    +++ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 167 IDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 223
Query: 141 IMTREPLF 148
           +    P F
Sbjct: 224 MAAGYPPF 231

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 76/151 (50%), Gaps = 16/151 (10%)
Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTD-LHQIIR-SDQQLTDDHCQYFLYQLLR 59
           EH N+I ++ ++          V I+ E M+   L   +R +D Q T       L  +  
Sbjct: 75  EHPNIIRLEGVV-----TNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIAS 129
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR-------TTSETDFMTEYVVTRW 112
           G++Y+   S +HRDL   N+L+N++   K+ DFGL+R         +ET  +   +  RW
Sbjct: 130 GMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRW 189
Query: 113 YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
             APE +    ++T+A D WS G ++ E+M+
Sbjct: 190 T-APEAIA-FRKFTSASDAWSYGIVMWEVMS 218

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 71/128 (55%), Gaps = 4/128 (3%)
Query: 22  NDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
           +++Y+V E +   ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 101 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 160
Query: 81  LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           ++    +++ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 161 IDEQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 217
Query: 141 IMTREPLF 148
           +    P F
Sbjct: 218 MAAGYPPF 225

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 75/149 (50%), Gaps = 14/149 (9%)
Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLR 59
           +H N+I ++ ++   K      V IV E M+   L   +R  D Q T       L  +  
Sbjct: 104 DHPNIIRLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS---ETDFMTE--YVVTRWYR 114
           G+KY+     +HRDL   N+L+N++   K+ DFGLAR      E  + T    +  RW  
Sbjct: 159 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRW-T 217
Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMT 143
           +PE +    ++T+A D+WS G +L E+M+
Sbjct: 218 SPEAIA-YRKFTSASDVWSYGIVLWEVMS 245

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 105/240 (43%), Gaps = 58/240 (24%)
Query: 24  VYIVYELMDTDLHQIIRSDQQLTDDHCQY--------FLYQLLRGLKYVHSASVLHRDLK 75
           +YI  EL + +L  ++ S + ++D++ +          L Q+  G+ ++HS  ++HRDLK
Sbjct: 84  LYIALELCNLNLQDLVES-KNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLK 142
Query: 76  PSNLLLNASCDLK-------------IGDFGLART--TSETDF---MTEYVVTRWYRAPE 117
           P N+L++ S                 I DFGL +   + +  F   +     T  +RAPE
Sbjct: 143 PQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPE 202
Query: 118 LLLNCTE------YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDAS 171
           LL            T +IDI+S+GC+   I+++     G  Y  +  +I  +       S
Sbjct: 203 LLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIF------S 256
Query: 172 LGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHP 231
           L  ++  + R  + +                   A DL+ +M+  DP KR T  + LRHP
Sbjct: 257 LDEMKCLHDRSLIAE-------------------ATDLISQMIDHDPLKRPTAMKVLRHP 297

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 98/215 (45%), Gaps = 32/215 (14%)
Query: 22  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 81
           +++++V E +       + ++  + +        + L+ L+++HS  V+HRD+K  N+LL
Sbjct: 90  DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL 149
Query: 82  NASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
                +K+ DFG  A+ T E    +  V T ++ APE++     Y   +DIWS+G +  E
Sbjct: 150 GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIE 208
Query: 141 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 200
           ++  EP +  ++ +  L LI    G+P+                             + P
Sbjct: 209 MIEGEPPYLNENPLRALYLIAT-NGTPE----------------------------LQNP 239
Query: 201 NKSSGAV-DLLEKMLVFDPNKRITVEEALRHPYLQ 234
            K S    D L + L  D  KR + +E L+H +L+
Sbjct: 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 70/128 (54%), Gaps = 4/128 (3%)
Query: 22  NDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
           +++Y+V E +   ++   +R   +  + H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 81  LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           ++    +++ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 230
Query: 141 IMTREPLF 148
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/125 (33%), Positives = 62/125 (49%), Gaps = 5/125 (4%)
Query: 42  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 101
           ++QL+        YQ+ RG++Y+ S   +HRDL   N+L+     +KI DFGLAR     
Sbjct: 133 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 192
Query: 102 DFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQL 157
           D+  +    R    + APE L +   YT   D+WS G +L EI T     +PG       
Sbjct: 193 DYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 251
Query: 158 RLITE 162
           +L+ E
Sbjct: 252 KLLKE 256

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 97/246 (39%), Gaps = 50/246 (20%)
Query: 25  YIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL-- 81
           Y+V+E M    +   I   +   +      +  +   L ++H+  + HRDLKP N+L   
Sbjct: 87  YLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEH 146
Query: 82  -NASCDLKIGDFGLARTTS--------ETDFMTEYVVTRWYRAPELLLNCTE----YTAA 128
            N    +KI DFGL              T  +     +  Y APE++   +E    Y   
Sbjct: 147 PNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKR 206
Query: 129 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 188
            D+WS+G IL  +++  P F G+                         SD         P
Sbjct: 207 CDLWSLGVILYILLSGYPPFVGR-----------------------CGSDCGWDRGEACP 243
Query: 189 RCRKQQFAT------RFPNK-----SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH 237
            C+   F +       FP+K     S  A DL+ K+LV D  +R++  + L+HP++Q   
Sbjct: 244 ACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303
Query: 238 DLNDEP 243
             N  P
Sbjct: 304 PENTLP 309

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 37/105 (35%), Positives = 57/105 (54%), Gaps = 4/105 (3%)
Query: 42  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 101
           ++Q+T        YQL RG++Y+ S   +HRDL   N+L+  +  ++I DFGLAR  +  
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNI 210
Query: 102 DFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           D+  +    R    + APE L +   YT   D+WS G ++ EI T
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFT 254

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 111/234 (47%), Gaps = 41/234 (17%)
Query: 20  TFNDVYIVYELMDTDLHQIIRSDQQ--LTDDHCQYFL---------YQLLRGLKYVHS-A 67
            +++VYI+YE M+ D   I++ D+   + D +   F+           +L    Y+H+  
Sbjct: 114 NYDEVYIIYEYMEND--SILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK 171
Query: 68  SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV-----TRWYRAPELLLNC 122
           ++ HRD+KPSN+L++ +  +K+ DFG      E+++M +  +     T  +  PE   N 
Sbjct: 172 NICHRDVKPSNILMDKNGRVKLSDFG------ESEYMVDKKIKGSRGTYEFMPPEFFSNE 225
Query: 123 TEYTAA-IDIWSVGCILGEIMTREPLFPGKDYVHQL--RLITELIGSPDDASLGFLRSDN 179
           + Y  A +DIWS+G  L  +      F  K  + +L   + T+ I  P D          
Sbjct: 226 SSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLD---------- 275
Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
            R +       +K   +  F   S+  +D L+  L  +P +RIT E+AL+H +L
Sbjct: 276 -RNHFLYPLTNKKSTCSNNFL--SNEDIDFLKLFLRKNPAERITSEDALKHEWL 326

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/125 (33%), Positives = 62/125 (49%), Gaps = 5/125 (4%)
Query: 42  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 101
           ++QL+        YQ+ RG++Y+ S   +HRDL   N+L+     +KI DFGLAR     
Sbjct: 144 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 203
Query: 102 DFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQL 157
           D+  +    R    + APE L +   YT   D+WS G +L EI T     +PG       
Sbjct: 204 DYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 262
Query: 158 RLITE 162
           +L+ E
Sbjct: 263 KLLKE 267

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 69/128 (53%), Gaps = 4/128 (3%)
Query: 22  NDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
           +++Y+V E     ++   +R   +  + H +++  Q++   +Y+HS  +++RDLKP NL+
Sbjct: 114 SNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLM 173
Query: 81  LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           ++    +K+ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 174 IDQQGYIKVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 230
Query: 141 IMTREPLF 148
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 69/128 (53%), Gaps = 4/128 (3%)
Query: 22  NDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
           +++Y+V E     ++   +R   +  + H +++  Q++   +Y+HS  +++RDLKP NL+
Sbjct: 115 SNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLM 174
Query: 81  LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           ++    +K+ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 175 IDQQGYIKVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 231
Query: 141 IMTREPLF 148
           +    P F
Sbjct: 232 MAAGYPPF 239

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/125 (33%), Positives = 62/125 (49%), Gaps = 5/125 (4%)
Query: 42  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 101
           ++QL+        YQ+ RG++Y+ S   +HRDL   N+L+     +KI DFGLAR     
Sbjct: 136 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 195
Query: 102 DFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQL 157
           D+  +    R    + APE L +   YT   D+WS G +L EI T     +PG       
Sbjct: 196 DYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 254
Query: 158 RLITE 162
           +L+ E
Sbjct: 255 KLLKE 259

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 98/215 (45%), Gaps = 32/215 (14%)
Query: 22  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 81
           +++++V E +       + ++  + +        + L+ L+++HS  V+HRD+K  N+LL
Sbjct: 91  DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL 150
Query: 82  NASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
                +K+ DFG  A+ T E    +  V T ++ APE++     Y   +DIWS+G +  E
Sbjct: 151 GMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIE 209
Query: 141 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 200
           ++  EP +  ++ +  L LI    G+P+                             + P
Sbjct: 210 MIEGEPPYLNENPLRALYLIA-TNGTPE----------------------------LQNP 240
Query: 201 NKSSGAV-DLLEKMLVFDPNKRITVEEALRHPYLQ 234
            K S    D L + L  D  KR + +E ++H +L+
Sbjct: 241 EKLSAIFRDFLNRCLEMDVEKRGSAKELIQHQFLK 275

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/125 (33%), Positives = 62/125 (49%), Gaps = 5/125 (4%)
Query: 42  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 101
           ++QL+        YQ+ RG++Y+ S   +HRDL   N+L+     +KI DFGLAR     
Sbjct: 144 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 203
Query: 102 DFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQL 157
           D+  +    R    + APE L +   YT   D+WS G +L EI T     +PG       
Sbjct: 204 DYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 262
Query: 158 RLITE 162
           +L+ E
Sbjct: 263 KLLKE 267

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/125 (33%), Positives = 62/125 (49%), Gaps = 5/125 (4%)
Query: 42  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 101
           ++QL+        YQ+ RG++Y+ S   +HRDL   N+L+     +KI DFGLAR     
Sbjct: 137 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 196
Query: 102 DFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQL 157
           D+  +    R    + APE L +   YT   D+WS G +L EI T     +PG       
Sbjct: 197 DYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 255
Query: 158 RLITE 162
           +L+ E
Sbjct: 256 KLLKE 260

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/125 (33%), Positives = 62/125 (49%), Gaps = 5/125 (4%)
Query: 42  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 101
           ++QL+        YQ+ RG++Y+ S   +HRDL   N+L+     +KI DFGLAR     
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188
Query: 102 DFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQL 157
           D+  +    R    + APE L +   YT   D+WS G +L EI T     +PG       
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247
Query: 158 RLITE 162
           +L+ E
Sbjct: 248 KLLKE 252

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 75/149 (50%), Gaps = 14/149 (9%)
Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLR 59
           +H N+I ++ ++   K      V IV E M+   L   +R  D Q T       L  +  
Sbjct: 104 DHPNIIRLEGVVTKSKP-----VMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS---ETDFMTE--YVVTRWYR 114
           G+KY+     +HRDL   N+L+N++   K+ DFGL+R      E  + T    +  RW  
Sbjct: 159 GMKYLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-T 217
Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMT 143
           +PE +    ++T+A D+WS G +L E+M+
Sbjct: 218 SPEAIA-YRKFTSASDVWSYGIVLWEVMS 245

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 70/128 (54%), Gaps = 4/128 (3%)
Query: 22  NDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
           +++Y+V E +   ++   +R   +  + H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 81  LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           ++    +++ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 230
Query: 141 IMTREPLF 148
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 70/128 (54%), Gaps = 4/128 (3%)
Query: 22  NDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
           +++Y+V E +   ++   +R   +  + H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 81  LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           ++    +++ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 230
Query: 141 IMTREPLF 148
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 56/105 (53%), Gaps = 4/105 (3%)
Query: 42  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 101
           ++Q+T        YQL RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR  +  
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 102 DFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           D   +    R    + APE L +   YT   D+WS G ++ EI T
Sbjct: 211 DXXKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFT 254

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 71/128 (55%), Gaps = 4/128 (3%)
Query: 22  NDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
           +++Y+V E +   ++   +R   +  + H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 81  LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           ++    +++ DFG A+      +      T  Y APE++L+   Y  A+D W++G ++ E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIILS-KGYNKAVDWWALGVLIYE 230
Query: 141 IMTREPLF 148
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/125 (33%), Positives = 62/125 (49%), Gaps = 5/125 (4%)
Query: 42  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 101
           ++QL+        YQ+ RG++Y+ S   +HRDL   N+L+     +KI DFGLAR     
Sbjct: 144 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 203
Query: 102 DFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQL 157
           D+  +    R    + APE L +   YT   D+WS G +L EI T     +PG       
Sbjct: 204 DYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 262
Query: 158 RLITE 162
           +L+ E
Sbjct: 263 KLLKE 267

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 70/128 (54%), Gaps = 4/128 (3%)
Query: 22  NDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
           +++Y+V E +   ++   +R   +  + H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 135 SNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 194
Query: 81  LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           ++    +++ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 195 IDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 251
Query: 141 IMTREPLF 148
           +    P F
Sbjct: 252 MAAGYPPF 259

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 70/128 (54%), Gaps = 4/128 (3%)
Query: 22  NDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
           +++Y+V E +   ++   +R   +  + H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 114 SNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 81  LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           ++    +++ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 230
Query: 141 IMTREPLF 148
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 70/128 (54%), Gaps = 4/128 (3%)
Query: 22  NDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
           +++Y+V E +   ++   +R   +  + H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 107 SNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 166
Query: 81  LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           ++    +++ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 167 IDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 223
Query: 141 IMTREPLF 148
           +    P F
Sbjct: 224 MAAGYPPF 231

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 56/105 (53%), Gaps = 4/105 (3%)
Query: 42  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 101
           ++Q+T        YQL RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR  +  
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 102 DFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           D   +    R    + APE L +   YT   D+WS G ++ EI T
Sbjct: 211 DXXKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFT 254

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 70/128 (54%), Gaps = 4/128 (3%)
Query: 22  NDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
           +++Y+V E +   ++   +R   +  + H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 115 SNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 174
Query: 81  LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           ++    +++ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 175 IDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 231
Query: 141 IMTREPLF 148
           +    P F
Sbjct: 232 MAAGYPPF 239

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 70/128 (54%), Gaps = 4/128 (3%)
Query: 22  NDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
           +++Y+V E +   ++   +R   +  + H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 114 SNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 81  LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           ++    +++ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 230
Query: 141 IMTREPLF 148
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 70/128 (54%), Gaps = 4/128 (3%)
Query: 22  NDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
           +++Y+V E +   ++   +R   +  + H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 109 SNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 168
Query: 81  LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           ++    +++ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 169 IDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 225
Query: 141 IMTREPLF 148
           +    P F
Sbjct: 226 MAAGYPPF 233

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/125 (33%), Positives = 62/125 (49%), Gaps = 5/125 (4%)
Query: 42  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 101
           ++QL+        YQ+ RG++Y+ S   +HRDL   N+L+     +KI DFGLAR     
Sbjct: 185 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 244
Query: 102 DFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQL 157
           D+  +    R    + APE L +   YT   D+WS G +L EI T     +PG       
Sbjct: 245 DYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 303
Query: 158 RLITE 162
           +L+ E
Sbjct: 304 KLLKE 308

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 34/128 (26%), Positives = 70/128 (54%), Gaps = 4/128 (3%)
Query: 22  NDVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
           +++Y+V E     ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NL+
Sbjct: 114 SNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLM 173
Query: 81  LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           ++    +++ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYE 230
Query: 141 IMTREPLF 148
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 104/231 (45%), Gaps = 29/231 (12%)
Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQY-FLYQLLRG 60
           HEN++  K I     +D  N + ++ E + +  L + +  ++   +   Q  +  Q+ +G
Sbjct: 70  HENIVKYKGIC---TEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKG 126
Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV------TRWYR 114
           + Y+ S   +HRDL   N+L+ +   +KIGDFGL +   ETD     V         WY 
Sbjct: 127 MDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEXXTVKDDRDSPVFWY- 184
Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF 174
           APE L+    Y A+ D+WS G  L E++T    +   D    + L  ++IG P    +  
Sbjct: 185 APECLMQSKFYIAS-DVWSFGVTLHELLT----YCDSD-SSPMALFLKMIG-PTHGQMTV 237
Query: 175 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVE 225
            R  N  +  ++LP C         PN       L+ K   F P+ R + +
Sbjct: 238 TRLVNTLKEGKRLP-CP--------PNCPDEVYQLMRKCWEFQPSNRTSFQ 279

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 34/128 (26%), Positives = 71/128 (55%), Gaps = 4/128 (3%)
Query: 22  NDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
           +++Y+V E +   ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 81  LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           ++    +++ DFG A+      +      T  Y APE++L    Y  A+D W++G ++ +
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYQ 230
Query: 141 IMTREPLF 148
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 75/149 (50%), Gaps = 14/149 (9%)
Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLR 59
           +H N+I ++ ++   K      V IV E M+   L   +R  D Q T       L  +  
Sbjct: 104 DHPNIIRLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS---ETDFMTE--YVVTRWYR 114
           G+KY+     +HRDL   N+L+N++   K+ DFGL+R      E  + T    +  RW  
Sbjct: 159 GMKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-T 217
Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMT 143
           +PE +    ++T+A D+WS G +L E+M+
Sbjct: 218 SPEAIA-YRKFTSASDVWSYGIVLWEVMS 245

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 104/231 (45%), Gaps = 29/231 (12%)
Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQY-FLYQLLRG 60
           HEN++  K I     +D  N + ++ E + +  L + +  ++   +   Q  +  Q+ +G
Sbjct: 82  HENIVKYKGICT---EDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKG 138
Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV------TRWYR 114
           + Y+ S   +HRDL   N+L+ +   +KIGDFGL +   ETD     V         WY 
Sbjct: 139 MDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEXXTVKDDRDSPVFWY- 196
Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF 174
           APE L+    Y A+ D+WS G  L E++T    +   D    + L  ++IG P    +  
Sbjct: 197 APECLMQSKFYIAS-DVWSFGVTLHELLT----YCDSD-SSPMALFLKMIG-PTHGQMTV 249
Query: 175 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVE 225
            R  N  +  ++LP C         PN       L+ K   F P+ R + +
Sbjct: 250 TRLVNTLKEGKRLP-CP--------PNCPDEVYQLMRKCWEFQPSNRTSFQ 291

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 75/151 (49%), Gaps = 16/151 (10%)
Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTD-LHQIIR-SDQQLTDDHCQYFLYQLLR 59
           EH N+I ++ ++          V I+ E M+   L   +R +D Q T       L  +  
Sbjct: 73  EHPNIIRLEGVV-----TNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIAS 127
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE-------TDFMTEYVVTRW 112
           G++Y+   S +HRDL   N+L+N++   K+ DFGL+R   E       T  +   +  RW
Sbjct: 128 GMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRW 187
Query: 113 YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
             APE +    ++T+A D WS G ++ E+M+
Sbjct: 188 -TAPEAIA-FRKFTSASDAWSYGIVMWEVMS 216

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 99/233 (42%), Gaps = 40/233 (17%)
Query: 25  YIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 83
           Y+V+E L    +   I+  +   +      +  +   L ++H+  + HRDLKP N+L  +
Sbjct: 87  YLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCES 146
Query: 84  S--------CDLKIGDFGLARTTSETDFMTEYVVT----RWYRAPELLL----NCTEYTA 127
                    CD  +G  G+    S T   T  + T      Y APE++       T Y  
Sbjct: 147 PEKVSPVKICDFDLGS-GMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDK 205
Query: 128 AIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL 187
             D+WS+G +L  +++  P F G                   A  G+ R +  R    +L
Sbjct: 206 RCDLWSLGVVLYIMLSGYPPFVGH----------------CGADCGWDRGEVCRVCQNKL 249
Query: 188 PRCRKQQFATRFPNK-----SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
                Q+    FP+K     SS A DL+ K+LV D  +R++  + L+HP++Q 
Sbjct: 250 FE-SIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQG 301

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 72/135 (53%), Gaps = 3/135 (2%)
Query: 20  TFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 78
           T + +Y V E ++  DL   I+   +  +    ++  ++  GL ++H   +++RDLK  N
Sbjct: 91  TVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRGIIYRDLKLDN 150
Query: 79  LLLNASCDLKIGDFGLARTTSETDFMT-EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 137
           ++L++   +KI DFG+ +        T E+  T  Y APE ++    Y  ++D W+ G +
Sbjct: 151 VMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPE-IIAYQPYGKSVDWWAYGVL 209
Query: 138 LGEIMTREPLFPGKD 152
           L E++  +P F G+D
Sbjct: 210 LYEMLAGQPPFDGED 224

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 116/281 (41%), Gaps = 72/281 (25%)
Query: 24  VYIVYELMDTDLHQ-IIRSDQQLTDDHC-QYFLYQLLRGLKYVHSA-SVLHRDLKPSNLL 80
           + +V+E++   L + II+S+ Q     C +  + Q+L+GL Y+H+   ++H D+KP N+L
Sbjct: 120 ICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENIL 179
Query: 81  LNAS-------------------------------------------------CDLKIGD 91
           L+ +                                                   +KI D
Sbjct: 180 LSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIAD 239
Query: 92  FGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF--- 148
            G A    +    TE + TR YR+ E+L+  + Y    DIWS  C+  E+ T + LF   
Sbjct: 240 LGNACWVHK--HFTEDIQTRQYRSLEVLIG-SGYNTPADIWSTACMAFELATGDYLFEPH 296
Query: 149 PGKDYVH---QLRLITELIGS-------PDDASLGFLRSDNARRYVRQL-PRCRKQQFAT 197
            G++Y      + LI EL+G            S  F       +++ +L P    +    
Sbjct: 297 SGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVE 356
Query: 198 RFP---NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
           ++     +++G  D L  ML   P KR T  E LRHP+L S
Sbjct: 357 KYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 75/149 (50%), Gaps = 14/149 (9%)
Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLR 59
           +H N+I ++ ++   K      V IV E M+   L   +R  D Q T       L  +  
Sbjct: 104 DHPNIIRLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS---ETDFMTE--YVVTRWYR 114
           G+KY+     +HRDL   N+L+N++   K+ DFGL+R      E  + T    +  RW  
Sbjct: 159 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-T 217
Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMT 143
           +PE +    ++T+A D+WS G +L E+M+
Sbjct: 218 SPEAIA-YRKFTSASDVWSYGIVLWEVMS 245

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 82/160 (51%), Gaps = 31/160 (19%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQ-------QLTDDHCQY 52
           ++H+ ++ +  ++      T   +YI+ E M    L   ++SD+       +L D     
Sbjct: 234 LQHDKLVKLHAVV------TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLID----- 282
Query: 53  FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW 112
           F  Q+  G+ ++   + +HRDL+ +N+L++AS   KI DFGLAR  ++          +W
Sbjct: 283 FSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVGAK-------FPIKW 335
Query: 113 YRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 150
             APE  +N   +T   D+WS G +L EI+T  R P +PG
Sbjct: 336 -TAPE-AINFGSFTIKSDVWSFGILLMEIVTYGRIP-YPG 372

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 116/281 (41%), Gaps = 72/281 (25%)
Query: 24  VYIVYELMDTDLHQ-IIRSDQQLTDDHC-QYFLYQLLRGLKYVHSA-SVLHRDLKPSNLL 80
           + +V+E++   L + II+S+ Q     C +  + Q+L+GL Y+H+   ++H D+KP N+L
Sbjct: 104 ICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENIL 163
Query: 81  LNAS-------------------------------------------------CDLKIGD 91
           L+ +                                                   +KI D
Sbjct: 164 LSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIAD 223
Query: 92  FGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF--- 148
            G A    +    TE + TR YR+ E+L+  + Y    DIWS  C+  E+ T + LF   
Sbjct: 224 LGNACWVHK--HFTEDIQTRQYRSLEVLIG-SGYNTPADIWSTACMAFELATGDYLFEPH 280
Query: 149 PGKDYVH---QLRLITELIGS-------PDDASLGFLRSDNARRYVRQL-PRCRKQQFAT 197
            G++Y      + LI EL+G            S  F       +++ +L P    +    
Sbjct: 281 SGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVE 340
Query: 198 RFP---NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
           ++     +++G  D L  ML   P KR T  E LRHP+L S
Sbjct: 341 KYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 381

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 75/150 (50%), Gaps = 16/150 (10%)
Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTD-LHQIIRS-DQQLTDDHCQYFLYQLLR 59
           +H NV+ ++ ++   K      V IV E M+   L   +R  D Q T       L  +  
Sbjct: 102 DHPNVVHLEGVVTRGKP-----VMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAA 156
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RWY 113
           G++Y+     +HRDL   N+L+N++   K+ DFGL+R   E D    Y  T      RW 
Sbjct: 157 GMRYLADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVI-EDDPEAVYTTTGGKIPVRW- 214
Query: 114 RAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
            APE  +   ++T+A D+WS G ++ E+M+
Sbjct: 215 TAPE-AIQYRKFTSASDVWSYGIVMWEVMS 243

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 74/149 (49%), Gaps = 14/149 (9%)
Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLR 59
           +H N+I ++ ++   K      V IV E M+   L   +R  D Q T       L  +  
Sbjct: 104 DHPNIIRLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS---ETDFMTE--YVVTRWYR 114
           G+KY+     +HRDL   N+L+N++   K+ DFGL R      E  + T    +  RW  
Sbjct: 159 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRW-T 217
Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMT 143
           +PE +    ++T+A D+WS G +L E+M+
Sbjct: 218 SPEAIA-YRKFTSASDVWSYGIVLWEVMS 245

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 80/151 (52%), Gaps = 16/151 (10%)
Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR-SDQQLTDDHCQYFLYQLLR 59
           +H NVI ++ ++    K T   V I+ E M+   L   +R +D Q T       L  +  
Sbjct: 92  DHPNVIHLEGVV---TKST--PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAA 146
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR----TTSE---TDFMTEYVVTRW 112
           G+KY+   + +HRDL   N+L+N++   K+ DFGL+R     TS+   T  +   +  RW
Sbjct: 147 GMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRW 206
Query: 113 YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
             APE  +   ++T+A D+WS G ++ E+M+
Sbjct: 207 -TAPE-AIQYRKFTSASDVWSYGIVMWEVMS 235

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 75/149 (50%), Gaps = 14/149 (9%)
Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLR 59
           +H N+I ++ ++   K      V IV E M+   L   +R  D Q T       L  +  
Sbjct: 104 DHPNIIRLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS---ETDFMTE--YVVTRWYR 114
           G+KY+     +HRDL   N+L+N++   K+ DFGL+R      E  + T    +  RW  
Sbjct: 159 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-T 217
Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMT 143
           +PE +    ++T+A D+WS G +L E+M+
Sbjct: 218 SPEAIA-YRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 75/149 (50%), Gaps = 14/149 (9%)
Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLR 59
           +H N+I ++ ++   K      V IV E M+   L   +R  D Q T       L  +  
Sbjct: 104 DHPNIIRLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS---ETDFMTE--YVVTRWYR 114
           G+KY+     +HRDL   N+L+N++   K+ DFGL+R      E  + T    +  RW  
Sbjct: 159 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-T 217
Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMT 143
           +PE +    ++T+A D+WS G +L E+M+
Sbjct: 218 SPEAIA-YRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 75/149 (50%), Gaps = 14/149 (9%)
Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLR 59
           +H N+I ++ ++   K      V IV E M+   L   +R  D Q T       L  +  
Sbjct: 104 DHPNIIRLEGVVTKSKP-----VMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS---ETDFMTE--YVVTRWYR 114
           G+KY+     +HRDL   N+L+N++   K+ DFGL+R      E  + T    +  RW  
Sbjct: 159 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-T 217
Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMT 143
           +PE +    ++T+A D+WS G +L E+M+
Sbjct: 218 SPEAIA-YRKFTSASDVWSYGIVLWEVMS 245

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 75/149 (50%), Gaps = 14/149 (9%)
Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLR 59
           +H N+I ++ ++   K      V IV E M+   L   +R  D Q T       L  +  
Sbjct: 104 DHPNIIRLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS---ETDFMTE--YVVTRWYR 114
           G+KY+     +HRDL   N+L+N++   K+ DFGL+R      E  + T    +  RW  
Sbjct: 159 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-T 217
Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMT 143
           +PE +    ++T+A D+WS G +L E+M+
Sbjct: 218 SPEAIA-YRKFTSASDVWSYGIVLWEVMS 245

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 37/124 (29%), Positives = 72/124 (58%), Gaps = 2/124 (1%)
Query: 20  TFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 78
           T + +  + +LM+  DLH  +      ++   +++  +++ GL+++H+  V++RDLKP+N
Sbjct: 263 TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPAN 322
Query: 79  LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 138
           +LL+    ++I D GLA   S+       V T  Y APE+L     Y ++ D +S+GC+L
Sbjct: 323 ILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGVAYDSSADWFSLGCML 381
Query: 139 GEIM 142
            +++
Sbjct: 382 FKLL 385

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 78/148 (52%), Gaps = 14/148 (9%)
Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDTD-LHQIIR-SDQQLTDDHCQYFLYQLLRG 60
           H N+I ++ +I       +  + I+ E M+   L + +R  D + +       L  +  G
Sbjct: 105 HHNIIRLEGVI-----SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAG 159
Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS---ETDFMTE--YVVTRWYRA 115
           +KY+ + + +HRDL   N+L+N++   K+ DFGL+R      E  + T    +  RW  A
Sbjct: 160 MKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW-TA 218
Query: 116 PELLLNCTEYTAAIDIWSVGCILGEIMT 143
           PE  ++  ++T+A D+WS G ++ E+MT
Sbjct: 219 PE-AISYRKFTSASDVWSFGIVMWEVMT 245

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 37/124 (29%), Positives = 72/124 (58%), Gaps = 2/124 (1%)
Query: 20  TFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 78
           T + +  + +LM+  DLH  +      ++   +++  +++ GL+++H+  V++RDLKP+N
Sbjct: 262 TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPAN 321
Query: 79  LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 138
           +LL+    ++I D GLA   S+       V T  Y APE+L     Y ++ D +S+GC+L
Sbjct: 322 ILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGVAYDSSADWFSLGCML 380
Query: 139 GEIM 142
            +++
Sbjct: 381 FKLL 384

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 75/149 (50%), Gaps = 14/149 (9%)
Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLR 59
           +H N+I ++ ++   K      V IV E M+   L   +R  D Q T       L  +  
Sbjct: 75  DHPNIIRLEGVVTKSKP-----VMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 129
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS---ETDFMTE--YVVTRWYR 114
           G+KY+     +HRDL   N+L+N++   K+ DFGL+R      E  + T    +  RW  
Sbjct: 130 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-T 188
Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMT 143
           +PE +    ++T+A D+WS G +L E+M+
Sbjct: 189 SPEAIA-YRKFTSASDVWSYGIVLWEVMS 216

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 33/128 (25%), Positives = 71/128 (55%), Gaps = 4/128 (3%)
Query: 22  NDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
           +++Y+V E +   ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NL+
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLI 173
Query: 81  LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           ++    +++ DFG A+      +      T  Y APE+++    Y  A+D W++G ++ E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPEIII-SKGYNKAVDWWALGVLIYE 230
Query: 141 IMTREPLF 148
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 75/149 (50%), Gaps = 14/149 (9%)
Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLR 59
           +H N+I ++ ++   K      V IV E M+   L   +R  D Q T       L  +  
Sbjct: 102 DHPNIIRLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 156
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS---ETDFMTE--YVVTRWYR 114
           G+KY+     +HRDL   N+L+N++   K+ DFGL+R      E  + T    +  RW  
Sbjct: 157 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-T 215
Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMT 143
           +PE +    ++T+A D+WS G +L E+M+
Sbjct: 216 SPEAIA-YRKFTSASDVWSYGIVLWEVMS 243

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 75/149 (50%), Gaps = 14/149 (9%)
Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLR 59
           +H N+I ++ ++   K      V IV E M+   L   +R  D Q T       L  +  
Sbjct: 92  DHPNIIRLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 146
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS---ETDFMTE--YVVTRWYR 114
           G+KY+     +HRDL   N+L+N++   K+ DFGL+R      E  + T    +  RW  
Sbjct: 147 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-T 205
Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMT 143
           +PE +    ++T+A D+WS G +L E+M+
Sbjct: 206 SPEAIA-YRKFTSASDVWSYGIVLWEVMS 233

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 37/124 (29%), Positives = 72/124 (58%), Gaps = 2/124 (1%)
Query: 20  TFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 78
           T + +  + +LM+  DLH  +      ++   +++  +++ GL+++H+  V++RDLKP+N
Sbjct: 263 TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPAN 322
Query: 79  LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 138
           +LL+    ++I D GLA   S+       V T  Y APE+L     Y ++ D +S+GC+L
Sbjct: 323 ILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGVAYDSSADWFSLGCML 381
Query: 139 GEIM 142
            +++
Sbjct: 382 FKLL 385

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 37/124 (29%), Positives = 72/124 (58%), Gaps = 2/124 (1%)
Query: 20  TFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 78
           T + +  + +LM+  DLH  +      ++   +++  +++ GL+++H+  V++RDLKP+N
Sbjct: 263 TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPAN 322
Query: 79  LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 138
           +LL+    ++I D GLA   S+       V T  Y APE+L     Y ++ D +S+GC+L
Sbjct: 323 ILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGVAYDSSADWFSLGCML 381
Query: 139 GEIM 142
            +++
Sbjct: 382 FKLL 385

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 75/149 (50%), Gaps = 14/149 (9%)
Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLR 59
           +H N+I ++ ++   K      V IV E M+   L   +R  D Q T       L  +  
Sbjct: 75  DHPNIIRLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 129
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS---ETDFMTE--YVVTRWYR 114
           G+KY+     +HRDL   N+L+N++   K+ DFGL+R      E  + T    +  RW  
Sbjct: 130 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-T 188
Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMT 143
           +PE +    ++T+A D+WS G +L E+M+
Sbjct: 189 SPEAIA-YRKFTSASDVWSYGIVLWEVMS 216

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 109/230 (47%), Gaps = 43/230 (18%)
Query: 15  PPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVL 70
           PP  D  + +++V E       TDL +  + +  L ++   Y   ++LRGL ++H   V+
Sbjct: 95  PPGMD--DQLWLVMEFCGAGSVTDLIKNTKGNT-LKEEWIAYICREILRGLSHLHQHKVI 151
Query: 71  HRDLKPSNLLLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTE----- 124
           HRD+K  N+LL  + ++K+ DFG++     T      ++ T ++ APE++  C E     
Sbjct: 152 HRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA-CDENPDAT 210
Query: 125 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV 184
           Y    D+WS+G    E+    P  P  D +H +R +             FL   N     
Sbjct: 211 YDFKSDLWSLGITAIEMAEGAP--PLCD-MHPMRAL-------------FLIPRNP---- 250
Query: 185 RQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
              PR + ++++ +F +        +E  LV + ++R   E+ ++HP+++
Sbjct: 251 --APRLKSKKWSKKFQS-------FIESCLVKNHSQRPATEQLMKHPFIR 291

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 42/125 (33%), Positives = 61/125 (48%), Gaps = 5/125 (4%)
Query: 42  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 101
           ++QL+        YQ+ RG++Y+ S   +HRDL   N+L+     +KI DFGLAR     
Sbjct: 144 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 203
Query: 102 DFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQL 157
           D   +    R    + APE L +   YT   D+WS G +L EI T     +PG       
Sbjct: 204 DXXKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 262
Query: 158 RLITE 162
           +L+ E
Sbjct: 263 KLLKE 267

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 117/279 (41%), Gaps = 70/279 (25%)
Query: 24  VYIVYELMDTDLHQ-IIRSDQQLTDDHC-QYFLYQLLRGLKYVHS-ASVLHRDLKPSNLL 80
           V +V+E++   L + II+S+ Q     C +  + Q+L+GL Y+HS   ++H D+KP N+L
Sbjct: 114 VCMVFEVLGHHLLKWIIKSNYQGLPVRCVKSIIRQVLQGLDYLHSKCKIIHTDIKPENIL 173
Query: 81  L--------------------------------NASCDL---------------KIGDFG 93
           +                                  + DL               KI D G
Sbjct: 174 MCVDDAYVRRMAAEATEWQKAGAPPPSGSAVSTAPAADLLVNPLDPRNADKIRVKIADLG 233
Query: 94  LARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF---PG 150
            A    +    TE + TR YR+ E+L+    Y+   DIWS  C+  E+ T + LF    G
Sbjct: 234 NACWVHK--HFTEDIQTRQYRSIEVLIGAG-YSTPADIWSTACMAFELATGDYLFEPHSG 290
Query: 151 KDYVH---QLRLITELIGS-PDDASLGFLRSD---NARRYVRQLPRCRKQQF------AT 197
           +DY      +  I EL+GS P   +L    S    N R  +R + + +            
Sbjct: 291 EDYSRDEDHIAHIIELLGSIPRHFALSGKYSREFFNRRGELRHITKLKPWSLFDVLVEKY 350
Query: 198 RFPNKSSGA-VDLLEKMLVFDPNKRITVEEALRHPYLQS 235
            +P++ +    D L  ML   P KR +  E LRHP+L S
Sbjct: 351 GWPHEDAAQFTDFLIPMLEMVPEKRASAGECLRHPWLNS 389

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 34/128 (26%), Positives = 70/128 (54%), Gaps = 4/128 (3%)
Query: 22  NDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
           +++Y+V E +   ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 81  LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           ++    +++ DFG A+      +      T  Y AP ++L    Y  A+D W++G ++ E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEYLAPAIIL-SKGYNKAVDWWALGVLIYE 230
Query: 141 IMTREPLF 148
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 75/145 (51%), Gaps = 3/145 (2%)
Query: 20  TFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 78
           T + +Y V E ++  DL   I+   +  + H  ++  ++  GL ++ S  +++RDLK  N
Sbjct: 413 TMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDN 472
Query: 79  LLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 137
           ++L++   +KI DFG+ +        T+ +  T  Y APE++     Y  ++D W+ G +
Sbjct: 473 VMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVL 531
Query: 138 LGEIMTREPLFPGKDYVHQLRLITE 162
           L E++  +  F G+D     + I E
Sbjct: 532 LYEMLAGQAPFEGEDEDELFQSIME 556

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 50/221 (22%), Positives = 94/221 (42%), Gaps = 37/221 (16%)
Query: 19  DTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDL 74
           + F+D   +Y +++     +L++ ++   +  +     F+ +L   L Y H   V+HRD+
Sbjct: 82  NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDI 141
Query: 75  KPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSV 134
           KP NLL+    +LKI DFG +   + +        T  Y  PE++   T +   +D+W  
Sbjct: 142 KPENLLMGYKGELKIADFGWS-VHAPSLRRRXMCGTLDYLPPEMIEGKT-HDEKVDLWCA 199
Query: 135 GCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQ 194
           G +  E +   P F    +    R I        +  L F                    
Sbjct: 200 GVLCYEFLVGMPPFDSPSHTETHRRIV-------NVDLKFP------------------- 233
Query: 195 FATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
                P  S G+ DL+ K+L + P +R+ ++  + HP++++
Sbjct: 234 -----PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKA 269

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 50/221 (22%), Positives = 94/221 (42%), Gaps = 37/221 (16%)
Query: 19  DTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDL 74
           + F+D   +Y +++     +L++ ++   +  +     F+ +L   L Y H   V+HRD+
Sbjct: 81  NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDI 140
Query: 75  KPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSV 134
           KP NLL+    +LKI DFG +   + +        T  Y  PE++   T +   +D+W  
Sbjct: 141 KPENLLMGYKGELKIADFGWS-VHAPSLRRRXMCGTLDYLPPEMIEGKT-HDEKVDLWCA 198
Query: 135 GCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQ 194
           G +  E +   P F    +    R I        +  L F                    
Sbjct: 199 GVLCYEFLVGMPPFDSPSHTETHRRIV-------NVDLKFP------------------- 232
Query: 195 FATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
                P  S G+ DL+ K+L + P +R+ ++  + HP++++
Sbjct: 233 -----PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKA 268

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 63.9 bits (154), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 86/214 (40%), Gaps = 30/214 (14%)
Query: 30  LMDTDLHQIIRSDQQ---LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD 86
           ++D   H + + + +   L +      L ++L GL+Y+H    +HRD+K  N+LL     
Sbjct: 100 VLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGS 159
Query: 87  LKIGDFGLARTTSETDFMTE------YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           ++I DFG++   +    +T       +V T  + APE++     Y    DIWS G    E
Sbjct: 160 VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIE 219
Query: 141 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 200
           + T     P   Y     L+  L   P     G    +  ++Y +   +           
Sbjct: 220 LATGAA--PYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRK----------- 266
Query: 201 NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
                   ++   L  DP KR T  E LRH + Q
Sbjct: 267 --------MISLCLQKDPEKRPTAAELLRHKFFQ 292

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 98/215 (45%), Gaps = 32/215 (14%)
Query: 22  NDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 81
           +++++V E +       + ++  + +        + L+ L+++HS  V+HR++K  N+LL
Sbjct: 91  DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRNIKSDNILL 150
Query: 82  NASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
                +K+ DFG  A+ T E    +  V T ++ APE++     Y   +DIWS+G +  E
Sbjct: 151 GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIE 209
Query: 141 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 200
           ++  EP +  ++ +  L LI    G+P+                             + P
Sbjct: 210 MIEGEPPYLNENPLRALYLIAT-NGTPE----------------------------LQNP 240
Query: 201 NKSSGAV-DLLEKMLVFDPNKRITVEEALRHPYLQ 234
            K S    D L + L  D  KR + +E ++H +L+
Sbjct: 241 EKLSAIFRDFLNRCLEMDVEKRGSAKELIQHQFLK 275

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 75/145 (51%), Gaps = 3/145 (2%)
Query: 20  TFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 78
           T + +Y V E ++  DL   I+   +  + H  ++  ++  GL ++ S  +++RDLK  N
Sbjct: 92  TMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDN 151
Query: 79  LLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 137
           ++L++   +KI DFG+ +        T+ +  T  Y APE++     Y  ++D W+ G +
Sbjct: 152 VMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVL 210
Query: 138 LGEIMTREPLFPGKDYVHQLRLITE 162
           L E++  +  F G+D     + I E
Sbjct: 211 LYEMLAGQAPFEGEDEDELFQSIME 235

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 86/214 (40%), Gaps = 30/214 (14%)
Query: 30  LMDTDLHQIIRSDQQ---LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD 86
           ++D   H + + + +   L +      L ++L GL+Y+H    +HRD+K  N+LL     
Sbjct: 95  VLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGS 154
Query: 87  LKIGDFGLARTTSETDFMTE------YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           ++I DFG++   +    +T       +V T  + APE++     Y    DIWS G    E
Sbjct: 155 VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIE 214
Query: 141 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 200
           + T     P   Y     L+  L   P     G    +  ++Y +   +           
Sbjct: 215 LATGAA--PYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRK----------- 261
Query: 201 NKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
                   ++   L  DP KR T  E LRH + Q
Sbjct: 262 --------MISLCLQKDPEKRPTAAELLRHKFFQ 287

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 34/123 (27%), Positives = 66/123 (53%), Gaps = 3/123 (2%)
Query: 23  DVYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 81
           D+++V +L+   DL   ++ +    ++  + F+ +L+  L Y+ +  ++HRD+KP N+LL
Sbjct: 89  DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILL 148
Query: 82  NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILG 139
           +    + I DF +A        +T    T+ Y APE+  +     Y+ A+D WS+G    
Sbjct: 149 DEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAY 208
Query: 140 EIM 142
           E++
Sbjct: 209 ELL 211

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 77/158 (48%), Gaps = 10/158 (6%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDV-YIVYELMDT-DLHQIIRSDQQ---LTDDHCQYFLY 55
           + H NV++ +++    +K   ND+  +  E  +  DL + +   +    L +   +  L 
Sbjct: 69  LNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS 128
Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDL---KIGDFGLARTTSETDFMTEYVVTRW 112
            +   L+Y+H   ++HRDLKP N++L         KI D G A+   + +  TE+V T  
Sbjct: 129 DISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQ 188
Query: 113 YRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFP 149
           Y APE LL   +YT  +D WS G +  E +T   P  P
Sbjct: 189 YLAPE-LLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 77/158 (48%), Gaps = 10/158 (6%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDV-YIVYELMDT-DLHQIIRSDQQ---LTDDHCQYFLY 55
           + H NV++ +++    +K   ND+  +  E  +  DL + +   +    L +   +  L 
Sbjct: 70  LNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS 129
Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDL---KIGDFGLARTTSETDFMTEYVVTRW 112
            +   L+Y+H   ++HRDLKP N++L         KI D G A+   + +  TE+V T  
Sbjct: 130 DISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQ 189
Query: 113 YRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFP 149
           Y APE LL   +YT  +D WS G +  E +T   P  P
Sbjct: 190 YLAPE-LLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 226

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 74/147 (50%), Gaps = 10/147 (6%)
Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGL 61
           +H N+I ++ ++   K       Y+    +DT L    ++D Q T       L  +  G+
Sbjct: 81  DHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLK---KNDGQFTVIQLVGMLRGISAGM 137
Query: 62  KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS---ETDFMTE--YVVTRWYRAP 116
           KY+     +HRDL   N+L+N++   K+ DFGL+R      E  + T    +  RW  AP
Sbjct: 138 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TAP 196
Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMT 143
           E +    ++T+A D+WS G ++ E+++
Sbjct: 197 EAIA-FRKFTSASDVWSYGIVMWEVVS 222

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 52/87 (59%), Gaps = 1/87 (1%)
Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRA 115
           Q+ +G+ Y+HS  +++RDLKPSN+ L  +  +KIGDFGL  +            T  Y +
Sbjct: 130 QITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSKGTLRYMS 189
Query: 116 PELLLNCTEYTAAIDIWSVGCILGEIM 142
           PE  ++  +Y   +D++++G IL E++
Sbjct: 190 PE-QISSQDYGKEVDLYALGLILAELL 215

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 34/128 (26%), Positives = 70/128 (54%), Gaps = 4/128 (3%)
Query: 22  NDVYIVYE-LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
           +++Y+V E +   ++   +R   + ++ H +++  Q++   +Y+HS  +++RDLKP NLL
Sbjct: 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 81  LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           ++    +++ DFG A+      +      T    APE++L    Y  A+D W++G ++ E
Sbjct: 174 IDQQGYIQVTDFGFAKRVKGRTWXL--CGTPEALAPEIIL-SKGYNKAVDWWALGVLIYE 230
Query: 141 IMTREPLF 148
           +    P F
Sbjct: 231 MAAGYPPF 238

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 80/148 (54%), Gaps = 11/148 (7%)
Query: 45  LTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKIGDFGLAR-TTSETD 102
            ++D  +++  +++  L Y+HS  +V++RDLK  NL+L+    +KI DFGL +    +  
Sbjct: 107 FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 166
Query: 103 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY--VHQLRLI 160
            M  +  T  Y APE+L +  +Y  A+D W +G ++ E+M     F  +D+  + +L L+
Sbjct: 167 TMKXFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 225
Query: 161 TEL----IGSPDDASL--GFLRSDNARR 182
            E+       P+  SL  G L+ D  +R
Sbjct: 226 EEIRFPRTLGPEAKSLLSGLLKKDPKQR 253

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 109/218 (50%), Gaps = 40/218 (18%)
Query: 43  QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSE 100
           ++ T+   Q ++ +++  L+++H   +++RD+K  N+LL+++  + + DFGL++     E
Sbjct: 154 ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE 213
Query: 101 TDFMTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL 159
           T+   ++  T  Y AP+++    + +  A+D WS+G ++ E++T    F           
Sbjct: 214 TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT---------- 263
Query: 160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSG-AVDLLEKMLVFDP 218
              + G  +       +++ +RR ++  P          +P + S  A DL++++L+ DP
Sbjct: 264 ---VDGEKNS------QAEISRRILKSEP---------PYPQEMSALAKDLIQRLLMKDP 305
Query: 219 NKRIT-----VEEALRHPYLQSLH--DLNDEPVCPRPF 249
            KR+       +E   H + Q ++  DL  + V P PF
Sbjct: 306 KKRLGCGPRDADEIKEHLFFQKINWDDLAAKKV-PAPF 342

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/111 (35%), Positives = 60/111 (54%), Gaps = 16/111 (14%)
Query: 42  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 101
           ++QL+     +F  Q+ +G+ ++ S + +HRD+   N+LL      KIGDFGLAR     
Sbjct: 160 EEQLSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR----- 214
Query: 102 DFM--TEYVV-------TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           D M  + Y+V        +W  APE + +C  YT   D+WS G +L EI +
Sbjct: 215 DIMNDSNYIVKGNARLPVKW-MAPESIFDCV-YTVQSDVWSYGILLWEIFS 263

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 100/216 (46%), Gaps = 36/216 (16%)
Query: 19  DTFNDVYIVYELMDTD-----LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRD 73
           +T  D+ +V  +M+       ++ +   +    +    ++  Q++ GL+++H  ++++RD
Sbjct: 255 ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRD 314
Query: 74  LKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCTEYTAAIDIW 132
           LKP N+LL+   +++I D GLA         T+ Y  T  + APELLL   EY  ++D +
Sbjct: 315 LKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYF 373
Query: 133 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 192
           ++G  L E++                           A+ G  R+   +   ++L + R 
Sbjct: 374 ALGVTLYEMI---------------------------AARGPFRARGEKVENKEL-KQRV 405
Query: 193 QQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEA 227
            + A  +P+K S  + D  E +L  DP KR+   + 
Sbjct: 406 LEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDG 441

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 80/148 (54%), Gaps = 11/148 (7%)
Query: 45  LTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKIGDFGLAR-TTSETD 102
            ++D  +++  +++  L Y+HS  +V++RDLK  NL+L+    +KI DFGL +    +  
Sbjct: 106 FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 165
Query: 103 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY--VHQLRLI 160
            M  +  T  Y APE+L +  +Y  A+D W +G ++ E+M     F  +D+  + +L L+
Sbjct: 166 TMKXFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 224
Query: 161 TEL----IGSPDDASL--GFLRSDNARR 182
            E+       P+  SL  G L+ D  +R
Sbjct: 225 EEIRFPRTLGPEAKSLLSGLLKKDPKQR 252

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/140 (31%), Positives = 72/140 (51%), Gaps = 19/140 (13%)
Query: 24  VYIVYELM-DTDLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 75
           +YI+ E M    L   ++SD+       +L D     F  Q+  G+ Y+   + +HRDL+
Sbjct: 83  IYIITEYMAKGSLLDFLKSDEGGKVLLPKLID-----FSAQIAEGMAYIERKNYIHRDLR 137
Query: 76  PSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYRAPELLLNCTEYTAAIDIW 132
            +N+L++ S   KI DFGLAR   + ++          +W  APE  +N   +T   D+W
Sbjct: 138 AANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKW-TAPE-AINFGCFTIKSDVW 195
Query: 133 SVGCILGEIMTREPL-FPGK 151
           S G +L EI+T   + +PG+
Sbjct: 196 SFGILLYEIVTYGKIPYPGR 215

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 80/148 (54%), Gaps = 11/148 (7%)
Query: 45  LTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKIGDFGLAR-TTSETD 102
            ++D  +++  +++  L Y+HS  +V++RDLK  NL+L+    +KI DFGL +    +  
Sbjct: 105 FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 164
Query: 103 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY--VHQLRLI 160
            M  +  T  Y APE+L +  +Y  A+D W +G ++ E+M     F  +D+  + +L L+
Sbjct: 165 TMKXFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 223
Query: 161 TEL----IGSPDDASL--GFLRSDNARR 182
            E+       P+  SL  G L+ D  +R
Sbjct: 224 EEIRFPRTLGPEAKSLLSGLLKKDPKQR 251

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 100/216 (46%), Gaps = 36/216 (16%)
Query: 19  DTFNDVYIVYELMDTD-----LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRD 73
           +T  D+ +V  +M+       ++ +   +    +    ++  Q++ GL+++H  ++++RD
Sbjct: 255 ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRD 314
Query: 74  LKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCTEYTAAIDIW 132
           LKP N+LL+   +++I D GLA         T+ Y  T  + APELLL   EY  ++D +
Sbjct: 315 LKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYF 373
Query: 133 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 192
           ++G  L E++                           A+ G  R+   +   ++L + R 
Sbjct: 374 ALGVTLYEMI---------------------------AARGPFRARGEKVENKEL-KQRV 405
Query: 193 QQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEA 227
            + A  +P+K S  + D  E +L  DP KR+   + 
Sbjct: 406 LEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDG 441

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 100/216 (46%), Gaps = 36/216 (16%)
Query: 19  DTFNDVYIVYELMDTD-----LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRD 73
           +T  D+ +V  +M+       ++ +   +    +    ++  Q++ GL+++H  ++++RD
Sbjct: 255 ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRD 314
Query: 74  LKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCTEYTAAIDIW 132
           LKP N+LL+   +++I D GLA         T+ Y  T  + APELLL   EY  ++D +
Sbjct: 315 LKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYF 373
Query: 133 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 192
           ++G  L E++                           A+ G  R+   +   ++L + R 
Sbjct: 374 ALGVTLYEMI---------------------------AARGPFRARGEKVENKELKQ-RV 405
Query: 193 QQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEA 227
            + A  +P+K S  + D  E +L  DP KR+   + 
Sbjct: 406 LEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDG 441

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 100/216 (46%), Gaps = 36/216 (16%)
Query: 19  DTFNDVYIVYELMDTD-----LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRD 73
           +T  D+ +V  +M+       ++ +   +    +    ++  Q++ GL+++H  ++++RD
Sbjct: 255 ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRD 314
Query: 74  LKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCTEYTAAIDIW 132
           LKP N+LL+   +++I D GLA         T+ Y  T  + APELLL   EY  ++D +
Sbjct: 315 LKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYF 373
Query: 133 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 192
           ++G  L E++                           A+ G  R+   +   ++L + R 
Sbjct: 374 ALGVTLYEMI---------------------------AARGPFRARGEKVENKELKQ-RV 405
Query: 193 QQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEA 227
            + A  +P+K S  + D  E +L  DP KR+   + 
Sbjct: 406 LEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDG 441

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 77/149 (51%), Gaps = 14/149 (9%)
Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR-SDQQLTDDHCQYFLYQLLR 59
           +H N+I ++ ++   K      V I+ E M+   L   +R +D + T       L  +  
Sbjct: 88  DHPNIIHLEGVVTKCKP-----VMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGS 142
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS---ETDFMTE--YVVTRWYR 114
           G+KY+   S +HRDL   N+L+N++   K+ DFG++R      E  + T    +  RW  
Sbjct: 143 GMKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRW-T 201
Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMT 143
           APE +    ++T+A D+WS G ++ E+M+
Sbjct: 202 APEAIAY-RKFTSASDVWSYGIVMWEVMS 229

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 80/148 (54%), Gaps = 11/148 (7%)
Query: 45  LTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKIGDFGLAR-TTSETD 102
            ++D  +++  +++  L Y+HS  +V++RDLK  NL+L+    +KI DFGL +    +  
Sbjct: 248 FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 307
Query: 103 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY--VHQLRLI 160
            M  +  T  Y APE+L +  +Y  A+D W +G ++ E+M     F  +D+  + +L L+
Sbjct: 308 TMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 366
Query: 161 TEL----IGSPDDASL--GFLRSDNARR 182
            E+       P+  SL  G L+ D  +R
Sbjct: 367 EEIRFPRTLGPEAKSLLSGLLKKDPKQR 394

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 80/148 (54%), Gaps = 11/148 (7%)
Query: 45  LTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKIGDFGLAR-TTSETD 102
            ++D  +++  +++  L Y+HS  +V++RDLK  NL+L+    +KI DFGL +    +  
Sbjct: 245 FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 304
Query: 103 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY--VHQLRLI 160
            M  +  T  Y APE+L +  +Y  A+D W +G ++ E+M     F  +D+  + +L L+
Sbjct: 305 TMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 363
Query: 161 TEL----IGSPDDASL--GFLRSDNARR 182
            E+       P+  SL  G L+ D  +R
Sbjct: 364 EEIRFPRTLGPEAKSLLSGLLKKDPKQR 391

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 74/160 (46%), Gaps = 21/160 (13%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLR 59
           +EH NV+    ++   K+  F   YI        L  II+S D Q        F   +  
Sbjct: 64  LEHPNVLKFIGVLYKDKRLNFITEYI----KGGTLRGIIKSMDSQYPWSQRVSFAKDIAS 119
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA-------------RTTSETDFMTE 106
           G+ Y+HS +++HRDL   N L+  + ++ + DFGLA             R+  + D    
Sbjct: 120 GMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKR 179
Query: 107 YVVTR--WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR 144
           Y V    ++ APE ++N   Y   +D++S G +L EI+ R
Sbjct: 180 YTVVGNPYWMAPE-MINGRSYDEKVDVFSFGIVLCEIIGR 218

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 100/246 (40%), Gaps = 50/246 (20%)
Query: 25  YIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL-- 81
           Y+V+E M    +   I   +   +      +  +   L ++H+  + HRDLKP N+L   
Sbjct: 87  YLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEH 146
Query: 82  -NASCDLKIGDFGLARTTS--------ETDFMTEYVVTRWYRAPELLLNCTE----YTAA 128
            N    +KI DF L              T  +     +  Y APE++   +E    Y   
Sbjct: 147 PNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKR 206
Query: 129 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLP 188
            D+WS+G IL  +++  P F G+             GS      G+ R +         P
Sbjct: 207 CDLWSLGVILYILLSGYPPFVGR------------CGS----DCGWDRGEAC-------P 243
Query: 189 RCRKQQFAT------RFPNK-----SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH 237
            C+   F +       FP+K     S  A DL+ K+LV D  +R++  + L+HP++Q   
Sbjct: 244 ACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303
Query: 238 DLNDEP 243
             N  P
Sbjct: 304 PENTLP 309

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/90 (40%), Positives = 52/90 (57%), Gaps = 5/90 (5%)
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT---SETDFMTEYVVTRWYRAP 116
           G+ ++H    +HRD+K +N+LL+ +   KI DFGLAR +   ++T   +  V T  Y AP
Sbjct: 145 GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAP 204
Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREP 146
           E L    E T   DI+S G +L EI+T  P
Sbjct: 205 EALRG--EITPKSDIYSFGVVLLEIITGLP 232

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 100/243 (41%), Gaps = 48/243 (19%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYEL-MDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++H N+I + +       +   D+Y+V EL    +L + +   +   +      +  +L 
Sbjct: 63  LDHPNIIRLYETF-----EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLS 117
Query: 60  GLKYVHSASVLHRDLKPSN-LLLNASCD--LKIGDFGLARTTSETDFMTEYVVTRWYRAP 116
            + Y H  +V HRDLKP N L L  S D  LK+ DFGLA        M   V T +Y +P
Sbjct: 118 AVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSP 177
Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 176
           ++L     Y    D WS G ++  ++   P F                 +P D  +    
Sbjct: 178 QVLEGL--YGPECDEWSAGVMMYVLLCGYPPF----------------SAPTDXEV---- 215
Query: 177 SDNARRYVRQLPRCRKQQFATRFPNK-----SSGAVDLLEKMLVFDPNKRITVEEALRHP 231
                     + + R+  F   FP K     S  A  L+ ++L   P +RIT  +AL H 
Sbjct: 216 ----------MLKIREGTFT--FPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHE 263
Query: 232 YLQ 234
           + +
Sbjct: 264 WFE 266

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 39/99 (39%), Positives = 52/99 (52%), Gaps = 13/99 (13%)
Query: 53  FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR- 111
           F  Q+  G+ Y+H+   +HR L   N+LL+    +KIGDFGLA+   E     EY   R 
Sbjct: 116 FAQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGH---EYYRVRE 172
Query: 112 -------WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
                  WY APE L  C  Y A+ D+WS G  L E++T
Sbjct: 173 DGDSPVFWY-APECLKECKFYYAS-DVWSFGVTLYELLT 209

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 39/99 (39%), Positives = 52/99 (52%), Gaps = 13/99 (13%)
Query: 53  FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR- 111
           F  Q+  G+ Y+H+   +HR L   N+LL+    +KIGDFGLA+   E     EY   R 
Sbjct: 117 FAQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGH---EYYRVRE 173
Query: 112 -------WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
                  WY APE L  C  Y A+ D+WS G  L E++T
Sbjct: 174 DGDSPVFWY-APECLKECKFYYAS-DVWSFGVTLYELLT 210

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/200 (23%), Positives = 96/200 (48%), Gaps = 26/200 (13%)
Query: 25  YIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 84
           +++  +   DL   ++  ++L ++H +++  ++   L Y+H   +++RDLK  N+LL++ 
Sbjct: 87  FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE 146
Query: 85  CDLKIGDFGLARTT-SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
             +K+ D+G+ +      D  + +  T  Y APE +L   +Y  ++D W++G ++ E+M 
Sbjct: 147 GHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMA 205
Query: 144 REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK- 202
               F             +++GS D+         N   Y+ Q+   ++     R P   
Sbjct: 206 GRSPF-------------DIVGSSDNP------DQNTEDYLFQVILEKQ----IRIPRSL 242
Query: 203 SSGAVDLLEKMLVFDPNKRI 222
           S  A  +L+  L  DP +R+
Sbjct: 243 SVKAASVLKSFLNKDPKERL 262

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 83/197 (42%), Gaps = 41/197 (20%)
Query: 53  FLYQLLRGLKYVHSASVLHRDLKPSNLLL--NASCDLKIGDFGLAR-----TTSETDFMT 105
            + Q+   L Y+H+  + HRD+KP N L   N S ++K+ DFGL++        E   MT
Sbjct: 173 IMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMT 232
Query: 106 EYVVTRWYRAPELLLNCTE-YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELI 164
               T ++ APE+L    E Y    D WS G +L  ++     FPG   V+    I++++
Sbjct: 233 TKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPG---VNDADTISQVL 289
Query: 165 GSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK---SSGAVDLLEKMLVFDPNKR 221
                                       ++     PN    S  A DLL  +L  + ++R
Sbjct: 290 ---------------------------NKKLCFENPNYNVLSPLARDLLSNLLNRNVDER 322
Query: 222 ITVEEALRHPYLQSLHD 238
                AL+HP++    D
Sbjct: 323 FDAMRALQHPWISQFSD 339

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 72/140 (51%), Gaps = 19/140 (13%)
Query: 24  VYIVYELM-DTDLHQIIRSDQ-------QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 75
           +YI+ E M    L   ++SD+       +L D     F  Q+  G+ Y+   + +HRDL+
Sbjct: 82  IYIITEFMAKGSLLDFLKSDEGGKVLLPKLID-----FSAQIAEGMAYIERKNYIHRDLR 136
Query: 76  PSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV---TRWYRAPELLLNCTEYTAAIDIW 132
            +N+L++ S   KI DFGLAR   + ++          +W  APE  +N   +T   ++W
Sbjct: 137 AANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKW-TAPE-AINFGCFTIKSNVW 194
Query: 133 SVGCILGEIMTREPL-FPGK 151
           S G +L EI+T   + +PG+
Sbjct: 195 SFGILLYEIVTYGKIPYPGR 214

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 100/243 (41%), Gaps = 48/243 (19%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYEL-MDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++H N+I + +       +   D+Y+V EL    +L + +   +   +      +  +L 
Sbjct: 80  LDHPNIIRLYETF-----EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLS 134
Query: 60  GLKYVHSASVLHRDLKPSN-LLLNASCD--LKIGDFGLARTTSETDFMTEYVVTRWYRAP 116
            + Y H  +V HRDLKP N L L  S D  LK+ DFGLA        M   V T +Y +P
Sbjct: 135 AVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSP 194
Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 176
           ++L     Y    D WS G ++  ++   P F                 +P D  +    
Sbjct: 195 QVLEGL--YGPECDEWSAGVMMYVLLCGYPPF----------------SAPTDXEV---- 232
Query: 177 SDNARRYVRQLPRCRKQQFATRFPNK-----SSGAVDLLEKMLVFDPNKRITVEEALRHP 231
                     + + R+  F   FP K     S  A  L+ ++L   P +RIT  +AL H 
Sbjct: 233 ----------MLKIREGTFT--FPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHE 280
Query: 232 YLQ 234
           + +
Sbjct: 281 WFE 283

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/200 (23%), Positives = 96/200 (48%), Gaps = 26/200 (13%)
Query: 25  YIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 84
           +++  +   DL   ++  ++L ++H +++  ++   L Y+H   +++RDLK  N+LL++ 
Sbjct: 83  FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE 142
Query: 85  CDLKIGDFGLARTT-SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
             +K+ D+G+ +      D  + +  T  Y APE +L   +Y  ++D W++G ++ E+M 
Sbjct: 143 GHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMA 201
Query: 144 REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK- 202
               F             +++GS D+         N   Y+ Q+   ++     R P   
Sbjct: 202 GRSPF-------------DIVGSSDNP------DQNTEDYLFQVILEKQ----IRIPRSL 238
Query: 203 SSGAVDLLEKMLVFDPNKRI 222
           S  A  +L+  L  DP +R+
Sbjct: 239 SVKAASVLKSFLNKDPKERL 258

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 79/151 (52%), Gaps = 16/151 (10%)
Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR-SDQQLTDDHCQYFLYQLLR 59
           +H NVI ++ ++    K T   V I+ E M+   L   +R +D Q T       L  +  
Sbjct: 66  DHPNVIHLEGVV---TKST--PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAA 120
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR----TTSE---TDFMTEYVVTRW 112
           G+KY+   + +HR L   N+L+N++   K+ DFGL+R     TS+   T  +   +  RW
Sbjct: 121 GMKYLADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRW 180
Query: 113 YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
             APE  +   ++T+A D+WS G ++ E+M+
Sbjct: 181 -TAPE-AIQYRKFTSASDVWSYGIVMWEVMS 209

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 97/200 (48%), Gaps = 26/200 (13%)
Query: 25  YIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 84
           +++  +   DL   ++  ++L ++H +++  ++   L Y+H   +++RDLK  N+LL++ 
Sbjct: 98  FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE 157
Query: 85  CDLKIGDFGLARTT-SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
             +K+ D+G+ +      D  + +  T  Y APE +L   +Y  ++D W++G ++ E+M 
Sbjct: 158 GHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMA 216
Query: 144 REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP-NK 202
               F             +++GS D+         N   Y+ Q+    KQ    R P + 
Sbjct: 217 GRSPF-------------DIVGSSDNP------DQNTEDYLFQVI-LEKQ---IRIPRSM 253
Query: 203 SSGAVDLLEKMLVFDPNKRI 222
           S  A  +L+  L  DP +R+
Sbjct: 254 SVKAASVLKSFLNKDPKERL 273

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 77/149 (51%), Gaps = 14/149 (9%)
Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR-SDQQLTDDHCQYFLYQLLR 59
           +H N+I ++ ++   K      V I+ E M+   L   +R +D + T       L  +  
Sbjct: 73  DHPNIIHLEGVVTKCKP-----VMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGS 127
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS---ETDFMTE--YVVTRWYR 114
           G+KY+   S +HRDL   N+L+N++   K+ DFG++R      E  + T    +  RW  
Sbjct: 128 GMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRW-T 186
Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMT 143
           APE +    ++T+A D+WS G ++ E+M+
Sbjct: 187 APEAIAY-RKFTSASDVWSYGIVMWEVMS 214

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/200 (23%), Positives = 96/200 (48%), Gaps = 26/200 (13%)
Query: 25  YIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 84
           +++  +   DL   ++  ++L ++H +++  ++   L Y+H   +++RDLK  N+LL++ 
Sbjct: 130 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE 189
Query: 85  CDLKIGDFGLARTT-SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
             +K+ D+G+ +      D  + +  T  Y APE +L   +Y  ++D W++G ++ E+M 
Sbjct: 190 GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMA 248
Query: 144 REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK- 202
               F             +++GS D+         N   Y+ Q+   ++     R P   
Sbjct: 249 GRSPF-------------DIVGSSDNP------DQNTEDYLFQVILEKQ----IRIPRSL 285
Query: 203 SSGAVDLLEKMLVFDPNKRI 222
           S  A  +L+  L  DP +R+
Sbjct: 286 SVKAASVLKSFLNKDPKERL 305

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 85/173 (49%), Gaps = 11/173 (6%)
Query: 20  TFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 78
           T + +Y V + ++  +L   ++ ++   +   +++  ++   L Y+HS ++++RDLKP N
Sbjct: 110 TADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPEN 169
Query: 79  LLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 137
           +LL++   + + DFGL +   E +  T  +  T  Y APE +L+   Y   +D W +G +
Sbjct: 170 ILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPE-VLHKQPYDRTVDWWCLGAV 228
Query: 138 LGEIMTREPLFPGKDYVHQ--------LRLITELIGSPDDASLGFLRSDNARR 182
           L E++   P F  ++            L+L   +  S      G L+ D  +R
Sbjct: 229 LYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKR 281

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 77/149 (51%), Gaps = 14/149 (9%)
Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR-SDQQLTDDHCQYFLYQLLR 59
           +H N+I ++ ++   K      V I+ E M+   L   +R +D + T       L  +  
Sbjct: 67  DHPNIIHLEGVVTKCKP-----VMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGS 121
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS---ETDFMTE--YVVTRWYR 114
           G+KY+   S +HRDL   N+L+N++   K+ DFG++R      E  + T    +  RW  
Sbjct: 122 GMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRW-T 180
Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMT 143
           APE +    ++T+A D+WS G ++ E+M+
Sbjct: 181 APEAIAY-RKFTSASDVWSYGIVMWEVMS 208

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 80/157 (50%), Gaps = 15/157 (9%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR--SDQQLTDDHCQYFLYQL 57
           ++H+ ++ +  ++      T   +YI+ E M+   L   ++  S  +LT +       Q+
Sbjct: 75  LQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 128
Query: 58  LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYR 114
             G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + ++          +W  
Sbjct: 129 AEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW-T 187
Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 150
           APE  +N   +T   D+WS G +L EI+T   + +PG
Sbjct: 188 APE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 223

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 36/90 (40%), Positives = 51/90 (56%), Gaps = 5/90 (5%)
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT---SETDFMTEYVVTRWYRAP 116
           G+ ++H    +HRD+K +N+LL+ +   KI DFGLAR +   ++T      V T  Y AP
Sbjct: 145 GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAP 204
Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREP 146
           E L    E T   DI+S G +L EI+T  P
Sbjct: 205 EALRG--EITPKSDIYSFGVVLLEIITGLP 232

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 65/127 (51%), Gaps = 19/127 (14%)
Query: 50  CQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD------- 102
           C +   Q+   ++++HS  ++HRDLKPSN+       +K+GDFGL     + +       
Sbjct: 120 CLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 103 ------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ 156
                   T  V T+ Y +PE  ++   Y+  +DI+S+G IL E+     L+P    + +
Sbjct: 180 PMPAYARHTGQVGTKLYMSPE-QIHGNSYSHKVDIFSLGLILFEL-----LYPFSTQMER 233
Query: 157 LRLITEL 163
           +R +T++
Sbjct: 234 VRTLTDV 240

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 80/157 (50%), Gaps = 15/157 (9%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR--SDQQLTDDHCQYFLYQL 57
           ++H+ ++ +  ++      T   +YI+ E M+   L   ++  S  +LT +       Q+
Sbjct: 71  LQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 124
Query: 58  LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYR 114
             G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + ++          +W  
Sbjct: 125 AEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW-T 183
Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 150
           APE  +N   +T   D+WS G +L EI+T   + +PG
Sbjct: 184 APE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 219

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 80/157 (50%), Gaps = 15/157 (9%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR--SDQQLTDDHCQYFLYQL 57
           ++H+ ++ +  ++      T   +YI+ E M+   L   ++  S  +LT +       Q+
Sbjct: 60  LQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 113
Query: 58  LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV---TRWYR 114
             G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + ++          +W  
Sbjct: 114 AEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW-T 172
Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 150
           APE  +N   +T   D+WS G +L EI+T   + +PG
Sbjct: 173 APE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 208

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 80/157 (50%), Gaps = 15/157 (9%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR--SDQQLTDDHCQYFLYQL 57
           ++H+ ++ +  ++      T   +YI+ E M+   L   ++  S  +LT +       Q+
Sbjct: 70  LQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 123
Query: 58  LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYR 114
             G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + ++          +W  
Sbjct: 124 AEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW-T 182
Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 150
           APE  +N   +T   D+WS G +L EI+T   + +PG
Sbjct: 183 APE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 218

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 80/157 (50%), Gaps = 15/157 (9%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR--SDQQLTDDHCQYFLYQL 57
           ++H+ ++ +  ++      T   +YI+ E M+   L   ++  S  +LT +       Q+
Sbjct: 65  LQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118
Query: 58  LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV---TRWYR 114
             G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + ++          +W  
Sbjct: 119 AEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW-T 177
Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 150
           APE  +N   +T   D+WS G +L EI+T   + +PG
Sbjct: 178 APE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/234 (24%), Positives = 104/234 (44%), Gaps = 36/234 (15%)
Query: 22  NDVYIVYELMDTDLHQIIRSDQQLTDDHC-QYFLYQL----LRGLKYV-HSASVLHRDLK 75
            D +I  ELM T   +  +    + DD   +  L ++    ++ L ++  +  ++HRD+K
Sbjct: 94  GDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIK 153
Query: 76  PSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL---LNCTEYTAAIDIW 132
           PSN+LL+ S ++K+ DFG++    ++   T     R Y APE +    +   Y    D+W
Sbjct: 154 PSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVW 213
Query: 133 SVGCILGEIMTREPLFPGKDYVHQLRLITELI-GSPDDASLGFLRSDNARRYVRQLPRCR 191
           S+G  L E+ T    FP   +      +T+++ G P                  QL    
Sbjct: 214 SLGITLYELATGR--FPYPKWNSVFDQLTQVVKGDPP-----------------QLSNSE 254
Query: 192 KQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVC 245
           +++F+  F       ++ +   L  D +KR   +E L+HP++    +   E  C
Sbjct: 255 EREFSPSF-------INFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVAC 301

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 37/127 (29%), Positives = 66/127 (51%), Gaps = 19/127 (14%)
Query: 50  CQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF------ 103
           C +   Q+   ++++HS  ++HRDLKPSN+       +K+GDFGL     + +       
Sbjct: 166 CLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 225
Query: 104 -MTEY------VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ 156
            M  Y      V T+ Y +PE  ++   Y+  +DI+S+G IL E+     L+     + +
Sbjct: 226 PMPAYATHXGQVGTKLYMSPE-QIHGNNYSHKVDIFSLGLILFEL-----LYSFSTQMER 279
Query: 157 LRLITEL 163
           +R+IT++
Sbjct: 280 VRIITDV 286

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 55/104 (52%), Gaps = 9/104 (8%)
Query: 53  FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-- 110
           F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + ++ + +  T  
Sbjct: 138 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 197
Query: 111 ----RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFP 149
               +W       L   ++T   D+WS G +L E+MTR  P +P
Sbjct: 198 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 239

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 60.5 bits (145), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 55/104 (52%), Gaps = 9/104 (8%)
Query: 53  FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-- 110
           F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + ++ + +  T  
Sbjct: 137 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 196
Query: 111 ----RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFP 149
               +W       L   ++T   D+WS G +L E+MTR  P +P
Sbjct: 197 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 238

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 60.5 bits (145), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 55/104 (52%), Gaps = 9/104 (8%)
Query: 53  FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-- 110
           F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + ++ + +  T  
Sbjct: 138 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 197
Query: 111 ----RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFP 149
               +W       L   ++T   D+WS G +L E+MTR  P +P
Sbjct: 198 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 239

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 55/104 (52%), Gaps = 9/104 (8%)
Query: 53  FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-- 110
           F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + ++ + +  T  
Sbjct: 133 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 192
Query: 111 ----RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFP 149
               +W       L   ++T   D+WS G +L E+MTR  P +P
Sbjct: 193 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 234

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 60.5 bits (145), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 55/104 (52%), Gaps = 9/104 (8%)
Query: 53  FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-- 110
           F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + ++ + +  T  
Sbjct: 136 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 195
Query: 111 ----RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFP 149
               +W       L   ++T   D+WS G +L E+MTR  P +P
Sbjct: 196 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 237

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/124 (31%), Positives = 62/124 (50%), Gaps = 10/124 (8%)
Query: 34  DLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDF 92
           DL   IR++    T      F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DF
Sbjct: 110 DLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADF 169
Query: 93  GLARTTSETDFMTEYVVT------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-E 145
           GLAR   + ++ + +  T      +W       L   ++T   D+WS G +L E+MTR  
Sbjct: 170 GLARDMYDKEYYSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGA 227
Query: 146 PLFP 149
           P +P
Sbjct: 228 PPYP 231

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/124 (31%), Positives = 62/124 (50%), Gaps = 10/124 (8%)
Query: 34  DLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDF 92
           DL   IR++    T      F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DF
Sbjct: 137 DLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADF 196
Query: 93  GLARTTSETDFMTEYVVT------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-E 145
           GLAR   + ++ + +  T      +W       L   ++T   D+WS G +L E+MTR  
Sbjct: 197 GLARDMYDKEYYSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGA 254
Query: 146 PLFP 149
           P +P
Sbjct: 255 PPYP 258

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 55/104 (52%), Gaps = 9/104 (8%)
Query: 53  FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-- 110
           F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + ++ + +  T  
Sbjct: 135 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 194
Query: 111 ----RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFP 149
               +W       L   ++T   D+WS G +L E+MTR  P +P
Sbjct: 195 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 236

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 55/104 (52%), Gaps = 9/104 (8%)
Query: 53  FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-- 110
           F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + ++ + +  T  
Sbjct: 156 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 215
Query: 111 ----RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFP 149
               +W       L   ++T   D+WS G +L E+MTR  P +P
Sbjct: 216 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 257

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/123 (34%), Positives = 64/123 (52%), Gaps = 17/123 (13%)
Query: 30  LMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKI 89
           +++TD    I +    T D   +F  Q+ +G+ ++ S + +HRD+   N+LL      KI
Sbjct: 147 VLETDPAFAIANSTASTRD-LLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKI 205
Query: 90  GDFGLARTTSETDFM--TEYVV-------TRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           GDFGLAR     D M  + Y+V        +W  APE + +C  YT   D+WS G +L E
Sbjct: 206 GDFGLAR-----DIMNDSNYIVKGNARLPVKW-MAPESIFDCV-YTVQSDVWSYGILLWE 258
Query: 141 IMT 143
           I +
Sbjct: 259 IFS 261

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 55/106 (51%), Gaps = 6/106 (5%)
Query: 42  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 101
           ++ LT      F +Q+ +G++Y+   S++HRDL   N+L+     +KI DFGL+R   E 
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 102 DFMTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           D   +     +  +W     L  +   YT   D+WS G +L EI+T
Sbjct: 204 DSXVKRSQGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIVT 247

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/101 (36%), Positives = 55/101 (54%), Gaps = 16/101 (15%)
Query: 52  YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM--TEYVV 109
           +F  Q+ +G+ ++ S + +HRD+   N+LL      KIGDFGLAR     D M  + Y+V
Sbjct: 168 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-----DIMNDSNYIV 222
Query: 110 -------TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
                   +W  APE + +C  YT   D+WS G +L EI +
Sbjct: 223 KGNARLPVKW-MAPESIFDCV-YTVQSDVWSYGILLWEIFS 261

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/101 (36%), Positives = 55/101 (54%), Gaps = 16/101 (15%)
Query: 52  YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM--TEYVV 109
           +F  Q+ +G+ ++ S + +HRD+   N+LL      KIGDFGLAR     D M  + Y+V
Sbjct: 164 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-----DIMNDSNYIV 218
Query: 110 -------TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
                   +W  APE + +C  YT   D+WS G +L EI +
Sbjct: 219 KGNARLPVKW-MAPESIFDCV-YTVQSDVWSYGILLWEIFS 257

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/101 (36%), Positives = 55/101 (54%), Gaps = 16/101 (15%)
Query: 52  YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM--TEYVV 109
           +F  Q+ +G+ ++ S + +HRD+   N+LL      KIGDFGLAR     D M  + Y+V
Sbjct: 156 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-----DIMNDSNYIV 210
Query: 110 -------TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
                   +W  APE + +C  YT   D+WS G +L EI +
Sbjct: 211 KGNARLPVKW-MAPESIFDCV-YTVQSDVWSYGILLWEIFS 249

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/98 (37%), Positives = 51/98 (52%), Gaps = 12/98 (12%)
Query: 53  FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--- 109
           F YQ+ +G+ ++ S + +HRDL   N+LL      KI DFGLAR        + YVV   
Sbjct: 166 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND---SNYVVKGN 222
Query: 110 ----TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
                +W  APE + NC  YT   D+WS G  L E+ +
Sbjct: 223 ARLPVKW-MAPESIFNCV-YTFESDVWSYGIFLWELFS 258

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/99 (39%), Positives = 52/99 (52%), Gaps = 13/99 (13%)
Query: 53  FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR- 111
           F  Q+  G+ Y+HS   +HR+L   N+LL+    +KIGDFGLA+   E     EY   R 
Sbjct: 122 FAQQICEGMAYLHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGH---EYYRVRE 178
Query: 112 -------WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
                  WY APE L     Y A+ D+WS G  L E++T
Sbjct: 179 DGDSPVFWY-APECLKEYKFYYAS-DVWSFGVTLYELLT 215

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/98 (37%), Positives = 51/98 (52%), Gaps = 12/98 (12%)
Query: 53  FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--- 109
           F YQ+ +G+ ++ S + +HRDL   N+LL      KI DFGLAR        + YVV   
Sbjct: 168 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND---SNYVVKGN 224
Query: 110 ----TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
                +W  APE + NC  YT   D+WS G  L E+ +
Sbjct: 225 ARLPVKW-MAPESIFNCV-YTFESDVWSYGIFLWELFS 260

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 80/157 (50%), Gaps = 15/157 (9%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR--SDQQLTDDHCQYFLYQL 57
           ++H+ ++ +  ++      T   +YI+ E M+   L   ++  S  +LT +       Q+
Sbjct: 61  LQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 114
Query: 58  LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV---TRWYR 114
             G+ ++   + +HR+L+ +N+L++ +   KI DFGLAR   + ++          +W  
Sbjct: 115 AEGMAFIEERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW-T 173
Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 150
           APE  +N   +T   D+WS G +L EI+T   + +PG
Sbjct: 174 APE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 209

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/98 (37%), Positives = 51/98 (52%), Gaps = 12/98 (12%)
Query: 53  FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--- 109
           F YQ+ +G+ ++ S + +HRDL   N+LL      KI DFGLAR        + YVV   
Sbjct: 173 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND---SNYVVKGN 229
Query: 110 ----TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
                +W  APE + NC  YT   D+WS G  L E+ +
Sbjct: 230 ARLPVKW-MAPESIFNCV-YTFESDVWSYGIFLWELFS 265

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 79/157 (50%), Gaps = 15/157 (9%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR--SDQQLTDDHCQYFLYQL 57
           ++H+ ++ +  ++      T   +YI+ E M+   L   ++  S  +LT +       Q+
Sbjct: 71  LQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 124
Query: 58  LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYR 114
             G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + +           +W  
Sbjct: 125 AEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW-T 183
Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 150
           APE  +N   +T   D+WS G +L EI+T   + +PG
Sbjct: 184 APE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 219

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 79/157 (50%), Gaps = 15/157 (9%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR--SDQQLTDDHCQYFLYQL 57
           ++H+ ++ +  ++      T   +YI+ E M+   L   ++  S  +LT +       Q+
Sbjct: 65  LQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118
Query: 58  LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYR 114
             G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + +           +W  
Sbjct: 119 AEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKW-T 177
Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 150
           APE  +N   +T   D+WS G +L EI+T   + +PG
Sbjct: 178 APE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 88/170 (51%), Gaps = 18/170 (10%)
Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTRW 112
           Q  +G+ Y+H+ S++HRDLK +N+ L+    +KIGDFGLA   S      ++     +  
Sbjct: 117 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 176
Query: 113 YRAPEL--LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG----S 166
           + APE+  + +   Y+   D+++ G +L E+MT +  +   +   Q   I  ++G    S
Sbjct: 177 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIFMVGRGYLS 233
Query: 167 PDDASLGFLRSDNARRYVRQLPRCRKQQFATR--FPNKSSGAVDLLEKML 214
           PD   L  +RS+  +   R +  C K++   R  FP +   +++LL + L
Sbjct: 234 PD---LSKVRSNCPKAMKRLMAECLKKKRDERPLFP-QILASIELLARSL 279

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 51/90 (56%), Gaps = 5/90 (5%)
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT---SETDFMTEYVVTRWYRAP 116
           G+ ++H    +HRD+K +N+LL+ +   KI DFGLAR +   ++    +  V T  Y AP
Sbjct: 136 GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAP 195
Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREP 146
           E L    E T   DI+S G +L EI+T  P
Sbjct: 196 EALRG--EITPKSDIYSFGVVLLEIITGLP 223

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 79/157 (50%), Gaps = 15/157 (9%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR--SDQQLTDDHCQYFLYQL 57
           ++H+ ++ +  ++      T   +YI+ E M+   L   ++  S  +LT +       Q+
Sbjct: 74  LQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 127
Query: 58  LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYR 114
             G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + +           +W  
Sbjct: 128 AEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW-T 186
Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 150
           APE  +N   +T   D+WS G +L EI+T   + +PG
Sbjct: 187 APE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 222

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/101 (36%), Positives = 55/101 (54%), Gaps = 16/101 (15%)
Query: 52  YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM--TEYVV 109
           +F  Q+ +G+ ++ S + +HRD+   N+LL      KIGDFGLAR     D M  + Y+V
Sbjct: 162 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-----DIMNDSNYIV 216
Query: 110 -------TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
                   +W  APE + +C  YT   D+WS G +L EI +
Sbjct: 217 KGNARLPVKWM-APESIFDCV-YTVQSDVWSYGILLWEIFS 255

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 79/157 (50%), Gaps = 15/157 (9%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR--SDQQLTDDHCQYFLYQL 57
           ++H+ ++ +  ++      T   +YI+ E M+   L   ++  S  +LT +       Q+
Sbjct: 73  LQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 126
Query: 58  LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYR 114
             G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + +           +W  
Sbjct: 127 AEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW-T 185
Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 150
           APE  +N   +T   D+WS G +L EI+T   + +PG
Sbjct: 186 APE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 221

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/98 (37%), Positives = 51/98 (52%), Gaps = 12/98 (12%)
Query: 53  FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--- 109
           F YQ+ +G+ ++ S + +HRDL   N+LL      KI DFGLAR        + YVV   
Sbjct: 150 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND---SNYVVKGN 206
Query: 110 ----TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
                +W  APE + NC  YT   D+WS G  L E+ +
Sbjct: 207 ARLPVKW-MAPESIFNCV-YTFESDVWSYGIFLWELFS 242

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 79/157 (50%), Gaps = 15/157 (9%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR--SDQQLTDDHCQYFLYQL 57
           ++H+ ++ +  ++      T   +YI+ E M+   L   ++  S  +LT +       Q+
Sbjct: 65  LQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118
Query: 58  LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYR 114
             G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + +           +W  
Sbjct: 119 AEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW-T 177
Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 150
           APE  +N   +T   D+WS G +L EI+T   + +PG
Sbjct: 178 APE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/98 (37%), Positives = 51/98 (52%), Gaps = 12/98 (12%)
Query: 53  FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--- 109
           F YQ+ +G+ ++ S + +HRDL   N+LL      KI DFGLAR        + YVV   
Sbjct: 173 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARHIKND---SNYVVKGN 229
Query: 110 ----TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
                +W  APE + NC  YT   D+WS G  L E+ +
Sbjct: 230 ARLPVKW-MAPESIFNCV-YTFESDVWSYGIFLWELFS 265

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 55/104 (52%), Gaps = 9/104 (8%)
Query: 53  FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-- 110
           F  Q+ +G+K++ S   +HRDL   N +L+    +K+ DFGLAR   + +F + +  T  
Sbjct: 136 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 195
Query: 111 ----RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFP 149
               +W       L   ++T   D+WS G +L E+MTR  P +P
Sbjct: 196 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 237

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 88/170 (51%), Gaps = 18/170 (10%)
Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTRW 112
           Q  +G+ Y+H+ S++HRDLK +N+ L+    +KIGDFGLA   S      ++     +  
Sbjct: 114 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 173
Query: 113 YRAPEL--LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG----S 166
           + APE+  + +   Y+   D+++ G +L E+MT +  +   +   Q   I  ++G    S
Sbjct: 174 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIFMVGRGYLS 230
Query: 167 PDDASLGFLRSDNARRYVRQLPRCRKQQFATR--FPNKSSGAVDLLEKML 214
           PD   L  +RS+  +   R +  C K++   R  FP +   +++LL + L
Sbjct: 231 PD---LSKVRSNCPKAMKRLMAECLKKKRDERPLFP-QILASIELLARSL 276

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/124 (31%), Positives = 62/124 (50%), Gaps = 10/124 (8%)
Query: 34  DLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDF 92
           DL   IR++    T      F  Q+ +G+K++ S   +HRDL   N +L+    +K+ DF
Sbjct: 119 DLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADF 178
Query: 93  GLARTTSETDFMTEYVVT------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-E 145
           GLAR   + +F + +  T      +W       L   ++T   D+WS G +L E+MTR  
Sbjct: 179 GLARDMYDKEFDSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGA 236
Query: 146 PLFP 149
           P +P
Sbjct: 237 PPYP 240

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 88/170 (51%), Gaps = 18/170 (10%)
Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTRW 112
           Q  +G+ Y+H+ S++HRDLK +N+ L+    +KIGDFGLA   S      ++     +  
Sbjct: 112 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171
Query: 113 YRAPEL--LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG----S 166
           + APE+  + +   Y+   D+++ G +L E+MT +  +   +   Q   I  ++G    S
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIFMVGRGYLS 228
Query: 167 PDDASLGFLRSDNARRYVRQLPRCRKQQFATR--FPNKSSGAVDLLEKML 214
           PD   L  +RS+  +   R +  C K++   R  FP +   +++LL + L
Sbjct: 229 PD---LSKVRSNCPKAMKRLMAECLKKKRDERPLFP-QILASIELLARSL 274

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 88/170 (51%), Gaps = 18/170 (10%)
Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTRW 112
           Q  +G+ Y+H+ S++HRDLK +N+ L+    +KIGDFGLA   S      ++     +  
Sbjct: 139 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 198
Query: 113 YRAPEL--LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG----S 166
           + APE+  + +   Y+   D+++ G +L E+MT +  +   +   Q   I  ++G    S
Sbjct: 199 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIFMVGRGYLS 255
Query: 167 PDDASLGFLRSDNARRYVRQLPRCRKQQFATR--FPNKSSGAVDLLEKML 214
           PD   L  +RS+  +   R +  C K++   R  FP +   +++LL + L
Sbjct: 256 PD---LSKVRSNCPKAMKRLMAECLKKKRDERPLFP-QILASIELLARSL 301

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 79/157 (50%), Gaps = 15/157 (9%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR--SDQQLTDDHCQYFLYQL 57
           ++H+ ++ +  ++      T   +YI+ E M+   L   ++  S  +LT +       Q+
Sbjct: 66  LQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 119
Query: 58  LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV---TRWYR 114
             G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + +           +W  
Sbjct: 120 AEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW-T 178
Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 150
           APE  +N   +T   D+WS G +L EI+T   + +PG
Sbjct: 179 APE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 214

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 79/157 (50%), Gaps = 15/157 (9%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR--SDQQLTDDHCQYFLYQL 57
           ++H+ ++ +  ++      T   +YI+ E M+   L   ++  S  +LT +       Q+
Sbjct: 67  LQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 120
Query: 58  LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV---TRWYR 114
             G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + +           +W  
Sbjct: 121 AEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW-T 179
Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 150
           APE  +N   +T   D+WS G +L EI+T   + +PG
Sbjct: 180 APE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 215

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 88/170 (51%), Gaps = 18/170 (10%)
Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTRW 112
           Q  +G+ Y+H+ S++HRDLK +N+ L+    +KIGDFGLA   S      ++     +  
Sbjct: 112 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171
Query: 113 YRAPEL--LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG----S 166
           + APE+  + +   Y+   D+++ G +L E+MT +  +   +   Q   I  ++G    S
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIFMVGRGYLS 228
Query: 167 PDDASLGFLRSDNARRYVRQLPRCRKQQFATR--FPNKSSGAVDLLEKML 214
           PD   L  +RS+  +   R +  C K++   R  FP +   +++LL + L
Sbjct: 229 PD---LSKVRSNCPKAMKRLMAECLKKKRDERPLFP-QILASIELLARSL 274

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 79/157 (50%), Gaps = 15/157 (9%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR--SDQQLTDDHCQYFLYQL 57
           ++H+ ++ +  ++      T   +YI+ E M+   L   ++  S  +LT +       Q+
Sbjct: 65  LQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118
Query: 58  LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV---TRWYR 114
             G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + +           +W  
Sbjct: 119 AEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW-T 177
Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 150
           APE  +N   +T   D+WS G +L EI+T   + +PG
Sbjct: 178 APE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/124 (31%), Positives = 62/124 (50%), Gaps = 10/124 (8%)
Query: 34  DLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDF 92
           DL   IR++    T      F  Q+ +G+K++ S   +HRDL   N +L+    +K+ DF
Sbjct: 118 DLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADF 177
Query: 93  GLARTTSETDFMTEYVVT------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-E 145
           GLAR   + +F + +  T      +W       L   ++T   D+WS G +L E+MTR  
Sbjct: 178 GLARDMYDKEFDSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGA 235
Query: 146 PLFP 149
           P +P
Sbjct: 236 PPYP 239

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 55/104 (52%), Gaps = 9/104 (8%)
Query: 53  FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-- 110
           F  Q+ +G+K++ S   +HRDL   N +L+    +K+ DFGLAR   + +F + +  T  
Sbjct: 138 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 197
Query: 111 ----RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFP 149
               +W       L   ++T   D+WS G +L E+MTR  P +P
Sbjct: 198 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 239

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 88/170 (51%), Gaps = 18/170 (10%)
Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTRW 112
           Q  +G+ Y+H+ S++HRDLK +N+ L+    +KIGDFGLA   S      ++     +  
Sbjct: 117 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 176
Query: 113 YRAPEL--LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG----S 166
           + APE+  + +   Y+   D+++ G +L E+MT +  +   +   Q   I  ++G    S
Sbjct: 177 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIFMVGRGYLS 233
Query: 167 PDDASLGFLRSDNARRYVRQLPRCRKQQFATR--FPNKSSGAVDLLEKML 214
           PD   L  +RS+  +   R +  C K++   R  FP +   +++LL + L
Sbjct: 234 PD---LSKVRSNCPKAMKRLMAECLKKKRDERPLFP-QILASIELLARSL 279

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 50/90 (55%), Gaps = 5/90 (5%)
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT---SETDFMTEYVVTRWYRAP 116
           G+ ++H    +HRD+K +N+LL+ +   KI DFGLAR +   ++       V T  Y AP
Sbjct: 139 GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAP 198
Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREP 146
           E L    E T   DI+S G +L EI+T  P
Sbjct: 199 EALRG--EITPKSDIYSFGVVLLEIITGLP 226

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 87/171 (50%), Gaps = 20/171 (11%)
Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA----RTTSETDFMTEYVVTR 111
           Q  +G+ Y+H+ S++HRDLK +N+ L+    +KIGDFGLA    R +    F        
Sbjct: 112 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 171
Query: 112 WYRAPEL--LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG---- 165
           W  APE+  + +   Y+   D+++ G +L E+MT +  +   +   Q   I  ++G    
Sbjct: 172 WM-APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIFMVGRGYL 227
Query: 166 SPDDASLGFLRSDNARRYVRQLPRCRKQQFATR--FPNKSSGAVDLLEKML 214
           SPD   L  +RS+  +   R +  C K++   R  FP +   +++LL + L
Sbjct: 228 SPD---LSKVRSNCPKAMKRLMAECLKKKRDERPLFP-QILASIELLARSL 274

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 55/104 (52%), Gaps = 9/104 (8%)
Query: 53  FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-- 110
           F  Q+ +G+K++ S   +HRDL   N +L+    +K+ DFGLAR   + +F + +  T  
Sbjct: 143 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 202
Query: 111 ----RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFP 149
               +W       L   ++T   D+WS G +L E+MTR  P +P
Sbjct: 203 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 244

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 87/171 (50%), Gaps = 20/171 (11%)
Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA----RTTSETDFMTEYVVTR 111
           Q  +G+ Y+H+ S++HRDLK +N+ L+    +KIGDFGLA    R +    F        
Sbjct: 132 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 191
Query: 112 WYRAPEL--LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG---- 165
           W  APE+  + +   Y+   D+++ G +L E+MT +  +   +   Q   I  ++G    
Sbjct: 192 WM-APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIFMVGRGYL 247
Query: 166 SPDDASLGFLRSDNARRYVRQLPRCRKQQFATR--FPNKSSGAVDLLEKML 214
           SPD   L  +RS+  +   R +  C K++   R  FP +   +++LL + L
Sbjct: 248 SPD---LSKVRSNCPKAMKRLMAECLKKKRDERPLFP-QILASIELLARSL 294

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 88/170 (51%), Gaps = 18/170 (10%)
Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTRW 112
           Q  +G+ Y+H+ S++HRDLK +N+ L+    +KIGDFGLA   S      ++     +  
Sbjct: 140 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 199
Query: 113 YRAPEL--LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG----S 166
           + APE+  + +   Y+   D+++ G +L E+MT +  +   +   Q   I  ++G    S
Sbjct: 200 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIFMVGRGYLS 256
Query: 167 PDDASLGFLRSDNARRYVRQLPRCRKQQFATR--FPNKSSGAVDLLEKML 214
           PD   L  +RS+  +   R +  C K++   R  FP +   +++LL + L
Sbjct: 257 PD---LSKVRSNCPKAMKRLMAECLKKKRDERPLFP-QILASIELLARSL 302

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/124 (31%), Positives = 62/124 (50%), Gaps = 10/124 (8%)
Query: 34  DLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDF 92
           DL   IR++    T      F  Q+ +G+K++ S   +HRDL   N +L+    +K+ DF
Sbjct: 177 DLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADF 236
Query: 93  GLARTTSETDFMTEYVVT------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-E 145
           GLAR   + +F + +  T      +W       L   ++T   D+WS G +L E+MTR  
Sbjct: 237 GLARDMYDKEFDSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGA 294
Query: 146 PLFP 149
           P +P
Sbjct: 295 PPYP 298

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/124 (31%), Positives = 62/124 (50%), Gaps = 10/124 (8%)
Query: 34  DLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDF 92
           DL   IR++    T      F  Q+ +G+K++ S   +HRDL   N +L+    +K+ DF
Sbjct: 119 DLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADF 178
Query: 93  GLARTTSETDFMTEYVVT------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-E 145
           GLAR   + +F + +  T      +W       L   ++T   D+WS G +L E+MTR  
Sbjct: 179 GLARDMLDKEFDSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGA 236
Query: 146 PLFP 149
           P +P
Sbjct: 237 PPYP 240

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 87/171 (50%), Gaps = 20/171 (11%)
Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA----RTTSETDFMTEYVVTR 111
           Q  +G+ Y+H+ S++HRDLK +N+ L+    +KIGDFGLA    R +    F        
Sbjct: 140 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 199
Query: 112 WYRAPEL--LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG---- 165
           W  APE+  + +   Y+   D+++ G +L E+MT +  +   +   Q   I  ++G    
Sbjct: 200 WM-APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIFMVGRGYL 255
Query: 166 SPDDASLGFLRSDNARRYVRQLPRCRKQQFATR--FPNKSSGAVDLLEKML 214
           SPD   L  +RS+  +   R +  C K++   R  FP +   +++LL + L
Sbjct: 256 SPD---LSKVRSNCPKAMKRLMAECLKKKRDERPLFP-QILASIELLARSL 302

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 54/99 (54%), Gaps = 8/99 (8%)
Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT----EYVVTR 111
           Q+  G+ Y+ S   +HRDL   N L+ A+  +KIGDFG++R    TD+        +  R
Sbjct: 141 QIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 200
Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLF 148
           W   PE ++   ++T   D+WS G IL EI T  ++P F
Sbjct: 201 WM-PPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWF 237

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 54/104 (51%), Gaps = 9/104 (8%)
Query: 53  FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-- 110
           F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + +  + +  T  
Sbjct: 137 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGA 196
Query: 111 ----RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFP 149
               +W       L   ++T   D+WS G +L E+MTR  P +P
Sbjct: 197 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 238

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/121 (32%), Positives = 62/121 (51%), Gaps = 9/121 (7%)
Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE----YVVTR 111
           ++  G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD+  +     +  R
Sbjct: 146 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITE--LIGSPD 168
           W  +PE L +   +T   D+WS G +L EI T  E  + G      LR + E  L+  PD
Sbjct: 206 WM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD 263
Query: 169 D 169
           +
Sbjct: 264 N 264

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/121 (32%), Positives = 62/121 (51%), Gaps = 9/121 (7%)
Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE----YVVTR 111
           ++  G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD+  +     +  R
Sbjct: 146 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITE--LIGSPD 168
           W  +PE L +   +T   D+WS G +L EI T  E  + G      LR + E  L+  PD
Sbjct: 206 WM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD 263
Query: 169 D 169
           +
Sbjct: 264 N 264

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 38/99 (38%), Positives = 52/99 (52%), Gaps = 13/99 (13%)
Query: 53  FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR- 111
           F  Q+  G+ Y+H+   +HR+L   N+LL+    +KIGDFGLA+   E     EY   R 
Sbjct: 122 FAQQICEGMAYLHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGH---EYYRVRE 178
Query: 112 -------WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
                  WY APE L     Y A+ D+WS G  L E++T
Sbjct: 179 DGDSPVFWY-APECLKEYKFYYAS-DVWSFGVTLYELLT 215

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 73/157 (46%), Gaps = 8/157 (5%)
Query: 24  VYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 83
           +Y+V E M       + S+  + +   +++  +++  L  +HS  ++HRD+KP N+LL+ 
Sbjct: 150 LYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDK 209
Query: 84  SCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAPELLLNCTE---YTAAIDIWSVGCIL 138
              LK+ DFG      ET  +     V T  Y +PE+L +      Y    D WSVG  L
Sbjct: 210 HGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 269
Query: 139 GEIMTREPLFPGKDYVHQLRLITELIGS---PDDASL 172
            E++  +  F     V     I +   S   P+DA +
Sbjct: 270 FEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDAEI 306

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/121 (32%), Positives = 62/121 (51%), Gaps = 9/121 (7%)
Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE----YVVTR 111
           ++  G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD+  +     +  R
Sbjct: 139 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 198
Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITE--LIGSPD 168
           W  +PE L +   +T   D+WS G +L EI T  E  + G      LR + E  L+  PD
Sbjct: 199 WM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD 256
Query: 169 D 169
           +
Sbjct: 257 N 257

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/121 (32%), Positives = 62/121 (51%), Gaps = 9/121 (7%)
Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE----YVVTR 111
           ++  G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD+  +     +  R
Sbjct: 137 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 196
Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITE--LIGSPD 168
           W  +PE L +   +T   D+WS G +L EI T  E  + G      LR + E  L+  PD
Sbjct: 197 WM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD 254
Query: 169 D 169
           +
Sbjct: 255 N 255

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/121 (32%), Positives = 62/121 (51%), Gaps = 9/121 (7%)
Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE----YVVTR 111
           ++  G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD+  +     +  R
Sbjct: 168 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 227
Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITE--LIGSPD 168
           W  +PE L +   +T   D+WS G +L EI T  E  + G      LR + E  L+  PD
Sbjct: 228 WM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD 285
Query: 169 D 169
           +
Sbjct: 286 N 286

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 105/244 (43%), Gaps = 43/244 (17%)
Query: 21  FNDVYIVYELMDT-DLHQIIRSDQQL---TDDHCQYFLYQLLRGLKYVHS---ASVLHRD 73
            N V +V E  +   L+ ++   + L   T  H   +  Q  +G+ Y+HS    +++HRD
Sbjct: 72  LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 131
Query: 74  LKPSNLLLNASCD-LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIW 132
           LKP NLLL A    LKI DFG A        MT    +  + APE +   + Y+   D++
Sbjct: 132 LKPPNLLLVAGGTVLKICDFGTACDIQ--THMTNNKGSAAWMAPE-VFEGSNYSEKCDVF 188
Query: 133 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 192
           S G IL E++TR   F             + IG P    +  + +      ++ LP+   
Sbjct: 189 SWGIILWEVITRRKPF-------------DEIGGPAFRIMWAVHNGTRPPLIKNLPK--- 232
Query: 193 QQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFD 252
                  P +S     L+ +    DP++R ++EE ++       H +   P    P  + 
Sbjct: 233 -------PIES-----LMTRCWSKDPSQRPSMEEIVK----IMTHLMRYFPGADEPLQYP 276
Query: 253 FEHS 256
            +HS
Sbjct: 277 CQHS 280

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/121 (32%), Positives = 62/121 (51%), Gaps = 9/121 (7%)
Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE----YVVTR 111
           ++  G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD+  +     +  R
Sbjct: 136 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 195
Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITE--LIGSPD 168
           W  +PE L +   +T   D+WS G +L EI T  E  + G      LR + E  L+  PD
Sbjct: 196 WM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD 253
Query: 169 D 169
           +
Sbjct: 254 N 254

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/121 (32%), Positives = 62/121 (51%), Gaps = 9/121 (7%)
Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE----YVVTR 111
           ++  G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD+  +     +  R
Sbjct: 140 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 199
Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITE--LIGSPD 168
           W  +PE L +   +T   D+WS G +L EI T  E  + G      LR + E  L+  PD
Sbjct: 200 WM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD 257
Query: 169 D 169
           +
Sbjct: 258 N 258

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/121 (32%), Positives = 62/121 (51%), Gaps = 9/121 (7%)
Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE----YVVTR 111
           ++  G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD+  +     +  R
Sbjct: 139 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 198
Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITE--LIGSPD 168
           W  +PE L +   +T   D+WS G +L EI T  E  + G      LR + E  L+  PD
Sbjct: 199 WM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD 256
Query: 169 D 169
           +
Sbjct: 257 N 257

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 53/107 (49%), Gaps = 8/107 (7%)
Query: 42  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 101
           ++ LT      F +Q+ +G++Y+    ++HRDL   N+L+     +KI DFGL+R   E 
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 102 DFMTEYVVTRWYRAPELLLNCTE-----YTAAIDIWSVGCILGEIMT 143
           D    YV     R P   +         YT   D+WS G +L EI+T
Sbjct: 204 D---SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/121 (32%), Positives = 62/121 (51%), Gaps = 9/121 (7%)
Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE----YVVTR 111
           ++  G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD+  +     +  R
Sbjct: 133 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 192
Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITE--LIGSPD 168
           W  +PE L +   +T   D+WS G +L EI T  E  + G      LR + E  L+  PD
Sbjct: 193 WM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD 250
Query: 169 D 169
           +
Sbjct: 251 N 251

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/126 (31%), Positives = 65/126 (51%), Gaps = 15/126 (11%)
Query: 24  VYIVYELMDTD-LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 82
           V I  EL++   L Q+++    L +D   Y+L Q L GL+Y+HS  +LH D+K  N+LL+
Sbjct: 160 VNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNVLLS 219
Query: 83  ------ASCDLK----IGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIW 132
                 A CD      +   GL ++    D++     T  + APE++L      A +D+W
Sbjct: 220 SDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPG---TETHMAPEVVLG-RSCDAKVDVW 275
Query: 133 SVGCIL 138
           S  C++
Sbjct: 276 SSCCMM 281

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 54/106 (50%), Gaps = 6/106 (5%)
Query: 42  DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET 101
           ++ LT      F +Q+ +G++Y+    ++HRDL   N+L+     +KI DFGL+R   E 
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 102 DFMTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           D   +     +  +W     L  +   YT   D+WS G +L EI+T
Sbjct: 204 DSXVKRSQGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIVT 247

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 80/177 (45%), Gaps = 13/177 (7%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           ++H N+I +  ++  P      ++  +  L+D    ++ +            +  Q+  G
Sbjct: 78  LDHRNLIRLYGVVLTPPMKMVTELAPLGSLLD----RLRKHQGHFLLGTLSRYAVQVAEG 133
Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEY-VVTRWYRAP 116
           + Y+ S   +HRDL   NLLL     +KIGDFGL R   + D    M E+  V   + AP
Sbjct: 134 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAP 193
Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFP--GKDYVHQLRLITELIGSPDD 169
           E L   T ++ A D W  G  L E+ T  +EP     G   +H++    E +  P+D
Sbjct: 194 ESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 249

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 80/177 (45%), Gaps = 13/177 (7%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           ++H N+I +  ++  P      ++  +  L+D    ++ +            +  Q+  G
Sbjct: 68  LDHRNLIRLYGVVLTPPMKMVTELAPLGSLLD----RLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEY-VVTRWYRAP 116
           + Y+ S   +HRDL   NLLL     +KIGDFGL R   + D    M E+  V   + AP
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAP 183
Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFP--GKDYVHQLRLITELIGSPDD 169
           E L   T ++ A D W  G  L E+ T  +EP     G   +H++    E +  P+D
Sbjct: 184 ESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 239

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 105/244 (43%), Gaps = 43/244 (17%)
Query: 21  FNDVYIVYELMDT-DLHQIIRSDQQL---TDDHCQYFLYQLLRGLKYVHS---ASVLHRD 73
            N V +V E  +   L+ ++   + L   T  H   +  Q  +G+ Y+HS    +++HRD
Sbjct: 71  LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130
Query: 74  LKPSNLLLNASCD-LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIW 132
           LKP NLLL A    LKI DFG A        MT    +  + APE +   + Y+   D++
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTA--CDIQTHMTNNKGSAAWMAPE-VFEGSNYSEKCDVF 187
Query: 133 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 192
           S G IL E++TR   F             + IG P    +  + +      ++ LP+   
Sbjct: 188 SWGIILWEVITRRKPF-------------DEIGGPAFRIMWAVHNGTRPPLIKNLPK--- 231
Query: 193 QQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFD 252
                  P +S     L+ +    DP++R ++EE ++       H +   P    P  + 
Sbjct: 232 -------PIES-----LMTRCWSKDPSQRPSMEEIVK----IMTHLMRYFPGADEPLQYP 275
Query: 253 FEHS 256
            +HS
Sbjct: 276 CQHS 279

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 80/177 (45%), Gaps = 13/177 (7%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           ++H N+I +  ++  P      ++  +  L+D    ++ +            +  Q+  G
Sbjct: 78  LDHRNLIRLYGVVLTPPMKMVTELAPLGSLLD----RLRKHQGHFLLGTLSRYAVQVAEG 133
Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEY-VVTRWYRAP 116
           + Y+ S   +HRDL   NLLL     +KIGDFGL R   + D    M E+  V   + AP
Sbjct: 134 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 193
Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFP--GKDYVHQLRLITELIGSPDD 169
           E L   T ++ A D W  G  L E+ T  +EP     G   +H++    E +  P+D
Sbjct: 194 ESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 249

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 80/177 (45%), Gaps = 13/177 (7%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           ++H N+I +  ++  P      ++  +  L+D    ++ +            +  Q+  G
Sbjct: 68  LDHRNLIRLYGVVLTPPMKMVTELAPLGSLLD----RLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEY-VVTRWYRAP 116
           + Y+ S   +HRDL   NLLL     +KIGDFGL R   + D    M E+  V   + AP
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFP--GKDYVHQLRLITELIGSPDD 169
           E L   T ++ A D W  G  L E+ T  +EP     G   +H++    E +  P+D
Sbjct: 184 ESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 239

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 80/177 (45%), Gaps = 13/177 (7%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           ++H N+I +  ++  P      ++  +  L+D    ++ +            +  Q+  G
Sbjct: 72  LDHRNLIRLYGVVLTPPMKMVTELAPLGSLLD----RLRKHQGHFLLGTLSRYAVQVAEG 127
Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEY-VVTRWYRAP 116
           + Y+ S   +HRDL   NLLL     +KIGDFGL R   + D    M E+  V   + AP
Sbjct: 128 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 187
Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFP--GKDYVHQLRLITELIGSPDD 169
           E L   T ++ A D W  G  L E+ T  +EP     G   +H++    E +  P+D
Sbjct: 188 ESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 243

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 80/177 (45%), Gaps = 13/177 (7%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           ++H N+I +  ++  P      ++  +  L+D    ++ +            +  Q+  G
Sbjct: 68  LDHRNLIRLYGVVLTPPMKMVTELAPLGSLLD----RLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEY-VVTRWYRAP 116
           + Y+ S   +HRDL   NLLL     +KIGDFGL R   + D    M E+  V   + AP
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFP--GKDYVHQLRLITELIGSPDD 169
           E L   T ++ A D W  G  L E+ T  +EP     G   +H++    E +  P+D
Sbjct: 184 ESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 239

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 80/177 (45%), Gaps = 13/177 (7%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           ++H N+I +  ++  P      ++  +  L+D    ++ +            +  Q+  G
Sbjct: 72  LDHRNLIRLYGVVLTPPMKMVTELAPLGSLLD----RLRKHQGHFLLGTLSRYAVQVAEG 127
Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEY-VVTRWYRAP 116
           + Y+ S   +HRDL   NLLL     +KIGDFGL R   + D    M E+  V   + AP
Sbjct: 128 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 187
Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFP--GKDYVHQLRLITELIGSPDD 169
           E L   T ++ A D W  G  L E+ T  +EP     G   +H++    E +  P+D
Sbjct: 188 ESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED 243

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 74/146 (50%), Gaps = 13/146 (8%)
Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY--QLLR 59
           +H +++ +  +I      T N V+I+ EL      +     ++ + D     LY  QL  
Sbjct: 69  DHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLST 122
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTRWYRAP 116
            L Y+ S   +HRD+   N+L++A+  +K+GDFGL+R   ++ +       +  +W  AP
Sbjct: 123 ALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-AP 181
Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIM 142
           E  +N   +T+A D+W  G  + EI+
Sbjct: 182 E-SINFRRFTSASDVWMFGVCMWEIL 206

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/123 (33%), Positives = 66/123 (53%), Gaps = 9/123 (7%)
Query: 24  VYIVYELMDTD-LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 82
           V I  EL++   L Q+++    L +D   Y+L Q L GL+Y+HS  +LH D+K  N+LL+
Sbjct: 141 VNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNVLLS 200
Query: 83  A-SCDLKIGDFGLARTTS----ETDFMT-EYV-VTRWYRAPELLLNCTEYTAAIDIWSVG 135
           +      + DFG A          D +T +Y+  T  + APE++L      A +D+WS  
Sbjct: 201 SDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLG-RSCDAKVDVWSSC 259
Query: 136 CIL 138
           C++
Sbjct: 260 CMM 262

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 56/95 (58%), Gaps = 5/95 (5%)
Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE---TDFMTEYVVTRW 112
           Q  +G+ Y+H+ +++HRD+K +N+ L+    +KIGDFGLA   S    +  + +   +  
Sbjct: 140 QTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVL 199
Query: 113 YRAPEL--LLNCTEYTAAIDIWSVGCILGEIMTRE 145
           + APE+  + +   ++   D++S G +L E+MT E
Sbjct: 200 WMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGE 234

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 39/121 (32%), Positives = 61/121 (50%), Gaps = 9/121 (7%)
Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE----YVVTR 111
           ++  G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD   +     +  R
Sbjct: 131 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 190
Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITE--LIGSPD 168
           W  +PE L +   +T   D+WS G +L EI T  E  + G      LR + E  L+  PD
Sbjct: 191 WM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD 248
Query: 169 D 169
           +
Sbjct: 249 N 249

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 39/121 (32%), Positives = 61/121 (50%), Gaps = 9/121 (7%)
Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE----YVVTR 111
           ++  G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD   +     +  R
Sbjct: 140 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 199
Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITE--LIGSPD 168
           W  +PE L +   +T   D+WS G +L EI T  E  + G      LR + E  L+  PD
Sbjct: 200 WM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD 257
Query: 169 D 169
           +
Sbjct: 258 N 258

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 59/103 (57%), Gaps = 6/103 (5%)
Query: 45  LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDF 103
           LT +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR    + D+
Sbjct: 141 LTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDY 200
Query: 104 MTE---YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           + +    +  +W  APE + +   YT   D+WS G +L EI +
Sbjct: 201 VRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFS 241

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 51/98 (52%), Gaps = 11/98 (11%)
Query: 53  FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR- 111
           F  Q+  G+ Y+H+   +HRDL   N+LL+    +KIGDFGLA+   E      Y V   
Sbjct: 139 FAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH--EXYRVRED 196
Query: 112 ------WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
                 WY APE L     Y A+ D+WS G  L E++T
Sbjct: 197 GDSPVFWY-APECLKEYKFYYAS-DVWSFGVTLYELLT 232

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 35/111 (31%), Positives = 58/111 (52%), Gaps = 8/111 (7%)
Query: 44  QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF 103
           +LT     +   Q+  G+ Y+ S   +HRDL   N L+  +  +KIGDFG++R    TD+
Sbjct: 124 ELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDY 183
Query: 104 MT----EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLF 148
                   +  RW   PE ++   ++T   D+WS+G +L EI T  ++P +
Sbjct: 184 YRVGGHTMLPIRWM-PPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWY 232

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 74/146 (50%), Gaps = 13/146 (8%)
Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY--QLLR 59
           +H +++ +  +I      T N V+I+ EL      +     ++ + D     LY  QL  
Sbjct: 449 DHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLST 502
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTRWYRAP 116
            L Y+ S   +HRD+   N+L++A+  +K+GDFGL+R   ++ +       +  +W  AP
Sbjct: 503 ALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-AP 561
Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIM 142
           E  +N   +T+A D+W  G  + EI+
Sbjct: 562 E-SINFRRFTSASDVWMFGVCMWEIL 586

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 38/100 (38%), Positives = 54/100 (54%), Gaps = 16/100 (16%)
Query: 53  FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE--YVV- 109
           F YQ+ +G++++   S +HRDL   N+L+     +KI DFGLAR     D M++  YVV 
Sbjct: 177 FAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLAR-----DIMSDSNYVVR 231
Query: 110 ------TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
                  +W  APE L     YT   D+WS G +L EI +
Sbjct: 232 GNARLPVKW-MAPESLFEGI-YTIKSDVWSYGILLWEIFS 269

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 85/213 (39%), Gaps = 58/213 (27%)
Query: 40  RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA---SCDLKIGDFGLAR 96
           R DQ  T+      +  +   ++Y+HS ++ HRD+KP NLL  +   +  LK+ DFG A+
Sbjct: 109 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
Query: 97  TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ 156
            T+                        +Y  + D+WS+G I+  ++   P F      H 
Sbjct: 169 ETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSN---HG 203
Query: 157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVD-----LLE 211
           L +      SP   +                 R R  Q+   FPN     V      L+ 
Sbjct: 204 LAI------SPGMKT-----------------RIRMGQY--EFPNPEWSEVSEEVKMLIR 238
Query: 212 KMLVFDPNKRITVEEALRHPYLQSLHDLNDEPV 244
            +L  +P +R+T+ E + HP++     +   P+
Sbjct: 239 NLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 271

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 39/121 (32%), Positives = 61/121 (50%), Gaps = 9/121 (7%)
Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE----YVVTR 111
           ++  G+ Y+++   +HRDL   N  +     +KIGDFG+ R   ETD+  +     +  R
Sbjct: 133 EIADGMAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 192
Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITE--LIGSPD 168
           W  +PE L +   +T   D+WS G +L EI T  E  + G      LR + E  L+  PD
Sbjct: 193 WM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD 250
Query: 169 D 169
           +
Sbjct: 251 N 251

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 39/204 (19%)
Query: 34  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDF 92
           DL   I     L ++  + F +Q+L  +++ H+  VLHRD+K  N+L++ +  +LK+ DF
Sbjct: 96  DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 155
Query: 93  GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 152
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L +++  +  F   +
Sbjct: 156 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 214
Query: 153 YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEK 212
                    E+IG               + + RQ                SS    L+  
Sbjct: 215 ---------EIIG--------------GQVFFRQ--------------RVSSECQHLIRW 237
Query: 213 MLVFDPNKRITVEEALRHPYLQSL 236
            L   P+ R T EE   HP++Q +
Sbjct: 238 CLALRPSDRPTFEEIQNHPWMQDV 261

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 56/106 (52%), Gaps = 15/106 (14%)
Query: 48  DHCQYFLY--QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT 105
           DH +   Y  Q+ +G++Y+ +   +HRDL   N+L+     +KIGDFGL +   +     
Sbjct: 112 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD---K 168
Query: 106 EYVVTR--------WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           E+   +        WY APE L   ++++ A D+WS G +L E+ T
Sbjct: 169 EFFKVKEPGESPIFWY-APESLTE-SKFSVASDVWSFGVVLYELFT 212

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 75/162 (46%), Gaps = 25/162 (15%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ-------QLTDDHCQY 52
           + HE ++ +  ++      +   +YIV E M    L   ++ +        QL D     
Sbjct: 319 LRHEKLVQLYAVV------SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD----- 367
Query: 53  FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-- 110
              Q+  G+ YV   + +HRDL+ +N+L+  +   K+ DFGLAR   + ++         
Sbjct: 368 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 427
Query: 111 -RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 150
            +W  APE  L    +T   D+WS G +L E+ T+  + +PG
Sbjct: 428 IKW-TAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPG 467

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 39/204 (19%)
Query: 34  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDF 92
           DL   I     L ++  + F +Q+L  +++ H+  VLHRD+K  N+L++ +  +LK+ DF
Sbjct: 128 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 187
Query: 93  GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 152
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L +++  +  F   +
Sbjct: 188 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 246
Query: 153 YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEK 212
                    E+IG               + + RQ                SS    L+  
Sbjct: 247 ---------EIIG--------------GQVFFRQ--------------RVSSECQHLIRW 269
Query: 213 MLVFDPNKRITVEEALRHPYLQSL 236
            L   P+ R T EE   HP++Q +
Sbjct: 270 CLALRPSDRPTFEEIQNHPWMQDV 293

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/123 (30%), Positives = 68/123 (55%), Gaps = 11/123 (8%)
Query: 25  YIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 84
           ++ Y++   DL++       LT +H   + +Q+ +G++++ S   +HRDL   N+LL+  
Sbjct: 130 FVPYKVAPEDLYKDF-----LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 184
Query: 85  CDLKIGDFGLARTT-SETDFMTE---YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
             +KI DFGLAR    + D++ +    +  +W  APE + +   YT   D+WS G +L E
Sbjct: 185 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWE 242
Query: 141 IMT 143
           I +
Sbjct: 243 IFS 245

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 39/204 (19%)
Query: 34  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDF 92
           DL   I     L ++  + F +Q+L  +++ H+  VLHRD+K  N+L++ +  +LK+ DF
Sbjct: 128 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 187
Query: 93  GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 152
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L +++  +  F   +
Sbjct: 188 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 246
Query: 153 YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEK 212
                    E+IG               + + RQ                SS    L+  
Sbjct: 247 ---------EIIG--------------GQVFFRQ--------------RVSSECQHLIRW 269
Query: 213 MLVFDPNKRITVEEALRHPYLQSL 236
            L   P+ R T EE   HP++Q +
Sbjct: 270 CLALRPSDRPTFEEIQNHPWMQDV 293

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 76/162 (46%), Gaps = 25/162 (15%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ-------QLTDDHCQY 52
           + HE ++ +  ++      +   +YIV E M+   L   ++ +        QL D   Q 
Sbjct: 67  LRHEKLVQLYAVV------SEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQ- 119
Query: 53  FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-- 110
               +  G+ YV   + +HRDL+ +N+L+  +   K+ DFGLAR   + ++         
Sbjct: 120 ----IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 175
Query: 111 -RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 150
            +W  APE  L    +T   D+WS G +L E+ T+  + +PG
Sbjct: 176 IKW-TAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPG 215

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/123 (30%), Positives = 68/123 (55%), Gaps = 11/123 (8%)
Query: 25  YIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 84
           ++ Y++   DL++       LT +H   + +Q+ +G++++ S   +HRDL   N+LL+  
Sbjct: 121 FVPYKVAPEDLYKDF-----LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 175
Query: 85  CDLKIGDFGLARTT-SETDFMTE---YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
             +KI DFGLAR    + D++ +    +  +W  APE + +   YT   D+WS G +L E
Sbjct: 176 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWE 233
Query: 141 IMT 143
           I +
Sbjct: 234 IFS 236

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 39/204 (19%)
Query: 34  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDF 92
           DL   I     L ++  + F +Q+L  +++ H+  VLHRD+K  N+L++ +  +LK+ DF
Sbjct: 129 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 188
Query: 93  GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 152
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L +++  +  F   +
Sbjct: 189 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 247
Query: 153 YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEK 212
                    E+IG               + + RQ                SS    L+  
Sbjct: 248 ---------EIIG--------------GQVFFRQ--------------RVSSECQHLIRW 270
Query: 213 MLVFDPNKRITVEEALRHPYLQSL 236
            L   P+ R T EE   HP++Q +
Sbjct: 271 CLALRPSDRPTFEEIQNHPWMQDV 294

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 39/204 (19%)
Query: 34  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDF 92
           DL   I     L ++  + F +Q+L  +++ H+  VLHRD+K  N+L++ +  +LK+ DF
Sbjct: 129 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 188
Query: 93  GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 152
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L +++  +  F   +
Sbjct: 189 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 247
Query: 153 YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEK 212
                    E+IG               + + RQ                SS    L+  
Sbjct: 248 ---------EIIG--------------GQVFFRQ--------------RVSSECQHLIRW 270
Query: 213 MLVFDPNKRITVEEALRHPYLQSL 236
            L   P+ R T EE   HP++Q +
Sbjct: 271 CLALRPSDRPTFEEIQNHPWMQDV 294

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 71/148 (47%), Gaps = 12/148 (8%)
Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGL 61
           +H N+I ++ ++   +       Y+    +DT L      D Q T       L  +  G+
Sbjct: 108 DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGM 164
Query: 62  KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RWYRA 115
           +Y+     +HRDL   N+L++++   K+ DFGL+R   E D    Y  T      RW  A
Sbjct: 165 RYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL-EDDPDAAYTTTGGKIPIRW-TA 222
Query: 116 PELLLNCTEYTAAIDIWSVGCILGEIMT 143
           PE +   T +++A D+WS G ++ E++ 
Sbjct: 223 PEAIAFRT-FSSASDVWSFGVVMWEVLA 249

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/123 (30%), Positives = 68/123 (55%), Gaps = 11/123 (8%)
Query: 25  YIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 84
           ++ Y++   DL++       LT +H   + +Q+ +G++++ S   +HRDL   N+LL+  
Sbjct: 121 FVPYKVAPEDLYKDF-----LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 175
Query: 85  CDLKIGDFGLARTT-SETDFMTE---YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
             +KI DFGLAR    + D++ +    +  +W  APE + +   YT   D+WS G +L E
Sbjct: 176 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWE 233
Query: 141 IMT 143
           I +
Sbjct: 234 IFS 236

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/123 (30%), Positives = 68/123 (55%), Gaps = 11/123 (8%)
Query: 25  YIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 84
           ++ Y++   DL++       LT +H   + +Q+ +G++++ S   +HRDL   N+LL+  
Sbjct: 167 FVPYKVAPEDLYKDF-----LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 221
Query: 85  CDLKIGDFGLARTT-SETDFMTE---YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
             +KI DFGLAR    + D++ +    +  +W  APE + +   YT   D+WS G +L E
Sbjct: 222 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWE 279
Query: 141 IMT 143
           I +
Sbjct: 280 IFS 282

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 56/106 (52%), Gaps = 15/106 (14%)
Query: 48  DHCQYFLY--QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT 105
           DH +   Y  Q+ +G++Y+ +   +HR+L   N+L+     +KIGDFGL +   +     
Sbjct: 113 DHIKLLQYTSQICKGMEYLGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQD---K 169
Query: 106 EYVVTR--------WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           EY   +        WY APE L   ++++ A D+WS G +L E+ T
Sbjct: 170 EYYKVKEPGESPIFWY-APESLTE-SKFSVASDVWSFGVVLYELFT 213

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 75/162 (46%), Gaps = 25/162 (15%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTD-LHQIIRSDQ-------QLTDDHCQY 52
           + HE ++ +  ++      +   +YIV E M    L   ++ +        QL D     
Sbjct: 70  LRHEKLVQLYAVV------SEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVD----- 118
Query: 53  FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-- 110
              Q+  G+ YV   + +HRDL+ +N+L+  +   K+ DFGLAR   + ++         
Sbjct: 119 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 178
Query: 111 -RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 150
            +W  APE  L    +T   D+WS G +L E+ T+  + +PG
Sbjct: 179 IKW-TAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 59/103 (57%), Gaps = 6/103 (5%)
Query: 45  LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDF 103
           LT +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR    + D+
Sbjct: 195 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 254
Query: 104 MTE---YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           + +    +  +W  APE + +   YT   D+WS G +L EI +
Sbjct: 255 VRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFS 295

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 6/99 (6%)
Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RW 112
           Q+  G+ YV   + +HRDL+ +N+L+  +   K+ DFGLAR   + ++          +W
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 347
Query: 113 YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 150
             APE  L    +T   D+WS G +L E+ T+  + +PG
Sbjct: 348 -TAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPG 384

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 6/99 (6%)
Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RW 112
           Q+  G+ YV   + +HRDL+ +N+L+  +   K+ DFGLAR   + ++          +W
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 347
Query: 113 YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 150
             APE  L    +T   D+WS G +L E+ T+  + +PG
Sbjct: 348 -TAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPG 384

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/137 (29%), Positives = 71/137 (51%), Gaps = 9/137 (6%)
Query: 5   NVIAIKDIIRPPKKDTFNDVYIVYELMD--TDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 62
            VI + D    P  D+F    ++ E M+   DL   I     L ++  + F +Q+L  ++
Sbjct: 74  GVIRLLDWFERP--DSF---VLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVR 128
Query: 63  YVHSASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 121
           + H+  VLHRD+K  N+L++ +  +LK+ DFG      +T + T++  TR Y  PE +  
Sbjct: 129 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRY 187
Query: 122 CTEYTAAIDIWSVGCIL 138
              +  +  +WS+G +L
Sbjct: 188 HRYHGRSAAVWSLGILL 204

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 6/99 (6%)
Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RW 112
           Q+  G+ YV   + +HRDL+ +N+L+  +   K+ DFGLAR   + ++          +W
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 347
Query: 113 YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 150
             APE  L    +T   D+WS G +L E+ T+  + +PG
Sbjct: 348 -TAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPG 384

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 75/162 (46%), Gaps = 25/162 (15%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ-------QLTDDHCQY 52
           + HE ++ +  ++      +   +YIV E M    L   ++ +        QL D     
Sbjct: 70  LRHEKLVQLYAVV------SEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVD----- 118
Query: 53  FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-- 110
              Q+  G+ YV   + +HRDL+ +N+L+  +   K+ DFGLAR   + ++         
Sbjct: 119 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 178
Query: 111 -RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 150
            +W  APE  L    +T   D+WS G +L E+ T+  + +PG
Sbjct: 179 IKW-TAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 59/103 (57%), Gaps = 6/103 (5%)
Query: 45  LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDF 103
           LT +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR    + D+
Sbjct: 197 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 256
Query: 104 MTE---YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           + +    +  +W  APE + +   YT   D+WS G +L EI +
Sbjct: 257 VRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFS 297

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 59/103 (57%), Gaps = 6/103 (5%)
Query: 45  LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDF 103
           LT +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR    + D+
Sbjct: 190 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249
Query: 104 MTE---YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           + +    +  +W  APE + +   YT   D+WS G +L EI +
Sbjct: 250 VRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFS 290

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 34  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDF 92
           DL   I     L ++  + F +Q+L  +++ H+  VLHRD+K  N+L++ +  +LK+ DF
Sbjct: 101 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 160
Query: 93  GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 138
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 161 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 205

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 34  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDF 92
           DL   I     L ++  + F +Q+L  +++ H+  VLHRD+K  N+L++ +  +LK+ DF
Sbjct: 123 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 182
Query: 93  GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 138
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 183 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 227

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 34  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDF 92
           DL   I     L ++  + F +Q+L  +++ H+  VLHRD+K  N+L++ +  +LK+ DF
Sbjct: 100 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 159
Query: 93  GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 138
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 160 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 204

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 34  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDF 92
           DL   I     L ++  + F +Q+L  +++ H+  VLHRD+K  N+L++ +  +LK+ DF
Sbjct: 101 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 160
Query: 93  GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 138
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 161 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 205

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 34  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDF 92
           DL   I     L ++  + F +Q+L  +++ H+  VLHRD+K  N+L++ +  +LK+ DF
Sbjct: 116 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 175
Query: 93  GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 138
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 176 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 220

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 34  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDF 92
           DL   I     L ++  + F +Q+L  +++ H+  VLHRD+K  N+L++ +  +LK+ DF
Sbjct: 115 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 174
Query: 93  GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 138
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 175 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 219

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 51/92 (55%), Gaps = 6/92 (6%)
Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE----YVVTR 111
           ++  G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD+  +     +  R
Sbjct: 138 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 197
Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           W  APE L +   +T + D+WS G +L EI +
Sbjct: 198 WM-APESLKDGV-FTTSSDMWSFGVVLWEITS 227

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 34  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDF 92
           DL   I     L ++  + F +Q+L  +++ H+  VLHRD+K  N+L++ +  +LK+ DF
Sbjct: 101 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 160
Query: 93  GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 138
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 161 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 205

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 75/162 (46%), Gaps = 25/162 (15%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ-------QLTDDHCQY 52
           + HE ++ +  ++      +   +YIV E M    L   ++ +        QL D     
Sbjct: 61  LRHEKLVQLYAVV------SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD----- 109
Query: 53  FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-- 110
              Q+  G+ YV   + +HRDL+ +N+L+  +   K+ DFGLAR   + ++         
Sbjct: 110 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 169
Query: 111 -RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 150
            +W  APE  L    +T   D+WS G +L E+ T+  + +PG
Sbjct: 170 IKW-TAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPG 209

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 75/162 (46%), Gaps = 25/162 (15%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ-------QLTDDHCQY 52
           + HE ++ +  ++      +   +YIV E M    L   ++ +        QL D     
Sbjct: 59  LRHEKLVQLYAVV------SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD----- 107
Query: 53  FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-- 110
              Q+  G+ YV   + +HRDL+ +N+L+  +   K+ DFGLAR   + ++         
Sbjct: 108 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 167
Query: 111 -RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 150
            +W  APE  L    +T   D+WS G +L E+ T+  + +PG
Sbjct: 168 IKW-TAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPG 207

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 34  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDF 92
           DL   I     L ++  + F +Q+L  +++ H+  VLHRD+K  N+L++ +  +LK+ DF
Sbjct: 135 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 194
Query: 93  GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 138
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 195 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 239

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 34  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDF 92
           DL   I     L ++  + F +Q+L  +++ H+  VLHRD+K  N+L++ +  +LK+ DF
Sbjct: 96  DLFDFITERGALQEELARSFFWQVLEAVRHCHNXGVLHRDIKDENILIDLNRGELKLIDF 155
Query: 93  GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 138
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 156 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 200

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 34  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDF 92
           DL   I     L ++  + F +Q+L  +++ H+  VLHRD+K  N+L++ +  +LK+ DF
Sbjct: 99  DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 158
Query: 93  GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 138
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 159 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 203

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 76/162 (46%), Gaps = 25/162 (15%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ-------QLTDDHCQY 52
           + HE ++ +  ++      +   +YIV E M+   L   ++ +        QL D   Q 
Sbjct: 67  LRHEKLVQLYAVV------SEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQ- 119
Query: 53  FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-- 110
               +  G+ YV   + +HRDL+ +N+L+  +   K+ DFGLAR   + ++         
Sbjct: 120 ----IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFP 175
Query: 111 -RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 150
            +W  APE  L    +T   D+WS G +L E+ T+  + +PG
Sbjct: 176 IKW-TAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPG 215

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 34  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDF 92
           DL   I     L ++  + F +Q+L  +++ H+  VLHRD+K  N+L++ +  +LK+ DF
Sbjct: 116 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 175
Query: 93  GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 138
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 176 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 220

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 51/92 (55%), Gaps = 6/92 (6%)
Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE----YVVTR 111
           ++  G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD+  +     +  R
Sbjct: 137 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 196
Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           W  APE L +   +T + D+WS G +L EI +
Sbjct: 197 WM-APESLKDGV-FTTSSDMWSFGVVLWEITS 226

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 74/146 (50%), Gaps = 13/146 (8%)
Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY--QLLR 59
           +H +++ +  +I      T N V+I+ EL      +     ++ + D     LY  QL  
Sbjct: 449 DHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLST 502
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTRWYRAP 116
            L Y+ S   +HRD+   N+L++++  +K+GDFGL+R   ++ +       +  +W  AP
Sbjct: 503 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-AP 561
Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIM 142
           E  +N   +T+A D+W  G  + EI+
Sbjct: 562 E-SINFRRFTSASDVWMFGVCMWEIL 586

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 75/162 (46%), Gaps = 25/162 (15%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ-------QLTDDHCQY 52
           + HE ++ +  ++      +   +YIV E M    L   ++ +        QL D     
Sbjct: 70  LRHEKLVQLYAVV------SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD----- 118
Query: 53  FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-- 110
              Q+  G+ YV   + +HRDL+ +N+L+  +   K+ DFGLAR   + ++         
Sbjct: 119 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 178
Query: 111 -RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 150
            +W  APE  L    +T   D+WS G +L E+ T+  + +PG
Sbjct: 179 IKW-TAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 63/122 (51%), Gaps = 9/122 (7%)
Query: 25  YIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 84
           ++ Y++   DL++       LT +H   + +Q+ +G++++ S   +HRDL   N+LL+  
Sbjct: 121 FVPYKVAPEDLYKDF-----LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 175
Query: 85  CDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEI 141
             +KI DFGLAR   +          R    + APE + +   YT   D+WS G +L EI
Sbjct: 176 NVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEI 234
Query: 142 MT 143
            +
Sbjct: 235 FS 236

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 34  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDF 92
           DL   I     L ++  + F +Q+L  +++ H+  VLHRD+K  N+L++ +  +LK+ DF
Sbjct: 115 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 174
Query: 93  GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 138
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 175 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 219

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 75/162 (46%), Gaps = 25/162 (15%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTD-LHQIIRSDQ-------QLTDDHCQY 52
           + HE ++ +  ++      +   +YIV E M    L   ++ +        QL D     
Sbjct: 70  LRHEKLVQLYAVV------SEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVD----- 118
Query: 53  FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-- 110
              Q+  G+ YV   + +HRDL+ +N+L+  +   K+ DFGLAR   + ++         
Sbjct: 119 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 178
Query: 111 -RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 150
            +W  APE  L    +T   D+WS G +L E+ T+  + +PG
Sbjct: 179 IKW-TAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 63/122 (51%), Gaps = 9/122 (7%)
Query: 25  YIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 84
           ++ Y++   DL++       LT +H   + +Q+ +G++++ S   +HRDL   N+LL+  
Sbjct: 130 FVPYKVAPEDLYKDF-----LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 184
Query: 85  CDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEI 141
             +KI DFGLAR   +          R    + APE + +   YT   D+WS G +L EI
Sbjct: 185 NVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEI 243
Query: 142 MT 143
            +
Sbjct: 244 FS 245

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 59/103 (57%), Gaps = 6/103 (5%)
Query: 45  LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDF 103
           LT +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR    + D+
Sbjct: 188 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 247
Query: 104 MTE---YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           + +    +  +W  APE + +   YT   D+WS G +L EI +
Sbjct: 248 VRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFS 288

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/126 (32%), Positives = 66/126 (52%), Gaps = 15/126 (11%)
Query: 24  VYIVYELMDTD-LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 82
           V I  EL++   L Q+I+    L +D   Y+L Q L GL+Y+H+  +LH D+K  N+LL+
Sbjct: 141 VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS 200
Query: 83  ------ASCD----LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIW 132
                 A CD    L +   GL ++    D++     T  + APE+++      A +DIW
Sbjct: 201 SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG---TETHMAPEVVMG-KPCDAKVDIW 256
Query: 133 SVGCIL 138
           S  C++
Sbjct: 257 SSCCMM 262

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 54/102 (52%), Gaps = 4/102 (3%)
Query: 45  LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM 104
           LT +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR   +    
Sbjct: 145 LTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX 204
Query: 105 TEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
                 R    + APE + +   YT   D+WS G +L EI +
Sbjct: 205 VRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 245

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/126 (32%), Positives = 66/126 (52%), Gaps = 15/126 (11%)
Query: 24  VYIVYELMDTD-LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 82
           V I  EL++   L Q+I+    L +D   Y+L Q L GL+Y+H+  +LH D+K  N+LL+
Sbjct: 125 VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS 184
Query: 83  ------ASCD----LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIW 132
                 A CD    L +   GL ++    D++     T  + APE+++      A +DIW
Sbjct: 185 SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG---TETHMAPEVVMG-KPCDAKVDIW 240
Query: 133 SVGCIL 138
           S  C++
Sbjct: 241 SSCCMM 246

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 34  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDF 92
           DL   I     L ++  + F +Q+L  +++ H+  VLHRD+K  N+L++ +  +LK+ DF
Sbjct: 116 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 175
Query: 93  GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 138
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 176 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 220

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 6/99 (6%)
Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RW 112
           Q+  G+ YV   + +HRDL+ +N+L+  +   K+ DFGLAR   + ++          +W
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 113 YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 150
             APE  L    +T   D+WS G +L E+ T+  + +PG
Sbjct: 182 -TAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 63/122 (51%), Gaps = 9/122 (7%)
Query: 25  YIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 84
           ++ Y++   DL++       LT +H   + +Q+ +G++++ S   +HRDL   N+LL+  
Sbjct: 121 FVPYKVAPEDLYKDF-----LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 175
Query: 85  CDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEI 141
             +KI DFGLAR   +          R    + APE + +   YT   D+WS G +L EI
Sbjct: 176 NVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEI 234
Query: 142 MT 143
            +
Sbjct: 235 FS 236

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 34  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDF 92
           DL   I     L ++  + F +Q+L  +++ H+  VLHRD+K  N+L++ +  +LK+ DF
Sbjct: 148 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 207
Query: 93  GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 138
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 208 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 252

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 34  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDF 92
           DL   I     L ++  + F +Q+L  +++ H+  VLHRD+K  N+L++ +  +LK+ DF
Sbjct: 128 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 187
Query: 93  GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 138
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 188 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 232

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 59/103 (57%), Gaps = 6/103 (5%)
Query: 45  LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDF 103
           LT +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR    + D+
Sbjct: 141 LTLEHLICYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 200
Query: 104 MTE---YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           + +    +  +W  APE + +   YT   D+WS G +L EI +
Sbjct: 201 VRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFS 241

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 75/162 (46%), Gaps = 25/162 (15%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ-------QLTDDHCQY 52
           + HE ++ +  ++      +   +YIV E M    L   ++ +        QL D     
Sbjct: 63  LRHEKLVQLYAVV------SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD----- 111
Query: 53  FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-- 110
              Q+  G+ YV   + +HRDL+ +N+L+  +   K+ DFGLAR   + ++         
Sbjct: 112 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 171
Query: 111 -RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 150
            +W  APE  L    +T   D+WS G +L E+ T+  + +PG
Sbjct: 172 IKW-TAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPG 211

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 59/103 (57%), Gaps = 6/103 (5%)
Query: 45  LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-SETDF 103
           LT +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR    + D+
Sbjct: 147 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 206
Query: 104 MTE---YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           + +    +  +W  APE + +   YT   D+WS G +L EI +
Sbjct: 207 VRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFS 247

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 34  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDF 92
           DL   I     L ++  + F +Q+L  +++ H+  VLHRD+K  N+L++ +  +LK+ DF
Sbjct: 96  DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 155
Query: 93  GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 138
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 156 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 200

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 34  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDF 92
           DL   I     L ++  + F +Q+L  +++ H+  VLHRD+K  N+L++ +  +LK+ DF
Sbjct: 143 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 202
Query: 93  GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 138
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 203 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 247

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 34  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDF 92
           DL   I     L ++  + F +Q+L  +++ H+  VLHRD+K  N+L++ +  +LK+ DF
Sbjct: 143 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 202
Query: 93  GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 138
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 203 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 247

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 54/103 (52%), Gaps = 9/103 (8%)
Query: 48  DHCQYFLY--QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT 105
           DH +   Y  Q+ +G++Y+ +   +HRDL   N+L+     +KIGDFGL +   +     
Sbjct: 115 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXX 174
Query: 106 EYVVTR-----WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           +          WY APE L   ++++ A D+WS G +L E+ T
Sbjct: 175 KVKEPGESPIFWY-APESLTE-SKFSVASDVWSFGVVLYELFT 215

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 34  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDF 92
           DL   I     L ++  + F +Q+L  +++ H+  VLHRD+K  N+L++ +  +LK+ DF
Sbjct: 143 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 202
Query: 93  GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 138
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 203 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 247

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/126 (32%), Positives = 66/126 (52%), Gaps = 15/126 (11%)
Query: 24  VYIVYELMDTD-LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 82
           V I  EL++   L Q+I+    L +D   Y+L Q L GL+Y+H+  +LH D+K  N+LL+
Sbjct: 139 VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS 198
Query: 83  ------ASCD----LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIW 132
                 A CD    L +   GL ++    D++     T  + APE+++      A +DIW
Sbjct: 199 SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG---TETHMAPEVVMG-KPCDAKVDIW 254
Query: 133 SVGCIL 138
           S  C++
Sbjct: 255 SSCCMM 260

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 6/99 (6%)
Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RW 112
           Q+  G+ YV   + +HRDL+ +N+L+  +   K+ DFGLAR   + ++          +W
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 113 YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 150
             APE  L    +T   D+WS G +L E+ T+  + +PG
Sbjct: 182 -TAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 34  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDF 92
           DL   I     L ++  + F +Q+L  +++ H+  VLHRD+K  N+L++ +  +LK+ DF
Sbjct: 129 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 188
Query: 93  GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 138
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 189 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 233

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 34  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDF 92
           DL   I     L ++  + F +Q+L  +++ H+  VLHRD+K  N+L++ +  +LK+ DF
Sbjct: 128 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 187
Query: 93  GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 138
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 188 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 232

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 54/103 (52%), Gaps = 9/103 (8%)
Query: 48  DHCQYFLY--QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT 105
           DH +   Y  Q+ +G++Y+ +   +HRDL   N+L+     +KIGDFGL +   +     
Sbjct: 116 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXX 175
Query: 106 EYVVTR-----WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           +          WY APE L   ++++ A D+WS G +L E+ T
Sbjct: 176 KVKEPGESPIFWY-APESLTE-SKFSVASDVWSFGVVLYELFT 216

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 34  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDF 92
           DL   I     L ++  + F +Q+L  +++ H+  VLHRD+K  N+L++ +  +LK+ DF
Sbjct: 129 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 188
Query: 93  GLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 138
           G      +T + T++  TR Y  PE +     +  +  +WS+G +L
Sbjct: 189 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 233

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 54/103 (52%), Gaps = 9/103 (8%)
Query: 48  DHCQYFLY--QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT 105
           DH +   Y  Q+ +G++Y+ +   +HRDL   N+L+     +KIGDFGL +   +     
Sbjct: 115 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXX 174
Query: 106 EYVVTR-----WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           +          WY APE L   ++++ A D+WS G +L E+ T
Sbjct: 175 KVKEPGESPIFWY-APESLTE-SKFSVASDVWSFGVVLYELFT 215

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 54/103 (52%), Gaps = 9/103 (8%)
Query: 48  DHCQYFLY--QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT 105
           DH +   Y  Q+ +G++Y+ +   +HRDL   N+L+     +KIGDFGL +   +     
Sbjct: 112 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXX 171
Query: 106 EYVVTR-----WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           +          WY APE L   ++++ A D+WS G +L E+ T
Sbjct: 172 KVKEPGESPIFWY-APESLTE-SKFSVASDVWSFGVVLYELFT 212

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 54/103 (52%), Gaps = 9/103 (8%)
Query: 48  DHCQYFLY--QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT 105
           DH +   Y  Q+ +G++Y+ +   +HRDL   N+L+     +KIGDFGL +   +     
Sbjct: 117 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXX 176
Query: 106 EYVVTR-----WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           +          WY APE L   ++++ A D+WS G +L E+ T
Sbjct: 177 KVKEPGESPIFWY-APESLTE-SKFSVASDVWSFGVVLYELFT 217

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 54/103 (52%), Gaps = 9/103 (8%)
Query: 48  DHCQYFLY--QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT 105
           DH +   Y  Q+ +G++Y+ +   +HRDL   N+L+     +KIGDFGL +   +     
Sbjct: 111 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXX 170
Query: 106 EYVVTR-----WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           +          WY APE L   ++++ A D+WS G +L E+ T
Sbjct: 171 KVKEPGESPIFWY-APESLTE-SKFSVASDVWSFGVVLYELFT 211

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 54/103 (52%), Gaps = 9/103 (8%)
Query: 48  DHCQYFLY--QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT 105
           DH +   Y  Q+ +G++Y+ +   +HRDL   N+L+     +KIGDFGL +   +     
Sbjct: 119 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXX 178
Query: 106 EYVVTR-----WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           +          WY APE L   ++++ A D+WS G +L E+ T
Sbjct: 179 KVKEPGESPIFWY-APESLTE-SKFSVASDVWSFGVVLYELFT 219

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 54/103 (52%), Gaps = 9/103 (8%)
Query: 48  DHCQYFLY--QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT 105
           DH +   Y  Q+ +G++Y+ +   +HRDL   N+L+     +KIGDFGL +   +     
Sbjct: 118 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXX 177
Query: 106 EYVVTR-----WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           +          WY APE L   ++++ A D+WS G +L E+ T
Sbjct: 178 KVKEPGESPIFWY-APESLTE-SKFSVASDVWSFGVVLYELFT 218

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 74/146 (50%), Gaps = 13/146 (8%)
Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY--QLLR 59
           +H +++ +  +I      T N V+I+ EL      +     ++ + D     LY  QL  
Sbjct: 69  DHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 122
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTRWYRAP 116
            L Y+ S   +HRD+   N+L++++  +K+GDFGL+R   ++ +       +  +W  AP
Sbjct: 123 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-AP 181
Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIM 142
           E  +N   +T+A D+W  G  + EI+
Sbjct: 182 E-SINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 74/146 (50%), Gaps = 13/146 (8%)
Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY--QLLR 59
           +H +++ +  +I      T N V+I+ EL      +     ++ + D     LY  QL  
Sbjct: 69  DHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 122
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTRWYRAP 116
            L Y+ S   +HRD+   N+L++++  +K+GDFGL+R   ++ +       +  +W  AP
Sbjct: 123 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-AP 181
Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIM 142
           E  +N   +T+A D+W  G  + EI+
Sbjct: 182 E-SINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 54/103 (52%), Gaps = 9/103 (8%)
Query: 48  DHCQYFLY--QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT 105
           DH +   Y  Q+ +G++Y+ +   +HRDL   N+L+     +KIGDFGL +   +     
Sbjct: 110 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXX 169
Query: 106 EYVVTR-----WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           +          WY APE L   ++++ A D+WS G +L E+ T
Sbjct: 170 KVKEPGESPIFWY-APESLTE-SKFSVASDVWSFGVVLYELFT 210

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 54/103 (52%), Gaps = 9/103 (8%)
Query: 48  DHCQYFLY--QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT 105
           DH +   Y  Q+ +G++Y+ +   +HRDL   N+L+     +KIGDFGL +   +     
Sbjct: 143 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXX 202
Query: 106 EYVVTR-----WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           +          WY APE L   ++++ A D+WS G +L E+ T
Sbjct: 203 KVKEPGESPIFWY-APESLTE-SKFSVASDVWSFGVVLYELFT 243

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 54/103 (52%), Gaps = 9/103 (8%)
Query: 48  DHCQYFLY--QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT 105
           DH +   Y  Q+ +G++Y+ +   +HRDL   N+L+     +KIGDFGL +   +     
Sbjct: 115 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXX 174
Query: 106 EYVVTR-----WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           +          WY APE L   ++++ A D+WS G +L E+ T
Sbjct: 175 KVKEPGESPIFWY-APESLTE-SKFSVASDVWSFGVVLYELFT 215

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 67/131 (51%), Gaps = 7/131 (5%)
Query: 24  VYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 82
           +Y+V E M   DL  ++ S+  + +   +++  +++  L  +HS   +HRD+KP N+LL+
Sbjct: 144 LYMVMEYMPGGDLVNLM-SNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD 202
Query: 83  ASCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAPELLLNCTE---YTAAIDIWSVGCI 137
            S  LK+ DFG     ++   +     V T  Y +PE+L +      Y    D WSVG  
Sbjct: 203 KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 262
Query: 138 LGEIMTREPLF 148
           L E++  +  F
Sbjct: 263 LYEMLVGDTPF 273

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 74/146 (50%), Gaps = 13/146 (8%)
Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY--QLLR 59
           +H +++ +  +I      T N V+I+ EL      +     ++ + D     LY  QL  
Sbjct: 66  DHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 119
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTRWYRAP 116
            L Y+ S   +HRD+   N+L++++  +K+GDFGL+R   ++ +       +  +W  AP
Sbjct: 120 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-AP 178
Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIM 142
           E  +N   +T+A D+W  G  + EI+
Sbjct: 179 E-SINFRRFTSASDVWMFGVCMWEIL 203

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 54/103 (52%), Gaps = 9/103 (8%)
Query: 48  DHCQYFLY--QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT 105
           DH +   Y  Q+ +G++Y+ +   +HRDL   N+L+     +KIGDFGL +   +     
Sbjct: 112 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXX 171
Query: 106 EYVVTR-----WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           +          WY APE L   ++++ A D+WS G +L E+ T
Sbjct: 172 KVKEPGESPIFWY-APESLTE-SKFSVASDVWSFGVVLYELFT 212

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 74/146 (50%), Gaps = 13/146 (8%)
Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY--QLLR 59
           +H +++ +  +I      T N V+I+ EL      +     ++ + D     LY  QL  
Sbjct: 71  DHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 124
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTRWYRAP 116
            L Y+ S   +HRD+   N+L++++  +K+GDFGL+R   ++ +       +  +W  AP
Sbjct: 125 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-AP 183
Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIM 142
           E  +N   +T+A D+W  G  + EI+
Sbjct: 184 E-SINFRRFTSASDVWMFGVCMWEIL 208

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 74/146 (50%), Gaps = 13/146 (8%)
Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY--QLLR 59
           +H +++ +  +I      T N V+I+ EL      +     ++ + D     LY  QL  
Sbjct: 74  DHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 127
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTRWYRAP 116
            L Y+ S   +HRD+   N+L++++  +K+GDFGL+R   ++ +       +  +W  AP
Sbjct: 128 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-AP 186
Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIM 142
           E  +N   +T+A D+W  G  + EI+
Sbjct: 187 E-SINFRRFTSASDVWMFGVCMWEIL 211

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 31/123 (25%), Positives = 68/123 (55%), Gaps = 6/123 (4%)
Query: 26  IVYELMDTD-LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 84
           +V E+ +   L++ ++ ++ + D +    ++Q+  G+KY+  ++ +HRDL   N+LL   
Sbjct: 446 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ 505
Query: 85  CDLKIGDFGLART-TSETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGE 140
              KI DFGL++   ++ ++       +W   + APE  +N  ++++  D+WS G ++ E
Sbjct: 506 HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWE 564
Query: 141 IMT 143
             +
Sbjct: 565 AFS 567

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 54/103 (52%), Gaps = 9/103 (8%)
Query: 48  DHCQYFLY--QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT 105
           DH +   Y  Q+ +G++Y+ +   +HRDL   N+L+     +KIGDFGL +   +     
Sbjct: 130 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXX 189
Query: 106 EYVVTR-----WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           +          WY APE L   ++++ A D+WS G +L E+ T
Sbjct: 190 KVKEPGESPIFWY-APESLTE-SKFSVASDVWSFGVVLYELFT 230

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 54/103 (52%), Gaps = 9/103 (8%)
Query: 48  DHCQYFLY--QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT 105
           DH +   Y  Q+ +G++Y+ +   +HRDL   N+L+     +KIGDFGL +   +     
Sbjct: 130 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXX 189
Query: 106 EYVVTR-----WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           +          WY APE L   ++++ A D+WS G +L E+ T
Sbjct: 190 KVKEPGESPIFWY-APESLTE-SKFSVASDVWSFGVVLYELFT 230

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 67/131 (51%), Gaps = 7/131 (5%)
Query: 24  VYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 82
           +Y+V E M   DL  ++ S+  + +   +++  +++  L  +HS   +HRD+KP N+LL+
Sbjct: 149 LYMVMEYMPGGDLVNLM-SNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD 207
Query: 83  ASCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAPELLLNCTE---YTAAIDIWSVGCI 137
            S  LK+ DFG     ++   +     V T  Y +PE+L +      Y    D WSVG  
Sbjct: 208 KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 267
Query: 138 LGEIMTREPLF 148
           L E++  +  F
Sbjct: 268 LYEMLVGDTPF 278

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/148 (25%), Positives = 65/148 (43%), Gaps = 3/148 (2%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           +EH N+I + DI    +   F  + +       DL   I    +L +    Y   QL+  
Sbjct: 86  VEHANIIKVLDIF---ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSA 142
Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 120
           + Y+    ++HRD+K  N+++     +K+ DFG A           +  T  Y APE+L+
Sbjct: 143 VGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLM 202
Query: 121 NCTEYTAAIDIWSVGCILGEIMTREPLF 148
                   +++WS+G  L  ++  E  F
Sbjct: 203 GNPYRGPELEMWSLGVTLYTLVFEENPF 230

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 74/146 (50%), Gaps = 13/146 (8%)
Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY--QLLR 59
           +H +++ +  +I      T N V+I+ EL      +     ++ + D     LY  QL  
Sbjct: 72  DHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 125
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTRWYRAP 116
            L Y+ S   +HRD+   N+L++++  +K+GDFGL+R   ++ +       +  +W  AP
Sbjct: 126 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-AP 184
Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIM 142
           E  +N   +T+A D+W  G  + EI+
Sbjct: 185 E-SINFRRFTSASDVWMFGVCMWEIL 209

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 63/122 (51%), Gaps = 9/122 (7%)
Query: 25  YIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 84
           ++ Y++   DL++       LT +H   + +Q+ +G++++ S   +HRDL   N+LL+  
Sbjct: 130 FVPYKVAPEDLYKDF-----LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 184
Query: 85  CDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEI 141
             +KI DFGLAR   +          R    + APE + +   YT   D+WS G +L EI
Sbjct: 185 NVVKICDFGLARDIYKDPDXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEI 243
Query: 142 MT 143
            +
Sbjct: 244 FS 245

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 74/146 (50%), Gaps = 13/146 (8%)
Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY--QLLR 59
           +H +++ +  +I      T N V+I+ EL      +     ++ + D     LY  QL  
Sbjct: 97  DHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 150
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTRWYRAP 116
            L Y+ S   +HRD+   N+L++++  +K+GDFGL+R   ++ +       +  +W  AP
Sbjct: 151 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-AP 209
Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIM 142
           E  +N   +T+A D+W  G  + EI+
Sbjct: 210 E-SINFRRFTSASDVWMFGVCMWEIL 234

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 29/113 (25%), Positives = 63/113 (55%), Gaps = 5/113 (4%)
Query: 35  LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL 94
           L++ ++ ++ + D +    ++Q+  G+KY+  ++ +HRDL   N+LL      KI DFGL
Sbjct: 112 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 171
Query: 95  ARTT-SETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           ++   ++ ++       +W   + APE  +N  ++++  D+WS G ++ E  +
Sbjct: 172 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFS 223

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 29/113 (25%), Positives = 63/113 (55%), Gaps = 5/113 (4%)
Query: 35  LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL 94
           L++ ++ ++ + D +    ++Q+  G+KY+  ++ +HRDL   N+LL      KI DFGL
Sbjct: 457 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 516
Query: 95  ART-TSETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           ++   ++ ++       +W   + APE  +N  ++++  D+WS G ++ E  +
Sbjct: 517 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFS 568

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 29/113 (25%), Positives = 63/113 (55%), Gaps = 5/113 (4%)
Query: 35  LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL 94
           L++ ++ ++ + D +    ++Q+  G+KY+  ++ +HRDL   N+LL      KI DFGL
Sbjct: 114 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 173
Query: 95  ARTT-SETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           ++   ++ ++       +W   + APE  +N  ++++  D+WS G ++ E  +
Sbjct: 174 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 29/113 (25%), Positives = 63/113 (55%), Gaps = 5/113 (4%)
Query: 35  LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL 94
           L++ ++ ++ + D +    ++Q+  G+KY+  ++ +HRDL   N+LL      KI DFGL
Sbjct: 114 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 173
Query: 95  ARTT-SETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           ++   ++ ++       +W   + APE  +N  ++++  D+WS G ++ E  +
Sbjct: 174 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 67/131 (51%), Gaps = 7/131 (5%)
Query: 24  VYIVYELM-DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 82
           +Y+V E M   DL  ++ S+  + +   +++  +++  L  +HS   +HRD+KP N+LL+
Sbjct: 149 LYMVMEYMPGGDLVNLM-SNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD 207
Query: 83  ASCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAPELLLNCTE---YTAAIDIWSVGCI 137
            S  LK+ DFG     ++   +     V T  Y +PE+L +      Y    D WSVG  
Sbjct: 208 KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 267
Query: 138 LGEIMTREPLF 148
           L E++  +  F
Sbjct: 268 LYEMLVGDTPF 278

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 50/92 (54%), Gaps = 6/92 (6%)
Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE----YVVTR 111
           ++  G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD   +     +  R
Sbjct: 138 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 197
Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           W  APE L +   +T + D+WS G +L EI +
Sbjct: 198 WM-APESLKDGV-FTTSSDMWSFGVVLWEITS 227

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 50/92 (54%), Gaps = 6/92 (6%)
Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE----YVVTR 111
           ++  G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD   +     +  R
Sbjct: 138 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 197
Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           W  APE L +   +T + D+WS G +L EI +
Sbjct: 198 WM-APESLKDGV-FTTSSDMWSFGVVLWEITS 227

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 50/92 (54%), Gaps = 6/92 (6%)
Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE----YVVTR 111
           ++  G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD   +     +  R
Sbjct: 135 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 194
Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           W  APE L +   +T + D+WS G +L EI +
Sbjct: 195 WM-APESLKDGV-FTTSSDMWSFGVVLWEITS 224

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 29/113 (25%), Positives = 63/113 (55%), Gaps = 5/113 (4%)
Query: 35  LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL 94
           L++ ++ ++ + D +    ++Q+  G+KY+  ++ +HRDL   N+LL      KI DFGL
Sbjct: 104 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 163
Query: 95  ARTT-SETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           ++   ++ ++       +W   + APE  +N  ++++  D+WS G ++ E  +
Sbjct: 164 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFS 215

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 74/162 (45%), Gaps = 25/162 (15%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ-------QLTDDHCQY 52
           + HE ++ +  ++      +   +YIV E M    L   ++ +        QL D     
Sbjct: 237 LRHEKLVQLYAVV------SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD----- 285
Query: 53  FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-- 110
              Q+  G+ YV   + +HRDL+ +N+L+  +   K+ DFGL R   + ++         
Sbjct: 286 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFP 345
Query: 111 -RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 150
            +W  APE  L    +T   D+WS G +L E+ T+  + +PG
Sbjct: 346 IKW-TAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPG 385

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 74/162 (45%), Gaps = 25/162 (15%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ-------QLTDDHCQY 52
           + HE ++ +  ++      +   +YIV E M    L   ++ +        QL D     
Sbjct: 70  LRHEKLVQLYAVV------SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD----- 118
Query: 53  FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-- 110
              Q+  G+ YV   + +HRDL  +N+L+  +   K+ DFGLAR   + ++         
Sbjct: 119 MAAQIASGMAYVERMNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 178
Query: 111 -RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 150
            +W  APE  L    +T   D+WS G +L E+ T+  + +PG
Sbjct: 179 IKW-TAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 54/102 (52%), Gaps = 4/102 (3%)
Query: 45  LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM 104
           LT +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR   +    
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX 204
Query: 105 TEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
                 R    + APE + +   YT   D+WS G +L EI +
Sbjct: 205 VRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS 245

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 29/113 (25%), Positives = 63/113 (55%), Gaps = 5/113 (4%)
Query: 35  LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL 94
           L++ ++ ++ + D +    ++Q+  G+KY+  ++ +HRDL   N+LL      KI DFGL
Sbjct: 98  LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 157
Query: 95  ARTT-SETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           ++   ++ ++       +W   + APE  +N  ++++  D+WS G ++ E  +
Sbjct: 158 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 73/146 (50%), Gaps = 13/146 (8%)
Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLY--QLLR 59
           +H +++ +  +I      T N V+I+ EL      +     ++ + D     LY  QL  
Sbjct: 69  DHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLST 122
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY---VVTRWYRAP 116
            L Y+ S   +HRD+   N+L++++  +K+GDFGL+R   ++         +  +W  AP
Sbjct: 123 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWM-AP 181
Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIM 142
           E  +N   +T+A D+W  G  + EI+
Sbjct: 182 E-SINFRRFTSASDVWMFGVCMWEIL 206

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 29/113 (25%), Positives = 63/113 (55%), Gaps = 5/113 (4%)
Query: 35  LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL 94
           L++ ++ ++ + D +    ++Q+  G+KY+  ++ +HRDL   N+LL      KI DFGL
Sbjct: 94  LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 153
Query: 95  ARTT-SETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           ++   ++ ++       +W   + APE  +N  ++++  D+WS G ++ E  +
Sbjct: 154 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFS 205

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/131 (25%), Positives = 67/131 (51%), Gaps = 3/131 (2%)
Query: 24  VYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 82
           ++ V E ++  DL   I+  ++  +   +++  +++  L ++H   +++RDLK  N+LL+
Sbjct: 99  LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLD 158
Query: 83  ASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 141
                K+ DFG+ +        T  +  T  Y APE+L     Y  A+D W++G +L E+
Sbjct: 159 HEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEML-YGPAVDWWAMGVLLYEM 217
Query: 142 MTREPLFPGKD 152
           +     F  ++
Sbjct: 218 LCGHAPFEAEN 228

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 29/113 (25%), Positives = 63/113 (55%), Gaps = 5/113 (4%)
Query: 35  LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL 94
           L++ ++ ++ + D +    ++Q+  G+KY+  ++ +HRDL   N+LL      KI DFGL
Sbjct: 92  LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 151
Query: 95  ARTT-SETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           ++   ++ ++       +W   + APE  +N  ++++  D+WS G ++ E  +
Sbjct: 152 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFS 203

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 53/101 (52%), Gaps = 6/101 (5%)
Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RW 112
           Q+  G+ Y+   + +HRDL+ +N+L+      KI DFGLAR   + +           +W
Sbjct: 113 QVAAGMAYIERMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKW 172
Query: 113 YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPGKD 152
             APE  L    +T   D+WS G +L E++T+  + +PG +
Sbjct: 173 -TAPEAAL-YGRFTIKSDVWSFGILLTELVTKGRVPYPGMN 211

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 37/114 (32%), Positives = 61/114 (53%), Gaps = 9/114 (7%)
Query: 53  FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW 112
           + +Q+ RG++++ S   +HRDL   N+LL+ +  +KI DFGLAR   +         TR 
Sbjct: 204 YSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRL 263
Query: 113 ---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPG----KDYVHQLR 158
              + APE + +   Y+   D+WS G +L EI +     +PG    +D+  +LR
Sbjct: 264 PLKWMAPESIFDKI-YSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDEDFCSRLR 316

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 77/190 (40%), Gaps = 42/190 (22%)
Query: 45  LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL-------ART 97
           LT+D   + L  + RGL+ +H+    HRDLKP+N+LL       + D G           
Sbjct: 131 LTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEG 190
Query: 98  TSETDFMTEYVVTRW---YRAPELL---LNCTEYTAAIDIWSVGCILGEIMTREPLFPGK 151
           + +   + ++   R    YRAPEL     +C       D+WS+GC+L  +M  E      
Sbjct: 191 SRQALTLQDWAAQRCTISYRAPELFSVQSHCV-IDERTDVWSLGCVLYAMMFGE------ 243
Query: 152 DYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLE 211
                          P D  + F + D+    V      + Q    + P  SS    LL 
Sbjct: 244 --------------GPYD--MVFQKGDSVALAV------QNQLSIPQSPRHSSALWQLLN 281
Query: 212 KMLVFDPNKR 221
            M+  DP++R
Sbjct: 282 SMMTVDPHQR 291

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 74/162 (45%), Gaps = 25/162 (15%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ-------QLTDDHCQY 52
           + HE ++ +  ++      +   +YIV E M    L   ++ +        QL D     
Sbjct: 70  LRHEKLVQLYAVV------SEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVD----- 118
Query: 53  FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-- 110
              Q+  G+ YV   + +HRDL+ +N+L+  +   K+ DFGLAR   + +          
Sbjct: 119 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFP 178
Query: 111 -RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 150
            +W  APE  L    +T   D+WS G +L E+ T+  + +PG
Sbjct: 179 IKW-TAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 51/92 (55%), Gaps = 6/92 (6%)
Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE----YVVTR 111
           ++  G+ Y+++   +HR+L   N ++     +KIGDFG+ R   ETD+  +     +  R
Sbjct: 138 EIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 197
Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           W  APE L +   +T + D+WS G +L EI +
Sbjct: 198 WM-APESLKDGV-FTTSSDMWSFGVVLWEITS 227

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 51/92 (55%), Gaps = 6/92 (6%)
Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE----YVVTR 111
           ++  G+ Y+++   +HR+L   N ++     +KIGDFG+ R   ETD+  +     +  R
Sbjct: 139 EIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 198
Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           W  APE L +   +T + D+WS G +L EI +
Sbjct: 199 WM-APESLKDGV-FTTSSDMWSFGVVLWEITS 228

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 72/151 (47%), Gaps = 8/151 (5%)
Query: 20  TFNDVYIVYELMDTDLHQIIRSDQQ-LTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPS 77
           T  DV+I  ELM T   ++ +  Q  + +         +++ L Y+     V+HRD+KPS
Sbjct: 95  TNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPS 154
Query: 78  NLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL----LNCTEYTAAIDIWS 133
           N+LL+    +K+ DFG++    +            Y APE +        +Y    D+WS
Sbjct: 155 NILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWS 214
Query: 134 VGCILGEIMTREPLFPGKDYVHQLRLITELI 164
           +G  L E+ T +  FP K+      ++T+++
Sbjct: 215 LGISLVELATGQ--FPYKNCKTDFEVLTKVL 243

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 59/136 (43%), Gaps = 3/136 (2%)
Query: 24  VYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 82
           +Y+  EL    L Q   +    L +     +L   L  L ++HS  ++H D+KP+N+ L 
Sbjct: 132 LYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLG 191
Query: 83  ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM 142
                K+GDFGL                  Y APELL     Y  A D++S+G  + E+ 
Sbjct: 192 PRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVA 249
Query: 143 TREPLFPGKDYVHQLR 158
               L  G +   QLR
Sbjct: 250 CNMELPHGGEGWQQLR 265

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 37/147 (25%), Positives = 69/147 (46%), Gaps = 10/147 (6%)
Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGL 61
           +H N+I ++ ++   +       Y+    +DT L      D Q T       L  +  G+
Sbjct: 108 DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGM 164
Query: 62  KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT-----SETDFMTEYVVTRWYRAP 116
           +Y+     +HRDL   N+L++++   K+ DFGL+R       +        +  RW  AP
Sbjct: 165 RYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWT-AP 223
Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMT 143
           E +   T +++A D+WS G ++ E++ 
Sbjct: 224 EAIAFRT-FSSASDVWSFGVVMWEVLA 249

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RW 112
           Q+  G+ YV   + +HRDL+ +N+L+  +   K+ DFGLAR   + +           +W
Sbjct: 112 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKW 171
Query: 113 YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPG 150
             APE  L    +T   D+WS G +L E+ T+  + +PG
Sbjct: 172 -TAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPG 208

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 38/153 (24%), Positives = 74/153 (48%), Gaps = 11/153 (7%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           ++H +++ +  II         ++Y   EL     H + R+   L       +  Q+ + 
Sbjct: 82  LDHPHIVKLIGIIEEEPTWIIMELYPYGELG----HYLERNKNSLKVLTLVLYSLQICKA 137
Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV---TRWYRAPE 117
           + Y+ S + +HRD+   N+L+ +   +K+GDFGL+R   + D+    V     +W  +PE
Sbjct: 138 MAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKW-MSPE 196
Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMT--REPLF 148
             +N   +T A D+W     + EI++  ++P F
Sbjct: 197 -SINFRRFTTASDVWMFAVCMWEILSFGKQPFF 228

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 38/153 (24%), Positives = 74/153 (48%), Gaps = 11/153 (7%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           ++H +++ +  II         ++Y   EL     H + R+   L       +  Q+ + 
Sbjct: 66  LDHPHIVKLIGIIEEEPTWIIMELYPYGELG----HYLERNKNSLKVLTLVLYSLQICKA 121
Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV---TRWYRAPE 117
           + Y+ S + +HRD+   N+L+ +   +K+GDFGL+R   + D+    V     +W  +PE
Sbjct: 122 MAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKW-MSPE 180
Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMT--REPLF 148
             +N   +T A D+W     + EI++  ++P F
Sbjct: 181 -SINFRRFTTASDVWMFAVCMWEILSFGKQPFF 212

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 31/114 (27%), Positives = 62/114 (54%), Gaps = 7/114 (6%)
Query: 35  LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL 94
           L++ ++ ++ + D +    ++Q+  G+KY+  ++ +HRDL   N+LL      KI DFGL
Sbjct: 98  LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 157
Query: 95  ART--TSETDFMTE---YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           ++     E  +  +       +WY APE  +N  ++++  D+WS G ++ E  +
Sbjct: 158 SKALRADENXYKAQTHGKWPVKWY-APE-CINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 38/153 (24%), Positives = 74/153 (48%), Gaps = 11/153 (7%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           ++H +++ +  II         ++Y   EL     H + R+   L       +  Q+ + 
Sbjct: 70  LDHPHIVKLIGIIEEEPTWIIMELYPYGELG----HYLERNKNSLKVLTLVLYSLQICKA 125
Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV---TRWYRAPE 117
           + Y+ S + +HRD+   N+L+ +   +K+GDFGL+R   + D+    V     +W  +PE
Sbjct: 126 MAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKW-MSPE 184
Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMT--REPLF 148
             +N   +T A D+W     + EI++  ++P F
Sbjct: 185 -SINFRRFTTASDVWMFAVCMWEILSFGKQPFF 216

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 8/99 (8%)
Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM----TEYVVTR 111
           Q+  G+ Y+     +HRDL   N L+     +KIGDFG++R    TD+        +  R
Sbjct: 143 QVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 202
Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLF 148
           W   PE +L   ++T   D+WS G +L EI T  ++P +
Sbjct: 203 WM-PPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPWY 239

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 6/92 (6%)
Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE----YVVTR 111
           ++  G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ET +  +     +  R
Sbjct: 138 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVR 197
Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           W  APE L +   +T + D+WS G +L EI +
Sbjct: 198 WM-APESLKDGV-FTTSSDMWSFGVVLWEITS 227

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 8/99 (8%)
Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM----TEYVVTR 111
           Q+  G+ Y+     +HRDL   N L+     +KIGDFG++R    TD+        +  R
Sbjct: 137 QVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 196
Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLF 148
           W   PE +L   ++T   D+WS G +L EI T  ++P +
Sbjct: 197 WM-PPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPWY 233

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/114 (28%), Positives = 60/114 (52%), Gaps = 6/114 (5%)
Query: 35  LHQ-IIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG 93
           LH+ ++   +++   +    L+Q+  G+KY+   + +HRDL   N+LL      KI DFG
Sbjct: 96  LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFG 155
Query: 94  LARTTSETD-FMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           L++     D + T     +W   + APE  +N  ++++  D+WS G  + E ++
Sbjct: 156 LSKALGADDSYYTARSAGKWPLKWYAPE-CINFRKFSSRSDVWSYGVTMWEALS 208

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 8/99 (8%)
Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM----TEYVVTR 111
           Q+  G+ Y+     +HRDL   N L+     +KIGDFG++R    TD+        +  R
Sbjct: 166 QVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLF 148
           W   PE +L   ++T   D+WS G +L EI T  ++P +
Sbjct: 226 WM-PPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPWY 262

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 73/161 (45%), Gaps = 14/161 (8%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQ--LTDDHCQYFLYQL 57
           + H N++ +  +I   K      +YIV E M    L   +RS  +  L  D    F   +
Sbjct: 62  LRHSNLVQLLGVIVEEK----GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 117
Query: 58  LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 117
              ++Y+   + +HRDL   N+L++     K+ DFGL +  S T   T  +  +W  APE
Sbjct: 118 CEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-DTGKLPVKW-TAPE 175
Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTRE----PLFPGKDYV 154
            L     ++   D+WS G +L EI +      P  P KD V
Sbjct: 176 ALREAA-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 215

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 74/161 (45%), Gaps = 14/161 (8%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQ--LTDDHCQYFLYQL 57
           + H N++ +  +I   K      +YIV E M    L   +RS  +  L  D    F   +
Sbjct: 71  LRHSNLVQLLGVIVEEK----GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 126
Query: 58  LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 117
              ++Y+   + +HRDL   N+L++     K+ DFGL +  S T   T  +  +W  APE
Sbjct: 127 CEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-DTGKLPVKW-TAPE 184
Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTRE----PLFPGKDYV 154
            L    +++   D+WS G +L EI +      P  P KD V
Sbjct: 185 ALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 224

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 74/161 (45%), Gaps = 14/161 (8%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQ--LTDDHCQYFLYQL 57
           + H N++ +  +I   K      +YIV E M    L   +RS  +  L  D    F   +
Sbjct: 56  LRHSNLVQLLGVIVEEK----GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 111
Query: 58  LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 117
              ++Y+   + +HRDL   N+L++     K+ DFGL +  S T   T  +  +W  APE
Sbjct: 112 CEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-DTGKLPVKW-TAPE 169
Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTRE----PLFPGKDYV 154
            L    +++   D+WS G +L EI +      P  P KD V
Sbjct: 170 ALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 209

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/106 (33%), Positives = 55/106 (51%), Gaps = 15/106 (14%)
Query: 48  DHCQYFLY--QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT 105
           D  +  LY  Q+ +G++Y+ S   +HRDL   N+L+ +   +KI DFGLA+         
Sbjct: 112 DASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP---LDK 168
Query: 106 EYVVTR--------WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           +Y V R        WY APE L +   ++   D+WS G +L E+ T
Sbjct: 169 DYYVVREPGQSPIFWY-APESLSD-NIFSRQSDVWSFGVVLYELFT 212

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 74/161 (45%), Gaps = 14/161 (8%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELM-DTDLHQIIRSDQQ--LTDDHCQYFLYQL 57
           + H N++ +  +I   K      +YIV E M    L   +RS  +  L  D    F   +
Sbjct: 243 LRHSNLVQLLGVIVEEK----GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 298
Query: 58  LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 117
              ++Y+   + +HRDL   N+L++     K+ DFGL +  S T   T  +  +W  APE
Sbjct: 299 CEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-DTGKLPVKW-TAPE 356
Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTRE----PLFPGKDYV 154
            L    +++   D+WS G +L EI +      P  P KD V
Sbjct: 357 ALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 396

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/126 (30%), Positives = 61/126 (48%), Gaps = 8/126 (6%)
Query: 24  VYIVYELM-DTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 81
           +YIV EL+   D    +R++  +L        +     G++Y+ S   +HRDL   N L+
Sbjct: 187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLV 246
Query: 82  NASCDLKIGDFGLARTTSETDFMTE----YVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 137
                LKI DFG++R  ++  +        V  +W  APE  LN   Y++  D+WS G +
Sbjct: 247 TEKNVLKISDFGMSREEADGVYAASGGLRQVPVKW-TAPE-ALNYGRYSSESDVWSFGIL 304
Query: 138 LGEIMT 143
           L E  +
Sbjct: 305 LWETFS 310

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/106 (33%), Positives = 55/106 (51%), Gaps = 15/106 (14%)
Query: 48  DHCQYFLY--QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT 105
           D  +  LY  Q+ +G++Y+ S   +HRDL   N+L+ +   +KI DFGLA+         
Sbjct: 113 DASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP---LDK 169
Query: 106 EYVVTR--------WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           +Y V R        WY APE L +   ++   D+WS G +L E+ T
Sbjct: 170 DYYVVREPGQSPIFWY-APESLSD-NIFSRQSDVWSFGVVLYELFT 213

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/221 (22%), Positives = 102/221 (46%), Gaps = 34/221 (15%)
Query: 19  DTFNDVYIVYELMDT-DLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP 76
           ++  ++ +++E +   D+ + I +   +L +     +++Q+   L+++HS ++ H D++P
Sbjct: 71  ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRP 130
Query: 77  SNLLLNA--SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSV 134
            N++     S  +KI +FG AR     D          Y APE+  +    TA  D+WS+
Sbjct: 131 ENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTAT-DMWSL 189
Query: 135 GCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ 193
           G ++  +++   P     +         ++I +  +A   F   + A             
Sbjct: 190 GTLVYVLLSGINPFLAETN--------QQIIENIMNAEYTF--DEEA------------- 226
Query: 194 QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
                F   S  A+D ++++LV +   R+T  EAL+HP+L+
Sbjct: 227 -----FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLK 262

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/106 (33%), Positives = 55/106 (51%), Gaps = 15/106 (14%)
Query: 48  DHCQYFLY--QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT 105
           D  +  LY  Q+ +G++Y+ S   +HRDL   N+L+ +   +KI DFGLA+         
Sbjct: 125 DASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP---LDK 181
Query: 106 EYVVTR--------WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           +Y V R        WY APE L +   ++   D+WS G +L E+ T
Sbjct: 182 DYYVVREPGQSPIFWY-APESLSD-NIFSRQSDVWSFGVVLYELFT 225

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 44/92 (47%), Gaps = 6/92 (6%)
Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM----TEYVVTR 111
           Q+  G+ Y+     +HRDL   N L+  +  +KI DFGL+R     D+      + +  R
Sbjct: 182 QVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIR 241
Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           W     +  N   YT   D+W+ G +L EI +
Sbjct: 242 WMPPESIFYN--RYTTESDVWAYGVVLWEIFS 271

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/238 (20%), Positives = 103/238 (43%), Gaps = 37/238 (15%)
Query: 22  NDVYIV--YELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 79
           N++Y+V  Y +    L  + + + +L ++  +++L +++  +  VH    +HRD+KP N+
Sbjct: 147 NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNI 206
Query: 80  LLNASCDLKIGDFGLARTTSETDFMTEYVV--TRWYRAPELLL----NCTEYTAAIDIWS 133
           L++ +  +++ DFG      E   +   V   T  Y +PE+L         Y    D WS
Sbjct: 207 LMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWS 266
Query: 134 VGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ 193
           +G  + E++  E  F  +  V                            Y + +    + 
Sbjct: 267 LGVCMYEMLYGETPFYAESLVET--------------------------YGKIMNHKERF 300
Query: 194 QFATRFPNKSSGAVDLLEKMLVFDPNK--RITVEEALRHPYLQSLHDLNDEPVCPRPF 249
           QF T+  + S  A DL+ +++    ++  +  +E+  +HP+   + D ++   C  P+
Sbjct: 301 QFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI-DWDNIRNCEAPY 357

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 38/146 (26%), Positives = 73/146 (50%), Gaps = 5/146 (3%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           + H N++     +  P   +    Y+    +   LH+   + +QL +       Y + +G
Sbjct: 91  LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKS-GAREQLDERRRLSMAYDVAKG 149
Query: 61  LKYVHSAS--VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV-TRWYRAPE 117
           + Y+H+ +  ++HR+LK  NLL++    +K+ DFGL+R  + T   ++    T  + APE
Sbjct: 150 MNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPE 209
Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMT 143
           +L +      + D++S G IL E+ T
Sbjct: 210 VLRDEPSNEKS-DVYSFGVILWELAT 234

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 38/146 (26%), Positives = 72/146 (49%), Gaps = 5/146 (3%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           + H N++     +  P   +    Y+    +   LH+   + +QL +       Y + +G
Sbjct: 91  LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKS-GAREQLDERRRLSMAYDVAKG 149
Query: 61  LKYVHSAS--VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV-TRWYRAPE 117
           + Y+H+ +  ++HRDLK  NLL++    +K+ DFGL+R  +     ++    T  + APE
Sbjct: 150 MNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPE 209
Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMT 143
           +L +      + D++S G IL E+ T
Sbjct: 210 VLRDEPSNEKS-DVYSFGVILWELAT 234

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 6/96 (6%)
Query: 53  FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-- 110
           F+  +  G++Y+ S + +HRDL   N +L     + + DFGL+R     D+  +   +  
Sbjct: 142 FMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKL 201
Query: 111 --RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR 144
             +W     L  N   YT   D+W+ G  + EIMTR
Sbjct: 202 PVKWLALESLADNL--YTVHSDVWAFGVTMWEIMTR 235

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/114 (27%), Positives = 60/114 (52%), Gaps = 6/114 (5%)
Query: 35  LHQ-IIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG 93
           LH+ ++   +++   +    L+Q+  G+KY+   + +HR+L   N+LL      KI DFG
Sbjct: 422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFG 481
Query: 94  LARTTSETD-FMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           L++     D + T     +W   + APE  +N  ++++  D+WS G  + E ++
Sbjct: 482 LSKALGADDSYYTARSAGKWPLKWYAPE-CINFRKFSSRSDVWSYGVTMWEALS 534

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 95/225 (42%), Gaps = 44/225 (19%)
Query: 24  VYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 83
           +Y+V E  + DL+  ++  + +     + +   +L  +  +H   ++H DLKP+N L+  
Sbjct: 131 IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-V 189
Query: 84  SCDLKIGDFGLARTT---SETDFMTEYVVTRWYRAPELLLNCTE----------YTAAID 130
              LK+ DFG+A      + +      V T  Y  PE + + +            +   D
Sbjct: 190 DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD 249
Query: 131 IWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRC 190
           +WS+GCIL  +   +   P +  ++Q+  +  +I  P+                      
Sbjct: 250 VWSLGCILYYMTYGKT--PFQQIINQISKLHAII-DPN---------------------- 284
Query: 191 RKQQFATRFPNKSSGAV-DLLEKMLVFDPNKRITVEEALRHPYLQ 234
                   FP+     + D+L+  L  DP +RI++ E L HPY+Q
Sbjct: 285 ----HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 95/225 (42%), Gaps = 44/225 (19%)
Query: 24  VYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 83
           +Y+V E  + DL+  ++  + +     + +   +L  +  +H   ++H DLKP+N L+  
Sbjct: 87  IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-V 145
Query: 84  SCDLKIGDFGLARTT---SETDFMTEYVVTRWYRAPELLLNCTE----------YTAAID 130
              LK+ DFG+A      + +      V T  Y  PE + + +            +   D
Sbjct: 146 DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD 205
Query: 131 IWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRC 190
           +WS+GCIL  +   +   P +  ++Q+  +  +I  P+                      
Sbjct: 206 VWSLGCILYYMTYGKT--PFQQIINQISKLHAII-DPN---------------------- 240
Query: 191 RKQQFATRFPNKSSGAV-DLLEKMLVFDPNKRITVEEALRHPYLQ 234
                   FP+     + D+L+  L  DP +RI++ E L HPY+Q
Sbjct: 241 ----HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 281

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 95/225 (42%), Gaps = 44/225 (19%)
Query: 24  VYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 83
           +Y+V E  + DL+  ++  + +     + +   +L  +  +H   ++H DLKP+N L+  
Sbjct: 83  IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-V 141
Query: 84  SCDLKIGDFGLARTT---SETDFMTEYVVTRWYRAPELLLNCTE----------YTAAID 130
              LK+ DFG+A      + +      V T  Y  PE + + +            +   D
Sbjct: 142 DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD 201
Query: 131 IWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRC 190
           +WS+GCIL  +   +   P +  ++Q+  +  +I  P+                      
Sbjct: 202 VWSLGCILYYMTYGKT--PFQQIINQISKLHAII-DPN---------------------- 236
Query: 191 RKQQFATRFPNKSSGAV-DLLEKMLVFDPNKRITVEEALRHPYLQ 234
                   FP+     + D+L+  L  DP +RI++ E L HPY+Q
Sbjct: 237 ----HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 277

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 47/87 (54%), Gaps = 5/87 (5%)
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT---SETDFMTEYVVTRWYRAP 116
            ++Y+ S   LHRDL   N L+N    +K+ DFGL+R      ET  +      RW  +P
Sbjct: 132 AMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRW--SP 189
Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMT 143
             +L  +++++  DIW+ G ++ EI +
Sbjct: 190 PEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 48/100 (48%), Gaps = 3/100 (3%)
Query: 45  LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM 104
           L+     +F   + RG+ Y+     +HRDL   N+L+  +   KI DFGL+R        
Sbjct: 129 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 188
Query: 105 T-EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           T   +  RW       LN + YT   D+WS G +L EI++
Sbjct: 189 TMGRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 95/225 (42%), Gaps = 44/225 (19%)
Query: 24  VYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 83
           +Y+V E  + DL+  ++  + +     + +   +L  +  +H   ++H DLKP+N L+  
Sbjct: 131 IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-V 189
Query: 84  SCDLKIGDFGLARTT---SETDFMTEYVVTRWYRAPELLLNCTE----------YTAAID 130
              LK+ DFG+A      + +      V T  Y  PE + + +            +   D
Sbjct: 190 DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD 249
Query: 131 IWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRC 190
           +WS+GCIL  +   +  F  +  ++Q+  +  +I  P+                      
Sbjct: 250 VWSLGCILYYMTYGKTPF--QQIINQISKLHAII-DPN---------------------- 284
Query: 191 RKQQFATRFPNKSSGAV-DLLEKMLVFDPNKRITVEEALRHPYLQ 234
                   FP+     + D+L+  L  DP +RI++ E L HPY+Q
Sbjct: 285 ----HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 95/225 (42%), Gaps = 44/225 (19%)
Query: 24  VYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 83
           +Y+V E  + DL+  ++  + +     + +   +L  +  +H   ++H DLKP+N L+  
Sbjct: 103 IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-V 161
Query: 84  SCDLKIGDFGLARTT---SETDFMTEYVVTRWYRAPELLLNCTE----------YTAAID 130
              LK+ DFG+A      + +      V T  Y  PE + + +            +   D
Sbjct: 162 DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD 221
Query: 131 IWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRC 190
           +WS+GCIL  +   +   P +  ++Q+  +  +I  P+                      
Sbjct: 222 VWSLGCILYYMTYGKT--PFQQIINQISKLHAII-DPN---------------------- 256
Query: 191 RKQQFATRFPNKSSGAV-DLLEKMLVFDPNKRITVEEALRHPYLQ 234
                   FP+     + D+L+  L  DP +RI++ E L HPY+Q
Sbjct: 257 ----HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 48/100 (48%), Gaps = 3/100 (3%)
Query: 45  LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM 104
           L+     +F   + RG+ Y+     +HRDL   N+L+  +   KI DFGL+R        
Sbjct: 139 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 198
Query: 105 T-EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           T   +  RW       LN + YT   D+WS G +L EI++
Sbjct: 199 TMGRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 65/126 (51%), Gaps = 11/126 (8%)
Query: 52  YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM----TEY 107
           + + Q+  G++Y+ S  V+H+DL   N+L+    ++KI D GL R     D+        
Sbjct: 149 HLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 208
Query: 108 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR--EPL--FPGKDYVHQLRLITEL 163
           +  RW  APE ++   +++   DIWS G +L E+ +   +P   +  +D V  +R   ++
Sbjct: 209 LPIRWM-APEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIR-NRQV 265
Query: 164 IGSPDD 169
           +  PDD
Sbjct: 266 LPCPDD 271

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 95/225 (42%), Gaps = 44/225 (19%)
Query: 24  VYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 83
           +Y+V E  + DL+  ++  + +     + +   +L  +  +H   ++H DLKP+N L+  
Sbjct: 84  IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-V 142
Query: 84  SCDLKIGDFGLARTT---SETDFMTEYVVTRWYRAPELLLNCTE----------YTAAID 130
              LK+ DFG+A      + +      V T  Y  PE + + +            +   D
Sbjct: 143 DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD 202
Query: 131 IWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRC 190
           +WS+GCIL  +   +   P +  ++Q+  +  +I  P+                      
Sbjct: 203 VWSLGCILYYMTYGKT--PFQQIINQISKLHAII-DPN---------------------- 237
Query: 191 RKQQFATRFPNKSSGAV-DLLEKMLVFDPNKRITVEEALRHPYLQ 234
                   FP+     + D+L+  L  DP +RI++ E L HPY+Q
Sbjct: 238 ----HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 278

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 65/126 (51%), Gaps = 11/126 (8%)
Query: 52  YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM----TEY 107
           + + Q+  G++Y+ S  V+H+DL   N+L+    ++KI D GL R     D+        
Sbjct: 132 HLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191
Query: 108 VVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR--EPL--FPGKDYVHQLRLITEL 163
           +  RW  APE ++   +++   DIWS G +L E+ +   +P   +  +D V  +R   ++
Sbjct: 192 LPIRWM-APEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIR-NRQV 248
Query: 164 IGSPDD 169
           +  PDD
Sbjct: 249 LPCPDD 254

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 38/126 (30%), Positives = 60/126 (47%), Gaps = 8/126 (6%)
Query: 24  VYIVYELM-DTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 81
           +YIV EL+   D    +R++  +L        +     G++Y+ S   +HRDL   N L+
Sbjct: 187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLV 246
Query: 82  NASCDLKIGDFGLARTTSE----TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCI 137
                LKI DFG++R  ++           V  +W  APE  LN   Y++  D+WS G +
Sbjct: 247 TEKNVLKISDFGMSREEADGVXAASGGLRQVPVKW-TAPE-ALNYGRYSSESDVWSFGIL 304
Query: 138 LGEIMT 143
           L E  +
Sbjct: 305 LWETFS 310

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/213 (22%), Positives = 89/213 (41%), Gaps = 34/213 (15%)
Query: 24  VYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN 82
           +Y++ E     +L++ ++      +      + +L   L Y H   V+HRD+KP NLLL 
Sbjct: 98  IYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHGKKVIHRDIKPENLLLG 157
Query: 83  ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM 142
              +LKI DFG +         T    T  Y  PE++     +   +D+W +G +  E++
Sbjct: 158 LKGELKIADFGWSVHAPSLRRKT-MCGTLDYLPPEMI-EGRMHNEKVDLWCIGVLCYELL 215
Query: 143 TREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK 202
              P F    +    R I ++                              +F    P  
Sbjct: 216 VGNPPFESASHNETYRRIVKV----------------------------DLKFPASVP-- 245
Query: 203 SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
            +GA DL+ K+L  +P++R+ + +   HP++++
Sbjct: 246 -TGAQDLISKLLRHNPSERLPLAQVSAHPWVRA 277

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 51/105 (48%), Gaps = 16/105 (15%)
Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART----TSETDFMTEYVVTR 111
           Q+ +G+ Y+    ++HRDL   N+L+ +   +KI DFGLAR       E +     +  +
Sbjct: 125 QIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK 184
Query: 112 WYRAPELLLNCTEY---TAAIDIWSVGCILGEIMTREPLFPGKDY 153
           W     + L C  Y   T   D+WS G  + E+MT    F GK Y
Sbjct: 185 W-----MALECIHYRKFTHQSDVWSYGVTIWELMT----FGGKPY 220

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 97/225 (43%), Gaps = 44/225 (19%)
Query: 24  VYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 83
           +Y+V E  + DL+  ++  + +     + +   +L  +  +H   ++H DLKP+N L+  
Sbjct: 131 IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-V 189
Query: 84  SCDLKIGDFGLAR-----TTS--------ETDFMTEYVVTRWYRAPELLLNCTEYTAAID 130
              LK+ DFG+A      TTS          ++M    +     + E   + ++ +   D
Sbjct: 190 DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSD 249
Query: 131 IWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRC 190
           +WS+GCIL  +   +  F  +  ++Q+  +  +I  P+                      
Sbjct: 250 VWSLGCILYYMTYGKTPF--QQIINQISKLHAII-DPN---------------------- 284
Query: 191 RKQQFATRFPNKSSGAV-DLLEKMLVFDPNKRITVEEALRHPYLQ 234
                   FP+     + D+L+  L  DP +RI++ E L HPY+Q
Sbjct: 285 ----HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 57/117 (48%), Gaps = 17/117 (14%)
Query: 39  IRSDQQLTDDHCQYFLYQLLRGLKYVHSAS--VLHRDLKPSNLLLNASCDLKIGDFGLAR 96
           + S   L+ D      YQ  R ++++H     ++HRDLK  NLLL+    +K+ DFG A 
Sbjct: 127 MESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSAT 186
Query: 97  TTS---------ETDFMTEYVVTR----WYRAPELLLNCTEYTAA--IDIWSVGCIL 138
           T S         +   + E  +TR     YR PE++   + +      DIW++GCIL
Sbjct: 187 TISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCIL 243

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 9/100 (9%)
Query: 51  QYFL---YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSETDFMT 105
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E ++  
Sbjct: 127 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 186
Query: 106 E--YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           E   V  +W     +L     YT   D+WS G  + E+MT
Sbjct: 187 EGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMT 224

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 9/100 (9%)
Query: 51  QYFL---YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSETDFMT 105
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E ++  
Sbjct: 117 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 106 E--YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           E   V  +W     +L     YT   D+WS G  + E+MT
Sbjct: 177 EGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMT 214

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 9/100 (9%)
Query: 51  QYFL---YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSETDFMT 105
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E ++  
Sbjct: 151 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 210
Query: 106 E--YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           E   V  +W     +L     YT   D+WS G  + E+MT
Sbjct: 211 EGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMT 248

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 9/100 (9%)
Query: 51  QYFL---YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSETDFMT 105
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E ++  
Sbjct: 118 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 177
Query: 106 E--YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           E   V  +W     +L     YT   D+WS G  + E+MT
Sbjct: 178 EGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMT 215

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 9/100 (9%)
Query: 51  QYFL---YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSETDFMT 105
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E ++  
Sbjct: 117 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 106 E--YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           E   V  +W     +L     YT   D+WS G  + E+MT
Sbjct: 177 EGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMT 214

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 9/100 (9%)
Query: 51  QYFL---YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSETDFMT 105
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E ++  
Sbjct: 142 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 201
Query: 106 E--YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           E   V  +W     +L     YT   D+WS G  + E+MT
Sbjct: 202 EGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMT 239

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 93/225 (41%), Gaps = 44/225 (19%)
Query: 24  VYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 83
           +Y+V E  + DL+  ++  + +     + +   +L  +  +H   ++H DLKP+N L+  
Sbjct: 103 IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-V 161
Query: 84  SCDLKIGDFGLARTTSETDFMT---EYVVTRWYRAPELLLNCTE----------YTAAID 130
              LK+ DFG+A               V T  Y  PE + + +            +   D
Sbjct: 162 DGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD 221
Query: 131 IWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRC 190
           +WS+GCIL  +   +   P +  ++Q+  +  +I  P+                      
Sbjct: 222 VWSLGCILYYMTYGKT--PFQQIINQISKLHAII-DPN---------------------- 256
Query: 191 RKQQFATRFPNKSSGAV-DLLEKMLVFDPNKRITVEEALRHPYLQ 234
                   FP+     + D+L+  L  DP +RI++ E L HPY+Q
Sbjct: 257 ----HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 52/102 (50%), Gaps = 10/102 (9%)
Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART--TSETDFMTE--YVVTR 111
           Q+ +G+ Y+    ++HRDL   N+L+ +   +KI DFGLAR     ET++  +   V  +
Sbjct: 127 QIAKGMSYLEDVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK 186
Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY 153
           W     +L     +T   D+WS G  + E+MT    F  K Y
Sbjct: 187 WMALESILRR--RFTHQSDVWSYGVTVWELMT----FGAKPY 222

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 9/100 (9%)
Query: 51  QYFL---YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSETDFMT 105
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E ++  
Sbjct: 117 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 106 E--YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           E   V  +W     +L     YT   D+WS G  + E+MT
Sbjct: 177 EGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMT 214

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 9/100 (9%)
Query: 51  QYFL---YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSETDFMT 105
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E ++  
Sbjct: 123 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 182
Query: 106 E--YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           E   V  +W     +L     YT   D+WS G  + E+MT
Sbjct: 183 EGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMT 220

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 9/100 (9%)
Query: 51  QYFL---YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSETDFMT 105
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E ++  
Sbjct: 121 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 180
Query: 106 E--YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           E   V  +W     +L     YT   D+WS G  + E+MT
Sbjct: 181 EGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMT 218

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 51/105 (48%), Gaps = 16/105 (15%)
Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART----TSETDFMTEYVVTR 111
           Q+ +G+ Y+    ++HRDL   N+L+ +   +KI DFGLAR       E +     +  +
Sbjct: 148 QIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK 207
Query: 112 WYRAPELLLNCTEY---TAAIDIWSVGCILGEIMTREPLFPGKDY 153
           W     + L C  Y   T   D+WS G  + E+MT    F GK Y
Sbjct: 208 W-----MALECIHYRKFTHQSDVWSYGVTIWELMT----FGGKPY 243

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 9/100 (9%)
Query: 51  QYFL---YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSETDFMT 105
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E ++  
Sbjct: 119 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 178
Query: 106 E--YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           E   V  +W     +L     YT   D+WS G  + E+MT
Sbjct: 179 EGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMT 216

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 9/100 (9%)
Query: 51  QYFL---YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSETDFMT 105
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E ++  
Sbjct: 124 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 183
Query: 106 E--YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           E   V  +W     +L     YT   D+WS G  + E+MT
Sbjct: 184 EGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMT 221

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 9/100 (9%)
Query: 51  QYFL---YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSETDFMT 105
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E ++  
Sbjct: 119 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 178
Query: 106 E--YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           E   V  +W     +L     YT   D+WS G  + E+MT
Sbjct: 179 EGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMT 216

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 9/100 (9%)
Query: 51  QYFL---YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSETDFMT 105
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E ++  
Sbjct: 120 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 179
Query: 106 E--YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           E   V  +W     +L     YT   D+WS G  + E+MT
Sbjct: 180 EGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMT 217

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 26/87 (29%), Positives = 50/87 (57%), Gaps = 5/87 (5%)
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAP 116
           G+ Y+  ASV+HRDL   N L+  +  +K+ DFG+ R   +  + T    T++   + +P
Sbjct: 115 GMAYLEEASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASP 173
Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMT 143
           E + + + Y++  D+WS G ++ E+ +
Sbjct: 174 E-VFSFSRYSSKSDVWSFGVLMWEVFS 199

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 9/100 (9%)
Query: 51  QYFL---YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSETDFMT 105
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E ++  
Sbjct: 120 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 179
Query: 106 E--YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           E   V  +W     +L     YT   D+WS G  + E+MT
Sbjct: 180 EGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMT 217

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 9/100 (9%)
Query: 51  QYFL---YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSETDFMT 105
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E ++  
Sbjct: 118 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 177
Query: 106 E--YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           E   V  +W     +L     YT   D+WS G  + E+MT
Sbjct: 178 EGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMT 215

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 9/100 (9%)
Query: 51  QYFL---YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSETDFMT 105
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E ++  
Sbjct: 117 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 106 E--YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           E   V  +W     +L     YT   D+WS G  + E+MT
Sbjct: 177 EGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMT 214

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 9/100 (9%)
Query: 51  QYFL---YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSETDFMT 105
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E ++  
Sbjct: 124 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 183
Query: 106 E--YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           E   V  +W     +L     YT   D+WS G  + E+MT
Sbjct: 184 EGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMT 221

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 6/95 (6%)
Query: 59  RGLKYVHS---ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--TRWY 113
           RGL Y+H      ++HRD+K +N+LL+   +  +GDFGLA+     D      V  T  +
Sbjct: 150 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGH 209
Query: 114 RAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF 148
            APE  L+  + +   D++  G +L E++T +  F
Sbjct: 210 IAPE-YLSTGKSSEKTDVFGYGVMLLELITGQRAF 243

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 9/100 (9%)
Query: 51  QYFL---YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSETDFMT 105
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E ++  
Sbjct: 120 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 179
Query: 106 E--YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           E   V  +W     +L     YT   D+WS G  + E+MT
Sbjct: 180 EGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMT 217

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 9/100 (9%)
Query: 51  QYFL---YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSETDFMT 105
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E ++  
Sbjct: 124 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 183
Query: 106 E--YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           E   V  +W     +L     YT   D+WS G  + E+MT
Sbjct: 184 EGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMT 221

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 9/100 (9%)
Query: 51  QYFL---YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSETDFMT 105
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E ++  
Sbjct: 120 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 179
Query: 106 E--YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           E   V  +W     +L     YT   D+WS G  + E+MT
Sbjct: 180 EGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMT 217

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 38/146 (26%), Positives = 72/146 (49%), Gaps = 11/146 (7%)
Query: 20  TFNDVYIVYELMD----TDLHQII-RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDL 74
            F D   +Y +MD     DL  ++ + + +L +D  ++++ +++  +  +H    +HRD+
Sbjct: 158 AFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVHRDI 217
Query: 75  KPSNLLLNASCDLKIGDFG--LARTTSETDFMTEYVVTRWYRAPELLL----NCTEYTAA 128
           KP N+LL+ +  +++ DFG  L      T   +  V T  Y +PE+L        +Y   
Sbjct: 218 KPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPE 277
Query: 129 IDIWSVGCILGEIMTREPLFPGKDYV 154
            D WS+G  + E++  E  F  +  V
Sbjct: 278 CDWWSLGVCMYEMLYGETPFYAESLV 303

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 38/146 (26%), Positives = 72/146 (49%), Gaps = 11/146 (7%)
Query: 20  TFNDVYIVYELMD----TDLHQII-RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDL 74
            F D   +Y +MD     DL  ++ + + +L +D  ++++ +++  +  +H    +HRD+
Sbjct: 142 AFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVHRDI 201
Query: 75  KPSNLLLNASCDLKIGDFG--LARTTSETDFMTEYVVTRWYRAPELLL----NCTEYTAA 128
           KP N+LL+ +  +++ DFG  L      T   +  V T  Y +PE+L        +Y   
Sbjct: 202 KPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPE 261
Query: 129 IDIWSVGCILGEIMTREPLFPGKDYV 154
            D WS+G  + E++  E  F  +  V
Sbjct: 262 CDWWSLGVCMYEMLYGETPFYAESLV 287

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 26/87 (29%), Positives = 48/87 (55%), Gaps = 5/87 (5%)
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV---TRWYRAP 116
            ++Y+ S   LHRDL   N L+N    +K+ DFGL+R   + ++ +        RW  +P
Sbjct: 112 AMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW--SP 169
Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMT 143
             +L  +++++  DIW+ G ++ EI +
Sbjct: 170 PEVLMYSKFSSKSDIWAFGVLMWEIYS 196

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 9/100 (9%)
Query: 51  QYFL---YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSETDFMT 105
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E ++  
Sbjct: 111 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 170
Query: 106 E--YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           E   V  +W     +L     YT   D+WS G  + E+MT
Sbjct: 171 EGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMT 208

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 54/106 (50%), Gaps = 15/106 (14%)
Query: 48  DHCQYFLY--QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT 105
           D  +  LY  Q+ +G++Y+ S   +HRDL   N+L+ +   +KI DFGLA+         
Sbjct: 109 DASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP---LDK 165
Query: 106 EYVVTR--------WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           +  V R        WY APE L +   ++   D+WS G +L E+ T
Sbjct: 166 DXXVVREPGQSPIFWY-APESLSD-NIFSRQSDVWSFGVVLYELFT 209

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 49/87 (56%), Gaps = 4/87 (4%)
Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR---WYRA 115
           RGL Y+H+ +++HRD+K  N+LL+ +   KI DFG+++  +E D      V +    Y  
Sbjct: 150 RGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYID 209
Query: 116 PELLLNCTEYTAAIDIWSVGCILGEIM 142
           PE  +     T   D++S G +L E++
Sbjct: 210 PEYFIK-GRLTEKSDVYSFGVVLFEVL 235

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 26/87 (29%), Positives = 48/87 (55%), Gaps = 5/87 (5%)
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV---TRWYRAP 116
            ++Y+ S   LHRDL   N L+N    +K+ DFGL+R   + ++ +        RW  +P
Sbjct: 116 AMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW--SP 173
Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMT 143
             +L  +++++  DIW+ G ++ EI +
Sbjct: 174 PEVLMYSKFSSKSDIWAFGVLMWEIYS 200

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 26/87 (29%), Positives = 48/87 (55%), Gaps = 5/87 (5%)
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV---TRWYRAP 116
            ++Y+ S   LHRDL   N L+N    +K+ DFGL+R   + ++ +        RW  +P
Sbjct: 117 AMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW--SP 174
Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMT 143
             +L  +++++  DIW+ G ++ EI +
Sbjct: 175 PEVLMYSKFSSKSDIWAFGVLMWEIYS 201

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 50/100 (50%), Gaps = 9/100 (9%)
Query: 51  QYFL---YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSETDFMT 105
           QY L    Q+ +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E ++  
Sbjct: 117 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 106 E--YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           E   V  +W     +L     YT   D+WS G  + E+MT
Sbjct: 177 EGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMT 214

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 48/100 (48%), Gaps = 3/100 (3%)
Query: 45  LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM 104
           L+     +F   + RG+ Y+     +HR+L   N+L+  +   KI DFGL+R        
Sbjct: 136 LSSQQLLHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKK 195
Query: 105 T-EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           T   +  RW       LN + YT   D+WS G +L EI++
Sbjct: 196 TMGRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 26/87 (29%), Positives = 48/87 (55%), Gaps = 5/87 (5%)
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV---TRWYRAP 116
            ++Y+ S   LHRDL   N L+N    +K+ DFGL+R   + ++ +        RW  +P
Sbjct: 132 AMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW--SP 189
Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMT 143
             +L  +++++  DIW+ G ++ EI +
Sbjct: 190 PEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 27/87 (31%), Positives = 49/87 (56%), Gaps = 5/87 (5%)
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV---TRWYRAP 116
            ++Y+ S   LHRDL   N L+N    +K+ DFGL+R   + ++ +        RW   P
Sbjct: 123 AMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW-SPP 181
Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMT 143
           E+L+  +++++  DIW+ G ++ EI +
Sbjct: 182 EVLMY-SKFSSKSDIWAFGVLMWEIYS 207

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 26/87 (29%), Positives = 48/87 (55%), Gaps = 5/87 (5%)
Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT---EYVVTRWYRAP 116
            ++Y+ S   LHRDL   N L+N    +K+ DFGL+R   + ++ +        RW  +P
Sbjct: 117 AMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRW--SP 174
Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMT 143
             +L  +++++  DIW+ G ++ EI +
Sbjct: 175 PEVLMYSKFSSKSDIWAFGVLMWEIYS 201

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 80/162 (49%), Gaps = 20/162 (12%)
Query: 1   MEHENVIAIKDI--IRPPKKDTFNDVYIVYELMD-TDLHQIIR--SDQQLTDDHCQYFLY 55
           ++H N++ +  +  + PP        YIV E M   +L   +R  + +++T     Y   
Sbjct: 85  IKHPNLVQLLGVCTLEPP-------FYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMAT 137
Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW--- 112
           Q+   ++Y+   + +HRDL   N L+  +  +K+ DFGL+R  +  D  T +   ++   
Sbjct: 138 QISSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMT-GDTYTAHAGAKFPIK 196
Query: 113 YRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPGKD 152
           + APE L   T ++   D+W+ G +L EI T    P +PG D
Sbjct: 197 WTAPESLAYNT-FSIKSDVWAFGVLLWEIATYGMSP-YPGID 236

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 78/164 (47%), Gaps = 24/164 (14%)
Query: 1   MEHENVIAIKDIIRPPKKDTFNDV--YIVYELMD-TDLHQIIRSDQQLTDDHCQY----- 52
           M+HEN++     I   K+ T  DV  +++    +   L   ++++    ++ C       
Sbjct: 75  MKHENIL---QFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMA 131
Query: 53  ----FLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA----RTTSETDFM 104
               +L++ + GLK  H  ++ HRD+K  N+LL  +    I DFGLA       S  D  
Sbjct: 132 RGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTH 191
Query: 105 TEYVVTRWYRAPELLLNCTEYT----AAIDIWSVGCILGEIMTR 144
            + V TR Y APE+L     +       ID++++G +L E+ +R
Sbjct: 192 GQ-VGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASR 234

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/142 (26%), Positives = 68/142 (47%), Gaps = 17/142 (11%)
Query: 56  QLLRGLKYVHSAS--VLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRW 112
           Q+L+GL+++H+ +  ++HRDLK  N+ +   +  +KIGD GLA T     F    + T  
Sbjct: 137 QILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA-TLKRASFAKAVIGTPE 195
Query: 113 YRAPELLLNCTEYTAAIDIWSVG-CILGEIMTREPLFPGKDYVHQLRLITELI--GSPDD 169
           + APE      +Y  ++D+++ G C L    +  P    ++     R +T  +   S D 
Sbjct: 196 FXAPEXYEE--KYDESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASFDK 253
Query: 170 ASL--------GFLRSDNARRY 183
            ++        G +R +   RY
Sbjct: 254 VAIPEVKEIIEGCIRQNKDERY 275

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 49/100 (49%), Gaps = 9/100 (9%)
Query: 51  QYFL---YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSETDFMT 105
           QY L    Q+  G+ Y+    ++HRDL   N+L+     +KI DFGLA+     E ++  
Sbjct: 114 QYLLNWCVQIAEGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 173
Query: 106 E--YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           E   V  +W     +L     YT   D+WS G  + E+MT
Sbjct: 174 EGGKVPIKWMALESILHRI--YTHQSDVWSYGVTVWELMT 211

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 4/87 (4%)
Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE---TDFMTEYVVTRWYRA 115
           RGL Y+H+ +++HRD+K  N+LL+ +   KI DFG+++  +E   T        T  Y  
Sbjct: 150 RGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYID 209
Query: 116 PELLLNCTEYTAAIDIWSVGCILGEIM 142
           PE  +     T   D++S G +L E++
Sbjct: 210 PEYFIK-GRLTEKSDVYSFGVVLFEVL 235

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 69/136 (50%), Gaps = 11/136 (8%)
Query: 25  YIVYELMD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 81
           YI+ E M   +L   +R  + Q+++     Y   Q+   ++Y+   + +HRDL   N L+
Sbjct: 83  YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV 142
Query: 82  NASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCIL 138
             +  +K+ DFGL+R  +  D  T +   ++   + APE  L   +++   D+W+ G +L
Sbjct: 143 GENHLVKVADFGLSRLMT-GDTFTAHAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFGVLL 200
Query: 139 GEIMT--REPLFPGKD 152
            EI T    P +PG D
Sbjct: 201 WEIATYGMSP-YPGID 215

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 69/136 (50%), Gaps = 11/136 (8%)
Query: 25  YIVYELMD-TDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 81
           YI+ E M   +L   +R  + Q+++     Y   Q+   ++Y+   + +HRDL   N L+
Sbjct: 83  YIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV 142
Query: 82  NASCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCTEYTAAIDIWSVGCIL 138
             +  +K+ DFGL+R  +  D  T +   ++   + APE  L   +++   D+W+ G +L
Sbjct: 143 GENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPE-SLAYNKFSIKSDVWAFGVLL 200
Query: 139 GEIMT--REPLFPGKD 152
            EI T    P +PG D
Sbjct: 201 WEIATYGMSP-YPGID 215
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	280
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	0.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-177
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-175
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-174
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-174
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-174
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-169
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-166
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-165
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-160
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-158
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-158
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-148
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-141
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-138
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-138
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-131
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-110
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	4e-99
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	5e-94
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-93
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-93
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-93
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	5e-93
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-92
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	9e-92
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	5e-91
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-89
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-89
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-89
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-80
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-56
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-52
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	4e-52
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	4e-52
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	5e-51
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-50
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	3e-49
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	7e-48
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-46
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-46
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	6e-46
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-45
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-45
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	7e-45
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	4e-44
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	4e-43
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	6e-43
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-42
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-42
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-42
3bhy_A	283	Death-associated protein kinase 3; death associate	4e-42
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-41
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	8e-41
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-40
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-40
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	5e-40
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	8e-40
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	9e-40
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-39
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-39
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-39
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-39
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-39
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	4e-39
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	5e-39
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-38
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-38
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-38
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-38
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-38
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-38
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	3e-38
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-38
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	4e-38
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	5e-38
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	5e-38
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	5e-38
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-37
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-37
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-37
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	4e-37
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	9e-37
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	9e-37
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-36
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	4e-36
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	7e-36
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	7e-36
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	7e-36
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-35
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-35
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-35
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	4e-35
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	6e-35
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-34
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	8e-34
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-33
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-33
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-33
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	5e-33
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	5e-33
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	8e-33
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-32
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-32
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-32
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-32
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	4e-32
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-31
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-31
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-31
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	4e-31
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-30
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	4e-30
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-29
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-29
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-28
3an0_A	340	Dual specificity mitogen-activated protein kinase;	9e-28
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-26
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-25
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-25
3aln_A	327	Dual specificity mitogen-activated protein kinase;	5e-25
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	6e-25
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	8e-25
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	8e-25
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	8e-25
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-24
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	4e-24
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-23
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-23
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-23
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-23
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-23
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-23
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-23
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	5e-23
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	8e-23
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	8e-23
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-22
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-22
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-22
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-22
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-22
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	7e-22
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-21
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-21
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-21
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-21
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-21
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	5e-21
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	7e-21
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-20
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-20
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	5e-20
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-19
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	5e-19
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-18
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-18
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-18
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-18
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-18
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-18
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-18
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-18
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	6e-18
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	6e-18
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	8e-18
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-17
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-17
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-17
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-17
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-17
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-17
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-17
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-17
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-17
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-17
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-17
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	4e-17
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	4e-17
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	5e-17
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	6e-17
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	6e-17
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	6e-17
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	6e-17
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	6e-17
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	6e-17
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	7e-17
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	7e-17
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	8e-17
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	8e-17
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-16
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-16
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-16
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-16
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-16
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-16
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-16
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-16
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-16
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-16
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-16
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-16
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	4e-16
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	7e-16
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-15
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-15
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-15
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-15
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-15
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-14
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-14
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-14
4aoj_A	329	High affinity nerve growth factor receptor; transf	6e-14
3uqc_A	286	Probable conserved transmembrane protein; structur	8e-14
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	8e-14
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-13
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-13
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-13
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-13
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-13
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-13
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-13
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	4e-13
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-12
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-12
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-12
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	4e-12
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-11
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-09
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	4e-08
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	9e-07
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-06
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-06
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	3e-06
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	3e-06
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-05

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  503 bits (1298), Expect = 0.0
 Identities = 150/281 (53%), Positives = 197/281 (70%), Gaps = 5/281 (1%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
             HEN+I I DIIR P  +   DVYIV +LM+TDL++++++ Q L++DH  YFLYQ+LRG
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRG 140

Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS----ETDFMTEYVVTRWYRAP 116
           LKY+HSA+VLHRDLKPSNLLLN +CDLKI DFGLAR        T F+TEYV TRWYRAP
Sbjct: 141 LKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200

Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 176
           E++LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I  ++GSP    L  + 
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 260

Query: 177 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 236
           +  AR Y+  LP   K  +   FPN  S A+DLL+KML F+P+KRI VE+AL HPYL+  
Sbjct: 261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320

Query: 237 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPD 277
           +D +DEP+   PF FD E     ++ ++ELI+ E+ +F P 
Sbjct: 321 YDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPG 361

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  492 bits (1269), Expect = e-177
 Identities = 102/277 (36%), Positives = 154/277 (55%), Gaps = 3/277 (1%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQ-LTDDHCQYFLYQLLR 59
             H N++ ++DI    ++   + +Y+V ELM TDL Q+I   +  ++  H QYF+Y +L 
Sbjct: 86  FHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILL 145

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GL  +H A V+HRDL P N+LL  + D+ I DF LAR  +     T YV  RWYRAPEL+
Sbjct: 146 GLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELV 205

Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           +    +T  +D+WS GC++ E+  R+ LF G  + +QL  I E++G+P    +    S +
Sbjct: 206 MQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPS 265

Query: 180 ARRYVRQ-LPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 238
           AR Y+R  L     + +    P     A+DL+ KML F+P +RI+ E+ALRHPY +SL D
Sbjct: 266 ARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFD 325

Query: 239 LNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFN 275
             D         F F+ S      + ++   E  +FN
Sbjct: 326 PLDLTEGL-SERFHFDESVTDVYDMHKIFTAEVERFN 361

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  487 bits (1255), Expect = e-175
 Identities = 141/286 (49%), Positives = 187/286 (65%), Gaps = 17/286 (5%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
            +HEN+I I +I RP   + FN+VYI+ ELM TDLH++I + Q L+DDH QYF+YQ LR 
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIST-QMLSDDHIQYFIYQTLRA 124

Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-----------TSETDFMTEYVV 109
           +K +H ++V+HRDLKPSNLL+N++CDLK+ DFGLAR            T +   M E+V 
Sbjct: 125 VKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA 184

Query: 110 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP-D 168
           TRWYRAPE++L   +Y+ A+D+WS GCIL E+  R P+FPG+DY HQL LI  +IG+P  
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244

Query: 169 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL 228
           D  L  + S  AR Y++ LP          FP  +   +DLL++MLVFDP KRIT +EAL
Sbjct: 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEAL 304

Query: 229 RHPYLQSLHDLNDEPVC----PRPFHFDFEHSSCTEDHIRELIWRE 270
            HPYLQ+ HD NDEP      P  F FD    + T   +++LIW E
Sbjct: 305 EHPYLQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLKKLIWNE 350

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  484 bits (1249), Expect = e-174
 Identities = 123/277 (44%), Positives = 170/277 (61%), Gaps = 5/277 (1%)

Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P      F D Y+V   M TDL +I+    + +++  QY +YQ+L+
Sbjct: 80  MQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG--LKFSEEKIQYLVYQMLK 137

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA V+HRDLKP NL +N  C+LKI DFGLAR       MT YVVTRWYRAPE++
Sbjct: 138 GLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD--AEMTGYVVTRWYRAPEVI 195

Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           L+   Y   +DIWSVGCI+ E++T + LF GKDY+ QL  I ++ G P    +  L    
Sbjct: 196 LSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 255

Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           A+ Y++ LP+  ++ F   FP  S  A DLLEKML  D +KR+T  +AL HP+ +   D 
Sbjct: 256 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDP 315

Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 276
            +E    +PF    EH   T D  ++ I++E V F+P
Sbjct: 316 EEETEAQQPFDDSLEHEKLTVDEWKQHIYKEIVNFSP 352

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  484 bits (1248), Expect = e-174
 Identities = 139/279 (49%), Positives = 183/279 (65%), Gaps = 5/279 (1%)

Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 85  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 143

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T+  D MT YV TRWYRAPE++
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA--DEMTGYVATRWYRAPEIM 201

Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 261

Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 262 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 321

Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   P+    E      D  + L + E + F P P
Sbjct: 322 DDEPVAD-PYDQSLESRDLLIDEWKSLTYDEVISFVPPP 359

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  483 bits (1245), Expect = e-174
 Identities = 126/279 (45%), Positives = 179/279 (64%), Gaps = 5/279 (1%)

Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M HENVI + D+  P +  D F D Y+V   M TDL ++++  ++L +D  Q+ +YQ+L+
Sbjct: 81  MRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLK 139

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GL+Y+H+A ++HRDLKP NL +N  C+LKI DFGLAR       MT YVVTRWYRAPE++
Sbjct: 140 GLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD--SEMTGYVVTRWYRAPEVI 197

Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   YT  +DIWSVGCI+ E++T + LF G D++ QL+ I ++ G+P    +  L+SD 
Sbjct: 198 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 257

Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           A+ Y++ LP   K+ FA+   N S  AV+LLEKMLV D  +R+T  EAL HPY +SLHD 
Sbjct: 258 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 317

Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
            DEP     +   F+    T D  + + ++E + F P  
Sbjct: 318 EDEPQVQ-KYDDSFDDVDRTLDEWKRVTYKEVLSFKPPR 355

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  475 bits (1223), Expect = e-169
 Identities = 107/329 (32%), Positives = 168/329 (51%), Gaps = 52/329 (15%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           ++ + +I + D+I P     F+++YIV E+ D+DL ++ ++   LT++H +  LY LL G
Sbjct: 82  LKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLG 141

Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS--------------------- 99
             ++H + ++HRDLKP+N LLN  C +K+ DFGLART +                     
Sbjct: 142 ENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHN 201

Query: 100 --ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-----------REP 146
                 +T +VVTRWYRAPEL+L    YT +IDIWS GCI  E++            R P
Sbjct: 202 KNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFP 261

Query: 147 LFPG-----------------KDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPR 189
           LFPG                 K    QL +I  +IG+P +  L  +      +Y++  P 
Sbjct: 262 LFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPH 321

Query: 190 CRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPF 249
            +      ++P+ S   ++LLE ML F+PNKRIT+++AL HPYL+ +     E    +  
Sbjct: 322 RKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKI 381

Query: 250 HFDFEHS-SCTEDHIRELIWRESVKFNPD 277
              F+     +E  +R +  +E   F+P+
Sbjct: 382 ILPFDDWMVLSETQLRYIFLKEVQSFHPE 410

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  468 bits (1207), Expect = e-166
 Identities = 114/337 (33%), Positives = 173/337 (51%), Gaps = 60/337 (17%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           + H++V+ + DI+ P   + F+++Y+V E+ D+D  ++ R+   LT+ H +  LY LL G
Sbjct: 109 LNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVG 168

Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD------------------ 102
           +KYVHSA +LHRDLKP+N L+N  C +K+ DFGLART    +                  
Sbjct: 169 VKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228

Query: 103 ----------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--------- 143
                      +T +VVTRWYRAPEL+L    YT AID+WS+GCI  E++          
Sbjct: 229 TFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288

Query: 144 --REPLFPGKDYV--------------------HQLRLITELIGSPDDASLGFLRSDNAR 181
             R PLFPG                         QL +I  ++G+P +  +  L  ++A+
Sbjct: 289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAK 348

Query: 182 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLND 241
           RY+R  P+      A RFP  S+ A+ LL++MLVF+PNKRIT+ E L HP+ + +     
Sbjct: 349 RYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEV 408

Query: 242 EPVCPRPFHFDFE-HSSCTEDHIRELIWRESVKFNPD 277
           E          F    +  E  +R    +E  +++P+
Sbjct: 409 ETNATEKVRLPFNDWMNMDEPQLRYAFVKEIQRYHPE 445

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  461 bits (1188), Expect = e-165
 Identities = 109/315 (34%), Positives = 176/315 (55%), Gaps = 43/315 (13%)

Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGL 61
            HEN++ + +++R        DVY+V++ M+TDLH +IR+   L   H QY +YQL++ +
Sbjct: 67  GHENIVNLLNVLRAD---NDRDVYLVFDYMETDLHAVIRA-NILEPVHKQYVVYQLIKVI 122

Query: 62  KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART----------------------TS 99
           KY+HS  +LHRD+KPSN+LLNA C +K+ DFGL+R+                        
Sbjct: 123 KYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDD 182

Query: 100 ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL 159
           +   +T+YV TRWYRAPE+LL  T+YT  ID+WS+GCILGEI+  +P+FPG   ++QL  
Sbjct: 183 DQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242

Query: 160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF----------------PNKS 203
           I  +I  P +  +  ++S  A+  +  L    + + + +                  + +
Sbjct: 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCN 302

Query: 204 SGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDF-EHSSCTEDH 262
             A+DLL+K+L F+PNKRI+  +AL+HP++   H+ N+EP C         ++   + D 
Sbjct: 303 EEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKHSIDD 362

Query: 263 IRELIWRESVKFNPD 277
            R L++ E  +   +
Sbjct: 363 YRNLVYSEISRRKRE 377

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  450 bits (1159), Expect = e-160
 Identities = 117/292 (40%), Positives = 171/292 (58%), Gaps = 18/292 (6%)

Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H+N+I + ++  P K  + F DVYIV ELMD +L Q+I+   +L  +   Y LYQ+L 
Sbjct: 81  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLC 138

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ + C LKI DFGLART   +  MT YVVTR+YRAPE++
Sbjct: 139 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 198

Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           L    Y   +DIWSVGCI+GE++    LFPG D++ Q   + E +G+P    +  L    
Sbjct: 199 LGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL-QPT 256

Query: 180 ARRYVRQLPRCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEA 227
            R YV   P+     F   FP+            K+S A DLL KMLV D +KRI+V+EA
Sbjct: 257 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 316

Query: 228 LRHPYLQSLHDLNDEPVC-PRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           L+HPY+   +D ++     P+      +    T +  +ELI++E +      
Sbjct: 317 LQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDLEHHH 368

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  442 bits (1140), Expect = e-158
 Identities = 105/258 (40%), Positives = 146/258 (56%), Gaps = 16/258 (6%)

Query: 1   MEHENVIAIKDIIRPPKK---------DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQ 51
           ++H+N++ + +I+ P               N VYIV E M+TDL  ++     L ++H +
Sbjct: 65  LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ-GPLLEEHAR 123

Query: 52  YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTS----ETDFMTE 106
            F+YQLLRGLKY+HSA+VLHRDLKP+NL +N     LKIGDFGLAR           ++E
Sbjct: 124 LFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSE 183

Query: 107 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGS 166
            +VT+WYR+P LLL+   YT AID+W+ GCI  E++T + LF G   + Q++LI E I  
Sbjct: 184 GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPV 243

Query: 167 PDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEE 226
             +     L S     Y+R       +      P  S  AVD LE++L F P  R+T EE
Sbjct: 244 VHEEDRQELLS-VIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEE 302

Query: 227 ALRHPYLQSLHDLNDEPV 244
           AL HPY+       DEP+
Sbjct: 303 ALSHPYMSIYSFPMDEPI 320

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  447 bits (1151), Expect = e-158
 Identities = 117/290 (40%), Positives = 174/290 (60%), Gaps = 18/290 (6%)

Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H+N+I++ ++  P K  + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L 
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLC 175

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ + C LKI DFGLART   +  MT YVVTR+YRAPE++
Sbjct: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 235

Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           L    Y   +DIWSVGCI+GE++  + LFPG+DY+ Q   + E +G+P    +  L    
Sbjct: 236 LGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL-QPT 293

Query: 180 ARRYVRQLPRCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEA 227
            R YV   P+     F   FP+            K+S A DLL KMLV DP KRI+V++A
Sbjct: 294 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 353

Query: 228 LRHPYLQSLHDLNDE-PVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 276
           L+HPY+   +D  +     P+ +    +    T +  +ELI++E +    
Sbjct: 354 LQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMNSEE 403

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  417 bits (1074), Expect = e-148
 Identities = 85/285 (29%), Positives = 133/285 (46%), Gaps = 15/285 (5%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVY--IVYELMDTDLHQIIRS----DQQLTDDHCQYFL 54
           + H N++ ++       +    D+Y  +V E +   LH+  R+             + FL
Sbjct: 76  LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFL 135

Query: 55  YQLLRGLKYVH--SASVLHRDLKPSNLLLN-ASCDLKIGDFGLARTTSETDFMTEYVVTR 111
           +QL+R +  +H  S +V HRD+KP N+L+N A   LK+ DFG A+  S ++    Y+ +R
Sbjct: 136 FQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSR 195

Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDAS 171
           +YRAPEL+     YT A+DIWSVGCI  E+M  EP+F G +   QL  I  ++G P    
Sbjct: 196 YYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREV 255

Query: 172 LGFLRSDNARRYVRQLPRC-RKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 230
           L  L   +    +           F+      +  A DLL  +L + P +R+   EAL H
Sbjct: 256 LRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315

Query: 231 PYLQSLHDLNDE-----PVCPRPFHFDFEHSSCTEDHIRELIWRE 270
           PY   LHD   +      +    F F         +  +  + R+
Sbjct: 316 PYFDELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQKAKLVRK 360

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  401 bits (1032), Expect = e-141
 Identities = 83/328 (25%), Positives = 150/328 (45%), Gaps = 55/328 (16%)

Query: 1   MEHENVIAIKDIIR---------------------------------PPKKDTFNDVYIV 27
           ++H N+I + D                                             + ++
Sbjct: 57  LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116

Query: 28  YELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 83
            E +   LH++++    S + +  +    ++YQL R + ++HS  + HRD+KP NLL+N+
Sbjct: 117 MEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNS 176

Query: 84  -SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIM 142
               LK+ DFG A+    ++    Y+ +R+YRAPEL+L  TEYT +ID+WS+GC+ GE++
Sbjct: 177 KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236

Query: 143 TREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK 202
             +PLF G+  + QL  I +++G+P    +  +            P  + + +    P  
Sbjct: 237 LGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVR---FPTLKAKDWRKILPEG 293

Query: 203 S-SGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVC-------------PRP 248
           + S A+DLLE++L ++P+ RI   EA+ HP+   L +  +  V              P+ 
Sbjct: 294 TPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQL 353

Query: 249 FHFDFEHSSCTEDHIRELIWRESVKFNP 276
           F+F     S    ++   I  ++   N 
Sbjct: 354 FNFSPYELSIIPGNVLNRILPKNFSPNY 381

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  394 bits (1015), Expect = e-138
 Identities = 82/278 (29%), Positives = 140/278 (50%), Gaps = 14/278 (5%)

Query: 1   MEHENVIAIKDIIRPP-KKDTFNDVYIVYELMDTDLHQIIR----SDQQLTDDHCQYFLY 55
           ++H N++ ++       +K     + +V + +   ++++ R    + Q L   + + ++Y
Sbjct: 104 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 163

Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCD-LKIGDFGLARTTSETDFMTEYVVTRWYR 114
           QL R L Y+HS  + HRD+KP NLLL+     LK+ DFG A+     +    Y+ +R+YR
Sbjct: 164 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 223

Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF 174
           APEL+   T+YT++ID+WS GC+L E++  +P+FPG   V QL  I +++G+P       
Sbjct: 224 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE---Q 280

Query: 175 LRSDNARRYVRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
           +R  N      + P+ +   +   F P     A+ L  ++L + P  R+T  EA  H + 
Sbjct: 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 340

Query: 234 QSLHDLNDEPVCPRP----FHFDFEHSSCTEDHIRELI 267
             L D N +    R     F+F  +  S        LI
Sbjct: 341 DELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILI 378

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  393 bits (1012), Expect = e-138
 Identities = 89/278 (32%), Positives = 142/278 (51%), Gaps = 14/278 (5%)

Query: 1   MEHENVIAIKDIIRPP-KKDTFNDVYIVYELMDTDLHQIIRS----DQQLTDDHCQYFLY 55
           ++H NV+ +K        K     + +V E +   +++  R      Q +     + ++Y
Sbjct: 89  VKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMY 148

Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCD-LKIGDFGLARTTSETDFMTEYVVTRWYR 114
           QLLR L Y+HS  + HRD+KP NLLL+     LK+ DFG A+     +    Y+ +R+YR
Sbjct: 149 QLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYR 208

Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF 174
           APEL+   T YT  IDIWS GC++ E+M  +PLFPG+  + QL  I +++G+P       
Sbjct: 209 APELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSRE---Q 265

Query: 175 LRSDNARRYVRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
           +++ N      + P+ R   F+  F P     A+DL+ ++L + P+ R+T  EAL HP+ 
Sbjct: 266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFF 325

Query: 234 QSLHDLN----DEPVCPRPFHFDFEHSSCTEDHIRELI 267
             L        +    P  F++  E  S   D I  L+
Sbjct: 326 DELRTGEARMPNGRELPPLFNWTKEELSVRPDLISRLV 363

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  372 bits (958), Expect = e-131
 Identities = 70/244 (28%), Positives = 129/244 (52%), Gaps = 13/244 (5%)

Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 62
             N+I + DI++ P         +   + +TD  Q+    Q LTD   ++++Y++L+ L 
Sbjct: 90  GPNIITLADIVKDPVS--RTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALD 144

Query: 63  YVHSASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 121
           Y HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++
Sbjct: 145 YCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 204

Query: 122 CTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPD-DASLGFLRSDN 179
              Y  ++D+WS+GC+L  ++ R EP F G D   QL  I +++G+ D    +     + 
Sbjct: 205 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 264

Query: 180 ARRYVRQLPRCRKQQFATRFPNK-----SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
             R+   L R  ++++     ++     S  A+D L+K+L +D   R+T  EA+ HPY  
Sbjct: 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 324

Query: 235 SLHD 238
           ++  
Sbjct: 325 TVVK 328

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  320 bits (823), Expect = e-110
 Identities = 73/250 (29%), Positives = 136/250 (54%), Gaps = 7/250 (2%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDL-HQIIRSDQQLTDDHCQYFLYQLLR 59
           ++H N++ + ++ R  ++     +++V+E  D  + H++ R  + + +   +   +Q L+
Sbjct: 59  LKHPNLVNLLEVFRRKRR-----LHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQ 113

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPEL 118
            + + H  + +HRD+KP N+L+     +K+ DFG AR  T  +D+  + V TRWYR+PEL
Sbjct: 114 AVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPEL 173

Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 178
           L+  T+Y   +D+W++GC+  E+++  PL+PGK  V QL LI + +G           ++
Sbjct: 174 LVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN 233

Query: 179 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 238
                V+       +    +FPN S  A+ LL+  L  DP +R+T E+ L HPY +++ +
Sbjct: 234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293

Query: 239 LNDEPVCPRP 248
           + D       
Sbjct: 294 IEDLAKEHDK 303

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  292 bits (750), Expect = 4e-99
 Identities = 77/240 (32%), Positives = 131/240 (54%), Gaps = 11/240 (4%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLR 59
           + HEN++ + ++ +  K+      Y+V+E +D  +   +      L     Q +L+Q++ 
Sbjct: 81  LRHENLVNLLEVCKKKKR-----WYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIIN 135

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPEL 118
           G+ + HS +++HRD+KP N+L++ S  +K+ DFG ART  +  +   + V TRWYRAPEL
Sbjct: 136 GIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPEL 195

Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL-GFLRS 177
           L+   +Y  A+D+W++GC++ E+   EPLFPG   + QL  I   +G+        F  +
Sbjct: 196 LVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELF--N 253

Query: 178 DNARRYVRQLPRCRKQQ-FATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 236
            N      +LP  ++++    R+P  S   +DL +K L  DP+KR    E L H + Q  
Sbjct: 254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  279 bits (716), Expect = 5e-94
 Identities = 90/262 (34%), Positives = 130/262 (49%), Gaps = 14/262 (5%)

Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS--DQQLTDDHCQYFLYQLLR 59
           EH NV+ + D+    + D    + +V+E +D DL   +    +  +  +  +  ++QLLR
Sbjct: 72  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 131

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GL ++HS  V+HRDLKP N+L+ +S  +K+ DFGLAR  S    +T  VVT WYRAPE+L
Sbjct: 132 GLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVL 191

Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL-GFLRSD 178
           L  + Y   +D+WSVGCI  E+  R+PLF G   V QL  I ++IG P +      +   
Sbjct: 192 LQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 250

Query: 179 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 238
                         Q       +      DLL K L F+P KRI+   AL HPY Q L  
Sbjct: 251 RQ-----AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL-- 303

Query: 239 LNDEPVCPRPFHFDFEHSSCTE 260
             +        H      + +E
Sbjct: 304 --ERCKENLDSHL-PPSQNTSE 322

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  277 bits (712), Expect = 1e-93
 Identities = 85/238 (35%), Positives = 122/238 (51%), Gaps = 9/238 (3%)

Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS--DQQLTDDHCQYFLYQLLR 59
           EH NV+ + D+    + D    V +V+E +D DL   +       L  +  +  + Q LR
Sbjct: 72  EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLR 131

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GL ++H+  ++HRDLKP N+L+ +   +K+ DFGLAR  S    +T  VVT WYRAPE+L
Sbjct: 132 GLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVL 191

Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL-GFLRSD 178
           L  T Y   +D+WSVGCI  E+  R+PLF G     QL  I +LIG P +      +   
Sbjct: 192 LQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLP 250

Query: 179 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 236
                    P    +   +  P        LL +ML F+P+KRI+   AL+H YL   
Sbjct: 251 RG-----AFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  277 bits (711), Expect = 2e-93
 Identities = 87/239 (36%), Positives = 135/239 (56%), Gaps = 10/239 (4%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLR 59
           + H N++++ D+I   +      + +V+E M+ DL +++      L D   + +LYQLLR
Sbjct: 76  LHHPNIVSLIDVIHSERC-----LTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLR 130

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPEL 118
           G+ + H   +LHRDLKP NLL+N+   LK+ DFGLAR         T  VVT WYRAP++
Sbjct: 131 GVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDV 190

Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL-GFLRS 177
           L+   +Y+ ++DIWS+GCI  E++T +PLFPG     QL  I  ++G+P+          
Sbjct: 191 LMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL 250

Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 236
              ++         K+ +++  P      +DLL  ML FDPNKRI+  +A+ HPY + L
Sbjct: 251 PLWKQR--TFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  275 bits (706), Expect = 5e-93
 Identities = 87/239 (36%), Positives = 127/239 (53%), Gaps = 11/239 (4%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLR 59
           ++H N++ + D+I   K+     + +V+E +D DL +++   +  L     + FL QLL 
Sbjct: 57  LKHSNIVKLYDVIHTKKR-----LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLN 111

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPEL 118
           G+ Y H   VLHRDLKP NLL+N   +LKI DFGLAR         T  +VT WYRAP++
Sbjct: 112 GIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDV 171

Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL-GFLRS 177
           L+   +Y+  IDIWSVGCI  E++   PLFPG     QL  I  ++G+P+  +       
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV--- 228

Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 236
               +Y           + +         +DLL KML  DPN+RIT ++AL H Y +  
Sbjct: 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  276 bits (707), Expect = 1e-92
 Identities = 96/251 (38%), Positives = 139/251 (55%), Gaps = 14/251 (5%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLR 59
           ++H N++ + DII   K      + +V+E +D DL Q +      +   + + FL+QLLR
Sbjct: 57  LKHANIVTLHDIIHTEKS-----LTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLR 111

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPEL 118
           GL Y H   VLHRDLKP NLL+N   +LK+ DFGLAR  +  T      VVT WYR P++
Sbjct: 112 GLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDI 171

Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL-GFLRS 177
           LL  T+Y+  ID+W VGCI  E+ T  PLFPG     QL  I  ++G+P + +  G L +
Sbjct: 172 LLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 231

Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH 237
           +  + Y    P+ R +   +  P   S   DLL K+L F+   RI+ E+A++HP+  SL 
Sbjct: 232 EEFKTY--NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL- 288

Query: 238 DLNDEPVCPRP 248
               E +   P
Sbjct: 289 ---GERIHKLP 296

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  274 bits (703), Expect = 9e-92
 Identities = 81/239 (33%), Positives = 124/239 (51%), Gaps = 12/239 (5%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLR 59
           + H N+I + D          +++ +V++ M+TDL  II+     LT  H + ++   L+
Sbjct: 69  LSHPNIIGLLDAFG-----HKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQ 123

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPEL 118
           GL+Y+H   +LHRDLKP+NLLL+ +  LK+ DFGLA++  S     T  VVTRWYRAPEL
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPEL 183

Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL-GFLRS 177
           L     Y   +D+W+VGCIL E++ R P  PG   + QL  I E +G+P +         
Sbjct: 184 LFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 243

Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 236
            +                   F       +DL++ + +F+P  RIT  +AL+  Y  + 
Sbjct: 244 PDY----VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 298

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  271 bits (696), Expect = 5e-91
 Identities = 86/244 (35%), Positives = 130/244 (53%), Gaps = 16/244 (6%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           ++H N+I +K +I    +     +++++E  + DL + +  +  ++    + FLYQL+ G
Sbjct: 90  LQHRNIIELKSVIHHNHR-----LHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLING 144

Query: 61  LKYVHSASVLHRDLKPSNLLLNASCD-----LKIGDFGLART-TSETDFMTEYVVTRWYR 114
           + + HS   LHRDLKP NLLL+ S       LKIGDFGLAR         T  ++T WYR
Sbjct: 145 VNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYR 204

Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL-G 173
            PE+LL    Y+ ++DIWS+ CI  E++ + PLFPG   + QL  I E++G PDD +  G
Sbjct: 205 PPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPG 264

Query: 174 FLRSDNARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPY 232
                +   + +  P+ R +              +DLL  ML  DP KRI+ + AL HPY
Sbjct: 265 VTALPD---WKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY 321

Query: 233 LQSL 236
               
Sbjct: 322 FSHN 325

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  269 bits (689), Expect = 1e-89
 Identities = 85/272 (31%), Positives = 134/272 (49%), Gaps = 19/272 (6%)

Query: 1   MEHENVIAIKDII---RPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQ 56
           ++HENV+ + +I      P       +Y+V++  + DL  ++ +   + T    +  +  
Sbjct: 73  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 132

Query: 57  LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR-----TTSETDFMTEYVVTR 111
           LL GL Y+H   +LHRD+K +N+L+     LK+ DFGLAR       S+ +  T  VVT 
Sbjct: 133 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 192

Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDAS 171
           WYR PELLL   +Y   ID+W  GCI+ E+ TR P+  G    HQL LI++L GS     
Sbjct: 193 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 252

Query: 172 L-GFLRSDNARRYVRQLPRCRKQQFATRFPN--KSSGAVDLLEKMLVFDPNKRITVEEAL 228
                  +   +   +L + +K++   R     +   A+DL++K+LV DP +RI  ++AL
Sbjct: 253 WPNVDNYELYEKL--ELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 310

Query: 229 RHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTE 260
            H +  S     D              +S  E
Sbjct: 311 NHDFFWS-----DPMPSDLKGMLSTHLTSMFE 337

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  267 bits (684), Expect = 1e-89
 Identities = 85/240 (35%), Positives = 131/240 (54%), Gaps = 12/240 (5%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLR 59
           ++H+N++ + D++   KK     + +V+E  D DL +   S +  L  +  + FL+QLL+
Sbjct: 58  LKHKNIVRLHDVLHSDKK-----LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLK 112

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPEL 118
           GL + HS +VLHRDLKP NLL+N + +LK+ +FGLAR         +  VVT WYR P++
Sbjct: 113 GLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDV 172

Query: 119 LLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASL-GFLR 176
           L     Y+ +ID+WS GCI  E+     PLFPG D   QL+ I  L+G+P +       +
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232

Query: 177 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 236
             + + Y                P  ++   DLL+ +L  +P +RI+ EEAL+HPY    
Sbjct: 233 LPDYKPYPM---YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  267 bits (685), Expect = 2e-89
 Identities = 85/263 (32%), Positives = 138/263 (52%), Gaps = 21/263 (7%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS------DQQLTDDHCQYFL 54
           ++HEN++ + D+I    K     + +V+E MD DL + + S       + L  +  +YF 
Sbjct: 60  LKHENIVRLYDVIHTENK-----LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQ 114

Query: 55  YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWY 113
           +QLL+GL + H   +LHRDLKP NLL+N    LK+GDFGLAR      +  +  VVT WY
Sbjct: 115 WQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWY 174

Query: 114 RAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL- 172
           RAP++L+    Y+ +IDIWS GCIL E++T +PLFPG +   QL+LI +++G+P+++   
Sbjct: 175 RAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWP 234

Query: 173 GFLRSDNARRYVRQLPRCRKQQFATRFPNK-----SSGAVDLLEKMLVFDPNKRITVEEA 227
              +      Y   + +   +                  +D L  +L  +P+ R++ ++A
Sbjct: 235 SVTKLPK---YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQA 291

Query: 228 LRHPYLQSLHDLNDEPVCPRPFH 250
           L HP+    +            H
Sbjct: 292 LHHPWFAEYYHHASMGGSRSHHH 314

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  247 bits (632), Expect = 2e-80
 Identities = 85/270 (31%), Positives = 126/270 (46%), Gaps = 38/270 (14%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS---------DQQLTDDHCQ 51
           ++H NVI+++ +           V+++++  + DL  II+            QL     +
Sbjct: 75  LKHPNVISLQKVFLSHAD---RKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVK 131

Query: 52  YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD----LKIGDFGLARTTSE-----TD 102
             LYQ+L G+ Y+H+  VLHRDLKP+N+L+         +KI D G AR  +       D
Sbjct: 132 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 191

Query: 103 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD---------Y 153
                VVT WYRAPELLL    YT AIDIW++GCI  E++T EP+F  +          +
Sbjct: 192 LDPV-VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH 250

Query: 154 VHQLRLITELIGSPDDA------SLGFLRSDNARRYVRQLPRCRKQQF-ATRFPNKSSGA 206
             QL  I  ++G P D        +    +            C   ++         S A
Sbjct: 251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKA 310

Query: 207 VDLLEKMLVFDPNKRITVEEALRHPYLQSL 236
             LL+K+L  DP KRIT E+A++ PY    
Sbjct: 311 FHLLQKLLTMDPIKRITSEQAMQDPYFLED 340

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  185 bits (472), Expect = 3e-56
 Identities = 73/252 (28%), Positives = 120/252 (47%), Gaps = 38/252 (15%)

Query: 18  KDTF---NDVYIVYELMDTDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHR 72
            + F   N + + +EL+  +L+++I+    Q  +    + F + +L+ L  +H   ++H 
Sbjct: 165 LENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHC 224

Query: 73  DLKPSNLLLN--ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAID 130
           DLKP N+LL       +K+ DFG +    E   +  Y+ +R+YRAPE++L    Y   ID
Sbjct: 225 DLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTYIQSRFYRAPEVILGA-RYGMPID 281

Query: 131 IWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDD--------ASLGFLRSDNAR- 181
           +WS+GCIL E++T  PL PG+D   QL  + EL+G P          A          R 
Sbjct: 282 MWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRY 341

Query: 182 ---------RYVRQLPRCRKQQFATRFPNKSSGA----------VDLLEKMLVFDPNKRI 222
                      V    R R+ +      ++  G           +D L++ L +DP  R+
Sbjct: 342 CTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRM 401

Query: 223 TVEEALRHPYLQ 234
           T  +ALRHP+L+
Sbjct: 402 TPGQALRHPWLR 413

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  174 bits (442), Expect = 3e-52
 Identities = 64/250 (25%), Positives = 103/250 (41%), Gaps = 29/250 (11%)

Query: 26  IVYELMDTDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLN 82
           +V+E++  +L  +I+    + +   + +    QLL GL Y+H    ++H D+KP N+L+ 
Sbjct: 107 MVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLME 166

Query: 83  ASCD------LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 136
                     +KI D G A    E    T  + TR YR+PE+LL    +    DIWS  C
Sbjct: 167 IVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGA-PWGCGADIWSTAC 223

Query: 137 ILGEIMTREPLFPGKDY------VHQLRLITELIGSPDDA-------SLGFLRSDNARRY 183
           ++ E++T + LF   +          +  I EL+G            +  F  S    R 
Sbjct: 224 LIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRN 283

Query: 184 VRQLPRCRKQQFATRFPNKSSGA----VDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           + +L     +   T     S        D L  ML  DP KR      + HP+L+    +
Sbjct: 284 ISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGM 343

Query: 240 NDEPVCPRPF 249
            +  V  R  
Sbjct: 344 EEIRVPDREL 353

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  172 bits (438), Expect = 4e-52
 Identities = 71/257 (27%), Positives = 116/257 (45%), Gaps = 42/257 (16%)

Query: 18  KDTF---NDVYIVYELMDTDLHQIIRSDQQ--LTDDHCQYFLYQLLRGLKYVHSASVLHR 72
            + F     + IV+EL+    +  I+ +       DH +   YQ+ + + ++HS  + H 
Sbjct: 83  LEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHT 142

Query: 73  DLKPSNLLLN-------------------ASCDLKIGDFGLARTTSETDFMTEYVVTRWY 113
           DLKP N+L                      + D+K+ DFG A  T + +  +  V TR Y
Sbjct: 143 DLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA--TYDDEHHSTLVSTRHY 200

Query: 114 RAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP------ 167
           RAPE++L    ++   D+WS+GCIL E      +FP  D    L ++  ++G        
Sbjct: 201 RAPEVILAL-GWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQ 259

Query: 168 --------DDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPN 219
                       L +    +A RYV +  +  K+   ++         DL++KML +DP 
Sbjct: 260 KTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHER-LFDLIQKMLEYDPA 318

Query: 220 KRITVEEALRHPYLQSL 236
           KRIT+ EAL+HP+   L
Sbjct: 319 KRITLREALKHPFFDLL 335

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  173 bits (441), Expect = 4e-52
 Identities = 69/259 (26%), Positives = 119/259 (45%), Gaps = 45/259 (17%)

Query: 18  KDTF---NDVYIVYELMDTDLHQIIRSDQQ--LTDDHCQYFLYQLLRGLKYVHS--ASVL 70
           K  F   N + +V+E++  +L+ ++R+     ++ +  + F  Q+   L ++ +   S++
Sbjct: 122 KRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSII 181

Query: 71  HRDLKPSNLLL--NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAA 128
           H DLKP N+LL       +KI DFG +        + +Y+ +R+YR+PE+LL    Y  A
Sbjct: 182 HCDLKPENILLCNPKRSAIKIVDFGSS--CQLGQRIYQYIQSRFYRSPEVLLGM-PYDLA 238

Query: 129 IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD------------------DA 170
           ID+WS+GCIL E+ T EPLF G + V Q+  I E++G P                   D 
Sbjct: 239 IDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDG 298

Query: 171 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGA---------------VDLLEKMLV 215
           +    ++ + +R  +     +             G                 DL+ +ML 
Sbjct: 299 TWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLD 358

Query: 216 FDPNKRITVEEALRHPYLQ 234
           +DP  RI    AL+H + +
Sbjct: 359 YDPKTRIQPYYALQHSFFK 377

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  170 bits (432), Expect = 5e-51
 Identities = 64/248 (25%), Positives = 106/248 (42%), Gaps = 39/248 (15%)

Query: 26  IVYELMDTDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN- 82
           I +EL+  +  + ++  + Q     H ++  YQL   L+++H   + H DLKP N+L   
Sbjct: 99  IAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVN 158

Query: 83  ------------------ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE 124
                              +  +++ DFG A  T + +  T  V TR YR PE++L    
Sbjct: 159 SEFETLYNEHKSCEEKSVKNTSIRVADFGSA--TFDHEHHTTIVATRHYRPPEVILEL-G 215

Query: 125 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD--------------DA 170
           +    D+WS+GCIL E      LF   +    L ++ +++G                   
Sbjct: 216 WAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKG 275

Query: 171 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 230
            L +  + +  RYV++  +  K               DL+ +ML FDP +RIT+ EAL H
Sbjct: 276 GLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQ-LFDLMRRMLEFDPAQRITLAEALLH 334

Query: 231 PYLQSLHD 238
           P+   L  
Sbjct: 335 PFFAGLTP 342

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  169 bits (428), Expect = 2e-50
 Identities = 36/246 (14%), Positives = 65/246 (26%), Gaps = 32/246 (13%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIR-------SDQQLTDDHCQYF 53
           +  ++      +          +  ++      DL  +                      
Sbjct: 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHIL 199

Query: 54  LYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWY 113
             QL+R    + S  ++H    P NL +     L +GD                 V   Y
Sbjct: 200 TAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR--GPASSVPVTY 257

Query: 114 RAPELL-LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL 172
              E L  +   +T A++ W +G  +  +      F       +       +  P   SL
Sbjct: 258 APREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSL 317

Query: 173 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 232
            F               C                  L+ + L FD  +R+   EA+  P 
Sbjct: 318 AF-------------GSC---------TPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPE 355

Query: 233 LQSLHD 238
              L +
Sbjct: 356 FLQLQN 361

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  165 bits (421), Expect = 3e-49
 Identities = 58/255 (22%), Positives = 107/255 (41%), Gaps = 53/255 (20%)

Query: 26  IVYELMDTDLHQIIRSDQQ--LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN- 82
           +++E +   L++II  +       +  + +  ++L+ L Y+   S+ H DLKP N+LL+ 
Sbjct: 113 LIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDD 172

Query: 83  ------------------------ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPEL 118
                                    S  +K+ DFG A  T ++D+    + TR YRAPE+
Sbjct: 173 PYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA--TFKSDYHGSIINTRQYRAPEV 230

Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDD--------- 169
           +LN   +  + D+WS GC+L E+ T   LF   +++  L ++  +I              
Sbjct: 231 ILNL-GWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKT 289

Query: 170 ----------ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPN 219
                       L +  + ++   ++ + +C           K     D L  +L  DP 
Sbjct: 290 NGSKYVNKDELKLAWPENASSINSIKHVKKCLPL----YKIIKHELFCDFLYSILQIDPT 345

Query: 220 KRITVEEALRHPYLQ 234
            R +  E L+H +L+
Sbjct: 346 LRPSPAELLKHKFLE 360

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  160 bits (408), Expect = 7e-48
 Identities = 52/246 (21%), Positives = 96/246 (39%), Gaps = 49/246 (19%)

Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 62
            + +I + D        T   +Y+V E  + DL+  ++  + +     + +   +L  + 
Sbjct: 87  SDKIIRLYDYEI-----TDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVH 141

Query: 63  YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE---TDFMTEYVVTRWYRAPELL 119
            +H   ++H DLKP+N L+     LK+ DFG+A        +      V T  Y  PE +
Sbjct: 142 TIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 200

Query: 120 LNC----------TEYTAAIDIWSVGCILGEIMTREPLFPG-KDYVHQLRLITELIGSPD 168
            +           ++ +   D+WS+GCIL  +   +  F    + + +L  I +      
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID------ 254

Query: 169 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL 228
                         +  + P                   D+L+  L  DP +RI++ E L
Sbjct: 255 ------------PNHEIEFP-----------DIPEKDLQDVLKCCLKRDPKQRISIPELL 291

Query: 229 RHPYLQ 234
            HPY+Q
Sbjct: 292 AHPYVQ 297

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  157 bits (398), Expect = 2e-46
 Identities = 61/263 (23%), Positives = 101/263 (38%), Gaps = 56/263 (21%)

Query: 1   MEHENVIAIKD--------IIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTD-DHC 50
           + H+ V+            +         + ++I  E  +   L+ +I S+      D  
Sbjct: 59  LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY 118

Query: 51  QYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET--------- 101
                Q+L  L Y+HS  ++HRDLKP N+ ++ S ++KIGDFGLA+    +         
Sbjct: 119 WRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178

Query: 102 ------DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH 155
                 D +T  + T  Y A E+L     Y   ID++S+G I  E++   P   G + V+
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVN 236

Query: 156 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP-NKSSGAVDLLEKML 214
            L+ +                            R    +F   F  NK      ++  ++
Sbjct: 237 ILKKL----------------------------RSVSIEFPPDFDDNKMKVEKKIIRLLI 268

Query: 215 VFDPNKRITVEEALRHPYLQSLH 237
             DPNKR      L   +L   H
Sbjct: 269 DHDPNKRPGARTLLNSGWLPVKH 291

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  160 bits (406), Expect = 2e-46
 Identities = 61/249 (24%), Positives = 95/249 (38%), Gaps = 44/249 (17%)

Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQII-RSDQQLTDDHCQYFLYQLLRG 60
           EH NVI      +          YI  EL    L + + + D           L Q   G
Sbjct: 76  EHPNVIRYFCTEK-----DRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSG 130

Query: 61  LKYVHSASVLHRDLKPSNLLL-----NASCDLKIGDFGLAR----TTSETDFMTEYVVTR 111
           L ++HS +++HRDLKP N+L+     +      I DFGL +            +    T 
Sbjct: 131 LAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTE 190

Query: 112 WYRAPELLLNCTE--YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDD 169
            + APE+L    +   T  +DI+S GC+   +++      GK    Q      L+G+   
Sbjct: 191 GWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN---ILLGACSL 247

Query: 170 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 229
             L                            ++   A +L+EKM+  DP KR + +  L+
Sbjct: 248 DCL------------------------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283

Query: 230 HPYLQSLHD 238
           HP+  SL  
Sbjct: 284 HPFFWSLEK 292

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  156 bits (397), Expect = 6e-46
 Identities = 53/256 (20%), Positives = 97/256 (37%), Gaps = 51/256 (19%)

Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 62
            + +I + D        T   +Y+V E  + DL+  ++  + +     + +   +L  + 
Sbjct: 68  SDKIIRLYDYEI-----TDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVH 122

Query: 63  YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE---TDFMTEYVVTRWYRAPELL 119
            +H   ++H DLKP+N L+     LK+ DFG+A        +      V T  Y  PE +
Sbjct: 123 TIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181

Query: 120 LN----------CTEYTAAIDIWSVGCILGEIMTREPLFPG-KDYVHQLRLITELIGSPD 168
            +           ++ +   D+WS+GCIL  +   +  F    + + +L  I        
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII------- 234

Query: 169 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEA 227
                                         FP+       D+L+  L  DP +RI++ E 
Sbjct: 235 -----------------------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 271

Query: 228 LRHPYLQSLHDLNDEP 243
           L HPY+Q      ++ 
Sbjct: 272 LAHPYVQIQTHPVNQM 287

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  153 bits (390), Expect = 1e-45
 Identities = 52/248 (20%), Positives = 90/248 (36%), Gaps = 50/248 (20%)

Query: 1   MEHENVIAIKD-----------IIRPPKKDTFNDVYIVYELMDT-DLHQII--RSDQQLT 46
           ++H N++                 +   +     ++I  E  D   L Q I  R  ++L 
Sbjct: 61  LDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLD 120

Query: 47  DDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE 106
                    Q+ +G+ Y+HS  +++RDLKPSN+ L  +  +KIGDFGL  +       T 
Sbjct: 121 KVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTR 180

Query: 107 YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGS 166
              T  Y +PE + +  +Y   +D++++G IL E++         +       +      
Sbjct: 181 SKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLH--VCDTAFETSKFFTDL------ 231

Query: 167 PDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEE 226
                                   R    +  F         LL+K+L   P  R    E
Sbjct: 232 ------------------------RDGIISDIF---DKKEKTLLQKLLSKKPEDRPNTSE 264

Query: 227 ALRHPYLQ 234
            LR   + 
Sbjct: 265 ILRTLTVW 272

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  154 bits (390), Expect = 2e-45
 Identities = 56/234 (23%), Positives = 80/234 (34%), Gaps = 42/234 (17%)

Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQII-RSDQQLTDDHCQYFLYQLLRGL 61
           H   + ++             +Y+  EL    L Q        L +     +L   L  L
Sbjct: 116 HPCCVRLEQAWE-----EGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLAL 170

Query: 62  KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 121
            ++HS  ++H D+KP+N+ L      K+GDFGL                  Y APELL  
Sbjct: 171 AHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG 230

Query: 122 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNAR 181
              Y  A D++S+G  + E+     L  G +   QLR   +    P              
Sbjct: 231 --SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLR---QGYLPP-------------- 271

Query: 182 RYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
                            F    SS    +L  ML  DP  R T E  L  P L+
Sbjct: 272 ----------------EFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLR 309

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  154 bits (392), Expect = 7e-45
 Identities = 52/256 (20%), Positives = 96/256 (37%), Gaps = 51/256 (19%)

Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLK 62
            + +I + D        T   +Y+V E  + DL+  ++  + +     + +   +L  + 
Sbjct: 115 SDKIIRLYDYEI-----TDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVH 169

Query: 63  YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE---TDFMTEYVVTRWYRAPELL 119
            +H   ++H DLKP+N L+     LK+ DFG+A        +      V    Y  PE +
Sbjct: 170 TIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAI 228

Query: 120 LN----------CTEYTAAIDIWSVGCILGEIMTREPLFPG-KDYVHQLRLITELIGSPD 168
            +           ++ +   D+WS+GCIL  +   +  F    + + +L  I        
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII------- 281

Query: 169 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEA 227
                                         FP+       D+L+  L  DP +RI++ E 
Sbjct: 282 -----------------------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 318

Query: 228 LRHPYLQSLHDLNDEP 243
           L HPY+Q      ++ 
Sbjct: 319 LAHPYVQIQTHPVNQM 334

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  150 bits (381), Expect = 4e-44
 Identities = 51/271 (18%), Positives = 94/271 (34%), Gaps = 57/271 (21%)

Query: 1   MEHENVIAIKD-------IIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLT---DDH 49
           +EH  ++   +         +         +YI  +L    +L   +     +       
Sbjct: 60  LEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSV 119

Query: 50  CQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM----- 104
           C +   Q+   ++++HS  ++HRDLKPSN+       +K+GDFGL     + +       
Sbjct: 120 CLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179

Query: 105 --------TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ 156
                   T  V T+ Y +PE +     Y+  +DI+S+G IL E++   P     + V  
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY--PFSTQMERVRT 236

Query: 157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVF 216
           L  +                              R  +F   F  K      +++ ML  
Sbjct: 237 LTDV------------------------------RNLKFPPLFTQKYPCEYVMVQDMLSP 266

Query: 217 DPNKRITVEEALRHPYLQSLHDLNDEPVCPR 247
            P +R      + +   + L       +  R
Sbjct: 267 SPMERPEAINIIENAVFEDLDFPGKTVLRQR 297

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  147 bits (373), Expect = 4e-43
 Identities = 68/246 (27%), Positives = 101/246 (41%), Gaps = 47/246 (19%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQ----LTDDHCQYFLY 55
           ++H N++   D I      T    YIV E  +  DL  +I    +    L ++     + 
Sbjct: 62  LKHPNIVRYYDRIIDRTNTTL---YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118

Query: 56  QLLRGLKYVHS-----ASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVV 109
           QL   LK  H       +VLHRDLKP+N+ L+   ++K+GDFGLAR    +T F   +V 
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVG 178

Query: 110 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDD 169
           T +Y +PE +     Y    DIWS+GC+L E+    P F           I E  G    
Sbjct: 179 TPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE--GKFR- 234

Query: 170 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEAL 228
                                       R P + S    +++ +ML      R +VEE L
Sbjct: 235 ----------------------------RIPYRYSDELNEIITRMLNLKDYHRPSVEEIL 266

Query: 229 RHPYLQ 234
            +P + 
Sbjct: 267 ENPLIL 272

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  149 bits (377), Expect = 6e-43
 Identities = 51/239 (21%), Positives = 95/239 (39%), Gaps = 40/239 (16%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQ--LTDDHCQYFLYQL 57
           M+H N++  ++            +YIV +  +  DL + I + +     +D    +  Q+
Sbjct: 80  MKHPNIVQYRESFE-----ENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQI 134

Query: 58  LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV-TRWYRAP 116
              LK+VH   +LHRD+K  N+ L     +++GDFG+AR  + T  +    + T +Y +P
Sbjct: 135 CLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSP 194

Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 176
           E+  N   Y    DIW++GC+L E+ T +  F      + +  I                
Sbjct: 195 EICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII--------------- 238

Query: 177 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
                     +             + S     L+ ++   +P  R +V   L   ++  
Sbjct: 239 ----SGSFPPVS-----------LHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  149 bits (378), Expect = 2e-42
 Identities = 77/244 (31%), Positives = 117/244 (47%), Gaps = 44/244 (18%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H  +I IK+       D   D YIV ELM+  +L   +  +++L +  C+ + YQ+L 
Sbjct: 197 LNHPCIIKIKNFF-----DA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 250

Query: 60  GLKYVHSASVLHRDLKPSNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 116
            ++Y+H   ++HRDLKP N+LL++    C +KI DFG ++   ET  M     T  Y AP
Sbjct: 251 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 310

Query: 117 ELLLNCTE--YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP--DDASL 172
           E+L++     Y  A+D WS+G IL              ++        L G P   +   
Sbjct: 311 EVLVSVGTAGYNRAVDCWSLGVIL--------------FI--C-----LSGYPPFSE--- 346

Query: 173 GFLRSDNARRYVRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHP 231
                   +  ++      K  F        S  A+DL++K+LV DP  R T EEALRHP
Sbjct: 347 -----HRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHP 401

Query: 232 YLQS 235
           +LQ 
Sbjct: 402 WLQD 405

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  146 bits (371), Expect = 2e-42
 Identities = 44/260 (16%), Positives = 94/260 (36%), Gaps = 30/260 (11%)

Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQ---LTDDHCQYFLYQLL 58
           H+N++ +  I    ++ T     ++ E      L+ ++        L +      L  ++
Sbjct: 66  HKNIVKLFAIE---EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122

Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCD----LKIGDFGLARTTSETDFMTEYVVTRWYR 114
            G+ ++    ++HR++KP N++     D     K+ DFG AR   + +       T  Y 
Sbjct: 123 GGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYL 182

Query: 115 APELL-------LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELI--G 165
            P++         +  +Y A +D+WS+G       T    F   +   + + +   I  G
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242

Query: 166 SPDDASLGFLRSDNAR-RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 224
            P  A  G  +++N    +   +P        +           +L  +L  D  K    
Sbjct: 243 KPSGAISGVQKAENGPIDWSGDMP-----VSCSLSRGLQVLLTPVLANILEADQEKCWGF 297

Query: 225 EEALRHP----YLQSLHDLN 240
           ++         +  + H  +
Sbjct: 298 DQFFAETSDILHRGNSHHHH 317

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  146 bits (370), Expect = 3e-42
 Identities = 48/251 (19%), Positives = 90/251 (35%), Gaps = 50/251 (19%)

Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTD---DHCQYFLYQLL 58
            +       + +         +YI  +L    +L   +     L D     C +   Q+ 
Sbjct: 115 MDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIA 174

Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF-------------MT 105
             ++++HS  ++HRDLKPSN+       +K+GDFGL     + +               T
Sbjct: 175 EAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHT 234

Query: 106 EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG 165
             V T+ Y +PE +     Y+  +DI+S+G IL E++         + V  +  +     
Sbjct: 235 GQVGTKLYMSPEQIHG-NNYSHKVDIFSLGLILFELLY--SFSTQMERVRIITDV----- 286

Query: 166 SPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVE 225
                                    R  +F   F  K      +++ ML   P +R    
Sbjct: 287 -------------------------RNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEAT 321

Query: 226 EALRHPYLQSL 236
           + + +   ++L
Sbjct: 322 DIIENAIFENL 332

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  145 bits (367), Expect = 4e-42
 Identities = 62/248 (25%), Positives = 108/248 (43%), Gaps = 38/248 (15%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H N+I + DI      +   DV ++ EL+   +L   +   + LT+D    FL Q+L 
Sbjct: 65  IRHPNIITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD 119

Query: 60  GLKYVHSASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRA 115
           G+ Y+HS  + H DLKP N++L      +  +K+ DFG+A      +       T  + A
Sbjct: 120 GVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVA 179

Query: 116 PELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL 175
           PE ++N        D+WS+G I   +++    F G+     L  I+         +  F 
Sbjct: 180 PE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISA-------VNYDFD 231

Query: 176 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
                                  F N S  A D + ++LV DP +R+T+ ++L H ++++
Sbjct: 232 EEY--------------------FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271

Query: 236 LHDLNDEP 243
           +   N   
Sbjct: 272 IRRRNVRG 279

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  144 bits (365), Expect = 1e-41
 Identities = 67/252 (26%), Positives = 105/252 (41%), Gaps = 46/252 (18%)

Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRG 60
            H N+I +KD       +T    ++V++LM   +L   +     L++   +  +  LL  
Sbjct: 82  GHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136

Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL- 119
           +  +H  +++HRDLKP N+LL+   ++K+ DFG +      + + E   T  Y APE++ 
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIE 196

Query: 120 ----LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP---DDASL 172
                N   Y   +D+WS G I+              Y   L     L GSP       +
Sbjct: 197 CSMNDNHPGYGKEVDMWSTGVIM--------------YT--L-----LAGSPPFWHRKQM 235

Query: 173 GFLRSDNARRYVRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHP 231
             LR   +  Y          QF +    + S    DL+ + LV  P KR T EEAL HP
Sbjct: 236 LMLRMIMSGNY----------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHP 285

Query: 232 YLQSLHDLNDEP 243
           + Q         
Sbjct: 286 FFQQYVVEEVRH 297

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  148 bits (375), Expect = 8e-41
 Identities = 57/252 (22%), Positives = 100/252 (39%), Gaps = 16/252 (6%)

Query: 1   MEHENVIAIKDIIRPPKKDTFND-VYIVYELMDT-DLHQIIRS---DQQLTDDHCQYFLY 55
           + H NV++ +++    +K   ND   +  E  +  DL + +        L +   +  L 
Sbjct: 69  LNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS 128

Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGLARTTSETDFMTEYVVTRW 112
            +   L+Y+H   ++HRDLKP N++L         KI D G A+   + +  TE+V T  
Sbjct: 129 DISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQ 188

Query: 113 YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL 172
           Y APELL    +YT  +D WS G +  E +T    F       Q           ++  +
Sbjct: 189 YLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR--EKSNEHIV 245

Query: 173 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 232
            +     A ++   LP              +      L+ ML++   +R T  +      
Sbjct: 246 VYDDLTGAVKFSSVLPTPNH-----LSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGC 300

Query: 233 LQSLHDLNDEPV 244
            Q+L  +    +
Sbjct: 301 FQALDSILSLKL 312

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  142 bits (360), Expect = 1e-40
 Identities = 63/243 (25%), Positives = 106/243 (43%), Gaps = 38/243 (15%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H NVI + D+      +   DV ++ EL+   +L   +   + L+++    F+ Q+L 
Sbjct: 72  VLHHNVITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126

Query: 60  GLKYVHSASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRA 115
           G+ Y+H+  + H DLKP N++L         +K+ DFGLA    +         T  + A
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVA 186

Query: 116 PELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL 175
           PE ++N        D+WS+G I   +++    F G      L  IT         S  F 
Sbjct: 187 PE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITS-------VSYDFD 238

Query: 176 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
                                  F + S  A D + K+LV +  KR+T++EALRHP++  
Sbjct: 239 EEF--------------------FSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278

Query: 236 LHD 238
           + +
Sbjct: 279 VDN 281

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  141 bits (358), Expect = 4e-40
 Identities = 65/250 (26%), Positives = 108/250 (43%), Gaps = 42/250 (16%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H N+I + D+      +   DV ++ EL+   +L   +   + L+++    F+ Q+L 
Sbjct: 72  VLHPNIITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126

Query: 60  GLKYVHSASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRA 115
           G+ Y+H+  + H DLKP N++L         +K+ DFGLA    +         T  + A
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVA 186

Query: 116 PELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG-SPDDASLGF 174
           PE ++N        D+WS+G I               Y+  L     L G SP      F
Sbjct: 187 PE-IVNYEPLGLEADMWSIGVIT--------------YI--L-----LSGASP------F 218

Query: 175 LRSDNARRYVRQLPRCRKQQFATR-FPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
           L  D  +  +  +       F    F   S  A D + K+LV +  KR+T++EALRHP++
Sbjct: 219 L-GDTKQETLANITAV-SYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

Query: 234 QSLHDLNDEP 243
             +       
Sbjct: 277 TPVDTQQAMV 286

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  141 bits (357), Expect = 5e-40
 Identities = 58/243 (23%), Positives = 111/243 (45%), Gaps = 48/243 (19%)

Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 61
           H ++I + D       ++ + +++V++LM   +L   +     L++   +  +  LL  +
Sbjct: 159 HPHIITLIDSY-----ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAV 213

Query: 62  KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 121
            ++H+ +++HRDLKP N+LL+ +  +++ DFG +      + + E   T  Y APE+L  
Sbjct: 214 SFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKC 273

Query: 122 CTE-----YTAAIDIWSVGCIL-----GEIMTREPLFPGKDYVHQLRLITELIGSPDDAS 171
             +     Y   +D+W+ G IL     G      P F  +  +  LR+I  + G      
Sbjct: 274 SMDETHPGYGKEVDLWACGVILFTLLAG-----SPPFWHRRQILMLRMI--MEGQYQ--- 323

Query: 172 LGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHP 231
                S                     + ++SS   DL+ ++L  DP  R+T E+AL+HP
Sbjct: 324 ---FSSPE-------------------WDDRSSTVKDLISRLLQVDPEARLTAEQALQHP 361

Query: 232 YLQ 234
           + +
Sbjct: 362 FFE 364

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  140 bits (355), Expect = 8e-40
 Identities = 71/272 (26%), Positives = 116/272 (42%), Gaps = 45/272 (16%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H++V+           +  + V++V EL     L ++ +  + LT+   +Y+L Q++ 
Sbjct: 98  LAHQHVVGFHGFF-----EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL 152

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--TRWYRAPE 117
           G +Y+H   V+HRDLK  NL LN   ++KIGDFGLA T  E D   + V+  T  Y APE
Sbjct: 153 GCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKVLCGTPNYIAPE 211

Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 177
           +L     ++  +D+WS+GCI+  ++  +P F           I                 
Sbjct: 212 VLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI----------------- 253

Query: 178 DNARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS- 235
                        +K ++    P   +  A  L++KML  DP  R T+ E L   +  S 
Sbjct: 254 -------------KKNEY--SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 298

Query: 236 -LHDLNDEPVCPRPFHFDFEHSSCTEDHIREL 266
            +           P  F    SS    + + L
Sbjct: 299 YIPARLPITCLTIPPRFSIAPSSLDPSNRKPL 330

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  142 bits (360), Expect = 9e-40
 Identities = 62/265 (23%), Positives = 103/265 (38%), Gaps = 61/265 (23%)

Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQII-------RSDQQLTDDHCQYFL 54
           +H NVI            T   +YI  EL + +L  ++        + +   + +    L
Sbjct: 67  DHPNVIRYYCSE-----TTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLL 121

Query: 55  YQLLRGLKYVHSASVLHRDLKPSNLLLNAS-------------CDLKIGDFGLART---- 97
            Q+  G+ ++HS  ++HRDLKP N+L++ S               + I DFGL +     
Sbjct: 122 RQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181

Query: 98  -TSETDFMTEYVVTRWYRAPELLLNCTE------YTAAIDIWSVGCILGEIMTREPLFPG 150
            +S    +     T  +RAPELL            T +IDI+S+GC+   I+++     G
Sbjct: 182 QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241

Query: 151 KDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLL 210
             Y  +  +I  +    +   L                            +  + A DL+
Sbjct: 242 DKYSRESNIIRGIFSLDEMKCLH-------------------------DRSLIAEATDLI 276

Query: 211 EKMLVFDPNKRITVEEALRHPYLQS 235
            +M+  DP KR T  + LRHP    
Sbjct: 277 SQMIDHDPLKRPTAMKVLRHPLFWP 301

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  143 bits (362), Expect = 1e-39
 Identities = 67/248 (27%), Positives = 111/248 (44%), Gaps = 38/248 (15%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++H N++ + D       +   + Y+V E     +L   I    +  +      + Q+L 
Sbjct: 93  LDHPNIMKLYDFF-----EDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLS 147

Query: 60  GLKYVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 116
           G+ Y+H  +++HRDLKP NLLL        +KI DFGL+        M E + T +Y AP
Sbjct: 148 GVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAP 207

Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 176
           E+L     Y    D+WS+G IL  ++   P F G+     LR +    G        F  
Sbjct: 208 EVLRKK--YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKV--EKGKYT-----FDS 258

Query: 177 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 236
            +                    + N S GA DL+++ML FD  +RI+ ++AL HP+++ +
Sbjct: 259 PE--------------------WKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298

Query: 237 HDLNDEPV 244
               +  +
Sbjct: 299 CSKKESGI 306

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  139 bits (353), Expect = 1e-39
 Identities = 63/256 (24%), Positives = 111/256 (43%), Gaps = 41/256 (16%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++H NVI + ++      +   DV ++ EL+   +L   +   + LT++    FL Q+L 
Sbjct: 71  IQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 125

Query: 60  GLKYVHSASVLHRDLKPSNLLL----NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRA 115
           G+ Y+HS  + H DLKP N++L         +KI DFGLA      +       T  + A
Sbjct: 126 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA 185

Query: 116 PELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL 175
           PE ++N        D+WS+G I   +++    F G      L  ++         +  F 
Sbjct: 186 PE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA-------VNYEFE 237

Query: 176 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
                                  F N S+ A D + ++LV DP KR+T++++L+HP+++ 
Sbjct: 238 DEY--------------------FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK- 276

Query: 236 LHDLNDEPVCPRPFHF 251
               + +    R    
Sbjct: 277 --PKDTQQALSRKASA 290

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  142 bits (360), Expect = 2e-39
 Identities = 63/250 (25%), Positives = 109/250 (43%), Gaps = 38/250 (15%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++H N++ + +       +     Y+V E+    +L   I S ++ ++      + Q+L 
Sbjct: 83  LDHPNIMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS 137

Query: 60  GLKYVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 116
           G+ Y+H   ++HRDLKP NLLL   +   +++I DFGL+     +  M + + T +Y AP
Sbjct: 138 GITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAP 197

Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 176
           E+L     Y    D+WS G IL  +++  P F G +    L+ +    G        F  
Sbjct: 198 EVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV--EKGKYT-----FEL 248

Query: 177 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 236
                                 +   S  A DL+ KML + P+ RI+  +AL H ++Q+ 
Sbjct: 249 PQ--------------------WKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY 288

Query: 237 HDLNDEPVCP 246
                    P
Sbjct: 289 TKEQISVDVP 298

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  138 bits (350), Expect = 2e-39
 Identities = 66/239 (27%), Positives = 108/239 (45%), Gaps = 43/239 (17%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H++V+           +  + V++V EL     L ++ +  + LT+   +Y+L Q++ 
Sbjct: 72  LAHQHVVGFHGFF-----EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL 126

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--TRWYRAPE 117
           G +Y+H   V+HRDLK  NL LN   ++KIGDFGLA T  E D   + V+  T  Y APE
Sbjct: 127 GCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKVLCGTPNYIAPE 185

Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 177
           +L     ++  +D+WS+GCI+  ++  +P F           I                 
Sbjct: 186 VLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI----------------- 227

Query: 178 DNARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
                        +K ++    P   +  A  L++KML  DP  R T+ E L   +  S
Sbjct: 228 -------------KKNEY--SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 271

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  139 bits (352), Expect = 2e-39
 Identities = 58/260 (22%), Positives = 112/260 (43%), Gaps = 41/260 (15%)

Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLH-QIIRSDQQLTDDHCQYFLYQLLRG 60
           H N++ + +       ++  ++ +++E +   D+  +I  S  +L +     +++Q+   
Sbjct: 60  HRNILHLHESF-----ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEA 114

Query: 61  LKYVHSASVLHRDLKPSNLLLNASCD--LKIGDFGLARTTSETDFMTEYVVTRWYRAPEL 118
           L+++HS ++ H D++P N++        +KI +FG AR     D          Y APE 
Sbjct: 115 LQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPE- 173

Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG-SPDDASLGFLRS 177
           +      + A D+WS+G ++              YV  L     L G +P      FL  
Sbjct: 174 VHQHDVVSTATDMWSLGTLV--------------YV--L-----LSGINP------FLAE 206

Query: 178 DNARRYVRQLPRCRKQQFATR-FPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 236
            N +     +    +  F    F   S  A+D ++++LV +   R+T  EAL+HP+L+  
Sbjct: 207 TNQQII-ENIMNA-EYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264

Query: 237 HDLNDEPVCPRPFHFDFEHS 256
            +     V     H  + H+
Sbjct: 265 IERVSTKVIRTLKHRRYYHT 284

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  139 bits (353), Expect = 4e-39
 Identities = 53/248 (21%), Positives = 107/248 (43%), Gaps = 37/248 (14%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLH-QIIRSDQQLTDDHCQYFLYQLL 58
           + H  +I + D       +   ++ ++ E +   +L  +I   D ++++     ++ Q  
Sbjct: 105 LHHPKLINLHDAF-----EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQAC 159

Query: 59  RGLKYVHSASVLHRDLKPSNLLL--NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 116
            GLK++H  S++H D+KP N++     +  +KI DFGLA   +  + +     T  + AP
Sbjct: 160 EGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAP 219

Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 176
           E +++        D+W++G +   +++    F G+D +  L+ +             F  
Sbjct: 220 E-IVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR-------CDWEFDE 271

Query: 177 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 236
                                 F + S  A D ++ +L  +P KR+TV +AL HP+L+  
Sbjct: 272 DA--------------------FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 311

Query: 237 HDLNDEPV 244
           H      +
Sbjct: 312 HSNLTSRI 319

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  137 bits (348), Expect = 5e-39
 Identities = 77/241 (31%), Positives = 116/241 (48%), Gaps = 38/241 (15%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H  +I IK+       D   D YIV ELM+  +L   +  +++L +  C+ + YQ+L 
Sbjct: 72  LNHPCIIKIKNFF-----DA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 125

Query: 60  GLKYVHSASVLHRDLKPSNLLLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 116
            ++Y+H   ++HRDLKP N+LL++    C +KI DFG ++   ET  M     T  Y AP
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 185

Query: 117 ELLLNCTE--YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF 174
           E+L++     Y  A+D WS    LG I+          ++        L G P      F
Sbjct: 186 EVLVSVGTAGYNRAVDCWS----LGVIL----------FI----C---LSGYPP-----F 219

Query: 175 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
                      Q+   +       +   S  A+DL++K+LV DP  R T EEALRHP+LQ
Sbjct: 220 SEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 279

Query: 235 S 235
            
Sbjct: 280 D 280

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  138 bits (350), Expect = 1e-38
 Identities = 49/287 (17%), Positives = 105/287 (36%), Gaps = 27/287 (9%)

Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQ---LTDDHCQYFLYQLL 58
           H+N++ +  I    ++ T     ++ E      L+ ++        L +      L  ++
Sbjct: 66  HKNIVKLFAIE---EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122

Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCD----LKIGDFGLARTTSETDFMTEYVVTRWYR 114
            G+ ++    ++HR++KP N++     D     K+ DFG AR   + +       T  Y 
Sbjct: 123 GGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYL 182

Query: 115 APELL-------LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELI--G 165
            P++         +  +Y A +D+WS+G       T    F   +   + + +   I  G
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242

Query: 166 SPDDASLGFLRSDNAR-RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 224
            P  A  G  +++N    +   +P        +           +L  +L  D  K    
Sbjct: 243 KPSGAISGVQKAENGPIDWSGDMP-----VSCSLSRGLQVLLTPVLANILEADQEKCWGF 297

Query: 225 EEALRHPY-LQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRE 270
           ++       +     ++   +     H  + HS  T     EL++++
Sbjct: 298 DQFFAETSDILHRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVYKQ 344

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  136 bits (345), Expect = 1e-38
 Identities = 62/240 (25%), Positives = 98/240 (40%), Gaps = 39/240 (16%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQ----LTDDHCQYFLY 55
           + H NVI              N++ IV EL D  DL ++I+  ++    + +     +  
Sbjct: 89  LNHPNVIKYYASFI-----EDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFV 143

Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYR 114
           QL   L+++HS  V+HRD+KP+N+ + A+  +K+GD GL R  +S+T      V T +Y 
Sbjct: 144 QLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYM 203

Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF 174
           +PE +     Y    DIWS+GC+L E+   +  F G                 D  +L  
Sbjct: 204 SPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYG-----------------DKMNLYS 245

Query: 175 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
           L     +     LP            + S     L+   +  DP KR  V          
Sbjct: 246 LCKKIEQCDYPPLPS----------DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRM 295

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  135 bits (343), Expect = 1e-38
 Identities = 68/238 (28%), Positives = 110/238 (46%), Gaps = 38/238 (15%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++H N++ + +I+     +  +  YIV EL    +L   I   ++ ++      + Q+  
Sbjct: 78  LDHPNIMKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFS 132

Query: 60  GLKYVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 116
           G+ Y+H  +++HRDLKP N+LL      CD+KI DFGL+    +   M + + T +Y AP
Sbjct: 133 GITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAP 192

Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 176
           E+L     Y    D+WS G IL  +++  P F GK+    L+ +    G        F  
Sbjct: 193 EVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV--ETGKYA-----FDL 243

Query: 177 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
                                 +   S  A DL+ KML F P+ RIT  + L HP++Q
Sbjct: 244 PQ--------------------WRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQ 281

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  140 bits (354), Expect = 2e-38
 Identities = 63/245 (25%), Positives = 114/245 (46%), Gaps = 38/245 (15%)

Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGL 61
           H N+I + D+      +     Y+V E  +  +L + I +  +  +      + Q+L G+
Sbjct: 105 HPNIIKLFDVF-----EDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGI 159

Query: 62  KYVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPEL 118
            Y+H  +++HRD+KP N+LL   N+  ++KI DFGL+   S+   + + + T +Y APE+
Sbjct: 160 CYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEV 219

Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 178
           L     Y    D+WS G I+  ++   P F G++    ++ +    G        F  +D
Sbjct: 220 LKKK--YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV--EKGKYY-----FDFND 270

Query: 179 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 238
                               + N S  A +L++ ML +D NKR T EEAL   +++   +
Sbjct: 271 --------------------WKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN 310

Query: 239 LNDEP 243
             ++ 
Sbjct: 311 NINKS 315

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  135 bits (342), Expect = 2e-38
 Identities = 61/240 (25%), Positives = 115/240 (47%), Gaps = 39/240 (16%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++H N++ + D I        +  Y+V++L+   +L + I + +  ++    + + Q+L 
Sbjct: 62  LQHPNIVRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE 116

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGLARTTSETDFMTEYVVTRWYRAP 116
            + Y HS  ++HR+LKP NLLL +      +K+ DFGLA   ++++    +  T  Y +P
Sbjct: 117 SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSP 176

Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 176
           E +L    Y+  +DIW+ G IL              Y+  L     L+G P      F  
Sbjct: 177 E-VLKKDPYSKPVDIWACGVIL--------------YI--L-----LVGYPP-----F-W 208

Query: 177 SDNARRYVRQLPRCRKQQFATR-FPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
            ++  R   Q+       + +  +   +  A  L++ ML  +P KRIT ++AL+ P++ +
Sbjct: 209 DEDQHRLYAQIKAG-AYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 267

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  135 bits (342), Expect = 2e-38
 Identities = 60/246 (24%), Positives = 113/246 (45%), Gaps = 53/246 (21%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYE------LMDTDLHQIIRSDQQLTDDHCQYFL 54
           ++H NV+ + +++  P +D    +Y+V+E      +M+      + + + L++D  +++ 
Sbjct: 93  LDHPNVVKLVEVLDDPNED---HLYMVFELVNQGPVME------VPTLKPLSEDQARFYF 143

Query: 55  YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV-TRWY 113
             L++G++Y+H   ++HRD+KPSNLL+     +KI DFG++     +D +    V T  +
Sbjct: 144 QDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAF 203

Query: 114 RAPELLLNCT-EYT-AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGS-P-DD 169
            APE L      ++  A+D+W++G  L              Y      +    G  P  D
Sbjct: 204 MAPESLSETRKIFSGKALDVWAMGVTL--------------YC----FVF---GQCPFMD 242

Query: 170 ASLGFLRSDNARRYVRQLPRCRKQQFAT-RFPNKSSGAVDLLEKMLVFDPNKRITVEEAL 228
             +  L S           + + Q       P+ +    DL+ +ML  +P  RI V E  
Sbjct: 243 ERIMCLHS-----------KIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIK 291

Query: 229 RHPYLQ 234
            HP++ 
Sbjct: 292 LHPWVT 297

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  135 bits (341), Expect = 3e-38
 Identities = 58/242 (23%), Positives = 100/242 (41%), Gaps = 43/242 (17%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-----TDLHQIIRSDQQLTDDHCQYFLY 55
           ++H N+I I ++      + ++++YIV E  +       +       + L++ +    + 
Sbjct: 77  LDHPNIIKIFEVF-----EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMK 131

Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLARTTSETDFMTEYVVTRW 112
           Q++  L Y HS  V+H+DLKP N+L    +    +KI DFGLA      +  T    T  
Sbjct: 132 QMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTAL 191

Query: 113 YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL 172
           Y APE+     + T   DIWS G ++  ++T    F G       +        P+    
Sbjct: 192 YMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA--TYKEPN---- 243

Query: 173 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 232
                                 +A      +  AVDLL++ML  DP +R +  + L H +
Sbjct: 244 ----------------------YAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEW 281

Query: 233 LQ 234
            +
Sbjct: 282 FK 283

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  134 bits (340), Expect = 3e-38
 Identities = 57/247 (23%), Positives = 95/247 (38%), Gaps = 38/247 (15%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++H N+I + +       +   D+Y+V EL    +L + +   +   +      +  +L 
Sbjct: 63  LDHPNIIRLYETF-----EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLS 117

Query: 60  GLKYVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 116
            + Y H  +V HRDLKP N L    +    LK+ DFGLA        M   V T +Y +P
Sbjct: 118 AVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSP 177

Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 176
           ++L     Y    D WS G ++  ++   P F        +  I    G+       F  
Sbjct: 178 QVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI--REGTFT-----FPE 228

Query: 177 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 236
            D                    + N S  A  L+ ++L   P +RIT  +AL H + +  
Sbjct: 229 KD--------------------WLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268

Query: 237 HDLNDEP 243
              +   
Sbjct: 269 LSSSPRN 275

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  136 bits (345), Expect = 4e-38
 Identities = 61/248 (24%), Positives = 116/248 (46%), Gaps = 39/248 (15%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++H N++ + D I        +  Y+V++L+   +L + I + +  ++    + + Q+L 
Sbjct: 85  LQHPNIVRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE 139

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGLARTTSETDFMTEYVVTRWYRAP 116
            + Y HS  ++HR+LKP NLLL +      +K+ DFGLA   ++++    +  T  Y +P
Sbjct: 140 SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSP 199

Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 176
           E +L    Y+  +DIW+ G IL              Y+  L     L+G P      F  
Sbjct: 200 E-VLKKDPYSKPVDIWACGVIL--------------YI--L-----LVGYPP-----F-W 231

Query: 177 SDNARRYVRQLPRCRKQQFATR-FPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
            ++  R   Q+       + +  +   +  A  L++ ML  +P KRIT ++AL+ P++ +
Sbjct: 232 DEDQHRLYAQIKAG-AYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290

Query: 236 LHDLNDEP 243
              +    
Sbjct: 291 RERVASAI 298

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  134 bits (339), Expect = 5e-38
 Identities = 52/242 (21%), Positives = 103/242 (42%), Gaps = 50/242 (20%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIV--Y----ELMDTDLHQIIRSDQQLTDDHCQYFL 54
           ++H +++ + +       +  N VY+V       E+       +    +  +++  ++F+
Sbjct: 68  LKHPSILELYNYF-----EDSNYVYLVLEMCHNGEMNR----YLKNRVKPFSENEARHFM 118

Query: 55  YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA-RTTSETDFMTEYVVTRWY 113
           +Q++ G+ Y+HS  +LHRDL  SNLLL  + ++KI DFGLA +     +       T  Y
Sbjct: 119 HQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNY 178

Query: 114 RAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLG 173
            +PE+    + +    D+WS+GC+   ++   P F      + L  +             
Sbjct: 179 ISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV------------- 224

Query: 174 FLRSDNARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPY 232
                                +    P+  S  A DL+ ++L  +P  R+++   L HP+
Sbjct: 225 -----------------VLADY--EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPF 265

Query: 233 LQ 234
           + 
Sbjct: 266 MS 267

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  138 bits (350), Expect = 5e-38
 Identities = 67/239 (28%), Positives = 110/239 (46%), Gaps = 38/239 (15%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++H N++ + +I+     +  +  YIV EL    +L   I   ++ ++      + Q+  
Sbjct: 78  LDHPNIMKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFS 132

Query: 60  GLKYVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 116
           G+ Y+H  +++HRDLKP N+LL      CD+KI DFGL+    +   M + + T +Y AP
Sbjct: 133 GITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAP 192

Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 176
           E+L     Y    D+WS G IL  +++  P F GK+    L+ +    G           
Sbjct: 193 EVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV--ETGKYA------FD 242

Query: 177 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
                                ++   S  A DL+ KML F P+ RIT  + L HP++Q 
Sbjct: 243 LP-------------------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  135 bits (342), Expect = 5e-38
 Identities = 57/239 (23%), Positives = 105/239 (43%), Gaps = 39/239 (16%)

Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DL-HQII-RSDQQLTDDHCQYFLYQLLR 59
              VI + ++      +  +++ ++ E     ++    +    + ++++     + Q+L 
Sbjct: 88  CPRVINLHEVY-----ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILE 142

Query: 60  GLKYVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 116
           G+ Y+H  +++H DLKP N+LL       D+KI DFG++R       + E + T  Y AP
Sbjct: 143 GVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAP 202

Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 176
           E +LN    T A D+W++G I   ++T    F G+D       I++        ++ +  
Sbjct: 203 E-ILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQ-------VNVDYSE 254

Query: 177 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
                                 F + S  A D ++ +LV +P KR T E  L H +LQ 
Sbjct: 255 ET--------------------FSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQ 293

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  135 bits (343), Expect = 1e-37
 Identities = 62/238 (26%), Positives = 106/238 (44%), Gaps = 37/238 (15%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLH-QIIRSDQQLTDDHCQYFLYQLL 58
           ++H N+I + D       ++ ND+ +V E +D  +L  +II     LT+     F+ Q+ 
Sbjct: 143 LDHANLIQLYDAF-----ESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQIC 197

Query: 59  RGLKYVHSASVLHRDLKPSNLLL--NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 116
            G++++H   +LH DLKP N+L     +  +KI DFGLAR     + +     T  + AP
Sbjct: 198 EGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAP 257

Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 176
           E ++N    +   D+WSVG I   +++    F G +    L  I                
Sbjct: 258 E-VVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILA-------CRWDLED 309

Query: 177 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
            +                    F + S  A + + K+L+ + + RI+  EAL+HP+L 
Sbjct: 310 EE--------------------FQDISEEAKEFISKLLIKEKSWRISASEALKHPWLS 347

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  135 bits (340), Expect = 2e-37
 Identities = 35/255 (13%), Positives = 74/255 (29%), Gaps = 55/255 (21%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTD-------LHQIIRSDQQLTDDHCQYF 53
           ++      +  +    +       + +Y  M ++       L     + + L        
Sbjct: 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQL 211

Query: 54  LYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWY 113
             Q++R L  +H   ++H  L+P +++L+    + +  F                V+R +
Sbjct: 212 TLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR---VVSSVSRGF 268

Query: 114 RAPELLLNC----------TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEL 163
             PEL              T  T + D W++G ++  I   +        +     I   
Sbjct: 269 EPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWI--- 325

Query: 164 IGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT 223
                             R  + +P                    LLE  L +    R+ 
Sbjct: 326 -----------------FRSCKNIP---------------QPVRALLEGFLRYPKEDRLL 353

Query: 224 VEEALRHPYLQSLHD 238
             +A+  P  + L  
Sbjct: 354 PLQAMETPEYEQLRT 368

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  133 bits (337), Expect = 3e-37
 Identities = 72/263 (27%), Positives = 107/263 (40%), Gaps = 60/263 (22%)

Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 61
           H N+I +KD+      D    VY+V ELM   +L   I   +  ++      L+ + + +
Sbjct: 75  HPNIITLKDVY-----DDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTV 129

Query: 62  KYVHSASVLHRDLKPSNLLL-----NASCDLKIGDFGLAR-TTSETDFMTEYVVTRWYRA 115
           +Y+H+  V+HRDLKPSN+L      N    ++I DFG A+   +E   +     T  + A
Sbjct: 130 EYLHAQGVVHRDLKPSNILYVDESGNPES-IRICDFGFAKQLRAENGLLMTPCYTANFVA 188

Query: 116 PELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP------DD 169
           PE +L    Y AA DIWS+G +L   M                    L G        DD
Sbjct: 189 PE-VLERQGYDAACDIWSLGVLL-YTM--------------------LTGYTPFANGPDD 226

Query: 170 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK-----SSGAVDLLEKMLVFDPNKRITV 224
                L             R    +F            S  A DL+ KML  DP++R+T 
Sbjct: 227 TPEEILA------------RIGSGKF--SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTA 272

Query: 225 EEALRHPYLQSLHDLNDEPVCPR 247
              LRHP++     L    +  +
Sbjct: 273 ALVLRHPWIVHWDQLPQYQLNRQ 295

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  137 bits (346), Expect = 4e-37
 Identities = 54/238 (22%), Positives = 101/238 (42%), Gaps = 37/238 (15%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDL-HQIIRSDQQLTDDHCQYFLYQLL 58
           + H  ++ + D       +  N++ ++YE M   +L  ++     ++++D    ++ Q+ 
Sbjct: 211 LRHPTLVNLHDAF-----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVC 265

Query: 59  RGLKYVHSASVLHRDLKPSNLLL--NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 116
           +GL ++H  + +H DLKP N++     S +LK+ DFGL         +     T  + AP
Sbjct: 266 KGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAP 325

Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 176
           E +          D+WSVG +   +++    F G++    LR +       +        
Sbjct: 326 E-VAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS--CDWN-----MDD 377

Query: 177 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
           S                     F   S    D + K+L+ DPN R+T+ +AL HP+L 
Sbjct: 378 SA--------------------FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLT 415

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  130 bits (330), Expect = 9e-37
 Identities = 50/220 (22%), Positives = 94/220 (42%), Gaps = 46/220 (20%)

Query: 22  NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
             VY++ E      +++ ++   +  +     ++ +L   L Y HS  V+HRD+KP NLL
Sbjct: 82  TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLL 141

Query: 81  LNASCDLKIGDFGLARTTSETDFMT-----EYVVTRWYRAPELLLNCTEYTAAIDIWSVG 135
           L ++ +LKI DFG +     +         +Y+       PE++     +   +D+WS+G
Sbjct: 142 LGSAGELKIADFGWSVHAPSSRRTDLCGTLDYL------PPEMIEG-RMHDEKVDLWSLG 194

Query: 136 CILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQF 195
            +  E +  +P F    Y    + I                               + +F
Sbjct: 195 VLCYEFLVGKPPFEANTYQETYKRI------------------------------SRVEF 224

Query: 196 ATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
              FP+  + GA DL+ ++L  +P++R  + E L HP++ 
Sbjct: 225 --TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 262

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  132 bits (335), Expect = 9e-37
 Identities = 62/255 (24%), Positives = 111/255 (43%), Gaps = 49/255 (19%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDL-HQIIR---SDQQLTDDHCQYFLY 55
           ++H +++ + +        +   +Y+V+E MD  DL  +I++   +    ++    +++ 
Sbjct: 83  LKHPHIVELLETY-----SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR 137

Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLARTTSETD-FMTEYVVTR 111
           Q+L  L+Y H  +++HRD+KP  +LL     S  +K+G FG+A    E+       V T 
Sbjct: 138 QILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTP 197

Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP--DD 169
            + APE ++    Y   +D+W  G IL              ++  L     L G      
Sbjct: 198 HFMAPE-VVKREPYGKPVDVWGCGVIL--------------FI--L-----LSGCLPFYG 235

Query: 170 ASLGFLRSDNARRYVRQLPRCRKQQFATR-FPNKSSGAVDLLEKMLVFDPNKRITVEEAL 228
                       +Y          +   R + + S  A DL+ +ML+ DP +RITV EAL
Sbjct: 236 TKERLFEGIIKGKY----------KMNPRQWSHISESAKDLVRRMLMLDPAERITVYEAL 285

Query: 229 RHPYLQSLHDLNDEP 243
            HP+L+       + 
Sbjct: 286 NHPWLKERDRYAYKI 300

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  131 bits (331), Expect = 3e-36
 Identities = 69/259 (26%), Positives = 113/259 (43%), Gaps = 40/259 (15%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H N+I +K+I      +T  ++ +V EL+   +L   I      ++      + Q+L 
Sbjct: 105 LSHPNIIKLKEIF-----ETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILE 159

Query: 60  GLKYVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 116
            + Y+H   ++HRDLKP NLL         LKI DFGL++       M     T  Y AP
Sbjct: 160 AVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAP 219

Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 176
           E +L    Y   +D+WSVG I               Y+  L     L G        F  
Sbjct: 220 E-ILRGCAYGPEVDMWSVGIIT--------------YI--L-----LCGFEP-----FYD 252

Query: 177 SDNARRYVRQLPRCRKQQFATR-FPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
               +   R++  C +  F +  +   S  A DL+ K++V DP KR+T  +AL+HP++  
Sbjct: 253 ERGDQFMFRRILNC-EYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTG 311

Query: 236 --LHDLNDEPVCPRPFHFD 252
              + ++ +    +   F+
Sbjct: 312 KAANFVHMDTAQKKLQEFN 330

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  131 bits (330), Expect = 4e-36
 Identities = 56/287 (19%), Positives = 95/287 (33%), Gaps = 81/287 (28%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELM----------------------------- 31
           + H N+  + ++      +    + +V EL                              
Sbjct: 85  LHHPNIARLYEVY-----EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQI 139

Query: 32  ------------DTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL 79
                        +        D    +      + Q+   L Y+H+  + HRD+KP N 
Sbjct: 140 CPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENF 199

Query: 80  LL--NASCDLKIGDFGLAR-----TTSETDFMTEYVVTRWYRAPELLLNCTE-YTAAIDI 131
           L   N S ++K+ DFGL++        E   MT    T ++ APE+L    E Y    D 
Sbjct: 200 LFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259

Query: 132 WSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCR 191
           WS G +L  ++     FPG +    +  +           L F   +             
Sbjct: 260 WSAGVLLHLLLMGAVPFPGVNDADTISQVLN-------KKLCFENPN------------- 299

Query: 192 KQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 238
                  +   S  A DLL  +L  + ++R     AL+HP++    D
Sbjct: 300 -------YNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  130 bits (328), Expect = 7e-36
 Identities = 56/249 (22%), Positives = 100/249 (40%), Gaps = 32/249 (12%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTD--LHQII-RSDQQLTDDHCQYFLYQL 57
               +++ I D+           + I+ E M+      +I  R DQ  T+      +  +
Sbjct: 79  SGGPHIVCILDVYENMHHGK-RCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDI 137

Query: 58  LRGLKYVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWYR 114
              ++++HS ++ HRD+KP NLL         LK+ DFG A+ T++    T    T +Y 
Sbjct: 138 GTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYYV 196

Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF 174
           APE +L   +Y  + D+WS+G I+  ++   P F           +   I        GF
Sbjct: 197 APE-VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL---GQYGF 252

Query: 175 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
              +                    +   S  A  L+  +L  DP +R+T+ + + HP++ 
Sbjct: 253 PNPE--------------------WSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWIN 292

Query: 235 SLHDLNDEP 243
               +   P
Sbjct: 293 QSMVVPQTP 301

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  128 bits (325), Expect = 7e-36
 Identities = 51/258 (19%), Positives = 90/258 (34%), Gaps = 65/258 (25%)

Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQII----RSDQQLTDDHCQYFLYQ 56
           +H +V+          +D  + + I  E  +   L   I    R      +   +  L Q
Sbjct: 69  QHSHVVRYFSAW---AED--DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQ 123

Query: 57  LLRGLKYVHSASVLHRDLKPSNLLLN-------------------ASCDLKIGDFGLART 97
           + RGL+Y+HS S++H D+KPSN+ ++                        KIGD G    
Sbjct: 124 VGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183

Query: 98  TSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL 157
            S             + A E+L     +    DI+++   +      EPL    D  H++
Sbjct: 184 ISSPQVE---EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEI 240

Query: 158 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFD 217
           R                      +  + ++P+             S    +LL+ M+  D
Sbjct: 241 R----------------------QGRLPRIPQVL-----------SQEFTELLKVMIHPD 267

Query: 218 PNKRITVEEALRHPYLQS 235
           P +R +    ++H  L S
Sbjct: 268 PERRPSAMALVKHSVLLS 285

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  129 bits (327), Expect = 7e-36
 Identities = 62/246 (25%), Positives = 107/246 (43%), Gaps = 31/246 (12%)

Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGL 61
           H N++ + ++            ++V EL++  +L + I+  +  ++    Y + +L+  +
Sbjct: 65  HPNIVKLHEVF-----HDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAV 119

Query: 62  KYVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLAR-TTSETDFMTEYVVTRWYRAPE 117
            ++H   V+HRDLKP NLL    N + ++KI DFG AR    +   +     T  Y APE
Sbjct: 120 SHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPE 179

Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 177
            LLN   Y  + D+WS+G IL  +++ +  F   D         E++         F   
Sbjct: 180 -LLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGE 238

Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH 237
                                + N S  A DL++ +L  DPNKR+ +     + +LQ   
Sbjct: 239 A--------------------WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278

Query: 238 DLNDEP 243
            L+  P
Sbjct: 279 QLSSNP 284

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  127 bits (322), Expect = 2e-35
 Identities = 52/251 (20%), Positives = 98/251 (39%), Gaps = 51/251 (20%)

Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 61
           H N++ + +     K+     +Y++ E     +L++ ++   +  +     F+ +L   L
Sbjct: 73  HPNILRMYNYFHDRKR-----IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADAL 127

Query: 62  KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT-----EYVVTRWYRAP 116
            Y H   V+HRD+KP NLL+    +LKI DFG +         T     +Y+       P
Sbjct: 128 HYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDYL------PP 181

Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 176
           E++     +   +D+W  G +  E +   P F    +    R I                
Sbjct: 182 EMIEGK-THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRI---------------- 224

Query: 177 SDNARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
                                +FP   S G+ DL+ K+L + P +R+ ++  + HP++++
Sbjct: 225 --------------VNVDL--KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKA 268

Query: 236 LHDLNDEPVCP 246
                  PV  
Sbjct: 269 NSRRVLPPVYQ 279

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  129 bits (325), Expect = 2e-35
 Identities = 56/252 (22%), Positives = 107/252 (42%), Gaps = 42/252 (16%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIV--Y----ELMDTDLHQIIRSDQQ---LTDDHCQ 51
           +++E  +  + II       +++VYI+  Y     ++  D +  +        +     +
Sbjct: 100 IKNEYCLTCEGII-----TNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK 154

Query: 52  YFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT----- 105
             +  +L    Y+H+  ++ HRD+KPSN+L++ +  +K+ DFG +    +          
Sbjct: 155 CIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGTY 214

Query: 106 EYVVTRWYRAPELLLNCTEY-TAAIDIWSVGCILGEIMTREPLFPGKDYVHQL--RLITE 162
           E++       PE   N + Y  A +DIWS+G  L  +      F  K  + +L   + T+
Sbjct: 215 EFM------PPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTK 268

Query: 163 LIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI 222
            I  P D +               L     ++        S+  +D L+  L  +P +RI
Sbjct: 269 NIEYPLDRN-------------HFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERI 315

Query: 223 TVEEALRHPYLQ 234
           T E+AL+H +L 
Sbjct: 316 TSEDALKHEWLA 327

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  130 bits (328), Expect = 2e-35
 Identities = 56/247 (22%), Positives = 101/247 (40%), Gaps = 31/247 (12%)

Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMD--TDLHQII-RSDQQLTDDHCQYFLYQLLR 59
             +++ I D+           + IV E +D      +I  R DQ  T+      +  +  
Sbjct: 114 CPHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 172

Query: 60  GLKYVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 116
            ++Y+HS ++ HRD+KP NLL      +  LK+ DFG A+ T+  + +T    T +Y AP
Sbjct: 173 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 232

Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 176
           E +L   +Y  + D+WS+G I+  ++   P F     +     +   I         F  
Sbjct: 233 E-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM---GQYEFPN 288

Query: 177 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 236
            +                    +   S     L+  +L  +P +R+T+ E + HP++   
Sbjct: 289 PE--------------------WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328

Query: 237 HDLNDEP 243
             +   P
Sbjct: 329 TKVPQTP 335

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  127 bits (321), Expect = 4e-35
 Identities = 53/248 (21%), Positives = 83/248 (33%), Gaps = 46/248 (18%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQ----LTDDHCQYFLY 55
             H N++ +       +       +++        L   I   +     LT+D   + L 
Sbjct: 83  FNHPNILRLVAYCLRERGAKHE-AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLL 141

Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART------TSETDFMTEYVV 109
            + RGL+ +H+    HRDLKP+N+LL       + D G           S      +   
Sbjct: 142 GICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWA 201

Query: 110 TR----WYRAPELLLN--CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITEL 163
            +     YRAPEL             D+WS+GC+L  +M  E  +   D V Q      L
Sbjct: 202 AQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY---DMVFQKGDSVAL 258

Query: 164 IGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT 223
                                      + Q    + P  SS    LL  M+  DP++R  
Sbjct: 259 A-------------------------VQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPH 293

Query: 224 VEEALRHP 231
           +   L   
Sbjct: 294 IPLLLSQL 301

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  126 bits (320), Expect = 6e-35
 Identities = 63/239 (26%), Positives = 103/239 (43%), Gaps = 38/239 (15%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++HEN++ ++DI      ++    Y+V +L+   +L   I      T+      + Q+L 
Sbjct: 63  IKHENIVTLEDIY-----ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLS 117

Query: 60  GLKYVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 116
            +KY+H   ++HRDLKP NLL      +  + I DFGL++   +   M+    T  Y AP
Sbjct: 118 AVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK-MEQNGIMSTACGTPGYVAP 176

Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 176
           E +L    Y+ A+D WS+G I   ++   P F  +        I E           F  
Sbjct: 177 E-VLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKE-------GYYEFES 228

Query: 177 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
                                 + + S  A D +  +L  DPN+R T E+AL HP++  
Sbjct: 229 PF--------------------WDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDG 267

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  127 bits (320), Expect = 3e-34
 Identities = 33/249 (13%), Positives = 68/249 (27%), Gaps = 48/249 (19%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-------DQQLTDDHCQYF 53
           ++      +  +    +       + +Y  M ++L              + L        
Sbjct: 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQL 216

Query: 54  LYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM--TEYVVTR 111
             Q++R L  +H   ++H  L+P +++L+    + +  F        +            
Sbjct: 217 TLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPP 276

Query: 112 WYRAPELLL----NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP 167
              A  +L     + T  T A D W++G  +  I   +        +     I       
Sbjct: 277 ETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWI------- 329

Query: 168 DDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA 227
                                 C          N       LLE  L +    R+   +A
Sbjct: 330 -------------------FRSC---------KNIPQPVRALLEGFLRYPKEDRLLPLQA 361

Query: 228 LRHPYLQSL 236
           +  P  + L
Sbjct: 362 METPEYEQL 370

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  126 bits (319), Expect = 8e-34
 Identities = 64/252 (25%), Positives = 109/252 (43%), Gaps = 46/252 (18%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++H N++ + D I           Y++++L+   +L + I + +  ++    + + Q+L 
Sbjct: 67  LKHPNIVRLHDSI-----SEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILE 121

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGLART-TSETDFMTEYVVTRWYRA 115
            + + H   V+HR+LKP NLLL +      +K+ DFGLA     E      +  T  Y +
Sbjct: 122 AVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLS 181

Query: 116 PELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP---DDASL 172
           PE +L    Y   +D+W+ G IL              Y+  L     L+G P   D+   
Sbjct: 182 PE-VLRKDPYGKPVDLWACGVIL--------------YI--L-----LVGYPPFWDEDQH 219

Query: 173 GFLRSDNARRYVRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHP 231
              +   A  Y           F +      +  A DL+ KML  +P+KRIT  EAL+HP
Sbjct: 220 RLYQQIKAGAY----------DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHP 269

Query: 232 YLQSLHDLNDEP 243
           ++     +    
Sbjct: 270 WISHRSTVASCM 281

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  121 bits (307), Expect = 2e-33
 Identities = 67/248 (27%), Positives = 102/248 (41%), Gaps = 57/248 (22%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIV--Y----ELMDTDLHQIIRSDQQLTDDHCQYFL 54
           + HENV+              N  Y+   Y    EL D      I  D  + +   Q F 
Sbjct: 62  LNHENVVKFYGHR-----REGNIQYLFLEYCSGGELFDR-----IEPDIGMPEPDAQRFF 111

Query: 55  YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTR 111
           +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T 
Sbjct: 112 HQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171

Query: 112 WYRAPELLLNCTEYTAA-IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA 170
            Y APELL    E+ A  +D+WS G +L                    ++          
Sbjct: 172 PYVAPELLKR-REFHAEPVDVWSCGIVL--------------TA----MLA--------- 203

Query: 171 SLGFL----RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEE 226
             G L     SD+ + Y        K+ +   +    S  + LL K+LV +P+ RIT+ +
Sbjct: 204 --GELPWDQPSDSCQEYSD---WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPD 258

Query: 227 ALRHPYLQ 234
             +  +  
Sbjct: 259 IKKDRWYN 266

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  124 bits (312), Expect = 2e-33
 Identities = 71/273 (26%), Positives = 116/273 (42%), Gaps = 42/273 (15%)

Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 61
           H N++  K++I      T   + I+ E     +L++ I +  + ++D  ++F  QLL G+
Sbjct: 75  HPNIVRFKEVI-----LTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGV 129

Query: 62  KYVHSASVLHRDLKPSNLLL--NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
            Y HS  + HRDLK  N LL  + +  LKI DFG ++++         V T  Y APE+L
Sbjct: 130 SYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 189

Query: 120 LNCTEYT-AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 178
           L   EY     D+WS G  L              YV        L+G     +  F   +
Sbjct: 190 LR-QEYDGKIADVWSCGVTL--------------YVM-------LVG-----AYPFEDPE 222

Query: 179 NARRYVRQLPRCRKQQFATRFPNK---SSGAVDLLEKMLVFDPNKRITVEEALRHP-YLQ 234
             R Y + + R    ++    P+    S     L+ ++ V DP  RI++ E   H  +L+
Sbjct: 223 EPRDYRKTIQRILSVKY--SIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLK 280

Query: 235 SLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELI 267
           +L               + E    + D I ++I
Sbjct: 281 NLPADLMNESNTGSQFQEPEQPMQSLDTIMQII 313

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  122 bits (308), Expect = 3e-33
 Identities = 52/260 (20%), Positives = 93/260 (35%), Gaps = 49/260 (18%)

Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT--DLHQIIRSDQQLTDDHCQYFLYQLLR 59
            H  VI + D       +T     +V E      DL   I     L +   + F  Q++ 
Sbjct: 96  GHPGVIRLLDWF-----ETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVA 150

Query: 60  GLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPEL 118
            +++ HS  V+HRD+K  N+L++      K+ DFG      +  +   +  TR Y  PE 
Sbjct: 151 AIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD-FDGTRVYSPPEW 209

Query: 119 LLNCTEYTAA-IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 177
           +    +Y A    +WS+G +L              Y     ++            G +  
Sbjct: 210 ISR-HQYHALPATVWSLGILL--------------YD----MVC-----------GDIPF 239

Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS-L 236
           +  +  +                + S     L+ + L   P+ R ++EE L  P++Q+  
Sbjct: 240 ERDQEILEAELHFP--------AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291

Query: 237 HDLNDEPVCPRPFHFDFEHS 256
            D+   P    P    +   
Sbjct: 292 EDVPLNPSKGGPAPLAWSLL 311

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  122 bits (307), Expect = 5e-33
 Identities = 71/275 (25%), Positives = 106/275 (38%), Gaps = 59/275 (21%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIV--Y----ELMDTDLHQIIRSDQQLTDDHCQYFL 54
           + HENV+              N  Y+   Y    EL D      I  D  + +   Q F 
Sbjct: 62  LNHENVVKFYGHR-----REGNIQYLFLEYCSGGELFDR-----IEPDIGMPEPDAQRFF 111

Query: 55  YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLA---RTTSETDFMTEYVVTR 111
           +QL+ G+ Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T 
Sbjct: 112 HQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171

Query: 112 WYRAPELLLNCTEYTAA-IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDA 170
            Y APELL    E+ A  +D+WS G +L                    ++          
Sbjct: 172 PYVAPELLKR-REFHAEPVDVWSCGIVL--------------TA----MLA--------- 203

Query: 171 SLGFL----RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEE 226
             G L     SD+ + Y        K+ +   +    S  + LL K+LV +P+ RIT+ +
Sbjct: 204 --GELPWDQPSDSCQEYSD---WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPD 258

Query: 227 ALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTED 261
             +  +      L      PR        S     
Sbjct: 259 IKKDRWYN--KPLKKGAKRPRVTSGGVSESPSGFS 291

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  122 bits (307), Expect = 5e-33
 Identities = 60/278 (21%), Positives = 123/278 (44%), Gaps = 49/278 (17%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H N++ + ++I     +T   +Y++ E     ++   + +  ++ +   +    Q++ 
Sbjct: 71  LNHPNIVKLFEVI-----ETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS 125

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
            ++Y H   ++HRDLK  NLLL+A  ++KI DFG +   +    +  +     Y APEL 
Sbjct: 126 AVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELF 185

Query: 120 LNCTEYT-AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 178
               +Y    +D+WS+G IL  +++    F                   D  +L  LR  
Sbjct: 186 QG-KKYDGPEVDVWSLGVILYTLVSGSLPF-------------------DGQNLKELRE- 224

Query: 179 NARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH 237
                     R  + ++  R P   S+   +LL++ LV +P KR T+E+ ++  ++ + H
Sbjct: 225 ----------RVLRGKY--RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272

Query: 238 DLNDEP--VCPRPFHFDFEHSS------CTEDHIRELI 267
           + ++    V P     D +          +++ I+E +
Sbjct: 273 EEDELKPFVEPELDISDQKRIDIMVGMGYSQEEIQESL 310

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  120 bits (304), Expect = 1e-32
 Identities = 61/278 (21%), Positives = 110/278 (39%), Gaps = 50/278 (17%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELM---DTDLHQIIRSDQQLTDDHCQYFLYQL 57
           + H+NVI + D++   +K     +Y+V E       ++   +  +++        +  QL
Sbjct: 63  LRHKNVIQLVDVLYNEEK---QKMYMVMEYCVCGMQEMLDSV-PEKRFPVCQAHGYFCQL 118

Query: 58  LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT---SETDFMTEYVVTRWYR 114
           + GL+Y+HS  ++H+D+KP NLLL     LKI   G+A      +  D       +  ++
Sbjct: 119 IDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQ 178

Query: 115 APELLLNCTEYT-AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGS-P-DDAS 171
            PE+      ++   +DIWS G  L              Y     + T   G  P +  +
Sbjct: 179 PPEIANGLDTFSGFKVDIWSAGVTL--------------YN----ITT---GLYPFEGDN 217

Query: 172 LGFLRSDNARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRH 230
           +  L                K  +    P        DLL+ ML ++P KR ++ +  +H
Sbjct: 218 IYKLFE-----------NIGKGSY--AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264

Query: 231 PYLQSLH--DLNDEPVCPRPFHFDFEHSSCTEDHIREL 266
            + +  H       P+ P P   D   S     ++ +L
Sbjct: 265 SWFRKKHPPAEAPVPIPPSPDTKDRWRSMTVVPYLEDL 302

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  121 bits (304), Expect = 2e-32
 Identities = 53/252 (21%), Positives = 96/252 (38%), Gaps = 56/252 (22%)

Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQ--LTDDHCQYFLYQ 56
           H N++         K+++         L +      +  + + + +  L+ D      YQ
Sbjct: 85  HPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQ 144

Query: 57  LLRGLKYVHSAS--VLHRDLKPSNLLLNASCDLKIGDFGLART---------TSETDFMT 105
             R ++++H     ++HRDLK  NLLL+    +K+ DFG A T         +++   + 
Sbjct: 145 TCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALV 204

Query: 106 EYVVTR----WYRAPEL--LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL 159
           E  +TR     YR PE+  L +        DIW++GCIL  +  R+  F           
Sbjct: 205 EEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG-------- 256

Query: 160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPN 219
                          LR  N  +Y   +P             + +    L+  ML  +P 
Sbjct: 257 -------------AKLRIVNG-KY--SIP---------PHDTQYTVFHSLIRAMLQVNPE 291

Query: 220 KRITVEEALRHP 231
           +R+++ E +   
Sbjct: 292 ERLSIAEVVHQL 303

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  120 bits (304), Expect = 2e-32
 Identities = 53/255 (20%), Positives = 90/255 (35%), Gaps = 51/255 (20%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT--DLHQIIRSDQQLTDDHCQYFLYQLL 58
           +EH N+I + DI      +      +V E   +  DL   I    +L +    Y   QL+
Sbjct: 86  VEHANIIKVLDIF-----ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLV 140

Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPEL 118
             + Y+    ++HRD+K  N+++     +K+ DFG A           +  T  Y APE+
Sbjct: 141 SAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEV 200

Query: 119 LLNCTEYT-AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 177
           L+    Y    +++WS+G  L              Y     L+                 
Sbjct: 201 LMG-NPYRGPELEMWSLGVTL--------------YT----LVF-----------EENPF 230

Query: 178 DNARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ-- 234
                 V               P   S   + L+  +L   P +R T+E+ +  P++   
Sbjct: 231 CELEETVEAAIHP---------PYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281

Query: 235 -SLHDLNDEPVCPRP 248
            +L D   E V    
Sbjct: 282 VNLADYTWEEVFRVN 296

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  120 bits (304), Expect = 2e-32
 Identities = 74/279 (26%), Positives = 126/279 (45%), Gaps = 52/279 (18%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           + H ++I + D+I      T  D+ +V E    +L   I   +++T+D  + F  Q++  
Sbjct: 66  LRHPHIIKLYDVI-----TTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICA 120

Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 120
           ++Y H   ++HRDLKP NLLL+ + ++KI DFGL+   ++ +F+     +  Y APE++ 
Sbjct: 121 IEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVIN 180

Query: 121 NCTEYT-AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGS-P-DDASLGFLRS 177
               Y    +D+WS G +L              YV        L+G  P DD  +  L  
Sbjct: 181 G-KLYAGPEVDVWSCGIVL--------------YV-------MLVGRLPFDDEFIPNLFK 218

Query: 178 DNARRYVRQLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHP----- 231
                      +     +    P+  S GA  L+ +M+V DP +RIT++E  R P     
Sbjct: 219 -----------KVNSCVY--VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265

Query: 232 ---YLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELI 267
              YL+ + ++       R      E    +ED+I E +
Sbjct: 266 LPDYLRPMEEVQGSYADSRIVSKLGEAMGFSEDYIVEAL 304

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  119 bits (301), Expect = 4e-32
 Identities = 56/259 (21%), Positives = 97/259 (37%), Gaps = 55/259 (21%)

Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGL 61
           H NV+ + +       +  +  Y+V+E M    +   I   +   +      +  +   L
Sbjct: 70  HRNVLELIEFF-----EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASAL 124

Query: 62  KYVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLAR--------TTSETDFMTEYVVT 110
            ++H+  + HRDLKP N+L    N    +KI DF L          +   T  +     +
Sbjct: 125 DFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS 184

Query: 111 RWYRAPELLLNCTE----YTAAIDIWSVGCIL-----------GEIMTREPLFPGKDYVH 155
             Y APE++   +E    Y    D+WS+G IL           G   +      G+    
Sbjct: 185 AEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244

Query: 156 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLV 215
              ++ E I         F   D                    + + S  A DL+ K+LV
Sbjct: 245 CQNMLFESIQE---GKYEFPDKD--------------------WAHISCAAKDLISKLLV 281

Query: 216 FDPNKRITVEEALRHPYLQ 234
            D  +R++  + L+HP++Q
Sbjct: 282 RDAKQRLSAAQVLQHPWVQ 300

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  118 bits (297), Expect = 1e-31
 Identities = 54/254 (21%), Positives = 96/254 (37%), Gaps = 54/254 (21%)

Query: 5   NVIAIKDIIRPPKKDTFNDVYIVYELMDT--DLHQIIRSDQQLTDDHCQYFLYQLLRGLK 62
            VI + D       +  +   ++ E  +   DL   I     L ++  + F +Q+L  ++
Sbjct: 109 GVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 163

Query: 63  YVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 121
           + H+  VLHRD+K  N+L++    +LK+ DFG      +T +   +  TR Y  PE +  
Sbjct: 164 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRY 222

Query: 122 CTEYTAA-IDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 180
              Y      +WS+G +L              Y     ++            G +  ++ 
Sbjct: 223 -HRYHGRSAAVWSLGILL--------------YD----MVC-----------GDIPFEHD 252

Query: 181 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS----- 235
              +R     R           SS    L+   L   P+ R T EE   HP++Q      
Sbjct: 253 EEIIRGQVFFR--------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ 304

Query: 236 -LHDLNDEPVCPRP 248
              +++   + P P
Sbjct: 305 ETAEIHLHSLSPGP 318

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  116 bits (294), Expect = 2e-31
 Identities = 65/239 (27%), Positives = 100/239 (41%), Gaps = 45/239 (18%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 59
             H ++I +  +I      T  D ++V E +   +L   I    ++ +   +    Q+L 
Sbjct: 68  FRHPHIIKLYQVI-----STPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS 122

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
            + Y H   V+HRDLKP N+LL+A  + KI DFGL+   S+ +F+     +  Y APE++
Sbjct: 123 AVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVI 182

Query: 120 LNCTEYT-AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGS-P-DDASLGFLR 176
                Y    +DIWS G IL              Y   L     L G+ P DD  +  L 
Sbjct: 183 SG-RLYAGPEVDIWSCGVIL--------------YA--L-----LCGTLPFDDEHVPTLF 220

Query: 177 SDNARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
                       + R   F    P   +     LL  ML  DP KR T+++   H + +
Sbjct: 221 K-----------KIRGGVF--YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFK 266

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  119 bits (299), Expect = 2e-31
 Identities = 67/279 (24%), Positives = 102/279 (36%), Gaps = 72/279 (25%)

Query: 26  IVYELMDTDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLN 82
           +V+E++   L + I     Q L     +  + Q+L+GL Y+H+   ++H D+KP N+LL+
Sbjct: 122 MVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLS 181

Query: 83  AS-------------------------------------------------CDLKIGDFG 93
            +                                                   +KI D G
Sbjct: 182 VNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLG 241

Query: 94  LARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD- 152
            A    +    TE + TR YR+ E+L+    Y    DIWS  C+  E+ T + LF     
Sbjct: 242 NACWVHKHF--TEDIQTRQYRSLEVLIGS-GYNTPADIWSTACMAFELATGDYLFEPHSG 298

Query: 153 -----YVHQLRLITELIGSPD-------DASLGFLRSDNARRYVRQLPRCRKQQFATRFP 200
                    + LI EL+G            S  F       +++ +L      +      
Sbjct: 299 EEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKY 358

Query: 201 NKS----SGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
             S    +G  D L  ML   P KR T  E LRHP+L S
Sbjct: 359 EWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  116 bits (292), Expect = 4e-31
 Identities = 47/238 (19%), Positives = 99/238 (41%), Gaps = 36/238 (15%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++H N++   D      K     + +V ELM +  L   ++  + +     + +  Q+L+
Sbjct: 82  LQHPNIVRFYDSWESTVKGK-KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILK 140

Query: 60  GLKYVHS--ASVLHRDLKPSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAP 116
           GL+++H+    ++HRDLK  N+ +      +KIGD GLA     + F    + T  + AP
Sbjct: 141 GLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAP 199

Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 176
           E+     +Y  ++D+++ G  + E+ T E  +       Q+         P  AS   + 
Sbjct: 200 EMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP--ASFDKVA 255

Query: 177 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
               +                          +++E  +  + ++R ++++ L H + Q
Sbjct: 256 IPEVK--------------------------EIIEGCIRQNKDERYSIKDLLNHAFFQ 287

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  114 bits (288), Expect = 3e-30
 Identities = 51/221 (23%), Positives = 89/221 (40%), Gaps = 37/221 (16%)

Query: 22  NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
             V I  EL++   L Q+I+    L +D   Y+L Q L GL+Y+H+  +LH D+K  N+L
Sbjct: 123 PWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVL 182

Query: 81  LNAS-CDLKIGDFGLAR-----TTSETDFMTEYVV-TRWYRAPELLLNCTEYTAAIDIWS 133
           L++      + DFG A         ++    +Y+  T  + APE+++      A +DIWS
Sbjct: 183 LSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWS 241

Query: 134 VGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ 193
             C++  ++      P   Y  +  L    I S                   ++P     
Sbjct: 242 SCCMMLHMLNGCH--PWTQY-FRGPLCL-KIASEPPPIR-------------EIP----- 279

Query: 194 QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
                 P+ +      +++ L  +P  R +  E  R     
Sbjct: 280 ------PSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  113 bits (286), Expect = 4e-30
 Identities = 56/224 (25%), Positives = 92/224 (41%), Gaps = 35/224 (15%)

Query: 22  NDVYIVYELMDTD-LHQIIRSDQ---QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 77
             + I  E +    L  ++RS     +  +    ++  Q+L GLKY+H   ++HRD+K  
Sbjct: 92  GFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGD 151

Query: 78  NLLLNA-SCDLKIGDFGLARTTSETDFMTEYVV-TRWYRAPE-LLLNCTEYTAAIDIWSV 134
           N+L+N  S  LKI DFG ++  +  +  TE    T  Y APE +      Y  A DIWS+
Sbjct: 152 NVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSL 211

Query: 135 GCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQ 194
           GC + E+ T +P  P  +       +   +G                    ++P      
Sbjct: 212 GCTIIEMATGKP--PFYELGEPQAAMF-KVGMFKVH--------------PEIP------ 248

Query: 195 FATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 238
                 + S+ A   + K    DP+KR    + L   +L+    
Sbjct: 249 -----ESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSK 287

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  112 bits (282), Expect = 1e-29
 Identities = 49/247 (19%), Positives = 88/247 (35%), Gaps = 52/247 (21%)

Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDTD--LHQII-RSDQQLTDDHCQYFLYQLLR 59
             +++ I D+           + IV E +D      +I  R DQ  T+      +  +  
Sbjct: 70  CPHIVRIVDVYENLYAGRKC-LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 128

Query: 60  GLKYVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 116
            ++Y+HS ++ HRD+KP NLL      +  LK+ DFG                     A 
Sbjct: 129 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF--------------------AK 168

Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 176
           E      +Y  + D+WS+G I+  ++   P F     +     +   I         F  
Sbjct: 169 ETTG--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM---GQYEFPN 223

Query: 177 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 236
            +                    +   S     L+  +L  +P +R+T+ E + HP++   
Sbjct: 224 PE--------------------WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263

Query: 237 HDLNDEP 243
             +   P
Sbjct: 264 TKVPQTP 270

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  115 bits (289), Expect = 1e-29
 Identities = 70/271 (25%), Positives = 116/271 (42%), Gaps = 50/271 (18%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 59
             H ++I +  +I      T +D+++V E +   +L   I  + +L +   +    Q+L 
Sbjct: 73  FRHPHIIKLYQVI-----STPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS 127

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           G+ Y H   V+HRDLKP N+LL+A  + KI DFGL+   S+ +F+     +  Y APE++
Sbjct: 128 GVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVI 187

Query: 120 LNCTEYT-AAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGS-P-DDASLGFLR 176
                Y    +DIWS G IL              Y   L     L G+ P DD  +  L 
Sbjct: 188 SG-RLYAGPEVDIWSSGVIL--------------YA--L-----LCGTLPFDDDHVPTLF 225

Query: 177 SDNARRYVRQLPRCRKQQFATRFPN-KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
                       +     F    P   +   + LL+ ML  DP KR T+++   H + + 
Sbjct: 226 K-----------KICDGIF--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ 272

Query: 236 LHDLNDEPVCPRPFHFDFEHSSCTEDHIREL 266
                D P    P    +  +   ++ ++E+
Sbjct: 273 -----DLPKYLFPEDPSYSSTMIDDEALKEV 298

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  109 bits (275), Expect = 1e-28
 Identities = 58/221 (26%), Positives = 97/221 (43%), Gaps = 36/221 (16%)

Query: 22  NDVYIVYELMDT----DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKP 76
            DV+I  ELMDT       Q+I   Q + +D        +++ L+++HS  SV+HRD+KP
Sbjct: 79  GDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKP 138

Query: 77  SNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE---LLLNCTEYTAAIDIWS 133
           SN+L+NA   +K+ DFG++    +          + Y APE     LN   Y+   DIWS
Sbjct: 139 SNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWS 198

Query: 134 VGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ 193
           +G  + E+      FP   +    + + +++  P                    P+    
Sbjct: 199 LGITMIELAILR--FPYDSWGTPFQQLKQVVEEPS-------------------PQLPAD 237

Query: 194 QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
           +F       S+  VD   + L  +  +R T  E ++HP+  
Sbjct: 238 KF-------SAEFVDFTSQCLKKNSKERPTYPELMQHPFFT 271

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  105 bits (264), Expect = 1e-26
 Identities = 51/229 (22%), Positives = 101/229 (44%), Gaps = 17/229 (7%)

Query: 22  NDVYIVYELMDTD-LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNL 79
            ++ I  E MD   L Q+++   ++ +         +++GL Y+     ++HRD+KPSN+
Sbjct: 104 GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 163

Query: 80  LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG 139
           L+N+  ++K+ DFG++    ++   + +V TR Y +PE L   T Y+   DIWS+G  L 
Sbjct: 164 LVNSRGEIKLCDFGVSGQLIDSMANS-FVGTRSYMSPERLQG-THYSVQSDIWSMGLSLV 221

Query: 140 EIMTREPLFPGKDYVHQLRLITELI-----------GSPDDASLGFLRSDNARRYVRQLP 188
           E+       P  D      +    +            +P      F         + +L 
Sbjct: 222 EMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELL 281

Query: 189 RCRKQQFATRFPNK--SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
                +   + P+   S    D + K L+ +P +R  +++ + H +++ 
Sbjct: 282 DYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 330

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  102 bits (255), Expect = 1e-25
 Identities = 50/220 (22%), Positives = 85/220 (38%), Gaps = 33/220 (15%)

Query: 22  NDVYIVYELMDTDLHQII-RSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNL 79
            DV+I  ELM T   ++  R    + +         +++ L Y+     V+HRD+KPSN+
Sbjct: 97  TDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNI 156

Query: 80  LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE----LLLNCTEYTAAIDIWSVG 135
           LL+    +K+ DFG++    +            Y APE          +Y    D+WS+G
Sbjct: 157 LLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLG 216

Query: 136 CILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQF 195
             L E+ T +  FP K+      ++T+++                      LP      F
Sbjct: 217 ISLVELATGQ--FPYKNCKTDFEVLTKVLQEE----------------PPLLP--GHMGF 256

Query: 196 ATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
                  S      ++  L  D  KR    + L H +++ 
Sbjct: 257 -------SGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  100 bits (252), Expect = 2e-25
 Identities = 48/165 (29%), Positives = 83/165 (50%), Gaps = 22/165 (13%)

Query: 3   HENVIAIKDI-IRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           H N+IA++ + ++ P       + +V E      L++++   +++  D    +  Q+ RG
Sbjct: 65  HPNIIALRGVCLKEPN------LCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARG 117

Query: 61  LKYVHS---ASVLHRDLKPSNLLLNASCD--------LKIGDFGLARTTSETDFMTEYVV 109
           + Y+H      ++HRDLK SN+L+    +        LKI DFGLAR    T  M+    
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGA 177

Query: 110 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV 154
             W  APE++   + ++   D+WS G +L E++T E  F G D +
Sbjct: 178 YAW-MAPEVI-RASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL 220

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  100 bits (252), Expect = 5e-25
 Identities = 51/222 (22%), Positives = 94/222 (42%), Gaps = 34/222 (15%)

Query: 22  NDVYIVYELMDTDLHQIIRS-----DQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLK 75
            D +I  ELM T   +  +      D  + ++         ++ L ++     ++HRD+K
Sbjct: 94  GDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIK 153

Query: 76  PSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL---LNCTEYTAAIDIW 132
           PSN+LL+ S ++K+ DFG++    ++   T     R Y APE +    +   Y    D+W
Sbjct: 154 PSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVW 213

Query: 133 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 192
           S+G  L E+ T    FP   +      +T+++                     QL    +
Sbjct: 214 SLGITLYELATGR--FPYPKWNSVFDQLTQVVKGD----------------PPQLSNSEE 255

Query: 193 QQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
           ++F       S   ++ +   L  D +KR   +E L+HP++ 
Sbjct: 256 REF-------SPSFINFVNLCLTKDESKRPKYKELLKHPFIL 290

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  100 bits (250), Expect = 6e-25
 Identities = 39/161 (24%), Positives = 74/161 (45%), Gaps = 13/161 (8%)

Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRG 60
           H N++        P+      + IV +  +   L+  + + + +           Q  RG
Sbjct: 79  HVNILLFMGYSTAPQ------LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARG 132

Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR---TTSETDFMTEYVVTRWYRAPE 117
           + Y+H+ S++HRDLK +N+ L+    +KIGDFGLA      S +    +   +  + APE
Sbjct: 133 MDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE 192

Query: 118 LLLN--CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ 156
           ++       Y+   D+++ G +L E+MT +  +   +   Q
Sbjct: 193 VIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 233

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  102 bits (256), Expect = 8e-25
 Identities = 47/210 (22%), Positives = 85/210 (40%), Gaps = 19/210 (9%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H +++ I + +    +      YIV E +    L +     Q+L       +L ++L 
Sbjct: 136 VVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPVAEAIAYLLEILP 193

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
            L Y+HS  +++ DLKP N++L     LK+ D G     +   ++     T  ++APE++
Sbjct: 194 ALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGYL---YGTPGFQAPEIV 249

Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP---DDASLGFLR 176
              T  T A DI++VG  L  +    P   G  YV  L     ++ +           + 
Sbjct: 250 R--TGPTVATDIYTVGRTLAALTLDLPTRNG-RYVDGLPEDDPVLKTYDSYGRLLRRAID 306

Query: 177 SDNARRY------VRQLPRCRKQQFATRFP 200
            D  +R+        QL    ++  A    
Sbjct: 307 PDPRQRFTTAEEMSAQLTGVLREVVAQDTG 336

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  101 bits (252), Expect = 8e-25
 Identities = 46/255 (18%), Positives = 80/255 (31%), Gaps = 33/255 (12%)

Query: 22  NDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 77
           N++++V   M      DL      D  + +    Y L  +L+ L Y+H    +HR +K S
Sbjct: 99  NELWVVTSFMAYGSAKDLICTHFMDG-MNELAIAYILQGVLKALDYIHHMGYVHRSVKAS 157

Query: 78  NLLLNASCDLKIGDFGLA--------RTTSETDFMTEYVVTRWYRAPELLL-NCTEYTAA 128
           ++L++    + +              R     DF    V    + +PE+L  N   Y A 
Sbjct: 158 HILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAK 217

Query: 129 IDIWSVGCILGEIMTREP----------LF-------PGKDYVHQLRLITELIGSPDDAS 171
            DI+SVG    E+               L        P       +      +      +
Sbjct: 218 SDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVA 277

Query: 172 LGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHP 231
              L         R            R    S      +E+ L  +P+ R +    L H 
Sbjct: 278 NSGLSDSLTTSTPRPSNGDSPSHPYHR--TFSPHFHHFVEQCLQRNPDARPSASTLLNHS 335

Query: 232 YLQSLHDLNDEPVCP 246
           + + +     E +  
Sbjct: 336 FFKQIKRRASEALPE 350

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score = 99.7 bits (249), Expect = 8e-25
 Identities = 47/162 (29%), Positives = 72/162 (44%), Gaps = 18/162 (11%)

Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ---QLTDDHCQYFLYQLL 58
           H N++ +            N V +V E  +   L+ ++   +     T  H   +  Q  
Sbjct: 60  HPNIVKLYGA-------CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 112

Query: 59  RGLKYVHS---ASVLHRDLKPSNLLLNASCD-LKIGDFGLARTTSETDFMTEYVVTRWYR 114
           +G+ Y+HS    +++HRDLKP NLLL A    LKI DFG A        MT    +  + 
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--MTNNKGSAAWM 170

Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ 156
           APE +   + Y+   D++S G IL E++TR   F        
Sbjct: 171 APE-VFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF 211

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score = 98.2 bits (245), Expect = 3e-24
 Identities = 38/164 (23%), Positives = 69/164 (42%), Gaps = 21/164 (12%)

Query: 3   HENVIAIKDI-IRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLR 59
           H N++ +  +   PP         +V E +   DL+  +      +        +  +  
Sbjct: 82  HPNIVKLYGLMHNPP--------RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIAL 133

Query: 60  GLKYVHS--ASVLHRDLKPSNLLL-----NASCDLKIGDFGLARTTSETDFMTEYVVTRW 112
           G++Y+ +    ++HRDL+  N+ L     NA    K+ DFGL++ +  +  ++  +    
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS--VSGLLGNFQ 191

Query: 113 YRAPELLLNCTE-YTAAIDIWSVGCILGEIMTREPLFPGKDYVH 155
           + APE +    E YT   D +S   IL  I+T E  F    Y  
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK 235

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score = 98.2 bits (245), Expect = 4e-24
 Identities = 40/160 (25%), Positives = 75/160 (46%), Gaps = 15/160 (9%)

Query: 3   HENVIA-IKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD---QQLTDDHCQYFLYQL 57
           H N++  +  + +PP       + IV E +    L++++      +QL +       Y +
Sbjct: 93  HPNIVLFMGAVTQPPN------LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDV 146

Query: 58  LRGLKYVHS--ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF-MTEYVVTRWYR 114
            +G+ Y+H+    ++HR+LK  NLL++    +K+ DFGL+R  + T         T  + 
Sbjct: 147 AKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWM 206

Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV 154
           APE +L         D++S G IL E+ T +  +   +  
Sbjct: 207 APE-VLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA 245

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 96.3 bits (240), Expect = 1e-23
 Identities = 38/165 (23%), Positives = 71/165 (43%), Gaps = 23/165 (13%)

Query: 1   MEHENVIA-IKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLL 58
           + HEN++  I   +      T   ++++    +   L+  ++    L    C   +  + 
Sbjct: 59  LRHENILGFIASDMTSRHSST--QLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIA 115

Query: 59  RGLKYVHSA--------SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV- 109
            GL ++H          ++ HRDLK  N+L+  +    I D GLA   S++    +    
Sbjct: 116 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNN 175

Query: 110 ----TRWYRAPELL-----LNCTEYTAAIDIWSVGCILGEIMTRE 145
               T+ Y APE+L     ++C +    +DIW+ G +L E+  R 
Sbjct: 176 PRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRM 220

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 97.1 bits (242), Expect = 1e-23
 Identities = 42/165 (25%), Positives = 68/165 (41%), Gaps = 23/165 (13%)

Query: 1   MEHENVIA-IKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLL 58
           M HEN++  I   I+     T   +Y++ +  +   L+  ++S   L         Y  +
Sbjct: 88  MRHENILGFIAADIKGTGSWT--QLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSV 144

Query: 59  RGLKYVHSA--------SVLHRDLKPSNLLLNASCDLKIGDFGLAR-----TTSETDFMT 105
            GL ++H+         ++ HRDLK  N+L+  +    I D GLA      T        
Sbjct: 145 SGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPN 204

Query: 106 EYVVTRWYRAPELL-----LNCTEYTAAIDIWSVGCILGEIMTRE 145
             V T+ Y  PE+L      N  +     D++S G IL E+  R 
Sbjct: 205 TRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRC 249

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 97.4 bits (242), Expect = 1e-23
 Identities = 33/251 (13%), Positives = 62/251 (24%), Gaps = 61/251 (24%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIR-----SDQQLTDDHCQYFL 54
                 +              N   +V EL     L   I       ++ +       F 
Sbjct: 124 SMQHMFMKFYSAH-----LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFA 178

Query: 55  YQLLRGLKYVHSASVLHRDLKPSNLLLNASCD-----------LKIGDFGLARTTS---E 100
            ++L  ++ VH   ++H D+KP N +L                L + D G +       +
Sbjct: 179 MRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPK 238

Query: 101 TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI 160
               T    T  ++  E+L N   +   ID + V   +  ++    +    +        
Sbjct: 239 GTIFTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMKVKNEGGE----- 292

Query: 161 TELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNK 220
                               RR                         +    ML      
Sbjct: 293 -------------CKPEGLFRRL-----------------PHLDMWNEFFHVMLNIPDCH 322

Query: 221 RITVEEALRHP 231
            +   + LR  
Sbjct: 323 HLPSLDLLRQK 333

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 96.2 bits (240), Expect = 2e-23
 Identities = 50/215 (23%), Positives = 81/215 (37%), Gaps = 29/215 (13%)

Query: 27  VYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCD 86
           V +++   + +       L +      L ++L GL+Y+H    +HRD+K  N+LL     
Sbjct: 100 VLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGS 159

Query: 87  LKIGDFGLARTTSETDFMTE------YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           ++I DFG++   +    +T       +V T  + APE++     Y    DIWS G    E
Sbjct: 160 VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIE 219

Query: 141 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 200
           + T     P   Y   ++++              L   N        P            
Sbjct: 220 LATGAA--PYHKY-PPMKVL-------------MLTLQNDP------PSLETGVQDKEML 257

Query: 201 NK-SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
            K       ++   L  DP KR T  E LRH + Q
Sbjct: 258 KKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQ 292

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score = 95.4 bits (238), Expect = 2e-23
 Identities = 29/155 (18%), Positives = 56/155 (36%), Gaps = 14/155 (9%)

Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQY--FLYQLLR 59
           H NV+ +    + P         ++   M    L+ ++        D  Q   F   + R
Sbjct: 66  HPNVLPVLGACQSPPAPHP---TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMAR 122

Query: 60  GLKYVHSAS--VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 117
           G+ ++H+    +    L   +++++     +I    +  +      M       W  APE
Sbjct: 123 GMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAP---AWV-APE 178

Query: 118 LLLN--CTEYTAAIDIWSVGCILGEIMTREPLFPG 150
            L          + D+WS   +L E++TRE  F  
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD 213

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 96.3 bits (240), Expect = 2e-23
 Identities = 56/243 (23%), Positives = 107/243 (44%), Gaps = 40/243 (16%)

Query: 3   HENVIAIKDI-IRPPKKDTFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQL 57
           H N+       I+       + +++V E       TDL +  +    L ++   Y   ++
Sbjct: 80  HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREI 138

Query: 58  LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF-MTEYVVTRWYRAP 116
           LRGL ++H   V+HRD+K  N+LL  + ++K+ DFG++     T      ++ T ++ AP
Sbjct: 139 LRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 198

Query: 117 ELLLNCTE----YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASL 172
           E++         Y    D+WS+G    E+    P  P  D +H +R +            
Sbjct: 199 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAP--PLCD-MHPMRAL------------ 243

Query: 173 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY 232
            FL   N        PR + ++++ +F          +E  LV + ++R   E+ ++HP+
Sbjct: 244 -FLIPRN------PAPRLKSKKWSKKF-------QSFIESCLVKNHSQRPATEQLMKHPF 289

Query: 233 LQS 235
           ++ 
Sbjct: 290 IRD 292

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score = 95.1 bits (237), Expect = 5e-23
 Identities = 36/167 (21%), Positives = 72/167 (43%), Gaps = 24/167 (14%)

Query: 3   HENVIA-IKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLR 59
           HENV+  +   + PP       + I+  L     L+ ++R     L  +  +    ++++
Sbjct: 88  HENVVLFMGACMSPPH------LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVK 141

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEY----VVTRWYR- 114
           G+ Y+H+  +LH+DLK  N+  + +  + I DFGL   +             +   W   
Sbjct: 142 GMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCH 200

Query: 115 -APELLLNCTE--------YTAAIDIWSVGCILGEIMTREPLFPGKD 152
            APE++   +         ++   D++++G I  E+  RE  F  + 
Sbjct: 201 LAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP 247

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score = 94.3 bits (235), Expect = 8e-23
 Identities = 41/166 (24%), Positives = 70/166 (42%), Gaps = 25/166 (15%)

Query: 3   HENVIA-IKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLR 59
           H NV+  I  + +  +      +  + E +    L  II+S D Q        F   +  
Sbjct: 66  HPNVLKFIGVLYKDKR------LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIAS 119

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF---------------M 104
           G+ Y+HS +++HRDL   N L+  + ++ + DFGLAR   +                   
Sbjct: 120 GMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKR 179

Query: 105 TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG 150
              V   ++ APE++     Y   +D++S G +L EI+ R    P 
Sbjct: 180 YTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPD 224

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 94.7 bits (236), Expect = 8e-23
 Identities = 54/226 (23%), Positives = 96/226 (42%), Gaps = 52/226 (23%)

Query: 22  NDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 77
            +++++ E +     TD+   +R    L ++        +L+ L Y+H+  V+HRD+K  
Sbjct: 115 EELWVLMEFLQGGALTDIVSQVR----LNEEQIATVCEAVLQALAYLHAQGVIHRDIKSD 170

Query: 78  NLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 136
           ++LL     +K+ DFG  A+ + +       V T ++ APE++   + Y   +DIWS+G 
Sbjct: 171 SILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR-SLYATEVDIWSLG- 228

Query: 137 ILGEIMTRE------PLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRC 190
               IM  E      P F        ++ +                 D+        P+ 
Sbjct: 229 ----IMVIEMVDGEPPYF----SDSPVQAM-------------KRLRDSPP------PKL 261

Query: 191 R-KQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
           +   + +           D LE+MLV DP +R T +E L HP+L  
Sbjct: 262 KNSHKVSPVL-------RDFLERMLVRDPQERATAQELLDHPFLLQ 300

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 94.2 bits (235), Expect = 1e-22
 Identities = 41/152 (26%), Positives = 68/152 (44%), Gaps = 11/152 (7%)

Query: 3   HENVIAIKDIIRPPKKDTFNDV-YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
             +V+ I D          +   Y+   L++  DL  ++R    L        + Q+   
Sbjct: 93  EPHVVPIHDF------GEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSA 146

Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF-MTEYVV-TRWYRAPEL 118
           L   H+A   HRD+KP N+L++A     + DFG+A  T++         V T +Y APE 
Sbjct: 147 LDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPER 206

Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPG 150
               +  T   DI+++ C+L E +T  P + G
Sbjct: 207 FSE-SHATYRADIYALTCVLYECLTGSPPYQG 237

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 95.1 bits (237), Expect = 1e-22
 Identities = 47/222 (21%), Positives = 95/222 (42%), Gaps = 34/222 (15%)

Query: 20  TFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 78
              D+++V +L+   DL   ++ +    ++  + F+ +L+  L Y+ +  ++HRD+KP N
Sbjct: 86  DEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDN 145

Query: 79  LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN--CTEYTAAIDIWSVGC 136
           +LL+    + I DF +A        +T    T+ Y APE+  +     Y+ A+D WS+G 
Sbjct: 146 ILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGV 205

Query: 137 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 196
              E++     +  +                         S +++  V            
Sbjct: 206 TAYELLRGRRPYHIRS------------------------STSSKEIVHTFETTVV---- 237

Query: 197 TRFPNK-SSGAVDLLEKMLVFDPNKRI-TVEEALRHPYLQSL 236
             +P+  S   V LL+K+L  +P++R   + +    PY+  +
Sbjct: 238 -TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 93.9 bits (234), Expect = 1e-22
 Identities = 56/220 (25%), Positives = 100/220 (45%), Gaps = 40/220 (18%)

Query: 22  NDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 77
           +++++V E +     TD    + ++  + +        + L+ L+++HS  V+HRD+K  
Sbjct: 90  DELWVVMEYLAGGSLTD----VVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSD 145

Query: 78  NLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 136
           N+LL     +K+ DFG  A+ T E    +  V T ++ APE++     Y   +DIWS+G 
Sbjct: 146 NILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGI 204

Query: 137 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 196
           +  E++  EP  P  +  + LR +             +L + N        P  +     
Sbjct: 205 MAIEMIEGEP--PYLN-ENPLRAL-------------YLIATNGT------PELQN---- 238

Query: 197 TRFPNKSSGA-VDLLEKMLVFDPNKRITVEEALRHPYLQS 235
              P K S    D L + L  D  KR + +E L+H +L+ 
Sbjct: 239 ---PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKI 275

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 94.0 bits (234), Expect = 2e-22
 Identities = 48/217 (22%), Positives = 94/217 (43%), Gaps = 35/217 (16%)

Query: 22  NDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
           +  ++V E        ++    + L +       +  L+GL Y+HS +++HRD+K  N+L
Sbjct: 127 HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNIL 186

Query: 81  LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTE--YTAAIDIWSVGCIL 138
           L+    +K+GDFG A   +  +     V T ++ APE++L   E  Y   +D+WS+G   
Sbjct: 187 LSEPGLVKLGDFGSASIMAPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 243

Query: 139 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 198
            E+  R+P  P  + ++ +  +             +  + N      + P  +   ++  
Sbjct: 244 IELAERKP--PLFN-MNAMSAL-------------YHIAQN------ESPALQSGHWSEY 281

Query: 199 FPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
           F        + ++  L   P  R T E  L+H ++  
Sbjct: 282 F-------RNFVDSCLQKIPQDRPTSEVLLKHRFVLR 311

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 92.0 bits (229), Expect = 7e-22
 Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 36/219 (16%)

Query: 22  NDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 77
            D++IV E       +D+ ++   ++ LT+D     L   L+GL+Y+H    +HRD+K  
Sbjct: 97  TDLWIVMEYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAG 154

Query: 78  NLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 136
           N+LLN     K+ DFG+  + T         + T ++ APE++     Y    DIWS+G 
Sbjct: 155 NILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYNCVADIWSLGI 213

Query: 137 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 196
              E+   +P  P  D +H +R I             F+   N        P  RK +  
Sbjct: 214 TAIEMAEGKP--PYAD-IHPMRAI-------------FMIPTNPP------PTFRKPE-- 249

Query: 197 TRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
                 S    D +++ LV  P +R T  + L+HP+++S
Sbjct: 250 ----LWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRS 284

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 91.1 bits (227), Expect = 1e-21
 Identities = 58/227 (25%), Positives = 97/227 (42%), Gaps = 47/227 (20%)

Query: 20  TFNDVYIVYELMDT----DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 75
           TF D   +Y  +      +L + IR      +   +++  +++  L+Y+H   ++HRDLK
Sbjct: 98  TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLK 157

Query: 76  PSNLLLNASCDLKIGDFGLAR---TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIW 132
           P N+LLN    ++I DFG A+     S+      +V T  Y +PELL        + D+W
Sbjct: 158 PENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE-KSACKSSDLW 216

Query: 133 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 192
           ++GCI+ +++   P F   +      LI + I          ++ +              
Sbjct: 217 ALGCIIYQLVAGLPPFRAGNE----YLIFQKI----------IKLE-------------- 248

Query: 193 QQFATRFPNK-SSGAVDLLEKMLVFDPNKRIT------VEEALRHPY 232
                 FP K    A DL+EK+LV D  KR+             HP+
Sbjct: 249 ----YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 291

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 91.1 bits (227), Expect = 1e-21
 Identities = 52/152 (34%), Positives = 85/152 (55%), Gaps = 11/152 (7%)

Query: 3   HENVIAIKDIIRPPKKDTFNDV-YIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           H+N++++ D+      D  +D  Y+V E ++   L + I S   L+ D    F  Q+L G
Sbjct: 70  HQNIVSMIDV------DEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDG 123

Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF-MTEYVV-TRWYRAPEL 118
           +K+ H   ++HRD+KP N+L++++  LKI DFG+A+  SET    T +V+ T  Y +PE 
Sbjct: 124 IKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQ 183

Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPG 150
                      DI+S+G +L E++  EP F G
Sbjct: 184 AKG-EATDECTDIYSIGIVLYEMLVGEPPFNG 214

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 92.3 bits (229), Expect = 3e-21
 Identities = 54/224 (24%), Positives = 100/224 (44%), Gaps = 37/224 (16%)

Query: 20  TFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN 78
           T + +  + +LM+  DLH  +      ++   +++  +++ GL+++H+  V++RDLKP+N
Sbjct: 263 TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPAN 322

Query: 79  LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCIL 138
           +LL+    ++I D GLA   S+       V T  Y APE+L     Y ++ D +S+GC+L
Sbjct: 323 ILLDEHGHVRISDLGLACDFSKKKPHA-SVGTHGYMAPEVLQKGVAYDSSADWFSLGCML 381

Query: 139 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR 198
            +++     F      H+ +   E+                  R    +           
Sbjct: 382 FKLLRGHSPF----RQHKTKDKHEID-----------------RMTLTMA--------VE 412

Query: 199 FPNK-SSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSL 236
            P+  S     LLE +L  D N+R+       +E    P+ +SL
Sbjct: 413 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 456

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 90.2 bits (224), Expect = 4e-21
 Identities = 56/263 (21%), Positives = 102/263 (38%), Gaps = 39/263 (14%)

Query: 1   MEHENVIA-IKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLL 58
           M+HEN++  I    R    D   D++++    +   L   +++   ++ +   +    + 
Sbjct: 75  MKHENILQFIGAEKRGTSVDV--DLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMA 131

Query: 59  RGLKYVHSA----------SVLHRDLKPSNLLLNASCDLKIGDFGLART---TSETDFMT 105
           RGL Y+H            ++ HRD+K  N+LL  +    I DFGLA             
Sbjct: 132 RGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTH 191

Query: 106 EYVVTRWYRAPELL----LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT 161
             V TR Y APE+L        +    ID++++G +L E+ +R     G    + L    
Sbjct: 192 GQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251

Query: 162 ELIGSPDDASLGFLRSDNARRYVR-QLP-RCRKQQFATRFPNKSSGAVDLLEKMLVFDPN 219
           E+       SL  ++     +  R  L    +K               + +E+    D  
Sbjct: 252 EI---GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAML-------CETIEECWDHDAE 301

Query: 220 KRIT---VEEALRHPYLQSLHDL 239
            R++   V E +    +Q L ++
Sbjct: 302 ARLSAGCVGERITQ--MQRLTNI 322

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 91.8 bits (228), Expect = 4e-21
 Identities = 54/254 (21%), Positives = 104/254 (40%), Gaps = 44/254 (17%)

Query: 20  TFNDVYIVYELMD-----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDL 74
           T  D+ +V  +M+       ++ +   +    +    ++  Q++ GL+++H  ++++RDL
Sbjct: 256 TKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDL 315

Query: 75  KPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCTEYTAAIDIWS 133
           KP N+LL+   +++I D GLA         T+ Y  T  + APELLL   EY  ++D ++
Sbjct: 316 KPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFA 374

Query: 134 VGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQ 193
           +G  L E++     F  +    + + + + +                             
Sbjct: 375 LGVTLYEMIAARGPFRARGEKVENKELKQRV-----------LEQAV------------- 410

Query: 194 QFATRFPNK-SSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSL--HDLNDEPVC 245
                +P+K S  + D  E +L  DP KR+     + +    HP  + +    L    + 
Sbjct: 411 ----TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLT 466

Query: 246 PRPFHFDFEHSSCT 259
           P PF  D       
Sbjct: 467 P-PFVPDSRTVYAK 479

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 89.8 bits (223), Expect = 5e-21
 Identities = 36/172 (20%), Positives = 65/172 (37%), Gaps = 23/172 (13%)

Query: 1   MEHENVIA-IKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLL 58
           + HEN++  I    +     T   +++V +  +   L   +     +T +          
Sbjct: 93  LRHENILGFIAADNKDNGTWT--QLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTA 149

Query: 59  RGLKYVHSA--------SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV- 109
            GL ++H          ++ HRDLK  N+L+  +    I D GLA          +    
Sbjct: 150 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN 209

Query: 110 ----TRWYRAPELL-----LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD 152
               T+ Y APE+L     +   E     DI+++G +  EI  R  +    +
Sbjct: 210 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 88.9 bits (221), Expect = 7e-21
 Identities = 53/229 (23%), Positives = 98/229 (42%), Gaps = 41/229 (17%)

Query: 22  NDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 77
             ++I+ E         +  ++  D+ LT+   Q    Q+L  L ++HS  ++HRDLK  
Sbjct: 89  GKLWIMIEFCPGGAVDAI--MLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAG 146

Query: 78  NLLLNASCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCT----EYTAAIDIW 132
           N+L+    D+++ DFG+ A+          ++ T ++ APE+++  T     Y    DIW
Sbjct: 147 NVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIW 206

Query: 133 SVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK 192
           S+G  L E+   EP  P  + ++ +R++                + +        P    
Sbjct: 207 SLGITLIEMAQIEP--PHHE-LNPMRVL-------------LKIAKSDP------PTLLT 244

Query: 193 QQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 240
                  P+K S    D L+  L  +P  R +  + L HP++ S+    
Sbjct: 245 -------PSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNK 286

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 89.9 bits (223), Expect = 2e-20
 Identities = 53/226 (23%), Positives = 95/226 (42%), Gaps = 38/226 (16%)

Query: 20  TFNDVYIVYELMDT-DL-HQIIRSDQQ-LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP 76
           T + + +V  LM+  DL   I    Q    +    ++  ++  GL+ +H   +++RDLKP
Sbjct: 255 TKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKP 314

Query: 77  SNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 136
            N+LL+    ++I D GLA    E   +   V T  Y APE++ N   YT + D W++GC
Sbjct: 315 ENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGC 373

Query: 137 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 196
           +L E++  +  F  +    +   +  L+                            ++  
Sbjct: 374 LLYEMIAGQSPFQQRKKKIKREEVERLV----------------------------KEVP 405

Query: 197 TRFPNK-SSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSL 236
             +  + S  A  L  ++L  DP +R+     +  E   HP  + L
Sbjct: 406 EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 88.1 bits (219), Expect = 2e-20
 Identities = 44/153 (28%), Positives = 78/153 (50%), Gaps = 7/153 (4%)

Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGL 61
           H  ++A+ D             YIV E +D   L  I+ ++  +T       +    + L
Sbjct: 71  HPAIVAVYDTGEAETPAG-PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 129

Query: 62  KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVV-TRWYRAPE 117
            + H   ++HRD+KP+N++++A+  +K+ DFG+AR  +++      T  V+ T  Y +PE
Sbjct: 130 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189

Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG 150
                    A  D++S+GC+L E++T EP F G
Sbjct: 190 QARG-DSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 86.6 bits (215), Expect = 5e-20
 Identities = 53/219 (24%), Positives = 99/219 (45%), Gaps = 40/219 (18%)

Query: 22  NDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 77
             ++I+ E +      DL +       L +      L ++L+GL Y+HS   +HRD+K +
Sbjct: 93  TKLWIIMEYLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAA 148

Query: 78  NLLLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC 136
           N+LL+   ++K+ DFG+A   ++T      +V T ++ APE++   + Y +  DIWS+G 
Sbjct: 149 NVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGI 207

Query: 137 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA 196
              E+   EP  P  +  H ++++             FL           +P+       
Sbjct: 208 TAIELARGEP--PHSEL-HPMKVL-------------FL-----------IPKNNPPTLE 240

Query: 197 TRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
             +   S    + +E  L  +P+ R T +E L+H ++  
Sbjct: 241 GNY---SKPLKEFVEACLNKEPSFRPTAKELLKHKFILR 276

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 85.4 bits (212), Expect = 2e-19
 Identities = 51/233 (21%), Positives = 96/233 (41%), Gaps = 53/233 (22%)

Query: 18  KDTFNDVYIVYELMDT----DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRD 73
           + +F D   +Y +M+     ++   +R   + ++ H +++  Q++   +Y+HS  +++RD
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166

Query: 74  LKPSNLLLNASCDLKIGDFGLARTTSETDFM----TEYVVTRWYRAPELLLNCTEYTAAI 129
           LKP NLL++    +++ DFG A+      +      E +      APE++L+   Y  A+
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEAL------APEIILS-KGYNKAV 219

Query: 130 DIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPR 189
           D W++G ++ E+    P F     +     I  + G                        
Sbjct: 220 DWWALGVLIYEMAAGYPPFFADQPIQIYEKI--VSGKV---------------------- 255

Query: 190 CRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSL 236
                   RFP+  SS   DLL  +L  D  KR       V +   H +  + 
Sbjct: 256 --------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 84.3 bits (209), Expect = 5e-19
 Identities = 39/179 (21%), Positives = 79/179 (44%), Gaps = 18/179 (10%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLL 58
           +  + ++  + +   P + +   + +V E + +  L   ++    +L       +  Q+ 
Sbjct: 81  LHSDFIVKYRGVSYGPGRQS---LRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 137

Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-------R 111
           +G++Y+ S   +HRDL   N+L+ +   +KI DFGLA+          YVV         
Sbjct: 138 KGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK--DYYVVREPGQSPIF 195

Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPGKDYVHQLRLITELIGSPD 168
           WY APE L +   ++   D+WS G +L E+ T   +   P  +++  +    ++     
Sbjct: 196 WY-APESLSDNI-FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 84.0 bits (208), Expect = 1e-18
 Identities = 36/213 (16%), Positives = 74/213 (34%), Gaps = 38/213 (17%)

Query: 35  LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL 94
           L  + +  +++  +  +++L +++  +  VH    +HRD+KP N+LL+    +++ DFG 
Sbjct: 149 LTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGS 208

Query: 95  A-RTTSETDFMTEYVV-TRWYRAPELLLN------CTEYTAAIDIWSVGCILGEIMTREP 146
             +  ++    +   V T  Y +PE+L           Y    D W++G    E+   + 
Sbjct: 209 CLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQT 268

Query: 147 LFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGA 206
            F           I                          +                  A
Sbjct: 269 PFYADSTAETYGKI--------------------------VHYKEHLSLPLVDEGVPEEA 302

Query: 207 VDLLEKMLVFDPNKRIT---VEEALRHPYLQSL 236
            D ++++L   P  R+      +   HP+   L
Sbjct: 303 RDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL 334

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 83.0 bits (206), Expect = 1e-18
 Identities = 56/237 (23%), Positives = 104/237 (43%), Gaps = 62/237 (26%)

Query: 29  ELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLK 88
           EL     H  +  ++  T++  +++  +++  L+Y+HS  V++RD+K  NL+L+    +K
Sbjct: 91  ELF---FH--LSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIK 145

Query: 89  IGDFGLARTTSETDFMTEYVVTRW------YRAPELLLNCTEYTAAIDIWSVGCILGEIM 142
           I DFGL +     + +++    +       Y APE+L +  +Y  A+D W +G ++ E+M
Sbjct: 146 ITDFGLCK-----EGISDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMM 199

Query: 143 TREPLFPGKD--YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 200
                F  +D   + +L L+ E+                                  RFP
Sbjct: 200 CGRLPFYNQDHERLFELILMEEI----------------------------------RFP 225

Query: 201 NK-SSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSL--HDLNDEPVCPRPF 249
              S  A  LL  +L  DP +R+       +E + H +  S+   D+  + + P PF
Sbjct: 226 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLP-PF 281

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 82.4 bits (204), Expect = 2e-18
 Identities = 45/176 (25%), Positives = 77/176 (43%), Gaps = 21/176 (11%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLL 58
           + HEN++  K I     +D  N + ++ E + +  L + +     ++       +  Q+ 
Sbjct: 80  LYHENIVKYKGIC---TEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQIC 136

Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-------R 111
           +G+ Y+ S   +HRDL   N+L+ +   +KIGDFGL +          Y V         
Sbjct: 137 KGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK--EYYTVKDDRDSPVF 194

Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP 167
           WY APE L+    +  A D+WS G  L E++T             + L  ++IG  
Sbjct: 195 WY-APECLMQSK-FYIASDVWSFGVTLHELLTY-----CDSDSSPMALFLKMIGPT 243

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 81.6 bits (202), Expect = 3e-18
 Identities = 36/152 (23%), Positives = 71/152 (46%), Gaps = 16/152 (10%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLL 58
           ++H+N++  K +     +     + ++ E +    L   ++   +++       +  Q+ 
Sbjct: 68  LQHDNIVKYKGVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 124

Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-------R 111
           +G++Y+ +   +HRDL   N+L+     +KIGDFGL +   +      + V         
Sbjct: 125 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK--EFFKVKEPGESPIF 182

Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           WY APE L     ++ A D+WS G +L E+ T
Sbjct: 183 WY-APESLTESK-FSVASDVWSFGVVLYELFT 212

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 81.9 bits (203), Expect = 3e-18
 Identities = 39/161 (24%), Positives = 69/161 (42%), Gaps = 23/161 (14%)

Query: 1   MEHENVIAIKDII-RPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQL 57
           +++ +V  +  I            V ++ +LM    L   +R     +   +   +  Q+
Sbjct: 74  VDNPHVCRLLGICLTST-------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 126

Query: 58  LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------R 111
            +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     +   EY         +
Sbjct: 127 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIK 184

Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 150
           W  A E  +    YT   D+WS G  + E+MT   +P + G
Sbjct: 185 WM-ALE-SILHRIYTHQSDVWSYGVTVWELMTFGSKP-YDG 222

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 82.9 bits (205), Expect = 3e-18
 Identities = 42/211 (19%), Positives = 88/211 (41%), Gaps = 36/211 (17%)

Query: 35  LHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL 94
           L  + + + +L ++  +++L +++  +  VH    +HRD+KP N+L++ +  +++ DFG 
Sbjct: 162 LTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGS 221

Query: 95  A-RTTSETDFMTEYVV-TRWYRAPELLLNCTE----YTAAIDIWSVGCILGEIMTREPLF 148
             +   +    +   V T  Y +PE+L         Y    D WS+G  + E++  E  F
Sbjct: 222 CLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF 281

Query: 149 PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVD 208
             +  V     I                          +    + QF T+  + S  A D
Sbjct: 282 YAESLVETYGKI--------------------------MNHKERFQFPTQVTDVSENAKD 315

Query: 209 LLEKMLVFDPNKRIT---VEEALRHPYLQSL 236
           L+ +++      R+    +E+  +HP+   +
Sbjct: 316 LIRRLIC-SREHRLGQNGIEDFKKHPFFSGI 345

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 82.0 bits (203), Expect = 3e-18
 Identities = 37/152 (24%), Positives = 71/152 (46%), Gaps = 16/152 (10%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLL 58
           ++H+N++  K +     +     + ++ E +    L   ++   +++       +  Q+ 
Sbjct: 99  LQHDNIVKYKGVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 155

Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-------R 111
           +G++Y+ +   +HRDL   N+L+     +KIGDFGL +   +      Y V         
Sbjct: 156 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK--EYYKVKEPGESPIF 213

Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           WY APE L     ++ A D+WS G +L E+ T
Sbjct: 214 WY-APESLTESK-FSVASDVWSFGVVLYELFT 243

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 81.8 bits (202), Expect = 4e-18
 Identities = 59/286 (20%), Positives = 100/286 (34%), Gaps = 44/286 (15%)

Query: 1   MEHENVIA-IKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLL 58
           MEH+N+   I    R           +V E      L + +               + + 
Sbjct: 64  MEHDNIARFIVGDERVTADGRME-YLLVMEYYPNGSLXKYLS-LHTSDWVSSCRLAHSVT 121

Query: 59  RGLKYVHSA---------SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF------ 103
           RGL Y+H+          ++ HRDL   N+L+       I DFGL+   +          
Sbjct: 122 RGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEE 181

Query: 104 ---MTEYVVTRWYRAPELL------LNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDY 153
                  V T  Y APE+L       +       +D++++G I  EI  R   LFPG+  
Sbjct: 182 DNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241

Query: 154 V-HQLRLITELIGSPDDASLGFLRSDNARRYVR-QLP-RCRKQQFATRFPNKSSGAVDLL 210
             +Q+   TE+    +  +   ++   +R   R + P   ++   A R         + +
Sbjct: 242 PEYQMAFQTEV---GNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVR------SLKETI 292

Query: 211 EKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPF-HFDFEH 255
           E     D   R+T + A     +  L  + +      P  H    H
Sbjct: 293 EDCWDQDAEARLTAQXAEE--RMAELMMIWERNKSVSPTAHHHHHH 336

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 81.5 bits (202), Expect = 6e-18
 Identities = 58/226 (25%), Positives = 97/226 (42%), Gaps = 49/226 (21%)

Query: 34  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG 93
           DL   I+S  +       ++  +++ GL+++HS  +++RDLK  N+LL+    +KI DFG
Sbjct: 104 DLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFG 163

Query: 94  LARTTSETDFMTEYVVTRW------YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL 147
           + +     + M     T        Y APE+LL   +Y  ++D WS G +L E++  +  
Sbjct: 164 MCK-----ENMLGDAKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSP 217

Query: 148 FPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK-SSGA 206
           F G+D       I       D+                             +P      A
Sbjct: 218 FHGQDEEELFHSIRM-----DNP---------------------------FYPRWLEKEA 245

Query: 207 VDLLEKMLVFDPNKRITVEEALR-HPYLQSL--HDLNDEPVCPRPF 249
            DLL K+ V +P KR+ V   +R HP  + +   +L  + + P PF
Sbjct: 246 KDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDP-PF 290

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 80.8 bits (200), Expect = 6e-18
 Identities = 36/161 (22%), Positives = 78/161 (48%), Gaps = 23/161 (14%)

Query: 1   MEHENVIAIKDII-RPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLL 58
           +++  ++ +  I              +V E+ +   L++ ++ ++ + D +    ++Q+ 
Sbjct: 75  LDNPYIVRMIGICEAES-------WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVS 127

Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-------R 111
            G+KY+  ++ +HRDL   N+LL      KI DFGL++     +    Y          +
Sbjct: 128 MGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE--NYYKAQTHGKWPVK 185

Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 150
           WY APE  +N  ++++  D+WS G ++ E  +  ++P + G
Sbjct: 186 WY-APE-CINYYKFSSKSDVWSFGVLMWEAFSYGQKP-YRG 223

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 80.4 bits (199), Expect = 8e-18
 Identities = 48/162 (29%), Positives = 70/162 (43%), Gaps = 24/162 (14%)

Query: 1   MEHENVIAIKDII-RPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQL 57
           ++H N+I +  ++  PP       + +V EL     L   +R             +  Q+
Sbjct: 78  LDHRNLIRLYGVVLTPP-------MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 130

Query: 58  LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------- 110
             G+ Y+ S   +HRDL   NLLL     +KIGDFGL R   + D    YV+        
Sbjct: 131 AEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND--DHYVMQEHRKVPF 188

Query: 111 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 150
            W  APE  L    ++ A D W  G  L E+ T  +EP + G
Sbjct: 189 AWC-APE-SLKTRTFSHASDTWMFGVTLWEMFTYGQEP-WIG 227

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 80.7 bits (200), Expect = 1e-17
 Identities = 48/236 (20%), Positives = 91/236 (38%), Gaps = 59/236 (25%)

Query: 29  ELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLK 88
           +LM    H  I+  ++  +   +++  +++  L ++H   +++RDLK  N+LL+     K
Sbjct: 110 DLM---FH--IQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCK 164

Query: 89  IGDFGLARTTSETDFMTEYVVTRW------YRAPELLLNCTEYTAAIDIWSVGCILGEIM 142
           + DFG+ +     + +   V T        Y APE+L     Y  A+D W++G +L E++
Sbjct: 165 LADFGMCK-----EGICNGVTTATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEML 218

Query: 143 TREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK 202
                F  ++       I       D+                             +P  
Sbjct: 219 CGHAPFEAENEDDLFEAILN-----DEV---------------------------VYPTW 246

Query: 203 -SSGAVDLLEKMLVFDPNKRI------TVEEALRHPYLQSL--HDLNDEPVCPRPF 249
               A  +L+  +  +P  R+           LRHP+ + +    LN   + P PF
Sbjct: 247 LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEP-PF 301

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 79.6 bits (197), Expect = 1e-17
 Identities = 43/162 (26%), Positives = 76/162 (46%), Gaps = 26/162 (16%)

Query: 1   MEHENVIAIKDII-RPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQL 57
            +H +++ +  +I   P       V+I+ EL    +L   ++     L       + YQL
Sbjct: 73  FDHPHIVKLIGVITENP-------VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL 125

Query: 58  LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------- 110
              L Y+ S   +HRD+   N+L++++  +K+GDFGL+R   ++     Y          
Sbjct: 126 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST----YYKASKGKLPI 181

Query: 111 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 150
           +W  APE  +N   +T+A D+W  G  + EI+    +P F G
Sbjct: 182 KWM-APE-SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQG 220

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 79.2 bits (196), Expect = 2e-17
 Identities = 34/138 (24%), Positives = 65/138 (47%), Gaps = 18/138 (13%)

Query: 24  VYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 81
           +YIV E +    L   +RS  + L         Y +  G+ ++ S   +HRDL   N L+
Sbjct: 78  IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLV 137

Query: 82  NASCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSV 134
           +    +K+ DFG+ R   +     +YV +       +W  APE + +  +Y++  D+W+ 
Sbjct: 138 DRDLCVKVSDFGMTRYVLD----DQYVSSVGTKFPVKWS-APE-VFHYFKYSSKSDVWAF 191

Query: 135 GCILGEIMT--REPLFPG 150
           G ++ E+ +  + P +  
Sbjct: 192 GILMWEVFSLGKMP-YDL 208

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 79.2 bits (196), Expect = 2e-17
 Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 19/158 (12%)

Query: 1   MEHENVIAIKDII---RPPKKDTFNDVYIVYELMDT-DLHQIIRSD--QQLTDDHCQYFL 54
           + H N++ +  +I   +         +YIV E M    L   +RS     L  D    F 
Sbjct: 71  LRHSNLVQLLGVIVEEKGG-------LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS 123

Query: 55  YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYR 114
             +   ++Y+   + +HRDL   N+L++     K+ DFGL +  S T    +  V +W  
Sbjct: 124 LDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-KWT- 181

Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 150
           APE  L   +++   D+WS G +L EI +  R P +P 
Sbjct: 182 APE-ALREKKFSTKSDVWSFGILLWEIYSFGRVP-YPR 217

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 80.4 bits (199), Expect = 2e-17
 Identities = 41/158 (25%), Positives = 70/158 (44%), Gaps = 20/158 (12%)

Query: 3   HENVIAIKDII--RPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLL 58
           H N++ +  +   + P       +YIV EL+   D    +R+   +L        +    
Sbjct: 171 HPNIVRLIGVCTQKQP-------IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAA 223

Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT----RWYR 114
            G++Y+ S   +HRDL   N L+     LKI DFG++R  ++  +     +     +W  
Sbjct: 224 AGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT- 282

Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 150
           APE L     Y++  D+WS G +L E  +    P +P 
Sbjct: 283 APEALNYGR-YSSESDVWSFGILLWETFSLGASP-YPN 318

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 79.5 bits (197), Expect = 2e-17
 Identities = 48/221 (21%), Positives = 92/221 (41%), Gaps = 57/221 (25%)

Query: 29  ELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLK 88
           EL    +   +  +    +D   ++L ++   L ++H   +++RDLKP N++LN    +K
Sbjct: 107 ELF---MQ--LEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVK 161

Query: 89  IGDFGLARTTSETDFMT-------EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 141
           + DFGL + +     +T       EY+      APE+L+  + +  A+D WS+G ++ ++
Sbjct: 162 LTDFGLCKESIHDGTVTHTFCGTIEYM------APEILMR-SGHNRAVDWWSLGALMYDM 214

Query: 142 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN 201
           +T  P F G++    +  I              L+                       P 
Sbjct: 215 LTGAPPFTGENRKKTIDKI--------------LKCK------------------LNLPP 242

Query: 202 K-SSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSL 236
             +  A DLL+K+L  +   R+        E   HP+ + +
Sbjct: 243 YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 79.6 bits (197), Expect = 2e-17
 Identities = 50/247 (20%), Positives = 101/247 (40%), Gaps = 56/247 (22%)

Query: 34  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG 93
           DL   ++  ++L ++H +++  ++   L Y+H   +++RDLK  N+LL++   +K+ D+G
Sbjct: 96  DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG 155

Query: 94  LARTTSETDFMTEYVVTRW------YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL 147
           + +     + +     T        Y APE+L    +Y  ++D W++G ++ E+M     
Sbjct: 156 MCK-----EGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSP 209

Query: 148 FPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK-SSGA 206
           F                              N   Y+ Q+   ++     R P   S  A
Sbjct: 210 FDIVGSSDNPD-------------------QNTEDYLFQVILEKQ----IRIPRSLSVKA 246

Query: 207 VDLLEKMLVFDPNKRI------TVEEALRHPYLQSL--HDLNDEPVCPRPF--------- 249
             +L+  L  DP +R+         +   HP+ +++    +  + V P PF         
Sbjct: 247 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVP-PFKPNISGEFG 305

Query: 250 --HFDFE 254
             +FD +
Sbjct: 306 LDNFDSQ 312

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 78.8 bits (195), Expect = 2e-17
 Identities = 35/153 (22%), Positives = 71/153 (46%), Gaps = 19/153 (12%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLL 58
           +++  ++ +  +           + +V E+     LH+ +    +++   +    L+Q+ 
Sbjct: 67  LDNPYIVRLIGVC------QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 120

Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-------R 111
            G+KY+   + +HRDL   N+LL      KI DFGL++     D  + Y          +
Sbjct: 121 MGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD--SYYTARSAGKWPLK 178

Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR 144
           WY APE  +N  ++++  D+WS G  + E ++ 
Sbjct: 179 WY-APE-CINFRKFSSRSDVWSYGVTMWEALSY 209

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 79.3 bits (196), Expect = 3e-17
 Identities = 46/222 (20%), Positives = 100/222 (45%), Gaps = 52/222 (23%)

Query: 29  ELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLK 88
           EL     H  +   ++ T+   Q ++ +++  L+++H   +++RD+K  N+LL+++  + 
Sbjct: 145 ELF---TH--LSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVV 199

Query: 89  IGDFGLARTTSETDFMTEYVVTRW-------YRAPELLLNCTE-YTAAIDIWSVGCILGE 140
           + DFGL++     +F+ +     +       Y AP+++      +  A+D WS+G ++ E
Sbjct: 200 LTDFGLSK-----EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYE 254

Query: 141 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFP 200
           ++T    F      +    I+  I          L+S+                    +P
Sbjct: 255 LLTGASPFTVDGEKNSQAEISRRI----------LKSE------------------PPYP 286

Query: 201 NK-SSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSL 236
            + S+ A DL++++L+ DP KR+       +E   H + Q +
Sbjct: 287 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 79.7 bits (197), Expect = 3e-17
 Identities = 46/180 (25%), Positives = 78/180 (43%), Gaps = 17/180 (9%)

Query: 20  TFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 75
            F D   +Y +M+     DL  ++ +   + +   +++  +++  L  +HS   +HRD+K
Sbjct: 137 AFQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVK 195

Query: 76  PSNLLLNASCDLKIGDFGLA-RTTSETDFMTEYVV-TRWYRAPELLLNC---TEYTAAID 130
           P N+LL+ S  LK+ DFG   +   E     +  V T  Y +PE+L +      Y    D
Sbjct: 196 PDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECD 255

Query: 131 IWSVGCILGEIMTREPLFPGKDYVHQLRLI---TELIGSPDDASLGFLRSDNARRYVRQL 187
            WSVG  L E++  +  F     V     I      +  PDD  +    S  A+  +   
Sbjct: 256 WWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDI----SKEAKNLICAF 311

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 78.9 bits (195), Expect = 4e-17
 Identities = 48/175 (27%), Positives = 70/175 (40%), Gaps = 21/175 (12%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + HE++I  K         +   + +V E +    L   +     +       F  Q+  
Sbjct: 90  LYHEHIIKYKGCCEDAGAAS---LQLVMEYVPLGSLRDYLPR-HSIGLAQLLLFAQQICE 145

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-------RW 112
           G+ Y+H+   +HRDL   N+LL+    +KIGDFGLA+   E      Y V         W
Sbjct: 146 GMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH--EYYRVREDGDSPVFW 203

Query: 113 YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSP 167
           Y APE L     +  A D+WS G  L E++T                  ELIG  
Sbjct: 204 Y-APECLKEYK-FYYASDVWSFGVTLYELLTH-----CDSSQSPPTKFLELIGIA 251

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 78.7 bits (195), Expect = 4e-17
 Identities = 50/223 (22%), Positives = 90/223 (40%), Gaps = 61/223 (27%)

Query: 29  ELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLK 88
           +L        +  +   T++  +++L +L   L ++HS  +++RDLKP N+LL+    +K
Sbjct: 112 DLF---TR--LSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIK 166

Query: 89  IGDFGLARTTSETDFMT-------EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 141
           + DFGL++ + + +          EY+      APE++     +T + D WS G ++ E+
Sbjct: 167 LTDFGLSKESIDHEKKAYSFCGTVEYM------APEVVNR-RGHTQSADWWSFGVLMFEM 219

Query: 142 MTREPLFPGKDY--VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF 199
           +T    F GKD      + L  +L                                    
Sbjct: 220 LTGTLPFQGKDRKETMTMILKAKL----------------------------------GM 245

Query: 200 PNK-SSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSL 236
           P   S  A  LL  +   +P  R+      VEE  RH +  ++
Sbjct: 246 PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI 288

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 79.4 bits (196), Expect = 4e-17
 Identities = 53/218 (24%), Positives = 95/218 (43%), Gaps = 50/218 (22%)

Query: 29  ELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSNLLLNASCDL 87
           EL     H  +  ++  ++D  +++  +++  L Y+HS  +V++RDLK  NL+L+    +
Sbjct: 234 ELF---FH--LSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHI 288

Query: 88  KIGDFGLAR-TTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREP 146
           KI DFGL +    +   M  +  T  Y APE+L +  +Y  A+D W +G ++ E+M    
Sbjct: 289 KITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRL 347

Query: 147 LFPGKD--YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK-S 203
            F  +D   + +L L+ E+                                  RFP    
Sbjct: 348 PFYNQDHEKLFELILMEEI----------------------------------RFPRTLG 373

Query: 204 SGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSL 236
             A  LL  +L  DP +R+       +E ++H +   +
Sbjct: 374 PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 78.7 bits (195), Expect = 5e-17
 Identities = 51/227 (22%), Positives = 96/227 (42%), Gaps = 53/227 (23%)

Query: 20  TFNDVYIVYELMD----TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 75
           TF D   ++ +MD     +L  ++R  Q+  +   +++  ++   L+Y+HS  +++RDLK
Sbjct: 74  TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLK 133

Query: 76  PSNLLLNASCDLKIGDFGLARTTSETDFM----TEYVVTRWYRAPELLLNCTEYTAAIDI 131
           P N+LL+ +  +KI DFG A+   +  +      +Y+      APE++     Y  +ID 
Sbjct: 134 PENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYI------APEVVST-KPYNKSIDW 186

Query: 132 WSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCR 191
           WS G ++ E++     F   + +     I  L                            
Sbjct: 187 WSFGILIYEMLAGYTPFYDSNTMKTYEKI--LNAEL------------------------ 220

Query: 192 KQQFATRFPNK-SSGAVDLLEKMLVFDPNKRI-----TVEEALRHPY 232
                 RFP   +    DLL +++  D ++R+       E+   HP+
Sbjct: 221 ------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 261

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 78.9 bits (195), Expect = 6e-17
 Identities = 48/231 (20%), Positives = 97/231 (41%), Gaps = 45/231 (19%)

Query: 34  DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFG 93
           DL   ++  ++L ++H +++  ++   L Y+H   +++RDLK  N+LL++   +K+ D+G
Sbjct: 139 DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG 198

Query: 94  LARTTSETDFMTEYVVTRW------YRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL 147
           + +     + +     T        Y APE+L    +Y  ++D W++G ++ E+M     
Sbjct: 199 MCK-----EGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSP 252

Query: 148 FPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK-SSGA 206
           F                              N   Y+ Q+   ++     R P   S  A
Sbjct: 253 FDIVGSSDNPD-------------------QNTEDYLFQVILEKQ----IRIPRSLSVKA 289

Query: 207 VDLLEKMLVFDPNKRI------TVEEALRHPYLQSL--HDLNDEPVCPRPF 249
             +L+  L  DP +R+         +   HP+ +++    +  + V P PF
Sbjct: 290 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVP-PF 339

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 78.4 bits (194), Expect = 6e-17
 Identities = 44/238 (18%), Positives = 93/238 (39%), Gaps = 64/238 (26%)

Query: 29  ELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLK 88
           +LM    + I +  +   + H  ++  ++  GL ++ S  +++RDLK  N++L++   +K
Sbjct: 107 DLM----YHIQQVGR-FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIK 161

Query: 89  IGDFGLARTTSETDFMT-------EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 141
           I DFG+ +        T       +Y+      APE++     Y  ++D W+ G +L E+
Sbjct: 162 IADFGMCKENIWDGVTTKTFCGTPDYI------APEIIAY-QPYGKSVDWWAFGVLLYEM 214

Query: 142 MTREPLFPGKD--YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF 199
           +  +  F G+D   + Q  +   +                                   +
Sbjct: 215 LAGQAPFEGEDEDELFQSIMEHNV----------------------------------AY 240

Query: 200 PNK-SSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSL--HDLNDEPVCPRPF 249
           P   S  AV + + ++   P KR+        +   H + + +    L  + + P P+
Sbjct: 241 PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQP-PY 297

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 78.5 bits (194), Expect = 6e-17
 Identities = 40/128 (31%), Positives = 69/128 (53%), Gaps = 11/128 (8%)

Query: 24  VYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 81
           + I+ E M+   L + +R  D + +       L  +  G+KY+ + + +HRDL   N+L+
Sbjct: 121 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV 180

Query: 82  NASCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCTEYTAAIDIWSVG 135
           N++   K+ DFGL+R   E D    Y  +      RW  APE  ++  ++T+A D+WS G
Sbjct: 181 NSNLVCKVSDFGLSRVL-EDDPEATYTTSGGKIPIRWT-APE-AISYRKFTSASDVWSFG 237

Query: 136 CILGEIMT 143
            ++ E+MT
Sbjct: 238 IVMWEVMT 245

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 77.2 bits (191), Expect = 6e-17
 Identities = 31/138 (22%), Positives = 63/138 (45%), Gaps = 18/138 (13%)

Query: 24  VYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 81
           + +V E M+   L   +R+       +        +  G+ Y+  A V+HRDL   N L+
Sbjct: 78  ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV 137

Query: 82  NASCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSV 134
             +  +K+ DFG+ R   +     +Y  +       +W  +PE + + + Y++  D+WS 
Sbjct: 138 GENQVIKVSDFGMTRFVLD----DQYTSSTGTKFPVKWA-SPE-VFSFSRYSSKSDVWSF 191

Query: 135 GCILGEIMT--REPLFPG 150
           G ++ E+ +  + P +  
Sbjct: 192 GVLMWEVFSEGKIP-YEN 208

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 78.1 bits (193), Expect = 6e-17
 Identities = 34/162 (20%), Positives = 71/162 (43%), Gaps = 25/162 (15%)

Query: 1   MEHENVIAIKDII-RPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQL 57
           ++H +++ +  +            + +V + +    L   +R     L       +  Q+
Sbjct: 72  LDHAHIVRLLGLCPGSS-------LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI 124

Query: 58  LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------- 110
            +G+ Y+    ++HR+L   N+LL +   +++ DFG+A      D   + ++        
Sbjct: 125 AKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD---KQLLYSEAKTPI 181

Query: 111 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 150
           +W  A E  ++  +YT   D+WS G  + E+MT   EP + G
Sbjct: 182 KWM-ALE-SIHFGKYTHQSDVWSYGVTVWELMTFGAEP-YAG 220

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 77.7 bits (192), Expect = 6e-17
 Identities = 28/130 (21%), Positives = 49/130 (37%), Gaps = 13/130 (10%)

Query: 24  VYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 81
             +V E +    L   ++     +          QL   + ++   +++H ++   N+LL
Sbjct: 87  NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILL 146

Query: 82  NASCDL--------KIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWS 133
               D         K+ D G++ T    D + E +   W   PE + N      A D WS
Sbjct: 147 IREEDRKTGNPPFIKLSDPGISITVLPKDILQERI--PWV-PPECIENPKNLNLATDKWS 203

Query: 134 VGCILGEIMT 143
            G  L EI +
Sbjct: 204 FGTTLWEICS 213

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 78.1 bits (193), Expect = 7e-17
 Identities = 37/153 (24%), Positives = 65/153 (42%), Gaps = 20/153 (13%)

Query: 1   MEHENVIAIKDII-RPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQL 57
           +++ +V  +  I            V ++ +LM    L   +R     +   +   +  Q+
Sbjct: 74  VDNPHVCRLLGICLTST-------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 126

Query: 58  LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------R 111
            +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     +   EY         +
Sbjct: 127 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIK 184

Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR 144
           W  A E  +    YT   D+WS G  + E+MT 
Sbjct: 185 WM-ALE-SILHRIYTHQSDVWSYGVTVWELMTF 215

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 79.2 bits (195), Expect = 7e-17
 Identities = 34/153 (22%), Positives = 71/153 (46%), Gaps = 19/153 (12%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLL 58
           +++  ++ +  +           + +V E+     LH+ +    +++   +    L+Q+ 
Sbjct: 393 LDNPYIVRLIGVC------QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 446

Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-------R 111
            G+KY+   + +HR+L   N+LL      KI DFGL++     D  + Y          +
Sbjct: 447 MGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD--SYYTARSAGKWPLK 504

Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR 144
           WY APE  +N  ++++  D+WS G  + E ++ 
Sbjct: 505 WY-APE-CINFRKFSSRSDVWSYGVTMWEALSY 535

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 79.1 bits (195), Expect = 8e-17
 Identities = 37/129 (28%), Positives = 63/129 (48%), Gaps = 15/129 (11%)

Query: 24  VYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 81
           V+I+ EL    +L   ++     L       + YQL   L Y+ S   +HRD+   N+L+
Sbjct: 465 VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV 524

Query: 82  NASCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSV 134
           +++  +K+GDFGL+R   ++     Y          +W  APE  +N   +T+A D+W  
Sbjct: 525 SSNDCVKLGDFGLSRYMEDST----YYKASKGKLPIKWM-APE-SINFRRFTSASDVWMF 578

Query: 135 GCILGEIMT 143
           G  + EI+ 
Sbjct: 579 GVCMWEILM 587

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 78.9 bits (195), Expect = 8e-17
 Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 19/158 (12%)

Query: 1   MEHENVIAIKDII---RPPKKDTFNDVYIVYELMDT-DLHQIIRSD--QQLTDDHCQYFL 54
           + H N++ +  +I   +         +YIV E M    L   +RS     L  D    F 
Sbjct: 243 LRHSNLVQLLGVIVEEKGG-------LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS 295

Query: 55  YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYR 114
             +   ++Y+   + +HRDL   N+L++     K+ DFGL +  S T    +  V +W  
Sbjct: 296 LDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-KWT- 353

Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 150
           APE  L   +++   D+WS G +L EI +  R P +P 
Sbjct: 354 APE-ALREKKFSTKSDVWSFGILLWEIYSFGRVP-YPR 389

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 76.9 bits (190), Expect = 1e-16
 Identities = 35/138 (25%), Positives = 61/138 (44%), Gaps = 18/138 (13%)

Query: 24  VYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 81
           ++I+ E M    L   +R    +            +   ++Y+ S   LHRDL   N L+
Sbjct: 94  IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV 153

Query: 82  NASCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSV 134
           N    +K+ DFGL+R   +     EY  +       RW   PE+L+    +++  DIW+ 
Sbjct: 154 NDQGVVKVSDFGLSRYVLD----DEYTSSVGSKFPVRWS-PPEVLMYSK-FSSKSDIWAF 207

Query: 135 GCILGEIMT--REPLFPG 150
           G ++ EI +  + P +  
Sbjct: 208 GVLMWEIYSLGKMP-YER 224

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 78.1 bits (193), Expect = 1e-16
 Identities = 48/222 (21%), Positives = 88/222 (39%), Gaps = 60/222 (27%)

Query: 29  ELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLK 88
           EL     H  ++ ++   +   +++  ++   L Y+HS ++++RDLKP N+LL++   + 
Sbjct: 125 ELF---YH--LQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIV 179

Query: 89  IGDFGLARTTSETDFMT-------EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 141
           + DFGL +   E +  T       EY+      APE+L     Y   +D W +G +L E+
Sbjct: 180 LTDFGLCKENIEHNSTTSTFCGTPEYL------APEVLHK-QPYDRTVDWWCLGAVLYEM 232

Query: 142 MTREPLFPGKD--YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF 199
           +   P F  ++   ++   L   L                                  + 
Sbjct: 233 LYGLPPFYSRNTAEMYDNILNKPL----------------------------------QL 258

Query: 200 P-NKSSGAVDLLEKMLVFDPNKRI----TVEEALRHPYLQSL 236
             N ++ A  LLE +L  D  KR+       E   H +   +
Sbjct: 259 KPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI 300

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 77.3 bits (191), Expect = 1e-16
 Identities = 45/152 (29%), Positives = 71/152 (46%), Gaps = 14/152 (9%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLL 58
             H NV+++  I    +        +V   M   DL   IR+     T      F  Q+ 
Sbjct: 83  FSHPNVLSLLGICLRSE----GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVA 138

Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------RW 112
           +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + ++ + +  T      +W
Sbjct: 139 KGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 198

Query: 113 YRAPELLLNCTEYTAAIDIWSVGCILGEIMTR 144
             A E  L   ++T   D+WS G +L E+MTR
Sbjct: 199 M-ALE-SLQTQKFTTKSDVWSFGVLLWELMTR 228

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 76.9 bits (190), Expect = 1e-16
 Identities = 39/139 (28%), Positives = 64/139 (46%), Gaps = 19/139 (13%)

Query: 24  VYIVYELMDT-DLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
            YI+ E M   +L   +R    Q+++     Y   Q+   ++Y+   + +HRDL   N L
Sbjct: 84  FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 143

Query: 81  LNASCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWS 133
           +  +  +K+ DFGL+R     D    Y          +W  APE  L   +++   D+W+
Sbjct: 144 VGENHLVKVADFGLSRLM-TGD---TYTAHAGAKFPIKWT-APE-SLAYNKFSIKSDVWA 197

Query: 134 VGCILGEIMT--REPLFPG 150
            G +L EI T    P +PG
Sbjct: 198 FGVLLWEIATYGMSP-YPG 215

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 78.2 bits (193), Expect = 1e-16
 Identities = 48/162 (29%), Positives = 80/162 (49%), Gaps = 25/162 (15%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSD--QQLTDDHCQYFLYQL 57
           ++H+ ++ +  ++      T   +YI+ E M    L   ++SD   +        F  Q+
Sbjct: 240 LQHDKLVKLHAVV------TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI 293

Query: 58  LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT------- 110
             G+ ++   + +HRDL+ +N+L++AS   KI DFGLAR   +     EY          
Sbjct: 294 AEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED----NEYTAREGAKFPI 349

Query: 111 RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 150
           +W  APE  +N   +T   D+WS G +L EI+T  R P +PG
Sbjct: 350 KWT-APE-AINFGSFTIKSDVWSFGILLMEIVTYGRIP-YPG 388

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 76.9 bits (190), Expect = 1e-16
 Identities = 34/138 (24%), Positives = 63/138 (45%), Gaps = 18/138 (13%)

Query: 24  VYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 81
            +I+ EL    +L   +      L       +  Q+ + + Y+ S + +HRD+   N+L+
Sbjct: 87  TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILV 146

Query: 82  NASCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSV 134
            +   +K+GDFGL+R   + D    Y          +W  +PE  +N   +T A D+W  
Sbjct: 147 ASPECVKLGDFGLSRYIEDED----YYKASVTRLPIKWM-SPE-SINFRRFTTASDVWMF 200

Query: 135 GCILGEIMT--REPLFPG 150
              + EI++  ++P F  
Sbjct: 201 AVCMWEILSFGKQP-FFW 217

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 77.4 bits (191), Expect = 2e-16
 Identities = 43/128 (33%), Positives = 63/128 (49%), Gaps = 11/128 (8%)

Query: 24  VYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 81
           V IV E M+   L   +R  D Q T       L  +  G+KY+     +HRDL   N+L+
Sbjct: 121 VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI 180

Query: 82  NASCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCTEYTAAIDIWSVG 135
           N++   K+ DFGL R   E D    Y         RW  +PE  +   ++T+A D+WS G
Sbjct: 181 NSNLVCKVSDFGLGRVL-EDDPEAAYTTRGGKIPIRWT-SPE-AIAYRKFTSASDVWSYG 237

Query: 136 CILGEIMT 143
            +L E+M+
Sbjct: 238 IVLWEVMS 245

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 77.0 bits (190), Expect = 2e-16
 Identities = 39/128 (30%), Positives = 63/128 (49%), Gaps = 11/128 (8%)

Query: 24  VYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 81
             IV E M+   L   +R+ D Q T       L  +  G++Y+     +HRDL   N+L+
Sbjct: 125 AMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLV 184

Query: 82  NASCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCTEYTAAIDIWSVG 135
           +++   K+ DFGL+R   E D    Y  T      RW  APE  +    +++A D+WS G
Sbjct: 185 DSNLVCKVSDFGLSRVL-EDDPDAAYTTTGGKIPIRWT-APE-AIAFRTFSSASDVWSFG 241

Query: 136 CILGEIMT 143
            ++ E++ 
Sbjct: 242 VVMWEVLA 249

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 76.1 bits (188), Expect = 2e-16
 Identities = 41/135 (30%), Positives = 71/135 (52%), Gaps = 11/135 (8%)

Query: 24  VYIVYELMDT-DLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
           +YI+ E M+   L   +++    +LT +       Q+  G+ ++   + +HRDL+ +N+L
Sbjct: 82  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 141

Query: 81  LNASCDLKIGDFGLARTTSETDFMTEYVV---TRWYRAPELLLNCTEYTAAIDIWSVGCI 137
           ++ +   KI DFGLAR   + ++          +W  APE +   T +T   D+WS G +
Sbjct: 142 VSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT-APEAINYGT-FTIKSDVWSFGIL 199

Query: 138 LGEIMT--REPLFPG 150
           L EI+T  R P +PG
Sbjct: 200 LTEIVTHGRIP-YPG 213

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 77.5 bits (191), Expect = 2e-16
 Identities = 42/158 (26%), Positives = 73/158 (46%), Gaps = 17/158 (10%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQL 57
           + HE ++ +  ++      +   +YIV E M    L   ++ +  + L          Q+
Sbjct: 236 LRHEKLVQLYAVV------SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQI 289

Query: 58  LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYR 114
             G+ YV   + +HRDL+ +N+L+  +   K+ DFGLAR   + ++          +W  
Sbjct: 290 ASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT- 348

Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 150
           APE       +T   D+WS G +L E+ T  R P +PG
Sbjct: 349 APE-AALYGRFTIKSDVWSFGILLTELTTKGRVP-YPG 384

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 77.8 bits (191), Expect = 2e-16
 Identities = 45/238 (18%), Positives = 93/238 (39%), Gaps = 64/238 (26%)

Query: 29  ELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLK 88
           +LM    H  I+   +  + H  ++  ++  GL ++ S  +++RDLK  N++L++   +K
Sbjct: 428 DLM---YH--IQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIK 482

Query: 89  IGDFGLARTTSETDFMT-------EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI 141
           I DFG+ +        T       +Y+      APE++     Y  ++D W+ G +L E+
Sbjct: 483 IADFGMCKENIWDGVTTKTFCGTPDYI------APEIIAY-QPYGKSVDWWAFGVLLYEM 535

Query: 142 MTREPLFPGKD--YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF 199
           +  +  F G+D   + Q  +   +                                   +
Sbjct: 536 LAGQAPFEGEDEDELFQSIMEHNV----------------------------------AY 561

Query: 200 PNK-SSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQSL--HDLNDEPVCPRPF 249
           P   S  AV + + ++   P KR+        +   H + + +    L  + + P P+
Sbjct: 562 PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQP-PY 618

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 77.6 bits (191), Expect = 3e-16
 Identities = 42/158 (26%), Positives = 73/158 (46%), Gaps = 17/158 (10%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQL 57
           + HE ++ +  ++      +   +YIV E M    L   ++ +  + L          Q+
Sbjct: 319 LRHEKLVQLYAVV------SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQI 372

Query: 58  LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---RWYR 114
             G+ YV   + +HRDL+ +N+L+  +   K+ DFGLAR   + ++          +W  
Sbjct: 373 ASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT- 431

Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMT--REPLFPG 150
           APE       +T   D+WS G +L E+ T  R P +PG
Sbjct: 432 APE-AALYGRFTIKSDVWSFGILLTELTTKGRVP-YPG 467

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 76.3 bits (188), Expect = 4e-16
 Identities = 45/155 (29%), Positives = 70/155 (45%), Gaps = 20/155 (12%)

Query: 1   MEHENVIAIKDII---RPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLY 55
             H NV+++  I                +V   M   DL   IR+     T      F  
Sbjct: 147 FSHPNVLSLLGICLRSEGS-------PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL 199

Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT----- 110
           Q+ +G+K++ S   +HRDL   N +L+    +K+ DFGLAR   + +F + +  T     
Sbjct: 200 QVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 259

Query: 111 -RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR 144
            +W  A E  L   ++T   D+WS G +L E+MTR
Sbjct: 260 VKWM-ALE-SLQTQKFTTKSDVWSFGVLLWELMTR 292

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 76.3 bits (188), Expect = 7e-16
 Identities = 38/141 (26%), Positives = 65/141 (46%), Gaps = 19/141 (13%)

Query: 24  VYIVYELMDT-DLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL 80
            YI+ E M   +L   +R    Q+++     Y   Q+   ++Y+   + +HR+L   N L
Sbjct: 291 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCL 350

Query: 81  LNASCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWS 133
           +  +  +K+ DFGL+R  +       Y          +W  APE  L   +++   D+W+
Sbjct: 351 VGENHLVKVADFGLSRLMTG----DTYTAHAGAKFPIKWT-APE-SLAYNKFSIKSDVWA 404

Query: 134 VGCILGEIMT--REPLFPGKD 152
            G +L EI T    P +PG D
Sbjct: 405 FGVLLWEIATYGMSP-YPGID 424

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 74.2 bits (183), Expect = 1e-15
 Identities = 40/129 (31%), Positives = 63/129 (48%), Gaps = 10/129 (7%)

Query: 24  VYIVYELMDT-DLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL 81
            +++   M   DL Q IRS  +  T      F  Q+ RG++Y+     +HRDL   N +L
Sbjct: 98  PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCML 157

Query: 82  NASCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPELLLNCTEYTAAIDIWSVG 135
           + S  +K+ DFGLAR   + ++ +           +W  A E L     +T   D+WS G
Sbjct: 158 DESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT-ALESLQT-YRFTTKSDVWSFG 215

Query: 136 CILGEIMTR 144
            +L E++TR
Sbjct: 216 VLLWELLTR 224

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 75.0 bits (184), Expect = 1e-15
 Identities = 36/123 (29%), Positives = 60/123 (48%), Gaps = 12/123 (9%)

Query: 28  YELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDL 87
              ++ +          LT +H   + +Q+ +G++++ S   +HRDL   N+LL+    +
Sbjct: 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVV 232

Query: 88  KIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSVGCILGE 140
           KI DFGLAR   +     +YV         +W  APE + +   YT   D+WS G +L E
Sbjct: 233 KICDFGLARDIYKDP---DYVRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWE 287

Query: 141 IMT 143
           I +
Sbjct: 288 IFS 290

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 73.9 bits (182), Expect = 2e-15
 Identities = 39/139 (28%), Positives = 60/139 (43%), Gaps = 23/139 (16%)

Query: 24  VYIVYELMDT-DLHQIIRS----------DQQLTDDHCQYFLYQLLRGLKYVHSASVLHR 72
             ++ ELM   DL   +RS              +         ++  G+ Y+++   +HR
Sbjct: 103 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHR 162

Query: 73  DLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCTEY 125
           DL   N ++     +KIGDFG+ R   ETD+   Y          RW  +PE L +   +
Sbjct: 163 DLAARNCMVAEDFTVKIGDFGMTRDIYETDY---YRKGGKGLLPVRWM-SPESLKDGV-F 217

Query: 126 TAAIDIWSVGCILGEIMTR 144
           T   D+WS G +L EI T 
Sbjct: 218 TTYSDVWSFGVVLWEIATL 236

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 73.5 bits (181), Expect = 2e-15
 Identities = 37/157 (23%), Positives = 62/157 (39%), Gaps = 19/157 (12%)

Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS------DQQLTDDHCQYFL 54
            H NVI +  +             ++   M   DLH  +         + +       F+
Sbjct: 94  SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153

Query: 55  YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT---- 110
             +  G++Y+ + + LHRDL   N +L     + + DFGL++     D    Y       
Sbjct: 154 VDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD---YYRQGRIAK 210

Query: 111 ---RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR 144
              +W  A E L +   YT+  D+W+ G  + EI TR
Sbjct: 211 MPVKWI-AIESLAD-RVYTSKSDVWAFGVTMWEIATR 245

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 73.1 bits (180), Expect = 3e-15
 Identities = 40/158 (25%), Positives = 65/158 (41%), Gaps = 20/158 (12%)

Query: 2   EHENVIAIKDI-IRPPKKDTFNDVYIVYELMDT-DLHQIIRS------DQQLTDDHCQYF 53
           +H +V  +  + +R   K       ++   M   DLH  + +         L       F
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142

Query: 54  LYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT--- 110
           +  +  G++Y+ S + +HRDL   N +L     + + DFGL+R     D    Y      
Sbjct: 143 MVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD---YYRQGCAS 199

Query: 111 ----RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR 144
               +W  A E L +   YT   D+W+ G  + EIMTR
Sbjct: 200 KLPVKWL-ALESLAD-NLYTVHSDVWAFGVTMWEIMTR 235

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 71.5 bits (176), Expect = 1e-14
 Identities = 40/142 (28%), Positives = 62/142 (43%), Gaps = 27/142 (19%)

Query: 24  VYIVYELMDT-DLHQIIRS--------------DQQLTDDHCQYFLYQLLRGLKYVHSAS 68
           V ++ E     DL   +R               +   +     +F  Q+ +G+ ++ S +
Sbjct: 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN 184

Query: 69  VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLN 121
            +HRD+   N+LL      KIGDFGLAR          Y+V        +W  APE + +
Sbjct: 185 CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS---NYIVKGNARLPVKWM-APESIFD 240

Query: 122 CTEYTAAIDIWSVGCILGEIMT 143
           C  YT   D+WS G +L EI +
Sbjct: 241 CV-YTVQSDVWSYGILLWEIFS 261

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 71.0 bits (175), Expect = 2e-14
 Identities = 33/90 (36%), Positives = 49/90 (54%), Gaps = 9/90 (10%)

Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW-----Y 113
            G+ ++H    +HRD+K +N+LL+ +   KI DFGLAR + +       + +R      Y
Sbjct: 144 NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA--QTVMTSRIVGTTAY 201

Query: 114 RAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
            APE L    E T   DI+S G +L EI+T
Sbjct: 202 MAPEALRG--EITPKSDIYSFGVVLLEIIT 229

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 70.7 bits (174), Expect = 2e-14
 Identities = 42/146 (28%), Positives = 60/146 (41%), Gaps = 31/146 (21%)

Query: 24  VYIVYELM-DTDLHQIIRS------------------DQQLTDDHCQYFLYQLLRGLKYV 64
             ++ E     DL   +R                   +  L  +    F YQ+ +G+ ++
Sbjct: 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL 161

Query: 65  HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPE 117
            S + +HRDL   N+LL      KI DFGLAR          YVV        +W  APE
Sbjct: 162 ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS---NYVVKGNARLPVKWM-APE 217

Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMT 143
            + NC  YT   D+WS G  L E+ +
Sbjct: 218 SIFNCV-YTFESDVWSYGIFLWELFS 242

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 69.6 bits (171), Expect = 6e-14
 Identities = 42/143 (29%), Positives = 62/143 (43%), Gaps = 28/143 (19%)

Query: 24  VYIVYELMDT-DLHQIIRS---------------DQQLTDDHCQYFLYQLLRGLKYVHSA 67
           + +V+E M   DL++ +RS                  L          Q+  G+ Y+   
Sbjct: 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL 177

Query: 68  SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLL 120
             +HRDL   N L+     +KIGDFG++R    TD+   Y V        RW   PE +L
Sbjct: 178 HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY---YRVGGRTMLPIRWM-PPESIL 233

Query: 121 NCTEYTAAIDIWSVGCILGEIMT 143
              ++T   D+WS G +L EI T
Sbjct: 234 Y-RKFTTESDVWSFGVVLWEIFT 255

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 69.0 bits (169), Expect = 8e-14
 Identities = 24/203 (11%), Positives = 46/203 (22%), Gaps = 50/203 (24%)

Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGL 61
              V  + D++      T     +V E +    L ++  +    +       +  L    
Sbjct: 90  KPGVARVLDVV-----HTRAGGLVVAEWIRGGSLQEVADT--SPSPVGAIRAMQSLAAAA 142

Query: 62  KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 121
              H A V      PS + ++   D+ +                                
Sbjct: 143 DAAHRAGVALSIDHPSRVRVSIDGDVVLAYPATMPDA----------------------- 179

Query: 122 CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR-LITELIGSP------------- 167
                   DI  +G  L  ++      P       L     +  G P             
Sbjct: 180 ----NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQ 235

Query: 168 -DDASLGFLRSDNARRYVRQLPR 189
               +   ++ D   R    L  
Sbjct: 236 ISAVAARSVQGDGGIRSASTLLN 258

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 69.3 bits (170), Expect = 8e-14
 Identities = 39/137 (28%), Positives = 60/137 (43%), Gaps = 18/137 (13%)

Query: 14  RPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRD 73
           R    +   +      L + +   ++  +  L       F YQ+ +G++++   S +HRD
Sbjct: 144 REKFSEDEIEYENQKRLEEEEDLNVLTFEDLL------CFAYQVAKGMEFLEFKSCVHRD 197

Query: 74  LKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCTEYT 126
           L   N+L+     +KI DFGLAR          YVV        +W  APE L     YT
Sbjct: 198 LAARNVLVTHGKVVKICDFGLARDIMSDS---NYVVRGNARLPVKWM-APESLFEGI-YT 252

Query: 127 AAIDIWSVGCILGEIMT 143
              D+WS G +L EI +
Sbjct: 253 IKSDVWSYGILLWEIFS 269

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 68.9 bits (169), Expect = 1e-13
 Identities = 44/144 (30%), Positives = 68/144 (47%), Gaps = 29/144 (20%)

Query: 24  VYIVYELMDT-DLHQIIRS----------------DQQLTDDHCQYFLYQLLRGLKYVHS 66
           +Y++ E     +L + +R+                ++Q+T        YQL RG++Y+ S
Sbjct: 116 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 175

Query: 67  ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELL 119
              +HRDL   N+L+  +  +KI DFGLAR  +  D    Y  T       +W  APE L
Sbjct: 176 QKCIHRDLAARNVLVTENNVMKIADFGLARDINNID---YYKKTTNGRLPVKWM-APEAL 231

Query: 120 LNCTEYTAAIDIWSVGCILGEIMT 143
            +   YT   D+WS G ++ EI T
Sbjct: 232 FDRV-YTHQSDVWSFGVLMWEIFT 254

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 68.8 bits (169), Expect = 1e-13
 Identities = 43/160 (26%), Positives = 71/160 (44%), Gaps = 32/160 (20%)

Query: 24  VYIVYELMDT-DLHQIIRS----------------DQQLTDDHCQYFLYQLLRGLKYVHS 66
           + ++ E     +L   +RS                   LT +H   + +Q+ +G++++ S
Sbjct: 107 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS 166

Query: 67  ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELL 119
              +HRDL   N+LL+    +KI DFGLAR   +     +YV         +W  APE +
Sbjct: 167 RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP---DYVRKGDARLPLKWM-APETI 222

Query: 120 LNCTEYTAAIDIWSVGCILGEIMT--REPLFPGKDYVHQL 157
            +   YT   D+WS G +L EI +    P +PG     + 
Sbjct: 223 FDRV-YTIQSDVWSFGVLLWEIFSLGASP-YPGVKIDEEF 260

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 68.4 bits (168), Expect = 1e-13
 Identities = 34/144 (23%), Positives = 60/144 (41%), Gaps = 29/144 (20%)

Query: 24  VYIVYELMDT-DLHQIIRS----------------DQQLTDDHCQYFLYQLLRGLKYVHS 66
           + +++      DLH+ +                     L      + + Q+  G++Y+ S
Sbjct: 87  LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS 146

Query: 67  ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELL 119
             V+H+DL   N+L+    ++KI D GL R     D    Y +        RW  APE +
Sbjct: 147 HHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD---YYKLLGNSLLPIRWM-APEAI 202

Query: 120 LNCTEYTAAIDIWSVGCILGEIMT 143
           +    ++   DIWS G +L E+ +
Sbjct: 203 MYGK-FSIDSDIWSYGVVLWEVFS 225

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 68.0 bits (167), Expect = 2e-13
 Identities = 43/144 (29%), Positives = 67/144 (46%), Gaps = 29/144 (20%)

Query: 24  VYIVYELMDT-DLHQIIRS----------------DQQLTDDHCQYFLYQLLRGLKYVHS 66
           + +V+E M   DL++ +R+                  +L      +   Q+  G+ Y+ S
Sbjct: 92  LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS 151

Query: 67  ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELL 119
              +HRDL   N L+ A+  +KIGDFG++R    TD+   Y V        RW   PE +
Sbjct: 152 QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY---YRVGGHTMLPIRWM-PPESI 207

Query: 120 LNCTEYTAAIDIWSVGCILGEIMT 143
           +   ++T   D+WS G IL EI T
Sbjct: 208 MY-RKFTTESDVWSFGVILWEIFT 230

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 68.5 bits (168), Expect = 2e-13
 Identities = 44/144 (30%), Positives = 68/144 (47%), Gaps = 29/144 (20%)

Query: 24  VYIVYELMDT-DLHQIIRS----------------DQQLTDDHCQYFLYQLLRGLKYVHS 66
           +Y++ E     +L + +R+                ++Q+T        YQL RG++Y+ S
Sbjct: 162 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 221

Query: 67  ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELL 119
              +HRDL   N+L+  +  +KI DFGLAR  +  D    Y  T       +W  APE L
Sbjct: 222 QKCIHRDLAARNVLVTENNVMKIADFGLARDINNID---YYKKTTNGRLPVKWM-APEAL 277

Query: 120 LNCTEYTAAIDIWSVGCILGEIMT 143
            +   YT   D+WS G ++ EI T
Sbjct: 278 FDRV-YTHQSDVWSFGVLMWEIFT 300

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 68.5 bits (168), Expect = 2e-13
 Identities = 43/144 (29%), Positives = 66/144 (45%), Gaps = 29/144 (20%)

Query: 24  VYIVYELMDT-DLHQIIRS----------------DQQLTDDHCQYFLYQLLRGLKYVHS 66
           +Y++ E     +L + +++                ++QL+        YQ+ RG++Y+ S
Sbjct: 150 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS 209

Query: 67  ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELL 119
              +HRDL   N+L+     +KI DFGLAR     D    Y  T       +W  APE L
Sbjct: 210 KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID---YYKKTTNGRLPVKWM-APEAL 265

Query: 120 LNCTEYTAAIDIWSVGCILGEIMT 143
            +   YT   D+WS G +L EI T
Sbjct: 266 FDRI-YTHQSDVWSFGVLLWEIFT 288

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 67.7 bits (166), Expect = 3e-13
 Identities = 36/138 (26%), Positives = 53/138 (38%), Gaps = 23/138 (16%)

Query: 24  VYIVYELMDT-DLHQIIRS-------DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 75
            +I+ ELM   DL   +R           L      +    +  G +Y+     +HRD+ 
Sbjct: 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIA 167

Query: 76  PSNLLLNASCD---LKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCTEY 125
             N LL         KIGDFG+AR      +   Y          +W   PE  +    +
Sbjct: 168 ARNCLLTCPGPGRVAKIGDFGMARDIYRASY---YRKGGCAMLPVKWM-PPEAFME-GIF 222

Query: 126 TAAIDIWSVGCILGEIMT 143
           T+  D WS G +L EI +
Sbjct: 223 TSKTDTWSFGVLLWEIFS 240

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 67.8 bits (166), Expect = 4e-13
 Identities = 36/138 (26%), Positives = 53/138 (38%), Gaps = 23/138 (16%)

Query: 24  VYIVYELMDT-DLHQIIRS-------DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK 75
            +I+ ELM   DL   +R           L      +    +  G +Y+     +HRD+ 
Sbjct: 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIA 208

Query: 76  PSNLLLNASCD---LKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCTEY 125
             N LL         KIGDFG+AR      +   Y          +W   PE  +    +
Sbjct: 209 ARNCLLTCPGPGRVAKIGDFGMARDIYRAGY---YRKGGCAMLPVKWM-PPEAFMEGI-F 263

Query: 126 TAAIDIWSVGCILGEIMT 143
           T+  D WS G +L EI +
Sbjct: 264 TSKTDTWSFGVLLWEIFS 281

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 65.7 bits (161), Expect = 1e-12
 Identities = 37/110 (33%), Positives = 56/110 (50%), Gaps = 12/110 (10%)

Query: 41  SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE 100
            ++ LT      F +Q+ +G++Y+    ++HRDL   N+L+     +KI DFGL+R   E
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202

Query: 101 TDFMTEYVVT-------RWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
            D    YV         +W  A E L +   YT   D+WS G +L EI+T
Sbjct: 203 ED---SYVKRSQGRIPVKWM-AIESLFDHI-YTTQSDVWSFGVLLWEIVT 247

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 65.3 bits (160), Expect = 2e-12
 Identities = 32/95 (33%), Positives = 50/95 (52%), Gaps = 16/95 (16%)

Query: 59  RGLKYVHSAS---VLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW--- 112
           RGL Y+H      ++HRD+K +N+LL+   +  +GDFGLA+     D    +V T     
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD---THVTTAVRGT 198

Query: 113 --YRAPELLLN--CTEYTAAIDIWSVGCILGEIMT 143
             + APE L     +E T   D++  G +L E++T
Sbjct: 199 IGHIAPEYLSTGKSSEKT---DVFGYGVMLLELIT 230

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 65.4 bits (160), Expect = 2e-12
 Identities = 39/144 (27%), Positives = 58/144 (40%), Gaps = 32/144 (22%)

Query: 24  VYIVYELMDT-DLHQIIRS----------------DQQLTDDHCQYFLYQLLRGLKYVHS 66
           +Y+  E     +L   +R                    L+     +F   + RG+ Y+  
Sbjct: 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ 160

Query: 67  ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELL 119
              +HRDL   N+L+  +   KI DFGL+R          YV         RW  A E  
Sbjct: 161 KQFIHRDLAARNILVGENYVAKIADFGLSRGQE------VYVKKTMGRLPVRWM-AIE-S 212

Query: 120 LNCTEYTAAIDIWSVGCILGEIMT 143
           LN + YT   D+WS G +L EI++
Sbjct: 213 LNYSVYTTNSDVWSYGVLLWEIVS 236

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 64.5 bits (158), Expect = 4e-12
 Identities = 31/106 (29%), Positives = 52/106 (49%), Gaps = 21/106 (19%)

Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRW-----Y 113
           RGL Y+H+ +++HRD+K  N+LL+ +   KI DFG+++  +E D    ++ T       Y
Sbjct: 150 RGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELD--QTHLSTVVKGTLGY 207

Query: 114 RAPELLLNCTEY------TAAIDIWSVGCILGEIMT-REPLFPGKD 152
             P       EY      T   D++S G +L E++  R  +     
Sbjct: 208 IDP-------EYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP 246

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 62.7 bits (153), Expect = 2e-11
 Identities = 37/152 (24%), Positives = 58/152 (38%), Gaps = 37/152 (24%)

Query: 24  VYIVYELMDT-DLHQIIRS------------------------DQQLTDDHCQYFLYQLL 58
           + +++E M   DL++ +RS                           L+         Q+ 
Sbjct: 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVA 184

Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVT-------R 111
            G+ Y+     +HRDL   N L+  +  +KI DFGL+R     D    Y          R
Sbjct: 185 AGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD---YYKADGNDAIPIR 241

Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT 143
           W   PE +     YT   D+W+ G +L EI +
Sbjct: 242 WM-PPESIFYNR-YTTESDVWAYGVVLWEIFS 271

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 57.2 bits (137), Expect = 1e-09
 Identities = 23/137 (16%), Positives = 47/137 (34%), Gaps = 14/137 (10%)

Query: 15  PPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRD 73
            P     + ++IV E     +       +  +    +  L+QL   L    ++    HRD
Sbjct: 128 RPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRD 187

Query: 74  LKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWS 133
           L   N+LL  +   K+      ++++                  L ++  +YT +     
Sbjct: 188 LHWGNVLLKKTSLKKLHYTLNGKSSTIPSC-------------GLQVSIIDYTLSRLERD 234

Query: 134 VGCILGEIMTREPLFPG 150
              +  ++   E LF G
Sbjct: 235 GIVVFCDVSMDEDLFTG 251

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 52.4 bits (126), Expect = 4e-08
 Identities = 19/74 (25%), Positives = 35/74 (47%), Gaps = 2/74 (2%)

Query: 25  YIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNAS 84
           ++V E +  DL +I   +             ++L  L+Y+H    +H D+K +NLLL   
Sbjct: 128 FMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYK 187

Query: 85  CDLKI--GDFGLAR 96
              ++   D+GL+ 
Sbjct: 188 NPDQVYLADYGLSY 201

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 48.6 bits (116), Expect = 9e-07
 Identities = 17/43 (39%), Positives = 26/43 (60%), Gaps = 2/43 (4%)

Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKI--GDFGLAR 96
           ++L  L+Y+H    +H D+K SNLLLN     ++   D+GLA 
Sbjct: 160 RILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 48.1 bits (115), Expect = 1e-06
 Identities = 17/46 (36%), Positives = 28/46 (60%), Gaps = 5/46 (10%)

Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLL-----NASCDLKIGDFGLAR 96
           QL+  ++YVHS ++++RD+KP N L+          + I DF LA+
Sbjct: 113 QLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 48.2 bits (115), Expect = 1e-06
 Identities = 8/43 (18%), Positives = 21/43 (48%), Gaps = 2/43 (4%)

Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKI--GDFGLAR 96
           +LL  L+++H    +H ++   N+ ++     ++    +G A 
Sbjct: 167 RLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 46.6 bits (111), Expect = 3e-06
 Identities = 21/76 (27%), Positives = 38/76 (50%), Gaps = 4/76 (5%)

Query: 25  YIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 83
            +V EL+   L  +     ++ +         Q++  ++Y+HS + +HRD+KP N L+  
Sbjct: 81  VMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGL 140

Query: 84  SCD---LKIGDFGLAR 96
                 + I DFGLA+
Sbjct: 141 GKKGNLVYIIDFGLAK 156

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 46.6 bits (111), Expect = 3e-06
 Identities = 13/46 (28%), Positives = 25/46 (54%), Gaps = 5/46 (10%)

Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLK-----IGDFGLAR 96
           Q+L  ++ +H  S+++RD+KP N L+            + DFG+ +
Sbjct: 114 QMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 45.4 bits (107), Expect = 1e-05
 Identities = 23/76 (30%), Positives = 39/76 (51%), Gaps = 4/76 (5%)

Query: 25  YIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA 83
            +V +L+   L  +     ++L+         Q++  +++VHS S LHRD+KP N L+  
Sbjct: 79  VLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 138

Query: 84  SCD---LKIGDFGLAR 96
                 + I DFGLA+
Sbjct: 139 GRRANQVYIIDFGLAK 154

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	280
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.87
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.63
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.52
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.31
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	98.78
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.53
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.51
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.5
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	98.09
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	97.81
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	97.69
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	97.62
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	97.06
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.02
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	96.46
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	95.93
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	95.93
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	95.44
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	93.74
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	93.48
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	93.35
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	92.98
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	91.61
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	90.87
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	90.05
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	89.5
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	89.48
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	88.48
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	87.97
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	86.03
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	85.51
3mes_A	424	Choline kinase; malaria, structural genomics, stru	83.5

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.1e-62  Score=422.76  Aligned_cols=276  Identities=53%  Similarity=0.976  Sum_probs=245.2

Q ss_pred             CCCcccccccccccCCCC-CCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~-~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+|||||++++++..... ....++|||||||+|+|.+++.+.+.+++.+++.+++||+.||.|||++||+||||||+||
T Consensus       110 l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NI  189 (398)
T 4b99_A          110 FKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNL  189 (398)
T ss_dssp             CCCTTBCCEEEECCCSSCTTTCCCEEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGE
T ss_pred             cCCCCcceEeeeeecccccccCCEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCcccc
Confidence            689999999999876521 2226799999999999999999889999999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC-----CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023568           80 LLNASCDLKIGDFGLARTTSET-----DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV  154 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~  154 (280)
                      |++.++.+||+|||+++.....     ....+.+||+.|+|||++.+...++.++||||+||++|||++|++||.+.+..
T Consensus       190 l~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~  269 (398)
T 4b99_A          190 LVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV  269 (398)
T ss_dssp             EECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH
T ss_pred             ccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH
Confidence            9999999999999999864322     23456799999999999988678899999999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ  234 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~  234 (280)
                      +++..|....+.++...+..........++..++......+...++..++++++||++||+.||.+|||++|+|+||||+
T Consensus       270 ~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~  349 (398)
T 4b99_A          270 HQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLA  349 (398)
T ss_dssp             HHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGT
T ss_pred             HHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhC
Confidence            99999999999999988877777777788888888777778888899999999999999999999999999999999999


Q ss_pred             cCcCCCCCCCCCCCCCCccCCCCCCHHHHHHHHHHHHHhhCC
Q 023568          235 SLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP  276 (280)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (280)
                      ..+++..++.+..+++.+++....+.+++++.+++|+.+|++
T Consensus       350 ~~~~p~~~p~~~~~~~~~~~~~~~~~~~~k~~i~~ei~~~~~  391 (398)
T 4b99_A          350 KYHDPDDEPDCAPPFDFAFDREALTRERIKEAIVAEIEDFHA  391 (398)
T ss_dssp             TTCCGGGSCCCSSCCCCHHHHSCCCHHHHHHHHHHHHHHHHH
T ss_pred             cCCCCccccCCCCCCCCccchhhcCHHHHHHHHHHHHHHHHH
Confidence            999988888888888888888889999999999999998864

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.7e-57  Score=375.68  Aligned_cols=199  Identities=27%  Similarity=0.525  Sum_probs=167.1

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      |+|||||+++++|+++     +.+|+|||||+|+|.+++.+.+++++.+++.++.||+.||+|||++||+||||||+|||
T Consensus        70 l~HpnIv~~~~~~~~~-----~~~~ivmEy~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NIL  144 (275)
T 3hyh_A           70 LRHPHIIKLYDVIKSK-----DEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLL  144 (275)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEEECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEE
T ss_pred             CCCCCCCeEEEEEEEC-----CEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeE
Confidence            6899999999999988     78999999999999999998899999999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 023568           81 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  160 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~i  160 (280)
                      ++.++.+||+|||+|+.........+.+||+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+.......+
T Consensus       145 l~~~~~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i  224 (275)
T 3hyh_A          145 LDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNI  224 (275)
T ss_dssp             ECTTCCEEECCSSCC---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             ECCCCCEEEeecCCCeecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            99999999999999988776666677899999999999988556678999999999999999999999998776666655


Q ss_pred             HHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 023568          161 TELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  235 (280)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~  235 (280)
                      ....                               ...+..+|+++++||++||+.||++|||++|+++||||+.
T Consensus       225 ~~~~-------------------------------~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          225 SNGV-------------------------------YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             HHTC-------------------------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             HcCC-------------------------------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence            4311                               0112357999999999999999999999999999999964

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.1e-56  Score=375.87  Aligned_cols=200  Identities=28%  Similarity=0.479  Sum_probs=177.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+|||||+++++|+++     +.+|||||||+ |+|.+++++.+.+++.+++.++.||+.||+|||++||+||||||+||
T Consensus        89 l~HpnIv~l~~~~~~~-----~~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNI  163 (311)
T 4aw0_A           89 LDHPFFVKLYFTFQDD-----EKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENI  163 (311)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             CCCCCCCeEEEEEEeC-----CEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHe
Confidence            6899999999999988     78999999997 59999999889999999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC---CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSET---DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  156 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~  156 (280)
                      |++.++.+||+|||+|+.....   ....+.+||+.|+|||++.+ ..++.++|+||+||++|+|++|++||.+.+....
T Consensus       164 Ll~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~  242 (311)
T 4aw0_A          164 LLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLI  242 (311)
T ss_dssp             EECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHH-SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             EEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            9999999999999999875432   33456799999999999987 7789999999999999999999999999887777


Q ss_pred             HHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHH------HhcC
Q 023568          157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEE------ALRH  230 (280)
Q Consensus       157 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~e------ll~h  230 (280)
                      ..+|.+..                               ...+..+++++++||++||+.||++|||++|      +++|
T Consensus       243 ~~~i~~~~-------------------------------~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~H  291 (311)
T 4aw0_A          243 FAKIIKLE-------------------------------YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAH  291 (311)
T ss_dssp             HHHHHHTC-------------------------------CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTS
T ss_pred             HHHHHcCC-------------------------------CCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCC
Confidence            77665411                               0112357999999999999999999999988      5899


Q ss_pred             cccccCc
Q 023568          231 PYLQSLH  237 (280)
Q Consensus       231 p~~~~~~  237 (280)
                      |||+++.
T Consensus       292 p~F~~id  298 (311)
T 4aw0_A          292 PFFESVT  298 (311)
T ss_dssp             GGGTTCC
T ss_pred             CCcCCCC
Confidence            9998763

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=3.5e-56  Score=378.07  Aligned_cols=202  Identities=26%  Similarity=0.506  Sum_probs=177.5

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+|||||+++++|+++     +.+|||||||+ |+|.+++.+ +++++.+++.++.||+.||+|||++||+||||||+||
T Consensus       128 l~HpnIV~l~~~~~~~-----~~~~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NI  201 (346)
T 4fih_A          128 YQHENVVEMYNSYLVG-----DELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSI  201 (346)
T ss_dssp             CCCTTBCCEEEEEEET-----TEEEEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             CCCCCCCcEEEEEEEC-----CEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHE
Confidence            6899999999999988     78999999998 599999876 6799999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      |++.+|.+||+|||+++..... ....+.+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+.
T Consensus       202 Ll~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~  280 (346)
T 4fih_A          202 LLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK  280 (346)
T ss_dssp             EECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred             EECCCCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH
Confidence            9999999999999999876543 44567899999999999877 778999999999999999999999999988777776


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  237 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~  237 (280)
                      .+......                            ....+..+++++++||++||+.||++|||++|+|+||||+...
T Consensus       281 ~i~~~~~~----------------------------~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~  331 (346)
T 4fih_A          281 MIRDNLPP----------------------------RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  331 (346)
T ss_dssp             HHHHSSCC----------------------------CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHHcCCCC----------------------------CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence            66542110                            0112235799999999999999999999999999999998753

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=5.3e-56  Score=371.56  Aligned_cols=199  Identities=26%  Similarity=0.461  Sum_probs=176.1

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+|||||+++++|+++     +.+|||||||+ |+|.+++.+.+.+++.+++.++.||+.||+|||++||+||||||+||
T Consensus        83 l~HpnIv~l~~~~~~~-----~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NI  157 (304)
T 3ubd_A           83 VNHPFIVKLHYAFQTE-----GKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENI  157 (304)
T ss_dssp             CCCTTEECEEEEEEET-----TEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGE
T ss_pred             CCCCCCCeEEEEEEEC-----CEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHe
Confidence            6899999999999988     77999999997 59999999889999999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCC-CCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSE-TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      |++.++.+||+|||+|+.... .....+.+||+.|+|||++.+ ..++.++|+||+||++|+|++|++||.+.+..+...
T Consensus       158 Ll~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~  236 (304)
T 3ubd_A          158 LLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMT  236 (304)
T ss_dssp             EECTTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             EEcCCCCEEecccccceeccCCCccccccccCcccCCHHHhcc-CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHH
Confidence            999999999999999986543 344567889999999999987 788999999999999999999999999998877777


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCccc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT-----VEEALRHPYL  233 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt-----~~ell~hp~~  233 (280)
                      .+.+..                               ...+..+|+++++||++||+.||++|||     ++|+++||||
T Consensus       237 ~i~~~~-------------------------------~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f  285 (304)
T 3ubd_A          237 MILKAK-------------------------------LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF  285 (304)
T ss_dssp             HHHHCC-------------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGG
T ss_pred             HHHcCC-------------------------------CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccc
Confidence            665411                               0112357999999999999999999998     5899999999


Q ss_pred             ccC
Q 023568          234 QSL  236 (280)
Q Consensus       234 ~~~  236 (280)
                      +++
T Consensus       286 ~~i  288 (304)
T 3ubd_A          286 STI  288 (304)
T ss_dssp             TTC
T ss_pred             cCC
Confidence            876

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=6.4e-55  Score=378.98  Aligned_cols=202  Identities=26%  Similarity=0.505  Sum_probs=177.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+|||||+++++|+++     +.+|||||||+ |+|.++++. +++++.+++.++.||+.||+|||++||+||||||+||
T Consensus       205 l~HpnIV~l~~~~~~~-----~~~~iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NI  278 (423)
T 4fie_A          205 YQHENVVEMYNSYLVG-----DELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSI  278 (423)
T ss_dssp             CCCTTBCCEEEEEEET-----TEEEEEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTE
T ss_pred             CCCCCCCceEEEEEEC-----CEEEEEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHE
Confidence            6899999999999988     78999999998 599999875 6799999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      |++.+|.+||+|||+|+..... ....+.+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+.
T Consensus       279 Ll~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~  357 (423)
T 4fie_A          279 LLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK  357 (423)
T ss_dssp             EECTTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred             EEcCCCCEEEecCccceECCCCCccccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH
Confidence            9999999999999999876543 44567899999999999987 778999999999999999999999999988777776


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  237 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~  237 (280)
                      .+.....                            .....+..+++++++||.+||+.||.+|||++|+|+||||+...
T Consensus       358 ~i~~~~~----------------------------~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~  408 (423)
T 4fie_A          358 MIRDNLP----------------------------PRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  408 (423)
T ss_dssp             HHHHSCC----------------------------CCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHHcCCC----------------------------CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence            6654211                            01112346799999999999999999999999999999998743

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2.7e-55  Score=371.59  Aligned_cols=205  Identities=23%  Similarity=0.326  Sum_probs=174.0

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+|||||+++++|+++     +.+|||||||+ |+|.++|++.+.+++.+++.++.||+.||+|||++||+||||||+||
T Consensus       107 l~HpnIV~l~~~~~~~-----~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NI  181 (336)
T 4g3f_A          107 LSSPRIVPLYGAVREG-----PWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNV  181 (336)
T ss_dssp             CCCTTBCCEEEEEEET-----TEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGE
T ss_pred             CCCCCCCcEEEEEEEC-----CEEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHE
Confidence            6899999999999987     77999999998 59999999888999999999999999999999999999999999999


Q ss_pred             EEcCCC-CeEEeecccccccCCCCc------cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 023568           80 LLNASC-DLKIGDFGLARTTSETDF------MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD  152 (280)
Q Consensus        80 li~~~~-~~kl~dfg~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~  152 (280)
                      |++.+| .+||+|||+|+.......      ....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+
T Consensus       182 Ll~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~  260 (336)
T 4g3f_A          182 LLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYF  260 (336)
T ss_dssp             EECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSTTTC
T ss_pred             EEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCC
Confidence            999987 699999999987544321      233579999999999988 778999999999999999999999998876


Q ss_pred             hHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHH-----
Q 023568          153 YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA-----  227 (280)
Q Consensus       153 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~el-----  227 (280)
                      ......++...                            ..+....++.+++.+.+||++||+.||.+|||+.|+     
T Consensus       261 ~~~~~~~i~~~----------------------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~  312 (336)
T 4g3f_A          261 RGPLCLKIASE----------------------------PPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVG  312 (336)
T ss_dssp             CSCCHHHHHHS----------------------------CCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHHHcC----------------------------CCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHH
Confidence            54444444331                            111223456789999999999999999999999997     


Q ss_pred             --------hcCcccccCcCC
Q 023568          228 --------LRHPYLQSLHDL  239 (280)
Q Consensus       228 --------l~hp~~~~~~~~  239 (280)
                              |+|||+....++
T Consensus       313 ~~l~~~~~l~hPw~~~~~~P  332 (336)
T 4g3f_A          313 KALQEVGGLKSPWKGEYKEP  332 (336)
T ss_dssp             HHHHHTTSSCSCSSSSCCCC
T ss_pred             HHHhhhhhccCCCcCCCCCC
Confidence                    579999887654

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.9e-55  Score=374.14  Aligned_cols=199  Identities=26%  Similarity=0.477  Sum_probs=175.4

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      |+|||||+++++|+++     +.+|||||||+ |+|.++|...  ..+++.+++.++.||+.||+|||++||+||||||+
T Consensus        80 l~HpnIV~~~~~~~~~-----~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~  154 (350)
T 4b9d_A           80 MKHPNIVQYRESFEEN-----GSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQ  154 (350)
T ss_dssp             CCCTTBCCEEEEEEET-----TEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGG
T ss_pred             CCCCCCCcEEEEEEEC-----CEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHH
Confidence            6899999999999988     77999999997 5999999654  45799999999999999999999999999999999


Q ss_pred             ceEEcCCCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023568           78 NLLLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  156 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~  156 (280)
                      |||++.+|.+||+|||+|+..... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.
T Consensus       155 NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~  233 (350)
T 4b9d_A          155 NIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL  233 (350)
T ss_dssp             GEEECTTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             HEEECCCCCEEEcccccceeecCCcccccccCCCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH
Confidence            999999999999999999876543 23345789999999999987 7789999999999999999999999999987777


Q ss_pred             HHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 023568          157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  235 (280)
Q Consensus       157 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~  235 (280)
                      +.++....                              ++.....+|+++++||.+||+.||.+|||++|+|+||||+.
T Consensus       234 ~~~i~~~~------------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  282 (350)
T 4b9d_A          234 VLKIISGS------------------------------FPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK  282 (350)
T ss_dssp             HHHHHHTC------------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred             HHHHHcCC------------------------------CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence            76665411                              11223467999999999999999999999999999999975

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.2e-54  Score=361.59  Aligned_cols=203  Identities=22%  Similarity=0.372  Sum_probs=168.0

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS--VLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~--i~H~dik~~   77 (280)
                      |+|||||+++++|++... +...+|||||||+ |+|.+++.+.+.+++..++.++.||+.||+|||++|  |+||||||+
T Consensus        82 l~HpnIV~~~~~~~~~~~-~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~  160 (290)
T 3fpq_A           82 LQHPNIVRFYDSWESTVK-GKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCD  160 (290)
T ss_dssp             CCCTTBCCEEEEEEEEET-TEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGG
T ss_pred             CCCCCCCcEEEEEeeccC-CCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChh
Confidence            689999999999976311 1156899999997 599999998889999999999999999999999998  999999999


Q ss_pred             ceEEcC-CCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023568           78 NLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  156 (280)
Q Consensus        78 Nili~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~  156 (280)
                      |||++. ++.+||+|||+|+.... ....+.+||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+.+....
T Consensus       161 NILl~~~~g~vKl~DFGla~~~~~-~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~  237 (290)
T 3fpq_A          161 NIFITGPTGSVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ  237 (290)
T ss_dssp             GEEESSTTSCEEECCTTGGGGCCT-TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH
T ss_pred             heeEECCCCCEEEEeCcCCEeCCC-CccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH
Confidence            999975 79999999999986443 33456789999999999865  589999999999999999999999987665443


Q ss_pred             HHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 023568          157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  235 (280)
Q Consensus       157 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~  235 (280)
                      +.......  ..+                          .......++++.+||.+||+.||++|||++|+|+||||++
T Consensus       238 ~~~~i~~~--~~~--------------------------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          238 IYRRVTSG--VKP--------------------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHTTT--CCC--------------------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHHHcC--CCC--------------------------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence            33221100  000                          1112356889999999999999999999999999999975

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=4.7e-53  Score=373.35  Aligned_cols=278  Identities=38%  Similarity=0.752  Sum_probs=240.4

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      |+||||+++++++.......+..+|+||||++|+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||
T Consensus        82 l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NIL  161 (432)
T 3n9x_A           82 LKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCL  161 (432)
T ss_dssp             CCCTTBCCEEEECCCSCTTTCCCEEEEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred             cCCCCcceEEEEEecCCCCcCCeEEEEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeE
Confidence            68999999999998775445567999999999999999998888999999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccccCCCC-----------------------ccccceeccccccccccccCCCCCcchhHHHHHHH
Q 023568           81 LNASCDLKIGDFGLARTTSETD-----------------------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCI  137 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~~~~-----------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~  137 (280)
                      ++.++.+||+|||+++......                       ......||++|+|||++.+...++.++||||+||+
T Consensus       162 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~i  241 (432)
T 3n9x_A          162 LNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCI  241 (432)
T ss_dssp             ECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHH
T ss_pred             ECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHH
Confidence            9999999999999998654331                       23567889999999997665789999999999999


Q ss_pred             HHHHHh-----------CCCCCCCCC-----------------hHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCc
Q 023568          138 LGEIMT-----------REPLFPGKD-----------------YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPR  189 (280)
Q Consensus       138 l~~ll~-----------g~~pf~~~~-----------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (280)
                      +|+|++           |.++|.+.+                 ..+++..+...+|.++...+..........++...+.
T Consensus       242 l~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~  321 (432)
T 3n9x_A          242 FAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPH  321 (432)
T ss_dssp             HHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCC
T ss_pred             HHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCC
Confidence            999997           556666654                 3678889999999999999888888888888888888


Q ss_pred             cccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCcCCCCCCCCCCCCCCccCC-CCCCHHHHHHHHH
Q 023568          190 CRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEH-SSCTEDHIRELIW  268 (280)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  268 (280)
                      .........++..++.+.+||++||+.||.+|||++|+|+||||++++....++.+..++...++. ...+.+++|+.++
T Consensus       322 ~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~  401 (432)
T 3n9x_A          322 RKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILPFDDWMVLSETQLRYIFL  401 (432)
T ss_dssp             CCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC---CCCCCCSSCTTCCCCHHHHHHHHH
T ss_pred             CCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcccCcCCCCCCCCChhhcccCCHHHHHHHHH
Confidence            777777888889999999999999999999999999999999999999888887777666666654 5789999999999


Q ss_pred             HHHHhhCCCC
Q 023568          269 RESVKFNPDP  278 (280)
Q Consensus       269 ~~~~~~~~~~  278 (280)
                      +|+.+|+|..
T Consensus       402 ~e~~~~~~~~  411 (432)
T 3n9x_A          402 KEVQSFHPEL  411 (432)
T ss_dssp             HHHHHHCTTC
T ss_pred             HHHHHhCccc
Confidence            9999999864

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=5.5e-53  Score=375.71  Aligned_cols=278  Identities=41%  Similarity=0.799  Sum_probs=239.1

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      |+|||||++++++..........+|+||||++|+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||
T Consensus       109 l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NIL  188 (458)
T 3rp9_A          109 LNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCL  188 (458)
T ss_dssp             CCCTTBCCEEEECCCSCTTTCCCEEEEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEE
T ss_pred             CCCCCCCceEEEEecCCcccCceEEEEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEE
Confidence            58999999999997665445578999999999999999998889999999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccccCCCC----------------------------ccccceeccccccccccccCCCCCcchhHH
Q 023568           81 LNASCDLKIGDFGLARTTSETD----------------------------FMTEYVVTRWYRAPELLLNCTEYTAAIDIW  132 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~~~~----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dvw  132 (280)
                      ++.++.+||+|||+++......                            .....+||++|+|||++.....++.++|||
T Consensus       189 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~Diw  268 (458)
T 3rp9_A          189 VNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVW  268 (458)
T ss_dssp             ECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHH
T ss_pred             ECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHH
Confidence            9999999999999998654221                            234457899999999876557899999999


Q ss_pred             HHHHHHHHHHh-----------CCCCCCCCC--------------------hHHHHHHHHHHhCCCCcccccccCChhHH
Q 023568          133 SVGCILGEIMT-----------REPLFPGKD--------------------YVHQLRLITELIGSPDDASLGFLRSDNAR  181 (280)
Q Consensus       133 slG~~l~~ll~-----------g~~pf~~~~--------------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  181 (280)
                      ||||++|||++           |.++|++.+                    ..+++..|.+.+|.++...+.........
T Consensus       269 SlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~  348 (458)
T 3rp9_A          269 SIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAK  348 (458)
T ss_dssp             HHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHH
T ss_pred             HHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHH
Confidence            99999999998           778887765                    35788889999999999998888888888


Q ss_pred             HHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCcCCCCCCCCCCCCCCccC-CCCCCH
Q 023568          182 RYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFE-HSSCTE  260 (280)
Q Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  260 (280)
                      .+....+..........++..++++.+||++||+.||.+|||++|+|+||||++++....++....+....++ ...++.
T Consensus       349 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~~~~~~~~  428 (458)
T 3rp9_A          349 RYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNATEKVRLPFNDWMNMDE  428 (458)
T ss_dssp             HHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGGCCCCSSCCCCSSCTTSCCCH
T ss_pred             HHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCccCCCCCCCCCCCccccccCCH
Confidence            8888888888888888899999999999999999999999999999999999999887777666655555554 356899


Q ss_pred             HHHHHHHHHHHHhhCCCC
Q 023568          261 DHIRELIWRESVKFNPDP  278 (280)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~  278 (280)
                      +++++.+++|+..|+|..
T Consensus       429 ~~~~~~~~~e~~~~~~~~  446 (458)
T 3rp9_A          429 PQLRYAFVKEIQRYHPEI  446 (458)
T ss_dssp             HHHHHHHHHHHTTTCTTC
T ss_pred             HHHHHHHHHHHHHhCccc
Confidence            999999999999999753

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-52  Score=362.74  Aligned_cols=273  Identities=46%  Similarity=0.851  Sum_probs=237.7

Q ss_pred             CCCcccccccccccCCC-CCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPK-KDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~-~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+||||+++++++.... ......+|+||||++++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+||
T Consensus        81 l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NI  159 (367)
T 1cm8_A           81 MRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNL  159 (367)
T ss_dssp             CCBTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred             CCCcCCCCceeeEecCCccccCceEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHE
Confidence            68999999999998763 223356899999998899999976 6799999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.++.+||+|||+++.....  .....+|+.|+|||++.+...++.++|+||+||++++|++|+.||.+.+..+++..
T Consensus       160 ll~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~  237 (367)
T 1cm8_A          160 AVNEDCELKILDFGLARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKE  237 (367)
T ss_dssp             EECTTCCEEECCCTTCEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             EEcCCCCEEEEeeecccccccc--cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9999999999999999876543  34567899999999988767889999999999999999999999999999999999


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCcCC
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL  239 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~~~  239 (280)
                      +.+..+.++..............+...++......+...++..++.+.+||++||+.||.+|||++|+|+||||+.+++.
T Consensus       238 i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~  317 (367)
T 1cm8_A          238 IMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT  317 (367)
T ss_dssp             HHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred             HHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCC
Confidence            99999999999888888888888999998888888888889999999999999999999999999999999999999988


Q ss_pred             CCCCCCCCCCCCccCCCCCCHHHHHHHHHHHHHhhCCC
Q 023568          240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPD  277 (280)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (280)
                      ..++... ++..+++....+.++|++++++|+..|+|.
T Consensus       318 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (367)
T 1cm8_A          318 EDEPQVQ-KYDDSFDDVDRTLDEWKRVTYKEVLSFKPP  354 (367)
T ss_dssp             ----CCC-CCCCC-----CCHHHHHHHHHHHHHTCCC-
T ss_pred             ccCCCCC-CCCCChhhhcCCHHHHHHHHHHHHHHhccc
Confidence            8776654 566777777889999999999999999864

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.3e-52  Score=362.89  Aligned_cols=275  Identities=50%  Similarity=0.897  Sum_probs=232.2

Q ss_pred             CCCcccccccccccCCC-CCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPK-KDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~-~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+||||+++++++.... ......+|+|||+++++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+||
T Consensus        85 l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NI  163 (367)
T 2fst_X           85 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL  163 (367)
T ss_dssp             CCCTTBCCCSEEECSCSSGGGCCCCEEEEECCCEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred             CCCCCCCcEEEEEecCCccccCCeEEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhE
Confidence            68999999999998652 122356899999999999999875 6799999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.++.+||+|||+++.....  .....+|+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+..+.+..
T Consensus       164 ll~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~  241 (367)
T 2fst_X          164 AVNEDCELKILDFGLARHTADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL  241 (367)
T ss_dssp             EECTTCCEEECC-----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             EECCCCCEEEeecccccccccc--CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9999999999999999875543  34568899999999988767889999999999999999999999999999999999


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCcCC
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL  239 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~~~  239 (280)
                      +.+..+.+...............++..++......+...++..++.+.+||++||+.||.+|||++|+|+||||+.++++
T Consensus       242 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~  321 (367)
T 2fst_X          242 ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP  321 (367)
T ss_dssp             HHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred             HHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCC
Confidence            99999999999888888888888888888877777888888999999999999999999999999999999999999988


Q ss_pred             CCCCCCCCCCCCccCCCCCCHHHHHHHHHHHHHhhCCCCC
Q 023568          240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDPT  279 (280)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (280)
                      ..++... ++..+++......+.|++++++|+.+|+|.+.
T Consensus       322 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~  360 (367)
T 2fst_X          322 DDEPVAD-PYDQSLESRDLLIDEWKSLTYDEVISFVPPPL  360 (367)
T ss_dssp             GGCCCCC-CCCGGGSSCCCCHHHHHHHHHHHHHHCCCCC-
T ss_pred             CCCCCCC-CCCcchhhccCCHHHHHHHHHHHHHHhccCcc
Confidence            8777655 67777777889999999999999999998753

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=8.9e-53  Score=361.84  Aligned_cols=228  Identities=29%  Similarity=0.496  Sum_probs=176.3

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      +|||||+++++|++.     +++|+|||||+ |+|.+++   +.+++.+++.+++||+.||+|||++||+||||||+|||
T Consensus        78 ~h~nIv~l~~~~~~~-----~~~~lvmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiL  149 (361)
T 4f9c_A           78 GQDNVMGVKYCFRKN-----DHVVIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFL  149 (361)
T ss_dssp             SBTTBCCCSEEEEET-----TEEEEEEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             CCCCCceEEEEEEEC-----CEEEEEEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeE
Confidence            699999999999988     78999999997 5999998   46999999999999999999999999999999999999


Q ss_pred             EcCC-CCeEEeecccccccCCCC-----------------------------ccccceeccccccccccccCCCCCcchh
Q 023568           81 LNAS-CDLKIGDFGLARTTSETD-----------------------------FMTEYVVTRWYRAPELLLNCTEYTAAID  130 (280)
Q Consensus        81 i~~~-~~~kl~dfg~~~~~~~~~-----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~D  130 (280)
                      ++.+ +.+||+|||+|+......                             ...+.+||+.|+|||++.+...++.++|
T Consensus       150 l~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~D  229 (361)
T 4f9c_A          150 YNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAID  229 (361)
T ss_dssp             EETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHH
T ss_pred             EeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccc
Confidence            9876 799999999997543321                             1234579999999999988677999999


Q ss_pred             HHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHHhCCCCccccc-----------ccCChhHHHHHHhCCcc--------
Q 023568          131 IWSVGCILGEIMTREPLFP-GKDYVHQLRLITELIGSPDDASLG-----------FLRSDNARRYVRQLPRC--------  190 (280)
Q Consensus       131 vwslG~~l~~ll~g~~pf~-~~~~~~~~~~i~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~--------  190 (280)
                      +||+||++|+|++|+.||. +.+..+++..|....|++......           .................        
T Consensus       230 iWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~  309 (361)
T 4f9c_A          230 MWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLT  309 (361)
T ss_dssp             HHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------
T ss_pred             hhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccc
Confidence            9999999999999999985 456778888998887754321110           00011111111111000        


Q ss_pred             ----ccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCc
Q 023568          191 ----RKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  237 (280)
Q Consensus       191 ----~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~  237 (280)
                          ........++.+|+++++||++||+.||++|||++|+|+||||+++.
T Consensus       310 ~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~  360 (361)
T 4f9c_A          310 SDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDMS  360 (361)
T ss_dssp             ------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred             cccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence                00111233457899999999999999999999999999999998763

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.8e-52  Score=363.66  Aligned_cols=271  Identities=41%  Similarity=0.788  Sum_probs=223.3

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL   81 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nili   81 (280)
                      .||||+++++++..+..   ..+|+|||||+|+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus        67 ~h~niv~l~~~~~~~~~---~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll  142 (388)
T 3oz6_A           67 GHENIVNLLNVLRADND---RDVYLVFDYMETDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL  142 (388)
T ss_dssp             TCTTBCCEEEEEECTTS---SCEEEEEECCSEEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred             CCCCCCeeeeEEecCCC---CEEEEEecccCcCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEE
Confidence            39999999999986532   57999999999999999976 689999999999999999999999999999999999999


Q ss_pred             cCCCCeEEeecccccccCC----------------------CCccccceeccccccccccccCCCCCcchhHHHHHHHHH
Q 023568           82 NASCDLKIGDFGLARTTSE----------------------TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG  139 (280)
Q Consensus        82 ~~~~~~kl~dfg~~~~~~~----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~  139 (280)
                      +.++.+||+|||+++....                      ........||+.|+|||++.+...++.++||||+||++|
T Consensus       143 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~  222 (388)
T 3oz6_A          143 NAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILG  222 (388)
T ss_dssp             CTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHH
T ss_pred             cCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHH
Confidence            9999999999999975432                      112344689999999999987678899999999999999


Q ss_pred             HHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccc---cccccccC-------------CCCC
Q 023568          140 EIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCR---KQQFATRF-------------PNKS  203 (280)
Q Consensus       140 ~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~-------------~~~~  203 (280)
                      +|++|++||.+.+...++..+...++.|...............++..+....   .......+             ...+
T Consensus       223 ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (388)
T 3oz6_A          223 EILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCN  302 (388)
T ss_dssp             HHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCC
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCC
Confidence            9999999999999999999999999999988776665555555444332221   11111111             2678


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCcccccCcCCCCCCCCCCCCCCccC-CCCCCHHHHHHHHHHHHHhhCC
Q 023568          204 SGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFE-HSSCTEDHIRELIWRESVKFNP  276 (280)
Q Consensus       204 ~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  276 (280)
                      +.+.+||++||+.||.+|||++|+|+||||+.+++++.++.+...+...+. ....+.+++++.+++|+.+|.+
T Consensus       303 ~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  376 (388)
T 3oz6_A          303 EEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKHSIDDYRNLVYSEISRRKR  376 (388)
T ss_dssp             HHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTTCCGGGCCCCSSCCCCC------CCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhhccCcccCCCHHHHhCCHHHHHhcCCccCCCCCCCCCCCccccccCCHHHHHHHHHHHHHHhhh
Confidence            999999999999999999999999999999999998888888877777665 4568899999999999988754

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=4.1e-51  Score=353.44  Aligned_cols=276  Identities=54%  Similarity=0.988  Sum_probs=240.9

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      |+||||+++++++...........|+||||++|+|.+++.. +.+++.++..++.|++.||+|||++||+||||||+||+
T Consensus        82 l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl  160 (364)
T 3qyz_A           82 FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLL  160 (364)
T ss_dssp             CCCTTBCCCCEEECCSSTTTCCCEEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred             cCCCCCccceeEEecCCccccceEEEEEcccCcCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEE
Confidence            58999999999998765444467999999999999999876 57999999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccccCCCC----ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023568           81 LNASCDLKIGDFGLARTTSETD----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  156 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~  156 (280)
                      ++.++.++|+|||++.......    ......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.
T Consensus       161 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~  240 (364)
T 3qyz_A          161 LNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ  240 (364)
T ss_dssp             ECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH
T ss_pred             ECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH
Confidence            9999999999999998654332    134568899999999987656789999999999999999999999999999999


Q ss_pred             HHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 023568          157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  236 (280)
Q Consensus       157 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~  236 (280)
                      +..+....+.+....+..........+....+..........++..++++.+||++||+.||.+|||++|+|+||||+..
T Consensus       241 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  320 (364)
T 3qyz_A          241 LNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  320 (364)
T ss_dssp             HHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             HHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence            99999999999988877777777777777777766666777778899999999999999999999999999999999999


Q ss_pred             cCCCCCCCCCCCCCCccCCCCCCHHHHHHHHHHHHHhhCCC
Q 023568          237 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPD  277 (280)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (280)
                      .+...++....++..+.+......+++++++++|+.+|+|.
T Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~  361 (364)
T 3qyz_A          321 YDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPG  361 (364)
T ss_dssp             CCGGGSCCCSSCCCCC-----CCHHHHHHHHHHHTGGGCC-
T ss_pred             cCcccccCCCCcCCcccccccCCHHHHHHHHHHHHHHhhhh
Confidence            88888888888888888888899999999999999999985

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2.1e-51  Score=365.46  Aligned_cols=272  Identities=43%  Similarity=0.793  Sum_probs=214.0

Q ss_pred             CCCcccccccccccCCCC-CCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~-~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||++++++|..... ....++|+||||++++|.+.+.  ..+++..++.++.||+.||+|||++||+||||||+||
T Consensus       118 l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NI  195 (464)
T 3ttj_A          118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI  195 (464)
T ss_dssp             CCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred             CCCCCCCcEEEEEccCCccccCCeEEEEEeCCCCCHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhE
Confidence            589999999999987632 3336789999999999998884  4599999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      |++.++.+||+|||+++............||+.|+|||++.+ ..++.++||||+||++|+|++|++||.+.+..+++..
T Consensus       196 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~  274 (464)
T 3ttj_A          196 VVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK  274 (464)
T ss_dssp             EECTTSCEEECCCCCC-----CCCC----CCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             EEeCCCCEEEEEEEeeeecCCCcccCCCcccccccCHHHHcC-CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            999999999999999988776655667889999999999988 6889999999999999999999999999999999999


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCC------------CHHHHHHHHHhcccCCCCCCCHHHH
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK------------SSGAVDLLEKMLVFDPNKRITVEEA  227 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~ll~~~L~~dp~~Rpt~~el  227 (280)
                      +.+.++.+.+..+.... .....+....+......++..++..            ++++++||++||+.||.+|||++|+
T Consensus       275 i~~~lg~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~  353 (464)
T 3ttj_A          275 VIEQLGTPCPEFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA  353 (464)
T ss_dssp             HHHHHCSCCHHHHTTSC-HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             HHHhcCCCCHHHHHHcc-hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHH
Confidence            99999999888765543 4455555555555444444444332            6789999999999999999999999


Q ss_pred             hcCcccccCcCCCCC-CCCCCCCCCccCCCCCCHHHHHHHHHHHHHhhCC
Q 023568          228 LRHPYLQSLHDLNDE-PVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP  276 (280)
Q Consensus       228 l~hp~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (280)
                      |+||||+.+.++... +..+..+...++....+.++|++++++|+.++..
T Consensus       354 L~Hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~  403 (464)
T 3ttj_A          354 LQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMNSEE  403 (464)
T ss_dssp             HTSTTTGGGCCHHHHSCCC-----------CCCHHHHHHHHHHHHHC---
T ss_pred             hcChhhhhccCcccccCCCCccCCcchhhccCCHHHHHHHHHHHHHHhhh
Confidence            999999988765543 2233445556677788999999999999987653

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=4.8e-50  Score=347.57  Aligned_cols=272  Identities=45%  Similarity=0.850  Sum_probs=237.2

Q ss_pred             CCCcccccccccccCCCC-CCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~-~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++..... ......|+||||++++|.+.+  ...+++..+..++.|++.||+|||+.||+||||||+||
T Consensus        98 l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NI  175 (371)
T 4exu_A           98 MQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIM--GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNL  175 (371)
T ss_dssp             CCCTTBCCCSEEECSCSSSTTCCCCEEEEECCCEEHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred             cCCCCchhhhhheeccCCcccceeEEEEEccccccHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHe
Confidence            589999999999987632 122345999999999999988  45699999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.++.++|+|||+++.....  .....+|+.|+|||.+.+...++.++|||||||++|+|++|..||.+.+..+.+..
T Consensus       176 ll~~~~~~kL~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  253 (371)
T 4exu_A          176 AVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQ  253 (371)
T ss_dssp             EECTTCCEEECSTTCC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             EECCCCCEEEEecCcccccccC--cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence            9999999999999999865443  34567899999999988767889999999999999999999999999999999999


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCcCC
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL  239 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~~~  239 (280)
                      +.+..+.+...............+....+......+...++..++.+.+||++||+.||.+|||++|+|+||||+.+..+
T Consensus       254 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  333 (371)
T 4exu_A          254 ILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDP  333 (371)
T ss_dssp             HHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCG
T ss_pred             HHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCc
Confidence            99999999998888888777788888887777777777788899999999999999999999999999999999999877


Q ss_pred             CCCCCCCCCCCCccCCCCCCHHHHHHHHHHHHHhhCC
Q 023568          240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP  276 (280)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (280)
                      ..+.....++....+....+.++|++.+++|+.+|+|
T Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (371)
T 4exu_A          334 EEETEAQQPFDDSLEHEKLTVDEWKQHIYKEIVNFSP  370 (371)
T ss_dssp             GGCCCCSSCCCCTTSSCCCCHHHHHHHHHHHHHHCCC
T ss_pred             ccccccccCcCcchhhcccchHHHHHHHHHHHHhccc
Confidence            7666666777777777778999999999999999987

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=3.7e-51  Score=370.84  Aligned_cols=203  Identities=25%  Similarity=0.406  Sum_probs=172.6

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++|||||+++++|++.     +.+|||||||. |+|.++|.+.+.+++..++.++.||+.||.|||++||+||||||+||
T Consensus       249 ~~HP~IV~l~~~f~~~-----~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNI  323 (689)
T 3v5w_A          249 GDCPFIVCMSYAFHTP-----DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANI  323 (689)
T ss_dssp             SCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGE
T ss_pred             CCCCCEeEEEEEEEEC-----CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHe
Confidence            4799999999999998     78999999997 59999999889999999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      |++.+|.+||+|||+|+...... ..+.+||+.|+|||++.+...|+.++|+|||||++|+|++|.+||.+.+.......
T Consensus       324 Lld~~G~vKL~DFGlA~~~~~~~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i  402 (689)
T 3v5w_A          324 LLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI  402 (689)
T ss_dssp             EECTTSCEEECCCTTCEECSSCC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHH
T ss_pred             EEeCCCCEEecccceeeecCCCC-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence            99999999999999998765443 45679999999999997546899999999999999999999999976532211111


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCcccc
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT-----VEEALRHPYLQ  234 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt-----~~ell~hp~~~  234 (280)
                      ......                            .....+..+|+++++||++||+.||.+|++     ++|+++||||+
T Consensus       403 ~~~i~~----------------------------~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~  454 (689)
T 3v5w_A          403 DRMTLT----------------------------MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR  454 (689)
T ss_dssp             HHHHHH----------------------------CCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGT
T ss_pred             HHhhcC----------------------------CCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCcccc
Confidence            111110                            001223468999999999999999999998     79999999999


Q ss_pred             cCc
Q 023568          235 SLH  237 (280)
Q Consensus       235 ~~~  237 (280)
                      ++.
T Consensus       455 ~id  457 (689)
T 3v5w_A          455 SLD  457 (689)
T ss_dssp             TCC
T ss_pred             CCC
Confidence            863

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.9e-49  Score=340.42  Aligned_cols=272  Identities=45%  Similarity=0.848  Sum_probs=235.1

Q ss_pred             CCCcccccccccccCCCC-CCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~-~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++..... ......|+||||++++|.+++.  ..+++..+..++.||+.||.|||++||+||||||+||
T Consensus        80 l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NI  157 (353)
T 3coi_A           80 MQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNL  157 (353)
T ss_dssp             CCCTTBCCCSEEECSCSSGGGCCCCEEEEECCSEEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGE
T ss_pred             cCCCCcccHhheEecccccccceeEEEEeccccCCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence            589999999999987632 1123469999999999988874  4699999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.++.++|+|||++......  .....+|+.|+|||.+.+...++.++|+|||||++|+|++|..||.+.+..+.+..
T Consensus       158 l~~~~~~~kl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  235 (353)
T 3coi_A          158 AVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQ  235 (353)
T ss_dssp             EECTTCCEEECSTTCTTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHH
T ss_pred             eECCCCcEEEeecccccCCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9999999999999999865433  34567899999999987767788999999999999999999999999999999999


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCcCC
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL  239 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~~~  239 (280)
                      +.+..+.++..............+...++......+...++..++.+.+||++||+.||.+|||++|+|+||||+.+...
T Consensus       236 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~  315 (353)
T 3coi_A          236 ILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDP  315 (353)
T ss_dssp             HHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCG
T ss_pred             HHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCc
Confidence            99999999988888777777777777777766667777778899999999999999999999999999999999998877


Q ss_pred             CCCCCCCCCCCCccCCCCCCHHHHHHHHHHHHHhhCC
Q 023568          240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP  276 (280)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (280)
                      ..++....++....+....+.++|++.+++|..+|.|
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (353)
T 3coi_A          316 EEETEAQQPFDDSLEHEKLTVDEWKQHIYKEIVNFSP  352 (353)
T ss_dssp             GGCCCCSSCCCCTTTTCCCCHHHHHHHHHHHHHTCCC
T ss_pred             cccccCCCCCccchhhccCCHHHHHHHHHHHHHhhcc
Confidence            7666666677777777789999999999999999986

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=3.4e-50  Score=364.94  Aligned_cols=207  Identities=26%  Similarity=0.457  Sum_probs=182.0

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      |+|||||+++++|++.     ..+|||||||+ |+|.++|.+ .+.+++.+++.++.||+.||.|||++||+||||||+|
T Consensus       211 l~hpnIv~l~~~~~~~-----~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~N  285 (573)
T 3uto_A          211 LRHPTLVNLHDAFEDD-----NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPEN  285 (573)
T ss_dssp             TCCTTBCCEEEEEECS-----SEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred             CCCCCCCeEEEEEEEC-----CEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhh
Confidence            6899999999999988     78999999997 599999864 4689999999999999999999999999999999999


Q ss_pred             eEEcCC--CCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023568           79 LLLNAS--CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  156 (280)
Q Consensus        79 ili~~~--~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~  156 (280)
                      ||++.+  +.+||+|||+++...........+||+.|+|||++.+ ..++.++||||+||++|+|++|.+||.+.+..+.
T Consensus       286 ill~~~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~-~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~  364 (573)
T 3uto_A          286 IMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET  364 (573)
T ss_dssp             EEESSSSCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH
T ss_pred             ccccCCCCCCEEEeeccceeEccCCCceeeeEECccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH
Confidence            999854  8999999999998877666677889999999999988 7789999999999999999999999999988887


Q ss_pred             HHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 023568          157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  236 (280)
Q Consensus       157 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~  236 (280)
                      +..+.......+                           ...++.+++++++||++||+.||.+|||++|+|+||||+..
T Consensus       365 ~~~i~~~~~~~~---------------------------~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~  417 (573)
T 3uto_A          365 LRNVKSCDWNMD---------------------------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG  417 (573)
T ss_dssp             HHHHHTTCCCCC---------------------------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             HHHHHhCCCCCC---------------------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCC
Confidence            777655322211                           12234679999999999999999999999999999999876


Q ss_pred             cCCC
Q 023568          237 HDLN  240 (280)
Q Consensus       237 ~~~~  240 (280)
                      ..+.
T Consensus       418 ~~~~  421 (573)
T 3uto_A          418 NAPG  421 (573)
T ss_dssp             CCTT
T ss_pred             CCCC
Confidence            5443

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=5.5e-51  Score=342.08  Aligned_cols=204  Identities=24%  Similarity=0.423  Sum_probs=154.9

Q ss_pred             CCCcccccccccccCCCC-------CCCCcEEEEEecCC-ccHHHHHHcCCC---CCHHHHHHHHHHHHHHHHHHHhCCc
Q 023568            1 MEHENVIAIKDIIRPPKK-------DTFNDVYIVYELMD-TDLHQIIRSDQQ---LTDDHCQYFLYQLLRGLKYVHSASV   69 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~-------~~~~~~~lv~e~~~-g~L~~~l~~~~~---l~~~~~~~i~~qil~~l~~LH~~~i   69 (280)
                      |+|||||+++++|.+...       ....++|+|||||+ |+|.+++.....   .++..++.++.||+.||+|||++||
T Consensus        60 l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~I  139 (299)
T 4g31_A           60 LEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGL  139 (299)
T ss_dssp             CCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             CCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcC
Confidence            689999999999976521       01135899999997 599999987654   4567789999999999999999999


Q ss_pred             cccCCCCCceEEcCCCCeEEeecccccccCCCC-------------ccccceeccccccccccccCCCCCcchhHHHHHH
Q 023568           70 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-------------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGC  136 (280)
Q Consensus        70 ~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~  136 (280)
                      +||||||+|||++.++.+||+|||+|+......             .....+||+.|+|||++.+ ..++.++|||||||
T Consensus       140 iHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGv  218 (299)
T 4g31_A          140 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGL  218 (299)
T ss_dssp             CCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTT-CCCCTHHHHHHHHH
T ss_pred             ccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcC-CCCCCHHHHHHHHH
Confidence            999999999999999999999999998654331             1234579999999999987 78899999999999


Q ss_pred             HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhccc
Q 023568          137 ILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVF  216 (280)
Q Consensus       137 ~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~  216 (280)
                      ++|||++   ||.+.  .+....+.......                           ++..++..++.+.+||++||+.
T Consensus       219 ilyell~---Pf~~~--~~~~~~~~~~~~~~---------------------------~p~~~~~~~~~~~~li~~~L~~  266 (299)
T 4g31_A          219 ILFELLY---PFSTQ--MERVRTLTDVRNLK---------------------------FPPLFTQKYPCEYVMVQDMLSP  266 (299)
T ss_dssp             HHHHHHS---CCSSH--HHHHHHHHHHHTTC---------------------------CCHHHHHHCHHHHHHHHHHTCS
T ss_pred             HHHHHcc---CCCCc--cHHHHHHHHHhcCC---------------------------CCCCCcccCHHHHHHHHHHcCC
Confidence            9999996   67543  22222222222111                           1112223467789999999999


Q ss_pred             CCCCCCCHHHHhcCcccccCc
Q 023568          217 DPNKRITVEEALRHPYLQSLH  237 (280)
Q Consensus       217 dp~~Rpt~~ell~hp~~~~~~  237 (280)
                      ||.+|||+.|+|+||||+++.
T Consensus       267 dP~~Rps~~eil~h~~~~~~~  287 (299)
T 4g31_A          267 SPMERPEAINIIENAVFEDLD  287 (299)
T ss_dssp             SGGGSCCHHHHHTSGGGCCC-
T ss_pred             ChhHCcCHHHHhcCHhhCCCC
Confidence            999999999999999998764

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=9.7e-50  Score=334.39  Aligned_cols=199  Identities=20%  Similarity=0.307  Sum_probs=161.1

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      |+|||||++++++..      +.+|||||||+ |+|.++|... .++++.++..++.||+.||+|||++||+||||||+|
T Consensus        89 l~HpNIV~l~g~~~~------~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~N  162 (307)
T 3omv_A           89 TRHVNILLFMGYMTK------DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNN  162 (307)
T ss_dssp             CCCTTBCCEEEEECS------SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSS
T ss_pred             CCCCCEeeEEEEEEC------CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHH
Confidence            689999999998754      34899999998 6999999754 679999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCC---CccccceeccccccccccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 023568           79 LLLNASCDLKIGDFGLARTTSET---DFMTEYVVTRWYRAPELLLNC--TEYTAAIDIWSVGCILGEIMTREPLFPGKDY  153 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~  153 (280)
                      ||++.++.+||+|||+|+.....   ......+||+.|+|||++.+.  ..++.++|||||||++|||++|+.||.+.+.
T Consensus       163 ILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~  242 (307)
T 3omv_A          163 IFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN  242 (307)
T ss_dssp             EEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred             EEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh
Confidence            99999999999999999865432   234556899999999998652  4588999999999999999999999998776


Q ss_pred             HHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 023568          154 VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  230 (280)
Q Consensus       154 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~h  230 (280)
                      ...+..+......                         .+..+..++..++.+.+|+.+||+.||++|||++|++++
T Consensus       243 ~~~~~~~~~~~~~-------------------------~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          243 RDQIIFMVGRGYA-------------------------SPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             HHHHHHHHHTTCC-------------------------CCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             HHHHHHHHhcCCC-------------------------CCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            6555444331111                         111223345678999999999999999999999987653

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=6.9e-50  Score=335.02  Aligned_cols=199  Identities=25%  Similarity=0.406  Sum_probs=170.5

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC-------------CCCCHHHHHHHHHHHHHHHHHHHh
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-------------QQLTDDHCQYFLYQLLRGLKYVHS   66 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-------------~~l~~~~~~~i~~qil~~l~~LH~   66 (280)
                      |+|||||++++++.++     +.+|||||||+ |+|.++|++.             ..+++.++..++.||+.||+|||+
T Consensus        72 l~HpnIV~l~g~~~~~-----~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~  146 (299)
T 4asz_A           72 LQHEHIVKFYGVCVEG-----DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS  146 (299)
T ss_dssp             CCCTTBCCEEEEECSS-----SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCCCCccEEEEEeeC-----CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            6899999999999987     67999999997 6999999753             369999999999999999999999


Q ss_pred             CCccccCCCCCceEEcCCCCeEEeecccccccCCCC---ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh
Q 023568           67 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT  143 (280)
Q Consensus        67 ~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~  143 (280)
                      ++|+||||||+|||++.++.+||+|||+++......   ......||+.|+|||++.+ ..++.++|||||||++|||++
T Consensus       147 ~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~k~DVwS~Gvvl~Ellt  225 (299)
T 4asz_A          147 QHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFT  225 (299)
T ss_dssp             TTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHT
T ss_pred             CCcccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHc
Confidence            999999999999999999999999999998654332   2234578999999999987 789999999999999999998


Q ss_pred             -CCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCC
Q 023568          144 -REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI  222 (280)
Q Consensus       144 -g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rp  222 (280)
                       |+.||.+.+..+....+.+...                              ...++..++++.+|+.+||+.||++||
T Consensus       226 ~G~~Pf~~~~~~~~~~~i~~~~~------------------------------~~~p~~~~~~~~~li~~cl~~dP~~RP  275 (299)
T 4asz_A          226 YGKQPWYQLSNNEVIECITQGRV------------------------------LQRPRTCPQEVYELMLGCWQREPHMRK  275 (299)
T ss_dssp             TTCCTTTTSCHHHHHHHHHHTCC------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred             CCCCCCCCCCHHHHHHHHHcCCC------------------------------CCCCccchHHHHHHHHHHcCCChhHCc
Confidence             9999999887777666544111                              112336789999999999999999999


Q ss_pred             CHHHHhcCcccccCc
Q 023568          223 TVEEALRHPYLQSLH  237 (280)
Q Consensus       223 t~~ell~hp~~~~~~  237 (280)
                      |++|+  ++|++++.
T Consensus       276 s~~~i--~~~L~~~~  288 (299)
T 4asz_A          276 NIKGI--HTLLQNLA  288 (299)
T ss_dssp             CHHHH--HHHHHHHH
T ss_pred             CHHHH--HHHHHHHH
Confidence            99999  45776553

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3.6e-49  Score=334.95  Aligned_cols=194  Identities=23%  Similarity=0.368  Sum_probs=160.9

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHH
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD---------------QQLTDDHCQYFLYQLLRGLKYV   64 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~---------------~~l~~~~~~~i~~qil~~l~~L   64 (280)
                      |+|||||++++++.+.     ..+|||||||+ |+|.+++++.               +++++.++..++.||+.||+||
T Consensus       100 l~HpnIV~l~g~~~~~-----~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yL  174 (329)
T 4aoj_A          100 LQHQHIVRFFGVCTEG-----RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL  174 (329)
T ss_dssp             CCCTTBCCEEEEECSS-----SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHH
T ss_pred             CCCCCCCcEEEEEEEC-----CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHH
Confidence            6899999999999987     67999999998 6999999753               3599999999999999999999


Q ss_pred             HhCCccccCCCCCceEEcCCCCeEEeecccccccCCCC---ccccceeccccccccccccCCCCCcchhHHHHHHHHHHH
Q 023568           65 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI  141 (280)
Q Consensus        65 H~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l  141 (280)
                      |+.+|+||||||+|||++.++.+||+|||+++......   ......||+.|+|||++.+ ..++.++|||||||++|||
T Consensus       175 H~~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~~sDvwS~Gvvl~El  253 (329)
T 4aoj_A          175 AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDVWSFGVVLWEI  253 (329)
T ss_dssp             HHTTCCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHH
T ss_pred             hcCCeecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcC-CCCCccccccchHHHHHHH
Confidence            99999999999999999999999999999998654332   2345678999999999987 7899999999999999999


Q ss_pred             Hh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCC
Q 023568          142 MT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNK  220 (280)
Q Consensus       142 l~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~  220 (280)
                      ++ |+.||.+.+..+.+..+.+...                              ...++..++++.+|+.+||+.||++
T Consensus       254 lt~G~~Pf~~~~~~~~~~~i~~g~~------------------------------~~~p~~~~~~~~~li~~cl~~dP~~  303 (329)
T 4aoj_A          254 FTYGKQPWYQLSNTEAIDCITQGRE------------------------------LERPRACPPEVYAIMRGCWQREPQQ  303 (329)
T ss_dssp             HTTSCCTTCSSCHHHHHHHHHHTCC------------------------------CCCCTTCCHHHHHHHHHHCCSSTTT
T ss_pred             HcCCCCCCCCCCHHHHHHHHHcCCC------------------------------CCCcccccHHHHHHHHHHcCcChhH
Confidence            98 9999999887777666544111                              1122357899999999999999999


Q ss_pred             CCCHHHHhcC
Q 023568          221 RITVEEALRH  230 (280)
Q Consensus       221 Rpt~~ell~h  230 (280)
                      |||++|++++
T Consensus       304 RPs~~ei~~~  313 (329)
T 4aoj_A          304 RHSIKDVHAR  313 (329)
T ss_dssp             SCCHHHHHHH
T ss_pred             CcCHHHHHHH
Confidence            9999999863

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=4.1e-49  Score=331.64  Aligned_cols=194  Identities=20%  Similarity=0.353  Sum_probs=167.2

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHH
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD----------------QQLTDDHCQYFLYQLLRGLKY   63 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~----------------~~l~~~~~~~i~~qil~~l~~   63 (280)
                      |+|||||++++++.++     ..+|||||||+ |+|.++|...                ..+++.++..++.||+.||+|
T Consensus        86 l~HpNIV~l~g~~~~~-----~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~y  160 (308)
T 4gt4_A           86 LQHPNVVCLLGVVTKD-----QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEY  160 (308)
T ss_dssp             CCCTTBCCEEEEECSS-----SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCcceEEEEC-----CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHH
Confidence            6899999999999987     66999999997 6999999643                358999999999999999999


Q ss_pred             HHhCCccccCCCCCceEEcCCCCeEEeecccccccCCC---CccccceeccccccccccccCCCCCcchhHHHHHHHHHH
Q 023568           64 VHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET---DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE  140 (280)
Q Consensus        64 LH~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~  140 (280)
                      ||+++|+||||||+|||++.++.+||+|||+++.....   .......||+.|+|||++.+ ..++.++|||||||++||
T Consensus       161 LH~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~~s~ksDVwSfGvvl~E  239 (308)
T 4gt4_A          161 LSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY-GKFSIDSDIWSYGVVLWE  239 (308)
T ss_dssp             HHHTTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHH
T ss_pred             HHhCCCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhC-CCCCccchhhhHHHHHHH
Confidence            99999999999999999999999999999999864332   22345688999999999987 789999999999999999


Q ss_pred             HHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCC
Q 023568          141 IMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPN  219 (280)
Q Consensus       141 ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~  219 (280)
                      |++ |..||.+.+..+....+....                              ....++..++.+.+++.+||+.||+
T Consensus       240 l~t~g~~Pf~~~~~~~~~~~i~~~~------------------------------~~~~p~~~~~~~~~li~~C~~~dP~  289 (308)
T 4gt4_A          240 VFSYGLQPYCGYSNQDVVEMIRNRQ------------------------------VLPCPDDCPAWVYALMIECWNEFPS  289 (308)
T ss_dssp             HHTTTCCTTTTCCHHHHHHHHHTTC------------------------------CCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred             HHhCCCCCCCCCCHHHHHHHHHcCC------------------------------CCCCcccchHHHHHHHHHHcCCChh
Confidence            998 899999988776666554311                              1122346789999999999999999


Q ss_pred             CCCCHHHHhcC
Q 023568          220 KRITVEEALRH  230 (280)
Q Consensus       220 ~Rpt~~ell~h  230 (280)
                      +|||++|++++
T Consensus       290 ~RPs~~ei~~~  300 (308)
T 4gt4_A          290 RRPRFKDIHSR  300 (308)
T ss_dssp             GSCCHHHHHHH
T ss_pred             HCcCHHHHHHH
Confidence            99999999874

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.6e-48  Score=337.98  Aligned_cols=271  Identities=43%  Similarity=0.777  Sum_probs=204.6

Q ss_pred             CCCcccccccccccCCCC-CCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~-~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++..... .....+|+||||++|+|.+.+.  ..+++..+..++.||+.||+|||++||+||||||+||
T Consensus        81 l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NI  158 (371)
T 2xrw_A           81 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI  158 (371)
T ss_dssp             CCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSEEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred             cCCCCccceEEeeccccccccccceEEEEEcCCCCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHE
Confidence            589999999999987631 2234799999999999999985  4699999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.++.+||+|||+++............||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..
T Consensus       159 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  237 (371)
T 2xrw_A          159 VVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK  237 (371)
T ss_dssp             EECTTSCEEECCCCC----------------CTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             EEcCCCCEEEEEeecccccccccccCCceecCCccCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            999999999999999987665544556788999999999987 6788999999999999999999999999999999999


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCC------------CCHHHHHHHHHhcccCCCCCCCHHHH
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEA  227 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~ll~~~L~~dp~~Rpt~~el  227 (280)
                      +.+..+.+.+....... .....+....+......+...++.            .++.+++||++||+.||.+|||++|+
T Consensus       238 i~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~  316 (371)
T 2xrw_A          238 VIEQLGTPCPEFMKKLQ-PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA  316 (371)
T ss_dssp             HHC-CCCCCHHHHTTSC-HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             HHHHhCCCCHHHHHHhh-hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHH
Confidence            98888887776554432 223333333332222221111111            25789999999999999999999999


Q ss_pred             hcCcccccCcCCCCC-CCCCCCCCCccCCCCCCHHHHHHHHHHHHHhhC
Q 023568          228 LRHPYLQSLHDLNDE-PVCPRPFHFDFEHSSCTEDHIRELIWRESVKFN  275 (280)
Q Consensus       228 l~hp~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (280)
                      |+||||+.+.++... ...+..+....++...+.++|++.++.++..|.
T Consensus       317 l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  365 (371)
T 2xrw_A          317 LQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDLE  365 (371)
T ss_dssp             HHSHHHHTTCCHHHHTCCCCCCCTTTTCCCCCCHHHHHHHHHHHHHHHC
T ss_pred             hCCcchhhhcCccccCCCCCCCCChhhccccCcHHHHHHHHHHHHHHHh
Confidence            999999987664322 222333344556677899999999999998875

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2.3e-47  Score=328.37  Aligned_cols=271  Identities=52%  Similarity=0.948  Sum_probs=224.6

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      |+||||+++++++...........|+||||++|+|.+++.. +.+++..+..++.|++.||+|||++||+||||||+||+
T Consensus        66 l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil  144 (353)
T 2b9h_A           66 FKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLL  144 (353)
T ss_dssp             CCCTTBCCEEEECCCSCSTTCCCEEEEECCCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred             CcCCCcCCeeeeecccccCccceEEEEEeccCccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeE
Confidence            58999999999987654334467999999999999999876 67999999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccccCCCC-----------ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 023568           81 LNASCDLKIGDFGLARTTSETD-----------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFP  149 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~  149 (280)
                      ++.++.++|+|||++.......           ......||+.|+|||++.+...++.++|+|||||++|+|++|.+||.
T Consensus       145 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  224 (353)
T 2b9h_A          145 INSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFP  224 (353)
T ss_dssp             ECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             EcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCC
Confidence            9999999999999998654321           12235789999999998765778999999999999999999999999


Q ss_pred             CCChHHHHHHHHHHhCCCCcc-cccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 023568          150 GKDYVHQLRLITELIGSPDDA-SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL  228 (280)
Q Consensus       150 ~~~~~~~~~~i~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell  228 (280)
                      +.+....+..+....+.+... ............+....+..........++.+++.+.+||++||+.||.+|||++|+|
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell  304 (353)
T 2b9h_A          225 GRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEAL  304 (353)
T ss_dssp             CSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             CCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHh
Confidence            999988888888888877643 3344445556666666666666666667788999999999999999999999999999


Q ss_pred             cCcccccCcCCCCCC----CCCCCCCCccCCCCCCHHHHHHHHHHHHH
Q 023568          229 RHPYLQSLHDLNDEP----VCPRPFHFDFEHSSCTEDHIRELIWRESV  272 (280)
Q Consensus       229 ~hp~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (280)
                      +||||+.+.....++    ..+..+.++......+.+.+++++++|+.
T Consensus       305 ~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (353)
T 2b9h_A          305 EHPYLQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLKKLIWNEIF  352 (353)
T ss_dssp             TSGGGTTTCCTTSSCCCCCCCGGGGGGGCCSSCCCHHHHHHHHHHHHT
T ss_pred             cCccccccCCcccccccCCCCcceeeecchhhcCCHHHHHHHHHHHhh
Confidence            999999987665433    22233445566778999999999999975

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.4e-47  Score=330.90  Aligned_cols=275  Identities=37%  Similarity=0.686  Sum_probs=216.4

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++..........+|+||||++|+|.+.+... ..+++..+..++.||+.||.|||+.||+||||||+||
T Consensus        86 l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NI  165 (362)
T 3pg1_A           86 FHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNI  165 (362)
T ss_dssp             CCCTTBCCCSEEEEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred             CCCcCccceeeeEEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHE
Confidence            589999999999965433333679999999999999988764 4799999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.++.++|+|||++.............+++.|+|||++.+...++.++|+|||||++|+|++|+.||.+.........
T Consensus       166 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~  245 (362)
T 3pg1_A          166 LLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNK  245 (362)
T ss_dssp             EECTTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             EEcCCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            99999999999999998665555556678899999999988767789999999999999999999999999999999999


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhC-CccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCcC
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQL-PRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  238 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~~  238 (280)
                      +....+.+...............+.... ............+..++.+.+||.+||+.||.+|||++|+|+||||+++.+
T Consensus       246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  325 (362)
T 3pg1_A          246 IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFD  325 (362)
T ss_dssp             HHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             HHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccC
Confidence            9999998887765555544444443322 222233344456678999999999999999999999999999999999875


Q ss_pred             CCCCCCCCCCCCCccCCCCCCHHHHHHHHHHHHHhhCC
Q 023568          239 LNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP  276 (280)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (280)
                      +.... ......+.+.....+...+++.+..|+.+|++
T Consensus       326 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~  362 (362)
T 3pg1_A          326 PLDLT-EGLSERFHFDESVTDVYDMHKIFTAEVERFND  362 (362)
T ss_dssp             GGGGT-TTCCCCCCCCTTCCCHHHHHHHHHHHHHHHC-
T ss_pred             ccccc-cccccccChhhhhhhHHHHHHHHHHHHHHhcC
Confidence            54322 12233355666788999999999999999874

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.1e-47  Score=325.03  Aligned_cols=231  Identities=38%  Similarity=0.740  Sum_probs=192.3

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+||||+++++++.++     ..+|+||||++|+|.+.+... ..+++.+++.++.|++.||+|||+.||+||||||+||
T Consensus        76 l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NI  150 (311)
T 3niz_A           76 LHHPNIVSLIDVIHSE-----RCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNL  150 (311)
T ss_dssp             CCCTTBCCEEEEECCS-----SCEEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred             cCCCCEeeeeeEEccC-----CEEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhE
Confidence            5899999999999987     679999999999999988764 4699999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||+++..... .......+|+.|+|||++.+...++.++|+||+||++|+|++|+.||.+....+.+.
T Consensus       151 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  230 (311)
T 3niz_A          151 LINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLP  230 (311)
T ss_dssp             EECTTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHH
T ss_pred             EECCCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence            9999999999999999876533 334456789999999998876778999999999999999999999999999888999


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  237 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~  237 (280)
                      .+....+.+.+..+.......... ................+..++++.+||++||+.||.+|||++|+|+||||+++.
T Consensus       231 ~i~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  308 (311)
T 3niz_A          231 KIFSILGTPNPREWPQVQELPLWK-QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD  308 (311)
T ss_dssp             HHHHHHCCCCTTTSGGGTTSHHHH-SCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred             HHHHHHCCCChHHhhhhhccchhh-hcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence            999999888776654432211100 011112223334445567899999999999999999999999999999998864

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=3.7e-47  Score=323.97  Aligned_cols=204  Identities=23%  Similarity=0.435  Sum_probs=179.3

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++.+.     ..+|+||||++ |+|.+++...+.+++.+++.++.|++.||+|||++||+||||||+||
T Consensus        71 l~hpnIv~l~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NI  145 (328)
T 3fe3_A           71 LNHPNIVKLFEVIETE-----KTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENL  145 (328)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred             CCCCCEeeEEEEEEEC-----CEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHE
Confidence            5899999999999887     77999999996 59999998888999999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.++.+||+|||++............+||+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+.......
T Consensus       146 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~  225 (328)
T 3fe3_A          146 LLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRER  225 (328)
T ss_dssp             EECTTSCEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             EEcCCCCEEEeeccCceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            99999999999999998776665566788999999999998855556899999999999999999999999887666655


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCcCC
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL  239 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~~~  239 (280)
                      +.....                               ..+...++++.+||++||+.||.+|||++|+++||||+.....
T Consensus       226 i~~~~~-------------------------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~~  274 (328)
T 3fe3_A          226 VLRGKY-------------------------------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEE  274 (328)
T ss_dssp             HHHCCC-------------------------------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCTT
T ss_pred             HHhCCC-------------------------------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCcc
Confidence            543110                               1122468999999999999999999999999999999887654


Q ss_pred             C
Q 023568          240 N  240 (280)
Q Consensus       240 ~  240 (280)
                      .
T Consensus       275 ~  275 (328)
T 3fe3_A          275 D  275 (328)
T ss_dssp             C
T ss_pred             c
Confidence            3

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.3e-47  Score=323.25  Aligned_cols=235  Identities=39%  Similarity=0.732  Sum_probs=192.3

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++.+.     ...|+||||++|+|.+++... ..+++..++.++.|++.||.|||+.||+||||||+||
T Consensus        57 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NI  131 (324)
T 3mtl_A           57 LKHANIVTLHDIIHTE-----KSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNL  131 (324)
T ss_dssp             CCCTTBCCEEEEEECS-----SCEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGE
T ss_pred             cCCCCCCeeeeEEeeC-----CEEEEEecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHE
Confidence            5899999999999987     679999999999999998764 4699999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||++...... .......+|+.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+...
T Consensus       132 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~  211 (324)
T 3mtl_A          132 LINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLH  211 (324)
T ss_dssp             EECTTCCEEECSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             EECCCCCEEEccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            9999999999999998765433 233456789999999999876778999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCcC
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  238 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~~  238 (280)
                      .+....+.+.+..+.......... ....+...........+.+++++.+||++||+.||.+|||++|+|+||||.++..
T Consensus       212 ~i~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  290 (324)
T 3mtl_A          212 FIFRILGTPTEETWPGILSNEEFK-TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE  290 (324)
T ss_dssp             HHHHHHCCCCTTTSTTGGGCHHHH-HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred             HHHHHhCCCChHhchhhhcchhhc-ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence            999999988877665443222111 1122222333334455678999999999999999999999999999999998875


Q ss_pred             CCC
Q 023568          239 LND  241 (280)
Q Consensus       239 ~~~  241 (280)
                      ...
T Consensus       291 ~~~  293 (324)
T 3mtl_A          291 RIH  293 (324)
T ss_dssp             TTS
T ss_pred             ccc
Confidence            443

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=4.8e-48  Score=330.60  Aligned_cols=195  Identities=25%  Similarity=0.375  Sum_probs=162.0

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHH
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD----------------QQLTDDHCQYFLYQLLRGLKYV   64 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~----------------~~l~~~~~~~i~~qil~~l~~L   64 (280)
                      +|||||++++++..+.    ..+|||||||+ |+|.++|++.                ..+++.++..++.||+.||+||
T Consensus       126 hhpnIV~l~g~~~~~~----~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yL  201 (353)
T 4ase_A          126 HHLNVVNLLGACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL  201 (353)
T ss_dssp             CCTTBCCEEEEECCTT----SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHH
T ss_pred             CCCcEEEEEEEEEecC----CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhH
Confidence            4699999999986542    45899999998 6999999753                3489999999999999999999


Q ss_pred             HhCCccccCCCCCceEEcCCCCeEEeecccccccCCCC---ccccceeccccccccccccCCCCCcchhHHHHHHHHHHH
Q 023568           65 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI  141 (280)
Q Consensus        65 H~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l  141 (280)
                      |+++|+||||||+|||++.++.+||+|||+|+......   ......||+.|+|||++.+ ..++.++|||||||++|||
T Consensus       202 H~~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~y~~ksDVwS~Gv~l~El  280 (353)
T 4ase_A          202 ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEI  280 (353)
T ss_dssp             HHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHH
T ss_pred             hhCCeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc-CCCCCcccEeehHHHHHHH
Confidence            99999999999999999999999999999998654332   2345678999999999987 7899999999999999999


Q ss_pred             Hh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCC
Q 023568          142 MT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNK  220 (280)
Q Consensus       142 l~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~  220 (280)
                      ++ |+.||.+.+....+..+.....                             ....++..++++.+++.+||+.||++
T Consensus       281 ~t~G~~Pf~~~~~~~~~~~~i~~g~-----------------------------~~~~p~~~~~~~~~li~~c~~~dP~~  331 (353)
T 4ase_A          281 FSLGASPYPGVKIDEEFCRRLKEGT-----------------------------RMRAPDYTTPEMYQTMLDCWHGEPSQ  331 (353)
T ss_dssp             TTTSCCSSTTCCCSHHHHHHHHHTC-----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred             HhCCCCCCCCCCHHHHHHHHHHcCC-----------------------------CCCCCccCCHHHHHHHHHHcCcChhH
Confidence            98 9999998764443333222111                             11222357899999999999999999


Q ss_pred             CCCHHHHhcC
Q 023568          221 RITVEEALRH  230 (280)
Q Consensus       221 Rpt~~ell~h  230 (280)
                      |||++|+++|
T Consensus       332 RPt~~eil~~  341 (353)
T 4ase_A          332 RPTFSELVEH  341 (353)
T ss_dssp             SCCHHHHHHH
T ss_pred             CcCHHHHHHH
Confidence            9999999987

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=5.9e-47  Score=320.06  Aligned_cols=230  Identities=37%  Similarity=0.636  Sum_probs=191.6

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcCCC--CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQ--LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~--l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      +||||+++++++..........+++||||++|+|.+++.....  +++.+++.++.|++.||+|||++||+||||||+||
T Consensus        72 ~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Ni  151 (308)
T 3g33_A           72 EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENI  151 (308)
T ss_dssp             CCTTBCCEEEEEEECCSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTE
T ss_pred             CCCCeEEeeeeeeccCCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence            5999999999998764323246899999999999999987544  99999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.++.++|+|||+++............||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......
T Consensus       152 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~  230 (308)
T 3g33_A          152 LVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGK  230 (308)
T ss_dssp             EECTTSCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHT-SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHH
T ss_pred             EEcCCCCEEEeeCccccccCCCcccCCccccccccCchHHcC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            999999999999999987766655567788999999999987 6789999999999999999999999999999999999


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  236 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~  236 (280)
                      +.+..+.++...+........    ...............+.+++.+.+||.+||+.||.+|||++|+|+||||+..
T Consensus       231 i~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~  303 (308)
T 3g33_A          231 IFDLIGLPPEDDWPRDVSLPR----GAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD  303 (308)
T ss_dssp             HHHHHCCCCTTTSCSSCSSCG----GGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred             HHHHhCCCChhhccchhhccc----cccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence            999888877665433221100    1112222233344456789999999999999999999999999999999864

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.1e-47  Score=333.41  Aligned_cols=238  Identities=34%  Similarity=0.641  Sum_probs=193.5

Q ss_pred             CCCcccccccccccCCCC-CCCCcEEEEEecCCccHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 023568            1 MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK   75 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~-~~~~~~~lv~e~~~g~L~~~l~----~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik   75 (280)
                      |+||||++++++|..... .....+|+||||+++++.+.+.    ....+++..++.++.||+.||+|||+.||+|||||
T Consensus        89 l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlk  168 (394)
T 4e7w_A           89 VKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIK  168 (394)
T ss_dssp             CCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             CCCCCcceEEEEEEecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCC
Confidence            689999999999976532 1224588999999988776654    35789999999999999999999999999999999


Q ss_pred             CCceEEc-CCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023568           76 PSNLLLN-ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV  154 (280)
Q Consensus        76 ~~Nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~  154 (280)
                      |+|||++ .++.+||+|||+++............+|+.|+|||++.+...++.++||||+||++|+|++|++||.+.+..
T Consensus       169 p~Nill~~~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~  248 (394)
T 4e7w_A          169 PQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI  248 (394)
T ss_dssp             GGGEEEETTTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             HHHEEEcCCCCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            9999999 799999999999987665555567788999999999987667999999999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccC-CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      +.+..+.+.++.+....+.........   ...+......+...+ +..++++.+||++||+.||.+|||+.|+++||||
T Consensus       249 ~~l~~i~~~~g~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  325 (394)
T 4e7w_A          249 DQLVEIIKVLGTPSREQIKTMNPNYME---HKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFF  325 (394)
T ss_dssp             HHHHHHHHHHCCCCHHHHHHHCGGGSS---SCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGG
T ss_pred             HHHHHHHHHhCCCCHHHHHhhChhhhh---hccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhh
Confidence            999999999998887654322111000   011111222222222 3489999999999999999999999999999999


Q ss_pred             ccCcCCCC
Q 023568          234 QSLHDLND  241 (280)
Q Consensus       234 ~~~~~~~~  241 (280)
                      +.+.....
T Consensus       326 ~~~~~~~~  333 (394)
T 4e7w_A          326 DELRTGEA  333 (394)
T ss_dssp             STTTSSCC
T ss_pred             hhhccccc
Confidence            99876543

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=7e-47  Score=316.72  Aligned_cols=229  Identities=38%  Similarity=0.686  Sum_probs=184.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+||||+++++++.+.     ...|+||||++++|.+++... +.+++..++.++.|++.||+|||++||+||||||+||
T Consensus        57 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni  131 (288)
T 1ob3_A           57 LKHSNIVKLYDVIHTK-----KRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNL  131 (288)
T ss_dssp             CCCTTBCCEEEEEECS-----SCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred             cCCCCEeeeeeEEccC-----CeEEEEEEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence            5899999999999987     679999999999999999764 6799999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.+||+|||++...... .......+|+.|+|||++.+...++.++|+||+||++|+|++|..||.+.+..+.+.
T Consensus       132 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~  211 (288)
T 1ob3_A          132 LINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLM  211 (288)
T ss_dssp             EECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             EEcCCCCEEEeECccccccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            9999999999999999765432 223456789999999999775678999999999999999999999999999888888


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  236 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~  236 (280)
                      .+.+..+.+....+.......  .+................+.+++.+.+||++||+.||.+|||++|+|+||||++.
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          212 RIFRILGTPNSKNWPNVTELP--KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             HHHHHHCCCCTTTSTTGGGST--TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             HHHHHHCCCChhhchhhhccc--ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence            888888877655443221100  0000111112222334455789999999999999999999999999999999764

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.8e-46  Score=317.33  Aligned_cols=235  Identities=36%  Similarity=0.700  Sum_probs=189.1

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD------QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDL   74 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~di   74 (280)
                      |+||||+++++++.++     +.+|+||||++|+|.+++...      ..+++..++.++.||+.||.|||+.||+||||
T Consensus        60 l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dl  134 (317)
T 2pmi_A           60 LKHENIVRLYDVIHTE-----NKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDL  134 (317)
T ss_dssp             CCBTTBCCEEEEECCT-----TEEEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred             cCCCCcceEEEEEEEC-----CeEEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCC
Confidence            5899999999999987     779999999999999998642      45999999999999999999999999999999


Q ss_pred             CCCceEEcCCCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 023568           75 KPSNLLLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY  153 (280)
Q Consensus        75 k~~Nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~  153 (280)
                      ||+||+++.++.+||+|||+++..... .......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+.
T Consensus       135 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~  214 (317)
T 2pmi_A          135 KPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND  214 (317)
T ss_dssp             CGGGEEECTTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             ChHHeEEcCCCCEEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence            999999999999999999999875433 2344567899999999998756789999999999999999999999999999


Q ss_pred             HHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCcccccc-----ccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 023568          154 VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQ-----FATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL  228 (280)
Q Consensus       154 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell  228 (280)
                      ...+..+....+.++...+.......  .+...........     .+......++++.+||++||+.||.+|||++|+|
T Consensus       215 ~~~~~~i~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l  292 (317)
T 2pmi_A          215 EEQLKLIFDIMGTPNESLWPSVTKLP--KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQAL  292 (317)
T ss_dssp             HHHHHHHHHHHCSCCTTTCGGGGGCT--TCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred             HHHHHHHHHHhCCCChhHhhhhhhhh--hcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHh
Confidence            99999999988887766544321100  0000000000000     1112235789999999999999999999999999


Q ss_pred             cCcccccCcCCCCC
Q 023568          229 RHPYLQSLHDLNDE  242 (280)
Q Consensus       229 ~hp~~~~~~~~~~~  242 (280)
                      +||||++......+
T Consensus       293 ~hp~f~~~~~~~~~  306 (317)
T 2pmi_A          293 HHPWFAEYYHHASM  306 (317)
T ss_dssp             TSGGGGGGCC----
T ss_pred             CChhhhcccchhhc
Confidence            99999988755443

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.9e-46  Score=314.68  Aligned_cols=230  Identities=35%  Similarity=0.668  Sum_probs=186.5

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++.++     ..+|+||||++|++.+.+.. .+.+++.+++.++.|++.||+|||++||+||||||+||
T Consensus        58 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Ni  132 (292)
T 3o0g_A           58 LKHKNIVRLHDVLHSD-----KKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNL  132 (292)
T ss_dssp             CCCTTBCCEEEEEEET-----TEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             CCCCCEeeEEeEEEeC-----CEEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence            5899999999999987     77999999999988887765 57899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCC-CCCCChHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPGKDYVHQL  157 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~p-f~~~~~~~~~  157 (280)
                      +++.++.++|+|||+++..... .......+|+.|+|||++.+...++.++|+||+||++|+|++|..| |.+.+....+
T Consensus       133 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~  212 (292)
T 3o0g_A          133 LINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL  212 (292)
T ss_dssp             EECTTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHH
T ss_pred             EEcCCCCEEEeecccceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHH
Confidence            9999999999999999875533 3345567899999999998756689999999999999999986655 7777778888


Q ss_pred             HHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCc
Q 023568          158 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  237 (280)
Q Consensus       158 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~  237 (280)
                      ..+....+.+....+........  +................+..++.+++||++||+.||++|||++|+|+||||+++.
T Consensus       213 ~~i~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  290 (292)
T 3o0g_A          213 KRIFRLLGTPTEEQWPSMTKLPD--YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             HHHHHHHCCCCTTTCTTGGGSTT--CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred             HHHHHHhCCCChhhhhhhccccc--ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence            99999888887765543221000  0000000011122233456899999999999999999999999999999998764

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.2e-46  Score=322.93  Aligned_cols=203  Identities=30%  Similarity=0.506  Sum_probs=177.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+||||++++++|++.     ..+|+||||++ |+|.+++.+.+.+++..+..++.||+.||.|||+.||+||||||+||
T Consensus        72 l~hpnIv~l~~~~~~~-----~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NI  146 (361)
T 2yab_A           72 VLHPNIITLHDVYENR-----TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENI  146 (361)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             CCCcCCCcEEEEEEeC-----CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence            5799999999999987     77999999996 69999998888999999999999999999999999999999999999


Q ss_pred             EEcCCC----CeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023568           80 LLNASC----DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH  155 (280)
Q Consensus        80 li~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~  155 (280)
                      +++.++    .++|+|||++.............||+.|+|||++.+ ..++.++|+||+||++|+|++|.+||.+.+...
T Consensus       147 ll~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~  225 (361)
T 2yab_A          147 MLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQE  225 (361)
T ss_dssp             EESCTTSSSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH
T ss_pred             EEeCCCCCccCEEEEecCCceEcCCCCccccCCCCccEECchHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            998776    799999999988766555567789999999999877 778999999999999999999999999988777


Q ss_pred             HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 023568          156 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  235 (280)
Q Consensus       156 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~  235 (280)
                      ....+.......+                           ...++.+++.+++||++||+.||.+|||++|+|+||||+.
T Consensus       226 ~~~~i~~~~~~~~---------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~  278 (361)
T 2yab_A          226 TLANITAVSYDFD---------------------------EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP  278 (361)
T ss_dssp             HHHHHHTTCCCCC---------------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred             HHHHHHhcCCCCC---------------------------chhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence            7666654221111                           1123467899999999999999999999999999999985


Q ss_pred             C
Q 023568          236 L  236 (280)
Q Consensus       236 ~  236 (280)
                      .
T Consensus       279 ~  279 (361)
T 2yab_A          279 V  279 (361)
T ss_dssp             S
T ss_pred             C
Confidence            4

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.1e-46  Score=321.72  Aligned_cols=200  Identities=29%  Similarity=0.496  Sum_probs=172.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      ++||||+++++++.+.     ..+|+||||++|+|.+++.+.+.+++.+++.++.|++.||.|||+.||+||||||+||+
T Consensus        66 l~hpnIv~l~~~~~~~-----~~~~lv~E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIl  140 (336)
T 3h4j_B           66 LRHPHIIKLYDVITTP-----TDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLL  140 (336)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEE
T ss_pred             CCCCCCCeEEEEEEeC-----CEEEEEEECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEE
Confidence            5899999999999988     67999999999999999988889999999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 023568           81 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLI  160 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~i  160 (280)
                      ++.++.+||+|||++............+||+.|+|||++.+....+.++||||+||++|+|++|..||.+......    
T Consensus       141 l~~~~~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~----  216 (336)
T 3h4j_B          141 LDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL----  216 (336)
T ss_dssp             ECTTCCEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC----
T ss_pred             EcCCCCEEEEEeccceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH----
Confidence            9999999999999998877666667778999999999998745557899999999999999999999976531110    


Q ss_pred             HHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 023568          161 TELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  236 (280)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~  236 (280)
                                                 ...........+...++.+.+||++||+.||.+|||++|+++||||+.-
T Consensus       217 ---------------------------~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          217 ---------------------------FKKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             ---------------------------BCCCCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred             ---------------------------HHHHHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence                                       0001111122334579999999999999999999999999999999753

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.9e-45  Score=314.35  Aligned_cols=199  Identities=27%  Similarity=0.445  Sum_probs=174.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||++++++|++.     ..+|+||||++ |+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||
T Consensus        62 l~hp~iv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NI  136 (337)
T 1o6l_A           62 TRHPFLTALKYAFQTH-----DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENL  136 (337)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGE
T ss_pred             CCCCcCcceEEEEEeC-----CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHE
Confidence            5799999999999988     77999999997 59999998888999999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccC-CCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      |++.++.++|+|||+++... ........+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+......
T Consensus       137 ll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~  215 (337)
T 1o6l_A          137 MLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE  215 (337)
T ss_dssp             EECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             EECCCCCEEEeeccchhhcccCCCcccccccChhhCChhhhcC-CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHH
Confidence            99999999999999998643 3334566789999999999977 778999999999999999999999999887666655


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYL  233 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rp-----t~~ell~hp~~  233 (280)
                      .+....                               ...+..+++.+.++|++||+.||.+||     +++|+++||||
T Consensus       216 ~i~~~~-------------------------------~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f  264 (337)
T 1o6l_A          216 LILMEE-------------------------------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF  264 (337)
T ss_dssp             HHHHCC-------------------------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGG
T ss_pred             HHHcCC-------------------------------CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCc
Confidence            554310                               011235789999999999999999999     99999999999


Q ss_pred             ccC
Q 023568          234 QSL  236 (280)
Q Consensus       234 ~~~  236 (280)
                      +.+
T Consensus       265 ~~~  267 (337)
T 1o6l_A          265 LSI  267 (337)
T ss_dssp             TTC
T ss_pred             CCC
Confidence            875

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.4e-46  Score=315.65  Aligned_cols=236  Identities=31%  Similarity=0.630  Sum_probs=181.6

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++.+.     ...++||||+++ +|.+++...+.+++..+..++.|++.||+|||+.||+||||||+||
T Consensus        59 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Ni  133 (311)
T 4agu_A           59 LKHPNLVNLLEVFRRK-----RRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENI  133 (311)
T ss_dssp             CCCTTBCCEEEEEEET-----TEEEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             CCCCCccchhheeecC-----CeEEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhE
Confidence            5899999999999887     779999999996 7778887778899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||.+...... .......+++.|+|||.+.+...++.++|+||+|+++|+|++|..||.+.+..+...
T Consensus       134 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~  213 (311)
T 4agu_A          134 LITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLY  213 (311)
T ss_dssp             EECTTSCEEECCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             EEcCCCCEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            9999999999999999875533 334556789999999999876778999999999999999999999999999988888


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCcC
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  238 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~~  238 (280)
                      .+.+..+...+.............................++.+++++.+||++||+.||.+|||++|+|+||||+++.+
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  293 (311)
T 4agu_A          214 LIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE  293 (311)
T ss_dssp             HHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-
T ss_pred             HHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccC
Confidence            88887776554332111100000000000000111122334678999999999999999999999999999999999875


Q ss_pred             CCC
Q 023568          239 LND  241 (280)
Q Consensus       239 ~~~  241 (280)
                      ...
T Consensus       294 ~~~  296 (311)
T 4agu_A          294 IED  296 (311)
T ss_dssp             ---
T ss_pred             HHH
Confidence            543

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.2e-45  Score=314.96  Aligned_cols=229  Identities=37%  Similarity=0.688  Sum_probs=180.9

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      |+||||+++++++.+.     ..+|+||||++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||+
T Consensus        90 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIl  164 (329)
T 3gbz_A           90 LQHRNIIELKSVIHHN-----HRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLL  164 (329)
T ss_dssp             CCCTTBCCEEEEEEET-----TEEEEEEECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred             cCCCCcceEEEEEecC-----CEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEE
Confidence            5899999999999987     77999999999999999998889999999999999999999999999999999999999


Q ss_pred             Ec-----CCCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023568           81 LN-----ASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV  154 (280)
Q Consensus        81 i~-----~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~  154 (280)
                      ++     .++.++|+|||++...... .......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..
T Consensus       165 l~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~  244 (329)
T 3gbz_A          165 LSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI  244 (329)
T ss_dssp             EEC-----CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             EecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH
Confidence            94     4455999999999865433 23445677999999999987566899999999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccc-cCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFAT-RFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      +.+..+....+.+....+.......  .+....+......... .....++.+.+||++||+.||.+|||++|+|+||||
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  322 (329)
T 3gbz_A          245 DQLFKIFEVLGLPDDTTWPGVTALP--DWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYF  322 (329)
T ss_dssp             HHHHHHHHHHCCCCTTTSTTGGGST--TCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred             HHHHHHHHHhCCCchhhhhhhhhhh--hhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCccc
Confidence            9999999888877765543221100  0000011111111111 112368999999999999999999999999999999


Q ss_pred             ccC
Q 023568          234 QSL  236 (280)
Q Consensus       234 ~~~  236 (280)
                      ++.
T Consensus       323 ~~~  325 (329)
T 3gbz_A          323 SHN  325 (329)
T ss_dssp             SSS
T ss_pred             CCC
Confidence            875

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-45  Score=314.85  Aligned_cols=232  Identities=35%  Similarity=0.655  Sum_probs=191.5

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+||||+++++++.+.     ...|+||||++++|.+++... ..+++..+..++.|++.||+|||+.||+||||||+||
T Consensus        69 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni  143 (346)
T 1ua2_A           69 LSHPNIIGLLDAFGHK-----SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNL  143 (346)
T ss_dssp             CCCTTBCCEEEEECCT-----TCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred             CCCCCCCeEEEEEeeC-----CceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHE
Confidence            5899999999999877     679999999999999998764 4699999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||+++..... .......+|+.|+|||++.+...++.++|+|||||++|+|++|.+||.+.+..+.+.
T Consensus       144 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~  223 (346)
T 1ua2_A          144 LLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLT  223 (346)
T ss_dssp             EECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             EEcCCCCEEEEecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence            9999999999999999876433 334556789999999999775678999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCcC
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  238 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~~  238 (280)
                      .+.+..+.+....+...+....  + .........+....++..++++.+||++||+.||.+|||++|+|+||||++...
T Consensus       224 ~i~~~~~~~~~~~~~~~~~~~~--~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~  300 (346)
T 1ua2_A          224 RIFETLGTPTEEQWPDMCSLPD--Y-VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG  300 (346)
T ss_dssp             HHHHHHCCCCTTTSSSTTSSTT--C-CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred             HHHHHcCCCChhhhhhhccCcc--c-ccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCC
Confidence            9988888877665543322100  0 000011111222334677899999999999999999999999999999988654


Q ss_pred             CC
Q 023568          239 LN  240 (280)
Q Consensus       239 ~~  240 (280)
                      +.
T Consensus       301 ~~  302 (346)
T 1ua2_A          301 PT  302 (346)
T ss_dssp             CC
T ss_pred             CC
Confidence            43

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=5.3e-46  Score=319.75  Aligned_cols=198  Identities=22%  Similarity=0.411  Sum_probs=170.8

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      +||||++++++|++.     ..+|+||||+. |+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||
T Consensus        82 ~hp~Iv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIL  156 (353)
T 3txo_A           82 NHPFLTQLFCCFQTP-----DRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVL  156 (353)
T ss_dssp             TCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEE
T ss_pred             CCCceeeEEEEEEeC-----CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEE
Confidence            699999999999988     77999999997 599999988889999999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccccCC-CCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           81 LNASCDLKIGDFGLARTTSE-TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      ++.++.+||+|||+++.... .......+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+..+....
T Consensus       157 l~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~  235 (353)
T 3txo_A          157 LDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA  235 (353)
T ss_dssp             ECTTSCEEECCCTTCBCSCC---------CCGGGCCHHHHHH-HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             ECCCCCEEEccccceeecccCCccccccCCCcCeEChhhcCC-CCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            99999999999999986433 233456789999999999877 6788999999999999999999999999887777766


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCH------HHHhcCccc
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV------EEALRHPYL  233 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~------~ell~hp~~  233 (280)
                      +.....                               ..+..+++++.++|++||+.||.+||++      +|+++||||
T Consensus       236 i~~~~~-------------------------------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f  284 (353)
T 3txo_A          236 ILNDEV-------------------------------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFF  284 (353)
T ss_dssp             HHHCCC-------------------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGG
T ss_pred             HHcCCC-------------------------------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcc
Confidence            654110                               1122478999999999999999999998      899999999


Q ss_pred             ccC
Q 023568          234 QSL  236 (280)
Q Consensus       234 ~~~  236 (280)
                      +++
T Consensus       285 ~~~  287 (353)
T 3txo_A          285 KEI  287 (353)
T ss_dssp             TTC
T ss_pred             cCC
Confidence            876

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=6.2e-45  Score=320.26  Aligned_cols=238  Identities=30%  Similarity=0.605  Sum_probs=189.6

Q ss_pred             CCCcccccccccccCCCC-CCCCcEEEEEecCCccHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 023568            1 MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK   75 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~-~~~~~~~lv~e~~~g~L~~~l~----~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik   75 (280)
                      |+|||||+++++|..... .....+++||||++++|.+.+.    ....+++..++.++.||+.||+|||++||+|||||
T Consensus       104 l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlk  183 (420)
T 1j1b_A          104 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIK  183 (420)
T ss_dssp             CCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCS
T ss_pred             cCCCCccceeeEEeccCCCCcceeEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Confidence            689999999999865321 1114578999999998887764    35789999999999999999999999999999999


Q ss_pred             CCceEEcCC-CCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023568           76 PSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV  154 (280)
Q Consensus        76 ~~Nili~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~  154 (280)
                      |+|||++.+ +.+||+|||+++............+|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..
T Consensus       184 p~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~  263 (420)
T 1j1b_A          184 PQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV  263 (420)
T ss_dssp             GGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             hhhEEEeCCCCeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence            999999965 5689999999987655554566788999999999987568899999999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCcccccccccc-CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR-FPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      +.+..+.+.++.+....+........ .  ..++......+... .+..++++++||++||+.||.+|||+.|+++||||
T Consensus       264 ~~l~~i~~~lg~p~~~~~~~~~~~~~-~--~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f  340 (420)
T 1j1b_A          264 DQLVEIIKVLGTPTREQIREMNPNYT-E--FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF  340 (420)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHHCSCCC-C--CCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             HHHHHHHHHhCCCCHHHHHhhChhhh-h--hccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhh
Confidence            99999999998887654322110000 0  00111111112222 24578999999999999999999999999999999


Q ss_pred             ccCcCCCC
Q 023568          234 QSLHDLND  241 (280)
Q Consensus       234 ~~~~~~~~  241 (280)
                      +.+.+...
T Consensus       341 ~~~~~~~~  348 (420)
T 1j1b_A          341 DELRDPNV  348 (420)
T ss_dssp             GGGGCTTC
T ss_pred             cccccccc
Confidence            98876543

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.2e-45  Score=321.26  Aligned_cols=235  Identities=32%  Similarity=0.657  Sum_probs=190.0

Q ss_pred             CCCcccccccccccCCCC---------------------------------CCCCcEEEEEecCCccHHHHHH----cCC
Q 023568            1 MEHENVIAIKDIIRPPKK---------------------------------DTFNDVYIVYELMDTDLHQIIR----SDQ   43 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~---------------------------------~~~~~~~lv~e~~~g~L~~~l~----~~~   43 (280)
                      |+||||++++++|.....                                 .....+++||||++|+|.+.+.    ..+
T Consensus        57 l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~  136 (383)
T 3eb0_A           57 LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGR  136 (383)
T ss_dssp             CCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTC
T ss_pred             cCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCC
Confidence            589999999999965421                                 1224589999999998877764    457


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc-CCCCeEEeecccccccCCCCccccceeccccccccccccC
Q 023568           44 QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN-ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC  122 (280)
Q Consensus        44 ~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  122 (280)
                      .+++..++.++.||+.||+|||+.||+||||||+||+++ .++.++|+|||+++............+|+.|+|||++.+.
T Consensus       137 ~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~  216 (383)
T 3eb0_A          137 SIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGA  216 (383)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCC
Confidence            899999999999999999999999999999999999998 5889999999999877666556677889999999998876


Q ss_pred             CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCcccccccccc-CCC
Q 023568          123 TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR-FPN  201 (280)
Q Consensus       123 ~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  201 (280)
                      ..++.++||||+||++|+|++|+.||.+.+..+.+..+.+..+.+....+.........   ...+......+... ...
T Consensus       217 ~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~  293 (383)
T 3eb0_A          217 TEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTE---VRFPTLKAKDWRKILPEG  293 (383)
T ss_dssp             SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC-----CCCCCCCCCCHHHHSCTT
T ss_pred             CCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCccccc---ccCCccCcccHHhhCCCC
Confidence            67899999999999999999999999999999999999999998876643322111000   01111112222222 235


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCcC
Q 023568          202 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  238 (280)
Q Consensus       202 ~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~~  238 (280)
                      .++++.+||++||+.||.+|||+.|+|+||||+.+.+
T Consensus       294 ~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  330 (383)
T 3eb0_A          294 TPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRN  330 (383)
T ss_dssp             CCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHHHHH
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHHHHh
Confidence            7999999999999999999999999999999987654

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-45  Score=310.26  Aligned_cols=198  Identities=23%  Similarity=0.463  Sum_probs=175.0

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++++.     ..+|+||||+. |+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||
T Consensus        63 l~hp~Iv~~~~~~~~~-----~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NI  137 (318)
T 1fot_A           63 VTHPFIIRMWGTFQDA-----QQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENI  137 (318)
T ss_dssp             CCBTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGE
T ss_pred             CCCCCCceEeEEEEeC-----CEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheE
Confidence            5799999999999987     77999999997 59999999888999999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.++.++|+|||+++.....  ....+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+.......
T Consensus       138 ll~~~g~~kL~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~  214 (318)
T 1fot_A          138 LLDKNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK  214 (318)
T ss_dssp             EECTTSCEEECCCSSCEECSSC--BCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH
T ss_pred             EEcCCCCEEEeecCcceecCCc--cccccCCccccCHhHhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9999999999999999875543  345688999999999877 7788999999999999999999999998887666665


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCcccc
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQ  234 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rp-----t~~ell~hp~~~  234 (280)
                      +....                               ....+..++++.++|++||+.||++||     +++++++||||+
T Consensus       215 i~~~~-------------------------------~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~  263 (318)
T 1fot_A          215 ILNAE-------------------------------LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFK  263 (318)
T ss_dssp             HHHCC-------------------------------CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGS
T ss_pred             HHhCC-------------------------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCcccc
Confidence            54310                               011235789999999999999999999     999999999998


Q ss_pred             cCc
Q 023568          235 SLH  237 (280)
Q Consensus       235 ~~~  237 (280)
                      ++.
T Consensus       264 ~~~  266 (318)
T 1fot_A          264 EVV  266 (318)
T ss_dssp             SCC
T ss_pred             CCC
Confidence            753

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.1e-45  Score=312.07  Aligned_cols=203  Identities=30%  Similarity=0.511  Sum_probs=176.5

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+||||+++++++.+.     ...|+||||++ |+|.+++...+.+++.++..++.|++.||.|||+.||+||||||+||
T Consensus        71 l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NI  145 (326)
T 2y0a_A           71 IQHPNVITLHEVYENK-----TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENI  145 (326)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred             CCCCCCCcEEEEEEeC-----CEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHE
Confidence            5899999999999987     77999999996 59999998888899999999999999999999999999999999999


Q ss_pred             EEcCCC----CeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023568           80 LLNASC----DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH  155 (280)
Q Consensus        80 li~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~  155 (280)
                      +++.++    .++|+|||+++............||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.....
T Consensus       146 ll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  224 (326)
T 2y0a_A          146 MLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQE  224 (326)
T ss_dssp             EESCSSSSSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH
T ss_pred             EEecCCCCCCCEEEEECCCCeECCCCCccccccCCcCcCCceeecC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH
Confidence            998877    799999999987765554566789999999999876 778999999999999999999999999887766


Q ss_pred             HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 023568          156 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  235 (280)
Q Consensus       156 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~  235 (280)
                      ....+.......+                           ...++..++.+.+||++||+.||.+|||++|+|+||||+.
T Consensus       225 ~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  277 (326)
T 2y0a_A          225 TLANVSAVNYEFE---------------------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP  277 (326)
T ss_dssp             HHHHHHHTCCCCC---------------------------HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSC
T ss_pred             HHHHHHhcCCCcC---------------------------ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccC
Confidence            6665544221111                           1122467899999999999999999999999999999976


Q ss_pred             C
Q 023568          236 L  236 (280)
Q Consensus       236 ~  236 (280)
                      .
T Consensus       278 ~  278 (326)
T 2y0a_A          278 K  278 (326)
T ss_dssp             C
T ss_pred             C
Confidence            4

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.1e-45  Score=315.02  Aligned_cols=200  Identities=27%  Similarity=0.454  Sum_probs=175.2

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||++++++|++.     ..+|+||||+. |+|.+++.+.+.+++.+++.++.||+.||.|||++||+||||||+||
T Consensus        75 ~~hp~iv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NI  149 (345)
T 1xjd_A           75 WEHPFLTHMFCTFQTK-----ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNI  149 (345)
T ss_dssp             TTCTTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGE
T ss_pred             CCCCCCCcEEEEEEeC-----CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhE
Confidence            3799999999999988     77999999997 59999998878999999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCC-CCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSE-TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||+++.... .......+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+......
T Consensus       150 ll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~  228 (345)
T 1xjd_A          150 LLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH  228 (345)
T ss_dssp             EECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             EECCCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcC-CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence            999999999999999986432 233456789999999999987 678999999999999999999999999988766666


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHH-HHhcCcccccCc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVE-EALRHPYLQSLH  237 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~-ell~hp~~~~~~  237 (280)
                      .+....                               ......+++.+.+||++||+.||.+||++. ++++||||+++.
T Consensus       229 ~i~~~~-------------------------------~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~  277 (345)
T 1xjd_A          229 SIRMDN-------------------------------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN  277 (345)
T ss_dssp             HHHHCC-------------------------------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred             HHHhCC-------------------------------CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCC
Confidence            554310                               011235789999999999999999999998 999999998864

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=4.8e-45  Score=306.97  Aligned_cols=202  Identities=24%  Similarity=0.415  Sum_probs=173.2

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++...     ...|+||||++ |+|.+++.+ ..+++.++..++.|++.||+|||+.||+||||||+||
T Consensus        74 l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Ni  147 (297)
T 3fxz_A           74 NKNPNIVNYLDSYLVG-----DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNI  147 (297)
T ss_dssp             CCCTTBCCEEEEEEET-----TEEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             CCCCCCCeEeEEEEEC-----CEEEEEEECCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHE
Confidence            5899999999999987     67999999996 599999976 4799999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||++...... .......||+.|+|||++.+ ..++.++||||+||++|+|++|..||.+.+......
T Consensus       148 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~  226 (297)
T 3fxz_A          148 LLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY  226 (297)
T ss_dssp             EECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHC-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred             EECCCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            9999999999999998865543 23445688999999999987 778999999999999999999999999887766655


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  237 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~  237 (280)
                      .+.......                            ......+++.+.+||.+||+.||.+|||++|+++||||+...
T Consensus       227 ~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  277 (297)
T 3fxz_A          227 LIATNGTPE----------------------------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK  277 (297)
T ss_dssp             HHHHHCSCC----------------------------CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHHhCCCCC----------------------------CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence            544321110                            011235688999999999999999999999999999998654

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=5e-45  Score=317.48  Aligned_cols=198  Identities=23%  Similarity=0.461  Sum_probs=168.9

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      +||||++++++|++.     ..+|+||||+. |+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||
T Consensus       111 ~hp~Iv~l~~~~~~~-----~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NIL  185 (396)
T 4dc2_A          111 NHPFLVGLHSCFQTE-----SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVL  185 (396)
T ss_dssp             TCTTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEE
T ss_pred             CCCCcCeeEEEEEEC-----CEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEE
Confidence            799999999999988     77999999997 599999988889999999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeeccccccc-CCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH----
Q 023568           81 LNASCDLKIGDFGLARTT-SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH----  155 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~----  155 (280)
                      ++.++.+||+|||+++.. .........+||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||.......    
T Consensus       186 l~~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~  264 (396)
T 4dc2_A          186 LDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ  264 (396)
T ss_dssp             ECTTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------
T ss_pred             ECCCCCEEEeecceeeecccCCCccccccCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccch
Confidence            999999999999999863 33344567789999999999987 778999999999999999999999997543111    


Q ss_pred             -----HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCH------
Q 023568          156 -----QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV------  224 (280)
Q Consensus       156 -----~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~------  224 (280)
                           ....+..                               .....++.+++++.+||++||+.||.+||++      
T Consensus       265 ~~~~~~~~~i~~-------------------------------~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~  313 (396)
T 4dc2_A          265 NTEDYLFQVILE-------------------------------KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGF  313 (396)
T ss_dssp             CCHHHHHHHHHH-------------------------------CCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHH
T ss_pred             hhHHHHHHHHhc-------------------------------cccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCH
Confidence                 1111111                               0112234579999999999999999999985      


Q ss_pred             HHHhcCcccccC
Q 023568          225 EEALRHPYLQSL  236 (280)
Q Consensus       225 ~ell~hp~~~~~  236 (280)
                      +|+++||||+++
T Consensus       314 ~ei~~Hpff~~i  325 (396)
T 4dc2_A          314 ADIQGHPFFRNV  325 (396)
T ss_dssp             HHHHHSTTTTTC
T ss_pred             HHHhcCccccCC
Confidence            899999999876

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.5e-46  Score=314.50  Aligned_cols=203  Identities=24%  Similarity=0.440  Sum_probs=176.5

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||+++++++.+.     ..+|+||||++| +|.+++... ..+++.++..++.|++.||.|||+.||+||||||+|
T Consensus        58 l~hpnIv~~~~~~~~~-----~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~N  132 (321)
T 1tki_A           58 ARHRNILHLHESFESM-----EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPEN  132 (321)
T ss_dssp             SCCTTBCCEEEEEEET-----TEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred             CCCCCCCeEeEEEecC-----CEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHH
Confidence            5899999999999887     779999999985 999999765 479999999999999999999999999999999999


Q ss_pred             eEEcC--CCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023568           79 LLLNA--SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  156 (280)
Q Consensus        79 ili~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~  156 (280)
                      |+++.  ++.++|+|||++.............||+.|+|||++.+ ..++.++|+||+||++|+|++|..||.+......
T Consensus       133 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  211 (321)
T 1tki_A          133 IIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI  211 (321)
T ss_dssp             EEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred             EEEccCCCCCEEEEECCCCeECCCCCccccccCChhhcCcHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHH
Confidence            99987  78999999999988766555566788999999999877 6678999999999999999999999999887776


Q ss_pred             HHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 023568          157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  236 (280)
Q Consensus       157 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~  236 (280)
                      ...+.......+.                           ..++.+++.+.+||++||+.||.+|||++|+|+||||+..
T Consensus       212 ~~~i~~~~~~~~~---------------------------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          212 IENIMNAEYTFDE---------------------------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             HHHHHHTCCCCCH---------------------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             HHHHHcCCCCCCh---------------------------hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence            6666542221111                           1234679999999999999999999999999999999864

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=7.3e-45  Score=321.24  Aligned_cols=203  Identities=29%  Similarity=0.492  Sum_probs=176.0

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+||||+++++++.+.     +..|+||||+. |+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+||
T Consensus        67 l~hpnIv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NI  141 (444)
T 3soa_A           67 LKHPNIVRLHDSISEE-----GHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENL  141 (444)
T ss_dssp             CCBTTBCCEEEEEECS-----SEEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTE
T ss_pred             CCCcCCCeEEEEEEEC-----CEEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHE
Confidence            6899999999999988     78999999997 59999999888999999999999999999999999999999999999


Q ss_pred             EEc---CCCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023568           80 LLN---ASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH  155 (280)
Q Consensus        80 li~---~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~  155 (280)
                      |++   .++.+||+|||++...... .......||+.|+|||++.+ ..++.++||||+||++|+|++|.+||.+.+...
T Consensus       142 ll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~  220 (444)
T 3soa_A          142 LLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPFWDEDQHR  220 (444)
T ss_dssp             EESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             EEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCccHHH
Confidence            998   4678999999999876543 33456789999999999877 678999999999999999999999999988777


Q ss_pred             HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 023568          156 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  235 (280)
Q Consensus       156 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~  235 (280)
                      ....+.......+                           ...++.+++.+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus       221 ~~~~i~~~~~~~~---------------------------~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~  273 (444)
T 3soa_A          221 LYQQIKAGAYDFP---------------------------SPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISH  273 (444)
T ss_dssp             HHHHHHHTCCCCC---------------------------TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred             HHHHHHhCCCCCC---------------------------ccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence            7666654221111                           1123467999999999999999999999999999999975


Q ss_pred             C
Q 023568          236 L  236 (280)
Q Consensus       236 ~  236 (280)
                      .
T Consensus       274 ~  274 (444)
T 3soa_A          274 R  274 (444)
T ss_dssp             H
T ss_pred             C
Confidence            4

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.6e-45  Score=316.68  Aligned_cols=206  Identities=28%  Similarity=0.425  Sum_probs=156.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+||||+++++++.+.     ..+|+||||++ |+|.+++...+++++..++.++.|++.||+|||++||+||||||+||
T Consensus        73 l~hpniv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Ni  147 (361)
T 3uc3_A           73 LRHPNIVRFKEVILTP-----THLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENT  147 (361)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGE
T ss_pred             CCCCCCCcEEEEEeeC-----CEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence            6899999999999987     77999999996 59999998878999999999999999999999999999999999999


Q ss_pred             EEcCCCC--eEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023568           80 LLNASCD--LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  157 (280)
Q Consensus        80 li~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~  157 (280)
                      +++.++.  +||+|||+++............||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.......
T Consensus       148 ll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~  227 (361)
T 3uc3_A          148 LLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY  227 (361)
T ss_dssp             EECSSSSCCEEECCCCCC---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH
T ss_pred             EEcCCCCceEEEeecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH
Confidence            9987665  99999999986544444556789999999999987444455699999999999999999999876432222


Q ss_pred             HHH-HHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 023568          158 RLI-TELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  236 (280)
Q Consensus       158 ~~i-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~  236 (280)
                      ..+ ........                          .......+++.+.+||++||+.||.+|||++|+++||||...
T Consensus       228 ~~~~~~~~~~~~--------------------------~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  281 (361)
T 3uc3_A          228 RKTIQRILSVKY--------------------------SIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN  281 (361)
T ss_dssp             HHHHHHHHTTCC--------------------------CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred             HHHHHHHhcCCC--------------------------CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence            211 11111000                          001112468999999999999999999999999999999765


Q ss_pred             c
Q 023568          237 H  237 (280)
Q Consensus       237 ~  237 (280)
                      .
T Consensus       282 ~  282 (361)
T 3uc3_A          282 L  282 (361)
T ss_dssp             C
T ss_pred             C
Confidence            4

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=4.8e-45  Score=315.03  Aligned_cols=203  Identities=28%  Similarity=0.508  Sum_probs=175.5

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+||||+++++++.+.     ...|+||||+.| +|.+.+...+.+++.++..++.||+.||.|||++||+||||||+||
T Consensus        85 l~hpnIv~~~~~~~~~-----~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NI  159 (362)
T 2bdw_A           85 LQHPNIVRLHDSIQEE-----SFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENL  159 (362)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGE
T ss_pred             CCCCCCCeEEEEEEeC-----CEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHE
Confidence            6899999999999988     779999999975 9999998888899999999999999999999999999999999999


Q ss_pred             EEcCC---CCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023568           80 LLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  156 (280)
Q Consensus        80 li~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~  156 (280)
                      +++.+   +.+||+|||++.............||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+....
T Consensus       160 ll~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~  238 (362)
T 2bdw_A          160 LLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL  238 (362)
T ss_dssp             EESCSSTTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             EEecCCCCCCEEEeecCcceEecCCcccccCCCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence            99765   4599999999987766555566789999999999877 6789999999999999999999999998887666


Q ss_pred             HHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 023568          157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  236 (280)
Q Consensus       157 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~  236 (280)
                      ...+.......+.                           ..++.+++.+.+||.+||+.||.+|||++|+|+||||...
T Consensus       239 ~~~i~~~~~~~~~---------------------------~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  291 (362)
T 2bdw_A          239 YAQIKAGAYDYPS---------------------------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR  291 (362)
T ss_dssp             HHHHHHTCCCCCT---------------------------TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred             HHHHHhCCCCCCc---------------------------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence            6655442111111                           1123568999999999999999999999999999999754

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.9e-45  Score=319.65  Aligned_cols=237  Identities=35%  Similarity=0.624  Sum_probs=179.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD---------QQLTDDHCQYFLYQLLRGLKYVHSASVLH   71 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~---------~~l~~~~~~~i~~qil~~l~~LH~~~i~H   71 (280)
                      |+||||++++++|.....   ..+|+||||++|+|.+++...         ..+++..++.++.||+.||+|||+.||+|
T Consensus        75 l~hpniv~~~~~~~~~~~---~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH  151 (405)
T 3rgf_A           75 LKHPNVISLQKVFLSHAD---RKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLH  151 (405)
T ss_dssp             CCCTTBCCCCEEEEETTT---TEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             cCCCCeeeEeeEEecCCC---CeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeC
Confidence            689999999999965322   679999999999999988531         24999999999999999999999999999


Q ss_pred             cCCCCCceEE----cCCCCeEEeecccccccCCC----CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh
Q 023568           72 RDLKPSNLLL----NASCDLKIGDFGLARTTSET----DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT  143 (280)
Q Consensus        72 ~dik~~Nili----~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~  143 (280)
                      |||||+|||+    +.++.++|+|||+++.....    .......||+.|+|||++.+...++.++|||||||++|+|++
T Consensus       152 ~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~  231 (405)
T 3rgf_A          152 RDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT  231 (405)
T ss_dssp             CCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHH
T ss_pred             CCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHh
Confidence            9999999999    67789999999999865432    223456789999999999876678999999999999999999


Q ss_pred             CCCCCCCCCh---------HHHHHHHHHHhCCCCcccccccCC-hhHHHHHHhCCcccccc------ccccCCCCCHHHH
Q 023568          144 REPLFPGKDY---------VHQLRLITELIGSPDDASLGFLRS-DNARRYVRQLPRCRKQQ------FATRFPNKSSGAV  207 (280)
Q Consensus       144 g~~pf~~~~~---------~~~~~~i~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~  207 (280)
                      |.+||.+...         .+.+..+...++.+....+..... .................      ........++.+.
T Consensus       232 g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (405)
T 3rgf_A          232 SEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAF  311 (405)
T ss_dssp             SSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHH
T ss_pred             CCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHH
Confidence            9999987654         578888999999888776554432 11222222221110000      0111223478899


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCcccccCcCCC
Q 023568          208 DLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN  240 (280)
Q Consensus       208 ~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~~~~  240 (280)
                      +||++||+.||.+|||++|+|+||||.....+.
T Consensus       312 ~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~~~~  344 (405)
T 3rgf_A          312 HLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPT  344 (405)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHTSGGGTSSSCCC
T ss_pred             HHHHHHccCCcccCCCHHHHhcChhhccCCCCc
Confidence            999999999999999999999999998765443

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.3e-44  Score=311.08  Aligned_cols=198  Identities=22%  Similarity=0.414  Sum_probs=174.0

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      +||||++++++|++.     ..+|+||||+. |+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||
T Consensus        79 ~hp~iv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIl  153 (353)
T 2i0e_A           79 KPPFLTQLHSCFQTM-----DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVM  153 (353)
T ss_dssp             CCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEE
T ss_pred             CCCEEeeEEEEEEcC-----CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEE
Confidence            699999999999987     77999999997 599999988788999999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccccC-CCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           81 LNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      ++.++.++|+|||+++... ........+||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.+.......
T Consensus       154 l~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~  232 (353)
T 2i0e_A          154 LDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS  232 (353)
T ss_dssp             ECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             EcCCCcEEEEeCCcccccccCCcccccccCCccccChhhhcC-CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence            9999999999999998643 2333456789999999999977 7789999999999999999999999999887766666


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCcccc
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQ  234 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rp-----t~~ell~hp~~~  234 (280)
                      +....                               ...+..+++++.+||++||+.||.+||     +++++++||||+
T Consensus       233 i~~~~-------------------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~  281 (353)
T 2i0e_A          233 IMEHN-------------------------------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR  281 (353)
T ss_dssp             HHHCC-------------------------------CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGT
T ss_pred             HHhCC-------------------------------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCcccc
Confidence            55410                               011235789999999999999999999     479999999998


Q ss_pred             cC
Q 023568          235 SL  236 (280)
Q Consensus       235 ~~  236 (280)
                      .+
T Consensus       282 ~~  283 (353)
T 2i0e_A          282 YI  283 (353)
T ss_dssp             TC
T ss_pred             CC
Confidence            75

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.1e-44  Score=313.53  Aligned_cols=200  Identities=24%  Similarity=0.446  Sum_probs=175.4

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||++++++|++.     ..+|+||||+. |+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||
T Consensus        96 ~~hp~Iv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NI  170 (373)
T 2r5t_A           96 VKHPFLVGLHFSFQTA-----DKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENI  170 (373)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred             CCCCCCCCEEEEEEeC-----CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHE
Confidence            5799999999999988     78999999997 59999998888999999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccC-CCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      |++.++.+||+|||+++... ........+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+......
T Consensus       171 ll~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~  249 (373)
T 2r5t_A          171 LLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD  249 (373)
T ss_dssp             EECTTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHH
T ss_pred             EECCCCCEEEeeCccccccccCCCccccccCCccccCHHHhCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            99999999999999998633 3334566789999999999987 778999999999999999999999999988776666


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCH----HHHhcCcccc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV----EEALRHPYLQ  234 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~----~ell~hp~~~  234 (280)
                      .+....                               ....+.+++.+.++|++||+.||.+||++    +++++||||+
T Consensus       250 ~i~~~~-------------------------------~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~  298 (373)
T 2r5t_A          250 NILNKP-------------------------------LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFS  298 (373)
T ss_dssp             HHHHSC-------------------------------CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGT
T ss_pred             HHHhcc-------------------------------cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCcccc
Confidence            654410                               01224678999999999999999999986    6999999998


Q ss_pred             cCc
Q 023568          235 SLH  237 (280)
Q Consensus       235 ~~~  237 (280)
                      .+.
T Consensus       299 ~~~  301 (373)
T 2r5t_A          299 LIN  301 (373)
T ss_dssp             TCC
T ss_pred             CCC
Confidence            753

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=5.3e-44  Score=304.05  Aligned_cols=234  Identities=38%  Similarity=0.630  Sum_probs=191.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||+++++++...........++||||++|+|.+++...  ..+++..+..++.|++.||.|||+.||+||||||+|
T Consensus        71 ~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~N  150 (326)
T 1blx_A           71 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQN  150 (326)
T ss_dssp             TCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred             cCCCCeEeeeeeeeecccCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHH
Confidence            479999999999873221122679999999999999999764  359999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      |+++.++.++|+|||++.............++..|+|||++.+ ..++.++|+|||||++|+|++|..||.+......+.
T Consensus       151 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  229 (326)
T 1blx_A          151 ILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG  229 (326)
T ss_dssp             EEECTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             eEEcCCCCEEEecCcccccccCCCCccccccccceeCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            9999999999999999987665544556778999999999977 678999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCcC
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  238 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~~  238 (280)
                      .+....+.+....+........    ...............+.++..+.+||.+||+.||.+|||++|+++||||+++..
T Consensus       230 ~i~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~  305 (326)
T 1blx_A          230 KILDVIGLPGEEDWPRDVALPR----QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  305 (326)
T ss_dssp             HHHHHHCCCCGGGSCTTCSSCG----GGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             HHHHHcCCCCcccCccccccch----hhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence            9988888776655432211000    011111222334445678999999999999999999999999999999998764


Q ss_pred             C
Q 023568          239 L  239 (280)
Q Consensus       239 ~  239 (280)
                      .
T Consensus       306 ~  306 (326)
T 1blx_A          306 C  306 (326)
T ss_dssp             C
T ss_pred             h
Confidence            3

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.5e-44  Score=310.46  Aligned_cols=197  Identities=23%  Similarity=0.414  Sum_probs=174.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++.+.     ..+|+||||+. |+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||
T Consensus        98 l~hp~iv~~~~~~~~~-----~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NI  172 (350)
T 1rdq_E           98 VNFPFLVKLEFSFKDN-----SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENL  172 (350)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             CCCCCCCeEEEEEEcC-----CEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceE
Confidence            5799999999999987     77999999996 69999998878899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      |++.++.++|+|||+++.....  ....+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+.......
T Consensus       173 ll~~~g~~kL~DFg~a~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~  249 (350)
T 1rdq_E          173 LIDQQGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK  249 (350)
T ss_dssp             EECTTSCEEECCCTTCEECSSC--BCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             EECCCCCEEEcccccceeccCC--cccccCCccccCHHHhcC-CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHH
Confidence            9999999999999999876543  345689999999999987 6788999999999999999999999998887666666


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCcccc
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT-----VEEALRHPYLQ  234 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt-----~~ell~hp~~~  234 (280)
                      +....                               ...+..+++.+.++|++||+.||.+||+     ++++++||||+
T Consensus       250 i~~~~-------------------------------~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~  298 (350)
T 1rdq_E          250 IVSGK-------------------------------VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA  298 (350)
T ss_dssp             HHHCC-------------------------------CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGT
T ss_pred             HHcCC-------------------------------CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcC
Confidence            54410                               0112357899999999999999999998     99999999998


Q ss_pred             cC
Q 023568          235 SL  236 (280)
Q Consensus       235 ~~  236 (280)
                      .+
T Consensus       299 ~~  300 (350)
T 1rdq_E          299 TT  300 (350)
T ss_dssp             TC
T ss_pred             CC
Confidence            75

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.1e-44  Score=314.33  Aligned_cols=204  Identities=23%  Similarity=0.452  Sum_probs=172.6

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++|||||+++++|.+.     ..+|+||||+. |+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+||
T Consensus        72 l~hp~Iv~l~~~~~~~-----~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NI  146 (384)
T 4fr4_A           72 LEHPFLVNLWYSFQDE-----EDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNI  146 (384)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             CCCCCCCcEEEEEEeC-----CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHe
Confidence            5899999999999988     77999999996 59999999888999999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceeccccccccccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC--TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  157 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~  157 (280)
                      |++.++.++|+|||+++............||+.|+|||++.+.  ..++.++|+|||||++|+|++|..||.........
T Consensus       147 ll~~~g~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~  226 (384)
T 4fr4_A          147 LLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSK  226 (384)
T ss_dssp             EECTTSCEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHH
T ss_pred             EECCCCCEEEeccceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHH
Confidence            9999999999999999887666656778899999999998642  45788999999999999999999999865422111


Q ss_pred             HHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCC-HHHHhcCcccccC
Q 023568          158 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT-VEEALRHPYLQSL  236 (280)
Q Consensus       158 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt-~~ell~hp~~~~~  236 (280)
                      ..+.....                            .....+..+++.+.+||++||+.||.+||+ ++++++||||+++
T Consensus       227 ~~~~~~~~----------------------------~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~  278 (384)
T 4fr4_A          227 EIVHTFET----------------------------TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI  278 (384)
T ss_dssp             HHHHHHHH----------------------------CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred             HHHHHHhh----------------------------cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcC
Confidence            11111000                            001122357899999999999999999998 9999999999876


Q ss_pred             c
Q 023568          237 H  237 (280)
Q Consensus       237 ~  237 (280)
                      .
T Consensus       279 ~  279 (384)
T 4fr4_A          279 N  279 (384)
T ss_dssp             C
T ss_pred             C
Confidence            3

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=5.8e-45  Score=313.33  Aligned_cols=237  Identities=34%  Similarity=0.596  Sum_probs=185.1

Q ss_pred             CCCcccccccccccCCCC---CCCCcEEEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 023568            1 MEHENVIAIKDIIRPPKK---DTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP   76 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~---~~~~~~~lv~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~   76 (280)
                      ++||||+++++++.....   ...+.+|+||||++|+|.+.+... ..+++.+++.++.|++.||+|||+.||+||||||
T Consensus        73 l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp  152 (351)
T 3mi9_A           73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKA  152 (351)
T ss_dssp             CCCTTBCCEEEEEEEC--------CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred             ccCCCcccHhheeeccccccccCCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCH
Confidence            589999999999987521   012568999999999999888754 6799999999999999999999999999999999


Q ss_pred             CceEEcCCCCeEEeecccccccCCC-----CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 023568           77 SNLLLNASCDLKIGDFGLARTTSET-----DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK  151 (280)
Q Consensus        77 ~Nili~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~  151 (280)
                      +||+++.++.++|+|||+++.....     .......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.
T Consensus       153 ~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  232 (351)
T 3mi9_A          153 ANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN  232 (351)
T ss_dssp             GGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             HHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999999999999764421     22345678999999999987667899999999999999999999999999


Q ss_pred             ChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccC--CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          152 DYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF--PNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       152 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      ........+....+..++..+................ ..........  ...++.+.+||++||+.||.+|||++|+|+
T Consensus       233 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          233 TEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVK-GQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             SHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCS-SCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ChHHHHHHHHHHhCCCChhhccccccchhhccccccc-ccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            9999999999988887776554332111000000000 0000000000  013788999999999999999999999999


Q ss_pred             CcccccCcC
Q 023568          230 HPYLQSLHD  238 (280)
Q Consensus       230 hp~~~~~~~  238 (280)
                      ||||.+...
T Consensus       312 hp~f~~~~~  320 (351)
T 3mi9_A          312 HDFFWSDPM  320 (351)
T ss_dssp             SGGGGSSSC
T ss_pred             CCCcCCCCC
Confidence            999987543

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2e-44  Score=309.15  Aligned_cols=199  Identities=23%  Similarity=0.452  Sum_probs=168.3

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      +||||++++++|++.     ..+|+||||+. |+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||
T Consensus        68 ~hp~iv~l~~~~~~~-----~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIl  142 (345)
T 3a8x_A           68 NHPFLVGLHSCFQTE-----SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVL  142 (345)
T ss_dssp             TCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEE
T ss_pred             CCCccCeEEEEEEeC-----CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEE
Confidence            799999999999987     77999999997 599999988789999999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccccC-CCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH-----
Q 023568           81 LNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV-----  154 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~-----  154 (280)
                      ++.++.++|+|||+++... ........+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||......     
T Consensus       143 l~~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~  221 (345)
T 3a8x_A          143 LDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ  221 (345)
T ss_dssp             ECTTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC------
T ss_pred             ECCCCCEEEEeccccccccCCCCcccccCCCccccCccccCC-CCCChHHhHHHHHHHHHHHHhCCCCcCCccccccccc
Confidence            9999999999999998633 3334556789999999999987 77899999999999999999999999763211     


Q ss_pred             ----HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCH------
Q 023568          155 ----HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV------  224 (280)
Q Consensus       155 ----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~------  224 (280)
                          .....+..                               .....+...++.+.++|++||+.||.+||++      
T Consensus       222 ~~~~~~~~~i~~-------------------------------~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~  270 (345)
T 3a8x_A          222 NTEDYLFQVILE-------------------------------KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGF  270 (345)
T ss_dssp             -CHHHHHHHHHH-------------------------------CCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHH
T ss_pred             ccHHHHHHHHHc-------------------------------CCCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCH
Confidence                11111111                               0011223579999999999999999999995      


Q ss_pred             HHHhcCcccccCc
Q 023568          225 EEALRHPYLQSLH  237 (280)
Q Consensus       225 ~ell~hp~~~~~~  237 (280)
                      +|+++||||+++.
T Consensus       271 ~~i~~hp~f~~~~  283 (345)
T 3a8x_A          271 ADIQGHPFFRNVD  283 (345)
T ss_dssp             HHHHTSGGGTTCC
T ss_pred             HHHhcCCccCCCC
Confidence            8999999998763

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.3e-44  Score=316.48  Aligned_cols=203  Identities=26%  Similarity=0.359  Sum_probs=173.9

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||++++++|++.     ..+|+||||++ |+|.+++.+ ..+++..++.++.||+.||.|||+.||+||||||+||
T Consensus       126 l~hp~Iv~l~~~~~~~-----~~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NI  199 (410)
T 3v8s_A          126 ANSPWVVQLFYAFQDD-----RYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNM  199 (410)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             CCCCCCCeEEEEEEEC-----CEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHe
Confidence            5899999999999987     77999999996 599999876 5799999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCC--ccccceeccccccccccccCCC---CCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023568           80 LLNASCDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPELLLNCTE---YTAAIDIWSVGCILGEIMTREPLFPGKDYV  154 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~---~~~~~DvwslG~~l~~ll~g~~pf~~~~~~  154 (280)
                      |++.++.+||+|||+++......  .....+||+.|+|||++.+...   ++.++|+|||||++|+|++|+.||.+.+..
T Consensus       200 Ll~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~  279 (410)
T 3v8s_A          200 LLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV  279 (410)
T ss_dssp             EECTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred             eECCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh
Confidence            99999999999999998765443  2346789999999999976322   778999999999999999999999998877


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCcc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNK--RITVEEALRHPY  232 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~--Rpt~~ell~hp~  232 (280)
                      ....++........                           ....+.+++.+++||++||+.+|.+  |++++|+++|||
T Consensus       280 ~~~~~i~~~~~~~~---------------------------~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~  332 (410)
T 3v8s_A          280 GTYSKIMNHKNSLT---------------------------FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF  332 (410)
T ss_dssp             HHHHHHHTHHHHCC---------------------------CCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGG
T ss_pred             hHHHHHHhcccccc---------------------------CCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCcc
Confidence            77777654211000                           0112357999999999999999988  999999999999


Q ss_pred             cccC
Q 023568          233 LQSL  236 (280)
Q Consensus       233 ~~~~  236 (280)
                      |+++
T Consensus       333 f~~~  336 (410)
T 3v8s_A          333 FKND  336 (410)
T ss_dssp             GCCS
T ss_pred             ccCC
Confidence            9875

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.4e-44  Score=318.50  Aligned_cols=206  Identities=22%  Similarity=0.432  Sum_probs=176.1

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||++++++|++.     ..+|+||||+. |+|.+++.+ .+.+++..++.++.||+.||.|||+.||+||||||+|
T Consensus       131 ~~hp~Iv~l~~~~~~~-----~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~N  205 (437)
T 4aw2_A          131 GDSKWITTLHYAFQDD-----NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDN  205 (437)
T ss_dssp             SCTTTBCCEEEEEECS-----SEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred             CCCCCEEEEEEEEeeC-----CEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHH
Confidence            5799999999999988     77999999996 699999987 5789999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCc--cccceecccccccccccc----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDF--MTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTREPLFPGKD  152 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~  152 (280)
                      ||++.++.+||+|||+++.......  ....+||+.|+|||++.+    ...++.++|+|||||++|||++|+.||.+.+
T Consensus       206 ILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~  285 (437)
T 4aw2_A          206 ILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES  285 (437)
T ss_dssp             EEECTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             eeEcCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999976544322  234689999999999862    3568899999999999999999999999988


Q ss_pred             hHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCC--CCCHHHHhcC
Q 023568          153 YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNK--RITVEEALRH  230 (280)
Q Consensus       153 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~--Rpt~~ell~h  230 (280)
                      ..+....+.....                          ...++...+.+++++++||++||+.+|.+  |++++|+++|
T Consensus       286 ~~~~~~~i~~~~~--------------------------~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          286 LVETYGKIMNHKE--------------------------RFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             HHHHHHHHHTHHH--------------------------HCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             hhHHHHhhhhccc--------------------------cccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence            7777776654211                          11122223467999999999999998888  9999999999


Q ss_pred             cccccCc
Q 023568          231 PYLQSLH  237 (280)
Q Consensus       231 p~~~~~~  237 (280)
                      |||+++.
T Consensus       340 pff~~i~  346 (437)
T 4aw2_A          340 PFFSGID  346 (437)
T ss_dssp             GGGTTCC
T ss_pred             CccCCCC
Confidence            9998763

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=9.4e-45  Score=312.85  Aligned_cols=239  Identities=33%  Similarity=0.574  Sum_probs=190.1

Q ss_pred             CCCcccccccccccCCCC--CCCCcEEEEEecCCccHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHH--hCCcccc
Q 023568            1 MEHENVIAIKDIIRPPKK--DTFNDVYIVYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVH--SASVLHR   72 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~--~~~~~~~lv~e~~~g~L~~~l~----~~~~l~~~~~~~i~~qil~~l~~LH--~~~i~H~   72 (280)
                      ++||||++++++|.....  .....+++||||++++|.+.+.    ....+++..+..++.|++.||.|||  +.||+||
T Consensus        76 l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~  155 (360)
T 3e3p_A           76 LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHR  155 (360)
T ss_dssp             HCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCS
T ss_pred             cCCCCcccHHHhhhccccccccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecC
Confidence            479999999999976422  1113488999999998776554    4567999999999999999999999  9999999


Q ss_pred             CCCCCceEEcC-CCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 023568           73 DLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK  151 (280)
Q Consensus        73 dik~~Nili~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~  151 (280)
                      ||||+||+++. ++.++|+|||+++............||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.
T Consensus       156 Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~  235 (360)
T 3e3p_A          156 DIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGD  235 (360)
T ss_dssp             CCCGGGEEEETTTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cCCHHHEEEeCCCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCC
Confidence            99999999997 89999999999987766655566788999999999877566899999999999999999999999999


Q ss_pred             ChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccc----cccCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 023568          152 DYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQF----ATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA  227 (280)
Q Consensus       152 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~el  227 (280)
                      +....+..+.+..+.++...+..........   .........+    .......++.+.+||.+||+.||.+|||+.|+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~  312 (360)
T 3e3p_A          236 NSAGQLHEIVRVLGCPSREVLRKLNPSHTDV---DLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEA  312 (360)
T ss_dssp             SHHHHHHHHHHHHCCCCHHHHHHHCTTCCCG---GGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             ChHHHHHHHHHHcCCCCHHHHHhcccchhhc---cccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHH
Confidence            9999999999988887765443221110000   0000001111    11222367899999999999999999999999


Q ss_pred             hcCcccccCcCCCCC
Q 023568          228 LRHPYLQSLHDLNDE  242 (280)
Q Consensus       228 l~hp~~~~~~~~~~~  242 (280)
                      |+||||+++......
T Consensus       313 l~hp~f~~~~~~~~~  327 (360)
T 3e3p_A          313 LCHPYFDELHDPATK  327 (360)
T ss_dssp             TTSGGGGGGGCTTCC
T ss_pred             hcCccccccCCcccc
Confidence            999999998766543

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2e-44  Score=320.57  Aligned_cols=200  Identities=29%  Similarity=0.503  Sum_probs=176.6

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++.+.     ..+|+||||++ |+|.+++.+.+.+++.+++.++.||+.||+|||+.||+||||||+||
T Consensus        73 l~HpnIv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NI  147 (476)
T 2y94_A           73 FRHPHIIKLYQVISTP-----SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENV  147 (476)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGE
T ss_pred             CCCCCCCcEEEEEEEC-----CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHE
Confidence            5899999999999987     77999999996 59999998888999999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.++.+||+|||++............+||+.|+|||++.+....+.++|+||+||++|+|++|..||.+.+.......
T Consensus       148 ll~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~  227 (476)
T 2y94_A          148 LLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKK  227 (476)
T ss_dssp             EECTTCCEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHH
T ss_pred             EEecCCCeEEEeccchhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHH
Confidence            99999999999999998876665566778999999999998755557899999999999999999999998876666655


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  236 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~  236 (280)
                      +.....                               ..+..+++.+.+||++||+.||.+|||++|+++||||+..
T Consensus       228 i~~~~~-------------------------------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          228 ICDGIF-------------------------------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             HHTTCC-------------------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             HhcCCc-------------------------------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence            543110                               1123468999999999999999999999999999999864

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=4e-45  Score=307.62  Aligned_cols=216  Identities=19%  Similarity=0.255  Sum_probs=152.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC--------Cccc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA--------SVLH   71 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~--------~i~H   71 (280)
                      |+|||||++++++.++.. ....+|||||||+ |+|.++++. .+++++.+..++.|++.||+|||++        +|+|
T Consensus        54 l~HpNIv~l~g~~~~~~~-~~~~~~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiH  131 (303)
T 3hmm_A           54 LRHENILGFIAADNKDNG-TWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAH  131 (303)
T ss_dssp             CCCTTBCCEEEEEEEECS-SSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEEC
T ss_pred             CCCCCCCcEEEEEEecCC-CceEEEEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEee
Confidence            589999999999986521 1136899999998 699999976 5799999999999999999999987        9999


Q ss_pred             cCCCCCceEEcCCCCeEEeecccccccCCCC-----ccccceeccccccccccccCC-----CCCcchhHHHHHHHHHHH
Q 023568           72 RDLKPSNLLLNASCDLKIGDFGLARTTSETD-----FMTEYVVTRWYRAPELLLNCT-----EYTAAIDIWSVGCILGEI  141 (280)
Q Consensus        72 ~dik~~Nili~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~-----~~~~~~DvwslG~~l~~l  141 (280)
                      |||||+|||++.++.+||+|||+++......     ......||+.|+|||++.+..     .++.++|||||||++|||
T Consensus       132 RDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El  211 (303)
T 3hmm_A          132 RDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI  211 (303)
T ss_dssp             SCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHH
T ss_pred             ccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHH
Confidence            9999999999999999999999998654332     123457999999999987632     356789999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhC-CccccccccccCC--CCCHHHHHHHHHhcccCC
Q 023568          142 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL-PRCRKQQFATRFP--NKSSGAVDLLEKMLVFDP  218 (280)
Q Consensus       142 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~--~~~~~~~~ll~~~L~~dp  218 (280)
                      ++|.+||......+          .|......  ............ .....+..+....  ..+..+.+|+.+||+.||
T Consensus       212 ~tg~~~~~~~~~~~----------~p~~~~~~--~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP  279 (303)
T 3hmm_A          212 ARRCSIGGIHEDYQ----------LPYYDLVP--SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANG  279 (303)
T ss_dssp             HHTBCBTTBCCCCC----------CTTTTTSC--SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSG
T ss_pred             HHCCCCCCcccccc----------ccchhccc--ccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCH
Confidence            99988765432100          00000000  000011111110 0001111111111  123567899999999999


Q ss_pred             CCCCCHHHHhcC
Q 023568          219 NKRITVEEALRH  230 (280)
Q Consensus       219 ~~Rpt~~ell~h  230 (280)
                      ++|||+.|+++.
T Consensus       280 ~~RPt~~ei~~~  291 (303)
T 3hmm_A          280 AARLTALRIKKT  291 (303)
T ss_dssp             GGSCCHHHHHHH
T ss_pred             hHCcCHHHHHHH
Confidence            999999999863

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=9.3e-45  Score=313.04  Aligned_cols=225  Identities=27%  Similarity=0.449  Sum_probs=179.2

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      +||||+++++++...     ...|+||||++++|.+++....  .+++.+++.++.||+.||+|||+.||+||||||+||
T Consensus        94 ~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI  168 (360)
T 3llt_A           94 NNNNIVKYHGKFMYY-----DHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENI  168 (360)
T ss_dssp             TGGGBCCEEEEEEET-----TEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             CCCCeecccceeeEC-----CeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccE
Confidence            599999999999987     7799999999889999997643  599999999999999999999999999999999999


Q ss_pred             EEcC-------------------------CCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHH
Q 023568           80 LLNA-------------------------SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSV  134 (280)
Q Consensus        80 li~~-------------------------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dvwsl  134 (280)
                      |++.                         ++.++|+|||++......  .....||+.|+|||++.+ ..++.++|||||
T Consensus       169 ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~Diwsl  245 (360)
T 3llt_A          169 LLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAPEVILN-LGWDVSSDMWSF  245 (360)
T ss_dssp             EESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHHHTT-CCCCTTHHHHHH
T ss_pred             EEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC--CcCccCcccccCcHHHcC-CCCCCccchHHH
Confidence            9975                         788999999999865443  345678999999999987 678999999999


Q ss_pred             HHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCcc---------------ccccccccC
Q 023568          135 GCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRC---------------RKQQFATRF  199 (280)
Q Consensus       135 G~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~  199 (280)
                      ||++|+|++|+.||.+.+..+.+..+....+..+..............+.......               .....+...
T Consensus       246 G~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~  325 (360)
T 3llt_A          246 GCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYK  325 (360)
T ss_dssp             HHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHH
T ss_pred             HHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccc
Confidence            99999999999999999999999999888876665432211111000000000000               000001111


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 023568          200 PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ  234 (280)
Q Consensus       200 ~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~  234 (280)
                      ...++.+.+||++||+.||.+|||++|+|+||||+
T Consensus       326 ~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          326 IIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             HCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             cchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence            12357888999999999999999999999999995

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.7e-44  Score=318.16  Aligned_cols=226  Identities=31%  Similarity=0.582  Sum_probs=184.0

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      +|+||+++++++...     .++++||||++++|.+++....  .+++..++.++.||+.||+|||+.||+||||||+||
T Consensus       157 ~~~~iv~~~~~~~~~-----~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NI  231 (429)
T 3kvw_A          157 NTMNVIHMLENFTFR-----NHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENI  231 (429)
T ss_dssp             SCSCBCCEEEEEEET-----TEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGE
T ss_pred             CCcCEEEEEeecccC-----CeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHe
Confidence            689999999999987     7899999999999999997653  599999999999999999999999999999999999


Q ss_pred             EEcCCCC--eEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023568           80 LLNASCD--LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  157 (280)
Q Consensus        80 li~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~  157 (280)
                      |++.++.  +||+|||++......  .....+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+
T Consensus       232 Ll~~~~~~~vkL~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l  308 (429)
T 3kvw_A          232 LLKQQGRSGIKVIDFGSSCYEHQR--VYTYIQSRFYRAPEVILG-ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQL  308 (429)
T ss_dssp             EESSTTSCCEEECCCTTCEETTCC--CCSSCSCGGGCCHHHHHT-BCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             EEccCCCcceEEeecccceecCCc--ccccCCCCCccChHHHhC-CCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            9999887  999999999765433  345688999999999987 67899999999999999999999999999999999


Q ss_pred             HHHHHHhCCCCcccccccCChhHHHHHHhC--Ccc---------------------------cccccc-ccCCCCCHHHH
Q 023568          158 RLITELIGSPDDASLGFLRSDNARRYVRQL--PRC---------------------------RKQQFA-TRFPNKSSGAV  207 (280)
Q Consensus       158 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~---------------------------~~~~~~-~~~~~~~~~~~  207 (280)
                      ..+.+..+.++..........  ..+....  +..                           ....+. ......++.+.
T Consensus       309 ~~i~~~~~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  386 (429)
T 3kvw_A          309 ACMIELLGMPSQKLLDASKRA--KNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFL  386 (429)
T ss_dssp             HHHHHHHCCCCHHHHHTBTTH--HHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHH
T ss_pred             HHHHHHcCCCCHHHHHhhhhh--hhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHH
Confidence            999999998887754432211  1111000  000                           000000 01123478899


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCcccccCc
Q 023568          208 DLLEKMLVFDPNKRITVEEALRHPYLQSLH  237 (280)
Q Consensus       208 ~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~  237 (280)
                      +||++||+.||++|||++|+|+||||+...
T Consensus       387 dli~~~L~~dP~~Rpta~e~L~Hpw~~~~~  416 (429)
T 3kvw_A          387 DFLKQCLEWDPAVRMTPGQALRHPWLRRRL  416 (429)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHTSTTTC---
T ss_pred             HHHHHHCCCChhhCCCHHHHhCChhhccCC
Confidence            999999999999999999999999998753

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2.8e-44  Score=306.25  Aligned_cols=200  Identities=24%  Similarity=0.472  Sum_probs=170.6

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+||||+++++++.+.     ..+|+||||++ |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||
T Consensus        78 l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Ni  152 (327)
T 3a62_A           78 VKHPFIVDLIYAFQTG-----GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENI  152 (327)
T ss_dssp             CCCTTBCCEEEEEECS-----SCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTE
T ss_pred             CCCCCccceeEEEEcC-----CEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHe
Confidence            5899999999999987     67999999997 59999998878899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||+++..... .......||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+......
T Consensus       153 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~  231 (327)
T 3a62_A          153 MLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTID  231 (327)
T ss_dssp             EECTTSCEEECCCSCC----------CTTSSCCTTSCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             EECCCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCcC-CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence            9999999999999998764332 33445678999999999977 678899999999999999999999999988766666


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYL  233 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rp-----t~~ell~hp~~  233 (280)
                      .+.....                               ...+.+++.+.++|++||+.||.+||     +++|+++||||
T Consensus       232 ~i~~~~~-------------------------------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f  280 (327)
T 3a62_A          232 KILKCKL-------------------------------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF  280 (327)
T ss_dssp             HHHHTCC-------------------------------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGG
T ss_pred             HHHhCCC-------------------------------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcc
Confidence            5544110                               11235789999999999999999999     89999999999


Q ss_pred             ccCc
Q 023568          234 QSLH  237 (280)
Q Consensus       234 ~~~~  237 (280)
                      +.+.
T Consensus       281 ~~~~  284 (327)
T 3a62_A          281 RHIN  284 (327)
T ss_dssp             SSCC
T ss_pred             cCCC
Confidence            8763

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=4e-45  Score=311.92  Aligned_cols=231  Identities=32%  Similarity=0.602  Sum_probs=179.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++.+.     ...|+||||+++ +|.+++...+.+++..+..++.|++.||.|||+.||+||||||+||
T Consensus        81 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Ni  155 (331)
T 4aaa_A           81 LRHENLVNLLEVCKKK-----KRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENI  155 (331)
T ss_dssp             CCCTTBCCEEEEEEET-----TEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred             CCCCCEeeEEEEeecC-----CEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheE
Confidence            5899999999999987     779999999996 6666767778899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||++...... .......+++.|+|||.+.+...++.++|+|||||++|+|++|..||.+.+......
T Consensus       156 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  235 (331)
T 4aaa_A          156 LVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLY  235 (331)
T ss_dssp             EECTTSCEEECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             EEcCCCcEEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence            9999999999999999765433 334456789999999999875678999999999999999999999999999888888


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  236 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~  236 (280)
                      .+....+...+.............................++.+++.+.+||.+||+.||.+|||++|+|+||||+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          236 HIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             HHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             HHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence            888877765544321110000000000000011112233455789999999999999999999999999999999764

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.2e-44  Score=315.47  Aligned_cols=235  Identities=18%  Similarity=0.258  Sum_probs=167.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      |+|||||++++++.+.     +.+|+||||++ |+|.+++...  ..+++..++.++.||+.||+|||++||+||||||+
T Consensus        83 l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~  157 (389)
T 3gni_B           83 FNHPNIVPYRATFIAD-----NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKAS  157 (389)
T ss_dssp             CCCTTBCCEEEEEEET-----TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred             CCCCCCCcEeEEEEEC-----CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence            5899999999999987     77999999997 5999999765  67999999999999999999999999999999999


Q ss_pred             ceEEcCCCCeEEeecccccccCCC--------CccccceeccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCC
Q 023568           78 NLLLNASCDLKIGDFGLARTTSET--------DFMTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLF  148 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~~l~~ll~g~~pf  148 (280)
                      |||++.++.++|+|||.+......        .......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||
T Consensus       158 NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf  237 (389)
T 3gni_B          158 HILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF  237 (389)
T ss_dssp             GEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             HEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCC
Confidence            999999999999999987643211        112334788999999998763 56889999999999999999999999


Q ss_pred             CCCChHHHHHHHHHHhCC--------CCcccccccCC----hhHHHHH---HhCCccccccccccCCCCCHHHHHHHHHh
Q 023568          149 PGKDYVHQLRLITELIGS--------PDDASLGFLRS----DNARRYV---RQLPRCRKQQFATRFPNKSSGAVDLLEKM  213 (280)
Q Consensus       149 ~~~~~~~~~~~i~~~~~~--------~~~~~~~~~~~----~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ll~~~  213 (280)
                      .+.+.......+......        +..........    .......   ...+.............+++.+.+||++|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  317 (389)
T 3gni_B          238 KDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQC  317 (389)
T ss_dssp             TTCCSTTHHHHC--------------------------------------------------------CCHHHHHHHHHH
T ss_pred             CCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHH
Confidence            887655444332221000        00000000000    0000000   00000011111223446799999999999


Q ss_pred             cccCCCCCCCHHHHhcCcccccCcCCC
Q 023568          214 LVFDPNKRITVEEALRHPYLQSLHDLN  240 (280)
Q Consensus       214 L~~dp~~Rpt~~ell~hp~~~~~~~~~  240 (280)
                      |+.||.+|||++|+|+||||+.+....
T Consensus       318 L~~dP~~Rpta~ell~hp~f~~~~~~~  344 (389)
T 3gni_B          318 LQRNPDARPSASTLLNHSFFKQIKRRA  344 (389)
T ss_dssp             TCSCTTTSCCHHHHTTSGGGGGC---C
T ss_pred             hhcCcccCCCHHHHhcCHHHHHHhhcc
Confidence            999999999999999999999887544

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=8.1e-44  Score=315.59  Aligned_cols=200  Identities=26%  Similarity=0.434  Sum_probs=173.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~-~~i~H~dik~~N   78 (280)
                      ++||||+++++++.+.     +.+|+||||++| +|.+++...+.+++..++.++.||+.||+|||+ .||+||||||+|
T Consensus       205 l~h~~iv~l~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~N  279 (446)
T 4ejn_A          205 SRHPFLTALKYSFQTH-----DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLEN  279 (446)
T ss_dssp             CSCTTSCCEEEEEEET-----TEEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGG
T ss_pred             CCCCeEeeEEEEEeeC-----CEEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHH
Confidence            5799999999999987     779999999974 999999888899999999999999999999998 999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCC-CCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023568           79 LLLNASCDLKIGDFGLARTTSE-TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  157 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~  157 (280)
                      ||++.++.++|+|||+++.... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.....
T Consensus       280 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~  358 (446)
T 4ejn_A          280 LMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF  358 (446)
T ss_dssp             EEECSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             EEECCCCCEEEccCCCceeccCCCcccccccCCccccCHhhcCC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHH
Confidence            9999999999999999986433 333456789999999999977 78899999999999999999999999988876666


Q ss_pred             HHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCcc
Q 023568          158 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPY  232 (280)
Q Consensus       158 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rp-----t~~ell~hp~  232 (280)
                      ..+....                               ...+..+++.+.+||.+||+.||.+||     |++|+++|||
T Consensus       359 ~~i~~~~-------------------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~  407 (446)
T 4ejn_A          359 ELILMEE-------------------------------IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRF  407 (446)
T ss_dssp             HHHHHCC-------------------------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred             HHHHhCC-------------------------------CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCcc
Confidence            5554311                               011235789999999999999999999     9999999999


Q ss_pred             cccCc
Q 023568          233 LQSLH  237 (280)
Q Consensus       233 ~~~~~  237 (280)
                      |+++.
T Consensus       408 f~~~~  412 (446)
T 4ejn_A          408 FAGIV  412 (446)
T ss_dssp             GTTCC
T ss_pred             ccCCC
Confidence            99863

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=3.9e-44  Score=311.51  Aligned_cols=204  Identities=25%  Similarity=0.453  Sum_probs=175.3

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      |+||||+++++++.+.     ..+|+||||++ |+|.+++... ..+++.++..++.||+.||+|||+.||+||||||+|
T Consensus       105 l~hpnIv~~~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~N  179 (387)
T 1kob_A          105 LHHPKLINLHDAFEDK-----YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPEN  179 (387)
T ss_dssp             CCSTTBCCEEEEEECS-----SEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred             CCCcCCCeEEEEEEeC-----CEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHH
Confidence            5899999999999987     77999999997 5999999764 479999999999999999999999999999999999


Q ss_pred             eEEcC--CCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023568           79 LLLNA--SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  156 (280)
Q Consensus        79 ili~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~  156 (280)
                      |+++.  ++.++|+|||+++............||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....
T Consensus       180 Ill~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~  258 (387)
T 1kob_A          180 IMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET  258 (387)
T ss_dssp             EEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH
T ss_pred             eEEecCCCCceEEEecccceecCCCcceeeeccCCCccCchhccC-CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHH
Confidence            99974  57799999999988766555556688999999999877 7788999999999999999999999999887666


Q ss_pred             HHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 023568          157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  236 (280)
Q Consensus       157 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~  236 (280)
                      +..+.......                           ....+..+++.+.+||++||+.||.+|||++|+|+||||+..
T Consensus       259 ~~~i~~~~~~~---------------------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  311 (387)
T 1kob_A          259 LQNVKRCDWEF---------------------------DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  311 (387)
T ss_dssp             HHHHHHCCCCC---------------------------CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             HHHHHhCCCCC---------------------------CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence            66554421110                           112234679999999999999999999999999999999875


Q ss_pred             c
Q 023568          237 H  237 (280)
Q Consensus       237 ~  237 (280)
                      .
T Consensus       312 ~  312 (387)
T 1kob_A          312 H  312 (387)
T ss_dssp             C
T ss_pred             c
Confidence            3

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.5e-44  Score=306.08  Aligned_cols=203  Identities=30%  Similarity=0.456  Sum_probs=169.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++.+.     ...|+||||++| +|.+++...+.+++.+++.++.|++.||+|||+.||+||||||+||
T Consensus        62 l~hpnIv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NI  136 (323)
T 3tki_A           62 LNHENVVKFYGHRREG-----NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL  136 (323)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             CCCCCCCeEEEEEecC-----CeEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHE
Confidence            5899999999999987     779999999975 9999998888899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC---CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSET---DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  156 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~  156 (280)
                      +++.++.++|+|||+++.....   .......||+.|+|||++.+...++.++|||||||++|+|++|..||........
T Consensus       137 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  216 (323)
T 3tki_A          137 LLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ  216 (323)
T ss_dssp             EECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH
T ss_pred             EEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH
Confidence            9999999999999999754322   2234568899999999998755567899999999999999999999987654321


Q ss_pred             -HHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 023568          157 -LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  235 (280)
Q Consensus       157 -~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~  235 (280)
                       .......                             ......+..+++.+.+||++||+.||.+|||++|+++||||+.
T Consensus       217 ~~~~~~~~-----------------------------~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~  267 (323)
T 3tki_A          217 EYSDWKEK-----------------------------KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK  267 (323)
T ss_dssp             HHHHHHTT-----------------------------CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             HHHHHhcc-----------------------------cccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcc
Confidence             1111110                             0011112357899999999999999999999999999999986


Q ss_pred             Cc
Q 023568          236 LH  237 (280)
Q Consensus       236 ~~  237 (280)
                      ..
T Consensus       268 ~~  269 (323)
T 3tki_A          268 PL  269 (323)
T ss_dssp             CC
T ss_pred             cc
Confidence            54

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=6e-44  Score=303.43  Aligned_cols=204  Identities=30%  Similarity=0.508  Sum_probs=176.9

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+||||+++++++.+.     ...|+||||++ ++|.+++.+.+.+++..+..++.|++.||.|||+.||+||||||+||
T Consensus        72 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NI  146 (321)
T 2a2a_A           72 VLHHNVITLHDVYENR-----TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENI  146 (321)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             CCCCCcceEEEEEecC-----CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHE
Confidence            5899999999999987     77999999996 59999998888899999999999999999999999999999999999


Q ss_pred             EEcCCC----CeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023568           80 LLNASC----DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH  155 (280)
Q Consensus        80 li~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~  155 (280)
                      +++.++    .++|+|||++.............||+.|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.....
T Consensus       147 l~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  225 (321)
T 2a2a_A          147 MLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQE  225 (321)
T ss_dssp             EESCTTSSSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH
T ss_pred             EEecCCCCcCCEEEccCccceecCccccccccCCCCCccCcccccC-CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH
Confidence            999887    799999999987766555566778999999999877 778899999999999999999999999887766


Q ss_pred             HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 023568          156 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  235 (280)
Q Consensus       156 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~  235 (280)
                      ....+.......+                           +..++..+..+.++|++||+.||.+|||++|+++||||+.
T Consensus       226 ~~~~i~~~~~~~~---------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~  278 (321)
T 2a2a_A          226 TLANITSVSYDFD---------------------------EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP  278 (321)
T ss_dssp             HHHHHHTTCCCCC---------------------------HHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSC
T ss_pred             HHHHHHhcccccC---------------------------hhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccC
Confidence            6665544221111                           1122467899999999999999999999999999999976


Q ss_pred             Cc
Q 023568          236 LH  237 (280)
Q Consensus       236 ~~  237 (280)
                      ..
T Consensus       279 ~~  280 (321)
T 2a2a_A          279 VD  280 (321)
T ss_dssp             SS
T ss_pred             CC
Confidence            53

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.2e-44  Score=312.79  Aligned_cols=205  Identities=20%  Similarity=0.341  Sum_probs=172.4

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||++++++|++.     ..+|+||||+. |+|.+++.+. ..+++..++.++.||+.||.|||+.||+||||||+|
T Consensus       118 ~~hp~Iv~l~~~~~~~-----~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~N  192 (412)
T 2vd5_A          118 GDRRWITQLHFAFQDE-----NYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDN  192 (412)
T ss_dssp             SCTTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred             cCCCCeeeEEEEEeeC-----CEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHH
Confidence            4799999999999988     78999999996 6999999764 589999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCc--cccceecccccccccccc------CCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDF--MTEYVVTRWYRAPELLLN------CTEYTAAIDIWSVGCILGEIMTREPLFPG  150 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~------~~~~~~~~DvwslG~~l~~ll~g~~pf~~  150 (280)
                      ||++.++.+||+|||+++.......  ....+||+.|+|||++.+      ...++.++|+|||||++|||++|+.||.+
T Consensus       193 ILld~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~  272 (412)
T 2vd5_A          193 ILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA  272 (412)
T ss_dssp             EEECTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             eeecCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCC
Confidence            9999999999999999987654322  234689999999999873      25678999999999999999999999999


Q ss_pred             CChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCC---CCHHHH
Q 023568          151 KDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKR---ITVEEA  227 (280)
Q Consensus       151 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~R---pt~~el  227 (280)
                      .+......++.....                          ....+.....+++++++||++||+ +|.+|   ++++|+
T Consensus       273 ~~~~~~~~~i~~~~~--------------------------~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei  325 (412)
T 2vd5_A          273 DSTAETYGKIVHYKE--------------------------HLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDF  325 (412)
T ss_dssp             SSHHHHHHHHHTHHH--------------------------HCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHH
T ss_pred             CCHHHHHHHHHhccc--------------------------CcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHH
Confidence            887777766654210                          001111223679999999999999 99998   599999


Q ss_pred             hcCcccccCc
Q 023568          228 LRHPYLQSLH  237 (280)
Q Consensus       228 l~hp~~~~~~  237 (280)
                      ++||||+++.
T Consensus       326 ~~Hpff~~i~  335 (412)
T 2vd5_A          326 RTHPFFFGLD  335 (412)
T ss_dssp             HTSGGGTTCC
T ss_pred             hcCCCcCCCC
Confidence            9999998763

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=3.1e-44  Score=305.73  Aligned_cols=205  Identities=28%  Similarity=0.504  Sum_probs=150.1

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      +||||+++++++.+.     ...|+||||++| +|.+++.+.+.+++.++..++.|++.||+|||++||+||||||+||+
T Consensus        64 ~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl  138 (325)
T 3kn6_A           64 GHPNIVKLHEVFHDQ-----LHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLL  138 (325)
T ss_dssp             TCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred             CCCCeeEEEEEEEcC-----CEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEE
Confidence            399999999999987     779999999975 99999998889999999999999999999999999999999999999


Q ss_pred             EcCCC---CeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH--
Q 023568           81 LNASC---DLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV--  154 (280)
Q Consensus        81 i~~~~---~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~--  154 (280)
                      ++.++   .++|+|||+++..... .......+|+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+..  
T Consensus       139 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  217 (325)
T 3kn6_A          139 FTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQ-NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT  217 (325)
T ss_dssp             EEC----CEEEECCCTTCEECCC-----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------
T ss_pred             EecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCccccc
Confidence            97765   7999999999865443 33455678999999999877 77899999999999999999999999875431  


Q ss_pred             -----HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          155 -----HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       155 -----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                           .....+...                           ........++.+++.+.+||++||+.||.+|||++|+++
T Consensus       218 ~~~~~~~~~~i~~~---------------------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          218 CTSAVEIMKKIKKG---------------------------DFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             CCCHHHHHHHHTTT---------------------------CCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             cccHHHHHHHHHcC---------------------------CCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence                 112111110                           000011112357999999999999999999999999999


Q ss_pred             CcccccCcCC
Q 023568          230 HPYLQSLHDL  239 (280)
Q Consensus       230 hp~~~~~~~~  239 (280)
                      ||||++....
T Consensus       271 h~w~~~~~~~  280 (325)
T 3kn6_A          271 NEWLQDGSQL  280 (325)
T ss_dssp             CGGGCTTCCC
T ss_pred             ChhhccCccC
Confidence            9999876433

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=6e-44  Score=306.78  Aligned_cols=203  Identities=31%  Similarity=0.503  Sum_probs=161.9

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+||||+++++++.+.     ...|+||||+. |+|.+++...+.+++.++..++.|++.||.|||+.||+||||||+||
T Consensus       105 l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NI  179 (349)
T 2w4o_A          105 LSHPNIIKLKEIFETP-----TEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENL  179 (349)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred             CCCCCCcceeeeEecC-----CeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccE
Confidence            5899999999999987     67999999997 59999998888899999999999999999999999999999999999


Q ss_pred             EEcC---CCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH-
Q 023568           80 LLNA---SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH-  155 (280)
Q Consensus        80 li~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~-  155 (280)
                      +++.   ++.++|+|||+++............||+.|+|||++.+ ..++.++|||||||++|+|++|..||....... 
T Consensus       180 ll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~  258 (349)
T 2w4o_A          180 LYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF  258 (349)
T ss_dssp             EESSSSTTCCEEECCCC----------------CGGGSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH
T ss_pred             EEecCCCCCCEEEccCccccccCcccccccccCCCCccCHHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH
Confidence            9975   88999999999987665554556788999999999987 678999999999999999999999998766543 


Q ss_pred             HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 023568          156 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  235 (280)
Q Consensus       156 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~  235 (280)
                      ....+.....                           ......++.++..+.+||++||+.||.+|||+.|+|+||||.+
T Consensus       259 ~~~~i~~~~~---------------------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  311 (349)
T 2w4o_A          259 MFRRILNCEY---------------------------YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTG  311 (349)
T ss_dssp             HHHHHHTTCC---------------------------CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             HHHHHHhCCC---------------------------ccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCC
Confidence            3333322110                           0011223467899999999999999999999999999999976


Q ss_pred             C
Q 023568          236 L  236 (280)
Q Consensus       236 ~  236 (280)
                      .
T Consensus       312 ~  312 (349)
T 2w4o_A          312 K  312 (349)
T ss_dssp             T
T ss_pred             C
Confidence            4

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.2e-43  Score=296.14  Aligned_cols=208  Identities=27%  Similarity=0.501  Sum_probs=178.4

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++...     ...|+||||+.| +|.+.+...+.+++..+..++.|++.||.|||++|++||||||+||
T Consensus        62 l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Ni  136 (284)
T 3kk8_A           62 LQHPNIVRLHDSIQEE-----SFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENL  136 (284)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred             cCCCCcCeEEEEEEcC-----CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHE
Confidence            5899999999999887     779999999975 9999998878899999999999999999999999999999999999


Q ss_pred             EEcCCCC---eEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023568           80 LLNASCD---LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  156 (280)
Q Consensus        80 li~~~~~---~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~  156 (280)
                      +++.++.   ++|+|||.+.............|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+....
T Consensus       137 l~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~  215 (284)
T 3kk8_A          137 LLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL  215 (284)
T ss_dssp             EESSSSTTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             EEecCCCCCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhcC-CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHH
Confidence            9976655   99999999987766655566789999999999977 6788999999999999999999999998877666


Q ss_pred             HHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 023568          157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  236 (280)
Q Consensus       157 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~  236 (280)
                      ...+.......+                           ...+...++.+.++|++||+.||.+|||++|+|+||||++.
T Consensus       216 ~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (284)
T 3kk8_A          216 YAQIKAGAYDYP---------------------------SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR  268 (284)
T ss_dssp             HHHHHHTCCCCC---------------------------TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSC
T ss_pred             HHHHHhccccCC---------------------------chhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCC
Confidence            665544221111                           11223678999999999999999999999999999999887


Q ss_pred             cCCCC
Q 023568          237 HDLND  241 (280)
Q Consensus       237 ~~~~~  241 (280)
                      .....
T Consensus       269 ~~~~~  273 (284)
T 3kk8_A          269 ERVAS  273 (284)
T ss_dssp             CCGGG
T ss_pred             hhHHh
Confidence            65443

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.8e-44  Score=309.04  Aligned_cols=206  Identities=32%  Similarity=0.489  Sum_probs=169.9

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      +||||+++++++++.     ..+|+||||+. |+|.+.+.+.+.+++.++..++.||+.||.|||++||+||||||+||+
T Consensus        74 ~hp~iv~~~~~~~~~-----~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl  148 (342)
T 2qr7_A           74 QHPNIITLKDVYDDG-----KYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNIL  148 (342)
T ss_dssp             TSTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred             CCCCcCeEEEEEEcC-----CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEE
Confidence            699999999999987     77999999997 599999998889999999999999999999999999999999999999


Q ss_pred             EcCC----CCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC---
Q 023568           81 LNAS----CDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD---  152 (280)
Q Consensus        81 i~~~----~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~---  152 (280)
                      +..+    +.++|+|||+++..... ......+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+..   
T Consensus       149 ~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~  227 (342)
T 2qr7_A          149 YVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT  227 (342)
T ss_dssp             ESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHH-HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC
T ss_pred             EecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcC-CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC
Confidence            8442    35999999999865433 33456788999999999876 567889999999999999999999998642   


Q ss_pred             hHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 023568          153 YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY  232 (280)
Q Consensus       153 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~  232 (280)
                      .......+.....                           ......++.+++.+.+||++||+.||.+|||++++++|||
T Consensus       228 ~~~~~~~i~~~~~---------------------------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~  280 (342)
T 2qr7_A          228 PEEILARIGSGKF---------------------------SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPW  280 (342)
T ss_dssp             HHHHHHHHHHCCC---------------------------CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred             HHHHHHHHccCCc---------------------------ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCe
Confidence            2333333322100                           0011223467999999999999999999999999999999


Q ss_pred             cccCcCCC
Q 023568          233 LQSLHDLN  240 (280)
Q Consensus       233 ~~~~~~~~  240 (280)
                      |..+....
T Consensus       281 ~~~~~~~~  288 (342)
T 2qr7_A          281 IVHWDQLP  288 (342)
T ss_dssp             HHTGGGSC
T ss_pred             ecCccccc
Confidence            98775443

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.9e-44  Score=311.30  Aligned_cols=203  Identities=30%  Similarity=0.453  Sum_probs=175.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      |+||||+++++++.+.     ..+|+||||++ ++|.+++... ..+++..+..++.||+.||+|||+.||+||||||+|
T Consensus       143 l~hpnIv~~~~~~~~~-----~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N  217 (373)
T 2x4f_A          143 LDHANLIQLYDAFESK-----NDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPEN  217 (373)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred             CCCCCCCeEEEEEEEC-----CEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHH
Confidence            5899999999999987     77999999997 5999988654 579999999999999999999999999999999999


Q ss_pred             eEE--cCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023568           79 LLL--NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  156 (280)
Q Consensus        79 ili--~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~  156 (280)
                      ||+  +.++.++|+|||+++............||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....
T Consensus       218 Ill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~  296 (373)
T 2x4f_A          218 ILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET  296 (373)
T ss_dssp             EEEEETTTTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHTT-CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred             EEEecCCCCcEEEEeCCCceecCCccccccccCCCcEeChhhccC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            999  5677899999999988766655566779999999999876 7788999999999999999999999999887777


Q ss_pred             HHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 023568          157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  236 (280)
Q Consensus       157 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~  236 (280)
                      +..+.......+                           ...++.+++.+.+||.+||+.||.+|||++|+|+||||++.
T Consensus       297 ~~~i~~~~~~~~---------------------------~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          297 LNNILACRWDLE---------------------------DEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             HHHHHHTCCCSC---------------------------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred             HHHHHhccCCCC---------------------------hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence            766654221111                           12234679999999999999999999999999999999865

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=6.5e-44  Score=296.86  Aligned_cols=203  Identities=27%  Similarity=0.451  Sum_probs=176.6

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+||||+++++++.+.     ...|+||||++| +|.+++...+.+++.++..++.|++.||.|||++|++||||||+||
T Consensus        63 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Ni  137 (277)
T 3f3z_A           63 LDHPNIIRLYETFEDN-----TDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENF  137 (277)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             CCCCCEeeEEEEEecC-----CeEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHE
Confidence            5899999999999987     779999999974 9999998888899999999999999999999999999999999999


Q ss_pred             EE---cCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023568           80 LL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  156 (280)
Q Consensus        80 li---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~  156 (280)
                      ++   +.++.++|+|||++.............+|+.|+|||.+.+  .++.++|+||||+++|+|++|..||.+......
T Consensus       138 l~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~  215 (277)
T 3f3z_A          138 LFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV  215 (277)
T ss_dssp             EESSSSTTCCEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             EEecCCCCCcEEEEecccceeccCccchhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHH
Confidence            99   7889999999999987766655667789999999999865  488999999999999999999999999887776


Q ss_pred             HHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 023568          157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  236 (280)
Q Consensus       157 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~  236 (280)
                      ...+.......+..                           .+...++.+.++|++||+.||.+|||+.++|+||||++.
T Consensus       216 ~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  268 (277)
T 3f3z_A          216 MLKIREGTFTFPEK---------------------------DWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ  268 (277)
T ss_dssp             HHHHHHCCCCCCHH---------------------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred             HHHHHhCCCCCCch---------------------------hhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence            66655422211111                           123568999999999999999999999999999999875


Q ss_pred             c
Q 023568          237 H  237 (280)
Q Consensus       237 ~  237 (280)
                      .
T Consensus       269 ~  269 (277)
T 3f3z_A          269 L  269 (277)
T ss_dssp             H
T ss_pred             c
Confidence            4

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=9.1e-44  Score=318.50  Aligned_cols=203  Identities=33%  Similarity=0.594  Sum_probs=174.1

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+||||+++++++.+.     ..+|+||||+. |+|.+.+.+.+.+++.++..++.||+.||.|||++||+||||||+||
T Consensus        78 l~hpniv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Ni  152 (486)
T 3mwu_A           78 LDHPNIMKLFEILEDS-----SSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENI  152 (486)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             CCCCCcCeEEEEEEcC-----CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHE
Confidence            5899999999999987     77999999997 59999998878999999999999999999999999999999999999


Q ss_pred             EEc---CCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023568           80 LLN---ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  156 (280)
Q Consensus        80 li~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~  156 (280)
                      +++   .++.++|+|||+++............||+.|+|||++.+  .++.++||||+||++|+|++|.+||.+.+....
T Consensus       153 l~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  230 (486)
T 3mwu_A          153 LLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI  230 (486)
T ss_dssp             EESSSSTTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             EEecCCCCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            995   456799999999987766555566789999999999875  588999999999999999999999999887777


Q ss_pred             HHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 023568          157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  236 (280)
Q Consensus       157 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~  236 (280)
                      +..+.........                           ..++.+++.+++||++||+.||.+|||+.|+|+||||+..
T Consensus       231 ~~~i~~~~~~~~~---------------------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~  283 (486)
T 3mwu_A          231 LKRVETGKYAFDL---------------------------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY  283 (486)
T ss_dssp             HHHHHHTCCCSCS---------------------------GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred             HHHHHhCCCCCCC---------------------------cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccC
Confidence            7666542211111                           1223578999999999999999999999999999999876


Q ss_pred             c
Q 023568          237 H  237 (280)
Q Consensus       237 ~  237 (280)
                      .
T Consensus       284 ~  284 (486)
T 3mwu_A          284 S  284 (486)
T ss_dssp             C
T ss_pred             c
Confidence            4

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.7e-43  Score=295.74  Aligned_cols=200  Identities=31%  Similarity=0.484  Sum_probs=162.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK   75 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik   75 (280)
                      ++||||+++++++.+.     ...|+||||++| +|.+.+..    ...+++..+..++.|++.||+|||+.||+|||||
T Consensus        77 l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dik  151 (285)
T 3is5_A           77 LDHPNIIKIFEVFEDY-----HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLK  151 (285)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCS
T ss_pred             CCCchHHhHHHheecC-----CeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCC
Confidence            5899999999999887     779999999975 99998853    4789999999999999999999999999999999


Q ss_pred             CCceEE---cCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 023568           76 PSNLLL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD  152 (280)
Q Consensus        76 ~~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~  152 (280)
                      |+||++   +.++.++|+|||++.............+++.|+|||++.  ..++.++|+||||+++|+|++|+.||.+.+
T Consensus       152 p~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~il~~ll~g~~pf~~~~  229 (285)
T 3is5_A          152 PENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK--RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS  229 (285)
T ss_dssp             GGGEEESSSSTTCCEEECCCCCCCC----------CTTGGGCCHHHHT--TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             HHHEEEecCCCCCCEEEEeeecceecCCcccCcCcccccCcCChHHhc--cCCCcccCeehHHHHHHHHHhCCCCCCCCC
Confidence            999999   456789999999998766555556678899999999885  467899999999999999999999999887


Q ss_pred             hHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 023568          153 YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY  232 (280)
Q Consensus       153 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~  232 (280)
                      .......+.....                            .........++.+.++|++||+.||.+|||++|+|+|||
T Consensus       230 ~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~  281 (285)
T 3is5_A          230 LEEVQQKATYKEP----------------------------NYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEW  281 (285)
T ss_dssp             HHHHHHHHHHCCC----------------------------CCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGG
T ss_pred             HHHHHhhhccCCc----------------------------ccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHH
Confidence            6555444332111                            111112246899999999999999999999999999999


Q ss_pred             ccc
Q 023568          233 LQS  235 (280)
Q Consensus       233 ~~~  235 (280)
                      |++
T Consensus       282 f~~  284 (285)
T 3is5_A          282 FKQ  284 (285)
T ss_dssp             GGC
T ss_pred             hhc
Confidence            975

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=4e-44  Score=303.23  Aligned_cols=196  Identities=27%  Similarity=0.324  Sum_probs=161.9

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++.+.     ..+|+||||++++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+||
T Consensus       114 ~~h~~iv~l~~~~~~~-----~~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NI  188 (311)
T 3p1a_A          114 GQHPCCVRLEQAWEEG-----GILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANI  188 (311)
T ss_dssp             CCCTTBCCEEEEEEET-----TEEEEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             cCCCcEEEEEEEEEeC-----CEEEEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHE
Confidence            3799999999999887     77999999999999998865 45699999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      |++.++.+||+|||++.............||+.|+|||++.+  .++.++|||||||++|+|++|..++.+....   ..
T Consensus       189 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~---~~  263 (311)
T 3p1a_A          189 FLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGW---QQ  263 (311)
T ss_dssp             EECGGGCEEECCCTTCEECC------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH---HH
T ss_pred             EECCCCCEEEccceeeeecccCCCCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHH---HH
Confidence            999999999999999987766555556678999999999875  6889999999999999999997766543221   11


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  235 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~  235 (280)
                      +..  +.                           ..+...+.+++.+.++|.+||+.||.+|||++|+|+||||++
T Consensus       264 ~~~--~~---------------------------~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          264 LRQ--GY---------------------------LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             HTT--TC---------------------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             Hhc--cC---------------------------CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence            110  00                           001122357899999999999999999999999999999975

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=8.1e-44  Score=319.42  Aligned_cols=202  Identities=33%  Similarity=0.582  Sum_probs=176.1

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+||||++++++|.+.     ..+|+|||||. |+|.+.+.....+++..+..++.||+.||.|||++||+||||||+||
T Consensus        93 l~hpniv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Ni  167 (494)
T 3lij_A           93 LDHPNIMKLYDFFEDK-----RNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENL  167 (494)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             CCCCCCCeEEEEEEeC-----CEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhE
Confidence            5899999999999987     77999999997 59999998878999999999999999999999999999999999999


Q ss_pred             EEcCC---CCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023568           80 LLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  156 (280)
Q Consensus        80 li~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~  156 (280)
                      +++..   +.+||+|||++.............||+.|+|||++.+  .++.++||||+||++|+|++|.+||.+......
T Consensus       168 l~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  245 (494)
T 3lij_A          168 LLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEI  245 (494)
T ss_dssp             EESCSSTTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             EEeCCCCCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            99764   4599999999988766655667789999999999864  688999999999999999999999999887777


Q ss_pred             HHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 023568          157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  236 (280)
Q Consensus       157 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~  236 (280)
                      ...+.........                           ..++.+++.+.+||++||+.||.+|||++|+|+||||+..
T Consensus       246 ~~~i~~~~~~~~~---------------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          246 LRKVEKGKYTFDS---------------------------PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             HHHHHHTCCCCCS---------------------------GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             HHHHHhCCCCCCc---------------------------hhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence            7666553221111                           1234679999999999999999999999999999999875

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=5.6e-44  Score=312.23  Aligned_cols=208  Identities=25%  Similarity=0.408  Sum_probs=161.5

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      ++||||++++++|..... +..++|+||||++ |+|.+++...+  .+++.+++.++.||+.||.|||+.||+||||||+
T Consensus       112 ~~hp~iv~l~~~~~~~~~-~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~  190 (400)
T 1nxk_A          112 SQCPHIVRIVDVYENLYA-GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPE  190 (400)
T ss_dssp             TTSTTBCCEEEEEEEEET-TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred             cCCCCcceEeEEEeeccc-CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcc
Confidence            379999999999875210 1167999999997 59999998653  5999999999999999999999999999999999


Q ss_pred             ceEEcC---CCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023568           78 NLLLNA---SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV  154 (280)
Q Consensus        78 Nili~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~  154 (280)
                      |||++.   ++.+||+|||+++...........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....
T Consensus       191 Nill~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~  269 (400)
T 1nxk_A          191 NLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL  269 (400)
T ss_dssp             GEEESSSSTTCCEEECCCTTCEECC-----------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTC
T ss_pred             eEEEecCCCCccEEEEecccccccCCCCccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCccc
Confidence            999987   78899999999987665555567788999999999876 78899999999999999999999999876421


Q ss_pred             H----HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 023568          155 H----QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  230 (280)
Q Consensus       155 ~----~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~h  230 (280)
                      .    ....+....                           .......+..++..+.+||++||+.||.+|||++|+++|
T Consensus       270 ~~~~~~~~~i~~~~---------------------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          270 AISPGMKTRIRMGQ---------------------------YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             SSCCSHHHHHHHTC---------------------------CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             cccHHHHHHHHcCc---------------------------ccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            1    111111100                           000011234679999999999999999999999999999


Q ss_pred             cccccCc
Q 023568          231 PYLQSLH  237 (280)
Q Consensus       231 p~~~~~~  237 (280)
                      |||....
T Consensus       323 p~~~~~~  329 (400)
T 1nxk_A          323 PWIMQST  329 (400)
T ss_dssp             HHHHTTT
T ss_pred             ccccCCC
Confidence            9997654

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=4.6e-44  Score=320.35  Aligned_cols=204  Identities=29%  Similarity=0.532  Sum_probs=177.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+||||+++++++.+.     ...|+||||+. |+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+||
T Consensus        83 l~hpniv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Ni  157 (484)
T 3nyv_A           83 LDHPNIMKLYEFFEDK-----GYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENL  157 (484)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred             CCCCCCCcEEEEEEeC-----CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHE
Confidence            5899999999999987     77999999997 59999999888999999999999999999999999999999999999


Q ss_pred             EE---cCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023568           80 LL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  156 (280)
Q Consensus        80 li---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~  156 (280)
                      ++   +.++.++|+|||+++............||+.|+|||++.+  .++.++||||+||++|+|++|.+||.+.+....
T Consensus       158 l~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  235 (484)
T 3nyv_A          158 LLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDI  235 (484)
T ss_dssp             EESSSSTTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             EEecCCCCCcEEEEeeeeeEEcccccccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence            99   5678899999999987766555566789999999999875  688999999999999999999999999887777


Q ss_pred             HHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 023568          157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  236 (280)
Q Consensus       157 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~  236 (280)
                      ...+.........                           ..++.+++.+++||++||+.||.+|||++|+|+||||+..
T Consensus       236 ~~~i~~~~~~~~~---------------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~  288 (484)
T 3nyv_A          236 LKKVEKGKYTFEL---------------------------PQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY  288 (484)
T ss_dssp             HHHHHHCCCCCCS---------------------------GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred             HHHHHcCCCCCCC---------------------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence            7766542211111                           1223578999999999999999999999999999999876


Q ss_pred             cC
Q 023568          237 HD  238 (280)
Q Consensus       237 ~~  238 (280)
                      ..
T Consensus       289 ~~  290 (484)
T 3nyv_A          289 TK  290 (484)
T ss_dssp             TC
T ss_pred             cc
Confidence            53

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.7e-43  Score=299.39  Aligned_cols=202  Identities=27%  Similarity=0.475  Sum_probs=171.6

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++...     ...|+||||++ ++|.+++.+ ..+++..+..++.|++.||.|||+.||+||||||+||
T Consensus        99 l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NI  172 (321)
T 2c30_A           99 YQHFNVVEMYKSYLVG-----EELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSI  172 (321)
T ss_dssp             CCCTTBCCEEEEEEET-----TEEEEEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             CCCCCcceEEEEEEEC-----CEEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence            5899999999999987     67999999997 599998764 6799999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||++...... .......||+.|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+......
T Consensus       173 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~  251 (321)
T 2c30_A          173 LLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK  251 (321)
T ss_dssp             EECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred             EECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            9999999999999998865543 23355688999999999877 778899999999999999999999999887666555


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  237 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~  237 (280)
                      .+.....   +.                         .......++.+.++|.+||+.||.+|||++|+++||||....
T Consensus       252 ~~~~~~~---~~-------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  302 (321)
T 2c30_A          252 RLRDSPP---PK-------------------------LKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTG  302 (321)
T ss_dssp             HHHHSSC---CC-------------------------CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred             HHhcCCC---CC-------------------------cCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence            5433111   00                         001124688999999999999999999999999999997653

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=7.7e-44  Score=306.38  Aligned_cols=202  Identities=29%  Similarity=0.502  Sum_probs=167.0

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK   75 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik   75 (280)
                      |+||||+++++++.+.     ..+|+||||++ |+|.+.+.+    ...+++..+..++.||+.||.|||++||+|||||
T Consensus        83 l~hpnIv~~~~~~~~~-----~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlk  157 (351)
T 3c0i_A           83 LKHPHIVELLETYSSD-----GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVK  157 (351)
T ss_dssp             CCCTTBCCEEEEEEET-----TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             CCCCCCCcEEEEEEeC-----CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Confidence            6899999999999987     77999999998 599888753    2359999999999999999999999999999999


Q ss_pred             CCceEEcCCCC---eEEeecccccccCCCC-ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 023568           76 PSNLLLNASCD---LKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK  151 (280)
Q Consensus        76 ~~Nili~~~~~---~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~  151 (280)
                      |+||+++.++.   ++|+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.
T Consensus       158 p~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~  236 (351)
T 3c0i_A          158 PHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFYGT  236 (351)
T ss_dssp             GGGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred             hHHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcC-CCCCchHhhHHHHHHHHHHHHCCCCCCCc
Confidence            99999986654   9999999998765543 2445679999999999987 67899999999999999999999999875


Q ss_pred             ChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 023568          152 DYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHP  231 (280)
Q Consensus       152 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp  231 (280)
                      . ......+.......                           .+..++.+++.+.+||++||+.||.+|||+.|+|+||
T Consensus       237 ~-~~~~~~i~~~~~~~---------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp  288 (351)
T 3c0i_A          237 K-ERLFEGIIKGKYKM---------------------------NPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHP  288 (351)
T ss_dssp             H-HHHHHHHHHTCCCC---------------------------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             H-HHHHHHHHcCCCCC---------------------------CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCh
Confidence            3 22333332211000                           0112246789999999999999999999999999999


Q ss_pred             ccccC
Q 023568          232 YLQSL  236 (280)
Q Consensus       232 ~~~~~  236 (280)
                      ||+..
T Consensus       289 ~~~~~  293 (351)
T 3c0i_A          289 WLKER  293 (351)
T ss_dssp             HHHTH
T ss_pred             hhcCC
Confidence            99764

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.1e-43  Score=298.61  Aligned_cols=201  Identities=26%  Similarity=0.523  Sum_probs=166.6

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+||||+++++++.+...   ..+|+||||++ ++|.+++. .+.+++.++..++.|++.||+|||++||+||||||+||
T Consensus        93 l~h~~iv~~~~~~~~~~~---~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni  168 (298)
T 2zv2_A           93 LDHPNVVKLVEVLDDPNE---DHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL  168 (298)
T ss_dssp             CCCTTBCCEEEEEECSSS---SEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred             CCCCCCCeEEEEEEcCCC---CEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence            589999999999987432   67999999997 48877643 46899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC-CccccceeccccccccccccCCC--CCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTE--YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  156 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~--~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~  156 (280)
                      +++.++.++|+|||++...... .......||+.|+|||.+.+...  .+.++|+|||||++|+|++|..||.+.+....
T Consensus       169 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~  248 (298)
T 2zv2_A          169 LVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL  248 (298)
T ss_dssp             EECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             EECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHH
Confidence            9999999999999999875543 23345678999999999876332  47789999999999999999999988775554


Q ss_pred             HHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 023568          157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ  234 (280)
Q Consensus       157 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~  234 (280)
                      ...+......                             ....+.+++.+.++|++||+.||.+|||++|+++||||+
T Consensus       249 ~~~~~~~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~  297 (298)
T 2zv2_A          249 HSKIKSQALE-----------------------------FPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT  297 (298)
T ss_dssp             HHHHHHCCCC-----------------------------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred             HHHHhcccCC-----------------------------CCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence            4443321000                             011236789999999999999999999999999999985

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.2e-43  Score=319.08  Aligned_cols=204  Identities=29%  Similarity=0.511  Sum_probs=177.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+||||+++++++++.     ..+|+|||||+ |+|.+.+.+.+.+++..+..++.||+.||+|||+.||+||||||+||
T Consensus       103 l~hpniv~~~~~~~~~-----~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Ni  177 (504)
T 3q5i_A          103 LDHPNIIKLFDVFEDK-----KYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENI  177 (504)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             CCCCCCCeEEEEEEcC-----CEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHE
Confidence            5899999999999987     77999999997 59999998888999999999999999999999999999999999999


Q ss_pred             EEcCCC---CeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023568           80 LLNASC---DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  156 (280)
Q Consensus        80 li~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~  156 (280)
                      +++.++   .++|+|||++.............||+.|+|||++.+  .++.++||||+||++|+|++|.+||.+.+....
T Consensus       178 l~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  255 (504)
T 3q5i_A          178 LLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDI  255 (504)
T ss_dssp             EESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             EEecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            998775   699999999988766655667789999999999864  688999999999999999999999999887777


Q ss_pred             HHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 023568          157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  236 (280)
Q Consensus       157 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~  236 (280)
                      ...+.......+                           ...++.+++.+++||++||+.||.+|||++|+|+||||+..
T Consensus       256 ~~~i~~~~~~~~---------------------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~  308 (504)
T 3q5i_A          256 IKKVEKGKYYFD---------------------------FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY  308 (504)
T ss_dssp             HHHHHHCCCCCC---------------------------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHT
T ss_pred             HHHHHcCCCCCC---------------------------ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhc
Confidence            766654211111                           11124679999999999999999999999999999999876


Q ss_pred             cC
Q 023568          237 HD  238 (280)
Q Consensus       237 ~~  238 (280)
                      ..
T Consensus       309 ~~  310 (504)
T 3q5i_A          309 AN  310 (504)
T ss_dssp             CC
T ss_pred             hh
Confidence            53

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.7e-43  Score=302.35  Aligned_cols=195  Identities=24%  Similarity=0.368  Sum_probs=169.3

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-c-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-T-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      |+||||+++++++.+.     ...++||||+. | +|.+++...+.+++..+..++.|++.||.|||+.||+||||||+|
T Consensus        86 l~h~~Iv~~~~~~~~~-----~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~N  160 (335)
T 3dls_A           86 VEHANIIKVLDIFENQ-----GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDEN  160 (335)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred             CCCCCEeeEEEEEeeC-----CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHH
Confidence            5899999999999987     77999999985 5 999999988899999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      |+++.++.++|+|||++.............||+.|+|||++.+....+.++|||||||++|+|++|..||......    
T Consensus       161 Ill~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----  236 (335)
T 3dls_A          161 IVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET----  236 (335)
T ss_dssp             EEECTTSCEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----
T ss_pred             EEEcCCCcEEEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----
Confidence            9999999999999999988766655566789999999999987455588999999999999999999999653210    


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  237 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~  237 (280)
                                                       ..........+++.+.+||++||+.||.+|||++++++||||+...
T Consensus       237 ---------------------------------~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  282 (335)
T 3dls_A          237 ---------------------------------VEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV  282 (335)
T ss_dssp             ---------------------------------TTTCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred             ---------------------------------HhhccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence                                             0000111234789999999999999999999999999999997643

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2.3e-43  Score=300.64  Aligned_cols=204  Identities=27%  Similarity=0.462  Sum_probs=171.2

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      +||||+++++++.+.     ..+|+||||+.| +|.+++...  +.+++.+++.++.|++.||+|||+.||+||||||+|
T Consensus        87 ~~~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~N  161 (327)
T 3lm5_A           87 SCPRVINLHEVYENT-----SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQN  161 (327)
T ss_dssp             TCTTBCCEEEEEECS-----SEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred             CCCCEEEEEEEEEeC-----CeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHH
Confidence            579999999999987     779999999975 999998643  679999999999999999999999999999999999


Q ss_pred             eEEcC---CCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023568           79 LLLNA---SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH  155 (280)
Q Consensus        79 ili~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~  155 (280)
                      |+++.   ++.++|+|||++.............|++.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+...
T Consensus       162 Il~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  240 (327)
T 3lm5_A          162 ILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNY-DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE  240 (327)
T ss_dssp             EEESCBTTBCCEEECCGGGCEEC---------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             EEEecCCCCCcEEEeeCccccccCCccccccccCCcCccCCeeecC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH
Confidence            99987   78999999999987766555556789999999999977 778899999999999999999999999988777


Q ss_pred             HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 023568          156 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  235 (280)
Q Consensus       156 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~  235 (280)
                      ....+........                           ...++.+++.+.++|++||+.||.+|||++++|+||||++
T Consensus       241 ~~~~i~~~~~~~~---------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~  293 (327)
T 3lm5_A          241 TYLNISQVNVDYS---------------------------EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQ  293 (327)
T ss_dssp             HHHHHHHTCCCCC---------------------------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCC
T ss_pred             HHHHHHhcccccC---------------------------chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcc
Confidence            6666554322211                           1223467899999999999999999999999999999988


Q ss_pred             CcC
Q 023568          236 LHD  238 (280)
Q Consensus       236 ~~~  238 (280)
                      +.-
T Consensus       294 ~~~  296 (327)
T 3lm5_A          294 WDF  296 (327)
T ss_dssp             CCT
T ss_pred             ccc
Confidence            753

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=5.7e-44  Score=322.34  Aligned_cols=203  Identities=26%  Similarity=0.432  Sum_probs=170.3

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      ++||||++++++|++.     ..+|+||||+. |+|.+++...+  .+++..++.++.||+.||.|||++||+||||||+
T Consensus       241 l~hp~Iv~l~~~~~~~-----~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPe  315 (576)
T 2acx_A          241 VNSRFVVSLAYAYETK-----DALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPE  315 (576)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred             cCCCCEeeEEEEEeeC-----CEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchh
Confidence            5899999999999987     77999999996 59999997654  4999999999999999999999999999999999


Q ss_pred             ceEEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023568           78 NLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  157 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~  157 (280)
                      |||++.++.+||+|||+++............||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.......
T Consensus       316 NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~-~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~  394 (576)
T 2acx_A          316 NILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR  394 (576)
T ss_dssp             GEEECTTSCEEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTT-CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH
T ss_pred             eEEEeCCCCeEEEecccceecccCccccccCCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCcccccchhH
Confidence            99999999999999999987765554556789999999999987 67889999999999999999999999876421111


Q ss_pred             HHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCcc
Q 023568          158 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPY  232 (280)
Q Consensus       158 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rp-----t~~ell~hp~  232 (280)
                      ..+....                    ...       .......+++++.+||++||+.||.+||     +++|+++|||
T Consensus       395 ~~i~~~i--------------------~~~-------~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~Hpf  447 (576)
T 2acx_A          395 EEVERLV--------------------KEV-------PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPL  447 (576)
T ss_dssp             HHHHHHH--------------------HHC-------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGG
T ss_pred             HHHHHHh--------------------hcc-------cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChh
Confidence            1111100                    000       0111235799999999999999999999     8999999999


Q ss_pred             cccC
Q 023568          233 LQSL  236 (280)
Q Consensus       233 ~~~~  236 (280)
                      |+++
T Consensus       448 F~~i  451 (576)
T 2acx_A          448 FKKL  451 (576)
T ss_dssp             GTTC
T ss_pred             hccC
Confidence            9975

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.6e-43  Score=325.97  Aligned_cols=199  Identities=22%  Similarity=0.415  Sum_probs=176.0

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      +||||++++++|++.     ..+||||||++ |+|.+++.+.+.+++..++.++.||+.||.|||+.||+||||||+|||
T Consensus       400 ~~~~i~~l~~~~~~~-----~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NIL  474 (674)
T 3pfq_A          400 KPPFLTQLHSCFQTM-----DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVM  474 (674)
T ss_dssp             CCTTBCCEEEECBCS-----SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEE
T ss_pred             CCCeEEEEEEEEEeC-----CEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEE
Confidence            699999999999988     77999999997 599999988889999999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccccC-CCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           81 LNASCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      ++.++.+||+|||+++... ........+||+.|+|||++.+ ..++.++|+|||||++|||++|+.||.+.+..+....
T Consensus       475 l~~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~  553 (674)
T 3pfq_A          475 LDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS  553 (674)
T ss_dssp             ECSSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTC-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             EcCCCcEEEeecceeeccccCCcccccccCCCcccCHhhhcC-CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence            9999999999999998633 3334556789999999999977 7889999999999999999999999999887777666


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCH-----HHHhcCcccc
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV-----EEALRHPYLQ  234 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~-----~ell~hp~~~  234 (280)
                      |....                               ...+..+++++.+||++||+.||.+||++     +|+++||||+
T Consensus       554 i~~~~-------------------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~  602 (674)
T 3pfq_A          554 IMEHN-------------------------------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR  602 (674)
T ss_dssp             HHSSC-------------------------------CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGS
T ss_pred             HHhCC-------------------------------CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCcccc
Confidence            64311                               11223579999999999999999999997     9999999998


Q ss_pred             cCc
Q 023568          235 SLH  237 (280)
Q Consensus       235 ~~~  237 (280)
                      .+.
T Consensus       603 ~i~  605 (674)
T 3pfq_A          603 YID  605 (674)
T ss_dssp             SCC
T ss_pred             CCC
Confidence            763

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2e-43  Score=294.34  Aligned_cols=199  Identities=26%  Similarity=0.485  Sum_probs=170.2

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++.+.     ...++||||++ |+|.+++.+.+.+++..+..++.|++.||+|||+.||+||||||+||
T Consensus        66 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Ni  140 (279)
T 3fdn_A           66 LRHPNILRLYGYFHDA-----TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENL  140 (279)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGE
T ss_pred             CCCCCCcchhheEecC-----CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhE
Confidence            5799999999999987     77999999998 59999998878899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.++.++|+|||++....... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.........
T Consensus       141 li~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~  218 (279)
T 3fdn_A          141 LLGSAGELKIADFGWSVHAPSSR-RTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR  218 (279)
T ss_dssp             EECTTSCEEECSCCEESCC---------CCCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH
T ss_pred             EEcCCCCEEEEeccccccCCccc-ccccCCCCCccCHhHhcc-CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHH
Confidence            99999999999999886544332 345678999999999877 7788999999999999999999999998877666655


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCc
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  237 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~  237 (280)
                      +.....                               ......++.+.+||.+||+.||.+|||++|+++||||+...
T Consensus       219 ~~~~~~-------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~  265 (279)
T 3fdn_A          219 ISRVEF-------------------------------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS  265 (279)
T ss_dssp             HHHTCC-------------------------------CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred             HHhCCC-------------------------------CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence            544211                               11224688999999999999999999999999999998764

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.9e-43  Score=299.58  Aligned_cols=239  Identities=43%  Similarity=0.742  Sum_probs=182.2

Q ss_pred             CCCcccccccccccCCCC---------CCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 023568            1 MEHENVIAIKDIIRPPKK---------DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLH   71 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~---------~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H   71 (280)
                      |+||||+++++++.....         ......|+||||++|+|.+++.+ +.+++..++.++.|++.||+|||++||+|
T Consensus        65 l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H  143 (320)
T 2i6l_A           65 LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLH  143 (320)
T ss_dssp             CCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBC
T ss_pred             cCCCCeeEEEEeccccccccccccccccccCceeEEeeccCCCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEec
Confidence            589999999999864321         12267899999999999999865 67999999999999999999999999999


Q ss_pred             cCCCCCceEEc-CCCCeEEeecccccccCCC----CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCC
Q 023568           72 RDLKPSNLLLN-ASCDLKIGDFGLARTTSET----DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREP  146 (280)
Q Consensus        72 ~dik~~Nili~-~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~  146 (280)
                      |||||+||+++ .++.++|+|||.++.....    .......++..|+|||.+.+...++.++|+|||||++|+|++|+.
T Consensus       144 ~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~  223 (320)
T 2i6l_A          144 RDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT  223 (320)
T ss_dssp             CCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred             CCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCC
Confidence            99999999997 5678999999999865432    223345678899999998765778999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHH
Q 023568          147 LFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEE  226 (280)
Q Consensus       147 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~e  226 (280)
                      ||.+.+.......+....+.............. ..+................+.++..+.+||++||+.||.+|||++|
T Consensus       224 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  302 (320)
T 2i6l_A          224 LFAGAHELEQMQLILESIPVVHEEDRQELLSVI-PVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEE  302 (320)
T ss_dssp             SSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTS-CHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred             CCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcC-cccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHH
Confidence            999998888888777765544433221110000 0001111111122233445678999999999999999999999999


Q ss_pred             HhcCcccccCcCCCC
Q 023568          227 ALRHPYLQSLHDLND  241 (280)
Q Consensus       227 ll~hp~~~~~~~~~~  241 (280)
                      +|+||||+...-+..
T Consensus       303 ll~hp~~~~~~~p~~  317 (320)
T 2i6l_A          303 ALSHPYMSIYSFPMD  317 (320)
T ss_dssp             HHTSHHHHTTCC---
T ss_pred             HhCCcccccccCccC
Confidence            999999987754443

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.8e-43  Score=295.87  Aligned_cols=202  Identities=27%  Similarity=0.368  Sum_probs=156.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLK   75 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~----~~~~l~~~~~~~i~~qil~~l~~LH~~-~i~H~dik   75 (280)
                      ++||||+++++++.+.     ...|+||||++|+|.+++.    ..+.+++..+..++.|++.||+|||++ |++|||||
T Consensus        63 ~~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlk  137 (290)
T 3fme_A           63 VDCPFTVTFYGALFRE-----GDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVK  137 (290)
T ss_dssp             CCCTTBCCEEEEEECS-----SSEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCS
T ss_pred             CCCCeEEEEeeeeecc-----CCEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCC
Confidence            4799999999999987     6799999999999888775    357899999999999999999999998 99999999


Q ss_pred             CCceEEcCCCCeEEeecccccccCCCCccccceeccccccccccc---cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 023568           76 PSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL---NCTEYTAAIDIWSVGCILGEIMTREPLFPGKD  152 (280)
Q Consensus        76 ~~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~  152 (280)
                      |+||+++.++.++|+|||++.............|++.|+|||.+.   ....++.++|+||+||++|+|++|..||....
T Consensus       138 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  217 (290)
T 3fme_A          138 PSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWG  217 (290)
T ss_dssp             GGGCEECTTCCEEBCCC---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCS
T ss_pred             HHHEEECCCCCEEEeecCCcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccC
Confidence            999999999999999999998766554445567899999999972   33678889999999999999999999998743


Q ss_pred             h-HHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 023568          153 Y-VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHP  231 (280)
Q Consensus       153 ~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp  231 (280)
                      . ............                             ........++.+.+++.+||+.||.+|||++|+++||
T Consensus       218 ~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp  268 (290)
T 3fme_A          218 TPFQQLKQVVEEPS-----------------------------PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHP  268 (290)
T ss_dssp             CHHHHHHHHHHSCC-----------------------------CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSH
T ss_pred             chHHHHHHHhccCC-----------------------------CCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCc
Confidence            2 233322222100                             0011135689999999999999999999999999999


Q ss_pred             ccccC
Q 023568          232 YLQSL  236 (280)
Q Consensus       232 ~~~~~  236 (280)
                      ||+..
T Consensus       269 ~f~~~  273 (290)
T 3fme_A          269 FFTLH  273 (290)
T ss_dssp             HHHHH
T ss_pred             ccccC
Confidence            99764

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=5.4e-43  Score=302.63  Aligned_cols=201  Identities=28%  Similarity=0.555  Sum_probs=173.5

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      +||||+++++++...     ...|+||||++| +|.+++.....+++..+..++.||+.||.|||+.|++|+||||+||+
T Consensus       158 ~hp~iv~~~~~~~~~-----~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl  232 (365)
T 2y7j_A          158 GHPHIITLIDSYESS-----SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENIL  232 (365)
T ss_dssp             TCTTBCCEEEEEEBS-----SEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             CCCCEeEEEEEEeeC-----CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence            699999999999887     779999999985 99999988788999999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccccCCCCccccceeccccccccccccC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023568           81 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC-----TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH  155 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~  155 (280)
                      ++.++.++|+|||++.............||+.|+|||++.+.     ..++.++|||||||++|+|++|..||.+.+...
T Consensus       233 ~~~~~~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~  312 (365)
T 2y7j_A          233 LDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL  312 (365)
T ss_dssp             ECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             ECCCCCEEEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH
Confidence            999999999999999877665555667899999999998642     357889999999999999999999999887666


Q ss_pred             HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 023568          156 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ  234 (280)
Q Consensus       156 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~  234 (280)
                      ....+........                           ...+...++.+.++|++||+.||.+|||++|+|+||||+
T Consensus       313 ~~~~i~~~~~~~~---------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~  364 (365)
T 2y7j_A          313 MLRMIMEGQYQFS---------------------------SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE  364 (365)
T ss_dssp             HHHHHHHTCCCCC---------------------------HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred             HHHHHHhCCCCCC---------------------------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence            6555543211111                           011235688999999999999999999999999999996

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=9.8e-43  Score=297.36  Aligned_cols=227  Identities=31%  Similarity=0.548  Sum_probs=181.3

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      .|++|+++++++...     +..|+||||++++|.+++...+  .+++.++..++.|++.||+|||++||+||||||+||
T Consensus        75 ~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni  149 (339)
T 1z57_A           75 STFRCVQMLEWFEHH-----GHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENI  149 (339)
T ss_dssp             CTTCBCCEEEEEEET-----TEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred             CceeeEeeecccccC-----CcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHE
Confidence            466799999999887     7899999999889999997654  689999999999999999999999999999999999


Q ss_pred             EEcC-------------------CCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHH
Q 023568           80 LLNA-------------------SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGE  140 (280)
Q Consensus        80 li~~-------------------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~  140 (280)
                      +++.                   ++.++|+|||++......  .....||+.|+|||++.+ ..++.++|+|||||++|+
T Consensus       150 l~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~e  226 (339)
T 1z57_A          150 LFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIE  226 (339)
T ss_dssp             EESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTT-SCCCTHHHHHHHHHHHHH
T ss_pred             EEeccccccccCCccccccccccCCCceEeeCcccccCccc--cccccCCccccChHHhhC-CCCCcchhhHHHHHHHHH
Confidence            9987                   678999999999875443  345678999999999987 778999999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccC--------------ChhHHHHHHhCCccccccccccCCCCCHHH
Q 023568          141 IMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR--------------SDNARRYVRQLPRCRKQQFATRFPNKSSGA  206 (280)
Q Consensus       141 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  206 (280)
                      |++|..||...+..+....+....+..+........              .............. ...........++.+
T Consensus       227 l~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l  305 (339)
T 1z57_A          227 YYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKP-LKEFMLSQDVEHERL  305 (339)
T ss_dssp             HHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCC-GGGGCSCCSHHHHHH
T ss_pred             HHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcc-hhhhcccchhhHHHH
Confidence            999999999999888888888888766654322111              01111111111100 001111122346789


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCcccccCc
Q 023568          207 VDLLEKMLVFDPNKRITVEEALRHPYLQSLH  237 (280)
Q Consensus       207 ~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~  237 (280)
                      .+||++||+.||.+|||++|+++||||+.+.
T Consensus       306 ~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  336 (339)
T 1z57_A          306 FDLIQKMLEYDPAKRITLREALKHPFFDLLK  336 (339)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHTTSGGGGGGG
T ss_pred             HHHHHHHhCcCcccccCHHHHhcCHHHHHHh
Confidence            9999999999999999999999999998865

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=4e-43  Score=291.89  Aligned_cols=200  Identities=28%  Similarity=0.459  Sum_probs=164.1

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++...     ...|+||||++ ++|.+++.+.+.+++..+..++.|++.||.|||++|++|+||+|+||
T Consensus        68 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Ni  142 (276)
T 2h6d_A           68 FRHPHIIKLYQVISTP-----TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENV  142 (276)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGE
T ss_pred             CCCCCEeEEEEEEecC-----CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhE
Confidence            5799999999999887     77999999997 59999998878899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.++.++|+|||.+.............+++.|+|||.+.+....+.++|+||||+++|+|++|..||...........
T Consensus       143 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~  222 (276)
T 2h6d_A          143 LLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKK  222 (276)
T ss_dssp             EECTTSCEEECCCCGGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             EECCCCCEEEeecccccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH
Confidence            99999999999999998766655455667899999999998744457899999999999999999999988776555554


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  236 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~  236 (280)
                      +....                               .......+..+.++|.+||+.||.+|||++|+++||||++.
T Consensus       223 ~~~~~-------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          223 IRGGV-------------------------------FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             HHHCC-------------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             hhcCc-------------------------------ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence            43311                               01123468899999999999999999999999999999764

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=3.5e-43  Score=297.82  Aligned_cols=219  Identities=23%  Similarity=0.380  Sum_probs=159.6

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      +||||+++++++.+.     +.+|+||||++ |+|.+++...+.+++..+..++.|++.||+|||++||+||||||+||+
T Consensus        69 ~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil  143 (316)
T 2ac3_A           69 GHRNVLELIEFFEEE-----DRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENIL  143 (316)
T ss_dssp             CCTTBCCEEEEEEET-----TEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred             CCCCeeeEEEEEeeC-----CEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEE
Confidence            699999999999987     77999999997 699999988788999999999999999999999999999999999999


Q ss_pred             EcCCCC---eEEeecccccccCCC--------Cccccceecccccccccccc----CCCCCcchhHHHHHHHHHHHHhCC
Q 023568           81 LNASCD---LKIGDFGLARTTSET--------DFMTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTRE  145 (280)
Q Consensus        81 i~~~~~---~kl~dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslG~~l~~ll~g~  145 (280)
                      ++.++.   ++|+|||++......        .......||+.|+|||++.+    ...++.++|||||||++|+|++|.
T Consensus       144 ~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~  223 (316)
T 2ac3_A          144 CEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGY  223 (316)
T ss_dssp             ESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSS
T ss_pred             EccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCC
Confidence            988766   999999998754321        11224568999999999864    134678999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 023568          146 PLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVE  225 (280)
Q Consensus       146 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~  225 (280)
                      .||.+....+..            .................+...........++.+++.+.+||++||+.||.+|||++
T Consensus       224 ~pf~~~~~~~~~------------~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~  291 (316)
T 2ac3_A          224 PPFVGRCGSDCG------------WDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAA  291 (316)
T ss_dssp             CSCCCCCCSCSC------------C----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred             CCCccccccccc------------ccccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHH
Confidence            999876421100            00000000000000000000000000111235789999999999999999999999


Q ss_pred             HHhcCcccccCc
Q 023568          226 EALRHPYLQSLH  237 (280)
Q Consensus       226 ell~hp~~~~~~  237 (280)
                      |+|+||||++..
T Consensus       292 e~l~hp~~~~~~  303 (316)
T 2ac3_A          292 QVLQHPWVQGCA  303 (316)
T ss_dssp             HHHHSTTCC---
T ss_pred             HHhcChhhcCCC
Confidence            999999998764

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=8.7e-43  Score=291.15  Aligned_cols=200  Identities=24%  Similarity=0.468  Sum_probs=173.0

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++.+.     ...|+||||++ |+|.+++.+.+.+++..+..++.|++.||.|||+.|++||||+|+||
T Consensus        71 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Ni  145 (284)
T 2vgo_A           71 LRHPNILRMYNYFHDR-----KRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENL  145 (284)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGE
T ss_pred             CCCCCEeeEEEEEEcC-----CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHE
Confidence            5799999999999987     77999999997 59999998878899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.++.++|+|||++....... .....|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......
T Consensus       146 l~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~  223 (284)
T 2vgo_A          146 LMGYKGELKIADFGWSVHAPSLR-RRTMCGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRR  223 (284)
T ss_dssp             EECTTCCEEECCCTTCEECSSSC-BCCCCSCGGGCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH
T ss_pred             EEcCCCCEEEecccccccCcccc-cccccCCCCcCCHHHhcc-CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHH
Confidence            99999999999999987654332 345678999999999887 6788999999999999999999999998876655544


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCcC
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  238 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~~  238 (280)
                      +....                               ....+..+..+.++|.+||+.||.+|||++++++||||+....
T Consensus       224 ~~~~~-------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~  271 (284)
T 2vgo_A          224 IVNVD-------------------------------LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSR  271 (284)
T ss_dssp             HHTTC-------------------------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred             Hhccc-------------------------------cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence            43210                               0112357899999999999999999999999999999987543

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=9.8e-43  Score=299.03  Aligned_cols=199  Identities=26%  Similarity=0.404  Sum_probs=170.1

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIR-SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~-~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+||||+++++++...     ...|+||||+.|+|.+++. ..+.+++.++..++.|++.||.|||+.||+||||||+||
T Consensus       111 l~hpniv~~~~~~~~~-----~~~~lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI  185 (348)
T 1u5q_A          111 LRHPNTIQYRGCYLRE-----HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNI  185 (348)
T ss_dssp             CCCTTBCCEEEEEEET-----TEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGE
T ss_pred             CCCCCEeeEEEEEEEC-----CeEEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHE
Confidence            5899999999999887     6799999999999999885 457899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceecccccccccccc--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  157 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~  157 (280)
                      +++.++.++|+|||++......   ....||+.|+|||++.+  ...++.++|||||||++|+|++|..||.+.+....+
T Consensus       186 ll~~~~~~kL~DfG~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~  262 (348)
T 1u5q_A          186 LLSEPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL  262 (348)
T ss_dssp             EEETTTEEEECCCTTCBSSSSB---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred             EECCCCCEEEeeccCceecCCC---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence            9999999999999999765443   35678999999999853  356788999999999999999999999988766655


Q ss_pred             HHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 023568          158 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  236 (280)
Q Consensus       158 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~  236 (280)
                      ..+..... +                            .......++.+.+||.+||+.||.+|||++++++||||...
T Consensus       263 ~~~~~~~~-~----------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~  312 (348)
T 1u5q_A          263 YHIAQNES-P----------------------------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  312 (348)
T ss_dssp             HHHHHSCC-C----------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             HHHHhcCC-C----------------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence            54433110 0                            01123568899999999999999999999999999999653

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=3.9e-43  Score=292.96  Aligned_cols=206  Identities=29%  Similarity=0.514  Sum_probs=172.2

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+||||+++++++.+.     ...|+||||++ ++|.+++.+.+.+++.++..++.|++.||.|||+.|++||||||+||
T Consensus        65 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Ni  139 (283)
T 3bhy_A           65 IRHPNIITLHDIFENK-----TDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENI  139 (283)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             CCCCCeeehhheecCC-----CeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHE
Confidence            5799999999999987     67999999996 69999998878899999999999999999999999999999999999


Q ss_pred             EEcCCC----CeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023568           80 LLNASC----DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH  155 (280)
Q Consensus        80 li~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~  155 (280)
                      +++.++    .++|+|||.+.............+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.....
T Consensus       140 l~~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~  218 (283)
T 3bhy_A          140 MLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGETKQE  218 (283)
T ss_dssp             EESCSSSSSCCEEECCCTTCEECC--------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred             EEecCCCCCCceEEEecccceeccCCCcccccCCCcCccCcceecC-CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH
Confidence            998876    799999999987665544456678999999999876 678899999999999999999999999887666


Q ss_pred             HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 023568          156 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  235 (280)
Q Consensus       156 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~  235 (280)
                      ....+........                           ...++..+..+.+++++||+.||.+|||++|+++||||+.
T Consensus       219 ~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~  271 (283)
T 3bhy_A          219 TLTNISAVNYDFD---------------------------EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA  271 (283)
T ss_dssp             HHHHHHTTCCCCC---------------------------HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred             HHHHhHhcccCCc---------------------------chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence            6555443211111                           1122467889999999999999999999999999999988


Q ss_pred             CcCC
Q 023568          236 LHDL  239 (280)
Q Consensus       236 ~~~~  239 (280)
                      +...
T Consensus       272 ~~~~  275 (283)
T 3bhy_A          272 IRRR  275 (283)
T ss_dssp             HHHC
T ss_pred             HHHH
Confidence            7533

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.6e-42  Score=301.52  Aligned_cols=225  Identities=32%  Similarity=0.567  Sum_probs=178.7

Q ss_pred             CcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHH--hCCccccCCCCCc
Q 023568            3 HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVH--SASVLHRDLKPSN   78 (280)
Q Consensus         3 Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH--~~~i~H~dik~~N   78 (280)
                      |++|+++++++...     ..+|+||||++|+|.+++...  +.+++..++.++.|++.||.|||  +.||+||||||+|
T Consensus       115 ~~~iv~~~~~~~~~-----~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~N  189 (382)
T 2vx3_A          115 KYYIVHLKRHFMFR-----NHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPEN  189 (382)
T ss_dssp             GGGBCCEEEEEEET-----TEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGG
T ss_pred             ceeEEEeeeeeccC-----CceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCccc
Confidence            45699999999987     789999999999999999764  46999999999999999999999  5799999999999


Q ss_pred             eEEc--CCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023568           79 LLLN--ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  156 (280)
Q Consensus        79 ili~--~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~  156 (280)
                      ||++  .++.+||+|||+++.....  .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.
T Consensus       190 Ill~~~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~  266 (382)
T 2vx3_A          190 ILLCNPKRSAIKIVDFGSSCQLGQR--IYQYIQSRFYRSPEVLLG-MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQ  266 (382)
T ss_dssp             EEESSTTSCCEEECCCTTCEETTCC--CCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             EEEecCCCCcEEEEeccCceecccc--cccccCCccccChHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            9995  4778999999999876543  345688999999999987 6789999999999999999999999999999999


Q ss_pred             HHHHHHHhCCCCcccccccCChhHHHHHHhCCcccc---------ccc--------cc-----------cCCC-------
Q 023568          157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK---------QQF--------AT-----------RFPN-------  201 (280)
Q Consensus       157 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~--------~~-----------~~~~-------  201 (280)
                      +..+.+..+.++........  ....+...++....         ..+        ..           ...+       
T Consensus       267 ~~~i~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  344 (382)
T 2vx3_A          267 MNKIVEVLGIPPAHILDQAP--KARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVA  344 (382)
T ss_dssp             HHHHHHHHCSCCHHHHTTCT--THHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHH
T ss_pred             HHHHHHHhCCCCHHHHHhhH--HHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccch
Confidence            99999988887765543221  11222221111000         000        00           0000       


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCc
Q 023568          202 KSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  237 (280)
Q Consensus       202 ~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~  237 (280)
                      .++.+++||++||+.||++|||++|+|+||||+...
T Consensus       345 ~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~~  380 (382)
T 2vx3_A          345 DYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTA  380 (382)
T ss_dssp             HHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC--
T ss_pred             hhHHHHHHHHHhcCCChhhCCCHHHHhcCcccccCC
Confidence            014789999999999999999999999999998754

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2.8e-43  Score=309.61  Aligned_cols=202  Identities=37%  Similarity=0.629  Sum_probs=158.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+||||+++++++..+      ..|+||||+. |+|.+++...+.+++.+++.++.|++.||+|||++||+||||||+||
T Consensus       197 l~hpniv~l~~~~~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NI  270 (419)
T 3i6u_A          197 LNHPCIIKIKNFFDAE------DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENV  270 (419)
T ss_dssp             CCCTTBCCCCEEEESS------EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred             CCCCCEeeEEEEEecC------ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhE
Confidence            5899999999998643      4899999997 59999998888999999999999999999999999999999999999


Q ss_pred             EEcCCC---CeEEeecccccccCCCCccccceecccccccccccc--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023568           80 LLNASC---DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV  154 (280)
Q Consensus        80 li~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~  154 (280)
                      |++.++   .+||+|||+++............||+.|+|||++.+  ...++.++|+|||||++|+|++|..||......
T Consensus       271 ll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~  350 (419)
T 3i6u_A          271 LLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ  350 (419)
T ss_dssp             EESSSSSSCCEEECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS
T ss_pred             EEecCCCcceEEEeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch
Confidence            997544   599999999988776655667789999999999853  356788999999999999999999999875432


Q ss_pred             HHH-HHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          155 HQL-RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       155 ~~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      ..+ ..+....                           ....+..++.+++.+.+||++||+.||.+|||++|+|+||||
T Consensus       351 ~~~~~~i~~~~---------------------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~  403 (419)
T 3i6u_A          351 VSLKDQITSGK---------------------------YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL  403 (419)
T ss_dssp             CCHHHHHHTTC---------------------------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred             HHHHHHHhcCC---------------------------CCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCccc
Confidence            211 1111100                           011122234679999999999999999999999999999999


Q ss_pred             cc
Q 023568          234 QS  235 (280)
Q Consensus       234 ~~  235 (280)
                      ++
T Consensus       404 ~~  405 (419)
T 3i6u_A          404 QD  405 (419)
T ss_dssp             CC
T ss_pred             CC
Confidence            65

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2e-42  Score=290.79  Aligned_cols=204  Identities=29%  Similarity=0.502  Sum_probs=175.1

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      +||||+++++++...     ...|+||||++ ++|.+++.+...+++..+..++.|++.||.|||+.|++|+||+|+||+
T Consensus        82 ~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil  156 (298)
T 1phk_A           82 GHPNIIQLKDTYETN-----TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENIL  156 (298)
T ss_dssp             TCTTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             CCCCEeeeeeeeccC-----CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEE
Confidence            499999999999887     77999999997 599999988789999999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccccCCCCccccceecccccccccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023568           81 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN-----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH  155 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~  155 (280)
                      ++.++.++|+|||.+.............+++.|+|||++.+     ...++.++|+||||+++|+|++|..||.+.+...
T Consensus       157 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~  236 (298)
T 1phk_A          157 LDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML  236 (298)
T ss_dssp             ECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             EcCCCcEEEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH
Confidence            99999999999999987665555566788999999999852     3567889999999999999999999998887666


Q ss_pred             HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 023568          156 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  235 (280)
Q Consensus       156 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~  235 (280)
                      ....+........                           ...++..+..+.++|.+||+.||.+|||++|+++||||++
T Consensus       237 ~~~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~  289 (298)
T 1phk_A          237 MLRMIMSGNYQFG---------------------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  289 (298)
T ss_dssp             HHHHHHHTCCCCC---------------------------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             HHHHHhcCCcccC---------------------------cccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhh
Confidence            6555544211111                           0112356889999999999999999999999999999987


Q ss_pred             Cc
Q 023568          236 LH  237 (280)
Q Consensus       236 ~~  237 (280)
                      ..
T Consensus       290 ~~  291 (298)
T 1phk_A          290 YV  291 (298)
T ss_dssp             TC
T ss_pred             cc
Confidence            64

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.3e-42  Score=296.07  Aligned_cols=230  Identities=29%  Similarity=0.557  Sum_probs=175.4

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      .||||+++++++.+...   ...++||||++ ++|.+++.   .+++.+++.++.|++.||+|||+.||+||||||+||+
T Consensus        89 ~~~~i~~~~~~~~~~~~---~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil  162 (330)
T 3nsz_A           89 GGPNIITLADIVKDPVS---RTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM  162 (330)
T ss_dssp             TSTTBCCEEEEEECTTT---CCEEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred             CCCCEEEeeeeeccCCC---CceEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEE
Confidence            39999999999987432   67999999998 58988884   4999999999999999999999999999999999999


Q ss_pred             EcCCC-CeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC-CChHHHHH
Q 023568           81 LNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG-KDYVHQLR  158 (280)
Q Consensus        81 i~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~-~~~~~~~~  158 (280)
                      ++.++ .++|+|||+++............++..|+|||.+.+...++.++|||||||++|+|++|..||.. .+....+.
T Consensus       163 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~  242 (330)
T 3nsz_A          163 IDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV  242 (330)
T ss_dssp             EETTTTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHH
T ss_pred             EcCCCCEEEEEeCCCceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHH
Confidence            99776 89999999998766655556678899999999998767789999999999999999999999854 45556666


Q ss_pred             HHHHHhCCCCccccc----ccCChhHHHHHHhCCcccccc--ccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 023568          159 LITELIGSPDDASLG----FLRSDNARRYVRQLPRCRKQQ--FATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY  232 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~  232 (280)
                      .+....+.+......    .....................  .......+++.+.+||++||+.||.+|||++|+|+|||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~  322 (330)
T 3nsz_A          243 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY  322 (330)
T ss_dssp             HHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGG
T ss_pred             HHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCcc
Confidence            666655432211000    000001111111110000000  01112237999999999999999999999999999999


Q ss_pred             cccCc
Q 023568          233 LQSLH  237 (280)
Q Consensus       233 ~~~~~  237 (280)
                      |+++.
T Consensus       323 f~~~~  327 (330)
T 3nsz_A          323 FYTVV  327 (330)
T ss_dssp             GTTCC
T ss_pred             Hhhhc
Confidence            99875

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.1e-42  Score=291.59  Aligned_cols=203  Identities=31%  Similarity=0.503  Sum_probs=173.6

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+||||+++++++.+.     ...|+||||++ ++|.+++...+.+++..+..++.|++.||.|||+.|++||||||+||
T Consensus        63 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NI  137 (304)
T 2jam_A           63 IKHENIVTLEDIYEST-----THYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENL  137 (304)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGC
T ss_pred             CCCCCeeehhhhcccC-----CEEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHE
Confidence            5899999999999887     77999999997 59999998878899999999999999999999999999999999999


Q ss_pred             EE---cCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023568           80 LL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  156 (280)
Q Consensus        80 li---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~  156 (280)
                      ++   +.++.++|+|||++...... ......|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+......
T Consensus       138 l~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~  215 (304)
T 2jam_A          138 LYLTPEENSKIMITDFGLSKMEQNG-IMSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKL  215 (304)
T ss_dssp             EESSSSTTCCEEBCSCSTTCCCCCB-TTHHHHSCCCBCCTTTBSS-CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred             EEecCCCCCCEEEccCCcceecCCC-ccccccCCCCccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence            99   77889999999998765433 2344568999999999877 7788999999999999999999999998876666


Q ss_pred             HHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 023568          157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  236 (280)
Q Consensus       157 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~  236 (280)
                      ...+.+.....                           ....++.+++.+.++|.+||+.||.+|||++|+++||||+..
T Consensus       216 ~~~i~~~~~~~---------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (304)
T 2jam_A          216 FEKIKEGYYEF---------------------------ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN  268 (304)
T ss_dssp             HHHHHHCCCCC---------------------------CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred             HHHHHcCCCCC---------------------------CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence            65554421110                           011234678999999999999999999999999999999875


Q ss_pred             c
Q 023568          237 H  237 (280)
Q Consensus       237 ~  237 (280)
                      .
T Consensus       269 ~  269 (304)
T 2jam_A          269 T  269 (304)
T ss_dssp             C
T ss_pred             C
Confidence            3

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2e-42  Score=295.80  Aligned_cols=203  Identities=30%  Similarity=0.472  Sum_probs=174.5

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++.+.     ...|+||||++ ++|.+++...+.+++.++..++.|++.||.|||++||+||||||+||
T Consensus        98 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NI  172 (335)
T 2owb_A           98 LAHQHVVGFHGFFEDN-----DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNL  172 (335)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred             CCCCCCCeEEEEEecC-----CeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhE
Confidence            5899999999999987     77999999998 59999998878899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||++...... .......|+..|+|||++.+ ..++.++|+||||+++|+|++|+.||..........
T Consensus       173 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  251 (335)
T 2owb_A          173 FLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL  251 (335)
T ss_dssp             EECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred             EEcCCCCEEEeeccCceecccCcccccccCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHH
Confidence            9999999999999999865432 23345678999999999877 678899999999999999999999998877655554


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCcC
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  238 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~~  238 (280)
                      .+....                               .......++.+.++|++||+.||.+|||++|+++||||++...
T Consensus       252 ~~~~~~-------------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~  300 (335)
T 2owb_A          252 RIKKNE-------------------------------YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI  300 (335)
T ss_dssp             HHHHTC-------------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred             HHhcCC-------------------------------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCc
Confidence            443210                               0112356889999999999999999999999999999987654


Q ss_pred             CC
Q 023568          239 LN  240 (280)
Q Consensus       239 ~~  240 (280)
                      +.
T Consensus       301 ~~  302 (335)
T 2owb_A          301 PA  302 (335)
T ss_dssp             CS
T ss_pred             cc
Confidence            43

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.7e-43  Score=299.21  Aligned_cols=206  Identities=25%  Similarity=0.426  Sum_probs=167.6

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHc--------------------------------------
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS--------------------------------------   41 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~--------------------------------------   41 (280)
                      |+||||+++++++.+.     ...++||||++ |+|.+++..                                      
T Consensus        85 l~hpniv~~~~~~~~~-----~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (345)
T 3hko_A           85 LHHPNIARLYEVYEDE-----QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRE  159 (345)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEE
T ss_pred             CCCCCcceeehhhccC-----CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccc
Confidence            5899999999999887     77999999996 599999852                                      


Q ss_pred             --CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC--CeEEeecccccccCCC-----Cccccceeccc
Q 023568           42 --DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC--DLKIGDFGLARTTSET-----DFMTEYVVTRW  112 (280)
Q Consensus        42 --~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nili~~~~--~~kl~dfg~~~~~~~~-----~~~~~~~~~~~  112 (280)
                        ...+++..++.++.|++.||+|||+.||+||||||+||+++.++  .++|+|||++......     .......||+.
T Consensus       160 ~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~  239 (345)
T 3hko_A          160 SLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPY  239 (345)
T ss_dssp             ECCHHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGG
T ss_pred             cccccccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCcc
Confidence              11246888999999999999999999999999999999998766  8999999999754321     12345678999


Q ss_pred             cccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccc
Q 023568          113 YRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCR  191 (280)
Q Consensus       113 y~aPE~~~~~-~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (280)
                      |+|||++.+. ..++.++|||||||++|+|++|..||.+.+..+....+.........                      
T Consensus       240 y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~----------------------  297 (345)
T 3hko_A          240 FVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFEN----------------------  297 (345)
T ss_dssp             GCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTS----------------------
T ss_pred             ccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCC----------------------
Confidence            9999998642 57788999999999999999999999998877766665542111111                      


Q ss_pred             cccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCcC
Q 023568          192 KQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  238 (280)
Q Consensus       192 ~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~~  238 (280)
                           ..++.+++.+.++|++||+.||.+|||+.++|+||||+++.+
T Consensus       298 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~  339 (345)
T 3hko_A          298 -----PNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD  339 (345)
T ss_dssp             -----GGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred             -----cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChH
Confidence                 112346899999999999999999999999999999988753

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.4e-42  Score=289.84  Aligned_cols=203  Identities=30%  Similarity=0.472  Sum_probs=173.9

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++.+.     +..|+||||++ ++|.+++...+.+++.++..++.|++.||+|||+.|++||||||+||
T Consensus        72 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Ni  146 (294)
T 2rku_A           72 LAHQHVVGFHGFFEDN-----DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNL  146 (294)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred             CCCCCEeeeeeeeccC-----CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhE
Confidence            5799999999999887     77999999998 59999998878999999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||.+...... .......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||......+...
T Consensus       147 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~  225 (294)
T 2rku_A          147 FLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL  225 (294)
T ss_dssp             EECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred             EEcCCCCEEEEeccCceecccCccccccccCCCCcCCcchhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            9999999999999999865432 23345678999999999876 678899999999999999999999998877655544


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCcC
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  238 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~~  238 (280)
                      .+....                               .......++.+.+++++||+.||.+|||++|+++||||.+...
T Consensus       226 ~~~~~~-------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~  274 (294)
T 2rku_A          226 RIKKNE-------------------------------YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI  274 (294)
T ss_dssp             HHHTTC-------------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred             HHhhcc-------------------------------CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCc
Confidence            332210                               0112356889999999999999999999999999999987654


Q ss_pred             CC
Q 023568          239 LN  240 (280)
Q Consensus       239 ~~  240 (280)
                      +.
T Consensus       275 ~~  276 (294)
T 2rku_A          275 PA  276 (294)
T ss_dssp             CS
T ss_pred             CC
Confidence            43

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.8e-42  Score=310.40  Aligned_cols=199  Identities=25%  Similarity=0.416  Sum_probs=168.6

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD----QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK   75 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~----~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik   75 (280)
                      ++||||++++++|++.     ..+|+||||++ |+|.+++...    ..+++..++.++.||+.||.|||++||+|||||
T Consensus       242 l~hp~Iv~l~~~~~~~-----~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLK  316 (543)
T 3c4z_A          242 VHSRFIVSLAYAFETK-----TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLK  316 (543)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred             cCCCCEeeEEEEEeeC-----CEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCC
Confidence            5899999999999987     77999999997 5999998753    469999999999999999999999999999999


Q ss_pred             CCceEEcCCCCeEEeecccccccCCCCc-cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh-
Q 023568           76 PSNLLLNASCDLKIGDFGLARTTSETDF-MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY-  153 (280)
Q Consensus        76 ~~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~-  153 (280)
                      |+|||++.+|.+||+|||+++....... ....+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+... 
T Consensus       317 P~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiwSlGvilyelltG~~PF~~~~~~  395 (543)
T 3c4z_A          317 PENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEK  395 (543)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCC
T ss_pred             hHHEEEeCCCCEEEeecceeeeccCCCcccccccCCccccChhhhcC-CCCChHHhcCcchHHHHHHHhCCCCCCCCccc
Confidence            9999999999999999999987654432 344689999999999987 7889999999999999999999999987632 


Q ss_pred             ---HHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCC-----HH
Q 023568          154 ---VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT-----VE  225 (280)
Q Consensus       154 ---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt-----~~  225 (280)
                         ......+...                               ....++.+++.+.+||++||+.||.+||+     ++
T Consensus       396 ~~~~~~~~~i~~~-------------------------------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~  444 (543)
T 3c4z_A          396 VENKELKQRVLEQ-------------------------------AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCD  444 (543)
T ss_dssp             CCHHHHHHHHHHC-------------------------------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSH
T ss_pred             hhHHHHHHHHhhc-------------------------------ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHH
Confidence               2222222110                               01122467999999999999999999995     58


Q ss_pred             HHhcCcccccC
Q 023568          226 EALRHPYLQSL  236 (280)
Q Consensus       226 ell~hp~~~~~  236 (280)
                      ++++||||+++
T Consensus       445 ei~~Hpff~~i  455 (543)
T 3c4z_A          445 GLRTHPLFRDI  455 (543)
T ss_dssp             HHHTSGGGTTC
T ss_pred             HHHcCccccCC
Confidence            99999999975

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=4e-42  Score=287.97  Aligned_cols=203  Identities=22%  Similarity=0.365  Sum_probs=166.1

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS--VLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~--i~H~dik~~   77 (280)
                      ++||||+++++++..... +...+|+||||++ ++|.+++...+.+++..+..++.|++.||.|||+.|  ++||||||+
T Consensus        82 l~h~~iv~~~~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~  160 (290)
T 1t4h_A           82 LQHPNIVRFYDSWESTVK-GKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCD  160 (290)
T ss_dssp             CCCTTBCCEEEEEEEESS-SCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGG
T ss_pred             CCCCCeeeeeeeeccccC-CCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHH
Confidence            589999999999876421 1266999999997 599999988788999999999999999999999999  999999999


Q ss_pred             ceEEc-CCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023568           78 NLLLN-ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  156 (280)
Q Consensus        78 Nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~  156 (280)
                      ||+++ .++.++|+|||++...... ......|++.|+|||.+.+  .++.++|+|||||++|+|++|..||........
T Consensus       161 Nil~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~  237 (290)
T 1t4h_A          161 NIFITGPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ  237 (290)
T ss_dssp             GEEESSTTSCEEECCTTGGGGCCTT-SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH
T ss_pred             HEEEECCCCCEEEeeCCCccccccc-ccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH
Confidence            99997 7899999999999755433 2345678999999998864  588999999999999999999999988654443


Q ss_pred             HHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 023568          157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  235 (280)
Q Consensus       157 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~  235 (280)
                      ..........                            ........++.+.++|.+||+.||.+|||++|+++||||++
T Consensus       238 ~~~~~~~~~~----------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          238 IYRRVTSGVK----------------------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHTTTCC----------------------------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHHhccCC----------------------------ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence            3222111000                            01112246789999999999999999999999999999975

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=8.7e-44  Score=308.93  Aligned_cols=199  Identities=18%  Similarity=0.267  Sum_probs=157.6

Q ss_pred             CCCccccccc-------ccccCCCC---------CCCC---cEEEEEecCCccHHHHHHcCCCCCH-------HHHHHHH
Q 023568            1 MEHENVIAIK-------DIIRPPKK---------DTFN---DVYIVYELMDTDLHQIIRSDQQLTD-------DHCQYFL   54 (280)
Q Consensus         1 l~Hpniv~l~-------~~~~~~~~---------~~~~---~~~lv~e~~~g~L~~~l~~~~~l~~-------~~~~~i~   54 (280)
                      ++|||||+++       +++++...         .+..   ..|+||||++|+|.+++...+.+++       ..+..++
T Consensus       133 l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~  212 (377)
T 3byv_A          133 IKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLT  212 (377)
T ss_dssp             CCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHH
T ss_pred             cCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHH
Confidence            4799999999       55444310         0000   3899999999999999986555555       8888999


Q ss_pred             HHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEeecccccccCCCCccccceeccccccccccccC----------CC
Q 023568           55 YQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC----------TE  124 (280)
Q Consensus        55 ~qil~~l~~LH~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------~~  124 (280)
                      .||+.||+|||++||+||||||+|||++.++.+||+|||+++..+..  .....| +.|+|||++.+.          ..
T Consensus       213 ~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~  289 (377)
T 3byv_A          213 LQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR--VVSSVS-RGFEPPELEARRATISYHRDRRTL  289 (377)
T ss_dssp             HHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTCE--EECCCC-TTCCCHHHHHHHTSTHHHHCCEEE
T ss_pred             HHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEechhheecCCc--ccCCCC-cCccChhhhccccccccccccccc
Confidence            99999999999999999999999999999999999999999864432  345567 999999999873          27


Q ss_pred             CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCH
Q 023568          125 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSS  204 (280)
Q Consensus       125 ~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  204 (280)
                      ++.++|||||||++|+|++|+.||.+........                                   ......+.+++
T Consensus       290 ~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~-----------------------------------~~~~~~~~~~~  334 (377)
T 3byv_A          290 MTFSFDAWALGLVIYWIWCADLPITKDAALGGSE-----------------------------------WIFRSCKNIPQ  334 (377)
T ss_dssp             CCHHHHHHHHHHHHHHHHHSSCCC------CCSG-----------------------------------GGGSSCCCCCH
T ss_pred             CChhhhHHHHHHHHHHHHHCCCCCcccccccchh-----------------------------------hhhhhccCCCH
Confidence            8899999999999999999999997654211100                                   01112246799


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCcccccCc
Q 023568          205 GAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  237 (280)
Q Consensus       205 ~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~  237 (280)
                      .+.+||.+||+.||.+|||+.|+++||||+.+.
T Consensus       335 ~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~  367 (377)
T 3byv_A          335 PVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR  367 (377)
T ss_dssp             HHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHH
T ss_pred             HHHHHHHHHcCCCchhCCCHHHHhhChHHHHHH
Confidence            999999999999999999999999999998754

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.7e-42  Score=288.50  Aligned_cols=200  Identities=26%  Similarity=0.484  Sum_probs=145.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||+++++++.+.     ...|+||||++ ++|.+++... +.+++..+..++.|++.||.|||+.|++||||||+|
T Consensus        68 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~N  142 (278)
T 3cok_A           68 LKHPSILELYNYFEDS-----NYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSN  142 (278)
T ss_dssp             BCCTTBCCEEEEEECS-----SEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGG
T ss_pred             CCCCCeEeEEEEEccC-----CeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHH
Confidence            5799999999999987     77999999997 5999999865 679999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023568           79 LLLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  157 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~  157 (280)
                      |+++.++.++|+|||.+...... .......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.........
T Consensus       143 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~  221 (278)
T 3cok_A          143 LLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL  221 (278)
T ss_dssp             EEECTTCCEEECCCTTCEECC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---
T ss_pred             EEEcCCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH
Confidence            99999999999999999865433 22334678999999999876 67888999999999999999999999876532222


Q ss_pred             HHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCc
Q 023568          158 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  237 (280)
Q Consensus       158 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~  237 (280)
                      ..+.                              . .........+..+.++|.+||+.||.+|||++++++||||....
T Consensus       222 ~~~~------------------------------~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  270 (278)
T 3cok_A          222 NKVV------------------------------L-ADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS  270 (278)
T ss_dssp             --CC------------------------------S-SCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred             HHHh------------------------------h-cccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence            1110                              0 00112235789999999999999999999999999999997643

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.9e-42  Score=287.69  Aligned_cols=203  Identities=29%  Similarity=0.454  Sum_probs=168.5

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++.+.     ...|+||||++| +|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||
T Consensus        62 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Ni  136 (276)
T 2yex_A           62 LNHENVVKFYGHRREG-----NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL  136 (276)
T ss_dssp             CCCTTBCCEEEEEEET-----TEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             cCCCCceeeeeEEEcC-----CEEEEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHE
Confidence            5899999999999887     779999999975 9999998778899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC---CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH-
Q 023568           80 LLNASCDLKIGDFGLARTTSET---DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH-  155 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~-  155 (280)
                      +++.++.++|+|||.+......   .......|++.|+|||.+.+....+.++|+||||+++|+|++|..||....... 
T Consensus       137 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~  216 (276)
T 2yex_A          137 LLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ  216 (276)
T ss_dssp             EECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH
T ss_pred             EEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH
Confidence            9999999999999998754322   223456789999999999874445789999999999999999999998765321 


Q ss_pred             HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 023568          156 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  235 (280)
Q Consensus       156 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~  235 (280)
                      ....+...                             .......+.+++.+.++|++||+.||.+|||++|+++||||+.
T Consensus       217 ~~~~~~~~-----------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~  267 (276)
T 2yex_A          217 EYSDWKEK-----------------------------KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK  267 (276)
T ss_dssp             HHHHHHTT-----------------------------CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             HHHHhhhc-----------------------------ccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccC
Confidence            22111110                             0001112356899999999999999999999999999999987


Q ss_pred             Cc
Q 023568          236 LH  237 (280)
Q Consensus       236 ~~  237 (280)
                      ..
T Consensus       268 ~~  269 (276)
T 2yex_A          268 PL  269 (276)
T ss_dssp             CC
T ss_pred             hh
Confidence            54

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=4.2e-42  Score=299.46  Aligned_cols=200  Identities=25%  Similarity=0.381  Sum_probs=161.5

Q ss_pred             CcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc
Q 023568            3 HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN   82 (280)
Q Consensus         3 Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nili~   82 (280)
                      ||||+++++++...     ..+|+|||+.+++|.+++.+.+.+++.++..++.||+.||.|||+.||+||||||+|||++
T Consensus       115 ~~~iv~~~~~~~~~-----~~~~lv~E~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~  189 (390)
T 2zmd_A          115 SDKIIRLYDYEITD-----QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV  189 (390)
T ss_dssp             CTTBCCEEEEEECS-----SEEEEEEECCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES
T ss_pred             CCeEEEEEEEEecC-----CEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE
Confidence            69999999999987     6799999977789999999888999999999999999999999999999999999999995


Q ss_pred             CCCCeEEeecccccccCCCC---ccccceecccccccccccc----------CCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 023568           83 ASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLN----------CTEYTAAIDIWSVGCILGEIMTREPLFP  149 (280)
Q Consensus        83 ~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~----------~~~~~~~~DvwslG~~l~~ll~g~~pf~  149 (280)
                       ++.+||+|||+++......   ......||+.|+|||++.+          ...++.++|||||||++|+|++|..||.
T Consensus       190 -~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~  268 (390)
T 2zmd_A          190 -DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ  268 (390)
T ss_dssp             -SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             -CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcch
Confidence             5889999999998754432   2345679999999999864          1368889999999999999999999998


Q ss_pred             CCCh-HHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 023568          150 GKDY-VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL  228 (280)
Q Consensus       150 ~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell  228 (280)
                      .... ...+..+.   ....                          ........+..+.+||++||+.||.+|||++|+|
T Consensus       269 ~~~~~~~~~~~~~---~~~~--------------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell  319 (390)
T 2zmd_A          269 QIINQISKLHAII---DPNH--------------------------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL  319 (390)
T ss_dssp             TCCCHHHHHHHHH---CTTS--------------------------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred             hhhHHHHHHHHHh---Cccc--------------------------cCCCCccchHHHHHHHHHHcccChhhCCCHHHHh
Confidence            7532 22222221   1000                          0011123478899999999999999999999999


Q ss_pred             cCcccccCc
Q 023568          229 RHPYLQSLH  237 (280)
Q Consensus       229 ~hp~~~~~~  237 (280)
                      +||||+...
T Consensus       320 ~hp~~~~~~  328 (390)
T 2zmd_A          320 AHPYVQIQT  328 (390)
T ss_dssp             TSHHHHSCC
T ss_pred             hCcCccccC
Confidence            999998654

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.4e-42  Score=301.31  Aligned_cols=228  Identities=29%  Similarity=0.456  Sum_probs=173.7

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCc
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSN   78 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~-~i~H~dik~~N   78 (280)
                      +||||++++++|...... ...+|+||||++++|.+.+...  +.+++..++.++.||+.||+|||++ ||+||||||+|
T Consensus        99 ~~~~iv~~~~~~~~~~~~-~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~N  177 (397)
T 1wak_A           99 NREMVVQLLDDFKISGVN-GTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPEN  177 (397)
T ss_dssp             GGGGBCCEEEEEEEEETT-EEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGG
T ss_pred             CcceeeeeecceeecCCC-CceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHH
Confidence            389999999999843111 1679999999999988887654  5699999999999999999999998 99999999999


Q ss_pred             eEEcCCC-------------------------------------------------CeEEeecccccccCCCCcccccee
Q 023568           79 LLLNASC-------------------------------------------------DLKIGDFGLARTTSETDFMTEYVV  109 (280)
Q Consensus        79 ili~~~~-------------------------------------------------~~kl~dfg~~~~~~~~~~~~~~~~  109 (280)
                      ||++.++                                                 .++|+|||.+......  .....|
T Consensus       178 Ill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~g  255 (397)
T 1wak_A          178 ILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQ  255 (397)
T ss_dssp             EEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCS
T ss_pred             eeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCC
Confidence            9998775                                                 7999999999876543  345678


Q ss_pred             ccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHHhCCCCcccccccCChhHHHH
Q 023568          110 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD------YVHQLRLITELIGSPDDASLGFLRSDNARRY  183 (280)
Q Consensus       110 ~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  183 (280)
                      |+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+      ....+..+.+..+.++...+.......  .+
T Consensus       256 t~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~--~~  332 (397)
T 1wak_A          256 TRQYRSLEVLIG-SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSK--EF  332 (397)
T ss_dssp             CGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGG--GT
T ss_pred             CCcccCChhhcC-CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccc--cc
Confidence            999999999987 678899999999999999999999998765      456777788878776654321110000  00


Q ss_pred             HHhCCccccc-------------cccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 023568          184 VRQLPRCRKQ-------------QFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  235 (280)
Q Consensus       184 ~~~~~~~~~~-------------~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~  235 (280)
                      ..........             .........++.+.+||++||+.||.+|||++|+|+||||++
T Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          333 FTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             BCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             cCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence            0000000000             000011123567899999999999999999999999999974

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.1e-42  Score=294.14  Aligned_cols=199  Identities=25%  Similarity=0.379  Sum_probs=159.2

Q ss_pred             cccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC
Q 023568            4 ENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNA   83 (280)
Q Consensus         4 pniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nili~~   83 (280)
                      |||+++++++.+.     ..+|+|||+.+++|.+++...+.+++.++..++.|++.||.|||+.||+||||||+|||++ 
T Consensus        69 ~~iv~~~~~~~~~-----~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-  142 (343)
T 3dbq_A           69 DKIIRLYDYEITD-----QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-  142 (343)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEECCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-
T ss_pred             CceEEEeeeEeeC-----CEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-
Confidence            9999999999987     7899999988889999999888999999999999999999999999999999999999997 


Q ss_pred             CCCeEEeecccccccCCCC---ccccceecccccccccccc----------CCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 023568           84 SCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLN----------CTEYTAAIDIWSVGCILGEIMTREPLFPG  150 (280)
Q Consensus        84 ~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~----------~~~~~~~~DvwslG~~l~~ll~g~~pf~~  150 (280)
                      ++.++|+|||+++......   ......||+.|+|||++.+          ...++.++|||||||++|+|++|+.||..
T Consensus       143 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  222 (343)
T 3dbq_A          143 DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ  222 (343)
T ss_dssp             TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchh
Confidence            6789999999998754432   2345678999999999853          25678899999999999999999999987


Q ss_pred             CChH-HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          151 KDYV-HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       151 ~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      .... .....+.   ....                          ........+..+.+||.+||+.||.+|||++|+|+
T Consensus       223 ~~~~~~~~~~~~---~~~~--------------------------~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~  273 (343)
T 3dbq_A          223 IINQISKLHAII---DPNH--------------------------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  273 (343)
T ss_dssp             CCSHHHHHHHHH---CTTS--------------------------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhHHHHHHHHh---cCCc--------------------------ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence            5322 2222111   1000                          01112245778999999999999999999999999


Q ss_pred             CcccccCc
Q 023568          230 HPYLQSLH  237 (280)
Q Consensus       230 hp~~~~~~  237 (280)
                      ||||+...
T Consensus       274 hp~~~~~~  281 (343)
T 3dbq_A          274 HPYVQIQT  281 (343)
T ss_dssp             SHHHHSCC
T ss_pred             CccccccC
Confidence            99997643

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=4.4e-42  Score=286.86  Aligned_cols=194  Identities=24%  Similarity=0.319  Sum_probs=159.9

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSD----QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP   76 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~----~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~   76 (280)
                      +||||+++++++.+.     +..|+||||++| +|.+++...    +.+++.++..++.||+.||+|||++||+||||||
T Consensus        69 ~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp  143 (289)
T 1x8b_A           69 QHSHVVRYFSAWAED-----DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKP  143 (289)
T ss_dssp             SCTTBCCEEEEEEET-----TEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred             CCCCeeeeeeeeecC-----CeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCH
Confidence            799999999999887     779999999975 999999754    6799999999999999999999999999999999


Q ss_pred             CceEEcCC-------------------CCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHH
Q 023568           77 SNLLLNAS-------------------CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCI  137 (280)
Q Consensus        77 ~Nili~~~-------------------~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~  137 (280)
                      +||+++.+                   ..++|+|||.+.......   ...+++.|+|||.+.+...++.++|||||||+
T Consensus       144 ~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~i  220 (289)
T 1x8b_A          144 SNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALT  220 (289)
T ss_dssp             GGEEEC--------------------CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHH
T ss_pred             HHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHH
Confidence            99999844                   479999999998765432   34589999999999875567789999999999


Q ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccC
Q 023568          138 LGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFD  217 (280)
Q Consensus       138 l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~d  217 (280)
                      +|+|++|.+++......   ..+..                              ...+......++.+.++|++||+.|
T Consensus       221 l~~l~~~~~~~~~~~~~---~~~~~------------------------------~~~~~~~~~~~~~~~~li~~~l~~d  267 (289)
T 1x8b_A          221 VVCAAGAEPLPRNGDQW---HEIRQ------------------------------GRLPRIPQVLSQEFTELLKVMIHPD  267 (289)
T ss_dssp             HHHHTTCCCCCSSSHHH---HHHHT------------------------------TCCCCCSSCCCHHHHHHHHHHTCSS
T ss_pred             HHHHhcCCCCCcchhHH---HHHHc------------------------------CCCCCCCcccCHHHHHHHHHHhCCC
Confidence            99999999876544321   11111                              1112233467999999999999999


Q ss_pred             CCCCCCHHHHhcCcccccC
Q 023568          218 PNKRITVEEALRHPYLQSL  236 (280)
Q Consensus       218 p~~Rpt~~ell~hp~~~~~  236 (280)
                      |.+|||++|+++||||++.
T Consensus       268 p~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          268 PERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             GGGSCCHHHHHTCTTC---
T ss_pred             cccCCCHHHHhhChHhhhh
Confidence            9999999999999999764

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=4e-42  Score=289.35  Aligned_cols=212  Identities=25%  Similarity=0.401  Sum_probs=163.5

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS--------DQQLTDDHCQYFLYQLLRGLKYVHSASVLH   71 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~--------~~~l~~~~~~~i~~qil~~l~~LH~~~i~H   71 (280)
                      ++||||+++++++...     +..|+||||++ ++|.+++..        .+.+++..+..++.|++.||.|||+.|++|
T Consensus        70 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H  144 (303)
T 2vwi_A           70 CHHPNIVSYYTSFVVK-----DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIH  144 (303)
T ss_dssp             CCCTTBCCEEEEEESS-----SCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             cCCCCEeeEEEEEeec-----CCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Confidence            5799999999999987     67999999996 599999863        456999999999999999999999999999


Q ss_pred             cCCCCCceEEcCCCCeEEeecccccccCCC------CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCC
Q 023568           72 RDLKPSNLLLNASCDLKIGDFGLARTTSET------DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTRE  145 (280)
Q Consensus        72 ~dik~~Nili~~~~~~kl~dfg~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~  145 (280)
                      |||+|+||+++.++.++|+|||.+......      .......+++.|+|||++.+...++.++|+||||+++|+|++|.
T Consensus       145 ~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~  224 (303)
T 2vwi_A          145 RDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA  224 (303)
T ss_dssp             CCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             CCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCC
Confidence            999999999999999999999998754332      12234578999999999876456889999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 023568          146 PLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVE  225 (280)
Q Consensus       146 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~  225 (280)
                      .||..............  +.++...                   ............+..+.++|.+||+.||.+|||++
T Consensus       225 ~pf~~~~~~~~~~~~~~--~~~~~~~-------------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~  283 (303)
T 2vwi_A          225 APYHKYPPMKVLMLTLQ--NDPPSLE-------------------TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAA  283 (303)
T ss_dssp             CTTTTSCGGGHHHHHHT--SSCCCTT-------------------C-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred             CCCccCchhhHHHHHhc--cCCCccc-------------------cccccchhhhhhhHHHHHHHHHHccCChhhCcCHH
Confidence            99988765443332221  1110000                   00011223346789999999999999999999999


Q ss_pred             HHhcCcccccCcC
Q 023568          226 EALRHPYLQSLHD  238 (280)
Q Consensus       226 ell~hp~~~~~~~  238 (280)
                      ++++||||++...
T Consensus       284 ~ll~h~~~~~~~~  296 (303)
T 2vwi_A          284 ELLRHKFFQKAKN  296 (303)
T ss_dssp             HHHTSTTC-----
T ss_pred             HHhhChhhhcCCC
Confidence            9999999987653

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.8e-41  Score=285.91  Aligned_cols=207  Identities=26%  Similarity=0.436  Sum_probs=169.9

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~--~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      |+||||+++++++.....   ...|+||||++++|.+++..  .+.+++..+..++.|++.||.|||++|++||||||+|
T Consensus        63 l~h~~i~~~~~~~~~~~~---~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~N  139 (305)
T 2wtk_C           63 LRHKNVIQLVDVLYNEEK---QKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGN  139 (305)
T ss_dssp             CCCTTBCCEEEEEECC------CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred             cCCCCeeEEEEEEEcCCC---CeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCccc
Confidence            589999999999854422   57999999999888888865  4679999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCC---CccccceeccccccccccccCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023568           79 LLLNASCDLKIGDFGLARTTSET---DFMTEYVVTRWYRAPELLLNCT-EYTAAIDIWSVGCILGEIMTREPLFPGKDYV  154 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~  154 (280)
                      |+++.++.++|+|||.+......   .......+++.|+|||++.+.. ..+.++|+||||+++|+|++|..||.+.+..
T Consensus       140 Il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~  219 (305)
T 2wtk_C          140 LLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY  219 (305)
T ss_dssp             EEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             EEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH
Confidence            99999999999999999865432   2234566899999999987622 3467999999999999999999999988766


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ  234 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~  234 (280)
                      .....+....                               .......++.+.++|++||+.||.+|||++|+++||||+
T Consensus       220 ~~~~~i~~~~-------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~  268 (305)
T 2wtk_C          220 KLFENIGKGS-------------------------------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFR  268 (305)
T ss_dssp             HHHHHHHHCC-------------------------------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHH
T ss_pred             HHHHHHhcCC-------------------------------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccc
Confidence            5555443310                               012235688999999999999999999999999999998


Q ss_pred             cCcCCCC
Q 023568          235 SLHDLND  241 (280)
Q Consensus       235 ~~~~~~~  241 (280)
                      .......
T Consensus       269 ~~~~~~~  275 (305)
T 2wtk_C          269 KKHPPAE  275 (305)
T ss_dssp             SCCCC-C
T ss_pred             cCCCCcC
Confidence            8765443

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=5.4e-42  Score=286.82  Aligned_cols=203  Identities=33%  Similarity=0.601  Sum_probs=172.9

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+||||+++++++.+.     ...|+||||+. ++|.+.+.+.+.+++.++..++.|++.||.|||+.|++||||+|+||
T Consensus        78 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NI  152 (287)
T 2wei_A           78 LDHPNIMKLFEILEDS-----SSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENI  152 (287)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred             ccCCCccEEEEEEeCC-----CeEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhE
Confidence            5899999999999887     67999999997 59999998778899999999999999999999999999999999999


Q ss_pred             EEcCC---CCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023568           80 LLNAS---CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  156 (280)
Q Consensus        80 li~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~  156 (280)
                      +++.+   +.++|+|||++.............+++.|+|||.+.+  .++.++|+||||+++|+|++|..||.+.+....
T Consensus       153 lv~~~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~  230 (287)
T 2wei_A          153 LLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI  230 (287)
T ss_dssp             EESCSSTTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             EEecCCCcccEEEeccCcceeecCCCccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence            99754   4699999999987665554556678999999999875  488999999999999999999999999877666


Q ss_pred             HHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 023568          157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  236 (280)
Q Consensus       157 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~  236 (280)
                      ...+........                           ...+..+++.+.++|++||+.||.+|||++|+|+||||++.
T Consensus       231 ~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~  283 (287)
T 2wei_A          231 LKRVETGKYAFD---------------------------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY  283 (287)
T ss_dssp             HHHHHHCCCCCC---------------------------SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred             HHHHHcCCCCCC---------------------------chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence            555543111000                           01123578999999999999999999999999999999876


Q ss_pred             c
Q 023568          237 H  237 (280)
Q Consensus       237 ~  237 (280)
                      .
T Consensus       284 ~  284 (287)
T 2wei_A          284 S  284 (287)
T ss_dssp             C
T ss_pred             c
Confidence            4

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=3.3e-42  Score=292.78  Aligned_cols=203  Identities=36%  Similarity=0.619  Sum_probs=166.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+||||+++++++...      ..|+||||+.| +|.+++...+.+++..+..++.||+.||.|||++||+||||||+||
T Consensus        72 l~h~~i~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NI  145 (322)
T 2ycf_A           72 LNHPCIIKIKNFFDAE------DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENV  145 (322)
T ss_dssp             CCCTTBCCEEEEEESS------SEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             CCCCCCceEeeEEcCC------ceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence            5899999999999764      38999999974 9999998888999999999999999999999999999999999999


Q ss_pred             EEcCCCC---eEEeecccccccCCCCccccceeccccccccccc--cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023568           80 LLNASCD---LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL--NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV  154 (280)
Q Consensus        80 li~~~~~---~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~  154 (280)
                      +++.++.   ++|+|||++.............|++.|+|||++.  +...++.++|+|||||++|+|++|..||......
T Consensus       146 l~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  225 (322)
T 2ycf_A          146 LLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ  225 (322)
T ss_dssp             EESSSSSSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS
T ss_pred             EEecCCCCCeEEEccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH
Confidence            9987654   9999999998776554445567899999999974  2367889999999999999999999999875432


Q ss_pred             H-HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          155 H-QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       155 ~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      . ....+....                           ....+..++..+..+.++|++||+.||.+|||++++|+||||
T Consensus       226 ~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~  278 (322)
T 2ycf_A          226 VSLKDQITSGK---------------------------YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL  278 (322)
T ss_dssp             SCHHHHHHHTC---------------------------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred             HHHHHHHHhCc---------------------------cccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCc
Confidence            1 111121100                           001112234678999999999999999999999999999999


Q ss_pred             ccC
Q 023568          234 QSL  236 (280)
Q Consensus       234 ~~~  236 (280)
                      +..
T Consensus       279 ~~~  281 (322)
T 2ycf_A          279 QDE  281 (322)
T ss_dssp             CCH
T ss_pred             CCH
Confidence            753

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2e-41  Score=291.14  Aligned_cols=226  Identities=28%  Similarity=0.516  Sum_probs=178.8

Q ss_pred             CcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            3 HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         3 Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      |++++++.+++...     ...|+||||++++|.+.+...  ..+++.+++.++.||+.||.|||++||+||||||+||+
T Consensus        81 ~~~~~~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIl  155 (355)
T 2eu9_A           81 KFLCVLMSDWFNFH-----GHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENIL  155 (355)
T ss_dssp             CSCBCCEEEEEEET-----TEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEE
T ss_pred             ceeEEEeeeeeeeC-----CeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEE
Confidence            44599999999887     779999999999998888654  47999999999999999999999999999999999999


Q ss_pred             E-------------------cCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHH
Q 023568           81 L-------------------NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI  141 (280)
Q Consensus        81 i-------------------~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l  141 (280)
                      +                   +.++.++|+|||+++.....  .....||+.|+|||++.+ ..++.++|+|||||++|+|
T Consensus       156 l~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el  232 (355)
T 2eu9_A          156 FVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEY  232 (355)
T ss_dssp             ESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHH
T ss_pred             EecccccccccccccccccccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeec-CCCCCccchHHHHHHHHHH
Confidence            9                   66889999999999865443  345678999999999987 7789999999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCCcccccccCC--------------hhHHHHHHhCCccccccccccCCCCCHHHH
Q 023568          142 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS--------------DNARRYVRQLPRCRKQQFATRFPNKSSGAV  207 (280)
Q Consensus       142 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  207 (280)
                      ++|..||.+.+.......+.+..+..+.........              .....+........ ..........+..+.
T Consensus       233 ~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~  311 (355)
T 2eu9_A          233 YRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPL-KSYMLQDSLEHVQLF  311 (355)
T ss_dssp             HHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCG-GGGCSCCSHHHHHHH
T ss_pred             HhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcc-cccccccchhHHHHH
Confidence            999999999998888888888888766543221110              00111111000000 000011112356899


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCcccccCc
Q 023568          208 DLLEKMLVFDPNKRITVEEALRHPYLQSLH  237 (280)
Q Consensus       208 ~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~  237 (280)
                      +||++||+.||.+|||++|+|+||||+++.
T Consensus       312 ~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  341 (355)
T 2eu9_A          312 DLMRRMLEFDPAQRITLAEALLHPFFAGLT  341 (355)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHTTSGGGGGCC
T ss_pred             HHHHHHhcCChhhCcCHHHHhcChhhcCCC
Confidence            999999999999999999999999999874

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-42  Score=297.12  Aligned_cols=204  Identities=20%  Similarity=0.390  Sum_probs=166.1

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      +||||+++++++...     ..+|+||||++ |+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||
T Consensus       117 ~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIl  191 (355)
T 1vzo_A          117 QSPFLVTLHYAFQTE-----TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENIL  191 (355)
T ss_dssp             TCTTBCCEEEEEEET-----TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred             CCCceeEEEEEEeeC-----ceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEE
Confidence            599999999999887     67999999997 599999988788999999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccccCCC--CccccceeccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023568           81 LNASCDLKIGDFGLARTTSET--DFMTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  157 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~  157 (280)
                      ++.++.++|+|||+++.....  .......||+.|+|||++.+. ..++.++|||||||++|+|++|..||.........
T Consensus       192 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~  271 (355)
T 1vzo_A          192 LDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ  271 (355)
T ss_dssp             ECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH
T ss_pred             ECCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH
Confidence            999999999999999765432  223446789999999998752 45788999999999999999999999765321111


Q ss_pred             HHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCcc
Q 023568          158 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPY  232 (280)
Q Consensus       158 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rp-----t~~ell~hp~  232 (280)
                      ..+....                   ..        ..+...+.++..+.+||++||+.||.+||     |++|+++|||
T Consensus       272 ~~~~~~~-------------------~~--------~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~  324 (355)
T 1vzo_A          272 AEISRRI-------------------LK--------SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF  324 (355)
T ss_dssp             HHHHHHH-------------------HH--------CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred             HHHHHHH-------------------hc--------cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence            1111100                   00        01122345789999999999999999999     9999999999


Q ss_pred             cccCc
Q 023568          233 LQSLH  237 (280)
Q Consensus       233 ~~~~~  237 (280)
                      |+.+.
T Consensus       325 f~~~~  329 (355)
T 1vzo_A          325 FQKIN  329 (355)
T ss_dssp             GTTCC
T ss_pred             hhcCC
Confidence            98763

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=9.3e-42  Score=287.20  Aligned_cols=204  Identities=25%  Similarity=0.416  Sum_probs=166.0

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||+++++++...     +..|+||||++| +|.+++.. .+.+++..+..++.|++.||.|||+.|++||||||+|
T Consensus        73 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~N  147 (302)
T 2j7t_A           73 CDHPYIVKLLGAYYHD-----GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGN  147 (302)
T ss_dssp             CCCTTBCCEEEEEECC------CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGG
T ss_pred             CCCCCEeeeeeeeeeC-----CeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHH
Confidence            5899999999999987     679999999975 89988865 5679999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCC-Cccccceeccccccccccc----cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 023568           79 LLLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLL----NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY  153 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~----~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~  153 (280)
                      |+++.++.++|+|||++...... .......|++.|+|||.+.    ....++.++|+||||+++|+|++|..||...+.
T Consensus       148 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~  227 (302)
T 2j7t_A          148 VLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP  227 (302)
T ss_dssp             EEECTTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred             EEECCCCCEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH
Confidence            99999999999999987542211 1223457899999999984    236788899999999999999999999998876


Q ss_pred             HHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          154 VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       154 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      ......+.....  +.                          .......+..+.++|++||+.||.+|||++++++||||
T Consensus       228 ~~~~~~~~~~~~--~~--------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  279 (302)
T 2j7t_A          228 MRVLLKIAKSDP--PT--------------------------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFV  279 (302)
T ss_dssp             HHHHHHHHHSCC--CC--------------------------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTT
T ss_pred             HHHHHHHhccCC--cc--------------------------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHH
Confidence            655544433110  00                          01112468899999999999999999999999999999


Q ss_pred             ccCc
Q 023568          234 QSLH  237 (280)
Q Consensus       234 ~~~~  237 (280)
                      +++.
T Consensus       280 ~~~~  283 (302)
T 2j7t_A          280 SSIT  283 (302)
T ss_dssp             TTCC
T ss_pred             hhhc
Confidence            8764

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=3.9e-42  Score=296.71  Aligned_cols=227  Identities=21%  Similarity=0.344  Sum_probs=170.1

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~-~i~H~dik~~N   78 (280)
                      ++||||+++++++.+.     ...|+||||++| +|.+++...+.+++..+..++.|++.||.|||+. ||+||||||+|
T Consensus        88 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~N  162 (360)
T 3eqc_A           88 CNSPYIVGFYGAFYSD-----GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSN  162 (360)
T ss_dssp             CCCTTBCCEEEEEEET-----TEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGG
T ss_pred             CCCCCEEEEeEEEEEC-----CEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHH
Confidence            5899999999999987     779999999975 9999998888999999999999999999999996 99999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      |+++.++.++|+|||++...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+......
T Consensus       163 il~~~~~~~kl~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  240 (360)
T 3eqc_A          163 ILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL  240 (360)
T ss_dssp             EEECTTCCEEECCCCCCHHHHHH-C----CCCCTTCCHHHHTT-CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHH
T ss_pred             EEECCCCCEEEEECCCCcccccc-cccCCCCCCCeECHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            99999999999999998754322 2345678999999999987 778999999999999999999999999877554433


Q ss_pred             HHHHHhC-CCCcccccc--------------cCChhHHHHHHhCCcccccccccc-CCCCCHHHHHHHHHhcccCCCCCC
Q 023568          159 LITELIG-SPDDASLGF--------------LRSDNARRYVRQLPRCRKQQFATR-FPNKSSGAVDLLEKMLVFDPNKRI  222 (280)
Q Consensus       159 ~i~~~~~-~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ll~~~L~~dp~~Rp  222 (280)
                      .+..... .........              ..............   ....+.. ...++..+.+||++||+.||.+||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  317 (360)
T 3eqc_A          241 MFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIV---NEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA  317 (360)
T ss_dssp             HHC------------------------------CCCHHHHHHHHH---HSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSC
T ss_pred             HhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHh---ccCCCCCCcccccHHHHHHHHHHhhcChhhCC
Confidence            3221111 000000000              00000111111110   0111111 124788999999999999999999


Q ss_pred             CHHHHhcCcccccCc
Q 023568          223 TVEEALRHPYLQSLH  237 (280)
Q Consensus       223 t~~ell~hp~~~~~~  237 (280)
                      |++|+|+||||+...
T Consensus       318 t~~ell~hp~~~~~~  332 (360)
T 3eqc_A          318 DLKQLMVHAFIKRSD  332 (360)
T ss_dssp             CHHHHHTSHHHHHHH
T ss_pred             CHHHHhhChHhhcch
Confidence            999999999998754

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.7e-41  Score=285.97  Aligned_cols=203  Identities=27%  Similarity=0.448  Sum_probs=170.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR-SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~-~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||+++++++...     ...|+||||++| +|.+++. ....+++..+..++.|++.||.|||+.|++|+||+|+|
T Consensus        81 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~N  155 (314)
T 3com_A           81 CDSPHVVKYYGSYFKN-----TDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGN  155 (314)
T ss_dssp             CCCTTBCCEEEEEEET-----TEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred             CCCCCCccEEEEEEeC-----CEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHH
Confidence            5899999999999887     679999999985 9999986 45789999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023568           79 LLLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  157 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~  157 (280)
                      |+++.++.++|+|||.+...... .......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.....
T Consensus       156 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~  234 (314)
T 3com_A          156 ILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI  234 (314)
T ss_dssp             EEECTTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSS-SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred             EEECCCCCEEEeecccchhhhhhccccCccCCCCCccChhhcCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence            99999999999999999765443 22345678999999999877 67889999999999999999999999887755544


Q ss_pred             HHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCc
Q 023568          158 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  237 (280)
Q Consensus       158 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~  237 (280)
                      ..+....   ...                         ......++..+.++|.+||..||.+|||++++++||||+...
T Consensus       235 ~~~~~~~---~~~-------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~  286 (314)
T 3com_A          235 FMIPTNP---PPT-------------------------FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK  286 (314)
T ss_dssp             HHHHHSC---CCC-------------------------CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred             HHHhcCC---Ccc-------------------------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence            3332210   000                         011124688999999999999999999999999999998754

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=3.2e-42  Score=293.45  Aligned_cols=181  Identities=26%  Similarity=0.461  Sum_probs=144.3

Q ss_pred             cEEEEEecCCc-cHHHHHHcCCC---CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEeeccccccc
Q 023568           23 DVYIVYELMDT-DLHQIIRSDQQ---LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT   98 (280)
Q Consensus        23 ~~~lv~e~~~g-~L~~~l~~~~~---l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~   98 (280)
                      .+|+||||++| +|.+++.....   .++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||+++..
T Consensus       135 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~  214 (332)
T 3qd2_B          135 YLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM  214 (332)
T ss_dssp             EEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             eEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCccccc
Confidence            48999999985 99999986543   567789999999999999999999999999999999999999999999999875


Q ss_pred             CCCC-------------ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 023568           99 SETD-------------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG  165 (280)
Q Consensus        99 ~~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~  165 (280)
                      ....             ......||+.|+|||++.+ ..++.++|+|||||++|+|++|..|+.     .....+.....
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~~~~~~-----~~~~~~~~~~~  288 (332)
T 3qd2_B          215 DQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHG-NNYSHKVDIFSLGLILFELLYSFSTQM-----ERVRIITDVRN  288 (332)
T ss_dssp             SCC--------------CCCSCC-CGGGSCHHHHHC-CCCCTHHHHHHHHHHHHHHHSCCCCHH-----HHHHHHHHHHT
T ss_pred             ccchhhccccccccccccccccCCCcCccChHHhcC-CCCcchhhHHHHHHHHHHHHHcCCChh-----HHHHHHHHhhc
Confidence            5431             2234578999999999987 778999999999999999999876542     11111111111


Q ss_pred             CCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 023568          166 SPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  236 (280)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~  236 (280)
                      .                           ..+..+...++.+.++|++||+.||.+|||++|+|+||||+++
T Consensus       289 ~---------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~  332 (332)
T 3qd2_B          289 L---------------------------KFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL  332 (332)
T ss_dssp             T---------------------------CCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred             c---------------------------CCCcccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence            1                           1111122347788999999999999999999999999999864

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.5e-42  Score=292.15  Aligned_cols=209  Identities=24%  Similarity=0.404  Sum_probs=167.1

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++......+ ...|+||||++ ++|.+++...+.+++.++..++.|++.||.|||++||+||||||+||
T Consensus        69 l~hp~iv~~~~~~~~~~~~~-~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Ni  147 (311)
T 3ork_A           69 LNHPAIVAVYDTGEAETPAG-PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANI  147 (311)
T ss_dssp             CCCTTBCCEEEEEEEEETTE-EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred             CCCCCcceEEEeeeccCCCC-cccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHE
Confidence            58999999999998763211 24599999997 59999998878999999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCC----ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETD----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH  155 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~  155 (280)
                      +++.++.++|+|||++.......    ......||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+...
T Consensus       148 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~  226 (311)
T 3ork_A          148 MISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS  226 (311)
T ss_dssp             EEETTSCEEECCCSCC------------------CCTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             EEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH
Confidence            99999999999999997654331    1234568999999999987 678999999999999999999999999887665


Q ss_pred             HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 023568          156 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  235 (280)
Q Consensus       156 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~  235 (280)
                      ....+......+                           .....+.+++++.++|.+||+.||.+||++.+++.|+|++.
T Consensus       227 ~~~~~~~~~~~~---------------------------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          227 VAYQHVREDPIP---------------------------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             HHHHHHHCCCCC---------------------------HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             HHHHHhcCCCCC---------------------------cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence            554443311111                           11123467999999999999999999999999999999986


Q ss_pred             CcC
Q 023568          236 LHD  238 (280)
Q Consensus       236 ~~~  238 (280)
                      ...
T Consensus       280 ~~~  282 (311)
T 3ork_A          280 HNG  282 (311)
T ss_dssp             HTT
T ss_pred             hcC
Confidence            543

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.4e-41  Score=292.84  Aligned_cols=234  Identities=26%  Similarity=0.418  Sum_probs=175.7

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCc
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSN   78 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~-~i~H~dik~~N   78 (280)
                      .||||+++++++...... ...+++|||+++++|.+++...  ..+++..+..++.||+.||+|||++ ||+||||||+|
T Consensus        84 ~~~~i~~~~~~~~~~~~~-~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~N  162 (373)
T 1q8y_A           84 GANHILKLLDHFNHKGPN-GVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPEN  162 (373)
T ss_dssp             HHTTBCCCCEEEEEEETT-EEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGG
T ss_pred             ccchHHHHHHHhhccCCC-CceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHH
Confidence            389999999999875221 1379999999988999999763  5699999999999999999999998 99999999999


Q ss_pred             eEEcC------CCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 023568           79 LLLNA------SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD  152 (280)
Q Consensus        79 ili~~------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~  152 (280)
                      |+++.      .+.++|+|||++......  .....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+
T Consensus       163 Ill~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~  239 (373)
T 1q8y_A          163 VLMEIVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDE  239 (373)
T ss_dssp             EEEEEEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             eEEeccCCCcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence            99953      447999999999876543  345678999999999987 678999999999999999999999998764


Q ss_pred             ------hHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCcccc---c----------cccccCCCCCHHHHHHHHHh
Q 023568          153 ------YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK---Q----------QFATRFPNKSSGAVDLLEKM  213 (280)
Q Consensus       153 ------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~----------~~~~~~~~~~~~~~~ll~~~  213 (280)
                            ....+..+...++..+.........  ...+.........   .          ......+..+..+.+||++|
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  317 (373)
T 1q8y_A          240 GHSYTKDDDHIAQIIELLGELPSYLLRNGKY--TRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPM  317 (373)
T ss_dssp             -----CHHHHHHHHHHHHCSCCHHHHHHCTT--HHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGG
T ss_pred             ccccCChHHHHHHHHHhcCCCCHHHHhccch--hhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHH
Confidence                  4566777777777766543321110  0000000000000   0          00011123467889999999


Q ss_pred             cccCCCCCCCHHHHhcCcccccCcCCCC
Q 023568          214 LVFDPNKRITVEEALRHPYLQSLHDLND  241 (280)
Q Consensus       214 L~~dp~~Rpt~~ell~hp~~~~~~~~~~  241 (280)
                      |+.||.+|||++|+|+||||++......
T Consensus       318 L~~dP~~Rpt~~ell~hp~f~~~~~~~~  345 (373)
T 1q8y_A          318 LQLDPRKRADAGGLVNHPWLKDTLGMEE  345 (373)
T ss_dssp             GCSSTTTCBCHHHHHTCGGGTTCTTCTT
T ss_pred             hccCccccCCHHHHhhChhhhcccCccc
Confidence            9999999999999999999998765443

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=4e-41  Score=284.57  Aligned_cols=200  Identities=23%  Similarity=0.359  Sum_probs=159.5

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCC---CCHHHHHHHHHHHHHHHHHHHhCC--ccccCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQ---LTDDHCQYFLYQLLRGLKYVHSAS--VLHRDL   74 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~---l~~~~~~~i~~qil~~l~~LH~~~--i~H~di   74 (280)
                      |+||||+++++++.+.     ..+++||||++ |+|.+++.+.+.   +++..+..++.|++.||+|||+.|  |+||||
T Consensus        91 l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Di  165 (309)
T 3p86_A           91 LRHPNIVLFMGAVTQP-----PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNL  165 (309)
T ss_dssp             CCCTTBCCEEEEECST-----TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTC
T ss_pred             CCCCCEeeEEEEEEEC-----CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCC
Confidence            5899999999999887     66999999997 599999987553   999999999999999999999999  999999


Q ss_pred             CCCceEEcCCCCeEEeecccccccCCCC-ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 023568           75 KPSNLLLNASCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY  153 (280)
Q Consensus        75 k~~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~  153 (280)
                      ||+||+++.++.++|+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.
T Consensus       166 kp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~  244 (309)
T 3p86_A          166 KSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDVYSFGVILWELATLQQPWGNLNP  244 (309)
T ss_dssp             CGGGEEECTTCCEEECCCC-----------------CCTTSCHHHHTT-CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH
T ss_pred             ChhhEEEeCCCcEEECCCCCCccccccccccccCCCCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            9999999999999999999997654432 2345678999999999987 6788999999999999999999999998876


Q ss_pred             HHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc--Cc
Q 023568          154 VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR--HP  231 (280)
Q Consensus       154 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~--hp  231 (280)
                      ......+.....                             .......+++.+.++|++||+.||.+|||++++++  .+
T Consensus       245 ~~~~~~~~~~~~-----------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~  295 (309)
T 3p86_A          245 AQVVAAVGFKCK-----------------------------RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRP  295 (309)
T ss_dssp             HHHHHHHHHSCC-----------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHHHHhcCC-----------------------------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            665554432111                             11223467899999999999999999999999998  45


Q ss_pred             cccc
Q 023568          232 YLQS  235 (280)
Q Consensus       232 ~~~~  235 (280)
                      +++.
T Consensus       296 ~~~~  299 (309)
T 3p86_A          296 LIKS  299 (309)
T ss_dssp             HHC-
T ss_pred             HHHh
Confidence            5543

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.2e-41  Score=290.55  Aligned_cols=218  Identities=25%  Similarity=0.375  Sum_probs=170.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHH------HHc--CCCCCHHHHHHHHHHHHHHHHHHHh-CCcc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQI------IRS--DQQLTDDHCQYFLYQLLRGLKYVHS-ASVL   70 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~------l~~--~~~l~~~~~~~i~~qil~~l~~LH~-~~i~   70 (280)
                      |+||||+++++++.+.     +..|+||||++| +|.++      +.+  ...+++..+..++.|++.||.|||+ .|++
T Consensus       100 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~  174 (348)
T 2pml_X          100 IKNEYCLTCEGIITNY-----DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNIC  174 (348)
T ss_dssp             CCCTTBCCCSEEEESS-----SEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEE
T ss_pred             CCCCCcceEEEEEeeC-----CeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEe
Confidence            5899999999999987     779999999985 99998      655  5789999999999999999999999 9999


Q ss_pred             ccCCCCCceEEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCc-chhHHHHHHHHHHHHhCCCCCC
Q 023568           71 HRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTA-AIDIWSVGCILGEIMTREPLFP  149 (280)
Q Consensus        71 H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~~DvwslG~~l~~ll~g~~pf~  149 (280)
                      ||||+|+||+++.++.++|+|||.+...... ......++..|+|||++.+...++. ++|+|||||++|+|++|..||.
T Consensus       175 H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  253 (348)
T 2pml_X          175 HRDVKPSNILMDKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS  253 (348)
T ss_dssp             CCCCCGGGEEECTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             ecCCChHhEEEcCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCC
Confidence            9999999999999999999999999875443 3355678999999999987435555 9999999999999999999999


Q ss_pred             CCCh-HHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 023568          150 GKDY-VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL  228 (280)
Q Consensus       150 ~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell  228 (280)
                      +... ......+.......+.......            ............+..++.+.+||++||+.||.+|||++|++
T Consensus       254 ~~~~~~~~~~~i~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l  321 (348)
T 2pml_X          254 LKISLVELFNNIRTKNIEYPLDRNHFL------------YPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDAL  321 (348)
T ss_dssp             CSSCSHHHHHHHTSCCCCCCCSSSSST------------TTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred             CCCcHHHHHHHHhccCcCCccchhhhh------------ccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHh
Confidence            8765 4444444322111111000000            00000111122246799999999999999999999999999


Q ss_pred             cCcccccC
Q 023568          229 RHPYLQSL  236 (280)
Q Consensus       229 ~hp~~~~~  236 (280)
                      +||||++.
T Consensus       322 ~hp~f~~~  329 (348)
T 2pml_X          322 KHEWLADT  329 (348)
T ss_dssp             TSGGGTTC
T ss_pred             cCccccCC
Confidence            99999764

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.1e-41  Score=285.24  Aligned_cols=206  Identities=23%  Similarity=0.401  Sum_probs=162.1

Q ss_pred             CCcccccccccccCCCCC-CCCcEEEEEecCCc-cHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            2 EHENVIAIKDIIRPPKKD-TFNDVYIVYELMDT-DLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~-~~~~~~lv~e~~~g-~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      +||||+++++++...... ....+|+||||+++ +|.+++...  ..+++..+..++.||+.||.|||+.|++|+||||+
T Consensus        79 ~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~  158 (326)
T 2x7f_A           79 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQ  158 (326)
T ss_dssp             CSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGG
T ss_pred             CCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHH
Confidence            699999999999874321 12679999999985 999999764  57999999999999999999999999999999999


Q ss_pred             ceEEcCCCCeEEeecccccccCCC-Cccccceecccccccccccc----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 023568           78 NLLLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTREPLFPGKD  152 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~  152 (280)
                      ||+++.++.++|+|||++...... .......|++.|+|||++.+    ...++.++|+|||||++|+|++|..||.+.+
T Consensus       159 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  238 (326)
T 2x7f_A          159 NVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH  238 (326)
T ss_dssp             GEEECTTCCEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             HEEEcCCCCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence            999999999999999998765433 22345678999999999863    2567889999999999999999999998877


Q ss_pred             hHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 023568          153 YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY  232 (280)
Q Consensus       153 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~  232 (280)
                      .......+....   .                          ........+..+.++|++||..||.+|||++++++|||
T Consensus       239 ~~~~~~~~~~~~---~--------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~  289 (326)
T 2x7f_A          239 PMRALFLIPRNP---A--------------------------PRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPF  289 (326)
T ss_dssp             HHHHHHHHHHSC---C--------------------------CCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHH
T ss_pred             HHHHHHHhhcCc---c--------------------------ccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChH
Confidence            655544332210   0                          00112356899999999999999999999999999999


Q ss_pred             cccC
Q 023568          233 LQSL  236 (280)
Q Consensus       233 ~~~~  236 (280)
                      |++.
T Consensus       290 ~~~~  293 (326)
T 2x7f_A          290 IRDQ  293 (326)
T ss_dssp             HHCC
T ss_pred             HhhC
Confidence            9764

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=4.4e-41  Score=284.99  Aligned_cols=204  Identities=21%  Similarity=0.319  Sum_probs=157.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~-~i~H~dik~~N   78 (280)
                      ++||||+++++++.+.     ..+|+||||+++.+..+... .+.+++..+..++.|++.||.|||++ |++||||||+|
T Consensus        81 ~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~N  155 (318)
T 2dyl_A           81 HDCPYIVQCFGTFITN-----TDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSN  155 (318)
T ss_dssp             TTCTTBCCEEEEEECS-----SEEEEEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGG
T ss_pred             cCCCceeeEEEEEecC-----CcEEEEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHH
Confidence            4799999999999987     67999999997677666643 57899999999999999999999996 99999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCccccceecccccccccccc----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-h
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTREPLFPGKD-Y  153 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~-~  153 (280)
                      |+++.++.++|+|||++.............+++.|+|||.+.+    ...++.++|||||||++|+|++|+.||.... .
T Consensus       156 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  235 (318)
T 2dyl_A          156 ILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD  235 (318)
T ss_dssp             EEECTTSCEEECCCTTC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH
T ss_pred             EEECCCCCEEEEECCCchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc
Confidence            9999999999999999987655544456678999999999852    3567889999999999999999999998743 3


Q ss_pred             HHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          154 VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       154 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      ......+.....                            ........+++.+.++|.+||+.||.+|||++++++||||
T Consensus       236 ~~~~~~~~~~~~----------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  287 (318)
T 2dyl_A          236 FEVLTKVLQEEP----------------------------PLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFI  287 (318)
T ss_dssp             HHHHHHHHHSCC----------------------------CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHH
T ss_pred             HHHHHHHhccCC----------------------------CCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHH
Confidence            333333322100                            0001123578999999999999999999999999999999


Q ss_pred             ccCc
Q 023568          234 QSLH  237 (280)
Q Consensus       234 ~~~~  237 (280)
                      +.+.
T Consensus       288 ~~~~  291 (318)
T 2dyl_A          288 KRYE  291 (318)
T ss_dssp             HHHH
T ss_pred             Hhcc
Confidence            8764

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=4.3e-41  Score=282.47  Aligned_cols=205  Identities=26%  Similarity=0.394  Sum_probs=164.4

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++.+.     +..|+||||++| +|.+++.+.+.+++.++..++.|++.||+|||++||+||||||+||
T Consensus        68 l~hp~iv~~~~~~~~~-----~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Ni  142 (294)
T 4eqm_A           68 LSHQNIVSMIDVDEED-----DCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNI  142 (294)
T ss_dssp             CCBTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred             CCCCCCceEEEeeeeC-----CeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence            5899999999999887     779999999975 9999998888999999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCC--ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  157 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~  157 (280)
                      +++.++.++|+|||++.......  ......||+.|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.......
T Consensus       143 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~  221 (294)
T 4eqm_A          143 LIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG-EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA  221 (294)
T ss_dssp             EECTTSCEEECCCSSSTTC-------------CCSSCCHHHHHT-CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH
T ss_pred             EECCCCCEEEEeCCCccccccccccccCccccCccccCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence            99999999999999998655432  2234578999999999987 77889999999999999999999999988755443


Q ss_pred             HHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCc
Q 023568          158 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  237 (280)
Q Consensus       158 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~  237 (280)
                      .....  ...                        ........+.+++.+.++|.+||+.||.+||+..+.+.+.|..-+.
T Consensus       222 ~~~~~--~~~------------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          222 IKHIQ--DSV------------------------PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             HHHHS--SCC------------------------CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             HHHhh--ccC------------------------CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence            32221  100                        0001122346799999999999999999999666666667765544

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=7.8e-41  Score=281.83  Aligned_cols=199  Identities=26%  Similarity=0.413  Sum_probs=170.3

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++...     ...|+||||++| +|.+++.. +.+++..+..++.|++.||.|||+.|++||||+|+||
T Consensus        77 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Ni  150 (303)
T 3a7i_A           77 CDSPYVTKYYGSYLKD-----TKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANV  150 (303)
T ss_dssp             CCCTTBCCEEEEEEET-----TEEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             CCCCCEeEEEEEEecC-----CeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheE
Confidence            5799999999999887     679999999985 99999865 6799999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCC-ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||.+....... ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||..........
T Consensus       151 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~  229 (303)
T 3a7i_A          151 LLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF  229 (303)
T ss_dssp             EECTTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred             EECCCCCEEEeecccceecCccccccCccCCCcCccCHHHHhc-CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHH
Confidence            99999999999999997755432 2345678999999999977 678889999999999999999999998877655544


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  236 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~  236 (280)
                      .+...                              ..+......+..+.++|.+||+.||.+|||++++++||||...
T Consensus       230 ~~~~~------------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  277 (303)
T 3a7i_A          230 LIPKN------------------------------NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN  277 (303)
T ss_dssp             HHHHS------------------------------CCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred             HhhcC------------------------------CCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence            43221                              0111223578899999999999999999999999999999653

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=3.9e-42  Score=294.05  Aligned_cols=212  Identities=24%  Similarity=0.391  Sum_probs=145.5

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      ++||||+++++++..... +...+|+||||++| +|.+++...+  .+++.+++.++.|++.||.|||++||+||||||+
T Consensus        79 ~~h~~i~~~~~~~~~~~~-~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~  157 (336)
T 3fhr_A           79 SGGPHIVCILDVYENMHH-GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPE  157 (336)
T ss_dssp             TTSTTBCCEEEEEEEEET-TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred             cCCCChHHHHHHHhhccC-CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence            479999999999986321 11568999999975 9999998653  6999999999999999999999999999999999


Q ss_pred             ceEEcC---CCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023568           78 NLLLNA---SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV  154 (280)
Q Consensus        78 Nili~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~  154 (280)
                      ||+++.   ++.++|+|||++....... .....+|+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+....
T Consensus       158 NIll~~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  235 (336)
T 3fhr_A          158 NLLYTSKEKDAVLKLTDFGFAKETTQNA-LQTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQ  235 (336)
T ss_dssp             GEEESCSSTTCCEEECCCTTCEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             HEEEEecCCCceEEEeccccceeccccc-cccCCCCcCccChhhhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCccch
Confidence            999976   4559999999998655432 345678999999999866 67888999999999999999999999776533


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ  234 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~  234 (280)
                      .....+.....                       ..........+..+++.+.+||++||+.||.+|||++|+|+||||+
T Consensus       236 ~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~  292 (336)
T 3fhr_A          236 AISPGMKRRIR-----------------------LGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWIN  292 (336)
T ss_dssp             --------------------------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHH
T ss_pred             hhhhhHHHhhh-----------------------ccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccc
Confidence            22111111000                       0000001122346799999999999999999999999999999998


Q ss_pred             cCcC
Q 023568          235 SLHD  238 (280)
Q Consensus       235 ~~~~  238 (280)
                      ....
T Consensus       293 ~~~~  296 (336)
T 3fhr_A          293 QSMV  296 (336)
T ss_dssp             TGGG
T ss_pred             cccc
Confidence            7543

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=5.6e-42  Score=296.91  Aligned_cols=192  Identities=17%  Similarity=0.160  Sum_probs=148.0

Q ss_pred             CcEEEEEecCCccHHHHHHcC-CCCCHHHH------HHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEeeccc
Q 023568           22 NDVYIVYELMDTDLHQIIRSD-QQLTDDHC------QYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL   94 (280)
Q Consensus        22 ~~~~lv~e~~~g~L~~~l~~~-~~l~~~~~------~~i~~qil~~l~~LH~~~i~H~dik~~Nili~~~~~~kl~dfg~   94 (280)
                      ..+|+||||++|+|.+++... ..+++..+      ..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus       161 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~  240 (371)
T 3q60_A          161 ANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSA  240 (371)
T ss_dssp             EEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTSCEEECCGGG
T ss_pred             eeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCCCEEEEecce
Confidence            348999999999999999763 34555555      67779999999999999999999999999999999999999999


Q ss_pred             ccccCCCCccccceecccccccccccc-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCccccc
Q 023568           95 ARTTSETDFMTEYVVTRWYRAPELLLN-CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLG  173 (280)
Q Consensus        95 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  173 (280)
                      ++..+...  ....+++.|+|||++.+ ...++.++|||||||++|+|++|+.||.+......            . ...
T Consensus       241 a~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~------------~-~~~  305 (371)
T 3q60_A          241 LWKVGTRG--PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK------------G-SWK  305 (371)
T ss_dssp             EEETTCEE--EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCT------------T-CCC
T ss_pred             eeecCCCc--cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccc------------c-chh
Confidence            98765432  24556699999999864 24678999999999999999999999987641100            0 000


Q ss_pred             ccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCc
Q 023568          174 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  237 (280)
Q Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~  237 (280)
                      ..         ...............+.+++.+.+||.+||+.||++|||++++|+||||+++.
T Consensus       306 ~~---------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  360 (371)
T 3q60_A          306 RP---------SLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQ  360 (371)
T ss_dssp             BC---------CTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHH
T ss_pred             hh---------hhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHH
Confidence            00         00000001111122347899999999999999999999999999999998754

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2e-41  Score=288.55  Aligned_cols=206  Identities=24%  Similarity=0.386  Sum_probs=148.1

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-----DQQLTDDHCQYFLYQLLRGLKYVHSA-SVLHRDL   74 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~-----~~~l~~~~~~~i~~qil~~l~~LH~~-~i~H~di   74 (280)
                      ++||||+++++++...     +..|+||||++|+|.+++..     ...+++..+..++.|++.||.|||+. |++||||
T Consensus        78 ~~h~niv~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dl  152 (327)
T 3aln_A           78 SDCPYIVQFYGALFRE-----GDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDI  152 (327)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCC
T ss_pred             CCCCcEeeeeeEEEeC-----CceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCC
Confidence            4799999999999987     67999999999999888763     57899999999999999999999999 9999999


Q ss_pred             CCCceEEcCCCCeEEeecccccccCCCCccccceeccccccccccc---cCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 023568           75 KPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL---NCTEYTAAIDIWSVGCILGEIMTREPLFPGK  151 (280)
Q Consensus        75 k~~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~  151 (280)
                      ||+||+++.++.++|+|||++.............|++.|+|||++.   ....++.++|+|||||++|+|++|..||.+.
T Consensus       153 kp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  232 (327)
T 3aln_A          153 KPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW  232 (327)
T ss_dssp             CGGGEEEETTTEEEECCCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC
T ss_pred             CHHHEEEcCCCCEEEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence            9999999999999999999998765554444557899999999984   2256889999999999999999999999865


Q ss_pred             ChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccc-cccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 023568          152 DYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQF-ATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  230 (280)
Q Consensus       152 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~h  230 (280)
                      ....  ..+.....                        ...... .......++.+.+++++||+.||.+|||++++++|
T Consensus       233 ~~~~--~~~~~~~~------------------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  286 (327)
T 3aln_A          233 NSVF--DQLTQVVK------------------------GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH  286 (327)
T ss_dssp             ---------CCCCC------------------------SCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             chHH--HHHHHHhc------------------------CCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence            3211  00000000                        000001 11223578999999999999999999999999999


Q ss_pred             cccccCc
Q 023568          231 PYLQSLH  237 (280)
Q Consensus       231 p~~~~~~  237 (280)
                      |||....
T Consensus       287 p~~~~~~  293 (327)
T 3aln_A          287 PFILMYE  293 (327)
T ss_dssp             HHHHHHH
T ss_pred             hHHHHhH
Confidence            9997654

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.4e-40  Score=279.07  Aligned_cols=204  Identities=26%  Similarity=0.416  Sum_probs=164.1

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD---QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP   76 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~---~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~   76 (280)
                      ++||||+++++++...     ...++||||++ ++|.+++...   ..+++..+..++.|++.||.|||+.|++|+||||
T Consensus        76 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p  150 (295)
T 2clq_A           76 LKHKNIVQYLGSFSEN-----GFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKG  150 (295)
T ss_dssp             CCCTTBCCEEEEEEET-----TEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred             CCCCCEeeEeeEEEeC-----CcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCCh
Confidence            5899999999999877     67999999997 5999999764   2567999999999999999999999999999999


Q ss_pred             CceEEcC-CCCeEEeecccccccCCC-CccccceeccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 023568           77 SNLLLNA-SCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLFPGKDY  153 (280)
Q Consensus        77 ~Nili~~-~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~  153 (280)
                      +||+++. ++.++|+|||.+...... .......|++.|+|||.+.+. ..++.++|+||||+++|+|++|..||.....
T Consensus       151 ~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  230 (295)
T 2clq_A          151 DNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE  230 (295)
T ss_dssp             GGEEEETTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS
T ss_pred             hhEEEECCCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc
Confidence            9999987 899999999999865433 223456789999999998652 2478899999999999999999999976543


Q ss_pred             HHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          154 VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       154 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      ............                            ..+......++.+.++|.+||+.||.+|||++++++||||
T Consensus       231 ~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~  282 (295)
T 2clq_A          231 PQAAMFKVGMFK----------------------------VHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFL  282 (295)
T ss_dssp             HHHHHHHHHHHC----------------------------CCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGG
T ss_pred             hhHHHHhhcccc----------------------------ccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhh
Confidence            322111111000                            0112234678999999999999999999999999999999


Q ss_pred             ccCc
Q 023568          234 QSLH  237 (280)
Q Consensus       234 ~~~~  237 (280)
                      +...
T Consensus       283 ~~~~  286 (295)
T 2clq_A          283 KVSS  286 (295)
T ss_dssp             CC--
T ss_pred             hhcc
Confidence            8654

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.3e-41  Score=286.25  Aligned_cols=224  Identities=16%  Similarity=0.264  Sum_probs=166.0

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ---QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP   76 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~---~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~   76 (280)
                      |+||||+++++++.....   ...|+||||++ ++|.+++....   .+++.++..++.|++.||+|||+.||+||||||
T Consensus        64 l~h~~iv~~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp  140 (319)
T 4euu_A           64 LNHKNIVKLFAIEEETTT---RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKP  140 (319)
T ss_dssp             CCCTTBCCEEEEEECTTT---CCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred             cCCCCcceEEEEeecCCC---ceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCH
Confidence            589999999999987633   47899999997 59999997643   399999999999999999999999999999999


Q ss_pred             CceEE----cCCCCeEEeecccccccCCCCccccceecccccccccccc-------CCCCCcchhHHHHHHHHHHHHhCC
Q 023568           77 SNLLL----NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN-------CTEYTAAIDIWSVGCILGEIMTRE  145 (280)
Q Consensus        77 ~Nili----~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DvwslG~~l~~ll~g~  145 (280)
                      +||++    +.++.+||+|||+++............||+.|+|||++..       ...++.++|||||||++|+|++|.
T Consensus       141 ~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~  220 (319)
T 4euu_A          141 GNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS  220 (319)
T ss_dssp             GGEEEEECTTSCEEEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSS
T ss_pred             HHEEEeccCCCCceEEEccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCC
Confidence            99999    7778899999999988766655566789999999999862       267888999999999999999999


Q ss_pred             CCCCCCChH-HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccc-c-ccccccCCCCCHHHHHHHHHhcccCCCCCC
Q 023568          146 PLFPGKDYV-HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCR-K-QQFATRFPNKSSGAVDLLEKMLVFDPNKRI  222 (280)
Q Consensus       146 ~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rp  222 (280)
                      .||...... .....+.+.....+............     ....+. . ..........+..+.++|++||+.||++||
T Consensus       221 ~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~  295 (319)
T 4euu_A          221 LPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAEN-----GPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCW  295 (319)
T ss_dssp             CSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTT-----CCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSC
T ss_pred             CCCCCCCccchhHHHHHHHhcCCCcccchhhhcccC-----CccccCccCCcccccchhHHHHhHHHHHHhccCChhhhc
Confidence            999764321 12222222222122111111100000     000000 0 000011123467889999999999999999


Q ss_pred             CHHHHhcCcc
Q 023568          223 TVEEALRHPY  232 (280)
Q Consensus       223 t~~ell~hp~  232 (280)
                      |++|+|+||-
T Consensus       296 s~~ell~h~~  305 (319)
T 4euu_A          296 GFDQFFAETS  305 (319)
T ss_dssp             CHHHHHHHHH
T ss_pred             cHHHhhhccH
Confidence            9999999985

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.4e-41  Score=298.14  Aligned_cols=202  Identities=28%  Similarity=0.372  Sum_probs=155.1

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      +|||||++++++.+.     ...|+|||||+|+|.+++.... .+++.++..++.||+.||.|||++||+||||||+||+
T Consensus        76 ~HpnIv~l~~~~~~~-----~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIl  150 (432)
T 3p23_A           76 EHPNVIRYFCTEKDR-----QFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNIL  150 (432)
T ss_dssp             CCTTBCCEEEEEEET-----TEEEEEEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEE
T ss_pred             CCCCcCeEEEEEecC-----CEEEEEEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEE
Confidence            699999999999887     7799999999999999997643 5667778899999999999999999999999999999


Q ss_pred             EcC-----CCCeEEeecccccccCCC----Cccccceecccccccccccc--CCCCCcchhHHHHHHHHHHHHh-CCCCC
Q 023568           81 LNA-----SCDLKIGDFGLARTTSET----DFMTEYVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILGEIMT-REPLF  148 (280)
Q Consensus        81 i~~-----~~~~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwslG~~l~~ll~-g~~pf  148 (280)
                      ++.     ...++|+|||+++.....    .......||+.|+|||++.+  ...++.++|||||||++|+|++ |..||
T Consensus       151 l~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf  230 (432)
T 3p23_A          151 ISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF  230 (432)
T ss_dssp             ECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTT
T ss_pred             EecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCc
Confidence            943     335789999999865433    22345678999999999874  2566779999999999999999 99999


Q ss_pred             CCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 023568          149 PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL  228 (280)
Q Consensus       149 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell  228 (280)
                      .......... +   .+......                        .......+..+.+||.+||+.||.+|||++|++
T Consensus       231 ~~~~~~~~~~-~---~~~~~~~~------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl  282 (432)
T 3p23_A          231 GKSLQRQANI-L---LGACSLDC------------------------LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVL  282 (432)
T ss_dssp             BSTTTHHHHH-H---TTCCCCTT------------------------SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             chhhHHHHHH-H---hccCCccc------------------------cCccccccHHHHHHHHHHHhCCHhhCCCHHHHH
Confidence            6654322211 1   11111000                        000012355688999999999999999999999


Q ss_pred             cCcccccC
Q 023568          229 RHPYLQSL  236 (280)
Q Consensus       229 ~hp~~~~~  236 (280)
                      +||||..+
T Consensus       283 ~hp~f~~~  290 (432)
T 3p23_A          283 KHPFFWSL  290 (432)
T ss_dssp             TSTTTCCH
T ss_pred             hCccccCh
Confidence            99999764

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.5e-40  Score=287.83  Aligned_cols=193  Identities=27%  Similarity=0.437  Sum_probs=162.2

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHH
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ----------------QLTDDHCQYFLYQLLRGLKYV   64 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~----------------~l~~~~~~~i~~qil~~l~~L   64 (280)
                      +||||+++++++.+.     ..+|+||||++ |+|.+++...+                .+++.++..++.||+.||+||
T Consensus       145 ~hpnIv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L  219 (370)
T 2psq_A          145 KHKNIINLLGACTQD-----GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL  219 (370)
T ss_dssp             CCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             CCCCEeeEEEEEccC-----CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHH
Confidence            799999999999887     67999999997 59999997643                489999999999999999999


Q ss_pred             HhCCccccCCCCCceEEcCCCCeEEeecccccccCCCC---ccccceeccccccccccccCCCCCcchhHHHHHHHHHHH
Q 023568           65 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI  141 (280)
Q Consensus        65 H~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l  141 (280)
                      |++||+||||||+|||++.++.+||+|||+++......   ......+++.|+|||++.+ ..++.++|||||||++|+|
T Consensus       220 H~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~el  298 (370)
T 2psq_A          220 ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEI  298 (370)
T ss_dssp             HHTTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHH
T ss_pred             HhCCeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcC-CCCCcHHHHHHHHHHHHHH
Confidence            99999999999999999999999999999998654432   2234556789999999987 7789999999999999999


Q ss_pred             Hh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCC
Q 023568          142 MT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNK  220 (280)
Q Consensus       142 l~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~  220 (280)
                      ++ |..||.+.........+....                              ........+..+.++|++||+.||.+
T Consensus       299 lt~g~~p~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~l~~li~~~l~~dP~~  348 (370)
T 2psq_A          299 FTLGGSPYPGIPVEELFKLLKEGH------------------------------RMDKPANCTNELYMMMRDCWHAVPSQ  348 (370)
T ss_dssp             HTTSCCSSTTCCGGGHHHHHHTTC------------------------------CCCCCTTSCHHHHHHHHHHTCSSGGG
T ss_pred             HcCCCCCCCCCCHHHHHHHHhcCC------------------------------CCCCCCCCCHHHHHHHHHHcCCChhh
Confidence            99 999998876544443332210                              11223357889999999999999999


Q ss_pred             CCCHHHHhcC
Q 023568          221 RITVEEALRH  230 (280)
Q Consensus       221 Rpt~~ell~h  230 (280)
                      |||++|++++
T Consensus       349 Rpt~~ell~~  358 (370)
T 2psq_A          349 RPTFKQLVED  358 (370)
T ss_dssp             SCCHHHHHHH
T ss_pred             CcCHHHHHHH
Confidence            9999999873

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=3.5e-41  Score=280.56  Aligned_cols=201  Identities=33%  Similarity=0.510  Sum_probs=165.4

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCC-----cc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSD----QQLTDDHCQYFLYQLLRGLKYVHSAS-----VL   70 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~----~~l~~~~~~~i~~qil~~l~~LH~~~-----i~   70 (280)
                      ++||||+++++++.+...   ..+|+||||++| +|.+++...    ..+++..+..++.|++.||+|||+.|     ++
T Consensus        62 l~h~~i~~~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iv  138 (279)
T 2w5a_A           62 LKHPNIVRYYDRIIDRTN---TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVL  138 (279)
T ss_dssp             CCCTTBCCEEEEEEEGGG---TEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------C
T ss_pred             cCCCCCCeEEEEEecCCC---ceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeE
Confidence            589999999998854322   679999999975 999999643    35999999999999999999999999     99


Q ss_pred             ccCCCCCceEEcCCCCeEEeecccccccCCCC-ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 023568           71 HRDLKPSNLLLNASCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFP  149 (280)
Q Consensus        71 H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~  149 (280)
                      ||||||+||+++.++.++|+|||.+....... ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.
T Consensus       139 H~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~  217 (279)
T 2w5a_A          139 HRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFT  217 (279)
T ss_dssp             CCCCSGGGEEECSSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHC-C-CCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             EeccchhhEEEcCCCCEEEecCchheeeccccccccccCCCccccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCc
Confidence            99999999999999999999999987655432 2234568899999999877 678899999999999999999999999


Q ss_pred             CCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          150 GKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       150 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      ..+.......+....                              ........+..+.++|.+||+.||.+|||++|+++
T Consensus       218 ~~~~~~~~~~i~~~~------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (279)
T 2w5a_A          218 AFSQKELAGKIREGK------------------------------FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  267 (279)
T ss_dssp             CSSHHHHHHHHHHTC------------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ccCHHHHHHHHhhcc------------------------------cccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            887655554443311                              11122356899999999999999999999999999


Q ss_pred             Cccccc
Q 023568          230 HPYLQS  235 (280)
Q Consensus       230 hp~~~~  235 (280)
                      |+|+..
T Consensus       268 ~~~~~~  273 (279)
T 2w5a_A          268 NPLILE  273 (279)
T ss_dssp             STTCCG
T ss_pred             Chhhhh
Confidence            999865

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.3e-40  Score=274.41  Aligned_cols=194  Identities=19%  Similarity=0.346  Sum_probs=164.6

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||+++++++.+.     ...|+||||++ ++|.+++... +.+++..+..++.|++.||+|||+.|++||||||+|
T Consensus        62 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~N  136 (269)
T 4hcu_A           62 LSHPKLVQLYGVCLEQ-----APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARN  136 (269)
T ss_dssp             CCCTTBCCEEEEECSS-----SSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             CCCCCEeeEEEEEecC-----CceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchhe
Confidence            5899999999999987     66999999997 5999999654 569999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCC--ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVH  155 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~~  155 (280)
                      |+++.++.++|+|||++.......  ......++..|+|||.+.+ ..++.++|+||+|+++|+|++ |..||.+.....
T Consensus       137 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~  215 (269)
T 4hcu_A          137 CLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE  215 (269)
T ss_dssp             EEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred             EEEcCCCCEEeccccccccccccccccccCcccccccCCHHHhcC-CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH
Confidence            999999999999999998654432  2234456778999999977 778999999999999999999 999999888766


Q ss_pred             HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 023568          156 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  230 (280)
Q Consensus       156 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~h  230 (280)
                      ....+.....                              .......++.+.+++.+||+.||.+|||++++++|
T Consensus       216 ~~~~~~~~~~------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          216 VVEDISTGFR------------------------------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             HHHHHHTTCC------------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhcCcc------------------------------CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            6655543111                              11123468899999999999999999999999975

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=4.6e-41  Score=296.82  Aligned_cols=203  Identities=31%  Similarity=0.409  Sum_probs=152.6

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcCCCC-------CHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQL-------TDDHCQYFLYQLLRGLKYVHSASVLHRDL   74 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~l-------~~~~~~~i~~qil~~l~~LH~~~i~H~di   74 (280)
                      +|||||++++++.+.     ..+|+|||||+|+|.+++......       ++..+..++.||+.||+|||++||+||||
T Consensus        67 ~HpnIv~~~~~~~~~-----~~~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDL  141 (434)
T 2rio_A           67 DHPNVIRYYCSETTD-----RFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDL  141 (434)
T ss_dssp             TSTTBCCEEEEEECS-----SEEEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred             CCCCcCeEEEEEecC-----CeEEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCC
Confidence            799999999999887     779999999999999999765433       33346789999999999999999999999


Q ss_pred             CCCceEEcCC-------------CCeEEeecccccccCCCC-----ccccceecccccccccccc------CCCCCcchh
Q 023568           75 KPSNLLLNAS-------------CDLKIGDFGLARTTSETD-----FMTEYVVTRWYRAPELLLN------CTEYTAAID  130 (280)
Q Consensus        75 k~~Nili~~~-------------~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~------~~~~~~~~D  130 (280)
                      ||+|||++.+             +.++|+|||+++......     ......||+.|+|||++.+      ...++.++|
T Consensus       142 kp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~D  221 (434)
T 2rio_A          142 KPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSID  221 (434)
T ss_dssp             SGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHH
T ss_pred             ChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhh
Confidence            9999999754             479999999998765432     1234578999999999865      256788999


Q ss_pred             HHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHH
Q 023568          131 IWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDL  209 (280)
Q Consensus       131 vwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  209 (280)
                      ||||||++|+|++ |..||.......  ..+.......  ....                      ....+.+++.+.++
T Consensus       222 iwSlG~il~ellt~g~~Pf~~~~~~~--~~i~~~~~~~--~~~~----------------------~~~~~~~~~~~~~l  275 (434)
T 2rio_A          222 IFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSL--DEMK----------------------CLHDRSLIAEATDL  275 (434)
T ss_dssp             HHHHHHHHHHHHTTSCCTTCSTTTHH--HHHHHTCCCC--CCCT----------------------TCCCHHHHHHHHHH
T ss_pred             hHhHHHHHHHHHhCCCCCCCCchhhH--HHHhcCCCCc--cccc----------------------ccccccchHHHHHH
Confidence            9999999999998 999997764332  1111110000  0000                      00011246789999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCccccc
Q 023568          210 LEKMLVFDPNKRITVEEALRHPYLQS  235 (280)
Q Consensus       210 l~~~L~~dp~~Rpt~~ell~hp~~~~  235 (280)
                      |++||+.||.+|||+.++++||||..
T Consensus       276 i~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          276 ISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             HHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             HHHHhhCChhhCCCHHHHHhCCccCC
Confidence            99999999999999999999999964

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=9.8e-41  Score=288.67  Aligned_cols=198  Identities=22%  Similarity=0.302  Sum_probs=165.6

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC-------CCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-------QQLTDDHCQYFLYQLLRGLKYVHSASVLHR   72 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~   72 (280)
                      |+||||+++++++...     ...|+||||+. |+|.+++...       ..+++.++..++.||+.||+|||++||+||
T Consensus       131 l~hpnIv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHr  205 (367)
T 3l9p_A          131 FNHQNIVRCIGVSLQS-----LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHR  205 (367)
T ss_dssp             CCCTTBCCEEEEECSS-----SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             CCCCCCCeEEEEEecC-----CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCC
Confidence            5899999999999887     66899999996 5999999753       359999999999999999999999999999


Q ss_pred             CCCCCceEEcCCC---CeEEeecccccccCC---CCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CC
Q 023568           73 DLKPSNLLLNASC---DLKIGDFGLARTTSE---TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-RE  145 (280)
Q Consensus        73 dik~~Nili~~~~---~~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~  145 (280)
                      ||||+|||++.++   .+||+|||+++....   ........+|+.|+|||++.+ ..++.++|||||||++|+|++ |.
T Consensus       206 Dlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~  284 (367)
T 3l9p_A          206 DIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGY  284 (367)
T ss_dssp             CCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             CCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCC
Confidence            9999999998555   499999999974322   122334567889999999877 778999999999999999998 99


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 023568          146 PLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVE  225 (280)
Q Consensus       146 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~  225 (280)
                      .||.+.........+.....                              .......++.+.+++++||+.||.+|||++
T Consensus       285 ~pf~~~~~~~~~~~i~~~~~------------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~  334 (367)
T 3l9p_A          285 MPYPSKSNQEVLEFVTSGGR------------------------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFA  334 (367)
T ss_dssp             CSSTTCCHHHHHHHHHTTCC------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCCCCCHHHHHHHHHcCCC------------------------------CCCCccCCHHHHHHHHHHcCCCHhHCcCHH
Confidence            99999887666655543211                              111235688999999999999999999999


Q ss_pred             HHhcCcccc
Q 023568          226 EALRHPYLQ  234 (280)
Q Consensus       226 ell~hp~~~  234 (280)
                      +++++.++.
T Consensus       335 eil~~l~~~  343 (367)
T 3l9p_A          335 IILERIEYC  343 (367)
T ss_dssp             HHHHHHHHH
T ss_pred             HHHHHHHHH
Confidence            999988764

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=7.7e-41  Score=284.18  Aligned_cols=193  Identities=27%  Similarity=0.440  Sum_probs=165.4

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC--ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD--TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~--g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      .||||+++++++...     ...++|||++.  ++|.+++...+.+++..+..++.|++.||+|||+.||+||||||+||
T Consensus       106 ~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NI  180 (320)
T 3a99_A          106 GFSGVIRLLDWFERP-----DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENI  180 (320)
T ss_dssp             SSCSBCCEEEEEECS-----SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             CCCCceEEEEEEecC-----CcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHE
Confidence            379999999999987     77999999996  69999998888999999999999999999999999999999999999


Q ss_pred             EEc-CCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLN-ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++ .++.++|+|||++....... .....||+.|+|||++.+....+.++|+|||||++|+|++|..||.....     
T Consensus       181 ll~~~~~~~kL~Dfg~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----  254 (320)
T 3a99_A          181 LIDLNRGELKLIDFGSGALLKDTV-YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----  254 (320)
T ss_dssp             EEETTTTEEEECCCTTCEECCSSC-BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----
T ss_pred             EEeCCCCCEEEeeCcccccccccc-ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-----
Confidence            999 68899999999998765432 34567899999999987745557889999999999999999999965321     


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  237 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~  237 (280)
                       +..  +                             .......+++.+.++|++||+.||.+|||++|+++||||++..
T Consensus       255 -~~~--~-----------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  301 (320)
T 3a99_A          255 -IIR--G-----------------------------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  301 (320)
T ss_dssp             -HHH--C-----------------------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             -hhc--c-----------------------------cccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence             100  0                             0011235789999999999999999999999999999998764

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2e-40  Score=282.22  Aligned_cols=193  Identities=21%  Similarity=0.315  Sum_probs=162.2

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      |+||||+++++++.+.     ...|+||||++ |+|.+++... +.+++.++..++.|++.||.|||+.||+||||||+|
T Consensus       107 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~N  181 (325)
T 3kul_A          107 FDHPNIIRLEGVVTRG-----RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARN  181 (325)
T ss_dssp             CCCTTBCCEEEEECGG-----GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred             CCCCCCCcEEEEEEeC-----CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcce
Confidence            5899999999999887     67999999997 5999999754 689999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCC----ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 023568           79 LLLNASCDLKIGDFGLARTTSETD----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDY  153 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~  153 (280)
                      |+++.++.++|+|||+++......    ......+|..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+...
T Consensus       182 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~  260 (325)
T 3kul_A          182 VLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF-RTFSSASDVWSFGVVMWEVLAYGERPYWNMTN  260 (325)
T ss_dssp             EEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH
T ss_pred             EEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH
Confidence            999999999999999998754432    1223345778999999976 678899999999999999999 9999998887


Q ss_pred             HHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          154 VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       154 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      ......+......                              ......++.+.++|.+||..||.+|||++++++
T Consensus       261 ~~~~~~~~~~~~~------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          261 RDVISSVEEGYRL------------------------------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             HHHHHHHHTTCCC------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHcCCCC------------------------------CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            7666555432111                              122357899999999999999999999999987

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.6e-40  Score=282.36  Aligned_cols=205  Identities=22%  Similarity=0.354  Sum_probs=155.1

Q ss_pred             CCCcccccccccccCCCCC-CCCcEEEEEecCCc-cHHHHHHcCC------CCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 023568            1 MEHENVIAIKDIIRPPKKD-TFNDVYIVYELMDT-DLHQIIRSDQ------QLTDDHCQYFLYQLLRGLKYVHSASVLHR   72 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~-~~~~~~lv~e~~~g-~L~~~l~~~~------~l~~~~~~~i~~qil~~l~~LH~~~i~H~   72 (280)
                      |+||||+++++++...... .....++||||+.+ +|.+++....      .+++.++..++.|++.||+|||++||+||
T Consensus        82 l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~  161 (323)
T 3qup_A           82 FDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHR  161 (323)
T ss_dssp             CCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             CCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccC
Confidence            5899999999999876321 11234999999985 9999986422      69999999999999999999999999999


Q ss_pred             CCCCCceEEcCCCCeEEeecccccccCCCCc---cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCC
Q 023568           73 DLKPSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLF  148 (280)
Q Consensus        73 dik~~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf  148 (280)
                      ||||+||+++.++.++|+|||+++.......   .....+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||
T Consensus       162 Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~  240 (323)
T 3qup_A          162 DLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD-NLYTVHSDVWAFGVTMWEIMTRGQTPY  240 (323)
T ss_dssp             CCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             CCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcC-CCCCCccchhhHHHHHHHHHhCCCCCc
Confidence            9999999999999999999999986544322   223455778999999877 778999999999999999999 99999


Q ss_pred             CCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCC-----
Q 023568          149 PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT-----  223 (280)
Q Consensus       149 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt-----  223 (280)
                      .+.+.......+....                              .....+..++.+.+++.+||+.||.+|||     
T Consensus       241 ~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~  290 (323)
T 3qup_A          241 AGIENAEIYNYLIGGN------------------------------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLR  290 (323)
T ss_dssp             TTCCGGGHHHHHHTTC------------------------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHH
T ss_pred             cccChHHHHHHHhcCC------------------------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            9877655554443211                              11223467899999999999999999999     


Q ss_pred             --HHHHhcCcccccC
Q 023568          224 --VEEALRHPYLQSL  236 (280)
Q Consensus       224 --~~ell~hp~~~~~  236 (280)
                        +++++.|||+...
T Consensus       291 ~~l~~~l~~~~~~~~  305 (323)
T 3qup_A          291 MELENILGHLSVLST  305 (323)
T ss_dssp             HHHHHHHHC------
T ss_pred             HHHHHHHHHhhhcCC
Confidence              8888899998764

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=3.1e-40  Score=275.51  Aligned_cols=194  Identities=20%  Similarity=0.319  Sum_probs=165.1

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||+++++++.+.     ...|+||||++ ++|.+++.. ...+++.++..++.|++.||.|||++||+||||||+|
T Consensus        76 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~N  150 (283)
T 3gen_A           76 LSHEKLVQLYGVCTKQ-----RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARN  150 (283)
T ss_dssp             CCCTTBCCEEEEECSS-----SSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGG
T ss_pred             CCCCCEeeEEEEEecC-----CCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccce
Confidence            5899999999999887     67999999996 599999976 5679999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCC--ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVH  155 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~~  155 (280)
                      |+++.++.++|+|||.+.......  ......+++.|+|||.+.+ ..++.++|+||+|+++|+|++ |..||.......
T Consensus       151 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~  229 (283)
T 3gen_A          151 CLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE  229 (283)
T ss_dssp             EEECTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred             EEEcCCCCEEEccccccccccccccccccCCccCcccCCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccChhH
Confidence            999999999999999998654432  1233455778999999987 678999999999999999998 999999888766


Q ss_pred             HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 023568          156 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  230 (280)
Q Consensus       156 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~h  230 (280)
                      ....+......                              ......++.+.+++.+||+.||.+|||++++++|
T Consensus       230 ~~~~~~~~~~~------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          230 TAEHIAQGLRL------------------------------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             HHHHHHTTCCC------------------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhcccCC------------------------------CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            66555432111                              1122458899999999999999999999999975

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2.2e-40  Score=274.26  Aligned_cols=194  Identities=20%  Similarity=0.318  Sum_probs=163.5

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||+++++++.+.     ...|+||||++ ++|.+++... ..+++.++..++.|++.||+|||+.|++||||||+|
T Consensus        60 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~N  134 (268)
T 3sxs_A           60 LSHPKLVKFYGVCSKE-----YPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARN  134 (268)
T ss_dssp             CCCTTBCCEEEEECSS-----SSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGG
T ss_pred             CCCCCEeeEEEEEccC-----CceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcce
Confidence            5899999999999887     67999999997 5899999764 459999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCc--cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDF--MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVH  155 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~~  155 (280)
                      |+++.++.++|+|||.+........  .....+++.|+|||.+.+ ..++.++|+||+|+++|+|++ |..||.......
T Consensus       135 il~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~  213 (268)
T 3sxs_A          135 CLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHY-FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE  213 (268)
T ss_dssp             EEECTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHH-SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred             EEECCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhc-cCCchhhhhHHHHHHHHHHHcCCCCCccccChHH
Confidence            9999999999999999986554422  233455778999999876 678899999999999999998 999999887666


Q ss_pred             HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 023568          156 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  230 (280)
Q Consensus       156 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~h  230 (280)
                      ....+.....                              .......++.+.+++++||+.||.+|||+++++++
T Consensus       214 ~~~~~~~~~~------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          214 VVLKVSQGHR------------------------------LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             HHHHHHTTCC------------------------------CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcCCC------------------------------CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            5554433111                              11122468899999999999999999999999985

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=6.2e-40  Score=277.64  Aligned_cols=200  Identities=25%  Similarity=0.380  Sum_probs=158.7

Q ss_pred             CcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc
Q 023568            3 HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLN   82 (280)
Q Consensus         3 Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nili~   82 (280)
                      ||||+++++++...     ...|+|||+.+++|.+++.+.+.+++..+..++.|++.||.|||+.||+||||||+||+++
T Consensus        87 ~~~iv~~~~~~~~~-----~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~  161 (313)
T 3cek_A           87 SDKIIRLYDYEITD-----QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV  161 (313)
T ss_dssp             CTTBCCEEEEEECS-----SEEEEEECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE
T ss_pred             CCceEEEEEEeecC-----CEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE
Confidence            69999999999887     6799999988889999999888999999999999999999999999999999999999996


Q ss_pred             CCCCeEEeecccccccCCCC---ccccceeccccccccccccC----------CCCCcchhHHHHHHHHHHHHhCCCCCC
Q 023568           83 ASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNC----------TEYTAAIDIWSVGCILGEIMTREPLFP  149 (280)
Q Consensus        83 ~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~----------~~~~~~~DvwslG~~l~~ll~g~~pf~  149 (280)
                      . +.++|+|||++.......   ......|++.|+|||++.+.          ..++.++|+||||+++|+|++|..||.
T Consensus       162 ~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~  240 (313)
T 3cek_A          162 D-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ  240 (313)
T ss_dssp             T-TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             C-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchh
Confidence            4 889999999998654432   12345789999999998641          467889999999999999999999997


Q ss_pred             CCChH-HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 023568          150 GKDYV-HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL  228 (280)
Q Consensus       150 ~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell  228 (280)
                      ..... .....+.   ...                          .........+..+.++|++||+.||.+|||++|++
T Consensus       241 ~~~~~~~~~~~~~---~~~--------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell  291 (313)
T 3cek_A          241 QIINQISKLHAII---DPN--------------------------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL  291 (313)
T ss_dssp             TCCSHHHHHHHHH---CTT--------------------------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred             hHHHHHHHHHHHH---hcc--------------------------cccCCcccchHHHHHHHHHHccCCcccCcCHHHHh
Confidence            75432 2221111   100                          00111224578899999999999999999999999


Q ss_pred             cCcccccCc
Q 023568          229 RHPYLQSLH  237 (280)
Q Consensus       229 ~hp~~~~~~  237 (280)
                      +||||+...
T Consensus       292 ~h~~~~~~~  300 (313)
T 3cek_A          292 AHPYVQIQT  300 (313)
T ss_dssp             TSHHHHCC-
T ss_pred             cCccccCCC
Confidence            999998654

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.7e-40  Score=284.87  Aligned_cols=205  Identities=14%  Similarity=0.126  Sum_probs=161.5

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      ++||||+++++++..... +....|+||||++++|.+++...+.+++.++..++.||+.||+|||+.||+||||||+||+
T Consensus       105 l~h~ni~~~~~~~~~~~~-~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl  183 (345)
T 2v62_A          105 LDYLGIPLFYGSGLTEFK-GRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLL  183 (345)
T ss_dssp             CSCCCCCCEEEEEEEESS-SCEEEEEEEECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             ccccCcceeecccccccC-CCcEEEEEEeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEE
Confidence            579999999999987311 1167999999997799999987779999999999999999999999999999999999999


Q ss_pred             EcCCC--CeEEeecccccccCCCC--------ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 023568           81 LNASC--DLKIGDFGLARTTSETD--------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG  150 (280)
Q Consensus        81 i~~~~--~~kl~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~  150 (280)
                      ++.++  .++|+|||+++......        ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+
T Consensus       184 l~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~  262 (345)
T 2v62_A          184 LGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG-VALSRRSDVEILGYCMLRWLCGKLPWEQ  262 (345)
T ss_dssp             EESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred             EccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            98877  99999999997654321        1144578999999999887 6789999999999999999999999965


Q ss_pred             C--ChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 023568          151 K--DYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL  228 (280)
Q Consensus       151 ~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell  228 (280)
                      .  +...............+.....            .          ......++.+.++|.+||+.||.+|||+++++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~------------~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~  320 (345)
T 2v62_A          263 NLKDPVAVQTAKTNLLDELPQSVLK------------W----------APSGSSCCEIAQFLVCAHSLAYDEKPNYQALK  320 (345)
T ss_dssp             GTTCHHHHHHHHHHHHHTTTHHHHH------------H----------SCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHH
T ss_pred             cccccHHHHHHHHhhcccccHHHHh------------h----------ccccccHHHHHHHHHHHhhcCcccCCCHHHHH
Confidence            3  2222222222211111111000            0          00115788999999999999999999999998


Q ss_pred             c
Q 023568          229 R  229 (280)
Q Consensus       229 ~  229 (280)
                      +
T Consensus       321 ~  321 (345)
T 2v62_A          321 K  321 (345)
T ss_dssp             H
T ss_pred             H
Confidence            7

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.8e-40  Score=283.91  Aligned_cols=193  Identities=26%  Similarity=0.431  Sum_probs=164.7

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHH
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ----------------QLTDDHCQYFLYQLLRGLKYV   64 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~----------------~l~~~~~~~i~~qil~~l~~L   64 (280)
                      +||||+++++++...     ...|+||||++ |+|.+++...+                .+++.++..++.||+.||+||
T Consensus       133 ~hpnIv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  207 (382)
T 3tt0_A          133 KHKNIINLLGACTQD-----GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL  207 (382)
T ss_dssp             CCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             CCchhhhheeeeccC-----CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHH
Confidence            799999999999987     66999999997 49999997643                499999999999999999999


Q ss_pred             HhCCccccCCCCCceEEcCCCCeEEeecccccccCCC---CccccceeccccccccccccCCCCCcchhHHHHHHHHHHH
Q 023568           65 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET---DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI  141 (280)
Q Consensus        65 H~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l  141 (280)
                      |+.||+||||||+||+++.++.+||+|||+++.....   .......+++.|+|||++.+ ..++.++|||||||++|+|
T Consensus       208 H~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el  286 (382)
T 3tt0_A          208 ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEI  286 (382)
T ss_dssp             HHTTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHH
T ss_pred             HhCCEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC-CCCCchhHHHHHHHHHHHH
Confidence            9999999999999999999999999999999865443   22334566889999999987 7889999999999999999


Q ss_pred             Hh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCC
Q 023568          142 MT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNK  220 (280)
Q Consensus       142 l~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~  220 (280)
                      ++ |..||.+.+..+....+.....                              .......++.+.+++++||+.||.+
T Consensus       287 lt~g~~p~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~l~~li~~~l~~dP~~  336 (382)
T 3tt0_A          287 FTLGGSPYPGVPVEELFKLLKEGHR------------------------------MDKPSNCTNELYMMMRDCWHAVPSQ  336 (382)
T ss_dssp             HTTSCCSSTTCCHHHHHHHHHTTCC------------------------------CCCCSSCCHHHHHHHHHHTCSSGGG
T ss_pred             HhCCCCCCCCCCHHHHHHHHHcCCC------------------------------CCCCccCCHHHHHHHHHHcCCChhh
Confidence            99 9999998876655544433111                              1122357899999999999999999


Q ss_pred             CCCHHHHhcC
Q 023568          221 RITVEEALRH  230 (280)
Q Consensus       221 Rpt~~ell~h  230 (280)
                      |||++|++++
T Consensus       337 Rps~~ell~~  346 (382)
T 3tt0_A          337 RPTFKQLVED  346 (382)
T ss_dssp             SCCHHHHHHH
T ss_pred             CcCHHHHHHH
Confidence            9999999985

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=4.4e-40  Score=276.69  Aligned_cols=206  Identities=27%  Similarity=0.401  Sum_probs=155.4

Q ss_pred             CCCcccccccccccCCCC--------CCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 023568            1 MEHENVIAIKDIIRPPKK--------DTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVL   70 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~--------~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~   70 (280)
                      ++||||+++++++.+...        ......|+||||++ |+|.+++... ..+++..+..++.|++.||+|||++|++
T Consensus        59 l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~  138 (303)
T 1zy4_A           59 LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGII  138 (303)
T ss_dssp             CCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             cCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCee
Confidence            589999999998865310        11257899999997 5999999754 4689999999999999999999999999


Q ss_pred             ccCCCCCceEEcCCCCeEEeecccccccCCC---------------CccccceeccccccccccccCCCCCcchhHHHHH
Q 023568           71 HRDLKPSNLLLNASCDLKIGDFGLARTTSET---------------DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVG  135 (280)
Q Consensus        71 H~dik~~Nili~~~~~~kl~dfg~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG  135 (280)
                      ||||||+||+++.++.++|+|||.+......               .......|++.|+|||++.+...++.++|+||||
T Consensus       139 H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG  218 (303)
T 1zy4_A          139 HRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLG  218 (303)
T ss_dssp             CSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHH
T ss_pred             cccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHH
Confidence            9999999999999999999999998765421               1223456899999999998756789999999999


Q ss_pred             HHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhc
Q 023568          136 CILGEIMTREPLFPGKD-YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKML  214 (280)
Q Consensus       136 ~~l~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L  214 (280)
                      |++|+|++   ||.... .......+.......                           .+......+..+.++|++||
T Consensus       219 ~il~~l~~---p~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~li~~~l  268 (303)
T 1zy4_A          219 IIFFEMIY---PFSTGMERVNILKKLRSVSIEF---------------------------PPDFDDNKMKVEKKIIRLLI  268 (303)
T ss_dssp             HHHHHHHS---CCSSHHHHHHHHHHHHSTTCCC---------------------------CTTCCTTTSHHHHHHHHHHT
T ss_pred             HHHHHHHh---ccCCchhHHHHHHhcccccccc---------------------------CccccccchHHHHHHHHHHH
Confidence            99999998   444321 122222221110000                           01122356788999999999


Q ss_pred             ccCCCCCCCHHHHhcCcccccC
Q 023568          215 VFDPNKRITVEEALRHPYLQSL  236 (280)
Q Consensus       215 ~~dp~~Rpt~~ell~hp~~~~~  236 (280)
                      +.||.+|||++++++||||+..
T Consensus       269 ~~dp~~Rps~~~ll~h~~~~~~  290 (303)
T 1zy4_A          269 DHDPNKRPGARTLLNSGWLPVK  290 (303)
T ss_dssp             CSSGGGSCCHHHHHHSSCSCCC
T ss_pred             hcCcccCcCHHHHhCCCCcCCC
Confidence            9999999999999999999653

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=5.6e-40  Score=282.89  Aligned_cols=195  Identities=25%  Similarity=0.382  Sum_probs=160.8

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCC------------------------------------
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQ------------------------------------   44 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~------------------------------------   44 (280)
                      +||||+++++++.+..    ..+++||||+. |+|.+++.....                                    
T Consensus        84 ~hpniv~~~~~~~~~~----~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (359)
T 3vhe_A           84 HHLNVVNLLGACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSS  159 (359)
T ss_dssp             CCTTBCCEEEEECSTT----SCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------
T ss_pred             CCcceeeeeeeeecCC----CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcc
Confidence            6999999999998752    45899999998 599999976433                                    


Q ss_pred             ------------------------------CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEeeccc
Q 023568           45 ------------------------------LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL   94 (280)
Q Consensus        45 ------------------------------l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nili~~~~~~kl~dfg~   94 (280)
                                                    +++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~  239 (359)
T 3vhe_A          160 QSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGL  239 (359)
T ss_dssp             ------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGG
T ss_pred             ccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccc
Confidence                                          89999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCC---ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcc
Q 023568           95 ARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDA  170 (280)
Q Consensus        95 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~  170 (280)
                      ++......   ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+...............     
T Consensus       240 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~-----  313 (359)
T 3vhe_A          240 ARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT-----  313 (359)
T ss_dssp             GSCTTSCTTCEEC--CEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTC-----
T ss_pred             eeeecccccchhccccCCCceeEChhhhcC-CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCC-----
Confidence            98654332   2344677889999999887 778899999999999999998 9999988764433333222111     


Q ss_pred             cccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 023568          171 SLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  230 (280)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~h  230 (280)
                                              ........++.+.+++.+||+.||.+|||++|+++|
T Consensus       314 ------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          314 ------------------------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             ------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------------CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence                                    111223578899999999999999999999999975

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=9.2e-40  Score=270.88  Aligned_cols=193  Identities=26%  Similarity=0.397  Sum_probs=153.9

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS---VLHRDLKP   76 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~---i~H~dik~   76 (280)
                      ++||||+++++++.+.     ...|+||||++ ++|.+++. .+.+++..+..++.|++.||.|||++|   ++||||||
T Consensus        63 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp  136 (271)
T 3dtc_A           63 LKHPNIIALRGVCLKE-----PNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKS  136 (271)
T ss_dssp             CCCTTBCCEEEEECCC-------CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSG
T ss_pred             cCCCCEeeEEEEEecC-----CceEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCch
Confidence            5899999999999987     67999999997 58988885 468999999999999999999999999   89999999


Q ss_pred             CceEEcC--------CCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 023568           77 SNLLLNA--------SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF  148 (280)
Q Consensus        77 ~Nili~~--------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf  148 (280)
                      +||+++.        ++.++|+|||.+....... .....|++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||
T Consensus       137 ~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~  214 (271)
T 3dtc_A          137 SNILILQKVENGDLSNKILKITDFGLAREWHRTT-KMSAAGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGEVPF  214 (271)
T ss_dssp             GGEEESSCCSSSCCSSCCEEECCCCC--------------CCGGGSCHHHHHH-CCCSHHHHHHHHHHHHHHHHHCCCTT
T ss_pred             HHEEEecccccccccCcceEEccCCccccccccc-ccCCCCccceeCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            9999986        7789999999998655432 235578999999999877 77899999999999999999999999


Q ss_pred             CCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 023568          149 PGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL  228 (280)
Q Consensus       149 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell  228 (280)
                      .+.+.......+....                             .........++.+.+++.+||+.||.+|||++|++
T Consensus       215 ~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l  265 (271)
T 3dtc_A          215 RGIDGLAVAYGVAMNK-----------------------------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNIL  265 (271)
T ss_dssp             TTSCHHHHHHHHHTSC-----------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCCHHHHHHhhhcCC-----------------------------CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence            9877655444332210                             01112235789999999999999999999999998


Q ss_pred             cC
Q 023568          229 RH  230 (280)
Q Consensus       229 ~h  230 (280)
                      ++
T Consensus       266 ~~  267 (271)
T 3dtc_A          266 DQ  267 (271)
T ss_dssp             HH
T ss_pred             HH
Confidence            74

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=3.9e-40  Score=278.67  Aligned_cols=194  Identities=26%  Similarity=0.393  Sum_probs=162.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCC------------------------CCHHHHHHHHH
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQ------------------------LTDDHCQYFLY   55 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~------------------------l~~~~~~~i~~   55 (280)
                      |+||||+++++++.+.     ...|+||||++ |+|.+++...+.                        +++.++..++.
T Consensus        83 l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  157 (314)
T 2ivs_A           83 VNHPHVIKLYGACSQD-----GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAW  157 (314)
T ss_dssp             CCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHH
T ss_pred             CCCCceeeEEEEEecC-----CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHH
Confidence            5899999999999887     67999999997 699999976443                        89999999999


Q ss_pred             HHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEeecccccccCCCC---ccccceeccccccccccccCCCCCcchhHH
Q 023568           56 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIW  132 (280)
Q Consensus        56 qil~~l~~LH~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dvw  132 (280)
                      |++.||.|||++||+||||||+||+++.++.++|+|||++.......   ......+++.|+|||.+.+ ..++.++|+|
T Consensus       158 qi~~~l~~lH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~  236 (314)
T 2ivs_A          158 QISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD-HIYTTQSDVW  236 (314)
T ss_dssp             HHHHHHHHHHHTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH-CEECHHHHHH
T ss_pred             HHHHHHHHHHHCCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcC-CCcCchhhHH
Confidence            99999999999999999999999999999999999999998654432   1234456788999999877 6788999999


Q ss_pred             HHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHH
Q 023568          133 SVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLE  211 (280)
Q Consensus       133 slG~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~  211 (280)
                      ||||++|+|++ |..||.+.........+....                              ........++.+.+++.
T Consensus       237 slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~li~  286 (314)
T 2ivs_A          237 SFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGH------------------------------RMERPDNCSEEMYRLML  286 (314)
T ss_dssp             HHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC------------------------------CCCCCTTCCHHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCC------------------------------cCCCCccCCHHHHHHHH
Confidence            99999999999 999998876544443332210                              11223467899999999


Q ss_pred             HhcccCCCCCCCHHHHhcC
Q 023568          212 KMLVFDPNKRITVEEALRH  230 (280)
Q Consensus       212 ~~L~~dp~~Rpt~~ell~h  230 (280)
                      +||+.||.+|||+++++++
T Consensus       287 ~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          287 QCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             HHTCSSGGGSCCHHHHHHH
T ss_pred             HHccCChhhCcCHHHHHHH
Confidence            9999999999999999874

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.1e-40  Score=286.38  Aligned_cols=206  Identities=16%  Similarity=0.140  Sum_probs=160.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++..... +....|+||||++++|.+++... +.+++.++..++.||+.||+|||+.||+||||||+||
T Consensus       105 l~h~~iv~~~~~~~~~~~-~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Ni  183 (364)
T 3op5_A          105 LKYLGVPKYWGSGLHDKN-GKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNL  183 (364)
T ss_dssp             CSCCCSCCEEEEEEEEET-TEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred             ccCCCCCeEEeeeeeccC-CcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHE
Confidence            579999999999987521 12568999999977999999765 6899999999999999999999999999999999999


Q ss_pred             EEc--CCCCeEEeecccccccCCCCc--------cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 023568           80 LLN--ASCDLKIGDFGLARTTSETDF--------MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFP  149 (280)
Q Consensus        80 li~--~~~~~kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~  149 (280)
                      |++  .++.++|+|||+++.......        .....||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.
T Consensus       184 ll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~Pf~  262 (364)
T 3op5_A          184 LLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG-VAPSRRGDLEILGYCMIQWLTGHLPWE  262 (364)
T ss_dssp             EEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred             EEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            999  889999999999976543211        133458999999999987 678999999999999999999999998


Q ss_pred             CCCh-HHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 023568          150 GKDY-VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL  228 (280)
Q Consensus       150 ~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell  228 (280)
                      +... ..............            ........       +  .....++.+.+++..||+.||.+||++++++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~------------~~~~~~~~-------~--~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~  321 (364)
T 3op5_A          263 DNLKDPKYVRDSKIRYREN------------IASLMDKC-------F--PAANAPGEIAKYMETVKLLDYTEKPLYENLR  321 (364)
T ss_dssp             GGTTCHHHHHHHHHHHHHC------------HHHHHHHH-------S--CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHH
T ss_pred             ccccCHHHHHHHHHHhhhh------------HHHHHHHh-------c--ccccCHHHHHHHHHHHhcCCCCCCCCHHHHH
Confidence            6432 22222111110000            00000000       0  0135789999999999999999999999998


Q ss_pred             c
Q 023568          229 R  229 (280)
Q Consensus       229 ~  229 (280)
                      +
T Consensus       322 ~  322 (364)
T 3op5_A          322 D  322 (364)
T ss_dssp             H
T ss_pred             H
Confidence            6

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=5.3e-40  Score=273.94  Aligned_cols=192  Identities=25%  Similarity=0.411  Sum_probs=151.2

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||+++++++.+      +..|+||||+++ +|.+++... ..+++..+..++.|++.||.|||+.|++||||||+|
T Consensus        73 l~h~~iv~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N  146 (281)
T 1mp8_A           73 FDHPHIVKLIGVITE------NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARN  146 (281)
T ss_dssp             CCCTTBCCEEEEECS------SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             CCCCccceEEEEEcc------CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHH
Confidence            589999999999853      458999999985 999999764 479999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCc--cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDF--MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVH  155 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~~  155 (280)
                      |+++.++.++|+|||+++.......  .....+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||.+....+
T Consensus       147 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~  225 (281)
T 1mp8_A          147 VLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND  225 (281)
T ss_dssp             EEEEETTEEEECC-------------------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred             EEECCCCCEEECccccccccCcccccccccCCCcccccChhhccc-CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH
Confidence            9999999999999999987554322  233455778999999876 778899999999999999996 999998877655


Q ss_pred             HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          156 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       156 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      ....+....                              .....+..++.+.+++.+||+.||.+|||+.++++
T Consensus       226 ~~~~i~~~~------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  269 (281)
T 1mp8_A          226 VIGRIENGE------------------------------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA  269 (281)
T ss_dssp             HHHHHHTTC------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHcCC------------------------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            554443210                              11123467899999999999999999999999986

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-40  Score=280.29  Aligned_cols=193  Identities=25%  Similarity=0.382  Sum_probs=159.6

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEec-CC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYEL-MD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~-~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      +||||+++++++...     +..++|||+ +. ++|.+++.+.+.+++..+..++.|++.||.|||+.||+||||||+||
T Consensus        96 ~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni  170 (312)
T 2iwi_A           96 GHPGVIRLLDWFETQ-----EGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENI  170 (312)
T ss_dssp             CCSSBCCEEEEC----------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGE
T ss_pred             CCCCeeeEEEEEecC-----CeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhE
Confidence            799999999999887     679999999 55 69999998878899999999999999999999999999999999999


Q ss_pred             EEc-CCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLN-ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++ .++.++|+|||++....... .....++..|+|||.+.+....+.++|+||||+++|+|++|+.||.....     
T Consensus       171 l~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----  244 (312)
T 2iwi_A          171 LIDLRRGCAKLIDFGSGALLHDEP-YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-----  244 (312)
T ss_dssp             EEETTTTEEEECCCSSCEECCSSC-BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----
T ss_pred             EEeCCCCeEEEEEcchhhhcccCc-ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-----
Confidence            999 78999999999998765443 34567899999999987744455689999999999999999999965321     


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  237 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~  237 (280)
                       +..  .                             ........++.+.++|++||+.||.+|||++|+++||||+...
T Consensus       245 -~~~--~-----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~  291 (312)
T 2iwi_A          245 -ILE--A-----------------------------ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA  291 (312)
T ss_dssp             -HHH--T-----------------------------CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred             -Hhh--h-----------------------------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence             110  0                             0012235789999999999999999999999999999998754

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=3.2e-40  Score=281.12  Aligned_cols=193  Identities=23%  Similarity=0.323  Sum_probs=161.1

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHH
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ----------------QLTDDHCQYFLYQLLRGLKYV   64 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~----------------~l~~~~~~~i~~qil~~l~~L   64 (280)
                      +||||+++++++.+.     ...|+||||++ |+|.+++.+.+                .+++.++..++.||+.||.||
T Consensus        84 ~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L  158 (327)
T 1fvr_A           84 HHPNIINLLGACEHR-----GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL  158 (327)
T ss_dssp             CCTTBCCEEEEEEET-----TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHH
T ss_pred             CCCchhhhceeeeeC-----CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHH
Confidence            799999999999887     77999999997 59999997654                799999999999999999999


Q ss_pred             HhCCccccCCCCCceEEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-
Q 023568           65 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-  143 (280)
Q Consensus        65 H~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-  143 (280)
                      |++||+||||||+||+++.++.++|+|||+++............+++.|+|||.+.+ ..++.++|+|||||++|+|++ 
T Consensus       159 H~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~  237 (327)
T 1fvr_A          159 SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSL  237 (327)
T ss_dssp             HHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTT
T ss_pred             HhCCccCCCCccceEEEcCCCeEEEcccCcCccccccccccCCCCCccccChhhhcc-ccCCchhcchHHHHHHHHHHcC
Confidence            999999999999999999999999999999875443333344566888999999876 677899999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCC
Q 023568          144 REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT  223 (280)
Q Consensus       144 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt  223 (280)
                      |..||.+.........+....                              ........++.+.++|.+||+.||.+|||
T Consensus       238 g~~pf~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps  287 (327)
T 1fvr_A          238 GGTPYCGMTCAELYEKLPQGY------------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPS  287 (327)
T ss_dssp             SCCTTTTCCHHHHHHHGGGTC------------------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCC
T ss_pred             CCCCCCCCcHHHHHHHhhcCC------------------------------CCCCCCCCCHHHHHHHHHHccCChhhCcC
Confidence            999998887655444332210                              01122356899999999999999999999


Q ss_pred             HHHHhcC
Q 023568          224 VEEALRH  230 (280)
Q Consensus       224 ~~ell~h  230 (280)
                      +++++++
T Consensus       288 ~~ell~~  294 (327)
T 1fvr_A          288 FAQILVS  294 (327)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            9999984

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=7.7e-40  Score=284.06  Aligned_cols=193  Identities=22%  Similarity=0.384  Sum_probs=161.6

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      |+||||+++++++...     ..+|+||||++ |+|.++++.. ..+++.++..++.|++.||+|||++||+||||||+|
T Consensus       169 l~hpniv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~N  243 (377)
T 3cbl_A          169 YSHPNIVRLIGVCTQK-----QPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARN  243 (377)
T ss_dssp             CCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred             CCCCCEEEEEEEEecC-----CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHH
Confidence            5899999999999877     66999999997 6999999764 469999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCcc---ccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDFM---TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYV  154 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~  154 (280)
                      ||++.++.+||+|||+++........   ....++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+.+..
T Consensus       244 il~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~  322 (377)
T 3cbl_A          244 CLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNY-GRYSSESDVWSFGILLWETFSLGASPYPNLSNQ  322 (377)
T ss_dssp             EEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH
T ss_pred             EEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999865443211   22345778999999876 678899999999999999998 99999988765


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      .....+.....                              ...+...++.+.+++.+||+.||.+|||++++++
T Consensus       323 ~~~~~~~~~~~------------------------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          323 QTREFVEKGGR------------------------------LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             HHHHHHHTTCC------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHcCCC------------------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            55444332111                              1112346889999999999999999999999986

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=6.1e-40  Score=279.19  Aligned_cols=193  Identities=20%  Similarity=0.306  Sum_probs=159.3

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||+++++++..      ...++||||+. |+|.+++... +.+++..+..++.|++.||+|||+.||+||||||+|
T Consensus        72 l~h~~iv~~~~~~~~------~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~N  145 (325)
T 3kex_A           72 LDHAHIVRLLGLCPG------SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARN  145 (325)
T ss_dssp             CCCTTBCCEEEEECB------SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTT
T ss_pred             CCCCCcCeEEEEEcC------CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchhe
Confidence            589999999999864      45899999997 6999999764 579999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCC---ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYV  154 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~  154 (280)
                      |+++.++.++|+|||+++......   ......++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+....
T Consensus       146 il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~  224 (325)
T 3kex_A          146 VLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF-GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA  224 (325)
T ss_dssp             EEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT
T ss_pred             EEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhcc-CCCChhhHhHHhHHHHHHHHhCCCCCccccCHH
Confidence            999999999999999998754432   2234566789999999987 678999999999999999999 99999987655


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  230 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~h  230 (280)
                      .....+....                              ........+.++.+++.+||+.||.+|||+++++++
T Consensus       225 ~~~~~~~~~~------------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          225 EVPDLLEKGE------------------------------RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             HHHHHHHTTC------------------------------BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             HHHHHHHcCC------------------------------CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            5444433211                              011122457788999999999999999999999985

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.1e-40  Score=280.07  Aligned_cols=195  Identities=25%  Similarity=0.359  Sum_probs=161.5

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCC-----------------------CCCHHHHHHHHHHH
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ-----------------------QLTDDHCQYFLYQL   57 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~-----------------------~l~~~~~~~i~~qi   57 (280)
                      +||||+++++++...     +..|+||||++ |+|.+++....                       .+++..+..++.||
T Consensus       107 ~hp~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi  181 (344)
T 1rjb_A          107 SHENIVNLLGACTLS-----GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQV  181 (344)
T ss_dssp             CCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHH
T ss_pred             CCCCeeeEEEEEeeC-----CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHH
Confidence            799999999999987     66999999997 59999997643                       37999999999999


Q ss_pred             HHHHHHHHhCCccccCCCCCceEEcCCCCeEEeecccccccCCCC---ccccceeccccccccccccCCCCCcchhHHHH
Q 023568           58 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSV  134 (280)
Q Consensus        58 l~~l~~LH~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dvwsl  134 (280)
                      +.||.|||+.||+||||||+||+++.++.++|+|||++.......   ......+|+.|+|||.+.+ ..++.++|||||
T Consensus       182 ~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~sl  260 (344)
T 1rjb_A          182 AKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSY  260 (344)
T ss_dssp             HHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHH
T ss_pred             HHHHHHHHhCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc-CCCChhHhHHHH
Confidence            999999999999999999999999999999999999998654332   1234566889999999877 778999999999


Q ss_pred             HHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHh
Q 023568          135 GCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKM  213 (280)
Q Consensus       135 G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~  213 (280)
                      ||++|+|++ |..||.+.........+.....                             ........++.+.+++.+|
T Consensus       261 G~il~el~t~g~~p~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~l~~li~~~  311 (344)
T 1rjb_A          261 GILLWEIFSLGVNPYPGIPVDANFYKLIQNGF-----------------------------KMDQPFYATEEIYIIMQSC  311 (344)
T ss_dssp             HHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTC-----------------------------CCCCCTTCCHHHHHHHHHH
T ss_pred             HHHHHHHHcCCCCCcccCCcHHHHHHHHhcCC-----------------------------CCCCCCCCCHHHHHHHHHH
Confidence            999999998 9999988764433333222100                             0112235689999999999


Q ss_pred             cccCCCCCCCHHHHhcCc
Q 023568          214 LVFDPNKRITVEEALRHP  231 (280)
Q Consensus       214 L~~dp~~Rpt~~ell~hp  231 (280)
                      |+.||.+|||+++++++.
T Consensus       312 l~~dp~~Rps~~~l~~~l  329 (344)
T 1rjb_A          312 WAFDSRKRPSFPNLTSFL  329 (344)
T ss_dssp             TCSSGGGSCCHHHHHHHH
T ss_pred             cCCCchhCcCHHHHHHHH
Confidence            999999999999999854

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=9.1e-40  Score=279.83  Aligned_cols=193  Identities=21%  Similarity=0.326  Sum_probs=162.3

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcC------------------------CCCCHHHHHHHHH
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSD------------------------QQLTDDHCQYFLY   55 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~------------------------~~l~~~~~~~i~~   55 (280)
                      |+||||+++++++.+.     ...|+||||++| +|.+++...                        ..+++.++..++.
T Consensus       107 l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~  181 (343)
T 1luf_A          107 FDNPNIVKLLGVCAVG-----KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIAR  181 (343)
T ss_dssp             CCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHH
T ss_pred             CCCCCEEEEEEEEccC-----CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHH
Confidence            5899999999999887     679999999975 999999763                        5799999999999


Q ss_pred             HHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEeecccccccCCCC---ccccceeccccccccccccCCCCCcchhHH
Q 023568           56 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIW  132 (280)
Q Consensus        56 qil~~l~~LH~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dvw  132 (280)
                      ||+.||.|||++||+||||||+||+++.++.++|+|||++.......   ......+++.|+|||.+.+ ..++.++|+|
T Consensus       182 qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~  260 (343)
T 1luf_A          182 QVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVW  260 (343)
T ss_dssp             HHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHH
T ss_pred             HHHHHHHHHHhCCeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhcc-CCcCcccccH
Confidence            99999999999999999999999999999999999999997644321   2234567889999999887 6789999999


Q ss_pred             HHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHH
Q 023568          133 SVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLE  211 (280)
Q Consensus       133 slG~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~  211 (280)
                      |||+++|+|++ |..||.+.........+...                              .........++.+.++++
T Consensus       261 slG~il~el~t~g~~p~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~l~~li~  310 (343)
T 1luf_A          261 AYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDG------------------------------NILACPENCPLELYNLMR  310 (343)
T ss_dssp             HHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT------------------------------CCCCCCTTCCHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCcCCCCChHHHHHHHhCC------------------------------CcCCCCCCCCHHHHHHHH
Confidence            99999999999 99999988766555444321                              011122357889999999


Q ss_pred             HhcccCCCCCCCHHHHhc
Q 023568          212 KMLVFDPNKRITVEEALR  229 (280)
Q Consensus       212 ~~L~~dp~~Rpt~~ell~  229 (280)
                      +||+.||.+|||+.++++
T Consensus       311 ~~l~~~p~~Rps~~~~~~  328 (343)
T 1luf_A          311 LCWSKLPADRPSFCSIHR  328 (343)
T ss_dssp             HHTCSSGGGSCCHHHHHH
T ss_pred             HHcccCcccCCCHHHHHH
Confidence            999999999999999987

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.3e-39  Score=271.93  Aligned_cols=196  Identities=13%  Similarity=0.129  Sum_probs=162.0

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      +|+||+++++++...     ...|+||||++++|.+++... ..+++.++..++.|++.||+|||++||+||||||+||+
T Consensus        64 ~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl  138 (298)
T 1csn_A           64 GCTGIPNVYYFGQEG-----LHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFL  138 (298)
T ss_dssp             TCTTCCCEEEEEEET-----TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEE
T ss_pred             cCCCCCeEEeecCCC-----ceeEEEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEE
Confidence            699999999999877     779999999988999999864 46999999999999999999999999999999999999


Q ss_pred             EcCCCC-----eEEeecccccccCCCC--------ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 023568           81 LNASCD-----LKIGDFGLARTTSETD--------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL  147 (280)
Q Consensus        81 i~~~~~-----~kl~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~p  147 (280)
                      ++.++.     ++|+|||++.......        ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.|
T Consensus       139 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p  217 (298)
T 1csn_A          139 IGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLP  217 (298)
T ss_dssp             ECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred             eccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHcCCCC
Confidence            987776     9999999998654432        1345678999999999877 7789999999999999999999999


Q ss_pred             CCCCCh---HHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCH
Q 023568          148 FPGKDY---VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV  224 (280)
Q Consensus       148 f~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~  224 (280)
                      |.+.+.   ......+.....                          ........+.+++.+.+++.+||+.||.+|||+
T Consensus       218 f~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~  271 (298)
T 1csn_A          218 WQGLKAATNKQKYERIGEKKQ--------------------------STPLRELCAGFPEEFYKYMHYARNLAFDATPDY  271 (298)
T ss_dssp             TSSCCSCCHHHHHHHHHHHHH--------------------------HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCH
T ss_pred             cchhhccccHHHHHHHHhhcc--------------------------CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCH
Confidence            988542   233333222111                          111122234678999999999999999999999


Q ss_pred             HHHhc
Q 023568          225 EEALR  229 (280)
Q Consensus       225 ~ell~  229 (280)
                      +++++
T Consensus       272 ~~l~~  276 (298)
T 1csn_A          272 DYLQG  276 (298)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99987

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.6e-39  Score=274.73  Aligned_cols=194  Identities=24%  Similarity=0.344  Sum_probs=162.0

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCC------------------CCCHHHHHHHHHHHHHHHH
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ------------------QLTDDHCQYFLYQLLRGLK   62 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~------------------~l~~~~~~~i~~qil~~l~   62 (280)
                      +||||+++++++.+.     ...++||||+++ +|.+++....                  .+++.++..++.|++.||.
T Consensus        85 ~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~  159 (313)
T 1t46_A           85 NHMNIVNLLGACTIG-----GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMA  159 (313)
T ss_dssp             CCTTBCCEEEEECSS-----SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHH
T ss_pred             cCCCeeeEEEEEecC-----CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHH
Confidence            799999999999887     669999999975 9999997643                  4899999999999999999


Q ss_pred             HHHhCCccccCCCCCceEEcCCCCeEEeecccccccCCCCc---cccceeccccccccccccCCCCCcchhHHHHHHHHH
Q 023568           63 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG  139 (280)
Q Consensus        63 ~LH~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~  139 (280)
                      |||++|++||||||+||+++.++.++|+|||++........   .....+++.|+|||.+.+ ..++.++|+||||+++|
T Consensus       160 ~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~  238 (313)
T 1t46_A          160 FLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLW  238 (313)
T ss_dssp             HHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHH
T ss_pred             HHHHCCeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcC-CCCChHHHHHHHHHHHH
Confidence            99999999999999999999999999999999986554422   234567889999999877 77899999999999999


Q ss_pred             HHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCC
Q 023568          140 EIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDP  218 (280)
Q Consensus       140 ~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp  218 (280)
                      +|++ |..||.+.........+......                             .......++.+.+++++||+.||
T Consensus       239 ellt~g~~p~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~dp  289 (313)
T 1t46_A          239 ELFSLGSSPYPGMPVDSKFYKMIKEGFR-----------------------------MLSPEHAPAEMYDIMKTCWDADP  289 (313)
T ss_dssp             HHHTTTCCSSTTCCSSHHHHHHHHHTCC-----------------------------CCCCTTSCHHHHHHHHHHTCSSG
T ss_pred             HHHhCCCCCCCcccchhHHHHHhccCCC-----------------------------CCCcccCCHHHHHHHHHHcCCCc
Confidence            9998 99999887644433333221110                             11123568899999999999999


Q ss_pred             CCCCCHHHHhcC
Q 023568          219 NKRITVEEALRH  230 (280)
Q Consensus       219 ~~Rpt~~ell~h  230 (280)
                      .+|||++|++++
T Consensus       290 ~~Rps~~ell~~  301 (313)
T 1t46_A          290 LKRPTFKQIVQL  301 (313)
T ss_dssp             GGSCCHHHHHHH
T ss_pred             hhCcCHHHHHHH
Confidence            999999999873

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=5.1e-40  Score=277.80  Aligned_cols=201  Identities=25%  Similarity=0.395  Sum_probs=161.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      |+||||+++++++.+.     ...++||||++| +|.+++.. .+.+++.++..++.|++.||+|||+.||+||||||+|
T Consensus        64 l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~N  138 (310)
T 3s95_A           64 LEHPNVLKFIGVLYKD-----KRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHN  138 (310)
T ss_dssp             CCCTTBCCEEEEEEET-----TEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTS
T ss_pred             CCCcCcccEEEEEecC-----CeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCe
Confidence            5899999999999987     679999999975 99999986 5789999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCcc---------------ccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDFM---------------TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT  143 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~~---------------~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~  143 (280)
                      |+++.++.++|+|||+++........               ....||+.|+|||.+.+ ..++.++||||||+++|+|++
T Consensus       139 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~  217 (310)
T 3s95_A          139 CLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIG  217 (310)
T ss_dssp             EEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHH
T ss_pred             EEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhc
Confidence            99999999999999999765433211               14578999999999987 788999999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCC
Q 023568          144 REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT  223 (280)
Q Consensus       144 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt  223 (280)
                      |..||........              .    ..........          ....+..++.+.+++.+||+.||.+|||
T Consensus       218 g~~~~~~~~~~~~--------------~----~~~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dP~~Rps  269 (310)
T 3s95_A          218 RVNADPDYLPRTM--------------D----FGLNVRGFLD----------RYCPPNCPPSFFPITVRCCDLDPEKRPS  269 (310)
T ss_dssp             TCCSSTTTSCBCT--------------T----SSBCHHHHHH----------HTCCTTCCTTHHHHHHHHTCSSGGGSCC
T ss_pred             CCCCCcchhhhHH--------------H----Hhhhhhcccc----------ccCCCCCCHHHHHHHHHHccCChhhCcC
Confidence            9998876421000              0    0000011110          1123467889999999999999999999


Q ss_pred             HHHHhcCcccccCc
Q 023568          224 VEEALRHPYLQSLH  237 (280)
Q Consensus       224 ~~ell~hp~~~~~~  237 (280)
                      ++++++  +++.+.
T Consensus       270 ~~~l~~--~L~~l~  281 (310)
T 3s95_A          270 FVKLEH--WLETLR  281 (310)
T ss_dssp             HHHHHH--HHHHHH
T ss_pred             HHHHHH--HHHHHH
Confidence            999987  665543

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.3e-39  Score=277.67  Aligned_cols=195  Identities=17%  Similarity=0.193  Sum_probs=159.6

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      +||||+++++++...     ...|+||||++++|.+++.. .+.+++.++..++.|++.||+|||+.||+||||||+||+
T Consensus        63 ~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nil  137 (330)
T 2izr_A           63 SGDGIPQVYYFGPCG-----KYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFL  137 (330)
T ss_dssp             SCTTSCCEEEEEEET-----TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred             CCCCCCEEEEEEecC-----CccEEEEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHee
Confidence            799999999999987     77999999998899999976 478999999999999999999999999999999999999


Q ss_pred             EcCCCC-----eEEeecccccccCCCCc--------cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 023568           81 LNASCD-----LKIGDFGLARTTSETDF--------MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL  147 (280)
Q Consensus        81 i~~~~~-----~kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~p  147 (280)
                      ++.++.     ++|+|||+++.......        .....||+.|+|||++.+ ..++.++|+|||||++|+|++|..|
T Consensus       138 l~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~P  216 (330)
T 2izr_A          138 IGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLG-KEQSRRDDLEALGHMFMYFLRGSLP  216 (330)
T ss_dssp             ECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred             eccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcC-CCCCchhHHHHHHHHHHHHhcCCCC
Confidence            998887     99999999986543321        245678999999999987 7789999999999999999999999


Q ss_pred             CCCCChH---HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCH
Q 023568          148 FPGKDYV---HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV  224 (280)
Q Consensus       148 f~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~  224 (280)
                      |.+.+..   .....+.......+.                          .......+ .+.+++.+||+.||.+||++
T Consensus       217 f~~~~~~~~~~~~~~i~~~~~~~~~--------------------------~~~~~~~p-~~~~li~~~l~~~p~~RP~~  269 (330)
T 2izr_A          217 WQGLKADTLKERYQKIGDTKRATPI--------------------------EVLCENFP-EMATYLRYVRRLDFFEKPDY  269 (330)
T ss_dssp             TTTCCCSSHHHHHHHHHHHHHHSCH--------------------------HHHTTTCH-HHHHHHHHHHHCCTTCCCCH
T ss_pred             ccccccccHHHHHHHHHhhhccCCH--------------------------HHHhccCh-HHHHHHHHHHhCCCCCCCCH
Confidence            9885432   333333221100000                          01111234 89999999999999999999


Q ss_pred             HHHhc
Q 023568          225 EEALR  229 (280)
Q Consensus       225 ~ell~  229 (280)
                      +++++
T Consensus       270 ~~l~~  274 (330)
T 2izr_A          270 DYLRK  274 (330)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            98876

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=5.3e-39  Score=266.01  Aligned_cols=193  Identities=17%  Similarity=0.247  Sum_probs=160.2

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSAS--VLHRDLK   75 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~--i~H~dik   75 (280)
                      ++||||+++++++.+...   ...++||||++ |+|.+++...+  .+++.++..++.|++.||+|||+.|  ++|||||
T Consensus        64 l~h~~iv~~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dik  140 (271)
T 3kmu_A           64 FSHPNVLPVLGACQSPPA---PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALN  140 (271)
T ss_dssp             CSCTTEECEEEEECTTTS---SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCS
T ss_pred             cCCCchhheEEEEccCCC---CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCc
Confidence            579999999999987633   56899999998 59999998765  4899999999999999999999999  9999999


Q ss_pred             CCceEEcCCCCeEEeecccccccCCCCccccceeccccccccccccCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 023568           76 PSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCT--EYTAAIDIWSVGCILGEIMTREPLFPGKDY  153 (280)
Q Consensus        76 ~~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~~DvwslG~~l~~ll~g~~pf~~~~~  153 (280)
                      |+||+++.++.++++|||++.....    ....+|+.|+|||.+.+..  .++.++|||||||++|+|++|+.||.+.+.
T Consensus       141 p~Nil~~~~~~~~l~~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~  216 (271)
T 3kmu_A          141 SRSVMIDEDMTARISMADVKFSFQS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN  216 (271)
T ss_dssp             GGGEEECTTSCEEEEGGGSCCTTSC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH
T ss_pred             cceEEEcCCcceeEEeccceeeecc----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh
Confidence            9999999999999999888655332    3456789999999987622  233479999999999999999999998876


Q ss_pred             HHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          154 VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       154 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      ......+.....                             .+...+..++.+.+++.+||+.||.+|||++++++
T Consensus       217 ~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          217 MEIGMKVALEGL-----------------------------RPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             HHHHHHHHHSCC-----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHhcCC-----------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            665544433111                             11223467999999999999999999999999986

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.6e-39  Score=267.53  Aligned_cols=194  Identities=19%  Similarity=0.334  Sum_probs=163.5

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||+++++++.+.     ...|+||||++ ++|.+++.+. +.+++..+..++.|++.||.|||+.|++||||||+|
T Consensus        60 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~N  134 (267)
T 3t9t_A           60 LSHPKLVQLYGVCLEQ-----APICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARN  134 (267)
T ss_dssp             CCCTTBCCEEEEECSS-----SSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGG
T ss_pred             CCCCCEeeEEEEEccC-----CCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchhe
Confidence            5899999999999887     66999999997 5999999764 569999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCC--ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVH  155 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~~  155 (280)
                      |+++.++.++|+|||.+.......  ......++..|+|||++.+ ..++.++|+||||+++|+|++ |..||.+.+...
T Consensus       135 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~  213 (267)
T 3t9t_A          135 CLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE  213 (267)
T ss_dssp             EEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred             EEECCCCCEEEcccccccccccccccccccccccccccChhhhcC-CCccchhchhhhHHHHHHHhccCCCCCCCCCHHH
Confidence            999999999999999988654331  1233456788999999876 678899999999999999999 899999887666


Q ss_pred             HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 023568          156 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  230 (280)
Q Consensus       156 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~h  230 (280)
                      ....+.....                              .......++.+.+++.+||+.||.+|||+++++++
T Consensus       214 ~~~~i~~~~~------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          214 VVEDISTGFR------------------------------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             HHHHHHTTCC------------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhcCCc------------------------------CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            5555433110                              01122468899999999999999999999999873

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2.3e-39  Score=280.58  Aligned_cols=193  Identities=24%  Similarity=0.372  Sum_probs=152.0

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      |+||||+++++++...     ...|+||||++ |+|.+++.+. ..+++.++..++.|++.||+|||+.||+||||||+|
T Consensus       103 l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N  177 (373)
T 2qol_A          103 FDHPNIIRLEGVVTKS-----KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARN  177 (373)
T ss_dssp             CCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             CCCCCCCeEEEEEeeC-----CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcce
Confidence            5899999999999887     67999999996 6999999765 479999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCc----cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDF----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDY  153 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~  153 (280)
                      |+++.++.+||+|||+++.......    .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+.
T Consensus       178 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~  256 (373)
T 2qol_A          178 ILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY-RKFTSASDVWSYGIVLWEVMSYGERPYWEMSN  256 (373)
T ss_dssp             EEECTTCCEEECCC----------------------CTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH
T ss_pred             EEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhcc-CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            9999999999999999986543321    122344678999999987 778999999999999999998 9999988876


Q ss_pred             HHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          154 VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       154 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      ......+.....                              .......+..+.+++.+||+.||.+|||++++++
T Consensus       257 ~~~~~~i~~~~~------------------------------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          257 QDVIKAVDEGYR------------------------------LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             HHHHHHHHTTEE------------------------------CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHcCCC------------------------------CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence            655544432111                              1112256889999999999999999999999886

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=9.6e-40  Score=273.24  Aligned_cols=190  Identities=17%  Similarity=0.275  Sum_probs=157.0

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQ-LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~-l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||+++++++.+.     ...|+||||++ |+|.+++.+.+. +++..+..++.|++.||.|||++||+||||||+|
T Consensus        69 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~N  143 (289)
T 4fvq_A           69 LSHKHLVLNYGVCVCG-----DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKN  143 (289)
T ss_dssp             SCCTTBCCEEEEECCT-----TCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred             CCCCCEeEEEEEEEeC-----CCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcce
Confidence            5899999999999987     66899999998 599999987654 9999999999999999999999999999999999


Q ss_pred             eEEcCCCC--------eEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhC-CCCCC
Q 023568           79 LLLNASCD--------LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFP  149 (280)
Q Consensus        79 ili~~~~~--------~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g-~~pf~  149 (280)
                      |+++.++.        ++|+|||.+......   ....++..|+|||.+.+...++.++|||||||++|+|++| .+||.
T Consensus       144 Ill~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~  220 (289)
T 4fvq_A          144 ILLIREEDRKTGNPPFIKLSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLS  220 (289)
T ss_dssp             EEEEECCBGGGTBCCEEEECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             EEEecCCcccccccceeeeccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcc
Confidence            99998887        999999998765432   2345788999999998756789999999999999999995 55665


Q ss_pred             CCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          150 GKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       150 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      ..+..........                                ........++.+.+++++||+.||.+|||++++++
T Consensus       221 ~~~~~~~~~~~~~--------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  268 (289)
T 4fvq_A          221 ALDSQRKLQFYED--------------------------------RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIR  268 (289)
T ss_dssp             TSCHHHHHHHHHT--------------------------------TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ccchHHHHHHhhc--------------------------------cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            5554333322211                                01112245778999999999999999999999998


Q ss_pred             C
Q 023568          230 H  230 (280)
Q Consensus       230 h  230 (280)
                      +
T Consensus       269 ~  269 (289)
T 4fvq_A          269 D  269 (289)
T ss_dssp             H
T ss_pred             H
Confidence            3

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=3e-39  Score=270.06  Aligned_cols=193  Identities=23%  Similarity=0.391  Sum_probs=163.5

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      |+||||+++++++.+.     ...|+||||++ ++|.+++...  ..+++..+..++.|++.||.|||++|++||||||+
T Consensus        66 l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~  140 (288)
T 3kfa_A           66 IKHPNLVQLLGVCTRE-----PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR  140 (288)
T ss_dssp             CCCTTBCCEEEEECSS-----SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGG
T ss_pred             CCCCCEeeEEEEEccC-----CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcc
Confidence            5899999999999887     67999999998 5999999763  45999999999999999999999999999999999


Q ss_pred             ceEEcCCCCeEEeecccccccCCCC--ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023568           78 NLLLNASCDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYV  154 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~  154 (280)
                      ||+++.++.++|+|||.+.......  ......+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||.+.+..
T Consensus       141 Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~  219 (288)
T 3kfa_A          141 NCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS  219 (288)
T ss_dssp             GEEECGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred             eEEEcCCCCEEEccCccceeccCCccccccCCccccCcCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999998765432  2234556788999999977 678999999999999999999 99999887755


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      .....+.....                              .......++.+.+++++||..||.+|||++++++
T Consensus       220 ~~~~~~~~~~~------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          220 QVYELLEKDYR------------------------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             GHHHHHHTTCC------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhccCC------------------------------CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence            54444332111                              1122357899999999999999999999999986

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=3.6e-39  Score=272.87  Aligned_cols=199  Identities=20%  Similarity=0.278  Sum_probs=155.2

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHH------cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIR------SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRD   73 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~------~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~d   73 (280)
                      |+||||+++++++.+....+....|+||||+. |+|.+++.      ..+.+++..+..++.|++.||.|||+.||+|||
T Consensus        93 l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~d  172 (313)
T 3brb_A           93 FSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRD  172 (313)
T ss_dssp             CCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCC
T ss_pred             CCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence            58999999999998875433346799999998 59999984      335699999999999999999999999999999


Q ss_pred             CCCCceEEcCCCCeEEeecccccccCCCC---ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 023568           74 LKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFP  149 (280)
Q Consensus        74 ik~~Nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~  149 (280)
                      |||+||+++.++.++|+|||++.......   ......+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||.
T Consensus       173 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~  251 (313)
T 3brb_A          173 LAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGMTPYP  251 (313)
T ss_dssp             CSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             CCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcC-CCccchhhhHHHHHHHHHHHhcCCCCCc
Confidence            99999999999999999999997654332   1233456788999999977 778999999999999999999 999998


Q ss_pred             CCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          150 GKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       150 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      +.........+....                              ........++.+.++|.+||..||.+|||++++++
T Consensus       252 ~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  301 (313)
T 3brb_A          252 GVQNHEMYDYLLHGH------------------------------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRL  301 (313)
T ss_dssp             TCCGGGHHHHHHTTC------------------------------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             cCCHHHHHHHHHcCC------------------------------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            876554444332211                              11122357899999999999999999999999987


Q ss_pred             C
Q 023568          230 H  230 (280)
Q Consensus       230 h  230 (280)
                      +
T Consensus       302 ~  302 (313)
T 3brb_A          302 Q  302 (313)
T ss_dssp             H
T ss_pred             H
Confidence            4

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.8e-39  Score=276.52  Aligned_cols=193  Identities=22%  Similarity=0.316  Sum_probs=159.9

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||+++++++.+.      ..++||||+. |+|.+++.. .+.+++..+..++.|++.||.|||+.||+||||||+|
T Consensus        74 l~h~~iv~~~~~~~~~------~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~N  147 (327)
T 3poz_A           74 VDNPHVCRLLGICLTS------TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARN  147 (327)
T ss_dssp             CCBTTBCCEEEEEESS------SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             CCCCCEeEEEEEEecC------CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChhe
Confidence            5899999999999865      3788999997 699999876 4679999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCc---cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYV  154 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~  154 (280)
                      |+++.++.+||+|||+++.......   .....+|..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....
T Consensus       148 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~  226 (327)
T 3poz_A          148 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS  226 (327)
T ss_dssp             EEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred             EEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhcc-CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH
Confidence            9999999999999999986544322   223455789999999987 788999999999999999999 99999887654


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  230 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~h  230 (280)
                      .....+.....                              ....+..+..+.+++.+||+.||.+|||+.+++++
T Consensus       227 ~~~~~~~~~~~------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          227 EISSILEKGER------------------------------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             GHHHHHHTTCC------------------------------CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCCC------------------------------CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            44433322111                              11223568899999999999999999999999975

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.5e-39  Score=271.98  Aligned_cols=195  Identities=24%  Similarity=0.365  Sum_probs=153.2

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+||||+++++++...     +..|+||||++| +|.+++.+.+.+++.++..++.|++.||.|||+.||+||||||+||
T Consensus        91 l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NI  165 (309)
T 2h34_A           91 LQEPHVVPIHDFGEID-----GQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENI  165 (309)
T ss_dssp             CCCTTBCCEEEEEEET-----TEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred             cCCCCeeEEEEEEeeC-----CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHE
Confidence            5899999999999887     779999999985 9999998878899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCC--ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  157 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~  157 (280)
                      +++.++.++|+|||++.......  ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+.....
T Consensus       166 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  244 (309)
T 2h34_A          166 LVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQGDQLSVMG  244 (309)
T ss_dssp             EECTTSCEEECSCCC----------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHH
T ss_pred             EEcCCCCEEEecCccCccccccccccccccCCCcCccCHHHHcC-CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHH
Confidence            99999999999999987654432  2335578999999999877 77888999999999999999999999886544222


Q ss_pred             HHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCC-CHHHHhc
Q 023568          158 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-TVEEALR  229 (280)
Q Consensus       158 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rp-t~~ell~  229 (280)
                      ..+..   .                         ........+.+++.+.++|.+||+.||.+|| |++++++
T Consensus       245 ~~~~~---~-------------------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          245 AHINQ---A-------------------------IPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             HHHHS---C-------------------------CCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             HHhcc---C-------------------------CCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence            22211   0                         0011123356789999999999999999999 8888876

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8e-39  Score=273.20  Aligned_cols=194  Identities=22%  Similarity=0.357  Sum_probs=157.5

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      |+||||+++++++...     ...|+||||++| +|.+++... +.+++.++..++.|++.||.|||+.||+||||||+|
T Consensus       103 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~N  177 (333)
T 1mqb_A          103 FSHHNIIRLEGVISKY-----KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARN  177 (333)
T ss_dssp             CCCTTBCCEEEEECSS-----SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             CCCCCCCcEEEEEecC-----CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhe
Confidence            5899999999999887     679999999985 999999764 679999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCc----cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDF----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDY  153 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~  153 (280)
                      |+++.++.++|+|||++........    .....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+...
T Consensus       178 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~  256 (333)
T 1mqb_A          178 ILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSN  256 (333)
T ss_dssp             EEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred             EEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhccc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCH
Confidence            9999999999999999986543311    122345778999999876 778899999999999999998 9999988876


Q ss_pred             HHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 023568          154 VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  230 (280)
Q Consensus       154 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~h  230 (280)
                      ......+.....                              .......++.+.+++++||+.||.+|||+.+++++
T Consensus       257 ~~~~~~~~~~~~------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          257 HEVMKAINDGFR------------------------------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             HHHHHHHHTTCC------------------------------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             HHHHHHHHCCCc------------------------------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            655544432111                              11123568899999999999999999999999873

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=6.2e-39  Score=272.39  Aligned_cols=194  Identities=24%  Similarity=0.388  Sum_probs=163.5

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD----------QQLTDDHCQYFLYQLLRGLKYVHSASV   69 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~----------~~l~~~~~~~i~~qil~~l~~LH~~~i   69 (280)
                      ++||||+++++++.+.     ...|+||||++ |+|.+++...          ..+++..+..++.|++.||.|||++||
T Consensus        85 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i  159 (322)
T 1p4o_A           85 FNCHHVVRLLGVVSQG-----QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKF  159 (322)
T ss_dssp             CCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             cCCCCEeeeEEEEccC-----CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCC
Confidence            5899999999999887     67999999997 5999998642          457999999999999999999999999


Q ss_pred             cccCCCCCceEEcCCCCeEEeecccccccCCCC---ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CC
Q 023568           70 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-RE  145 (280)
Q Consensus        70 ~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~  145 (280)
                      +||||||+||+++.++.++|+|||++.......   ......+++.|+|||.+.+ ..++.++|+||||+++|+|++ |.
T Consensus       160 ~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~  238 (322)
T 1p4o_A          160 VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAE  238 (322)
T ss_dssp             BCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSC
T ss_pred             ccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhcc-CCCCchhhHHHHHHHHHHHHhcCC
Confidence            999999999999999999999999997654332   1234566889999999877 778999999999999999999 89


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 023568          146 PLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVE  225 (280)
Q Consensus       146 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~  225 (280)
                      .||.+.+.......+...                              .........++.+.+++++||+.||.+|||+.
T Consensus       239 ~p~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  288 (322)
T 1p4o_A          239 QPYQGLSNEQVLRFVMEG------------------------------GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFL  288 (322)
T ss_dssp             CTTTTSCHHHHHHHHHTT------------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CccccCCHHHHHHHHHcC------------------------------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHH
Confidence            999888766555444321                              01112236789999999999999999999999


Q ss_pred             HHhcC
Q 023568          226 EALRH  230 (280)
Q Consensus       226 ell~h  230 (280)
                      |++++
T Consensus       289 e~l~~  293 (322)
T 1p4o_A          289 EIISS  293 (322)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99985

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=5.2e-40  Score=279.29  Aligned_cols=216  Identities=21%  Similarity=0.291  Sum_probs=157.5

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC----------Cc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA----------SV   69 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~----------~i   69 (280)
                      |+||||+++++++..... ....+|+||||++ |+|.+++.. ..+++..+..++.|++.||+|||+.          ||
T Consensus        75 l~hpniv~~~~~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~i  152 (322)
T 3soc_A           75 MKHENILQFIGAEKRGTS-VDVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAI  152 (322)
T ss_dssp             CCCTTBCCEEEEEEEECS-SSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEE
T ss_pred             CCCCCchhhcceeccCCC-CCceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCE
Confidence            589999999999987532 1145899999997 599999976 5699999999999999999999999          99


Q ss_pred             cccCCCCCceEEcCCCCeEEeecccccccCCCC---ccccceeccccccccccccC----CCCCcchhHHHHHHHHHHHH
Q 023568           70 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNC----TEYTAAIDIWSVGCILGEIM  142 (280)
Q Consensus        70 ~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~----~~~~~~~DvwslG~~l~~ll  142 (280)
                      +||||||+||+++.++.+||+|||+++......   ......||+.|+|||++.+.    ..++.++|||||||++|+|+
T Consensus       153 vH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~  232 (322)
T 3soc_A          153 SHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELA  232 (322)
T ss_dssp             ECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHH
Confidence            999999999999999999999999997654332   23346789999999998763    23456789999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhC-CccccccccccCC--CCCHHHHHHHHHhcccCCC
Q 023568          143 TREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL-PRCRKQQFATRFP--NKSSGAVDLLEKMLVFDPN  219 (280)
Q Consensus       143 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~--~~~~~~~~ll~~~L~~dp~  219 (280)
                      +|+.||.+................+.           ........ ...........++  ..+..+.++|++||+.||+
T Consensus       233 tg~~pf~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~  301 (322)
T 3soc_A          233 SRCTAADGPVDEYMLPFEEEIGQHPS-----------LEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAE  301 (322)
T ss_dssp             TTBTTSSSCCCCCCCTTHHHHCSSCC-----------HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGG
T ss_pred             hCCCCCCCCcchhccchhhhhccCCc-----------hhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChh
Confidence            99999987542111111111111110           01111100 0001111111111  1245699999999999999


Q ss_pred             CCCCHHHHhc
Q 023568          220 KRITVEEALR  229 (280)
Q Consensus       220 ~Rpt~~ell~  229 (280)
                      +|||++|+++
T Consensus       302 ~Rps~~ell~  311 (322)
T 3soc_A          302 ARLSAGCVGE  311 (322)
T ss_dssp             GSCCHHHHHH
T ss_pred             hCcCHHHHHH
Confidence            9999999986

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=6.6e-39  Score=268.60  Aligned_cols=192  Identities=19%  Similarity=0.303  Sum_probs=160.9

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++..      ...|+||||+. ++|.+++.+.+.+++..+..++.|++.||.|||+.|++||||||+||
T Consensus        75 l~h~~i~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Ni  148 (291)
T 1xbb_A           75 LDNPYIVRMIGICEA------ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNV  148 (291)
T ss_dssp             CCCTTBCCEEEEEES------SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             CCCCCEEEEEEEECC------CCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceE
Confidence            589999999999943      45899999998 59999999888899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCc----cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDF----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYV  154 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~  154 (280)
                      +++.++.++|+|||++........    .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||.+.+..
T Consensus       149 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~  227 (291)
T 1xbb_A          149 LLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS  227 (291)
T ss_dssp             EEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred             EEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhcc-CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence            999999999999999986544321    122345688999999876 667889999999999999999 99999988765


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      .....+....                              .....+..++.+.+++++||+.||.+|||+.++++
T Consensus       228 ~~~~~~~~~~------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          228 EVTAMLEKGE------------------------------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             HHHHHHHTTC------------------------------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHcCC------------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            5544433210                              11122467899999999999999999999999986

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=9.6e-39  Score=267.42  Aligned_cols=198  Identities=22%  Similarity=0.324  Sum_probs=151.4

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||++++++...      ...++||||++ ++|.+++.. ...+++.++..++.|++.||.|||+.||+||||||+|
T Consensus        77 l~h~~iv~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~N  150 (289)
T 3og7_A           77 TRHVNILLFMGYSTA------PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNN  150 (289)
T ss_dssp             CCCTTBCCEEEEECS------SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             CCCCcEEEEEeeccC------CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccce
Confidence            589999999997543      45899999998 599999964 4679999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCC---Cccccceecccccccccccc--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 023568           79 LLLNASCDLKIGDFGLARTTSET---DFMTEYVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILGEIMTREPLFPGKDY  153 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~  153 (280)
                      |+++.++.++|+|||++......   .......||+.|+|||++..  ...++.++||||||+++|+|++|+.||.+...
T Consensus       151 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~  230 (289)
T 3og7_A          151 IFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN  230 (289)
T ss_dssp             EEEETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred             EEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch
Confidence            99999999999999998754432   22345678999999999862  25678899999999999999999999988766


Q ss_pred             HHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          154 VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       154 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      ......+.......+                         .........++.+.+++.+||+.||.+|||++++++
T Consensus       231 ~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          231 RDQIIEMVGRGSLSP-------------------------DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             HHHHHHHHHHTSCCC-------------------------CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhcccccCc-------------------------chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            555544433221111                         111223467899999999999999999999999986

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=4.9e-39  Score=285.43  Aligned_cols=192  Identities=25%  Similarity=0.409  Sum_probs=162.0

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      |+||||+++++++..      ..+|+||||+. |+|.++++..  ..+++..+..++.||+.||+|||++||+||||||+
T Consensus       240 l~h~~iv~l~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~  313 (454)
T 1qcf_A          240 LQHDKLVKLHAVVTK------EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAA  313 (454)
T ss_dssp             CCCTTBCCEEEEECS------SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGG
T ss_pred             CCCCCEeeEEEEEeC------CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHH
Confidence            689999999999863      45899999997 5999999754  37999999999999999999999999999999999


Q ss_pred             ceEEcCCCCeEEeecccccccCCCC--ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023568           78 NLLLNASCDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYV  154 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~  154 (280)
                      |||++.++.+||+|||+++......  ......++..|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+..
T Consensus       314 Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~  392 (454)
T 1qcf_A          314 NILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP  392 (454)
T ss_dssp             GEEECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             HEEECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhcc-CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999998754432  1223345778999999976 778999999999999999999 99999998877


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      +....+......                              ..+...++.+.++|.+||..||.+|||++++++
T Consensus       393 ~~~~~i~~~~~~------------------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          393 EVIRALERGYRM------------------------------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             HHHHHHHHTCCC------------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHcCCCC------------------------------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence            666655432111                              112356889999999999999999999999986

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=4.3e-39  Score=268.34  Aligned_cols=193  Identities=20%  Similarity=0.340  Sum_probs=158.1

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      |+||||+++++++.+.      ..|+||||+. ++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+|
T Consensus        70 l~h~~i~~~~~~~~~~------~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~N  143 (281)
T 3cc6_A           70 LDHPHIVKLIGIIEEE------PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRN  143 (281)
T ss_dssp             HCCTTBCCEEEEECSS------SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGG
T ss_pred             CCCCCcceEEEEEcCC------CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccce
Confidence            4799999999998754      3689999998 5999999754 569999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCc--cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDF--MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVH  155 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~~  155 (280)
                      |+++.++.++|+|||++........  .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||.......
T Consensus       144 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~  222 (281)
T 3cc6_A          144 ILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF-RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD  222 (281)
T ss_dssp             EEEEETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG
T ss_pred             EEECCCCcEEeCccCCCcccccccccccccCCCCcceeCchhhcc-CCCCchhccHHHHHHHHHHHhCCCCCcccCChHH
Confidence            9999999999999999986554321  233456788999999876 778899999999999999998 999998776555


Q ss_pred             HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 023568          156 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  230 (280)
Q Consensus       156 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~h  230 (280)
                      ....+.....                              .......++.+.+++.+||+.||.+|||++|++++
T Consensus       223 ~~~~~~~~~~------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          223 VIGVLEKGDR------------------------------LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             HHHHHHHTCC------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhcCCC------------------------------CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence            4444332111                              11123568899999999999999999999999874

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.4e-39  Score=273.16  Aligned_cols=192  Identities=22%  Similarity=0.317  Sum_probs=154.9

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||+++++++...      ..++|||++. |+|.+++.. .+.+++..+..++.|++.||.|||+.||+||||||+|
T Consensus        74 l~hp~iv~~~~~~~~~------~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~N  147 (327)
T 3lzb_A           74 VDNPHVCRLLGICLTS------TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARN  147 (327)
T ss_dssp             CCBTTBCCCCEEEESS------SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             CCCCCeeEEEEEEecC------CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHH
Confidence            5899999999999865      3788999997 599999976 4679999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCc---cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYV  154 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~  154 (280)
                      |+++.++.++|+|||+++.......   .....+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....
T Consensus       148 Il~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~  226 (327)
T 3lzb_A          148 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS  226 (327)
T ss_dssp             EEEEETTEEEECCTTC----------------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred             EEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcC-CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH
Confidence            9999999999999999986544321   233455778999999987 778999999999999999999 99999887655


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      .....+....                              .....+..+.++.+++++||+.||.+|||++|+++
T Consensus       227 ~~~~~~~~~~------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          227 EISSILEKGE------------------------------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             GHHHHHHTTC------------------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHcCC------------------------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            5444333211                              11122356889999999999999999999999996

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=3.5e-39  Score=274.65  Aligned_cols=199  Identities=22%  Similarity=0.306  Sum_probs=164.2

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC-------CCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-------QQLTDDHCQYFLYQLLRGLKYVHSASVLHR   72 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~   72 (280)
                      |+||||+++++++...     ...|+||||++ ++|.+++...       ..+++.++..++.|++.||.|||+.||+||
T Consensus        90 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~  164 (327)
T 2yfx_A           90 FNHQNIVRCIGVSLQS-----LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHR  164 (327)
T ss_dssp             CCCTTBCCEEEEECSS-----SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             CCCCCCCeEEEEEcCC-----CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecC
Confidence            5899999999999987     66899999996 6999999764       349999999999999999999999999999


Q ss_pred             CCCCCceEEcC---CCCeEEeecccccccCCC---CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CC
Q 023568           73 DLKPSNLLLNA---SCDLKIGDFGLARTTSET---DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-RE  145 (280)
Q Consensus        73 dik~~Nili~~---~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~  145 (280)
                      ||||+||+++.   +..++|+|||++......   .......+++.|+|||.+.+ ..++.++||||||+++|+|++ |.
T Consensus       165 dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~  243 (327)
T 2yfx_A          165 DIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGY  243 (327)
T ss_dssp             CCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             cCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcC-CCCCchhhHHHHHHHHHHHHcCCC
Confidence            99999999984   446999999998753322   12234567889999999877 678899999999999999998 99


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 023568          146 PLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVE  225 (280)
Q Consensus       146 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~  225 (280)
                      .||...........+.....                              .......++.+.++|.+||+.||.+|||++
T Consensus       244 ~p~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  293 (327)
T 2yfx_A          244 MPYPSKSNQEVLEFVTSGGR------------------------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFA  293 (327)
T ss_dssp             CSSTTCCHHHHHHHHHTTCC------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCCCcCHHHHHHHHhcCCC------------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHH
Confidence            99988876555544432110                              112235788999999999999999999999


Q ss_pred             HHhcCccccc
Q 023568          226 EALRHPYLQS  235 (280)
Q Consensus       226 ell~hp~~~~  235 (280)
                      +++++.|+..
T Consensus       294 ~ll~~l~~~~  303 (327)
T 2yfx_A          294 IILERIEYCT  303 (327)
T ss_dssp             HHHHHHHHHH
T ss_pred             HHHHHHHHHh
Confidence            9999988643

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.5e-39  Score=268.55  Aligned_cols=194  Identities=18%  Similarity=0.291  Sum_probs=162.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      |+||||+++++++..      ...|+||||+++ +|.+++.+. ..+++..+..++.|++.||.|||+.|++||||||+|
T Consensus        67 l~h~~i~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N  140 (287)
T 1u59_A           67 LDNPYIVRLIGVCQA------EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARN  140 (287)
T ss_dssp             CCCTTBCCEEEEEES------SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred             CCCCCEeEEEEEecC------CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchhe
Confidence            589999999999943      458999999985 999999643 569999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCc----cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDF----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDY  153 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~  153 (280)
                      |+++.++.++|+|||++........    .....+++.|+|||.+.+ ..++.++|+||||+++|+|++ |+.||.....
T Consensus       141 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~  219 (287)
T 1u59_A          141 VLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG  219 (287)
T ss_dssp             EEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT
T ss_pred             EEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence            9999999999999999986643321    223456789999999876 678899999999999999998 9999998876


Q ss_pred             HHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 023568          154 VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHP  231 (280)
Q Consensus       154 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp  231 (280)
                      ......+....                              .....+..++.+.++|.+||..||.+|||+++++++.
T Consensus       220 ~~~~~~i~~~~------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l  267 (287)
T 1u59_A          220 PEVMAFIEQGK------------------------------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM  267 (287)
T ss_dssp             HHHHHHHHTTC------------------------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHhcCC------------------------------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            65554443210                              1122346789999999999999999999999999865

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=6.1e-39  Score=284.47  Aligned_cols=192  Identities=23%  Similarity=0.363  Sum_probs=158.9

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      |+||||+++++++....    ..+|+||||+. |+|.+++.+.+  .+++..+..++.|++.||+|||++||+||||||+
T Consensus       243 l~h~niv~~~~~~~~~~----~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~  318 (450)
T 1k9a_A          243 LRHSNLVQLLGVIVEEK----GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAAR  318 (450)
T ss_dssp             CCCTTBCCEEEEEECTT----SCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred             ccCCCEEEEEEEEEcCC----CceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHh
Confidence            68999999999976652    36999999997 59999997644  3799999999999999999999999999999999


Q ss_pred             ceEEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 023568           78 NLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQ  156 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~~~  156 (280)
                      |||++.++.+||+|||+++.....  .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+.
T Consensus       319 Nill~~~~~~kl~DfG~a~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~  395 (450)
T 1k9a_A          319 NVLVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV  395 (450)
T ss_dssp             GEEECTTSCEEECCCTTCEECC--------CCCTTTSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH
T ss_pred             hEEECCCCCEEEeeCCCccccccc--ccCCCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            999999999999999999854432  223456788999999987 788999999999999999998 9999988765554


Q ss_pred             HHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       157 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      ...+.....                              ...+...++.+.++|++||+.||.+|||+.++++
T Consensus       396 ~~~i~~~~~------------------------------~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          396 VPRVEKGYK------------------------------MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             HHHHHTTCC------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHcCCC------------------------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            444332110                              1122357899999999999999999999999976

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=5.5e-40  Score=278.95  Aligned_cols=207  Identities=21%  Similarity=0.319  Sum_probs=159.4

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ----QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK   75 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~----~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik   75 (280)
                      ++||||+++++++...     +..|+||||++ |+|.+++....    .+++.++..++.|++.||.|||+.|++|||||
T Consensus        92 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlk  166 (321)
T 2qkw_B           92 CRHPHLVSLIGFCDER-----NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVK  166 (321)
T ss_dssp             CCCTTBCCEEEECCCT-----TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred             CCCCCEeeEEEEEcCC-----CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCC
Confidence            5899999999999877     67999999997 59999986532    59999999999999999999999999999999


Q ss_pred             CCceEEcCCCCeEEeecccccccCCC---CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 023568           76 PSNLLLNASCDLKIGDFGLARTTSET---DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD  152 (280)
Q Consensus        76 ~~Nili~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~  152 (280)
                      |+||+++.++.++|+|||+++.....   .......||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+..
T Consensus       167 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~p~~~~~  245 (321)
T 2qkw_B          167 SINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIK-GRLTEKSDVYSFGVVLFEVLCARSAIVQSL  245 (321)
T ss_dssp             STTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHH-CBCCTHHHHHHHHHHHHHHHHCCTTCSCSS
T ss_pred             HHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcC-CCCCcccchHhHHHHHHHHHhCCCcccccC
Confidence            99999999999999999999764432   22344568999999999877 678899999999999999999999997654


Q ss_pred             hHHHHHHHH---HHhCCCCcccccccCChhHHHHHHhCCcccccc-ccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 023568          153 YVHQLRLIT---ELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQ-FATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL  228 (280)
Q Consensus       153 ~~~~~~~i~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell  228 (280)
                      .........   ......                  .+....... .....+..+..+.+++.+||+.||++|||++|++
T Consensus       246 ~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell  307 (321)
T 2qkw_B          246 PREMVNLAEWAVESHNNG------------------QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL  307 (321)
T ss_dssp             SSSCCCHHHHTHHHHTTT------------------CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             cHHHHHHHHHhhhccccc------------------cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHH
Confidence            211110000   000000                  000000000 0111223467789999999999999999999999


Q ss_pred             cCc
Q 023568          229 RHP  231 (280)
Q Consensus       229 ~hp  231 (280)
                      ++.
T Consensus       308 ~~L  310 (321)
T 2qkw_B          308 WKL  310 (321)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            854

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1e-38  Score=272.60  Aligned_cols=193  Identities=27%  Similarity=0.455  Sum_probs=163.0

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHH
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ----------------QLTDDHCQYFLYQLLRGLKYV   64 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~----------------~l~~~~~~~i~~qil~~l~~L   64 (280)
                      +||||+++++++...     +.+|+||||++ |+|.+++...+                .+++.++..++.||+.||.||
T Consensus        99 ~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L  173 (334)
T 2pvf_A           99 KHKNIINLLGACTQD-----GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL  173 (334)
T ss_dssp             CCTTBCCEEEEECSS-----SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCEeeEEEEEccC-----CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHH
Confidence            799999999999887     67999999997 59999997643                389999999999999999999


Q ss_pred             HhCCccccCCCCCceEEcCCCCeEEeecccccccCCCCc---cccceeccccccccccccCCCCCcchhHHHHHHHHHHH
Q 023568           65 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI  141 (280)
Q Consensus        65 H~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l  141 (280)
                      |+.||+||||||+||+++.++.++|+|||++........   .....+++.|+|||++.+ ..++.++||||||+++|+|
T Consensus       174 H~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el  252 (334)
T 2pvf_A          174 ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEI  252 (334)
T ss_dssp             HHTTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHH
T ss_pred             HhCCeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcC-CCcChHHHHHHHHHHHHHH
Confidence            999999999999999999999999999999986554321   233456788999999877 6788999999999999999


Q ss_pred             Hh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCC
Q 023568          142 MT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNK  220 (280)
Q Consensus       142 l~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~  220 (280)
                      ++ |..||.+.........+.....                              .......++.+.+++++||+.||.+
T Consensus       253 lt~g~~p~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~l~~li~~~l~~dp~~  302 (334)
T 2pvf_A          253 FTLGGSPYPGIPVEELFKLLKEGHR------------------------------MDKPANCTNELYMMMRDCWHAVPSQ  302 (334)
T ss_dssp             HTTSCCSSTTCCHHHHHHHHHHTCC------------------------------CCCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred             HhCCCCCcCcCCHHHHHHHHhcCCC------------------------------CCCCccCCHHHHHHHHHHccCChhh
Confidence            99 9999998876555544433110                              1122357889999999999999999


Q ss_pred             CCCHHHHhcC
Q 023568          221 RITVEEALRH  230 (280)
Q Consensus       221 Rpt~~ell~h  230 (280)
                      |||++|++++
T Consensus       303 Rps~~ell~~  312 (334)
T 2pvf_A          303 RPTFKQLVED  312 (334)
T ss_dssp             SCCHHHHHHH
T ss_pred             CcCHHHHHHH
Confidence            9999999974

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.7e-39  Score=271.40  Aligned_cols=211  Identities=18%  Similarity=0.348  Sum_probs=156.6

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      |+||||+++++++.....   ..+++||||++ |+|.+++...+ .+++.++..++.|++.||+|||+.||+||||||+|
T Consensus        68 l~h~~iv~~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~N  144 (295)
T 3ugc_A           68 LQHDNIVKYKGVCYSAGR---RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRN  144 (295)
T ss_dssp             CCCTTBCCEEEEECHHHH---TSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             CCCCCEeeEEEEEecCCC---CceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhh
Confidence            589999999999865422   45899999996 59999997654 59999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCC----ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETD----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV  154 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~  154 (280)
                      |+++.++.++|+|||++.......    ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||......
T Consensus       145 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~  223 (295)
T 3ugc_A          145 ILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSPPAE  223 (295)
T ss_dssp             EEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH
T ss_pred             EEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcC-CCCChHHHHHHHHHHHHHHHhcccccCCChHH
Confidence            999999999999999998654432    1233456778999999987 67899999999999999999999988654211


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                           .....+.......      .........   ............++.+.+++++||+.||.+|||++|+++
T Consensus       224 -----~~~~~~~~~~~~~------~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          224 -----FMRMIGNDKQGQM------IVFHLIELL---KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             -----HHHHHCTTCCTHH------HHHHHHHHH---HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -----HHhhhcCccccch------hHHHHHHHH---hccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                 1111111111000      000000100   111112234467899999999999999999999999986

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=7.3e-39  Score=271.09  Aligned_cols=195  Identities=25%  Similarity=0.382  Sum_probs=160.4

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCC----------------CCHHHHHHHHHHHHHHHHHH
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQ----------------LTDDHCQYFLYQLLRGLKYV   64 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~----------------l~~~~~~~i~~qil~~l~~L   64 (280)
                      +||||+++++++....    ..+|+||||++ |+|.+++.....                +++..+..++.|++.||.||
T Consensus        89 ~hp~iv~~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~l  164 (316)
T 2xir_A           89 HHLNVVNLLGACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL  164 (316)
T ss_dssp             CCTTBCCEEEEECCTT----SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCeeeEEEEEecCC----CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHH
Confidence            6999999999987652    45899999998 599999986543                89999999999999999999


Q ss_pred             HhCCccccCCCCCceEEcCCCCeEEeecccccccCCCC---ccccceeccccccccccccCCCCCcchhHHHHHHHHHHH
Q 023568           65 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI  141 (280)
Q Consensus        65 H~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l  141 (280)
                      |+.||+||||||+||+++.++.++|+|||++.......   ......+++.|+|||++.+ ..++.++|+|||||++|+|
T Consensus       165 H~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l  243 (316)
T 2xir_A          165 ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEI  243 (316)
T ss_dssp             HHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHH
T ss_pred             HhCCcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcc-ccccchhHHHHHHHHHHHH
Confidence            99999999999999999999999999999998654332   1234567889999999877 7788999999999999999


Q ss_pred             Hh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCC
Q 023568          142 MT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNK  220 (280)
Q Consensus       142 l~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~  220 (280)
                      ++ |..||.+...............                             ........++.+.+++.+||+.||.+
T Consensus       244 ~t~g~~p~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~l~~li~~~l~~dp~~  294 (316)
T 2xir_A          244 FSLGASPYPGVKIDEEFCRRLKEGT-----------------------------RMRAPDYTTPEMYQTMLDCWHGEPSQ  294 (316)
T ss_dssp             HTTSCCSSTTCCCSHHHHHHHHHTC-----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred             HhCCCCCCcccchhHHHHHHhccCc-----------------------------cCCCCCCCCHHHHHHHHHHcCCChhh
Confidence            98 9999988654333222211110                             01122356889999999999999999


Q ss_pred             CCCHHHHhcC
Q 023568          221 RITVEEALRH  230 (280)
Q Consensus       221 Rpt~~ell~h  230 (280)
                      |||++++++|
T Consensus       295 Rps~~ell~~  304 (316)
T 2xir_A          295 RPTFSELVEH  304 (316)
T ss_dssp             SCCHHHHHHH
T ss_pred             CcCHHHHHHH
Confidence            9999999985

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.4e-38  Score=267.30  Aligned_cols=194  Identities=25%  Similarity=0.347  Sum_probs=158.1

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||+++++++....    ...|+||||+++ +|.+++.+ ...+++.++..++.|++.||+|||++|++||||||+|
T Consensus        83 l~h~~iv~~~~~~~~~~----~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~N  158 (298)
T 3f66_A           83 FSHPNVLSLLGICLRSE----GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARN  158 (298)
T ss_dssp             CCCTTBCCCCEEECCSS----SCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             CCCCCEeeeeeEEEcCC----CceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchhe
Confidence            58999999999865432    568999999985 99999976 4569999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCC-----ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 023568           79 LLLNASCDLKIGDFGLARTTSETD-----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKD  152 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~  152 (280)
                      |+++.++.++|+|||.++......     ......+++.|+|||.+.+ ..++.++|+||||+++|+|++ |.+||.+.+
T Consensus       159 il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~  237 (298)
T 3f66_A          159 CMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVN  237 (298)
T ss_dssp             EEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSC
T ss_pred             EEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCccCC
Confidence            999999999999999998654432     1233456788999999977 778899999999999999999 677887766


Q ss_pred             hHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          153 YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       153 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      .......+.....                              .......++.+.+++.+||+.||.+|||++++++
T Consensus       238 ~~~~~~~~~~~~~------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          238 TFDITVYLLQGRR------------------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             TTTHHHHHHTTCC------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHhcCCC------------------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            5444433322111                              1112346889999999999999999999999987

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-38  Score=265.97  Aligned_cols=194  Identities=26%  Similarity=0.375  Sum_probs=158.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||+++++++.+..    ...++||||+. |+|.+++.. ...+++.++..++.|++.||+|||+.|++||||||+|
T Consensus        79 l~h~~iv~~~~~~~~~~----~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~N  154 (298)
T 3pls_A           79 LNHPNVLALIGIMLPPE----GLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARN  154 (298)
T ss_dssp             CCCTTBCCCCEEECCSS----SCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             CCCCCeeeEEEEEecCC----CCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcce
Confidence            58999999999998762    33499999996 699999976 4679999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCC-----CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 023568           79 LLLNASCDLKIGDFGLARTTSET-----DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKD  152 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~  152 (280)
                      |+++.++.++|+|||+++.....     .......+++.|+|||.+.+ ..++.++|+||||+++|+|++ |.+||...+
T Consensus       155 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~~~~~~~~  233 (298)
T 3pls_A          155 CMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQT-YRFTTKSDVWSFGVLLWELLTRGAPPYRHID  233 (298)
T ss_dssp             EEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTT-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred             EEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhcc-CCCChhhchhhHHHHHHHHhhCCCCCCccCC
Confidence            99999999999999999754432     12234567889999999977 778899999999999999999 556666655


Q ss_pred             hHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          153 YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       153 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      .......+.....                              .......++.+.+++++||+.||.+|||++++++
T Consensus       234 ~~~~~~~~~~~~~------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          234 PFDLTHFLAQGRR------------------------------LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             GGGHHHHHHTTCC------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhhcCCC------------------------------CCCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            4444433332111                              1112356889999999999999999999999987

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=4.7e-39  Score=274.47  Aligned_cols=193  Identities=23%  Similarity=0.354  Sum_probs=159.8

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHc--------------CCCCCHHHHHHHHHHHHHHHHHHHh
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS--------------DQQLTDDHCQYFLYQLLRGLKYVHS   66 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~--------------~~~l~~~~~~~i~~qil~~l~~LH~   66 (280)
                      +||||+++++++...     ..+|+||||+++ +|.+++..              ...+++..+..++.|++.||.|||+
T Consensus       108 ~h~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~  182 (333)
T 2i1m_A          108 QHENIVNLLGACTHG-----GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS  182 (333)
T ss_dssp             CCTTBCCEEEEECSS-----SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCCeeeEEEEEecC-----CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc
Confidence            799999999999887     679999999975 99999864              2468999999999999999999999


Q ss_pred             CCccccCCCCCceEEcCCCCeEEeecccccccCCCC---ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh
Q 023568           67 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT  143 (280)
Q Consensus        67 ~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~  143 (280)
                      .||+||||||+||+++.++.++|+|||++.......   ......+++.|+|||.+.+ ..++.++|||||||++|+|++
T Consensus       183 ~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t  261 (333)
T 2i1m_A          183 KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFS  261 (333)
T ss_dssp             TTEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTT
T ss_pred             CCcccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhcc-CCCChHHHHHHHHHHHHHHHc
Confidence            999999999999999999999999999998654332   1234566889999999877 678899999999999999998


Q ss_pred             -CCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCC
Q 023568          144 -REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI  222 (280)
Q Consensus       144 -g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rp  222 (280)
                       |..||.+.........+......                             .......++.+.+++.+||+.||.+||
T Consensus       262 ~g~~p~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rp  312 (333)
T 2i1m_A          262 LGLNPYPGILVNSKFYKLVKDGYQ-----------------------------MAQPAFAPKNIYSIMQACWALEPTHRP  312 (333)
T ss_dssp             TSCCSSTTCCSSHHHHHHHHHTCC-----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred             CCCCCCcccchhHHHHHHHhcCCC-----------------------------CCCCCCCCHHHHHHHHHHhccChhhCc
Confidence             99999887644433333221110                             011234688999999999999999999


Q ss_pred             CHHHHhc
Q 023568          223 TVEEALR  229 (280)
Q Consensus       223 t~~ell~  229 (280)
                      |++++++
T Consensus       313 s~~~l~~  319 (333)
T 2i1m_A          313 TFQQICS  319 (333)
T ss_dssp             CHHHHHH
T ss_pred             CHHHHHH
Confidence            9999987

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2.1e-38  Score=264.89  Aligned_cols=191  Identities=23%  Similarity=0.361  Sum_probs=156.4

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSAS--VLHRDLKP   76 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~--i~H~dik~   76 (280)
                      ++||||+++++++.+.       .++||||+. |+|.+.+.+. ..+++..+..++.|++.||+|||+.|  |+||||||
T Consensus        80 l~h~~i~~~~~~~~~~-------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp  152 (287)
T 4f0f_A           80 LNHPNIVKLYGLMHNP-------PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRS  152 (287)
T ss_dssp             CCCTTBCCEEEEETTT-------TEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSG
T ss_pred             CCCCCchhhheeecCC-------CeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCc
Confidence            5799999999999766       379999998 6999888654 57999999999999999999999999  99999999


Q ss_pred             CceEEcCCCC-----eEEeecccccccCCCCccccceecccccccccccc-CCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 023568           77 SNLLLNASCD-----LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN-CTEYTAAIDIWSVGCILGEIMTREPLFPG  150 (280)
Q Consensus        77 ~Nili~~~~~-----~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DvwslG~~l~~ll~g~~pf~~  150 (280)
                      +||+++.++.     ++|+|||+++.....  .....|++.|+|||++.+ ...++.++|+|||||++|+|++|+.||..
T Consensus       153 ~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  230 (287)
T 4f0f_A          153 PNIFLQSLDENAPVCAKVADFGLSQQSVHS--VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE  230 (287)
T ss_dssp             GGEEESCCCTTCSCCEEECCCTTCBCCSSC--EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             ceEEEeccCCCCceeEEeCCCCcccccccc--ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcc
Confidence            9999988776     999999999765443  345678999999999843 24567899999999999999999999987


Q ss_pred             CChHHH--HHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 023568          151 KDYVHQ--LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL  228 (280)
Q Consensus       151 ~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell  228 (280)
                      ......  ...+.. .+                            ..+......++.+.+++.+||+.||.+|||+++++
T Consensus       231 ~~~~~~~~~~~~~~-~~----------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll  281 (287)
T 4f0f_A          231 YSYGKIKFINMIRE-EG----------------------------LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIV  281 (287)
T ss_dssp             CCCCHHHHHHHHHH-SC----------------------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             ccccHHHHHHHHhc-cC----------------------------CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHH
Confidence            653322  222111 00                            11122346789999999999999999999999998


Q ss_pred             c
Q 023568          229 R  229 (280)
Q Consensus       229 ~  229 (280)
                      +
T Consensus       282 ~  282 (287)
T 4f0f_A          282 K  282 (287)
T ss_dssp             H
T ss_pred             H
Confidence            6

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.2e-39  Score=277.34  Aligned_cols=195  Identities=24%  Similarity=0.341  Sum_probs=150.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      |+||||+++++++....    +..|+||||++ |+|.+++.+. ..+++.++..++.|++.||+|||++||+||||||+|
T Consensus       147 l~hpnIv~~~~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N  222 (373)
T 3c1x_A          147 FSHPNVLSLLGICLRSE----GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARN  222 (373)
T ss_dssp             CCCTTBCCCCEEECCCS----SCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             CCCCCcceEEEEEEcCC----CCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchhe
Confidence            58999999999865432    46899999998 4999999764 468999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCC-----ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 023568           79 LLLNASCDLKIGDFGLARTTSETD-----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKD  152 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~  152 (280)
                      |+++.++.+||+|||+++......     ......+++.|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+
T Consensus       223 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~ellt~~~~p~~~~~  301 (373)
T 3c1x_A          223 CMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVN  301 (373)
T ss_dssp             EEECTTCCEEECCC---------------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred             EEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcC-CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCC
Confidence            999999999999999998654322     1233456788999999887 788999999999999999999 788888765


Q ss_pred             hHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 023568          153 YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  230 (280)
Q Consensus       153 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~h  230 (280)
                      ..+....+....                              ........+..+.+++.+||+.||.+|||++|++++
T Consensus       302 ~~~~~~~~~~~~------------------------------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          302 TFDITVYLLQGR------------------------------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             SSCHHHHHHTTC------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcCC------------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            443333322110                              011123578899999999999999999999999873

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2.3e-38  Score=268.52  Aligned_cols=200  Identities=21%  Similarity=0.305  Sum_probs=159.5

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||+++++++.+.     ...++||||+. ++|.+++...+ .+++.++..++.|++.||+|||+.|++||||||+|
T Consensus        86 l~h~~iv~~~~~~~~~-----~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~N  160 (319)
T 2y4i_B           86 TRHENVVLFMGACMSP-----PHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKN  160 (319)
T ss_dssp             CCCTTBCCCCEEEECS-----SCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTT
T ss_pred             CCCCCEeEEEEEEecC-----CceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhh
Confidence            5799999999999987     67999999997 59999997654 79999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCC------Cccccceecccccccccccc--------CCCCCcchhHHHHHHHHHHHHhC
Q 023568           79 LLLNASCDLKIGDFGLARTTSET------DFMTEYVVTRWYRAPELLLN--------CTEYTAAIDIWSVGCILGEIMTR  144 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~------~~~~~~~~~~~y~aPE~~~~--------~~~~~~~~DvwslG~~l~~ll~g  144 (280)
                      |+++ ++.++|+|||++......      .......|++.|+|||++.+        ...++.++||||||+++|+|++|
T Consensus       161 Il~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g  239 (319)
T 2y4i_B          161 VFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAR  239 (319)
T ss_dssp             EEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHS
T ss_pred             EEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhC
Confidence            9998 679999999998754321      22234568999999999864        24578899999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCH
Q 023568          145 EPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV  224 (280)
Q Consensus       145 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~  224 (280)
                      ..||...........+......                             .......+..+.+++.+||..||.+|||+
T Consensus       240 ~~p~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~  290 (319)
T 2y4i_B          240 EWPFKTQPAEAIIWQMGTGMKP-----------------------------NLSQIGMGKEISDILLFCWAFEQEERPTF  290 (319)
T ss_dssp             SCSSSSCCHHHHHHHHHTTCCC-----------------------------CCCCSSCCTTHHHHHHHHHCSSTTTSCCH
T ss_pred             CCCCCCCCHHHHHHHhccCCCC-----------------------------CCCcCCCCHHHHHHHHHHhcCChhhCcCH
Confidence            9999988766555444321100                             01112467889999999999999999999


Q ss_pred             HHHhcCcccccCc
Q 023568          225 EEALRHPYLQSLH  237 (280)
Q Consensus       225 ~ell~hp~~~~~~  237 (280)
                      +++++  .++.+.
T Consensus       291 ~~l~~--~l~~l~  301 (319)
T 2y4i_B          291 TKLMD--MLEKLP  301 (319)
T ss_dssp             HHHHH--HHTTC-
T ss_pred             HHHHH--HHHHHH
Confidence            99997  444443

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=6.5e-39  Score=287.40  Aligned_cols=193  Identities=22%  Similarity=0.400  Sum_probs=162.4

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      |+||||+++++++...     ..+|+||||+. |+|.+++++.  ..+++..+..++.||+.||+|||++||+||||||+
T Consensus       273 l~hpniv~l~~~~~~~-----~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~  347 (495)
T 1opk_A          273 IKHPNLVQLLGVCTRE-----PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAAR  347 (495)
T ss_dssp             CCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred             cCCCCEeeEEEEEecC-----CcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChh
Confidence            6899999999999887     66999999998 6999999753  46999999999999999999999999999999999


Q ss_pred             ceEEcCCCCeEEeecccccccCCCCc--cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023568           78 NLLLNASCDLKIGDFGLARTTSETDF--MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYV  154 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~  154 (280)
                      |||++.++.+||+|||+++.......  .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..
T Consensus       348 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~  426 (495)
T 1opk_A          348 NCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS  426 (495)
T ss_dssp             GEEECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred             hEEECCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhc-CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999987544321  223445778999999876 678899999999999999999 99999987755


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      .....+.....                              .......++.+.++|.+||+.||.+|||++++++
T Consensus       427 ~~~~~~~~~~~------------------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          427 QVYELLEKDYR------------------------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             GHHHHHHTTCC------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHcCCC------------------------------CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence            54444322110                              1122357899999999999999999999999986

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=7.9e-39  Score=275.22  Aligned_cols=202  Identities=9%  Similarity=0.088  Sum_probs=157.8

Q ss_pred             CCCccccccc---------------ccccCCCCCCCCcEEEEEecCCccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHH
Q 023568            1 MEHENVIAIK---------------DIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKY   63 (280)
Q Consensus         1 l~Hpniv~l~---------------~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~   63 (280)
                      ++||||++++               +++...    ....|+||||++++|.+++...  +.+++.++..++.||+.||.|
T Consensus        99 l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~----~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~  174 (352)
T 2jii_A           99 AAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQ----DKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEF  174 (352)
T ss_dssp             HCCHHHHHHHHHHTTCTTCSCCCCCEEEEET----TTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHH
T ss_pred             hcccchhhhhhhhccCCccCccchhhccccC----CcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4688888854               444431    1679999999977999999875  789999999999999999999


Q ss_pred             HHhCCccccCCCCCceEEcCCC--CeEEeecccccccCCCC--------ccccceeccccccccccccCCCCCcchhHHH
Q 023568           64 VHSASVLHRDLKPSNLLLNASC--DLKIGDFGLARTTSETD--------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWS  133 (280)
Q Consensus        64 LH~~~i~H~dik~~Nili~~~~--~~kl~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dvws  133 (280)
                      ||++||+||||||+||+++.++  .++|+|||+++......        ......||+.|+|||++.+ ..++.++||||
T Consensus       175 LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s  253 (352)
T 2jii_A          175 LHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG-CGPSRRSDLQS  253 (352)
T ss_dssp             HHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT-CCCCHHHHHHH
T ss_pred             HHhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc-CCCCchhhHHH
Confidence            9999999999999999999988  89999999997654321        1234578999999999887 67899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCC-hHHHH-HHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHH
Q 023568          134 VGCILGEIMTREPLFPGKD-YVHQL-RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLE  211 (280)
Q Consensus       134 lG~~l~~ll~g~~pf~~~~-~~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~  211 (280)
                      |||++|+|++|+.||.... ..... .........+.....                      .......+++.+.++++
T Consensus       254 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~l~~li~  311 (352)
T 2jii_A          254 LGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVG----------------------PCGHWIRPSETLQKYLK  311 (352)
T ss_dssp             HHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEEC----------------------TTSCEECCCHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhh----------------------hccccCCCcHHHHHHHH
Confidence            9999999999999998764 22222 222221111111100                      00011256899999999


Q ss_pred             HhcccCCCCCCCHHHHhc
Q 023568          212 KMLVFDPNKRITVEEALR  229 (280)
Q Consensus       212 ~~L~~dp~~Rpt~~ell~  229 (280)
                      +||+.||.+|||++++++
T Consensus       312 ~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          312 VVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             HHHTCCTTCCCCHHHHHH
T ss_pred             HHHhCChhhCCCHHHHHH
Confidence            999999999999999987

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.3e-38  Score=266.48  Aligned_cols=191  Identities=28%  Similarity=0.404  Sum_probs=149.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHh---CCccccC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ---QLTDDHCQYFLYQLLRGLKYVHS---ASVLHRD   73 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~---~l~~~~~~~i~~qil~~l~~LH~---~~i~H~d   73 (280)
                      ++||||+++++++.+.       .|+||||++ |+|.+++....   .+++..+..++.|++.||+|||+   +||+|||
T Consensus        58 l~hp~iv~~~~~~~~~-------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~d  130 (307)
T 2eva_A           58 VNHPNIVKLYGACLNP-------VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD  130 (307)
T ss_dssp             CCCTTBCCEEEBCTTT-------TEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCC
T ss_pred             CCCCCcCeEEEEEcCC-------cEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCC
Confidence            5899999999998754       799999997 59999998654   47899999999999999999999   8999999


Q ss_pred             CCCCceEEcCCCC-eEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 023568           74 LKPSNLLLNASCD-LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD  152 (280)
Q Consensus        74 ik~~Nili~~~~~-~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~  152 (280)
                      |||+||+++.++. +||+|||++......  .....||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||....
T Consensus       131 lkp~NIll~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~  207 (307)
T 2eva_A          131 LKPPNLLLVAGGTVLKICDFGTACDIQTH--MTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPFDEIG  207 (307)
T ss_dssp             CSGGGEEEETTTTEEEECCCCC--------------CCTTSSCHHHHTC-CCCCTHHHHHHHHHHHHHHHHTCCTTTTTC
T ss_pred             CChhHEEEeCCCCEEEEcccccccccccc--cccCCCCCceEChhhhCC-CCCCcHHHHHHHHHHHHHHHHCCCCchhhC
Confidence            9999999998887 799999998765433  234568999999999987 778999999999999999999999998653


Q ss_pred             hHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          153 YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       153 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      ...... +....                           ....+......++.+.+++.+||+.||.+|||++++++
T Consensus       208 ~~~~~~-~~~~~---------------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  256 (307)
T 2eva_A          208 GPAFRI-MWAVH---------------------------NGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK  256 (307)
T ss_dssp             SSHHHH-HHHHH---------------------------TTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccHHHH-HHHHh---------------------------cCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            221110 00000                           00111223467899999999999999999999999997

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.4e-38  Score=292.52  Aligned_cols=192  Identities=19%  Similarity=0.306  Sum_probs=161.0

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+|||||++++++..+      ..++||||+. |+|.+++...+.+++.++..++.||+.||+|||++||+||||||+||
T Consensus       427 l~hpnIv~l~~~~~~~------~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NI  500 (635)
T 4fl3_A          427 LDNPYIVRMIGICEAE------SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNV  500 (635)
T ss_dssp             CCCTTBCCEEEEEESS------SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             CCCCCEeeEEEEEecC------CEEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhE
Confidence            6899999999999643      4899999997 59999999888999999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCC----ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023568           80 LLNASCDLKIGDFGLARTTSETD----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYV  154 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~  154 (280)
                      |++.++.+||+|||+++......    ......++..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..
T Consensus       501 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~  579 (635)
T 4fl3_A          501 LLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS  579 (635)
T ss_dssp             EEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred             EEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999998654332    1223455788999999977 788999999999999999998 99999998876


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      +....+.....                              .......++.+.++|.+||+.||.+|||++++++
T Consensus       580 ~~~~~i~~~~~------------------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          580 EVTAMLEKGER------------------------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             HHHHHHHTTCC------------------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHcCCC------------------------------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            66655543211                              1122357899999999999999999999999976

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=4.1e-39  Score=274.01  Aligned_cols=210  Identities=22%  Similarity=0.309  Sum_probs=159.9

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHhC---Ccccc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ----QLTDDHCQYFLYQLLRGLKYVHSA---SVLHR   72 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~----~l~~~~~~~i~~qil~~l~~LH~~---~i~H~   72 (280)
                      ++||||+++++++.+.     ...++||||+.| +|.+++....    .+++..+..++.|++.||+|||+.   ||+||
T Consensus        84 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~  158 (326)
T 3uim_A           84 AVHRNLLRLRGFCMTP-----TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHR  158 (326)
T ss_dssp             CCCTTBCCCCEEECCS-----SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECC
T ss_pred             ccCCCccceEEEEecC-----CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeC
Confidence            5799999999999987     668999999975 9999997643    499999999999999999999999   99999


Q ss_pred             CCCCCceEEcCCCCeEEeecccccccCCC--CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 023568           73 DLKPSNLLLNASCDLKIGDFGLARTTSET--DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG  150 (280)
Q Consensus        73 dik~~Nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~  150 (280)
                      ||||+||+++.++.++|+|||++......  .......||+.|+|||.+.+ ..++.++|||||||++|+|++|..||..
T Consensus       159 Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~  237 (326)
T 3uim_A          159 DVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDL  237 (326)
T ss_dssp             CCSGGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHH-SEECHHHHHHHHHHHHHHHHHCCCSBCH
T ss_pred             CCchhhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhcc-CCCCccccchhHHHHHHHHHhCCCcccc
Confidence            99999999999999999999999865433  22344568999999999877 6688999999999999999999999963


Q ss_pred             CC-----hHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccc-cccCCCCCHHHHHHHHHhcccCCCCCCCH
Q 023568          151 KD-----YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQF-ATRFPNKSSGAVDLLEKMLVFDPNKRITV  224 (280)
Q Consensus       151 ~~-----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~  224 (280)
                      ..     .......+.....   .....               ....... ....+..+..+.+++.+||+.||.+|||+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~---~~~~~---------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~  299 (326)
T 3uim_A          238 ARLANDDDVMLLDWVKGLLK---EKKLE---------------ALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKM  299 (326)
T ss_dssp             HHHTTTSCSBHHHHHTTTTS---SCCST---------------TSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCH
T ss_pred             cccccccchhHHHHHHHHhh---chhhh---------------hhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCH
Confidence            11     0001111100000   00000               0000000 01111235789999999999999999999


Q ss_pred             HHHhcCcccc
Q 023568          225 EEALRHPYLQ  234 (280)
Q Consensus       225 ~ell~hp~~~  234 (280)
                      +|+++|-.-.
T Consensus       300 ~ell~~L~~~  309 (326)
T 3uim_A          300 SEVVRMLEGD  309 (326)
T ss_dssp             HHHHHHHHTS
T ss_pred             HHHHHHhcCc
Confidence            9999977643

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=7.2e-39  Score=267.07  Aligned_cols=199  Identities=25%  Similarity=0.367  Sum_probs=162.3

Q ss_pred             CCCcccccccccccCCC-----------CCCCCcEEEEEecCCc-cHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHh
Q 023568            1 MEHENVIAIKDIIRPPK-----------KDTFNDVYIVYELMDT-DLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHS   66 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~-----------~~~~~~~~lv~e~~~g-~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~   66 (280)
                      |+||||+++++++....           ......+|+||||+++ +|.+++.+.  ..+++..+..++.|++.||.|||+
T Consensus        61 l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~  140 (284)
T 2a19_B           61 LDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS  140 (284)
T ss_dssp             CCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            58999999999986410           0011568999999985 999999653  679999999999999999999999


Q ss_pred             CCccccCCCCCceEEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCC
Q 023568           67 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREP  146 (280)
Q Consensus        67 ~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~  146 (280)
                      .||+|+||||+||+++.++.++|+|||++.............+++.|+|||.+.+ ..++.++|+||||+++|+|++|..
T Consensus       141 ~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~  219 (284)
T 2a19_B          141 KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCD  219 (284)
T ss_dssp             TTEECSCCSGGGEEEEETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHC-SCCCTHHHHHHHHHHHHHHHSCCS
T ss_pred             CCeeeccCCHHHEEEcCCCCEEECcchhheeccccccccccCCcccccChhhhcc-CCCcchhhhHHHHHHHHHHHhcCC
Confidence            9999999999999999999999999999987766554556678999999999887 778899999999999999999998


Q ss_pred             CCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHH
Q 023568          147 LFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEE  226 (280)
Q Consensus       147 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~e  226 (280)
                      |+....  .....+..                                 .......+..+.++|++||+.||.+|||+.|
T Consensus       220 ~~~~~~--~~~~~~~~---------------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e  264 (284)
T 2a19_B          220 TAFETS--KFFTDLRD---------------------------------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSE  264 (284)
T ss_dssp             SHHHHH--HHHHHHHT---------------------------------TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             cchhHH--HHHHHhhc---------------------------------ccccccCCHHHHHHHHHHccCChhhCcCHHH
Confidence            764211  11111100                                 0112356889999999999999999999999


Q ss_pred             HhcCccccc
Q 023568          227 ALRHPYLQS  235 (280)
Q Consensus       227 ll~hp~~~~  235 (280)
                      ++++.+.-.
T Consensus       265 ~l~~l~~~~  273 (284)
T 2a19_B          265 ILRTLTVWK  273 (284)
T ss_dssp             HHHHHHHHT
T ss_pred             HHHHHHHHh
Confidence            999987543

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=3.8e-39  Score=293.99  Aligned_cols=229  Identities=23%  Similarity=0.280  Sum_probs=167.6

Q ss_pred             CCCcccccccccccCCCC-CCCCcEEEEEecCC-ccHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 023568            1 MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMD-TDLHQIIRSDQ---QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK   75 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~-~~~~~~~lv~e~~~-g~L~~~l~~~~---~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik   75 (280)
                      |+||||+++++++..... ......|+||||++ |+|.+++....   .+++..+..++.|++.||+|||+.||+|||||
T Consensus        69 L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLK  148 (676)
T 3qa8_A           69 LNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLK  148 (676)
T ss_dssp             CCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCC
T ss_pred             CCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCC
Confidence            589999999999876321 11267899999996 59999997643   69999999999999999999999999999999


Q ss_pred             CCceEEcCCCC---eEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 023568           76 PSNLLLNASCD---LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD  152 (280)
Q Consensus        76 ~~Nili~~~~~---~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~  152 (280)
                      |+||+++.++.   ++|+|||.+.............|++.|+|||.+.+ ..++.++|+||+||++|+|++|..||.+..
T Consensus       149 P~NILl~~~g~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSLGviLyeLltG~~Pf~~~~  227 (676)
T 3qa8_A          149 PENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNW  227 (676)
T ss_dssp             STTEEEECCSSSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCC-SCCSTTHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred             HHHeEeecCCCceeEEEcccccccccccccccccccCCcccCChHHhcc-CCCCchhHHHHHHHHHHHHHHCCCCCCccc
Confidence            99999997765   89999999988776665667789999999999877 788999999999999999999999998764


Q ss_pred             hHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCcccc-ccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 023568          153 YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK-QQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHP  231 (280)
Q Consensus       153 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp  231 (280)
                      ....+.......+............        ....... .......+.+++.+.++|++||..||.+|||++|+++||
T Consensus       228 ~~~~~~~~i~~~~~~~~~~~~~l~g--------~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp  299 (676)
T 3qa8_A          228 QPVQWHGKVREKSNEHIVVYDDLTG--------AVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVG  299 (676)
T ss_dssp             HHHHSSTTCC------CCSCCCCSS--------SCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCT
T ss_pred             chhhhhhhhhcccchhhhhhhhhcc--------ccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCH
Confidence            3322110000000000000000000        0000000 001112234678899999999999999999999999999


Q ss_pred             ccccCcC
Q 023568          232 YLQSLHD  238 (280)
Q Consensus       232 ~~~~~~~  238 (280)
                      ||+.+.+
T Consensus       300 ~F~~l~~  306 (676)
T 3qa8_A          300 CFQALDS  306 (676)
T ss_dssp             THHHHHH
T ss_pred             HHHHHHH
Confidence            9987653

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=6.3e-39  Score=270.60  Aligned_cols=207  Identities=26%  Similarity=0.348  Sum_probs=159.6

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS---DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP   76 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~---~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~   76 (280)
                      |+||||+++++++.+.     ...++||||++ ++|.+++..   ...+++..+..++.|++.||.|||+.|++||||||
T Consensus        87 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp  161 (307)
T 2nru_A           87 CQHENLVELLGFSSDG-----DDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKS  161 (307)
T ss_dssp             CCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCG
T ss_pred             cCCCCeEEEEEEEecC-----CceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCH
Confidence            5899999999999887     67999999996 699999863   35699999999999999999999999999999999


Q ss_pred             CceEEcCCCCeEEeecccccccCCCC---ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 023568           77 SNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY  153 (280)
Q Consensus        77 ~Nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~  153 (280)
                      +||+++.++.++|+|||++.......   ......|++.|+|||.+.+  .++.++|+||||+++|+|++|..||.....
T Consensus       162 ~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~  239 (307)
T 2nru_A          162 ANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHRE  239 (307)
T ss_dssp             GGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBS
T ss_pred             HHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcc
Confidence            99999999999999999987654322   1234578999999998865  478899999999999999999999987653


Q ss_pred             HHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 023568          154 VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  230 (280)
Q Consensus       154 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~h  230 (280)
                      ......+..........         ...+       ............+..+.+++.+||+.||.+|||+++++++
T Consensus       240 ~~~~~~~~~~~~~~~~~---------~~~~-------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          240 PQLLLDIKEEIEDEEKT---------IEDY-------IDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             SSBTTHHHHHHHTTSCC---------HHHH-------SCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             hHHHHHHHHHhhhhhhh---------hhhh-------ccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            33222222211111000         0000       0001111112345678999999999999999999999863

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1e-38  Score=265.72  Aligned_cols=192  Identities=22%  Similarity=0.352  Sum_probs=153.0

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      |+||||+++++++....    ...|+||||+++ +|.+++.+.+  .+++..+..++.|++.||.|||+.|++||||||+
T Consensus        71 l~h~~iv~~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~  146 (278)
T 1byg_A           71 LRHSNLVQLLGVIVEEK----GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAAR  146 (278)
T ss_dssp             CCCTTBCCEEEEECCC------CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             CCCCCEeeEEEEEEcCC----CceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcc
Confidence            58999999999976542    468999999985 9999997644  3899999999999999999999999999999999


Q ss_pred             ceEEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 023568           78 NLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQ  156 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~~~  156 (280)
                      ||+++.++.++|+|||++......  .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||......+.
T Consensus       147 Nil~~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~  223 (278)
T 1byg_A          147 NVLVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV  223 (278)
T ss_dssp             GEEECTTSCEEECCCCC--------------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH
T ss_pred             eEEEeCCCcEEEeecccccccccc--ccCCCccccccCHHHhCC-CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            999999999999999998765443  223456888999999876 778999999999999999998 9999988765444


Q ss_pred             HHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       157 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      ...+...                              .........++.+.++|++||+.||.+|||+.++++
T Consensus       224 ~~~~~~~------------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          224 VPRVEKG------------------------------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             HHHHTTT------------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHhcC------------------------------CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence            3333210                              011223467899999999999999999999999986

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.9e-38  Score=264.11  Aligned_cols=192  Identities=23%  Similarity=0.403  Sum_probs=160.9

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      |+||||+++++++..      +..|+||||+. ++|.+++....  .+++.++..++.|++.||.|||+.|++||||||+
T Consensus        65 l~h~~i~~~~~~~~~------~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~  138 (279)
T 1qpc_A           65 LQHQRLVRLYAVVTQ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAA  138 (279)
T ss_dssp             CCCTTBCCEEEEECS------SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred             CCCcCcceEEEEEcC------CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHh
Confidence            589999999999864      34899999996 59999996543  7999999999999999999999999999999999


Q ss_pred             ceEEcCCCCeEEeecccccccCCCCc--cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023568           78 NLLLNASCDLKIGDFGLARTTSETDF--MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYV  154 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~  154 (280)
                      ||+++.++.++|+|||.+........  .....++..|+|||.+.+ ..++.++|+||||+++++|++ |..||.+....
T Consensus       139 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~  217 (279)
T 1qpc_A          139 NILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP  217 (279)
T ss_dssp             GEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred             hEEEcCCCCEEECCCcccccccCcccccccCCCCccCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH
Confidence            99999999999999999987654321  233456778999999876 678899999999999999999 99999988766


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      +....+.....                              .......+..+.+++.+||..||++|||++++++
T Consensus       218 ~~~~~~~~~~~------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          218 EVIQNLERGYR------------------------------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             HHHHHHHTTCC------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhcccC------------------------------CCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            65554432110                              1112357899999999999999999999999987

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.7e-38  Score=266.02  Aligned_cols=210  Identities=24%  Similarity=0.435  Sum_probs=159.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIR-SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~-~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      |+||||+++++++.+...   ..+|+||||+++ +|.+++. ....+++.++..++.|++.||+|||+.||+||||||+|
T Consensus        80 l~h~~i~~~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~N  156 (302)
T 4e5w_A           80 LYHENIVKYKGICTEDGG---NGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARN  156 (302)
T ss_dssp             CCCTTBCCEEEEEEC------CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred             CCCCCeeeeeeEEecCCC---ceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchhe
Confidence            589999999999987633   569999999975 9999995 45679999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCC----ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETD----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV  154 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~  154 (280)
                      |+++.++.++|+|||++.......    ......+|..|+|||.+.+ ..++.++|+||||+++|+|++|..|+....  
T Consensus       157 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~--  233 (302)
T 4e5w_A          157 VLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQ-SKFYIASDVWSFGVTLHELLTYCDSDSSPM--  233 (302)
T ss_dssp             EEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHH--
T ss_pred             EEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecC-CCCCcchhHHHHHHHHHHHHHccCCCcchh--
Confidence            999999999999999998755432    2334567888999999877 677889999999999999999998864321  


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                         .......+......       .........   .........+.+++.+.+++++||+.||.+|||++++++
T Consensus       234 ---~~~~~~~~~~~~~~-------~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          234 ---ALFLKMIGPTHGQM-------TVTRLVNTL---KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             ---HHHHHHHCSCCGGG-------HHHHHHHHH---HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             ---hHHhhccCCccccc-------CHHHHHHHH---hccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence               11111111111110       011111111   011112234468999999999999999999999999986

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2.5e-38  Score=265.30  Aligned_cols=198  Identities=18%  Similarity=0.192  Sum_probs=156.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++|+|++..+..+....    ...++||||++++|.+++.. .+.+++.++..++.|++.||.|||+.||+||||||+||
T Consensus        61 l~~~~~i~~~~~~~~~~----~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NI  136 (296)
T 4hgt_A           61 MQGGVGIPTIRWCGAEG----DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNF  136 (296)
T ss_dssp             HTTSTTCCCEEEEEEET----TEEEEEEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             hcCCCCCCeeeeecCCC----CceEEEEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHe
Confidence            35777666666554331    67899999998899999974 46799999999999999999999999999999999999


Q ss_pred             EE---cCCCCeEEeecccccccCCCC--------ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 023568           80 LL---NASCDLKIGDFGLARTTSETD--------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF  148 (280)
Q Consensus        80 li---~~~~~~kl~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf  148 (280)
                      ++   +.++.++|+|||+++......        ......||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||
T Consensus       137 l~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf  215 (296)
T 4hgt_A          137 LMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPW  215 (296)
T ss_dssp             EECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             eeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcC-CCCCchhHHHHHHHHHHHHhcCCCCC
Confidence            99   788999999999998654432        1235678999999999987 67899999999999999999999999


Q ss_pred             CCCChH---HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 023568          149 PGKDYV---HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVE  225 (280)
Q Consensus       149 ~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~  225 (280)
                      .+.+..   .....+....                          ...+.+......++.+.+++.+||+.||.+|||++
T Consensus       216 ~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~  269 (296)
T 4hgt_A          216 QGLKAATKRQKYERISEKK--------------------------MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYS  269 (296)
T ss_dssp             SSCCCSSSSSHHHHHHHHH--------------------------HHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHH
T ss_pred             cccchhhhhhhhhhhhccc--------------------------ccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHH
Confidence            875422   1111111100                          00111122346789999999999999999999999


Q ss_pred             HHhc
Q 023568          226 EALR  229 (280)
Q Consensus       226 ell~  229 (280)
                      ++++
T Consensus       270 ~l~~  273 (296)
T 4hgt_A          270 YLRQ  273 (296)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9987

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=8.3e-39  Score=268.95  Aligned_cols=204  Identities=21%  Similarity=0.326  Sum_probs=153.6

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH--------hCCccc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH--------SASVLH   71 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH--------~~~i~H   71 (280)
                      ++||||+++++++..... ....+|+||||++ |+|.++++. ..+++..+..++.|++.||+|||        +.||+|
T Consensus        59 l~h~niv~~~~~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH  136 (301)
T 3q4u_A           59 LRHENILGFIASDMTSRH-SSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAH  136 (301)
T ss_dssp             CCCTTBCCEEEEEEEEET-TEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEEC
T ss_pred             ccCcCeeeEEEeeccccC-CCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeec
Confidence            589999999998665311 1156899999998 599999954 67999999999999999999999        999999


Q ss_pred             cCCCCCceEEcCCCCeEEeecccccccCCCCc-----cccceeccccccccccccCC-----CCCcchhHHHHHHHHHHH
Q 023568           72 RDLKPSNLLLNASCDLKIGDFGLARTTSETDF-----MTEYVVTRWYRAPELLLNCT-----EYTAAIDIWSVGCILGEI  141 (280)
Q Consensus        72 ~dik~~Nili~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~-----~~~~~~DvwslG~~l~~l  141 (280)
                      |||||+||+++.++.+||+|||+++.......     .....||+.|+|||++.+..     .++.++|||||||++|+|
T Consensus       137 ~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el  216 (301)
T 3q4u_A          137 RDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV  216 (301)
T ss_dssp             SCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHH
Confidence            99999999999999999999999975443321     23347899999999987632     234689999999999999


Q ss_pred             HhC----------CCCCCCCCh----HHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHH
Q 023568          142 MTR----------EPLFPGKDY----VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAV  207 (280)
Q Consensus       142 l~g----------~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  207 (280)
                      ++|          ..||.....    ...........+..+..                       +........++.+.
T Consensus       217 ~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~l~  273 (301)
T 3q4u_A          217 ARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNI-----------------------PNRWFSDPTLTSLA  273 (301)
T ss_dssp             HTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCC-----------------------CGGGGGSHHHHHHH
T ss_pred             HhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCC-----------------------ChhhccCccHHHHH
Confidence            999          778765321    12221111110100000                       00000112457899


Q ss_pred             HHHHHhcccCCCCCCCHHHHhc
Q 023568          208 DLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       208 ~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      +++.+||+.||.+|||++++++
T Consensus       274 ~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          274 KLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             HHHHHHCCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhhcChhhCCCHHHHHH
Confidence            9999999999999999999986

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.3e-38  Score=271.06  Aligned_cols=211  Identities=19%  Similarity=0.307  Sum_probs=161.0

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      |+||||+++++++.....   ..+|+||||++ ++|.+++.. ...+++..+..++.|++.||+|||+.||+||||||+|
T Consensus        81 l~h~~i~~~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~N  157 (327)
T 3lxl_A           81 LHSDFIVKYRGVSYGPGR---QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARN  157 (327)
T ss_dssp             CCCTTBCCEEEEEECSSS---CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred             cCCCceeEEEEEEecCCC---ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhh
Confidence            589999999999875432   67999999996 699999976 4569999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCC----ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETD----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV  154 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~  154 (280)
                      |+++.++.++|+|||++.......    ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||......
T Consensus       158 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~  236 (327)
T 3lxl_A          158 ILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD-NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE  236 (327)
T ss_dssp             EEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH
T ss_pred             EEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhcc-CCCChHHhHHHHHHHHHHHHhCCCCCccccch
Confidence            999999999999999998654332    2234567888999999877 67789999999999999999999998764321


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  230 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~h  230 (280)
                      ....     .....       ............   .........+..++.+.++|++||+.||.+|||++|++++
T Consensus       237 ~~~~-----~~~~~-------~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          237 FLRM-----MGCER-------DVPALSRLLELL---EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             HHHH-----CC-----------CCHHHHHHHHH---HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hhhh-----ccccc-------ccccHHHHHHHh---hcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            1100     00000       000001111111   1111122345689999999999999999999999999763

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.9e-38  Score=265.52  Aligned_cols=193  Identities=25%  Similarity=0.352  Sum_probs=159.9

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      |+||||+++++++...      ..++||||+. ++|.+++.+. +.+++..+..++.|++.||.|||+.|++|+||||+|
T Consensus        78 l~h~~i~~~~~~~~~~------~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~N  151 (291)
T 1u46_A           78 LDHRNLIRLYGVVLTP------PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARN  151 (291)
T ss_dssp             CCCTTBCCEEEEECSS------SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred             CCCCCcccEEEEEccC------CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchhe
Confidence            5899999999999865      2899999997 5999998753 579999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCc----cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDF----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDY  153 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~  153 (280)
                      |+++.++.++|+|||++........    .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||.+.+.
T Consensus       152 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~  230 (291)
T 1u46_A          152 LLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG  230 (291)
T ss_dssp             EEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred             EEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcccCCH
Confidence            9999999999999999987544321    223456778999999876 667889999999999999999 9999998876


Q ss_pred             HHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          154 VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       154 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      ......+......                             .......+..+.+++.+||..||.+|||+.++++
T Consensus       231 ~~~~~~~~~~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  277 (291)
T 1u46_A          231 SQILHKIDKEGER-----------------------------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  277 (291)
T ss_dssp             HHHHHHHHTSCCC-----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHccCCC-----------------------------CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            6655554331110                             1122357899999999999999999999999997

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.5e-38  Score=271.23  Aligned_cols=198  Identities=24%  Similarity=0.356  Sum_probs=141.4

Q ss_pred             CCcccccccccccCCCC---CCCCcEEEEEecCCccHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccC
Q 023568            2 EHENVIAIKDIIRPPKK---DTFNDVYIVYELMDTDLHQIIRS---DQQLTDDHCQYFLYQLLRGLKYVHSAS--VLHRD   73 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~---~~~~~~~lv~e~~~g~L~~~l~~---~~~l~~~~~~~i~~qil~~l~~LH~~~--i~H~d   73 (280)
                      +||||+++++++.....   .....+++||||++|+|.+++..   .+.+++.++..++.||+.||.|||+.|  |+|||
T Consensus        84 ~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~D  163 (337)
T 3ll6_A           84 GHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRD  163 (337)
T ss_dssp             TSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCC
T ss_pred             cCCChhhccccccccccccccCCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEcc
Confidence            49999999999843211   12256899999999999998864   567999999999999999999999999  99999


Q ss_pred             CCCCceEEcCCCCeEEeecccccccCCCCcc-------------ccceeccccccccccc--cCCCCCcchhHHHHHHHH
Q 023568           74 LKPSNLLLNASCDLKIGDFGLARTTSETDFM-------------TEYVVTRWYRAPELLL--NCTEYTAAIDIWSVGCIL  138 (280)
Q Consensus        74 ik~~Nili~~~~~~kl~dfg~~~~~~~~~~~-------------~~~~~~~~y~aPE~~~--~~~~~~~~~DvwslG~~l  138 (280)
                      |||+||+++.++.++|+|||++.........             ....+|+.|+|||++.  ....++.++|||||||++
T Consensus       164 ikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il  243 (337)
T 3ll6_A          164 LKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCIL  243 (337)
T ss_dssp             CCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHH
T ss_pred             CCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHH
Confidence            9999999999999999999999865543211             1446899999999983  226678899999999999


Q ss_pred             HHHHhCCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCC
Q 023568          139 GEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDP  218 (280)
Q Consensus       139 ~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp  218 (280)
                      |+|++|..||............   .                              ........+..+.++|++||+.||
T Consensus       244 ~el~~g~~p~~~~~~~~~~~~~---~------------------------------~~~~~~~~~~~~~~li~~~l~~~p  290 (337)
T 3ll6_A          244 YLLCFRQHPFEDGAKLRIVNGK---Y------------------------------SIPPHDTQYTVFHSLIRAMLQVNP  290 (337)
T ss_dssp             HHHHHSSCCC---------------C------------------------------CCCTTCCSSGGGHHHHHHHSCSSG
T ss_pred             HHHHhCCCCCcchhHHHhhcCc---c------------------------------cCCcccccchHHHHHHHHHccCCh
Confidence            9999999999765422111100   0                              001123457789999999999999


Q ss_pred             CCCCCHHHHhcCcc
Q 023568          219 NKRITVEEALRHPY  232 (280)
Q Consensus       219 ~~Rpt~~ell~hp~  232 (280)
                      .+|||++|++++-.
T Consensus       291 ~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          291 EERLSIAEVVHQLQ  304 (337)
T ss_dssp             GGSCCHHHHHHHHH
T ss_pred             hhCcCHHHHHHHHH
Confidence            99999999998753

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=3.8e-38  Score=264.30  Aligned_cols=198  Identities=18%  Similarity=0.188  Sum_probs=156.3

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++|++++..+..+....    ...++||||++++|.+++.. .+.+++.++..++.|++.||+|||++||+||||||+||
T Consensus        61 l~~~~~i~~~~~~~~~~----~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NI  136 (296)
T 3uzp_A           61 MQGGVGIPTIRWCGAEG----DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNF  136 (296)
T ss_dssp             HTTSTTCCCEEEEEEET----TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred             hhcCCCCCccccccCCC----CceEEEEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHe
Confidence            35777666666554331    67899999998899999973 46799999999999999999999999999999999999


Q ss_pred             EE---cCCCCeEEeecccccccCCCCc--------cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 023568           80 LL---NASCDLKIGDFGLARTTSETDF--------MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF  148 (280)
Q Consensus        80 li---~~~~~~kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf  148 (280)
                      ++   +.++.++|+|||++........        .....||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||
T Consensus       137 l~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf  215 (296)
T 3uzp_A          137 LMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPW  215 (296)
T ss_dssp             EECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             EEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCC
Confidence            99   4888999999999986544321        245678999999999987 67899999999999999999999999


Q ss_pred             CCCCh---HHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 023568          149 PGKDY---VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVE  225 (280)
Q Consensus       149 ~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~  225 (280)
                      .+...   ......+.....                          ....+...+..++.+.+++++||+.||.+|||++
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  269 (296)
T 3uzp_A          216 QGLKAATKRQKYERISEKKM--------------------------STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYS  269 (296)
T ss_dssp             SSCCCSSSSSHHHHHHHHHH--------------------------HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHH
T ss_pred             CCcCchhhhhhhhhhccccc--------------------------CCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHH
Confidence            87432   112222211000                          0011122346789999999999999999999999


Q ss_pred             HHhc
Q 023568          226 EALR  229 (280)
Q Consensus       226 ell~  229 (280)
                      ++++
T Consensus       270 ~l~~  273 (296)
T 3uzp_A          270 YLRQ  273 (296)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9987

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=3e-38  Score=280.21  Aligned_cols=192  Identities=25%  Similarity=0.394  Sum_probs=156.9

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~--~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      |+||||+++++++.+      ..+|+||||+. |+|.+++..  ...+++.++..++.|++.||+|||++||+||||||+
T Consensus       236 l~hp~iv~~~~~~~~------~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~  309 (452)
T 1fmk_A          236 LRHEKLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAA  309 (452)
T ss_dssp             CCCTTBCCEEEEECS------SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             CCCCCEeeEEEEEcC------CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChh
Confidence            689999999999865      34899999997 599999964  356999999999999999999999999999999999


Q ss_pred             ceEEcCCCCeEEeecccccccCCCCc--cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023568           78 NLLLNASCDLKIGDFGLARTTSETDF--MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYV  154 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~  154 (280)
                      |||++.++.+||+|||+++.......  .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....
T Consensus       310 Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~  388 (452)
T 1fmk_A          310 NILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR  388 (452)
T ss_dssp             GEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred             hEEECCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhc-CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999986544321  223445778999999877 678999999999999999999 99999988776


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      +....+.....                              ....+..++.+.++|.+||+.||.+|||++++++
T Consensus       389 ~~~~~i~~~~~------------------------------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~  433 (452)
T 1fmk_A          389 EVLDQVERGYR------------------------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  433 (452)
T ss_dssp             HHHHHHHTTCC------------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHcCCC------------------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            66555433111                              1112356889999999999999999999999987

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=5e-38  Score=264.35  Aligned_cols=192  Identities=23%  Similarity=0.398  Sum_probs=147.4

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ--QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      ++||||+++++++..... +...+|+||||++| +|.+++....  .+++.++..++.|++.||+|||+.||+||||||+
T Consensus        68 ~~h~~i~~~~~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~  146 (299)
T 3m2w_A           68 SQCPHIVRIVDVYENLYA-GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPE  146 (299)
T ss_dssp             TTSTTBCCEEEEEEEEET-TEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred             ccCCCchhHHhhhhhhcC-CCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHH
Confidence            479999999999976110 11679999999975 9999997654  6999999999999999999999999999999999


Q ss_pred             ceEEcC---CCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023568           78 NLLLNA---SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV  154 (280)
Q Consensus        78 Nili~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~  154 (280)
                      ||+++.   ++.++|+|||++.....                      ..++.++|+|||||++|+|++|..||.+....
T Consensus       147 Nil~~~~~~~~~~kl~Dfg~a~~~~~----------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~  204 (299)
T 3m2w_A          147 NLLYTSKRPNAILKLTDFGFAKETTG----------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL  204 (299)
T ss_dssp             GEEESSSSTTCCEEECCCTTCEECTT----------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC----
T ss_pred             HEEEecCCCCCcEEEecccccccccc----------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcch
Confidence            999998   78899999998854332                      34667899999999999999999999776432


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ  234 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~  234 (280)
                      .....+...                       ............+..+++.+.++|.+||+.||.+|||++|+++||||+
T Consensus       205 ~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~  261 (299)
T 3m2w_A          205 AISPGMKTR-----------------------IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM  261 (299)
T ss_dssp             ---CCSCCS-----------------------SCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             hhhHHHHHH-----------------------HhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhc
Confidence            211100000                       000000000111246799999999999999999999999999999998


Q ss_pred             cCcC
Q 023568          235 SLHD  238 (280)
Q Consensus       235 ~~~~  238 (280)
                      +...
T Consensus       262 ~~~~  265 (299)
T 3m2w_A          262 QSTK  265 (299)
T ss_dssp             TGGG
T ss_pred             cccc
Confidence            7653

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.2e-38  Score=286.65  Aligned_cols=192  Identities=18%  Similarity=0.295  Sum_probs=158.2

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      |+|||||++++++..+      .+|+||||++ |+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|
T Consensus       393 l~hpniv~l~~~~~~~------~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~N  466 (613)
T 2ozo_A          393 LDNPYIVRLIGVCQAE------ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARN  466 (613)
T ss_dssp             CCCTTBCCEEEEEESS------SEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             CCCCCEeeEEEEeccC------CeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHH
Confidence            5899999999999753      4899999997 5999999654 569999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCc----cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDF----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDY  153 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~  153 (280)
                      ||++.++.+||+|||+++.......    .....++..|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+.
T Consensus       467 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~  545 (613)
T 2ozo_A          467 VLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG  545 (613)
T ss_dssp             EEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS
T ss_pred             EEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH
Confidence            9999999999999999987543321    122344678999999976 788999999999999999998 9999999887


Q ss_pred             HHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          154 VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       154 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      .+....+.....                              ....+..++.+.++|.+||..||.+|||++++++
T Consensus       546 ~~~~~~i~~~~~------------------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          546 PEVMAFIEQGKR------------------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             HHHHHHHHTTCC------------------------------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHcCCC------------------------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            666655543110                              1122357899999999999999999999999854

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.6e-39  Score=283.81  Aligned_cols=221  Identities=16%  Similarity=0.272  Sum_probs=161.6

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ---QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP   76 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~---~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~   76 (280)
                      |+||||+++++++.....   ...|+||||+. |+|.+++....   .+++..+..++.|++.||+|||+.||+||||||
T Consensus        64 l~hpnIv~~~~~~~~~~~---~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp  140 (396)
T 4eut_A           64 LNHKNIVKLFAIEEETTT---RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKP  140 (396)
T ss_dssp             CCCTTBCCEEEEEECTTT---CCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred             cCCCCCCeEEEeeccCCC---CeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCH
Confidence            589999999999987633   47899999997 59999997533   399999999999999999999999999999999


Q ss_pred             CceEE----cCCCCeEEeecccccccCCCCccccceeccccccccccccC-------CCCCcchhHHHHHHHHHHHHhCC
Q 023568           77 SNLLL----NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC-------TEYTAAIDIWSVGCILGEIMTRE  145 (280)
Q Consensus        77 ~Nili----~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~~DvwslG~~l~~ll~g~  145 (280)
                      +||++    +.++.+||+|||+++............||+.|+|||++.+.       ..++.++|+|||||++|+|++|+
T Consensus       141 ~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~  220 (396)
T 4eut_A          141 GNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS  220 (396)
T ss_dssp             GGEEEEECTTSCEEEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSS
T ss_pred             HHEEEeecCCCceeEEEecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCC
Confidence            99999    77778999999999877666555667899999999998641       45677999999999999999999


Q ss_pred             CCCCCCChH-HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCcccc--ccccccCCCCCHHHHHHHHHhcccCCCCCC
Q 023568          146 PLFPGKDYV-HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRK--QQFATRFPNKSSGAVDLLEKMLVFDPNKRI  222 (280)
Q Consensus       146 ~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rp  222 (280)
                      .||.+.... .....+.+.....+............     ....+..  ..........+..+.++|++||+.||++||
T Consensus       221 ~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~  295 (396)
T 4eut_A          221 LPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAEN-----GPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCW  295 (396)
T ss_dssp             CSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTT-----CCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSC
T ss_pred             CCCCCCCcccchHHHHHHHhcCCCcccchhheeccC-----CCcccCccCCcccccchHHHhhchHHHHHhhccChhhhc
Confidence            999764321 11222222222222221111100000     0000000  000011123467888999999999999999


Q ss_pred             CHHHHhc
Q 023568          223 TVEEALR  229 (280)
Q Consensus       223 t~~ell~  229 (280)
                      |++|+++
T Consensus       296 s~~e~l~  302 (396)
T 4eut_A          296 GFDQFFA  302 (396)
T ss_dssp             CHHHHHH
T ss_pred             cHHHHHH
Confidence            9999865

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=4e-38  Score=267.23  Aligned_cols=209  Identities=24%  Similarity=0.345  Sum_probs=159.6

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+||||+++++++.+...   ..+|+||||++ |+|.+++.. ..+++.++..++.|++.||+|||+.||+||||||+||
T Consensus        90 l~h~~iv~~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Ni  165 (318)
T 3lxp_A           90 LYHEHIIKYKGCCEDAGA---ASLQLVMEYVPLGSLRDYLPR-HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNV  165 (318)
T ss_dssp             CCCTTBCCEEEEEEETTT---TEEEEEECCCTTCBHHHHGGG-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             CCCcchhhEEEEEecCCC---ceEEEEEecccCCcHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheE
Confidence            589999999999987533   67999999997 599999976 4599999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCC----ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETD----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH  155 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~  155 (280)
                      +++.++.++|+|||++.......    ......++..|+|||++.+ ..++.++|+||||+++|+|++|..||.......
T Consensus       166 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~  244 (318)
T 3lxp_A          166 LLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE-YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF  244 (318)
T ss_dssp             EECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH
T ss_pred             EEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCcccccchhh
Confidence            99999999999999998765432    2234567888999999977 677889999999999999999999987642211


Q ss_pred             HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          156 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       156 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                           ....+......       .........   ............++.+.++|++||+.||.+|||++|+++
T Consensus       245 -----~~~~~~~~~~~-------~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          245 -----LELIGIAQGQM-------TVLRLTELL---ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             -----HHHHCSCCHHH-------HHHHHHHHH---HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----hhhhcccccch-------hHHHHHHHH---hcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                 00001000000       000000000   111112233467899999999999999999999999985

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.8e-37  Score=262.10  Aligned_cols=200  Identities=30%  Similarity=0.464  Sum_probs=151.2

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK   75 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik   75 (280)
                      |+||||+++++++...     +..++||||+++ +|.+++..    ...+++..+..++.|++.||.|||+.|++||||+
T Consensus        89 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~  163 (310)
T 2wqm_A           89 LNHPNVIKYYASFIED-----NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIK  163 (310)
T ss_dssp             CCCTTBCCEEEEEEET-----TEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred             CCCCCEeeEEEEEEcC-----CcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCc
Confidence            5899999999999987     679999999985 99998863    4679999999999999999999999999999999


Q ss_pred             CCceEEcCCCCeEEeecccccccCCCC-ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh-
Q 023568           76 PSNLLLNASCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY-  153 (280)
Q Consensus        76 ~~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~-  153 (280)
                      |+||+++.++.++|+|||++....... ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+... 
T Consensus       164 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~  242 (310)
T 2wqm_A          164 PANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN  242 (310)
T ss_dssp             GGGEEECTTSCEEECCC------------------CCSSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTC---CC
T ss_pred             HHHEEEcCCCCEEEEeccceeeecCCCccccccCCCeeEeChHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCCcccchh
Confidence            999999999999999999987654432 2334578999999999877 7788999999999999999999999976532 


Q ss_pred             -HHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 023568          154 -VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY  232 (280)
Q Consensus       154 -~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~  232 (280)
                       ......+.. ...+                            .......+..+.+++.+||..||.+|||++++++  .
T Consensus       243 ~~~~~~~~~~-~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~--~  291 (310)
T 2wqm_A          243 LYSLCKKIEQ-CDYP----------------------------PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD--V  291 (310)
T ss_dssp             HHHHHHHHHT-TCSC----------------------------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH--H
T ss_pred             HHHHHHHhhc-ccCC----------------------------CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHH--H
Confidence             122221111 0000                            0011357889999999999999999999999987  4


Q ss_pred             cccCc
Q 023568          233 LQSLH  237 (280)
Q Consensus       233 ~~~~~  237 (280)
                      ++.++
T Consensus       292 l~~l~  296 (310)
T 2wqm_A          292 AKRMH  296 (310)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            44444

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.7e-38  Score=266.79  Aligned_cols=202  Identities=22%  Similarity=0.317  Sum_probs=152.1

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC--------Cccc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA--------SVLH   71 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~--------~i~H   71 (280)
                      ++||||+++++++..... ....+|+||||++| +|.++++. ..+++..+..++.|++.||.|||+.        ||+|
T Consensus        88 ~~h~~i~~~~~~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH  165 (337)
T 3mdy_A           88 MRHENILGFIAADIKGTG-SWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAH  165 (337)
T ss_dssp             CCCTTBCCEEEEEEESCG-GGCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEEC
T ss_pred             hcCCCeeeEEEEEccCCC-CCCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEe
Confidence            489999999999886522 12468999999975 99999976 5799999999999999999999999        9999


Q ss_pred             cCCCCCceEEcCCCCeEEeecccccccCCCCc-----cccceeccccccccccccCCCCCc------chhHHHHHHHHHH
Q 023568           72 RDLKPSNLLLNASCDLKIGDFGLARTTSETDF-----MTEYVVTRWYRAPELLLNCTEYTA------AIDIWSVGCILGE  140 (280)
Q Consensus        72 ~dik~~Nili~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~------~~DvwslG~~l~~  140 (280)
                      |||||+||+++.++.+||+|||++........     .....||+.|+|||++.+ .....      ++|||||||++|+
T Consensus       166 ~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~~~~~DiwslG~il~e  244 (337)
T 3mdy_A          166 RDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE-SLNRNHFQSYIMADMYSFGLILWE  244 (337)
T ss_dssp             SCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTT-CCCTTCTHHHHHHHHHHHHHHHHH
T ss_pred             cccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhccc-ccCCccccCccccchHHHHHHHHH
Confidence            99999999999999999999999976543321     124578999999999876 33333      3999999999999


Q ss_pred             HHhC----------CCCCCCCCh----HHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCcccccccccc--CCCCCH
Q 023568          141 IMTR----------EPLFPGKDY----VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATR--FPNKSS  204 (280)
Q Consensus       141 ll~g----------~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  204 (280)
                      |++|          +.||.....    ............                         .....+..  ....++
T Consensus       245 l~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~  299 (337)
T 3mdy_A          245 VARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKK-------------------------LRPSFPNRWSSDECLR  299 (337)
T ss_dssp             HHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSC-------------------------CCCCCCGGGGGSHHHH
T ss_pred             HHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhc-------------------------cCccccccchhhHHHH
Confidence            9999          556654321    111111111000                         00011111  113467


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcC
Q 023568          205 GAVDLLEKMLVFDPNKRITVEEALRH  230 (280)
Q Consensus       205 ~~~~ll~~~L~~dp~~Rpt~~ell~h  230 (280)
                      .+.+++.+||+.||.+|||+++++++
T Consensus       300 ~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          300 QMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            79999999999999999999999974

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.3e-38  Score=270.40  Aligned_cols=218  Identities=20%  Similarity=0.229  Sum_probs=151.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---------Ccc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA---------SVL   70 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~---------~i~   70 (280)
                      ++||||+++++.+......+...+|+||||++ |+|.+++.. ...++..+..++.||+.||+|||+.         ||+
T Consensus        64 ~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~iv  142 (336)
T 3g2f_A           64 MEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAIS  142 (336)
T ss_dssp             CCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEE
T ss_pred             ccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhh-cccchhHHHHHHHHHHHHHHHHHhhhcccccccccee
Confidence            57999999998654432223357899999996 599999976 4559999999999999999999999         999


Q ss_pred             ccCCCCCceEEcCCCCeEEeecccccccCCCC---------ccccceeccccccccccccC------CCCCcchhHHHHH
Q 023568           71 HRDLKPSNLLLNASCDLKIGDFGLARTTSETD---------FMTEYVVTRWYRAPELLLNC------TEYTAAIDIWSVG  135 (280)
Q Consensus        71 H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~------~~~~~~~DvwslG  135 (280)
                      ||||||+|||++.++.+||+|||+++......         ......||+.|+|||++.+.      ..++.++||||||
T Consensus       143 H~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG  222 (336)
T 3g2f_A          143 HRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALG  222 (336)
T ss_dssp             CSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHH
T ss_pred             ecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHH
Confidence            99999999999999999999999997654321         12345689999999998752      2345689999999


Q ss_pred             HHHHHHHhCCCCCCC-CChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhC-CccccccccccCC---CCCHHHHHHH
Q 023568          136 CILGEIMTREPLFPG-KDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL-PRCRKQQFATRFP---NKSSGAVDLL  210 (280)
Q Consensus       136 ~~l~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~ll  210 (280)
                      |++|+|++|..||.. .........+....+..+          ......... .......++..++   ..++.+.++|
T Consensus       223 ~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  292 (336)
T 3g2f_A          223 LIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHP----------TFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI  292 (336)
T ss_dssp             HHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSC----------CHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHH
T ss_pred             HHHHHHHhcCCcCCCccchhHHHHhhhcccCCCc----------hHHHHHhhhcccccCCCCCcccccccchHHHHHHHH
Confidence            999999999665533 221110000000000000          000000000 0011111222111   1345799999


Q ss_pred             HHhcccCCCCCCCHHHHhc
Q 023568          211 EKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       211 ~~~L~~dp~~Rpt~~ell~  229 (280)
                      .+||+.||++|||++|+++
T Consensus       293 ~~cl~~dP~~Rps~~e~l~  311 (336)
T 3g2f_A          293 EDCWDQDAEARLTAQXAEE  311 (336)
T ss_dssp             HHHSCSSGGGSCCHHHHHH
T ss_pred             HHHhcCChhhCcchHHHHH
Confidence            9999999999999999954

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2.3e-37  Score=285.38  Aligned_cols=192  Identities=25%  Similarity=0.413  Sum_probs=159.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||+++++++.+      +..|+||||++ |+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|
T Consensus       448 l~HpnIv~l~~~~~~------~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~N  521 (656)
T 2j0j_A          448 FDHPHIVKLIGVITE------NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARN  521 (656)
T ss_dssp             CCCTTBCCEEEEECS------SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             CCCCCCCeEEEEEec------CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHh
Confidence            589999999999854      34899999998 6999999764 479999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCc--cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDF--MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVH  155 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~~  155 (280)
                      ||++.++.++|+|||+++.......  .....+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+
T Consensus       522 ILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~  600 (656)
T 2j0j_A          522 VLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND  600 (656)
T ss_dssp             EEEEETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred             EEEeCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcC-CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH
Confidence            9999999999999999987654322  223456788999999977 688999999999999999997 999999988776


Q ss_pred             HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          156 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       156 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      ....+.....                              ....+..++.+.++|.+||..||.+|||+.++++
T Consensus       601 ~~~~i~~~~~------------------------------~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          601 VIGRIENGER------------------------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             HHHHHHHTCC------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHcCCC------------------------------CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            6655543111                              1123467899999999999999999999999986

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.1e-37  Score=281.76  Aligned_cols=192  Identities=25%  Similarity=0.381  Sum_probs=161.3

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~--~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      |+||||+++++++.+      ..+|+||||+. |+|.+++..  ...+++.++..++.||+.||+|||++||+||||||+
T Consensus       319 l~hpniv~~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~  392 (535)
T 2h8h_A          319 LRHEKLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAA  392 (535)
T ss_dssp             CCCTTBCCEEEEECS------SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             CCCCCEeeEEEEEee------ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHh
Confidence            689999999999865      34899999997 599999964  356999999999999999999999999999999999


Q ss_pred             ceEEcCCCCeEEeecccccccCCCC--ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023568           78 NLLLNASCDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYV  154 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~  154 (280)
                      |||++.++.+||+|||+++......  ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....
T Consensus       393 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~  471 (535)
T 2h8h_A          393 NILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR  471 (535)
T ss_dssp             GEEECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH
T ss_pred             hEEEcCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999998655331  1223345778999999877 778999999999999999999 99999988776


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      +....+.....                              .......+..+.+||.+||+.||++|||++++++
T Consensus       472 ~~~~~i~~~~~------------------------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  516 (535)
T 2h8h_A          472 EVLDQVERGYR------------------------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  516 (535)
T ss_dssp             HHHHHHHTTCC------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHcCCC------------------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            66555433111                              0112357889999999999999999999999987

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1e-37  Score=264.29  Aligned_cols=201  Identities=25%  Similarity=0.374  Sum_probs=154.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK   75 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik   75 (280)
                      |+||||+++++++..... .....|+||||+.+ +|.+++..    ...+++.++..++.|++.||.|||+.||+|||||
T Consensus        83 l~h~~iv~~~~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlk  161 (317)
T 2buj_A           83 FNHPNILRLVAYCLRERG-AKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLK  161 (317)
T ss_dssp             CCCTTBCCCCEEEEEEET-TEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred             cCCCCeeeEEEEEEeccC-CCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence            589999999999974311 11578999999985 99998864    4679999999999999999999999999999999


Q ss_pred             CCceEEcCCCCeEEeecccccccCCCCc----------cccceeccccccccccccCC--CCCcchhHHHHHHHHHHHHh
Q 023568           76 PSNLLLNASCDLKIGDFGLARTTSETDF----------MTEYVVTRWYRAPELLLNCT--EYTAAIDIWSVGCILGEIMT  143 (280)
Q Consensus        76 ~~Nili~~~~~~kl~dfg~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~--~~~~~~DvwslG~~l~~ll~  143 (280)
                      |+||+++.++.++|+|||.+........          .....|++.|+|||++.+..  .++.++||||||+++|+|++
T Consensus       162 p~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~  241 (317)
T 2buj_A          162 PTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMF  241 (317)
T ss_dssp             GGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHH
T ss_pred             HHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHh
Confidence            9999999999999999998875432211          12335688999999986522  26789999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCC
Q 023568          144 REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT  223 (280)
Q Consensus       144 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt  223 (280)
                      |+.||.......                      .........      .......+..++.+.++|.+||+.||.+|||
T Consensus       242 g~~p~~~~~~~~----------------------~~~~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps  293 (317)
T 2buj_A          242 GEGPYDMVFQKG----------------------DSVALAVQN------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPH  293 (317)
T ss_dssp             SSCTTHHHHHTT----------------------SCHHHHHHC------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred             CCCChhhhhccc----------------------chhhHHhhc------cCCCCccccCCHHHHHHHHHHhhcChhhCCC
Confidence            999985311000                      000000000      0001112457899999999999999999999


Q ss_pred             HHHHhcC
Q 023568          224 VEEALRH  230 (280)
Q Consensus       224 ~~ell~h  230 (280)
                      +++++++
T Consensus       294 ~~~ll~~  300 (317)
T 2buj_A          294 IPLLLSQ  300 (317)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            9999985

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2.3e-37  Score=267.39  Aligned_cols=190  Identities=17%  Similarity=0.211  Sum_probs=153.2

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS-----DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK   75 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~-----~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik   75 (280)
                      .|+||+++++++...     +..|+||||++ |+|.+++..     .+.+++.++..++.||+.||+|||+.||+|||||
T Consensus       125 ~~~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiK  199 (365)
T 3e7e_A          125 MQHMFMKFYSAHLFQ-----NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIK  199 (365)
T ss_dssp             GGGGBCCEEEEEECS-----SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCS
T ss_pred             hhhhhhhhheeeecC-----CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCC
Confidence            399999999999987     67999999997 699999973     4679999999999999999999999999999999


Q ss_pred             CCceEEcC-----------CCCeEEeecccccccC---CCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHH
Q 023568           76 PSNLLLNA-----------SCDLKIGDFGLARTTS---ETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI  141 (280)
Q Consensus        76 ~~Nili~~-----------~~~~kl~dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l  141 (280)
                      |+|||++.           ++.+||+|||+++...   .........||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus       200 p~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el  278 (365)
T 3e7e_A          200 PDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCM  278 (365)
T ss_dssp             GGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT-CCBSTHHHHHHHHHHHHHH
T ss_pred             HHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC-CCCCccccHHHHHHHHHHH
Confidence            99999988           8999999999996432   3333456779999999999987 6689999999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCC
Q 023568          142 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKR  221 (280)
Q Consensus       142 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~R  221 (280)
                      ++|+.||......              ...                   ....+..  ...+..+.+++..||+.+|.+|
T Consensus       279 ltg~~pf~~~~~~--------------~~~-------------------~~~~~~~--~~~~~~~~~~~~~~l~~~p~~r  323 (365)
T 3e7e_A          279 LFGTYMKVKNEGG--------------ECK-------------------PEGLFRR--LPHLDMWNEFFHVMLNIPDCHH  323 (365)
T ss_dssp             HHSSCCCEEEETT--------------EEE-------------------ECSCCTT--CSSHHHHHHHHHHHHCCCCTTC
T ss_pred             HhCCCccccCCCC--------------cee-------------------echhccc--cCcHHHHHHHHHHHcCCCCCCc
Confidence            9999998654210              000                   0000000  0236678899999999999999


Q ss_pred             CCHHHHhcCcc
Q 023568          222 ITVEEALRHPY  232 (280)
Q Consensus       222 pt~~ell~hp~  232 (280)
                      ++..+.+.+.+
T Consensus       324 ~~~~~~l~~~l  334 (365)
T 3e7e_A          324 LPSLDLLRQKL  334 (365)
T ss_dssp             CCCHHHHHHHH
T ss_pred             chHHHHHHHHH
Confidence            76555555443

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.5e-37  Score=261.02  Aligned_cols=211  Identities=18%  Similarity=0.341  Sum_probs=158.0

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      |+||||+++++++.....   ..+++||||++ ++|.+++.+. ..+++.++..++.|++.||.|||+.||+||||||+|
T Consensus        99 l~h~~iv~~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~N  175 (326)
T 2w1i_A           99 LQHDNIVKYKGVCYSAGR---RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRN  175 (326)
T ss_dssp             CCCTTBCCEEEEECC-------CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred             CCCCCeeeEEEEEEecCC---CceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcce
Confidence            589999999999876532   46899999997 5999999765 469999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCc----cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDF----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV  154 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~  154 (280)
                      |+++.++.++|+|||++........    .....++..|+|||.+.+ ..++.++||||||+++|+|++|..||..... 
T Consensus       176 Ili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~~~~~~~~-  253 (326)
T 2w1i_A          176 ILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSPPA-  253 (326)
T ss_dssp             EEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH-
T ss_pred             EEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcC-CCCCchhhHHHHHHHHHHHHhcCCCCCCCHH-
Confidence            9999999999999999987654321    233456778999999877 6678999999999999999999988864311 


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                          ......+.......      ........+   .........+..++.+.++|++||+.||.+|||+.++++
T Consensus       254 ----~~~~~~~~~~~~~~------~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          254 ----EFMRMIGNDKQGQM------IVFHLIELL---KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             ----HHHHHHCTTCCTHH------HHHHHHHHH---HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ----HHHHhhccccchhh------hHHHHHHHh---hcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                11111111111000      000000000   001111223467899999999999999999999999986

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=4.4e-37  Score=273.83  Aligned_cols=200  Identities=17%  Similarity=0.209  Sum_probs=156.3

Q ss_pred             CCC-cccccccccccCCCCCCCCcEEEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEH-ENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~H-pniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      |+| ++|..+..++...     ...+|||||++++|.+++.. .+.+++.++..++.||+.||.|||++||+||||||+|
T Consensus        59 L~~~~~i~~i~~~~~~~-----~~~~lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~N  133 (483)
T 3sv0_A           59 LQGGTGIPNVRWFGVEG-----DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN  133 (483)
T ss_dssp             TTTSTTCCCEEEEEEET-----TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred             hcCCCCCCeEEEEEeeC-----CEEEEEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcce
Confidence            345 5555555555554     67899999998899999975 5689999999999999999999999999999999999


Q ss_pred             eEE---cCCCCeEEeecccccccCCCCc--------cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 023568           79 LLL---NASCDLKIGDFGLARTTSETDF--------MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL  147 (280)
Q Consensus        79 ili---~~~~~~kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~p  147 (280)
                      ||+   +.++.++|+|||+++.......        .....||..|+|||++.+ ..++.++|||||||++|+|++|+.|
T Consensus       134 ILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDvwSlGvil~elltG~~P  212 (483)
T 3sv0_A          134 FLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLG-IEQSRRDDLESLGYVLMYFLRGSLP  212 (483)
T ss_dssp             EEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred             EEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcC-CCCChHHHHHHHHHHHHHHHhCCCC
Confidence            999   6889999999999986554321        225678999999999987 7789999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 023568          148 FPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA  227 (280)
Q Consensus       148 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~el  227 (280)
                      |.+.........+.+.....                       ...........++..+.++|.+||+.||.+||+++++
T Consensus       213 f~~~~~~~~~~~~~~i~~~~-----------------------~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el  269 (483)
T 3sv0_A          213 WQGLKAGTKKQKYEKISEKK-----------------------VATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYL  269 (483)
T ss_dssp             TSSCCCSSHHHHHHHHHHHH-----------------------HHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHH
T ss_pred             CccccchhHHHHHHHHhhcc-----------------------ccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHH
Confidence            98865422222221111000                       0011112223668999999999999999999999988


Q ss_pred             hc
Q 023568          228 LR  229 (280)
Q Consensus       228 l~  229 (280)
                      ++
T Consensus       270 ~~  271 (483)
T 3sv0_A          270 KR  271 (483)
T ss_dssp             HH
T ss_pred             HH
Confidence            74

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=8.7e-37  Score=261.18  Aligned_cols=203  Identities=20%  Similarity=0.286  Sum_probs=155.2

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH--------hCCccc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH--------SASVLH   71 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH--------~~~i~H   71 (280)
                      ++||||+++++++..... ....+|+||||+++ +|.+++.+ ..+++.++..++.|++.||.|||        +.||+|
T Consensus        93 l~h~ni~~~~~~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH  170 (342)
T 1b6c_B           93 LRHENILGFIAADNKDNG-TWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAH  170 (342)
T ss_dssp             CCCTTBCCEEEEEECCCS-SCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEEC
T ss_pred             cCCCcEEEEEeeecccCC-ccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeee
Confidence            579999999999987631 11379999999985 99999976 57999999999999999999999        899999


Q ss_pred             cCCCCCceEEcCCCCeEEeecccccccCCCC-----ccccceeccccccccccccCCC-----CCcchhHHHHHHHHHHH
Q 023568           72 RDLKPSNLLLNASCDLKIGDFGLARTTSETD-----FMTEYVVTRWYRAPELLLNCTE-----YTAAIDIWSVGCILGEI  141 (280)
Q Consensus        72 ~dik~~Nili~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~-----~~~~~DvwslG~~l~~l  141 (280)
                      |||||+||+++.++.++|+|||++.......     ......||+.|+|||++.+...     ++.++|||||||++|+|
T Consensus       171 ~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el  250 (342)
T 1b6c_B          171 RDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI  250 (342)
T ss_dssp             SCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHH
Confidence            9999999999999999999999997654432     2345578999999999876322     22689999999999999


Q ss_pred             HhC----------CCCCCCCCh----HHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccC--CCCCHH
Q 023568          142 MTR----------EPLFPGKDY----VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF--PNKSSG  205 (280)
Q Consensus       142 l~g----------~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  205 (280)
                      ++|          ..||.....    .........  .                       .......+..+  ...+..
T Consensus       251 ~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~--~-----------------------~~~~~~~~~~~~~~~~~~~  305 (342)
T 1b6c_B          251 ARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC--E-----------------------QKLRPNIPNRWQSCEALRV  305 (342)
T ss_dssp             HTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHT--T-----------------------SCCCCCCCGGGGTSHHHHH
T ss_pred             HhccCcCCcccccccCccccCcCcccHHHHHHHHH--H-----------------------HHhCCCCcccccchhHHHH
Confidence            999          677765421    111111110  0                       00000111111  123467


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcC
Q 023568          206 AVDLLEKMLVFDPNKRITVEEALRH  230 (280)
Q Consensus       206 ~~~ll~~~L~~dp~~Rpt~~ell~h  230 (280)
                      +.+++.+||+.||.+|||+++++++
T Consensus       306 l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          306 MAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             HHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHhccChhhCCCHHHHHHH
Confidence            8899999999999999999999974

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.2e-37  Score=273.23  Aligned_cols=178  Identities=19%  Similarity=0.240  Sum_probs=147.3

Q ss_pred             CcEEEEEecCCccHHHHHH------c-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEeeccc
Q 023568           22 NDVYIVYELMDTDLHQIIR------S-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGL   94 (280)
Q Consensus        22 ~~~~lv~e~~~g~L~~~l~------~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nili~~~~~~kl~dfg~   94 (280)
                      ...+++|+++.++|.+++.      . .+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus       178 ~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~~kL~DFG~  257 (413)
T 3dzo_A          178 LSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEH  257 (413)
T ss_dssp             CSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGG
T ss_pred             cceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCCeEEEEeccc
Confidence            4589999999999999884      1 24588899999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCccccceeccccccccccc---------cCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 023568           95 ARTTSETDFMTEYVVTRWYRAPELLL---------NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIG  165 (280)
Q Consensus        95 ~~~~~~~~~~~~~~~~~~y~aPE~~~---------~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~i~~~~~  165 (280)
                      ++..+..  .....| +.|+|||++.         ....++.++|||||||++|+|++|+.||.+.+......       
T Consensus       258 a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~-------  327 (413)
T 3dzo_A          258 LVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSE-------  327 (413)
T ss_dssp             CEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSG-------
T ss_pred             eeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHH-------
Confidence            8875544  345567 9999999983         22557789999999999999999999997754211000       


Q ss_pred             CCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCc
Q 023568          166 SPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  237 (280)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~  237 (280)
                                                  ......+.+++.+.+||.+||+.||.+|||+.++++||||+.+.
T Consensus       328 ----------------------------~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~  371 (413)
T 3dzo_A          328 ----------------------------WIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR  371 (413)
T ss_dssp             ----------------------------GGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             ----------------------------HHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHH
Confidence                                        00111235789999999999999999999999999999998753

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.2e-37  Score=266.23  Aligned_cols=196  Identities=16%  Similarity=0.156  Sum_probs=147.2

Q ss_pred             CcccccccccccCCCCC--------CCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccc
Q 023568            3 HENVIAIKDIIRPPKKD--------TFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH-SASVLHR   72 (280)
Q Consensus         3 Hpniv~l~~~~~~~~~~--------~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH-~~~i~H~   72 (280)
                      ||||++++++|.+....        ....+|+||||+. |++.+.+.+ +.+++.+++.++.||+.||+||| +.||+||
T Consensus       108 hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHr  186 (336)
T 2vuw_A          108 PPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFEHR  186 (336)
T ss_dssp             CHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHHHHHHHCCBCS
T ss_pred             cHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHhCCEeEC
Confidence            78888888888761100        1267999999996 556666544 67999999999999999999999 9999999


Q ss_pred             CCCCCceEEcCCC--------------------CeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHH
Q 023568           73 DLKPSNLLLNASC--------------------DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIW  132 (280)
Q Consensus        73 dik~~Nili~~~~--------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dvw  132 (280)
                      ||||+|||++.++                    .+||+|||+++.....    ...||+.|+|||++.+..  +.++|||
T Consensus       187 DlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g~~--~~~~Diw  260 (336)
T 2vuw_A          187 DLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTGDG--DYQFDIY  260 (336)
T ss_dssp             CCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCCCS--SHHHHHH
T ss_pred             CCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcCCC--ccceehh
Confidence            9999999999887                    8999999999876543    458899999999998733  8899999


Q ss_pred             HHHHH-HHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHH
Q 023568          133 SVGCI-LGEIMTREPLFPGKDYVH-QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLL  210 (280)
Q Consensus       133 slG~~-l~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll  210 (280)
                      |+|++ .++++.|..||.+..... ....+......                        ........++.+++++++||
T Consensus       261 sl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~s~~~~dli  316 (336)
T 2vuw_A          261 RLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTF------------------------KTKCNTPAMKQIKRKIQEFH  316 (336)
T ss_dssp             HHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCC------------------------SSCCCSHHHHHHHHHHHHHH
T ss_pred             hhhCCCCcccccccCCCcchhhhhHHHHhhhhhhcc------------------------CcccchhhhhhcCHHHHHHH
Confidence            98777 777888998885422111 11111111000                        00111112234688999999


Q ss_pred             HHhcccCCCCCCCHHHHh-cCcccc
Q 023568          211 EKMLVFDPNKRITVEEAL-RHPYLQ  234 (280)
Q Consensus       211 ~~~L~~dp~~Rpt~~ell-~hp~~~  234 (280)
                      ++||+.|     |++|+| +||||+
T Consensus       317 ~~~L~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          317 RTMLNFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             HHGGGSS-----SHHHHHHHCGGGC
T ss_pred             HHHhccC-----CHHHHHhcCCCcC
Confidence            9999977     999999 999995

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=7.2e-36  Score=277.32  Aligned_cols=191  Identities=25%  Similarity=0.358  Sum_probs=152.3

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+||||+++++++......+....||||||++| +|.+++..  .+++.++..++.||+.||.|||++||+||||||+||
T Consensus       136 l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NI  213 (681)
T 2pzi_A          136 VVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENI  213 (681)
T ss_dssp             CCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             cCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHe
Confidence            589999999999987633222237999999985 99888744  899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.+ .+||+|||+++.....   ....||+.|+|||++.+  ..+.++|||||||++|+|++|.+||.+....     
T Consensus       214 ll~~~-~~kl~DFG~a~~~~~~---~~~~gt~~y~aPE~~~~--~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~-----  282 (681)
T 2pzi_A          214 MLTEE-QLKLIDLGAVSRINSF---GYLYGTPGFQAPEIVRT--GPTVATDIYTVGRTLAALTLDLPTRNGRYVD-----  282 (681)
T ss_dssp             EECSS-CEEECCCTTCEETTCC---SCCCCCTTTSCTTHHHH--CSCHHHHHHHHHHHHHHHHSCCCEETTEECS-----
T ss_pred             EEeCC-cEEEEecccchhcccC---CccCCCccccCHHHHcC--CCCCceehhhhHHHHHHHHhCCCCCcccccc-----
Confidence            99885 8999999999876543   45678999999999876  3488999999999999999999888653100     


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  236 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~  236 (280)
                           +.+         ..                  ......++.+.++|.+||+.||.+||+..+.+.|+|+..+
T Consensus       283 -----~~~---------~~------------------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          283 -----GLP---------ED------------------DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             -----SCC---------TT------------------CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             -----ccc---------cc------------------ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence                 000         00                  0000236789999999999999999999999999988643

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.9e-33  Score=234.98  Aligned_cols=170  Identities=13%  Similarity=0.082  Sum_probs=134.5

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++||||+++++++.+.     +..|+||||++ ++|.++++.  .....++..++.|++.||+|||++||+||||||+||
T Consensus        88 l~hp~iv~~~~~~~~~-----~~~~lv~e~~~g~~L~~~l~~--~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NI  160 (286)
T 3uqc_A           88 IDKPGVARVLDVVHTR-----AGGLVVAEWIRGGSLQEVADT--SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRV  160 (286)
T ss_dssp             CCCTTBCCEEEEEEET-----TEEEEEEECCCEEEHHHHHTT--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGE
T ss_pred             CCCCCcceeeEEEEEC-----CcEEEEEEecCCCCHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccE
Confidence            5899999999999987     77999999997 499999854  346667899999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.++.++|++++                   |++        .++.++|||||||++|+|++|+.||.+.+....+. 
T Consensus       161 ll~~~g~~kl~~~~-------------------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~-  212 (286)
T 3uqc_A          161 RVSIDGDVVLAYPA-------------------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA-  212 (286)
T ss_dssp             EEETTSCEEECSCC-------------------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE-
T ss_pred             EEcCCCCEEEEecc-------------------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH-
Confidence            99999999998543                   222        36789999999999999999999998764211000 


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                                ....             .............+.+++.+.++|.+||+.||.+| |++|+++
T Consensus       213 ----------~~~~-------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~  258 (286)
T 3uqc_A          213 ----------PAER-------------DTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN  258 (286)
T ss_dssp             ----------ECCB-------------CTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred             ----------HHHH-------------HhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence                      0000             00000111122345789999999999999999999 9999998

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=1.2e-33  Score=256.34  Aligned_cols=134  Identities=18%  Similarity=0.171  Sum_probs=103.4

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      .|+||++++++++++     +.+||||||++| +|.++|.+.+.+++.   .|+.||+.||+|+|++||+||||||+|||
T Consensus       300 ~~~~i~~~~~~~ed~-----~~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNIL  371 (569)
T 4azs_A          300 AGFDAPAVLAHGENA-----QSGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVM  371 (569)
T ss_dssp             TTCCCCCEEEEEECS-----SEEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEE
T ss_pred             CCCCeeEEEEEEEEC-----CEEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEE
Confidence            599999999999998     789999999986 999999998889875   47899999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCC
Q 023568           81 LNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTRE  145 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~  145 (280)
                      ++.+|.+||+|||+++..... ....+.+||+.|+|||++.+  ....++|+||+|++++++.++.
T Consensus       372 L~~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~  435 (569)
T 4azs_A          372 VDARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPW  435 (569)
T ss_dssp             ECTTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC-------------------CCCCTTH
T ss_pred             ECCCCCEEEeecccCeeCCCCCccccCceechhhccHHHhCC--CCCCcccccccccchhhhcccc
Confidence            999999999999999865443 34456789999999999876  4567899999999988776554

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.87  E-value=6.5e-24  Score=191.59  Aligned_cols=133  Identities=19%  Similarity=0.243  Sum_probs=110.0

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+||||+++..++...     ...||||||++ ++|.+++.+        +..++.|++.||.|||++||+||||||+||
T Consensus       396 l~h~nIv~~~~~~~~~-----~~~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NI  462 (540)
T 3en9_A          396 VKDFGIPAPYIFDVDL-----DNKRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNF  462 (540)
T ss_dssp             GGGGTCCCCCEEEEET-----TTTEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSE
T ss_pred             cCCCCcCceEEEEEeC-----CccEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHE
Confidence            5799999555544444     44799999997 699999865        678999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCc--------cccceecccccccccccc-CCCCCcchhHHHHHHHHHHHHhCCCCC
Q 023568           80 LLNASCDLKIGDFGLARTTSETDF--------MTEYVVTRWYRAPELLLN-CTEYTAAIDIWSVGCILGEIMTREPLF  148 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~-~~~~~~~~DvwslG~~l~~ll~g~~pf  148 (280)
                      |++.  .+||+|||+++.......        .....||+.|+|||++.+ ...|+..+|+|+.++-..+.+.++.+|
T Consensus       463 Ll~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          463 IFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             EESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             EECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            9998  999999999988765421        235688999999999864 134677889999999988888777655

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.63  E-value=1.1e-16  Score=132.95  Aligned_cols=88  Identities=20%  Similarity=0.235  Sum_probs=71.0

Q ss_pred             ccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC
Q 023568            7 IAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASC   85 (280)
Q Consensus         7 v~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nili~~~~   85 (280)
                      +++.+++..      +..|+||||++| +|.+ +.      ......++.|++.||.|||+.||+||||||+|||++ ++
T Consensus       164 ~~v~~~~~~------~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~  229 (282)
T 1zar_A          164 LAVPKVYAW------EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EE  229 (282)
T ss_dssp             SSSCCEEEE------ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TT
T ss_pred             CCcCeEEec------cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CC
Confidence            666665543      346999999975 9988 42      133557999999999999999999999999999999 99


Q ss_pred             CeEEeecccccccCCCCccccceeccccccccccc
Q 023568           86 DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL  120 (280)
Q Consensus        86 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~  120 (280)
                      .++|+|||+++..            ..+.|||.+.
T Consensus       230 ~vkl~DFG~a~~~------------~~~~a~e~l~  252 (282)
T 1zar_A          230 GIWIIDFPQSVEV------------GEEGWREILE  252 (282)
T ss_dssp             EEEECCCTTCEET------------TSTTHHHHHH
T ss_pred             cEEEEECCCCeEC------------CCCCHHHHHH
Confidence            9999999998643            3457888764

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.52  E-value=4.4e-15  Score=121.69  Aligned_cols=72  Identities=19%  Similarity=0.284  Sum_probs=61.5

Q ss_pred             cEEEEEecCCc------cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCceEEcCCCCeEEeecccc
Q 023568           23 DVYIVYELMDT------DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVH-SASVLHRDLKPSNLLLNASCDLKIGDFGLA   95 (280)
Q Consensus        23 ~~~lv~e~~~g------~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH-~~~i~H~dik~~Nili~~~~~~kl~dfg~~   95 (280)
                      ..+|||||+++      +|.++...   .++..+..++.|++.||.+|| +.||+||||||+|||++.  .++|+|||++
T Consensus       142 ~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl~~--~~~liDFG~a  216 (258)
T 1zth_A          142 KNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID--KVYFIDMGQA  216 (258)
T ss_dssp             TTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEESS--SEEECCCTTC
T ss_pred             CCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC--cEEEEECccc
Confidence            36899999953      67776533   346678899999999999999 999999999999999988  8999999998


Q ss_pred             cccC
Q 023568           96 RTTS   99 (280)
Q Consensus        96 ~~~~   99 (280)
                      ....
T Consensus       217 ~~~~  220 (258)
T 1zth_A          217 VTLR  220 (258)
T ss_dssp             EETT
T ss_pred             ccCC
Confidence            7653

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.31  E-value=5.5e-13  Score=114.25  Aligned_cols=91  Identities=16%  Similarity=0.137  Sum_probs=66.7

Q ss_pred             CcccccccccccCC-CCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            3 HENVIAIKDIIRPP-KKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         3 Hpniv~l~~~~~~~-~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      |+|+++++...... .+-.....+|||||++| +|.++.      ....+..++.|++.+|.+||++||+||||||.|||
T Consensus       164 ~~nL~rL~~~gv~vp~p~~~~~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NIL  237 (397)
T 4gyi_A          164 FAFMKALYEEGFPVPEPIAQSRHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNIL  237 (397)
T ss_dssp             HHHHHHHHHTTCSCCCEEEEETTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEE
T ss_pred             HHHHHHHHhcCCCCCeeeeccCceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEE
Confidence            67888887665432 11000123699999987 665442      12345678899999999999999999999999999


Q ss_pred             EcCCCC----------eEEeecccccccC
Q 023568           81 LNASCD----------LKIGDFGLARTTS   99 (280)
Q Consensus        81 i~~~~~----------~kl~dfg~~~~~~   99 (280)
                      ++.++.          +.++||+-+....
T Consensus       238 l~~dgd~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          238 IREEKDAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             EEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred             EeCCCCcccccccccceEEEEeCCcccCC
Confidence            987763          8899999776543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=98.78  E-value=6.6e-09  Score=84.78  Aligned_cols=84  Identities=14%  Similarity=0.085  Sum_probs=65.9

Q ss_pred             CcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---------------
Q 023568            3 HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS---------------   66 (280)
Q Consensus         3 Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~---------------   66 (280)
                      |..+.++++++.+.     +..|+|||+++| +|.+.+.     +......++.++..+|+.||+               
T Consensus        69 ~~~vP~v~~~~~~~-----~~~~lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~  138 (263)
T 3tm0_A           69 KLPVPKVLHFERHD-----GWSNLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSR  138 (263)
T ss_dssp             TSCCCCEEEEEEET-----TEEEEEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHH
T ss_pred             CCCCCeEEEEEecC-----CceEEEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHH
Confidence            45677888888765     678999999998 7776631     223345788899999999998               


Q ss_pred             --------------------------------------------CCccccCCCCCceEEcCCCCeEEeeccccc
Q 023568           67 --------------------------------------------ASVLHRDLKPSNLLLNASCDLKIGDFGLAR   96 (280)
Q Consensus        67 --------------------------------------------~~i~H~dik~~Nili~~~~~~kl~dfg~~~   96 (280)
                                                                  .+++|+|+++.||+++.++.+.|+||+.+.
T Consensus       139 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          139 LAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                                        448999999999999876556799998653

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.53  E-value=1.1e-07  Score=81.27  Aligned_cols=92  Identities=14%  Similarity=0.221  Sum_probs=70.8

Q ss_pred             CcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---------------
Q 023568            3 HENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS---------------   66 (280)
Q Consensus         3 Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~---------------   66 (280)
                      +..+.+++.++.+..  ..+..|+|||+++| .+.+..  ...++..+...++.+++.+|+.||+               
T Consensus        97 ~vpvP~~~~~~~~~~--~~g~~~~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~  172 (359)
T 3dxp_A           97 DVPVAKMYALCEDES--VIGRAFYIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPG  172 (359)
T ss_dssp             SSCCCCEEEEECCTT--TTSSCEEEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCS
T ss_pred             CCCCCcEEEECCCCC--ccCCeEEEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCC
Confidence            345777887776552  11457999999997 553321  2457889999999999999999997               


Q ss_pred             -------------------------------------------CCccccCCCCCceEEcCCCC--eEEeeccccccc
Q 023568           67 -------------------------------------------ASVLHRDLKPSNLLLNASCD--LKIGDFGLARTT   98 (280)
Q Consensus        67 -------------------------------------------~~i~H~dik~~Nili~~~~~--~kl~dfg~~~~~   98 (280)
                                                                 .+++|+|+++.||+++.++.  +.|+||+.+...
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          173 NYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             CHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             CchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                                                       35899999999999987653  689999988653

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.51  E-value=4e-08  Score=82.03  Aligned_cols=121  Identities=18%  Similarity=0.197  Sum_probs=81.4

Q ss_pred             cEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------
Q 023568           23 DVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS-----------------------------------   66 (280)
Q Consensus        23 ~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~-----------------------------------   66 (280)
                      ..|+||++++| +|.+...  ..++.++...++.|+...++.||+                                   
T Consensus        90 ~~~~vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (304)
T 3sg8_A           90 MSFAGFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKG  167 (304)
T ss_dssp             CSCEEEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCH
T ss_pred             cceEEEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCc
Confidence            45899999998 6654332  457888888899999999998886                                   


Q ss_pred             -----------------------CCccccCCCCCceEEcC--CCCeEEeecccccccCCCCc---cccc---ee------
Q 023568           67 -----------------------ASVLHRDLKPSNLLLNA--SCDLKIGDFGLARTTSETDF---MTEY---VV------  109 (280)
Q Consensus        67 -----------------------~~i~H~dik~~Nili~~--~~~~kl~dfg~~~~~~~~~~---~~~~---~~------  109 (280)
                                             ..++|+|+++.||+++.  .+.+.++||+.+........   ....   .+      
T Consensus       168 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~  247 (304)
T 3sg8_A          168 PQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSK  247 (304)
T ss_dssp             HHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHH
T ss_pred             ccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHH
Confidence                                   13699999999999988  45578999998875433210   0000   00      


Q ss_pred             ---cccccc-ccccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 023568          110 ---TRWYRA-PELLLNCTEYTAAIDIWSVGCILGEIMTREPLF  148 (280)
Q Consensus       110 ---~~~y~a-PE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf  148 (280)
                         ...... |+....   .....+.|++|.+++.+.+|..+|
T Consensus       248 ~l~~Y~~~~~~~~~~r---~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          248 ILNHYKHKDIPTVLEK---YRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHTCSCHHHHHHH---HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHcCCCCcHHHHHH---HHHHHHHHHHHHHHHHHHcCCHHH
Confidence               000111 121111   112368999999999999998765

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.50  E-value=7.6e-08  Score=78.09  Aligned_cols=79  Identities=15%  Similarity=0.171  Sum_probs=58.5

Q ss_pred             cccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------
Q 023568            6 VIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS----------------   68 (280)
Q Consensus         6 iv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~----------------   68 (280)
                      +.+++++....     +..++|||+++| +| + .   ...+   ...++.++...|+.||+..                
T Consensus        77 vP~~~~~~~~~-----~~~~~v~e~i~G~~l-~-~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~  143 (264)
T 1nd4_A           77 CAAVLDVVTEA-----GRDWLLLGEVPGQDL-L-S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIER  143 (264)
T ss_dssp             BCCEEEEEECS-----SCEEEEEECCSSEET-T-T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHH
T ss_pred             CCeEEEeccCC-----CCCEEEEEecCCccc-C-c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHH
Confidence            55677777665     568999999987 66 3 2   1122   2356777888888888753                


Q ss_pred             ------------------------------------------ccccCCCCCceEEcCCCCeEEeecccccc
Q 023568           69 ------------------------------------------VLHRDLKPSNLLLNASCDLKIGDFGLART   97 (280)
Q Consensus        69 ------------------------------------------i~H~dik~~Nili~~~~~~kl~dfg~~~~   97 (280)
                                                                ++|+|++|.||+++.++.+.|+||+.+..
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          144 ARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                                      99999999999998776567999997643

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=98.09  E-value=0.00012  Score=57.07  Aligned_cols=96  Identities=16%  Similarity=0.134  Sum_probs=64.7

Q ss_pred             cHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEcCCCCeEEeecccccccCCCCccccceecc
Q 023568           34 DLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTR  111 (280)
Q Consensus        34 ~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~-~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  111 (280)
                      +|.++|+. +.+++|++++.++.|.+.+|.-+-. +.-..+=+.|..|++..+|.|.+.+ ..+.           ....
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~~~~  101 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------AGEP  101 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------cccc
Confidence            79999874 5789999999999999999887622 2212333457899999999988774 1110           1122


Q ss_pred             ccccccccccCCCCCcchhHHHHHHHHHHHHh
Q 023568          112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMT  143 (280)
Q Consensus       112 ~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~  143 (280)
                      .+.|||...  ...+.+.=|+|||+++|.-+-
T Consensus       102 ~~~~pe~~~--~~~te~~~IysLG~tLY~ALD  131 (229)
T 2yle_A          102 PPVAGKLGY--SQCMETEVIESLGIIIYKALD  131 (229)
T ss_dssp             -----CCSS--SSSCHHHHHHHHHHHHHHHHT
T ss_pred             CCCChhhcc--ccchHHHHHHHHHHHHHHHhh
Confidence            356787652  355678899999999999876

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=97.69  E-value=0.00012  Score=60.86  Aligned_cols=76  Identities=25%  Similarity=0.298  Sum_probs=54.4

Q ss_pred             CcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------
Q 023568           22 NDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA---------------------------------   67 (280)
Q Consensus        22 ~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~---------------------------------   67 (280)
                      +..|+|||+++| .+.+...  ..++..+...++.|+...|+.||+.                                 
T Consensus        86 g~~~~v~e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~  163 (306)
T 3tdw_A           86 GNPFVGYRKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPL  163 (306)
T ss_dssp             SCEEEEEECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGG
T ss_pred             CceEEEEeccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccc
Confidence            457899999998 6655321  3455666666666666666666642                                 


Q ss_pred             ---------------------------CccccCCCCCceEEcC---CCCe-EEeecccccccC
Q 023568           68 ---------------------------SVLHRDLKPSNLLLNA---SCDL-KIGDFGLARTTS   99 (280)
Q Consensus        68 ---------------------------~i~H~dik~~Nili~~---~~~~-kl~dfg~~~~~~   99 (280)
                                                 .++|+|+++.||+++.   ++.+ .|+||+.+....
T Consensus       164 l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd  226 (306)
T 3tdw_A          164 LDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD  226 (306)
T ss_dssp             SCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred             cchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence                                       3589999999999987   4565 799999886543

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=97.62  E-value=0.00011  Score=59.65  Aligned_cols=83  Identities=23%  Similarity=0.315  Sum_probs=56.8

Q ss_pred             cccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------
Q 023568            6 VIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSA-----------------   67 (280)
Q Consensus         6 iv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~-----------------   67 (280)
                      +.+++++.++.     +..|+|||+++| ++.+.....    ......+..++...|+-||+.                 
T Consensus        82 VP~v~~~~~~~-----~~~~lvme~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~  152 (272)
T 4gkh_A           82 LPTIKHFIRTP-----DDAWLLTTAIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQ  152 (272)
T ss_dssp             CCCEEEEEEET-----TEEEEEEECCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHH
T ss_pred             cCeEEEEEEEC-----CeEEEEEEeeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhh
Confidence            45666776665     568999999987 666654321    122334555555555555531                 


Q ss_pred             -----------------------------------------CccccCCCCCceEEcCCCCeEEeecccccc
Q 023568           68 -----------------------------------------SVLHRDLKPSNLLLNASCDLKIGDFGLART   97 (280)
Q Consensus        68 -----------------------------------------~i~H~dik~~Nili~~~~~~kl~dfg~~~~   97 (280)
                                                               .++|+|+.+.||+++.++.+-|+||+.+..
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          153 AQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                                                     168999999999999877677999997643

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.02  E-value=0.00047  Score=58.39  Aligned_cols=31  Identities=16%  Similarity=0.221  Sum_probs=25.7

Q ss_pred             CCccccCCCCCceEEcCCCCeEEeecccccc
Q 023568           67 ASVLHRDLKPSNLLLNASCDLKIGDFGLART   97 (280)
Q Consensus        67 ~~i~H~dik~~Nili~~~~~~kl~dfg~~~~   97 (280)
                      ..++|+|+.+.||+++.+..+.|+||+.+..
T Consensus       222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~  252 (357)
T 3ats_A          222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVAL  252 (357)
T ss_dssp             CEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred             ceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence            4689999999999999644478999997754

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=96.46  E-value=0.004  Score=52.08  Aligned_cols=30  Identities=20%  Similarity=0.292  Sum_probs=27.0

Q ss_pred             CCccccCCCCCceEEcCCCCeEEeeccccc
Q 023568           67 ASVLHRDLKPSNLLLNASCDLKIGDFGLAR   96 (280)
Q Consensus        67 ~~i~H~dik~~Nili~~~~~~kl~dfg~~~   96 (280)
                      .+++|+|+++.||+++.++.+.++||+.+.
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            579999999999999888889999999764

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=95.93  E-value=0.015  Score=47.93  Aligned_cols=31  Identities=19%  Similarity=0.202  Sum_probs=25.7

Q ss_pred             CccccCCCCCceEEcCCCCeEEeecccccccC
Q 023568           68 SVLHRDLKPSNLLLNASCDLKIGDFGLARTTS   99 (280)
Q Consensus        68 ~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~   99 (280)
                      .++|+|+.+.||+ ..++.+.++||+.+....
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g~  204 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSGMND  204 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEEEC
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEecccccCCC
Confidence            3899999999999 566779999999876433

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=95.93  E-value=0.016  Score=49.74  Aligned_cols=32  Identities=19%  Similarity=0.300  Sum_probs=26.3

Q ss_pred             hCCccccCCCCCceEEcCCCCeEEeeccccccc
Q 023568           66 SASVLHRDLKPSNLLLNASCDLKIGDFGLARTT   98 (280)
Q Consensus        66 ~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~   98 (280)
                      ...++|||+.+.||+++.+ .+.++||..+...
T Consensus       226 ~~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~G  257 (397)
T 2olc_A          226 AETLIHGDLHTGSIFASEH-ETKVIDPEFAFYG  257 (397)
T ss_dssp             CCEEECSCCSGGGEEECSS-CEEECCCTTCEEE
T ss_pred             CCceeeCCCCcCcEEEeCC-CeEEEeCcccccC
Confidence            3569999999999999876 4899999876543

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=95.44  E-value=0.013  Score=50.81  Aligned_cols=79  Identities=9%  Similarity=-0.002  Sum_probs=46.5

Q ss_pred             HhCCccccCCCCCceEEcCCCCeEEeecccccccCCCCcccccee--ccccccccccccCCC--CCcchhHHHHHHHHHH
Q 023568           65 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVV--TRWYRAPELLLNCTE--YTAAIDIWSVGCILGE  140 (280)
Q Consensus        65 H~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~--~~~y~aPE~~~~~~~--~~~~~DvwslG~~l~~  140 (280)
                      +...++|+|+++.||+++.++ +.++||+.+..............  ...|.+|+.......  .....++.+.+..+|+
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            456799999999999998876 99999998865443211111111  234555554321011  1122444566777777


Q ss_pred             HHhC
Q 023568          141 IMTR  144 (280)
Q Consensus       141 ll~g  144 (280)
                      ...+
T Consensus       309 ~y~~  312 (420)
T 2pyw_A          309 LFNK  312 (420)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            6654

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=93.74  E-value=0.069  Score=44.25  Aligned_cols=30  Identities=27%  Similarity=0.264  Sum_probs=25.4

Q ss_pred             CCccccCCCCCceEEcCCCCeEEeeccccccc
Q 023568           67 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTT   98 (280)
Q Consensus        67 ~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~   98 (280)
                      ..++|+|+++.||+++ + .+.++||+.+...
T Consensus       195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g  224 (328)
T 1zyl_A          195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARNG  224 (328)
T ss_dssp             CEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred             eeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence            4589999999999998 4 8999999877543

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=93.48  E-value=0.03  Score=46.37  Aligned_cols=31  Identities=29%  Similarity=0.283  Sum_probs=25.8

Q ss_pred             CCccccCCCCCceEEcCCCCeEEeecccccc
Q 023568           67 ASVLHRDLKPSNLLLNASCDLKIGDFGLART   97 (280)
Q Consensus        67 ~~i~H~dik~~Nili~~~~~~kl~dfg~~~~   97 (280)
                      .+++|+|+++.||+++.++.+.++||+.+..
T Consensus       187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          187 AGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            3689999999999998876568999987643

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=93.35  E-value=0.042  Score=45.76  Aligned_cols=33  Identities=27%  Similarity=0.365  Sum_probs=27.9

Q ss_pred             CCccccCCCCCceEEcCC----CCeEEeecccccccC
Q 023568           67 ASVLHRDLKPSNLLLNAS----CDLKIGDFGLARTTS   99 (280)
Q Consensus        67 ~~i~H~dik~~Nili~~~----~~~kl~dfg~~~~~~   99 (280)
                      ..++|||+.+.||+++.+    +.+.++||+.+....
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~  219 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH  219 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence            469999999999999874    678999999876543

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=92.98  E-value=0.074  Score=44.56  Aligned_cols=33  Identities=18%  Similarity=0.254  Sum_probs=28.3

Q ss_pred             CCccccCCCCCceEEcCCCCeEEeecccccccC
Q 023568           67 ASVLHRDLKPSNLLLNASCDLKIGDFGLARTTS   99 (280)
Q Consensus        67 ~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~   99 (280)
                      .+++|+|+.+.||+++.++.+.++||+.+....
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~  238 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLAP  238 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEEEC
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeCC
Confidence            358999999999999988889999998876543

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=91.61  E-value=0.15  Score=43.01  Aligned_cols=29  Identities=28%  Similarity=0.535  Sum_probs=24.4

Q ss_pred             CccccCCCCCceEEcCCCCeEEeecccccc
Q 023568           68 SVLHRDLKPSNLLLNASCDLKIGDFGLART   97 (280)
Q Consensus        68 ~i~H~dik~~Nili~~~~~~kl~dfg~~~~   97 (280)
                      +++|+|+.+.||+++.++ +.++||..+..
T Consensus       213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~~  241 (369)
T 3c5i_A          213 VFCHNDLQENNIINTNKC-LRLIDFEYSGF  241 (369)
T ss_dssp             EEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred             EEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence            589999999999998654 89999997753

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=90.87  E-value=0.16  Score=44.44  Aligned_cols=15  Identities=33%  Similarity=0.428  Sum_probs=14.1

Q ss_pred             CccccCCCCCceEEc
Q 023568           68 SVLHRDLKPSNLLLN   82 (280)
Q Consensus        68 ~i~H~dik~~Nili~   82 (280)
                      .++|+|+.+.|||++
T Consensus       291 v~cHnDl~~gNIL~~  305 (458)
T 2qg7_A          291 VLCHCDLLSSNIINT  305 (458)
T ss_dssp             EEECSCCCGGGEEEC
T ss_pred             eEEecCCCCCcEEee
Confidence            489999999999998

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=90.05  E-value=0.11  Score=45.12  Aligned_cols=30  Identities=33%  Similarity=0.438  Sum_probs=24.1

Q ss_pred             CccccCCCCCceEEcCC----------------------------CCeEEeecccccc
Q 023568           68 SVLHRDLKPSNLLLNAS----------------------------CDLKIGDFGLART   97 (280)
Q Consensus        68 ~i~H~dik~~Nili~~~----------------------------~~~kl~dfg~~~~   97 (280)
                      .++|+|+.+.||+++.+                            +.+.|+||+.+..
T Consensus       250 v~~H~Dl~~gNiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lIDfEya~~  307 (429)
T 1nw1_A          250 TFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYASY  307 (429)
T ss_dssp             EEECSCCCGGGEEEEC------------------------------CCEECCCTTCEE
T ss_pred             EEEeCCCCCCeEEeeCCccccccccccccccccccccccccccCCCeEEEEecccCCc
Confidence            48999999999999875                            6788999887753

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=89.50  E-value=0.16  Score=43.30  Aligned_cols=30  Identities=27%  Similarity=0.390  Sum_probs=26.3

Q ss_pred             CccccCCCCCceEEcCC----CCeEEeecccccc
Q 023568           68 SVLHRDLKPSNLLLNAS----CDLKIGDFGLART   97 (280)
Q Consensus        68 ~i~H~dik~~Nili~~~----~~~kl~dfg~~~~   97 (280)
                      .++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             EEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             EEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            48999999999999876    7899999998753

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=88.48  E-value=1.6  Score=33.82  Aligned_cols=113  Identities=13%  Similarity=0.124  Sum_probs=72.8

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-c-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-T-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      .||+.+.. .+-+++     +.+.+.++.-+ + ++.. +   +.++.....+++.+|+....++  ..-+|--+.|+|+
T Consensus        43 ~~~~Fl~~-~I~e~e-----D~v~~~y~~~~~~~~f~~-i---k~~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL  110 (215)
T 4ann_A           43 HSPYFIDA-ELTELR-----DSFQIHYDINDNHTPFDN-I---KSFTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDEL  110 (215)
T ss_dssp             CCTTBCCE-EEEECS-----SEEEEEECCCTTSEEGGG-G---GGSCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGE
T ss_pred             cCCcccce-EEEEcc-----cEEEEEEEcCcccCCHHH-H---HhcCHHHHHHHHHHHHHHHHHh--cCceEEEEecceE
Confidence            35555544 333333     45666666654 3 4444 3   5688999999999999877444  3346778999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF  148 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf  148 (280)
                      +++.++.+++.=.|....                ++|.      ..+...=+-.+=|++..++.++..|
T Consensus       111 ~f~~~~~p~i~~RGik~~----------------l~P~------~~~ee~fL~qyKAliiall~~K~~F  157 (215)
T 4ann_A          111 FFTRDGLPIAKTRGLQNV----------------VDPL------PVSEAEFLTRYKALVICAFNEKQSF  157 (215)
T ss_dssp             EECTTSCEEESCCEETTT----------------BSCC------CCCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred             EEcCCCCEEEEEccCccC----------------CCCC------CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence            999999999986664322                1221      2222333446677888888887655

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=87.97  E-value=0.23  Score=42.58  Aligned_cols=29  Identities=28%  Similarity=0.392  Sum_probs=24.9

Q ss_pred             ccccCCCCCceEE------cCCCCeEEeecccccc
Q 023568           69 VLHRDLKPSNLLL------NASCDLKIGDFGLART   97 (280)
Q Consensus        69 i~H~dik~~Nili------~~~~~~kl~dfg~~~~   97 (280)
                      ++|+|+.+.||++      +.+..+.++||..|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6899999999999      3467799999998864

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=86.03  E-value=4.4  Score=31.41  Aligned_cols=99  Identities=18%  Similarity=0.148  Sum_probs=65.7

Q ss_pred             CcEEEEEecCC-c-cHHHHHHcCCCCCHHHHHHHHHHHHHHHH-HHHhCCccccCCCCCceEEcCCCCeEEeeccccccc
Q 023568           22 NDVYIVYELMD-T-DLHQIIRSDQQLTDDHCQYFLYQLLRGLK-YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT   98 (280)
Q Consensus        22 ~~~~lv~e~~~-g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~-~LH~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~   98 (280)
                      +.+.+.++.-+ + ++..+    +.++..+..+++.+|+.... ++  ..-+|--+.|+|++++.++.+++.=.|.-.. 
T Consensus        61 D~~~i~y~~~~~~~~f~~i----~~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~~~~p~i~hRGi~~~-  133 (219)
T 4ano_A           61 DEVKVVIKPPSSFLTFAAI----RKTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNRALEPFFLHVGVKES-  133 (219)
T ss_dssp             SEEEEEEECCTTCEEHHHH----HTSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECTTCCEEESCCEETTT-
T ss_pred             CEEEEEEEcCcccCcHHHH----HhcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeCCCcEEEEEcCCccc-
Confidence            45777777764 3 55544    46889999999888888655 33  3446778999999999999999987765322 


Q ss_pred             CCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 023568           99 SETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF  148 (280)
Q Consensus        99 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf  148 (280)
                                     ++|.      ..+...=+-++=|++..++.++.-|
T Consensus       134 ---------------lpP~------e~~ee~fl~qyKali~all~~K~~F  162 (219)
T 4ano_A          134 ---------------LPPD------EWDDERLLREVKATVLALTEGEYRF  162 (219)
T ss_dssp             ---------------BSSC------SCCHHHHHHHHHHHHHHHTTCSSCH
T ss_pred             ---------------CCCC------CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence                           2232      1222223346677777787776544

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=83.50  E-value=0.46  Score=41.08  Aligned_cols=29  Identities=24%  Similarity=0.471  Sum_probs=25.7

Q ss_pred             CccccCCCCCceEEcCCCCeEEeecccccc
Q 023568           68 SVLHRDLKPSNLLLNASCDLKIGDFGLART   97 (280)
Q Consensus        68 ~i~H~dik~~Nili~~~~~~kl~dfg~~~~   97 (280)
                      .++|+|+.+.||+ +.++.+.++||..+..
T Consensus       263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          263 VFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            4899999999999 7788899999998753

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	280
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-76
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	5e-72
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-71
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	6e-61
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-59
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-57
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-55
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-55
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-55
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	4e-54
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-52
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-51
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-51
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	4e-51
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	7e-51
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	4e-50
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-49
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-49
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	5e-49
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-48
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	4e-48
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-47
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-47
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-47
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-46
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	8e-45
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	5e-44
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	4e-42
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	5e-40
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	6e-40
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-38
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-38
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-35
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-34
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	6e-34
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-33
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	5e-33
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-32
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	3e-32
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	6e-32
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	9e-32
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-31
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	6e-31
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	6e-31
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	4e-30
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	9e-30
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-29
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-28
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	5e-28
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-27
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-27
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	4e-27
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-26
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	4e-26
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	6e-26
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-25
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-25
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	7e-25
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	7e-25
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-24
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-24
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-23
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-14

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  235 bits (599), Expect = 1e-76
 Identities = 148/281 (52%), Positives = 194/281 (69%), Gaps = 5/281 (1%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
             HEN+I I DIIR P  +   DVY+V  LM  DL++++++ Q L++DH  YFLYQ+LRG
Sbjct: 63  FRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRG 121

Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR----TTSETDFMTEYVVTRWYRAP 116
           LKY+HSA+VLHRDLKPSNLLLN +CDLKI DFGLAR        T F+TEYV TRWYRAP
Sbjct: 122 LKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181

Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 176
           E++LN   YT +IDIWSVGCIL E+++  P+FPGK Y+ QL  I  ++GSP    L  + 
Sbjct: 182 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241

Query: 177 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 236
           +  AR Y+  LP   K  +   FPN  S A+DLL+KML F+P+KRI VE+AL HPYL+  
Sbjct: 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301

Query: 237 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPD 277
           +D +DEP+   PF FD E     ++ ++ELI+ E+ +F P 
Sbjct: 302 YDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPG 342

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  223 bits (568), Expect = 5e-72
 Identities = 139/279 (49%), Positives = 183/279 (65%), Gaps = 5/279 (1%)

Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M+HENVI + D+  P +  + FNDVY+V  LM  DL+ I++  Q+LTDDH Q+ +YQ+LR
Sbjct: 74  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILR 132

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GLKY+HSA ++HRDLKPSNL +N  C+LKI DFGLAR T +   MT YV TRWYRAPE++
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIM 190

Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   Y   +DIWSVGCI+ E++T   LFPG D++ QL+LI  L+G+P    L  + S++
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250

Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           AR Y++ L +  K  FA  F   +  AVDLLEKMLV D +KRIT  +AL H Y    HD 
Sbjct: 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 310

Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP 278
           +DEPV   P+   FE      D  + L + E + F P P
Sbjct: 311 DDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVPPP 348

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  221 bits (563), Expect = 3e-71
 Identities = 126/277 (45%), Positives = 179/277 (64%), Gaps = 5/277 (1%)

Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           M HENVI + D+  P +  D F D Y+V   M TDL ++++  ++L +D  Q+ +YQ+L+
Sbjct: 74  MRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLK 132

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GL+Y+H+A ++HRDLKP NL +N  C+LKI DFGLAR       MT YVVTRWYRAPE++
Sbjct: 133 GLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE--MTGYVVTRWYRAPEVI 190

Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           LN   YT  +DIWSVGCI+ E++T + LF G D++ QL+ I ++ G+P    +  L+SD 
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250

Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL 239
           A+ Y++ LP   K+ FA+   N S  AV+LLEKMLV D  +R+T  EAL HPY +SLHD 
Sbjct: 251 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 310

Query: 240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP 276
            DEP     +   F+    T D  + + ++E + F P
Sbjct: 311 EDEPQVQ-KYDDSFDDVDRTLDEWKRVTYKEVLSFKP 346

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (490), Expect = 6e-61
 Identities = 84/250 (33%), Positives = 128/250 (51%), Gaps = 10/250 (4%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTD-LHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H N+I + D          +++ +V++ M+TD    I  +   LT  H + ++   L+
Sbjct: 57  LSHPNIIGLLDAFGHK-----SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQ 111

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPEL 118
           GL+Y+H   +LHRDLKP+NLLL+ +  LK+ DFGLA++  S     T  VVTRWYRAPEL
Sbjct: 112 GLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPEL 171

Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 178
           L     Y   +D+W+VGCIL E++ R P  PG   + QL  I E +G+P +     + S 
Sbjct: 172 LFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 231

Query: 179 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 238
                 +  P          F       +DL++ + +F+P  RIT  +AL+  Y  +   
Sbjct: 232 PDYVTFKSFP---GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 288

Query: 239 LNDEPVCPRP 248
                  PRP
Sbjct: 289 PTPGCQLPRP 298

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 2e-59
 Identities = 79/265 (29%), Positives = 138/265 (52%), Gaps = 14/265 (5%)

Query: 1   MEHENVIAIKDIIRPP-KKDTFNDVYIVYELMDTDLHQII----RSDQQLTDDHCQYFLY 55
           ++H N++ ++       +K     + +V + +   ++++     R+ Q L   + + ++Y
Sbjct: 70  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129

Query: 56  QLLRGLKYVHSASVLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYR 114
           QL R L Y+HS  + HRD+KP NLLL+  +  LK+ DFG A+     +    Y+ +R+YR
Sbjct: 130 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 189

Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF 174
           APEL+   T+YT++ID+WS GC+L E++  +P+FPG   V QL  I +++G+P       
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE---Q 246

Query: 175 LRSDNARRYVRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
           +R  N      + P+ +   +   F P     A+ L  ++L + P  R+T  EA  H + 
Sbjct: 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306

Query: 234 QSLHD----LNDEPVCPRPFHFDFE 254
             L D    L +    P  F+F  +
Sbjct: 307 DELRDPNVKLPNGRDTPALFNFTTQ 331

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (469), Expect = 3e-57
 Identities = 117/286 (40%), Positives = 175/286 (61%), Gaps = 18/286 (6%)

Query: 1   MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H+N+I++ ++  P K  + F DVY+V ELMD +L Q+I+   +L  +   Y LYQ+L 
Sbjct: 73  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLC 130

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ + C LKI DFGLART   +  MT YVVTR+YRAPE++
Sbjct: 131 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190

Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           L    Y   +DIWSVGCI+GE++  + LFPG+DY+ Q   + E +G+P    +  L+   
Sbjct: 191 LGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ-PT 248

Query: 180 ARRYVRQLPRCRKQQFATRFPN------------KSSGAVDLLEKMLVFDPNKRITVEEA 227
            R YV   P+     F   FP+            K+S A DLL KMLV DP KRI+V++A
Sbjct: 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308

Query: 228 LRHPYLQSLHDLNDEPVC-PRPFHFDFEHSSCTEDHIRELIWRESV 272
           L+HPY+   +D  +     P+ +    +    T +  +ELI++E +
Sbjct: 309 LQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVM 354

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 1e-55
 Identities = 82/251 (32%), Positives = 129/251 (51%), Gaps = 10/251 (3%)

Query: 1   MEHENVIAIKDIIRPPKKDTF---NDVYIVYELMDTDLHQI-IRSDQQLTDDHCQYFLYQ 56
           ++HENV+ + +I R            +Y+V++  + DL  +      + T    +  +  
Sbjct: 66  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 125

Query: 57  LLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR-----TTSETDFMTEYVVTR 111
           LL GL Y+H   +LHRD+K +N+L+     LK+ DFGLAR       S+ +  T  VVT 
Sbjct: 126 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185

Query: 112 WYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDAS 171
           WYR PELLL   +Y   ID+W  GCI+ E+ TR P+  G    HQL LI++L GS     
Sbjct: 186 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245

Query: 172 LGFLRSDNARRYVRQL-PRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 230
              + +      +  +  + RK +   +   +   A+DL++K+LV DP +RI  ++AL H
Sbjct: 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305

Query: 231 PYLQSLHDLND 241
            +  S    +D
Sbjct: 306 DFFWSDPMPSD 316

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 2e-55
 Identities = 86/238 (36%), Positives = 124/238 (52%), Gaps = 7/238 (2%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELM--DTDLHQIIRSDQQLTDDHCQYFLYQLL 58
            EH NV+ + D+    + D    + +V+E +  D   +     +  +  +  +  ++QLL
Sbjct: 67  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126

Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPEL 118
           RGL ++HS  V+HRDLKP N+L+ +S  +K+ DFGLAR  S    +T  VVT WYRAPE+
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV 186

Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 178
           LL  + Y   +D+WSVGCI  E+  R+PLF G   V QL  I ++IG P +         
Sbjct: 187 LLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW----PR 241

Query: 179 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 236
           +     +       Q       +      DLL K L F+P KRI+   AL HPY Q L
Sbjct: 242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 2e-55
 Identities = 50/250 (20%), Positives = 104/250 (41%), Gaps = 22/250 (8%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLR 59
                ++            +  ++ I  E MD   L Q+++   ++ +         +++
Sbjct: 61  CNSPYIVGFYGAFY-----SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIK 115

Query: 60  GLKYVHSA-SVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPEL 118
           GL Y+     ++HRD+KPSN+L+N+  ++K+ DFG++    ++     +V TR Y +PE 
Sbjct: 116 GLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPER 174

Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY-VHQLRLITELIGSPDD-------- 169
           L     Y+   DIWS+G  L E+       P  D    +L    ++ G   +        
Sbjct: 175 LQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233

Query: 170 --ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK--SSGAVDLLEKMLVFDPNKRITVE 225
                 +         + +L      +   + P+   S    D + K L+ +P +R  ++
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 293

Query: 226 EALRHPYLQS 235
           + + H +++ 
Sbjct: 294 QLMVHAFIKR 303

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 4e-54
 Identities = 93/241 (38%), Positives = 135/241 (56%), Gaps = 10/241 (4%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQ--LTDDHCQYFLYQLL 58
           + H N++ + D+I      T N +Y+V+E +  DL + + +     +     + +L+QLL
Sbjct: 58  LNHPNIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 112

Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE
Sbjct: 113 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 172

Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 177
           +LL C  Y+ A+DIWS+GCI  E++TR  LFPG   + QL  I   +G+PD+    +   
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVV--WPGV 230

Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH 237
            +   Y    P+  +Q F+   P        LL +ML +DPNKRI+ + AL HP+ Q + 
Sbjct: 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290

Query: 238 D 238
            
Sbjct: 291 K 291

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (430), Expect = 3e-52
 Identities = 59/238 (24%), Positives = 93/238 (39%), Gaps = 37/238 (15%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLH-QIIRSDQQLTDDHCQYFLYQLLR 59
           + HENV+      R       N  Y+  E          I  D  + +   Q F +QL+ 
Sbjct: 60  LNHENVVKFYGHRREG-----NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA 114

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR---TTSETDFMTEYVVTRWYRAP 116
           G+ Y+H   + HRD+KP NLLL+   +LKI DFGLA      +    + +   T  Y AP
Sbjct: 115 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 174

Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 176
           ELL     +   +D+WS G +L  ++  E  +       Q                    
Sbjct: 175 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---------------- 218

Query: 177 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
                          K+ +   +    S  + LL K+LV +P+ RIT+ +  +  +  
Sbjct: 219 ------------WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 264

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (424), Expect = 2e-51
 Identities = 52/236 (22%), Positives = 99/236 (41%), Gaps = 39/236 (16%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H N++ +              VY++ E      +++ ++   +  +     ++ +L  
Sbjct: 63  LRHPNILRLYGYFHDA-----TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 117

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
            L Y HS  V+HRD+KP NLLL ++ +LKI DFG +     +   T    T  Y  PE++
Sbjct: 118 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-LCGTLDYLPPEMI 176

Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
                +   +D+WS+G +  E +  +P F    Y    + I+ +  +  D          
Sbjct: 177 EG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD---------- 225

Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
                                  + GA DL+ ++L  +P++R  + E L HP++ +
Sbjct: 226 ---------------------FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  167 bits (424), Expect = 3e-51
 Identities = 85/236 (36%), Positives = 123/236 (52%), Gaps = 9/236 (3%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++H N++ + D+I   K+     + +V+E +D      +   +  L     + FL QLL 
Sbjct: 57  LKHSNIVKLYDVIHTKKR-----LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLN 111

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPEL 118
           G+ Y H   VLHRDLKP NLL+N   +LKI DFGLAR            +VT WYRAP++
Sbjct: 112 GIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDV 171

Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 178
           L+   +Y+  IDIWSVGCI  E++   PLFPG     QL  I  ++G+P+  S  +    
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPN--SKNWPNVT 229

Query: 179 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
              +Y           + +         +DLL KML  DPN+RIT ++AL H Y +
Sbjct: 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  169 bits (428), Expect = 4e-51
 Identities = 56/260 (21%), Positives = 105/260 (40%), Gaps = 37/260 (14%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTD--LHQIIRSDQQLTDDHCQYFLYQLL 58
           + H  ++ + D          N++ ++YE M       ++     ++++D    ++ Q+ 
Sbjct: 80  LRHPTLVNLHDAFEDD-----NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVC 134

Query: 59  RGLKYVHSASVLHRDLKPSNLLLNA--SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 116
           +GL ++H  + +H DLKP N++     S +LK+ DFGL         +     T  + AP
Sbjct: 135 KGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAP 194

Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 176
           E+           D+WSVG +   +++    F G++    LR +     + DD       
Sbjct: 195 EVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD------- 246

Query: 177 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 236
                               + F   S    D + K+L+ DPN R+T+ +AL HP+L   
Sbjct: 247 --------------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG 286

Query: 237 HDLNDEPVCPRPFHFDFEHS 256
           +    +   P   +     S
Sbjct: 287 NAPGRDSQIPSSRYTKIRDS 306

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  168 bits (425), Expect = 7e-51
 Identities = 71/245 (28%), Positives = 134/245 (54%), Gaps = 15/245 (6%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLR 59
               N+I + DI++ P   T     +V+E ++ TD  Q+ ++   LTD   ++++Y++L+
Sbjct: 87  RGGPNIITLADIVKDPVSRTP---ALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILK 140

Query: 60  GLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPEL 118
            L Y HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PEL
Sbjct: 141 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 200

Query: 119 LLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDAS-LGFLR 176
           L++   Y  ++D+WS+GC+L  ++  +EP F G D   QL  I +++G+ D    +    
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260

Query: 177 SDNARRYVRQLPRCRKQQFATRFPNK-----SSGAVDLLEKMLVFDPNKRITVEEALRHP 231
            +   R+   L R  ++++     ++     S  A+D L+K+L +D   R+T  EA+ HP
Sbjct: 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 320

Query: 232 YLQSL 236
           Y  ++
Sbjct: 321 YFYTV 325

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  164 bits (416), Expect = 4e-50
 Identities = 62/239 (25%), Positives = 104/239 (43%), Gaps = 38/239 (15%)

Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRG 60
            H N+I +KD       +T    ++V++LM   +L   +     L++   +  +  LL  
Sbjct: 68  GHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122

Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 120
           +  +H  +++HRDLKP N+LL+   ++K+ DFG +      + + E   T  Y APE++ 
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIE 182

Query: 121 -----NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL 175
                N   Y   +D+WS G I+  ++   P F  +  +  LR+I               
Sbjct: 183 CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM-------------- 228

Query: 176 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
                            Q  +  + + S    DL+ + LV  P KR T EEAL HP+ Q
Sbjct: 229 -------------SGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (412), Expect = 2e-49
 Identities = 54/241 (22%), Positives = 97/241 (40%), Gaps = 40/241 (16%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDL--HQIIRSDQQLTDDHCQYFLYQLL 58
            +H N++ + D          N+++I+ E          ++  ++ LT+   Q    Q L
Sbjct: 66  CDHPNIVKLLDAFYYE-----NNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 120

Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPE 117
             L Y+H   ++HRDLK  N+L     D+K+ DFG++   T        ++ T ++ APE
Sbjct: 121 DALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPE 180

Query: 118 LLLNCT----EYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLG 173
           +++  T     Y    D+WS+G  L E+   EP     + +  L  I +           
Sbjct: 181 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK----------- 229

Query: 174 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
                             +     +    SS   D L+K L  + + R T  + L+HP++
Sbjct: 230 -----------------SEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 272

Query: 234 Q 234
            
Sbjct: 273 T 273

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  163 bits (414), Expect = 2e-49
 Identities = 54/275 (19%), Positives = 107/275 (38%), Gaps = 41/275 (14%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H N I  +           +  ++V E    +    +    + L +       +  L+
Sbjct: 72  LRHPNTIQYRGCYLRE-----HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQ 126

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GL Y+HS +++HRD+K  N+LL+    +K+GDFG A   +       +V T ++ APE++
Sbjct: 127 GLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVI 183

Query: 120 LNCTE--YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 177
           L   E  Y   +D+WS+G    E+  R+P     + +  L  I                 
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI----------------- 226

Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH 237
                        + +  A +  + S    + ++  L   P  R T E  L+H ++    
Sbjct: 227 ------------AQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 274

Query: 238 DLND-EPVCPRPFHFDFEHSSCTEDHIRELIWRES 271
                  +  R      E  +     +++++++E+
Sbjct: 275 PPTVIMDLIQRTKDAVRELDNLQYRKMKKILFQEA 309

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (409), Expect = 5e-49
 Identities = 77/240 (32%), Positives = 118/240 (49%), Gaps = 8/240 (3%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           ++H+N++ + D++            +               +  L  +  + FL+QLL+G
Sbjct: 58  LKHKNIVRLHDVLH----SDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKG 113

Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR-TTSETDFMTEYVVTRWYRAPELL 119
           L + HS +VLHRDLKP NLL+N + +LK+ +FGLAR         +  VVT WYR P++L
Sbjct: 114 LGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173

Query: 120 LNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 178
                Y+ +ID+WS GCI  E+     PLFPG D   QL+ I  L+G+P +     +   
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM--T 231

Query: 179 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 238
               Y                P  ++   DLL+ +L  +P +RI+ EEAL+HPY      
Sbjct: 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (410), Expect = 1e-48
 Identities = 62/282 (21%), Positives = 114/282 (40%), Gaps = 32/282 (11%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQII--RSDQQLTDDHCQYFLYQL 57
            +  +++ I D+           + IV E +D  +L   I  R DQ  T+      +  +
Sbjct: 62  SQCPHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSI 120

Query: 58  LRGLKYVHSASVLHRDLKPSNLLLNASCD---LKIGDFGLARTTSETDFMTEYVVTRWYR 114
              ++Y+HS ++ HRD+KP NLL  +      LK+ DFG A+ T+  + +T    T +Y 
Sbjct: 121 GEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYV 180

Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGF 174
           APE+L    +Y  + D+WS+G I+  ++   P F     +     +   I          
Sbjct: 181 APEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI---------- 229

Query: 175 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
                 R    + P          +   S     L+  +L  +P +R+T+ E + HP++ 
Sbjct: 230 ------RMGQYEFPN-------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 276

Query: 235 SLHDLNDEPVC-PRPFHFDFEHSSCTEDHIRELIWRESVKFN 275
               +   P+   R    D E     ++ +   +    V + 
Sbjct: 277 QSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYE 318

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 4e-48
 Identities = 52/265 (19%), Positives = 112/265 (42%), Gaps = 37/265 (13%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ-QLTDDHCQYFLYQLL 58
             H N++ + +       ++  ++ +++E +   D+ + I +   +L +     +++Q+ 
Sbjct: 58  ARHRNILHLHESF-----ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVC 112

Query: 59  RGLKYVHSASVLHRDLKPSNLLLNA--SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 116
             L+++HS ++ H D++P N++     S  +KI +FG AR     D          Y AP
Sbjct: 113 EALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAP 172

Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 176
           E+  +    + A D+WS+G ++  +++    F  +     +  I     + D+       
Sbjct: 173 EVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE------- 224

Query: 177 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 236
                                 F   S  A+D ++++LV +   R+T  EAL+HP+L+  
Sbjct: 225 --------------------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264

Query: 237 HDLNDEPVCPRPFHFDFEHSSCTED 261
            +     V     H  + H+   +D
Sbjct: 265 IERVSTKVIRTLKHRRYYHTLIKKD 289

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  160 bits (405), Expect = 1e-47
 Identities = 53/242 (21%), Positives = 103/242 (42%), Gaps = 37/242 (15%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQ-IIRSDQQLTDDHCQYFLYQLL 58
           + H  +I + D           ++ ++ E +   +L   I   D ++++     ++ Q  
Sbjct: 83  LHHPKLINLHDAFEDK-----YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQAC 137

Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCD--LKIGDFGLARTTSETDFMTEYVVTRWYRAP 116
            GLK++H  S++H D+KP N++        +KI DFGLA   +  + +     T  + AP
Sbjct: 138 EGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAP 197

Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 176
           E++          D+W++G +   +++    F G+D +  L+ +       D+       
Sbjct: 198 EIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE------- 249

Query: 177 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL 236
                                 F + S  A D ++ +L  +P KR+TV +AL HP+L+  
Sbjct: 250 --------------------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289

Query: 237 HD 238
           H 
Sbjct: 290 HS 291

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (399), Expect = 1e-47
 Identities = 69/244 (28%), Positives = 103/244 (42%), Gaps = 45/244 (18%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQII----RSDQQLTDDHCQYFLY 55
           ++H N++   D I      T   +YIV E  +  DL  +I    +  Q L ++     + 
Sbjct: 60  LKHPNIVRYYDRIIDRTNTT---LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 116

Query: 56  QLLRGLKYVHSAS-----VLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVV 109
           QL   LK  H  S     VLHRDLKP+N+ L+   ++K+GDFGLAR    +T F   +V 
Sbjct: 117 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVG 176

Query: 110 TRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDD 169
           T +Y +PE  +N   Y    DIWS+GC+L E+    P F           I         
Sbjct: 177 TPYYMSPE-QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI--------- 226

Query: 170 ASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 229
                                R+ +F       S    +++ +ML      R +VEE L 
Sbjct: 227 ---------------------REGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265

Query: 230 HPYL 233
           +P +
Sbjct: 266 NPLI 269

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 3e-47
 Identities = 53/243 (21%), Positives = 101/243 (41%), Gaps = 37/243 (15%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
            ++ N++   D          +++++V E +       + ++  + +        + L+ 
Sbjct: 74  NKNPNIVNYLDSYL-----VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQA 128

Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELL 119
           L+++HS  V+HRD+K  N+LL     +K+ DFG     T E    +  V T ++ APE++
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188

Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
                Y   +DIWS+G +  E++  EP +  ++ +  L LI                   
Sbjct: 189 TR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI------------------- 228

Query: 180 ARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 238
                             + P K S+   D L + L  D  KR + +E L+H +L+    
Sbjct: 229 ----------ATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP 278

Query: 239 LND 241
           L+ 
Sbjct: 279 LSS 281

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  155 bits (394), Expect = 2e-46
 Identities = 59/238 (24%), Positives = 102/238 (42%), Gaps = 37/238 (15%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++H N++A+ DI           +Y++ +L+   +L   I      T+      ++Q+L 
Sbjct: 64  IKHPNIVALDDIYESG-----GHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD 118

Query: 60  GLKYVHSASVLHRDLKPSNLLL---NASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 116
            +KY+H   ++HRDLKP NLL    +    + I DFGL++       ++    T  Y AP
Sbjct: 119 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAP 178

Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 176
           E+L     Y+ A+D WS+G I   ++   P F  ++       I +     D        
Sbjct: 179 EVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDS------- 230

Query: 177 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
                                 + + S  A D +  ++  DP KR T E+AL+HP++ 
Sbjct: 231 --------------------PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA 268

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (381), Expect = 8e-45
 Identities = 55/246 (22%), Positives = 99/246 (40%), Gaps = 47/246 (19%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++H   + +    +         +Y         +L + IR      +   +++  +++ 
Sbjct: 65  LDHPFFVKLYFTFQDD-----EKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 119

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLART---TSETDFMTEYVVTRWYRAP 116
            L+Y+H   ++HRDLKP N+LLN    ++I DFG A+     S+      +V T  Y +P
Sbjct: 120 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179

Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 176
           ELL        + D+W++GCI+ +++   P F   +     + I +L     +       
Sbjct: 180 ELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE------- 231

Query: 177 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA------LRH 230
                                        A DL+EK+LV D  KR+  EE         H
Sbjct: 232 ------------------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAH 267

Query: 231 PYLQSL 236
           P+ +S+
Sbjct: 268 PFFESV 273

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 5e-44
 Identities = 45/238 (18%), Positives = 96/238 (40%), Gaps = 36/238 (15%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++H N++   D      K     + +V ELM +  L   ++  + +     + +  Q+L+
Sbjct: 65  LQHPNIVRFYDSWESTVKGK-KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILK 123

Query: 60  GLKYVHSAS--VLHRDLKPSNLLLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 116
           GL+++H+ +  ++HRDLK  N+ +   +  +KIGD GLA       F    + T  + AP
Sbjct: 124 GLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL-KRASFAKAVIGTPEFMAP 182

Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLR 176
           E+     +Y  ++D+++ G  + E+ T E  +       Q+         P         
Sbjct: 183 EMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD----- 235

Query: 177 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ 234
                                          +++E  +  + ++R ++++ L H + Q
Sbjct: 236 -----------------------KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 4e-42
 Identities = 62/240 (25%), Positives = 108/240 (45%), Gaps = 38/240 (15%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTD-LHQIIRSDQQLTDDHCQYFLYQLLR 59
           ++H NVI + ++      +   DV ++ EL+    L   +   + LT++    FL Q+L 
Sbjct: 70  IQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 124

Query: 60  GLKYVHSASVLHRDLKPSNLLLN----ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRA 115
           G+ Y+HS  + H DLKP N++L         +KI DFGLA      +       T  + A
Sbjct: 125 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA 184

Query: 116 PELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL 175
           PE++ N        D+WS+G I   +++    F G      L  ++ +    +D      
Sbjct: 185 PEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED------ 237

Query: 176 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
                                  F N S+ A D + ++LV DP KR+T++++L+HP+++ 
Sbjct: 238 ---------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 5e-40
 Identities = 46/243 (18%), Positives = 92/243 (37%), Gaps = 40/243 (16%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLL 58
             H N++            T   + IV +  + + L+  +   + +           Q  
Sbjct: 61  TRHVNILLFMGY------STAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTA 114

Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE---TDFMTEYVVTRWYRA 115
           +G+ Y+H+ S++HRDLK +N+ L+    +KIGDFGLA   S    +    +   +  + A
Sbjct: 115 QGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174

Query: 116 PELLL--NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLG 173
           PE++   +   Y+   D+++ G +L E+MT +  +   +   Q+  +             
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG----------- 223

Query: 174 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL 233
                  R Y+                N       L+ + L    ++R    + L    +
Sbjct: 224 -------RGYLSPDLS-------KVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS--I 267

Query: 234 QSL 236
           + L
Sbjct: 268 ELL 270

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (347), Expect = 6e-40
 Identities = 50/240 (20%), Positives = 94/240 (39%), Gaps = 46/240 (19%)

Query: 2   EHENVIAIKDIIRPPKKDTFNDVYIVYELMD--TDLHQIIRSDQQLTDDHCQYFLYQLLR 59
               VI + D    P     +   ++ E  +   DL   I     L ++  + F +Q+L 
Sbjct: 67  GFSGVIRLLDWFERP-----DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 121

Query: 60  GLKYVHSASVLHRDLKPSNLLLNAS-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPEL 118
            +++ H+  VLHRD+K  N+L++ +  +LK+ DFG      +T   T++  TR Y  PE 
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEW 180

Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 178
           +     +  +  +WS+G +L +++  +  F   + + + ++                   
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR---------------- 224

Query: 179 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD 238
                                   SS    L+   L   P+ R T EE   HP++Q +  
Sbjct: 225 ---------------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL 263

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  136 bits (344), Expect = 2e-38
 Identities = 51/242 (21%), Positives = 99/242 (40%), Gaps = 40/242 (16%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLR 59
            +   ++ +      P     + +  + +LM+  DLH  +      ++   +++  +++ 
Sbjct: 64  GDCPFIVCMSYAFHTP-----DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIIL 118

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
           GL+++H+  V++RDLKP+N+LL+    ++I D GLA   S+       V T  Y APE+L
Sbjct: 119 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVL 177

Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
                Y ++ D +S+GC+L +++     F       +  +                    
Sbjct: 178 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID------------------- 218

Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV-----EEALRHPYLQ 234
                    R           + S     LLE +L  D N+R+       +E    P+ +
Sbjct: 219 ---------RMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 269

Query: 235 SL 236
           SL
Sbjct: 270 SL 271

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 4e-38
 Identities = 55/239 (23%), Positives = 99/239 (41%), Gaps = 40/239 (16%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLR 59
            EH  +  +    +     T  +++ V E ++  DL   I+S  +       ++  +++ 
Sbjct: 60  WEHPFLTHMFCTFQ-----TKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIIL 114

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR-TTSETDFMTEYVVTRWYRAPEL 118
           GL+++HS  +++RDLK  N+LL+    +KI DFG+ +           +  T  Y APE+
Sbjct: 115 GLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEI 174

Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 178
           LL   +Y  ++D WS G +L E++  +  F G+D       I                  
Sbjct: 175 LLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI------------------ 215

Query: 179 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVE-EALRHPYLQSL 236
                        +             A DLL K+ V +P KR+ V  +  +HP  + +
Sbjct: 216 -------------RMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 261

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  126 bits (317), Expect = 2e-35
 Identities = 54/243 (22%), Positives = 95/243 (39%), Gaps = 35/243 (14%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H  ++A+ D             YIV E +D   L  I+ ++  +T       +    +
Sbjct: 64  LNHPAIVAVYDTGEAETPA-GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ 122

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR----TTSETDFMTEYVVTRWYRA 115
            L + H   ++HRD+KP+N++++A+  +K+ DFG+AR    + +        + T  Y +
Sbjct: 123 ALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182

Query: 116 PELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFL 175
           PE         A  D++S+GC+L E++T EP F G   V            P  A     
Sbjct: 183 PEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA----- 236

Query: 176 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS 235
                                 R    S+    ++ K L  +P  R      +R   L  
Sbjct: 237 ----------------------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRAD-LVR 273

Query: 236 LHD 238
           +H+
Sbjct: 274 VHN 276

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 2e-34
 Identities = 44/233 (18%), Positives = 82/233 (35%), Gaps = 39/233 (16%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQL 57
           + H N++ +  +I     +    +YIV E M    L   +RS     L  D    F   +
Sbjct: 57  LRHSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 112

Query: 58  LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 117
              ++Y+   + +HRDL   N+L++     K+ DFGL +  S T       +   + APE
Sbjct: 113 CEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPE 170

Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRS 177
            L    +++   D+WS G +L EI +   +   +  +  +                    
Sbjct: 171 ALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-------------------- 209

Query: 178 DNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 230
                    +PR  K               ++++     D   R +  +    
Sbjct: 210 ---------VPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  124 bits (311), Expect = 6e-34
 Identities = 63/287 (21%), Positives = 111/287 (38%), Gaps = 24/287 (8%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTD-DHCQYFLYQLLR 59
           M   +++ + D       +  + V +   L +  L  I + + +     + +    QLL 
Sbjct: 77  MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136

Query: 60  GLKYVH-SASVLHRDLKPSNLLLNASC----DLKIGDFGLARTTSETDFMTEYVVTRWYR 114
           GL Y+H    ++H D+KP N+L+         ++I    L       +  T  + TR YR
Sbjct: 137 GLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196

Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDY------VHQLRLITELIGSPD 168
           +PE+LL    +    DIWS  C++ E++T + LF   +          +  I EL+G   
Sbjct: 197 SPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELP 255

Query: 169 DASL-------GFLRSDNARRYVRQLPRCRKQQFATR----FPNKSSGAVDLLEKMLVFD 217
              L        F  S    R + +L     +   T       +++    D L  ML  D
Sbjct: 256 SYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLD 315

Query: 218 PNKRITVEEALRHPYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIR 264
           P KR      + HP+L+    + +  V  R  +          + +R
Sbjct: 316 PRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWFEEVR 362

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 1e-33
 Identities = 50/243 (20%), Positives = 95/243 (39%), Gaps = 44/243 (18%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTD-LHQIIRSDQQLTDDHCQYFLYQLLR 59
             H  + A+K   +       + +  V E  +   L   +  ++  T++  +++  +++ 
Sbjct: 62  TRHPFLTALKYAFQTH-----DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVS 116

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
            L+Y+HS  V++RD+K  NL+L+    +KI DFGL +         +            +
Sbjct: 117 ALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV 176

Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           L   +Y  A+D W +G ++ E+M     F  +D+     LI                   
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI------------------- 217

Query: 180 ARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYL 233
                        ++   RFP   S  A  LL  +L  DP +R+       +E + H + 
Sbjct: 218 -----------LMEEI--RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

Query: 234 QSL 236
            S+
Sbjct: 265 LSI 267

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  120 bits (303), Expect = 5e-33
 Identities = 47/242 (19%), Positives = 101/242 (41%), Gaps = 45/242 (18%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + H  +I +    +         ++++ + ++  +L  ++R  Q+  +   +++  ++  
Sbjct: 61  VTHPFIIRMWGTFQDA-----QQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL 115

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 119
            L+Y+HS  +++RDLKP N+LL+ +  +KI DFG A+   +         T  Y APE +
Sbjct: 116 ALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPE-V 172

Query: 120 LNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDN 179
           ++   Y  +ID WS G ++ E++     F   + +     I                   
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI------------------- 213

Query: 180 ARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQ 234
                 + P           P  +    DLL +++  D ++R+       E+   HP+ +
Sbjct: 214 -LNAELRFP-----------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFK 261

Query: 235 SL 236
            +
Sbjct: 262 EV 263

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 2e-32
 Identities = 50/245 (20%), Positives = 85/245 (34%), Gaps = 45/245 (18%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD---TDLHQIIRSDQQLTDDHCQYFLYQL 57
           + HE ++ +  ++      +   +YIV E M            + + L          Q+
Sbjct: 69  LRHEKLVQLYAVV------SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQI 122

Query: 58  LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF--MTEYVVTRWYRA 115
             G+ YV   + +HRDL+ +N+L+  +   K+ DFGLAR   + ++           + A
Sbjct: 123 ASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA 182

Query: 116 PELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPDDASLGF 174
           PE  L    +T   D+WS G +L E+ T+    +PG      L  +      P       
Sbjct: 183 PEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP----- 236

Query: 175 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR--HPY 232
                                    P       DL+ +    +P +R T E        Y
Sbjct: 237 -------------------------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271

Query: 233 LQSLH 237
             S  
Sbjct: 272 FTSTE 276

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (298), Expect = 3e-32
 Identities = 37/244 (15%), Positives = 97/244 (39%), Gaps = 41/244 (16%)

Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGL 61
              ++ +    +         ++++ + ++  +L   +   ++ T+   Q ++ +++  L
Sbjct: 88  SPFLVTLHYAFQTE-----TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLAL 142

Query: 62  KYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSE---TDFMTEYVVTRWYRAPEL 118
           +++H   +++RD+K  N+LL+++  + + DFGL++                  +     +
Sbjct: 143 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 202

Query: 119 LLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 178
               + +  A+D WS+G ++ E++T    F      +    I+  I   +          
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP--------- 253

Query: 179 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYL 233
                                   S+ A DL++++L+ DP KR+       +E   H + 
Sbjct: 254 ------------------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 295

Query: 234 QSLH 237
           Q ++
Sbjct: 296 QKIN 299

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 6e-32
 Identities = 42/245 (17%), Positives = 90/245 (36%), Gaps = 46/245 (18%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLR 59
           +++  ++ +  I             +V E+ +   L++ ++ ++ + D +    ++Q+  
Sbjct: 65  LDNPYIVRMIGIC------EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSM 118

Query: 60  GLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR----TTSETDFMTEYVVTRWYRA 115
           G+KY+  ++ +HRDL   N+LL      KI DFGL++      +     T       + A
Sbjct: 119 GMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 178

Query: 116 PELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPDDASLGF 174
           PE +    ++++  D+WS G ++ E  +  +  + G        ++              
Sbjct: 179 PECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-------------- 223

Query: 175 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT---VEEALRHP 231
                            K +             DL+     +D   R     VE  LR+ 
Sbjct: 224 ----------------EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267

Query: 232 YLQSL 236
           Y   +
Sbjct: 268 YYDVV 272

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 9e-32
 Identities = 45/248 (18%), Positives = 86/248 (34%), Gaps = 30/248 (12%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLR 59
           + HEN++            T+  +++V +  +   L   +     +T +           
Sbjct: 54  LRHENILGFIAADNKDN-GTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTAS 111

Query: 60  GLKYVHSA--------SVLHRDLKPSNLLLNASCDLKIGDFGLAR-----TTSETDFMTE 106
           GL ++H          ++ HRDLK  N+L+  +    I D GLA      T +       
Sbjct: 112 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 171

Query: 107 YVVTRWYRAPELLLNC-----TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLIT 161
            V T+ Y APE+L +       E     DI+++G +  EI  R  +  G    +QL    
Sbjct: 172 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYD 230

Query: 162 ELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKR 221
            +   P    +  +  +   R     P    +  +            ++ +    +   R
Sbjct: 231 LVPSDPSVEEMRKVVCEQKLR-----PNIPNRWQSCEALRV---MAKIMRECWYANGAAR 282

Query: 222 ITVEEALR 229
           +T     +
Sbjct: 283 LTALRIKK 290

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (290), Expect = 3e-31
 Identities = 50/256 (19%), Positives = 85/256 (33%), Gaps = 63/256 (24%)

Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQ----------------- 44
           HEN++ +              +Y+++E     DL   +RS ++                 
Sbjct: 100 HENIVNLLGACT-----LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154

Query: 45  ------LTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTT 98
                 LT +    F YQ+ +G++++   S +HRDL   N+L+     +KI DFGLAR  
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDI 214

Query: 99  SETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYV 154
                        +   + APE L     YT   D+WS G +L EI +     +PG    
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273

Query: 155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKML 214
                + +                    +    P              +     +++   
Sbjct: 274 ANFYKLIQ------------------NGFKMDQP-----------FYATEEIYIIMQSCW 304

Query: 215 VFDPNKRITVEEALRH 230
            FD  KR +       
Sbjct: 305 AFDSRKRPSFPNLTSF 320

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 6e-31
 Identities = 45/243 (18%), Positives = 87/243 (35%), Gaps = 45/243 (18%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDL---HQIIRSDQQLTDDHCQYFLYQL 57
           ++H+ ++ +  ++      T   +YI+ E M+           S  +LT +       Q+
Sbjct: 65  LQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118

Query: 58  LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF--MTEYVVTRWYRA 115
             G+ ++   + +HRDL+ +N+L++ +   KI DFGLAR   + ++           + A
Sbjct: 119 AEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA 178

Query: 116 PELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPDDASLGF 174
           PE  +N   +T   D+WS G +L EI+T     +PG      ++ +              
Sbjct: 179 PE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP----- 232

Query: 175 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR--HPY 232
                                     N       L+       P  R T +        +
Sbjct: 233 -------------------------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267

Query: 233 LQS 235
             +
Sbjct: 268 FTA 270

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 6e-31
 Identities = 40/244 (16%), Positives = 87/244 (35%), Gaps = 47/244 (19%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLL 58
           +++  ++ +  + +         + +V E+     LH+ +    +++   +    L+Q+ 
Sbjct: 66  LDNPYIVRLIGVCQAEA------LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 119

Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD----FMTEYVVTRWYR 114
            G+KY+   + +HRDL   N+LL      KI DFGL++     D      +       + 
Sbjct: 120 MGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179

Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPDDASLG 173
           APE  +N  ++++  D+WS G  + E ++  +  +        +  I             
Sbjct: 180 APE-CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI------------- 225

Query: 174 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT---VEEALRH 230
                             + +     P        L+    ++    R     VE+ +R 
Sbjct: 226 -----------------EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268

Query: 231 PYLQ 234
            Y  
Sbjct: 269 CYYS 272

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (280), Expect = 4e-30
 Identities = 45/234 (19%), Positives = 80/234 (34%), Gaps = 41/234 (17%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD--TDLHQIIRSDQQLTDDHCQYFLYQLL 58
           ++H N+I +  ++          + +V EL    + L ++ +            +  Q+ 
Sbjct: 68  LDHRNLIRLYGVV------LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 121

Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRA 115
            G+ Y+ S   +HRDL   NLLL     +KIGDFGL R   + D    M E+    +   
Sbjct: 122 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181

Query: 116 PELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPDDASLGF 174
               L    ++ A D W  G  L E+ T  +  + G +    L  I              
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI-------------- 227

Query: 175 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEAL 228
                           ++ +   R  +      +++ +     P  R T     
Sbjct: 228 ---------------DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR 266

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  112 bits (282), Expect = 9e-30
 Identities = 50/273 (18%), Positives = 105/273 (38%), Gaps = 25/273 (9%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           +    ++ ++   +    D  N   ++  +   ++   +R   + ++ H +++  Q++  
Sbjct: 98  VNFPFLVKLEFSFK----DNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT 153

Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 120
            +Y+HS  +++RDLKP NLL++    +++ DFG A+             T    APE++L
Sbjct: 154 FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWTLCGTPEALAPEIIL 211

Query: 121 NCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNA 180
           +   Y  A+D W++G ++ E+    P F     +     I                S + 
Sbjct: 212 S-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH-----FSSDL 265

Query: 181 RRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDLN 240
           +  +R      +     RF N  +G  D+         +     +  +  P++       
Sbjct: 266 KDLLR---NLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPG 322

Query: 241 DEPVCPRPFHFDFEHSSCTEDHIRELIWRESVK 273
           D        +FD       E+ IR  I  +  K
Sbjct: 323 DTS------NFD----DYEEEEIRVSINEKCGK 345

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (275), Expect = 2e-29
 Identities = 36/235 (15%), Positives = 80/235 (34%), Gaps = 41/235 (17%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELM--DTDLHQIIRSDQQLTDDHCQYFLYQLL 58
           + HE ++ +  +           ++I+ E M     L+ +     +            + 
Sbjct: 56  LSHEKLVQLYGVCTKQ-----RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVC 110

Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF--MTEYVVTRWYRAP 116
             ++Y+ S   LHRDL   N L+N    +K+ DFGL+R   + ++           +  P
Sbjct: 111 EAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPP 170

Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPDDASLGFL 175
           E+L+  +++++  DIW+ G ++ EI +  +  +           I + +           
Sbjct: 171 EVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP------ 223

Query: 176 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 230
                                      S     ++        ++R T +  L +
Sbjct: 224 ------------------------HLASEKVYTIMYSCWHEKADERPTFKILLSN 254

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (268), Expect = 4e-28
 Identities = 46/246 (18%), Positives = 78/246 (31%), Gaps = 54/246 (21%)

Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIR----------------SDQQL 45
           H N+I +              +Y+  E     +L   +R                +   L
Sbjct: 70  HPNIINLLGACEHR-----GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 124

Query: 46  TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT 105
           +     +F   + RG+ Y+     +HRDL   N+L+  +   KI DFGL+R        T
Sbjct: 125 SSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT 184

Query: 106 EYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELI 164
              +   + A E  LN + YT   D+WS G +L EI++     + G         + +  
Sbjct: 185 MGRLPVRWMAIE-SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 243

Query: 165 GSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITV 224
                                               N      DL+ +     P +R + 
Sbjct: 244 RLEKP------------------------------LNCDDEVYDLMRQCWREKPYERPSF 273

Query: 225 EEALRH 230
            + L  
Sbjct: 274 AQILVS 279

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (265), Expect = 5e-28
 Identities = 37/235 (15%), Positives = 79/235 (33%), Gaps = 41/235 (17%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTD-DHCQYFLYQLL 58
           + H  ++ +  +           + +V+E M+   L   +R+ + L   +        + 
Sbjct: 57  LSHPKLVQLYGVCLEQ-----APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVC 111

Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR--TTSETDFMTEYVVTRWYRAP 116
            G+ Y+  A V+HRDL   N L+  +  +K+ DFG+ R     +    T       + +P
Sbjct: 112 EGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASP 171

Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPDDASLGFL 175
           E+    + Y++  D+WS G ++ E+ +  +  +  +     +  I+              
Sbjct: 172 EVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP------ 224

Query: 176 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 230
                                      S+    ++       P  R      LR 
Sbjct: 225 ------------------------RLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  106 bits (264), Expect = 1e-27
 Identities = 37/256 (14%), Positives = 74/256 (28%), Gaps = 43/256 (16%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQI-IRSDQQLTDDHCQYFLYQLLR 59
           M+    I              +   +V EL+   L  +     ++ +         Q++ 
Sbjct: 59  MQGGVGIPTIRWC----GAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMIS 114

Query: 60  GLKYVHSASVLHRDLKPSNLL---LNASCDLKIGDFGLARTTSETD--------FMTEYV 108
            ++Y+HS + +HRD+KP N L         + I DFGLA+   +                
Sbjct: 115 RIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 174

Query: 109 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPD 168
            T  Y +    L   E +   D+ S+G +L         + G     +            
Sbjct: 175 GTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR----------- 222

Query: 169 DASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT---VE 225
                       ++Y R   +              S     L        + +     + 
Sbjct: 223 ------------QKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLR 270

Query: 226 EALRHPYLQSLHDLND 241
           +  R+ + +     + 
Sbjct: 271 QLFRNLFHRQGFSYDY 286

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (262), Expect = 2e-27
 Identities = 49/235 (20%), Positives = 89/235 (37%), Gaps = 42/235 (17%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELM--DTDLHQIIRSDQQLTDDHCQYFLYQLL 58
            +H +++ +  +I      T N V+I+ EL         +      L       + YQL 
Sbjct: 65  FDHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 118

Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAP 116
             L Y+ S   +HRD+   N+L++++  +K+GDFGL+R   ++ +   ++  +   + AP
Sbjct: 119 TALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178

Query: 117 ELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPDDASLGFL 175
           E + N   +T+A D+W  G  + EI+      F G      +  I               
Sbjct: 179 ESI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI--------------- 222

Query: 176 RSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 230
                             +     PN       L+ K   +DP++R    E    
Sbjct: 223 ---------------ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  104 bits (261), Expect = 4e-27
 Identities = 46/238 (19%), Positives = 83/238 (34%), Gaps = 43/238 (18%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQII--RSDQQLTDDHCQYFLYQLL 58
            +H NVI ++ ++          V I+ E M+         ++D Q T       L  + 
Sbjct: 84  FDHPNVIHLEGVVTKS-----TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIA 138

Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPEL 118
            G+KY+   + +HRDL   N+L+N++   K+ DFGL+R   +      Y      + P  
Sbjct: 139 AGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIR 198

Query: 119 LL-----NCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPDDASL 172
                     ++T+A D+WS G ++ E+M+  E  +        +  I +    P     
Sbjct: 199 WTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPP--- 255

Query: 173 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 230
                                       +  S    L+      D N R    + +  
Sbjct: 256 ---------------------------MDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  103 bits (257), Expect = 2e-26
 Identities = 38/233 (16%), Positives = 69/233 (29%), Gaps = 37/233 (15%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
            E+     + + +R           + +  + T           L+         Q+  G
Sbjct: 95  FEYMAYGDLNEFLR--SMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAG 152

Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPE 117
           + Y+     +HRDL   N L+  +  +KI DFGL+R     D+        +   +  PE
Sbjct: 153 MAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPE 212

Query: 118 LLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPDDASLGFLR 176
            +     YT   D+W+ G +L EI +     + G  +   +  +                
Sbjct: 213 SIFYN-RYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYV---------------- 255

Query: 177 SDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 229
                         R         N      +L+       P  R +     R
Sbjct: 256 --------------RDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (255), Expect = 4e-26
 Identities = 47/280 (16%), Positives = 97/280 (34%), Gaps = 50/280 (17%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD--TDLHQIIRSDQQLTDDHCQYFLYQLL 58
           +++ +V  +  I           V ++ +LM     L  +      +   +   +  Q+ 
Sbjct: 68  VDNPHVCRLLGICLTS------TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 121

Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRA 115
           +G+ Y+    ++HRDL   N+L+     +KI DFGLA+     +         V   + A
Sbjct: 122 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181

Query: 116 PELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPDDASLGF 174
            E +L+   YT   D+WS G  + E+MT     + G        ++              
Sbjct: 182 LESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-------------- 226

Query: 175 LRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH---- 230
                            K +   + P  +     ++ K  + D + R    E +      
Sbjct: 227 ----------------EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270

Query: 231 ---PYLQSLHDLNDEPVCPRPFHFDFEHSSCTEDHIRELI 267
              P    +   ++    P P   +F  +   E+ + +++
Sbjct: 271 ARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVV 310

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  101 bits (252), Expect = 6e-26
 Identities = 31/210 (14%), Positives = 68/210 (32%), Gaps = 17/210 (8%)

Query: 19  DTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS 77
                  +V +L+   L  ++    ++ +         Q+L  ++ +H  S+++RD+KP 
Sbjct: 71  QEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPD 130

Query: 78  NLLLNASC-----DLKIGDFGLAR--------TTSETDFMTEYVVTRWYRAPELLLNCTE 124
           N L+          + + DFG+ +                     T  Y +    L   E
Sbjct: 131 NFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR-E 189

Query: 125 YTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYV 184
            +   D+ ++G +    +     + G       +    +        L  L +     + 
Sbjct: 190 QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFY 249

Query: 185 RQLPRCRKQQFATRFPNKSSGAVDLLEKML 214
           + +   R   F    P+       L  K+L
Sbjct: 250 KYMHYARNLAFDAT-PDYDY-LQGLFSKVL 277

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (249), Expect = 2e-25
 Identities = 44/238 (18%), Positives = 80/238 (33%), Gaps = 43/238 (18%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQ--YFLYQLL 58
             H NV+++  I    +        +V   M     +    ++           F  Q+ 
Sbjct: 85  FSHPNVLSLLGICLRSE----GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVA 140

Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF-----MTEYVVTRWY 113
           +G+K++ S   +HRDL   N +L+    +K+ DFGLAR   + +F      T   +   +
Sbjct: 141 KGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 200

Query: 114 RAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLITELIGSPDDASL 172
            A E L    ++T   D+WS G +L E+MTR  P +P  +       + +          
Sbjct: 201 MALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 259

Query: 173 GFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH 230
                                              +++ K        R +  E +  
Sbjct: 260 ------------------------------PDPLYEVMLKCWHPKAEMRPSFSELVSR 287

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 99.4 bits (247), Expect = 3e-25
 Identities = 40/231 (17%), Positives = 83/231 (35%), Gaps = 34/231 (14%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
           ++H N++ +  +            ++ Y  +   L +   + Q+++     Y   Q+   
Sbjct: 70  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSA 127

Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR-TTSETDFMTEYVVTRWYRAPELL 119
           ++Y+   + +HRDL   N L+  +  +K+ DFGL+R  T +T                  
Sbjct: 128 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 187

Query: 120 LNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSD 178
           L   +++   D+W+ G +L EI T     +PG D      L+                  
Sbjct: 188 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE----------------- 230

Query: 179 NARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 229
             + Y  + P                   +L+     ++P+ R +  E  +
Sbjct: 231 --KDYRMERP-----------EGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.4 bits (244), Expect = 7e-25
 Identities = 43/236 (18%), Positives = 87/236 (36%), Gaps = 43/236 (18%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELM--DTDLHQIIRSDQQLTDDHCQYFLYQLL 58
             H N+I ++ +I       +  + I+ E M        +   D + +       L  + 
Sbjct: 66  FSHHNIIRLEGVIS-----KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 120

Query: 59  RGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR----TTSETDFMTEYVVTRWYR 114
            G+KY+ + + +HRDL   N+L+N++   K+ DFGL+R        T   +   +   + 
Sbjct: 121 AGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180

Query: 115 APELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL-RLITELIGSPDDASLG 173
           APE +      +A+ D+WS G ++ E+MT       +   H++ + I +    P      
Sbjct: 181 APEAISYRKFTSAS-DVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTP---- 235

Query: 174 FLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR 229
                                      +  S    L+ +    +  +R    + + 
Sbjct: 236 --------------------------MDCPSAIYQLMMQCWQQERARRPKFADIVS 265

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.8 bits (245), Expect = 7e-25
 Identities = 50/249 (20%), Positives = 93/249 (37%), Gaps = 57/249 (22%)

Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIR----------------SDQQL 45
           H+N+I +              +Y++ E     +L + ++                 ++QL
Sbjct: 78  HKNIINLLGACTQD-----GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 46  TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMT 105
           +        YQ+ RG++Y+ S   +HRDL   N+L+     +KI DFGLAR     D+  
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 192

Query: 106 E---YVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLIT 161
           +     +   + APE L +   YT   D+WS G +L EI T     +PG       +L+ 
Sbjct: 193 KTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL- 250

Query: 162 ELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKR 221
                                        ++     +  N ++    ++       P++R
Sbjct: 251 -----------------------------KEGHRMDKPSNCTNELYMMMRDCWHAVPSQR 281

Query: 222 ITVEEALRH 230
            T ++ +  
Sbjct: 282 PTFKQLVED 290

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.3 bits (244), Expect = 1e-24
 Identities = 52/251 (20%), Positives = 86/251 (34%), Gaps = 60/251 (23%)

Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS------------------DQ 43
           H N++ +                ++ E     DL   +R                   + 
Sbjct: 86  HMNIVNLLGACTIG-----GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140

Query: 44  QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLAR---TTSE 100
            L  +    F YQ+ +G+ ++ S + +HRDL   N+LL      KI DFGLAR     S 
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200

Query: 101 TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRL 159
                   +   + APE + NC  YT   D+WS G  L E+ +     +PG     +   
Sbjct: 201 YVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259

Query: 160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNK-SSGAVDLLEKMLVFDP 218
           +                               K+ F    P    +   D+++     DP
Sbjct: 260 MI------------------------------KEGFRMLSPEHAPAEMYDIMKTCWDADP 289

Query: 219 NKRITVEEALR 229
            KR T ++ ++
Sbjct: 290 LKRPTFKQIVQ 300

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.0 bits (243), Expect = 1e-24
 Identities = 54/259 (20%), Positives = 96/259 (37%), Gaps = 57/259 (22%)

Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQ----------------L 45
           H NV+ +      P       + ++ E     +L   +RS +                 L
Sbjct: 76  HLNVVNLLGACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131

Query: 46  TDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD--- 102
           T +H   + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR   +     
Sbjct: 132 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191

Query: 103 FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYVHQLRLIT 161
              +  +   + APE + +   YT   D+WS G +L EI +     +PG     +     
Sbjct: 192 RKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF---- 246

Query: 162 ELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKR 221
                               R +++  R R           +      +      +P++R
Sbjct: 247 -------------------CRRLKEGTRMR------APDYTTPEMYQTMLDCWHGEPSQR 281

Query: 222 ITVEEALRHPYLQSLHDLN 240
            T  E + H  L +L   N
Sbjct: 282 PTFSELVEH--LGNLLQAN 298

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.9 bits (235), Expect = 2e-23
 Identities = 46/243 (18%), Positives = 87/243 (35%), Gaps = 51/243 (20%)

Query: 3   HENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQ----------LTDDHCQ 51
             +V+ +  ++            ++ ELM   DL   +RS +            +     
Sbjct: 82  CHHVVRLLGVVSQG-----QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136

Query: 52  YFLYQLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDF---MTEYV 108
               ++  G+ Y+++   +HRDL   N ++     +KIGDFG+ R   ETD+     + +
Sbjct: 137 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 109 VTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQLRLITELIGSP 167
           +   + +PE L +   +T   D+WS G +L EI T  E  + G      LR +       
Sbjct: 197 LPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV------- 248

Query: 168 DDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA 227
                                   +     +  N      +L+     ++P  R +  E 
Sbjct: 249 -----------------------MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEI 285

Query: 228 LRH 230
           +  
Sbjct: 286 ISS 288

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 67.9 bits (165), Expect = 2e-14
 Identities = 21/140 (15%), Positives = 45/140 (32%), Gaps = 21/140 (15%)

Query: 1   MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRG 60
            E   +  ++ +  P     +    ++ EL+D      +R       ++    L  +L  
Sbjct: 63  NEFRALQKLQGLAVPKVYA-WEGNAVLMELIDAKELYRVR------VENPDEVLDMILEE 115

Query: 61  LKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD-----FMTEYVVTRWYRA 115
           +   +   ++H DL   N+L++    + I DF  +    E             +  ++  
Sbjct: 116 VAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFS- 173

Query: 116 PELLLNCTEYTAAIDIWSVG 135
                    Y    DI S  
Sbjct: 174 -------RTYRTEKDINSAI 186

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	280
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.68
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	97.38
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	96.45
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	96.16
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	94.63
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	93.01
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	85.58

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-55  Score=373.42  Aligned_cols=272  Identities=46%  Similarity=0.858  Sum_probs=233.8

Q ss_pred             CCCcccccccccccCCCC-CCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~-~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+|||||+++++|..... ....++|+||||++++|.++++. +++++..++.++.||+.||+|||++||+||||||+||
T Consensus        74 l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NI  152 (346)
T d1cm8a_          74 MRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNL  152 (346)
T ss_dssp             CCBTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred             cCCCCeeEEEEEeccCccccccceEEEEEecccccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchh
Confidence            689999999999987642 22356899999998888888765 6899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      |++.++.++++|||+++.....  .....||+.|+|||++.+...++.++||||+||++|+|++|++||.+.+....+..
T Consensus       153 L~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~  230 (346)
T d1cm8a_         153 AVNEDCELKILDFGLARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKE  230 (346)
T ss_dssp             EECTTCCEEECCCTTCEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             hcccccccccccccceeccCCc--cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHH
Confidence            9999999999999999876554  45678899999999998767789999999999999999999999999999999999


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCcCC
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL  239 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~~~  239 (280)
                      +....+.++...................+..........++..++.+++||++||+.||.+|||++|+|+||||+.+.+.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~  310 (346)
T d1cm8a_         231 IMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT  310 (346)
T ss_dssp             HHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred             HHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCc
Confidence            99999999988887777777777888888888888888888999999999999999999999999999999999999877


Q ss_pred             CCCCCCCCCCCCccCCCCCCHHHHHHHHHHHHHhhCC
Q 023568          240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNP  276 (280)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (280)
                      +.++... .+...++....+.+++++++.+|+.+|+|
T Consensus       311 ~~~~~~~-~~~~~~~~~~~~~~e~k~~~~~e~~~~~~  346 (346)
T d1cm8a_         311 EDEPQVQ-KYDDSFDDVDRTLDEWKRVTYKEVLSFKP  346 (346)
T ss_dssp             ----CCC-CCCCC-----CCHHHHHHHHHHHHHTCCC
T ss_pred             cccccCC-CCCCchhhhhcCHHHHHHHHHHHhhcCCC
Confidence            7766543 34455566678899999999999999987

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-53  Score=363.90  Aligned_cols=276  Identities=53%  Similarity=0.978  Sum_probs=233.9

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      |+||||+++++++..........+|++|++++|+|.+++.. +++++..++.++.|++.||+|||++||+||||||+|||
T Consensus        63 l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NIL  141 (345)
T d1pmea_          63 FRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLL  141 (345)
T ss_dssp             CCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred             cCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEE
Confidence            68999999999998764434356788888888899999976 57999999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccccCCC----CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023568           81 LNASCDLKIGDFGLARTTSET----DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  156 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~  156 (280)
                      ++.++.+||+|||+++.....    .......||+.|+|||++.....++.++|+||+||++|+|++|+.||.+.+..+.
T Consensus       142 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~  221 (345)
T d1pmea_         142 LNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ  221 (345)
T ss_dssp             ECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             ECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH
Confidence            999999999999999764433    2235567899999999987667789999999999999999999999999999999


Q ss_pred             HHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 023568          157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  236 (280)
Q Consensus       157 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~  236 (280)
                      ...+....+.+....................+..........++..++.+++||.+||+.||.+|||++|+|+||||+..
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~  301 (345)
T d1pmea_         222 LNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  301 (345)
T ss_dssp             HHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             HHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence            99988888888877665555555666666666666666777788899999999999999999999999999999999999


Q ss_pred             cCCCCCCCCCCCCCCccCCCCCCHHHHHHHHHHHHHhhCCC
Q 023568          237 HDLNDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPD  277 (280)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (280)
                      .++..++....++.++.+......+++++++++|..+|+|.
T Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~e~~~~~~~  342 (345)
T d1pmea_         302 YDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPG  342 (345)
T ss_dssp             CCGGGSCCCSSCC--------CCHHHHHHHHHHHSGGGSTT
T ss_pred             CCCccCccccCccCCChhhhhCCHHHHHHHHHHHHHhcCCC
Confidence            88888888778888877777889999999999999999985

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-54  Score=359.42  Aligned_cols=232  Identities=34%  Similarity=0.626  Sum_probs=192.6

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHH-HHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQ-IIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~-~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++|||||+++++|.++     +++|+||||+.|++.. +....+.+++.+++.+++||+.||+|||++||+||||||+||
T Consensus        57 l~hpnIv~~~~~~~~~-----~~~~ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NI  131 (299)
T d1ua2a_          57 LSHPNIIGLLDAFGHK-----SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNL  131 (299)
T ss_dssp             CCCTTBCCEEEEECCT-----TCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred             CCCCCEeEEEeeeccC-----CceeehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceE
Confidence            6899999999999988     7799999999975544 445567899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      |++.++.+||+|||+++..... .......||+.|+|||++.+...++.++||||+||++|+|++|.+||.+.+..+++.
T Consensus       132 li~~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~  211 (299)
T d1ua2a_         132 LLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLT  211 (299)
T ss_dssp             EECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             EecCCCccccccCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHH
Confidence            9999999999999999876544 334556899999999998775778999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCcC
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHD  238 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~~  238 (280)
                      .|.+..+.+....+.........   .........+....++..++++++||++||+.||++|||++|+|+||||++...
T Consensus       212 ~i~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~  288 (299)
T d1ua2a_         212 RIFETLGTPTEEQWPDMCSLPDY---VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG  288 (299)
T ss_dssp             HHHHHHCCCCTTTSSSTTSSTTC---CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred             HHHHhcCCCChhhccchhccchh---hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCC
Confidence            99999998877655433221100   011111222333445678999999999999999999999999999999987654


Q ss_pred             CC
Q 023568          239 LN  240 (280)
Q Consensus       239 ~~  240 (280)
                      +.
T Consensus       289 p~  290 (299)
T d1ua2a_         289 PT  290 (299)
T ss_dssp             CC
T ss_pred             CC
Confidence            43

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-54  Score=354.46  Aligned_cols=197  Identities=26%  Similarity=0.496  Sum_probs=174.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++|||||++++++.++     +.+|+|||||+ |+|.+++.+.+.+++.+++.++.||+.||+|||++||+||||||+||
T Consensus        63 l~hpnIv~~~~~~~~~-----~~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Ni  137 (263)
T d2j4za1          63 LRHPNILRLYGYFHDA-----TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENL  137 (263)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred             cCCCCCCeEEEEEEEC-----CEEEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccc
Confidence            6899999999999988     77999999998 59999998888999999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      |++.++.+||+|||+++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....
T Consensus       138 ll~~~~~~kl~DFG~a~~~~~~~-~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~  215 (263)
T d2j4za1         138 LLGSAGELKIADFGWSVHAPSSR-RTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR  215 (263)
T ss_dssp             EECTTSCEEECCCCSCSCCCCCC-CEETTEEGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH
T ss_pred             eecCCCCEeecccceeeecCCCc-ccccCCCCcccCHHHHcC-CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHH
Confidence            99999999999999998765432 345689999999999988 6789999999999999999999999999887766665


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  235 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~  235 (280)
                      +.+..                               ...++.+++++++||.+||+.||.+|||++|+|+||||++
T Consensus       216 i~~~~-------------------------------~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         216 ISRVE-------------------------------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             HHTTC-------------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             HHcCC-------------------------------CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence            54311                               0112357899999999999999999999999999999964

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-54  Score=357.63  Aligned_cols=202  Identities=30%  Similarity=0.452  Sum_probs=170.2

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+|||||++++++.++     +.+|+|||||+ |+|.+++.+.+.+++.+++.++.||+.||+|||++||+||||||+||
T Consensus        60 l~HpnIv~~~~~~~~~-----~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NI  134 (271)
T d1nvra_          60 LNHENVVKFYGHRREG-----NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL  134 (271)
T ss_dssp             CCCTTBCCEEEEEEET-----TEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred             CCCCCEeeEeeeeccC-----ceeEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHE
Confidence            6899999999999988     77999999997 59999998888999999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC---CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSET---DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  156 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~  156 (280)
                      |++.++.+||+|||+|+.....   .......||+.|+|||++.+...++.++||||+||++|+|++|+.||........
T Consensus       135 Ll~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~  214 (271)
T d1nvra_         135 LLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ  214 (271)
T ss_dssp             EECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH
T ss_pred             EECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH
Confidence            9999999999999999865332   2345678999999999998745567889999999999999999999987653322


Q ss_pred             HHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 023568          157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  235 (280)
Q Consensus       157 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~  235 (280)
                      .......                            .......++.+++++.+||++||+.||++|||++|+|+||||+.
T Consensus       215 ~~~~~~~----------------------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~  265 (271)
T d1nvra_         215 EYSDWKE----------------------------KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK  265 (271)
T ss_dssp             HHHHHHT----------------------------TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             HHHHHhc----------------------------CCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence            2111110                            01111223357899999999999999999999999999999974

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-53  Score=360.54  Aligned_cols=274  Identities=51%  Similarity=0.910  Sum_probs=235.8

Q ss_pred             CCCcccccccccccCCCC-CCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~-~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+|||||+++++|..... +.....|+++++++|+|.+++.. +++++.+++.++.||+.||+|||++||+||||||+||
T Consensus        74 l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NI  152 (348)
T d2gfsa1          74 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL  152 (348)
T ss_dssp             CCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred             cCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccc
Confidence            689999999999976532 22245666666666899999865 6799999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      |++.++.++++|||.+......  .....|++.|+|||.+.+...++.++|+||+||++|+|++|++||.+.+.......
T Consensus       153 Li~~~~~~kl~dfg~a~~~~~~--~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~  230 (348)
T d2gfsa1         153 AVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL  230 (348)
T ss_dssp             EECTTCCEEECCC----CCTGG--GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             cccccccccccccchhcccCcc--cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9999999999999998765443  35678899999999988767789999999999999999999999999999999999


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCcCC
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLHDL  239 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~~~  239 (280)
                      +....+.+...............................+...++.+++||++||+.||.+|||++|+|+||||+++.++
T Consensus       231 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~  310 (348)
T d2gfsa1         231 ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP  310 (348)
T ss_dssp             HHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCT
T ss_pred             HHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCC
Confidence            99999988888777777777777777777777777777788899999999999999999999999999999999999888


Q ss_pred             CCCCCCCCCCCCccCCCCCCHHHHHHHHHHHHHhhCCCC
Q 023568          240 NDEPVCPRPFHFDFEHSSCTEDHIRELIWRESVKFNPDP  278 (280)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (280)
                      ..++.. .++..+++......+++++.+.+|+.+|.|.|
T Consensus       311 ~~~~~~-~~~~~~~~~~~~~~~~~k~~~~~e~~~~~p~~  348 (348)
T d2gfsa1         311 DDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVPPP  348 (348)
T ss_dssp             TSCCCC-CCCCCGGGGCCCCHHHHHHHHHHHHHTCCCCC
T ss_pred             ccCCCC-CCCCCcccchhcCHHHHHHHHHHHhhccCCCC
Confidence            877754 46777788889999999999999999999876

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-53  Score=352.70  Aligned_cols=200  Identities=25%  Similarity=0.436  Sum_probs=173.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+|||||+++++|.++     +.+|+|||||+ |+|.+++.+ +.+++.+++.++.||+.||+|||++||+||||||+||
T Consensus        74 l~HpnIv~~~~~~~~~-----~~~~ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NI  147 (293)
T d1yhwa1          74 NKNPNIVNYLDSYLVG-----DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNI  147 (293)
T ss_dssp             CCCTTBCCEEEEEEET-----TEEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             CCCCCEeeEeEEEEEC-----CEEEEEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHe
Confidence            6899999999999988     77999999997 599998765 5799999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      |++.++.+||+|||+++..... .......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+....+.
T Consensus       148 Ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~  226 (293)
T d1yhwa1         148 LLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY  226 (293)
T ss_dssp             EECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSS-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred             EECCCCcEeeccchhheeeccccccccccccCCCccChhhhcC-CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHH
Confidence            9999999999999999876543 33456789999999999987 778899999999999999999999999888776665


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  235 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~  235 (280)
                      .+..... +.                           ...++.+++.+++||++||+.||.+|||++|+|+||||+.
T Consensus       227 ~~~~~~~-~~---------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~  275 (293)
T d1yhwa1         227 LIATNGT-PE---------------------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI  275 (293)
T ss_dssp             HHHHHCS-CC---------------------------CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred             HHHhCCC-CC---------------------------CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence            5543211 00                           1112357899999999999999999999999999999975

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.6e-53  Score=354.32  Aligned_cols=203  Identities=29%  Similarity=0.512  Sum_probs=164.2

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+|||||+++++|+++     +.+|+|||||+ |+|.+++.+.+.+++.+++.++.||+.||+|||++||+||||||+||
T Consensus        64 l~HpnIv~l~~~~~~~-----~~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Ni  138 (307)
T d1a06a_          64 IKHPNIVALDDIYESG-----GHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENL  138 (307)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred             CCCCCCCcEEEEEEEC-----CEEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccce
Confidence            6899999999999988     77999999997 69999999888999999999999999999999999999999999999


Q ss_pred             EEc---CCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023568           80 LLN---ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  156 (280)
Q Consensus        80 li~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~  156 (280)
                      ++.   .++.+||+|||+++...........+||+.|+|||++.+ ..++.++||||+||++|+|++|..||.+......
T Consensus       139 l~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~  217 (307)
T d1a06a_         139 LYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL  217 (307)
T ss_dssp             EESSSSTTCCEEECCC------------------CTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             eecccCCCceEEEeccceeEEccCCCeeeeeeeCccccCcHHHcC-CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHH
Confidence            994   478999999999988776666667889999999999987 7789999999999999999999999999887766


Q ss_pred             HHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 023568          157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  236 (280)
Q Consensus       157 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~  236 (280)
                      ...+.+.....                           ....++.+|+++.+||++||+.||++|||++|+|+||||++.
T Consensus       218 ~~~i~~~~~~~---------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  270 (307)
T d1a06a_         218 FEQILKAEYEF---------------------------DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD  270 (307)
T ss_dssp             HHHHHTTCCCC---------------------------CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred             HHHHhccCCCC---------------------------CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            66654421111                           112234689999999999999999999999999999999763

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.7e-52  Score=356.56  Aligned_cols=207  Identities=27%  Similarity=0.469  Sum_probs=180.5

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      |+|||||+++++|+++     +.+|+|||||+ |+|.+++.+ .+.+++.+++.++.||+.||.|||++||+||||||+|
T Consensus        80 l~HpnIv~~~~~~~~~-----~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~N  154 (350)
T d1koaa2          80 LRHPTLVNLHDAFEDD-----NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPEN  154 (350)
T ss_dssp             TCCTTBCCEEEEEEET-----TEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred             CCCCCCCcEEEEEEEC-----CEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhH
Confidence            6899999999999988     78999999997 599999854 4679999999999999999999999999999999999


Q ss_pred             eEEcC--CCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023568           79 LLLNA--SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  156 (280)
Q Consensus        79 ili~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~  156 (280)
                      ||++.  ++.+||+|||+++............||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.
T Consensus       155 Ill~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~  233 (350)
T d1koaa2         155 IMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET  233 (350)
T ss_dssp             EEESSTTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHT-CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             eeeccCCCCeEEEeecchheecccccccceecCcccccCHHHHcC-CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHH
Confidence            99954  67899999999998776666667889999999999987 7788999999999999999999999999888777


Q ss_pred             HHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 023568          157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  236 (280)
Q Consensus       157 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~  236 (280)
                      +..+.......+.                           ..++.+++++++||++||+.||++|||++|+|+||||+..
T Consensus       234 ~~~i~~~~~~~~~---------------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~  286 (350)
T d1koaa2         234 LRNVKSCDWNMDD---------------------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG  286 (350)
T ss_dssp             HHHHHHTCCCSCC---------------------------GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred             HHHHHhCCCCCCc---------------------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            7777653222211                           1223578999999999999999999999999999999876


Q ss_pred             cCCC
Q 023568          237 HDLN  240 (280)
Q Consensus       237 ~~~~  240 (280)
                      ..+.
T Consensus       287 ~~~~  290 (350)
T d1koaa2         287 NAPG  290 (350)
T ss_dssp             TCCS
T ss_pred             CCCC
Confidence            5443

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-52  Score=348.26  Aligned_cols=200  Identities=28%  Similarity=0.486  Sum_probs=172.9

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+|||||+++++|+++     +.+|+|||||+ |+|.+++...+.+++..++.++.|++.||+|||+.||+||||||+||
T Consensus        65 l~HpnIv~l~~~~~~~-----~~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NI  139 (288)
T d1uu3a_          65 LDHPFFVKLYFTFQDD-----EKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENI  139 (288)
T ss_dssp             CCSTTBCCEEEEEECS-----SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             cCCCCeeEEEEEEEEC-----CEEEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCcccc
Confidence            6899999999999988     77999999998 59999998889999999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC---CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSET---DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  156 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~  156 (280)
                      |++.++.+||+|||+++.....   .......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+....
T Consensus       140 ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~  218 (288)
T d1uu3a_         140 LLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI  218 (288)
T ss_dssp             EECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             ccCCCceEEecccccceecccCCcccccccccCCccccCceeecc-CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHH
Confidence            9999999999999999875433   22345679999999999987 7789999999999999999999999999887776


Q ss_pred             HHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHH------HhcC
Q 023568          157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEE------ALRH  230 (280)
Q Consensus       157 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~e------ll~h  230 (280)
                      ..++.+..                               ...+..+++++++||++||+.||.+|||++|      +++|
T Consensus       219 ~~~i~~~~-------------------------------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~H  267 (288)
T d1uu3a_         219 FQKIIKLE-------------------------------YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAH  267 (288)
T ss_dssp             HHHHHTTC-------------------------------CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTS
T ss_pred             HHHHHcCC-------------------------------CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcC
Confidence            66654310                               0112357999999999999999999999998      5889


Q ss_pred             cccccCc
Q 023568          231 PYLQSLH  237 (280)
Q Consensus       231 p~~~~~~  237 (280)
                      |||+++.
T Consensus       268 pff~~i~  274 (288)
T d1uu3a_         268 PFFESVT  274 (288)
T ss_dssp             GGGTTCC
T ss_pred             CccCCCC
Confidence            9998863

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-52  Score=348.70  Aligned_cols=204  Identities=29%  Similarity=0.510  Sum_probs=178.2

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+|||||+++++|++.     +.+|+|||||+ |+|.+++.+.+.+++..++.++.|++.||+|||+.||+||||||+||
T Consensus        70 l~HpnIv~~~~~~~~~-----~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Ni  144 (293)
T d1jksa_          70 IQHPNVITLHEVYENK-----TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENI  144 (293)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             CCCCCCCcEEEEEEEC-----CEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceE
Confidence            6899999999999988     78999999997 59999998888999999999999999999999999999999999999


Q ss_pred             EEcCCC----CeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023568           80 LLNASC----DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH  155 (280)
Q Consensus        80 li~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~  155 (280)
                      +++.++    .+|++|||++.............||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+..+
T Consensus       145 ll~~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~  223 (293)
T d1jksa_         145 MLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQE  223 (293)
T ss_dssp             EESCSSSSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             EEecCCCcccceEecchhhhhhcCCCccccccCCCCcccCHHHHcC-CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH
Confidence            998766    499999999988766655667789999999999987 778999999999999999999999999988777


Q ss_pred             HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 023568          156 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  235 (280)
Q Consensus       156 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~  235 (280)
                      .+..+.......+                           ...++..|+.+++||++||+.||++|||++|+|+||||+.
T Consensus       224 ~~~~i~~~~~~~~---------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  276 (293)
T d1jksa_         224 TLANVSAVNYEFE---------------------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP  276 (293)
T ss_dssp             HHHHHHTTCCCCC---------------------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC
T ss_pred             HHHHHHhcCCCCC---------------------------chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence            7766654221111                           1123467999999999999999999999999999999986


Q ss_pred             Cc
Q 023568          236 LH  237 (280)
Q Consensus       236 ~~  237 (280)
                      ..
T Consensus       277 ~~  278 (293)
T d1jksa_         277 KD  278 (293)
T ss_dssp             --
T ss_pred             CC
Confidence            53

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-52  Score=350.14  Aligned_cols=199  Identities=27%  Similarity=0.441  Sum_probs=177.2

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++|||||+++++|++.     +.+|+|||||+ |+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||
T Consensus        62 l~hp~Iv~l~~~~~~~-----~~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NI  136 (337)
T d1o6la_          62 TRHPFLTALKYAFQTH-----DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENL  136 (337)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGE
T ss_pred             CCCCCEEEEEeeeccc-----cccccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHe
Confidence            6899999999999998     78999999998 59999999889999999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCC-CCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSE-TDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      |++.+|.+||+|||+++.... .......+||+.|+|||++.+ ..++.++|+||+||++|+|++|++||.+.+......
T Consensus       137 Ll~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~-~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~  215 (337)
T d1o6la_         137 MLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE  215 (337)
T ss_dssp             EECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             EecCCCCEEEeecccccccccCCcccccceeCHHHhhhhhccC-CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHH
Confidence            999999999999999987543 344567899999999999988 778999999999999999999999999988766665


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYL  233 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rp-----t~~ell~hp~~  233 (280)
                      .+....                               ...+..+|+++++||++||++||.+|+     +++|+++||||
T Consensus       216 ~i~~~~-------------------------------~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f  264 (337)
T d1o6la_         216 LILMEE-------------------------------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF  264 (337)
T ss_dssp             HHHHCC-------------------------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGG
T ss_pred             HHhcCC-------------------------------CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCccc
Confidence            554310                               112235799999999999999999999     49999999999


Q ss_pred             ccC
Q 023568          234 QSL  236 (280)
Q Consensus       234 ~~~  236 (280)
                      +++
T Consensus       265 ~~i  267 (337)
T d1o6la_         265 LSI  267 (337)
T ss_dssp             TTC
T ss_pred             ccC
Confidence            875

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-52  Score=348.69  Aligned_cols=202  Identities=26%  Similarity=0.437  Sum_probs=171.4

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      |+|||||++++++.++     +.+|+|||||+ |+|.+++.+ .+.+++.+++.++.||+.||.|||++||+||||||+|
T Consensus        66 l~HpnIv~l~~~~~~~-----~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~N  140 (288)
T d2jfla1          66 CDHPNIVKLLDAFYYE-----NNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGN  140 (288)
T ss_dssp             CCCTTBCCEEEEEEET-----TEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred             CCCCCCCeEEEEEeeC-----CeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhh
Confidence            6899999999999988     77999999997 599998764 5679999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCC-Cccccceecccccccccccc----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 023568           79 LLLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLN----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDY  153 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~  153 (280)
                      ||++.++.+||+|||+++..... .......||+.|+|||++.+    ...++.++||||+||++|+|++|+.||.+.+.
T Consensus       141 Ill~~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~  220 (288)
T d2jfla1         141 ILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP  220 (288)
T ss_dssp             EEECTTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG
T ss_pred             eeECCCCCEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH
Confidence            99999999999999999765432 22346789999999999853    25578899999999999999999999998877


Q ss_pred             HHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          154 VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       154 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      .+.+..+.....                            +....++.+++++.+||++||+.||.+|||++|+|+||||
T Consensus       221 ~~~~~~i~~~~~----------------------------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~  272 (288)
T d2jfla1         221 MRVLLKIAKSEP----------------------------PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV  272 (288)
T ss_dssp             GGHHHHHHHSCC----------------------------CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGG
T ss_pred             HHHHHHHHcCCC----------------------------CCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence            666655543110                            0111123578999999999999999999999999999999


Q ss_pred             cc
Q 023568          234 QS  235 (280)
Q Consensus       234 ~~  235 (280)
                      +.
T Consensus       273 ~~  274 (288)
T d2jfla1         273 TV  274 (288)
T ss_dssp             CC
T ss_pred             CC
Confidence            64

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=5.3e-52  Score=353.83  Aligned_cols=204  Identities=25%  Similarity=0.466  Sum_probs=179.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      |+|||||+++++|+++     +.+|||||||+ |+|.+.+.+. .++++.+++.++.||+.||+|||++||+||||||+|
T Consensus        83 l~HpnIv~~~~~~~~~-----~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~N  157 (352)
T d1koba_          83 LHHPKLINLHDAFEDK-----YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPEN  157 (352)
T ss_dssp             CCSTTBCCEEEEEECS-----SEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred             CCCCCCCcEEEEEEEC-----CEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccccccc
Confidence            6899999999999988     78999999998 5999988654 479999999999999999999999999999999999


Q ss_pred             eEEc--CCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023568           79 LLLN--ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  156 (280)
Q Consensus        79 ili~--~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~  156 (280)
                      ||++  .++.+||+|||+++............||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....
T Consensus       158 ILl~~~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~  236 (352)
T d1koba_         158 IMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET  236 (352)
T ss_dssp             EEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH
T ss_pred             ccccccCCCeEEEeecccceecCCCCceeeccCcccccCHHHHcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            9997  578999999999998877666677889999999999987 7789999999999999999999999999988877


Q ss_pred             HHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 023568          157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  236 (280)
Q Consensus       157 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~  236 (280)
                      +..+.......+                           ...++.+++++.+||++||+.||.+|||++|+|+||||+..
T Consensus       237 ~~~i~~~~~~~~---------------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         237 LQNVKRCDWEFD---------------------------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             HHHHHHCCCCCC---------------------------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             HHHHHhCCCCCC---------------------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence            777655322211                           12234689999999999999999999999999999999865


Q ss_pred             c
Q 023568          237 H  237 (280)
Q Consensus       237 ~  237 (280)
                      .
T Consensus       290 ~  290 (352)
T d1koba_         290 H  290 (352)
T ss_dssp             C
T ss_pred             c
Confidence            3

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-52  Score=341.44  Aligned_cols=201  Identities=24%  Similarity=0.422  Sum_probs=167.1

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSAS--VLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~--i~H~dik~~   77 (280)
                      |+|||||+++++|++... +...+|+|||||+ |+|.+++.+.+.+++.+++.++.||+.||+|||++|  |+||||||+
T Consensus        65 l~HpnIv~~~~~~~~~~~-~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~  143 (270)
T d1t4ha_          65 LQHPNIVRFYDSWESTVK-GKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCD  143 (270)
T ss_dssp             CCCTTBCCEEEEEEEESS-SCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGG
T ss_pred             CCCCCeeeEEEEEeeccc-cCCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChh
Confidence            689999999999976421 1257899999997 599999988889999999999999999999999999  999999999


Q ss_pred             ceEEc-CCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023568           78 NLLLN-ASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  156 (280)
Q Consensus        78 Nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~  156 (280)
                      |||++ .++.+||+|||+++..... ......||+.|+|||++.+  .++.++||||+||++|+|++|+.||.+......
T Consensus       144 NILl~~~~~~~Kl~DFGla~~~~~~-~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~  220 (270)
T d1t4ha_         144 NIFITGPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ  220 (270)
T ss_dssp             GEEESSTTSCEEECCTTGGGGCCTT-SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH
T ss_pred             hceeeCCCCCEEEeecCcceeccCC-ccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH
Confidence            99996 4789999999999764433 3456789999999999865  589999999999999999999999987654443


Q ss_pred             H-HHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 023568          157 L-RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ  234 (280)
Q Consensus       157 ~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~  234 (280)
                      + ..+..  +..+                           .......++++.+||++||+.||++|||++|+|+||||+
T Consensus       221 ~~~~i~~--~~~~---------------------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         221 IYRRVTS--GVKP---------------------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             HHHHHTT--TCCC---------------------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             HHHHHHc--CCCC---------------------------cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            3 22211  0000                           111235688999999999999999999999999999995

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-51  Score=343.23  Aligned_cols=232  Identities=38%  Similarity=0.647  Sum_probs=193.2

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIR--SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~--~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++||||++++++|..........+|++|||+++++..+..  ....+++..++.++.|++.||+|||++||+||||||+|
T Consensus        67 ~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~N  146 (305)
T d1blxa_          67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQN  146 (305)
T ss_dssp             TCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred             cCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccE
Confidence            3799999999999754333336799999999986555443  34679999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      ||++.++.+||+|||.++............||+.|+|||++.+ ..++.++||||+||++|+|++|++||.+.+..+.+.
T Consensus       147 ILi~~~~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~-~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~  225 (305)
T d1blxa_         147 ILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG  225 (305)
T ss_dssp             EEECTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             EEEcCCCCeeecchhhhhhhcccccCCCcccChhhcCcchhcC-CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHH
Confidence            9999999999999999987766666677899999999999987 788999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  237 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~  237 (280)
                      .+.+..+.+....+........    ...............+..++.+++||++||+.||++|||++|+|+||||+++.
T Consensus       226 ~i~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~  300 (305)
T d1blxa_         226 KILDVIGLPGEEDWPRDVALPR----QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE  300 (305)
T ss_dssp             HHHHHHCCCCGGGSCTTCSSCG----GGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             HHHHhhCCCchhcccccccchh----hhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence            9999999887765443221110    11112223334445567899999999999999999999999999999999875

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-52  Score=346.18  Aligned_cols=232  Identities=40%  Similarity=0.747  Sum_probs=194.4

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~--~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      |+|||||+++++|.++     +++|+||||++|++.+++..  .+.+++.+++.++.|++.||+|||++||+||||||+|
T Consensus        58 l~Hp~Iv~~~~~~~~~-----~~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeN  132 (298)
T d1gz8a_          58 LNHPNIVKLLDVIHTE-----NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQN  132 (298)
T ss_dssp             CCCTTBCCEEEEEEET-----TEEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             CCCCcEEEeccccccc-----cceeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchh
Confidence            6899999999999988     78999999999887777643  4679999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023568           79 LLLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  157 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~  157 (280)
                      ||++.++.+||+|||.++..... .......||+.|+|||.+.....++.++|+||+||++|+|++|+.||.+.+..+.+
T Consensus       133 Il~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~  212 (298)
T d1gz8a_         133 LLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL  212 (298)
T ss_dssp             EEECTTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             eeecccCcceeccCCcceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHH
Confidence            99999999999999999876443 44556789999999999887677789999999999999999999999999999999


Q ss_pred             HHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCc
Q 023568          158 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  237 (280)
Q Consensus       158 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~  237 (280)
                      ..+.+..+.+.+..+.....  ........+...........+..++++.+||++||+.||.+|||++|+|+||||+++.
T Consensus       213 ~~i~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~  290 (298)
T d1gz8a_         213 FRIFRTLGTPDEVVWPGVTS--MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT  290 (298)
T ss_dssp             HHHHHHHCCCCTTTSTTGGG--STTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             HHHHHhcCCCchhhcccccc--ccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCC
Confidence            99988888777655432211  1111122233334444555667899999999999999999999999999999999875


Q ss_pred             CC
Q 023568          238 DL  239 (280)
Q Consensus       238 ~~  239 (280)
                      .+
T Consensus       291 ~p  292 (298)
T d1gz8a_         291 KP  292 (298)
T ss_dssp             CC
T ss_pred             CC
Confidence            43

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-53  Score=356.42  Aligned_cols=226  Identities=22%  Similarity=0.364  Sum_probs=169.2

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~-~~i~H~dik~~N   78 (280)
                      |+|||||+++++|.++     .++|+|||||. |+|.+++.+.+.+++.+++.++.|++.||.|||+ +||+||||||+|
T Consensus        61 l~HpnIv~l~~~~~~~-----~~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~N  135 (322)
T d1s9ja_          61 CNSPYIVGFYGAFYSD-----GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSN  135 (322)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGG
T ss_pred             CCCCCCCcEEEEEEEC-----CEEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHH
Confidence            6899999999999988     77999999998 5999999888899999999999999999999997 599999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH-HH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH-QL  157 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~-~~  157 (280)
                      ||++.++.+||+|||+|+..... ...+.+||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+... ..
T Consensus       136 ILl~~~~~vkl~DFGla~~~~~~-~~~~~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~  213 (322)
T d1s9ja_         136 ILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL  213 (322)
T ss_dssp             EEECTTCCEEECCCCCCHHHHHH-TC---CCSSCCCCHHHHHC-SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHH
T ss_pred             eeECCCCCEEEeeCCCccccCCC-ccccccCCccccCchHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence            99999999999999999865432 2346789999999999988 789999999999999999999999998876432 22


Q ss_pred             HHHHHHhCCCCcccccc--------------cCChhHHHHHHhCCccccccccccC-CCCCHHHHHHHHHhcccCCCCCC
Q 023568          158 RLITELIGSPDDASLGF--------------LRSDNARRYVRQLPRCRKQQFATRF-PNKSSGAVDLLEKMLVFDPNKRI  222 (280)
Q Consensus       158 ~~i~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ll~~~L~~dp~~Rp  222 (280)
                      ..+....+.+.......              ..............   ....+... ...|.++++||++||+.||.+||
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~  290 (322)
T d1s9ja_         214 MFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIV---NEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA  290 (322)
T ss_dssp             HC------------------------------CCCCHHHHHHHHH---TSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhh---ccCCccCccccCCHHHHHHHHHHcCCChhHCc
Confidence            22222222111110000              00000001111100   11111111 23689999999999999999999


Q ss_pred             CHHHHhcCcccccC
Q 023568          223 TVEEALRHPYLQSL  236 (280)
Q Consensus       223 t~~ell~hp~~~~~  236 (280)
                      |++|+|+||||++.
T Consensus       291 ta~e~L~Hpf~~~~  304 (322)
T d1s9ja_         291 DLKQLMVHAFIKRS  304 (322)
T ss_dssp             CHHHHHTSHHHHHH
T ss_pred             CHHHHhhCHhhCcC
Confidence            99999999999764

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.4e-51  Score=345.35  Aligned_cols=198  Identities=25%  Similarity=0.372  Sum_probs=170.4

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+|||||+++++|.++     +.+|+|||||.| +|..++..++++++.+++.++.||+.||.|||++||+||||||+||
T Consensus        72 l~HpnIv~~~~~~~~~-----~~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NI  146 (309)
T d1u5ra_          72 LRHPNTIQYRGCYLRE-----HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNI  146 (309)
T ss_dssp             CCCTTBCCEEEEEEET-----TEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGE
T ss_pred             CCCCCEeeEEEEEEEC-----CEEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceE
Confidence            6899999999999987     779999999985 6666667778899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceecccccccccccc--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN--CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQL  157 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~  157 (280)
                      |++.++.+||+|||+++.....   ....||+.|+|||++.+  ...++.++|||||||++|+|++|..||.+.+..+.+
T Consensus       147 Ll~~~~~~Kl~DFG~a~~~~~~---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~  223 (309)
T d1u5ra_         147 LLSEPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL  223 (309)
T ss_dssp             EEETTTEEEECCCTTCBSSSSB---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred             EECCCCCEEEeecccccccCCC---CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHH
Confidence            9999999999999999875443   45689999999999865  245788999999999999999999999988876666


Q ss_pred             HHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 023568          158 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  235 (280)
Q Consensus       158 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~  235 (280)
                      ..+.....                             ........|+.+.+||++||+.||.+|||++|+|+||||..
T Consensus       224 ~~i~~~~~-----------------------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~  272 (309)
T d1u5ra_         224 YHIAQNES-----------------------------PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (309)
T ss_dssp             HHHHHSCC-----------------------------CCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             HHHHhCCC-----------------------------CCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence            55543110                             00112356899999999999999999999999999999975

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-52  Score=340.79  Aligned_cols=199  Identities=33%  Similarity=0.517  Sum_probs=159.2

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCC-----cc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS----DQQLTDDHCQYFLYQLLRGLKYVHSAS-----VL   70 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH~~~-----i~   70 (280)
                      |+|||||++++++.+...   ..+|+|||||+ |+|.+++.+    .+.+++.+++.++.||+.||+|||+.|     |+
T Consensus        60 l~HpnIv~~~~~~~~~~~---~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~Ii  136 (269)
T d2java1          60 LKHPNIVRYYDRIIDRTN---TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVL  136 (269)
T ss_dssp             CCCTTBCCEEEEEEC-------CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC------
T ss_pred             CCCCCEeeEEEEEEeCCC---CEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEE
Confidence            689999999999976532   56999999997 599999853    467999999999999999999999976     99


Q ss_pred             ccCCCCCceEEcCCCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 023568           71 HRDLKPSNLLLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFP  149 (280)
Q Consensus        71 H~dik~~Nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~  149 (280)
                      ||||||+|||++.++.+||+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.
T Consensus       137 HrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyel~tg~~Pf~  215 (269)
T d2java1         137 HRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFT  215 (269)
T ss_dssp             ---CCGGGEEECTTSCEEECCHHHHHHC-----------CCCSCCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             eCcCchhhcCcCCCCcEEEeeccceeecccCCCccccCCCCcccCCHHHHcC-CCCChHHHHHhhCHHHHHHhhCCCCCC
Confidence            9999999999999999999999999876544 33456789999999999977 778999999999999999999999999


Q ss_pred             CCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          150 GKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       150 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      +.+..+....+....                              ....+..+|+++.+||++||+.||.+|||++|+|+
T Consensus       216 ~~~~~~~~~~i~~~~------------------------------~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         216 AFSQKELAGKIREGK------------------------------FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             CSSHHHHHHHHHHTC------------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCHHHHHHHHHcCC------------------------------CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            988766666554311                              11222357899999999999999999999999999


Q ss_pred             Cccc
Q 023568          230 HPYL  233 (280)
Q Consensus       230 hp~~  233 (280)
                      |||+
T Consensus       266 hp~i  269 (269)
T d2java1         266 NPLI  269 (269)
T ss_dssp             STTC
T ss_pred             CCcC
Confidence            9995

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.5e-51  Score=338.95  Aligned_cols=203  Identities=29%  Similarity=0.508  Sum_probs=177.4

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      .|||||+++++|.++     +++|||||||+ |+|.++++..+.+++.+++.++.||+.||+|||++||+||||||+||+
T Consensus        68 ~hpnIv~~~~~~~~~-----~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nil  142 (277)
T d1phka_          68 GHPNIIQLKDTYETN-----TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENIL  142 (277)
T ss_dssp             TCTTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             CCCCeEEEEeecccC-----cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEE
Confidence            399999999999988     78999999997 599999988889999999999999999999999999999999999999


Q ss_pred             EcCCCCeEEeecccccccCCCCccccceecccccccccccc-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023568           81 LNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN-----CTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH  155 (280)
Q Consensus        81 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~  155 (280)
                      ++.++.+||+|||+++............||+.|+|||.+.+     ...++.++||||+||++|+|++|+.||.+.+...
T Consensus       143 l~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~  222 (277)
T d1phka_         143 LDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML  222 (277)
T ss_dssp             ECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             EcCCCCeEEccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH
Confidence            99999999999999998776655667789999999999863     2456789999999999999999999999998777


Q ss_pred             HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 023568          156 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  235 (280)
Q Consensus       156 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~  235 (280)
                      ....+.......+                           ....+.+|+++++||++||+.||.+|||++|+|+||||+.
T Consensus       223 ~~~~i~~~~~~~~---------------------------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         223 MLRMIMSGNYQFG---------------------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             HHHHHHHTCCCCC---------------------------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             HHHHHHhCCCCCC---------------------------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence            7666654211111                           1122367999999999999999999999999999999976


Q ss_pred             C
Q 023568          236 L  236 (280)
Q Consensus       236 ~  236 (280)
                      .
T Consensus       276 ~  276 (277)
T d1phka_         276 Y  276 (277)
T ss_dssp             T
T ss_pred             h
Confidence            3

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.6e-51  Score=343.47  Aligned_cols=197  Identities=23%  Similarity=0.468  Sum_probs=176.2

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++|||||++++++.++     +.+|+|||||.| +|.+++.....+++..++.++.||+.||+|||++||+||||||+||
T Consensus        61 l~HpnIv~~~~~~~~~-----~~~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NI  135 (316)
T d1fota_          61 VTHPFIIRMWGTFQDA-----QQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENI  135 (316)
T ss_dssp             CCBTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGE
T ss_pred             ccCcChhheeeeEeeC-----CeeeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchhe
Confidence            6899999999999988     789999999975 9999999889999999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      |++.+|.+||+|||+++.....  ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+...+
T Consensus       136 Ll~~~g~vkL~DFG~a~~~~~~--~~~~~Gt~~Y~APE~l~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~  212 (316)
T d1fota_         136 LLDKNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK  212 (316)
T ss_dssp             EECTTSCEEECCCSSCEECSSC--BCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH
T ss_pred             eEcCCCCEEEecCccceEeccc--cccccCcccccCHHHHcC-CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHH
Confidence            9999999999999999876544  346789999999999987 6788999999999999999999999999887777666


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCcccc
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQ  234 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rp-----t~~ell~hp~~~  234 (280)
                      +....                               ...++.+++++.++|++||+.||.+|+     |++++++||||+
T Consensus       213 i~~~~-------------------------------~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~  261 (316)
T d1fota_         213 ILNAE-------------------------------LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFK  261 (316)
T ss_dssp             HHHCC-------------------------------CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGS
T ss_pred             HHcCC-------------------------------CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccc
Confidence            64411                               012235789999999999999999996     999999999999


Q ss_pred             cC
Q 023568          235 SL  236 (280)
Q Consensus       235 ~~  236 (280)
                      ++
T Consensus       262 ~i  263 (316)
T d1fota_         262 EV  263 (316)
T ss_dssp             SC
T ss_pred             cC
Confidence            86

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3.3e-51  Score=350.58  Aligned_cols=202  Identities=25%  Similarity=0.408  Sum_probs=172.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++|||||+++++|.+.     +.+|+|||||+ |+|.+++.+...+++.+++.++.||+.||.|||++||+||||||+||
T Consensus        64 ~~hpnIv~l~~~~~~~-----~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NI  138 (364)
T d1omwa3          64 GDCPFIVCMSYAFHTP-----DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANI  138 (364)
T ss_dssp             SCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             CCCCcEEEEEEEEEEC-----CEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeecccee
Confidence            4799999999999988     77999999998 59999998889999999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      |++.++.+||+|||+++...... .....||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+.......
T Consensus       139 Ll~~~g~iKl~DFGla~~~~~~~-~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~  217 (364)
T d1omwa3         139 LLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI  217 (364)
T ss_dssp             EECSSSCEEECCCTTCEECSSSC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHH
T ss_pred             EEcCCCcEEEeeeceeeecCCCc-ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            99999999999999998765543 35568999999999997656789999999999999999999999987653322221


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCC-----HHHHhcCcccc
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT-----VEEALRHPYLQ  234 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt-----~~ell~hp~~~  234 (280)
                      ......                            .....+..+++++++||.+||+.||.+|||     ++|+++||||+
T Consensus       218 ~~~~~~----------------------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~  269 (364)
T d1omwa3         218 DRMTLT----------------------------MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR  269 (364)
T ss_dssp             HHHSSS----------------------------CCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGT
T ss_pred             HHhccc----------------------------CCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCcccc
Confidence            111111                            111223468999999999999999999999     79999999998


Q ss_pred             cC
Q 023568          235 SL  236 (280)
Q Consensus       235 ~~  236 (280)
                      ++
T Consensus       270 ~i  271 (364)
T d1omwa3         270 SL  271 (364)
T ss_dssp             TC
T ss_pred             CC
Confidence            76

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-50  Score=344.65  Aligned_cols=269  Identities=43%  Similarity=0.792  Sum_probs=204.5

Q ss_pred             CCCcccccccccccCCCC-CCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~-~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++|||||+++++|..... ....++|+|||||.|++.+.+  .+.+++..++.++.||+.||.|||++||+||||||+||
T Consensus        73 l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Ni  150 (355)
T d2b1pa1          73 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI  150 (355)
T ss_dssp             CCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred             cCCCCeeEEEEEEecccccccCceeEEEEeccchHHHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccc
Confidence            589999999999976532 233789999999999888777  46799999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      |++.++.++++|||+++............+|+.|+|||++.+ ..++.++|+||+||++++|++|++||.+.+.......
T Consensus       151 l~~~~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~-~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~  229 (355)
T d2b1pa1         151 VVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK  229 (355)
T ss_dssp             EECTTCCEEECCCCC---------------CCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             ccccccceeeechhhhhccccccccccccccccccChhhhcC-CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHH
Confidence            999999999999999988777666677789999999999988 7889999999999999999999999999999999999


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccC------------CCCCHHHHHHHHHhcccCCCCCCCHHHH
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF------------PNKSSGAVDLLEKMLVFDPNKRITVEEA  227 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~ll~~~L~~dp~~Rpt~~el  227 (280)
                      +....+.+.+..+.... ..................+..+            ...++++++||++||+.||++||||+|+
T Consensus       230 i~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~el  308 (355)
T d2b1pa1         230 VIEQLGTPCPEFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA  308 (355)
T ss_dssp             HHHHHCCCCHHHHTTSC-HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             HHHhccCCCHHHHHHhh-hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHH
Confidence            99988888777655432 3333344433332222222111            1246789999999999999999999999


Q ss_pred             hcCcccccCcCCCCC-CCCCCCCCCccCCCCCCHHHHHHHHHHHHHh
Q 023568          228 LRHPYLQSLHDLNDE-PVCPRPFHFDFEHSSCTEDHIRELIWRESVK  273 (280)
Q Consensus       228 l~hp~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (280)
                      |+||||+.+.++..+ ...+..+..+.++.+.+.++|+++|.+|+++
T Consensus       309 L~Hpw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (355)
T d2b1pa1         309 LQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMN  355 (355)
T ss_dssp             HTSTTTGGGCCHHHHTCCCC-------CCCCCCHHHHHHHHHHHHHC
T ss_pred             hcCcccCCCCCcccccCCCCCCCCcchhhhhcCHHHHHHHHHHHhcC
Confidence            999999987654432 3344555556777889999999999999863

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-51  Score=343.09  Aligned_cols=199  Identities=27%  Similarity=0.458  Sum_probs=176.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++|||||++++++++.     +.+|+|||||+ |+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+||
T Consensus        60 ~~hp~Iv~~~~~~~~~-----~~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~Ni  134 (320)
T d1xjda_          60 WEHPFLTHMFCTFQTK-----ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNI  134 (320)
T ss_dssp             TTCTTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGE
T ss_pred             CCCCcEEEEEEEEccC-----CceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccce
Confidence            5899999999999998     78999999997 59999999888999999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC-CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      |++.++.+||+|||+++..... .......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+......
T Consensus       135 L~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~  213 (320)
T d1xjda_         135 LLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH  213 (320)
T ss_dssp             EECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             eecCCCceeccccchhhhcccccccccccCCCCCcCCHHHHcC-CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHH
Confidence            9999999999999999865433 33456789999999999988 778899999999999999999999999988777766


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHH-HHhcCcccccC
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVE-EALRHPYLQSL  236 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~-ell~hp~~~~~  236 (280)
                      .+...  .                             +..++.+|+.+.+||++||+.||.+|||+. |+++||||+++
T Consensus       214 ~i~~~--~-----------------------------~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~  261 (320)
T d1xjda_         214 SIRMD--N-----------------------------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI  261 (320)
T ss_dssp             HHHHC--C-----------------------------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred             HHHcC--C-----------------------------CCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccC
Confidence            65431  0                             112235799999999999999999999996 89999999876

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.9e-50  Score=344.12  Aligned_cols=197  Identities=23%  Similarity=0.408  Sum_probs=176.0

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++|||||+++++|.+.     ..+|+||||+. |+|.+++.+.+.+++.+++.++.||+.||.|||++||+||||||+||
T Consensus        98 l~hpnIv~~~~~~~~~-----~~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NI  172 (350)
T d1rdqe_          98 VNFPFLVKLEFSFKDN-----SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENL  172 (350)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             cCCCcEeecccccccc-----cccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHc
Confidence            6899999999999988     77999999997 59999998888999999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLRL  159 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      |++.++.+||+|||+++.....  .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......
T Consensus       173 Ll~~~g~ikL~DFG~a~~~~~~--~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~  249 (350)
T d1rdqe_         173 LIDQQGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK  249 (350)
T ss_dssp             EECTTSCEEECCCTTCEECSSC--BCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             ccCCCCCEEeeeceeeeecccc--cccccCccccCCHHHHcC-CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHH
Confidence            9999999999999999876544  346789999999999987 7788999999999999999999999999887777666


Q ss_pred             HHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCcccc
Q 023568          160 ITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYLQ  234 (280)
Q Consensus       160 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rp-----t~~ell~hp~~~  234 (280)
                      +.....                               ..++.+++++.+||++||+.||.+|+     |++++++||||+
T Consensus       250 i~~~~~-------------------------------~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~  298 (350)
T d1rdqe_         250 IVSGKV-------------------------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA  298 (350)
T ss_dssp             HHHCCC-------------------------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGT
T ss_pred             HhcCCC-------------------------------CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCcccc
Confidence            644211                               11235799999999999999999995     999999999998


Q ss_pred             cC
Q 023568          235 SL  236 (280)
Q Consensus       235 ~~  236 (280)
                      ++
T Consensus       299 ~~  300 (350)
T d1rdqe_         299 TT  300 (350)
T ss_dssp             TC
T ss_pred             CC
Confidence            75

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=4.8e-50  Score=333.66  Aligned_cols=228  Identities=38%  Similarity=0.697  Sum_probs=186.9

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCccHHHHH-HcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQII-RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l-~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+|||||+++++|.++     +..|++||++.+++...+ ...+.+++..++.++.||+.||+|||+.||+||||||+||
T Consensus        57 l~hpnIv~~~~~~~~~-----~~~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NI  131 (286)
T d1ob3a_          57 LKHSNIVKLYDVIHTK-----KRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNL  131 (286)
T ss_dssp             CCCTTBCCEEEEEECS-----SCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred             CCCCcEEeeeeecccC-----CceeEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCcee
Confidence            6899999999999988     779999999998655544 5568899999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCC-ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      |++.++.+|++|||.+....... ......+++.|+|||.+.+...++.++|+||+||++|+|++|+.||.+.+..+.+.
T Consensus       132 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~  211 (286)
T d1ob3a_         132 LINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLM  211 (286)
T ss_dssp             EECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             eEcCCCCEEecccccceecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHH
Confidence            99999999999999998755432 23455789999999999876778999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQS  235 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~  235 (280)
                      ++....+.++...+......  ...................+..++.+.+||++||+.||++|||++|+|+||||++
T Consensus       212 ~i~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         212 RIFRILGTPNSKNWPNVTEL--PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             HHHHHHCCCCTTTSTTGGGS--TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             HHHHhhCCCChhhccchhhh--hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence            99998888776654332211  0111122222333345556678999999999999999999999999999999974

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-50  Score=341.98  Aligned_cols=203  Identities=24%  Similarity=0.444  Sum_probs=177.1

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQ-QLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++|||||+++++|+++     +.+|+|||||+| +|.+++.+.+ .+++.+++.++.||+.||+|||++||+||||||+|
T Consensus        58 l~HpnIv~~~~~~~~~-----~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~N  132 (321)
T d1tkia_          58 ARHRNILHLHESFESM-----EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPEN  132 (321)
T ss_dssp             SCCTTBCCEEEEEEET-----TEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred             CCCCCCCeEEEEEEEC-----CEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccc
Confidence            6899999999999988     789999999985 9999998654 79999999999999999999999999999999999


Q ss_pred             eEEcC--CCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023568           79 LLLNA--SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQ  156 (280)
Q Consensus        79 ili~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~  156 (280)
                      ||++.  ...++|+|||+++............+++.|+|||.+.+ ..++.++||||+||++|+|++|..||.+.+..+.
T Consensus       133 Ill~~~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~-~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~  211 (321)
T d1tkia_         133 IIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI  211 (321)
T ss_dssp             EEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred             eeecCCCceEEEEcccchhhccccCCcccccccccccccchhccC-CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHH
Confidence            99975  45799999999988766655666788999999999877 7788999999999999999999999999988777


Q ss_pred             HHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 023568          157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSL  236 (280)
Q Consensus       157 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~  236 (280)
                      ...+.......+.                           ..++.+|+++++||++||+.||.+|||++|+|+||||+.-
T Consensus       212 ~~~i~~~~~~~~~---------------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  264 (321)
T d1tkia_         212 IENIMNAEYTFDE---------------------------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             HHHHHHTCCCCCH---------------------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             HHHHHhCCCCCCh---------------------------hhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence            7776653221111                           1234679999999999999999999999999999999753

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-50  Score=341.33  Aligned_cols=237  Identities=30%  Similarity=0.607  Sum_probs=191.7

Q ss_pred             CCCcccccccccccCCCC-CCCCcEEEEEecCCccHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 023568            1 MEHENVIAIKDIIRPPKK-DTFNDVYIVYELMDTDLHQIIR----SDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLK   75 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~-~~~~~~~lv~e~~~g~L~~~l~----~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik   75 (280)
                      |+|||||+++++|..... ....++|||||||++++.+.+.    ....+++.+++.++.||+.||+|||++||+|||||
T Consensus        70 l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiK  149 (350)
T d1q5ka_          70 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIK  149 (350)
T ss_dssp             CCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCC
T ss_pred             cCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCC
Confidence            689999999999965421 2225789999999987655553    45679999999999999999999999999999999


Q ss_pred             CCceEEcCCC-CeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023568           76 PSNLLLNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV  154 (280)
Q Consensus        76 ~~Nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~  154 (280)
                      |+|||++.++ .+||+|||+++............|++.|+|||.+.+...++.++||||+||++|||++|.+||.+.+..
T Consensus       150 p~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~  229 (350)
T d1q5ka_         150 PQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV  229 (350)
T ss_dssp             GGGEEECTTTCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH
T ss_pred             cceEEEecCCCceeEecccchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH
Confidence            9999999775 899999999988766666677889999999999887678999999999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccc-cccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQF-ATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      +.+..+.+.++.+....+.........   ...+....... ....+..++++.+||++||+.||.+|||++|+|+||||
T Consensus       230 ~~l~~i~~~~g~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f  306 (350)
T d1q5ka_         230 DQLVEIIKVLGTPTREQIREMNPNYTE---FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF  306 (350)
T ss_dssp             HHHHHHHHHHCCCCHHHHHHHCC---C---CCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             HHHHHHHHHhCCChHHhhhhhccchhh---ccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence            999999999998876654322211100   00111111111 12234679999999999999999999999999999999


Q ss_pred             ccCcCCC
Q 023568          234 QSLHDLN  240 (280)
Q Consensus       234 ~~~~~~~  240 (280)
                      +++.+..
T Consensus       307 ~~~~~~~  313 (350)
T d1q5ka_         307 DELRDPN  313 (350)
T ss_dssp             GGGGCTT
T ss_pred             ccccCCC
Confidence            9987654

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-51  Score=344.52  Aligned_cols=210  Identities=26%  Similarity=0.436  Sum_probs=169.0

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      ++|||||+++++|++... ...++|+|||||+ |+|.++|.+.  ..+++.+++.++.||+.||+|||++||+||||||+
T Consensus        62 ~~hpnIv~l~~~~~~~~~-~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~  140 (335)
T d2ozaa1          62 SQCPHIVRIVDVYENLYA-GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPE  140 (335)
T ss_dssp             TTSTTBCCEEEEEEEEET-TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred             cCCCCCCeEEEEEeeccc-CCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccc
Confidence            379999999999976311 1167999999997 5999999764  47999999999999999999999999999999999


Q ss_pred             ceEEcC---CCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023568           78 NLLLNA---SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYV  154 (280)
Q Consensus        78 Nili~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~  154 (280)
                      |||++.   .+.+||+|||+++............||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..
T Consensus       141 NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~  219 (335)
T d2ozaa1         141 NLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL  219 (335)
T ss_dssp             GEEESCSSTTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCG-GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC
T ss_pred             ccccccccccccccccccceeeeccCCCccccccCCcccCCcHHHcC-CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHH
Confidence            999975   56799999999988776666677889999999999887 77899999999999999999999999887644


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCcccccccc-ccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFA-TRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYL  233 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~  233 (280)
                      .....+........                        ..++ ..++.+|+++.+||++||+.||++|||++|+|+||||
T Consensus       220 ~~~~~~~~~i~~~~------------------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~  275 (335)
T d2ozaa1         220 AISPGMKTRIRMGQ------------------------YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI  275 (335)
T ss_dssp             --------CCCSCS------------------------SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHH
T ss_pred             HHHHHHHHHHhcCC------------------------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHh
Confidence            43333322111000                        0010 1122578999999999999999999999999999999


Q ss_pred             ccC
Q 023568          234 QSL  236 (280)
Q Consensus       234 ~~~  236 (280)
                      ..-
T Consensus       276 ~~~  278 (335)
T d2ozaa1         276 MQS  278 (335)
T ss_dssp             HTT
T ss_pred             hCC
Confidence            754

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-49  Score=328.50  Aligned_cols=193  Identities=27%  Similarity=0.444  Sum_probs=165.6

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC--ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD--TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~--g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      .|||||+++++|++.     +..|+||||+.  +++.+++.+.+.+++.+++.++.||+.||+|||++||+||||||+||
T Consensus        67 ~h~nIv~~~~~~~~~-----~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NI  141 (273)
T d1xwsa_          67 GFSGVIRLLDWFERP-----DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENI  141 (273)
T ss_dssp             SSCSBCCEEEEEECS-----SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             CCCCccEEEEEEeeC-----CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccce
Confidence            399999999999988     77999999996  38889998888999999999999999999999999999999999999


Q ss_pred             EEcC-CCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           80 LLNA-SCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        80 li~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      |++. ++.+||+|||+++..... ......||+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+      
T Consensus       142 ll~~~~~~vkl~DFG~a~~~~~~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------  214 (273)
T d1xwsa_         142 LIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------  214 (273)
T ss_dssp             EEETTTTEEEECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------
T ss_pred             EEecCCCeEEECccccceecccc-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------
Confidence            9985 478999999999865443 34567899999999999875566788999999999999999999997632      


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  237 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~  237 (280)
                      .+..  +                             .....+.+|+++++||++||+.||++|||++|+|+||||+++.
T Consensus       215 ~i~~--~-----------------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~  262 (273)
T d1xwsa_         215 EIIR--G-----------------------------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  262 (273)
T ss_dssp             HHHH--C-----------------------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             HHhh--c-----------------------------ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence            1111  0                             0012235799999999999999999999999999999998764

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-48  Score=317.75  Aligned_cols=199  Identities=21%  Similarity=0.292  Sum_probs=161.4

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++|||||++++++..      ..+|+|||||+ |+|.+++... ..+++.++..++.||+.||+|||++||+||||||+|
T Consensus        61 l~HpnIv~~~~~~~~------~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~N  134 (276)
T d1uwha_          61 TRHVNILLFMGYSTA------PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNN  134 (276)
T ss_dssp             CCCTTBCCEEEEECS------SSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             CCCCCEeeeeEEEec------cEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHH
Confidence            689999999998654      34899999998 6999999754 679999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCC---CccccceeccccccccccccC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 023568           79 LLLNASCDLKIGDFGLARTTSET---DFMTEYVVTRWYRAPELLLNC--TEYTAAIDIWSVGCILGEIMTREPLFPGKDY  153 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~  153 (280)
                      ||++.++.+||+|||+++.....   .......||+.|+|||++.+.  ..++.++|||||||++|||++|+.||.+.+.
T Consensus       135 iLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~  214 (276)
T d1uwha_         135 IFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN  214 (276)
T ss_dssp             EEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred             EEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh
Confidence            99999999999999999765432   223456789999999998652  3578899999999999999999999998776


Q ss_pred             HHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 023568          154 VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  230 (280)
Q Consensus       154 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~h  230 (280)
                      ...+..+.......                         ..........++.+.+|+.+||+.||.+|||++|++++
T Consensus       215 ~~~~~~~~~~~~~~-------------------------p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         215 RDQIIFMVGRGYLS-------------------------PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             HHHHHHHHHHTSCC-------------------------CCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHhcCCCC-------------------------CcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            65554443321111                         11123344678999999999999999999999999986

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-47  Score=323.13  Aligned_cols=234  Identities=34%  Similarity=0.608  Sum_probs=182.8

Q ss_pred             CCCcccccccccccCCCC---CCCCcEEEEEecCCccHHHHH-HcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 023568            1 MEHENVIAIKDIIRPPKK---DTFNDVYIVYELMDTDLHQII-RSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKP   76 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~---~~~~~~~lv~e~~~g~L~~~l-~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~   76 (280)
                      |+||||+++++++.....   ...+++|+||||+++++.... .....+++..++.++.|++.||.|||++||+||||||
T Consensus        66 l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp  145 (318)
T d3blha1          66 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKA  145 (318)
T ss_dssp             CCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred             hcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCc
Confidence            689999999999876421   112579999999997666555 4457899999999999999999999999999999999


Q ss_pred             CceEEcCCCCeEEeecccccccCCC-----CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 023568           77 SNLLLNASCDLKIGDFGLARTTSET-----DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGK  151 (280)
Q Consensus        77 ~Nili~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~  151 (280)
                      +|||++.++.++++|||+++.....     .......||+.|+|||++.+...++.++||||+||++|+|++|+.||.+.
T Consensus       146 ~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~  225 (318)
T d3blha1         146 ANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN  225 (318)
T ss_dssp             GGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             hheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCC
Confidence            9999999999999999999755432     22344578999999999987678899999999999999999999999999


Q ss_pred             ChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccC--CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          152 DYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRF--PNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       152 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      +.......+....+.+.+....................... .....+  ...++.+++||.+||+.||++|||++|+|+
T Consensus       226 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         226 TEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKR-KVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             SHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCB-CHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccc-cchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            99999999999999888776555443333322222211111 111111  124788999999999999999999999999


Q ss_pred             Cccccc
Q 023568          230 HPYLQS  235 (280)
Q Consensus       230 hp~~~~  235 (280)
                      ||||+.
T Consensus       305 Hpff~~  310 (318)
T d3blha1         305 HDFFWS  310 (318)
T ss_dssp             SGGGSS
T ss_pred             Chhhcc
Confidence            999975

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-48  Score=326.83  Aligned_cols=194  Identities=25%  Similarity=0.365  Sum_probs=164.4

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCC-----------------------CCCHHHHHHHHHHH
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ-----------------------QLTDDHCQYFLYQL   57 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~-----------------------~l~~~~~~~i~~qi   57 (280)
                      +|||||++++++.+.     +.+|+|||||+ |+|.++|++.+                       .+++.++..++.||
T Consensus        99 ~HpnIv~l~~~~~~~-----~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi  173 (325)
T d1rjba_          99 SHENIVNLLGACTLS-----GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQV  173 (325)
T ss_dssp             CCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHH
T ss_pred             CCCcEeEEEEEEeeC-----CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHH
Confidence            799999999999988     67999999997 69999997542                       48999999999999


Q ss_pred             HHHHHHHHhCCccccCCCCCceEEcCCCCeEEeecccccccCCCC---ccccceeccccccccccccCCCCCcchhHHHH
Q 023568           58 LRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSV  134 (280)
Q Consensus        58 l~~l~~LH~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dvwsl  134 (280)
                      +.||+|||++||+||||||+||+++.++.+||+|||+|+......   ......||+.|+|||++.+ ..++.++|||||
T Consensus       174 ~~gl~yLH~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwS~  252 (325)
T d1rjba_         174 AKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSY  252 (325)
T ss_dssp             HHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHH
T ss_pred             HHHHHHHHhCCeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC-CCCCcceeccch
Confidence            999999999999999999999999999999999999998654432   2345678999999999887 788999999999


Q ss_pred             HHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHh
Q 023568          135 GCILGEIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKM  213 (280)
Q Consensus       135 G~~l~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~  213 (280)
                      ||++|||++ |.+||.+.+....+.++.....                             ....+...++++.+||++|
T Consensus       253 Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~-----------------------------~~~~p~~~~~~l~~li~~c  303 (325)
T d1rjba_         253 GILLWEIFSLGVNPYPGIPVDANFYKLIQNGF-----------------------------KMDQPFYATEEIYIIMQSC  303 (325)
T ss_dssp             HHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTC-----------------------------CCCCCTTCCHHHHHHHHHH
T ss_pred             hHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC-----------------------------CCCCCCcCCHHHHHHHHHH
Confidence            999999997 8999998765555544433111                             0112335789999999999


Q ss_pred             cccCCCCCCCHHHHhcC
Q 023568          214 LVFDPNKRITVEEALRH  230 (280)
Q Consensus       214 L~~dp~~Rpt~~ell~h  230 (280)
                      |+.||++|||++|+++|
T Consensus       304 l~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         304 WAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             TCSSGGGSCCHHHHHHH
T ss_pred             cCCChhHCcCHHHHHHH
Confidence            99999999999999975

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-48  Score=319.94  Aligned_cols=197  Identities=20%  Similarity=0.336  Sum_probs=165.5

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      |+|||||+++++++++      ..|||||||+ |+|.+++.+.+.+++.++..++.||+.||+|||++||+||||||+||
T Consensus        65 l~HpnIv~~~g~~~~~------~~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Ni  138 (277)
T d1xbba_          65 LDNPYIVRMIGICEAE------SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNV  138 (277)
T ss_dssp             CCCTTBCCEEEEEESS------SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             CCCCCCceEEEEeccC------CEEEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhh
Confidence            6899999999998653      4799999997 59999999889999999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCC----ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023568           80 LLNASCDLKIGDFGLARTTSETD----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYV  154 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~  154 (280)
                      |++.++.+||+|||+++......    ......||+.|+|||.+.+ ..++.++|||||||++|||++ |+.||.+.+..
T Consensus       139 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~  217 (277)
T d1xbba_         139 LLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS  217 (277)
T ss_dssp             EEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred             cccccCcccccchhhhhhccccccccccccccCCCceecCchhhcC-CCCCchhhhccchhhhhHHhhCCCCCCCCCCHH
Confidence            99999999999999998654332    1234567899999999987 778899999999999999997 89999998866


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHH---hcCc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA---LRHP  231 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~el---l~hp  231 (280)
                      +....+.+.                              .....++..++++.+|+.+||+.||++|||++++   |+|+
T Consensus       218 ~~~~~i~~~------------------------------~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         218 EVTAMLEKG------------------------------ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  267 (277)
T ss_dssp             HHHHHHHTT------------------------------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHHHcC------------------------------CCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence            655544331                              0112234678999999999999999999999998   4666


Q ss_pred             ccc
Q 023568          232 YLQ  234 (280)
Q Consensus       232 ~~~  234 (280)
                      |++
T Consensus       268 ~~~  270 (277)
T d1xbba_         268 YYD  270 (277)
T ss_dssp             HHH
T ss_pred             Hhh
Confidence            654

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.8e-47  Score=318.17  Aligned_cols=194  Identities=24%  Similarity=0.354  Sum_probs=156.2

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      |+|||||++++++.++     +.+|+|||||+ |+|.+++... +.+++.++..++.||+.||+|||++||+||||||+|
T Consensus        84 l~HpnIv~l~g~~~~~-----~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~N  158 (299)
T d1jpaa_          84 FDHPNVIHLEGVVTKS-----TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARN  158 (299)
T ss_dssp             CCCTTBCCEEEEECSS-----SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             CCCCCCccEEEEEeeC-----CEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccce
Confidence            6899999999999887     67999999998 5999988764 579999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCcc------ccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDFM------TEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGK  151 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~  151 (280)
                      ||++.++.+||+|||+++........      ....+|+.|+|||.+.+ ..++.++|||||||++|||++ |+.||.+.
T Consensus       159 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~  237 (299)
T d1jpaa_         159 ILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDM  237 (299)
T ss_dssp             EEECTTCCEEECCC-----------------------CGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             EEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhc-CCCCcccccccchHHHHHHHhCCCCCCCCC
Confidence            99999999999999999865443211      22456889999999887 788999999999999999998 89999998


Q ss_pred             ChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 023568          152 DYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  230 (280)
Q Consensus       152 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~h  230 (280)
                      ...+....+.....                              ...+...++.+.+|+.+||+.||.+|||++|++++
T Consensus       238 ~~~~~~~~i~~~~~------------------------------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         238 TNQDVINAIEQDYR------------------------------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             CHHHHHHHHHTTCC------------------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             CHHHHHHHHHcCCC------------------------------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            87766655543111                              11223578999999999999999999999998874

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-47  Score=316.40  Aligned_cols=231  Identities=33%  Similarity=0.613  Sum_probs=187.0

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++|||||+++++|.+.     ...++||+++.| +|..++...+.+++..++.++.|++.||+|||++||+||||||+||
T Consensus        58 l~h~niv~~~~~~~~~-----~~~~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NI  132 (292)
T d1unla_          58 LKHKNIVRLHDVLHSD-----KKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNL  132 (292)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             cCcCCEEeeccccccc-----cceeEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCccc
Confidence            5899999999999988     779999999986 7777778888999999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCCC-ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCC-CCCCChHHHH
Q 023568           80 LLNASCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPGKDYVHQL  157 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~p-f~~~~~~~~~  157 (280)
                      |++.++.+||+|||.++...... ......+++.|+|||.+.+...++.++||||+||++|+|++|..| |.+.+..+..
T Consensus       133 li~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~  212 (292)
T d1unla_         133 LINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL  212 (292)
T ss_dssp             EECTTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHH
T ss_pred             ccccCCceeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHH
Confidence            99999999999999998765443 334456788999999988756789999999999999999998877 5566677788


Q ss_pred             HHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCc
Q 023568          158 RLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQSLH  237 (280)
Q Consensus       158 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~~~~  237 (280)
                      ..+....+.+....+.........  ................+..++.+.+||++||+.||.+|||++|+|+||||+++.
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~  290 (292)
T d1unla_         213 KRIFRLLGTPTEEQWPSMTKLPDY--KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             HHHHHHHCCCCTTTCTTGGGSTTC--CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred             HHHHhhcCCCChhhhhhhhhcccc--cccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence            888888887776554332211000  000000111223344567899999999999999999999999999999998765


Q ss_pred             C
Q 023568          238 D  238 (280)
Q Consensus       238 ~  238 (280)
                      .
T Consensus       291 ~  291 (292)
T d1unla_         291 P  291 (292)
T ss_dssp             C
T ss_pred             C
Confidence            3

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-47  Score=310.92  Aligned_cols=194  Identities=19%  Similarity=0.359  Sum_probs=155.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      |+|||||++++++..+     +.+|+|||||. |+|.+++... ..++++.+..++.|++.||+|||+.+|+||||||+|
T Consensus        57 l~HpnIv~~~g~~~~~-----~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~N  131 (263)
T d1sm2a_          57 LSHPKLVQLYGVCLEQ-----APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARN  131 (263)
T ss_dssp             CCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGG
T ss_pred             cCCCCcccccceeccC-----CceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhh
Confidence            6899999999999887     66999999997 6999998754 568999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCc--cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDF--MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVH  155 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~~  155 (280)
                      ||++.++.+||+|||+++.......  .....||+.|+|||++.+ ..++.++|||||||++|||++ |.+||...+..+
T Consensus       132 ill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~  210 (263)
T d1sm2a_         132 CLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE  210 (263)
T ss_dssp             EEECGGGCEEECSCC------------------CTTSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH
T ss_pred             eeecCCCCeEecccchheeccCCCceeecceecCcccCChHHhcC-CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH
Confidence            9999999999999999987554322  234578999999999987 778999999999999999998 677787777666


Q ss_pred             HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 023568          156 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  230 (280)
Q Consensus       156 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~h  230 (280)
                      ....+......                              ..+...++.+.+++.+||+.||++|||++|+++|
T Consensus       211 ~~~~i~~~~~~------------------------------~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         211 VVEDISTGFRL------------------------------YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             HHHHHHHTCCC------------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhcCCC------------------------------CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence            66655442111                              1122468899999999999999999999999985

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-47  Score=316.02  Aligned_cols=198  Identities=19%  Similarity=0.304  Sum_probs=167.4

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      |+|||||+++++++++      .+|+|||||+ |+|.+++.. .+.+++.++..++.||+.||+|||++||+||||||+|
T Consensus        66 l~HpnIv~l~g~~~~~------~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~N  139 (285)
T d1u59a_          66 LDNPYIVRLIGVCQAE------ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARN  139 (285)
T ss_dssp             CCCTTBCCEEEEEESS------SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred             CCCCCEeeEeeeeccC------eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhh
Confidence            6899999999998753      4899999998 599998865 4679999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCC----ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 023568           79 LLLNASCDLKIGDFGLARTTSETD----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDY  153 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~  153 (280)
                      |+++.++.+||+|||+++......    ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+.
T Consensus       140 ill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~  218 (285)
T d1u59a_         140 VLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG  218 (285)
T ss_dssp             EEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT
T ss_pred             eeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhC-CCCCccchhhcchHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999998755432    1234567899999999877 678999999999999999998 9999999887


Q ss_pred             HHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHH---hcC
Q 023568          154 VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEA---LRH  230 (280)
Q Consensus       154 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~el---l~h  230 (280)
                      .+....+.+..                              .+..++.+++++.+||.+||+.||++|||+.++   |+|
T Consensus       219 ~~~~~~i~~~~------------------------------~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~  268 (285)
T d1u59a_         219 PEVMAFIEQGK------------------------------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA  268 (285)
T ss_dssp             HHHHHHHHTTC------------------------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHHHHcCC------------------------------CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            66665554311                              112234678999999999999999999999888   678


Q ss_pred             ccccc
Q 023568          231 PYLQS  235 (280)
Q Consensus       231 p~~~~  235 (280)
                      +|++-
T Consensus       269 ~~~~~  273 (285)
T d1u59a_         269 CYYSL  273 (285)
T ss_dssp             HHHHH
T ss_pred             HHHHh
Confidence            88754

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=3.2e-47  Score=322.45  Aligned_cols=230  Identities=29%  Similarity=0.554  Sum_probs=175.6

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nil   80 (280)
                      .||||++++++|.....   ..+|+|||||++ +|.++.   +.+++.+++.++.||+.||+|||++||+||||||+|||
T Consensus        88 ~hpnIv~~~~~~~~~~~---~~~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NIL  161 (328)
T d3bqca1          88 GGPNIITLADIVKDPVS---RTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM  161 (328)
T ss_dssp             TSTTBCCEEEEEECTTT---CSEEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred             CCCCCcEEEEEEEecCC---CceeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceE
Confidence            49999999999986533   679999999985 776653   67999999999999999999999999999999999999


Q ss_pred             EcCCC-CeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHH
Q 023568           81 LNASC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD-YVHQLR  158 (280)
Q Consensus        81 i~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~-~~~~~~  158 (280)
                      ++.++ .++|+|||+++............+|+.|+|||.+.+...++.++|+||+||++++|++|..||.... ......
T Consensus       162 i~~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~  241 (328)
T d3bqca1         162 IDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV  241 (328)
T ss_dssp             EETTTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHH
T ss_pred             EcCCCCeeeecccccceeccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHH
Confidence            98755 5999999999887766666777899999999999886778999999999999999999999997764 445666


Q ss_pred             HHHHHhCCCCcccccccC-ChhHHHHHHhCCcccccc-----ccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 023568          159 LITELIGSPDDASLGFLR-SDNARRYVRQLPRCRKQQ-----FATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPY  232 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~  232 (280)
                      .+.+.++.+......... ......+...........     .......+++++++||++||+.||.+|||++|+|+|||
T Consensus       242 ~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~  321 (328)
T d3bqca1         242 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY  321 (328)
T ss_dssp             HHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             HHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence            666666533221110000 000000000011111111     11122347899999999999999999999999999999


Q ss_pred             cccCc
Q 023568          233 LQSLH  237 (280)
Q Consensus       233 ~~~~~  237 (280)
                      |+++.
T Consensus       322 F~~v~  326 (328)
T d3bqca1         322 FYTVV  326 (328)
T ss_dssp             GTTSC
T ss_pred             cCCCC
Confidence            98764

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.1e-46  Score=312.68  Aligned_cols=198  Identities=22%  Similarity=0.394  Sum_probs=162.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      |+|||||++++++.++     +.+|+|||||+ |+|.+++.+.  ..+++..+..++.||+.||+|||++||+||||||+
T Consensus        70 l~HpnIv~~~~~~~~~-----~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~  144 (287)
T d1opja_          70 IKHPNLVQLLGVCTRE-----PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR  144 (287)
T ss_dssp             CCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             CCCCCEecCCccEeeC-----CeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccC
Confidence            6899999999999987     67999999998 6999998653  57999999999999999999999999999999999


Q ss_pred             ceEEcCCCCeEEeecccccccCCCCc--cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCC-CCCCChH
Q 023568           78 NLLLNASCDLKIGDFGLARTTSETDF--MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL-FPGKDYV  154 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~p-f~~~~~~  154 (280)
                      |||++.++.+||+|||+++.......  .....|++.|+|||.+.+ ..++.++||||+||++|||++|..| |.+.+..
T Consensus       145 NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~  223 (287)
T d1opja_         145 NCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS  223 (287)
T ss_dssp             GEEECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             eEEECCCCcEEEccccceeecCCCCceeeccccccccccChHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH
Confidence            99999999999999999987654422  234567899999999887 7889999999999999999996555 5554444


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHPYLQ  234 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp~~~  234 (280)
                      .....+...                              .....++..++.+.+|+++||+.||.+|||++|+++  +|+
T Consensus       224 ~~~~~i~~~------------------------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~--~L~  271 (287)
T d1opja_         224 QVYELLEKD------------------------------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ--AFE  271 (287)
T ss_dssp             HHHHHHHTT------------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHH
T ss_pred             HHHHHHhcC------------------------------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH--HHH
Confidence            333332220                              011223467899999999999999999999999976  454


Q ss_pred             cC
Q 023568          235 SL  236 (280)
Q Consensus       235 ~~  236 (280)
                      .+
T Consensus       272 ~~  273 (287)
T d1opja_         272 TM  273 (287)
T ss_dssp             HT
T ss_pred             HH
Confidence            44

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-47  Score=312.77  Aligned_cols=198  Identities=22%  Similarity=0.386  Sum_probs=164.6

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      |+|||||++++++.++      .+|+|||||+ |+|.+++...  .++++.++..++.||+.||.|||++||+||||||+
T Consensus        65 l~HpnIv~~~g~~~~~------~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~  138 (272)
T d1qpca_          65 LQHQRLVRLYAVVTQE------PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAA  138 (272)
T ss_dssp             CCCTTBCCEEEEECSS------SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred             CCCCCEeEEEeeeccC------CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchh
Confidence            6899999999987543      4799999997 6999987543  36999999999999999999999999999999999


Q ss_pred             ceEEcCCCCeEEeecccccccCCCC--ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023568           78 NLLLNASCDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYV  154 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~  154 (280)
                      |||++.++.+||+|||+++......  ......||+.|+|||++.+ ..++.++|||||||++|||++ |.+||...+..
T Consensus       139 NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~  217 (272)
T d1qpca_         139 NILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP  217 (272)
T ss_dssp             GEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred             heeeecccceeeccccceEEccCCccccccccCCcccccChHHHhC-CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999998765442  2345678999999999887 678899999999999999999 46666666665


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc--Ccc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR--HPY  232 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~--hp~  232 (280)
                      +....+.....                              ...++..++.+.+|+++||+.||++|||++++++  |+|
T Consensus       218 ~~~~~i~~~~~------------------------------~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         218 EVIQNLERGYR------------------------------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             HHHHHHHTTCC------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHhcCC------------------------------CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence            55555433111                              1122357899999999999999999999999998  788


Q ss_pred             ccc
Q 023568          233 LQS  235 (280)
Q Consensus       233 ~~~  235 (280)
                      |++
T Consensus       268 fts  270 (272)
T d1qpca_         268 FTA  270 (272)
T ss_dssp             HHH
T ss_pred             hhc
Confidence            864

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-46  Score=304.43  Aligned_cols=194  Identities=20%  Similarity=0.333  Sum_probs=166.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++|||||++++++.++     +.+|+||||++ |+|.+++.. ...+++..+..++.|++.||+|||+.||+||||||+|
T Consensus        56 l~HpnIv~~~g~~~~~-----~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~N  130 (258)
T d1k2pa_          56 LSHEKLVQLYGVCTKQ-----RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARN  130 (258)
T ss_dssp             CCCTTBCCEEEEECCS-----SSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGG
T ss_pred             cCCCceeeEEEEEeeC-----CceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCccccccccee
Confidence            6899999999999887     67999999997 689988754 4679999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCc--cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDF--MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVH  155 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~~  155 (280)
                      |+++.++.+||+|||+++.......  .....+|+.|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+..+
T Consensus       131 ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~  209 (258)
T d1k2pa_         131 CLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE  209 (258)
T ss_dssp             EEECTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH
T ss_pred             EEEcCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcC-CCCCcceeecccchhhHhHHhcCCCCCCCCCHHH
Confidence            9999999999999999986544322  334678999999999987 778999999999999999998 899999988777


Q ss_pred             HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 023568          156 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  230 (280)
Q Consensus       156 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~h  230 (280)
                      ....+.+....                              ..+...++.+.+||++||+.||++|||++++++|
T Consensus       210 ~~~~i~~~~~~------------------------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         210 TAEHIAQGLRL------------------------------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             HHHHHHTTCCC------------------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhCCCC------------------------------CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence            66665442111                              1122467899999999999999999999999987

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2.1e-46  Score=310.13  Aligned_cols=204  Identities=26%  Similarity=0.413  Sum_probs=161.5

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNL   79 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Ni   79 (280)
                      ++|||||++++++..... ....+|+|||||+| +|.+++...+.+++.+++.++.||+.||+|||++||+||||||+||
T Consensus        64 ~~hpniv~~~~~~~~~~~-~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NI  142 (277)
T d1o6ya_          64 LNHPAIVAVYDTGEAETP-AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANI  142 (277)
T ss_dssp             CCCTTBCCEEEEEEEECS-SSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             cCCCCCCcccceeeeccC-CCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCccc
Confidence            589999999999987532 11458999999985 9999998888999999999999999999999999999999999999


Q ss_pred             EEcCCCCeEEeecccccccCCC----CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023568           80 LLNASCDLKIGDFGLARTTSET----DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKDYVH  155 (280)
Q Consensus        80 li~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~  155 (280)
                      |++.++.++++|||.+......    .......||+.|+|||++.+ ..++.++||||+||++|+|++|++||.+.+..+
T Consensus       143 ll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~  221 (277)
T d1o6ya_         143 MISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS  221 (277)
T ss_dssp             EEETTSCEEECCCTTCEECC----------------TTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcC-CCCCcceecccchHHHHHHHhCCCCCCCcCHHH
Confidence            9999999999999988754332    23345689999999999987 778999999999999999999999999988766


Q ss_pred             HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCC-CHHHHhcCcccc
Q 023568          156 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-TVEEALRHPYLQ  234 (280)
Q Consensus       156 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rp-t~~ell~hp~~~  234 (280)
                      ...++......+                           .....+.+|+.+.++|++||+.||.+|| |++++ .|+|.+
T Consensus       222 ~~~~~~~~~~~~---------------------------~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l-~~~l~r  273 (277)
T d1o6ya_         222 VAYQHVREDPIP---------------------------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEM-RADLVR  273 (277)
T ss_dssp             HHHHHHHCCCCC---------------------------GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHH-HHHHHH
T ss_pred             HHHHHHhcCCCC---------------------------CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHH-HHHHHH
Confidence            655544311111                           1123346899999999999999999999 55554 466653

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-45  Score=305.02  Aligned_cols=193  Identities=25%  Similarity=0.398  Sum_probs=154.0

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++|||||++++++.+      +.+|+||||++ |+|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|
T Consensus        65 l~HpnIv~l~~~~~~------~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~N  138 (273)
T d1mp8a_          65 FDHPHIVKLIGVITE------NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARN  138 (273)
T ss_dssp             CCCTTBCCEEEEECS------SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             CCCCCEeeEEEEEec------CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhh
Confidence            689999999999964      45899999998 589888754 4679999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCC--ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVH  155 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~~  155 (280)
                      |+++.++.+||+|||+++......  ......||+.|+|||.+.+ ..++.++|||||||++|||++ |.+||.+.+..+
T Consensus       139 Ill~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~-~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~  217 (273)
T d1mp8a_         139 VLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND  217 (273)
T ss_dssp             EEEEETTEEEECC-------------------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred             eeecCCCcEEEccchhheeccCCcceeccceecCcccchhhHhcc-CCCCCccccccchHHHHHHHhcCCCCCCCCCHHH
Confidence            999999999999999998754432  2344567899999999987 788999999999999999998 899999887766


Q ss_pred             HHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 023568          156 QLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  230 (280)
Q Consensus       156 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~h  230 (280)
                      ....+....                              ....++.+++.+.+||.+||+.||.+|||++|++++
T Consensus       218 ~~~~i~~~~------------------------------~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         218 VIGRIENGE------------------------------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             HHHHHHTTC------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcCC------------------------------CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            655543311                              112344679999999999999999999999999875

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-45  Score=311.61  Aligned_cols=203  Identities=20%  Similarity=0.377  Sum_probs=169.0

Q ss_pred             CcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE
Q 023568            3 HENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL   81 (280)
Q Consensus         3 Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nili   81 (280)
                      ||||+++++++++.     ..+|+||||+. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||++
T Consensus        88 ~pnIv~~~~~~~~~-----~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill  162 (322)
T d1vzoa_          88 SPFLVTLHYAFQTE-----TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL  162 (322)
T ss_dssp             CTTBCCEEEEEEET-----TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred             CCeEEEeeeeeccC-----CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceee
Confidence            48999999999988     77999999998 5999999988899999999999999999999999999999999999999


Q ss_pred             cCCCCeEEeecccccccCCC--CccccceeccccccccccccC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023568           82 NASCDLKIGDFGLARTTSET--DFMTEYVVTRWYRAPELLLNC-TEYTAAIDIWSVGCILGEIMTREPLFPGKDYVHQLR  158 (280)
Q Consensus        82 ~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~~l~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +.++.++|+|||+++.....  .......|++.|+|||.+.+. ..++.++|||||||++|+|++|..||.+.+......
T Consensus       163 ~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~  242 (322)
T d1vzoa_         163 DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA  242 (322)
T ss_dssp             CTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH
T ss_pred             cCCCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            99999999999999865433  234557789999999998763 356789999999999999999999998876444333


Q ss_pred             HHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCC-----CHHHHhcCccc
Q 023568          159 LITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRI-----TVEEALRHPYL  233 (280)
Q Consensus       159 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rp-----t~~ell~hp~~  233 (280)
                      .+.+...                           ......++..++.+.+||++||+.||.+||     |++|+++||||
T Consensus       243 ~i~~~~~---------------------------~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff  295 (322)
T d1vzoa_         243 EISRRIL---------------------------KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF  295 (322)
T ss_dssp             HHHHHHH---------------------------HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred             HHHHhcc---------------------------cCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhh
Confidence            3322110                           001122346799999999999999999999     58999999999


Q ss_pred             ccCc
Q 023568          234 QSLH  237 (280)
Q Consensus       234 ~~~~  237 (280)
                      +.++
T Consensus       296 ~~i~  299 (322)
T d1vzoa_         296 QKIN  299 (322)
T ss_dssp             TTCC
T ss_pred             cCCC
Confidence            8865

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-45  Score=306.58  Aligned_cols=195  Identities=25%  Similarity=0.369  Sum_probs=155.6

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHH
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD----------------QQLTDDHCQYFLYQLLRGLKYV   64 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~----------------~~l~~~~~~~i~~qil~~l~~L   64 (280)
                      +|||||++++++..+.    ..+++|||||+ |+|.++++..                ..+++.++..++.||+.||+||
T Consensus        75 ~h~~iv~~~~~~~~~~----~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~yl  150 (299)
T d1ywna1          75 HHLNVVNLLGACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL  150 (299)
T ss_dssp             CCTTBCCEEEEECSTT----SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHH
T ss_pred             CCCeEEEeeeeeccCC----CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHH
Confidence            6999999999987652    56899999998 6999999643                2489999999999999999999


Q ss_pred             HhCCccccCCCCCceEEcCCCCeEEeecccccccCCC---CccccceeccccccccccccCCCCCcchhHHHHHHHHHHH
Q 023568           65 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET---DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI  141 (280)
Q Consensus        65 H~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l  141 (280)
                      |++||+||||||+|||++.++.+||+|||+++.....   .......||+.|+|||++.+ ..++.++||||+||++|||
T Consensus       151 H~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gvil~el  229 (299)
T d1ywna1         151 ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEI  229 (299)
T ss_dssp             HHTTCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHH
T ss_pred             HhCCCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhc-CCCCcccceeehHHHHHHH
Confidence            9999999999999999999999999999999864433   22345678999999999987 7889999999999999999


Q ss_pred             HhC-CCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCC
Q 023568          142 MTR-EPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNK  220 (280)
Q Consensus       142 l~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~  220 (280)
                      ++| .+||.+.+....+..+.....                             .+..+...++++.+++.+||+.||.+
T Consensus       230 lt~~~~p~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~l~~li~~cl~~dP~~  280 (299)
T d1ywna1         230 FSLGASPYPGVKIDEEFCRRLKEGT-----------------------------RMRAPDYTTPEMYQTMLDCWHGEPSQ  280 (299)
T ss_dssp             HTTSCCSSTTCCCSHHHHHHHHHTC-----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred             HhCCCCCCCCCCHHHHHHHHHhcCC-----------------------------CCCCCccCCHHHHHHHHHHcCCChhH
Confidence            986 578887664444333322111                             11223357899999999999999999


Q ss_pred             CCCHHHHhcC
Q 023568          221 RITVEEALRH  230 (280)
Q Consensus       221 Rpt~~ell~h  230 (280)
                      |||++|+++|
T Consensus       281 Rpt~~eil~~  290 (299)
T d1ywna1         281 RPTFSELVEH  290 (299)
T ss_dssp             SCCHHHHHHH
T ss_pred             CcCHHHHHHH
Confidence            9999999986

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-45  Score=302.32  Aligned_cols=200  Identities=25%  Similarity=0.388  Sum_probs=160.5

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS--DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~--~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      ++|||||++++++.+.      .+|+|||||. |+|.+++..  .+.+++.++..++.||+.||+|||++||+||||||+
T Consensus        69 l~h~nIv~~~g~~~~~------~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~  142 (285)
T d1fmka3          69 LRHEKLVQLYAVVSEE------PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAA  142 (285)
T ss_dssp             CCCTTBCCEEEEECSS------SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             cccCCEeEEEEEEecC------CeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccce
Confidence            6899999999998543      4799999998 588888753  357999999999999999999999999999999999


Q ss_pred             ceEEcCCCCeEEeecccccccCCCC--ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCChH
Q 023568           78 NLLLNASCDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDYV  154 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g-~~pf~~~~~~  154 (280)
                      |||++.++.+||+|||+++......  ......||+.|+|||.+.+ ..++.++|||||||++|||++| .+|+.+....
T Consensus       143 NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~  221 (285)
T d1fmka3         143 NILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR  221 (285)
T ss_dssp             GEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred             EEEECCCCcEEEcccchhhhccCCCceeeccccccccccChHHHhC-CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999998754432  2344678999999999987 7889999999999999999995 5666666655


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc--Ccc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR--HPY  232 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~--hp~  232 (280)
                      +.+..+.+...                              ....+.+++.+.++|.+||+.||++|||++++++  ++|
T Consensus       222 ~~~~~i~~~~~------------------------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~  271 (285)
T d1fmka3         222 EVLDQVERGYR------------------------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  271 (285)
T ss_dssp             HHHHHHHTTCC------------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred             HHHHHHHhcCC------------------------------CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhh
Confidence            55555443111                              1223467899999999999999999999999998  888


Q ss_pred             cccCc
Q 023568          233 LQSLH  237 (280)
Q Consensus       233 ~~~~~  237 (280)
                      |+...
T Consensus       272 ~~~~~  276 (285)
T d1fmka3         272 FTSTE  276 (285)
T ss_dssp             TSCSC
T ss_pred             hcCCC
Confidence            87653

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-44  Score=300.43  Aligned_cols=193  Identities=22%  Similarity=0.364  Sum_probs=153.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCCc-cHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMDT-DLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      |+|||||++++++.+.     ..+++|||||.+ ++.+.+... +.+++.++..++.|++.||+|||+.||+||||||+|
T Consensus        66 l~H~nIv~~~g~~~~~-----~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~N  140 (283)
T d1mqba_          66 FSHHNIIRLEGVISKY-----KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARN  140 (283)
T ss_dssp             CCCTTBCCEEEEECSS-----SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             cCCCCEeeeeEEEecC-----CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccce
Confidence            6899999999999887     669999999985 788877654 679999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCC----ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCCh
Q 023568           79 LLLNASCDLKIGDFGLARTTSETD----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-EPLFPGKDY  153 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g-~~pf~~~~~  153 (280)
                      ||++.++.+||+|||+++......    ......||+.|+|||.+.+ ..++.++|||||||++|||++| .+|+...+.
T Consensus       141 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~  219 (283)
T d1mqba_         141 ILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSN  219 (283)
T ss_dssp             EEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred             EEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHcc-CCCCCcccccccHHHHHHHHhCCCCccccCCH
Confidence            999999999999999998654331    1233567899999999887 7889999999999999999995 555555555


Q ss_pred             HHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          154 VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       154 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      .+....+.....                              +..+...+..+.+++.+||+.||++|||+.|+++
T Consensus       220 ~~~~~~i~~~~~------------------------------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         220 HEVMKAINDGFR------------------------------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             HHHHHHHHTTCC------------------------------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHhccCC------------------------------CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence            444444332111                              1222357889999999999999999999999987

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-44  Score=298.17  Aligned_cols=193  Identities=25%  Similarity=0.347  Sum_probs=161.1

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      |+|||||++++++.++      .+++|||||+ |++.+.+.. .+.+++..+..++.|++.||.|||++||+||||||+|
T Consensus        68 l~H~nIv~~~g~~~~~------~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~N  141 (273)
T d1u46a_          68 LDHRNLIRLYGVVLTP------PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARN  141 (273)
T ss_dssp             CCCTTBCCEEEEECSS------SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred             CCCCCEEEEEEEEeec------chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHH
Confidence            6899999999999754      4789999997 688887754 4579999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCc----cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDF----MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDY  153 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~  153 (280)
                      |+++.++.+||+|||+++.......    .....++..|+|||.+.+ ..++.++|||||||++|||++ |.+||.+.+.
T Consensus       142 Ill~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~  220 (273)
T d1u46a_         142 LLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG  220 (273)
T ss_dssp             EEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred             hccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhC-CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH
Confidence            9999999999999999987644321    233456889999999987 788999999999999999998 8999999988


Q ss_pred             HHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 023568          154 VHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALR  229 (280)
Q Consensus       154 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~  229 (280)
                      .+....+.+...                             .+...+.+++.+.++|++||+.||++|||++|+++
T Consensus       221 ~~~~~~i~~~~~-----------------------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         221 SQILHKIDKEGE-----------------------------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             HHHHHHHHTSCC-----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHhCCC-----------------------------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            777766644111                             11223467899999999999999999999999864

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-44  Score=298.31  Aligned_cols=192  Identities=27%  Similarity=0.436  Sum_probs=164.5

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHH
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD----------------QQLTDDHCQYFLYQLLRGLKYV   64 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~----------------~~l~~~~~~~i~~qil~~l~~L   64 (280)
                      +|||||++++++.++     ..+|+|||||+ |+|.++|...                ..+++.++..++.||+.||+||
T Consensus        77 ~HpnIv~~~~~~~~~-----~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~yl  151 (299)
T d1fgka_          77 KHKNIINLLGACTQD-----GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL  151 (299)
T ss_dssp             CCTTBCCEEEEECSS-----SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             CCCeEEecccccccC-----CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHh
Confidence            799999999999987     67999999997 6999999754                3589999999999999999999


Q ss_pred             HhCCccccCCCCCceEEcCCCCeEEeecccccccCCCC---ccccceeccccccccccccCCCCCcchhHHHHHHHHHHH
Q 023568           65 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEI  141 (280)
Q Consensus        65 H~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l  141 (280)
                      |+.||+||||||+|||++.++.+||+|||.++......   ......+++.|+|||.+.+ ..++.++|||||||++|||
T Consensus       152 H~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-~~y~~k~DiwS~Gvvl~el  230 (299)
T d1fgka_         152 ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEI  230 (299)
T ss_dssp             HHTTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHH
T ss_pred             hhCCEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcC-CCCCchhhhHHhHHHHHHh
Confidence            99999999999999999999999999999998654432   2345678999999999987 7899999999999999999


Q ss_pred             Hh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCC
Q 023568          142 MT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNK  220 (280)
Q Consensus       142 l~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~  220 (280)
                      ++ |.+||.+....+....+....                              .+..+...++.+.+||.+||+.||++
T Consensus       231 l~~g~~p~~~~~~~~~~~~i~~~~------------------------------~~~~p~~~~~~l~~li~~cl~~dP~~  280 (299)
T d1fgka_         231 FTLGGSPYPGVPVEELFKLLKEGH------------------------------RMDKPSNCTNELYMMMRDCWHAVPSQ  280 (299)
T ss_dssp             HTTSCCSSTTCCHHHHHHHHHTTC------------------------------CCCCCSSCCHHHHHHHHHHTCSSGGG
T ss_pred             ccCCCCCCCCCCHHHHHHHHHcCC------------------------------CCCCCccchHHHHHHHHHHccCCHhH
Confidence            98 799998877665554443211                              11223357899999999999999999


Q ss_pred             CCCHHHHhc
Q 023568          221 RITVEEALR  229 (280)
Q Consensus       221 Rpt~~ell~  229 (280)
                      |||+.|+++
T Consensus       281 Rps~~eil~  289 (299)
T d1fgka_         281 RPTFKQLVE  289 (299)
T ss_dssp             SCCHHHHHH
T ss_pred             CcCHHHHHH
Confidence            999999987

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-44  Score=303.55  Aligned_cols=193  Identities=23%  Similarity=0.317  Sum_probs=163.5

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHH
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD----------------QQLTDDHCQYFLYQLLRGLKYV   64 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~----------------~~l~~~~~~~i~~qil~~l~~L   64 (280)
                      +|||||++++++.+.     +.+|+||||++ |+|.++++..                ..+++.++..++.||+.||.||
T Consensus        69 ~HpnIv~~~~~~~~~-----~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~l  143 (309)
T d1fvra_          69 HHPNIINLLGACEHR-----GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL  143 (309)
T ss_dssp             CCTTBCCEEEEEEET-----TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHH
T ss_pred             CCCCEeeEEEEEecC-----CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhh
Confidence            699999999999987     77999999998 6999999653                5799999999999999999999


Q ss_pred             HhCCccccCCCCCceEEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhC
Q 023568           65 HSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR  144 (280)
Q Consensus        65 H~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g  144 (280)
                      |+.||+||||||+|||++.++.+||+|||+++............||..|+|||.+.+ ..++.++|||||||++|||++|
T Consensus       144 H~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSfGvil~ell~~  222 (309)
T d1fvra_         144 SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSL  222 (309)
T ss_dssp             HHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTT
T ss_pred             hcCCccccccccceEEEcCCCceEEccccccccccccccccceecCCcccchHHhcc-CCCCccceeehhHHHHHHHHhc
Confidence            999999999999999999999999999999987665544456678999999999987 7789999999999999999996


Q ss_pred             -CCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCC
Q 023568          145 -EPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRIT  223 (280)
Q Consensus       145 -~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt  223 (280)
                       .+||.+.+..+....+.+.                              ..+..+..+++.+.+||++||+.||++|||
T Consensus       223 ~~~p~~~~~~~~~~~~i~~~------------------------------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs  272 (309)
T d1fvra_         223 GGTPYCGMTCAELYEKLPQG------------------------------YRLEKPLNCDDEVYDLMRQCWREKPYERPS  272 (309)
T ss_dssp             SCCTTTTCCHHHHHHHGGGT------------------------------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCC
T ss_pred             CCCCCCCCCHHHHHHHHHhc------------------------------CCCCCCccCCHHHHHHHHHHcCCChhHCcC
Confidence             5678887766655544321                              011223457899999999999999999999


Q ss_pred             HHHHhcC
Q 023568          224 VEEALRH  230 (280)
Q Consensus       224 ~~ell~h  230 (280)
                      ++|++++
T Consensus       273 ~~eil~~  279 (309)
T d1fvra_         273 FAQILVS  279 (309)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            9999987

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-44  Score=295.47  Aligned_cols=193  Identities=22%  Similarity=0.358  Sum_probs=155.3

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD--QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPS   77 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~   77 (280)
                      |+|||||++++++.++.    +.+|+||||++ |+|.+++.+.  ..+++..++.++.||+.||.|||+.+|+||||||+
T Consensus        57 l~HpnIv~~~g~~~~~~----~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~  132 (262)
T d1byga_          57 LRHSNLVQLLGVIVEEK----GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAAR  132 (262)
T ss_dssp             CCCTTBCCEEEEECCC------CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             CCCCCEeeEEEEEEecC----CcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchH
Confidence            68999999999886532    45899999997 6999999654  35999999999999999999999999999999999


Q ss_pred             ceEEcCCCCeEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 023568           78 NLLLNASCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYVHQ  156 (280)
Q Consensus        78 Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~~~  156 (280)
                      ||+++.++.++|+|||+++.....  .....++..|+|||.+.+ ..++.++|||||||++|||++ |++||...+..+.
T Consensus       133 Nil~~~~~~~kl~dfg~s~~~~~~--~~~~~~~~~y~aPE~l~~-~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~  209 (262)
T d1byga_         133 NVLVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV  209 (262)
T ss_dssp             GEEECTTSCEEECCCCC--------------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH
T ss_pred             hheecCCCCEeecccccceecCCC--CccccccccCCChHHHhC-CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHH
Confidence            999999999999999999875543  334567889999999987 788999999999999999998 7888888766555


Q ss_pred             HHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 023568          157 LRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  230 (280)
Q Consensus       157 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~h  230 (280)
                      ...+.+                              ...+...+..++.+.+||++||+.||.+|||+.+++++
T Consensus       210 ~~~i~~------------------------------~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         210 VPRVEK------------------------------GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             HHHHTT------------------------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHc------------------------------CCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            544422                              11122334678999999999999999999999999873

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-44  Score=302.27  Aligned_cols=194  Identities=22%  Similarity=0.304  Sum_probs=159.8

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      |+|||||++++++.++      ..+++||++. |+|.+.+.. ...+++..+..++.||+.||+|||++||+||||||+|
T Consensus        68 l~HpnIv~l~g~~~~~------~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~N  141 (317)
T d1xkka_          68 VDNPHVCRLLGICLTS------TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARN  141 (317)
T ss_dssp             CCCTTBCCEEEEEESS------SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             CCCCCEeeEEEEEecC------CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhc
Confidence            6899999999999865      3677778776 699887765 4679999999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCCc---cccceeccccccccccccCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023568           79 LLLNASCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMT-REPLFPGKDYV  154 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~-g~~pf~~~~~~  154 (280)
                      ||++.++.+||+|||+++.......   .....||+.|+|||.+.+ ..++.++|||||||++|||++ |.+||.+.+..
T Consensus       142 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~  220 (317)
T d1xkka_         142 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS  220 (317)
T ss_dssp             EEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG
T ss_pred             ceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhc-CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH
Confidence            9999999999999999987544322   233467999999999987 788999999999999999998 89999887755


Q ss_pred             HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 023568          155 HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRHP  231 (280)
Q Consensus       155 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~hp  231 (280)
                      +....+.+..                              ....++..++.+.+++.+||+.||.+|||+.|+++|.
T Consensus       221 ~~~~~i~~~~------------------------------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l  267 (317)
T d1xkka_         221 EISSILEKGE------------------------------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF  267 (317)
T ss_dssp             GHHHHHHHTC------------------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHcCC------------------------------CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence            5444443311                              1122245789999999999999999999999999873

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2e-43  Score=295.37  Aligned_cols=193  Identities=21%  Similarity=0.323  Sum_probs=162.4

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCC------------------------CCCHHHHHHHHH
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ------------------------QLTDDHCQYFLY   55 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~------------------------~l~~~~~~~i~~   55 (280)
                      |+||||+++++++...     ...++||||++ |+|.+++....                        .+++..+..++.
T Consensus        73 l~h~niv~~~~~~~~~-----~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~  147 (301)
T d1lufa_          73 FDNPNIVKLLGVCAVG-----KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIAR  147 (301)
T ss_dssp             CCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHH
T ss_pred             cCCCCcccceeeeccC-----CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHH
Confidence            6899999999999987     67999999997 69999986422                        389999999999


Q ss_pred             HHHHHHHHHHhCCccccCCCCCceEEcCCCCeEEeecccccccCCC---CccccceeccccccccccccCCCCCcchhHH
Q 023568           56 QLLRGLKYVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET---DFMTEYVVTRWYRAPELLLNCTEYTAAIDIW  132 (280)
Q Consensus        56 qil~~l~~LH~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dvw  132 (280)
                      |++.||+|||++|++||||||+|||++.++.+||+|||+++.....   .......+++.|+|||.+.+ ..++.++|||
T Consensus       148 qi~~gl~ylH~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~t~ksDVw  226 (301)
T d1lufa_         148 QVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVW  226 (301)
T ss_dssp             HHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHH
T ss_pred             HHHHHhhhcccCCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc-CCCChhhhhc
Confidence            9999999999999999999999999999999999999999754332   22335678899999999987 7899999999


Q ss_pred             HHHHHHHHHHhCC-CCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHH
Q 023568          133 SVGCILGEIMTRE-PLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLE  211 (280)
Q Consensus       133 slG~~l~~ll~g~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~  211 (280)
                      ||||++|||++|. +||.+.+..+....+.+.                              ..+..+..+++++.+||.
T Consensus       227 S~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~------------------------------~~~~~p~~~~~~~~~li~  276 (301)
T d1lufa_         227 AYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDG------------------------------NILACPENCPLELYNLMR  276 (301)
T ss_dssp             HHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT------------------------------CCCCCCTTCCHHHHHHHH
T ss_pred             cchhhHHHHHccCCCCCCCCCHHHHHHHHHcC------------------------------CCCCCCccchHHHHHHHH
Confidence            9999999999985 788888777666655431                              112233467899999999


Q ss_pred             HhcccCCCCCCCHHHHhc
Q 023568          212 KMLVFDPNKRITVEEALR  229 (280)
Q Consensus       212 ~~L~~dp~~Rpt~~ell~  229 (280)
                      +||+.||++|||+.|+++
T Consensus       277 ~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         277 LCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             HHTCSSGGGSCCHHHHHH
T ss_pred             HHcCCChhHCcCHHHHHH
Confidence            999999999999999965

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-43  Score=295.39  Aligned_cols=193  Identities=24%  Similarity=0.345  Sum_probs=162.7

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCC------------------CCCHHHHHHHHHHHHHHHH
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQ------------------QLTDDHCQYFLYQLLRGLK   62 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~------------------~l~~~~~~~i~~qil~~l~   62 (280)
                      +|||||++++++.+.     ..+|+|||||+ |+|.++++...                  .+++..+..++.||+.||+
T Consensus        85 ~HpnIv~~~g~~~~~-----~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~  159 (311)
T d1t46a_          85 NHMNIVNLLGACTIG-----GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMA  159 (311)
T ss_dssp             CCTTBCCEEEEECSS-----SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHH
T ss_pred             CCCCEEEEEEEEeeC-----CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHH
Confidence            699999999999987     67999999997 59999987533                  5999999999999999999


Q ss_pred             HHHhCCccccCCCCCceEEcCCCCeEEeecccccccCCC---CccccceeccccccccccccCCCCCcchhHHHHHHHHH
Q 023568           63 YVHSASVLHRDLKPSNLLLNASCDLKIGDFGLARTTSET---DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILG  139 (280)
Q Consensus        63 ~LH~~~i~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~  139 (280)
                      |||++|++||||||+||+++.++.++++|||.++.....   .......||+.|+|||.+.+ ..++.++|||||||++|
T Consensus       160 ~LH~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwS~G~~l~  238 (311)
T d1t46a_         160 FLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLW  238 (311)
T ss_dssp             HHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHH
T ss_pred             HHHhCCeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC-CCCCCcccccchHHHHH
Confidence            999999999999999999999999999999999875543   22345688999999999987 78899999999999999


Q ss_pred             HHHh-CCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCC
Q 023568          140 EIMT-REPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDP  218 (280)
Q Consensus       140 ~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp  218 (280)
                      ||++ |.+||.+.+....+.++.....                             .+......++.+.+||.+||+.||
T Consensus       239 ellt~g~p~~~~~~~~~~~~~~i~~~~-----------------------------~~~~~~~~~~~l~~Li~~cl~~dP  289 (311)
T d1t46a_         239 ELFSLGSSPYPGMPVDSKFYKMIKEGF-----------------------------RMLSPEHAPAEMYDIMKTCWDADP  289 (311)
T ss_dssp             HHHTTTCCSSTTCCSSHHHHHHHHHTC-----------------------------CCCCCTTSCHHHHHHHHHHTCSSG
T ss_pred             HHHhCCCCCCCCCCHHHHHHHHHhcCC-----------------------------CCCCcccccHHHHHHHHHHcCCCh
Confidence            9998 7777877765555544433111                             111223568999999999999999


Q ss_pred             CCCCCHHHHhc
Q 023568          219 NKRITVEEALR  229 (280)
Q Consensus       219 ~~Rpt~~ell~  229 (280)
                      .+|||++|+++
T Consensus       290 ~~RPs~~~il~  300 (311)
T d1t46a_         290 LKRPTFKQIVQ  300 (311)
T ss_dssp             GGSCCHHHHHH
T ss_pred             hHCcCHHHHHH
Confidence            99999999986

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-42  Score=290.68  Aligned_cols=199  Identities=24%  Similarity=0.383  Sum_probs=167.6

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD----------QQLTDDHCQYFLYQLLRGLKYVHSASV   69 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~----------~~l~~~~~~~i~~qil~~l~~LH~~~i   69 (280)
                      ++|||||++++++..+     ...++|||||. |+|.+++...          ..+++..+..++.|++.||.|||+++|
T Consensus        80 l~h~nIv~~~~~~~~~-----~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~i  154 (308)
T d1p4oa_          80 FNCHHVVRLLGVVSQG-----QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKF  154 (308)
T ss_dssp             CCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             cCCCCEeeeeeEEecC-----CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCe
Confidence            5899999999999877     67999999997 6999988532          347999999999999999999999999


Q ss_pred             cccCCCCCceEEcCCCCeEEeecccccccCCCC---ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhC-C
Q 023568           70 LHRDLKPSNLLLNASCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTR-E  145 (280)
Q Consensus        70 ~H~dik~~Nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g-~  145 (280)
                      +||||||+|||++.++.+||+|||+++......   ......+|+.|+|||.+.+ ..++.++|||||||++|||++| .
T Consensus       155 vHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~-~~~~~~~Dv~S~G~il~El~t~~~  233 (308)
T d1p4oa_         155 VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAE  233 (308)
T ss_dssp             BCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSC
T ss_pred             eeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHcc-CCCCcccccccHHHHHHHHHhCCC
Confidence            999999999999999999999999998654432   2344578999999999987 7788999999999999999997 5


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 023568          146 PLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVE  225 (280)
Q Consensus       146 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~  225 (280)
                      +||.+.+..+.+..+.+..                              .....+..++.+.++|.+||+.||.+|||++
T Consensus       234 ~p~~~~~~~~~~~~i~~~~------------------------------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~  283 (308)
T d1p4oa_         234 QPYQGLSNEQVLRFVMEGG------------------------------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFL  283 (308)
T ss_dssp             CTTTTSCHHHHHHHHHTTC------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCCCCCHHHHHHHHHhCC------------------------------CCCCcccchHHHHHHHHHHcCCChhHCcCHH
Confidence            8898887776666554311                              1122346789999999999999999999999


Q ss_pred             HHhc------Cccccc
Q 023568          226 EALR------HPYLQS  235 (280)
Q Consensus       226 ell~------hp~~~~  235 (280)
                      ++++      +|+|++
T Consensus       284 ~il~~L~~~~~~~~~~  299 (308)
T d1p4oa_         284 EIISSIKEEMEPGFRE  299 (308)
T ss_dssp             HHHHHHGGGSCTTHHH
T ss_pred             HHHHHHHHhcCCCCcC
Confidence            9997      666654

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-42  Score=288.59  Aligned_cols=195  Identities=24%  Similarity=0.321  Sum_probs=156.7

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      |+|||||++++++....    +..++|||||+ |+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|
T Consensus        85 l~HpnIv~~~g~~~~~~----~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~N  160 (311)
T d1r0pa_          85 FSHPNVLSLLGICLRSE----GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARN  160 (311)
T ss_dssp             CCCTTBCCCCEEEEETT----TEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             CCCCCEeEEeEEEEecC----CceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHh
Confidence            68999999999976431    56999999998 5999988754 468899999999999999999999999999999999


Q ss_pred             eEEcCCCCeEEeecccccccCCCC-----ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-
Q 023568           79 LLLNASCDLKIGDFGLARTTSETD-----FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPGKD-  152 (280)
Q Consensus        79 ili~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~~~-  152 (280)
                      ||++.++.+||+|||+++......     ......||..|+|||.+.+ ..++.++||||||+++|||++|..||.... 
T Consensus       161 ILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~SfGivl~El~t~~~p~~~~~~  239 (311)
T d1r0pa_         161 CMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVN  239 (311)
T ss_dssp             EEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCC---
T ss_pred             EeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhc-CCCCChhHhhhhHHHHHHHHHCCCCCCCCCC
Confidence            999999999999999998654332     1233567899999999887 788999999999999999999777765543 


Q ss_pred             hHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 023568          153 YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVEEALRH  230 (280)
Q Consensus       153 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~ell~h  230 (280)
                      ..+....+..  +                            ..+..++..++.+.+|+.+||+.||++|||+.|+++|
T Consensus       240 ~~~~~~~i~~--g----------------------------~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         240 TFDITVYLLQ--G----------------------------RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             ---CHHHHHT--T----------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHc--C----------------------------CCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            2222222211  0                            0111223578899999999999999999999999987

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-41  Score=284.37  Aligned_cols=215  Identities=19%  Similarity=0.249  Sum_probs=152.9

Q ss_pred             CCCcccccccccccCCCCCCCCcEEEEEecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh--------CCccc
Q 023568            1 MEHENVIAIKDIIRPPKKDTFNDVYIVYELMD-TDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHS--------ASVLH   71 (280)
Q Consensus         1 l~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~--------~~i~H   71 (280)
                      ++|||||++++++.+... ....+|+|||||. |+|.+++++ .++++.++..++.|++.||+|||+        +||+|
T Consensus        54 ~~HpnIv~~~~~~~~~~~-~~~~~~lv~Ey~~~g~L~~~l~~-~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvH  131 (303)
T d1vjya_          54 LRHENILGFIAADNKDNG-TWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAH  131 (303)
T ss_dssp             CCCTTBCCEEEEEEEECS-SSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEEC
T ss_pred             CCCCcCcceEEEEEeCCC-cceEEEEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeec
Confidence            589999999999986532 1146899999997 699999986 579999999999999999999996        59999


Q ss_pred             cCCCCCceEEcCCCCeEEeecccccccCCCC-----ccccceeccccccccccccCC-----CCCcchhHHHHHHHHHHH
Q 023568           72 RDLKPSNLLLNASCDLKIGDFGLARTTSETD-----FMTEYVVTRWYRAPELLLNCT-----EYTAAIDIWSVGCILGEI  141 (280)
Q Consensus        72 ~dik~~Nili~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~-----~~~~~~DvwslG~~l~~l  141 (280)
                      |||||+|||++.++.+||+|||+++......     ......||+.|+|||.+.+..     .++.++|||||||++|||
T Consensus       132 rDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el  211 (303)
T d1vjya_         132 RDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI  211 (303)
T ss_dssp             SCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHH
T ss_pred             cccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHH
Confidence            9999999999999999999999998654321     223467899999999986522     246689999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhC-CccccccccccCC--CCCHHHHHHHHHhcccCC
Q 023568          142 MTREPLFPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQL-PRCRKQQFATRFP--NKSSGAVDLLEKMLVFDP  218 (280)
Q Consensus       142 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~--~~~~~~~~ll~~~L~~dp  218 (280)
                      ++|..||.......          .+...  ............... .....+..+....  .....+.+++.+||+.||
T Consensus       212 ~tg~~~~~~~~~~~----------~~~~~--~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp  279 (303)
T d1vjya_         212 ARRCSIGGIHEDYQ----------LPYYD--LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANG  279 (303)
T ss_dssp             HHTBCBTTBCCCCC----------CTTTT--TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSG
T ss_pred             hhCCCCCCcccccc----------cchhh--cccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCH
Confidence            99988775432100          00000  000001111111111 1111111111111  123458899999999999


Q ss_pred             CCCCCHHHHhc
Q 023568          219 NKRITVEEALR  229 (280)
Q Consensus       219 ~~Rpt~~ell~  229 (280)
                      ++|||+.|+++
T Consensus       280 ~~Rps~~ei~~  290 (303)
T d1vjya_         280 AARLTALRIKK  290 (303)
T ss_dssp             GGSCCHHHHHH
T ss_pred             hHCcCHHHHHH
Confidence            99999999986

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-40  Score=278.04  Aligned_cols=206  Identities=17%  Similarity=0.198  Sum_probs=156.4

Q ss_pred             CCCccccc-ccccccCCCCCCCCcEEEEEecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 023568            1 MEHENVIA-IKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRS-DQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSN   78 (280)
Q Consensus         1 l~Hpniv~-l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~N   78 (280)
                      ++|+|+|. +.+++.+.     ...++||||+++++.+.+.. .+.+++..+..++.|++.||+|||++||+||||||+|
T Consensus        59 l~~~~~i~~~~~~~~~~-----~~~~ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~N  133 (299)
T d1ckia_          59 MQGGVGIPTIRWCGAEG-----DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDN  133 (299)
T ss_dssp             STTSTTCCCEEEEEEET-----TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred             ccCCCcccEEEEEEecC-----CEEEEEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhh
Confidence            45666554 55555555     67999999999988877654 5689999999999999999999999999999999999


Q ss_pred             eEEcC---CCCeEEeecccccccCCCC--------ccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCC
Q 023568           79 LLLNA---SCDLKIGDFGLARTTSETD--------FMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPL  147 (280)
Q Consensus        79 ili~~---~~~~kl~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~p  147 (280)
                      ||++.   +..++|+|||+++......        ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.|
T Consensus       134 Il~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~el~tg~~P  212 (299)
T d1ckia_         134 FLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLP  212 (299)
T ss_dssp             EEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTT-BCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred             ccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhC-CCCCChhhEEecCHHHHHHHhCCCc
Confidence            99853   5579999999998654321        2245679999999999987 7789999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHH--
Q 023568          148 FPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVE--  225 (280)
Q Consensus       148 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~--  225 (280)
                      |...........+.....                       .....+.+...+.+|+++.+++.+||+.||++||+++  
T Consensus       213 ~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i  269 (299)
T d1ckia_         213 WQGLKAATKRQKYERISE-----------------------KKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYL  269 (299)
T ss_dssp             TCCCC-------HHHHHH-----------------------HHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHH
T ss_pred             ccccchHHHHHHHHHhhc-----------------------ccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence            988765443333222100                       0001112233456799999999999999999999987  


Q ss_pred             -HHhcCccccc
Q 023568          226 -EALRHPYLQS  235 (280)
Q Consensus       226 -ell~hp~~~~  235 (280)
                       ++|+|+|.+.
T Consensus       270 ~~~l~~~~~~~  280 (299)
T d1ckia_         270 RQLFRNLFHRQ  280 (299)
T ss_dssp             HHHHHHHHHHH
T ss_pred             HHHHHHHHHHc
Confidence             5577877644

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.1e-39  Score=271.40  Aligned_cols=195  Identities=13%  Similarity=0.134  Sum_probs=158.9

Q ss_pred             CcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE
Q 023568            3 HENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSD-QQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL   81 (280)
Q Consensus         3 Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nili   81 (280)
                      |+||+++++++...     ...|+||||++++|.++++.. ..+++.++..++.|++.||.|||++||+||||||+||++
T Consensus        60 ~~~i~~~~~~~~~~-----~~~~~vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili  134 (293)
T d1csna_          60 CTGIPNVYYFGQEG-----LHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLI  134 (293)
T ss_dssp             CTTCCCEEEEEEET-----TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE
T ss_pred             CCCCCEEEEEeecC-----CccEEEEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceee
Confidence            59999999999887     779999999999999998764 579999999999999999999999999999999999999


Q ss_pred             cC-----CCCeEEeecccccccCCC--------CccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 023568           82 NA-----SCDLKIGDFGLARTTSET--------DFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLF  148 (280)
Q Consensus        82 ~~-----~~~~kl~dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf  148 (280)
                      +.     ++.++|+|||+++.....        .......||+.|+|||++.+ ..++.++|+|||||++|+|++|..||
T Consensus       135 ~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~Pf  213 (293)
T d1csna_         135 GRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPW  213 (293)
T ss_dssp             CCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             cCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcC-CCCChHHHHHHhhHHHHHHHhCCCcC
Confidence            64     577999999999865432        12234679999999999987 77899999999999999999999999


Q ss_pred             CCCChH---HHHHHHHHHhCCCCcccccccCChhHHHHHHhCCccccccccccCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 023568          149 PGKDYV---HQLRLITELIGSPDDASLGFLRSDNARRYVRQLPRCRKQQFATRFPNKSSGAVDLLEKMLVFDPNKRITVE  225 (280)
Q Consensus       149 ~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~L~~dp~~Rpt~~  225 (280)
                      .+....   ....++.....                          ........+.+++++.+++..|+..+|++||+.+
T Consensus       214 ~~~~~~~~~~~~~~i~~~~~--------------------------~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~  267 (293)
T d1csna_         214 QGLKAATNKQKYERIGEKKQ--------------------------STPLRELCAGFPEEFYKYMHYARNLAFDATPDYD  267 (293)
T ss_dssp             SSCCSCCHHHHHHHHHHHHH--------------------------HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHH
T ss_pred             CCccchhHHHHHHHHHhccC--------------------------CCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHH
Confidence            876432   22222222100                          1111223456789999999999999999999988


Q ss_pred             HHhc
Q 023568          226 EALR  229 (280)
Q Consensus       226 ell~  229 (280)
                      .+.+
T Consensus       268 ~l~~  271 (293)
T d1csna_         268 YLQG  271 (293)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            7654

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=6.9e-40  Score=280.80  Aligned_cols=231  Identities=26%  Similarity=0.407  Sum_probs=166.9

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCC--ccHHHHH--HcCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCC
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMD--TDLHQII--RSDQQLTDDHCQYFLYQLLRGLKYVHS-ASVLHRDLKP   76 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~--g~L~~~l--~~~~~l~~~~~~~i~~qil~~l~~LH~-~~i~H~dik~   76 (280)
                      .||||+++++++.....   ...+++|+++.  ++.....  .....+++..++.++.||+.||+|||+ .||+||||||
T Consensus        78 ~~~~iv~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp  154 (362)
T d1q8ya_          78 GANHILKLLDHFNHKGP---NGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKP  154 (362)
T ss_dssp             HHTTBCCCCEEEEEEET---TEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSG
T ss_pred             CcCceEEEEEEeeeccc---cceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCCh
Confidence            47999999999976533   45666666664  3443333  345689999999999999999999998 8999999999


Q ss_pred             CceEEcCCCC------eEEeecccccccCCCCccccceeccccccccccccCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 023568           77 SNLLLNASCD------LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILGEIMTREPLFPG  150 (280)
Q Consensus        77 ~Nili~~~~~------~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ll~g~~pf~~  150 (280)
                      +|||++.++.      ++++|||.+......  .....||+.|+|||++.+ ..++.++|+||+||++++|++|+.||.+
T Consensus       155 ~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pF~~  231 (362)
T d1q8ya_         155 ENVLMEIVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEP  231 (362)
T ss_dssp             GGEEEEEEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred             hHeeeeccCcccccceeeEeecccccccccc--cccccccccccChhhccc-cCCCccccccchHHHHHHHHHCCCCCCC
Confidence            9999987653      899999998765433  356789999999999987 7788999999999999999999999986


Q ss_pred             CC------hHHHHHHHHHHhCCCCcccccccCChhHHHHHHh------CCcccccc-------ccccCCCCCHHHHHHHH
Q 023568          151 KD------YVHQLRLITELIGSPDDASLGFLRSDNARRYVRQ------LPRCRKQQ-------FATRFPNKSSGAVDLLE  211 (280)
Q Consensus       151 ~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~-------~~~~~~~~~~~~~~ll~  211 (280)
                      .+      ....+......++.++.........  ...+...      ........       .....+..++.+++||.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~  309 (362)
T d1q8ya_         232 DEGHSYTKDDDHIAQIIELLGELPSYLLRNGKY--TRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS  309 (362)
T ss_dssp             -------CHHHHHHHHHHHHCSCCHHHHHHCTT--HHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHG
T ss_pred             CccccccchhHHHHHHHHHhCCCCHHHhhcccc--cccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHH
Confidence            54      2455666677777765543321111  0110000      00000000       00111235788999999


Q ss_pred             HhcccCCCCCCCHHHHhcCcccccCcCCC
Q 023568          212 KMLVFDPNKRITVEEALRHPYLQSLHDLN  240 (280)
Q Consensus       212 ~~L~~dp~~Rpt~~ell~hp~~~~~~~~~  240 (280)
                      +||+.||.+|||++|+|+||||++....+
T Consensus       310 ~mL~~dP~~Rpta~e~L~Hp~f~~~~~~~  338 (362)
T d1q8ya_         310 PMLQLDPRKRADAGGLVNHPWLKDTLGME  338 (362)
T ss_dssp             GGGCSSTTTCBCHHHHHTCGGGTTCTTCT
T ss_pred             HHCCCChhHCcCHHHHhcCcccCCCCCcc
Confidence            99999999999999999999999665443

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.68  E-value=3.8e-18  Score=131.74  Aligned_cols=116  Identities=17%  Similarity=0.139  Sum_probs=79.0

Q ss_pred             CCcccccccccccCCCCCCCCcEEEEEecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE
Q 023568            2 EHENVIAIKDIIRPPKKDTFNDVYIVYELMDTDLHQIIRSDQQLTDDHCQYFLYQLLRGLKYVHSASVLHRDLKPSNLLL   81 (280)
Q Consensus         2 ~Hpniv~l~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dik~~Nili   81 (280)
                      .|+++++.+++.         ..+++|||+++...      ..++...+..++.|++.+|+|||++||+||||||+|||+
T Consensus        72 ~~~~v~~~~~~~---------~~~lvme~~~~~~~------~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv  136 (191)
T d1zara2          72 QGLAVPKVYAWE---------GNAVLMELIDAKEL------YRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLV  136 (191)
T ss_dssp             TTSSSCCEEEEE---------TTEEEEECCCCEEG------GGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE
T ss_pred             cCCCcceEEEec---------CCEEEEEeeccccc------cchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheee
Confidence            466666665542         13799999987321      235566678899999999999999999999999999999


Q ss_pred             cCCCCeEEeecccccccCCCCcccccee-ccccccccccccCCCCCcchhHHHHHHH
Q 023568           82 NASCDLKIGDFGLARTTSETDFMTEYVV-TRWYRAPELLLNCTEYTAAIDIWSVGCI  137 (280)
Q Consensus        82 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~-~~~y~aPE~~~~~~~~~~~~DvwslG~~  137 (280)
                      +.++ ++|+|||.+.....+... .... ... .-.+.+ . ..++.++|+||+.--
T Consensus       137 ~~~~-~~liDFG~a~~~~~~~~~-~~l~rd~~-~~~~~f-~-r~y~~~~d~~s~~~~  188 (191)
T d1zara2         137 SEEG-IWIIDFPQSVEVGEEGWR-EILERDVR-NIITYF-S-RTYRTEKDINSAIDR  188 (191)
T ss_dssp             ETTE-EEECCCTTCEETTSTTHH-HHHHHHHH-HHHHHH-H-HHHCCCCCHHHHHHH
T ss_pred             eCCC-EEEEECCCcccCCCCCcH-HHHHHHHH-HHHHHH-c-CCCCCcccHHHHHHH
Confidence            8654 899999998765533211 0000 000 001112 1 467788999997543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=97.38  E-value=0.00011  Score=57.51  Aligned_cols=28  Identities=25%  Similarity=0.266  Sum_probs=24.1

Q ss_pred             ccccCCCCCceEEcCCCCeEEeeccccc
Q 023568           69 VLHRDLKPSNLLLNASCDLKIGDFGLAR   96 (280)
Q Consensus        69 i~H~dik~~Nili~~~~~~kl~dfg~~~   96 (280)
                      ++|+|+.+.||+++.++..-|+||+.+.
T Consensus       185 l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         185 FSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             EECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             EEEeeccCcceeecCCceEEEeechhcc
Confidence            7899999999999977666799998764

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=96.45  E-value=0.001  Score=51.39  Aligned_cols=29  Identities=21%  Similarity=0.126  Sum_probs=24.8

Q ss_pred             ccccCCCCCceEEcCCCCeEEeecccccc
Q 023568           69 VLHRDLKPSNLLLNASCDLKIGDFGLART   97 (280)
Q Consensus        69 i~H~dik~~Nili~~~~~~kl~dfg~~~~   97 (280)
                      ++|+|+.+.||+++.+..+-|+||+.+..
T Consensus       177 liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         177 VTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             EECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             EEeCCCCCcceEEeCCceEEEEEchhccc
Confidence            79999999999999876677999987643

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=96.16  E-value=0.0027  Score=52.54  Aligned_cols=30  Identities=20%  Similarity=0.245  Sum_probs=25.6

Q ss_pred             CccccCCCCCceEEcCCCCeEEeeccccccc
Q 023568           68 SVLHRDLKPSNLLLNASCDLKIGDFGLARTT   98 (280)
Q Consensus        68 ~i~H~dik~~Nili~~~~~~kl~dfg~~~~~   98 (280)
                      .++|||+.+.||+++.++ ++++||..+...
T Consensus       224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~~G  253 (392)
T d2pula1         224 TLIHGDLHTGSIFASEHE-TKVIDPEFAFYG  253 (392)
T ss_dssp             EEECSCCCGGGEEECSSC-EEECCCTTCEEE
T ss_pred             ceeccCCcCCceeEcCCc-eEEechhhcccC
Confidence            589999999999998765 899999887543

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=94.63  E-value=0.0041  Score=49.62  Aligned_cols=30  Identities=30%  Similarity=0.287  Sum_probs=26.4

Q ss_pred             CCccccCCCCCceEEcCCCCeEEeeccccc
Q 023568           67 ASVLHRDLKPSNLLLNASCDLKIGDFGLAR   96 (280)
Q Consensus        67 ~~i~H~dik~~Nili~~~~~~kl~dfg~~~   96 (280)
                      .|++|+|+.++||+++.+...-++||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            469999999999999988777899999764

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=93.01  E-value=0.06  Score=42.81  Aligned_cols=29  Identities=28%  Similarity=0.280  Sum_probs=23.4

Q ss_pred             CCccccCCCCCceEEcCCCCeEEeecccccc
Q 023568           67 ASVLHRDLKPSNLLLNASCDLKIGDFGLART   97 (280)
Q Consensus        67 ~~i~H~dik~~Nili~~~~~~kl~dfg~~~~   97 (280)
                      .+++|+|+.+.|||++.+  ..++||+-+..
T Consensus       192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ceeecCCCCcccEEEeCC--ceEEechhccc
Confidence            358999999999999743  45899997754

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=85.58  E-value=0.14  Score=41.81  Aligned_cols=15  Identities=40%  Similarity=0.629  Sum_probs=13.3

Q ss_pred             ccccCCCCCceEEcC
Q 023568           69 VLHRDLKPSNLLLNA   83 (280)
Q Consensus        69 i~H~dik~~Nili~~   83 (280)
                      +||+|+.+.||++..
T Consensus       220 ~CHnDL~~~NiL~~~  234 (395)
T d1nw1a_         220 FCHNDLQEGNILLPK  234 (395)
T ss_dssp             EECSCCCGGGEEEEC
T ss_pred             EEecCCCcccEeecc
Confidence            689999999999854